PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Xia, Y; Yang, WW; Bu, W; Ji, HT; Zhao, XQ; Zheng, YH; Lin, X; Li, Y; Lu, ZM				Xia, Yan; Yang, Weiwei; Bu, Wen; Ji, Haitao; Zhao, Xueqiang; Zheng, Yanhua; Lin, Xin; Li, Yi; Lu, Zhimin			Differential Regulation of c-Jun Protein Plays an Instrumental Role in Chemoresistance of Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; TRANSCRIPTION FACTOR; DOWN-REGULATION; OSMOTIC-STRESS; P53 ACTIVITY; DNA-BINDING; IN-VIVO; AP-1; APOPTOSIS; DEGRADATION	The chemotherapeutic drug cisplatin (cis-diamminedichloro-platinum(II) (CDDP)) is widely used in the treatment of human cancers. However, the mechanism underlying intrinsic tumor resistance to CDDP remains elusive. Here, we demonstrate that treatment with CDDP resulted in down-regulation of c-Jun expression via caspase-9-dependent cleavage of c-Jun at Asp-65 and MEKK1-mediated ubiquitylation and degradation of c-Jun in CDDP-sensitive cancer cells. In contrast, activation of JNK2 (but not JNK1) phosphorylated and up-regulated the expression of c-Jun in CDDP-resistant cells. Activated c-Jun bound to the promoter regions of the MDR1 gene and promoted the expression of MDR1. Expression of a cleavage-resistant c-Jun mutant (D65A) suppressed CDDP-induced apoptosis of CDDP-sensitive cells, whereas depletion of JNK2, c-Jun, or MDR1 in CDDP-resistant cancer cells promoted apoptosis upon CDDP treatment. In addition, mammary gland tumors induced by polyomavirus middle T antigen in JNK2(-/-) mice were more sensitive to CDDP compared with those in JNK2(+/+) mice. These findings highlight the instrumental role of c-Jun in the resistance of tumors to treatment with CDDP and indicate that c-Jun is a molecular target for improving cancer therapy.	[Xia, Yan; Yang, Weiwei; Ji, Haitao; Zheng, Yanhua; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Xia, Yan; Yang, Weiwei; Ji, Haitao; Zheng, Yanhua; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Zhao, Xueqiang; Lin, Xin; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xia, Yan] Nanjing Univ, Model Anim Res Ctr, Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Bu, Wen; Li, Yi] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Bu, Wen; Li, Yi] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Lin, Xin; Lu, Zhimin] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Nanjing University; Baylor College of Medicine; Baylor College of Medicine	Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA.	zhiminlu@mdanderson.org	yang, zheng/HGC-7753-2022; Ji, Haitao/L-1615-2013; Li, Yi/A-7635-2009	Li, Yi/0000-0002-9976-518X	National Institutes of Health [2R01 CA109035, 1R01 CA169603]; NCI [R01 CA124820, CA016672]; Ministry of Science and Technology of China [2009CB918703]; Cancer Prevention and Research Institute of Texas, American Cancer Society Research Scholar Award [RP110252]; James S. McDonnell Foundation; Sister Institution Network Fund of The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA109035, P30CA016672, R01CA169603, R01CA124820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Cancer Prevention and Research Institute of Texas, American Cancer Society Research Scholar Award; James S. McDonnell Foundation; Sister Institution Network Fund of The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01 CA109035 and 1R01 CA169603 (to Z. L.), R01 CA124820 (to Y. L.), and CA016672 (to The University of Texas MD Anderson Cancer Center) from NCI. This work was also supported by 973 Project 2009CB918703 from the Ministry of Science and Technology of China (to Y. X.) and by Research Grant RP110252 from the Cancer Prevention and Research Institute of Texas, American Cancer Society Research Scholar Award RSG-09277-01-CSM, a research grant from the James S. McDonnell Foundation, and the Sister Institution Network Fund of The University of Texas MD Anderson Cancer Center (to Z. L.).	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOS TJ, 1988, CELL, V52, P705, DOI 10.1016/0092-8674(88)90408-4; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bu W, 2009, J MAMMARY GLAND BIOL, V14, P401, DOI 10.1007/s10911-009-9154-4; Chen HH, 2009, MOL CELL BIOL, V29, P3657, DOI 10.1128/MCB.01640-08; Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443; Cui W, 2000, MOL CARCINOGEN, V29, P219, DOI 10.1002/1098-2744(200012)29:4<219::AID-MC1004>3.0.CO;2-D; Daschner PJ, 1999, BREAST CANCER RES TR, V53, P229, DOI 10.1023/A:1006138803392; Du ZJ, 2006, P NATL ACAD SCI USA, V103, P17396, DOI 10.1073/pnas.0608607103; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hayakawa J, 1999, J BIOL CHEM, V274, P31648, DOI 10.1074/jbc.274.44.31648; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Kondo K, 2006, INT J CANCER, V118, P230, DOI 10.1002/ijc.21283; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Martin LP, 2008, CLIN CANCER RES, V14, P1291, DOI 10.1158/1078-0432.CCR-07-2238; McCabe JT, 2001, BRAIN RES BULL, V55, P347, DOI 10.1016/S0361-9230(01)00520-2; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; Reddy JP, 2010, P NATL ACAD SCI USA, V107, P3728, DOI 10.1073/pnas.0910665107; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; SHARP FR, 1991, J NEUROSCI, V11, P2321, DOI 10.1523/jneurosci.11-08-02321.1991; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Xia Y, 2007, MOL CELL BIOL, V27, P510, DOI 10.1128/MCB.01355-06; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	47	15	17	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19321	19329		10.1074/jbc.M113.475442	http://dx.doi.org/10.1074/jbc.M113.475442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23678002	Green Published, hybrid			2022-12-25	WOS:000321515800003
J	Yu, HC; Lin, CS; Tai, WT; Liu, CY; Shiau, CW; Chen, KF				Yu, Hui-Chuan; Lin, Chen-Si; Tai, Wei-Tien; Liu, Chun-Yu; Shiau, Chung-Wai; Chen, Kuen-Feng			Nilotinib Induces Autophagy in Hepatocellular Carcinoma through AMPK Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SIGNALING PATHWAYS; BCR-ABL; INHIBITOR; PP2A; PHOSPHORYLATION; SORAFENIB; IMATINIB; CELLS; TUMORIGENESIS	Hepatocellular carcinoma (HCC) is the most common liver cancer and the third-leading cause of cancer death worldwide. Nilotinib is an orally available receptor tyrosine kinase inhibitor approved for chronic myelogenous leukemia. This study investigated the effect of nilotinib on HCC. Nilotinib did not induce cellular apoptosis. Instead, staining with acridine orange and microtubule-associated protein 1 light chain 3 revealed that nilotinib induced autophagy in a dose- and time-dependent manner in HCC cell lines, including PLC5, Huh-7, and Hep3B. Moreover, nilotinib up-regulated the phosphryaltion of AMP-activated kinase (AMPK) and protein phosphatase PP2A inactivation were detected after nilotinib treatment. Up-regulating PP2A activity suppressed nilotinib-induced AMPK phosphorylation and autophagy, suggesting that PP2A mediates the effect of nilotinib on AMPK phosphorylation and autophagy. Our data indicate that nilotinib-induced AMPK activation is mediated by PP2A, and AMPK activation and subsequent autophagy might be a major mechanism of action of nilotinib. Growth of PLC5 tumor xenografts in BALB/c nude mice was inhibited by daily oral treatment with nilotinib. Western blot analysis showed both increased phospho-AMPK expression and decreased PP2A activity in vivo. Together, our results reveal that nilotinib induces autophagy, but not apoptosis in HCC, and that the autophagy-inducing activity is associated with PP2A-regulated AMPK phosphorylation.	[Yu, Hui-Chuan; Tai, Wei-Tien; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 100, Taiwan; [Yu, Hui-Chuan; Tai, Wei-Tien; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei 100, Taiwan; [Lin, Chen-Si] Natl Taiwan Univ Hosp, Sch Vet Med, Taipei 100, Taiwan; [Lin, Chen-Si] Coll Med, Taipei 100, Taiwan; [Liu, Chun-Yu; Shiau, Chung-Wai] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Liu, Chun-Yu] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chen, KF (corresponding author), 7 Chung Shan South Rd, Taipei, Taiwan.	kfchen1970@ntu.edu.tw	Lin, Chen-Si/AAD-3733-2019	Lin, Chen-Si/0000-0003-2254-8344; Chen, Kuen-Feng/0000-0002-4686-7019	National Taiwan University Hospital [NTUH 101P01]; National Science Council, Taiwan [NSC99-2314-B-002-017-MY2, NSC101-2325-B-002-032]	National Taiwan University Hospital(National Taiwan University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grants NTUH 101P01 (to K.-F. C.) from the National Taiwan University Hospital and NSC99-2314-B-002-017-MY2 (to K.-F. C.), and NSC101-2325-B-002-032 (to K.-F. C.) from the National Science Council, Taiwan.	Adnane L, 2006, METHOD ENZYMOL, V407, P597, DOI 10.1016/S0076-6879(05)07047-3; Al-Kandari FA, 2007, ANN NUCL MED, V21, P439, DOI 10.1007/s12149-007-0050-y; Allen KD, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3801; Auclair D, 2007, LEUKEMIA, V21, P439, DOI 10.1038/sj.leu.2404508; Barnard G, 2007, PRION, V1, P121, DOI 10.4161/pri.1.2.4439; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cauchi C, 2012, CANCER CHEMOTH PHARM, V69, P977, DOI 10.1007/s00280-011-1785-7; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Chen KF, 2011, MOL CANCER THER, V10, P892, DOI 10.1158/1535-7163.MCT-10-0794; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Forchap SL, 2012, LEUKEMIA, V26, P490, DOI 10.1038/leu.2011.231; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Gimeno-Alcaniz JV, 2003, J MOL BIOL, V333, P201, DOI 10.1016/j.jmb.2003.08.022; Govender VM, 2007, BIOSCI TRENDS, V1, P121; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hiwase DK, 2009, LEUKEMIA, V23, P1205, DOI 10.1038/leu.2009.45; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Italiano A, 2012, ANN SURG ONCOL, V19, P1551, DOI 10.1245/s10434-011-2120-6; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang MR, 2009, J PATHOL, V217, P702, DOI 10.1002/path.2509; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; Magnaudeix A, 2013, NEUROBIOL AGING, V34, P770, DOI 10.1016/j.neurobiolaging.2012.06.026; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Martinelli G, 2007, BIOL-TARGETS THER, V1, P121; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Quintas-Cardama A, 2008, FUTURE ONCOL, V4, P611, DOI 10.2217/14796694.4.5.611; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013662; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Weigel MT, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3191; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhou ST, 2012, CANCER LETT, V323, P115, DOI 10.1016/j.canlet.2012.02.017	49	70	71	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18249	18259		10.1074/jbc.M112.446385	http://dx.doi.org/10.1074/jbc.M112.446385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23677989	hybrid, Green Published			2022-12-25	WOS:000320721900029
J	Wen, J; Yang, HB; Zhou, B; Lou, HF; Duan, SM				Wen, Jing; Yang, Hong-Bin; Zhou, Bing; Lou, Hui-Fang; Duan, Shumin			beta-Catenin Is Critical for Cerebellar Foliation and Lamination	PLOS ONE			English	Article							GRANULE NEURON PRECURSORS; MOUSE CEREBELLUM; INT-1 PROTOONCOGENE; NERVOUS-SYSTEM; PURKINJE-CELLS; DIFFERENTIATION; EXPRESSION; MORPHOGENESIS; PROLIFERATION; COMPLEXITY	The cerebellum has a conserved foliation pattern and a well-organized layered structure. The process of foliation and lamination begins around birth. beta-catenin is a downstream molecule of Wnt signaling pathway, which plays a critical role in tissue organization. Lack of beta-catenin at early embryonic stages leads to either prenatal or neonatal death, therefore it has been difficult to resolve its role in cerebellar foliation and lamination. Here we used GFAP-Cre to ablate beta-catenin in neuronal cells of the cerebellum after embryonic day 12.5, and found an unexpected role of beta-catenin in determination of the foliation pattern. In the mutant mice, the positions of fissure formation were changed, and the meninges were improperly incorporated into fissures. At later stages, some lobules were formed by Purkinje cells remaining in deep regions of the cerebellum and the laminar structure was dramatically altered. Our results suggest that beta-catenin is critical for cerebellar foliation and lamination. We also found a non cell-autonomous role of beta-catenin in some developmental properties of major cerebellar cell types during specific stages.	[Wen, Jing; Zhou, Bing; Duan, Shumin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Wen, Jing; Zhou, Bing; Duan, Shumin] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurosci, Shanghai, Peoples R China; [Wen, Jing; Yang, Hong-Bin; Lou, Hui-Fang; Duan, Shumin] Zhejiang Univ, Sch Med, Key Lab Neurobiol Zhejiang Prov, Dept Neurobiol,Key Lab Med Neurobiol,Minist Hlth, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang University	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China.	duanshumin@zju.edu.cn	Yang, Hongbin/AAV-8689-2020; Zhou, Bing/J-3281-2015	Yang, Hongbin/0000-0001-8574-1542	Major State Basic Research Program of China [2011CB504400]; National Natural Science Foundation of China [31190060, 81221003, 30730037, 30870834]; PCSIRT	Major State Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by grants from the Major State Basic Research Program of China (2011CB504400), the National Natural Science Foundation of China (31190060; 81221003; 30730037; 30870834), and PCSIRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Basson MA, 2008, DEVELOPMENT, V135, P889, DOI 10.1242/dev.011569; Brault V, 2001, DEVELOPMENT, V128, P1253; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; Casper KB, 2007, GENESIS, V45, P292, DOI 10.1002/dvg.20287; Cheng YL, 2010, DEVELOPMENT, V137, P519, DOI 10.1242/dev.027045; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hashimoto M, 2003, J NEUROSCI, V23, P11342; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hoser M, 2007, J NEUROSCI, V27, P5495, DOI 10.1523/JNEUROSCI.1384-07.2007; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Kaemmerer WF, 2000, MOL THER, V2, P446, DOI 10.1006/mthe.2000.0134; Komuro H, 2003, CELL MOL LIFE SCI, V60, P1084, DOI 10.1007/s00018-003-2248-z; LAUDER JM, 1974, BRAIN RES, V76, P33, DOI 10.1016/0006-8993(74)90511-3; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Lorenz A, 2011, MOL CELL BIOL, V31, P3326, DOI 10.1128/MCB.05718-11; MARES V, 1970, BRAIN RES, V23, P343, DOI 10.1016/0006-8993(70)90061-2; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Millen KJ, 1995, DEVELOPMENT, V121, P3935; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Pei YX, 2012, DEVELOPMENT, V139, P1724, DOI 10.1242/dev.050104; ROSS ME, 1990, P NATL ACAD SCI USA, V87, P4189, DOI 10.1073/pnas.87.11.4189; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schuller U, 2007, BRAIN RES, V1140, P161, DOI 10.1016/j.brainres.2006.05.105; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Smith KM, 2006, NAT NEUROSCI, V9, P787, DOI 10.1038/nn1705; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Sudarov A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-26; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Wang J, 2008, J BIOL CHEM, V283, P21668, DOI 10.1074/jbc.M709939200; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Xu JS, 2000, DEVELOPMENT, V127, P1833; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Yue Q, 2005, DEVELOPMENT, V132, P3281, DOI 10.1242/dev.01891	44	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64451	10.1371/journal.pone.0064451	http://dx.doi.org/10.1371/journal.pone.0064451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691221	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900100
J	Dutta, N; Mukhopadhyay, A; Dasgupta, AK; Chakrabarti, K				Dutta, Nalok; Mukhopadhyay, Arka; Dasgupta, Anjan Kr.; Chakrabarti, Krishanu			Nanotechnology Enabled Enhancement of Enzyme Activity and Thermostability: Study on Impaired Pectate Lyase from Attenuated Macrophomina phaseolina in Presence of Hydroxyapatite Nanoparticle	PLOS ONE			English	Article							HOST-PATHOGEN INTERACTIONS; ERWINIA-CHRYSANTHEMI; PLANT; COMPENSATION; IMPROVEMENT; EXPRESSION	In this paper we show that hydroxyapatite nanoparticles (NP) can not only act as a chaperon (by imparting thermostability) but can serve as a synthetic enhancer of activity of an isolated extracellular pectate lyase (APL) with low native state activity. The purified enzyme (an attenuated strain of Macrophomina phaseolina) showed feeble activity at 50 degrees C and pH 5.6. However, on addition of 10.5 mu g/ml of hydroxyapatite nanoparticles (NP), APL activity increased 27.7 fold with a 51 fold increase in half-life at a temperature of 90 degrees C as compared to untreated APL. The chaperon like activity of NP was evident from entropy-enthalpy compensation profile of APL. The upper critical temperature for such compensation was elevated from 50 degrees C to 90 degrees C in presence of NP. This dual role of NP in enhancing activity and conferring thermostability to a functionally impaired enzyme is reported for the first time.	[Dutta, Nalok; Mukhopadhyay, Arka; Dasgupta, Anjan Kr.; Chakrabarti, Krishanu] Univ Calcutta, Dept Biochem, Kolkata, India	University of Calcutta	Chakrabarti, K (corresponding author), Univ Calcutta, Dept Biochem, Kolkata, India.	kcbioc@gmail.com	Dasgupta, Anjan/T-5634-2019; Dutta, Nalok/AAA-3620-2022; Mukhopadhyay, Arka/K-4326-2015	Dutta, Nalok/0000-0002-3864-4501; Mukhopadhyay, Arka/0000-0002-9090-9386	WBDST under Govt. of West Bengal	WBDST under Govt. of West Bengal	This study was supported by the grant from WBDST under Govt. of West Bengal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLING S, 1995, MICROBIOL-UK, V141, P873, DOI 10.1099/13500872-141-4-873; Basu S, 2008, BIORESOURCE TECHNOL, V99, P8088, DOI 10.1016/j.biortech.2008.03.032; CERVONE F, 1989, PLANT PHYSIOL, V90, P542, DOI 10.1104/pp.90.2.542; Chronopoulou L, 2011, SOFT MATTER, V7, P2653, DOI 10.1039/c0sm00712a; Cornish-Bowden A, 2002, J BIOSCIENCES, V27, P121, DOI 10.1007/BF02703768; DAVIS KR, 1984, PLANT PHYSIOL, V74, P52, DOI 10.1104/pp.74.1.52; DUBE H C, 1975, Proceedings of the Indian National Science Academy Part B Biological Sciences, V41, P576; FAVELATORRES E, 2005, ENZYME TECHNOLOGY, P273; Gonzalez-Mendoza D, 2010, GENET MOL RES, V9, P162, DOI 10.4238/vol9-1gmr680; JARVIS MC, 1984, PLANT CELL ENVIRON, V7, P153, DOI 10.1111/1365-3040.ep11614586; Kaur G, 2004, BIORESOURCE TECHNOL, V94, P239, DOI 10.1016/j.biortech.2003.05.003; KEEN NT, 1984, J BACTERIOL, V159, P825, DOI 10.1128/JB.159.3.825-831.1984; KELEMU S, 1993, APPL ENVIRON MICROB, V59, P1756, DOI 10.1128/AEM.59.6.1756-1761.1993; Konwarh R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225107; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liao CH, 1997, J APPL MICROBIOL, V83, P10, DOI 10.1046/j.1365-2672.1997.00158.x; Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8; Mukhopadhyay A, 2012, BIORESOURCE TECHNOL, V127, P25, DOI [10.1016/j.biortech.2012.09.087, DOI 10.1016/J.BI0RTECH.2012.09.087]; Mukhopadhyay A, 2012, BIORESOURCE TECHNOL, V116, P348, DOI 10.1016/j.biortech.2012.03.094; Ortega N, 2004, INT J FOOD SCI TECH, V39, P631, DOI 10.1111/j.1365-2621.2004.00822.x; Pereira JF, 2002, BIOTECHNOL LETT, V24, P831, DOI 10.1023/A:1015502721909; Perombelon MCM, 1980, ECOLOGY SOFT ROT ERW, DOI 10.1146; Reddy BV, 2011, INT RES J MICROBIOL, V2, P153; Sharma D.C., 2004, BIOTECHNOLGICAL APPR, P164; Sharp K, 2001, PROTEIN SCI, V10, P661, DOI 10.1110/ps.37801; Singha S, 2010, J NANOSCI NANOTECHNO, V10, P826, DOI 10.1166/jnn.2010.1805; Soriano M, 2005, CURR MICROBIOL, V50, P114, DOI 10.1007/s00284-004-4382-8; SWAIN M, 1995, ELECTROPHORESIS, V16, P948, DOI 10.1002/elps.11501601159; Xiao ZH, 2008, APPL ENVIRON MICROB, V74, P1183, DOI 10.1128/AEM.02220-07; Zhao QX, 2007, WORLD J MICROB BIOT, V23, P1057, DOI 10.1007/s11274-006-9331-1	30	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63567	10.1371/journal.pone.0063567	http://dx.doi.org/10.1371/journal.pone.0063567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691068	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700049
J	Ibiricu, LM; Martinez, RD; Casal, GA; Cerda, IA				Ibiricu, Lucio M.; Martinez, Ruben D.; Casal, Gabriel A.; Cerda, Ignacio A.			The Behavioral Implications of a Multi-Individual Bonebed of a Small Theropod Dinosaur	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; GEOMETRIC MORPHOMETRICS; GREGARIOUSNESS; ASSEMBLAGES; SAUROPODA; PATAGONIA; LENGTH	Background: Central Patagonia, Argentina, preserves an abundant and rich fossil record. Among vertebrate fossils from the Upper Cretaceous Bajo Barreal Formation of Patagonia, five individuals of the small, non-avian theropod dinosaur Aniksosaurus darwini were recovered. Group behavior is an important aspect of dinosaur paleoecology, but it is not well-documented and is poorly understood among non-avian Theropoda. Methods/Principal Findings: The taphonomic association of individuals from the Bajo Barreal Formation and aspects of their bone histology suggest gregarious behavior for Aniksosaurus, during at least a portion of the life history of this species. Histology indicates that the specimens were juvenile to sub-adult individuals. In addition, morphological differences between individuals, particularly proportions of the appendicular bones, are probably related to body-size dimorphism rather than ontogenetic stage. Conclusions/Significance: Gregarious behaviour may have conferred a selective advantage on Aniksosaurus individuals, contributing to their successful exploitation of the Cretaceous paleoenvironment preserved in the Bajo Barreal Formation. The monospecific assemblage of Aniksosaurus specimens constitutes only the second body fossil association of small, coelurosaurian theropods in South America and adds valuable information about the paleoecologies of non-avian theropod dinosaurs, particularly in the early Late Cretaceous of Patagonia.	[Ibiricu, Lucio M.] Ctr Nacl Patagon CONICET CENPAT, Lab Paleontol, Puerto Madryn, Chubut, Argentina; [Martinez, Ruben D.; Casal, Gabriel A.] Univ Nacl Patagonia San Juan Bosco, Lab Paleovertebrados, Comodoro Rivadavia, Chubut, Argentina; [Cerda, Ignacio A.] Univ Nacl Rio Negro, Inst Invest Paleobiol & Geol, CONICET, Museo Carlos Ameghino, Cipolletti, Rio Negro, Argentina	Centro Nacional Patagonico (CENPAT); Universidad Nacional de la Patagonia San Juan Bosco; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Ibiricu, LM (corresponding author), Ctr Nacl Patagon CONICET CENPAT, Lab Paleontol, Puerto Madryn, Chubut, Argentina.	ibiriculm@yahoo.com.ar						Barco Jose Luis, 2006, Ichnos, V13, P237, DOI 10.1080/10420940600843682; Barden HE, 2011, J VERTEBR PALEONTOL, V31, P641, DOI 10.1080/02724634.2011.557112; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Behrensmeyer AK, 1990, TAPHONOMY, P291; Berger J, 2001, P ROY SOC B-BIOL SCI, V268, P131, DOI 10.1098/rspb.2000.1341; Bonnan MF, 2008, J VERTEBR PALEONTOL, V28, P422, DOI 10.1671/0272-4634(2008)28[422:ULAGMT]2.0.CO;2; Carpenter K, 2005, LIFE O PAST, P23; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Castanet J., 1993, BONE, P245; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; Chinsamy Turan A., 2005, MICROSTRUCTURE DINOS; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; Coria RA, 2006, GEODIVERSITAS, V28, P71; Coria Rodolfo A., 2007, P229; Currie PJ, 2005, LIFE O PAST, P313; Eberth DA, 2010, CAN J EARTH SCI, V47, P1119, DOI 10.1139/E10-045; Figari E., 1990, 3 REUN ARGENTINA SED, V1, P130; Francillon-Vieillot H, 1990, SKELETAL BIOMINERALI, V1, P832; Gutierrez Maria A., 2007, Journal of Taphonomy, V5, P151; Hone DWE, 2012, J VERTEBR PALEONTOL, V32, P1082, DOI 10.1080/02724634.2012.680998; Hone DWE, 2010, LETHAIA, V43, P232, DOI 10.1111/j.1502-3931.2009.00187.x; Isles TE, 2009, HIST BIOL, V21, P139, DOI 10.1080/08912960903450505; JOHNSON RG, 1960, GEOL SOC AM BULL, V71, P1075, DOI 10.1130/0016-7606(1960)71[1075:MAMFAO]2.0.CO;2; Kaliontzopoulou A, 2007, J MORPHOL, V268, P152, DOI 10.1002/jmor.10494; KIDWELL S M, 1986, Palaios, V1, P228, DOI 10.2307/3514687; KREUTZER LA, 1988, QUATERNARY RES, V30, P221, DOI 10.1016/0033-5894(88)90026-9; Lockley M, 2002, CRETACEOUS RES, V23, P383, DOI 10.1006/cres.2002.1006; Lockley MG, 1999, PALAEOGEOGR PALAEOCL, V150, P25, DOI 10.1016/S0031-0182(99)00005-X; Longrich NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013419; Martinez RD, 2004, J VERTEBR PALEONTOL, V24, P107, DOI 10.1671/9.1; Martinez Ruben D., 2006, Revista del Museo Argentino de Ciencias Naturales, V8, P243; Mathews JC, 2009, J VERTEBR PALEONTOL, V29, P286, DOI 10.1080/02724634.2009.10010382; Molnar RE, 2005, LIFE O PAST, P284; Moreno K, 2012, ACTA PALAEONTOL POL, V57, P73, DOI 10.4202/app.2010.0119; Novas Fernando E, 2012, Rev. Mus. Argent. Cienc. Nat., V14, P57; Qi Z, 2007, PALAEONTOLOGY, V50, P1023, DOI 10.1111/j.1475-4983.2007.00709.x; Raath M.A., 1990, P91, DOI 10.1017/CBO9780511608377.010; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Roach Brian T., 2007, Bulletin of the Peabody Museum of Natural History, V48, P103, DOI 10.3374/0079-032X(2007)48[103:AROCPH]2.0.CO;2; ROGERS R R, 1990, Palaios, V5, P394, DOI 10.2307/3514834; Salgado L, 2012, J VERTEBR PALEONTOL, V32, P603, DOI 10.1080/02724634.2012.661004; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Varricchio DJ, 2008, ACTA PALAEONTOL POL, V53, P567, DOI 10.4202/app.2008.0402; VARRICCHIO DJ, 1993, CAN J EARTH SCI, V30, P997, DOI 10.1139/e93-083	46	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64253	10.1371/journal.pone.0064253	http://dx.doi.org/10.1371/journal.pone.0064253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691183	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700086
J	Zhang, L; Li, B				Zhang, Li; Li, Bing			Surround Modulation Characteristics of Local Field Potential and Spiking Activity in Primary Visual Cortex of Cat	PLOS ONE			English	Article							MACAQUE V1 NEURONS; CLASSICAL RECEPTIVE-FIELD; SYNCHRONIZED GAMMA-OSCILLATIONS; STRIATE CORTEX; INTERNEURON NETWORKS; SPATIAL SUMMATION; CORTICAL-NEURONS; AREA MT; SUPPRESSION; MECHANISMS	In primary visual cortex, spiking activity that evoked by stimulus confined in receptive field can be modulated by surround stimulus. This center-surround interaction is hypothesized to be the basis of visual feature integration and segregation. Spiking output has been extensively reported to be surround suppressive. However, less is known about the modulation properties of the local field potential (LFP), which generally reflects synaptic inputs. We simultaneously recorded spiking activity and LFP in the area 17 of anesthetized cats to examine and compare their modulation characteristics. When the stimulus went beyond the classical receptive field, LFP exhibited decreased power along the gamma band (30-100 Hz) in most of our recording sites. Further investigation revealed that suppression of the LFP gamma mean power (gLFP) depended on the angle between the center and surround orientations. The strongest suppression was induced when center and surround orientations were parallel. Moreover, the surround influence of the gLFP exhibited an asymmetric spatial organization. These results demonstrate that the gLFP has similar but not identical surround modulation properties, as compared to the spiking activity. The spatiotemporal integration of LFP implies that the oscillation and synchronization of local synaptic inputs may have important functions in surround modulation.	[Zhang, Li; Li, Bing] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Zhang, Li] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, L (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	fff008@gmail.com	Zhang, Li/C-3846-2008	Zhang, Li/0000-0002-5745-0382	Hi-Tech Research and Development Program of China [2007AA02Z313]; National Basic Research Program of China [2005CB724301]	Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from Hi-Tech Research and Development Program of China (2007AA02Z313), National Basic Research Program of China (2005CB724301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Anderson JS, 2001, J NEUROSCI, V21, P2104, DOI 10.1523/JNEUROSCI.21-06-02104.2001; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Asahi T, 2006, ANESTH ANALG, V102, P772, DOI 10.1213/01.ane.0000196536.60320.f9; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Bartolo MJ, 2011, EUR J NEUROSCI, V34, P1857, DOI 10.1111/j.1460-9568.2011.07877.x; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; BAUER R, 1995, BRAIN RES, V669, P291, DOI 10.1016/0006-8993(94)01273-K; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bosking WH, 1997, J NEUROSCI, V17, P2112; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chalk M, 2010, NEURON, V66, P114, DOI 10.1016/j.neuron.2010.03.013; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GRAY CM, 1990, EUR J NEUROSCI, V2, P607, DOI 10.1111/j.1460-9568.1990.tb00450.x; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kitamura A, 2003, J PHARMACOL EXP THER, V304, P162, DOI 10.1124/jpet.102.043273; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Lippert MT, 2010, MAGN RESON IMAGING, V28, P1087, DOI 10.1016/j.mri.2009.12.028; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nishikawa K, 2000, J NEUROSCI, V20, P5915, DOI 10.1523/JNEUROSCI.20-16-05915.2000; Nishimoto S, 2005, J NEUROPHYSIOL, V93, P3524, DOI 10.1152/jn.01169.2004; Ohtani Y, 2002, VISION RES, V42, P1825, DOI 10.1016/S0042-6989(02)00103-7; ORSER BA, 1994, J NEUROSCI, V14, P7747; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Partha Mitra HB, 2008, OBSERVED BRAIN DYNAM; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Philipp Berens GAK, 2008, FRONTIERS SYSTEMS NE, V2; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Sengpiel F, 1997, EXP BRAIN RES, V116, P216, DOI 10.1007/PL00005751; Series P, 2003, J PHYSIOL-PARIS, V97, P453, DOI 10.1016/j.jphysparis.2004.01.023; Siegel M, 2003, J NEUROSCI, V23, P4251; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; SLEPIAN D, 1978, BELL SYST TECH J, V57, P1371, DOI 10.1002/j.1538-7305.1978.tb02104.x; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Toth LJ, 1996, P NATL ACAD SCI USA, V93, P9869, DOI 10.1073/pnas.93.18.9869; Walker GA, 1999, J NEUROSCI, V19, P10536; WANG Y, 1995, NEUROREPORT, V6, P1969, DOI 10.1097/00001756-199510010-00005; Webb BS, 2005, J NEUROSCI, V25, P11666, DOI 10.1523/JNEUROSCI.3414-05.2005; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Williams AL, 2003, J NEUROPHYSIOL, V89, P525, DOI 10.1152/jn.00048.2002; XIAO DK, 1995, P NATL ACAD SCI USA, V92, P11303, DOI 10.1073/pnas.92.24.11303; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	65	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64492	10.1371/journal.pone.0064492	http://dx.doi.org/10.1371/journal.pone.0064492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691231	gold, Green Submitted, Green Published			2022-12-25	WOS:000319052700100
J	La Torre, D; Conti, A; Aguennouz, M; De Pasquale, MG; Romeo, S; Angileri, FF; Cardali, S; Tomasello, C; Alafaci, C; Germano, A				La Torre, Domenico; Conti, Alfredo; Aguennouz, M'Hammed; De Pasquale, Maria Grazia; Romeo, Sara; Angileri, Filippo Flavio; Cardali, Salvatore; Tomasello, Chiara; Alafaci, Concetta; Germano, Antonino			Telomere Length Modulation in Human Astroglial Brain Tumors	PLOS ONE			English	Article							BINDING FACTOR-I; COLORECTAL-CARCINOMA; HUMAN GLIOMAS; DNA-CONTENT; POLY(ADP-RIBOSE) POLYMERASE; GENOME INSTABILITY; BREAST-CANCER; EXPRESSION; TRF1; DYSFUNCTION	Background: Telomeres alteration during carcinogenesis and tumor progression has been described in several cancer types. Telomeres length is stabilized by telomerase (h-TERT) and controlled by several proteins that protect telomere integrity, such as the Telomere Repeat-binding Factor (TRF) 1 and 2 and the tankyrase-poli-ADP-ribose polymerase (TANKs-PARP) complex. Objective: To investigate telomere dysfunction in astroglial brain tumors we analyzed telomeres length, telomerase activity and the expression of a panel of genes controlling the length and structure of telomeres in tissue samples obtained in vivo from astroglial brain tumors with different grade of malignancy. Materials and Methods: Eight Low Grade Astrocytomas (LGA), 11 Anaplastic Astrocytomas (AA) and 11 Glioblastoma Multiforme (GBM) samples were analyzed. Three samples of normal brain tissue (NBT) were used as controls. Telomeres length was assessed through Southern Blotting. Telomerase activity was evaluated by a telomere repeat amplification protocol (TRAP) assay. The expression levels of TRF1, TRF2, h-TERT and TANKs-PARP complex were determined through Immunoblotting and RT-PCR. Results: LGA were featured by an up-regulation of TRF1 and 2 and by shorter telomeres. Conversely, AA and GBM were featured by a down-regulation of TRF1 and 2 and an up-regulation of both telomerase and TANKs-PARP complex. Conclusions: In human astroglial brain tumours, up-regulation of TRF1 and TRF2 occurs in the early stages of carcinogenesis determining telomeres shortening and genomic instability. In a later stage, up-regulation of PARP-TANKs and telomerase activation may occur together with an ADP-ribosylation of TRF1, causing a reduced ability to bind telomeric DNA, telomeres elongation and tumor malignant progression.	[La Torre, Domenico; Conti, Alfredo; Aguennouz, M'Hammed; De Pasquale, Maria Grazia; Romeo, Sara; Angileri, Filippo Flavio; Cardali, Salvatore; Alafaci, Concetta; Germano, Antonino] Univ Messina, Sch Med, Dept Neurosci, Messina, Italy; [Tomasello, Chiara] Univ Messina, Sch Med, Dept Med Oncol, Messina, Italy	University of Messina; University of Messina	La Torre, D (corresponding author), Univ Messina, Sch Med, Dept Neurosci, Messina, Italy.	dlatorre@unime.it	Angileri, Filippo/AAL-4851-2021; Angileri, Filippo/N-8556-2019; Cardali, Salvatore/AAC-1381-2019; Angileri, Filippo Flavio/J-3533-2012; Conti, Alfredo/H-3022-2019; La Torre, Domenico/AAB-9893-2019; Aguennouz, M'hammed/O-9520-2019	Angileri, Filippo/0000-0002-1107-4115; Angileri, Filippo Flavio/0000-0002-1107-4115; Conti, Alfredo/0000-0002-9408-2662; Aguennouz, M'hammed/0000-0003-0440-0354; La Torre, Domenico/0000-0002-3918-8798; CARDALI, Salvatore Massimiliano/0000-0002-0950-9140	Italian Ministry of University and Research [prot. 2008979M8K]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This Paper was supported in part by Italian Ministry of University and Research; Grant number: prot. 2008979M8K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Aragona M, 2001, ANTICANCER RES, V21, P2135; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Callen E, 2004, MUTAT RES-REV MUTAT, V567, P85, DOI 10.1016/j.mrrev.2004.06.003; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; di Fagagna FD, 1999, NAT GENET, V23, P76; Donaldson L, 1999, J UROLOGY, V162, P1788, DOI 10.1016/S0022-5347(05)68239-0; Evans SK, 2000, J CELL SCI, V113, P3357; Fordyce CA, 2005, J UROLOGY, V173, P610, DOI 10.1097/01.ju.0000143195.49685.ce; Fordyce CA, 2006, BREAST CANCER RES TR, V99, P193, DOI 10.1007/s10549-006-9204-1; Garcia-Aranda C, 2006, CANCER-AM CANCER SOC, V106, P541, DOI 10.1002/cncr.21625; Gertler R, 2004, J CLIN ONCOL, V22, P1807, DOI 10.1200/JCO.2004.09.160; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JK, 1999, BREAST CANCER RES TR, V54, P59, DOI 10.1023/A:1006128228761; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HIYAMA E, 1992, JPN J CANCER RES, V83, P159, DOI 10.1111/j.1349-7006.1992.tb00081.x; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Kanauchi H, 2003, J CLIN ENDOCR METAB, V88, P3690, DOI 10.1210/jc.2002-020965; Karlseder J, 2003, CANCER LETT, V194, P189, DOI 10.1016/S0304-3835(02)00706-1; Kleinschmidt-DeMasters BK, 1998, J CLIN PATHOL, V51, P284, DOI 10.1136/jcp.51.4.284; La Torre D, 2005, NEUROSURGERY, V56, P802, DOI 10.1227/01.NEU.0000156468.41461.6F; Le SY, 1998, NEUROSURGERY, V42, P1120, DOI 10.1097/00006123-199805000-00099; Lin X, 2006, CLIN CANCER RES, V12, P5720, DOI 10.1158/1078-0432.CCR-05-2809; Lundblad V, 2001, CURR BIOL, V11, pR957, DOI 10.1016/S0960-9822(01)00573-5; Maitra A, 1999, CANCER-AM CANCER SOC, V85, P741, DOI 10.1002/(SICI)1097-0142(19990201)85:3<741::AID-CNCR25>3.0.CO;2-6; MANUELIDIS L, 1994, J NEURO-ONCOL, V18, P225, DOI 10.1007/BF01328957; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Morii K, 1997, BIOCHEM BIOPH RES CO, V239, P830, DOI 10.1006/bbrc.1997.7562; Nakanishi K, 2003, CLIN CANCER RES, V9, P1105; ODAGIRI E, 1994, CANCER-AM CANCER SOC, V73, P2978, DOI 10.1002/1097-0142(19940615)73:12<2978::AID-CNCR2820731215>3.0.CO;2-5; Oh BK, 2005, AM J PATHOL, V166, P73, DOI 10.1016/S0002-9440(10)62233-X; Ohyashiki JH, 2001, INT J ONCOL, V18, P593; Patel MM, 2002, HEAD NECK-J SCI SPEC, V24, P1060, DOI 10.1002/hed.10169; Pennisi E, 1998, SCIENCE, V282, P1395, DOI 10.1126/science.282.5393.1395; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sano T, 1998, BRIT J CANCER, V77, P1633, DOI 10.1038/bjc.1998.267; SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1, DOI 10.1016/0304-419X(91)90003-4; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Weil RJ, 1999, MODERN PATHOL, V12, P41; Wright WE, 2005, J AM GERIATR SOC, V53, pS292, DOI 10.1111/j.1532-5415.2005.53492.x; WRIGHT WE, 1995, TRENDS CELL BIOL, V5, P293, DOI 10.1016/S0962-8924(00)89044-3; Yokota T, 2003, CANCER-AM CANCER SOC, V98, P110, DOI 10.1002/cncr.11428; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	50	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64296	10.1371/journal.pone.0064296	http://dx.doi.org/10.1371/journal.pone.0064296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691191	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400116
J	Sumi, T; Oki, S; Kitajima, K; Meno, C				Sumi, Tomoyuki; Oki, Shinya; Kitajima, Keiko; Meno, Chikara			Epiblast Ground State Is Controlled by Canonical Wnt/beta-Catenin Signaling in the Postimplantation Mouse Embryo and Epiblast Stem Cells	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; BETA-CATENIN; SELF-RENEWAL; PLURIPOTENT CELLS; AXIS FORMATION; LAYER FORMATION; DIFFERENTIATION; GASTRULATION; GENE; REQUIREMENT	Epiblast stem cells (EpiSCs) are primed pluripotent stem cells and can be derived from postimplantation mouse embryos. We now show that the absence of canonical Wnt/beta-catenin signaling is essential for maintenance of the undifferentiated state in mouse EpiSCs and in the epiblast of mouse embryos. Attenuation of Wnt signaling with the small-molecule inhibitor XAV939 or deletion of the beta-catenin gene blocked spontaneous differentiation of EpiSCs toward mesoderm and enhanced the expression of pluripotency factor genes, allowing propagation of EpiSCs as a homogeneous population. EpiSCs were efficiently established and propagated from single epiblast cells in the presence of both XAV939 and the Rho kinase (ROCK) inhibitor Y27632. Cell transplantation revealed that EpiSCs were able to contribute to primordial germ cells and descendants of all three germ layers in a host embryo, suggesting that they maintained pluripotency, even after prolonged culture with XAV939. Such an improvement in the homogeneity of pluripotency achieved with the use of a Wnt inhibitor should prove advantageous for manipulation of primed pluripotent stem cells.	[Sumi, Tomoyuki; Oki, Shinya; Kitajima, Keiko; Meno, Chikara] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan	Kyushu University	Meno, C (corresponding author), Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan.	meno@dev.med.kyushu-u.ac.jp	Oki, Shinya/J-7662-2019	Oki, Shinya/0000-0002-4767-3259	Sumitomo Foundation; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21116002, 23570233, 23770254]	Sumitomo Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Sumitomo Foundation, the Japan Society for the Promotion of Science, and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grant nos. 21116002, 23570233, and 23770254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bernemann C, 2011, STEM CELLS, V29, P1496, DOI 10.1002/stem.709; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Brault V, 2001, DEVELOPMENT, V128, P1253; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chenoweth JG, 2010, METHODS MOL BIOL, V636, P25, DOI 10.1007/978-1-60761-691-7_2; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Dottori M, 2001, DEVELOPMENT, V128, P4127; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hong SH, 2011, CELL STEM CELL, V9, P24, DOI 10.1016/j.stem.2011.06.002; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ohtsuka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045220; Oki S, 2010, DEV DYNAM, V239, P1768, DOI 10.1002/dvdy.22282; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Tam PPL, 1997, DEVELOPMENT, V124, P1631; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tsang TE, 2001, INT J DEV BIOL, V45, P549; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoo YD, 2011, STEM CELLS, V29, P1975, DOI 10.1002/stem.758	54	72	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63378	10.1371/journal.pone.0063378	http://dx.doi.org/10.1371/journal.pone.0063378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691040	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400062
J	Schmidt, SK; Ebel, S; Keil, E; Woite, C; Ernst, JF; Benzin, AE; Rupp, J; Daubener, W				Schmidt, Silvia K.; Ebel, Sebastian; Keil, Eric; Woite, Claudia; Ernst, Joachim F.; Benzin, Anika E.; Rupp, Jan; Daeubener, Walter			Regulation of IDO Activity by Oxygen Supply: Inhibitory Effects on Antimicrobial and Immunoregulatory Functions	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ARYL-HYDROCARBON RECEPTOR; INDUCIBLE FACTOR-I; INDOLEAMINE 2,3-DIOXYGENASE; STAPHYLOCOCCUS-AUREUS; IFN-GAMMA; HYPOXIA; CELLS; HIF-1-ALPHA; INFECTION	Tryptophan is an essential amino acid for human beings as well as for some microorganisms. In human cells the interferon-gamma (IFN-gamma) inducible enzyme indoleamine 2,3-dioxygenase (IDO) reduces local tryptophan levels and is therefore able to mediate broad-spectrum effector functions: IDO activity restricts the growth of various clinically relevant pathogens such as bacteria, parasites and viruses. On the other hand, it has been observed that IDO has immunoregulatory functions as it efficiently controls the activation and survival of T-cells. Although these important effects have been analysed in much detail, they have been observed in vitro using cells cultured in the presence of 20% O-2 (normoxia). Such high oxygen concentrations are not present in vivo especially within infected and inflamed tissues. We therefore analysed IDO-mediated effects under lower oxygen concentrations in vitro and observed that the function of IDO is substantially impaired in tumour cells as well as in native cells. Hypoxia led to reduced IDO expression and as a result to reduced production of kynurenine, the downstream product of tryptophan degradation. Consequently, effector functions of IDO were abrogated under hypoxic conditions: in different human cell lines such as tumour cells (glioblastoma, HeLa) but also in native cells (human foreskin fibroblasts; HFF) IDO lost the capacity to inhibit the growth of bacteria (Staphylococcus aureus), parasites (Toxoplasma gondii) or viruses (herpes simplex virus type 1). Additionally, IDO could no longer efficiently control the proliferation of T-cells that have been co-cultured with IDO expressing HFF cells in vitro. In conclusion, the potent antimicrobial as well as immunoregulatory functions of IDO were substantially impaired under hypoxic conditions that pathophysiologically occurs in vivo.	[Schmidt, Silvia K.; Ebel, Sebastian; Keil, Eric; Woite, Claudia; Daeubener, Walter] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Ernst, Joachim F.] Univ Dusseldorf, Inst Mol Mycol, D-40225 Dusseldorf, Germany; [Benzin, Anika E.; Rupp, Jan] Med Univ Lubeck, Inst Med Microbiol & Hyg, D-23538 Lubeck, Germany; [Rupp, Jan] Med Clin III UK SH, Lubeck, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Lubeck	Daubener, W (corresponding author), Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany.	daeubene@uni-duesseldorf.de	Rupp, Jan/C-8794-2011	Rupp, Jan/0000-0001-8722-1233	German Federal Ministry of Education BMBF [01KI1002E, 01GN0951]; German Research Concil (DFG) [RU729]; Manchot Graduate School "Molecules of Infection" (GS MOI); Forschungsforderung UKD	German Federal Ministry of Education BMBF(Federal Ministry of Education & Research (BMBF)); German Research Concil (DFG); Manchot Graduate School "Molecules of Infection" (GS MOI); Forschungsforderung UKD	This study was supported by German Federal Ministry of Education BMBF grant 01KI1002E and 01GN0951 (WD), German Research Concil (DFG) grant RU729 (WD), Manchot Graduate School "Molecules of Infection" (GS MOI) (WD) and Forschungsforderung UKD (WD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi MK, 2009, MOL THER, V17, P51, DOI 10.1038/mt.2008.232; Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Baffert F, 2010, MOL CANCER THER, V9, P1945, DOI 10.1158/1535-7163.MCT-10-0053; BILZER T, 1991, VIRCHOWS ARCH A, V418, P281, DOI 10.1007/BF01600156; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001; Daubener W, 2009, THROMB HAEMOSTASIS, V102, P1110, DOI 10.1160/TH09-04-0250; Darcy CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021185; DAUBENER W, 1993, J NEUROIMMUNOL, V43, P31, DOI 10.1016/0165-5728(93)90072-7; DAUBENER W, 1994, J IMMUNOL METHODS, V168, P39, DOI 10.1016/0022-1759(94)90207-0; Davis DA, 2001, BLOOD, V97, P3244, DOI 10.1182/blood.V97.10.3244; Eza DE, 2006, HIV MED, V7, P415, DOI 10.1111/j.1468-1293.2006.00393.x; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Fluckiger U, 2001, Ther Umsch, V58, P614, DOI 10.1024/0040-5930.58.10.614; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; GREEN GM, 1964, J CLIN INVEST, V43, P769, DOI 10.1172/JCI104961; Herbert A, 2011, BRIT J DERMATOL, V164, P308, DOI 10.1111/j.1365-2133.2010.10086.x; Hucke C, 2004, INFECT IMMUN, V72, P2723, DOI 10.1128/IAI.72.5.2723-2730.2004; Huttunen R, 2010, SHOCK, V33, P149, DOI 10.1097/SHK.0b013e3181ad3195; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; JONSSON K, 1988, ANN SURG, V208, P783; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; MacKenzie CR, 2007, CURR DRUG METAB, V8, P237, DOI 10.2174/138920007780362518; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Muccio CF, 2008, RADIOL MED, V113, P747, DOI 10.1007/s11547-008-0254-9; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Robinson MA, 2011, FREE RADICAL BIO MED, V51, P1952, DOI 10.1016/j.freeradbiomed.2011.08.034; Roth A, 2010, P NATL ACAD SCI USA, V107, P19502, DOI 10.1073/pnas.1008178107; Sakiniene E, 1997, CLIN EXP IMMUNOL, V110, P370, DOI 10.1046/j.1365-2249.1997.4431456.x; Sasaki S, 1998, INFECT IMMUN, V66, P1017, DOI 10.1128/IAI.66.3.1017-1022.1998; Schmidt SK, 2009, EUR J IMMUNOL, V39, P2755, DOI 10.1002/eji.200939535; Spear W, 2006, CELL MICROBIOL, V8, P339, DOI 10.1111/j.1462-5822.2005.00628.x; Stichternoth C, 2011, EUKARYOT CELL, V10, P502, DOI 10.1128/EC.00289-10; Thiel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000853; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Wiese M, 2012, INFECT IMMUN, V80, P1455, DOI 10.1128/IAI.05972-11; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	47	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63301	10.1371/journal.pone.0063301	http://dx.doi.org/10.1371/journal.pone.0063301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675474	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100035
J	Streitner, F; Herrmann, T; Kuschyk, J; Lang, S; Doesch, C; Papavassiliu, T; Streitner, I; Veltmann, C; Haghi, D; Borggrefe, M				Streitner, Florian; Herrmann, Thomas; Kuschyk, Juergen; Lang, Siegfried; Doesch, Christina; Papavassiliu, Theano; Streitner, Ines; Veltmann, Christian; Haghi, Dariusch; Borggrefe, Martin			Impact of Shocks on Mortality in Patients with Ischemic or Dilated Cardiomyopathy and Defibrillators Implanted for Primary Prevention	PLOS ONE			English	Article							CARDIOVERTER-DEFIBRILLATOR; MYOCARDIAL-INFARCTION; VENTRICULAR-ARRHYTHMIAS; HEART-FAILURE; SURVIVAL; THERAPY; TRIAL; DEATH; RISK	Background: Emerging interest is seen in the paradox of defibrillator shocks for ventricular tachyarrhythmia and increased mortality risk. Particularly in patients with dilated cardiomyopathy (DCM), the prognostic importance of shocks is unclear. The purpose of this study was to compare the outcome after shocks in patients with ischemic cardiomyopathy (ICM) or DCM and defibrillators (ICD) implanted for primary prevention. Methods and Results: Data of 561 patients were analyzed (mean age 68.6 +/- 10.6 years, mean left ventricular ejection fraction 28.6 +/- 7.3%). During a median follow-up of 49.3 months, occurrence of device therapies and all-cause mortality were recorded. 74 out of 561 patients (13.2%) experienced >= 1 appropriate and 51 out of 561 patients (9.1%) >= 1 inappropriate shock. All-cause mortality was 24.2% (136 out of 561 subjects). Appropriate shock was associated with a trend to higher mortality in the overall patient population (HR 1.48, 95% CI 0.96-2.28, log rank p = 0.072). The effect was significant in ICM patients (HR 1.61, 95% CI 1.00-2.59, log rank p = 0.049) but not in DCM patients (HR 1.03, 95% CI 0.36-2.96, log rank p = 0.96). Appropriate shocks occurring before the median follow-up revealed a much stronger impact on mortality (HR for the overall patient population 2.12, 95% CI 1.24-3.63, p = 0.005). The effect was driven by ICM patients (HR 2.48, 95% CI 1.41-4.37, p = 0.001), as appropriate shocks again did not influence survival of DCM patients (HR 0.63, 95% CI 0.083-4.75, p = 0.65). Appropriate shocks occurring after the median follow-up and inappropriate shocks occurring at any time revealed no impact on survival in any of the groups (p = ns). Conclusion: Appropriate shocks are associated with reduced survival in patients with ICM but not in patients with DCM and ICDs implanted for primary prevention. Furthermore, the negative effect of appropriate shocks on survival in ICM patients is only evident within the first 4 years after device implantation.	[Streitner, Florian; Herrmann, Thomas; Kuschyk, Juergen; Lang, Siegfried; Doesch, Christina; Papavassiliu, Theano; Streitner, Ines; Veltmann, Christian; Haghi, Dariusch; Borggrefe, Martin] Univ Mannheim, Med Ctr, Dept Med Cardiol 1, D-68131 Mannheim, Germany	University of Mannheim	Streitner, F (corresponding author), Univ Mannheim, Med Ctr, Dept Med Cardiol 1, D-68131 Mannheim, Germany.	florian.streitner@umm.de	Veltmann, Christian/ABD-3448-2021	Veltmann, Christian/0000-0001-7587-1124				Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; Dichtl W, 2011, CLIN CARDIOL, V34, P433, DOI 10.1002/clc.20910; Dorian P, 2010, CIRCULATION, V122, P2645, DOI 10.1161/CIRCULATIONAHA.109.924225; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; KELLY P, 1990, J AM COLL CARDIOL, V15, P267, DOI 10.1016/S0735-1097(10)80046-4; Moss AJ, 2004, CIRCULATION, V110, P3760, DOI 10.1161/01.CIR.0000150390.04704.B7; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Packer DL, 2009, CIRCULATION, V120, P2170, DOI 10.1161/CIRCULATIONAHA.109.853689; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889; Sweeney MO, 2010, CIRCULATION, V122, P2638, DOI 10.1161/CIRCULATIONAHA.110.000208; Sweeney MO, 2010, HEART RHYTHM, V7, P353, DOI 10.1016/j.hrthm.2009.11.027; Wathen M, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.020; Wathen MS, 2004, CIRCULATION, V110, P2591, DOI 10.1161/01.CIR.0000145610.64014.E4; Zipes DP, 2006, EUR HEART J, V27, P2099, DOI 10.1093/eurheartj/ehl199	16	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63911	10.1371/journal.pone.0063911	http://dx.doi.org/10.1371/journal.pone.0063911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675514	gold, Green Submitted, Green Published			2022-12-25	WOS:000318852400056
J	Bui, S; Oppedal, F; Korsoen, OJ; Sonny, D; Dempster, T				Bui, Samantha; Oppedal, Frode; Korsoen, Oyvind J.; Sonny, Damien; Dempster, Tim			Group Behavioural Responses of Atlantic Salmon (Salmo salar L.) to Light, Infrasound and Sound Stimuli	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; EUROPEAN SILVER EELS; SCALE SEA-CAGES; AVOIDANCE RESPONSES; ESCAPE TRAJECTORIES; JUVENILE SALMONIDS; STROBE LIGHTS; FISH; SUBMERGENCE; INTENSITIES	Understanding species-specific flight behaviours is essential in developing methods of guiding fish spatially, and requires knowledge on how groups of fish respond to aversive stimuli. By harnessing their natural behaviours, the use of physical manipulation or other potentially harmful procedures can be minimised. We examined the reactions of sea-caged groups of 50 salmon (13316364 g) to short-term exposure to visual or acoustic stimuli. In light experiments, fish were exposed to one of three intensities of blue LED light (high, medium and low) or no light (control). Sound experiments included exposure to infrasound (12 Hz), a surface disturbance event, the combination of infrasound and surface disturbance, or no stimuli. Groups that experienced light, infrasound, and the combination of infrasound and surface disturbance treatments, elicited a marked change in vertical distribution, where fish dived to the bottom of the sea-cage for the duration of the stimulus. Light treatments, but not sound, also reduced the total echo-signal strength (indicative of swim bladder volume) after exposure to light, compared to pre-stimulus levels. Groups in infrasound and combination treatments showed increased swimming activity during stimulus application, with swimming speeds tripled compared to that of controls. In all light and sound treatments, fish returned to their pre-stimulus swimming depths and speeds once exposure had ceased. This work establishes consistent, short-term avoidance responses to these stimuli, and provides a basis for methods to guide fish for aquaculture applications, or create avoidance barriers for conservation purposes. In doing so, we can achieve the manipulation of group position with minimal welfare impacts, to create more sustainable practices.	[Bui, Samantha; Dempster, Tim] Univ Melbourne, Dept Zool, SALTT, Melbourne, Vic 3010, Australia; [Oppedal, Frode; Korsoen, Oyvind J.] Inst Marine Res, Matredal, Norway; [Sonny, Damien] ProFish Technol, Namur, Belgium; [Dempster, Tim] SINTEF Fisheries & Aquaculture, Ctr Res Based Innovat Aquaculture Technol CREATE, Trondheim, Norway	University of Melbourne; Institute of Marine Research - Norway; SINTEF	Bui, S (corresponding author), Univ Melbourne, Dept Zool, SALTT, Melbourne, Vic 3010, Australia.	samanthassbui@gmail.com	Bui, Samantha/AAD-1880-2021; Dempster, Tim/E-9630-2011	Bui, Samantha/0000-0002-7885-2989; Dempster, Tim/0000-0001-8041-426X; Oppedal, Frode/0000-0001-8625-0331	Norwegian Research Council through the Centre for Research-Based Innovation in Aquaculture Technology (Trondheim)	Norwegian Research Council through the Centre for Research-Based Innovation in Aquaculture Technology (Trondheim)	Funding was provided by the Norwegian Research Council through the Centre for Research-Based Innovation in Aquaculture Technology (Trondheim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI MA, 1961, CAN J ZOOLOG, V39, P511, DOI 10.1139/z61-055; BJORDAL A, 1993, FISH FARMING TECHNOLOGY, P203; BLAXTER JHS, 1981, J MAR BIOL ASSOC UK, V61, P851, DOI 10.1017/S0025315400023006; Bratland S, 2010, AQUACULT INT, V18, P991, DOI 10.1007/s10499-009-9317-8; Coutant CC, 2001, AM FISH S S, V26, P105; Dempster T, 2011, J ANIM SCI, V89, P4281, DOI 10.2527/jas.2011-3894; Dempster T, 2008, AQUACULTURE, V276, P103, DOI 10.1016/j.aquaculture.2008.01.018; Dempster T, 2009, AQUACULTURE, V288, P254, DOI 10.1016/j.aquaculture.2008.12.003; DILL LM, 1974, ANIM BEHAV, V22, P711, DOI 10.1016/S0003-3472(74)80022-9; Domenici P, 1997, MAR BIOL, V128, P29, DOI 10.1007/s002270050065; DOMENICI P, 1993, J EXP BIOL, V177, P253; Domenici P, 1997, J EXP BIOL, V200, P1165; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Domenici P, 2011, J EXP BIOL, V214, P2474, DOI 10.1242/jeb.053801; Eaton R.C., 1984, P213; Endler J.A., 1991, P169; Enger P.S., 1989, P575; Fange R, 1953, ACTA PHYSIOLOGI S110, V23, P1; Folkedal O, 2010, AQUACULTURE, V307, P170, DOI 10.1016/j.aquaculture.2010.06.001; FUREVIK DM, 1993, AQUACULTURE, V110, P119, DOI 10.1016/0044-8486(93)90266-2; GEHRKE PC, 1994, J FISH BIOL, V44, P741, DOI 10.1111/j.1095-8649.1994.tb01252.x; Gutherie DM, 1993, BEHAV TELEOST FISHES, P90; Hamel MJ, 2008, N AM J FISH MANAGE, V28, P394, DOI 10.1577/M06-254.1; Hawkins A.D., 1983, P347; HAWKINS AD, 1978, J FISH BIOL, V13, P655, DOI 10.1111/j.1095-8649.1978.tb03480.x; Huntingford F., 2012, Aquaculture and behavior, P220; Karlsen HE, 2004, J EXP BIOL, V207, P4185, DOI 10.1242/jeb.01274; Kelley Jennifer L., 2008, P269; Knudsen FR, 1997, J FISH BIOL, V51, P824, DOI 10.1006/jfbi.1997.0486; KNUDSEN FR, 1992, J FISH BIOL, V40, P523, DOI 10.1111/j.1095-8649.1992.tb02602.x; KNUDSEN FR, 1994, J FISH BIOL, V45, P227, DOI 10.1111/j.1095-8649.1994.tb01302.x; Korsoen OJ, 2012, AQUACULT ENG, V51, P1, DOI 10.1016/j.aquaeng.2012.04.001; Korsoen OJ, 2009, AQUACULTURE, V296, P373, DOI 10.1016/j.aquaculture.2009.08.036; Marras S, 2011, J EXP BIOL, V214, P3102, DOI 10.1242/jeb.056648; Meager JJ, 2011, J FISH BIOL, V78, P1437, DOI 10.1111/j.1095-8649.2011.02951.x; Mesquita FD, 2008, APPL ANIM BEHAV SCI, V111, P402, DOI 10.1016/j.applanim.2007.06.014; Millot S, 2009, APPL ANIM BEHAV SCI, V119, P108, DOI 10.1016/j.applanim.2009.03.009; MORK OI, 1994, AQUACULTURE, V127, P317, DOI 10.1016/0044-8486(94)90234-8; Nemeth Richard S., 1992, North American Journal of Fisheries Management, V12, P684, DOI 10.1577/1548-8675(1992)012<0684:ROJCAC>2.3.CO;2; Nottestad L, 1998, ICES J MAR SCI, V55, P1133, DOI 10.1006/jmsc.1998.0416; ONA E, 1990, J MAR BIOL ASSOC UK, V70, P107, DOI 10.1017/S002531540003424X; Oppedal F, 2011, AQUACULTURE, V315, P361, DOI 10.1016/j.aquaculture.2011.02.037; Oppedal F, 2011, AQUACULTURE, V311, P1, DOI 10.1016/j.aquaculture.2010.11.020; Popper AN, 1998, T AM FISH SOC, V127, P673, DOI 10.1577/1548-8659(1998)127<0673:AOSAOS>2.0.CO;2; POPPER AN, 1973, J ACOUST SOC AM, V53, P1515, DOI 10.1121/1.1913496; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rader RB, 2007, WEST N AM NATURALIST, V67, P524, DOI 10.3398/1527-0904(2007)67[524:TSVSOF]2.0.CO;2; Richards NS, 2007, N AM J FISH MANAGE, V27, P1310, DOI 10.1577/M06-239.1; Sand O, 2001, AM FISH S S, V26, P183; Sand O, 2000, ENVIRON BIOL FISH, V57, P327, DOI 10.1023/A:1007575426155; Sand O., 1984, P3; Sand O, 2000, PHILOS T ROY SOC B, V355, P1295, DOI 10.1098/rstb.2000.0687; SCHWARZ AL, 1985, ENVIRON BIOL FISH, V13, P3, DOI 10.1007/BF00004851; Sonny D, 2006, J FISH BIOL, V69, P735, DOI 10.1111/j.1095-8649.2006.01146.x; Stien LH, 2007, AQUACULT ENG, V37, P115, DOI 10.1016/j.aquaeng.2007.03.002; Welton JS, 2002, FISHERIES MANAG ECOL, V9, P11, DOI 10.1046/j.1365-2400.2002.00252.x	57	23	23	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63696	10.1371/journal.pone.0063696	http://dx.doi.org/10.1371/journal.pone.0063696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691087	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900054
J	Calderon, VE; Valbuena, G; Goez, Y; Judy, BM; Huante, MB; Sutjita, P; Johnston, RK; Estes, DM; Hunter, RL; Actor, JK; Cirillo, JD; Endsley, JJ				Calderon, Veronica E.; Valbuena, Gustavo; Goez, Yenny; Judy, Barbara M.; Huante, Matthew B.; Sutjita, Putri; Johnston, R. Katie; Estes, D. Mark; Hunter, Robert L.; Actor, Jeffrey K.; Cirillo, Jeffrey D.; Endsley, Janice J.			A Humanized Mouse Model of Tuberculosis	PLOS ONE			English	Article							RESTRICTED IMMUNE-RESPONSES; MYCOBACTERIUM-BOVIS BCG; T-CELL DEPLETION; TREHALOSE 6,6'-DIMYCOLATE; LATENT TUBERCULOSIS; HIV LATENCY; MICE; GRANULYSIN; INFECTION; PATHOLOGY	Mycobacterium tuberculosis (M.tb) is the second leading infectious cause of death worldwide and the primary cause of death in people living with HIV/AIDS. There are several excellent animal models employed to study tuberculosis (TB), but many have limitations for reproducing human pathology and none are amenable to the direct study of HIV/M.tb co-infection. The humanized mouse has been increasingly employed to explore HIV infection and other pathogens where animal models are limiting. Our goal was to develop a small animal model of M.tb infection using the bone marrow, liver, thymus (BLT) humanized mouse. NOD-SCID/gamma(null)(c) mice were engrafted with human fetal liver and thymus tissue, and supplemented with CD34(+) fetal liver cells. Excellent reconstitution, as measured by expression of the human CD45 pan leukocyte marker by peripheral blood populations, was observed at 12 weeks after engraftment. Human T cells (CD3, CD4, CD8), as well as natural killer cells and monocyte/macrophages were all observed within the human leukocyte (CD45(+)) population. Importantly, human T cells were functionally competent as determined by proliferative capacity and effector molecule (e.g. IFN-gamma, granulysin, perforin) expression in response to positive stimuli. Animals infected intranasally with M.tb had progressive bacterial infection in the lung and dissemination to spleen and liver from 2-8 weeks post infection. Sites of infection in the lung were characterized by the formation of organized granulomatous lesions, caseous necrosis, bronchial obstruction, and crystallization of cholesterol deposits. Human T cells were distributed throughout the lung, liver, and spleen at sites of inflammation and bacterial growth and were organized to the periphery of granulomas. These preliminary results demonstrate the potential to use the humanized mouse as a model of experimental TB.	[Calderon, Veronica E.; Valbuena, Gustavo; Goez, Yenny; Judy, Barbara M.; Endsley, Janice J.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Huante, Matthew B.; Sutjita, Putri; Johnston, R. Katie; Endsley, Janice J.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Estes, D. Mark] Univ Georgia, Athens, GA 30602 USA; [Hunter, Robert L.; Actor, Jeffrey K.] Univ Texas Houston, Hlth Sci Ctr, Dept Pathol, Houston, TX USA; [Cirillo, Jeffrey D.] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University System of Georgia; University of Georgia; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Endsley, JJ (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	jjendsle@utmb.edu	Cirillo, Jeffrey D./L-4286-2019	Cirillo, Jeffrey D./0000-0003-3058-2702; Actor, Jeffrey/0000-0002-9265-7012	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [R21AI089362]; Department of Microbiology and Immunology; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas; McLaughlin Endowment Fund, University of Texas Medical Branch, Galveston, Texas; NIH/NIAID Biodefense Training Program [AI060549]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, R21AI089362, T32AI060549] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Microbiology and Immunology; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas; McLaughlin Endowment Fund, University of Texas Medical Branch, Galveston, Texas; NIH/NIAID Biodefense Training Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) (R21AI089362), the Department of Microbiology and Immunology, and the Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas. V. Calderon was supported by a pre-doctoral fellowship from the McLaughlin Endowment Fund, University of Texas Medical Branch, Galveston, Texas. M. Huante was supported by an NIH/NIAID Biodefense Training Program T32 fellowship (AI060549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2007, INFECT IMMUN, V75, P5210, DOI 10.1128/IAI.00624-07; Andre MC, 2010, J IMMUNOL, V185, P2710, DOI 10.4049/jimmunol.1000583; Arnold L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018045; Babu GR, 2012, TUBERCULOSIS, V92, P301, DOI 10.1016/j.tube.2012.02.009; Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Bente DA, 2005, J VIROL, V79, P13797, DOI 10.1128/JVI.79.21.13797-13799.2005; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brenchley JM, 2011, BLOOD, V118, P847, DOI 10.1182/blood-2010-12-325936; Collins J, 1998, AM J ROENTGENOL, V171, P365, DOI 10.2214/ajr.171.2.9694453; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Denton PW, 2011, AIDS REV, V13, P135; Denton PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008829; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Diedrich CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009611; DIELI S, 1998, SCIENCE, V282, P121; Driver ER, 2012, ANTIMICROB AGENTS CH, V56, P3181, DOI 10.1128/AAC.00217-12; Endsley JJ, 2007, VACCINE, V25, P8384, DOI 10.1016/j.vaccine.2007.10.011; Endsley JJ, 2006, J LEUKOCYTE BIOL, V79, P71, DOI 10.1189/jlb.0505239; Endsley JJ, 2004, J IMMUNOL, V173, P2607, DOI 10.4049/jimmunol.173.4.2607; Flynn JL, 2003, TUBERCULOSIS, V83, P116, DOI 10.1016/S1472-9792(02)00059-8; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gille C, 2012, HUM IMMUNOL, V73, P346, DOI 10.1016/j.humimm.2012.01.006; Guidry TV, 2006, MICROBIOL-SGM, V152, P3765, DOI 10.1099/mic.0.29290-0; Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786; Helke KL, 2006, TUBERCULOSIS, V86, P337, DOI 10.1016/j.tube.2005.09.001; Hoff DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017550; Hogg AE, 2009, J LEUKOCYTE BIOL, V86, P1191, DOI 10.1189/jlb.0409222; Hogg A, 2011, TUBERCULOSIS, V91, pS75, DOI 10.1016/j.tube.2011.10.015; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Hunter RL, 2006, AM J PATHOL, V168, P1249, DOI 10.2353/ajpath.2006.050848; Hunter RL, 2007, TUBERCULOSIS, V87, P267, DOI 10.1016/j.tube.2006.11.003; Hunter RL, 2011, TUBERCULOSIS, V91, P497, DOI 10.1016/j.tube.2011.03.007; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Jaiswal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007251; Kaushal D, 2012, J MED PRIMATOL, V41, P191, DOI 10.1111/j.1600-0684.2012.00536.x; KONG Y, 2011, CURR PROTOC MICROBIO; Kong Y, 2010, P NATL ACAD SCI USA, V107, P12239, DOI 10.1073/pnas.1000643107; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; Larsen M. H, 2007, CURR PROTOC MICROBIO; Libby SJ, 2010, P NATL ACAD SCI USA, V107, P15589, DOI 10.1073/pnas.1005566107; Ly LH, 2009, INDIAN J EXP BIOL, V47, P432; Marsden MD, 2012, J VIROL, V86, P339, DOI 10.1128/JVI.06366-11; Mattila JT, 2011, J IMMUNOL, V186, P3527, DOI 10.4049/jimmunol.1003773; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; Mehra S, 2011, J MED PRIMATOL, V40, P233, DOI 10.1111/j.1600-0684.2011.00485.x; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Moreno A, 2006, INT J PARASITOL, V36, P361, DOI 10.1016/j.ijpara.2005.10.012; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Ochoa MT, 2001, NAT MED, V7, P174, DOI 10.1038/84620; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Tanaka S, 2012, J IMMUNOL, V188, P6145, DOI 10.4049/jimmunol.1103660; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zelmer A, 2012, J ANTIMICROB CHEMOTH, V67, P1948, DOI 10.1093/jac/dks161; Zheng CF, 2007, BLOOD, V109, P2049, DOI 10.1182/blood-2006-03-009720	61	66	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63331	10.1371/journal.pone.0063331	http://dx.doi.org/10.1371/journal.pone.0063331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691024	Green Submitted, gold, Green Published			2022-12-25	WOS:000319107900036
J	Nagy, Z; Alexander, DC; Thomas, DL; Weiskopf, N; Sereno, MI				Nagy, Zoltan; Alexander, Daniel C.; Thomas, David L.; Weiskopf, Nikolaus; Sereno, Martin I.			Using High Angular Resolution Diffusion Imaging Data to Discriminate Cortical Regions	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; TRANSMIT FIELD; THICKNESS; BRAIN; SEGMENTATION; LOCALIZATION; ORIENTATION; ANISOTROPY; SCHEMES; DENSITY	Brodmann's 100-year-old summary map has been widely used for cortical localization in neuroscience. There is a pressing need to update this map using non-invasive, high-resolution and reproducible data, in a way that captures individual variability. We demonstrate here that standard HARDI data has sufficiently diverse directional variation among grey matter regions to inform parcellation into distinct functional regions, and that this variation is reproducible across scans. This characterization of the signal variation as non-random and reproducible is the critical condition for successful cortical parcellation using HARDI data. This paper is a first step towards an individual cortex-wide map of grey matter microstructure, The gray/white matter and pial boundaries were identified on the high-resolution structural MRI images. Two HARDI data sets were collected from each individual and aligned with the corresponding structural image. At each vertex point on the surface tessellation, the diffusion-weighted signal was extracted from each image in the HARDI data set at a point, half way between gray/white matter and pial boundaries. We then derived several features of the HARDI profile with respect to the local cortical normal direction, as well as several fully orientationally invariant features. These features were taken as a fingerprint of the underlying grey matter tissue, and used to distinguish separate cortical areas. A support-vector machine classifier, trained on three distinct areas in repeat 1 achieved 80-82% correct classification of the same three areas in the unseen data from repeat 2 in three volunteers. Though gray matter anisotropy has been mostly overlooked hitherto, this approach may eventually form the foundation of a new cortical parcellation method in living humans. Our approach allows for further studies on the consistency of HARDI based parcellation across subjects and comparison with independent microstructural measures such as ex-vivo histology.	[Nagy, Zoltan; Weiskopf, Nikolaus] UCL, UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Alexander, Daniel C.] UCL, Dept Comp Sci, Ctr Med Image Comp, London, England; [Thomas, David L.] UCL, UCL Inst Neurol, Dept Brain Repair & Rehabil, London, England; [Sereno, Martin I.] UCL, London, England; [Sereno, Martin I.] Univ London, Birkbeck Coll, Dept Psychol, London WC1E 7HU, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; Birkbeck University London	Nagy, Z (corresponding author), UCL, UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	z.nagy@ucl.ac.uk	Sereno, Martin I/F-7657-2012; Nagy, Zoltan/AAI-2485-2019; Weiskopf, Nikolaus/B-9357-2008	Sereno, Martin I/0000-0002-7598-7829; Nagy, Zoltan/0000-0001-6611-6362; Weiskopf, Nikolaus/0000-0001-5239-1881; Thomas, David/0000-0003-1491-1641; Alexander, Daniel/0000-0003-2439-350X	Wolfson Royal Society Grant; NIH [RO1 MH 081990]; EPSRC [EP/E007748, EP/H046410/01]; EU CONNECT consortium; Wellcome Trust [079866/Z/06/Z]; SLMS Captial Equipment funding, UCL; UCLH/UCL CBRC; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081990] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/G007748/1] Funding Source: researchfish; EPSRC [EP/G007748/1] Funding Source: UKRI	Wolfson Royal Society Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU CONNECT consortium; Wellcome Trust(Wellcome TrustEuropean Commission); SLMS Captial Equipment funding, UCL; UCLH/UCL CBRC; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work and open access to the publication were supported by the Wellcome Trust (079866/Z/06/Z). MIS is supported by The Wolfson Royal Society Grant and the NIH (RO1 MH 081990). DCA is supported by EPSRC (EP/E007748 and EP/H046410/01) and the EU CONNECT consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Wellcome Trust Centre for Neuroimaging is supported by the Wellcome Trust. The Centre has an institutional research agreement with Siemens Healthcare. NW is Associate Editor of the journal Frontiers in Brain Imaging Methods, provides scientific advice for different multi-center studies/imaging center and works as a professional consultant on MRI scanners. NW received research funding from the Wellcome Trust; the SLMS Captial Equipment funding, UCL; UCLH/UCL CBRC. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Amaral D.G., 2000, PRINCIPLES NEURAL SC, V4, P317; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Annese J, 2005, CEREB CORTEX, V15, P1044, DOI 10.1093/cercor/bhh205; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Brodmann, 1909, VERGLEICHENDE LOKALI; Brodmann K, 2006, BROADMANNS LOCALISAT; Budde MD, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00003; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deoni J, 2006, P ISMRM 14 ANN M, P2734; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Geyer S, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00019; Ghosh Aurobrata, 2012, P COMP DIFF MRI WORK; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Haroon H, 2010, P OHBM 16 ANN M; Heidemann RM, 2010, MAGN RESON MED, V64, P9, DOI 10.1002/mrm.22480; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Jansons KM, 2003, LECT NOTES COMPUT SC, V2732, P672; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kleinnijenhuis M., 2011, P INT SOC MAGN RESON, P2085; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lutti A, 2013, NEUROIMAGE UNPUB; Lutti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032379; Lutti A, 2010, MAGN RESON MED, V64, P229, DOI 10.1002/mrm.22421; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; McNab JA, 2013, NEUROIMAGE, V69, P87, DOI 10.1016/j.neuroimage.2012.11.065; Mohammadi S, 2013, NEUROIMAGE, V70, P377, DOI 10.1016/j.neuroimage.2012.12.058; Nagy Z, 2007, MAGN RESON MED, V58, P763, DOI 10.1002/mrm.21379; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Papadakis NG, 1999, J MAGN RESON, V137, P67, DOI 10.1006/jmre.1998.1673; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Sereno MI, 2013, CEREB CORTEX, V23, P2261, DOI 10.1093/cercor/bhs213; Seunarine KK, DIFFUSION MRI, P55; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Solano-Castiella E, 2010, NEUROIMAGE, V49, P2958, DOI 10.1016/j.neuroimage.2009.11.027; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Uylings HB, 2008, HDB BRAIN BEHAV HUMA, P63; Vogt C., 1919, J PSYCHOL NEUROL, V25, P279; von Economo C, 1925, CYTOARCHITEKTONIK HI; von Meynert T, 1867, VIERTELJSCHR PSYCHIA, V1, P126; Weiskopf N, 2011, NEUROIMAGE, V54, P2116, DOI 10.1016/j.neuroimage.2010.10.023; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang H, 2011, NEUROIMAGE, V56, P1301, DOI 10.1016/j.neuroimage.2011.01.084; Zilles K, 2004, J ANAT, V205, P417, DOI 10.1111/j.0021-8782.2004.00357.x; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	61	29	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63842	10.1371/journal.pone.0063842	http://dx.doi.org/10.1371/journal.pone.0063842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691102	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000319107900062
J	Nylander, A; Svensater, G; Senadheera, DB; Cvitkovitch, DG; Davies, JR; Persson, K				Nylander, Asa; Svensater, Gunnel; Senadheera, Dilani B.; Cvitkovitch, Dennis G.; Davies, Julia R.; Persson, Karina			Structural and Functional Analysis of the N-terminal Domain of the Streptococcus gordonii Adhesin Sgo0707	PLOS ONE			English	Article							ANTIGEN-I/II FAMILY; CRYSTAL-STRUCTURE; SURFACE-PROTEINS; PILUS ADHESIN; WEB SERVER; BINDING; COLLAGEN; IDENTIFICATION; MODEL; HSA	The commensal Streptococcus gordonii expresses numerous surface adhesins with which it interacts with other microorganisms, host cells and salivary proteins to initiate dental plaque formation. However, this Gram-positive bacterium can also spread to non-oral sites such as the heart valves and cause infective endocarditis. One of its surface adhesins, Sgo0707, is a large protein composed of a non-repetitive N-terminal region followed by several C-terminal repeat domains and a cell wall sorting motif. Here we present the crystal structure of the Sgo0707 N-terminal domains, refined to 2.1 A resolution. The model consists of two domains, N1 and N2. The largest domain, N1, comprises a putative binding cleft with a single cysteine located in its centre and exhibits an unexpected structural similarity to the variable domains of the streptococcal Antigen I/II adhesins. The N2-domain has an IgG-like fold commonly found among Gram-positive surface adhesins. Binding studies performed on S. gordonii wild-type and a Sgo0707 deficient mutant show that the Sgo0707 adhesin is involved in binding to type-1 collagen and to oral keratinocytes.	[Nylander, Asa] Umea Univ, Dept Odontol, Div Oral Microbiol, Umea, Sweden; [Svensater, Gunnel; Davies, Julia R.] Malmo Univ, Fac Odontol, Dept Oral Biol, Malmo, Sweden; [Senadheera, Dilani B.; Cvitkovitch, Dennis G.] Univ Toronto, Dent Res Inst, Toronto, ON, Canada; [Persson, Karina] Umea Univ, Dept Chem, Umea, Sweden	Umea University; Malmo University; University of Toronto; Umea University	Persson, K (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	karina.persson@chem.umu.se	Svensäter, Gunnel/S-8250-2018; Cvitkovitch, Dennis/AAF-9311-2020; Davies, Julia/H-4194-2011	Davies, Julia/0000-0001-5888-664X	Umea Center for Microbial Research and the Swedish Research Council [2011-4186]; NIH [R01DE013230-03, CIHR-MT15431]; Swedish Dental Society and the Knowledge Foundation; SHEFC; BBSRC; Swedish National Graduate School in Odontological Science [01944647]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013230] Funding Source: NIH RePORTER	Umea Center for Microbial Research and the Swedish Research Council; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Dental Society and the Knowledge Foundation; SHEFC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish National Graduate School in Odontological Science; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by Umea Center for Microbial Research and the Swedish Research Council grant 2011-4186 to KP, NIH grant R01DE013230-03 and CIHR-MT15431 to DGC, the Swedish Dental Society and the Knowledge Foundation to JRD and GS. The Aberdeen Proteome Facility is funded by the SHEFC and BBSRC. angstrom N is supported by The Swedish National Graduate School in Odontological Science. Case No 01944647. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Davies JR, 2009, MICROBIOL-SGM, V155, P1977, DOI 10.1099/mic.0.027854-0; de Paz LEC, 2009, APPL ENVIRON MICROB, V75, P1734, DOI 10.1128/AEM.02000-08; Demuth DR, 1996, MOL MICROBIOL, V20, P403, DOI 10.1111/j.1365-2958.1996.tb02627.x; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Forsgren N, 2009, PROTEIN SCI; Heddle C, 2003, MOL MICROBIOL, V50, P597, DOI 10.1046/j.1365-2958.2003.03711.x; Holm L, 2006, CURRENT PROTOCOLS BI; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Jakubovics NS, 2005, INFECT IMMUN, V73, P6629, DOI 10.1128/IAI.73.10.6629-6638.2005; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; Jenkinson HF, 1997, MOL MICROBIOL, V23, P183, DOI 10.1046/j.1365-2958.1997.2021577.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kesimer M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-163; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; Linke C, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.376434; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNab R, 1996, INFECT IMMUN, V64, P4204, DOI 10.1128/IAI.64.10.4204-4210.1996; McNab R, 1999, J BACTERIOL, V181, P3087, DOI 10.1128/JB.181.10.3087-3095.1999; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Nakano K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1491; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Ponnuraj K, 2007, PROTEINS, V69, P199, DOI 10.1002/prot.21464; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Ramboarina S, 2010, J BIOL CHEM, V285, P32446, DOI 10.1074/jbc.M110.128165; Shen S, 2005, ARCH ORAL BIOL, V50, P23, DOI 10.1016/j.archoralbio.2004.07.002; Siqueira WL, 2007, J PROTEOME RES, V6, P2152, DOI 10.1021/pr060580k; Takahashi Y, 2006, INFECT IMMUN, V74, P740, DOI 10.1128/IAI.74.1.740-743.2006; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Thomas GJ, 2001, CRIT REV ORAL BIOL M, V12, P479, DOI 10.1177/10454411010120060301; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	53	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63768	10.1371/journal.pone.0063768	http://dx.doi.org/10.1371/journal.pone.0063768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691093	Green Published, gold			2022-12-25	WOS:000319107900058
J	Ishikawa, D; Takeuchi, S; Nakagawa, T; Sano, T; Nakade, J; Nanjo, S; Yamada, T; Ebi, H; Zhao, L; Yasumoto, K; Nakamura, T; Matsumoto, K; Kagamu, H; Yoshizawa, H; Yano, S				Ishikawa, Daisuke; Takeuchi, Shinji; Nakagawa, Takayuki; Sano, Takako; Nakade, Junya; Nanjo, Shigeki; Yamada, Tadaaki; Ebi, Hiromichi; Zhao, Lu; Yasumoto, Kazuo; Nakamura, Takahiro; Matsumoto, Kunio; Kagamu, Hiroshi; Yoshizawa, Hirohisa; Yano, Seiji			mTOR Inhibitors Control the Growth of EGFR Mutant Lung Cancer Even after Acquiring Resistance by HGF	PLOS ONE			English	Article							MET KINASE INHIBITOR; GEFITINIB RESISTANCE; MESENCHYMAL TRANSITION; NONSMALL CELL; MUTATIONS; THERAPY; EXPRESSION; AMPLIFICATION; ACTIVATION; EVEROLIMUS	Resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), gefitinib and erlotinib, is a critical problem in the treatment of EGFR mutant lung cancer. Several mechanisms, including bypass signaling by hepatocyte growth factor (HGF)-triggered Met activation, are implicated as mediators of resistance. The mammalian target of rapamycin (mTOR), is a downstream conduit of EGFR and MET signaling, and is thus considered a therapeutically attractive target in the treatment of various types of cancers. The purpose of this study was to examine whether 2 clinically approved mTOR inhibitors, temsirolimus and everolimus, overcome HGF-dependent resistance to EGFR-TKIs in EGFR mutant lung cancer cells. Both temsirolimus and everolimus inhibited the phosphorylation of p70S6K and 4E-BP1, which are downstream targets of the mTOR pathway, and reduced the viability of EGFR mutant lung cancer cells, PC-9, and HCC827, even in the presence of HGF in vitro. In a xenograft model, temsirolimus suppressed the growth of PC-9 cells overexpressing the HGF-gene; this was associated with suppression of the mTOR signaling pathway and tumor angiogenesis. In contrast, erlotinib did not suppress this signaling pathway or tumor growth. Multiple mechanisms, including the inhibition of vascular endothelial growth factor production by tumor cells and suppression of endothelial cell viability, contribute to the anti-angiogenic effect of temsirolimus. These findings indicate that mTOR inhibitors may be useful for controlling HGF-triggered EGFR-TKI resistance in EGFR mutant lung cancer, and they provide the rationale for clinical trials of mTOR inhibitors in patients stratified by EGFR mutation and HGF expression status.	[Ishikawa, Daisuke; Takeuchi, Shinji; Nakagawa, Takayuki; Sano, Takako; Nakade, Junya; Nanjo, Shigeki; Yamada, Tadaaki; Ebi, Hiromichi; Zhao, Lu; Yasumoto, Kazuo; Yano, Seiji] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 920, Japan; [Nakamura, Takahiro; Matsumoto, Kunio] Kanazawa Univ, Canc Res Inst, Div Tumor Dynam & Regulat, Kanazawa, Ishikawa 920, Japan; [Kagamu, Hiroshi; Yoshizawa, Hirohisa] Niigata Univ, Med & Dent Hosp, Dept Med 2, Niigata, Japan	Kanazawa University; Kanazawa University; Niigata University	Yano, S (corresponding author), Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 920, Japan.	syano@staff.kanazawa-u.ac.jp	Ebi, Hiromichi/AAA-7358-2019; Yamada, Tadaaki/L-5378-2015; YANO, SEIJI/D-8465-2015; Matsumoto, Kunio/D-8441-2015	Ebi, Hiromichi/0000-0003-3155-7576; Yamada, Tadaaki/0000-0002-6945-281X; Matsumoto, Kunio/0000-0002-6532-4482	KAKENHI; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Chugai Pharmaceutical Co., Ltd.; Kyowa Hakko Kirin Co., Ltd.; Eisai Co., Ltd.	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chugai Pharmaceutical Co., Ltd.; Kyowa Hakko Kirin Co., Ltd.(Kyowa Kirin Ltd); Eisai Co., Ltd.(Eisai Co Ltd)	This study was supported by KAKENHI (Grants-in-Aid for Scientific Research on Innovative Areas 'Integrative Research on Cancer Microenvironment Network' (to SY) and Grant-in-Aid for Young Scientists (to TY and ST)), and Grants-in-Aid for Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Seiji Yano received honoraria from Chugai Pharmaceutical Co., Ltd. and AstraZeneca. Seiji Yano received research funding from Chugai Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd. and Eisai Co., Ltd. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Donev IS, 2011, CLIN CANCER RES, V17, P2260, DOI 10.1158/1078-0432.CCR-10-1993; Dong S, 2012, CANCER CHEMOTH PHARM, V70, P707, DOI 10.1007/s00280-012-1946-3; Ekman S, 2012, J THORAC ONCOL, V7, P947, DOI 10.1097/JTO.0b013e31825581bd; Endoh H, 2006, J THORAC ONCOL, V1, P629; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Feng X, 2010, US PHARM, V35, P4; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Habib Samy L, 2011, Genes Cancer, V2, P1051, DOI 10.1177/1947601912445376; Hudson CC, 2003, MOL CELL, V11, P1491; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Leighl NB, 2012, J CLIN ONCOL, V28, P7524; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Morinaga R, 2007, LUNG CANCER, V58, P411, DOI 10.1016/j.lungcan.2007.05.014; Nakagawa T, 2012, MOL CANCER THER, V11, P2149, DOI 10.1158/1535-7163.MCT-12-0195; Oh MH, 2012, VIRCHOWS ARCH, V460, P601, DOI 10.1007/s00428-012-1239-6; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Papadimitrakopoulou VA, 2012, J THORAC ONCOL, V7, P1594, DOI 10.1097/JTO.0b013e3182614835; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Price KA, 2012, J THORAC ONCOL, V1, P1623; Reungwetwattana T, 2012, J THORAC ONCOL, V7, P919, DOI 10.1097/JTO.0b013e31824de0d6; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; TAKEBAYASHI T, 1995, J CELL BIOL, V129, P1411, DOI 10.1083/jcb.129.5.1411; Takeuchi S, 2012, AM J PATHOL, V181, P1034, DOI 10.1016/j.ajpath.2012.05.023; Tatematsu A, 2008, CLIN CANCER RES, V14, P6092, DOI 10.1158/1078-0432.CCR-08-0332; Turke AB, 2010, CANCER CELL, V17, P174; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Uramoto H, 2011, LUNG CANCER, V73, P361, DOI 10.1016/j.lungcan.2011.01.008; Uramoto H, 2010, ANTICANCER RES, V30, P2513; Wang W, 2012, CLIN CANCER RES, V18, P1663, DOI 10.1158/1078-0432.CCR-11-1171; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Yamada T, 2012, CLIN CANCER RES, V18, P3592, DOI 10.1158/1078-0432.CCR-11-2972; Yamada T, 2010, CLIN CANCER RES, V16, P174, DOI 10.1158/1078-0432.CCR-09-1204; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yano S, 2012, CANCER SCI, V103, P1189, DOI 10.1111/j.1349-7006.2012.02279.x; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Yasuda H, 2012, LANCET ONCOL, V13, pE23, DOI 10.1016/S1470-2045(11)70129-2; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200; Zakowski MF, 2006, NEW ENGL J MED, V355, P213, DOI 10.1056/NEJMc053610; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	50	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62104	10.1371/journal.pone.0062104	http://dx.doi.org/10.1371/journal.pone.0062104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690929	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400008
J	Liu, TB; Wang, YN; Baker, GM; Fahmy, H; Jiang, LH; Xue, CY				Liu, Tong-Bao; Wang, Yina; Baker, Gregory M.; Fahmy, Hany; Jiang, Linghuo; Xue, Chaoyang			The Glucose Sensor-Like Protein Hxs1 Is a High-Affinity Glucose Transporter and Required for Virulence in Cryptococcus neoformans	PLOS ONE			English	Article							COUPLED RECEPTOR; SACCHAROMYCES-CEREVISIAE; HEXOSE TRANSPORTER; IDENTIFICATION; MECHANISMS; EXPRESSION; PATHWAYS; SUBUNIT; GENES; GPR1	Cryptococcus is a major fungal pathogen that frequently causes systemic infection in patients with compromised immunity. Glucose, an important signal molecule and the preferred carbon source for Cryptococcus, plays a critical role in fungal development and virulence. Cryptococcus contains more than 50 genes sharing high sequence homology with hexose transporters in Saccharomyces cerevisiae. However, there is no report on their function in glucose sensing or transport. In this study, we investigated two hexose transporter-like proteins (Hxs1 and Hxs2) in Cryptococcus that share the highest sequence identity with the glucose sensors Snf3 and Rgt2 in S. cerevisiae. The expression of HXS1 is repressed by high glucose, while the HXS2 expression is not regulated by glucose. Functional studies showed that Hxs1 is required for fungal resistance to oxidative stress and fungal virulence. The hxs1 Delta mutant exhibited a significant reduction in glucose uptake activity, indicating that Hxs1 is required for glucose uptake. Heterologous expression of Cryptococcus HXS1 rendered the S. cerevisiae mutant lacking all 20 hexose transporters a high glucose uptake activity, demonstrating that Hxs1 functions as a glucose transporter. Heterologous expression of HXS1 in the snf3 Delta rgt2 Delta double mutant did not complement its growth in YPD medium containing the respiration inhibitor antimycin A, suggesting that Hxs1 may not function as a glucose sensor. Taken together, our results demonstrate that Hxs1 is a high-affinity glucose transporter and required for fungal virulence.	[Liu, Tong-Bao; Wang, Yina; Baker, Gregory M.; Fahmy, Hany; Xue, Chaoyang] Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Newark, NJ 07103 USA; [Xue, Chaoyang] Univ Med & Dent New Jersey, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Wang, Yina] Tianjing Med Univ, Tianjin, Peoples R China; [Jiang, Linghuo] Jiangnan Univ, Sch Biotechnol, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tianjin Medical University; Jiangnan University	Xue, CY (corresponding author), Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Newark, NJ 07103 USA.	xuech@umdnj.edu	Wang, Yina/N-8534-2017; LIU, Tong-Bao/GQA-8152-2022; Liu, Tongbao/I-4170-2013	Wang, Yina/0000-0003-1909-728X; LIU, Tong-Bao/0000-0002-9111-8826; Liu, Tongbao/0000-0002-9111-8826	American Heart Association [12SDG9110034]; Key Project of Jiangnan University Independent Scientific Research Plan [JUSRP51313B]	American Heart Association(American Heart Association); Key Project of Jiangnan University Independent Scientific Research Plan	This study was supported by American Heart Association grant 12SDG9110034 to C.X.. L.J. was supported by the Key Project of Jiangnan University Independent Scientific Research Plan (JUSRP51313B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Brown V, 2006, EUKARYOT CELL, V5, P1726, DOI 10.1128/EC.00186-06; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Chikamori M, 2005, FUNGAL GENET BIOL, V42, P646, DOI 10.1016/j.fgb.2005.04.004; D'Souza CA, 2001, FEMS MICROBIOL REV, V25, P349, DOI 10.1111/j.1574-6976.2001.tb00582.x; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Hicks JK, 2005, EUKARYOT CELL, V4, P1971, DOI 10.1128/EC.4.12.1971-1981.2005; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Johnston M, 2005, BIOCHEM SOC T, V33, P247, DOI 10.1042/BST0330247; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kronstad J, 2012, EUKARYOT CELL, V11, P109, DOI 10.1128/EC.05273-11; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Liu TB, 2011, EUKARYOT CELL, V10, P791, DOI 10.1128/EC.00004-11; Luberto C, 2003, J CLIN INVEST, V112, P1080, DOI 10.1172/JCI200318309; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Okagaki LH, 2011, EUKARYOT CELL, V10, P1306, DOI 10.1128/EC.05179-11; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Ozcan S, 1997, YEAST, V13, P127; Price MS, 2011, MBIO, V2, DOI 10.1128/mBio.00103-11; Pukkila-Worley R, 2004, FEMS YEAST RES, V4, P361, DOI 10.1016/S1567-1356(03)00241-1; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Stasyk OG, 2008, EUKARYOT CELL, V7, P735, DOI 10.1128/EC.00028-08; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; Wang P, 1999, CURR OPIN MICROBIOL, V2, P358, DOI 10.1016/S1369-5274(99)80063-0; Wang YN, 2011, EUKARYOT CELL, V10, P618, DOI 10.1128/EC.00327-10; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Williams V, 2011, EUKARYOT CELL, V10, P293, DOI 10.1128/EC.00252-10; Xue CY, 2010, MBIO, V1, DOI 10.1128/mBio.00084-10; Xue CY, 2006, MOL BIOL CELL, V17, P667, DOI 10.1091/mbc.E05-07-0699; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Yankulov K, 2011, NUCLEUS-PHILA, V2, P513, DOI 10.4161/nucl.2.6.17710	38	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64239	10.1371/journal.pone.0064239	http://dx.doi.org/10.1371/journal.pone.0064239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691177	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400108
J	McCaskill, JL; Marsh, GA; Monaghan, P; Wang, LF; Doran, T; McMillan, NAJ				McCaskill, Jana L.; Marsh, Glenn A.; Monaghan, Paul; Wang, Lin-Fa; Doran, Timothy; McMillan, Nigel A. J.			Potent Inhibition of Hendra Virus Infection via RNA Interference and Poly I:C Immune Activation	PLOS ONE			English	Article							NIPAH-VIRUS; W-PROTEIN; V-PROTEIN; HORSES; THERAPEUTICS; TRANSMISSION; ACCUMULATION; ENCEPHALITIS; RIBAVIRIN; THERAPY	Hendra virus (HeV) is a highly pathogenic zoonotic paramyxovirus that causes fatal disease in a wide range of species, including humans. HeV was first described in Australia in 1994, and has continued to re-emerge with increasing frequency. HeV is of significant concern to human health due to its high mortality rate, increasing emergence, absence of vaccines and limited post exposure therapies. Here we investigate the use of RNA interference (RNAi) based therapeutics targeting HeV in conjunction with the TLR3 agonist Poly I:C and show that they are potent inhibitors of HeV infection in vitro. We found that short interfering RNAs (siRNAs) targeting the abundantly expressed N, P and M genes of HeV caused over 95% reduction of HeV virus titre, protein and mRNA. Furthermore, we found that the combination of HeV targeting siRNA and Poly I:C had an additive effect in suppressing HeV infection. Our results demonstrate for the first time that RNAi and type I interferon stimulation are effective inhibitors of HeV replication in vitro and may provide an effective therapy for this highly lethal, zoonotic pathogen.	[McCaskill, Jana L.; McMillan, Nigel A. J.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Marsh, Glenn A.; Monaghan, Paul; Wang, Lin-Fa; Doran, Timothy] CSIRO, Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [McMillan, Nigel A. J.] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4215, Australia; [McMillan, Nigel A. J.] Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Griffith University; Menzies Health Institute Queensland; Griffith University	McMillan, NAJ (corresponding author), Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia.	n.mcmillan@griffith.edu.au	McMillan, Nigel/AAQ-5416-2021; Doran, Timothy J/B-3824-2011; Marsh, Glenn A/A-5418-2013; wang, lin/GSE-3040-2022; Monaghan, Paul/H-1973-2013	Doran, Timothy J/0000-0002-9716-5148; Marsh, Glenn A/0000-0002-3469-1837; McMillan, Nigel/0000-0002-9471-1406	National Health and Medical Research Council (NHMRC) of Australia [1040904, 631402]; UQ Diamantina Institute; Australian Postgraduate Award; Australian Federation of Graduate Women Fellowship; Australian Microscopy and Microanalysis Research Facility	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); UQ Diamantina Institute; Australian Postgraduate Award(Australian Government); Australian Federation of Graduate Women Fellowship; Australian Microscopy and Microanalysis Research Facility	This work was supported by program grant APP 1040904 and 631402 from the National Health and Medical Research Council (NHMRC) of Australia. JM was supported by UQ Diamantina Institute, Australian Postgraduate Award and the Australian Federation of Graduate Women Fellowship. The authors acknowledge the support of the Australian Microscopy and Microanalysis Research Facility. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellini WJ, 2005, J NEUROVIROL, V11, P481, DOI 10.1080/13550280500187435; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Bossart KN, 2011, SCI TRANSL MED, V3; Broder CC, 2012, CURR OPIN VIROL, V2, P176, DOI 10.1016/j.coviro.2012.02.016; Burnett JC, 2011, BIOTECHNOL J, V6, P1130, DOI 10.1002/biot.201100054; Buti M, 2011, CLIN LIVER DIS, V15, P473, DOI 10.1016/j.cld.2011.05.007; Crameri G, 2002, J VIROL METHODS, V99, P41, DOI 10.1016/S0166-0934(01)00377-9; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Georges-Courbot MC, 2006, ANTIMICROB AGENTS CH, V50, P1768, DOI 10.1128/AAC.50.5.1768-1772.2006; Gish RG, 2011, ANTIVIR THER, V16, P547, DOI 10.3851/IMP1798; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Homaira N, 2010, EPIDEMIOL INFECT, P1; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Khairuddin N, 2011, IMMUNOL CELL BIOL; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Marsh GA, 2012, CURR OPIN VIROL; Marsh GA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-95; Marsh GA, 2011, EMERG INFECT DIS, V17, P2232, DOI 10.3201/eid1712.111162; Marsh GA, 2010, EMERG INFECT DIS, V16, P1767, DOI 10.3201/eid1611.100501; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Mungall BA, 2008, ANTIVIR RES, V80, P324, DOI 10.1016/j.antiviral.2008.07.004; OSullivan JD, 1997, LANCET, V349, P93, DOI 10.1016/S0140-6736(96)06162-4; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rodriguez JJ, 2004, VIRAL IMMUNOL, V17, P210, DOI 10.1089/0882824041310568; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Shaw ML, 2005, J VIROL, V79, P6078, DOI 10.1128/JVI.79.10.6078-6088.2005; Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004; Tulac S, 2004, MOL HUM REPROD, V10, P705, DOI 10.1093/molehr/gah105; Virtue ER, 2011, J VIROL, V85, P4031, DOI 10.1128/JVI.02412-10; Wright PJ, 2005, ARCH VIROL, V150, P521, DOI 10.1007/s00705-004-0417-5; Wu SY, 2011, GENE THER, V18, P14, DOI 10.1038/gt.2010.113	35	8	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64360	10.1371/journal.pone.0064360	http://dx.doi.org/10.1371/journal.pone.0064360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691205	Green Published, gold			2022-12-25	WOS:000319107400122
J	Ostermann, C; Ruttger, A; Schubert, E; Schrodl, W; Sachse, K; Reinhold, P				Ostermann, Carola; Ruettger, Anke; Schubert, Evelyn; Schroedl, Wieland; Sachse, Konrad; Reinhold, Petra			Infection, Disease, and Transmission Dynamics in Calves after Experimental and Natural Challenge with a Bovine Chlamydia psittaci Isolate	PLOS ONE			English	Article							CHLAMYDOPHILA-PSITTACI; PET BIRDS; PREVALENCE; SPP.; CATTLE; ASSOCIATION; NEUTROPHILS; POPULATION; PNEUMONIAE; PROTEINS	Chlamydia (C.) psittaci is the causative agent of psittacosis, a zoonotic disease in birds and man. In addition, C. psittaci has been repeatedly found in domestic animals and is, at least in calves, also able to induce respiratory disease. Knowledge about transmission routes in cattle herds is still deficient, and nothing is known about differences in host response after either experimental or natural exposure to C. psittaci. Therefore, our recently developed respiratory infection model was exploited to evaluate (i) the presence of the pathogen in blood, excretions and air, (ii) the possibility of transmission and (iii) clinical symptoms, acute phase and immune response until 5 weeks after exposure. In this prospective study, intrabronchial inoculation of 10 8 inclusion-forming units of C. psittaci (n = 21 calves) led to reproducible acute respiratory illness (of approximately one week), accompanied by a systemic inflammatory reaction with an innate immune response dominated by neutrophils. Excretion and/or exhalation of the pathogen was sufficient to transmit the infection to naive sentinel calves (n = 3) co-housed with the infected animals. Sentinel calves developed mild to subclinical infections only. Notably, excretion of the pathogen, predominantly via feces, occurred more frequently in animals naturally exposed to C. psittaci (i. e. sentinels) as compared to experimentally-inoculated calves. The humoral immune response was generally weak, and did not emerge regularly following experimental infection; however, it was largely absent after naturally acquired infection.	[Ostermann, Carola; Ruettger, Anke; Schubert, Evelyn; Sachse, Konrad; Reinhold, Petra] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany; [Schubert, Evelyn; Sachse, Konrad] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, OIE World Org Anim Hlth Reference Lab Chlamydiosi, Jena, Germany; [Schroedl, Wieland] Univ Leipzig, Fac Vet, Inst Bacteriol & Mycol, D-04109 Leipzig, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Leipzig University	Ostermann, C (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany.	carola.ostermann@fli.bund.de	Sachse, Konrad/GWC-4999-2022	Sachse, Konrad/0000-0003-1230-1786	Federal Ministry of Education and Research (BMBF) of Germany [01 KI 0720]	Federal Ministry of Education and Research (BMBF) of Germany(Federal Ministry of Education & Research (BMBF))	This study was financially supported by the Federal Ministry of Education and Research (BMBF) of Germany (www.bmbf.de) under Grant no. 01 KI 0720 "Zoonotic chlamydiae - Models of chronic and persistent infections in humans and animals". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2005, IMMUNOLOGY, V114, P246, DOI 10.1111/j.1365-2567.2004.02088.x; Bashmakov YK, 2010, WORLD J HEPATOL, V2, P74, DOI 10.4254/wjh.v2.i2.74; Beeckman DSA, 2009, CLIN MICROBIOL INFEC, V15, P11, DOI 10.1111/j.1469-0691.2008.02669.x; Borel N, 2006, VET PATHOL, V43, P702, DOI 10.1354/vp.43-5-702; BOVARNICK MR, 1950, J BACTERIOL, V59, P509, DOI 10.1128/JB.59.4.509-522.1950; CAY B, 1989, VET MICROBIOL, V20, P123, DOI 10.1016/0378-1135(89)90035-7; Christian JG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002283; Confer Anthony W., 2009, Animal Health Research Reviews, V10, P145, DOI 10.1017/S1466252309990193; Del Rio L, 2000, J COMP PATHOL, V123, P171, DOI 10.1053/jcpa.2000.0411; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Gaede W, 2008, ZOONOSES PUBLIC HLTH, V55, P184, DOI 10.1111/j.1863-2378.2008.01108.x; Harkinezhad T, 2007, J MED MICROBIOL, V56, P1097, DOI 10.1099/jmm.0.47157-0; Harkinezhad T, 2009, J MED MICROBIOL, V58, P1207, DOI 10.1099/jmm.0.011379-0; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; Henning K, 2000, DEUT TIERARZTL WOCH, V107, P49; Hotzel H, 2004, VET MICROBIOL, V103, P121, DOI 10.1016/j.vetmic.2004.06.009; Igietseme JU, 2011, EXPERT REV VACCINES, V10, P1585, DOI [10.1586/erv.11.139, 10.1586/ERV.11.139]; Jee JB, 2004, J CLIN MICROBIOL, V42, P5664, DOI 10.1128/JCM.42.12.5664-5672.2004; Jiang XZ, 2010, IMMUNOLOGY, V129, P556, DOI 10.1111/j.1365-2567.2009.03157.x; Jorgensen I, 2011, CELL HOST MICROBE, V10, P21, DOI 10.1016/j.chom.2011.06.008; Kaleta EF, 2003, AVIAN PATHOL, V32, P435, DOI 10.1080/03079450310001593613; Kauffold J, 2007, ANIM REPROD SCI, V102, P111, DOI 10.1016/j.anireprosci.2006.10.013; Kauffold J, 2006, THERIOGENOLOGY, V66, P1816, DOI 10.1016/j.theriogenology.2006.04.042; Kemmerling K, 2009, J DAIRY SCI, V92, P4347, DOI 10.3168/jds.2009-2051; Lambertz J, 2011, THESIS TIERARZTLICHE; Lenzko H, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-29; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Moazed TC, 1998, J INFECT DIS, V177, P1322, DOI 10.1086/515280; Mohri M, 2007, RES VET SCI, V83, P30, DOI 10.1016/j.rvsc.2006.10.017; Moroney JF, 1998, CLIN INFECT DIS, V26, P1425, DOI 10.1086/516368; Nicholas R, 2008, MYCOPLASMA DISEASES OF RUMINANTS, P132, DOI 10.1079/9780851990125.0132; Niemczuk K., 2003, Polish Journal of Veterinary Sciences, V6, P125; Nikunen S, 2007, COMP IMMUNOL MICROB, V30, P143, DOI 10.1016/j.cimid.2006.11.004; Orro T, 2011, COMP IMMUNOL MICROB, V34, P23, DOI 10.1016/j.cimid.2009.10.005; Ostermann C, 2012, VEJ J IN PRESS; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; Poudel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044961; Reinhold P, 2008, VET J, V175, P202, DOI 10.1016/j.tvjl.2007.01.004; Reinhold P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030125; Reinhold P, 2011, VET J, V189, P257, DOI 10.1016/j.tvjl.2010.09.003; Reinhold P, 2008, VET RES, V39, DOI 10.1051/vetres:2008012; Rodolakis A, 2010, VET MICROBIOL, V140, P382, DOI 10.1016/j.vetmic.2009.03.014; Rupp J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006020; Sachse K, 2005, MOL CELL PROBE, V19, P41, DOI 10.1016/j.mcp.2004.09.005; Sachse Konrad, 2003, Methods Mol Biol, V216, P123; Sachse K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-63; Sako T, 2002, ATHEROSCLEROSIS, V162, P253, DOI 10.1016/S0021-9150(01)00710-9; Schofl G, 2011, J BACTERIOL, V193, P4258, DOI 10.1128/JB.05382-11; Schroedl W, 2001, J ENDOTOXIN RES, V7, P49, DOI 10.1179/096805101101532530; Sprague LD, 2009, VET J, V181, P274, DOI 10.1016/j.tvjl.2008.04.002; Theegarten D, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-14; Twomey DF, 2006, VET J, V171, P574, DOI 10.1016/j.tvjl.2004.12.012; Van Droogenbroeck C, 2009, VET MICROBIOL, V135, P78, DOI 10.1016/j.vetmic.2008.09.047; Van Droogenbroeck C, 2009, VET MICROBIOL, V135, P31, DOI 10.1016/j.vetmic.2008.09.042; Vanrompay D, 2007, EMERG INFECT DIS, V13, P1108, DOI 10.3201/eid1307.070074; Wehrend A, 2005, THERIOGENOLOGY, V63, P923, DOI 10.1016/j.theriogenology.2004.05.009	57	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64066	10.1371/journal.pone.0064066	http://dx.doi.org/10.1371/journal.pone.0064066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691148	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400099
J	Petrache, I; Kamocki, K; Poirier, C; Pewzner-Jung, Y; Laviad, EL; Schweitzer, KS; Van Demark, M; Justice, MJ; Hubbard, WC; Futerman, AH				Petrache, Irina; Kamocki, Krzysztof; Poirier, Christophe; Pewzner-Jung, Yael; Laviad, Elad L.; Schweitzer, Kelly S.; Van Demark, Mary; Justice, Matthew J.; Hubbard, Walter C.; Futerman, Anthony H.			Ceramide Synthases Expression and Role of Ceramide Synthase-2 in the Lung: Insight from Human Lung Cells and Mouse Models	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; SUBSTRATE-SPECIFICITY; APOPTOSIS; EMPHYSEMA; ABLATION; CHAIN; MICE	Increases in ceramide levels have been implicated in the pathogenesis of both acute or chronic lung injury models. However, the role of individual ceramide species, or of the enzymes that are responsible for their synthesis, in lung health and disease has not been clarified. We now show that C24- and C16-ceramides are the most abundant lung ceramide species, paralleled by high expression of their synthetic enzymes, ceramide synthase 2 (CerS2) and CerS5, respectively. Furthermore, the ceramide species synthesis in the lung is homeostatically regulated, since mice lacking very long acyl chain C24-ceramides due to genetic deficiency of CerS2 displayed a ten-fold increase in C16-ceramides and C16-dihydroceramides along with elevation of acid sphingomyelinase and CerS5 activities. Despite relatively preserved total lung ceramide levels, inhibition of de novo sphingolipid synthesis at the level of CerS2 was associated with significant airflow obstruction, airway inflammation, and increased lung volumes. Our results suggest that ceramide species homeostasis is crucial for lung health and that CerS2 dysfunction may predispose to inflammatory airway and airspace diseases.	[Petrache, Irina; Kamocki, Krzysztof; Poirier, Christophe; Schweitzer, Kelly S.; Van Demark, Mary; Justice, Matthew J.] Indiana Univ, Dept Med, Div Pulm & Crit Care Med, Indianapolis, IN 46204 USA; [Petrache, Irina] Richard L Roudebush Veteran Affairs Med Ctr, Indianapolis, IN USA; [Pewzner-Jung, Yael; Laviad, Elad L.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Hubbard, Walter C.] Johns Hopkins Univ, Dept Clin Pharmacol, Baltimore, MD USA	Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Weizmann Institute of Science; Johns Hopkins University	Petrache, I (corresponding author), Indiana Univ, Dept Med, Div Pulm & Crit Care Med, Indianapolis, IN 46204 USA.	ipetrach@iu.edu; tony.futerman@weizmann.ac.il	Pewzner, Faivish/I-6225-2017; Petrache, Irina/AAZ-9648-2020	Pewzner, Faivish/0000-0002-7490-8121; Futerman, Anthony/0000-0003-0013-0115	NIH [R01HL077328]; Reba and John Smith Chair of Respiratory Diseases; English Chair of Respiratory Diseases; Bi-national Scientific Foundation [2009242]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077328, R01HL105772] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reba and John Smith Chair of Respiratory Diseases; English Chair of Respiratory Diseases; Bi-national Scientific Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH R01HL077328 (IP), the Reba and John Smith and English Chairs of Respiratory Diseases (IP) and a Bi-national Scientific Foundation research grant (2009242) (IP and AHF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN ND, 1988, NATURE, V333, P852, DOI 10.1038/333852a0; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Ben-David O, 2011, J BIOL CHEM, V286, P30022, DOI 10.1074/jbc.M111.261206; Breslow DK, NATURE, V463, P1048; Clauss M, 2011, J CLIN INVEST, V121, P2470, DOI 10.1172/JCI43881; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Kamocki K, 2013, AM J RESP CELL MOL, V48, P87, DOI 10.1165/rcmb.2012-0254OC; Kroesen BJ, 2003, J BIOL CHEM, V278, P14723, DOI 10.1074/jbc.M210756200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Medler TR, 2008, AM J RESP CELL MOL, V38, P639, DOI 10.1165/rcmb.2007-0274OC; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Renert AF, 2009, J PROTEOME RES, V8, P4810, DOI 10.1021/pr9005316; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719	19	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62968	10.1371/journal.pone.0062968	http://dx.doi.org/10.1371/journal.pone.0062968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690971	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400025
J	van Well, GTJ; Sanders, MS; Ouburg, S; Kumar, V; van Furth, AM; Morre, SA				van Well, Gijs Th J.; Sanders, Marieke S.; Ouburg, Sander; Kumar, Vinod; van Furth, A. Marceline; Morre, Servaas A.			Single Nucleotide Polymorphisms in Pathogen Recognition Receptor Genes Are Associated with Susceptibility to Meningococcal Meningitis in a Pediatric Cohort	PLOS ONE			English	Article							NERVOUS-SYSTEM INFECTIONS; TOLL-LIKE RECEPTOR-4; BACTERIAL-MENINGITIS; PNEUMOCOCCAL MENINGITIS; INFLAMMATORY RESPONSES; SCHOOL-AGE; DISEASE; TLR4; NOD2; MUTATIONS	Bacterial meningitis (BM) is a serious infection of the central nervous system, frequently occurring in childhood and often resulting in hearing loss, learning disabilities, and encephalopathy. Previous studies showed that genetic variation in innate immune response genes affects susceptibility, severity, and outcome of BM. The aim of this study is to describe whether single nucleotide polymorphisms (SNPs) in pathogen recognition gene products are associated with susceptibility to develop BM in single genes analysis as well as SNP combinations. Genotype frequencies of seven SNPs, in five immune response genes encoding for Toll-like receptors (TLRs), nucleotide oligomerization domain (NOD) proteins and caspase-1 (CASP1), in 391 children with meningococcal meningitis (MM) and 82 children with pneumococcal meningitis were compared with a large cohort of 1141 ethnically matched healthy controls. Carriage of TLR4 +896 GG mutant predisposed to susceptibility to develop MM (p = 1.2*10(-5), OR = 9.4, 95% CI = 3.0-29.2). The NOD2 SNP8 mutant was significantly more frequent in MM patients compared to controls (p = 0.0004, OR = 12.2, 95% CI = 2.6-57.8). Combined carriage of TLR2 +2477 and TLR4 +896 mutants was strongly associated with MM (p = 4.2*10(-5), OR = 8.6, 95% CI = 2.7-27.3). A carrier trait of TLR4 +896 and NOD2 SNP8 mutants was also strongly associated with susceptibility to develop MM (p = 4.2*10(-5), OR = 10.6, 95% CI = 2.9-38.6). This study associates SNPs in TLR4 and NOD2 with susceptibility to develop MM.	[van Well, Gijs Th J.; Sanders, Marieke S.; van Furth, A. Marceline] Vrije Univ Amsterdam Med Ctr, Dept Pediat Infect Dis Immunol & Rheumatol, Amsterdam, Netherlands; [van Well, Gijs Th J.] Maastricht Univ Med Ctr, Dept Pediat, Maastricht, Netherlands; [Sanders, Marieke S.; Ouburg, Sander; Morre, Servaas A.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Immunogenet Lab, Amsterdam, Netherlands; [Kumar, Vinod] Univ Groningen, Univ Med Ctr Groningen, Dept Human Genet, NL-9713 AV Groningen, Netherlands; [Morre, Servaas A.] Maastricht Univ Med Ctr, Fac Hlth Med & Life Sci, Sch Oncol & Dev Biol, Res Inst,Dept Genet & Cell Biol,Inst Publ Hlth Ge, Maastricht, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Maastricht University; Maastricht University Medical Centre (MUMC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen; Maastricht University; Maastricht University Medical Centre (MUMC)	Morre, SA (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Immunogenet Lab, Amsterdam, Netherlands.	samorretravel@yahoo.co.uk	Ouburg, Sander/H-5775-2019; van Well, Gijs/L-3904-2013; Kumar, Vinod/ABC-4866-2020	Ouburg, Sander/0000-0002-2092-0002; Kumar, Vinod/0000-0002-2775-6049; Van Furth, Marceline/0000-0003-1666-8956				Abraham C, 2006, INFLAMM BOWEL DIS, V12, P641, DOI 10.1097/01.MIB.0000225332.83861.5f; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Allen A, 2003, PEDIATR INFECT DIS J, V22, P1018, DOI 10.1097/01.inf.0000095431.15606.68; (AMC/RIVM) NRLfBM, 2011, BACT MEN NETH ANN RE; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Becker CE, 2007, SEMIN IMMUNOPATHOL, V29, P239, DOI 10.1007/s00281-007-0081-4; Beutler E, 2001, BLOOD CELL MOL DIS, V27, P728, DOI 10.1006/bcmd.2001.0441; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Borm MEA, 2005, INT J IMMUNOGENET, V32, P401, DOI 10.1111/j.1744-313X.2005.00546.x; Bottcher T, 2003, NEUROSCI LETT, V344, P17, DOI 10.1016/S0304-3940(03)00404-X; Brand A, 2008, EUR J HUM GENET, V16, P5, DOI 10.1038/sj.ejhg.5201942; Brand A, 2009, EUR J HUM GENET, V17, P977, DOI 10.1038/ejhg.2009.32; Brouwer MC, 2010, LANCET INFECT DIS, V10, P262, DOI 10.1016/S1473-3099(10)70045-1; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; Chauhan VS, 2009, GLIA, V57, P414, DOI 10.1002/glia.20770; Corr SC, 2009, J INNATE IMMUN, V1, P350, DOI 10.1159/000200774; de Jonge RCJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058707; de Jonge RCJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-232; Faber J, 2009, ACTA PAEDIATR, V98, P548, DOI 10.1111/j.1651-2227.2008.01163.x; Gerber J, 2010, CURR OPIN NEUROL, V23, P312, DOI 10.1097/WCO.0b013e32833950dd; Haralambous E, 2003, EPIDEMIOL INFECT, V130, P413, DOI 10.1017/S0950268803008513; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Koedel U, 2002, ANN NEUROL, V51, P319, DOI 10.1002/ana.10103; Koomen I, 2004, ACTA PAEDIATR, V93, P1378, DOI 10.1080/08035250410033349; Koomen I, 2003, PEDIATRICS, V112, P1049, DOI 10.1542/peds.112.5.1049; Lee WC, 2003, AM J EPIDEMIOL, V158, P397, DOI 10.1093/aje/kwg150; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanders MS, 2011, GENES IMMUN, V12, P321, DOI 10.1038/gene.2011.20; Sanders MS, 2011, CLIN INFECT DIS, V52, P475, DOI 10.1093/cid/ciq155; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Somand D, 2009, EMERG MED CLIN N AM, V27, P89, DOI 10.1016/j.emc.2008.07.004; Sterka D, 2006, GLIA, V53, P322, DOI 10.1002/glia.20286; Sterka D, 2006, J NEUROIMMUNOL, V179, P65, DOI 10.1016/j.jneuroim.2006.06.009; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van Well GTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035837; Wagner J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015376; Woehrl B, 2011, J CLIN INVEST, V121, P3943, DOI 10.1172/JCI57522	44	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64252	10.1371/journal.pone.0064252	http://dx.doi.org/10.1371/journal.pone.0064252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691182	gold, Green Published			2022-12-25	WOS:000319107400110
J	Jiang, XF; Chen, J; Zhang, L; Sappington, TW; Luo, LZ				Jiang, Xing Fu; Chen, Jian; Zhang, Lei; Sappington, Thomas W.; Luo, Li Zhi			Increased Long-Flight Activity Triggered in Beet Armyworm by Larval Feeding on Diet Containing Cry1Ac Protoxin	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; SPODOPTERA-EXIGUA LEPIDOPTERA; SEASONAL EXPRESSION PROFILES; BACILLUS-THURINGIENSIS TOXIN; BT COTTON; COMMERCIAL FORMULATIONS; HELIOTHIS-VIRESCENS; TRANSGENIC COTTON; ZEA LEPIDOPTERA; MULTIPLE CROPS	Evaluating ecological safety and conducting pest risk analysis for transgenic crops are vitally important before their commercial planting. The beet armyworm, Spodoptera exigua, a long-distance migratory insect pest, is not a direct target of transgenic Cry1Ac-expressing cotton in China, but nevertheless it has recently become an important pest. Migrants leaving their natal field arrive in other appropriate habitat far away in a short time, often followed by larval outbreaks. S. exigua has low susceptibility to Cry1Ac. However, our results from laboratory experiments identified (i) sublethal effects of Cry1Ac protoxin on larval development rate, larval and pupal weight, and adult lifetime fecundity, and (ii) increased long-flight behavior triggered by Cry1Ac which may contribute to larval outbreaks elsewhere. No significant differences in larval mortality, pupation rate, adult emergence rate, longevity, pre-oviposition period, or oviposition period were observed between controls and larvae fed on artificial diet incorporating a low concentration of Cry1Ac protoxin. The negative sublethal effects on some developmental and reproductive traits and lack of effect on others suggest they do not contribute to the observed severity of S. exigua outbreaks after feeding on Cry1Ac cotton. Interestingly, the percentage of long fliers increased significantly when larvae were reared on diet containing either of two low-dose treatments of Cry1Ac, suggesting a possible increased propensity to disperse long distances triggered by Cry1Ac. We hypothesize that negative effects on development and reproduction caused by Cry1Ac in the diet are offset by increased flight propensity triggered by the poor food conditions, thereby improving the chances of escaping adverse local conditions before oviposition. Increased long-flight propensity in turn may amplify the area damaged by outbreak populations. This phenomenon might be common in other migratory insect pests receiving sublethal doses of Bt toxins and warrants further study.	[Jiang, Xing Fu; Chen, Jian; Zhang, Lei; Luo, Li Zhi] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Sappington, Thomas W.] USDA ARS, Corn Insects & Crop Genet Res Unit, Genet Lab ISU, Ames, IA USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; United States Department of Agriculture (USDA)	Jiang, XF (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	xfjiang@ippcaas.cn; lzluo@ippcaas.cn			National Department of Transgenic Crops Cultivation Research Foundation [2009ZX08011-018B]; National Department of Public Benefit Research Foundation [201203020, 200903051]; National Natural Science Foundation of China [31000850, 31071677, 30871641]	National Department of Transgenic Crops Cultivation Research Foundation; National Department of Public Benefit Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by projects under the National Department of Transgenic Crops Cultivation Research Foundation (No. 2009ZX08011-018B), the National Department of Public Benefit Research Foundation (201203020, 200903051), and the National Natural Science Foundation of China (No. 31000850, 31071677, 30871641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk JJ, 2006, J ECON ENTOMOL, V99, P1835, DOI 10.1603/0022-0493-99.5.1835; Adamczyk JJ, 2003, FLA ENTOMOL, V86, P229, DOI 10.1653/0015-4040(2003)086[0229:SATOOB]2.0.CO;2; Adamczyk JJ, 2001, J ECON ENTOMOL, V94, P1589, DOI 10.1603/0022-0493-94.6.1589; Adamczyk John J. Jr., 2001, Journal of Insect Science (Tucson), V1, P1; ALI A, 1992, ENVIRON ENTOMOL, V21, P780, DOI 10.1093/ee/21.4.780; Anilkumar KJ, 2009, J CHEM ECOL, V35, P785, DOI 10.1007/s10886-009-9665-x; Arshad M, 2011, PAK J ZOOL, V43, P529; Bao HB, 2009, PEST MANAG SCI, V65, P170, DOI 10.1002/ps.1664; BURRIS E, 1994, FLA ENTOMOL, V77, P454, DOI 10.2307/3495699; Chen Z.-h., 1987, Entomological Knowledge, V24, P299; Danks HV, 1987, INSECT DORMANCY ECOL; EVELEENS K G, 1973, Environmental Entomology, V2, P497, DOI 10.1093/ee/2.4.497; Feng HQ, 2003, B ENTOMOL RES, V93, P115, DOI 10.1079/BER2002221; Greenberg SM, 2010, SOUTHWEST ENTOMOL, V35, P539, DOI 10.3958/059.035.0406; Jiang X.F., 1998, 21 CENTURY ADV PLANT, P371; Jiang X. F., 1998, AGROCHEMICAL SCI TEC, V6, P8; Jiang X. F., 1999, PLANT PROTECTION, V25, P32; Jiang Xinfu, 1999, Acta Entomologica Sinica, V42, P270; Jiang XF, 2010, J INSECT PHYSIOL, V56, P1631, DOI 10.1016/j.jinsphys.2010.06.006; Jiang Xing-Fu, 2002, Acta Entomologica Sinica, V45, P275; Jiang Xingfu, 2000, Acta Phytophylacica Sinica, V27, P327; Jiang XF, 2011, ENVIRON ENTOMOL, V40, P516, DOI 10.1603/EN10199; KENNEDY JS, 1961, NATURE, V189, P785, DOI 10.1038/189785a0; KIMURA S, 1991, ANN REPORT SOC PLANT, V42, P148; Liu YQ, 2002, PLANT PROTECTION, V30, P84; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; Luo Lizhi, 1995, Acta Entomologica Sinica, V38, P38; Luttrell RG, 1998, J ENTOMOL SCI, V33, P365, DOI 10.18474/0749-8004-33.4.365; Luttrell RG, 1999, J ECON ENTOMOL, V92, P21, DOI 10.1093/jee/92.1.21; MEADE T, 1991, ENVIRON ENTOMOL, V20, P1636, DOI 10.1093/ee/20.6.1636; MIKKOLA K, 1970, J ANIM ECOL, V39, P593, DOI 10.2307/2856; Mitchell E.R., 1979, P386; Naranjo SE, 2011, J AGR FOOD CHEM, V59, P5842, DOI 10.1021/jf102939c; Nava-Camberos U., 2000, Proceedings Beltwide Cotton Conferences, V2, P1337; Oku T., 1978, Bulletin of the Tohoku National Agricultural Experiment Station, P97; Olsen KM, 2005, J ECON ENTOMOL, V98, P1007, DOI 10.1603/0022-0493-98.3.1007; [潘家荣 PAN Jiarong], 2006, [核农学报, Acta Agriculturae Nucleatae Sinica], V20, P544; Prutz G, 2005, PHYTOPARASITICA, V33, P467, DOI 10.1007/BF02981396; Qaim M, 2003, SCIENCE, V299, P900, DOI 10.1126/science.1080609; Qaim M, 2009, ANNU REV RESOUR ECON, V1, P665, DOI 10.1146/annurev.resource.050708.144203; Ramenofsky M, 2007, BIOSCIENCE, V57, P135, DOI 10.1641/B570208; RANKIN MA, 1992, ANNU REV ENTOMOL, V37, P533, DOI 10.1146/annurev.en.37.010192.002533; RUBERSON JR, 1994, FLA ENTOMOL, V77, P440, DOI 10.2307/3495698; Sivasupramaniam S, 2008, J ECON ENTOMOL, V101, P546, DOI 10.1603/0022-0493(2008)101[546:TACOCE]2.0.CO;2; Sparks A.N., 1979, P382; Stewart S. D., 2000, 2000 Proceedings Beltwide Cotton Conferences, San Antonio, USA, 4-8 January, 2000: Volume 2., P1043; Stewart SD, 2001, J ECON ENTOMOL, V94, P752, DOI 10.1603/0022-0493-94.3.752; Stipanovic RD, 2008, ENVIRON ENTOMOL, V37, P1081, DOI 10.1603/0046-225X(2008)37[1081:EORAGO]2.0.CO;2; Stipanovic RD, 2006, J CHEM ECOL, V32, P959, DOI 10.1007/s10886-006-9052-9; STONE TB, 1993, J ECON ENTOMOL, V86, P989, DOI 10.1093/jee/86.4.989; Su H. H., 2010, AGR SCI TECH, V11, P140; [苏宏华 Su Honghua], 2010, [植物保护, Plant Protection], V36, P1; Summy K. R., 1996, 1996 Proceedings Beltwide Cotton Conferences, Nashville, TN, USA, January 9-12, 1996: Volume 2., P837; Tisdale RA, 2001, ANN ENTOMOL SOC AM, V94, P415, DOI 10.1603/0013-8746(2001)094[0415:RAPFEF]2.0.CO;2; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Wan P, 2005, J ECON ENTOMOL, V98, P195, DOI 10.1603/0022-0493-98.1.195; Wang Juan, 2008, Acta Entomologica Sinica, V51, P889; Wang WQ, 2002, CHINA COTTON, V29, P27; Westbrook JK, 2008, INTEGR COMP BIOL, V48, P99, DOI 10.1093/icb/icn040; Wu G, 2009, J APPL ENTOMOL, V133, P90, DOI 10.1111/j.1439-0418.2008.01328.x; Wu G, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14125; Wu KM, 2003, J ECON ENTOMOL, V96, P1322, DOI 10.1603/0022-0493-96.4.1322; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xia J. Y., 2000, CHINA COTTON, V27, P10; Yu YueShu, 2004, Jiangsu Journal of Agricultural Sciences, V20, P169; Zhang JuHong, 2012, African Journal of Biotechnology, V11, P9873; Zhang L, 2008, ARCH INSECT BIOCHEM, V68, P63, DOI 10.1002/arch.20255; Zhang L, 2008, ENVIRON ENTOMOL, V37, P1389, DOI 10.1603/0046-225X-37.6.1389; Zhang Xiaoli, 2007, Acta Phytophylacica Sinica, V34, P391; Zhao KF, 2011, CROP PROT, V30, P476, DOI 10.1016/j.cropro.2010.11.026; [郑霞林 Zheng Xialin], 2010, [植物保护, Plant Protection], V36, P34	73	6	9	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63554	10.1371/journal.pone.0063554	http://dx.doi.org/10.1371/journal.pone.0063554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675489	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100042
J	Aleixandre, P; Montoya, JH; Mila, B				Aleixandre, Pau; Hernandez Montoya, Julio; Mila, Borja			Speciation on Oceanic Islands: Rapid Adaptive Divergence vs. Cryptic Speciation in a Guadalupe Island Songbird (Aves: Junco)	PLOS ONE			English	Article							GENETIC DIVERSITY; MORPHOLOGICAL DIVERSIFICATION; PHENOTYPIC DIVERGENCE; MAINLAND POPULATIONS; EVOLUTION; BIRDS; RADIATION; WARBLER; DNA; DIFFERENTIATION	The evolutionary divergence of island populations, and in particular the tempo and relative importance of neutral and selective factors, is of central interest to the study of speciation. The rate of phenotypic evolution upon island colonization can vary greatly among taxa, and cases of convergent evolution can further confound the inference of correct evolutionary histories. Given the potential lability of phenotypic characters, molecular dating of insular lineages analyzed in a phylogenetic framework provides a critical tool to test hypotheses of phenotypic divergence since colonization. The Guadalupe junco is the only insular form of the polymorphic dark-eyed junco (Junco hyemalis), and shares eye and plumage color with continental morphs, yet presents an enlarged bill and reduced body size. Here we use variation in mtDNA sequence, morphological traits and song variables to test whether the Guadalupe junco evolved rapidly following a recent colonization by a mainland form of the dark-eyed junco, or instead represents a well-differentiated "cryptic" lineage adapted to the insular environment through long-term isolation, with plumage coloration a result of evolutionary convergence. We found high mtDNA divergence of the island lineage with respect to both continental J. hyemalis and J. phaeonotus, representing a history of isolation of about 600,000 years. The island lineage was also significantly differentiated in morphological and male song variables. Moreover, and contrary to predictions regarding diversity loss on small oceanic islands, we document relatively high levels of both haplotypic and song-unit diversity on Guadalupe Island despite long-term isolation in a very small geographic area. In contrast to prevailing taxonomy, the Guadalupe junco is an old, well-differentiated evolutionary lineage, whose similarity to mainland juncos in plumage and eye color is due to evolutionary convergence. Our findings confirm the role of remote islands in driving divergence and speciation, but also their potential role as repositories of ancestral diversity.	[Aleixandre, Pau; Mila, Borja] Spanish Res Council CSIC, Natl Museum Nat Sci, Madrid, Spain; [Hernandez Montoya, Julio] GECI, Ensenada, Baja California, Mexico; [Mila, Borja] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA USA	Consejo Superior de Investigaciones Cientificas (CSIC); University of California System; University of California Los Angeles	Aleixandre, P (corresponding author), Spanish Res Council CSIC, Natl Museum Nat Sci, Madrid, Spain.	pau.aleixandre.mallol@gmail.com	Mila, Borja/L-4867-2014	Mila, Borja/0000-0002-6446-0079	Spanish Ministry of Science and Innovation [CGL2011-25866]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was funded by a grant from the Spanish Ministry of Science and Innovation (CGL2011-25866) to BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 1973, Auk, V90, P411; Baker MC, 1996, ANIM BEHAV, V51, P853, DOI 10.1006/anbe.1996.0089; Baker MC, 2006, BIOL J LINN SOC, V89, P331, DOI 10.1111/j.1095-8312.2006.00677.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Benkman CW, 2003, EVOLUTION, V57, P1176; Boessenkool S, 2007, CONSERV GENET, V8, P705, DOI 10.1007/s10592-006-9219-5; Brekke P, 2011, MOL ECOL, V20, P29, DOI 10.1111/j.1365-294X.2010.04923.x; Bryant WE, 1887, ADDITIONS ORNITHOLOG, P269; Buckley TR, 2009, P ROY SOC B-BIOL SCI, V276, P1055, DOI 10.1098/rspb.2008.1552; CARSON HL, 1976, ANNU REV ECOL SYST, V7, P311, DOI 10.1146/annurev.es.07.110176.001523; Charif R. A., 2008, RAVEN PRO 1 3 USERS; Chaves JA, 2012, J EVOLUTION BIOL, V25, P509, DOI 10.1111/j.1420-9101.2011.02447.x; Clegg SM, 2002, EVOLUTION, V56, P2090; Clegg SM, 2010, PHILOS T R SOC B, V365, P1077, DOI 10.1098/rstb.2009.0281; Coyne JA, 2004, SPECIATION, V37; DEGNAN SM, 1993, EVOLUTION, V47, P1105, DOI 10.1111/j.1558-5646.1993.tb02139.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dwight J, 1918, B AM MUS NAT HIST, V38, P0269; Emerson BC, 2001, TRENDS ECOL EVOL, V16, P707, DOI 10.1016/S0169-5347(01)02305-9; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fleischer RC, 2008, CURR BIOL, V18, P1927, DOI 10.1016/j.cub.2008.10.051; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Fu YX, 1997, GENETICS, V147, P915; Grant P.R., 1999, RECOGNITION STATES L, V2; Grant P.R., 2007, WHY SPECIES MULTIPLY; Grant P.R., 1998, EVOLUTION ISLANDS; Grant PR, 2001, OIKOS, V92, P385, DOI 10.1034/j.1600-0706.2001.920301.x; Hamao S, 2000, J ETHOL, V18, P53, DOI 10.1007/s101640070025; Hargreaves S, 2010, CONSERV GENET, V11, P1317, DOI 10.1007/s10592-009-9960-7; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hendry AP, 2006, P R SOC B, V273, P1887, DOI 10.1098/rspb.2006.3534; Hey J., 2011, DOCUMENTATION IMA2; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Howell T. R., 1954, Condor, V56, P283, DOI 10.2307/1364852; Illera JC, 2007, MOL ECOL, V16, P4599, DOI 10.1111/j.1365-294X.2007.03543.x; JEHL J R JR, 1985, Transactions of the San Diego Society of Natural History, V20, P313; Johnson JA, 2009, MOL ECOL, V18, P54, DOI [10.1111/j.1365-294X.2009.04240.x, 10.1111/j.1365-294X.2008.04012.x]; Keogh JS, 2005, EVOLUTION, V59, P226; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Lovette IJ, 2002, P ROY SOC B-BIOL SCI, V269, P37, DOI 10.1098/rspb.2001.1789; Lovette IJ, 2010, MOL PHYLOGENET EVOL, V57, P753, DOI 10.1016/j.ympev.2010.07.018; MANI GS, 1990, PROC R SOC SER B-BIO, V240, P29, DOI 10.1098/rspb.1990.0025; MARLER P., 1961, WILSON BULL, V73, P193; Mason RAB, 2011, CONSERV GENET, V12, P91, DOI 10.1007/s10592-009-9993-y; Mathys BA, 2011, P ROY SOC B-BIOL SCI, V278, P2392, DOI 10.1098/rspb.2010.2302; McCormack JE, 2008, P ROY SOC B-BIOL SCI, V275, P2155, DOI 10.1098/rspb.2008.0470; Mila B, 2008, CONDOR, V110, P335, DOI 10.1525/cond.2008.8396; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Mila B, 2007, MOL ECOL, V16, P159, DOI 10.1111/j.1365-294X.2006.03119.x; Mila B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-158; Miller A. H., 1941, University of California Publications in Zoology, V44, P173; Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321; MIRSKY EN, 1976, CONDOR, V78, P230, DOI 10.2307/1366858; Nei M., 1987, MOL EVOLUTIONARY GEN; Nolan V, 2002, DARK EYED JUNCO JUNC; Odeen A, 2003, MOL ECOL, V12, P2113, DOI 10.1046/j.1365-294X.2003.01883.x; Omland KE, 1999, MOL PHYLOGENET EVOL, V12, P224, DOI 10.1006/mpev.1999.0611; Phillimore AB, 2008, MOL ECOL, V17, P2839, DOI 10.1111/j.1365-294X.2008.03794.x; Pieplow ND, 2011, WILSON J ORNITHOL, V123, P464, DOI 10.1676/10-126.1; Price T, 2008, SPECIATION BIRDS; Rambaut A., 2007, TRACER V1 4; Randall JM, 2008, ISLA GUADALUPE RESTA, P231; Rasner CA, 2004, MOL ECOL, V13, P671, DOI 10.1046/j.1365-294X.2004.02104.x; Ribas CC, 2006, AUK, V123, P660, DOI 10.1642/0004-8038(2006)123[660:MSAPOD]2.0.CO;2; Ridgway R, 1877, BIRDS GUADALUPE ISLA; Rocamora GJ, 2003, IBIS, V145, pE34, DOI 10.1046/j.1474-919X.2003.00140.x; Ruber L, 2001, J EVOLUTION BIOL, V14, P325, DOI 10.1046/j.1420-9101.2001.00269.x; Sanaa A, 2010, SCI HORTIC-AMSTERDAM, V125, P740, DOI 10.1016/j.scienta.2010.05.014; Scott SN, 2003, EVOLUTION, V57, P2147; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; TARR CL, 1995, MOL ECOL, V4, P527, DOI 10.1111/j.1365-294X.1995.tb00251.x; Tayer OB, 1908, CONDOR, V10, P101; Tinghitella RM, 2011, J EVOLUTION BIOL, V24, P1199, DOI 10.1111/j.1420-9101.2011.02255.x; Tzika AC, 2008, MOL ECOL, V17, P4943, DOI 10.1111/j.1365-294X.2008.03967.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x	79	22	22	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63242	10.1371/journal.pone.0063242	http://dx.doi.org/10.1371/journal.pone.0063242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675466	gold, Green Published, Green Submitted			2022-12-25	WOS:000318852400032
J	Barbadoro, P; Santarelli, L; Croce, N; Bracci, M; Vincitorio, D; Prospero, E; Minelli, A				Barbadoro, Pamela; Santarelli, Lory; Croce, Nicola; Bracci, Massimo; Vincitorio, Daniela; Prospero, Emilia; Minelli, Andrea			Rotating Shift-Work as an Independent Risk Factor for Overweight Italian Workers: A Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; WEIGHT-GAIN; CARDIOVASCULAR-DISEASE; OBESITY; HEALTH; IMPACT; CANCER; TIME	Background: A job-related factor is attracting a growing interest as a possible determinant of body weight gain in shift-workers. Objective: The aim of the study was to reinvestigate the issue of overweight between rotating shift workers and daytime workers, taking into consideration possible confounding covariate factors. Methods: This is a cross-sectional study, conducted by reviewing data from subjects participating in an occupational surveillance program in 2008. Participants answered a self-administered questionnaire to retrieve information about sociodemographic factors and working conditions (job schedule type, job-related physical activity, time in job), subjective health status, health care visits during the previous year, and lifestyle factors (dietary habits, leisure time physical activity, alcohol consumption). Participants underwent a medical examination for measurement of BMI, and acquisition of medical history. Results: Compared to daytime workers (N = 229), rotating shift workers (N = 110) displayed higher BMI (mean BMI was 27.6+/-3.9 and 26.7+/-3.6 for shift workers, and daytime workers, respectively; p<0.05). Logistic regression analysis allowed to highlight the role of rotating shift-work as an independent risk factor for increased body weight (OR 1.93, 95% CI 1.01-3.71), being aged between 35 and 54 years was a major determinant of increased BMI (OR 2.39, 95% CI 1.14-5.00). In addition, family history of obesity was the strongest determinant of overweight/obesity (OR 9.79, 95% CI 1.28-74.74). Interestingly, no significant association was found between overweight and other potentially relevant factors, such as diet quality and food choices, alcohol consumption, levels of occupational and leisure-time physical activity. Conclusions: Present findings seem to support the notion that rotating shift work is an independent risk factor for overweight, regardless of workers' dietary habits and physical activity levels.	[Barbadoro, Pamela; Vincitorio, Daniela; Prospero, Emilia] Univ Politecn Marche, Sch Med, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Santarelli, Lory; Croce, Nicola; Bracci, Massimo] Univ Politecn Marche, Sch Med, Dept Mol & Clin Sci, Ancona, Italy; [Minelli, Andrea] Univ Urbino Carlo Bo, Dept Earth Life & Environm Sci, Urbino, Italy	Marche Polytechnic University; Marche Polytechnic University; University of Urbino	Prospero, E (corresponding author), Univ Politecn Marche, Sch Med, Dept Biomed Sci & Publ Hlth, Ancona, Italy.	e.prospero@univpm.it	Santarelli, Lory/AAU-4494-2020; barbadoro, pamela/AAC-5041-2022; Bracci, Massimo/K-1192-2018	Bracci, Massimo/0000-0003-3901-5376; santarelli, lory/0000-0003-1015-7098; Prospero, Emilia/0000-0002-2387-8639; BARBADORO, Pamela/0000-0003-1495-0165	Universita Politecnica delle Marche	Universita Politecnica delle Marche	Funding provided by Universita Politecnica delle Marche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; Artinian NT, 2004, PUBLIC HEALTH NURS, V21, P425, DOI 10.1111/j.0737-1209.2004.21506.x; Atkinson G, 2007, PHYSIOL BEHAV, V90, P229, DOI 10.1016/j.physbeh.2006.09.015; Barness LA, 2007, AM J MED GENET A, V143A, P3016, DOI 10.1002/ajmg.a.32035; Biggi N, 2008, CHRONOBIOL INT, V25, P443, DOI 10.1080/07420520802114193; Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Contento IR, 2006, J ADOLESCENT HEALTH, V38, P575, DOI 10.1016/j.jadohealth.2005.05.025; Costa G, 2003, OCCUP MED-OXFORD, V53, P83, DOI 10.1093/occmed/kqg045; Costa G, 2010, SCAND J WORK ENV HEA, V36, P163, DOI 10.5271/sjweh.2899; Croce N, 2007, G Ital Med Lav Ergon, V29, P488; de Assis MAA, 2003, J HUM NUTR DIET, V16, P283, DOI 10.1046/j.1365-277X.2003.00448.x; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Eurispes istituto di studi politici economici e sociali, 2004, LAV NOTT SCELT NEC R; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; GANS KM, 1993, J NUTR EDUC, V25, P29; Garaulet M, 2010, INT J OBESITY, V34, P1667, DOI 10.1038/ijo.2010.118; Istituto nazionale di Statistica (ISTAT), 2010, VIT QUOT 2009 IND MU; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Karlsson BH, 2003, INT ARCH OCC ENV HEA, V76, P424, DOI 10.1007/s00420-003-0440-y; Kim M., 2000, NUTR CLIN CARE, V3, P163, DOI [10.1046/j.1523-5408.2000.00045.x, DOI 10.1046/J.1523-5408.2000.00045.X]; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Knutsson Anders, 2002, Nutrition and Health (Bicester), V16, P133; Kwak L, 2011, SCAND J WORK ENV HEA, V37, P6, DOI 10.5271/sjweh.3085; Lowden A, 2010, SCAND J WORK ENV HEA, V36, P150, DOI 10.5271/sjweh.2898; Macagnan J, 2012, CHRONOBIOL INT, V29, P336, DOI 10.3109/07420528.2011.653851; Manenschijn L, 2011, J CLIN ENDOCR METAB, V96, pE1862, DOI 10.1210/jc.2011-1551; Morikawa Y, 2007, SCAND J WORK ENV HEA, V33, P45, DOI 10.5271/sjweh.1063; Niedhammer I, 1996, INT J OBESITY, V20, P625; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Puttonen S, 2010, SCAND J WORK ENV HEA, V36, P96, DOI 10.5271/sjweh.2894; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schousboe K, 2004, INT J OBESITY, V28, P39, DOI 10.1038/sj.ijo.0802524; Sookoian S, 2007, J INTERN MED, V261, P285, DOI 10.1111/j.1365-2796.2007.01766.x; Stevens RG, 2011, OCCUP ENVIRON MED, V68, P154, DOI 10.1136/oem.2009.053512; Sudo N, 2001, INT J FOOD SCI NUTR, V52, P367, DOI 10.1080/09637480120057530; Suter PM, 2005, CRIT REV CL LAB SCI, V42, P197, DOI 10.1080/10408360590913542; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; Trost SG, 2003, AM J PREV MED, V25, P277, DOI 10.1016/S0749-3797(03)00217-4; van Amelsvoort LGPM, 2004, J OCCUP ENVIRON MED, V46, P699, DOI 10.1097/01.jom.0000131794.83723.45; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; van Duijvenbode DC, 2009, INT J OBESITY, V33, P807, DOI 10.1038/ijo.2009.121; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Wells JCK, 2009, INT J OBESITY, V33, P1331, DOI 10.1038/ijo.2009.175; World Health Organization, 2004, OB PREV MAN GLOB EP; World Health Organization, 2000, NONC DIS MENT HLTH C; Zhao I, 2012, J OCCUP ENVIRON MED, V54, P525, DOI 10.1097/JOM.0b013e31824e1073; Zhao I, 2011, J OCCUP ENVIRON MED, V53, P153, DOI 10.1097/JOM.0b013e318205e1e8	50	48	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63289	10.1371/journal.pone.0063289	http://dx.doi.org/10.1371/journal.pone.0063289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675472	Green Submitted, Green Published, gold			2022-12-25	WOS:000318852400034
J	Hesser, H; Molander, P; Jungermann, M; Andersson, G				Hesser, Hugo; Molander, Peter; Jungermann, Mikael; Andersson, Gerhard			Costs of Suppressing Emotional Sound and Countereffects of a Mindfulness Induction: An Experimental Analog of Tinnitus Impact	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; THOUGHT SUPPRESSION; SELF-CONTROL; COMMITMENT THERAPY; COGNITIVE CONTROL; WORKING-MEMORY; ACCEPTANCE; MECHANISMS; DEPLETION; PAIN	Tinnitus is the experience of sounds without an appropriate external auditory source. These auditory sensations are intertwined with emotional and attentional processing. Drawing on theories of mental control, we predicted that suppressing an affectively negative sound mimicking the psychoacoustic features of tinnitus would result in decreased persistence in a mentally challenging task (mental arithmetic) that required participants to ignore the same sound, but that receiving a mindfulness exercise would reduce this effect. Normal hearing participants (N = 119) were instructed to suppress an affectively negative sound under cognitive load or were given no such instructions. Next, participants received either a mindfulness induction or an attention control task. Finally, all participants worked with mental arithmetic while exposed to the same sound. The length of time participants could persist in the second task served as the dependent variable. As hypothesized, results indicated that an auditory suppression rationale reduced time of persistence relative to no such rationale, and that a mindfulness induction counteracted this detrimental effect. The study may offer new insights into the mechanisms involved in the development of tinnitus interference. Implications are also discussed in the broader context of attention control strategies and the effects of emotional sound on task performance. The ironic processes of mental control may have an analog in the experience of sounds.	[Hesser, Hugo; Molander, Peter; Andersson, Gerhard] Linkoping Univ, Swedish Inst Disabil Res, Dept Behav Sci & Learning, Linkoping, Sweden; [Jungermann, Mikael] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Andersson, Gerhard] Karolinska Inst, Dept Clin Neurosci, Psychiat Sect, Stockholm, Sweden	Linkoping University; Linkoping University; Karolinska Institutet	Hesser, H (corresponding author), Linkoping Univ, Swedish Inst Disabil Res, Dept Behav Sci & Learning, Linkoping, Sweden.	hugo.hesser@liu.se	Andersson, Gerhard/J-8529-2012	Andersson, Gerhard/0000-0003-4753-6745	Swedish Research Council (HEAD Linneaus grant)	Swedish Research Council (HEAD Linneaus grant)	The study was sponsored in part by a grant from the Swedish Research Council (HEAD Linneaus grant). The authors report no financial relationships with commercial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AHLES TA, 1983, COGNITIVE THER RES, V7, P159, DOI 10.1007/BF01190070; Alberts HJEM, 2012, COGNITION EMOTION, V26, P863, DOI 10.1080/02699931.2011.625402; Andersson G, 2000, J SPEECH LANG HEAR R, V43, P1168, DOI 10.1044/jslhr.4305.1168; Andersson G, 2002, CLIN PSYCHOL REV, V22, P977, DOI 10.1016/S0272-7358(01)00124-6; Andersson G, 2006, ACTA OTO-LARYNGOL, V126, P39, DOI 10.1080/03655230600895226; Andersson G, 2006, AUDIOL NEURO-OTOL, V11, P301, DOI 10.1159/000094460; Arch JJ, 2006, BEHAV RES THER, V44, P1849, DOI 10.1016/j.brat.2005.12.007; Banbury SP, 2001, HUM FACTORS, V43, P12, DOI 10.1518/001872001775992462; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; BLITZ B, 1971, J ABNORM PSYCHOL, V77, P42, DOI 10.1037/h0030418; Bradley M. M., 2007, B3 U FLOR; Budd RJ, 1996, J PSYCHOSOM RES, V41, P327, DOI 10.1016/S0022-3999(96)00171-7; CIOFFI D, 1991, PSYCHOL BULL, V109, P25, DOI 10.1037/0033-2909.109.1.25; CIOFFI D, 1993, J PERS SOC PSYCHOL, V64, P274, DOI 10.1037/0022-3514.64.2.274; Davis CG, 2008, REHABIL PSYCHOL, V53, P128, DOI 10.1037/0090-5550.53.2.128; Eifert G. H., 2005, ACCEPTANCE COMMITMEN; Erisman SM, 2010, EMOTION, V10, P72, DOI 10.1037/a0017162; Erskine JAK, 2010, PSYCHOL SCI, V21, P1225, DOI 10.1177/0956797610378687; FOWLER E P, 1955, Ann Otol Rhinol Laryngol, V64, P29; Gailliot MT, 2007, J PERS SOC PSYCHOL, V92, P325, DOI 10.1037/0022-3514.92.2.325; GLASS DC, 1969, J PERS SOC PSYCHOL, V12, P200, DOI 10.1037/h0027629; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hallam R., 1984, CONTRIBUTIONS MED PS, V3, P31; Hasson D, 2010, J EPIDEMIOL COMMUN H, V64, P453, DOI 10.1136/jech.2009.095430; Hayes SC, 1999, PSYCHOL REC, V49, P33, DOI 10.1007/BF03395305; Hayes SC, 2011, ANNU REV CLIN PSYCHO, V7, P141, DOI 10.1146/annurev-clinpsy-032210-104449; Heinecke K, 2008, J BEHAV MED, V31, P179, DOI 10.1007/s10865-007-9145-0; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); Hesser H, 2012, J CONSULT CLIN PSYCH, V80, P649, DOI 10.1037/a0027021; Hesser H, 2011, CLIN PSYCHOL REV, V31, P545, DOI 10.1016/j.cpr.2010.12.006; Hesser H, 2009, REHABIL PSYCHOL, V54, P381, DOI 10.1037/a0017565; Hesser H, 2009, INT J AUDIOL, V48, P295, DOI 10.1080/14992020802635325; Hesser H, 2009, BEHAV RES THER, V47, P523, DOI 10.1016/j.brat.2009.02.002; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Jha AP, 2007, COGN AFFECT BEHAV NE, V7, P109, DOI 10.3758/CABN.7.2.109; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; JONES DM, 1993, J EXP PSYCHOL LEARN, V19, P369, DOI 10.1037/0278-7393.19.2.369; Levitt JT, 2004, BEHAV THER, V35, P747, DOI 10.1016/S0005-7894(04)80018-2; Lockwood AH, 2002, NEW ENGL J MED, V347, P904, DOI 10.1056/NEJMra013395; Masedo AI, 2007, BEHAV RES THER, V45, P199, DOI 10.1016/j.brat.2006.02.006; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Mitchell JP, 2007, PSYCHOL SCI, V18, P292, DOI 10.1111/j.1467-9280.2007.01891.x; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Penner, 1996, Int Tinnitus J, V2, P3; Philippot P, 2012, CLIN PSYCHOL PSYCHOT, V19, P411, DOI 10.1002/cpp.756; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Roemer L, 2002, CLIN PSYCHOL-SCI PR, V9, P54, DOI 10.1093/clipsy/9.1.54; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Salters-Pednault K., 2010, EMOTION REGULATION P, P137; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Tyler JM, 2008, SELF IDENTITY, V7, P305, DOI 10.1080/15298860701799997; TYLER RS, 1983, J SPEECH HEAR DISORD, V48, P150, DOI 10.1044/jshd.4802.150; Wegner DM, 2011, AM PSYCHOL, V66, P671, DOI 10.1037/a0024985; Wegner DM, 2009, SCIENCE, V325, P48, DOI 10.1126/science.1167346; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; Wegner DM, 1996, J PERS SOC PSYCHOL, V71, P680, DOI 10.1037/0022-3514.71.4.680; Wenzlaff EM, 2000, ANNU REV PSYCHOL, V51, P59, DOI 10.1146/annurev.psych.51.1.59; Werner K, 2010, TXB EMOTION REGULATI, P13, DOI DOI 10.1016/J.CPR.2016.10.005; Westin V, 2008, BEHAV RES THER, V46, P1259, DOI 10.1016/j.brat.2008.08.008; Westin V, 2008, INT J AUDIOL, V47, pS112, DOI 10.1080/14992020802301688; Westin VZ, 2011, BEHAV RES THER, V49, P737, DOI 10.1016/j.brat.2011.08.001	62	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e64540	10.1371/journal.pone.0064540	http://dx.doi.org/10.1371/journal.pone.0064540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143FO	23675540	gold, Green Published, Green Submitted			2022-12-25	WOS:000318852400071
J	Kobayashi, K; Ikeda, Y; Asada, M; Inagaki, H; Kawada, T; Suzuki, H				Kobayashi, Katsunori; Ikeda, Yumiko; Asada, Minoru; Inagaki, Hirofumi; Kawada, Tomoyuki; Suzuki, Hidenori			Corticosterone Facilitates Fluoxetine-Induced Neuronal Plasticity in the Hippocampus	PLOS ONE			English	Article							FIBER SYNAPTIC-TRANSMISSION; DENTATE GYRUS; MOSSY FIBER; SUBVENTRICULAR ZONE; CELL-PROLIFERATION; DEPRESSION; NEUROGENESIS; ANTIDEPRESSANTS; SEROTONIN; SEVERITY	The hippocampal dentate gyrus has been implicated in a neuronal basis of antidepressant action. We have recently shown a distinct form of neuronal plasticity induced by the serotonergic antidepressant fluoxetine, that is, a reversal of maturation of the dentate granule cells in adult mice. This "dematuration'' is induced in a large population of dentate neurons and maintained for at least one month after withdrawal of fluoxetine, suggesting long-lasting strong influence of dematuration on brain functioning. However, reliable induction of dematuration required doses of fluoxetine higher than suggested optimal doses for mice (10 to 18 mg/kg/day), which casts doubt on the clinical relevance of this effect. Since our previous studies were performed in naive mice, in the present study, we reexamined effects of fluoxetine using mice treated with chronic corticosterone that model neuroendocrine pathophysiology associated with depression. In corticosterone-treated mice, fluoxetine at 10 mg/kg/day downregulated expression of mature granule cell markers and attenuated strong frequency facilitation at the synapse formed by the granule cell axon mossy fiber, suggesting the induction of granule cell dematuration. In addition, fluoxetine caused marked enhancement of dopaminergic modulation at the mossy fiber synapse. In vehicle-treated mice, however, fluoxetine at this dose had no significant effects. The plasma level of fluoxetine was comparable to that in patients taking chronic fluoxetine, and corticosterone did not affect it. These results indicate that corticosterone facilitates fluoxetine-induced plastic changes in the dentate granule cells. Our finding may provide insight into neuronal mechanisms underlying enhanced responsiveness to antidepressant medication in certain pathological conditions.	[Kobayashi, Katsunori; Ikeda, Yumiko; Asada, Minoru; Suzuki, Hidenori] Nippon Med Sch, Grad Sch Med, Dept Pharmacol, Bunkyo Ku, Tokyo 113, Japan; [Kobayashi, Katsunori; Suzuki, Hidenori] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama, Japan; [Inagaki, Hirofumi; Kawada, Tomoyuki] Nippon Med Sch, Grad Sch Med, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 113, Japan	Nippon Medical School; Japan Science & Technology Agency (JST); Nippon Medical School	Kobayashi, K (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Pharmacol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.	kkatsu-tky@umin.ac.jp	Kobayashi, Katsunori/V-5326-2018	Kobayashi, Katsunori/0000-0001-8537-8448	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology; MEXT, Japan [22500342, 23110519]	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (to K. K. and H. S.), Grant-in-Aid for Scientific Research from MEXT, Japan (22500342 and 23110519 to K. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JC, 1998, J CHROMATOGR B, V707, P175, DOI 10.1016/S0378-4347(97)00588-4; Barr JL, 2011, NEUROSCIENCE, V182, P105, DOI 10.1016/j.neuroscience.2011.03.020; Brezun JM, 1999, NEUROSCIENCE, V89, P999, DOI 10.1016/S0306-4522(98)00693-9; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; DRATCU L, 1989, PROG NEURO-PSYCHOPH, V13, P99, DOI 10.1016/0278-5846(89)90007-9; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Dwivedi Y, 2006, NEUROSCIENCE, V139, P1017, DOI 10.1016/j.neuroscience.2005.12.058; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Khan A, 2002, J CLIN PSYCHOPHARM, V22, P40, DOI 10.1097/00004714-200202000-00007; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kobayashi K, 1996, SCIENCE, V273, P648, DOI 10.1126/science.273.5275.648; Kobayashi K, 2008, J NEUROSCI, V28, P6272, DOI 10.1523/JNEUROSCI.1656-08.2008; Kobayashi K, 2007, NEUROPHARMACOLOGY, V52, P552, DOI 10.1016/j.neuropharm.2006.08.026; Kobayashi K, 2012, NEUROPSYCHOPHARMACOL, V37, P1500, DOI 10.1038/npp.2011.335; Kobayashi K, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-12; Kobayashi K, 2010, VITAM HORM, V82, P65, DOI 10.1016/S0083-6729(10)82004-7; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; Kobayashi K, 2009, MOL NEUROBIOL, V39, P24, DOI 10.1007/s12035-008-8049-5; Lau WM, 2007, RESTOR NEUROL NEUROS, V25, P17; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mori-Kawakami F, 2003, J PHYSIOL-LONDON, V553, P37, DOI 10.1113/jphysiol.2003.045948; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Ohira K, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-26; Parker KJ, 2003, HORM BEHAV, V43, P60, DOI 10.1016/S0018-506X(02)00016-8; PATO MT, 1991, J CLIN PSYCHOPHARM, V11, P224, DOI 10.1097/00004714-199106000-00024; Qiu Guang, 2007, Neurosci Bull, V23, P131, DOI 10.1007/s12264-007-0019-9; Rainer Q, 2012, MOL PHARMACOL, V81, P106, DOI 10.1124/mol.111.075796; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sousa N, 1999, J NEUROCYTOL, V28, P541, DOI 10.1023/A:1007015321767; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6	35	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63662	10.1371/journal.pone.0063662	http://dx.doi.org/10.1371/journal.pone.0063662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675498	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400050
J	Fabricant, SA; Kemp, DJ; Krajicek, J; Bosakova, Z; Herberstein, ME				Fabricant, Scott A.; Kemp, Darrell J.; Krajicek, Jan; Bosakova, Zuzana; Herberstein, Marie E.			Mechanisms of Color Production in a Highly Variable Shield-Back Stinkbug, Tectocoris diopthalmus (Heteroptera: Scutelleridae), and Why It Matters	PLOS ONE			English	Article							SEXUALLY SELECTED TRAIT; WARNING SIGNAL; INTERFERENCE REFLECTORS; APOSEMATIC PREY; SELECTION; PIGMENTS; PTERIDINES; IRIDESCENCE; EXPRESSION; AVOIDANCE	Theory suggests that aposematism, specifically the learned avoidance of unprofitable prey via memorable color patterns, should result in selection for pattern uniformity. However, many examples to the contrary are seen in nature. Conversely, honest sexual signals are likely to exhibit greater variation because they reflect underlying variation in mate quality. Here we aim to characterize and quantify the mechanistic causes of color in Tectocoris diopthalmus to shed light on the costs of color production, and thus the potential information content of its color signals. We use Tectocoris diopthalmus because it is a weakly-defended stinkbug, and presents elements that have classically been studied in the context of aposematism (red coloring), and sexual selection (sexual dichromatism and iridescent coloring). Pigment analysis reveals that variation in orange coloration is due to the amount of erythropterin pigment, stored in intracellular granules. This pigment is common in Heteroptera, and as an endogenously produced excretory byproduct is unlikely to reflect mate quality or variation in unprofitability of the bug. Electron microscopy reveals the iridescent patches are caused by an epicuticular multilayer reflector, and the hue and patch size are directly related to the layer widths and extent of coverage of this layering. Furthermore, we identified melanin as an essential component of the multilayer reflector system; therefore, the quality of the iridescent patches may be affected by aspects of rearing environment and immunocompetence. We posit that T. diopthalmus has co-opted the melanic patches of a 'typical' red and black aposematic signal, transforming it into a complex and variable iridescent signal that may enhance its capacity to display individual quality.	[Fabricant, Scott A.; Kemp, Darrell J.; Herberstein, Marie E.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Krajicek, Jan; Bosakova, Zuzana] Charles Univ Prague, Dept Analyt Chem, CR-12840 Prague, Czech Republic	Macquarie University; Charles University Prague	Fabricant, SA (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	scott.fabricant@mq.edu.au	Bosáková, Zuzana/M-4364-2017; Fabricant, Scott/H-1005-2014; Kemp, Darrell/ABC-9638-2021; Herberstein, Marie/D-2042-2011	Bosáková, Zuzana/0000-0002-8483-5739; Fabricant, Scott/0000-0003-3080-7895; Kemp, Darrell/0000-0002-5845-5513; Herberstein, Marie/0000-0001-5071-2952	Macquarie University Research Excellence Scholarship; Grant Agency of the Czech Republic [P505/11/1459]; Ministry of Education of the Czech Republic [MSM0021620857]; Charles University SVV (Specificky Vysokoskolsky Vyzkum, or Specific University Research) student grant	Macquarie University Research Excellence Scholarship; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University SVV (Specificky Vysokoskolsky Vyzkum, or Specific University Research) student grant	Funding was provided by a Macquarie University Research Excellence Scholarship, as well as additional financial support from the Grant Agency of the Czech Republic, P505/11/1459, the Ministry of Education of the Czech Republic, MSM0021620857 and Charles University SVV (Specificky Vysokoskolsky Vyzkum, or Specific University Research) student grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH JR, 1986, P ENTOMOL SOC WASH, V88, P409; BALLARD E, 1927, BULL ENT RES, V17, P295, DOI 10.1017/S0007485300019362; BALLARD E., 1926, BULL ENT RES, V16, P329, DOI 10.1017/S0007485300028625; Bel Y, 1997, ARCH INSECT BIOCHEM, V34, P83, DOI 10.1002/(SICI)1520-6327(1997)34:1<83::AID-ARCH7>3.3.CO;2-Q; Blount JD, 2012, FUNCT ECOL, V26, P334, DOI 10.1111/j.1365-2435.2012.01961.x; Blount JD, 2009, P ROY SOC B-BIOL SCI, V276, P871, DOI 10.1098/rspb.2008.1407; Cassis G., 2006, Denisia, P275; Doucet SM, 2009, J R SOC INTERFACE, V6, pS115, DOI 10.1098/rsif.2008.0395.focus; Durrer H., 1972, International J Insect Morph Embryol, V1, P233, DOI 10.1016/0020-7322(72)90031-1; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Exnerova A, 2006, BIOL J LINN SOC, V88, P143, DOI 10.1111/j.1095-8312.2006.00611.x; Fitzpatrick S, 1998, ANN ZOOL FENN, V35, P67; Fitzstephens DM, 2000, ANIM BEHAV, V60, P851, DOI 10.1006/anbe.2000.1548; Forsman A, 1999, EVOL ECOL, V13, P131, DOI 10.1023/A:1006630911975; Fox DL, 1976, ANIMAL BIOCHROMES ST, V2d; Friman VP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006761; Gamberale-Stille G, 1999, EVOL ECOL, V13, P579, DOI 10.1023/A:1006741626575; GIBERT JM, 2007, PLOS GENET, V3, pR100; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; GREENWOOD JJD, 1989, BIOL J LINN SOC, V36, P213, DOI 10.1111/j.1095-8312.1989.tb00491.x; Grether GF, 2001, P ROY SOC B-BIOL SCI, V268, P1245, DOI 10.1098/rspb.2001.1624; Ham AD, 2006, BEHAV ECOL SOCIOBIOL, V60, P482, DOI 10.1007/s00265-006-0190-4; Han FT, 1999, ANAL CHEM, V71, P1265, DOI 10.1021/ac981218v; HARMSEN R, 1966, J EXP BIOL, V45, P1; Hazel WN, 2002, EVOLUTION, V56, P342, DOI 10.1111/j.0014-3820.2002.tb01344.x; Ihalainen E, 2007, J EVOLUTION BIOL, V20, P780, DOI 10.1111/j.1420-9101.2006.01234.x; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Jacot A, 2005, J EVOLUTION BIOL, V18, P1060, DOI 10.1111/j.1420-9101.2005.00899.x; Kayser H., 1985, P367; Kemp DJ, 2007, EVOLUTION, V61, P168, DOI 10.1111/j.1558-5646.2007.00014.x; KODRICBROWN A, 1984, AM NAT, V124, P309, DOI 10.1086/284275; Kroiss J, 2009, NATURWISSENSCHAFTEN, V96, P983, DOI 10.1007/s00114-009-0553-6; Lindstedt C, 2011, BEHAV ECOL, V22, P580, DOI 10.1093/beheco/arr017; Lindstedt C, 2010, FUNCT ECOL, V24, P759, DOI 10.1111/j.1365-2435.2010.01686.x; Lindstedt C, 2010, EVOLUTION, V64, P68, DOI 10.1111/j.1558-5646.2009.00796.x; Lindstrom L, 2001, P NATL ACAD SCI USA, V98, P9181, DOI 10.1073/pnas.161071598; Maan ME, 2009, P NATL ACAD SCI USA, V106, P19072, DOI 10.1073/pnas.0903327106; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; McGraw KJ, 2007, PIGM CELL RES, V20, P301, DOI 10.1111/j.1600-0749.2007.00386.x; McGraw KJ, 2005, ANIM BEHAV, V69, P757, DOI 10.1016/j.anbehav.2004.06.022; McGraw KJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P391, DOI 10.1007/s00265-004-0853-y; McGraw KJ, 2002, J EXP BIOL, V205, P3747; MELBER C, 1992, COMP BIOCHEM PHYS B, V101, P115, DOI 10.1016/0305-0491(92)90167-P; MERLINI L, 1966, J INSECT PHYSIOL, V12, P123, DOI 10.1016/0022-1910(66)90070-9; Miyamoto K., 2002, FORMA TOKYO, V17, P155; Niva CC, 2002, COMP BIOCHEM PHYS B, V132, P653, DOI 10.1016/S1096-4959(02)00081-7; Noge K, 2012, J CHEM ECOL, V38, P1050, DOI 10.1007/s10886-012-0166-y; Nokelainen O, 2012, P ROY SOC B-BIOL SCI, V279, P257, DOI 10.1098/rspb.2011.0880; Noyes JA, 2007, OPT EXPRESS, V15, P4351, DOI 10.1364/OE.15.004351; Prudic KL, 2007, BEHAV ECOL, V18, P41, DOI 10.1093/beheco/arl046; Rantala MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2453, DOI 10.1098/rspb.2000.1305; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROPER TJ, 1987, ANIM BEHAV, V35, P739, DOI 10.1016/S0003-3472(87)80110-0; Rutowski RL, 2010, FUNCT ECOL, V24, P767, DOI 10.1111/j.1365-2435.2010.01693.x; Ruxton GD, 2005, AVOIDING ATTACK EVOL; SCHAEFER CW, 1972, ANN ENTOMOL SOC AM, V65, P810, DOI 10.1093/aesa/65.4.810; SCHULTZ TD, 1989, NATURE, V337, P72, DOI 10.1038/337072a0; SCHULTZ TD, 1985, J EXP BIOL, V117, P111; SCHULTZ TD, 1985, J EXP BIOL, V117, P87; Seago AE, 2009, J R SOC INTERFACE, V6, pS165, DOI 10.1098/rsif.2008.0354.focus; Shawkey MD, 2003, P ROY SOC B-BIOL SCI, V270, P1455, DOI 10.1098/rspb.2003.2390; Siva-Jothy MT, 2000, P ROY SOC B-BIOL SCI, V267, P2523, DOI 10.1098/rspb.2000.1315; Speed MP, 2007, EVOLUTION, V61, P623, DOI 10.1111/j.1558-5646.2007.00054.x; STADDON BW, 1987, AUST J ZOOL, V35, P227, DOI 10.1071/ZO9870227; Staples JK, 2002, J CHEM ECOL, V28, P601, DOI 10.1023/A:1014552414580; Stavenga DG, 2011, PHILOS T R SOC B, V366, P709, DOI 10.1098/rstb.2010.0197; Stevens M, 2012, P ROY SOC B-BIOL SCI, V279, P417, DOI 10.1098/rspb.2011.1932; Stoehr AM, 2006, FUNCT ECOL, V20, P276, DOI 10.1111/j.1365-2435.2006.01090.x; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sugumaran M, 1998, ADV INSECT PHYSIOL, V27, P229, DOI 10.1016/S0065-2806(08)60014-4; Sun MX, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/2/026003; Talloen W, 2004, EVOLUTION, V58, P360, DOI 10.1111/j.0014-3820.2004.tb01651.x; Thery M, 2010, ADV INSECT PHYSIOL, V38, P267, DOI 10.1016/S0065-2806(10)38001-5; Vigneron JP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021907; WEIDNER VR, 1981, J OPT SOC AM, V71, P856, DOI 10.1364/JOSA.71.000856; Wijnen B, 2007, J INSECT PHYSIOL, V53, P1206, DOI 10.1016/j.jinsphys.2007.06.016; Xu M, 2010, J MORPHOL, V271, P1300, DOI 10.1002/jmor.10870	79	20	21	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64082	10.1371/journal.pone.0064082	http://dx.doi.org/10.1371/journal.pone.0064082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23675520	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700203
J	Portela, A; Liz, J; Nogales, V; Setien, F; Villanueva, A; Esteller, M				Portela, A.; Liz, J.; Nogales, V.; Setien, F.; Villanueva, A.; Esteller, M.			DNA methylation determines nucleosome occupancy in the 5 '-CpG islands of tumor suppressor genes	ONCOGENE			English	Article						DNA methylation; tumor suppressor gene; nucleosome; CpG island; DNA methyltransferase	CHROMATIN; PROMOTERS; TISSUES; DNMT3B	Promoter CpG island hypermethylation of tumor suppressor genes is an epigenetic hallmark of human cancer commonly associated with nucleosome occupancy and the transcriptional silencing of the neighboring gene. Nucleosomes can determine the underlying DNA methylation status. Herein, we show that the opposite is also true: DNA methylation can determine nucleosome positioning. Using a cancer model and digital nucleosome positioning techniques, we demonstrate that the induction of DNA hypomethylation events by genetic (DNMT1/DNMT3B deficient cells) or drug (a DNA demethylating agent) approaches is associated with the eviction of nucleosomes from previously hypermethylated CpG islands of tumor suppressor genes. Most importantly, the establishment of a stable cell line that restores DNMT1/DNMT3B deficiency shows that nucleosomes reoccupy their positions in de novo methylated CpG islands. Finally, we extend these results to the genomic level, combining a DNA methylation microarray and the nucleosome positioning technique. Using this global approach, we observe the dependency of nucleosome occupancy upon the DNA methylation status. Thus, our results suggest that there is a close association between hypermethylated CpG islands and the presence of nucleosomes, such that each of these epigenetic mechanisms can determine the recruitment of the other.	[Portela, A.; Liz, J.; Nogales, V.; Setien, F.; Esteller, M.] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Catalonia, Spain; [Villanueva, A.] Bellvitge Biomed Res Inst IDIBELL, Translat Res Lab, Catalan Inst Oncol, Barcelona, Catalonia, Spain; [Esteller, M.] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Catalonia, Spain; [Esteller, M.] ICREA, Barcelona, Catalonia, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA	Esteller, M (corresponding author), Hosp Duran & Reynals, Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, 3rd Floor,Avda Gran Via Km 2-7, Barcelona 08908, Catalonia, Spain.	mesteller@idibell.cat	Esteller, Manel/L-5956-2014	Esteller, Manel/0000-0003-4490-6093; Portela, Anna/0000-0003-2184-2584; Nogales, Vanesa/0000-0002-4905-5278	Ministerio de Ciencia e Innovacion (MICINN) [SAF2011-22803]; European Research Council (ERC) Advanced Grant EPINORC; Cellex Foundation; Health and Science Departments of the Catalan Government (Generalitat de Catalunya); Fondo de Investigaciones Sanitarias Grant [PI08-1345]; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council (ERC) Advanced Grant EPINORC(European Research Council (ERC)); Cellex Foundation(Foundation CELLEX); Health and Science Departments of the Catalan Government (Generalitat de Catalunya); Fondo de Investigaciones Sanitarias Grant; ICREA(ICREA)	This work was supported by the Ministerio de Ciencia e Innovacion (MICINN), grant number SAF2011-22803 (ME), the European Research Council (ERC) Advanced Grant EPINORC (ME), Cellex Foundation, the Health and Science Departments of the Catalan Government (Generalitat de Catalunya) and a Fondo de Investigaciones Sanitarias Grant PI08-1345 (ME). AP is a Sara Borrell Postdoctoral Fellow. ME is an ICREA Research Professor.	Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Christensen BC, 2009, CANCER RES, V69, P6315, DOI 10.1158/0008-5472.CAN-09-1073; Davey CS, 2004, NUCLEIC ACIDS RES, V32, P4322, DOI 10.1093/nar/gkh749; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Felle M, 2011, NUCLEIC ACIDS RES, V39, P6956, DOI 10.1093/nar/gkr263; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Gowher H, 2005, BIOCHEMISTRY-US, V44, P9899, DOI 10.1021/bi047634t; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Carmona FJ, 2012, J PATHOL, V228, P230, DOI 10.1002/path.4011; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Lee JY, 2012, J AM CHEM SOC, V134, P173, DOI 10.1021/ja210273w; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Pandiyan K, 2013, NUCLEIC ACIDS RES, V41, P3973, DOI 10.1093/nar/gkt077; Pennings Sari, 2005, Briefings in Functional Genomics & Proteomics, V3, P351, DOI 10.1093/bfgp/3.4.351; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Sharma S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001286; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shen L, 2010, NUCLEIC ACIDS RES, V38, P6054, DOI 10.1093/nar/gkq456; Youssef EM, 2004, CANCER BIOL THER, V3, P82, DOI 10.4161/cbt.3.1.591	34	27	29	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 21	2013	32	47					5421	5428		10.1038/onc.2013.162	http://dx.doi.org/10.1038/onc.2013.162			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	254PM	23686312	hybrid, Green Published			2022-12-25	WOS:000327177600005
J	Rohira, AD; Chen, CY; Allen, JR; Johnson, DL				Rohira, Aarti D.; Chen, Chun-Yuan; Allen, Justin R.; Johnson, Deborah L.			Covalent Small Ubiquitin-like Modifier (SUMO) Modification of Maf1 Protein Controls RNA Polymerase III-dependent Transcription Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; NEGATIVE REGULATOR; CELL-PROLIFERATION; GENE-EXPRESSION; ONCOGENESIS	RNA polymerase (pol) III transcribes genes that determine biosynthetic capacity. Induction of these genes is required for oncogenic transformation. The transcriptional repressor, Maf1, plays a central role in the repression of these and other genes that promote oncogenesis. Our studies identify an important new role for SUMOylation in repressing RNA pol III-dependent transcription. We show that a key mechanism by which this occurs is through small ubiquitin-like modifier (SUMO) modification of Maf1 by both SUMO1 and SUMO2. Mutation of each lysine residue revealed that Lys-35 is the major SUMOylation site on Maf1 and that the deSUMOylase, SENP1, is responsible for controlling Maf1K35 SUMOylation. SUMOylation of Maf1 is unaffected by rapamycin inhibition of mammalian target of rapamycin (mTOR) and mTOR-dependent Maf1 phosphorylation. By preventing SUMOylation at Lys-35, Maf1 is impaired in its ability to both repress transcription and suppress colony growth. Although SUMOylation does not alter Maf1 subcellular localization, Maf1K35R is defective in its ability to associate with RNA pol III. This impairs Maf1 recruitment to tRNA gene promoters and its ability to facilitate the dissociation of RNA pol III from these promoters. These studies identify a novel role for SUMOylation in controlling Maf1 and RNA pol III-mediated transcription. Given the emerging roles of SENP1, Maf1, and RNA pol III transcription in oncogenesis, our studies support the idea that deSUMOylation of Maf1 and induction of its gene targets play a critical role in cancer development.	[Johnson, Deborah L.] Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90033 USA; [Johnson, Deborah L.] Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California	Johnson, DL (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, 2011 Zonal Ave, Los Angeles, CA 90033 USA.	johnsond@usc.edu			National Institutes of Health [CA108614]; NATIONAL CANCER INSTITUTE [R01CA108614, R01CA074138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA108614 (to D. L. J.).	Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Boguta M, 2013, BBA-GENE REGUL MECH, V1829, P376, DOI 10.1016/j.bbagrm.2012.11.004; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Fromm JA, 2008, MOL CELL BIOL, V28, P6483, DOI 10.1128/MCB.00288-08; Han Y, 2010, J BIOL CHEM, V285, P12906, DOI 10.1074/jbc.M109.071431; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Johnson DL, 2008, SCIENCE, V320, P461, DOI 10.1126/science.1158680; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Johnson SAS, 2003, MOL CELL BIOL, V23, P3043, DOI 10.1128/MCB.23.9.3043-3051.2003; Kantidakis T, 2010, P NATL ACAD SCI USA, V107, P11823, DOI 10.1073/pnas.1005188107; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; Li X, 2008, CELL DEATH DIFFER, V15, P739, DOI 10.1038/sj.cdd.4402303; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Michels AA, 2010, MOL CELL BIOL, V30, P3749, DOI 10.1128/MCB.00319-10; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Sarge KD, 2011, INT REV CEL MOL BIO, V288, P167, DOI 10.1016/B978-0-12-386041-5.00004-2; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002; Wang Q, 2013, ONCOGENE, V32, P2493, DOI 10.1038/onc.2012.250; Zhong SP, 2007, MOL CELL BIOL, V27, P54, DOI 10.1128/MCB.01365-06	25	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19288	19295		10.1074/jbc.M113.473744	http://dx.doi.org/10.1074/jbc.M113.473744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23673667	Green Published, hybrid			2022-12-25	WOS:000321335800061
J	Dembek, M; Stabler, RA; Witney, AA; Wren, BW; Fairweather, NF				Dembek, Marcin; Stabler, Richard A.; Witney, Adam A.; Wren, Brendan W.; Fairweather, Neil F.			Transcriptional Analysis of Temporal Gene Expression in Germinating Clostridium difficile 630 Endospores	PLOS ONE			English	Article							SPORE GERMINATION; SUPERDORMANT SPORES; BACILLUS-SUBTILIS; COGERMINANTS; TRANSMISSION; SPORULATION; OUTGROWTH; GLYCINE; DORMANT; GENOME	Clostridium difficile is the leading cause of hospital acquired diarrhoea in industrialised countries. Under conditions that are not favourable for growth, the pathogen produces metabolically dormant endospores via asymmetric cell division. These are extremely resistant to both chemical and physical stress and provide the mechanism by which C. difficile can evade the potentially fatal consequences of exposure to heat, oxygen, alcohol, and certain disinfectants. Spores are the primary infective agent and must germinate to allow for vegetative cell growth and toxin production. While spore germination in Bacillus is well understood, little is known about C. difficile germination and outgrowth. Here we use genome-wide transcriptional analysis to elucidate the temporal gene expression patterns in C. difficile 630 endospore germination. We have optimized methods for large scale production and purification of spores. The germination characteristics of purified spores have been characterized and RNA extraction protocols have been optimized. Gene expression was highly dynamic during germination and outgrowth, and was found to involve a large number of genes. Using this genome-wide, microarray approach we have identified 511 genes that are significantly up-or down-regulated during C. difficile germination (p <= 0.01). A number of functional groups of genes appeared to be co-regulated. These included transport, protein synthesis and secretion, motility and chemotaxis as well as cell wall biogenesis. These data give insight into how C. difficile re-establishes its metabolism, re-builds the basic structures of the vegetative cell and resumes growth.	[Dembek, Marcin; Fairweather, Neil F.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, MRC, Ctr Mol Bacteriol & Infect, London, England; [Stabler, Richard A.; Wren, Brendan W.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Witney, Adam A.] Univ London, Div Clin Sci, London, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London	Fairweather, NF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, MRC, Ctr Mol Bacteriol & Infect, London, England.	n.fairweather@imperial.ac.uk	Dembek, Marcin/AAA-8852-2021	Witney, Adam/0000-0003-4561-7170; Dembek, Marcin/0000-0003-2831-3335; Stabler, Richard/0000-0002-2402-6630	Wellcome Trust [089875/Z/09/Z]; Medical Research Council [G0800170] Funding Source: researchfish; MRC [G0800170] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust studentship 089875/Z/09/Z to M.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi D, 2013, FOOD MICROBIOL, V33, P11, DOI 10.1016/j.fm.2012.08.004; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; BLEYMAN M, 1969, J BACTERIOL, V97, P27, DOI 10.1128/JB.97.1.27-31.1969; Carroll KC, 2011, ANNU REV MICROBIOL, V65, P501, DOI 10.1146/annurev-micro-090110-102824; CHAMBON P, 1968, J BIOL CHEM, V243, P5110; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Deneve C, 2009, INT J ANTIMICROB AG, V33, pS24, DOI 10.1016/S0924-8579(09)70012-3; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Ghosh S, 2010, J APPL MICROBIOL, V108, P582, DOI 10.1111/j.1365-2672.2009.04442.x; Ghosh S, 2012, J BACTERIOL, V194, P2221, DOI 10.1128/JB.00151-12; Ghosh S, 2009, J BACTERIOL, V191, P1787, DOI 10.1128/JB.01668-08; JENG YH, 1974, J BACTERIOL, V119, P514, DOI 10.1128/JB.119.2.514-521.1974; Keijser BJF, 2007, J BACTERIOL, V189, P3624, DOI 10.1128/JB.01736-06; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Nerandzic MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012285; Paredes-Sabja D, 2008, J BACTERIOL, V190, P1190, DOI 10.1128/JB.01748-07; Paredes-Sabja D, 2011, TRENDS MICROBIOL, V19, P85, DOI 10.1016/j.tim.2010.10.004; Paredes-Sabja D, 2009, APPL ENVIRON MICROB, V75, P6299, DOI 10.1128/AEM.00822-09; Paredes-Sabja D, 2009, J BACTERIOL, V191, P3822, DOI 10.1128/JB.00158-09; Permpoonpattana P, 2011, J BACTERIOL, V23, P6491; Ramirez N, 2010, J BACTERIOL, V192, P418, DOI 10.1128/JB.01226-09; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; RUIZHERRERA J, 1994, CRIT REV MICROBIOL, V20, P143, DOI 10.3109/10408419409113553; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SETLOW P, 1974, J BACTERIOL, V117, P1171, DOI 10.1128/JB.117.3.1171-1177.1974; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stringer SC, 2005, APPL ENVIRON MICROB, V71, P4998, DOI 10.1128/AEM.71.9.4998-5003.2005; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wang G, 2011, J APPL MICROBIOL, V111, P1212, DOI 10.1111/j.1365-2672.2011.05135.x; Wheeldon LJ, 2011, J APPL MICROBIOL, V110, P987, DOI 10.1111/j.1365-2672.2011.04953.x; Wheeldon LJ, 2008, J APPL MICROBIOL, V105, P2223, DOI 10.1111/j.1365-2672.2008.03965.x; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983; Xiao YH, 2011, FOOD MICROBIOL, V28, P266, DOI 10.1016/j.fm.2010.03.016	42	49	49	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64011	10.1371/journal.pone.0064011	http://dx.doi.org/10.1371/journal.pone.0064011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691138	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700070
J	Drewnowski, A; Rehm, CD				Drewnowski, Adam; Rehm, Colin D.			Vegetable Cost Metrics Show That Potatoes and Beans Provide Most Nutrients Per Penny	PLOS ONE			English	Article							NUTRITIONAL QUALITY; FOODS; VALIDATION; CONSUMPTION; FRUITS; DIETS	Vegetables are important sources of dietary fiber, vitamins and minerals in the diets of children. The United States Department of Agriculture (USDA) National School Lunch Program has new requirements for weekly servings of vegetable subgroups as well as beans and peas. This study estimated the cost impact of meeting the USDA requirements using 2008 national prices for 98 vegetables, fresh, frozen, and canned. Food costs were calculated per 100 grams, per 100 calories, and per edible cup. Rank 6 score, a nutrient density measure was based on six nutrients: dietary fiber; potassium; magnesium; and vitamins A, C, and K. Individual nutrient costs were measured as the monetary cost of 10% daily value of each nutrient per cup equivalent. ANOVAs with post hoc tests showed that beans and starchy vegetables, including white potatoes, were cheaper per 100 calories than were dark-green and deep-yellow vegetables. Fresh, frozen, and canned vegetables had similar nutrient profiles and provided comparable nutritional value. However, less than half (n = 46) of the 98 vegetables listed by the USDA were were consumed >5 times by children and adolescents in the 2003-4 National Health and Nutrition Examination Survey database. For the more frequently consumed vegetables, potatoes and beans were the lowest-cost sources of potassium and fiber. These new metrics of affordable nutrition can help food service and health professionals identify those vegetable subgroups in the school lunch that provide the best nutritional value per penny.	[Drewnowski, Adam; Rehm, Colin D.] Univ Washington, Ctr Publ Hlth Nutr, Sch Publ Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Drewnowski, A (corresponding author), Univ Washington, Ctr Publ Hlth Nutr, Sch Publ Hlth, Seattle, WA 98195 USA.	adamdrew@u.washington.edu	REHM, COLIN D./J-1215-2019; Drewnowski, Adam/HCI-4117-2022	REHM, COLIN D./0000-0002-7644-0040; 	US Potato Board	US Potato Board	This research supported in part by the US Potato Board. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, FED REG; Bevans KB, 2011, J SCHOOL HEALTH, V81, P424, DOI 10.1111/j.1746-1561.2011.00611.x; Carlson A, 2012, ARE HEALTHIER FOODS; Cockroft JE, 2005, PUBLIC HEALTH NUTR, V8, P861, DOI 10.1079/PHN2005734; Cullen KW, 2011, PUBLIC HEALTH NUTR, V14, P1876, DOI 10.1017/S1368980011000656; Darmon N, 2005, J AM DIET ASSOC, V105, P1881, DOI 10.1016/j.jada.2005.09.005; Darmon N, 2009, AM J CLIN NUTR, V89, P1227, DOI 10.3945/ajcn.2008.26465; Davidson R, 1993, ESTIMATION INFERENCE; Drewnowski A, 2004, AM J PUBLIC HEALTH, V94, P1555, DOI 10.2105/AJPH.94.9.1555; Drewnowski A, 2011, J AM COLL NUTR, V30, p422S, DOI 10.1080/07315724.2011.10719986; Drewnowski A, 2010, AM J CLIN NUTR, V92, P1181, DOI 10.3945/ajcn.2010.29300; Drewnowski A, 2010, AM J CLIN NUTR, V91, p1095S, DOI 10.3945/ajcn.2010.28450D; Fulgoni VL, 2009, J NUTR, V139, P1549, DOI 10.3945/jn.108.101360; Harris DM, 2012, CHILD OBES, V8, P294, DOI 10.1089/chi.2012.0094; Katz DL, 2010, AM J CLIN NUTR, V91, p1102S, DOI 10.3945/ajcn.2010.28450E; Maillot M, 2008, J NUTR, V138, P1107, DOI 10.1093/jn/138.6.1107; Monsivais P, 2011, HEALTH AFFAIR, V30, P1471, DOI 10.1377/hlthaff.2010.1273; Ranney C. K., 2004, NUTR TODAY, V39, P161, DOI DOI 10.1097/00017285-200407000-00006; Rayner M, 2009, UK OFC NUTR PROF MOD; Rehm CD, 2011, AM J CLIN NUTR, V94, P1333, DOI 10.3945/ajcn.111.015560; Shanklin CW, 2001, J AM DIET ASSOC, V101, P1358, DOI 10.1016/S0002-8223(01)00325-X; Stallings VA, 2010, SCH MEALS BUILDING B; Stewart H., 2011, MUCH DO FRUITS VEGET; U.S. Department of Agriculture, CHOOS MYPLATE TIPS R; U.S. Department of Agriculture, 2006, USDA MON INT; U.S. Department of Agriculture & Center for Nutrition Policy and Promotion, 2008, DEV CNPP PRIC DAT; U.S. Department of Agriculture & U.S. Department of Health and Human Services, 2010, USDA MON INT	27	48	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63277	10.1371/journal.pone.0063277	http://dx.doi.org/10.1371/journal.pone.0063277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691007	Green Submitted, gold, Green Published			2022-12-25	WOS:000319052700027
J	Eicher, JD; Powers, NR; Cho, K; Miller, LL; Mueller, KL; Ring, SM; Tomblin, JB; Gruen, JR				Eicher, John D.; Powers, Natalie R.; Cho, Kelly; Miller, Laura L.; Mueller, Kathryn L.; Ring, Susan M.; Tomblin, J. Bruce; Gruen, Jeffrey R.			Associations of Prenatal Nicotine Exposure and the Dopamine Related Genes ANKK1 and DRD2 to Verbal Language	PLOS ONE			English	Article							READING DISABILITIES; MATERNAL SMOKING; DEVELOPMENTAL DISORDERS; NONWORD REPETITION; FETAL NICOTINE; RECEPTOR GENE; A1 ALLELE; IMPAIRMENT; CHILDREN; TOBACCO	Language impairment (LI) and reading disability (RD) are common pediatric neurobehavioral disorders that frequently co-occur, suggesting they share etiological determinants. Recently, our group identified prenatal nicotine exposure as a factor for RD and poor reading performance. Using smoking questionnaire and language data from the Avon Longitudinal Study of Parents and Children, we first determined if this risk could be expanded to other communication disorders by evaluating whether prenatal nicotine exposure increases risk for LI and poor performance on language tasks. Prenatal nicotine exposure increased LI risk (OR = 1.60; p = 0.0305) in a dose-response fashion with low (OR = 1.25; p = 0.1202) and high (OR = 3.84; p = 0.0002) exposures. Next, hypothesizing that the effects of prenatal nicotine may also implicate genes that function in nicotine related pathways, we determined whether known nicotine dependence (ND) genes associate with performance on language tasks. We assessed the association of 33 variants previously implicated in ND with LI and language abilities, finding association between ANKK1/DRD2 and performance on language tasks (p <= 0.0003). The associations of markers within ANKK1 were replicated in a separate LI case-control cohort (p<0.05). Our results show that smoking during pregnancy increases the risk for LI and poor performance on language tasks and that ANKK1/DRD2 contributes to language performance. More precisely, these findings suggest that prenatal environmental factors influence in utero development of neural circuits vital to language. Our association of ANKK1/DRD2 further implicates the role of nicotine-related pathways and dopamine signaling in language processing, particularly in comprehension and phonological memory.	[Eicher, John D.; Powers, Natalie R.; Gruen, Jeffrey R.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Cho, Kelly] Yale Univ, Sch Med, Dept Epidemiol, New Haven, CT 06510 USA; [Cho, Kelly] Yale Univ, Sch Med, Dept Publ Hlth, New Haven, CT 06510 USA; [Cho, Kelly] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Aging, Boston, MA 02115 USA; [Cho, Kelly] Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Miller, Laura L.; Ring, Susan M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Mueller, Kathryn L.; Tomblin, J. Bruce] Univ Iowa, Dept Speech, Iowa City, IA USA; [Mueller, Kathryn L.; Tomblin, J. Bruce] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Mueller, Kathryn L.; Tomblin, J. Bruce] Univ Iowa, Dept Audiol, Iowa City, IA USA; [Gruen, Jeffrey R.] Yale Univ, Sch Med, Yale Child Hlth Res Ctr, Dept Pediat, New Haven, CT 06510 USA; [Gruen, Jeffrey R.] Yale Univ, Sch Med, Yale Child Hlth Res Ctr, Dept Investigat Med, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Bristol; University of Iowa; University of Iowa; University of Iowa; Yale University; Yale University	Gruen, JR (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	jeffrey.gruen@yale.edu		Powers, Natalie/0000-0001-6313-1719	National Institutes of Health (NIH) [R01NS43530, T32 MH014235, T32 GM007223]; National Institute on Deafness and Other Communication Disorders [F31DC012270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC012270] Funding Source: NIH RePORTER; Medical Research Council [G9815508] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council, the Wellcome Trust and the University of Bristol provide core support for ALSPAC. This research was funded by R01NS43530 (J.R.G.), T32 MH014235 (K.C.), and T32 GM007223 (J.D.E.) from the National Institutes of Health (NIH) along with F31DC012270 from the National Institute on Deafness and Other Communication Disorders (J.D.E.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaver KM, 2010, J NEURAL TRANSM, V117, P827, DOI 10.1007/s00702-010-0421-8; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; BERMAN SM, 1995, BEHAV GENET, V25, P45, DOI 10.1007/BF02197241; Bertolino A, 2009, NEUROSCIENCE, V164, P288, DOI 10.1016/j.neuroscience.2009.04.038; Bertolino A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009348; Bishop DVM, 2008, GENES BRAIN BEHAV, V7, P365, DOI 10.1111/j.1601-183X.2007.00360.x; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Bolton JL, 2010, BEHAV GENET, V40, P630, DOI 10.1007/s10519-010-9372-y; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Buka SL, 2003, AM J PSYCHIAT, V160, P1978, DOI 10.1176/appi.ajp.160.11.1978; Catts HW, 2005, J SPEECH LANG HEAR R, V48, P1378, DOI 10.1044/1092-4388(2005/096); Cho K, 2013, J PEDIATR-US, V162, P713, DOI 10.1016/j.jpeds.2012.09.041; Couto JM, 2010, AM J MED GENET B, V153B, P447, DOI 10.1002/ajmg.b.30999; Dwyer Jennifer B., 2008, Birth Defects Research, V84, P30, DOI 10.1002/bdrc.20118; Ernst M, 2001, J AM ACAD CHILD PSY, V40, P630, DOI 10.1097/00004583-200106000-00007; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; FRIED PA, 1992, J DEV BEHAV PEDIATR, V13, P383; Fried PA, 1997, NEUROTOXICOL TERATOL, V19, P171, DOI 10.1016/S0892-0362(97)00015-9; Gathercole S. E., 1996, CHILDRENS TEST NONWO; Gathercole S. E., 1993, WORKING MEMORY LANGU; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; Ginzel KH, 2007, J HEALTH PSYCHOL, V12, P215, DOI 10.1177/1359105307074240; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gupta P, 1999, CARN S COGN, P447; Hettinger JA, 2012, BEHAV BRAIN FUNCT, V8, DOI [10.1186/s1744-9081-0-1, 10.1186/1744-9081-8-19]; Huang WH, 2009, NEUROPSYCHOPHARMACOL, V34, P319, DOI 10.1038/npp.2008.37; Kafouri S, 2009, INT J EPIDEMIOL, V38, P158, DOI 10.1093/ije/dyn250; Lee JC, 2012, BRAIN LANG, V123, P154, DOI 10.1016/j.bandl.2012.07.009; London ED, 2009, PSYCHIAT RES-NEUROIM, V174, P163, DOI 10.1016/j.pscychresns.2009.07.008; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; Mill J, 2008, J CHILD PSYCHOL PSYC, V49, P1020, DOI 10.1111/j.1469-7610.2008.01909.x; Montgomery JW, 2003, J COMMUN DISORD, V36, P221, DOI 10.1016/S0021-9924(03)00021-2; Muneoka K, 1997, DEV BRAIN RES, V102, P117, DOI 10.1016/S0165-3806(97)00092-8; Newbury DF, 2010, GENOME MED, V2, DOI 10.1186/gm127; Newbury DF, 2009, AM J HUM GENET, V85, P264, DOI 10.1016/j.ajhg.2009.07.004; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; Nithart C, 2009, DEV NEUROPSYCHOL, V34, P296, DOI 10.1080/87565640902801841; Noble EP, 1997, AM J MED GENET, V74, P162; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; Odd DE, 2009, LANCET, V373, P1615, DOI 10.1016/S0140-6736(09)60244-0; Pauly JR, 2008, ACTA PAEDIATR, V97, P1331, DOI 10.1111/j.1651-2227.2008.00852.x; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; Slotkin TA, 2010, BRAIN RES BULL, V82, P124, DOI 10.1016/j.brainresbull.2010.02.015; Stratton K., 1996, FETAL ALCOHOL SYNDRO; Stroud LR, 2009, PEDIATRICS, V123, pE842, DOI 10.1542/peds.2008-2084; Stuebing KK, 2002, AM EDUC RES J, V39, P469, DOI 10.3102/00028312039002469; Tomblin JB, 1998, INT J LANG COMM DIS, V33, P357; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; United States Federal Trade Commission (FTC), 2000, TAR NIC CARB MON SMO; Viding E, 2004, J CHILD PSYCHOL PSYC, V45, P315, DOI 10.1111/j.1469-7610.2004.00223.x; Ward C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-81; Wechsler D., 1992, WISC IIIUK WECHSLER; Wechsler D., 1996, WECHSLER OBJECTIVE L; Weismer SE, 2000, J SPEECH LANG HEAR R, V43, P865, DOI 10.1044/jslhr.4304.865; Weitzman M, 2002, NEUROTOXICOL TERATOL, V24, P397, DOI 10.1016/S0892-0362(02)00201-5; Wise JC, 2007, J SPEECH LANG HEAR R, V50, P1093, DOI 10.1044/1092-4388(2007/076); Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yang BZ, 2007, HUM MOL GENET, V16, P2844, DOI 10.1093/hmg/ddm240; Zhu JM, 2012, J NEUROSCI, V32, P9410, DOI 10.1523/JNEUROSCI.1041-12.2012	62	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63762	10.1371/journal.pone.0063762	http://dx.doi.org/10.1371/journal.pone.0063762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691092	gold, Green Published, Green Submitted			2022-12-25	WOS:000319052700059
J	Janssen, A; Beerling, E; Medema, R; van Rheenen, J				Janssen, Aniek; Beerling, Evelyne; Medema, Rene; van Rheenen, Jacco			Intravital FRET Imaging of Tumor Cell Viability and Mitosis during Chemotherapy	PLOS ONE			English	Article							MITOTIC ARREST; DOCETAXEL TAXOTERE(R); SPINDLE CHECKPOINT; ANTIMITOTIC DRUGS; INDUCED APOPTOSIS; CANCER-CELLS; TAXOL; MICROSCOPY; MICROTUBULES; PACLITAXEL	Taxanes, such as docetaxel, are microtubule-targeting chemotherapeutics that have been successfully used in the treatment of cancer. Based on data obtained from cell cultures, it is believed that taxanes induce tumor cell death by specifically perturbing mitotic progression. Here, we report on data that suggest that this generally accepted view may be too simplified. We describe a high-resolution intravital imaging method to simultaneously visualize mitotic progression and the onset of apoptosis. To directly compare in vitro and in vivo data, we have visualized the effect of docetaxel on mitotic progression in mouse and human colorectal tumor cell lines both in vitro and in isogenic tumors in mice. We show that docetaxel-induced apoptosis in vitro occurs via mitotic cell death, whereas the vast majority of tumor cells in their natural environment die independent of mitotic defects. This demonstrates that docetaxel exerts its anti-tumor effects in vivo through means other than mitotic perturbation. The differences between in vitro and in vivo mechanisms of action of chemotherapeutics may explain the limited response to many of the anti-mitotic agents that are currently validated in clinical trials. Our data illustrate the requirement and power of our intravital imaging technique to study and validate the mode of action of chemotherapeutic agents in vivo, which will be essential to understand and improve their clinical efficacy.	[Janssen, Aniek; Medema, Rene] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Janssen, Aniek; Medema, Rene] Univ Med Ctr Utrecht, Dept Med Oncol & Canc Genom, Utrecht, Netherlands; [Beerling, Evelyne; van Rheenen, Jacco] Hubrecht Inst KNAW, Utrecht, Netherlands; [Beerling, Evelyne; van Rheenen, Jacco] Univ Med Ctr Utrecht, Utrecht, Netherlands	Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Medema, R (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	r.medema@nki.nl; j.vanrheenen@hubrecht.eu	van Rheenen, Jacco/G-3655-2014	Janssen, Aniek/0000-0001-6731-6657; Medema, Rene/0000-0002-6754-0381	Netherlands Organisation for Scientific Research (NWO) [ZonMw 918.46.61]; TI Pharma [T3-105];  [VIDI 91710330];  [NWO 175.01.2007.00];  [834.11.002]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); TI Pharma; ; ; 	This work was supported by The Netherlands Organisation for Scientific Research (NWO) (R.H.M. and A.J.: ZonMw 918.46.61), (E.B. and J.v.R. VIDI 91710330) and TI Pharma (R.H.M and A.J.: T3-105) and equipment grants (NWO 175.01.2007.00 and 834.11.002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerling E, 2011, J CELL SCI, V124, P299, DOI 10.1242/jcs.072728; Bins AD, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-2; BISSERY MC, 1995, ANTI-CANCER DRUG, V6, P339, DOI 10.1097/00001813-199506000-00001; Bissery MC, 1995, ANTI-CANCER DRUG, V6, P365; BRITO DA, 2008, CELL MOTIL CYTOSKELE; Chen JG, 2002, CANCER RES, V62, P1935; Davies AM, 2003, EXPERT OPIN PHARMACO, V4, P553, DOI 10.1517/14656566.4.4.553; Fitzpatrick FA, 2003, INT IMMUNOPHARMACOL, V3, P1699, DOI 10.1016/j.intimp.2003.08.007; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gligorijevic B., 2009, J VIS EXP; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Horwitz S B, 1994, Ann Oncol, V5 Suppl 6, pS3; Huszar D, 2009, CANCER METAST REV, V28, P197, DOI 10.1007/s10555-009-9185-8; Ikui AE, 2005, CELL CYCLE, V4, P1385, DOI 10.4161/cc.4.10.2061; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Javeed A, 2009, EUR J PHARM SCI, V38, P283, DOI 10.1016/j.ejps.2009.08.009; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Keese M, 2010, INT J CANCER, V126, P104, DOI 10.1002/ijc.24730; Keese M, 2007, DIFFERENTIATION, V75, P809, DOI 10.1111/j.1432-0436.2007.00186.x; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lok W, 2010, ANTI-CANCER DRUG, V21, P339, DOI 10.1097/CAD.0b013e3283350dd1; MILAS L, 1995, CANCER CHEMOTH PHARM, V35, P297, DOI 10.1007/BF00689448; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; Noguchi S, 2006, CANCER SCI, V97, P813, DOI 10.1111/j.1349-7006.2006.00265.x; Orth JD, 2011, CANCER RES, V71, P4608, DOI 10.1158/0008-5472.CAN-11-0412; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; RINGEL I, 1991, J NATL CANCER I, V83, P288, DOI 10.1093/jnci/83.4.288; Ritsma L., 2012, INTRAVITAL, V1; Ritsma L, 2013, NAT PROTOC, V8, P583, DOI 10.1038/nprot.2013.026; Ritsma L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004394; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Smakman N, 2005, ONCOGENE, V24, P8338, DOI 10.1038/sj.onc.1208995; Symmans WF, 2000, CLIN CANCER RES, V6, P4610; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tighe A, 2001, EMBO REP, V2, P609, DOI 10.1093/embo-reports/kve127; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; van Munster EB, 2005, ADV BIOCHEM ENG BIOT, V95, P143; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zomer A, 2011, CLIN TRANSL ONCOL, V13, P848, DOI 10.1007/s12094-011-0745-3	47	48	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64029	10.1371/journal.pone.0064029	http://dx.doi.org/10.1371/journal.pone.0064029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691140	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700072
J	Xu, DC; Chen, W; Li, XK; Zhang, Y; Li, X; Lei, H; Wei, YD; Li, WM; Hu, DY; Wedick, NM; Wang, JS; Xu, YW; Li, J; Ma, YS				Xu, Dachun; Chen, Wei; Li, Xiankai; Zhang, Yi; Li, Xin; Lei, Hou; Wei, Yidong; Li, Weiming; Hu, Dayi; Wedick, Nicole M.; Wang, Jinsong; Xu, Yawei; Li, Jue; Ma, Yunsheng			Factors Associated with Blood Pressure Control in Hypertensive Patients with Coronary Heart Disease: Evidence from the Chinese Cholesterol Education Program	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; DIABETES-MELLITUS; RISK-FACTORS; MANAGEMENT; TRIAL; INTERVENTIONS; PROGRESSION; AMLODIPINE; GUIDELINES; REDUCTION	Blood pressure (BP) remains poorly controlled among hypertensive patients with coronary heart disease (CHD) in China. Improvement of its management will require an understanding of the patient characteristics and treatment factors associated with uncontrolled hypertension. A cross-sectional survey of 3,279 patients from 52 centers in China was performed to examine potential barriers to adequate blood pressure control of hypertensive patients with CHD. Uncontrolled hypertension was defined as blood pressure >= 130/or 80 mmHg. Multivariable logistic regression was used to identify factors associated with poor blood pressure control. Mean age of the patients was 65 years, 40% were women, and mean BMI was 25 kg/m(2). Mean systolic blood pressure was 136 +/- 18 mmHg and mean diastolic blood pressure was 80 +/- 11 mmHg. Only 18% of patients had a mean blood pressure <130/80 mmHg during the study period. Multivariate analysis revealed several independent factors of poor blood pressure control: body mass index >= 23 kg/m(2), the presence of stable angina pectoris (SAP), family history of diabetes, and use of calcium channel blockers (CCB). Further analysis showed that non-dihydropyridine calcium antagonist was significantly correlated with low BP control rate. Some of these may be amenable to modification. The results of our study suggest that overweight, the presence of SAP and family history of diabetes are important factors for tight BP control in primary care. In addition, non-dihydropyridine calcium channel blockers appear less effective than other therapies in control of blood pressure and should not be the first choice among hypertensive patients with CHD. Further identification of patients at risk of poor BP control can lead to targeted interventions to improve management.	[Xu, Dachun; Chen, Wei; Li, Xiankai; Zhang, Yi; Lei, Hou; Wei, Yidong; Li, Weiming; Xu, Yawei] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Cardiol, Shanghai 200092, Peoples R China; [Xu, Dachun; Hu, Dayi; Li, Jue] Tongji Univ, Sch Med, Heart Lung & Blood Vessel Ctr, Shanghai 200092, Peoples R China; [Li, Xin] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Cardiol, Shanghai 200092, Peoples R China; [Li, Jue] Tongji Univ, Minist Educ China, Key Lab Arrhythmias, Shanghai 200092, Peoples R China; [Wedick, Nicole M.; Wang, Jinsong; Ma, Yunsheng] Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, Worcester, MA USA; [Wang, Jinsong] Yangzhou Univ, Sch Med, Dept Prevent Med, Yangzhou, Peoples R China	Tongji University; Tongji University; Tongji University; Ministry of Education, China; Tongji University; University of Massachusetts System; University of Massachusetts Worcester; Yangzhou University	Xu, YW (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Cardiol, Shanghai 200092, Peoples R China.	xdc77@yahoo.com.cn; jueli@tongji.edu.cn	li, wj/HGD-7322-2022; Zhang, Yi/ABD-4822-2020; 黎, 伟/GXM-4040-2022; Ma, Yunsheng/D-9665-2016	Ma, Yunsheng/0000-0003-2317-3716; Xu, Dachun/0000-0002-4123-6613	National Natural Science Foundation of China [81270194, 81270193]; National Key Basic Research Program of China [2013CB531100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (81270194 to Dr. Dachun Xu, 81270193 to Dr. Yidong Wei). It was also supported in part by the National Key Basic Research Program of China grant No. 2013CB531100 to Dr. Yi-Han Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; CAPPUCCIO FP, 1994, CONTRIB NEPHROL, V106, P148; de la Sierra A, 2010, HYPERTENS RES, V33, P767, DOI 10.1038/hr.2010.111; Egan BM, 2011, CIRCULATION, V124, P1046, DOI 10.1161/CIRCULATIONAHA.111.030189; Elisaf MS, 1999, CORONARY ARTERY DIS, V10, P257; Fox KM, 2003, LANCET, V362, P782; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hu DY, 2008, CIRC J, V72, P2040, DOI 10.1253/circj.CJ-08-0417; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Jorgensen B, 2000, J AM COLL CARDIOL, V35, P592, DOI 10.1016/S0735-1097(99)00599-9; Julius S, 2006, HYPERTENSION, V48, P385, DOI 10.1161/01.HYP.0000236119.96301.f2; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; KRIKLER DM, 1982, AM HEART J, V104, P702, DOI 10.1016/0002-8703(82)90259-9; Mehta RH, 2008, EUR HEART J, V29, P3052, DOI 10.1093/eurheartj/ehn478; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Pitt B, 2000, CIRCULATION, V102, P1503, DOI 10.1161/01.CIR.102.13.1503; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Smith SC, 2005, CIRCULATION, V111, pE134, DOI 10.1161/01.CIR.0000157743.54710.04; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Turnbull F, 2003, LANCET, V362, P1527; World Health Organization & Regional Office for the Western Pacific, 2000, AS PAC PERSP RED OB; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; 1999, J HYPERTENS, V17, P151	24	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63135	10.1371/journal.pone.0063135	http://dx.doi.org/10.1371/journal.pone.0063135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690989	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700022
J	Atzeni, F; Boiardi, L; Vaglio, A; Nicoli, D; Farnetti, E; Palmisano, A; Pipitone, N; Martorana, D; Moroni, G; Longhi, S; Bonatti, F; Buzio, C; Salvarani, C				Atzeni, Fabiola; Boiardi, Luigi; Vaglio, Augusto; Nicoli, Davide; Farnetti, Enrico; Palmisano, Alessandra; Pipitone, Nicolo; Martorana, Davide; Moroni, Gabriella; Longhi, Selena; Bonatti, Francesco; Buzio, Carlo; Salvarani, Carlo			TLR-4 and VEGF Polymorphisms in Chronic Periaortitis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GIANT-CELL ARTERITIS; FACTOR GENE POLYMORPHISMS; IDIOPATHIC RETROPERITONEAL FIBROSIS; RHEUMATOID-ARTHRITIS; ADVANCED ATHEROSCLEROSIS; ANKYLOSING-SPONDYLITIS; VESSEL VASCULITIS; BEHCETS-DISEASE; CROHNS-DISEASE	Objective: Chronic periaortitis (CP) is a rare disease that is characterised by fibro-inflammatory tissue surrounding the abdominal aorta and has both non-aneurysmal (idiopathic retroperitoneal fibrosis [IRF]) and aneurysmal forms (inflammatory abdominal aortic aneurysm [IAAA]). We investigated whether toll-like receptor 4 (TLR-4) and vascular endothelial growth factor (VEGF) polymorphisms were associated with susceptibility to, and the clinical features of CP. Methods: One hundred and two CP patients and 200 healthy controls were molecularly genotyped for TLR-4 gene polymorphism (+896 A/G) (rs4986790), VEGF mutations +936 C/T (rs3025039) and -634 C/G (rs2010963), and an 18 base pair (bp) insertion/deletion (I/D) polymorphism at -2549 of the VEGF promoter region. The patients were grouped on the basis of the type of CP (IRF or IAAA), and the presence or absence of established atherosclerotic disease (ischemic heart disease, cerebrovascular disease, and peripheral arterial disease). Results: There were no significant differences in the distribution of the studied polymorphisms between the patients and controls. However, carriage of the +936 T allele was significantly more frequent in the patients with IRF than in those with IAAA (26.5% vs 5.3%; p = 0.046; OR 6.49 [95% CI 0.82-51.54]). There were significantly more carriers of the I allele among the patients with ureteral obstruction (83.8% vs 58.8%; p = 0.006; OR 3.63 [95% CI 1.42-9.28]) and those who received conservative treatment (48.5% vs 23.5%; p = 0.015; OR 3.06 [95% CI 1.22-7.721]) than among those without, and II homozygosity was significantly more frequent in the patients with deep vein thrombosis than in those without (30.4% vs 11.7%, p = 0.031; OR 3.31 [95% CI 1.07-10.21]). Conclusion: The VEGF +936 C/T polymorphism may be associated with an increased risk of developing the non-aneurysmal IRF form of CP. Carriers of the I allele and II homozygosity are respectively at increased risk of developing ureteral obstruction and deep vein thrombosis.	[Atzeni, Fabiola] L Sacco Univ Hosp Milan, Rheumatol Unit, Milan, Italy; [Boiardi, Luigi; Pipitone, Nicolo; Salvarani, Carlo] Azienda Osped ASMN, Ist Ricovero & Cura Carattere Sci, Dept Internal Med, Rheumatol Unit, Reggio Emilia, Italy; [Vaglio, Augusto; Palmisano, Alessandra; Buzio, Carlo] Univ Hosp Parma, Nephrol Unit, Parma, Italy; [Nicoli, Davide; Farnetti, Enrico] Arcispedale S Maria Nuova, Mol Biol Lab, Ist Ricovero & Cura Carattere Sci, Reggio Emilia, Italy; [Martorana, Davide; Bonatti, Francesco] Univ Hosp Parma, Mol Genet Unit, Parma, Italy; [Moroni, Gabriella; Longhi, Selena] Policlin Hosp, Nephrol Unit, Ist Ricovero & Cura Carattere Sci, Milan, Italy	University of Milan; Luigi Sacco Hospital; IRCCS Arcispedale S. Maria Nuova; University of Parma; University Hospital of Parma; IRCCS Arcispedale S. Maria Nuova; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Parma; University Hospital of Parma; IRCCS Ca Granda Ospedale Maggiore Policlinico	Salvarani, C (corresponding author), Azienda Osped ASMN, Ist Ricovero & Cura Carattere Sci, Dept Internal Med, Rheumatol Unit, Reggio Emilia, Italy.	salvarani.carlo@asmn.re.it	Salvarani, Carlo/K-2431-2018; Moroni, Gabriella/J-8183-2015; Martorana, Davide/K-6374-2016; Vaglio, Augusto/AHE-8117-2022; Bonatti, Francesco/K-6362-2016; Farnetti, Enrico/AAM-1371-2020	Moroni, Gabriella/0000-0003-4955-6061; Martorana, Davide/0000-0002-7572-7031; Vaglio, Augusto/0000-0002-3814-9172; Bonatti, Francesco/0000-0002-5067-5423; Salvarani, Carlo/0000-0001-5426-5133; Farnetti, Enrico/0000-0002-7858-1867	Rheumatology Department of Reggio Emilia	Rheumatology Department of Reggio Emilia	This project was financially supported by the Rheumatology Department of Reggio Emilia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2006, ANN RHEUM DIS, V65, P1099, DOI 10.1136/ard.2005.045476; Alvarez-Rodriguez L, 2011, CLIN EXP RHEUMATOL, V29, P795; Alvarez-Rodriguez L, 2011, AUTOIMMUN REV, V10, P790, DOI 10.1016/j.autrev.2011.06.002; Alvarez-Rodriguez L, 2011, RHEUMATOLOGY, V50, P1562, DOI 10.1093/rheumatology/ker168; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Armigliato M, 2002, THYROID, V12, P829, DOI 10.1089/105072502760339415; Boiardi L, 2003, J RHEUMATOL, V30, P2160; Boiardi L, 2009, CLIN EXP RHEUMATOL, V27, pS43; Boiardi L, 2009, CLIN EXP RHEUMATOL, V27, pS40; Boiardi L, 2011, RHEUMATOLOGY, V50, P1025, DOI 10.1093/rheumatology/keq416; Breunis WB, 2006, ARTHRITIS RHEUM, V54, P1588, DOI 10.1002/art.21811; Brogan IJ, 1999, HUM IMMUNOL, V60, P1245, DOI 10.1016/S0198-8859(99)00132-9; Butt C, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-1; Cacciola RR, 2002, HAEMATOLOGICA, V87, P774; Chen JB, 2007, HUM HERED, V63, P196, DOI 10.1159/000099996; Corradi D, 2007, KIDNEY INT, V72, P742, DOI 10.1038/sj.ki.5002427; Deng JS, 2009, CIRC RES, V104, P488, DOI 10.1161/CIRCRESAHA.108.185777; Carvalho JF, 2007, J CLIN IMMUNOL, V27, P246, DOI 10.1007/s10875-007-9083-1; Han SW, 2004, RHEUMATOLOGY, V43, P1173, DOI 10.1093/rheumatology/keh281; Hong J, 2007, J GASTROEN HEPATOL, V22, P1760, DOI 10.1111/j.1440-1746.2006.04727.x; Kaneko H, 2011, CARDIOVASC RES, V91, P358, DOI 10.1093/cvr/cvr080; Kardar AH, 2002, J UROLOGY, V168, P550, DOI 10.1016/S0022-5347(05)64677-0; Karvinen H, 2011, GENE THER, V18, P1166, DOI 10.1038/gt.2011.66; Kim DH, 2008, BIOL BLOOD MARROW TR, V14, P1408, DOI 10.1016/j.bbmt.2008.09.022; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Lee KM, 2009, IMMUNOL LETT, V125, P31, DOI 10.1016/j.imlet.2009.05.006; Lorenz E, 2001, BIOL BLOOD MARROW TR, V7, P384, DOI 10.1053/bbmt.2001.v7.pm11529488; Mangieri D, 2012, NEPHROL DIA IN PRESS; Martorana D, 2006, ARTHRIT RHEUM-ARTHR, V55, P126, DOI 10.1002/art.21698; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Minoretti P, 2006, NEUROSCI LETT, V391, P147, DOI 10.1016/j.neulet.2005.08.047; Pabst S, 2006, CLIN EXP IMMUNOL, V143, P420, DOI 10.1111/j.1365-2249.2006.03008.x; Palmisano A, 2009, BEST PRACT RES CL RH, V23, P339, DOI 10.1016/j.berh.2008.12.002; Palomino-Morales R, 2009, J RHEUMATOL, V36, P1501, DOI 10.3899/jrheum.081286; Pointon JJ, 2008, J RHEUMATOL, V35, P1609; Prakash S, 2012, CYTOKINE, V58, P261, DOI 10.1016/j.cyto.2012.01.020; RAMSHAW AL, 1994, J CLIN PATHOL, V47, P721, DOI 10.1136/jcp.47.8.721; RAMSHAW AL, 1994, HISTOPATHOLOGY, V24, P23, DOI 10.1111/j.1365-2559.1994.tb01267.x; RAMSHAW AL, 1990, HISTOPATHOLOGY, V17, P543, DOI 10.1111/j.1365-2559.1990.tb00794.x; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Restuccia G, 2012, ARTHRITIS RHEUM-US, V64, P549, DOI 10.1002/art.33362; Salvarani C, 2004, J RHEUMATOL, V31, P1785; Salvarani C, 2011, MEDICINE, V90, P28, DOI 10.1097/MD.0b013e318207231e; Sambrook J, 1989, MOL CLONING LAB MANU; Sanchez E, 2004, TISSUE ANTIGENS, V63, P54, DOI 10.1111/j.1399-0039.2004.00162.x; Shahbazi M, 2002, J AM SOC NEPHROL, V13, P260, DOI 10.1681/ASN.V131260; Shen XY, 2010, DIGESTION, V81, P69, DOI 10.1159/000260417; Torres O, 2010, CLIN EXP RHEUMATOL, V28, pS110; Vaglio A, 2003, AM J MED, V114, P454, DOI 10.1016/S0002-9343(03)00056-1; Vaglio A, 2011, CURR OPIN RHEUMATOL, V23, P1, DOI 10.1097/BOR.0b013e328341137d; van Bommel EFH, 2007, AM J KIDNEY DIS, V49, P615, DOI 10.1053/j.ajkd.2007.02.268; Verheul HMW, 2000, BLOOD, V96, P4216, DOI 10.1182/blood.V96.13.4216; WALKER DI, 1972, BRIT J SURG, V59, P609, DOI 10.1002/bjs.1800590807; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692	54	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62330	10.1371/journal.pone.0062330	http://dx.doi.org/10.1371/journal.pone.0062330			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690937	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400011
J	Cai, PF; Piao, XY; Hao, LL; Liu, S; Hou, N; Wang, H; Chen, QJ				Cai, Pengfei; Piao, Xianyu; Hao, Lili; Liu, Shuai; Hou, Nan; Wang, Heng; Chen, Qijun			A Deep Analysis of the Small Non-Coding RNA Population in Schistosoma japonicum Eggs	PLOS ONE			English	Article							TERMINAL REPEAT RETROTRANSPOSON; ORIENTAL BLOOD FLUKE; ARGONAUTE PROTEINS; ENDOGENOUS SIRNAS; MICRORNAS; IDENTIFICATION; GENOME; MANSONI; GENES; DIVERSIFICATION	Background: Schistosoma japonicum is a parasitic flatworm that causes zoonotic schistosomiasis. The typical outcome of schistosomiasis is hepatic granuloma and fibrosis, which is primarily induced by soluble egg-derived antigens. Although schistosomal eggs represent an important pathogenic stage to the host, the biology of this critical stage is largely unknown. We previously investigated the expression profiles of sncRNAs during different developmental stages of this parasite. However, using small RNA extracted from egg-deposited liver tissues generated limited information about sncRNAs in eggs. Here, we characterized the complete small RNAome in this stage of the parasite after optimization of RNA purification. Methodology and Principal Findings: A library, SjE, was constructed with the small RNA extracted from S. japonicum eggs and subjected to high-throughput sequencing. The data were depicted by comprehensive bioinformatic analysis to explore the expression features of sncRNAs in the egg stage. MicroRNAs accounted for about one quarter of the total small RNA population in this stage, with a strongly biased expression pattern of certain miRNA family members. Sja-miR-71, sja-miR-71-5p, and sja-miR-36-3p were suggested to play important roles in embryo development. A panel of transfer RNA fragments (tRFs) precisely processed from the 59 end of mature tRNAs was identified for the first time, which represented a strong egg stage-biased expression. The tRNA-Ala derived small RNAs were the most highly expressed Sj-tRFs in eggs. Further, the expression of siRNAs from 29 types of well-defined transposable elements (TEs) was observed to be relatively stable among different developmental stages. Conclusions and Significance: In this study, we characterized the sncRNA profile in the egg stage of S. japonicum. Featured expression of sncRNAs, especially the tRNA-derived small RNAs, was identified, which was further compared with that of other developmental stages. These novel findings would facilitate a deeper understanding of the biology of schistosomal parasites.	[Cai, Pengfei; Piao, Xianyu; Liu, Shuai; Hou, Nan; Chen, Qijun] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Cai, Pengfei; Piao, Xianyu; Liu, Shuai; Hou, Nan; Chen, Qijun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Qijun] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China; [Wang, Heng] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Microbiol & Parasitol, Beijing 100730, Peoples R China; [Wang, Heng] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Hao, Lili] Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jilin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Southwest Minzu University	Chen, QJ (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	qijun.chen@ipbcams.ac.cn	Cai, Pengfe/AAF-2759-2020	Cai, Pengfei/0000-0003-4975-4615	National Natural Science Foundation of China [NSFC 81270026, 30901254]; National S & T Major Program [2012ZX10004-220, 2008ZX10004-011]; intramural grant from Institute of Pathogen Biology, CAMS [2012IPB207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S & T Major Program; intramural grant from Institute of Pathogen Biology, CAMS	This study was supported by the National Natural Science Foundation of China (NSFC 81270026 and 30901254), the National S & T Major Program (Grant No. 2012ZX10004-220 and 2008ZX10004-011), and the intramural grant from Institute of Pathogen Biology, CAMS (2012IPB207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Cai PF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001745; Cai PF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001256; Chen J, 2010, PARASITOL RES, V107, P889, DOI 10.1007/s00436-010-1946-3; Chen MX, 2011, EXP PARASITOL, V128, P116, DOI 10.1016/j.exppara.2011.02.019; Chen MX, 2011, PARASITOL RES; Copeland CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-464; Cucher M, 2011, INT J PARASITOL, V41, P439, DOI 10.1016/j.ijpara.2010.11.010; Dalton JP, 1997, PARASITOLOGY, V115, P29, DOI 10.1017/S0031182097001091; Dalzell JJ, 2010, INT J PARASITOL, V40, P1303, DOI 10.1016/j.ijpara.2010.03.010; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Fairfax KC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002490; Fischer S, 2011, BIOCHEM SOC T, V39, P159, DOI 10.1042/BST0390159; Friedlander MR, 2009, P NATL ACAD SCI USA, V106, P11546, DOI 10.1073/pnas.0905222106; Gomes MD, 2011, GENOMICS, V98, P96, DOI 10.1016/j.ygeno.2011.05.007; Gomes MS, 2009, PARASITOL INT, V58, P61, DOI 10.1016/j.parint.2008.10.002; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hao LL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-55; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Huang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008206; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; La Flamme AC, 2003, J IMMUNOL, V170, P470, DOI 10.4049/jimmunol.170.1.470; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laha T, 2002, INT J PARASITOL, V32, P1163, DOI 10.1016/S0020-7519(02)00063-2; Laha T, 2002, GENE, V284, P149, DOI 10.1016/S0378-1119(02)00381-5; Laha T, 2001, GENE, V264, P59, DOI 10.1016/S0378-1119(00)00601-6; Laha T, 2000, BBA-GENE STRUCT EXPR, V1492, P477, DOI 10.1016/S0167-4781(00)00112-3; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Liu M, 2011, CELL RES, V21, P1605, DOI 10.1038/cr.2011.102; Liu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026448; Lockyer AE, 2003, PARASITOLOGY, V126, P203, DOI 10.1017/S0031182002002792; Lu YC, 2009, RNA, V15, P1483, DOI 10.1261/rna.1702009; Luo R, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-90; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nunes CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-288; Obbard DJ, 2008, CURR BIOL, V18, pR561, DOI 10.1016/j.cub.2008.05.035; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Poole CB, 2010, MOL BIOCHEM PARASIT, V169, P87, DOI 10.1016/j.molbiopara.2009.10.004; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Rutitzky LI, 2011, EUR J IMMUNOL, V41, P2677, DOI 10.1002/eji.201041327; Simoes MC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-47; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; van der Vlugt LEPM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030883; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang ZX, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000596; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Xu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-521; Xue XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004034; Zaccone P, 2009, EUR J IMMUNOL, V39, P1098, DOI 10.1002/eji.200838871; Zhao GH, 2011, INFECT GENET EVOL, V11, P610, DOI 10.1016/j.meegid.2011.01.015; Zhao QP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001503; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	71	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64003	10.1371/journal.pone.0064003	http://dx.doi.org/10.1371/journal.pone.0064003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691136	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400096
J	Gallego, X; Cox, RJ; Laughlin, JR; Stitzel, JA; Ehringer, MA				Gallego, Xavier; Cox, Ryan J.; Laughlin, James R.; Stitzel, Jerry A.; Ehringer, Marissa A.			Alternative CHRNB4 3'-UTRs Mediate the Allelic Effects of SNP rs1948 on Gene Expression	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; HUMAN ALPHA-3; LUNG-CANCER; TRANSCRIPTIONAL REGULATION; TRANSLATIONAL CONTROL; UNTRANSLATED REGIONS; SUBSTANCE DEPENDENCE; SUBUNIT; CLUSTER; RISK	Common genetic factors strongly contribute to both nicotine, the main addictive component of tobacco, and alcohol use. Several lines of evidence suggest nicotinic acetylcholine receptors as common sites of action for nicotine and alcohol. Specifically, rs1948, a single-nucleotide polymorphism (SNP) located in the CHRNB4 3'-untranslated region (UTR), has been associated to early age of initiation for both alcohol and tobacco use. To determine the allelic effects of rs1948 on gene expression, two rs1948-containing sequences of different lengths corresponding to the CHRNB4 3'-UTR were cloned into pGL3-promoter luciferase reporter vectors. Data obtained showed that the allelic effects of SNP rs1948 on luciferase expression are mediated by the length and species of transcripts generated. In addition, it was found that miR-3157 increased the overall luciferase expression while miR-138, a microRNA known to play a role in neuroadaptation to drug abuse, decreased luciferase expression when compared to basal conditions. These findings demonstrate the importance of SNP rs1948 on the regulation of CHRNB4 expression and provide the first evidence of CHRNB4 down-regulation by miR-138.	[Gallego, Xavier; Cox, Ryan J.; Laughlin, James R.; Stitzel, Jerry A.; Ehringer, Marissa A.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Stitzel, Jerry A.; Ehringer, Marissa A.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Ehringer, MA (corresponding author), Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA.	Marissa.Ehringer@colorado.edu		STITZEL, JERRY/0000-0001-8161-6525	National Institutes of Health [R21 DA026901, R01 AA017889]; Silvio O.Conte Center Award [5P50MH086383-03]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Silvio O.Conte Center Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health R21 DA026901 (MAE, JAS), National Institutes of Health R01 AA017889 (MAE), and Silvio O.Conte Center Award 5P50MH086383-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Bashirullah A, 2001, P NATL ACAD SCI USA, V98, P7025, DOI 10.1073/pnas.111145698; Battaglioli E, 1998, J NEUROCHEM, V71, P1261; Benfante R, 2007, J BIOL CHEM, V282, P13290, DOI 10.1074/jbc.M608616200; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2010, TRENDS PHARMACOL SCI, V31, P46, DOI 10.1016/j.tips.2009.10.004; Bierut LJ, 1998, ARCH GEN PSYCHIAT, V55, P982, DOI 10.1001/archpsyc.55.11.982; Boorman JPB, 2000, J PHYSIOL-LONDON, V529, P565, DOI 10.1111/j.1469-7793.2000.00565.x; Boyd RT, 1996, NEUROSCI LETT, V208, P73, DOI 10.1016/0304-3940(96)12561-1; Bruschweiler-Li L, 2010, NEUROSCIENCE, V166, P864, DOI 10.1016/j.neuroscience.2010.01.026; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; Deneris ES, 2000, EUR J PHARMACOL, V393, P69, DOI 10.1016/S0014-2999(99)00883-3; Doyle GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023373; Ehringer MA, 2010, AM J MED GENET B, V153B, P600, DOI 10.1002/ajmg.b.31027; ENG CM, 1991, GENOMICS, V9, P278, DOI 10.1016/0888-7543(91)90253-B; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Flatscher-Bader T, 2009, NUTR RES REV, V22, P148, DOI 10.1017/S0954422409990114; Ford LP, 1999, NUCLEIC ACIDS RES, V27, P1159, DOI 10.1093/nar/27.4.1159; Fornasari D, 1997, MOL PHARMACOL, V51, P250, DOI 10.1124/mol.51.2.250; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Francis N, 2002, J BIOL CHEM, V277, P6511, DOI 10.1074/jbc.M105616200; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Medel YFF, 2007, J BIOL CHEM, V282, P19062, DOI 10.1074/jbc.M702354200; Funk D, 2006, ALCOHOL RES HEALTH, V29, P186; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gallego X, 2012, AMINO ACIDS, V43, P897, DOI 10.1007/s00726-011-1149-y; Gallego X, 2012, ALCOHOL, V46, P205, DOI 10.1016/j.alcohol.2011.11.005; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grucza RA, 2010, ADDICT BIOL, V15, P346, DOI 10.1111/j.1369-1600.2010.00220.x; Haller G, 2012, HUM MOL GENET, V21, P647, DOI 10.1093/hmg/ddr498; Hoft NR, 2011, GENES BRAIN BEHAV, V10, P176, DOI 10.1111/j.1601-183X.2010.00650.x; HU MJ, 1994, J NEUROCHEM, V62, P392; Improgo MRD, 2010, MOL CANCER RES, V8, P194, DOI 10.1158/1541-7786.MCR-09-0185; Joslyn G, 2008, P NATL ACAD SCI USA, V105, P20368, DOI 10.1073/pnas.0810970105; Kapoor M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033513; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Klaff P, 1996, PLANT MOL BIOL, V32, P89, DOI 10.1007/BF00039379; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Larizza A, 2002, COMPUT CHEM, V26, P479, DOI 10.1016/S0097-8485(02)00009-8; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; McDonough J, 1997, J NEUROSCI, V17, P2273; McDonough J, 2000, J BIOL CHEM, V275, P28962, DOI 10.1074/jbc.M004181200; Melnikova IN, 2001, J BIOL CHEM, V276, P19040, DOI 10.1074/jbc.M010735200; Mexal S, 2007, J BIOL CHEM, V282, P13220, DOI 10.1074/jbc.M610694200; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; RAIMONDI E, 1992, GENOMICS, V12, P849, DOI 10.1016/0888-7543(92)90324-L; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Schlaepfer Isabel R, 2008, Curr Drug Abuse Rev, V1, P124; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Scofield MD, 2010, NEUROSCIENCE, V170, P1056, DOI 10.1016/j.neuroscience.2010.08.007; Scofield MD, 2008, NEUROREPORT, V19, P687, DOI 10.1097/WNR.0b013e3282fbcef7; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Sherva R, 2010, NEUROPSYCHOPHARMACOL, V35, P1921, DOI 10.1038/npp.2010.64; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Tammen I, 1998, MAMM GENOME, V9, P263, DOI 10.1007/s003359900743; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Wang JC, 2009, MOL PSYCHIATR, V14, P501, DOI 10.1038/mp.2008.42; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Xu XH, 2006, MOL CELL BIOL, V26, P5636, DOI 10.1128/MCB.00456-06; YANG XD, 1995, J BIOL CHEM, V270, P8514, DOI 10.1074/jbc.270.15.8514; Yang XD, 1997, J NEUROBIOL, V32, P311, DOI 10.1002/(SICI)1097-4695(199703)32:3<311::AID-NEU5>3.0.CO;2-A; Zoli M, 1998, J NEUROSCI, V18, P4461	81	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63699	10.1371/journal.pone.0063699	http://dx.doi.org/10.1371/journal.pone.0063699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691088	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400076
J	Murray, MY; Birkland, TP; Howe, JD; Rowan, AD; Fidock, M; Parks, WC; Gavrilovic, J				Murray, Megan Y.; Birkland, Timothy P.; Howe, Jonathan D.; Rowan, Andrew D.; Fidock, Mark; Parks, William C.; Gavrilovic, Jelena			Macrophage Migration and Invasion Is Regulated by MMP10 Expression	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; GENE-EXPRESSION; 1-MATRIX METALLOPROTEINASE; STROMELYSIN-2 MMP-10; DEPENDENT REGULATION; TISSUE INHIBITOR; HUMAN MONOCYTES; PSEUDOMONAS-AERUGINOSA; ATHEROSCLEROTIC PLAQUE; ENDOTHELIAL-CELLS	This study was designed to identify metalloproteinase determinants of macrophage migration and led to the specific hypothesis that matrix metalloproteinase 10 (MMP10/stromelysin-2) facilitates macrophage migration. We first profiled expression of all MMPs in LPS-stimulated primary murine bone marrow-derived macrophages and Raw264.7 cells and found that MMP10 was stimulated early (3 h) and down-regulated later (24 h). Based on this pattern of expression, we speculated that MMP10 plays a role in macrophage responses, such as migration. Indeed, using time lapse microscopy, we found that RNAi silencing of MMP10 in primary macrophages resulted in markedly reduced migration, which was reversed with exogenous active MMP10 protein. Mmp10(-/-) bone marrow-derived macrophages displayed significantly reduced migration over a two-dimensional fibronectin matrix. Invasion of primary wild-type macrophages into Matrigel supplemented with fibronectin was also markedly impaired in Mmp10(-/-) cells. MMP10 expression in macrophages thus emerges as an important moderator of cell migration and invasion. These findings support the hypothesis that MMP10 promotes macrophage movement and may have implications in understanding the control of macrophages in several pathologies, including the abnormal wound healing response associated with pro-inflammatory conditions.	[Murray, Megan Y.; Howe, Jonathan D.; Gavrilovic, Jelena] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Birkland, Timothy P.; Parks, William C.] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA; [Fidock, Mark] Pfizer Global Res & Dev, Sandwich, Kent, England; [Rowan, Andrew D.] Newcastle Univ, Sch Med, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle, England	University of East Anglia; University of Washington; University of Washington Seattle; Pfizer; Newcastle University - UK	Gavrilovic, J (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	J.Gavrilovic@uea.ac.uk	Parks, William C./AAH-6786-2021; Gavrilovic, Jelena/J-7754-2013	Gavrilovic, Jelena/0000-0002-5312-1784	BBSRC Industrial Collaborative Awards in Science and Engineering Studentship; Pfizer [BBS/S/N/2006/13098]; MRC [G0801127]; National Institutes of Health [HL098067, HL089455]; Arthritis Research UK; Medical Research Council [G0801127] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098067, R01HL089455] Funding Source: NIH RePORTER	BBSRC Industrial Collaborative Awards in Science and Engineering Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work in the Gavrilovic lab was supported by a BBSRC Industrial Collaborative Awards in Science and Engineering Studentship with Pfizer #BBS/S/N/2006/13098 and MRC Grant #G0801127. Work in the Parks lab was supported by National Institutes of Health grants HL098067 and HL089455 and work in the Rowan lab was supported by Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Awad AE, 2010, AM J PHYSIOL-CELL PH, V298, pC679, DOI 10.1152/ajpcell.00351.2009; Baker N, 2012, ARTHRITIS RHEUM-US, V64, P2289, DOI 10.1002/art.34411; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P3244, DOI 10.1002/art.22167; Bhavsar PJ, 2009, EXP CELL RES, V315, P3345, DOI 10.1016/j.yexcr.2009.08.010; Bister V, 2007, J CUTAN PATHOL, V34, P889, DOI 10.1111/j.1600-0560.2007.00744.x; Bord S, 1998, BONE, V23, P7, DOI 10.1016/S8756-3282(98)00064-7; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Gao CZ, 2008, MOL BIOL CELL, V19, P3020, DOI 10.1091/mbc.E07-11-1203; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han YP, 2001, J CELL SCI, V114, P131; HEMBRY RM, 1986, J CELL SCI, V81, P105; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Huang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042507; Jacob SS, 2001, BBA-MOL CELL RES, V1540, P50, DOI 10.1016/S0167-4889(01)00116-1; Jevnikar Z, 2012, EUR J IMMUNOL, V42, P3429, DOI 10.1002/eji.201242610; Johnson JL, 2006, CIRCULATION, V113, P2435, DOI 10.1161/CIRCULATIONAHA.106.613281; Kassim SY, 2007, INFECT IMMUN, V75, P5640, DOI 10.1128/IAI.00799-07; Korpos E, 2010, CELL TISSUE RES, V339, P47, DOI 10.1007/s00441-009-0853-3; Krampert M, 2004, MOL BIOL CELL, V15, P5242, DOI 10.1091/mbc.E04-02-0109; LI YY, 1992, J IMMUNOL, V149, P3174; Lorente L, 2009, CRIT CARE, V13, DOI 10.1186/cc8115; Lu YB, 2005, J LEUKOCYTE BIOL, V78, P259, DOI 10.1189/jlb.0904498; Madlener M, 1996, BIOCHEM J, V320, P659, DOI 10.1042/bj3200659; Manicone AM, 2009, J IMMUNOL, V182, P3866, DOI 10.4049/jimmunol.0713949; Matias-Roman S, 2005, BLOOD, V105, P3956, DOI 10.1182/blood-2004-06-2382; Murphy G, 1997, MATRIX BIOL, V15, P511, DOI 10.1016/S0945-053X(97)90025-1; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nareika A, 2005, AM J PHYSIOL-ENDOC M, V289, pE534, DOI 10.1152/ajpendo.00462.2004; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; Orbe J, 2007, J THROMB HAEMOST, V5, P91, DOI 10.1111/j.1538-7836.2006.02276.x; Reel B, 2011, BRIT J PHARMACOL, V163, P1679, DOI 10.1111/j.1476-5381.2011.01298.x; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Reiss K, 2006, PHARMACOL THERAPEUT, V111, P985, DOI 10.1016/j.pharmthera.2006.02.009; Rhee JW, 2007, J BIOCHEM MOL BIOL, V40, P88; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; Sabeh F, J CELL BIOL, V185, P11; Salmela MT, 2004, SCAND J GASTROENTERO, V39, P1095, DOI 10.1080/00365520410003470; Schnabl B, 2005, BIOCHEM BIOPH RES CO, V335, P87, DOI 10.1016/j.bbrc.2005.07.043; Shankavaram UT, 2001, J BIOL CHEM, V276, P19027, DOI 10.1074/jbc.M009562200; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Treiber M, 2011, GASTROENTEROLOGY, V141, P1473, DOI 10.1053/j.gastro.2011.06.087; Uzui H, 2002, CIRCULATION, V106, P3024, DOI 10.1161/01.CIR.0000041433.94868.12; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Verollet C, 2011, EUR J IMMUNOL, V41, P2805, DOI 10.1002/eji.201141538; WALKER EB, 1985, J LEUKOCYTE BIOL, V37, P121, DOI 10.1002/jlb.37.2.121; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb.0306152; Wells JEA, 2003, J NEUROSCI, V23, P10107, DOI 10.1523/jneurosci.23-31-10107.2003; Wenzel J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00071; Wheeler AP, 2007, EXP CELL RES, V313, P3505, DOI 10.1016/j.yexcr.2007.07.014; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Worley JR, 2003, J BIOL CHEM, V278, P51340, DOI 10.1074/jbc.M310865200; Worthylake RA, 2001, CURR OPIN CELL BIOL, V13, P569, DOI 10.1016/S0955-0674(00)00253-2; Xie B, 1998, J BIOL CHEM, V273, P11576, DOI 10.1074/jbc.273.19.11576; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006	72	65	66	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63555	10.1371/journal.pone.0063555	http://dx.doi.org/10.1371/journal.pone.0063555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691065	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400068
J	Aubry-Kientz, M; Herault, B; Ayotte-Trepanier, C; Baraloto, C; Rossi, V				Aubry-Kientz, Melaine; Herault, Bruno; Ayotte-Trepanier, Charles; Baraloto, Christopher; Rossi, Vivien			Toward Trait-Based Mortality Models for Tropical Forests	PLOS ONE			English	Article							RAIN-FOREST; TREE MORTALITY; FUNCTIONAL TRAITS; WOOD DENSITY; ABOVEGROUND BIOMASS; NEOTROPICAL TREE; GROWTH-RESPONSES; LEAF TOUGHNESS; SEED SIZE; RATES	Tree mortality in tropical forests is a complex ecological process for which modelling approaches need to be improved to better understand, and then predict, the evolution of tree mortality in response to global change. The mortality model introduced here computes an individual probability of dying for each tree in a community. The mortality model uses the ontogenetic stage of the tree because youngest and oldest trees are more likely to die. Functional traits are integrated as proxies of the ecological strategies of the trees to permit generalization among all species in the community. Data used to parametrize the model were collected at Paracou study site, a tropical rain forest in French Guiana, where 20,408 trees have been censused for 18 years. A Bayesian framework was used to select useful covariates and to estimate the model parameters. This framework was developed to deal with sources of uncertainty, including the complexity of the mortality process itself and the field data, especially historical data for which taxonomic determinations were uncertain. Uncertainty about the functional traits was also considered, to maximize the information they contain. Four functional traits were strong predictors of tree mortality: wood density, maximum height, laminar toughness and stem and branch orientation, which together distinguished the light-demanding, fast-growing trees from slow-growing trees with lower mortality rates. Our modelling approach formalizes a complex ecological problem and offers a relevant mathematical framework for tropical ecologists to process similar uncertain data at the community level.	[Aubry-Kientz, Melaine; Herault, Bruno] Univ Antilles Guyane, UMR Ecol Forets Guyane, Kourou, France; [Herault, Bruno; Ayotte-Trepanier, Charles; Rossi, Vivien] CIRAD, UMR Ecol Forets Guyane, Kourou, France; [Baraloto, Christopher] INRA, UMR Ecol Forets Guyane, Kourou, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE	Aubry-Kientz, M (corresponding author), Univ Antilles Guyane, UMR Ecol Forets Guyane, Kourou, France.	melaine.aubry-kientz@ecofog.gf	Hérault, Bruno/B-2765-2011; Baraloto, Christopher/ABG-2500-2020; Rossi, Vivien/C-9721-2009	Hérault, Bruno/0000-0002-6950-7286; Baraloto, Christopher/0000-0001-7322-8581; Rossi, Vivien/0000-0001-5458-1523	project Climfor (Fondation pour la Recherche sur la Biodiversite); project Guyasim (European structural fundings, PO-Feder); French Ministry of Agriculture (MAAP); "Investissement d'Avenir" grant [ANR-10-LABX-0025]; CIRAD; CNRS	project Climfor (Fondation pour la Recherche sur la Biodiversite); project Guyasim (European structural fundings, PO-Feder); French Ministry of Agriculture (MAAP); "Investissement d'Avenir" grant(French National Research Agency (ANR)); CIRAD; CNRS(Centre National de la Recherche Scientifique (CNRS))	Funding came from the project Climfor (Fondation pour la Recherche sur la Biodiversite), from the project Guyasim (European structural fundings, PO-Feder) and from a BGF grant for the project GuyaSpaSE from the French Ministry of Agriculture (MAAP). This work has benefited from an "Investissement d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-0025). MAK is supported by a PhD grant from CIRAD and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder D, 2000, FOREST ECOL MANAG, V130, P141, DOI 10.1016/S0378-1127(99)00196-6; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Baraloto C, 2005, J ECOL, V93, P1156, DOI 10.1111/j.1365-2745.2005.01041.x; Baraloto C, 2007, AM J BOT, V94, P901, DOI 10.3732/ajb.94.6.901; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Baraloto C, 2010, FUNCT ECOL, V24, P208, DOI 10.1111/j.1365-2435.2009.01600.x; Bohlman S, 2012, J ECOL, V100, P508, DOI 10.1111/j.1365-2745.2011.01935.x; CAREY EV, 1994, BIOTROPICA, V26, P255, DOI 10.2307/2388846; Chao KJ, 2008, J ECOL, V96, P281, DOI 10.1111/j.1365-2745.2007.01343.x; Chao KJ, 2009, J VEG SCI, V20, P260, DOI 10.1111/j.1654-1103.2009.05755.x; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Corlett RT, 2011, TRENDS ECOL EVOL, V26, P606, DOI 10.1016/j.tree.2011.06.015; de Toledo JJ, 2011, FOREST ECOL MANAG, V262, P331, DOI 10.1016/j.foreco.2011.03.039; Delbart N, 2010, BIOGEOSCIENCES, V7, P3027, DOI 10.5194/bg-7-3027-2010; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; Gourlet-Fleury S, 2005, FOREST ECOL MANAG, V209, P69, DOI 10.1016/j.foreco.2005.01.010; Gourlet-Fleury S, 1999, DATA MANAGEMENT MODE, P473; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Herault B, 2010, OECOLOGIA, V164, P243, DOI 10.1007/s00442-010-1602-8; Herault B, 2010, J APPL ECOL, V47, P821, DOI 10.1111/j.1365-2664.2010.01826.x; Jacobsen AL, 2005, PLANT PHYSIOL, V139, P546, DOI 10.1104/pp.104.058404; Jansen PA, 2008, ECOLOGY, V89, P3490, DOI 10.1890/07-1682.1; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; Kitajima K, 2010, NEW PHYTOL, V186, P708, DOI 10.1111/j.1469-8137.2010.03212.x; Kraft NJB, 2010, NEW PHYTOL, V188, P1124, DOI 10.1111/j.1469-8137.2010.03444.x; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Lewis SL, 2004, J ECOL, V92, P929, DOI 10.1111/j.0022-0477.2004.00923.x; McCullagh P, 1989, GEN LINEAR MODELS; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Phillips OL, 2010, NEW PHYTOL, V187, P631, DOI 10.1111/j.1469-8137.2010.03359.x; Phillips PD, 2004, ECOL MODEL, V173, P335, DOI 10.1016/j.ecolmodel.2003.09.023; Poorter L, 2005, OECOLOGIA, V142, P378, DOI 10.1007/s00442-004-1732-y; Poorter L, 2003, ECOLOGY, V84, P602, DOI 10.1890/0012-9658(2003)084[0602:AORFTS]2.0.CO;2; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Poorter L, 2006, ECOLOGY, V87, P1289, DOI 10.1890/0012-9658(2006)87[1289:AOMTST]2.0.CO;2; R Development Core Team, 2010, R LANG ENV STAT COMP; Rejou-Mechain M, 2011, FOREST ECOL MANAG, V261, P187, DOI 10.1016/j.foreco.2010.10.003; Richardson S, 1997, J ROY STAT SOC B MET, V59, P731, DOI 10.1111/1467-9868.00095; Robert C.P., 2004, TECHNOMETRICS, V2nd ed., DOI [10.1007/978-1-4757-4145-2, DOI 10.2307/1270959]; Ruger N, 2012, ECOLOGY, V93, P2626, DOI 10.1890/12-0622.1; Ruger N, 2011, OIKOS, V120, P1047, DOI 10.1111/j.1600-0706.2010.19021.x; Rutishauser E, 2010, J VEG SCI, V21, P672, DOI 10.1111/j.1654-1103.2010.01175.x; Sheil D, 1996, J ECOL, V84, P91, DOI 10.2307/2261703; Stephenson NL, 2011, ECOL MONOGR, V81, P527, DOI 10.1890/10-1077.1; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Wagner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034074; Wagner F, 2011, AGR FOREST METEOROL, V151, P1202, DOI 10.1016/j.agrformet.2011.04.012; Wagner F, 2010, BIOTROPICA, V42, P664, DOI 10.1111/j.1744-7429.2010.00644.x; Westbrook JW, 2011, AM NAT, V177, P800, DOI 10.1086/659963; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright S Joseph, 2010, Ecology, V91, P3664, DOI 10.1890/09-2335.1; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178	61	22	23	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63678	10.1371/journal.pone.0063678	http://dx.doi.org/10.1371/journal.pone.0063678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675500	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100046
J	Risher, ML; Fleming, RL; Boutros, N; Semenova, S; Wilson, WA; Levin, ED; Markou, A; Swartzwelder, HS; Acheson, SK				Risher, Mary-Louise; Fleming, Rebekah L.; Boutros, Nathalie; Semenova, Svetlana; Wilson, Wilkie A.; Levin, Edward D.; Markou, Athina; Swartzwelder, H. Scott; Acheson, Shawn K.			Long-Term Effects of Chronic Intermittent Ethanol Exposure in Adolescent and Adult Rats: Radial-Arm Maze Performance and Operant Food Reinforced Responding	PLOS ONE			English	Article							SPRAGUE-DAWLEY RATS; COLLEGE BINGE DRINKING; ALCOHOL-USE DISORDERS; ELEVATED PLUS-MAZE; SPATIAL MEMORY; DEVELOPMENTAL DIFFERENCES; CONFIDENCE-INTERVALS; MATURE HIPPOCAMPUS; TESTING HYPOTHESES; POWER CALCULATIONS	Background: Adolescence is not only a critical period of late-stage neurological development in humans, but is also a period in which ethanol consumption is often at its highest. Given the prevalence of ethanol use during this vulnerable developmental period we assessed the long-term effects of chronic intermittent ethanol (CIE) exposure during adolescence, compared to adulthood, on performance in the radial-arm maze (RAM) and operant food-reinforced responding in male rats. Methodology/Principal Findings: Male Sprague Dawley rats were exposed to CIE (or saline) and then allowed to recover. Animals were then trained in either the RAM task or an operant task using fixed-and progressive-ratio schedules. After baseline testing was completed all animals received an acute ethanol challenge while blood ethanol levels (BECs) were monitored in a subset of animals. CIE exposure during adolescence, but not adulthood decreased the amount of time that animals spent in the open portions of the RAM arms (reminiscent of deficits in risk-reward integration) and rendered animals more susceptible to the acute effects of an ethanol challenge on working memory tasks. The operant food reinforced task showed that these effects were not due to altered food motivation or to differential sensitivity to the nonspecific performance-disrupting effects of ethanol. However, CIE pre-treated animals had lower BEC levels than controls during the acute ethanol challenges indicating persistent pharmacokinetic tolerance to ethanol after the CIE treatment. There was little evidence of enduring effects of CIE alone on traditional measures of spatial and working memory. Conclusions/Significance: These effects indicate that adolescence is a time of selective vulnerability to the long-term effects of repeated ethanol exposure on neurobehavioral function and acute ethanol sensitivity. The positive and negative findings reported here help to further define the nature and extent of the impairments observed after adolescent CIE and provide direction for future research.	[Risher, Mary-Louise; Fleming, Rebekah L.; Levin, Edward D.; Swartzwelder, H. Scott; Acheson, Shawn K.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Risher, Mary-Louise; Fleming, Rebekah L.; Swartzwelder, H. Scott; Acheson, Shawn K.] Durham Vet Affairs Med Ctr, Neurobiol Res Lab, Durham, NC USA; [Wilson, Wilkie A.] Duke Univ, Social Sci Res Inst, Durham, NC USA; [Boutros, Nathalie; Semenova, Svetlana; Markou, Athina] Univ Calif San Diego, La Jolla, CA 92093 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; University of California System; University of California San Diego	Acheson, SK (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA.	shawn.acheson@duke.edu	Acheson, Shawn/A-3299-2016; Levin, Edward/GLV-2991-2022; Risher, Louise/AAP-2646-2020	Risher, Louise/0000-0002-3139-4378	NIAAA [U01-AA019925-01-NADIA, U01-AA019970-NADIA, I01BX007080, 2-010-10S]; Bristol-Myers Squibb Co.; Pfizer; Astra-Zeneca; Abbott GmbH and Company; AstraZeneca; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA019970, U01AA019925] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001267] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Bristol-Myers Squibb Co.(Bristol-Myers Squibb); Pfizer(Pfizer); Astra-Zeneca(AstraZeneca); Abbott GmbH and Company; AstraZeneca(AstraZeneca); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the NIAAA grant U01-AA019925-01-NADIA to HSS; U01-AA019970-NADIA to AM; Veteran Affairs Senior Research Career Scientist awards to HSS; VA Career Development Award I01BX007080 to SKA; VA Career Development Award 2-010-10S to RLF. The NIH and VA had no further role in the study design, collection, analysis, and interpretation of data, writing of the report, or decision to submit the article for publication.; AM has received contract research support from Bristol-Myers Squibb Co., Pfizer, and Astra-Zeneca, and honoraria/consulting fees from Abbott GmbH and Company, AstraZeneca, and Pfizer during the past 3 years. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The remaining authors report no financial conflicts of interests. There are no actual or potential financial conflicts of interest.	Acheson SK, 1999, ALCOHOL, V18, P23, DOI 10.1016/S0741-8329(98)00063-9; Acheson SK, 1998, ALCOHOL CLIN EXP RES, V22, P1437, DOI 10.1111/j.1530-0277.1998.tb03932.x; Acheson SK, 2001, ALCOHOL, V23, P167, DOI 10.1016/S0741-8329(01)00127-6; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Anderson RI, 2010, ALCOHOL CLIN EXP RES, V34, P2106, DOI 10.1111/j.1530-0277.2010.01307.x; BEHAR D, 1983, ALCOHOL CLIN EXP RES, V7, P404, DOI 10.1111/j.1530-0277.1983.tb05495.x; Bisby JA, 2010, BIOL PSYCHIAT, V68, P280, DOI 10.1016/j.biopsych.2010.01.010; Bisby JA, 2010, PSYCHOPHARMACOLOGY, V208, P67, DOI 10.1007/s00213-009-1709-y; Brasser SM, 2002, BEHAV NEUROSCI, V116, P305, DOI 10.1037//0735-7044.116.2.305; Broadwater M, 2011, ALCOHOL CLIN EXP RES, V35, P1392, DOI 10.1111/j.1530-0277.2011.01474.x; Chin VS, 2011, ALCOHOL, V45, P473, DOI 10.1016/j.alcohol.2011.03.001; Colegrave N, 2003, BEHAV ECOL, V14, P446, DOI 10.1093/beheco/14.3.446; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Dawson DA, 2004, J STUD ALCOHOL, V65, P477, DOI 10.15288/jsa.2004.65.477; Doremus TL, 2004, ANN NY ACAD SCI, V1021, P427, DOI 10.1196/annals.1308.057; Doremus TL, 2003, PHARMACOL BIOCHEM BE, V75, P411, DOI 10.1016/S0091-3057(03)00134-5; Doremus-Fitzwater TL, 2007, ALCOHOL CLIN EXP RES, V31, P1516, DOI 10.1111/j.1530-0277.2007.00457.x; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Fleming RL, 2012, ALCOHOL CLIN EXP RES, V36, P279, DOI 10.1111/j.1530-0277.2011.01615.x; Fleming RL, 2013, ALCOHOL CLI IN PRESS; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Ginsburg BC, 2008, PHYSIOL BEHAV, V94, P374, DOI 10.1016/j.physbeh.2008.01.026; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hefner K, 2007, PSYCHOPHARMACOLOGY, V191, P311, DOI 10.1007/s00213-006-0646-2; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Huynh H., 1970, J AM STAT ASSOC, V65, P1582, DOI DOI 10.1080/01621459.1970.10481187; Keselman HJ, 2008, PSYCHOL METHODS, V13, P110, DOI 10.1037/1082-989X.13.2.110; Lesaffre E, 2001, EUR HEART J, V22, P898, DOI 10.1053/euhj.2000.2323; Li TK, 2004, BIOL PSYCHIAT, V56, P718, DOI 10.1016/j.biopsych.2004.03.006; Little PJ, 1996, ALCOHOL CLIN EXP RES, V20, P1346, DOI 10.1111/j.1530-0277.1996.tb01133.x; Lopez MF, 2003, ADDICT BIOL, V8, P419, DOI 10.1080/13556210310001648176; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; MARKOU A, 1993, PSYCHOPHARMACOLOGY, V112, P163, DOI 10.1007/BF02244907; Markwiese BJ, 1998, ALCOHOL CLIN EXP RES, V22, P416, DOI 10.1111/j.1530-0277.1998.tb03668.x; Matthews DB, 2008, ALCOHOL, V42, P617, DOI 10.1016/j.alcohol.2008.09.001; McLaughlin PJ, 2008, PHARMACOL BIOCHEM BE, V89, P304, DOI 10.1016/j.pbb.2008.01.002; Morris SA, 2010, ALCOHOL, V44, P89, DOI 10.1016/j.alcohol.2009.10.017; Moy SS, 1998, ALCOHOL CLIN EXP RES, V22, P1485, DOI 10.1111/j.1530-0277.1998.tb03940.x; Novier A, 2012, NEUROSCI LETT, V512, P38, DOI 10.1016/j.neulet.2012.01.059; Onwuegbuzie A.J., 2004, UNDERSTANDING STAT, V3, P201, DOI DOI 10.1207/S15328031US0304_1; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pyapali GK, 1999, ALCOHOL, V19, P107, DOI 10.1016/S0741-8329(99)00021-X; Quoilin C, 2010, PSYCHOPHARMACOLOGY, V212, P501, DOI 10.1007/s00213-010-1971-z; Rajendran P, 2004, ANN NY ACAD SCI, V1021, P441, DOI 10.1196/annals.1308.060; Ramirez RL, 2010, PHARMACOL BIOCHEM BE, V95, P242, DOI 10.1016/j.pbb.2010.01.013; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Ranstam J, 2008, ACTA RADIOL, V49, P521, DOI 10.1080/02841850802075058; Ristuccia RC, 2005, ALCOHOL CLIN EXP RES, V29, P1809, DOI 10.1097/01.alc.0000183010.72764.cd; Ristuccia RC, 2008, ALCOHOL, V42, P623, DOI 10.1016/j.alcohol.2008.08.002; Rohde P, 1996, J AM ACAD CHILD PSY, V35, P101, DOI 10.1097/00004583-199601000-00018; Schramm-Sapyta NL, 2010, ALCOHOL CLIN EXP RES, V34, P2061, DOI 10.1111/j.1530-0277.2010.01302.x; Semenova S, 2012, PSYCHOPHARMACOLOGY, V219, P433, DOI 10.1007/s00213-011-2458-2; Sher KJ, 1999, DEV PSYCHOPATHOL, V11, P933, DOI 10.1017/S0954579499002394; Silveri MM, 1998, ALCOHOL CLIN EXP RES, V22, P670, DOI 10.1111/j.1530-0277.1998.tb04310.x; Silvers JM, 2006, ALCOHOL, V39, P151, DOI 10.1016/j.alcohol.2006.09.001; Silvers JM, 2003, ALCOHOL CLIN EXP RES, V27, P1606, DOI 10.1097/01.ALC.0000090141.66526.22; Simon NW, 2011, J NEUROSCI, V31, P17460, DOI 10.1523/JNEUROSCI.3772-11.2011; Sklar AL, 2012, ALCOHOLISM CLIN EXPT; Slawecki CJ, 2006, BEHAV PHARMACOL, V17, P605, DOI 10.1097/01.fbp.0000236272.10418.62; Smithson M., 2012, SCRIPTS SOFTWARE NON; Smithson M., 2003, CONFIDENCE INTERVALS; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Steinberg L, 2004, ANN NY ACAD SCI, V1021, P51, DOI 10.1196/annals.1308.005; STRUBE MJ, 1989, J APPL PSYCHOL, V74, P247, DOI 10.1037/0021-9010.74.2.247; Swartzwelder HS, 1998, ALCOHOL, V15, P311, DOI 10.1016/S0741-8329(97)00135-3; Swartzwelder HS, 1995, ALCOHOL CLIN EXP RES, V19, P1480, DOI 10.1111/j.1530-0277.1995.tb01011.x; SWARTZWELDER HS, 1995, ALCOHOL CLIN EXP RES, V19, P320, DOI 10.1111/j.1530-0277.1995.tb01509.x; Terry AV, 2008, NEUROSCIENCE, V156, P1005, DOI 10.1016/j.neuroscience.2008.08.030; Varlinskaya EI, 2004, ALCOHOL CLIN EXP RES, V28, P40, DOI 10.1097/01.ALC.0000108655.51087.DF; Vetter-O'Hagen C, 2009, ALCOHOL ALCOHOLISM, V44, P547, DOI 10.1093/alcalc/agp048; Wechsler H, 2000, J AM COLL HEALTH, V48, P199, DOI 10.1080/07448480009599305; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713; White AM, 2000, ALCOHOL CLIN EXP RES, V24, P1251, DOI 10.1111/j.1530-0277.2000.tb02091.x; White AM, 2002, PHARMACOL BIOCHEM BE, V73, P673, DOI 10.1016/S0091-3057(02)00860-2; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Wills TA, 2008, ALCOHOL CLIN EXP RES, V32, P1350, DOI 10.1111/j.1530-0277.2008.00709.x	80	50	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62940	10.1371/journal.pone.0062940	http://dx.doi.org/10.1371/journal.pone.0062940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675442	Green Submitted, gold, Green Published			2022-12-25	WOS:000319036100023
J	Vanmarsenille, L; Verbeeck, J; Belet, S; Roebroek, AJ; Van de Putte, T; Nevelsteen, J; Callaerts-Vegh, Z; D'Hooge, R; Marynen, P; Froyen, G				Vanmarsenille, Lieselot; Verbeeck, Jelle; Belet, Stefanie; Roebroek, Anton J.; Van de Putte, Tom; Nevelsteen, Joke; Callaerts-Vegh, Zsuzsanna; D'Hooge, Rudi; Marynen, Peter; Froyen, Guy			Generation and Characterization of an Nxf7 Knockout Mouse to Study NXF5 Deficiency in a Patient with Intellectual Disability	PLOS ONE			English	Article							EXPORT FACTOR FAMILY; MENTAL-RETARDATION; MESSENGER-RNA; GENE; DUPLICATIONS; ARCHITECTURE; TRAFFICKING; EXPRESSION; RECEPTORS; PROTEINS	Members of the Nuclear eXport Factor (NXF) family are involved in the export of mRNA from the nucleus to the cytoplasm, or hypothesized to play a role in transport of cytoplasmic mRNA. We previously reported on the loss of NXF5 in a male patient with a syndromic form of intellectual disability. To study the functional role of NXF5 we identified the mouse counterpart. Based on synteny, mouse Nxf2 is the ortholog of human NXF5. However, we provide several lines of evidence that mouse Nxf7 is the actual functional equivalent of NXF5. Both Nxf7 and NXF5 are predominantly expressed in the brain, show cytoplasmic localization, and present as granules in neuronal dendrites suggesting a role in cytoplasmic mRNA metabolism in neurons. Nxf7 was primarily detected in the pyramidal cells of the hippocampus and in layer V of the cortex. Similar to human NXF2, mouse Nxf2 is highly expressed in testis and shows a nuclear localization. Interestingly, these findings point to a different evolutionary path for both NXF genes in human and mouse. We thus generated and validated Nxf7 knockout mice, which were fertile and did not present any gross anatomical or morphological abnormalities. Expression profiling in the hippocampus and the cortex did not reveal significant changes between wild-type and Nxf7 knockout mice. However, impaired spatial memory was observed in these KO mice when evaluated in the Morris water maze test. In conclusion, our findings provide strong evidence that mouse Nxf7 is the functional counterpart of human NXF5, which might play a critical role in mRNA metabolism in the brain.	[Vanmarsenille, Lieselot; Verbeeck, Jelle; Belet, Stefanie; Nevelsteen, Joke; Froyen, Guy] VIB Ctr Biol Dis, Human Genome Lab, Louvain, Belgium; [Vanmarsenille, Lieselot; Verbeeck, Jelle; Belet, Stefanie; Nevelsteen, Joke; Marynen, Peter; Froyen, Guy] Katholieke Univ Leuven, Dept Human Genet, Human Genome Lab, Louvain, Belgium; [Roebroek, Anton J.] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Van de Putte, Tom] Katholieke Univ Leuven, Dept Human Genet, Lab Mol Biol Celgen, Louvain, Belgium; [Callaerts-Vegh, Zsuzsanna; D'Hooge, Rudi] Katholieke Univ Leuven, Lab Biol Psychol, Louvain, Belgium; [D'Hooge, Rudi] Katholieke Univ Leuven, LIND, Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven	Froyen, G (corresponding author), VIB Ctr Biol Dis, Human Genome Lab, Louvain, Belgium.	guy.froyen@med.kuleuven.be			Fund for Scientific Research-Flanders (FWO Vlaanderen), Belgium [G.0217.07N, G.0886.11]	Fund for Scientific Research-Flanders (FWO Vlaanderen), Belgium(FWO)	This work was supported by research grants [G.0217.07N to P. M., G.0886.11 to G. F.] from the Fund for Scientific Research-Flanders (FWO Vlaanderen; http://www.fwo.be/), Belgium. J.N. was a doctoral student of the Fund for Scientific Research-Flanders (FWO Vlaanderen), Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bauters M, 2008, GENOME RES, V18, P847, DOI 10.1101/gr.075903.107; D'Hooge R, 2005, J NEUROSCI, V25, P6539, DOI 10.1523/JNEUROSCI.0283-05.2005; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Frints SGM, 2003, AM J MED GENET A, V119A, P367, DOI 10.1002/ajmg.a.20195; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Grillo L, 2010, EUR J MED GENET, V53, P113, DOI 10.1016/j.ejmg.2010.01.001; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Izaurralde E, 2001, CELL MOL LIFE SCI, V58, P1105, DOI 10.1007/PL00000924; Jun L, 2001, CURR BIOL, V11, P1381, DOI 10.1016/S0960-9822(01)00419-5; Katahira J, 2008, NUCLEIC ACIDS RES, V36, P616, DOI 10.1093/nar/gkm556; Pan JY, 2009, DEV BIOL, V330, P167, DOI 10.1016/j.ydbio.2009.03.022; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Sasaki M, 2005, GENOMICS, V85, P641, DOI 10.1016/j.ygeno.2005.01.003; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; STEWART CA, 1993, BEHAV NEUROSCIENCE P, P107; Takano K, 2007, NUCLEIC ACIDS RES, V35, P2513, DOI 10.1093/nar/gkm125; Tan W, 2005, NUCLEIC ACIDS RES, V33, P3855, DOI 10.1093/nar/gki706; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; UMANS L, 1995, J BIOL CHEM, V270, P19778, DOI 10.1074/jbc.270.34.19778; Vandewalle J, 2009, AM J HUM GENET, V85, P809, DOI 10.1016/j.ajhg.2009.10.019; Yang J, 2001, MOL CELL, V8, P397, DOI 10.1016/S1097-2765(01)00303-3; Zhou J, 2011, MOL REPROD DEV, V78, P241, DOI 10.1002/mrd.21291	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e64144	10.1371/journal.pone.0064144	http://dx.doi.org/10.1371/journal.pone.0064144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675524	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100057
J	Zhou, W; Wang, HD; Zhu, XX; Shan, JJ; Yin, AL; Cai, BC; Di, LQ				Zhou, Wei; Wang, Haidan; Zhu, Xuanxuan; Shan, Jinjun; Yin, Ailing; Cai, Baochang; Di, Liuqing			Improvement of Intestinal Absorption of Forsythoside A and Chlorogenic Acid by Different Carboxymethyl Chitosan and Chito-oligosaccharide, Application to Flos Lonicerae - Fructus Forsythiae Herb Couple Preparations	PLOS ONE			English	Article							IN-SITU; DELIVERY-SYSTEMS; DRUG-DELIVERY; ENHANCERS; RATS; TRANSPORT; INSULIN; ANTIOXIDANT; MECHANISM; PERFUSION	The current study aims to investigate the effect of chitosan derivatives on the intestinal absorption and bioavailabilities of forsythoside A (FTA) and Chlorogenic acid (CHA), the major active components in Flos Lonicerae - Fructus Forsythiae herb couple. Biopharmaceutics and pharmacokinetics properties of the two compounds have been characterized in vitro, in situ as well as in rats. Based on the identified biopharmaceutics characteristics of the two compounds, the effect of chitosan derivatives as an absorption enhancer on the intestinal absorption and pharmacokinetics of FTA and CHA in pure compound form as well as extract form were investigated in vitro, in situ and in vivo. Both FTA and CHA demonstrated very limited intestinal permeabilities, leading to oral bioavailabilities being only 0.50% and 0.13% in rats, respectively. Results from both in vitro, in situ as well as in vivo studies consistently indicated that Chito-oligosaccharide (COS) at dosage of 25 mg/kg could enhance intestinal permeabilities significantly as well as the in vivo bioavailabilities of both FTA and CHA than CMCs in Flos Lonicerae - Fructus Forsythiae herb couple preparations, and was safe for gastrointestine from morphological observation. Besides, treatment with Flos Lonicerae - Fructus Forsythiae herb couple preparations with COS at the dosage of 25 mg/kg prevented MDCK damage after influenza virus propagation, which was significantly better than control. The current findings not only identified the usefulness of COS for the improved delivery of Flos Lonicerae - Fructus Forsythiae preparations but also demonstrated the importance of biopharmaceutical characterization in the dosage form development of traditional Chinese medicine.	[Zhou, Wei; Yin, Ailing; Cai, Baochang; Di, Liuqing] Nanjing Univ Chinese Med, Coll Pharm, Nanjing, Jiangsu, Peoples R China; [Zhou, Wei; Di, Liuqing] Jiangsu Engn Res Ctr Efficient Delivery Syst TCM, Nanjing, Jiangsu, Peoples R China; [Zhou, Wei; Di, Liuqing] Nanjing Engn Res Ctr Industrializat Chinese Med P, Nanjing, Jiangsu, Peoples R China; [Wang, Haidan; Zhu, Xuanxuan] Nanjing Univ Chinese Med, Dept Pharmacol, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China; [Shan, Jinjun] Nanjing Univ Chinese Med, Med Coll 1, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Di, LQ (corresponding author), Nanjing Univ Chinese Med, Coll Pharm, Nanjing, Jiangsu, Peoples R China.	diliuqing@hotmail.com	wang, haidan/HGC-7982-2022; Zhou, Wei/I-5964-2014		National Natural Science Foundation of China [81073071, 81273655]; "Qing Lan" Project from Jiangsu Provincial Technology Innovation Team Support Scheme; priority Academic Program Development of Jiangsu Higher Education Institution [ysxk-2010]; program sponsored for scientific innovation research of college graduate in the Jiangsu province [623]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Qing Lan" Project from Jiangsu Provincial Technology Innovation Team Support Scheme; priority Academic Program Development of Jiangsu Higher Education Institution; program sponsored for scientific innovation research of college graduate in the Jiangsu province	The present study is supported financially by the National Natural Science Foundation of China (81073071, 81273655), "Qing Lan" Project from Jiangsu Provincial Technology Innovation Team Support Scheme, the priority Academic Program Development of Jiangsu Higher Education Institution (No.ysxk-2010) and a 2012 program sponsored for scientific innovation research of college graduate in the Jiangsu province (623). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artursson P, 1994, PHARM RES, V11, P358; BARRY BW, 1983, DERMATOLOGICAL FORMU, P127; Bernkop-Schnurch A, 2012, EUR J PHARM BIOPHARM, V81, P463, DOI 10.1016/j.ejpb.2012.04.007; Du Qiu, 2009, Yaoxue Xuebao, V44, P922; Fetih G, 2005, J CONTROL RELEASE, V106, P287, DOI 10.1016/j.jconrel.2005.05.017; Gao Y, 2008, INT J PHARM, V359, P70, DOI 10.1016/j.ijpharm.2008.03.016; Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3; Hu K. J., 2001, J HARBIN MED U, V35, P430; ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450; Jonker C, 2002, INT J PHARMACEUT, V238, P205, DOI 10.1016/S0378-5173(02)00068-6; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c; Kuang Hai-Xue, 2009, Chinese Journal of Natural Medicines, V7, P278, DOI 10.3724/SP.J.1009.2009.00278; [刘碧源 Liu Biyuan], 2003, [中国生化药物杂志, Chinese Journal of Biochemical Pharmaceutics], V24, P73; Ma YuanYuan, 2010, Scientia Agricultura Sinica, V43, P3237; Mehrbod P, 2009, DARU, V17, P88; Qu HH, 2008, J PHARM PHARMACOL, V60, P261, DOI 10.1211/jpp.60.2.0016; RAFTER JJ, 1986, GUT, V27, P1320, DOI 10.1136/gut.27.11.1320; Salama NN, 2006, ADV DRUG DELIVER REV, V58, P15, DOI 10.1016/j.addr.2006.01.003; Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740; Shang XF, 2011, J ETHNOPHARMACOL, V138, P1, DOI 10.1016/j.jep.2011.08.016; THOMSON ABR, 1986, J CLIN INVEST, V77, P279, DOI 10.1172/JCI112288; Uchiyama T, 1999, J PHARM PHARMACOL, V51, P1241, DOI 10.1211/0022357991776976; Wang GN, 2010, J CHROMATOGR B, V878, P102, DOI 10.1016/j.jchromb.2009.11.029; Yamamoto A, 1996, J PHARM PHARMACOL, V48, P1285, DOI 10.1111/j.2042-7158.1996.tb03937.x; Ye JX, 2010, J PHARMACEUT BIOMED, V52, P625, DOI 10.1016/j.jpba.2010.01.035; Yuan W., 2007, FOOD RES DEV, V28, P185; Zhang LW, 2002, EXTRACTION METHOD BI; Zhou W, 2012, PHYTOMEDICINE, V20, P47, DOI 10.1016/j.phymed.2012.09.014; Zhou W, 2012, ACTA PHARMACOL SIN, V33, P1069, DOI 10.1038/aps.2012.58; Zou YX, 2012, INT J MOL SCI, V13, P16544, DOI 10.3390/ijms131216544	30	22	25	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63348	10.1371/journal.pone.0063348	http://dx.doi.org/10.1371/journal.pone.0063348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675483	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100041
J	Smoothey, AF				Smoothey, Amy F.			Habitat-Associations of Turban Snails on Intertidal and Subtidal Rocky Reefs	PLOS ONE			English	Article							NORTHERN NEW-ZEALAND; NEW-SOUTH-WALES; PYURA-STOLONIFERA HELLER; ALGAL ASSEMBLAGES; MACROINVERTEBRATE COMMUNITIES; MUSCULISTA-SENHOUSIA; MARINE-INVERTEBRATES; SPATIAL-PATTERNS; CORALLINE ALGAE; HARD SUBSTRATA	Patchiness of habitat has important influences on distributions and abundances of organisms. Given the increasing threat of loss and alteration of habitats due to pressures associated with humans, there is a need for ecologists to understand species' requirements for habitat and to predict changes to taxa under various future environmental conditions. This study tested hypotheses about the generality of patterns described for one species of marine intertidal turban snail for a different, yet closely-related species in subtidal habitats along the coast of New South Wales, Australia. These two closely-related species live in similar habitats, yet under quite different conditions, which provided an opportunity to investigate how similar types of habitats influence patterns of distribution, abundance and size-structure in intertidal versus subtidal environments. For each species, there were similar associations between biogenically structured habitat and densities. The intertidal species, Turbo undulates, were more abundant, with greater proportions of small individuals in habitats formed by the canopy-forming alga, Hormosira banksii, the solitary ascidian, Pyura stolonifera or the turfing red alga, Corallina officinalis compared to simple habitat (bare rock). Similarly, more Turbo torquatus were found in biogenically structured subtidal habitat, i.e. canopy-forming algae, Ecklonia radiata, mixed algal communities ('fringe'), or turfing red algae (Corallina officinalis and Amphiroa aniceps) than where habitat is simple (barrens). Small T. torquatus were more abundant in areas of turf and 'fringe', while large snails were more abundant in areas of kelp and barrens. These patterns were found at each location sampled (i.e. eight intertidal and two subtidal rocky reefs) and at all times of sampling, across each environment. This study highlighted the consistent influence of biogenically structured habitats on the distribution, abundance and size-structure of intertidal and subtidal turban snails and forms a basis for increasing the understanding of the potential underlying processes causing such patterns.	[Smoothey, Amy F.] Univ Sydney, Sch Biol Sci, Ctr Res Ecol Impacts Coastal Cities, Marine Ecol Labs A11, Sydney, NSW 2006, Australia	University of Sydney	Smoothey, AF (corresponding author), Cronulla Fisheries Res Ctr Excellence, NSW Dept Primary Ind, Cronulla, NSW, Australia.	amy.smoothey@dpi.nsw.gov.au			Australian Postgraduate Award; Australian Research Council through the Centre for Research on Ecological Impacts of Coastal Cities	Australian Postgraduate Award(Australian Government); Australian Research Council through the Centre for Research on Ecological Impacts of Coastal Cities(Australian Research Council)	The research in this manuscript was funded by an Australian Postgraduate Award (AFS) and the Australian Research Council through the Centre for Research on Ecological Impacts of Coastal Cities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro AC, 2007, ESTUAR COAST, V30, P431, DOI 10.1007/BF02819389; Alfaro AC, 2006, ESTUARIES COASTS, V29, P731, DOI 10.1007/BF02786524; Beck MW, 1998, MAR ECOL PROG SER, V169, P165, DOI 10.3354/meps169165; Beck MW, 1997, OIKOS, V78, P265, DOI 10.2307/3546293; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; Blount C, 2004, THESIS SYDNEY U SYDN; Castilla JC, 2004, MAR ECOL PROG SER, V268, P119, DOI 10.3354/meps268119; Chapman MG, 2000, J EXP MAR BIOL ECOL, V244, P181, DOI 10.1016/S0022-0981(99)00140-9; CHAPMAN MG, 1994, AUST J MAR FRESH RES, V45, P635; Chapman MG, 1998, J EXP MAR BIOL ECOL, V224, P265, DOI 10.1016/S0022-0981(97)00202-5; CHOAT JH, 1982, J EXP MAR BIOL ECOL, V60, P129, DOI 10.1016/0022-0981(82)90155-1; Cole VJ, 2007, J EXP MAR BIOL ECOL, V348, P191, DOI 10.1016/j.jembe.2007.05.001; Coleman MA, 2002, J EXP MAR BIOL ECOL, V267, P53, DOI 10.1016/S0022-0981(01)00358-6; Crooks JA, 1999, J EXP MAR BIOL ECOL, V240, P53, DOI 10.1016/S0022-0981(99)00041-6; Crooks JA, 1998, MAR ECOL PROG SER, V162, P137, DOI 10.3354/meps162137; Crowe T, 1996, J EXP MAR BIOL ECOL, V206, P83, DOI 10.1016/S0022-0981(96)02615-9; Crowe T. P., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P273, DOI 10.1023/A:1009911928100; Crowe TP, 1999, J EXP MAR BIOL ECOL, V237, P31, DOI 10.1016/S0022-0981(98)00211-1; Dumont C, 2004, MAR ECOL PROG SER, V276, P93, DOI 10.3354/meps276093; Ettinger-Epstein P, 2008, AUSTRAL ECOL, V33, P594, DOI 10.1111/j.1442-9993.2007.01824.x; Fairweather Peter G., 2007, P1; FIELDING PJ, 1994, S AFR J ZOOL, V29, P46; Firth LB, 2010, OECOLOGIA, V162, P163, DOI 10.1007/s00442-009-1441-7; FLETCHER WJ, 1987, ECOL MONOGR, V57, P89, DOI 10.2307/1942640; Foster M.S., 1988, MEMOIRS CALIFORNIA A, V9, P1; FOSTER MS, 1990, HYDROBIOLOGIA, V192, P21, DOI 10.1007/BF00006225; Fowler-Walker MJ, 2002, MAR ECOL PROG SER, V240, P49, DOI 10.3354/meps240049; Gee JM, 1996, J MAR BIOL ASSOC UK, V76, P177, DOI 10.1017/S0025315400029106; Goodsell PJ, 2009, MAR ECOL PROG SER, V384, P23, DOI 10.3354/meps08037; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; HARVEY M, 1995, LIMNOL OCEANOGR, V40, P94, DOI 10.4319/lo.1995.40.1.0094; Jeffery CJ, 2001, J EXP MAR BIOL ECOL, V256, P85, DOI 10.1016/S0022-0981(00)00307-5; Jenkins SR, 2001, MAR ECOL PROG SER, V217, P207, DOI 10.3354/meps217207; JOLL LM, 1980, AUST J MAR FRESH RES, V31, P319, DOI 10.1071/MF9800319; JONES GP, 1990, AUST J ECOL, V15, P505, DOI 10.1111/j.1442-9993.1990.tb01474.x; Kelaher BP, 2003, J EXP MAR BIOL ECOL, V282, P23, DOI 10.1016/S0022-0981(02)00443-4; Kelaher BP, 2001, J MAR BIOL ASSOC UK, V81, P917, DOI 10.1017/S0025315401004842; Kelaher BP, 2007, REV CHIL HIST NAT, V80, P173; Kendrick GA, 1999, HYDROBIOLOGIA, V399, P275; KENNELLY SJ, 1983, J EXP MAR BIOL ECOL, V68, P257, DOI 10.1016/0022-0981(83)90057-6; KEOUGH MJ, 1982, OECOLOGIA, V54, P348, DOI 10.1007/BF00380003; KOLASA J, 1991, ECOLOGICAL HETEROGEN; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lewis J. R., 1964, ECOLOGY ROCKY SHORES; Lilley SA, 2006, OECOLOGIA, V148, P672, DOI 10.1007/s00442-006-0411-6; MARTINEZ E, 1993, ECOL APPL, V3, P417, DOI 10.2307/1941911; Melville AJ, 2001, AUSTRAL ECOL, V26, P102, DOI 10.1111/j.1442-9993.2001.01089.pp.x; Menge BA, 2001, MARINE COMMUNITY ECOLOGY, P221; Monteiro SM, 2002, J EXP MAR BIOL ECOL, V270, P171, DOI 10.1016/S0022-0981(02)00020-5; O'Connor NE, 2007, J MAR BIOL ASSOC UK, V87, P551, DOI 10.1017/S0025315407050503; PETERS RH, 1991, CRITIQUE ECOLOGY; POVEY A, 1991, OIKOS, V61, P355, DOI 10.2307/3545243; RAFFAELLI DG, 1978, J ANIM ECOL, V47, P71, DOI 10.2307/3923; Ricciardi A, 1997, CAN J FISH AQUAT SCI, V54, P2596, DOI 10.1139/cjfas-54-11-2596; SCHIEL DR, 1986, OCEANOGR MAR BIOL, V24, P265; Steneck RS, 2001, MARINE COMMUNITY ECOLOGY, P445; Thompson RC, 2002, ENVIRON CONSERV, V29, P168, DOI 10.1017/S0376892902000115; Tilman D., 1989, P89; Underwood A.J., 1984, P151; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, 1990, J EXP MAR BIOL ECOL, V137, P25, DOI 10.1016/0022-0981(90)90058-K; UNDERWOOD AJ, 1991, AUST J ECOL, V16, P231, DOI 10.1111/j.1442-9993.1991.tb01050.x; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P51, DOI 10.1016/S0022-0981(00)00179-9; Underwood AJ, 1993, SPECIES DIVERSITY EC, P38; Vanderklift MA, 2004, MAR FRESHWATER RES, V55, P93, DOI 10.1071/MF03057; WALSBY JR, 1977, NEW ZEAL J MAR FRESH, V11, P211, DOI 10.1080/00288330.1977.9515674; WEINER J, 1995, J ECOL, V83, P153, DOI 10.2307/2261159; Wernberg T, 2008, MAR ECOL PROG SER, V362, P169, DOI 10.3354/meps07416; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; WORTHINGTON DG, 1989, J EXP MAR BIOL ECOL, V129, P61, DOI 10.1016/0022-0981(89)90063-4	73	17	17	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e61257	10.1371/journal.pone.0061257	http://dx.doi.org/10.1371/journal.pone.0061257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675409	Green Submitted, gold, Green Published			2022-12-25	WOS:000318852400005
J	Ray, D; Ye, P				Ray, Debjit; Ye, Ping			Characterization of the Metabolic Requirements in Yeast Meiosis	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL TRANSPORTER; GLYCOGEN-PHOSPHORYLASE; CELLULAR-METABOLISM; ESCHERICHIA-COLI; SPORULATION; GENOME; GENE; IDENTIFICATION; GROWTH	The diploid yeast Saccharomyces cerevisiae undergoes mitosis in glucose-rich medium but enters meiosis in acetate sporulation medium. The transition from mitosis to meiosis involves a remarkable adaptation of the metabolic machinery to the changing environment to meet new energy and biosynthesis requirements. Biochemical studies indicate that five metabolic pathways are active at different stages of sporulation: glutamate formation, tricarboxylic acid cycle, glyoxylate cycle, gluconeogenesis, and glycogenolysis. A dynamic synthesis of macromolecules, including nucleotides, amino acids, and lipids, is also observed. However, the metabolic requirements of sporulating cells are poorly understood. In this study, we apply flux balance analyses to uncover optimal principles driving the operation of metabolic networks over the entire period of sporulation. A meiosis-specific metabolic network is constructed, and flux distribution is simulated using ten objective functions combined with time-course expression-based reaction constraints. By systematically evaluating the correlation between computational and experimental fluxes on pathways and macromolecule syntheses, the metabolic requirements of cells are determined: sporulation requires maximization of ATP production and macromolecule syntheses in the early phase followed by maximization of carbohydrate breakdown and minimization of ATP production in the middle and late stages. Our computational models are validated by in silico deletion of enzymes known to be essential for sporulation. Finally, the models are used to predict novel metabolic genes required for sporulation. This study indicates that yeast cells have distinct metabolic requirements at different phases of meiosis, which may reflect regulation that realizes the optimal outcome of sporulation. Our meiosis-specific network models provide a framework for an in-depth understanding of the roles of enzymes and reactions, and may open new avenues for engineering metabolic pathways to improve sporulation efficiency.	[Ray, Debjit; Ye, Ping] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Ray, Debjit] Washington State Univ, Pullman, WA 99164 USA; [Ye, Ping] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Ye, P (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	pye@wsu.edu	Ray, Debjit/J-9302-2016	Ray, Debjit/0000-0002-7192-9859	March of Dimes Basil O'Connor Starter Scholar Research Award [5-FY10-485]	March of Dimes Basil O'Connor Starter Scholar Research Award(March of Dimes)	This work was supported by the March of Dimes Basil O'Connor Starter Scholar Research Award (grant number #5-FY10-485) to PY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA A, 1986, MOL GEN GENET, V204, P310, DOI 10.1007/BF00425515; Andersen MR, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.12; Aon JC, 1996, EXP CELL RES, V222, P157, DOI 10.1006/excr.1996.0020; Blank LM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r49; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Briza P, 2002, YEAST, V19, P403, DOI 10.1002/yea.843; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Casal M, 1996, MICROBIOL-UK, V142, P1385, DOI 10.1099/13500872-142-6-1385; CHENG C, 1995, MOL CELL BIOL, V15, P6632; COLONNA WJ, 1978, J BACTERIOL, V134, P844, DOI 10.1128/JB.134.3.844-853.1978; CORTASSA S, 1995, BIOTECHNOL BIOENG, V47, P193, DOI 10.1002/bit.260470211; DARAN JM, 1995, EUR J BIOCHEM, V233, P520, DOI 10.1111/j.1432-1033.1995.520_2.x; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; DICKINSON JR, 1986, J GEN MICROBIOL, V132, P2605; DICKINSON JR, 1983, P NATL ACAD SCI-BIOL, V80, P5847, DOI 10.1073/pnas.80.19.5847; DICKINSON JR, 1986, MOL GEN GENET, V204, P103; Dobson PD, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-145; Engel SR, 2010, NUCLEIC ACIDS RES, V38, pD433, DOI 10.1093/nar/gkp917; Enyenihi AH, 2003, GENETICS, V163, P47; ESPOSITO MS, 1969, J BACTERIOL, V100, P180, DOI 10.1128/JB.100.1.180-186.1969; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gille C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.62; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; HENRY SA, 1973, J BACTERIOL, V114, P1158, DOI 10.1128/JB.114.3.1158-1163.1973; Hildyard JCW, 2003, BIOCHEM J, V374, P607, DOI 10.1042/BJ20030995; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; HOPPER AK, 1974, J BACTERIOL, V119, P619, DOI 10.1128/JB.119.2.619-628.1974; HOPPER AK, 1975, GENETICS, V80, P41; HWANG PK, 1989, MOL CELL BIOL, V9, P1659, DOI 10.1128/MCB.9.4.1659; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; KAPLAN RS, 1995, J BIOL CHEM, V270, P4108, DOI 10.1074/jbc.270.8.4108; KIM KS, 1986, MOL CELL BIOL, V6, P1936, DOI 10.1128/MCB.6.6.1936; Kloimwieder A, 2011, G3-GENES GENOM GENET, V1, P143, DOI 10.1534/g3.111.000323; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Paiva S, 2004, YEAST, V21, P201, DOI 10.1002/yea.1056; Palmieri L, 2000, BBA-BIOENERGETICS, V1459, P363, DOI 10.1016/S0005-2728(00)00173-0; Palmieri L, 1999, J BIOL CHEM, V274, P22184, DOI 10.1074/jbc.274.32.22184; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200; Parisi MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-346; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046; RATH VL, 1992, J MOL BIOL, V225, P1027, DOI 10.1016/0022-2836(92)90102-P; ROTH R, 1970, J BACTERIOL, V101, P53, DOI 10.1128/JB.101.1.53-57.1970; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Strathern J. N., 1981, MOL BIOL YEAST SACCH; Sugden Mary C, 2003, Biochem J, V374, pe1, DOI 10.1042/BJ20031105; Swiegers JH, 2001, YEAST, V18, P585, DOI 10.1002/yea.712; VANDERCAMMEN A, 1989, EUR J BIOCHEM, V182, P613, DOI 10.1111/j.1432-1033.1989.tb14870.x; Vargas FA, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-75; VARMA A, 1993, J THEOR BIOL, V165, P477, DOI 10.1006/jtbi.1993.1202; Walker G.M., 1998, YEAST PHYSL BIOTECHN; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	68	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63707	10.1371/journal.pone.0063707	http://dx.doi.org/10.1371/journal.pone.0063707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23675502	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600069
J	Tottey, W; Denonfoux, J; Jaziri, F; Parisot, N; Missaoui, M; Hill, D; Borrel, G; Peyretaillade, E; Alric, M; Harris, HMB; Jeffery, IB; Claesson, MJ; O'Toole, PW; Peyret, P; Brugere, JF				Tottey, William; Denonfoux, Jeremie; Jaziri, Faouzi; Parisot, Nicolas; Missaoui, Mohiedine; Hill, David; Borrel, Guillaume; Peyretaillade, Eric; Alric, Monique; Harris, Hugh M. B.; Jeffery, Ian B.; Claesson, Marcus J.; O'Toole, Paul W.; Peyret, Pierre; Brugere, Jean-Francois			The Human Gut Chip "HuGChip'', an Explorative Phylogenetic Microarray for Determining Gut Microbiome Diversity at Family Level	PLOS ONE			English	Article							HUMAN INTESTINAL MICROBIOTA; ECOLOGY; METABOLISM; ALIGNMENT; RESOURCE; REVEALS; HEALTH; FLORA; DIET	Evaluating the composition of the human gut microbiota greatly facilitates studies on its role in human pathophysiology, and is heavily reliant on culture-independent molecular methods. A microarray designated the Human Gut Chip (HuGChip) was developed to analyze and compare human gut microbiota samples. The PhylArray software was used to design specific and sensitive probes. The DNA chip was composed of 4,441 probes (2,442 specific and 1,919 explorative probes) targeting 66 bacterial families. A mock community composed of 16S rRNA gene sequences from intestinal species was used to define the threshold criteria to be used to analyze complex samples. This was then experimentally verified with three human faecal samples and results were compared (i) with pyrosequencing of the V4 hypervariable region of the 16S rRNA gene, (ii) metagenomic data, and (iii) qPCR analysis of three phyla. When compared at both the phylum and the family level, high Pearson's correlation coefficients were obtained between data from all methods. The HuGChip development and validation showed that it is not only able to assess the known human gut microbiota but could also detect unknown species with the explorative probes to reveal the large number of bacterial sequences not yet described in the human gut microbiota, overcoming the main inconvenience encountered when developing microarrays.	[Tottey, William; Denonfoux, Jeremie; Jaziri, Faouzi; Parisot, Nicolas; Missaoui, Mohiedine; Borrel, Guillaume; Peyretaillade, Eric; Alric, Monique; Peyret, Pierre; Brugere, Jean-Francois] Univ Auvergne, Clermont Univ, EA CIDAM 4678, Clermont Ferrand, France; [Jaziri, Faouzi; Missaoui, Mohiedine; Hill, David] ISIMA LIMOS, CNRS, UMR 6158, Aubiere, France; [Harris, Hugh M. B.; Jeffery, Ian B.; Claesson, Marcus J.; O'Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Harris, Hugh M. B.; Jeffery, Ian B.; Claesson, Marcus J.; O'Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); University College Cork; University College Cork	Brugere, JF (corresponding author), Univ Auvergne, Clermont Univ, EA CIDAM 4678, Clermont Ferrand, France.	jf.brugere@udamail.fr	Jeffery, Ian/I-4010-2013; Brugère, Jean-François/AAB-4001-2019; O'Toole, Paul W/G-1593-2012; Claesson, Marcus/K-7639-2015; Claesson, Marcus/AAE-4145-2019; Parisot, Nicolas/C-8116-2012	Brugère, Jean-François/0000-0002-1559-2331; O'Toole, Paul W/0000-0001-5377-0824; Claesson, Marcus/0000-0002-5712-0623; Claesson, Marcus/0000-0002-5712-0623; Parisot, Nicolas/0000-0001-5217-8415; PEYRET, Pierre/0000-0003-3114-0586; Jeffery, Ian/0000-0001-9183-7292; Tottey, william/0000-0002-8716-0319	PhD studentship; European Union; Auvergne Council; Govt. of Ireland Dept. Agriculture, Fisheries, and Food/Health Research Board FHRI award; Alimentary Pharmabiotic Center	PhD studentship; European Union(European Commission); Auvergne Council; Govt. of Ireland Dept. Agriculture, Fisheries, and Food/Health Research Board FHRI award; Alimentary Pharmabiotic Center	This work was supported by a PhD studentship supported by the European Union and the Auvergne Council to WT. MJC, HH, IBG, and PWOT are members of the ELDERMET consortium (http://eldermet.ucc.ie) whose work is supported in part by the (Govt. of Ireland) Dept. Agriculture, Fisheries, and Food/Health Research Board FHRI award to the ELDERMET project, as well as the Alimentary Pharmabiotic Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ashelford KE, 2002, NUCLEIC ACIDS RES, V30, P3481, DOI 10.1093/nar/gkf450; Blanchard AP, 1996, BIOSENS BIOELECTRON, V11, P687, DOI 10.1016/0956-5663(96)83302-1; Bodrossy L, 2003, ENVIRON MICROBIOL, V5, P566, DOI 10.1046/j.1462-2920.2003.00450.x; Brugere JF, 2009, EXPERT REV MOL DIAGN, V9, P353, DOI 10.1586/ERM.09.16; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dugat-Bony E, 2012, ENVIRON MICROBIOL, V14, P356, DOI 10.1111/j.1462-2920.2011.02559.x; Fraher MH, 2012, NAT REV GASTRO HEPAT, V9, P312, DOI 10.1038/nrgastro.2012.44; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gentry TJ, 2006, MICROB ECOL, V52, P159, DOI 10.1007/s00248-006-9072-6; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrington CR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-195; Hill MJ, 1997, EUR J CANCER PREV, V6, pS43, DOI 10.1097/00008469-199703001-00009; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mihajlovski A, 2008, RES MICROBIOL, V159, P516, DOI 10.1016/j.resmic.2008.06.007; Mihajlovski A, 2010, ENV MICROBIOL REP, V2, P272, DOI 10.1111/j.1758-2229.2009.00116.x; Militon C, 2007, BIOINFORMATICS, V23, P2550, DOI 10.1093/bioinformatics/btm392; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Paliy O, 2012, FEMS MICROBIOL ECOL, V79, P2, DOI 10.1111/j.1574-6941.2011.01222.x; Paliy O, 2009, APPL ENVIRON MICROB, V75, P3572, DOI 10.1128/AEM.02764-08; Palmer C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj007; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Parisot N, 2012, BIOINFORMATICS, V28, P3161, DOI 10.1093/bioinformatics/bts597; Peplies J, 2003, APPL ENVIRON MICROB, V69, P1397, DOI 10.1128/AEM.69.3.1397-1407.2003; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Scanlan PD, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-79; Severgnini M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp499; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	57	35	41	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e62544	10.1371/journal.pone.0062544	http://dx.doi.org/10.1371/journal.pone.0062544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690942	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900009
J	Bajaj, S; Adhikari, BM; Dhamala, M				Bajaj, Sahil; Adhikari, Bhim Mani; Dhamala, Mukesh			Higher Frequency Network Activity Flow Predicts Lower Frequency Node Activity in Intrinsic Low-Frequency BOLD Fluctuations	PLOS ONE			English	Article							RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; DEFAULT MODE; HUMAN BRAIN; CORTEX; FMRI; ENERGETICS; IMAGERY; SIGNAL; ROLES	The brain remains electrically and metabolically active during resting conditions. The low-frequency oscillations (LFO) of the blood oxygen level-dependent (BOLD) signal of functional magnetic resonance imaging (fMRI) coherent across distributed brain regions are known to exhibit features of this activity. However, these intrinsic oscillations may undergo dynamic changes in time scales of seconds to minutes during resting conditions. Here, using wavelet-transform based time-frequency analysis techniques, we investigated the dynamic nature of default-mode networks from intrinsic BOLD signals recorded from participants maintaining visual fixation during resting conditions. We focused on the default-mode network consisting of the posterior cingulate cortex (PCC), the medial prefrontal cortex (mPFC), left middle temporal cortex (LMTC) and left angular gyrus (LAG). The analysis of the spectral power and causal flow patterns revealed that the intrinsic LFO undergo significant dynamic changes over time. Dividing the frequency interval 0 to 0.25 Hz of LFO into four intervals slow-5 (0.01-0.027 Hz), slow-4 (0.027-0.073 Hz), slow-3 (0.073-0.198 Hz) and slow-2 (0.198-0.25 Hz), we further observed significant positive linear relationships of slow-4 in-out flow of network activity with slow-5 node activity, and slow-3 in-out flow of network activity with slow-4 node activity. The network activity associated with respiratory related frequency (slow-2) was found to have no relationship with the node activity in any of the frequency intervals. We found that the net causal flow towards a node in slow-3 band was correlated with the number of fibers, obtained from diffusion tensor imaging (DTI) data, from the other nodes connecting to that node. These findings imply that so-called resting state is not 'entirely' at rest, the higher frequency network activity flow can predict the lower frequency node activity, and the network activity flow can reflect underlying structural connectivity.	[Bajaj, Sahil; Adhikari, Bhim Mani; Dhamala, Mukesh] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30303 USA; [Dhamala, Mukesh] Georgia State Univ, Inst Neurosci, Joint Ctr Adv Brain Imaging, Ctr Behav Neurosci, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Dhamala, M (corresponding author), Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30303 USA.	mdhamala@phy-astr.gsu.edu	Bajaj, Sahil/C-6580-2016; Adhikari, Bhim/K-7390-2019; Dhamala, Mukesh/AAX-3207-2021	Bajaj, Sahil/0000-0003-0629-6036; 	United States National Science Foundation (NSF) [BCS 0955037]; Division Of Behavioral and Cognitive Sci [0955037] Funding Source: National Science Foundation	United States National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	A United States National Science Foundation (NSF) CAREER Award (BCS 0955037) to the author MD supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Balduzzi D, 2008, P NATL ACAD SCI USA, V105, P15641, DOI 10.1073/pnas.0808310105; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G., 2006, RHYTHMS BRAIN; Chang C, 2010, FILM COMMENT, V46, P81; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Hutchison RM, 2013, HUM BRAIN MAPP, V34, P2154, DOI 10.1002/hbm.22058; Hwang K, 2010, J NEUROSCI, V30, P15535, DOI 10.1523/JNEUROSCI.2825-10.2010; Jbabdi S, 2011, BRAIN CONNECT, V1, P169, DOI 10.1089/brain.2011.0033; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Keilholz SD, 2010, BRAIN STRUCT FUNCT, V215, P129, DOI 10.1007/s00429-010-0276-7; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Liu X, 2013, P NATL ACAD SCI USA, V110, P4392, DOI 10.1073/pnas.1216856110; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Luo J, 2004, ACTA PHARMACOL SIN, V25, P637; Maandag NJG, 2007, P NATL ACAD SCI USA, V104, P20546, DOI 10.1073/pnas.0709515104; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Meister IG, 2004, COGNITIVE BRAIN RES, V19, P219, DOI 10.1016/j.cogbrainres.2003.12.005; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rypma B, 2009, INTELLIGENCE, V37, P207, DOI 10.1016/j.intell.2008.12.004; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Smith K, 2012, NATURE, V489, P356, DOI 10.1038/489356a; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Talairach J., 1988, COPLANAR STEREOTAXIC; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Wen XT, 2012, J NEUROSCI, V32, P1284, DOI 10.1523/JNEUROSCI.2817-11.2012; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Zhou ZY, 2009, BRAIN RES, V1289, P22, DOI 10.1016/j.brainres.2009.06.096; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	58	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64466	10.1371/journal.pone.0064466	http://dx.doi.org/10.1371/journal.pone.0064466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691225	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700098
J	Bournaud, C; de Faria, SM; dos Santos, JMF; Tisseyre, P; Silva, M; Chaintreuil, C; Gross, E; James, EK; Prin, Y; Moulin, L				Bournaud, Caroline; de Faria, Sergio Miana; Ferreira dos Santos, Jose Miguel; Tisseyre, Pierre; Silva, Michele; Chaintreuil, Clemence; Gross, Eduardo; James, Euan K.; Prin, Yves; Moulin, Lionel			Burkholderia Species Are the Most Common and Preferred Nodulating Symbionts of the Piptadenia Group (Tribe Mimoseae)	PLOS ONE			English	Article							PUDICA RHIZOBIAL SYMBIONTS; SP-NOV.; ROOT-NODULES; NITROGEN-FIXATION; CUPRIAVIDUS-TAIWANENSIS; PHASEOLUS-VULGARIS; MYCORRHIZAL FUNGI; FIX NITROGEN; SPP.; LEGUMES	Burkholderia legume symbionts (also called a-rhizobia) are ancient in origin and are the main nitrogen-fixing symbionts of species belonging to the large genus Mimosa in Brazil. We investigated the extent of the affinity between Burkholderia and species in the tribe Mimoseae by studying symbionts of the genera Piptadenia (P.), Parapiptadenia (Pp.), Pseudopiptadenia (Ps.), Pityrocarpa (Py.), Anadenanthera (A.) and Microlobius (Mi.), all of which are native to Brazil and are phylogenetically close to Mimosa, and which together with Mimosa comprise the "Piptadenia group''. We characterized 196 strains sampled from 18 species from 17 locations in Brazil using two neutral markers and two symbiotic genes in order to assess their species affiliations and the evolution of their symbiosis genes. We found that Burkholderia are common and highly diversified symbionts of species in the Piptadenia group, comprising nine Burkholderia species, of which three are new ones and one was never reported as symbiotic (B. phenoliruptrix). However, a-rhizobia were also detected and were occasionally dominant on a few species. A strong sampling site effect on the rhizobial nature of symbionts was detected, with the symbiont pattern of the same legume species changing drastically from location to location, even switching from beta to alpha-rhizobia. Coinoculation assays showed a strong affinity of all the Piptadenia group species towards Burkholderia genotypes, with the exception of Mi. foetidus. Phylogenetic analyses of neutral and symbiotic markers showed that symbiosis genes in Burkholderia from the Piptadenia group have evolved mainly through vertical transfer, but also by horizontal transfer in two species.	[Bournaud, Caroline; Prin, Yves] UMR LSTM, CIRAD, Montpellier, France; [de Faria, Sergio Miana; Silva, Michele] EMBRAPA Agrobiol, Seropedica, RJ, Brazil; [Ferreira dos Santos, Jose Miguel; Gross, Eduardo] Univ Estadual Santa Cruz, Depto Ciencias Agr & Ambientais, Ilheus, BA, Brazil; [Tisseyre, Pierre; Chaintreuil, Clemence; Moulin, Lionel] UMR LSTM, IRD, Montpellier, France; [James, Euan K.] James Hutton Inst, Dundee, Scotland	CIRAD; Universite de Montpellier; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Santa Cruz; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; James Hutton Institute	Moulin, L (corresponding author), UMR LSTM, IRD, Montpellier, France.	lionel.moulin@ird.fr	de Faria, Sergio Miana/C-1405-2013; James, Euan K/K-1135-2012; Moulin, Lionel/C-2921-2008	James, Euan K/0000-0001-7969-6570; Moulin, Lionel/0000-0001-9068-6912; de Faria, Sergio/0000-0001-5066-046X; Ferreira dos Santos, Jose Miguel/0000-0001-6174-1126	CIRAD (France); ANR (French National Agency of Research) [ANR JCJC2009-BETASYM]; CNPq [492683/04-2]	CIRAD (France); ANR (French National Agency of Research)(French National Research Agency (ANR)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CB was funded by a Ph.D. grant from CIRAD (France). The authors are indebted to ANR (French National Agency of Research, ANR JCJC2009-BETASYM) and CNPq (Process No. 492683/04-2) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadou C, 2008, GENOME RES, V18, P1472, DOI 10.1101/gr.076448.108; Ardley JK, 2012, INT J SYST EVOL MICR, V62, P2579, DOI 10.1099/ijs.0.035097-0; Barrett CF, 2005, SYST APPL MICROBIOL, V28, P57, DOI 10.1016/j.syapm.2004.09.002; Bontemps C, 2010, MOL ECOL, V19, P44, DOI 10.1111/j.1365-294X.2009.04458.x; Chen WM, 2008, INT J SYST EVOL MICR, V58, P2174, DOI 10.1099/ijs.0.65816-0; Chen WM, 2007, INT J SYST EVOL MICR, V57, P1055, DOI 10.1099/ijs.0.64873-0; Chen WM, 2006, INT J SYST EVOL MICR, V56, P1847, DOI 10.1099/ijs.0.64325-0; Chen WM, 2005, NEW PHYTOL, V168, P661, DOI 10.1111/j.1469-8137.2005.01533.x; Chen WM, 2005, APPL ENVIRON MICROB, V71, P7461, DOI 10.1128/AEM.71.11.7461-7471.2005; Chen WM, 2003, J BACTERIOL, V185, P7266, DOI 10.1128/JB.185.24.7266-7272.2003; Chen WM, 2001, INT J SYST EVOL MICR, V51, P1729, DOI 10.1099/00207713-51-5-1729; Coenye T, 2004, SYST APPL MICROBIOL, V27, P623, DOI 10.1078/0723202042369992; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Correa M, 1984, DICIONARIO PLANTAS U, V4; Cummings SP, 2009, ENVIRON MICROBIOL, V11, P2510, DOI 10.1111/j.1462-2920.2009.01975.x; da Silva K, 2012, SYST APPL MICROBIOL, V35, P175, DOI 10.1016/j.syapm.2011.10.005; de Faria SM, 2010, J EXP BOT, V61, P3119, DOI 10.1093/jxb/erq142; De Souza C, 2004, J ETHNOPHARMACOL, V90, P87; DEFARIA SM, 1984, NEW PHYTOL, V98, P317, DOI 10.1111/j.1469-8137.1984.tb02742.x; dos Reis FB, 2010, NEW PHYTOL, V186, P934, DOI 10.1111/j.1469-8137.2010.03267.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elliott GN, 2007, ANN BOT-LONDON, V100, P1403, DOI 10.1093/aob/mcm227; Elliott GN, 2007, NEW PHYTOL, V173, P168, DOI 10.1111/j.1469-8137.2006.01894.x; Elliott GN, 2009, ENVIRON MICROBIOL, V11, P762, DOI 10.1111/j.1462-2920.2008.01799.x; Franco AA, 1997, SOIL BIOL BIOCHEM, V29, P897, DOI 10.1016/S0038-0717(96)00229-5; Freitas ADS, 2010, J ARID ENVIRON, V74, P344, DOI 10.1016/j.jaridenv.2009.09.018; Garau G, 2009, SOIL BIOL BIOCHEM, V41, P125, DOI 10.1016/j.soilbio.2008.10.011; Gaunt MW, 2001, INT J SYST EVOL MICR, V51, P2037, DOI 10.1099/00207713-51-6-2037; Gross E, 2002, ANN BOT-LONDON, V90, P175, DOI 10.1093/aob/mcf184; Gyaneshwar P, 2011, MOL PLANT MICROBE IN, V24, P1276, DOI 10.1094/MPMI-06-11-0172; Jesus Ederson da Conceição, 2005, Rev. Árvore, V29, P545, DOI 10.1590/S0100-67622005000400006; Jobson RW, 2007, SYST BOT, V32, P569, DOI 10.1600/036364407782250544; Klonowska A, 2012, FEMS MICROBIOL ECOL, V81, P618, DOI 10.1111/j.1574-6941.2012.01393.x; Laguerre G, 2001, MICROBIOL-SGM, V147, P981, DOI 10.1099/00221287-147-4-981; Lewis G, 2005, LEGUMES WORLD; LEWIS G P, 1991, Kew Bulletin, V46, P159, DOI 10.2307/4110755; Liu XY, 2012, FEMS MICROBIOL ECOL, V80, P417, DOI 10.1111/j.1574-6941.2012.01310.x; Lopez-Lopez A, 2012, INT J SYST EVOL MICR, V62, P2264, DOI 10.1099/ijs.0.033555-0; Maynaud G, 2012, SYST APPL MICROBIOL, V35, P65, DOI 10.1016/j.syapm.2011.11.002; Mishra RPN, 2012, FEMS MICROBIOL ECOL, V79, P487, DOI 10.1111/j.1574-6941.2011.01235.x; MOREIRA FMD, 1992, NEW PHYTOL, V121, P563, DOI 10.1111/j.1469-8137.1992.tb01126.x; Moulin L, 2004, MOL PHYLOGENET EVOL, V30, P720, DOI 10.1016/S1055-7903(03)00255-0; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Nicholas K.B., GENEDOC TOOL EDITING; Pagano MC, 2008, AGROFOREST SYST, V74, P231, DOI 10.1007/s10457-008-9177-7; Payne GW, 2005, APPL ENVIRON MICROB, V71, P3917, DOI 10.1128/AEM.71.7.3917-3927.2005; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sarita S, 2005, FEMS MICROBIOL ECOL, V54, P1, DOI 10.1016/j.femsec.2005.02.015; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt CA, 2010, J NAT PROD, V73, P2035, DOI 10.1021/np100523s; Scotti MR, 2004, ANN FOREST SCI, V61, P87, DOI 10.1051/forest:2003088; Sheu SY, 2012, INT J SYST EVOL MICR, V62, P2272, DOI 10.1099/ijs.0.037408-0; Sheu SY, 2013, INT J SYST EVOL MICR, V63, P435, DOI 10.1099/ijs.0.039859-0; Simon MF, 2011, AM J BOT, V98, P1201, DOI 10.3732/ajb.1000520; Sprent J. I., 2009, LEGUME MODULATION GL; Stepkowski T, 2005, APPL ENVIRON MICROB, V71, P7041, DOI 10.1128/AEM.71.11.7041-7052.2005; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taule C, 2012, APPL ENVIRON MICROB, V78, P1692, DOI 10.1128/AEM.06215-11; Vincent JM., 1970, MANUAL PRATICAL STUD; Wang ET, 1999, INT J SYST BACTERIOL, V49, P1479, DOI 10.1099/00207713-49-4-1479; Zurdo-Pineiro JL, 2004, SYST APPL MICROBIOL, V27, P469, DOI 10.1078/0723202041438437	63	68	69	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63478	10.1371/journal.pone.0063478	http://dx.doi.org/10.1371/journal.pone.0063478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691052	gold, Green Published			2022-12-25	WOS:000319052700038
J	Galvis, L; Dunlop, JWC; Duda, G; Fratzl, P; Masic, A				Galvis, Leonardo; Dunlop, John W. C.; Duda, Georg; Fratzl, Peter; Masic, Admir			Polarized Raman Anisotropic Response of Collagen in Tendon: Towards 3D Orientation Mapping of Collagen in Tissues	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CORTICAL BONE; PEPTIDE; SPECTROSCOPY; SCATTERING; FIBRILS; MICROSPECTROSCOPY; CARTILAGE; PACKING	In this study, polarized Raman spectroscopy (PRS) was used to characterize the anisotropic response of the amide I band of collagen as a basis for evaluating three-dimensional collagen fibril orientation in tissues. Firstly, the response was investigated theoretically by applying classical Raman theory to collagen-like peptide crystal structures. The theoretical methodology was then tested experimentally, by measuring amide I intensity anisotropy in rat tail as a function of the orientation of the incident laser polarization. For the theoretical study, several collagen-like triple-helical peptide crystal structures obtained from the Protein Data Bank were rotated "in plane'' and "out of plane'' to evaluate the role of molecular orientation on the intensity of the amide I band. Collagen-like peptides exhibit a sinusoidal anisotropic response when rotated "in plane'' with respect to the polarized incident laser. Maximal intensity was obtained when the polarization of the incident light is perpendicular to the molecule and minimal when parallel. In the case of "out of plane'' rotation of the molecular structure a decreased anisotropic response was observed, becoming completely isotropic when the structure was perpendicular to the plane of observation. The theoretical Raman response of collagen was compared to that of alpha helical protein fragments. In contrast to collagen, alpha helices have a maximal signal when incident light is parallel to the molecule and minimal when perpendicular. For out-of-plane molecular orientations alpha-helix structures display a decreased average intensity. Results obtained from experiments on rat tail tendon are in excellent agreement with the theoretical predictions, thus demonstrating the high potential of PRS for experimental evaluation of the three-dimensional orientation of collagen fibers in biological tissues.	[Galvis, Leonardo; Dunlop, John W. C.; Fratzl, Peter; Masic, Admir] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Galvis, Leonardo; Duda, Georg] Charite Campus Virchow Klinikum, Berlin Brandenburg Sch Regenerat Therapies BSRT, Berlin, Germany; [Duda, Georg] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Duda, Georg] Charite, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Masic, A (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany.	masic@mpikg.mpg.de	Duda, Georg N/H-2085-2016; Fratzl, Peter/H-9095-2012; Dunlop, John W C/A-1997-2012	Duda, Georg N/0000-0001-7605-3908; Fratzl, Peter/0000-0003-4437-7830; Dunlop, John W C/0000-0003-2741-6383; Masic, Admir/0000-0002-1207-4926	Berlin-Brandenburg School for Regenerative Therapies; DFG (Deutsche Forschungsgemeinshaft); Alexander von Humboldt Foundation; Federal Ministry of Education and Research; Max Planck Society in the framework of the Max Planck Research Award	Berlin-Brandenburg School for Regenerative Therapies; DFG (Deutsche Forschungsgemeinshaft)(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society in the framework of the Max Planck Research Award	Authors acknowledge the Berlin-Brandenburg School for Regenerative Therapies and the DFG (Deutsche Forschungsgemeinshaft) for the support of this research. A.M. and P.F. are grateful for support by the Alexander von Humboldt Foundation and the Max Planck Society in the framework of the Max Planck Research Award funded by the Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bonifacio A, 2010, VIB SPECTROSC, V53, P314, DOI 10.1016/j.vibspec.2010.04.004; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; Daxer A, 1997, INVEST OPHTH VIS SCI, V38, P121; de Visser SK, 2008, OSTEOARTHR CARTILAGE, V16, P689, DOI 10.1016/j.joca.2007.09.015; Enkhbayar P, 2008, COMPUT BIOL CHEM, V32, P307, DOI 10.1016/j.compbiolchem.2008.03.012; Everall N.J., 2007, VIBRATIONAL SPECTROS; Falgayrac G, 2010, APPL SPECTROSC, V64, P775, DOI 10.1366/000370210791666255; Fratzl P., 2008, P1, DOI 10.1007/978-0-387-73906-9_1; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Gamsjaeger S, 2010, BONE, V47, P392, DOI 10.1016/j.bone.2010.04.608; Gamsjager S, 2009, VIBRATIONAL SPECTROS; Gamsjager S, 2009, PROC SPIE, V7166, DOI 10.1117/12.807914; Gierlinger N, 2010, J EXP BOT, V61, P587, DOI 10.1093/jxb/erp325; HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7; Janko M, 2010, OPT LETT, V35, P2765, DOI 10.1364/OL.35.002765; Kaab MJ, 2000, CELLS TISSUES ORGANS, V167, P106, DOI 10.1159/000016774; Kazanci M, 2007, BONE, V41, P456, DOI 10.1016/j.bone.2007.04.200; Kazanci M, 2006, J STRUCT BIOL, V156, P489, DOI 10.1016/j.jsb.2006.06.011; Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Launey ME, 2010, ANNU REV MATER RES, V40, P25, DOI [10.1146/annurev-matsci-070909-104427, 10.1146/annurev-matsci-070909-10442]; Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339; Lefevre T, 2009, VIB SPECTROSC, V51, P136, DOI 10.1016/j.vibspec.2008.11.012; Masic A, 2011, BIOMACROMOLECULES, V12, P3989, DOI 10.1021/bm201008b; Raghavan M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3426310; Rousseau ME, 2006, BIOMACROMOLECULES, V7, P2512, DOI 10.1021/bm060280w; Seto J, 2008, ADV FUNCT MATER, V18, P1905, DOI 10.1002/adfm.200800214; Tanaka M, 2006, J MATER SCI, V41, P963, DOI 10.1007/s10853-006-6595-7; Timlin JA, 1999, APPL SPECTROSC, V53, P1429, DOI 10.1366/0003702991945786; Tsuboi M, 1997, APPL SPECTROSC REV, V32, P263, DOI 10.1080/05704929708003316; Tsuboi M, 1996, BIOCHEMISTRY-US, V35, P10403, DOI 10.1021/bi9527707; TSUDA H, 1994, J DENT RES, V73, P1703, DOI 10.1177/00220345940730110501; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; WILSER WT, 1975, J CHEM PHYS, V62, P720, DOI 10.1063/1.430476	37	54	54	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63518	10.1371/journal.pone.0063518	http://dx.doi.org/10.1371/journal.pone.0063518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691057	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700041
J	Sugi, H; Abe, T; Kobayashi, T; Chaen, S; Ohnuki, Y; Saeki, Y; Sugiura, S				Sugi, Haruo; Abe, Takahiro; Kobayashi, Takakazu; Chaen, Shigeru; Ohnuki, Yoshiki; Saeki, Yasutake; Sugiura, Seiryo			Enhancement of Force Generated by Individual Myosin Heads in Skinned Rabbit Psoas Muscle Fibers at Low Ionic Strength	PLOS ONE			English	Article							X-RAY-DIFFRACTION; ACTOMYOSIN ATPASE ACTIVITY; SKELETAL-MUSCLE; CROSS-BRIDGE; TROPONIN-TROPOMYOSIN; VELOCITY RELATION; THICK FILAMENTS; RELAXED MUSCLE; CONTRACTION; ACTIN	Although evidence has been presented that, at low ionic strength, myosin heads in relaxed skeletal muscle fibers form linkages with actin filaments, the effect of low ionic strength on contraction characteristics of Ca2+-activated muscle fibers has not yet been studied in detail. To give information about the mechanism of muscle contraction, we have examined the effect of low ionic strength on the mechanical properties and the contraction characteristics of skinned rabbit psoas muscle fibers in both relaxed and maximally Ca2+-activated states. By progressively decreasing KCl concentration from 125 mM to 0 mM (corresponding to a decrease in ionic strength m from 170 mM to 50 mM), relaxed fibers showed changes in mechanical response to sinusoidal length changes and ramp stretches, which are consistent with the idea of actin-myosin linkage formation at low ionic strength. In maximally Ca2+-activated fibers, on the other hand, the maximum isometric force increased about twofold by reducing KCl concentration from 125 to 0 mM. Unexpectedly, determination of the force-velocity curves indicated that, the maximum unloaded shortening velocity V-max, remained unchanged at low ionic strength. This finding indicates that the actin-myosin linkages, which has been detected in relaxed fibers at low ionic strength, are broken quickly on Ca2+ activation, so that the linkages in relaxed fibers no longer provide any internal resistance against fiber shortening. The force-velocity curves, obtained at various levels of steady Ca2+-activated isometric force, were found to be identical if they are normalized with respect to the maximum isometric force. The MgATPase activity of muscle fibers during isometric force generation was found not to change appreciably at low ionic strength despite the two-fold increase in Ca2+-activated isometric force. These results can be explained in terms of enhancement of force generated by individual myosin heads, but not by any changes in kinetic properties of cyclic actin-myosin interaction.	[Sugi, Haruo] Teikyo Univ, Sch Med, Dept Physiol, Tokyo 173, Japan; [Abe, Takahiro; Kobayashi, Takakazu] Shibaura Inst Technol, Dept Elect Engn, Tokyo 108, Japan; [Chaen, Shigeru] Nihon Univ, Coll Humanities & Sci, Dept Integrated Sci Phys & Biol, Tokyo, Japan; [Ohnuki, Yoshiki; Saeki, Yasutake] Tsurumi Univ, Sch Dent, Dept Physiol, Yokohama, Kanagawa, Japan; [Sugiura, Seiryo] Univ Tokyo, Grad Sch Frontier Sci, Tokyo, Japan	Teikyo University; Shibaura Institute of Technology; Nihon University; Tsurumi University; University of Tokyo	Sugi, H (corresponding author), Teikyo Univ, Sch Med, Dept Physiol, Tokyo 173, Japan.	sugi@kyf.biglobe.ne.jp						Bagshaw CR., 1993, MUSCLE CONTRACTION, DOI 10.1007/978-94-015-6839-5; BRENNER B, 1984, BIOPHYS J, V46, P299, DOI 10.1016/S0006-3495(84)84026-6; BRENNER B, 1982, P NATL ACAD SCI-BIOL, V79, P7288, DOI 10.1073/pnas.79.23.7288; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; CHALOVICH JM, 1981, J BIOL CHEM, V256, P575; EDMAN KAP, 1988, J PHYSIOL-LONDON, V404, P301, DOI 10.1113/jphysiol.1988.sp017291; GLYN H, 1985, J PHYSIOL-LONDON, V365, P259, DOI 10.1113/jphysiol.1985.sp015770; GORDON AM, 1973, J GEN PHYSIOL, V62, P550, DOI 10.1085/jgp.62.5.550; GULATI J, 1981, J GEN PHYSIOL, V78, P233, DOI 10.1085/jgp.78.3.233; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; IWAMOTO H, 1990, J PHYSIOL-LONDON, V422, P185, DOI 10.1113/jphysiol.1990.sp017979; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MATSUDA T, 1984, P NATL ACAD SCI-BIOL, V81, P2364, DOI 10.1073/pnas.81.8.2364; Minoda H, 2011, BIOCHEM BIOPH RES CO, V405, P651, DOI 10.1016/j.bbrc.2011.01.087; Potma EJ, 1996, J PHYSIOL-LONDON, V496, P1; SUGI H, 1992, P NATL ACAD SCI USA, V89, P6134, DOI 10.1073/pnas.89.13.6134; Sugi H, 1997, P NATL ACAD SCI USA, V94, P4378, DOI 10.1073/pnas.94.9.4378; SUGI H, 1988, J PHYSIOL-LONDON, V407, P215, DOI 10.1113/jphysiol.1988.sp017411; Sugi H, 2011, J MUSCLE RES CELL M, V32, P343; Sugi H, 2013, J PHYSL SCI S, V103, pS35; Sugi H, 2008, P NATL ACAD SCI USA, V105, P17396, DOI 10.1073/pnas.0809581105; Sugi H, 2013, BIOPHYS J, V104, p305A, DOI 10.1016/j.bpj.2012.11.1700; SUTOH K, 1989, J MOL BIOL, V206, P357, DOI 10.1016/0022-2836(89)90485-3; SUZUKI S, 1983, J GEN PHYSIOL, V81, P531, DOI 10.1085/jgp.81.4.531; THAMES MD, 1974, J GEN PHYSIOL, V63, P509, DOI 10.1085/jgp.63.4.509; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; XU SG, 1987, J MUSCLE RES CELL M, V8, P39, DOI 10.1007/BF01767263	28	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63658	10.1371/journal.pone.0063658	http://dx.doi.org/10.1371/journal.pone.0063658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691080	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700056
J	Yildiz, G; Arslan-Ergul, A; Bagislar, S; Konu, O; Yuzugullu, H; Gursoy-Yuzugullu, O; Ozturk, N; Ozen, C; Ozdag, H; Erdal, E; Karademir, S; Sagol, O; Mizrak, D; Bozkaya, H; Ilk, HG; Ilk, O; Bilen, B; Cetin-Atalay, R; Akar, N; Ozturk, M				Yildiz, Gokhan; Arslan-Ergul, Ayca; Bagislar, Sevgi; Konu, Ozlen; Yuzugullu, Haluk; Gursoy-Yuzugullu, Ozge; Ozturk, Nuri; Ozen, Cigdem; Ozdag, Hilal; Erdal, Esra; Karademir, Sedat; Sagol, Ozgul; Mizrak, Dilsa; Bozkaya, Hakan; Ilk, Hakki Gokhan; Ilk, Ozlem; Bilen, Biter; Cetin-Atalay, Rengul; Akar, Nejat; Ozturk, Mehmet			Genome-Wide Transcriptional Reorganization Associated with Senescence-to-Immortality Switch during Human Hepatocellular Carcinogenesis	PLOS ONE			English	Article							CELLULAR SENESCENCE; REPLICATIVE SENESCENCE; MOLECULAR SIGNATURE; MICROARRAY ANALYSIS; TELOMERE LENGTH; HEPATITIS-C; CARCINOMA; LIVER; GENE; EXPRESSION	Senescence is a permanent proliferation arrest in response to cell stress such as DNA damage. It contributes strongly to tissue aging and serves as a major barrier against tumor development. Most tumor cells are believed to bypass the senescence barrier (become "immortal") by inactivating growth control genes such as TP53 and CDKN2A. They also reactivate telomerase reverse transcriptase. Senescence-to-immortality transition is accompanied by major phenotypic and biochemical changes mediated by genome-wide transcriptional modifications. This appears to happen during hepatocellular carcinoma (HCC) development in patients with liver cirrhosis, however, the accompanying transcriptional changes are virtually unknown. We investigated genome-wide transcriptional changes related to the senescence-to-immortality switch during hepatocellular carcinogenesis. Initially, we performed transcriptome analysis of senescent and immortal clones of Huh7 HCC cell line, and identified genes with significant differential expression to establish a senescence-related gene list. Through the analysis of senescence-related gene expression in different liver tissues we showed that cirrhosis and HCC display expression patterns compatible with senescent and immortal phenotypes, respectively; dysplasia being a transitional state. Gene set enrichment analysis revealed that cirrhosis/senescence-associated genes were preferentially expressed in non-tumor tissues, less malignant tumors, and differentiated or senescent cells. In contrast, HCC/immortality genes were up-regulated in tumor tissues, or more malignant tumors and progenitor cells. In HCC tumors and immortal cells genes involved in DNA repair, cell cycle, telomere extension and branched chain amino acid metabolism were up-regulated, whereas genes involved in cell signaling, as well as in drug, lipid, retinoid and glycolytic metabolism were down-regulated. Based on these distinctive gene expression features we developed a 15-gene hepatocellular immortality signature test that discriminated HCC from cirrhosis with high accuracy. Our findings demonstrate that senescence bypass plays a central role in hepatocellular carcinogenesis engendering systematic changes in the transcription of genes regulating DNA repair, proliferation, differentiation and metabolism.	[Yildiz, Gokhan; Arslan-Ergul, Ayca; Bagislar, Sevgi; Konu, Ozlen; Yuzugullu, Haluk; Gursoy-Yuzugullu, Ozge; Ozturk, Nuri; Ozen, Cigdem; Bilen, Biter; Cetin-Atalay, Rengul; Ozturk, Mehmet] Bilkent Univ, Dept Mol Biol & Genet, BilGen Genet & Biotechnol Ctr, Ankara, Turkey; [Yildiz, Gokhan; Bagislar, Sevgi; Yuzugullu, Haluk; Gursoy-Yuzugullu, Ozge; Ozturk, Mehmet] Univ Grenoble 1, INSERM, CRI U823, Grenoble, France; [Ozdag, Hilal; Akar, Nejat] Ankara Univ, Inst Biotechnol, TR-06100 Ankara, Turkey; [Erdal, Esra] Dokuz Eylul Univ, Sch Med, Dept Med Biol, Izmir, Turkey; [Karademir, Sedat] Dokuz Eylul Univ, Sch Med, Dept Surg, Izmir, Turkey; [Sagol, Ozgul] Dokuz Eylul Univ, Sch Med, Dept Pathol, Izmir, Turkey; [Mizrak, Dilsa; Bozkaya, Hakan] Ankara Univ, Dept Gastroenterol, TR-06100 Ankara, Turkey; [Ilk, Hakki Gokhan] Ankara Univ, Dept Elect Engn, TR-06100 Ankara, Turkey; [Ilk, Ozlem] Middle E Tech Univ, Dept Stat, TR-06531 Ankara, Turkey	Ihsan Dogramaci Bilkent University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Ankara University; Dokuz Eylul University; Dokuz Eylul University; Dokuz Eylul University; Ankara University; Ankara University; Middle East Technical University	Ozturk, M (corresponding author), Bilkent Univ, Dept Mol Biol & Genet, BilGen Genet & Biotechnol Ctr, Ankara, Turkey.	ozturk@fen.bilkent.edu.tr	Cetin-Atalay, Rengul/F-5780-2013; Özdag, Hilal/C-9929-2009; Ozturk, Nuri/F-4140-2011; ERGUL, AYCA ARSLAN/AAH-1655-2020; YILDIZ, Gokhan/AAE-7001-2019; Akar, Nejat/H-2949-2019; Ilk, Ozlem/L-9093-2013; Erdal, Esra/AAE-1339-2019; Cetin-Atalay, Rengul/O-9826-2014; ILK, HAKKI GOKHAN/AAA-1055-2021; ozturk, mehmet/G-3330-2014; ERGUL, AYCA ARSLAN/F-6655-2012; OZTURK, MEHMET/AAS-7241-2021; Erdal, Esra/T-9057-2018	Cetin-Atalay, Rengul/0000-0003-2408-6606; Özdag, Hilal/0000-0001-7940-2499; Ozturk, Nuri/0000-0001-5206-4127; ERGUL, AYCA ARSLAN/0000-0001-7024-907X; YILDIZ, Gokhan/0000-0002-6714-3343; Ilk, Ozlem/0000-0002-4179-0534; Erdal, Esra/0000-0001-7264-0574; Cetin-Atalay, Rengul/0000-0003-2408-6606; ILK, HAKKI GOKHAN/0000-0003-4365-8286; ERGUL, AYCA ARSLAN/0000-0001-7024-907X; OZTURK, MEHMET/0000-0002-6092-9706; Erdal, Esra/0000-0001-7264-0574; Ozen, Cigdem/0000-0001-8098-3454; Bilen, Biter/0000-0001-9452-3512; Bagislar Bremang, Sevgi/0000-0003-3203-9607; Yuzugullu, Haluk/0000-0002-1039-2998	TUBITAK [104S045, 106S151, 109S191, 111T558, BIDEB-2211, BIDEB-2214]; State Planning Office (DPT-Kaniltek Project); EMBO fellowships; Turkish Academy of Sciences; Institut National de Cancer; La Ligue Nationale Contre le Cancer in France (Equipe labelisee)	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); State Planning Office (DPT-Kaniltek Project)(Turkiye Cumhuriyeti Kalkinma Bakanligi); EMBO fellowships; Turkish Academy of Sciences(Turkish Academy of Sciences); Institut National de Cancer; La Ligue Nationale Contre le Cancer in France (Equipe labelisee)	This study was supported by grants from TUBITAK (104S045, 106S151, 109S191, 111T558) with additional support from State Planning Office (DPT-Kaniltek Project), Turkish Academy of Sciences, Institut National de Cancer and La Ligue Nationale Contre le Cancer in France (Equipe labelisee). G.Y. was supported by TUBITAK (BIDEB-2211 and BIDEB-2214) and EMBO fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI S, 1991, HEPATOLOGY, V14, P776, DOI 10.1002/hep.1840140506; Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Brunt EM, 2007, LIVER INT, V27, P662, DOI 10.1111/j.1478-3231.2007.01470.x; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173; Caron C, 2010, ONCOGENE, V29, P5171, DOI 10.1038/onc.2010.259; Chang YJE, 2000, J VIROL, V74, P4174, DOI 10.1128/JVI.74.9.4174-4182.2000; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Clemente C, 2002, CANCER LETT, V178, P123, DOI 10.1016/S0304-3835(01)00843-6; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Deng YB, 2010, CANCER SCI, V101, P1501, DOI 10.1111/j.1349-7006.2010.01549.x; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; FUJIWARA Y, 1993, CANCER RES, V53, P857; Grimes A, 2009, CANCER RES TREAT, V41, P187, DOI 10.4143/crt.2009.41.4.187; Gursoy-Yuzugullu O, 2011, LIVER INT, V31, P561, DOI 10.1111/j.1478-3231.2011.02474.x; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Kang SK, 2004, STEM CELLS, V22, P1356, DOI 10.1634/stemcells.2004-0023; Kim JW, 2004, HEPATOLOGY, V39, P518, DOI 10.1002/hep.20053; KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774; Kojima H, 1997, GASTROENTEROLOGY, V112, P493, DOI 10.1053/gast.1997.v112.pm9024303; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; Muto Y, 1999, NEW ENGL J MED, V340, P1046, DOI 10.1056/NEJM199904013401315; Nam SW, 2005, HEPATOLOGY, V42, P809, DOI 10.1002/hep.20878; Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048; Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103; Paradis V, 2003, AM J PATHOL, V163, P733, DOI 10.1016/S0002-9440(10)63700-5; Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747; Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271; Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552; Rudolph KL, 2009, GASTROENTEROLOGY, V137, P754, DOI 10.1053/j.gastro.2009.07.037; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Shirakami Y, 2012, BBA-MOL CELL BIOL L, V1821, P124, DOI 10.1016/j.bbalip.2011.06.023; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang X, 2007, ONCOGENE, V26, P7302, DOI 10.1038/sj.onc.1210542; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Urabe Y, 1996, LIVER, V16, P293; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xu XR, 2001, P NATL ACAD SCI USA, V98, P15089, DOI 10.1073/pnas.241522398; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100; Zou JX, 2007, P NATL ACAD SCI USA, V104, P18067, DOI 10.1073/pnas.0705814104	68	45	47	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64016	10.1371/journal.pone.0064016	http://dx.doi.org/10.1371/journal.pone.0064016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691139	Green Submitted, gold, Green Published			2022-12-25	WOS:000319052700071
J	Gonzalez, CA; Valencia, JA; Mora, A; Gonzalez, F; Velasco, B; Porras, MA; Salgado, J; Polo, SM; Hevia-Montiel, N; Cordero, S; Rubinsky, B				Gonzalez, Cesar A.; Valencia, Jose A.; Mora, Alfredo; Gonzalez, Fernando; Velasco, Beatriz; Porras, Martin A.; Salgado, Javier; Polo, Salvador M.; Hevia-Montiel, Nidiyare; Cordero, Sergio; Rubinsky, Boris			Volumetric Electromagnetic Phase-Shift Spectroscopy of Brain Edema and Hematoma	PLOS ONE			English	Article							MAGNETIC INDUCTION TOMOGRAPHY; ELECTRICAL-IMPEDANCE TOMOGRAPHY; DIELECTRIC-PROPERTIES; BIOLOGICAL TISSUES; INTRACEREBRAL HEMORRHAGE; WATER-CONTENT; RECONSTRUCTION; BIOIMPEDANCE; FEASIBILITY; SENSITIVITY	Motivated by the need of poor and rural Mexico, where the population has limited access to advanced medical technology and services, we have developed a new paradigm for medical diagnostic based on the technology of "Volumetric Electromagnetic Phase Shift Spectroscopy'' (VEPS), as an inexpensive partial substitute to medical imaging. VEPS, can detect changes in tissue properties inside the body through non-contact, multi-frequency electromagnetic measurements from the exterior of the body, and thereby provide rapid and inexpensive diagnostics in a way that is amenable for use in economically disadvantaged parts of the world. We describe the technology and report results from a limited pilot study with 46 healthy volunteers and eight patients with CT radiology confirmed brain edema and brain hematoma. Data analysis with a non-parametric statistical Mann-Whitney U test, shows that in the frequency range of from 26 MHz to 39 MHz, VEPS can distinguish non-invasively and without contact, with a statistical significance of p < 0.05, between healthy subjects and those with a medical conditions in the brain. In the frequency range of between 153 MHz to 166 MHz it can distinguish with a statistical significance of p < 0.05 between subjects with brain edema and those with a hematoma in the brain. A classifier build from measurements in these two frequency ranges can provide instantaneous diagnostic of the medical condition of the brain of a patient, from a single set of measurements. While this is a small-scale pilot study, it illustrates the potential of VEPS to change the paradigm of medical diagnostic of brain injury through a VEPS classifier-based technology. Obviously substantially larger-scale studies are needed to verify and expand on the findings in this small pilot study.	[Gonzalez, Cesar A.; Cordero, Sergio] Inst Politecn Nacl, Escuela Super Med, Mexico City 07738, DF, Mexico; [Gonzalez, Cesar A.; Mora, Alfredo; Gonzalez, Fernando; Velasco, Beatriz; Polo, Salvador M.] Univ Ejercito, EMGS EMM FAM, Mexico City, DF, Mexico; [Valencia, Jose A.; Porras, Martin A.; Salgado, Javier; Cordero, Sergio] Cent Mil Hosp, Secc Imagen Secc Unidad Cuidados Intens, Mexico City, DF, Mexico; [Hevia-Montiel, Nidiyare] Univ Nacl Autonoma Mexico, Dept Ciencias Computac IIMAS, Mexico City 04510, DF, Mexico; [Cordero, Sergio] Hosp Gen Balbuena, Mexico City, DF, Mexico; [Rubinsky, Boris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; University of California System; University of California Berkeley	Gonzalez, CA (corresponding author), Inst Politecn Nacl, Escuela Super Med, Mexico City 07738, DF, Mexico.	cgonzalezd@ipn.mx	; Hevia-Montiel, Nidiyare/R-6626-2016	gonzalez, cesar/0000-0003-0882-1439; Hevia-Montiel, Nidiyare/0000-0003-4238-7496				Adeoye O, 2010, NAT REV NEUROL, V6, P593, DOI 10.1038/nrneurol.2010.146; ALZEIBAK S, 1993, PHYS MED BIOL, V38, P151, DOI 10.1088/0031-9155/38/1/011; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Blumrosen G, 2009, SIXTH INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P120, DOI [10.1109/BSN.2009.15, 10.1109/P3644.14]; Duck F.A., 1990, MED PHYS, V18; Flores O, 2008, IEEE ENG MED BIO, P678, DOI 10.1109/IEMBS.2008.4649243; Gabriel C, 2005, BIOELECTROMAGNETICS, pS12, DOI 10.1002/bem.20147; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; GEDDES LA, 1967, MED BIOL ENG, V5, P271, DOI 10.1007/BF02474537; Gonzalez CA, 2009, PHYSIOL MEAS, V30, P809, DOI 10.1088/0967-3334/30/8/006; GONZALEZ CA, 2008, 9 S MEX CIR AS COMP, V4, P29; GONZALEZ CA, INT C ELECT BIOIMPED, DOI DOI 10.1088/1742-6596/224/1/012123; GONZALEZ CA, 2007, IEEE T BIOMEDICAL EN, V54; Gonzales CA, 2005, P ANN INT IEEE EMBS, P3518, DOI 10.1109/IEMBS.2005.1617238; Gonzalez CA, 2006, PHYSIOL MEAS, V27, P829, DOI 10.1088/0967-3334/27/9/006; Gonzalez CA, 2006, PHYSIOL MEAS, V27, P539, DOI 10.1088/0967-3334/27/6/007; Gonzalez CA, 2010, COMPUT SIST, V14, P187; Grasso G, 2002, NEUROSURGERY, V50, P1064, DOI 10.1097/00006123-200205000-00023; Griffiths H, 2001, MEAS SCI TECHNOL, V12, P1126, DOI 10.1088/0957-0233/12/8/319; Griffiths H, 1999, ANN NY ACAD SCI, V873, P335, DOI 10.1111/j.1749-6632.1999.tb09481.x; Grimnes S., 2000, BIOIMPEDANCE BIOELEC, pxi; HART LW, 1988, IEEE T BIO-MED ENG, V35, P1011, DOI 10.1109/10.8686; HENDERSON RP, 1978, IEEE T BIO-MED ENG, V25, P250, DOI 10.1109/TBME.1978.326329; HOLDER DS, 2005, ELECT IMPEDANCE TOMO, P456; Kao HP, 1999, IEEE T BIO-MED ENG, V46, P1121, DOI 10.1109/10.784144; Kawooya MG, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.97747; Korjenevsky AV, 1999, ANN NY ACAD SCI, V873, P346, DOI 10.1111/j.1749-6632.1999.tb09482.x; Laufer S, 2009, IEEE T BIO-MED ENG, V56, P525, DOI 10.1109/TBME.2008.2003105; Laufer S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005178; Lionheart WRB, 2004, PHYSIOL MEAS, V25, P125, DOI 10.1088/0967-3334/25/1/021; Merwa R, 2004, PHYSIOL MEAS, V25, P347, DOI 10.1088/0967-3334/25/1/038; Metherall P, 1996, NATURE, V380, P509, DOI 10.1038/380509a0; Mori K, 2002, J NEUROTRAUM, V19, P1261, DOI 10.1089/08977150260338047; Morucci JP, 1996, CRIT REV BIOMED ENG, V24, P655, DOI 10.1615/CritRevBiomedEng.v24.i4-6.60; NETZ J, 1993, PHYSIOL MEAS, V14, P463, DOI 10.1088/0967-3334/14/4/007; Newell JC, 1996, IEEE T BIO-MED ENG, V43, P133, DOI 10.1109/10.481982; Nierman DM, 1996, J SURG RES, V65, P101, DOI 10.1006/jsre.1996.0350; Otten DM, 2000, IEEE T BIO-MED ENG, V47, P1376, DOI 10.1109/10.871411; Peyman A, 2001, PHYS MED BIOL, V46, P1617, DOI 10.1088/0031-9155/46/6/303; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Rojas R, 2008, PHYSIOL MEAS, V29, pS255, DOI 10.1088/0967-3334/29/6/S22; RUBINSKY B, 2012, Patent No. 8101421; RUBINSKY B, 2011, Patent No. 07910374; RUBINSKY B, 2009, Patent No. 7638341; Scharfetter H, 2003, IEEE T BIO-MED ENG, V50, P870, DOI 10.1109/TBME.2003.813533; Scharfetter H, 2001, PHYSIOL MEAS, V22, P131, DOI 10.1088/0967-3334/22/1/317; Schmid G, 2005, PHYS MED BIOL, V50, P4711, DOI 10.1088/0031-9155/50/19/019; SCHURER L, 1998, ACTA NEUROCHIR, V94, P150; SCHWAN H P, 1957, Adv Biol Med Phys, V5, P147; Soleimani M, 2006, IEEE T MED IMAGING, V25, P1521, DOI 10.1109/TMI.2006.884196; STOY RD, 1982, PHYS MED BIOL, V27, P501, DOI 10.1088/0031-9155/27/4/002; Tang T, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/7/S06; TARJAN PP, 1968, IEEE T BIO-MED ENG, VBM15, P266, DOI 10.1109/TBME.1968.4502577; THOMASSET M A, 1962, Lyon Med, V94, P107; Webster J. G., 1990, ELECT IMPEDANCE TOMO; *WORLD HLTH ORG, WHO REP	56	22	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63223	10.1371/journal.pone.0063223	http://dx.doi.org/10.1371/journal.pone.0063223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691001	Green Published, gold			2022-12-25	WOS:000319107400036
J	Gut, IM; Beske, PH; Hubbard, KS; Lyman, ME; Hamilton, TA; McNutt, PM				Gut, Ian M.; Beske, Phillip H.; Hubbard, Kyle S.; Lyman, Megan E.; Hamilton, Tracey A.; McNutt, Patrick M.			Novel Application of Stem Cell-Derived Neurons to Evaluate the Time- and Dose-Dependent Progression of Excitotoxic Injury	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; IN-VITRO; MONOSODIUM GLUTAMATE; MOLECULAR-MECHANISMS; BRAIN LESIONS; DEATH; APOPTOSIS; NECROSIS; CULTURES; DEPOLARIZATION	Glutamate receptor (GluR)-mediated neurotoxicity is implicated in a variety of disorders ranging from ischemia to neural degeneration. Under conditions of elevated glutamate, the excessive activation of GluRs causes internalization of pathologic levels of Ca2+, culminating in bioenergetic failure, organelle degradation, and cell death. Efforts to characterize cellular and molecular aspects of excitotoxicity and conduct therapeutic screening for pharmacologic inhibitors of excitogenic progression have been hindered by limitations associated with primary neuron culture. To address this, we evaluated glutamate-induced neurotoxicity in highly enriched glutamatergic neurons (ESNs) derived from murine embryonic stem cells. As of 18 days in vitro (DIV 18), ESNs were synaptically coupled, exhibited spontaneous network activity with neurotypic mEPSCs and expressed NMDARs and AMPARs with physiological current: voltage behaviors. Addition of 0.78-200 mu M glutamate evoked reproducible time-and dose-dependent metabolic failure in 6 h, with a calculated EC50 value of 0.44 mu M at 24 h. Using a combination of cell viability assays and electrophysiology, we determined that glutamate-induced toxicity was specifically mediated by NMDARs and could be inhibited by addition of NMDAR antagonists, increased extracellular Mg2+ or substitution of Ba2+ for Ca2+. Glutamate treatment evoked neurite fragmentation and focal swelling by both immunocytochemistry and scanning electron microscopy. Presentation of morphological markers of cell death was dose-dependent, with 0.78-200 mu M glutamate resulting in apoptosis and 3000 mu M glutamate generating a mixture of necrosis and apoptosis. Addition of neuroprotective small molecules reduced glutamate-induced neurotoxicity in a dose-dependent fashion. These data indicate that ESNs replicate many of the excitogenic mechanisms observed in primary neuron culture, offering a moderate-throughput model of excitotoxicity that combines the verisimilitude of primary neurons with the flexibility and scalability of cultured cells. ESNs therefore offer a physiologically relevant platform that exhibits characteristic NMDAR responses, and appears suitable to evaluate molecular mechanisms of glutamate-induced excitotoxicity and screen for candidate therapeutics.	[Gut, Ian M.; Beske, Phillip H.; Hubbard, Kyle S.; Lyman, Megan E.; Hamilton, Tracey A.; McNutt, Patrick M.] USA, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA	Research Institute of Chemical Defense - China	McNutt, PM (corresponding author), USA, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA.	patrick.mcnutt@us.army.mil	McNutt, Patrick/AAS-8535-2020	McNutt, Patrick/0000-0002-5703-4565	National Institutes of Health National Institute of Allergy and Infectious Diseases [AOD12058-0001-0000]; Defense Threat Reduction Agency - Joint Science and Technology Office, Medical ST Division [CBM.THRTOX.01.10.RC.021]	National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Defense Threat Reduction Agency - Joint Science and Technology Office, Medical ST Division(United States Department of DefenseDefense Threat Reduction Agency)	This work was funded by the National Institutes of Health National Institute of Allergy and Infectious Diseases (IAA number AOD12058-0001-0000) and the Defense Threat Reduction Agency - Joint Science and Technology Office, Medical S&T Division (grant number CBM.THRTOX.01.10.RC.021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MM, 2004, CURR MOL MED, V4, P137, DOI 10.2174/1566524043479202; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Cheung NS, 1998, NEUROPHARMACOLOGY, V37, P1419, DOI 10.1016/S0028-3908(98)00123-3; Deshpande LS, 2007, J PHARMACOL EXP THER, V322, P443, DOI 10.1124/jpet.107.123182; Di X, 2010, NEUROSCIENCE, V168, P778, DOI 10.1016/j.neuroscience.2010.04.019; Didier M, 1996, J NEUROSCI, V16, P2238; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; Fatokun AA, 2008, EXP BRAIN RES, V186, P151, DOI 10.1007/s00221-007-1218-3; Hilton GD, 2006, EUR J NEUROSCI, V24, P3008, DOI 10.1111/j.1460-9568.2006.05189.x; Hubbard KS, 2012, BMC NEUROSC IN PRESS; Hubbard KS, 2013, F1000 RES, P2; Hubbard Kyle S, 2012, BMC Res Notes, V5, P437, DOI 10.1186/1756-0500-5-437; Itazawa SI, 1997, J NEUROPHYSIOL, V78, P2592, DOI 10.1152/jn.1997.78.5.2592; Koike T, 2008, NEUROCHEM INT, V52, P751, DOI 10.1016/j.neuint.2007.09.007; Koutsilleri E, 2007, PARKINSONISM RELAT D, V13, pS329, DOI 10.1016/S1353-8020(08)70025-7; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kume T, 2000, BRAIN RES, V852, P279, DOI 10.1016/S0006-8993(99)02226-X; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Levchenko-Lambert Y, 2011, J NEUROSCI, V31, P9359, DOI 10.1523/JNEUROSCI.6761-10.2011; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Ma SW, 2012, NEUROTOXICOLOGY, V33, P59, DOI 10.1016/j.neuro.2011.11.003; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; McDonough JH, 1997, NEUROSCI BIOBEHAV R, V21, P559, DOI 10.1016/S0149-7634(96)00050-4; McNutt P, 2011, BIOCHEM BIOPH RES CO, V405, P85, DOI 10.1016/j.bbrc.2010.12.132; Mesngon M, 2011, TOXINS, V3, P489, DOI 10.3390/toxins3050489; Muller GJ, 2004, BRAIN PATHOL, V14, P415; Munir M, 1995, J NEUROSCI, V15, P7847; Nicotera P, 1999, J CEREBR BLOOD F MET, V19, P583, DOI 10.1097/00004647-199906000-00001; OGURA A, 1988, EXP BRAIN RES, V73, P447, DOI 10.1007/BF00406601; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; SOMBATI S, 1991, BRAIN RES, V566, P316, DOI 10.1016/0006-8993(91)91716-E; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Sun DA, 2001, STROKE, V32, P2344, DOI 10.1161/hs1001.097242; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085	42	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64423	10.1371/journal.pone.0064423	http://dx.doi.org/10.1371/journal.pone.0064423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691214	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400125
J	Henden, JA; Yoccoz, NG; Ims, RA; Langeland, K				Henden, John-Andre; Yoccoz, Nigel G.; Ims, Rolf A.; Langeland, Knut			How Spatial Variation in Areal Extent and Configuration of Labile Vegetation States Affect the Riparian Bird Community in Arctic Tundra	PLOS ONE			English	Article							HABITAT FRAGMENTATION; SPECIES RICHNESS; RELATIVE IMPORTANCE; SHRUB EXPANSION; NEST PREDATORS; REINDEER; WILLOW; OCCUPANCY; IMPACTS; RESPONSES	The Arctic tundra is currently experiencing an unprecedented combination of climate change, change in grazing pressure by large herbivores and growing human activity. Thickets of tall shrubs represent a conspicuous vegetation state in northern and temperate ecosystems, where it serves important ecological functions, including habitat for wildlife. Thickets are however labile, as tall shrubs respond rapidly to both abiotic and biotic environmental drivers. Our aim was to assess how large-scale spatial variation in willow thicket areal extent, configuration and habitat structure affected bird abundance, occupancy rates and species richness so as to provide an empirical basis for predicting the outcome of environmental change for riparian tundra bird communities. Based on a 4-year count data series, obtained through a large-scale study design in low arctic tundra in northern Norway, statistical hierarchical community models were deployed to assess relations between habitat configuration and bird species occupancy and community richness. We found that species abundance, occupancy and richness were greatly affected by willow areal extent and configuration, habitat features likely to be affected by intense ungulate browsing as well as climate warming. In sum, total species richness was maximized in large and tall willow patches of small to intermediate degree of fragmentation. These community effects were mainly driven by responses in the occupancy rates of species depending on tall willows for foraging and breeding, while species favouring other vegetation states were not affected. In light of the predicted climate driven willow shrub encroachment in riparian tundra habitats, our study predicts that many bird species would increase in abundance, and that the bird community as a whole could become enriched. Conversely, in tundra regions where overabundance of large herbivores leads to decreased areal extent, reduced height and increased fragmentation of willow thickets, bird community richness and species-specific abundance are likely to be significantly reduced.	[Henden, John-Andre; Yoccoz, Nigel G.; Ims, Rolf A.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Yoccoz, Nigel G.; Ims, Rolf A.; Langeland, Knut] Norwegian Inst Nat Res, FRAM Ctr, Dept Arctic Ecol, Tromso, Norway	UiT The Arctic University of Tromso; Norwegian Institute Nature Research	Henden, JA (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway.	john-andre.henden@uit.no	Yoccoz, Nigel/C-8561-2014	Yoccoz, Nigel/0000-0003-2192-1039; Henden, John-Andre/0000-0002-8825-1167	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study, which is a contribution from the "EcoFinn'' project, was financed by the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Baril LM, 2011, ECOL APPL, V21, P2283, DOI 10.1890/10-0169.1; Berger J, 2001, ECOL APPL, V11, P947, DOI 10.2307/3061004; Beschta RL, 2007, WEST N AM NATURALIST, V67, P613, DOI 10.3398/1527-0904(2007)67[613:IWHANY]2.0.CO;2; Bliss L, 1997, ECOSYSTEMS WORLD 3 P, P211; Bliss L.C., 1973, Annual Res Ecol Syst, V4, P359, DOI 10.1146/annurev.es.04.110173.002043; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Brookshire ENJ, 2002, OECOLOGIA, V132, P559, DOI 10.1007/s00442-002-1007-4; Chalfoun AD, 2002, ECOL APPL, V12, P858, DOI 10.1890/1051-0761(2002)012[0858:SNPIFP]2.0.CO;2; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Den Herder M, 2004, J APPL ECOL, V41, P870, DOI 10.1111/j.0021-8901.2004.00952.x; den Herder M, 2008, BASIC APPL ECOL, V9, P324, DOI 10.1016/j.baae.2007.03.005; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Ehrich D, 2012, OECOLOGIA, V168, P141, DOI 10.1007/s00442-011-2059-0; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Environmental Systems Research Institute, 2002, ARCGIS 9 1 ARCINFO; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Feinsinger Peter, 1994, P258; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Forbes BC, 2009, P NATL ACAD SCI USA, V106, P22041, DOI 10.1073/pnas.0908286106; Forbes BC, 2010, GLOBAL CHANGE BIOL, V16, P1542, DOI 10.1111/j.1365-2486.2009.02047.x; Ford HA, 2001, BIOL CONSERV, V97, P71, DOI 10.1016/S0006-3207(00)00101-4; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Goebel PC, 2003, ECOL APPL, V13, P1595, DOI 10.1890/01-5314; *GRASS DEV TEAM, 2006, GEOGR RES AN SUPP SY; Haftorn S., 1971, NORGES FUGLER; Hausner VH, 2003, ECOL APPL, V13, P999, DOI 10.1890/1051-0761(2003)13[999:SITFML]2.0.CO;2; Hausner VH, 2002, ECOSCIENCE, V9, P470, DOI 10.1080/11956860.2002.11682735; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Helzer CJ, 1999, ECOL APPL, V9, P1448; Henden JA, 2011, BASIC APPL ECOL, V12, P413, DOI 10.1016/j.baae.2011.05.006; Henden JA, 2011, POLAR BIOL, V34, P533, DOI 10.1007/s00300-010-0908-7; Ims RA, 2007, ECOSYSTEMS, V10, P607, DOI 10.1007/s10021-007-9060-9; Ims RA, 2012, BIOL CONSERV, V149, P2, DOI 10.1016/j.biocon.2012.02.008; JARVINEN O, 1978, Holarctic Ecology, V1, P351; Kery M, 2008, J APPL ECOL, V45, P589, DOI 10.1111/j.1365-2664.2007.01441.x; Kery M, 2009, ENVIRON ECOL STAT SE, V3, P639, DOI 10.1007/978-0-387-78151-8_28; Kery M, 2009, ECOLOGY, V90, P1279, DOI 10.1890/07-1794.1; Killengreen ST, 2007, BIOL CONSERV, V135, P459, DOI 10.1016/j.biocon.2006.10.039; Kitti H, 2009, POLAR BIOL, V32, P253, DOI 10.1007/s00300-008-0526-9; KROODSMA RL, 1984, WILSON BULL, V96, P426; Liebezeit JR, 2009, ECOL APPL, V19, P1628, DOI 10.1890/08-1661.1; Lindenmayer DB, 2007, TRENDS ECOL EVOL, V22, P127, DOI 10.1016/j.tree.2006.11.006; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martin JL, 2010, BIOL INVASIONS, V12, P353, DOI 10.1007/s10530-009-9628-8; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Moen A., 1999, NASJONALATLAS NORGE; Moen J, 2003, AMBIO, V32, P397, DOI 10.1639/0044-7447(2003)032[0397:RITSMA]2.0.CO;2; Mortelliti A, 2010, DIVERS DISTRIB, V16, P941, DOI 10.1111/j.1472-4642.2010.00701.x; Myers-Smith IH, 2011, AMBIO, V40, P610, DOI 10.1007/s13280-011-0168-y; Oksanen Lauri, 1995, Acta Botanica Fennica, V153, P1; Olofsson J, 2009, GLOBAL CHANGE BIOL, V15, P2681, DOI 10.1111/j.1365-2486.2009.01935.x; Pajunen A, 2008, POLAR BIOL, V31, P1233, DOI 10.1007/s00300-008-0462-8; Phillips ML, 2003, J WILDLIFE MANAGE, V67, P104, DOI 10.2307/3803066; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ratcliffe D.A., 2005, LAPLAND NATURAL HIST; Ravolainen VT, 2011, BASIC APPL ECOL, V12, P643, DOI 10.1016/j.baae.2011.09.009; Ravolainen VT, 2009, THESIS U TROMSO; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Royle J. Andrew, 2012, Journal of Ornithology, V152, pS521, DOI 10.1007/s10336-010-0619-4; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; Sokolov V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050335; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Sturm M, 2010, SCI AM, V302, P66, DOI 10.1038/scientificamerican0510-66; Summerville KS, 2001, ECOLOGY, V82, P1360, DOI 10.1890/0012-9658(2001)082[1360:EOEHFO]2.0.CO;2; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; WILCOVE DS, 1985, ECOLOGY, V66, P1211, DOI 10.2307/1939174; Yu Q, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045505; Zanette L, 2000, ECOLOGY, V81, P1654, DOI 10.1890/0012-9658(2000)081[1654:FSISFE]2.0.CO;2; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	85	14	15	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63312	10.1371/journal.pone.0063312	http://dx.doi.org/10.1371/journal.pone.0063312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691020	gold, Green Submitted, Green Published			2022-12-25	WOS:000319107400049
J	Kremer, T; Jagasia, R; Herrmann, A; Matile, H; Borroni, E; Francis, F; Kuhn, HG; Czech, C				Kremer, Thomas; Jagasia, Ravi; Herrmann, Annika; Matile, Hugues; Borroni, Edilio; Francis, Fiona; Kuhn, Hans Georg; Czech, Christian			Analysis of Adult Neurogenesis: Evidence for a Prominent "Non-Neurogenic" DCX-Protein Pool in Rodent Brain	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; DOUBLECORTIN-LIKE-KINASE; NEURONAL MIGRATION; KNOCKOUT MICE; HIPPOCAMPAL NEUROGENESIS; STRUCTURAL PLASTICITY; TRANSGENIC MICE; DENTATE GYRUS; RAT NEOCORTEX; EXPRESSION	Here, we have developed a highly sensitive immunoassay for Dcx to characterize expression in brain and cerebrospinal fluid (CSF) of rodents. We demonstrate that Dcx is widely expressed during development in various brain regions and as well can be detected in cerebrospinal fluid of rats (up to 30 days postnatal). While Dcx protein level decline in adulthood and were detectable in neurogenic regions of the adult rodent brain, similar levels were also detectable in brain regions expected to bear no neurogenesis including the cerebral cortex and CA1/CA3 enriched hippocampus. We monitored DCX protein levels after paradigms to increase or severely decrease adult hippocampal neurogenesis, namely physical activity and cranial radiation, respectively. In both paradigms, Dcx protein- and mRNA-levels clearly reflected changes in neurogenesis in the hippocampus. However, basal Dcx-levels are unaffected in non-neurogenic regions (e.g. CA1/CA3 enriched hippocampus, cortex). These data suggest that there is a substantial "non-neurogenic" pool of Dcx- protein, whose regulation can be uncoupled from adult neurogenesis suggesting caution for the interpretation of such studies.	[Kremer, Thomas; Jagasia, Ravi; Herrmann, Annika; Borroni, Edilio; Czech, Christian] F Hoffmann La Roche & Cie AG, Pharma Res & Early Dev, DTA Neurosci, Basel, Switzerland; [Matile, Hugues] F Hoffmann La Roche & Cie AG, pRED Pharma Res & Early Dev, Small Mol Res, Discovery Technol, Basel, Switzerland; [Francis, Fiona] Inst Natl Sante & Rech Med, UMR S839, Paris, France; [Francis, Fiona] Univ Paris 06, Paris, France; [Francis, Fiona] Inst Fer Moulin, Paris, France; [Kuhn, Hans Georg] Univ Gothenburg, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, Gothenburg, Sweden	Roche Holding; Novartis; Roche Holding; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Gothenburg	Kremer, T (corresponding author), F Hoffmann La Roche & Cie AG, Pharma Res & Early Dev, DTA Neurosci, Basel, Switzerland.	Thomas.kremer@roche.com	Francis, Fiona/B-5854-2016; Kuhn, Hans-Georg/L-8127-2014	Kuhn, Hans-Georg/0000-0003-4247-5613; Czech, Christian/0000-0001-7746-0134; Francis, Fiona/0000-0001-8542-7537	Inserm Avenir program; French Agence National de la Recherche [ANR- 08-MNP-013]; Fondation Bettencourt Schueller; Fondation Jerome Lejeune	Inserm Avenir program(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Agence National de la Recherche(French National Research Agency (ANR)); Fondation Bettencourt Schueller; Fondation Jerome Lejeune	FF acknowledges the support of the Inserm Avenir program, the French Agence National de la Recherche (ANR- 08-MNP-013), the Fondation Bettencourt Schueller, the Fondation Jerome Lejeune, and the Ile de France region through the Neuropole (Nerf) for support of EB and animal house facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gomez-Climent MA, 2008, CEREB CORTEX, V18, P2229, DOI 10.1093/cercor/bhm255; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Bloch J, 2011, J COMP NEUROL, V519, P775, DOI 10.1002/cne.22547; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; Danzer SC, 2012, EXP NEUROL, V233, P22, DOI 10.1016/j.expneurol.2011.05.023; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2001, MOL CELL NEUROSCI, V18, P307, DOI 10.1006/mcne.2001.1022; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Graham ME, 2004, BIOCHEM J, V381, P471, DOI 10.1042/BJ20040324; Hagihara Hideo, 2009, J Vis Exp, DOI 10.3791/1543; Haslinger A, 2009, EUR J NEUROSCI, V29, P2103, DOI 10.1111/j.1460-9568.2009.06768.x; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kerjan G, 2009, P NATL ACAD SCI USA, V106, P6766, DOI 10.1073/pnas.0812687106; Kim S, 2011, NEUROSCI LETT, V498, P47, DOI 10.1016/j.neulet.2011.04.059; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lavado A, 2010, PLOS BIOL, P8; Luzzati F, 2009, CEREB CORTEX, V19, P1028, DOI 10.1093/cercor/bhn145; Manohar S, 2012, NEUROSCIENCE, V202, P169, DOI 10.1016/j.neuroscience.2011.12.013; Marlatt MW, 2011, EXP NEUROL, V230, P291, DOI 10.1016/j.expneurol.2011.05.008; Mizumatsu S, 2003, CANCER RES, V63, P4021; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nosten-Bertrand M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002473; Pekcec A, 2006, NEUROREPORT, V17, P571, DOI 10.1097/00001756-200604240-00003; Saaltink DJ, 2012, J COMP NEUROL, V520, P2805, DOI 10.1002/cne.23144; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Shapiro LA, 2007, BRAIN RES, V1149, P30, DOI 10.1016/j.brainres.2006.07.032; Tamura Y, 2007, EUR J NEUROSCI, V25, P3489, DOI 10.1111/j.1460-9568.2007.05617.x; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Tint I, 2009, J NEUROSCI, V29, P10995, DOI 10.1523/JNEUROSCI.3399-09.2009; Tuy FPD, 2008, DEV NEUROSCI-BASEL, V30, P171, DOI 10.1159/000109861; Valero J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016832; Vreugdenhil E, 2007, EUR J NEUROSCI, V25, P635, DOI 10.1111/j.1460-9568.2007.05318.x; Wolf SA, 2011, BRAIN BEHAV IMMUN, V25, P971, DOI 10.1016/j.bbi.2010.10.014; Xiong K, 2008, EXP NEUROL, V211, P271, DOI 10.1016/j.expneurol.2008.02.003; Yang P, 2008, J NEUROSCI, V28, P2231, DOI 10.1523/JNEUROSCI.3574-07.2008; Zappaterra MD, 2007, J PROTEOME RES, V6, P3537, DOI 10.1021/pr070247w	54	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e59269	10.1371/journal.pone.0059269	http://dx.doi.org/10.1371/journal.pone.0059269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690918	Green Submitted, gold, Green Published			2022-12-25	WOS:000319107400004
J	Skejic, J; Hodgson, WC				Skejic, Jure; Hodgson, Wayne C.			Population Divergence in Venom Bioactivities of Elapid Snake Pseudonaja textilis: Role of Procoagulant Proteins in Rapid Rodent Prey Incapacitation	PLOS ONE			English	Article							AUSTRALIAN BROWN SNAKE; PRESYNAPTIC NEUROTOXIN; NEUROMUSCULAR ACTIVITY; MOLECULAR EVOLUTION; ADAPTATION; CLONING; YIELDS; DIET	This study looked at how toxic proteins in venoms of adult Australian eastern Brown snakes Pseudonaja textilis from South Australian and Queensland populations interact with physiological functions of the lab SD rat Rattus norvegicus. Circulatory collapse and incoagulable blood occurred instantly after injection of venom under the dorsal skin of anaesthetised and mechanically ventilated rats in an imitation of a P. textilis bite. Intravenous injection of purified P. textilis (Mackay, QLD) venom prothrombin activator proteins caused instant failure of circulation, testifying of high toxicity of these proteins and suggesting their role in rapid incapacitation of rodent prey. The hypothesis is further supported by circulatory collapse occurring instantly despite artificial respiration in envenomed rats and the finding of extremely high venom procoagulant potency in rat plasma. LC-MS and physiology assays revealed divergent venom composition and biological activity of South Australian (Barossa locality) and Queensland (Mackay locality) populations, which may be driven by selection for different prey. The Queensland venom of P. textilis was found to be more procoagulant and to exhibit predominately presynaptic neurotoxicity, while the South Australian venom contained diverse postsynaptic type II and III alpha-neurotoxins in addition to the presynaptic neurotoxins and caused significantly faster onset of neuromuscular blockade in the rat phrenic nerve-diaphragm preparation. LC-MS analysis found evidence of multiple coagulation factor X-like proteins in P. textilis venoms, including a match to P. textilis coagulation factor X isoform 2, previously known to be expressed only in the liver.	[Skejic, Jure] Univ Melbourne, Inst BIO21, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Skejic, Jure; Hodgson, Wayne C.] Monash Univ, Dept Pharmacol, Monash Venom Grp, Clayton, Vic 3168, Australia	University of Melbourne; Monash University	Skejic, J (corresponding author), Univ Melbourne, Inst BIO21, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	jskejic@student.unimelb.edu.au		Hodgson, Wayne/0000-0002-9919-0144	Australian Government; University of Melbourne; Department of Biochemistry and Molecular Biology at the University of Melbourne	Australian Government(Australian GovernmentCGIAR); University of Melbourne(University of Melbourne); Department of Biochemistry and Molecular Biology at the University of Melbourne	Jure Skejic is supported by the International Postgraduate Research Scholarship from the Australian Government, Melbourne International Research Scholarship from the University of Melbourne and Studentship from the Department of Biochemistry and Molecular Biology at the University of Melbourne (www.unimelb.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armugam A, 2004, ARCH BIOCHEM BIOPHYS, V421, P10, DOI 10.1016/j.abb.2003.09.045; Barber CM, 2012, TOXICOL LETT, V210, P318, DOI 10.1016/j.toxlet.2012.02.001; Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048; Birrell GW, 2006, MOL CELL PROTEOMICS, V5, P379, DOI 10.1074/mcp.M500270-MCP200; BULBRING E, 1946, BRIT J PHARM CHEMOTH, V1, P38; Calvete JJ, 2011, J PROTEOMICS, V74, P510, DOI 10.1016/j.jprot.2011.01.003; Coulter A.R., 1979, NEUROTOXINS FUNDAMEN, P260; da Silva NJ, 2001, COMP BIOCHEM PHYS C, V128, P425, DOI 10.1016/S1532-0456(00)00215-5; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Daltry Jennifer C., 1996, Symposia of the Zoological Society of London, V70, P155; FAIRLEY N. HAMILTON, 1929, MED JOUR AUSTRALIA, V1, P313; Fleay David, 1943, VICTORIAN NAT, V59, P147; Flight S, 2006, ECOTOXICOLOGY, V15, P133, DOI 10.1007/s10646-005-0047-z; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Gibbs HL, 2009, TOXICON, V53, P672, DOI 10.1016/j.toxicon.2009.01.034; GINSBORG BL, 1960, BRIT J PHARM CHEMOTH, V15, P410, DOI 10.1111/j.1476-5381.1960.tb01264.x; Gong NL, 1999, EUR J BIOCHEM, V265, P982, DOI 10.1046/j.1432-1327.1999.00800.x; Gong NL, 2001, BIOCHEM J, V358, P647, DOI 10.1042/0264-6021:3580647; HARVEY AL, 1994, TOXICON, V32, P257, DOI 10.1016/0041-0101(94)90078-7; Herrera M, 2012, J PROTEOMICS, V75, P2128, DOI 10.1016/j.jprot.2012.01.006; Hodgson WC, 2007, NEUROPHARMACOLOGY, V52, P1229, DOI 10.1016/j.neuropharm.2007.01.002; Hodgson WC, 2002, CLIN EXP PHARMACOL P, V29, P807, DOI 10.1046/j.1440-1681.2002.03740.x; JAYANTHI GP, 1988, TOXICON, V26, P257, DOI 10.1016/0041-0101(88)90216-4; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Masci PP, 1998, ANAESTH INTENS CARE, V26, P276, DOI 10.1177/0310057X9802600308; Masci PP, 2000, BLOOD COAGUL FIBRIN, V11, P385, DOI 10.1097/00001721-200006000-00011; Mirtschin PJ, 2006, ECOTOXICOLOGY, V15, P531, DOI 10.1007/s10646-006-0089-x; O'Leary MA, 2010, J PHARMACOL TOX MET, V61, P27, DOI 10.1016/j.vascn.2009.06.004; Reza MA, 2006, J THROMB HAEMOST, V4, P1346, DOI 10.1111/j.1538-7836.2006.01969.x; SANOMARTINS IS, 1994, TOXICON, V32, P1045, DOI 10.1016/0041-0101(94)90388-3; SHINE R, 1989, HERPETOLOGICA, V45, P195; Skinner A, 2005, MOL PHYLOGENET EVOL, V37, P558, DOI 10.1016/j.ympev.2005.06.020; Starkov VG, 2007, TOXICON, V49, P995, DOI 10.1016/j.toxicon.2007.01.010; SU MJ, 1983, TOXICON, V21, P143, DOI 10.1016/0041-0101(83)90057-0; TYLER MI, 1987, EUR J BIOCHEM, V166, P139, DOI 10.1111/j.1432-1033.1987.tb13493.x; WARRELL DA, 1977, Q J MED, V46, P33; Williams DJ, 2008, ZOOTAXA, P47	37	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63988	10.1371/journal.pone.0063988	http://dx.doi.org/10.1371/journal.pone.0063988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691135	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400095
J	Villabona-Arenas, CJ; Zanotto, PMD				Villabona-Arenas, Christian Julian; de Andrade Zanotto, Paolo Marinho			Worldwide Spread of Dengue Virus Type 1	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR EVOLUTION; POPULATION-DYNAMICS; FEVER; PHYLOGEOGRAPHY; EPIDEMIOLOGY; SEROTYPE-3; OUTBREAK; TRANSMISSION; PHILIPPINES	Background: DENV-1 is one of the four viral serotypes that causes Dengue, the most common mosquito-borne viral disease of humans. The prevalence of these viruses has grown in recent decades and is now present in more than 100 countries. Limited studies document the spread of DENV-1 over the world despite its importance for human health. Methodology/Principal Findings: We used representative DENV-1 envelope gene sequences to unravel the dynamics of viral diffusion under a Bayesian phylogeographic approach. Data included strains from 45 distinct geographic locations isolated from 1944 to 2009. The estimated mean rate of nucleotide substitution was 6.56x10(-4) substitutions/site/year. The larger genotypes (I, IV and V) had a distinctive phylogenetic structure and since 1990 they experienced effective population size oscillations. Thailand and Indonesia represented the main sources of strains for neighboring countries. Besides, Asia broadcast lineages into the Americas and the Pacific region that diverged in isolation. Also, a transmission network analysis revealed the pivotal role of Indochina in the global diffusion of DENV-1 and of the Caribbean in the diffusion over the Americas. Conclusions/Significance: The study summarizes the spatiotemporal DENV-1 worldwide spread that may help disease control.	[Villabona-Arenas, Christian Julian; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil	Universidade de Sao Paulo	Zanotto, PMD (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil.	pzanotto@usp.br	de A. Zanotto, Paolo M./B-9286-2019	de A. Zanotto, Paolo M./0000-0002-8167-0625; Villabona Arenas, Christian Julian/0000-0001-9928-3968	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2010/19059-7]; FAPESP [2011/17071-2]; CNPq - PQ	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - PQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) grant 2010/19059-7. CJVA holds the FAPESP scholarship 2011/17071-2 and PMAZ holds a CNPq - PQ scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Nuegoonpipat A, 2004, VIROLOGY, V329, P505, DOI 10.1016/j.virol.2004.08.029; Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Aviles G, 2002, ARCH VIROL, V147, P2075, DOI 10.1007/s00705-002-0886-3; Baillie GJ, 2008, MOL PHYLOGENET EVOL, V47, P717, DOI 10.1016/j.ympev.2008.02.015; Barrero PR, 2004, VIRUS RES, V101, P135, DOI 10.1016/j.virusres.2003.12.033; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Caceres C, 2008, ARCH VIROL, V153, P1967, DOI 10.1007/s00705-008-0200-0; Carvalho SES, 2010, VIRUS GENES, V40, P60, DOI 10.1007/s11262-009-0428-0; CDC, 2011, NEGL TROP DIS; Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562; Chen SP, 2011, INFECT GENET EVOL, V11, P1183, DOI 10.1016/j.meegid.2011.03.025; de A Zanotto PM, 2002, MOL EPIDEMIOLOGY HUM, P167; de Laval F, 2012, EMERG INFECT DIS, V18, P342, DOI 10.3201/eid1802.111333; Domingo C, 2011, J TRAVEL MED, V18, P183, DOI 10.1111/j.1708-8305.2011.00501.x; Downs WG, 1973, ARTHROPOD BORNE VIRU; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duncombe J, 2012, AM J TROP MED HYG, V86, P753, DOI 10.4269/ajtmh.2012.11-0650; Duong V, 2011, INFECT GENET EVOL J, P1; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Effler PV, 2005, EMERG INFECT DIS, V11, P742; FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3; Fisher RP, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-15; Foster JE, 2004, VIROLOGY, V324, P48, DOI 10.1016/j.virol.2004.03.020; Foster JE, 2003, VIROLOGY, V306, P126, DOI 10.1016/S0042-6822(02)00033-8; Gibbons RV, 2012, EMERG INFECT DIS, V18, P623, DOI 10.3201/eid1804.110134; Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686; Gubler D.J., 1998, EMERG INFECT DIS, V1, P1; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; Halasa YA, 2012, AM J TROP MED HYG, V86, P745, DOI 10.4269/ajtmh.2012.11-0784; HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Hirschler B, 2012, REUTERS; Holmes EC, 2004, MOL ECOL, V13, P745, DOI 10.1046/j.1365-294X.2003.02051.x; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; HOTTA S, 1952, J INFECT DIS, V90, P1, DOI 10.1093/infdis/90.1.1; Imrie A, 2006, ANN TROP MED PARASIT, V100, P327, DOI 10.1179/136485906X105589; Ito M, 2007, J TRAVEL MED, V14, P233, DOI 10.1111/j.1708-8305.2007.00130.x; Itrat A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002620; Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Kantachuvessiri Aree, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P56; Karabatsos N, 1985, INT CATALOGUE ARBO S; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Leal ED, 2000, MEM I OSWALDO CRUZ, V95, P193; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lepers C, 2002, DEN 1 OUTBREAK PACIF; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Mizuno Y, 2012, TRAVEL MED INFECT DI, V10, P86, DOI 10.1016/j.tmaid.2012.02.005; Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; PAHO, 1981, EPIDEMIOLOGICAL B, V2, P9; PAHO, 2012, NUMB REP CAS DENG FI; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; Ronquist F, 2011, ANNU REV ECOL EVOL S, V42, P441, DOI 10.1146/annurev-ecolsys-102209-144710; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Salda LTD, 2005, AM J TROP MED HYG, V73, P796, DOI 10.4269/ajtmh.2005.73.796; Schatzmayr HG, 1986, MEM I O CRUZ, V81, P245, DOI [10.1590/S0074-02761986000200019, DOI 10.1590/S0074-]; SEARO, 2012, REP CAS DF DHF SEL C; Setiati T. E., 2006, Dengue Bulletin, V30, P1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Teoh BT, 2010, EMERG INFECT DIS, V16, P1783, DOI 10.3201/eid1611.100721; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Villabona-Arenas CJ, 2011, INFECT GENET EVOL, V11, P878, DOI 10.1016/j.meegid.2011.02.007; Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; WHO, 2013, DENGUE; WHO, 2013, 17 NEGL TROP DIS; Wichmann O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000996; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; WPRO, 2012, DENG SIT UPD; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Yamanaka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027322; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	90	57	66	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62649	10.1371/journal.pone.0062649	http://dx.doi.org/10.1371/journal.pone.0062649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675416	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100005
J	Giesert, F; Hofmann, A; Burger, A; Zerle, J; Kloos, K; Hafen, U; Ernst, L; Zhang, JZ; Vogt-Weisenhorn, DM; Wurst, W				Giesert, Florian; Hofmann, Andreas; Buerger, Alexander; Zerle, Julia; Kloos, Karina; Hafen, Ulrich; Ernst, Luise; Zhang, Jingzhong; Vogt-Weisenhorn, Daniela Maria; Wurst, Wolfgang			Expression Analysis of Lrrk1, Lrrk2 and Lrrk2 Splice Variants in Mice	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; PROTEIN-KINASE ACTIVITY; RICH REPEAT KINASE-2; PARKINSONS-DISEASE; GTP-BINDING; GENE; LEUCINE-RICH-REPEAT-KINASE-2; LOCALIZATION; G2019S; BRAIN	Missense mutations in the leucine-rich repeat kinase 2 gene (LRRK2) are linked to autosomal dominant forms of Parkinson's disease (PD). In order to get insights into the physiological role of Lrrk2, we examined the distribution of Lrrk2 mRNA and different splice variants in the developing murine embryo and the adult brain of Mus musculus. To analyse if the Lrrk2-paralog, Lrrk1, may have redundant functions in PD-development, we also compared Lrrk1 and Lrrk2 expression in the same tissues. Using radioactive in situ hybridization, we found ubiquitous expression of both genes at low level from embryonic stage E9.5 onward, which progressively increased up until birth. The developing central nervous system (CNS) displayed no prominent Lrrk2 mRNA signals at these time-points. However, in the entire postnatal brain Lrrk2 became detectable, showing strongest level in the striatum and the cortex of adult mice; Lrrk1 was only detectable in the mitral cell layer of the olfactory bulb. Thus, due to the non-overlapping expression patterns, a redundant function of Lrrk2 and Lrrk1 in the pathogenesis of PD seems to be unlikely. Quantification of Lrrk2 mRNA and protein level in several brain regions by real-time PCR and Western blot verified the striatum and cortex as hotspots of postnatal Lrrk2 expression. Strong expression of Lrrk2 is mainly found in neurons, specifically in the dopamine receptor 1 (DRD1a) and 2 (DRD2)-positive subpopulations of the striatal medium spiny neurons. Finally, we identified 2 new splice-variants of Lrrk2 in RNA-samples from various adult brain regions and organs: a variant with a skipped exon 5 and a truncated variant terminating in an alternative exon 42a. In order to identify the origin of these two splice variants, we also analysed primary neural cultures independently and found cell-specific expression patterns for these variants in microglia and astrocytes.	[Giesert, Florian; Hofmann, Andreas; Buerger, Alexander; Zerle, Julia; Kloos, Karina; Hafen, Ulrich; Ernst, Luise; Zhang, Jingzhong; Vogt-Weisenhorn, Daniela Maria; Wurst, Wolfgang] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Dev Genet, Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Munich, Ctr Live & Food Sci, Freising Weihenstephan, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] German Ctr Neurodegenerat Dis, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Wurst, W (corresponding author), Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Dev Genet, Neuherberg, Germany.	wurst@helmholtz-muenchen.de	Giesert, Florian/AAF-6499-2020	Giesert, Florian/0000-0001-6825-8858; Wurst, Wolfgang/0000-0003-4422-7410; Vogt Weisenhorn, Daniela/0000-0002-4566-6506	Federal Ministry of Education and Research (National Genome Research Network) [01GS08174 Parkinson, Glia 01GN1009C, 01GS0858]; Helmholtz Association (Helmholtz Alliance "Mental Health in an Ageing Society") [HelMA HA215]; European Commission [SyBoSS HEALTH-F4-2010-242129]	Federal Ministry of Education and Research (National Genome Research Network); Helmholtz Association (Helmholtz Alliance "Mental Health in an Ageing Society"); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Federal Ministry of Education and Research (National Genome Research Network, 01GS08174 Parkinson, Glia 01GN1009C and Disease Genes to Protein Pathways 01GS0858 to WW), the Helmholtz Association (Helmholtz Alliance "Mental Health in an Ageing Society" (HelMA HA215), and the European Commission (SyBoSS HEALTH-F4-2010-242129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2009, GENE THER, V16, P142, DOI 10.1038/gt.2008.123; Biskup S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-102; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Cho HJ, 2012, HUM MOL GENET; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; Delic S, 2008, GENES BRAIN BEHAV, V7, P821, DOI 10.1111/j.1601-183X.2008.00412.x; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; Fujioka S, 2012, NEURODEGENER DIS, V10, P257, DOI 10.1159/000334285; Funayama M, 2005, ANN NEUROL, V57, P918, DOI 10.1002/ana.20484; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Galter D, 2006, ANN NEUROL, V59, P714, DOI 10.1002/ana.20808; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Giasson BI, 2006, ANN NEUROL, V59, P315, DOI 10.1002/ana.20791; Gillardon F, 2012, NEUROSCIENCE, V208, P41, DOI 10.1016/j.neuroscience.2012.02.001; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Han BS, 2008, NEUROSCI LETT, V442, P190, DOI 10.1016/j.neulet.2008.06.086; Hatano T, 2007, HUM MOL GENET, V16, P678, DOI 10.1093/hmg/ddm013; Haugarvoll K, 2007, NEUROSCI LETT, V416, P299, DOI 10.1016/j.neulet.2007.02.020; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Higashi S, 2007, BRAIN RES, V1155, P208, DOI 10.1016/j.brainres.2007.04.034; Higashi S, 2007, J NEUROCHEM, V100, P368, DOI 10.1111/j.1471-4159.2006.04246.x; Hinkle KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-25; Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Kawamura K, 2002, GEN COMP ENDOCR, V126, P130, DOI 10.1006/gcen.2002.7784; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; Korr D, 2006, CELL SIGNAL, V18, P910, DOI 10.1016/j.cellsig.2005.08.015; Kruger R, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-33; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Larsen K, 2009, MOL BIOL REP, V36, P237, DOI 10.1007/s11033-007-9172-5; Lesage S, 2005, ANN NEUROL, V58, P784, DOI 10.1002/ana.20636; Lesage S, 2009, J MED GENET, V46, P458, DOI 10.1136/jmg.2008.062612; Lewis PA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002680; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Maekawa T, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-15; Maekawa T, 2010, BIOCHEM BIOPH RES CO, V392, P431, DOI 10.1016/j.bbrc.2010.01.041; Mandemakers W, 2012, NEUROBIOL DIS; Marin I, 2008, J MOL EVOL, V67, P41, DOI 10.1007/s00239-008-9122-4; Marin I, 2006, MOL BIOL EVOL, V23, P2423, DOI 10.1093/molbev/msl114; Meixner A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001172; Melrose H, 2006, NEUROSCIENCE, V139, P791, DOI 10.1016/j.neuroscience.2006.01.017; Melrose HL, 2007, NEUROSCIENCE, V147, P1047, DOI 10.1016/j.neuroscience.2007.05.027; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; MENSAH PL, 1982, ANAT EMBRYOL, V164, P387, DOI 10.1007/BF00315760; Miklossy J, 2006, J NEUROPATH EXP NEUR, V65, P953, DOI 10.1097/01.jnen.0000235121.98052.54; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Rajput A, 2006, NEUROLOGY, V67, P1506, DOI 10.1212/01.wnl.0000240220.33950.0c; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Sharma S, 2011, NEUROPATH APPL NEURO, V37, P777, DOI 10.1111/j.1365-2990.2011.01187.x; Simon-Sanchez J, 2006, EUR J NEUROSCI, V23, P659, DOI 10.1111/j.1460-9568.2006.04616.x; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Taylor JP, 2007, NEUROGENETICS, V8, P95, DOI 10.1007/s10048-006-0075-8; Taymans JM, 2006, J NEUROCHEM, V98, P951, DOI 10.1111/j.1471-4159.2006.03919.x; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Westerlund M, 2008, NEUROSCIENCE, V152, P429, DOI 10.1016/j.neuroscience.2007.10.062; Zechel S, 2010, INT J DEV NEUROSCI, V28, P391, DOI 10.1016/j.ijdevneu.2010.04.002; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	75	54	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63778	10.1371/journal.pone.0063778	http://dx.doi.org/10.1371/journal.pone.0063778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675505	Green Published, gold			2022-12-25	WOS:000318852400053
J	Lin, YY; Kao, HW; Li, JJ; Hwang, JJ; Tseng, YL; Lin, WJ; Lin, MH; Ting, G; Wang, HE				Lin, Yi-Yu; Kao, Hao-Wen; Li, Jia-Je; Hwang, Jeng-Jong; Tseng, Yun-Long; Lin, Wuu-Jyh; Lin, Ming-Hsien; Ting, Gann; Wang, Hsin-Ell			Tumor Burden Talks in Cancer Treatment with PEGylated Liposomal Drugs	PLOS ONE			English	Article							CELL LUNG-CANCER; X-RAY-SENSITIVITY; AUGER-ELECTRON; THERAPEUTIC-EFFICACY; MONOCLONAL-ANTIBODIES; COLON-CARCINOMA; XENOGRAFT MODEL; HAMSTER-CELLS; BREAST-CANCER; MOUSE MODEL	Purpose: PEGylated liposomes are important drug carriers that can passively target tumor by enhanced permeability and retention (EPR) effect in neoplasm lesions. This study demonstrated that tumor burden determines the tumor uptake, and also the tumor response, in cancer treatment with PEGylated liposomal drugs in a C26/tk-luc colon carcinoma-bearing mouse model. Methods: Empty PEGylated liposomes (NanoX) and those encapsulated with VNB (NanoVNB) were labeled with In-111 to obtain InNanoX and InVNBL in high labeling yield and radiochemical purity (all >90%). BALB/c mice bearing either small (58.4 +/- 8.0 mm(3)) or large (102.4 +/- 22.0 mm(3)) C26/tk-luc tumors in the right dorsal flank were intravenously administered with NanoVNB, InNanoX, InVNBL, or NanoX as a control, every 7 days for 3 times. The therapeutic efficacy was evaluated by body weight loss, tumor growth inhibition (using calipers and bioluminescence imaging) and survival fraction. The scintigraphic imaging of tumor mouse was performed during and after treatment. Results: The biodistribution study of InVNBL revealed a clear inverse correlation (r(2)=0.9336) between the tumor uptake and the tumor mass ranged from 27.6 to 623.9 mg. All three liposomal drugs showed better therapeutic efficacy in small-tumor mice than in large-tumor mice. Tumor-bearing mice treated with InVNBL (a combination drug) showed the highest tumor growth inhibition rate and survival fraction compared to those treated with NanoVNB (chemodrug only) and InNanoX (radionuclide only). Specific tumor targeting and significantly increased tumor uptake after periodical treatment with InVNBL were evidenced by scintigraphic imaging, especially in mice bearing small tumors. Conclusion: The significant differences in the outcomes of cancer treatment and molecular imaging between animals bearing small and large tumors revealed that tumor burden is a critical and discriminative factor in cancer therapy using PEGylated liposomal drugs.	[Lin, Yi-Yu; Kao, Hao-Wen; Li, Jia-Je; Hwang, Jeng-Jong; Wang, Hsin-Ell] Natl Yang Ming Univ, Taipei 112, Taiwan; [Tseng, Yun-Long] Taiwan Liposome Co, Taipei, Taiwan; [Lin, Wuu-Jyh] Inst Nucl Energy Res, Tao Yuan, Taiwan; [Lin, Ming-Hsien] Taipei City Hosp, Zhongxiao Branch, Taipei, Taiwan; [Ting, Gann] Natl Hlth Res Inst, Miaoli, Taiwan	National Yang Ming Chiao Tung University; Institute of Nuclear Energy Research - Taiwan; Taipei City Hospital; National Health Research Institutes - Taiwan	Wang, HE (corresponding author), Natl Yang Ming Univ, Taipei 112, Taiwan.	hewang@ym.edu.tw			National Health Research Institutes (Miaoli, Taiwan, ROC) [97A1-NMPP01-007]; Department of Health, Taipei City Government [99001-62-034, 10001-62-013]	National Health Research Institutes (Miaoli, Taiwan, ROC)(National Health Research Institutes - Taiwan); Department of Health, Taipei City Government	This study was supported by grants from the National Health Research Institutes (Miaoli, Taiwan, ROC) (97A1-NMPP01-007) and the Department of Health, Taipei City Government (99001-62-034 and 10001-62-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Lila AS, 2012, INT J PHARMACEUT, V438, P176, DOI 10.1016/j.ijpharm.2012.08.030; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Bajetta E, 1996, J CLIN ONCOL, V14, P2546, DOI 10.1200/JCO.1996.14.9.2546; BEANEY RP, 1984, LANCET, V1, P131; Behr TM, 2000, EUR J NUCL MED, V27, P753, DOI 10.1007/s002590000272; Bradley AJ, 1998, ARCH BIOCHEM BIOPHYS, V357, P185, DOI 10.1006/abbi.1998.0798; Chang CH, 2006, ANTICANCER RES, V26, P159; Chang YJ, 2010, NUCL MED BIOL, V37, P95, DOI 10.1016/j.nucmedbio.2009.08.006; Chen CC, 2007, NUCL INSTRUM METH A, V571, P437, DOI 10.1016/j.nima.2006.10.129; Chen LC, 2008, NUCL MED BIOL, V35, P883, DOI 10.1016/j.nucmedbio.2008.09.005; Chen P, 2003, J NUCL MED, V44, P1469; Cheng WWK, 2008, J CONTROL RELEASE, V126, P50, DOI 10.1016/j.jconrel.2007.11.005; Chow TH, 2008, NUCL MED BIOL, V35, P623, DOI 10.1016/j.nucmedbio.2008.04.001; Chow TH, 2009, J NUCL MED, V50, P2073, DOI 10.2967/jnumed.109.063503; Conroy T, 1996, J CLIN ONCOL, V14, P164, DOI 10.1200/JCO.1996.14.1.164; Dancey JE, 2006, NAT REV DRUG DISCOV, V5, P649, DOI 10.1038/nrd2089; DILLEHAY LE, 1995, INT J RADIAT ONCOL, V33, P417, DOI 10.1016/0360-3016(95)00182-X; Edelstein MP, 1996, SEMIN ONCOL, V23, P41; Fukuoka K, 2001, LUNG CANCER-J IASLC, V34, P451, DOI 10.1016/S0169-5002(01)00265-3; GABIZON A, 1994, CANCER RES, V54, P987; GonzalezCid M, 1997, ANTI-CANCER DRUG, V8, P529, DOI 10.1097/00001813-199706000-00017; GUTMANN R, 1992, CANCER RES, V52, P1993; Harrington KJ, 2000, BRIT J CANCER, V83, P684, DOI 10.1054/bjoc.2000.1320; HILMAS DE, 1974, CANCER, V33, P103, DOI 10.1002/1097-0142(197401)33:1<103::AID-CNCR2820330116>3.0.CO;2-7; HOWELL RW, 1993, RADIAT RES, V134, P71, DOI 10.2307/3578503; Huber PE, 2005, CANCER RES, V65, P3643, DOI 10.1158/0008-5472.CAN-04-1668; JAIN RK, 1990, CANCER RES, V50, pS814; JAIN RK, 1988, CANCER RES, V48, P7022; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; KEREIAKES JG, 1992, MED PHYS, V19, P1359, DOI 10.1118/1.596925; LASIC DD, 1995, SCIENCE, V267, P1275, DOI 10.1126/science.7871422; Lin YY, 2009, CANCER BIOTHER RADIO, V24, P453, DOI 10.1089/cbr.2008.0572; Mariani G, 2000, J NUCL MED, V41, P1519; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Peracchia MT, 1999, J CONTROL RELEASE, V60, P121, DOI 10.1016/S0168-3659(99)00063-2; POTIER P, 1989, SEMIN ONCOL, V16, P2; SENIOR J, 1991, BIOCHIM BIOPHYS ACTA, V1062, P77, DOI 10.1016/0005-2736(91)90337-8; Sgouros G, 2005, J NUCL MED, V46, p18S; SINCLAIR WK, 1966, RADIAT RES, V29, P450, DOI 10.2307/3572025; Stathopoulos GT, 2008, CLIN EXP METASTAS, V25, P43, DOI 10.1007/s10585-007-9100-z; Tan YY, 1999, CLIN CANCER RES, V5, P2157; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Uusijarvi H, 2006, MED PHYS, V33, P3260, DOI 10.1118/1.2229428; Vogel C, 1999, ANN ONCOL, V10, P397, DOI 10.1023/A:1008364222793; Yoshimoto M, 2006, NUCL MED BIOL, V33, P963, DOI 10.1016/j.nucmedbio.2006.08.006	47	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63078	10.1371/journal.pone.0063078	http://dx.doi.org/10.1371/journal.pone.0063078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675454	gold, Green Submitted, Green Published			2022-12-25	WOS:000318852400023
J	Ma, X; Wehland, M; Schulz, H; Saar, K; Hubner, N; Infanger, M; Bauer, J; Grimm, D				Ma, Xiao; Wehland, Markus; Schulz, Herbert; Saar, Katrin; Huebner, Norbert; Infanger, Manfred; Bauer, Johann; Grimm, Daniela			Genomic Approach to Identify Factors That Drive the Formation of Three-Dimensional Structures by EA.hy926 Endothelial Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; DOWN-REGULATION; ANGIOGENESIS; PROTEINS; GRAVITY; CANCER; WEIGHTLESSNESS; PROLIFERATION	Understanding the mechanisms responsible for tube formation by endothelial cells (ECs) is of major interest and importance in medicine and tissue engineering. Endothelial cells of the human cell line EA.hy926 behave ambivalently when cultured on a random positioning machine (RPM) simulating microgravity. Some cells form tube-like three-dimensional (3D) aggregates, while other cells (AD) continue to grow adherently. Between the fifth and seventh day of culturing, the two types of cell growth achieve the greatest balance. We harvested ECs that grew either adherently or as 3D aggregates separately after five and seven days of incubation on the RPM, and applied gene array analysis and PCR techniques to investigate their gene expression profiles in comparison to ECs growing adherently under normal static 1 g laboratory conditions for equal periods of time. Using gene arrays, 1,625 differentially expressed genes were identified. A strong overrepresentation of transient expression differences was found in the five-day, RPM-treated samples, where the number of genes being differentially expressed in comparison to 1 g cells was highest as well as the degree of alteration regarding distinct genes. We found 27 genes whose levels of expression were changed at least 4-fold in RPM-treated cells as compared to 1 g controls. These genes code for signal transduction and angiogenic factors, cell adhesion, membrane transport proteins or enzymes involved in serine biosynthesis. Fifteen of them, with IL8 (interleukin 8) and VWF (von Willebrand factor) the most prominently affected, showed linkages to genes of another 20 proteins that are important in cell structure maintenance and angiogenesis and extended their network of interaction. Thus, the study reveals numerous genes, which mutually influence each other during initiation of 3D growth of endothelial cells.	[Ma, Xiao; Grimm, Daniela] Aarhus Univ, Inst Biomed, Aarhus, Denmark; [Wehland, Markus; Infanger, Manfred; Grimm, Daniela] Univ Magdeburg, Clin Plast Aesthet & Hand Surg, D-39106 Magdeburg, Germany; [Schulz, Herbert; Saar, Katrin; Huebner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany; [Bauer, Johann] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Aarhus University; Otto von Guericke University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society	Grimm, D (corresponding author), Aarhus Univ, Inst Biomed, Aarhus, Denmark.	daniela.grimm@farm.au.dk		Grimm, Daniela/0000-0002-4991-3105; Saar, Kathrin/0000-0002-4483-1557; Wehland, Markus/0000-0002-8160-859X	European Space Agency [ESA-CORA-GBF-2010-201]; European Space Agency (ESTEC) [4000102118]; German Space Agency DLR (DLR/BMWi) [50WB1124]	European Space Agency(European Space AgencyEuropean Commission); European Space Agency (ESTEC)(European Space Agency); German Space Agency DLR (DLR/BMWi)	This study was supported by the European Space Agency (ESA-CORA-GBF-2010-201, ESTEC contract number 4000102118, Acronym TUBES), and the German Space Agency DLR (DLR/BMWi grant 50WB1124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2009, MOL IMMUNOL, V46, P3345, DOI 10.1016/j.molimm.2009.07.019; ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; Balsara RD, 2008, THROMB HAEMOSTASIS, V100, P1029, DOI 10.1160/TH08-07-0427; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Bell SE, 2001, J CELL SCI, V114, P2755; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benndorf R, 2003, CIRC RES, V93, P438, DOI 10.1161/01.RES.0000088358.99466.04; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Cho JE, 2012, AM J RHINOL ALLERGY, V26, P177, DOI 10.2500/ajra.2012.26.3753; Cines DB, 1998, BLOOD, V91, P3527; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Fan YF, 2008, J CEREBR BLOOD F MET, V28, P90, DOI 10.1038/sj.jcbfm.9600509; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Grimm D, 2002, CARDIOVASC PATHOL, V11, P229, DOI 10.1016/S1054-8807(01)00116-8; Grimm D, 2010, TISSUE ENG PT A, V16, P1559, DOI [10.1089/ten.tea.2009.0524, 10.1089/ten.TEA.2009.0524]; Grimm D, 2009, TISSUE ENG PT A, V15, P2267, DOI 10.1089/ten.tea.2008.0576; Grosse J, 2012, FASEB J, V26, P5124, DOI 10.1096/fj.12-215749; Grosse J, 2012, FASEB J, V26, P639, DOI 10.1096/fj.11-194886; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Infanger M, 2006, APOPTOSIS, V11, P749, DOI 10.1007/s10495-006-5697-7; Infanger M, 2008, ANN VASC SURG, V22, P273, DOI 10.1016/j.avsg.2007.11.002; Infanger M, 2007, J CELL BIOCHEM, V101, P1439, DOI 10.1002/jcb.21261; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kang CY, 2011, EUR J APPL PHYSIOL, V111, P2131, DOI 10.1007/s00421-011-1844-0; Kinoshita MO, 2009, NEUROSCI LETT, V453, P21, DOI 10.1016/j.neulet.2009.02.001; Kraehenbuehl TP, 2009, BIOMATERIALS, V30, P4318, DOI 10.1016/j.biomaterials.2009.04.057; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee NY, 2012, MOL BIOL CELL, V23, P2412, DOI 10.1091/mbc.E11-12-0993; Lenting PJ, 2012, J THROMB HAEMOST, V10, P2428, DOI 10.1111/jth.12008; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Ma H, 2009, J OCUL PHARMACOL TH, V25, P409, DOI 10.1089/jop.2009.0030; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Mehboob S, 2010, J BIOL CHEM, V285, P14572, DOI 10.1074/jbc.M109.080028; Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Monkley SJ, 2011, DEV BIOL, V349, P494, DOI 10.1016/j.ydbio.2010.11.010; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Pietsch J, 2011, CURR MOL MED, V11, P350, DOI 10.2174/156652411795976600; Pietsch J, 2013, INT J MOL SCI, V14, P1164, DOI 10.3390/ijms14011164; Pietsch J, 2012, PROTEOMICS, V12, P2539, DOI 10.1002/pmic.201200070; Pietsch J, 2011, PROTEOMICS, V11, P2095, DOI 10.1002/pmic.201000817; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; Schneider JG, 2011, BONE, V48, P54, DOI 10.1016/j.bone.2010.09.016; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Sowa G, 2008, BIOCHEMISTRY-US, V47, P101, DOI 10.1021/bi701709s; Turner NA, 2010, MATRIX BIOL, V29, P613, DOI 10.1016/j.matbio.2010.06.007; Ulbrich C, 2008, J CELL BIOCHEM, V104, P1324, DOI 10.1002/jcb.21710; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; Ulbrich C, 2010, CELL PHYSIOL BIOCHEM, V25, P551, DOI 10.1159/000303059; Vie N, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-14; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Yao JHS, 2006, BIOCHEM BIOPH RES CO, V342, P1396, DOI 10.1016/j.bbrc.2006.02.100	61	28	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e64402	10.1371/journal.pone.0064402	http://dx.doi.org/10.1371/journal.pone.0064402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675535	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000318852400068
J	Zou, Z; Huang, B; Wu, X; Zhang, H; Qi, J; Bradner, J; Nair, S; Chen, LF				Zou, Z.; Huang, B.; Wu, X.; Zhang, H.; Qi, J.; Bradner, J.; Nair, S.; Chen, L-F			Brd4 maintains constitutively active NF-kappa B in cancer cells by binding to acetylated RelA	ONCOGENE			English	Article						Brd4; cancer; degradation; JQ; NF-kappa B; ubiquitination	POSTTRANSLATIONAL MODIFICATIONS; DOWN-REGULATION; PROTEINS; TARGET; INFLAMMATION; INHIBITOR	Acetylation of the RelA subunit of NF-kappa B at lysine-310 regulates the transcriptional activation of NF-kappa B target genes and contributes to maintaining constitutively active NF-kappa B in tumors. Bromodomain-containing factor Brd4 has been shown to bind to acetylated lysine-310 (AcLys310) and to regulate the transcriptional activity of NF-kappa B, but the role of this binding in maintaining constitutively active NF-kappa B in tumors remains elusive. In this study, we demonstrate the structural basis for the binding of bromodomains (BDs) of bromodomain-containing protein 4 ( Brd4) to AcLys310 and identify the BD inhibitor JQ1 as an effective small molecule to block this interaction. JQ1 suppresses TNF-alpha-mediated NF-kappa B activation and NF-kappa B-dependent target gene expression. In addition, JQ1 inhibits the proliferation and transformation potential of A549 lung cancer cells and suppresses the tumorigenicity of A549 cells in severe combined immunodeficiency mice. Furthermore, we demonstrate that depletion of Brd4 or treatment of cells with JQ1 induces the ubiquitination and degradation of the constitutively active nuclear form of RelA. Our results identify a novel function of Brd4 in maintaining the persistently active form of NF-kappa B found in tumors, and they suggest that interference with the interaction between acetylated RelA and Brd4 could be a potential therapeutic approach for the treatment of NF-kappa B-driven cancer.	[Zou, Z.; Huang, B.; Wu, X.; Zhang, H.; Nair, S.; Chen, L-F] Univ Illinois, Coll Med, Dept Biochem, Urbana, IL 61801 USA; [Qi, J.; Bradner, J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chen, L-F] Univ Illinois, Coll Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Harvard University; Dana-Farber Cancer Institute; University of Illinois System; University of Illinois Urbana-Champaign	Chen, LF (corresponding author), Univ Illinois, Coll Med, Dept Biochem, MC-714, Urbana, IL 61801 USA.	lfchen@life.illinois.edu	Nair, Satish/AAY-2510-2021; 高, 雨莉/HGU-8187-2022	Zou, Zhenhua/0000-0003-0296-6231	UIUC; NIH [DK-085158]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK093865, R01DK085158] Funding Source: NIH RePORTER	UIUC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members in the Chen lab for discussion and A Lamb for assistance in the preparation of the manuscript. This work is supported in part by funds provided by UIUC (to LFC) and NIH grants DK-085158 (to LFC).	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chiarella C, 2009, ROUTL INT STUD MONEY, P1; Choi KC, 2009, MOL CANCER RES, V7, P2011, DOI 10.1158/1541-7786.MCR-09-0239; Chung CW, 2012, PROGR MED CHEM, V51, P1, DOI 10.1016/B978-0-12-396493-9.00001-7; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Huang B, 2012, ONCOGENE, V31, P527, DOI 10.1038/onc.2011.252; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Jang MK, 2009, J VIROL, V83, P2592, DOI 10.1128/JVI.02275-08; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lee AY, 2009, J BIOL CHEM, V284, P2778, DOI 10.1074/jbc.M805835200; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Oliver SS, 2011, ANGEW CHEM INT EDIT, V50, P5801, DOI 10.1002/anie.201101414; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sen R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000257; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; Zhang GT, 2012, J BIOL CHEM, V287, P28840, DOI 10.1074/jbc.M112.359505; Zheng G, 2009, J VIROL, V83, P8683, DOI 10.1128/JVI.00674-09; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	51	169	177	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2014	33	18					2395	2404		10.1038/onc.2013.179	http://dx.doi.org/10.1038/onc.2013.179			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AG5ID	23686307	Green Accepted			2022-12-25	WOS:000335451800012
J	Bosco-Clement, G; Zhang, F; Chen, Z; Zhou, HM; Li, H; Mikami, I; Hirata, T; Yagui-Beltran, A; Lui, N; Do, HT; Cheng, T; Tseng, HH; Choi, H; Fang, LT; Kim, IJ; Yue, D; Wang, C; Zheng, Q; Fujii, N; Mann, M; Jablons, DM; He, B				Bosco-Clement, G.; Zhang, F.; Chen, Z.; Zhou, H-M; Li, H.; Mikami, I.; Hirata, T.; Yagui-Beltran, A.; Lui, N.; Do, H. T.; Cheng, T.; Tseng, H-H; Choi, H.; Fang, L-T; Kim, I-J; Yue, D.; Wang, C.; Zheng, Q.; Fujii, N.; Mann, M.; Jablons, D. M.; He, B.			Targeting Gli transcription activation by small molecule suppresses tumor growth	ONCOGENE			English	Article						cancer; targeted therapy; Gli; TAF9; Hedgehog pathway	HEDGEHOG PATHWAY INHIBITOR; SIGNALING PATHWAY; CANCER; MEDULLOBLASTOMA; MEDIATORS; PROMOTER; EMX2; P53	Targeted inhibition of Hedgehog signaling at the cell membrane has been associated with anticancer activity in preclinical and early clinical studies. Hedgehog signaling involves activation of Gli transcription factors that can also be induced by alternative pathways. In this study, we identified an interaction between Gli proteins and a transcription coactivator TBP-associated factor 9 (TAF9), and validated its functional relevance in regulating Gli transactivation. We also describe a novel, synthetic small molecule, FN1-8, that efficiently interferes with Gli/TAF9 interaction and downregulate Gli/TAF9-dependent transcriptional activity. More importantly, FN1-8 suppresses cancer cell proliferation in vitro and inhibits tumor growth in vivo. Our results suggest that blocking Gli transactivation, an important control point of multiple oncogenic pathways, may be an effective anticancer strategy.	[Bosco-Clement, G.; Zhang, F.; Chen, Z.; Li, H.; Mikami, I.; Hirata, T.; Yagui-Beltran, A.; Lui, N.; Do, H. T.; Cheng, T.; Tseng, H-H; Choi, H.; Fang, L-T; Kim, I-J; Yue, D.; Zheng, Q.; Jablons, D. M.; He, B.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Surg, Thorac Oncol Program, San Francisco, CA 94115 USA; [Zhang, F.] Tsinghua Univ, Grad Sch Shenzhen, Div Life & Hlth Sci, Shenzhen 518057, Peoples R China; [Chen, Z.; Zhou, H-M] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Mikami, I.; Hirata, T.] Nippon Med Sch, Dept Surg, Div Thorac Surg, Tokyo 113, Japan; [Yue, D.; Wang, C.] Tianjin Med Univ, Canc Inst & Hosp, Dept Lung Canc, Tianjin, Peoples R China; [Zheng, Q.] Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China; [Fujii, N.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Mann, M.] Univ Calif San Francisco, Dept Surg, Div Cardiothorac Surg, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Tsinghua University; Nippon Medical School; Tianjin Medical University; Peking University; St Jude Children's Research Hospital; University of California System; University of California San Francisco	He, B (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Surg, Thorac Oncol Program, San Francisco, CA 94115 USA.	david.jablons@ucsfmedctr.org; biao.he@ucsfmedctr.org	Fujii, Naoaki/I-6423-2013; Fang, Li Tai/ABA-6638-2021; Tseng, Hsin-Hui Katty/AAG-1941-2019	Fang, Li Tai/0000-0003-3201-5162; 	Joan's Legacy: Uniting Against Lung Cancer Research Grant; NIH/NCI [R01CA125030, R01CA132566]; Eileen D Ludwig Endowed for Thoracic Oncology Research; Bonnie J Addario Lung Cancer Foundation; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley and Oberman Foundation; Honeywell Foundation; Barbara Isackson Lung Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA132566, R01CA125030] Funding Source: NIH RePORTER	Joan's Legacy: Uniting Against Lung Cancer Research Grant; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eileen D Ludwig Endowed for Thoracic Oncology Research; Bonnie J Addario Lung Cancer Foundation; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley and Oberman Foundation; Honeywell Foundation; Barbara Isackson Lung Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Joan's Legacy: Uniting Against Lung Cancer Research Grant, NIH/NCI Grant R01CA125030, and the Eileen D Ludwig Endowed for Thoracic Oncology Research (to BH); NIH/NCI Grant R01CA132566, the Bonnie J Addario Lung Cancer Foundation, the Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley and Oberman Foundation, Honeywell Foundation and the Barbara Isackson Lung Cancer Research Fund (to DMJ).	Arai MA, 2011, ORG BIOMOL CHEM, V9, P1133, DOI 10.1039/c0ob00677g; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Choi Y, 2000, J BIOL CHEM, V275, P15912, DOI 10.1074/jbc.275.21.15912; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; FALGOUT B, 1988, J VIROL, V62, P622, DOI 10.1128/JVI.62.2.622-625.1988; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; He B, 2010, US Patent No, Patent No. 7714014; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hosoya T, 2008, CHEMBIOCHEM, V9, P1082, DOI 10.1002/cbic.200700511; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Jung DJ, 2006, DRUG DISCOV TODAY, V11, P452, DOI 10.1016/j.drudis.2006.03.011; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Mullor JL, 2001, CURR BIOL, V11, P769, DOI 10.1016/S0960-9822(01)00229-9; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Okamoto J, 2010, ONCOGENE, V29, P5969, DOI 10.1038/onc.2010.330; Okamoto J, 2011, CLIN LUNG CANCER, V12, P237, DOI 10.1016/j.cllc.2011.03.025; Raz DJ, 2008, CLIN CANCER RES, V14, P5565, DOI 10.1158/1078-0432.CCR-08-0544; Reguart N, 2004, BIOCHEM BIOPH RES CO, V323, P229, DOI 10.1016/j.bbrc.2004.08.075; Rifai Y, 2011, BIOORG MED CHEM LETT, V21, P718, DOI 10.1016/j.bmcl.2010.11.126; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Rovnak J, 2006, J VIROL, V80, P12041, DOI 10.1128/JVI.01425-06; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Shimogawa H, 2004, J AM CHEM SOC, V126, P3461, DOI 10.1021/ja038855+; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Yoon JW, 1998, J BIOL CHEM, V273, P3496, DOI 10.1074/jbc.273.6.3496	51	37	38	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 17	2014	33	16					2087	2097		10.1038/onc.2013.164	http://dx.doi.org/10.1038/onc.2013.164			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF3GH	23686308	Green Accepted, Green Submitted			2022-12-25	WOS:000334599100008
J	Chandrasekaran, S; Ghosh, J; Port, GC; Koh, EI; Caparon, MG				Chandrasekaran, Sukantha; Ghosh, Joydeep; Port, Gary C.; Koh, Eun-ik; Caparon, Michael G.			Analysis of Polymorphic Residues Reveals Distinct Enzymatic and Cytotoxic Activities of the Streptococcus pyogenes NAD(+) Glycohydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; CYTOLYSIN-MEDIATED TRANSLOCATION; HELICOBACTER-PYLORI; STREPTOLYSIN-O; TISSUE TROPISM; TOXIN; GENE; PROTEIN; VACA; ASSOCIATION	The Streptococcus pyogenes NAD(+) glycohydrolase (SPN) is secreted from the bacterial cell and translocated into the host cell cytosol where it contributes to cell death. Recent studies suggest that SPN is evolving and has diverged into NAD(+) glycohydrolase-inactive variants that correlate with tissue tropism. However, the role of SPN in both cytotoxicity and niche selection are unknown. To gain insight into the forces driving the adaptation of SPN, a detailed comparison of representative glycohydrolase activity-proficient and -deficient variants was conducted. Of a total 454 amino acids, the activity-deficient variants differed at only nine highly conserved positions. Exchanging residues between variants revealed that no one single residue could account for the inability of the deficient variants to cleave the glycosidic bond of beta-NAD(+) into nicotinamide and ADP-ribose; rather, reciprocal changes at 3 specific residues were required to both abolish activity of the proficient version and restore full activity to the deficient variant. Changing any combination of 1 or 2 residues resulted in intermediate activity. However, a change to any 1 residue resulted in a significant decrease in enzyme efficiency. A similar pattern involving multiple residues was observed for comparison with a second highly conserved activity-deficient variant class. Remarkably, despite differences in glycohydrolase activity, all versions of SPN were equally cytotoxic to cultured epithelial cells. These data indicate that the glycohydrolase activity of SPN may not be the only contribution the toxin has to the pathogenesis of S. pyogenes and that both versions of SPN play an important role during infection.	[Chandrasekaran, Sukantha; Ghosh, Joydeep; Port, Gary C.; Koh, Eun-ik; Caparon, Michael G.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Caparon, MG (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave,Box 8230, St Louis, MO 63110 USA.	caparon@borcim.wustl.edu			National Institutes of Health from the United States Public Health Service [AI064721]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064721] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064721 from the United States Public Health Service.	ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Bessen DE, 2011, J BACTERIOL, V193, P6651, DOI 10.1128/JB.05263-11; Bricker AL, 2005, INFECT IMMUN, V73, P6562, DOI 10.1128/IAI.73.10.6562-6566.2005; Bricker AL, 2002, MOL MICROBIOL, V44, P257, DOI 10.1046/j.1365-2958.2002.02876.x; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Ghosh J, 2006, MOL MICROBIOL, V62, P1203, DOI 10.1111/j.1365-2958.2006.05430.x; Ghosh J, 2010, J BIOL CHEM, V285, P5683, DOI 10.1074/jbc.M109.070300; HANSKI E, 1992, INFECT IMMUN, V60, P5119, DOI 10.1128/IAI.60.12.5119-5125.1992; Ji XH, 2002, FEMS MICROBIOL LETT, V206, P253, DOI 10.1016/S0378-1097(01)00543-2; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; KARASAWA T, 1995, FEMS MICROBIOL LETT, V130, P201; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kushner S. H., 1978, IMPROVED METHOD TRAN, P17; Lizano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003450; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; Magassa N, 2010, EMBO REP, V11, P400, DOI 10.1038/embor.2010.37; Meehl MA, 2005, PLOS PATHOG, V1, P362, DOI 10.1371/journal.ppat.0010035; Michos A, 2006, J BIOL CHEM, V281, P8216, DOI 10.1074/jbc.M511674200; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Riddle DJ, 2010, J BACTERIOL, V192, P3735, DOI 10.1128/JB.00234-10; SCOTT JR, 1986, J EXP MED, V164, P1641, DOI 10.1084/jem.164.5.1641; Smith CL, 2011, STRUCTURE, V19, P192, DOI 10.1016/j.str.2010.12.013; Stevens DL, 2000, J INFECT DIS, V182, P1117, DOI 10.1086/315850; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Tatsuno I, 2007, MICROBIOL-SGM, V153, P4253, DOI 10.1099/mic.0.2007/009555-0; van Doorn LJ, 1999, GASTROENTEROLOGY, V116, P823, DOI 10.1016/S0016-5085(99)70065-X; Zhang S, 2006, INFECT IMMUN, V74, P4200, DOI 10.1128/IAI.00493-06	30	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20064	20075		10.1074/jbc.M113.481556	http://dx.doi.org/10.1074/jbc.M113.481556			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689507	hybrid, Green Published			2022-12-25	WOS:000321515800068
J	Hifumi, E; Fujimoto, N; Arakawa, M; Saito, E; Matsumoto, S; Kobayashi, N; Uda, T				Hifumi, Emi; Fujimoto, Naoko; Arakawa, Mitsue; Saito, Eri; Matsumoto, Shingo; Kobayashi, Nobuyuki; Uda, Taizo			Biochemical Features of a Catalytic Antibody Light Chain, 22F6, Prepared from Human Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-HYDROLYZING ACTIVITY; IGG ANTIBODIES; PEPTIDE; BINDING; HEAVY; AUTOANTIBODIES; SEQUENCE; ABILITY; VIRUS; GP41	Human antibody light chains belonging to subgroup II of germ line genes were amplified by a seminested PCR technique using B-lymphocytes taken from a human adult infected with influenza virus. Each gene of the human light chains was transferred into the Escherichia coli system. The recovered light chain was highly purified using a two-step purification system. Light chain 22F6 showed interesting catalytic features. The light chain cleaved a peptide bond of synthetic peptidyl-4-methyl-coumaryl-7-amide (MCA) substrates, such as QAR-MCA and EAR-MCA, indicating amidase activity. It also hydrolyzed a phosphodiester bond of both DNA and RNA. From the analysis of amino acid sequences and molecular modeling, the 22F6 light chain possesses two kinds of active sites as amidase and nuclease in close distances. The 22F6 catalytic light chain could suppress the infection of influenza virus type A (H1N1) of Madin-Darby canine kidney cells in an in vitro assay. In addition, the catalytic light chain clearly inhibited the infection of the influenza virus of BALB/c mice via nasal administration in an in vivo assay. In the experiment, the titer in the serum of the mice coinfected with the 22F6 light chain and H1N1 virus became considerably lowered compared with that of 22F6-non-coinfected mice. Note that the catalytic light chain was prepared from human peripheral lymphocyte and plays an important role in preventing infection by influenza virus. Considering the fact that the human light chain did not show any acute toxicity for mice, our procedure developed in this study must be unique and noteworthy for developing new drugs.	[Hifumi, Emi] Oita Univ, Res Ctr Appl Med Engn, Oita 8701192, Japan; [Fujimoto, Naoko; Saito, Eri; Matsumoto, Shingo; Uda, Taizo] Oita Univ, Dept Appl Chem, Fac Engn, Oita 8701192, Japan; [Arakawa, Mitsue] Oita Univ, Dept Nursing, Fac Med, Yufu City, Oita 8795593, Japan; [Kobayashi, Nobuyuki] Nagasaki Univ, Sch Pharmaceut Sci, Nagasaki 8528521, Japan; [Hifumi, Emi; Uda, Taizo] JST CREST Japan Sci & Technol Corp, Kawaguchi, Saitama 3320012, Japan	Oita University; Oita University; Oita University; Nagasaki University	Hifumi, E (corresponding author), Oita Univ, Res Ctr Appl Med Engn, Dan Noharu 700, Oita 8701192, Japan.	e-hifumi@oita-u.ac.jp		Uda, Taizo/0000-0001-8146-7902	Japan Science and Technology Agency (CREST/"Establishment of Innovative Manufacturing Technology Based on Nanoscience")	Japan Science and Technology Agency (CREST/"Establishment of Innovative Manufacturing Technology Based on Nanoscience")	This work was supported by the Japan Science and Technology Agency (CREST/"Establishment of Innovative Manufacturing Technology Based on Nanoscience").	Adachi K, 2008, ARCH VIROL, V153, P15, DOI 10.1007/s00705-007-1051-9; Andrievskaya OA, 2002, IMMUNOL LETT, V81, P191, DOI 10.1016/S0165-2478(02)00006-8; Durova OM, 2009, MOL IMMUNOL, V47, P87, DOI 10.1016/j.molimm.2008.12.020; GAO QS, 1994, J BIOL CHEM, V269, P32389; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gololobov GV, 1997, MOL IMMUNOL, V34, P1083, DOI 10.1016/S0161-5890(97)00129-6; Hatiuchi K, 2003, IMMUNOL LETT, V86, P249, DOI 10.1016/S0165-2478(03)00030-0; Hifumi E, 2003, BIOTECHNOL BIOENG, V84, P485, DOI 10.1002/bit.10806; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Hifumi E, 2000, APPL BIOCHEM BIOTECH, V83, P209, DOI 10.1385/ABAB:83:1-3:209; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Hifumi E, 2012, FASEB J, V26, P1607, DOI 10.1096/fj.11-195339; Hifumi E, 2011, J AM CHEM SOC, V133, P15015, DOI 10.1021/ja203922r; Kanyshkova TG, 1997, FEBS LETT, V416, P23, DOI 10.1016/S0014-5793(97)01163-0; Kim YR, 2006, J BIOL CHEM, V281, P15287, DOI 10.1074/jbc.M600937200; Kolesnikov AV, 2000, P NATL ACAD SCI USA, V97, P13526, DOI 10.1073/pnas.200360497; Kozyr AV, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/683829; Krasnorutskii MA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1065, DOI 10.1134/S0006297911090124; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Lee D. C. W., 2007, Signal Transduction, V7, P64, DOI 10.1002/sita.200600117; Matsuura K, 1998, BIOCHEM BIOPH RES CO, V243, P719, DOI 10.1006/bbrc.1998.8164; MATSUURA K, 1994, BIOCHEM BIOPH RES CO, V204, P57, DOI 10.1006/bbrc.1994.2425; MEI S, 1991, J BIOL CHEM, V266, P15571; Mitsuda Y, 2004, BIOTECHNOL BIOENG, V86, P217, DOI 10.1002/bit.20031; Ohara K, 2004, BIOCHEM BIOPH RES CO, V315, P612, DOI 10.1016/j.bbrc.2004.01.094; Okochi N, 2007, APPL MICROBIOL BIOT, V77, P597, DOI 10.1007/s00253-007-1197-0; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Parkhomenko TA, 2010, BIOCHIMIE, V92, P545, DOI 10.1016/j.biochi.2010.01.022; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Ponomarenko NA, 2007, BIOCHEMISTRY-US, V46, P14598, DOI 10.1021/bi7013954; Redegeld FA, 2003, TRENDS IMMUNOL, V24, P181, DOI 10.1016/S1471-4906(03)00059-0; Rodkey LS, 2000, APPL BIOCHEM BIOTECH, V83, P95, DOI 10.1385/ABAB:83:1-3:95; Sapparapu G, 2009, J BIOL CHEM, V284, P24622, DOI 10.1074/jbc.M109.011858; Schmidt NJ, 1989, DIAGNOSTIC PROCEDURE, V6th, P51; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Smirnov I, 2011, P NATL ACAD SCI USA, V108, P15954, DOI 10.1073/pnas.1108460108; SUN M, 1994, J IMMUNOL, V153, P5121; Takizawa N, 2010, VIROLOGY, V401, P248, DOI 10.1016/j.virol.2010.02.030; Thiagarajan P, 2000, BIOCHEMISTRY-US, V39, P6459, DOI 10.1021/bi992588w; Uda T, 2004, J BIOSCI BIOENG, V97, P143, DOI 10.1016/S1389-1723(04)70183-8; Wootla B, 2011, BLOOD, V117, P2257, DOI 10.1182/blood-2010-07-296103	44	13	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19558	19568		10.1074/jbc.M113.454579	http://dx.doi.org/10.1074/jbc.M113.454579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23677996	Green Published, hybrid			2022-12-25	WOS:000321515800022
J	Kunugi, M; Takabayashi, A; Tanaka, A				Kunugi, Motoshi; Takabayashi, Atsushi; Tanaka, Ayumi			Evolutionary Changes in Chlorophyllide a Oxygenase (CAO) Structure Contribute to the Acquisition of a New Light-harvesting Complex in Micromonas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN COMPLEXES; PROCHLOROTHRIX-HOLLANDICA; CRYSTAL-STRUCTURE; PHOTOSYSTEM-II; A/B-PROTEIN; ANTENNA; CYANOBACTERIA; DEGRADATION; CONVERSION; INSIGHTS	Chlorophyll b is found in photosynthetic prokaryotes and primary and secondary endosymbionts, although their light-harvesting systems are quite different. Chlorophyll b is synthesized from chlorophyll a by chlorophyllide a oxygenase (CAO), which is a Rieske-mononuclear iron oxygenase. Comparison of the amino acid sequences of CAO among photosynthetic organisms elucidated changes in the domain structures of CAO during evolution. However, the evolutionary relationship between the light-harvesting system and the domain structure of CAO remains unclear. To elucidate this relationship, we investigated the CAO structure and the pigment composition of chlorophyll-protein complexes in the prasinophyte Micromonas. The Micromonas CAO is composed of two genes, MpCAO1 and MpCAO2, that possess Rieske and mononuclear iron-binding motifs, respectively. Only when both genes were introduced into the chlorophyll b-less Arabidopsis mutant (ch1-1) was chlorophyll b accumulated, indicating that cooperation between the two subunits is required to synthesize chlorophyll b. Although Micromonas has a characteristic light-harvesting system in which chlorophyll b is incorporated into the core antennas of reaction centers, chlorophyll b was also incorporated into the core antennas of reaction centers of the Arabidopsis transformants that contained the two Micromonas CAO proteins. Based on these results, we discuss the evolutionary relationship between the structures of CAO and light-harvesting systems.	[Kunugi, Motoshi; Takabayashi, Atsushi; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Takabayashi, Atsushi; Tanaka, Ayumi] Japan Core Res Evolutionary Sci & Technol, Sapporo, Hokkaido 0600819, Japan	Hokkaido University	Takabayashi, A (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Kita Ku, N19 W8, Sapporo, Hokkaido 0600819, Japan.	takabayashi@pop.lowtem.hokudai.ac.jp	Tanaka, Ayumi/D-9003-2012; Takabayashi, Atsushi/G-1998-2011; Takabayashi, Atsushi/AAH-6025-2020	Takabayashi, Atsushi/0000-0003-1100-7462; Takabayashi, Atsushi/0000-0003-1100-7462	Japan Society for the Promotion of Science [23770035, 24370017]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Young Scientists 23770035 (to A. Takabayashi) and by Scientific Research 24370017 (to A. Tanaka) from the Japan Society for the Promotion of Science.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; ANDERSON JM, 1980, BIOCHIM BIOPHYS ACTA, V591, P113, DOI 10.1016/0005-2728(80)90225-X; ANDERSON JM, 1978, FEBS LETT, V92, P227, DOI 10.1016/0014-5793(78)80760-1; Bibby TS, 2003, NATURE, V424, P1051, DOI 10.1038/nature01933; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; D'Ordine RL, 2009, J MOL BIOL, V392, P481, DOI 10.1016/j.jmb.2009.07.022; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; Garczarek L, 2000, P NATL ACAD SCI USA, V97, P4098, DOI 10.1073/pnas.070040897; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harada J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060026; Hirashima M, 2006, J BIOL CHEM, V281, P15385, DOI 10.1074/jbc.M602903200; Horie Y, 2009, J BIOL CHEM, V284, P17449, DOI 10.1074/jbc.M109.008912; Ito H, 1996, J BIOL CHEM, V271, P1475, DOI 10.1074/jbc.271.3.1475; Jakoncic J, 2007, FEBS J, V274, P2470, DOI 10.1111/j.1742-4658.2007.05783.x; Kouril R, 2012, BBA-BIOENERGETICS, V1817, P2, DOI 10.1016/j.bbabio.2011.05.024; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lepetit B, 2007, BIOCHEMISTRY-US, V46, P9813, DOI 10.1021/bi7008344; Martins BM, 2005, STRUCTURE, V13, P817, DOI 10.1016/j.str.2005.03.008; Nagata N, 2004, PLANTA, V218, P1019, DOI 10.1007/s00425-003-1181-6; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; Renger T, 2010, CHEMPHYSCHEM, V11, P1141, DOI 10.1002/cphc.200900932; Sakuraba Y, 2012, PLANT CELL PHYSIOL, V53, P505, DOI 10.1093/pcp/pcs006; Sakuraba Y, 2010, PLANT CELL PHYSIOL, V51, P1055, DOI 10.1093/pcp/pcq050; Sakuraba Y, 2009, J BIOL CHEM, V284, P36689, DOI 10.1074/jbc.M109.008144; Satoh S, 2001, J BIOL CHEM, V276, P4293, DOI 10.1074/jbc.M008238200; Satoh S, 2006, PLANT CELL PHYSIOL, V47, P1622, DOI 10.1093/pcp/pcl026; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; Shimoda Y, 2012, PLANT J, V72, P501, DOI 10.1111/j.1365-313X.2012.05095.x; Six C, 2005, MOL BIOL EVOL, V22, P2217, DOI 10.1093/molbev/msi220; Takabayashi A, 2011, PLANT CELL PHYSIOL, V52, P2103, DOI 10.1093/pcp/pcr138; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; TANAKA A, 1991, PLANT CELL PHYSIOL, V32, P195, DOI 10.1093/oxfordjournals.pcp.a078064; Tanaka R, 2005, PHOTOSYNTH RES, V85, P327, DOI 10.1007/s11120-005-6807-z; Tanaka R, 2011, BBA-BIOENERGETICS, V1807, P968, DOI 10.1016/j.bbabio.2011.01.002; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Tanaka R, 2010, ADV PHOTOSYNTH RESP, V31, P55; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomitani A, 1999, NATURE, V400, P159, DOI 10.1038/22101; Tsugama D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-22; van der Staay GWM, 1998, PLANT MOL BIOL, V36, P709, DOI 10.1023/A:1005930210515; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Yamasato A, 2005, PLANT CELL, V17, P1585, DOI 10.1105/tpc.105.031518; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	48	20	22	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19330	19341		10.1074/jbc.M113.462663	http://dx.doi.org/10.1074/jbc.M113.462663			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23677999	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000321515800004
J	Li, CR; Ebert, PJR; Li, QJ				Li, Chaoran; Ebert, Peter J. R.; Li, Qi-Jing			T Cell Receptor (TCR) and Transforming Growth Factor beta (TGF-beta) Signaling Converge on DNA (Cytosine-5)-methyltransferase to Control forkhead box protein 3 (foxp3) Locus Methylation and Inducible Regulatory T Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXP3; METHYLTRANSFERASE 1; GENE-EXPRESSION; CUTTING EDGE; KINASE-B; INDUCTION; LINEAGE; PROTEIN; MAINTENANCE; RESPONSES	Naive T cells can be induced to differentiate into Foxp3(+) regulatory T cells (iTregs) upon suboptimal T cell receptor (TCR) stimulus or TCR stimulus in conjunction with TGF-beta signaling; however, we do not fully understand how these signals coordinately control foxp3 expression. Here, we show that strong TCR activation, in terms of both duration and ligand affinity, causes the accumulation of DNA (cytosine-5)-methyltransferase 1 (DNMT1) and DNMT3b and their specific enrichment at the foxp3 locus, which leads to increased CpG methylation and inhibits foxp3 transcription. During this process the augmentation of DNMT1 is regulated through at least two post-transcriptional mechanisms; that is, strong TCR signal inactivates GSK3 beta to rescue DNMT1 protein from proteasomal degradation, and strong TCR signal suppresses miR-148a to derepress DNMT1 mRNA translation. Meanwhile, TGF-beta signaling antagonizes DNMT1 accumulation via activation of p38 MAP kinase. Thus, independent of transcription factor activation, TCR and TGF-beta signals converge on DNMT1 to modulate the expression of foxp3 epigenetically, which marks mother cell iTreg lineage choice within the genome of differentiating daughter cells.	[Li, Chaoran; Li, Qi-Jing] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Ebert, Peter J. R.] Genentech Inc, San Francisco, CA 94080 USA	Duke University; Roche Holding; Genentech	Li, QJ (corresponding author), Duke Univ, Med Ctr, Dept Immunol, 207 Res Dr, Durham, NC 27710 USA.	Qi-Jing.Li@Duke.edu			National Institutes of Health [RAI091878A, RAI091878B]; American Diabetes Association [1-10-JF-28]; American Cancer Society [RSG-10-157-01-LIB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI091878, R01AI091878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RAI091878A and RAI091878B (NIAID). This work was also supported by grants from the American Diabetes Association (1-10-JF-28) and the American Cancer Society (RSG-10-157-01-LIB).	Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Ebert PJR, 2008, IMMUNITY, V29, P734, DOI 10.1016/j.immuni.2008.09.014; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; GOODE N, 1992, J BIOL CHEM, V267, P16878; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; REAY PA, 1994, J IMMUNOL, V152, P3946; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun LD, 2007, CELL SIGNAL, V19, P2255, DOI 10.1016/j.cellsig.2007.06.014; SZYF M, 1991, J BIOL CHEM, V266, P10027; Tao X, 1997, J IMMUNOL, V158, P4237; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	58	35	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19127	19139		10.1074/jbc.M113.453357	http://dx.doi.org/10.1074/jbc.M113.453357			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23687305	hybrid, Green Published			2022-12-25	WOS:000321335800047
J	Gerber, S				Gerber, Sylvain			On the Relationship between the Macroevolutionary Trajectories of Morphological Integration and Morphological Disparity	PLOS ONE			English	Article							COVARIANCE-MATRIX; CONSTRAINTS; RADIATION; EVOLUTION; EXAMPLES; PATTERNS; SCALE	How does the organization of phenotypes relate to their propensity to vary? How do evolutionary changes in this organization affect large-scale phenotypic evolution? Over the last decade, studies of morphological integration and modularity have renewed our understanding of the organizational and variational properties of complex phenotypes. Much effort has been made to unravel the connections among the genetic, developmental, and functional contexts leading to differential integration among morphological traits and individuation of variational modules. Yet, their macroevolutionary consequences on the dynamics of morphological disparity-the large-scale variety of organismal designs-are still largely unknown. Here, I investigate the relationship between morphological integration and morphological disparity throughout the entire evolutionary history of crinoids (echinoderms). Quantitative analyses of interspecific patterns of variation and covariation among characters describing the stem, cup, arm, and tegmen of the crinoid body do not show any significant concordance between the temporal trajectories of disparity and overall integration. Nevertheless, the results reveal marked differences in the patterns of integration for Palaeozoic and post-Palaeozoic crinoids. Post-Palaeozoic crinoids have a higher degree of integration and occupy a different region of the space of integration patterns, corresponding to more heterogeneously structured matrices of correlation among traits. Particularly, increased covariation is observed between subsets of characters from the dorsal cup and from the arms. These analyses show that morphological disparity is not dependent on the overall degree of evolutionary integration but rather on the way integration is distributed among traits. Hence, temporal changes in disparity dynamics are likely constrained by reorganizations of the modularity of the crinoid morphology and not by changes in the variability of individual traits. The differences in integration patterns explain the more stereotyped morphologies of post-Palaeozoic crinoids and, from a broader macroevolutionary perspective, call for a greater attention to the distributional heterogeneities of constraints in morphospace.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Gerber, S (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	s.gerber@bath.ac.uk			Leverhulme Trust research grant [F/00 351/Z]	Leverhulme Trust research grant(Leverhulme Trust)	This research was supported by a Leverhulme Trust research grant (Grant F/00 351/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERCH P, 1980, AM ZOOL, V20, P653; ALROY J, 1994, SYST BIOL, V43, P430, DOI 10.2307/2413678; Altenberg L, 2005, MODULARITY UNDERSTAN, P100; Arthur W, 2001, EVOL DEV, V3, P271, DOI 10.1046/j.1525-142x.2001.003004271.x; Arthur Wallace, 1997, ORIGIN ANIMAL BODY P; Baumiller TK, 2008, ANNU REV EARTH PL SC, V36, P221, DOI [10.1146/annurev.earth.36.031207.124116, 10.1146/annurev.earth36.031207.124116]; Baumiller TK, 2010, P NATL ACAD SCI USA, V107, P5893, DOI 10.1073/pnas.0914199107; CAMIN JH, 1965, EVOLUTION, V19, P311, DOI 10.2307/2406441; Chernoff B., 1999, MORPHOLOGICAL INTEGR, P319; Ciampaglio CN, 2002, EVOL DEV, V4, P170, DOI 10.1046/j.1525-142X.2002.02001.x; Deline B, 2011, PALEOBIOLOGY, V37, P214, DOI 10.1666/09063.1; Eble GJ, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P253; Erwin DH, 2007, PALAEONTOLOGY, V50, P57, DOI 10.1111/j.1475-4983.2006.00614.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Foote M, 1999, PALEOBIOLOGY, V25, P1, DOI 10.1666/0094-8373(1999)25[1:MDITER]2.0.CO;2; Foote M, 1996, SCIENCE, V274, P1492, DOI 10.1126/science.274.5292.1492; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; FOOTE M, 1995, PALEOBIOLOGY, V21, P273, DOI 10.1017/S0094837300013300; FOOTE M, 1992, PALEOBIOLOGY, V18, P1, DOI 10.1017/S0094837300012185; Foote Mike, 1994, Contributions from the Museum of Paleontology University of Michigan, V29, P1; Foote Mike, 1995, Contributions from the Museum of Paleontology University of Michigan, V29, P135; Gerber S, 2011, EVOLUTION, V65, P3241, DOI 10.1111/j.1558-5646.2011.01363.x; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Hara Y, 2006, DEV GENES EVOL, V216, P797, DOI 10.1007/s00427-006-0108-1; Jablonski D, 2000, PALEOBIOLOGY, V26, P15, DOI 10.1666/0094-8373(2000)26[15:MAMSAH]2.0.CO;2; Kauffman S.A., 1983, Symposium of the British Society for Developmental Biology, V6, P195; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; LEWONTIN RC, 1978, SCI AM, V239, P212, DOI 10.1038/scientificamerican0978-212; MCKINNEY M L, 1989, Palaios, V4, P3, DOI 10.2307/3514729; McShea DW, 1998, BIODIVERSITY DYNAMICS, P91; Mitteroecker P, 2009, EVOLUTION, V63, P727, DOI 10.1111/j.1558-5646.2008.00587.x; O'Keefe FR, 2001, SYST BIOL, V50, P657, DOI 10.1080/106351501753328794; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Pavlicev M, 2009, EVOL BIOL, V36, P157, DOI 10.1007/s11692-008-9042-7; Raff R.A., 1996, SHAPE LIFE; Rasskin-Gutman Diego, 2005, P207; RAUP D M, 1987, P121; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schlosser G., 2004, MODULARITY DEV EVOLU; Shibata TF, 2008, ZOOL SCI, V25, P1075, DOI 10.2108/zsj.25.1075; SIMMS MJ, 1993, PALAEONTOLOGY, V36, P91; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Stadler BMR, 2001, J THEOR BIOL, V213, P241, DOI 10.1006/jtbi.2001.2423; Wagner GP, 1996, AM ZOOL, V36, P36; WAGNER GP, 1984, J MATH BIOL, V21, P77, DOI 10.1007/BF00275224; WILLS MA, 1994, PALEOBIOLOGY, V20, P93, DOI 10.1017/S009483730001263X	50	19	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63913	10.1371/journal.pone.0063913	http://dx.doi.org/10.1371/journal.pone.0063913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691115	gold, Green Published			2022-12-25	WOS:000319107900065
J	Luth, W; Jardine, C; Bubela, T				Luth, Westerly; Jardine, Cindy; Bubela, Tania			When Pictures Waste a Thousand Words: Analysis of the 2009 H1N1 Pandemic on Television News	PLOS ONE			English	Article							VACCINATION; RISK; MEDIA; PERCEPTION; ATTENTION; ATTITUDES; COVERAGE; CHILDREN; ADULTS; PRINT	Objectives: Effective communication by public health agencies during a pandemic promotes the adoption of recommended health behaviours. However, more information is not always the solution. Rather, attention must be paid to how information is communicated. Our study examines the television news, which combines video and audio content. We analyse (1) the content of television news about the H1N1 pandemic and vaccination campaign in Alberta, Canada; (2) the extent to which television news content conveyed key public health agency messages; (3) the extent of discrepancies in audio versus visual content. Methods: We searched for "swine flu'' and "H1N1'' in local English news broadcasts from the CTV online video archive. We coded the audio and visual content of 47 news clips during the peak period of coverage from April to November 2009 and identified discrepancies between audio and visual content. Results: The dominant themes on CTV news were the vaccination rollout, vaccine shortages, long line-ups (queues) at vaccination clinics and defensive responses by public health officials. There were discrepancies in the priority groups identified by the provincial health agency (Alberta Health and Wellness) and television news coverage as well as discrepancies between audio and visual content of news clips. Public health officials were presented in official settings rather than as public health practitioners. Conclusion: The news footage did not match the main public health messages about risk levels and priority groups. Public health agencies lost control of their message as the media focused on failures in the rollout of the vaccination campaign. Spokespeople can enhance their local credibility by emphasizing their role as public health practitioners. Public health agencies need to learn from the H1N1 pandemic so that future television communications do not add to public confusion, demonstrate bureaucratic ineffectiveness and contribute to low vaccination rates.	[Luth, Westerly; Bubela, Tania] Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB, Canada; [Jardine, Cindy] Univ Alberta, Sch Publ Hlth, Ctr Hlth Promot Studies, Edmonton, AB, Canada	University of Alberta; University of Alberta	Bubela, T (corresponding author), Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB, Canada.	tbubela@ualberta.ca	Bubela, Tania/F-4860-2014	Bubela, Tania/0000-0002-0807-2899	Operating Grant on Health Systems Research on H1N1 (Institute for Population and Public Health) from the Canadian Institutes of Health Research (CIHR) [RES0008252]; Frederick Banting & Charles Best CIHR Master's Award [GSM-123188]	Operating Grant on Health Systems Research on H1N1 (Institute for Population and Public Health) from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Frederick Banting & Charles Best CIHR Master's Award	This study was supported by an Operating Grant on Health Systems Research on H1N1 (Institute for Population and Public Health) (Project No. RES0008252) from the Canadian Institutes of Health Research (CIHR). Westerly Luth is supported by a Frederick Banting & Charles Best CIHR Master's Award (Funding reference number: GSM-123188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Health and Wellness, 2008, INFL SELF CAR CAR PR; Alberta Health and Wellness, 2009, ALB PLAN PAND INFL; Alberta Health and Wellness Alberta Health Services, 2010, PAND H1N1 2009 ALB E; [Anonymous], 2009, WHAT IS PHAS 6; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Brase GL, 2004, J APPL SOC PSYCHOL, V34, P2469, DOI 10.1111/j.1559-1816.2004.tb01987.x; BRAUN CC, 1995, ERGONOMICS, V38, P2207, DOI 10.1080/00140139508925263; Brown KF, 2010, VACCINE, V28, P4181, DOI 10.1016/j.vaccine.2010.04.012; Bubela T, 2009, NAT BIOTECHNOL, V27, P514, DOI 10.1038/nbt0609-514; Burt RS, 2005, BROKERAGE CLOSURE IN; Cappella JN, 1996, ANN AM ACAD POLIT SS, V546, P71, DOI 10.1177/0002716296546001007; Carducci A, 2011, PATIENT EDUC COUNS, V82, P475, DOI 10.1016/j.pec.2010.12.025; Chen N.N.T., 2011, INT PUBL HLTH J, V3, P45; Covello VT, 2016, ANN INT COMMUN ASS, V15, P359, DOI [10.1080/23808985.1992.11678816, DOI 10.1080/23808985.1992.11678816]; CSA Standards, 2010, VIUC H1N1 INFL PAND; Driedger SM, 2007, RISK ANAL, V27, P775, DOI 10.1111/j.1539-6924.2007.00922.x; Fogarty AS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-181; Gallup, 2011, REC  64 RAT HON ETH; Hawkins RP, 2005, HUM COMMUN RES, V31, P162, DOI 10.1093/hcr/31.1.162; Health Quality Council of Alberta, 2010, REV ALB RESP 2009 IN; Henrich N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018479; Henrich N, 2011, HEALTH PROMOT PRACT, V12, P610, DOI 10.1177/1524839910363536; Hidiroglu S, 2010, VACCINE, V28, P8120, DOI 10.1016/j.vaccine.2010.09.104; Higgins JW, 2006, J HEALTH COMMUN, V11, P343, DOI 10.1080/10810730600614110; Hilton S, 2011, J EPIDEMIOL COMMUN H, V65, P941, DOI 10.1136/jech.2010.119875; Ipsos, 2012, WHAT DO PHARM DOCT S; Ipsos MORI, 2011, DOCT MOST TRUST; Landau J, 2009, PUBLIC UNDERST SCI, V18, P325, DOI 10.1177/0963662507080551; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lefevere J, 2012, COMMUN RES, V39, P103, DOI 10.1177/0093650210387124; Linc Group Corp, 2009, ACT REV ALB HLTH WEL; Lynch MM, 2012, MATERN CHILD HLTH J, V16, P1657, DOI 10.1007/s10995-011-0865-y; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Mayo Ann M, 2004, J Am Acad Nurse Pract, V16, P402, DOI 10.1111/j.1745-7599.2004.tb00390.x; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Nisbet MC, 2007, SCIENTIST, V21, P38; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011292; Ofri D, 2009, NEW ENGL J MED, V361, P2594, DOI 10.1056/NEJMp0911047; Pew Research Center for the People and the Press, 2009, FEW HALF WOULD GET V; QSR International, 2011, NVIVO 9; Rachiotis G, 2010, EURO SURVEILL, V15; Rachul CM, 2011, CAN J PUBLIC HEALTH, V102, P200, DOI 10.1007/BF03404896; Reader's Digest Australia, 2010, AUSTR MOST TRUST; Rogers WA, 2009, HEALTH EXPECT, V12, P331, DOI 10.1111/j.1369-7625.2009.00562.x; Schmitt KL, 2003, J COMMUN, V53, P265, DOI 10.1111/j.1460-2466.2003.tb02590.x; Scott B.M., 2005, QUALITATIVE RES REPO, V6, P59, DOI [DOI 10.1080/17459430500262190, https://doi.org/10.1080/17459430500262190]; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Shih TJ, 2008, MASS COMMUN SOC, V11, P141, DOI 10.1080/15205430701668121; Siegrist M, 2005, J RISK RES, V8, P145, DOI 10.1080/1366987032000105315; Statistics Canada, 2012, POP DWELL COUNTS CAN; Statistics Canada, 2010, DAIL CAN COMM HLTH S; To KW, 2010, AM J INFECT CONTROL, V38, P623, DOI 10.1016/j.ajic.2010.05.015; Walter D, 2012, EUROSURVEILLANCE, V17, P9; World Health Organization, 2009, WHO PAND PHAS DESCR	54	9	9	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64070	10.1371/journal.pone.0064070	http://dx.doi.org/10.1371/journal.pone.0064070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RJ	23691150	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107900077
J	Tops, W; Verguts, E; Callens, M; Brysbaert, M				Tops, Wim; Verguts, Ellen; Callens, Maaike; Brysbaert, Marc			Do Students with Dyslexia Have a Different Personality Profile as Measured with the Big Five?	PLOS ONE			English	Article							LEARNING-DISABILITIES; HIGHER-EDUCATION; COLLEGE-STUDENTS; ADULTS; METACOGNITION; METAANALYSIS	Background: Few studies are available about the personality profile of higher education students with dyslexia and to which extent this could be any different from their non-dyslexic peers. Aims and Sample(s): To obtain empirical evidence, we compared the personality profile of a group of 100 Dutch-speaking students with dyslexia with that of a control group of 100 students without learning disabilities. Methods: The NEO-PI-R based on the Big Five in personality research was used. Results and Conclusions: Our study showed no differences in the personality between both groups. This agrees with a recent meta-analysis of English findings (Swanson & Hsieh, 2009), suggesting that students with dyslexia do not perceive themselves differently than their non-dyslexic peers. Practical implications and directions for future research are considered.	[Tops, Wim; Callens, Maaike; Brysbaert, Marc] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Verguts, Ellen] VZW Kinsbergen Orientatiectr, Antwerp, Belgium	Ghent University	Tops, W (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	wimtops@gmail.com	Brysbaert, Marc/A-3910-2011	Brysbaert, Marc/0000-0002-3645-3189; Tops, Wim/0000-0002-7889-8610	Government of Flanders	Government of Flanders	This study was made possible by an Odysseus Grant awarded by the Government of Flanders to Marc Brysbaert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Passe N, 2006, DYSLEXIA, V12, P256, DOI 10.1002/dys.318; Borkowski J.G., SELF REGULATION LEAR, P45; Brus B, 1991, VERANTWOORDING HANDL; Callens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038081; Carroll JM, 2006, BRIT J EDUC PSYCHOL, V76, P651, DOI 10.1348/000709905X66233; Cattell R.B., 1946, DESCRIPTION MEASUREM; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Cumming G, 2001, ED PSYCHOL MEASUREME, V61, P530; De Pessemier P, 2009, TEST GEVORDERD LEZEN; De Smedt B, 2010, NEUROPSYCHOLOGIA, V48, P3973, DOI 10.1016/j.neuropsychologia.2010.10.018; EYSENCK HJ, 1991, PERS INDIV DIFFER, V12, P773, DOI 10.1016/0191-8869(91)90144-Z; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Gerber P. J., 2009, LEARNING ACHIEVE REV, P231; Gobel SM, 2010, Q J EXP PSYCHOL, V63, P1361, DOI 10.1080/17470210903359206; Hatcher J, 2002, BRIT J EDUC PSYCHOL, V72, P119, DOI 10.1348/000709902158801; Hendriks AAJ, 1999, PERS INDIV DIFFER, V27, P307, DOI 10.1016/S0191-8869(98)00245-1; Hoekstra H. A., 1996, HANDLEIDING NEO PERS; Mason A, 2005, PEDIATR CLIN N AM, V52, P61, DOI 10.1016/j.pcl.2004.11.001; McCrae RR, 2000, J PERS SOC PSYCHOL, V78, P173, DOI 10.1037/0022-3514.78.1.173; Roberts BW, 2005, J RES PERS, V39, P166, DOI 10.1016/j.jrp.2004.08.002; Rose LT, 2012, MIND BRAIN EDUC, V6, P1, DOI 10.1111/j.1751-228X.2011.01135.x; Rourke B.P., 1989, NONVERBAL LEARNING D; Sideridis GD, 2006, J LEARN DISABIL-US, V39, P215, DOI 10.1177/00222194060390030301; Stichting Dyslexie Nederland, 2008, DIAGN BEH DYSL BROCH; Swanson HL, 2009, REV EDUC RES, V79, P1362, DOI 10.3102/0034654309350931; Szmalec A, 2011, J EXP PSYCHOL LEARN, V37, P1270, DOI 10.1037/a0023820; Tops W, 2012, ANN DYSLEXIA, V62, P186, DOI 10.1007/s11881-012-0072-6; Trainin G, 2005, LEARN DISABILITY Q, V28, P261, DOI 10.2307/4126965; van den Bos K., 1999, VERANTWOORDING HANDL; Vaughn S., 2003, LEARNING DISABILITIE, V18, P137, DOI [10.1111/1540-5826.00070, DOI 10.1111/1540-5826.00070]; Waldo SL, 1999, J PSYCHOEDUC ASSESS, V17, P196, DOI 10.1177/073428299901700301	31	7	7	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64484	10.1371/journal.pone.0064484	http://dx.doi.org/10.1371/journal.pone.0064484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RJ	23691229	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107900103
J	Young, I; Li, J; McDaid, L				Young, Ingrid; Li, Jessica; McDaid, Lisa			Awareness and Willingness to Use HIV Pre-Exposure Prophylaxis amongst Gay and Bisexual Men in Scotland: Implications for Biomedical HIV Prevention	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; LIMITED KNOWLEDGE; CONDOM USE; SEX; POSTEXPOSURE	Objectives: To investigate the awareness of, and willingness to use, HIV Pre-Exposure Prophylaxis (PrEP), and willingness to take part in a PrEP study among gay and bisexual men in Scotland. Methods: Cross-sectional survey of 17 gay commercial venues in Glasgow and Edinburgh in May 2011 (N = 1515, 65.2% response rate); 1393 are included in the analyses. Results: Just under one-third of participants had heard of PrEP (n = 434; 31.2%), with awareness associated with being aged older than 35 years, talking to UAI partners about HIV, and with having had an HIV or STI test in the previous 12 months. Around half were willing to take part in a PrEP study (n = 695; 49.9%) or to take PrEP on a daily basis (n = 756; 54.3%). In multivariate analysis, willingness to take PrEP was associated with lower levels of education, regular gay scene attendance, 'high-risk' unprotected anal intercourse (UAI) and testing for HIV or STI in the previous 12 months. Reasons for not wanting to participate in a PrEP study or take PrEP included perceptions of low personal risk of HIV and concerns with using medication as an HIV prevention method. Conclusions: There is a willingness to engage in new forms of HIV prevention and research amongst a significant number of gay and bisexual men in Scotland. Future biomedical HIV interventions need to consider the links between sexual risk behaviour, testing, and potential PrEP use.	[Young, Ingrid; Li, Jessica; McDaid, Lisa] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT	Young, I (corresponding author), MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	i.young@sphsu.mrc.ac.uk		Young, Ingrid/0000-0002-1242-5992; McDaid, Lisa/0000-0002-7711-8723	UK Medical Research Council; Gay Men's Survey as part of the Sexual Health programme at the MRC/CSO Social and Public Health Sciences Unit [MC_A540_5TK60]; Medical Research Council [MC_UU_12017/2, MC_U130031238] Funding Source: researchfish; MRC [MC_U130031238, MC_UU_12017/2] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gay Men's Survey as part of the Sexual Health programme at the MRC/CSO Social and Public Health Sciences Unit; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council (http://www.mrc.ac.uk/index.htm) funds IY, JL, LMD and the Gay Men's Survey as part of the Sexual Health programme (MC_A540_5TK60) at the MRC/CSO Social and Public Health Sciences Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaizu A, 2012, SEX TRANSM INFECT; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Brooks RA, 2011, AIDS CARE, V23, P1136, DOI 10.1080/09540121.2011.554528; Ezzy D., 2002, QUALITATIVE ANAL PRA; FDA, 2012, FDA APPR 1 DRUG RED; Gay Men's Health (GMH), 2011, GAY MENS HLTH 2010 2; Gibbs G.R., 2007, ANAL QUALITATIVE DAT; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Jackson T, 2012, AIDS BEHAV, V16, P1853, DOI 10.1007/s10461-012-0188-z; Kashuba ADM, 2012, LANCET, V379, P2409, DOI 10.1016/S0140-6736(11)61852-7; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Leonardi M, 2011, INT J STD AIDS, V22, P738, DOI 10.1258/ijsa.2011.011057; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Lorente N, 2011, AIDS CARE; Mansergh G, 2010, JAIDS-J ACQ IMM DEF, V55, pE14, DOI 10.1097/QAI.0b013e3181f27616; McCormack S, 2012, INT J STD AIDS, V23, P1, DOI 10.1258/ijsa.2011.051211; McDaid LM, 2011, SEX TRANSM INFECT, V87, P221, DOI 10.1136/sti.2010.044560; McDaid LM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-798; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Sigma Research, 2011, SIGM PAN INS BLAST 6; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; THNG C, 2012, HIV MED S1, V13, P84; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; van Griensven F, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-13	28	51	52	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64038	10.1371/journal.pone.0064038	http://dx.doi.org/10.1371/journal.pone.0064038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RJ	23691143	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000319107900074
J	Duong-Ly, KC; Woo, HN; Dunn, CA; Xu, WL; Babic, A; Bessman, MJ; Amzel, LM; Gabelli, SB				Duong-Ly, Krisna C.; Woo, Hyun Nyun; Dunn, Christopher A.; Xu, WenLian; Babic, Andrej; Bessman, Maurice J.; Amzel, L. Mario; Gabelli, Sandra B.			A UDP-X Diphosphatase from Streptococcus pneumoniae Hydrolyzes Precursors of Peptidoglycan Biosynthesis	PLOS ONE			English	Article							ISOMORPHOUS REPLACEMENT; SOLUTION SCATTERING; NUDIX HYDROLASES; STRUCTURAL BASIS; PYROPHOSPHOHYDROLASE; PYROPHOSPHATASE; SYSTEM; ERRORS	The gene for a Nudix enzyme (SP_1669) was found to code for a UDP-X diphosphatase. The SP_1669 gene is localized among genes encoding proteins that participate in cell division in Streptococcus pneumoniae. One of these genes, MurF, encodes an enzyme that catalyzes the last step of the Mur pathway of peptidoglycan biosynthesis. Mur pathway substrates are all derived from UDP-glucosamine and all are potential Nudix substrates. We showed that UDP-X diphosphatase can hydrolyze the Mur pathway substrates UDP-N-acetylmuramic acid and UDP-N-acetylmuramoyl-L-alanine. The 1.39 A resolution crystal structure of this enzyme shows that it folds as an asymmetric homodimer with two distinct active sites, each containing elements of the conserved Nudix box sequence. In addition to its Nudix catalytic activity, the enzyme has a 3959 RNA exonuclease activity. We propose that the structural asymmetry in UDP-X diphosphatase facilitates the recognition of these two distinct classes of substrates, Nudix substrates and RNA. UDP-X diphosphatase is a prototype of a new family of Nudix enzymes with unique structural characteristics: two monomers, each consisting of an N-terminal helix bundle domain and a C-terminal Nudix domain, form an asymmetric dimer with two distinct active sites. These enzymes function to hydrolyze bacterial cell wall precursors and degrade RNA.	[Duong-Ly, Krisna C.; Amzel, L. Mario; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Woo, Hyun Nyun; Dunn, Christopher A.; Xu, WenLian; Bessman, Maurice J.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21205 USA; [Woo, Hyun Nyun; Dunn, Christopher A.; Xu, WenLian; Bessman, Maurice J.] Johns Hopkins Univ, McCollum Pratt Inst, Baltimore, MD 21205 USA; [Babic, Andrej] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Geneva; University of Lausanne; Johns Hopkins University	Amzel, LM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	mamzel@jhmi.edu; gabelli@jhmi.edu	Babič, Andrej/E-8687-2017; Gabelli, Sandra B/A-3705-2008	Babič, Andrej/0000-0001-7612-1704; Gabelli, Sandra B/0000-0003-1205-5204; Dunn, Christopher/0000-0001-7899-0110; Duong-Ly, Krisna/0000-0002-4593-8145; Amzel, L. Mario/0000-0002-0129-9572	National Institutes of Health (NIH) [GM066895]; National Science Foundation; NIH training grant [T32 GM008403]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008403, R01GM066895] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH),(www.nih.gov) (GM066895 to LMA) and a National Science Foundation Graduate Research Fellowship (www.nsf.gov) to KCD. KCD was also supported by NIH training grant T32 GM008403 to the Program in Molecular Biophysics at Johns Hopkins University. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U.S. Department of Energy (energy.gov), Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility. Use of the National Synchrotron Light Source, Brookhaven National Laboratory, and beamline X6A and X9, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-98CH10886. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Allaire M, 2011, J SYNCHROTRON RADIAT, V18, P41, DOI 10.1107/S0909049510036022; AMES BN, 1960, J BIOL CHEM, V235, P769; Babic A, 2007, TETRAHEDRON LETT, V48, P4403, DOI 10.1016/j.tetlet.2007.04.098; Babic A, 2008, TETRAHEDRON-ASYMMETR, V19, P2265, DOI 10.1016/j.tetasy.2008.09.029; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Boto AN, 2011, PROTEINS, V79, P2455, DOI 10.1002/prot.23069; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Duong-Ly KC, 2011, J BACTERIOL, V193, P3175, DOI 10.1128/JB.00089-11; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer W, 2000, RES MICROBIOL, V151, P421, DOI 10.1016/S0923-2508(00)00174-1; Fiske CH, 1925, J BIOL CHEM, V66, P375; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gabelli SB, 2007, BIOPHYS J, p213A; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Gabelli SB, 2004, STRUCTURE, V12, P927, DOI 10.1016/j.str.2004.03.028; Gabelli SB, 2003, BIOCHEMISTRY-US, V42, P8598; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Heyen CA, 2009, BIOCHEM BIOPH RES CO, V390, P1414, DOI 10.1016/j.bbrc.2009.11.007; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2000, J APPL CRYSTALLOGR, V33, P775, DOI 10.1107/S0021889800001382; Messing SAJ, 2009, STRUCTURE, V17, P472, DOI 10.1016/j.str.2008.12.022; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Molecular Operating Environment (MOE), 2019, MOL OP ENV MOE; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Swapna LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036688; TERWILLIGER TC, 1994, ACTA CRYSTALLOGR D, V50, P11, DOI 10.1107/S0907444993008224; TERWILLIGER TC, 1994, ACTA CRYSTALLOGR D, V50, P17, DOI 10.1107/S0907444993008236; TERWILLIGER TC, 1983, ACTA CRYSTALLOGR A, V39, P813, DOI 10.1107/S0108767383001592; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P45, DOI 10.1107/S0907444902018048; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P6, DOI 10.1107/S0108767387099987; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Williams T., 1993, GNUPLOT INTERACTIVE; Xu WL, 2001, MOL MICROBIOL, V39, P286, DOI 10.1046/j.1365-2958.2001.02267.x	45	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64241	10.1371/journal.pone.0064241	http://dx.doi.org/10.1371/journal.pone.0064241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691178	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700085
J	le Roex, N; Koets, AP; van Helden, PD; Hoal, EG				le Roex, Nikki; Koets, Ad P.; van Helden, Paul D.; Hoal, Eileen G.			Gene Polymorphisms in African Buffalo Associated with Susceptibility to Bovine Tuberculosis Infection	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; WILDLIFE; RESISTANCE; SLC11A1; INNATE; CATTLE	Bovine tuberculosis (BTB) is a chronic, highly infectious disease that affects humans, cattle and numerous species of wildlife. In developing countries such as South Africa, the existence of extensive wildlife-human-livestock interfaces poses a significant risk of Mycobacterium bovis transmission between these groups, and has far-reaching ecological, economic and public health impacts. The African buffalo (Syncerus caffer), acts as a maintenance host for Mycobacterium bovis, and maintains and transmits the disease within the buffalo and to other species. In this study we aimed to investigate genetic susceptibility of buffalo for Mycobacterium bovis infection. Samples from 868 African buffalo of the Cape buffalo subspecies were used in this study. SNPs (n = 69), with predicted functional consequences in genes related to the immune system, were genotyped in this buffalo population by competitive allele-specific SNP genotyping. Case-control association testing and statistical analyses identified three SNPs associated with BTB status in buffalo. These SNPs, SNP41, SNP137 and SNP144, are located in the SLC7A13, DMBT1 and IL1a genes, respectively. SNP137 remained significantly associated after permutation testing. The three genetic polymorphisms identified are located in promising candidate genes for further exploration into genetic susceptibility to BTB in buffalo and other bovids, such as the domestic cow. These polymorphisms/genes may also hold potential for marker-assisted breeding programmes, with the aim of breeding more BTB-resistant animals and herds within both the national parks and the private sector.	[le Roex, Nikki; van Helden, Paul D.; Hoal, Eileen G.] Univ Stellenbosch, Fac Hlth, MRC Ctr Mol & Cellular Biol, DST NRF Ctr Excellence Biomed TB Res,Div Mol Biol, Cape Town, South Africa; [Koets, Ad P.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Koets, Ad P.] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Utrecht, Netherlands	National Research Foundation - South Africa; Stellenbosch University; Utrecht University; Utrecht University	le Roex, N (corresponding author), Univ Stellenbosch, Fac Hlth, MRC Ctr Mol & Cellular Biol, DST NRF Ctr Excellence Biomed TB Res,Div Mol Biol, Cape Town, South Africa.	nikkileroex@sun.ac.za		Koets, Ad/0000-0001-9809-3679; Hoal, Eileen/0000-0002-6444-5688	WOTRO Science for Global Development [W01.65.321.00]	WOTRO Science for Global Development	This study was predominantly funded by a grant from WOTRO Science for Global Development (grant W01.65.321.00) awarded to PVH, EGH and AK. NLR was supported by a student stipend from this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2008, CLIN VACCINE IMMUNOL, V15, P1272, DOI 10.1128/CVI.00114-08; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Bellamy R., 1998, Tubercle and Lung Disease, V79, P83, DOI 10.1054/tuld.1998.0009; Beltan E, 2000, MICROB PATHOGENESIS, V28, P313, DOI 10.1006/mpat.1999.0345; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; Brotherstone S, 2010, J DAIRY SCI, V93, P1234, DOI 10.3168/jds.2009-2609; Caron A, 2003, ECOL APPL, V13, P1338, DOI 10.1890/02-5266; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Driscoll EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018806; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Hoal EG, 2004, INT J TUBERC LUNG D, V8, P1464; Hope JC, 2008, COMP IMMUNOL MICROB, V31, P77, DOI 10.1016/j.cimid.2007.07.003; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Ligtenberg AJM, 2010, INT J MOL SCI, V11, P5213, DOI 10.3390/ijms1112521; Mackintosh CG, 2000, INFECT IMMUN, V68, P1620, DOI 10.1128/IAI.68.3.1620-1625.2000; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Michel AL, 2009, VET MICROBIOL, V133, P335, DOI 10.1016/j.vetmic.2008.07.023; Michel AL, 2006, VET MICROBIOL, V112, P91, DOI 10.1016/j.vetmic.2005.11.035; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Ngandolo BNR, 2009, PREV VET MED, V89, P81, DOI 10.1016/j.prevetmed.2009.02.003; Palacin M, 2005, PHYSIOLOGY, V20, P112, DOI 10.1152/physiol.00051.2004; Palaniyar N, 2010, INNATE IMMUN-LONDON, V16, P131, DOI 10.1177/1753425910370498; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Roex NL, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0048792; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schmidt DR, 2007, BIOMATERIALS, V28, P371, DOI 10.1016/j.biomaterials.2006.08.041; Simonsen BT, 1998, MOL ECOL, V7, P225, DOI 10.1046/j.1365-294x.1998.00343.x; Sun LP, 2012, VET IMMUNOL IMMUNOP, V147, P195, DOI 10.1016/j.vetimm.2012.04.016; Velez DR, 2009, INT J TUBERC LUNG D, V13, P1068; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Vordermeier M, 2004, VET REC, V155, P37	36	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64494	10.1371/journal.pone.0064494	http://dx.doi.org/10.1371/journal.pone.0064494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691232	Green Published, gold			2022-12-25	WOS:000319052700101
J	Yano, H; Uemura, M; Endo, S; Kanamori, H; Inomata, S; Kakuta, R; Ichimura, S; Ogawa, M; Shimojima, M; Ishibashi, N; Aoyagi, T; Hatta, M; Gu, Y; Yamada, M; Tokuda, K; Kunishima, H; Kitagawa, M; Hirakata, Y; Kaku, M				Yano, Hisakazu; Uemura, Mina; Endo, Shiro; Kanamori, Hajime; Inomata, Shinya; Kakuta, Risako; Ichimura, Sadahiro; Ogawa, Miho; Shimojima, Masahiro; Ishibashi, Noriomi; Aoyagi, Tetsuji; Hatta, Masumitsu; Gu, Yoshiaki; Yamada, Mitsuhiro; Tokuda, Koichi; Kunishima, Hiroyuki; Kitagawa, Miho; Hirakata, Yoichi; Kaku, Mitsuo			Molecular Characteristics of Extended-Spectrum beta-Lactamases in Clinical Isolates from Escherichia coli at a Japanese Tertiary Hospital	PLOS ONE			English	Article							QUINOLONE RESISTANCE; EMERGENCE; PREVALENCE	The prevalence of ESBL has been increasing worldwide. In this study, we investigated the molecular characteristics of ESBL among clinical isolates of Escherichia coli from a Japanese tertiary hospital. A total of 71 consecutive and nonduplicate clinical isolates of ESBL-positive E. coli collected at Tohoku University Hospital between January 2008 and March 2011 were studied. The antimicrobial susceptibility profile of these strains was determined. PCR and sequencing were performed to identify genes for beta-lactamase (bla(TEM), bla(SHV), bla(OXA-1-like), and bla(CTX-M)) and plasmid-mediated quinolone resistance determinants (PMQR). The isolates were also analyzed by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Of the 71 strains, 68 were positive for CTX-M, 28 were positive for TEM, four were positive for OXA-1, and one was positive for SHV. Sequencing revealed that CTX-M-14 was the most prevalent (31/71), followed by CTX-M-27 (21/71) and then CTX-M-15 (9/71). Of the 28 TEM-positive strains, one was TEM-10 and the rest were TEM-1. One SHV-positive strain was SHV-12. The 21 CTX-M-27-producing isolates were divided into 14 unique PFGE types, while the 9 CTX-M-15 producers were divided into 8 types. Based on MLST, 9 CTX-M-14 procedures, 19 CTX-M-27 procedures, and 8 CTX-M-15 producers belonged to ST131. Thirty-five (94.6%) of the 37 ST131 E. coli strains showed resistance to levofloxacin, which was a higher rate than among non-ST131 strains (63.6%). Among ESBL-producing isolates, one, two, and six possessed qnrB, qnrS, qepA, and aac(6')-Ib-cr, respectively. Of the 6 isolates with aac(6')-Ib-cr, 4 carried the CTX-M-15 gene. Our data suggest that CTX-M-15-producing E. coli ST131 has emerged as a worldwide pandemic clone, while CTX-M-27 (a variant of CTX-M-14) is also spreading among E. coli ST131 in Japan.	[Yano, Hisakazu; Uemura, Mina; Endo, Shiro; Kanamori, Hajime; Inomata, Shinya; Ishibashi, Noriomi; Aoyagi, Tetsuji; Hatta, Masumitsu; Tokuda, Koichi; Kitagawa, Miho; Hirakata, Yoichi; Kaku, Mitsuo] Tohoku Univ, Grad Sch Med, Dept Infect Control & Lab Diagnost, Sendai, Miyagi 980, Japan; [Kakuta, Risako] Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 980, Japan; [Ichimura, Sadahiro; Ogawa, Miho; Shimojima, Masahiro] BML Inc, Dept Bacteriol, Kawagoe, Saitama, Japan; [Gu, Yoshiaki; Yamada, Mitsuhiro; Kunishima, Hiroyuki] Tohoku Univ, Grad Sch Med, Dept Reg Cooperat Infect Dis, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; BML, Inc.; Tohoku University	Yano, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Infect Control & Lab Diagnost, Sendai, Miyagi 980, Japan.	yanohisa@med.tohoku.ac.jp	HATTA, MOCHAMMAD/D-3742-2019; YAMADA, MITSUHIRO/Q-8003-2016; Kaku, Mitsuo/E-5811-2017	HATTA, MOCHAMMAD/0000-0002-8456-4203; YAMADA, MITSUHIRO/0000-0002-0832-1939; Kanamori, Hajime/0000-0003-3026-5272				Bonnet R, 2003, J ANTIMICROB CHEMOTH, V52, P29, DOI 10.1093/jac/dkg256; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; *CLIN LAB STAND I, 2009, M100S19 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Ender PT, 2009, J CLIN MICROBIOL, V47, P3780, DOI 10.1128/JCM.01361-09; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Heffernan HM, 2009, INT J ANTIMICROB AG, V34, P544, DOI 10.1016/j.ijantimicag.2009.07.014; Johnson JR, 2010, PEDIATR INFECT DIS J, V29, P473, DOI 10.1097/INF.0b013e3181c89bd7; Jorgensen RL, 2010, J ANTIMICROB CHEMOTH, V65, P460, DOI 10.1093/jac/dkp484; Kanamori H, 2011, J ANTIMICROB CHEMOTH, V66, P2255, DOI 10.1093/jac/dkr283; Karisik E, 2006, J ANTIMICROB CHEMOTH, V58, P665, DOI 10.1093/jac/dkl309; Kuroda H, 2012, DIAGN MICR INFEC DIS, V74, P201, DOI 10.1016/j.diagmicrobio.2012.06.011; Lautenbach E, 2001, CLIN INFECT DIS, V33, P1288, DOI 10.1086/322667; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Ministry of Health Labour and Welfare, 2011, ETH GUID EP STUD; Muzaheed, 2008, J ANTIMICROB CHEMOTH, V61, P1393, DOI 10.1093/jac/dkn109; Ode T, 2009, INT J ANTIMICROB AG, V34, P347, DOI 10.1016/j.ijantimicag.2009.05.007; Owens RC, 2011, J CLIN MICROBIOL, V49, P3406, DOI 10.1128/JCM.00993-11; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Pitout JDD, 2004, CLIN INFECT DIS, V38, P1736, DOI 10.1086/421094; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pitout JDD, 2007, ANTIMICROB AGENTS CH, V51, P1281, DOI 10.1128/AAC.01377-06; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463; Vigil KJ, 2010, CLIN INFECT DIS, V50, P374, DOI 10.1086/649866	27	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64359	10.1371/journal.pone.0064359	http://dx.doi.org/10.1371/journal.pone.0064359			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691204	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700090
J	Chakravarty, S; Reddy, BR; Sudhakar, SR; Saxena, S; Das, T; Meghah, V; Swamy, CVB; Kumar, A; Idris, MM				Chakravarty, Sumana; Reddy, Bommana R.; Sudhakar, Sreesha R.; Saxena, Sandeep; Das, Tapatee; Meghah, Vuppalapaty; Swamy, Cherukuvada V. Brahmendra; Kumar, Arvind; Idris, Mohammed M.			Chronic Unpredictable Stress (CUS)-Induced Anxiety and Related Mood Disorders in a Zebrafish Model: Altered Brain Proteome Profile Implicates Mitochondrial Dysfunction	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; BIPOLAR DISORDER; GENE-EXPRESSION; BDNF EXPRESSION; ADULT ZEBRAFISH; FRONTAL-CORTEX; BEHAVIOR; DEPRESSION; NEUROPROTECTION; COMORBIDITY	Anxiety and depression are major chronic mood disorders, and the etiopathology for each appears to be repeated exposure to diverse unpredictable stress factors. Most of the studies on anxiety and related mood disorders are performed in rodents, and a good model is chronic unpredictable stress (CUS). In this study, we have attempted to understand the molecular basis of the neuroglial and behavioral changes underlying CUS-induced mood disorders in the simplest vertebrate model, the zebrafish, Danio rerio. Zebrafish were subjected to a CUS paradigm in which two different stressors were used daily for 15 days, and thorough behavioral analyses were performed to assess anxiety and related mood disorder phenotypes using the novel tank test, shoal cohesion and scototaxis. Fifteen days of exposure to chronic stressors appears to induce an anxiety and related mood disorder phenotype. Decreased neurogenesis, another hallmark of anxiety and related disorders in rodents, was also observed in this zebrafish model. The common molecular markers of rodent anxiety and related disorders, corticotropin-releasing factor (CRF), calcineurin (ppp3r1a) and phospho cyclic AMP response element binding protein (pCREB), were also replicated in the fish model. Finally, using 2DE FTMS/ITMSMS proteomics analyses, 18 proteins were found to be deregulated in zebrafish anxiety and related disorders. The most affected process was mitochondrial function, 4 of the 18 differentially regulated proteins were mitochondrial proteins: PHB2, SLC25A5, VDAC3 and IDH2, as reported in rodent and clinical samples. Thus, the zebrafish CUS model and proteomics can facilitate not only uncovering new molecular targets of anxiety and related mood disorders but also the routine screening of compounds for drug development.	[Chakravarty, Sumana; Reddy, Bommana R.; Das, Tapatee] CSIR Indian Inst Chem Technol IICT, Chem Biol Div, Hyderabad, Andhra Pradesh, India; [Sudhakar, Sreesha R.; Saxena, Sandeep; Meghah, Vuppalapaty; Swamy, Cherukuvada V. Brahmendra; Kumar, Arvind; Idris, Mohammed M.] CSIR Ctr Cellular & Mol Biol CCMB, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chakravarty, S (corresponding author), CSIR Indian Inst Chem Technol IICT, Chem Biol Div, Hyderabad, Andhra Pradesh, India.	sumana98@gmail.com; idris@ccmb.res.in	Chakravarty, Sumana/AAW-2823-2021	Das, Tapatee/0000-0002-5703-045X; Kumar, Arvind/0000-0003-2879-3826	DST (Department of Science and Technology), India; CSIR (Council of Scientific and Industrial Research) network project [BSC0115]; DBT (Department of Biotechnology), India	DST (Department of Science and Technology), India(Department of Science & Technology (India)); CSIR (Council of Scientific and Industrial Research) network project; DBT (Department of Biotechnology), India(Department of Biotechnology (DBT) India)	Funding came from DST (Department of Science and Technology), India, CSIR (Council of Scientific and Industrial Research) network project BSC0115, and DBT (Department of Biotechnology), India, for providing Ramalingaswami Re-entry fellowship to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisman H, 2008, NEUROSCI BIOBEHAV R, V32, P1185, DOI 10.1016/j.neubiorev.2008.03.001; Anitha A, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-12; Bale TL, 2002, J NEUROSCI, V22, P193, DOI 10.1523/JNEUROSCI.22-01-00193.2002; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Blaser RE, 2011, PHYSIOL BEHAV, V104, P831, DOI 10.1016/j.physbeh.2011.07.029; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Brecht S, 2003, NEUROSCIENCE, V120, P1037, DOI 10.1016/S0306-4522(03)00404-4; Buske C, 2011, PROG NEURO-PSYCHOPH, V35, P1409, DOI 10.1016/j.pnpbp.2010.09.003; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Carboni L, 2006, NEUROSCIENCE, V137, P1237, DOI 10.1016/j.neuroscience.2005.10.045; Davison EJ, 2009, PROTEOMICS, V9, P4284, DOI 10.1002/pmic.200900126; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Doyon C, 2005, J ENDOCRINOL, V186, P123, DOI 10.1677/joe.1.06142; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Fanous S, 2010, NEUROSCIENCE, V167, P598, DOI 10.1016/j.neuroscience.2010.02.064; Ferrer I, 2007, NEUROSCI LETT, V415, P205, DOI 10.1016/j.neulet.2007.01.026; Filiou MD, 2011, BIOL PSYCHIAT, V70, P1074, DOI 10.1016/j.biopsych.2011.06.009; Gebauer DL, 2011, PHARMACOL BIOCHEM BE, V99, P480, DOI 10.1016/j.pbb.2011.04.021; Gerlai R, 2008, ALCOHOL CLIN EXP RES, V32, P1763, DOI 10.1111/j.1530-0277.2008.00761.x; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Gerlai R, 2010, BEHAV BRAIN RES, V207, P223, DOI 10.1016/j.bbr.2009.10.008; Graff LA, 2009, INFLAMM BOWEL DIS, V15, P1105, DOI 10.1002/ibd.20873; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Guo S, 2004, GENES BRAIN BEHAV, V3, P63, DOI 10.1046/j.1601-183X.2003.00053.x; Hashimoto M, 2004, J BIOL CHEM, V279, P23622, DOI 10.1074/jbc.M313784200; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hsieh J, 2010, NEUROBIOL DIS, V39, P73, DOI 10.1016/j.nbd.2010.01.008; Johnston-Wilson NL, 2000, MOL PSYCHIATR, V5, P142, DOI 10.1038/sj.mp.4000696; Jungke P, 2011, PSYCHOPHARMACOLOGY, V213, P757, DOI 10.1007/s00213-010-2032-3; Kedracka-Krok S, 2010, J NEUROCHEM, V113, P848, DOI 10.1111/j.1471-4159.2010.06652.x; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb; Khalyfa A, 2001, J BIOL CHEM, V276, P22915, DOI 10.1074/jbc.M101011200; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2011, CURR TOP BEHAV NEURO, V7, P121, DOI 10.1007/7854_2010_108; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Lakshminarasimhan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030481; LaPlant Q, 2009, BIOL PSYCHIAT, V65, P874, DOI 10.1016/j.biopsych.2009.01.024; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Miller N, 2007, BEHAV BRAIN RES, V184, P157, DOI 10.1016/j.bbr.2007.07.007; Nissen S, 2012, AM J MED GENET B, V159B, P941, DOI 10.1002/ajmg.b.32099; Pardon MC, 2005, NEUROSCIENCE, V132, P561, DOI 10.1016/j.neuroscience.2005.01.033; Piato AL, 2011, PROG NEURO-PSYCHOPH, V35, P561, DOI 10.1016/j.pnpbp.2010.12.018; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Reina S, 2010, FEBS LETT, V584, P2837, DOI 10.1016/j.febslet.2010.04.066; Saxena S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014118; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Singh SK, 2010, ZEBRAFISH, V7, P169, DOI 10.1089/zeb.2010.0657; Sneddon LU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018181; Stewart A, 2012, NEUROPHARMACOLOGY, V62, P135, DOI 10.1016/j.neuropharm.2011.07.037; Stewart A, 2011, PROG NEURO-PSYCHOPH, V35, P1421, DOI 10.1016/j.pnpbp.2010.11.035; Sulser F, 2002, ANN MED, V34, P348, DOI 10.1080/078538902320772106; Suri D, 2013, BIOL PSYCHIAT, V73, P658, DOI 10.1016/j.biopsych.2012.10.023; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang MH, 2010, TOXICOL SCI, V113, P60, DOI 10.1093/toxsci/kfp248; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yeo SY, 2007, P NATL ACAD SCI USA, V104, P5913, DOI 10.1073/pnas.0607062104; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206	64	102	105	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63302	10.1371/journal.pone.0063302	http://dx.doi.org/10.1371/journal.pone.0063302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691016	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400047
J	Cisse, O; Fajardy, I; Dickes-Coopman, A; Moitrot, E; Montel, V; Deloof, S; Rousseaux, J; Vieau, D; Laborie, C				Cisse, Ouma; Fajardy, Isabelle; Dickes-Coopman, Anne; Moitrot, Emmanuelle; Montel, Valerie; Deloof, Sylvie; Rousseaux, Jean; Vieau, Didier; Laborie, Christine			Mild Gestational Hyperglycemia in Rat Induces Fetal Overgrowth and Modulates Placental Growth Factors and Nutrient Transporters Expression	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER; DIABETIC PREGNANCY; GENE-EXPRESSION; MATERNAL LIPIDS; FAT TRANSPORT; TIME-COURSE; STREPTOZOTOCIN; NICOTINAMIDE; METABOLISM; WOMEN	Mild gestational hyperglycemia is often associated with fetal overgrowth that can predispose the offspring to metabolic diseases later in life. We hypothesized that unfavorable intrauterine environment may compromise the development of placenta and contribute to fetal overgrowth. Therefore, we developed a rat model and investigated the effects of maternal dysglycemia on fetal growth and placental gene expression. Female rats were treated with single injection of nicotinamide plus streptozotocin (N-STZ) 1-week before mating and were studied at gestational day 21. N-STZ pregnant females displayed impaired glucose tolerance that is associated with a lower insulin secretion. Moderate hyperglycemia induced fetal overgrowth in 40% of newborns, from pregnancies with 10 to 14 pups. The incidence of macrosomia was less than 5% in the N-STZ pregnancies when the litter size exceeds 15 newborns. We found that placental mass and the labyrinthine layer were increased in macrosomic placentas. The expression of genes involved in placental development and nutrient transfer was down regulated in the N-STZ placentas of macrosomic and normosomic pups from pregnancies with 10 to 14 ones. However, we observed that lipoprotein lipase 1 (LPL1) gene expression was significantly increased in the N-STZ placentas of macrosomic pups. In pregnancies with 15 pups or more, the expression of IGFs and glucose transporter genes was also modulated in the control placentas with no additional effect in the N-STZ ones. These data suggest that placental gene expression is modulated by gestational conditions that might disrupt the fetal growth. We described here a new model of maternal glucose intolerance that results in fetal overgrowth. We proposed that over-expression of LPL1 in the placenta may contribute to the increased fetal growth in the N-STZ pregnancies. N-STZ model offers the opportunity to determinate whether these neonatal outcomes may contribute to developmental programming of metabolic diseases in adulthood.	[Cisse, Ouma; Fajardy, Isabelle; Dickes-Coopman, Anne; Moitrot, Emmanuelle; Montel, Valerie; Deloof, Sylvie; Rousseaux, Jean; Vieau, Didier; Laborie, Christine] Univ Lille Nord France, Unite Environm Perinatal & Croissance, EA 4489, Lille, France; [Fajardy, Isabelle; Moitrot, Emmanuelle; Rousseaux, Jean] Ctr Biol & Pathol, Pole Biochim & Biol Mol, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Laborie, C (corresponding author), Univ Lille Nord France, Unite Environm Perinatal & Croissance, EA 4489, Lille, France.	christine.laborie@univ-lille1.fr		Montel, Valerie/0000-0002-7286-4209; vieau, didier/0000-0002-3254-3662	Conseil Regional du Nord-Pas de Calais	Conseil Regional du Nord-Pas de Calais(Region Hauts-de-FranceRegion Ile-de-France)	This study was supported by grants from French Ministry of Education and grants from the Conseil Regional du Nord-Pas de Calais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsells M, 2009, J CLIN ENDOCR METAB, V94, P4284, DOI 10.1210/jc.2009-1231; Barker DJP, 2010, J DEV ORIG HLTH DIS, V1, P360, DOI 10.1017/S2040174410000280; BOILEAU P, 1995, J CLIN INVEST, V96, P309, DOI 10.1172/JCI118036; Caminos JE, 2005, J CLIN ENDOCR METAB, V90, P4276, DOI 10.1210/jc.2004-0930; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Damasceno DC, 2011, EXP CLIN ENDOCR DIAB, V119, P408, DOI 10.1055/s-0030-1269886; Das UG, 1998, AM J PHYSIOL-REG I, V274, pR339, DOI 10.1152/ajpregu.1998.274.2.R339; Diaz-Flores M, 2006, LIFE SCI, V78, P2601, DOI 10.1016/j.lfs.2005.10.022; Dyer JS, 2011, SEMIN REPROD MED, V29, P266, DOI 10.1055/s-0031-1275521; Entringer S, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/632548; Ericsson A, 2007, J PHYSIOL-LONDON, V581, P1323, DOI 10.1113/jphysiol.2007.131185; Fajardy I, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-21; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Herrera E, 2010, BEST PRACT RES CL EN, V24, P515, DOI 10.1016/j.beem.2010.05.006; Jawerbaum A, 2010, ENDOCR REV, V31, P680, DOI 10.1210/er.2009-0038; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Kappen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038445; Kappen C, 2011, REPROD TOXICOL, V31, P41, DOI 10.1016/j.reprotox.2010.09.002; Kaymak O, 2011, J OBSTET GYNAECOL RE, V37, P986, DOI 10.1111/j.1447-0756.2010.01469.x; KNOPP RH, 1986, BIOL NEONATE, V50, P297, DOI 10.1159/000242614; Landon MB, 2011, OBSTET GYNECOL, V117, P218, DOI 10.1097/AOG.0b013e318203ebe0; Leach L, 2009, J ANAT, V215, P69, DOI 10.1111/j.1469-7580.2009.01098.x; LEDOUX SP, 1988, DIABETES, V37, P1015, DOI 10.2337/diabetes.37.8.1015; Lindegaard MLS, 2006, J LIPID RES, V47, P2581, DOI 10.1194/jlr.M600236-JLR200; Lindegaard MLS, 2005, J LIPID RES, V46, P2339, DOI 10.1194/jlr.M500277-JLR200; Luo ZC, 2011, DIABETIC MED, V28, P1068, DOI 10.1111/j.1464-5491.2011.03366.x; Masiello P, 1998, DIABETES, V47, P224, DOI 10.2337/diabetes.47.2.224; MASIELLO P, 1977, EXPERIENTIA, V33, P1246, DOI 10.1007/BF01922358; Matsuyama-Yokono A, 2009, METABOLISM, V58, P379, DOI 10.1016/j.metabol.2008.10.012; Merzouk H, 2000, CLIN SCI, V98, P21, DOI 10.1042/cs0980021; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Ogura K, 1999, J ENDOCRINOL, V160, P443, DOI 10.1677/joe.0.1600443; Quesnel H, 2008, ANIMAL, V2, P1842, DOI 10.1017/S175173110800308X; Radaelli T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.019; Retnakaran R, 2010, J CLIN ENDOCR METAB, V95, P670, DOI 10.1210/jc.2009-1990; Rudge MVC, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-19; Salbaum JM, 2011, DIABETOLOGIA, V54, P1909, DOI 10.1007/s00125-011-2132-6; SANDOVICI I, 2012, REPROD BIOMED ONLINE; Schaefer-Graf UM, 2011, DIABETIC MED, V28, P1053, DOI 10.1111/j.1464-5491.2011.03346.x; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Sferruzzi-Perri AN, 2011, ENDOCRINOLOGY, V152, P3202, DOI 10.1210/en.2011-0240; Sferruzzi-Perri AN, 2011, J PHYSIOL-LONDON, V589, P7, DOI 10.1113/jphysiol.2010.198622; SHAFRIR E, 1987, BIOL NEONATE, V51, P102, DOI 10.1159/000242639; Simeoni U, 2009, SEMIN FETAL NEONAT M, V14, P119, DOI 10.1016/j.siny.2009.01.002; Son GH, 2010, ACTA OBSTET GYN SCAN, V89, P700, DOI 10.3109/00016341003605677; Tahara A, 2008, BASIC CLIN PHARMACOL, V103, P560, DOI 10.1111/j.1742-7843.2008.00321.x; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036727; Yu Yang, 2008, Archives of Physiology and Biochemistry, V114, P99, DOI 10.1080/13813450802033776 	50	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64251	10.1371/journal.pone.0064251	http://dx.doi.org/10.1371/journal.pone.0064251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691181	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400109
J	Karwacki, MT; Kadouri, DE; Bendaoud, M; Izano, EA; Sampathkumar, V; Inzana, TJ; Kaplan, JB				Karwacki, Michael T.; Kadouri, Daniel E.; Bendaoud, Meriem; Izano, Era A.; Sampathkumar, Vandana; Inzana, Thomas J.; Kaplan, Jeffrey B.			Antibiofilm Activity of Actinobacillus pleuropneumoniae Serotype 5 Capsular Polysaccharide	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS; BACTERIAL BIOFILMS; ACTINOMYCETEMCOMITANS; EXPRESSION; RESISTANCE; VIRULENCE; AUREUS; DNA; EXOPOLYSACCHARIDE; PATHOGENESIS	Cell-free extracts isolated from colony biofilms of Actinobacillus pleuropneumoniae serotype 5 were found to inhibit biofilm formation by Staphylococcus aureus, S. epidermidis and Aggregatibacter actinomycetemcomitans, but not by A. pleuropneumoniae serotype 5 itself, in a 96-well microtiter plate assay. Physical and chemical analyses indicated that the antibiofilm activity in the extract was due to high-molecular-weight polysaccharide. Extracts isolated from a mutant strain deficient in the production of serotype 5 capsular polysaccharide did not exhibit antibiofilm activity. A plasmid harboring the serotype 5 capsule genes restored the antibiofilm activity in the mutant extract. Purified serotype 5 capsular polysaccharide also exhibited antibiofilm activity against S. aureus. A. pleuropneumoniae wild-type extracts did not inhibit S. aureus growth, but did inhibit S. aureus intercellular adhesion and binding of S. aureus cells to stainless steel surfaces. Furthermore, polystyrene surfaces coated with A. pleuropneumoniae wild-type extracts, but not with capsule-mutant extracts, resisted S. aureus biofilm formation. Our findings suggest that the A. pleuropneumoniae serotype 5 capsule inhibits cell-to-cell and cell-to-surface interactions of other bacteria. A. pleuropneumoniae serotype 5 capsular polysaccharide is one of a growing number of bacterial polysaccharides that exhibit broad-spectrum, nonbiocidal antibiofilm activity. Future studies on these antibiofilm polysaccharides may uncover novel functions for bacterial polysaccharides in nature, and may lead to the development of new classes of antibiofilm agents for industrial and clinical applications.	[Karwacki, Michael T.; Kadouri, Daniel E.; Bendaoud, Meriem; Izano, Era A.; Sampathkumar, Vandana] Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07103 USA; [Inzana, Thomas J.] Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA USA; [Kaplan, Jeffrey B.] American Univ, Dept Biol, Washington, DC 20016 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Virginia Polytechnic Institute & State University; American University	Kaplan, JB (corresponding author), American Univ, Dept Biol, Washington, DC 20016 USA.	kaplanjb@american.edu		Bendaoud, Meriem/0000-0001-7476-4159	Department of the Army [W81XWH-12-2-0131]; National Institute of Allergy and Infectious Diseases [AI82329]; Foundation of the University of Medicine and Dentistry of New Jersey; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082329] Funding Source: NIH RePORTER	Department of the Army; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Foundation of the University of Medicine and Dentistry of New Jersey; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by grants from the Department of the Army (USAMRAA # W81XWH-12-2-0131), the National Institute of Allergy and Infectious Diseases (AI82329), and the Foundation of the University of Medicine and Dentistry of New Jersey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN E, 1987, EUR J BIOCHEM, V170, P185, DOI 10.1111/j.1432-1033.1987.tb13685.x; Auerbach ID, 2000, J BACTERIOL, V182, P3809, DOI 10.1128/JB.182.13.3809-3815.2000; Bendaoud M, 2011, J BACTERIOL, V193, P3879, DOI 10.1128/JB.00311-11; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dubreuil J. Daniel, 2000, Animal Health Research Reviews, V1, P73, DOI 10.1017/S1466252300000074; Fine DH, 1999, MICROBIOL-SGM, V145, P1335, DOI 10.1099/13500872-145-6-1335; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; INZANA TJ, 1993, INFECT IMMUN, V61, P1682, DOI 10.1128/IAI.61.5.1682-1686.1993; INZANA TJ, 1987, INFECT IMMUN, V55, P1573, DOI 10.1128/IAI.55.7.1573-1579.1987; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Izano EA, 2009, MICROB PATHOGENESIS, V46, P207, DOI 10.1016/j.micpath.2009.01.004; Jacques M, 2004, CAN J VET RES, V68, P81; Jiang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018514; Kanmani P, 2011, BIORESOURCE TECHNOL, V102, P4827, DOI 10.1016/j.biortech.2010.12.118; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; Kaplan JB, 2002, APPL ENVIRON MICROB, V68, P4943, DOI 10.1128/AEM.68.10.4943-4950.2002; Kim J, 2009, WATER RES, V43, P5252, DOI 10.1016/j.watres.2009.08.044; Kim Y, 2009, BIOCHEM BIOPH RES CO, V379, P324, DOI 10.1016/j.bbrc.2008.12.053; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Ramsey MM, 2009, P NATL ACAD SCI USA, V106, P1578, DOI 10.1073/pnas.0809533106; Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07; Rendueles O, 2013, ENVIRON MICROBIOL, V15, P334, DOI 10.1111/j.1462-2920.2012.02810.x; Rendueles O, 2011, MBIO, V2, DOI 10.1128/mBio.00043-11; Rice SA, 2005, J BACTERIOL, V187, P3477, DOI 10.1128/JB.187.10.3477-3485.2005; Sayem S M Abu, 2011, Microb Cell Fact, V10, P74, DOI 10.1186/1475-2859-10-74; Schooling S.R., 2004, BIOFILMS, V1, P91, DOI 10.1017/; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; Ward CK, 1998, INFECT IMMUN, V66, P3326, DOI 10.1128/IAI.66.7.3326-3336.1998	38	26	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63844	10.1371/journal.pone.0063844	http://dx.doi.org/10.1371/journal.pone.0063844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691104	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400082
J	Liu, ML; Song, W; Li, P; Huang, Y; Gong, XH; Zhou, G; Jia, XL; Zheng, LS; Fan, YB				Liu, Meili; Song, Wei; Li, Ping; Huang, Yan; Gong, Xianghui; Zhou, Gang; Jia, Xiaoling; Zheng, Lisha; Fan, Yubo			Galanin Protects against Nerve Injury after Shear Stress in Primary Cultured Rat Cortical Neurons	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; IN-VITRO; CELL-DEATH; APOPTOSIS; ACTIVATION; BAX; PHOSPHORYLATION; EXPRESSION; TOXICITY; RELEASE	The neuropeptide galanin and its receptors (GalR) are found to be up-regulated in brains suffering from nerve injury, but the specific role played by galanin remains unclear. This study aimed to explore the neuroprotective role of galanin after shear stress induced nerve injury in the primary cultured cortical neurons of rats. Our results demonstrated that no significant changes in cell death and viability were found after galanin treatment when subjected to a shear stress of 5 dyn/cm(2) for 12 h, after increasing magnitude of shear stress to 10 dyn/cm(2) for 12 h, cell death was significantly increased, while galanin can inhibit the nerve injury induced by shear stress with 10 dyn/cm(2) for 12 h. Moreover, Gal2-11 (an agonist of GalR2/3) could also effectively inhibit shear stress-induced nerve injury of primary cultured cortical neurons in rats. Although GalR2 is involved in the galanin protection mechanism, there was no GalR3 expression in this system. Moreover, galanin increased the excitatory postsynaptic currents (EPSCs), which can effectively inhibit the physiological effects of shear stress. Galanin was also found to inhibit the activation of p53 and Bax, and further reversed the down regulation of Bcl-2 induced by shear stress. Our results strongly demonstrated that galanin plays a neuroprotective role in injured cortical neurons of rats.	[Fan, Yubo] Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China; Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China	Beihang University	Fan, YB (corresponding author), Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China.	yubofan@buaa.edu.cn	zheng, lisha/AAX-2714-2021; Gong, Xianghui/AAW-1133-2020	Gong, Xianghui/0000-0002-6411-4272	National Basic Research Program of China (973 Program) [2011CB710901]; National Natural Science Foundation of China [31100666, 11120101001, 10925208]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by National Basic Research Program of China (973 Program, 2011CB710901, www.most.gov.cn), the National Natural Science Foundation of China (No. 31100666, 11120101001, 10925208 www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badie-Mahdavi H, 2005, NEUROSCIENCE, V133, P591, DOI 10.1016/j.neuroscience.2005.02.042; Bhushan S, 2009, MOL CARCINOGEN, V48, P1093, DOI 10.1002/mc.20559; Branchek TA, 2000, TRENDS PHARMACOL SCI, V21, P109, DOI 10.1016/S0165-6147(00)01446-2; Brecht S, 1997, MOL BRAIN RES, V48, P7, DOI 10.1016/S0169-328X(97)00070-3; Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3; Chafik D, 2003, TISSUE ENG, V9, P233, DOI 10.1089/107632703764664701; Cheng Y, 2010, J ALZHEIMERS DIS, V20, P1143, DOI 10.3233/JAD-2010-091234; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Counts Scott E, 2003, Mol Interv, V3, P137, DOI 10.1124/mi.3.3.137; Counts SE, 2006, DEMENT GERIATR COGN, V21, P205, DOI 10.1159/000090906; Cui J, 2010, J ALZHEIMERS DIS, V19, P529, DOI 10.3233/JAD-2010-1246; Ding XL, 2006, NEUROBIOL DIS, V21, P413, DOI 10.1016/j.nbd.2005.08.016; Eldering E, 2004, EUR J IMMUNOL, V34, P1950, DOI 10.1002/eji.200324817; Elliott-Hunt CR, 2007, J NEUROCHEM, V100, P780, DOI 10.1111/j.1471-4159.2006.04239.x; Gladman SJ, 2010, NEUROSCIENCE, V171, P577, DOI 10.1016/j.neuroscience.2010.07.009; Gupta R, 2003, J COMP NEUROL, V461, P174, DOI 10.1002/cne.10692; Huang Y, 2010, ARCH MED RES, V41, P497, DOI 10.1016/j.arcmed.2010.10.002; Jellinger KA, 2000, J NEURAL TRANSM, V107, P1, DOI 10.1007/s007020050001; Kilinc D, 2007, P ANN INT IEEE EMBS, P5395, DOI 10.1109/IEMBS.2007.4353562; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kim IA, 2006, J BIOSCI BIOENG, V101, P120, DOI 10.1263/jbb.101.120; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Liu HX, 2001, P NATL ACAD SCI USA, V98, P9960, DOI 10.1073/pnas.161293598; Liu ML, 2011, NEUROCHEM RES, V36, P1863, DOI 10.1007/s11064-011-0506-2; Liu ML, 2011, NEUROTOX RES, V20, P270, DOI 10.1007/s12640-011-9240-4; O'Meara G, 2000, P NATL ACAD SCI USA, V97, P11569, DOI 10.1073/pnas.210254597; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramalho RM, 2004, J NEUROCHEM, V90, P567, DOI 10.1111/j.1471-4159.2004.02517.x; Rao VLR, 2002, J NEUROCHEM, V83, P1072, DOI 10.1046/j.1471-4159.2002.01208.x; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Sekiya T, 2003, EXP NEUROL, V184, P648, DOI 10.1016/S0014-4886(03)00288-7; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Tomiyama A, 2006, JNCI-J NATL CANCER I, V98, P1462, DOI 10.1093/jnci/djj395; Tortosa A, 1998, ACTA NEUROPATHOL, V95, P407, DOI 10.1007/s004010050817; Wang C, 2007, NEUROSCIENCE, V144, P46, DOI 10.1016/j.neuroscience.2006.08.083; Westphal D, 2007, J VIROL, V81, P7178, DOI 10.1128/JVI.00404-07	38	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63473	10.1371/journal.pone.0063473	http://dx.doi.org/10.1371/journal.pone.0063473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691051	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400065
J	Macaulay, GJ; Pena, H; Fassler, SMM; Pedersen, G; Ona, E				Macaulay, Gavin J.; Pena, Hector; Fassler, Sascha M. M.; Pedersen, Geir; Ona, Egil			Accuracy of the Kirchhoff-Approximation and Kirchhoff-Ray-Mode Fish Swimbladder Acoustic Scattering Models	PLOS ONE			English	Article							PERFECTLY MATCHED LAYER; ASPECT TARGET STRENGTH; SOUND-SCATTERING; WALLEYE POLLOCK; FINITE-LENGTH; HIGH-FREQUENCY; PACIFIC HAKE; CYLINDERS; BACKSCATTER; BODIES	The acoustic backscatter from pressure release prolate spheroids and a three-dimensional representation of a fish swimbladder (Chilean jack mackerel, Trachurus symmetricus murphyi) was calculated using four target strength models (Kirchhoff-approximation, Kirchhoff-ray-mode, finite element solution of the Helmholtz equation, and prolate-spheroid-modal-series). Smoothly varying errors were found in the Kirchhoff-approximation and Kirchhoff-ray-mode model results when compared to the other models, and provide objective criteria for constraining the use of the KA and KRM models. A generic correction technique is also proposed for the prolate spheroid estimates and tentatively tested on a jack mackerel swimbladder, resulting in improvements to the target strength estimates from the Kirchhoff-approximation and Kirchhoff-ray-mode models.	[Macaulay, Gavin J.; Pena, Hector; Ona, Egil] Inst Marine Res, N-5024 Bergen, Norway; [Fassler, Sascha M. M.] Wageningen Inst Marine Resources & Ecosyst Studie, Ijmuiden, Netherlands; [Pedersen, Geir] Christian Michelsen Res AS, CMR Instrumentat, Bergen, Norway	Institute of Marine Research - Norway; Wageningen University & Research	Macaulay, GJ (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	gavin.macaulay@imr.no	Fässler, Sascha MM/C-8949-2009; Pedersen, Geir/AAB-4748-2022; Pedersen, Geir/H-9193-2016	Macaulay, Gavin/0000-0003-2518-6537; Pedersen, Geir/0000-0002-6202-2745	Institute of Marine Research [13225]; Norwegian Research Council [190318/S40]; Dutch KB WOT Fisheries Programme [KB-14-012-009-IMARES]	Institute of Marine Research; Norwegian Research Council(Research Council of NorwayEuropean Commission); Dutch KB WOT Fisheries Programme	This work was funded by Institute of Marine Research (www.imr.no) Project 13225: "In situ target strength measurements and acoustic modelling of the echoes from fish''; Norwegian Research Council (www.forskningsradet.no) through the WESTZOO project (contract 190318/S40); and the Dutch KB WOT Fisheries 2011 Programme (http://www.kennisonline.wur.nl) via the project "Underpinning Acoustics'' (KB-14-012-009-IMARES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159; Blaxter J.H.S., 1978, ADVANCES IN COMPARATIVE PHYSIOLOGY AND BIOCHEMISTRY, V7, P311; Born, 2013, PRINCIPLES OPTICS EL; CLAY CS, 1994, J ACOUST SOC AM, V96, P1661, DOI 10.1121/1.410245; CLAY CS, 1992, J ACOUST SOC AM, V92, P2173, DOI 10.1121/1.405211; COMSOL, 2012, COMSOL MULT 4 2A AC; DO MA, 1990, J ACOUST SOC AM, V87, P1588, DOI 10.1121/1.399406; FOOTE K G, 1985, Fiskeridirektoratets Skrifter Serie Havundersokelser, V18, P1; FOOTE KG, 1985, J ACOUST SOC AM, V78, P688, DOI 10.1121/1.392438; Foote KG, 2002, J ACOUST SOC AM, V111, P1644, DOI 10.1121/1.1458939; FOOTE KG, 1980, J ACOUST SOC AM, V67, P2084, DOI 10.1121/1.384452; FOOTE KG, 1988, J ACOUST SOC AM, V83, P9, DOI 10.1121/1.396190; Furusawa M., 1988, Journal of the Acoustical Society of Japan (E), V9, P13, DOI 10.1250/ast.9.13; GAUNAURD GC, 1985, IEEE J OCEANIC ENG, V10, P213, DOI 10.1109/JOE.1985.1145097; GLADWELL GM, 1966, J SOUND VIB, V3, P233, DOI 10.1016/0022-460X(66)90092-7; Hansen GA, 2005, MESH ENHANCEMENT SEL; Hazen EL, 2004, ICES J MAR SCI, V61, P363, DOI 10.1016/j.icesjms.2004.01.005; Henderson MJ, 2007, CAN J FISH AQUAT SCI, V64, P1781, DOI 10.1139/F07-134; HENDERSON MJ, 2005, THESIS U WASHINGTON; HICKLING R, 1962, J ACOUST SOC AM, V34, P1582, DOI 10.1121/1.1909055; Ihlenburg F., 1998, FINITE ELEMENT ANAL; JECH JM, 1995, J ACOUST SOC AM, V98, P2262, DOI 10.1121/1.413340; Kang D, 2004, FISHERIES SCI, V70, P819, DOI 10.1111/j.1444-2906.2004.00875.x; Lilja J, 2004, CAN J FISH AQUAT SCI, V61, P2227, DOI 10.1139/F04-166; MACLENNAN DN, 1990, J ACOUST SOC AM, V87, P1, DOI 10.1121/1.399285; McClatchie S, 1996, ICES J MAR SCI, V53, P847, DOI 10.1006/jmsc.1996.0106; McClatchie S, 1998, ICES J MAR SCI, V55, P482, DOI 10.1006/jmsc.1998.0348; MEECHAM WC, 1956, J RATION MECH ANAL, V5, P323; Pena H, 2008, ICES J MAR SCI, V65, P1751, DOI 10.1093/icesjms/fsn190; Qi QA, 1998, J COMPUT PHYS, V139, P166, DOI 10.1006/jcph.1997.5868; Reeder DB, 2004, J ACOUST SOC AM, V116, P747, DOI 10.1121/1.1648318; Reeder DB, 2004, J ACOUST SOC AM, V116, P729, DOI 10.1121/1.1648681; Sawada K, 1999, FISHERIES SCI, V65, P193, DOI 10.2331/fishsci.65.193; STANTON TK, 1989, J ACOUST SOC AM, V86, P691, DOI 10.1121/1.398193; Tang Y, 2009, ICES J MAR SCI, V66, P1176, DOI 10.1093/icesjms/fsp080; WATERMAN PC, 1969, J ACOUST SOC AM, V45, P1417, DOI 10.1121/1.1911619; Ye Z, 1997, J ACOUST SOC AM, V102, P877, DOI 10.1121/1.419910; Zhang S., 1996, COMPUTATION SPECIAL	38	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64055	10.1371/journal.pone.0064055	http://dx.doi.org/10.1371/journal.pone.0064055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691146	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400098
J	Massonnet-Bruneel, B; Corre-Catelin, N; Lacroix, R; Lees, RS; Hoang, KP; Nimmo, D; Alphey, L; Reiter, P				Massonnet-Bruneel, Blandine; Corre-Catelin, Nicole; Lacroix, Renaud; Lees, Rosemary S.; Kim Phuc Hoang; Nimmo, Derric; Alphey, Luke; Reiter, Paul			Fitness of Transgenic Mosquito Aedes aegypti Males Carrying a Dominant Lethal Genetic System	PLOS ONE			English	Article							STERILE INSECT TECHNIQUE; ENGINEERED MALE MOSQUITOS; TETRACYCLINE RESIDUES; POPULATION-CONTROL; AUTOCIDAL CONTROL; BORNE DISEASES; BONE MEALS; SUPPRESSION; FECUNDITY; VECTORS	OX513A is a transgenic strain of Aedes aegypti engineered to carry a dominant, non-sex-specific, late-acting lethal genetic system that is repressed in the presence of tetracycline. It was designed for use in a sterile-insect (SIT) pest control system called RIDLH (Release of Insects carrying a Dominant Lethal gene) by which transgenic males are released in the field to mate with wild females; in the absence of tetracycline, the progeny from such matings will not survive. We investigated the mating fitness of OX513A in the laboratory. Male OX513A were as effective as Rockefeller (ROCK) males at inducing refractoriness to further mating in wild type females and there was no reduction in their ability to inseminate multiple females. They had a lower mating success but yielded more progeny than the wild-type comparator strain (ROCK) when one male of each strain was caged with a ROCK female. Mating success and fertility of groups of 10 males-with different ratios of RIDL to ROCK-competing for five ROCK females was similar, but the median longevity of RIDL males was somewhat (18%) lower. We conclude that the fitness under laboratory conditions of OX513A males carrying a tetracycline repressible lethal gene is comparable to that of males of the wild-type comparator strain.	[Massonnet-Bruneel, Blandine; Corre-Catelin, Nicole; Lacroix, Renaud; Reiter, Paul] Inst Pasteur, Unite Insectes & Malad Infect, Paris, France; [Lacroix, Renaud; Nimmo, Derric; Alphey, Luke] Oxitec Ltd, Oxford, England; [Lees, Rosemary S.; Kim Phuc Hoang; Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford	Massonnet-Bruneel, B (corresponding author), Inst Pasteur, Unite Insectes & Malad Infect, Paris, France.	blandine.bruneel@lyon.unicancer.fr; paul.reiter@pasteur.fr	Lees, Rosemary Susan/H-3425-2019	Lees, Rosemary Susan/0000-0002-4232-9125; Alphey, Luke/0000-0002-2916-3802	Institut Pasteur (Paris); Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; EU [FP7-261504 EDENext]	Institut Pasteur (Paris); Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission)	RL, RSL, HKP, DN, and LA are or have been employees or students of Oxitec Ltd and/or the University of Oxford. Oxitec and the University of Oxford hold intellectual property relating to the subject matter of this paper. This work was supported by Institut Pasteur (Paris) and funded in part by a grant to the Regents of the University of California from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative. This study was partially funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext112 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Allen ML, 2004, J ECON ENTOMOL, V97, P1181, DOI 10.1603/0022-0493(2004)097[1181:PFOTSO]2.0.CO;2; Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Alphey L, 2002, INSECT BIOCHEM MOLEC, V32, P1243, DOI 10.1016/S0965-1748(02)00087-5; Alphey L, 2002, MOL BIOCHEM PARASIT, V121, P173, DOI 10.1016/S0166-6851(02)00040-3; Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey Luke, 2009, Journal of Biology (London), V8, P40, DOI 10.1186/jbiol143; Andreasen MH, 2005, MED VET ENTOMOL, V19, P238, DOI 10.1111/j.1365-2915.2005.00565.x; Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Catteruccia F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S7; Christophides GK, 2005, CELL MICROBIOL, V7, P325, DOI 10.1111/j.1462-5822.2005.00495.x; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; FOSTER W A, 1975, Journal of Insect Physiology, V21, P1085, DOI 10.1016/0022-1910(75)90120-1; Fraser MJ, 2012, ANNU REV ENTOMOL, V57, P267, DOI 10.1146/annurev.ento.54.110807.090545; GEORGE J. A., 1967, MOSQUITO NEWS, V27, P82; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; GWADZ RW, 1968, MOSQ NEWS, V28, P586; GWADZ RW, 1970, MOSQ NEWS, V30, P355; Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; HAUSERMANN W, 1975, J MED ENTOMOL, V11, P707, DOI 10.1093/jmedent/11.6.707; Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; JONES JC, 1973, J INSECT PHYSIOL, V19, P435, DOI 10.1016/0022-1910(73)90118-2; Korner U, 2001, FOOD ADDIT CONTAM, V18, P293, DOI 10.1080/02652030010021521; Kuhne M, 2001, FOOD ADDIT CONTAM, V18, P593, DOI 10.1080/02652030110036506; Lambrechts L, 2008, TRENDS PARASITOL, V24, P4, DOI 10.1016/j.pt.2007.09.009; Marrelli M.T., 2006, TRENDS PARASITOL; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; Mishra K, 2005, ANN TROP MED PARASIT, V99, P803, DOI 10.1179/136485905X65189; Moats W, 1999, ADV EXP MED BIOL, P459; Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337; Morrison NI, 2012, GENETICALLY  MODIFIE; Nolan T, 2011, GENETICA, V139, P33, DOI 10.1007/s10709-010-9482-8; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Reiter P., 1997, DENGUE DENGUE HEMORR; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; WHO/TDR, 2009, DENG GUID DIAGN TREA; WHO-TDR, 2006, TDRSWG08 WHOTDR; Wimmer EA, 2003, NAT REV GENET, V4, P225, DOI 10.1038/nrg1021	44	43	46	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62711	10.1371/journal.pone.0062711	http://dx.doi.org/10.1371/journal.pone.0062711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690948	gold, Green Published			2022-12-25	WOS:000319107400014
J	Moller, TC; Wirth, VF; Roberts, NI; Bender, J; Bach, A; Jacky, BPS; Stromgaard, K; Deussing, JM; Schwartz, TW; Martinez, KL				Moller, Thor C.; Wirth, Volker F.; Roberts, Nina I.; Bender, Julia; Bach, Anders; Jacky, Birgitte P. S.; Stromgaard, Kristian; Deussing, Jan M.; Schwartz, Thue W.; Martinez, Karen L.			PDZ Domain-Mediated Interactions of G Protein-Coupled Receptors with Postsynaptic Density Protein 95: Quantitative Characterization of Interactions	PLOS ONE			English	Article							5-HT2A SEROTONIN RECEPTORS; BINDING DOMAIN; PSD-95; ASSOCIATION; NEURONS; LIGAND; POTENT; PALMITOYLATION; RECOGNITION; SELECTIVITY	G protein-coupled receptors (GPCRs) constitute the largest family of membrane proteins in the human genome. Their signaling is regulated by scaffold proteins containing PDZ domains, but although these interactions are important for GPCR function, they are still poorly understood. We here present a quantitative characterization of the kinetics and affinity of interactions between GPCRs and one of the best characterized PDZ scaffold proteins, postsynaptic density protein 95 (PSD-95), using fluorescence polarization (FP) and surface plasmon resonance (SPR). By comparing these in vitro findings with colocalization of the full-length proteins in cells and with previous studies, we suggest that the range of relevant interactions might extend to interactions with K-i = 450 mu M in the in vitro assays. Within this range, we identify novel PSD-95 interactions with the chemokine receptor CXCR2, the neuropeptide Y receptor Y-2, and four of the somatostatin receptors (SSTRs). The interaction with SSTR1 was further investigated in mouse hippocampal neurons, where we found a clear colocalization between the endogenously expressed proteins, indicating a potential for further investigation of the role of this interaction. The approach can easily be transferred to other receptors and scaffold proteins and this could help accelerate the discovery and quantitative characterization of GPCR-PDZ interactions.	[Moller, Thor C.; Wirth, Volker F.; Roberts, Nina I.; Martinez, Karen L.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Moller, Thor C.; Wirth, Volker F.; Roberts, Nina I.; Martinez, Karen L.] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Jacky, Birgitte P. S.; Schwartz, Thue W.] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Jacky, Birgitte P. S.; Schwartz, Thue W.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Bach, Anders; Stromgaard, Kristian] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Bender, Julia; Deussing, Jan M.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Deussing, Jan M.] Helmholtz Ctr Munich, Inst Dev Genet, Clin Cooperat Grp Mol Neurogenet, Munich, Germany	University of Copenhagen; University of Copenhagen; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Martinez, KL (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	martinez@nano.ku.dk	Deussing, Jan M/ABB-5993-2021; Møller, Thor C/T-9452-2018; Martinez, Karen/W-3709-2019; martinez, karen L/J-5933-2013	Møller, Thor C/0000-0002-2256-577X; Martinez, Karen/0000-0003-0932-8080; martinez, karen L/0000-0003-0932-8080; Bach, Anders/0000-0003-4305-9910; Stromgaard, Kristian/0000-0003-2206-4737; Deussing, Jan/0000-0002-9329-5252; Schwartz, Thue W./0000-0002-0261-6904	Lundbeck Foundation; Lundbeck Foundation Center for Biomembranes and Nanomedicine; programs BioScaRT (University of Copenhagen); UNIK Synthetic Biology (Danish Research Council)	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation Center for Biomembranes and Nanomedicine; programs BioScaRT (University of Copenhagen); UNIK Synthetic Biology (Danish Research Council)	This work was supported by: Lundbeck Foundation; Lundbeck Foundation Center for Biomembranes and Nanomedicine; programs BioScaRT (University of Copenhagen); and UNIK Synthetic Biology (Danish Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Bach A, 2008, J MED CHEM, V51, P6450, DOI 10.1021/jm800836w; Bach A, 2009, ANGEW CHEM INT EDIT, V48, P9685, DOI 10.1002/anie.200904741; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Cai C, 2008, NEUROSCIENCE, V157, P833, DOI 10.1016/j.neuroscience.2008.09.048; Chi CN, 2006, J BIOL CHEM, V281, P36811, DOI 10.1074/jbc.M607883200; Chi CN, 2010, J BIOL CHEM, V285, P28252, DOI 10.1074/jbc.M110.124040; Christenn M, 2007, FEBS LETT, V581, P5173, DOI 10.1016/j.febslet.2007.10.003; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Gavarini S, 2006, MOL BIOL CELL, V17, P4619, DOI 10.1091/mbc.E06-03-0218; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Keppler A, 2004, METHODS, V32, P437, DOI 10.1016/j.ymeth.2003.10.007; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kurakin A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000953; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Lloret N, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/3/035501; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Mok H, 2002, J NEUROSCI, V22, P5253; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Xia Z, 2003, NEUROSCIENCE, V122, P907, DOI 10.1016/S0306-4522(03)00589-X; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200	43	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63352	10.1371/journal.pone.0063352	http://dx.doi.org/10.1371/journal.pone.0063352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691031	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400058
J	Silva, R; Furlong, MJ; Wilson, LJ; Walter, GH				Silva, Rehan; Furlong, Michael J.; Wilson, Lewis J.; Walter, Gimme H.			How Predictable Are the Behavioral Responses of Insects to Herbivore Induced Changes in Plants? Responses of Two Congeneric Thrips to Induced Cotton Plants	PLOS ONE			English	Article							WESTERN FLOWER THRIPS; HOST-PLANT; OVIPOSITION BEHAVIOR; FRANKLINIELLA-SCHULTZEI; CONSPECIFIC FEMALES; PHYTOPHAGOUS THRIPS; VOLATILE EMISSIONS; INTERACTION WEBS; JASMONIC ACID; ATTRACTION	Changes in plants following insect attack are referred to as induced responses. These responses are widely viewed as a form of defence against further insect attack. In the current study we explore whether it is possible to make generalizations about induced plant responses given the unpredictability and variability observed in insect-plant interactions. Experiments were conducted to test for consistency in the responses of two congeneric thrips, Frankliniella schultzei Trybom and Frankliniella occidentalis Pergrande (Thysanoptera: Thripidae) to cotton seedlings (Gossypium hirsutum Linneaus (Malvales: Malvaceae)) damaged by various insect herbivores. In dual-choice experiments that compared intact and damaged cotton seedlings, F. schultzei was attracted to seedlings damaged by Helicoverpa armigera (Hubner) (Lepidoptera: Noctuidae), Tetranychus urticae (Koch) (Trombidiforms: Tetranychidae), Tenebrio molitor Linnaeus (Coleoptera: Tenebrionidae), F. schultzei and F. occidentalis but not to mechanically damaged seedlings. In similar tests, F. occidentalis was attracted to undamaged cotton seedlings when simultaneously exposed to seedlings damaged by H. armigera, T. molitor or F. occidentalis. However, when exposed to F. schultzei or T. urticae damaged plants, F. occidentalis was more attracted towards damaged plants. A quantitative relationship was also apparent, F. schultzei showed increased attraction to damaged seedlings as the density of T. urticae or F. schultzei increased. In contrast, although F. occidentalis demonstrated increased attraction to plants damaged by higher densities of T. urticae, there was a negative relationship between attraction and the density of damaging conspecifics. Both species showed greater attraction to T. urticae damaged seedlings than to seedlings damaged by conspecifics. Results demonstrate that the responses of both species of thrips were context dependent, making generalizations difficult to formulate.	[Silva, Rehan; Furlong, Michael J.; Walter, Gimme H.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Wilson, Lewis J.] CSIRO Plant Ind, Cotton Res Unit, Narrabri, NSW, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Silva, R (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	ranawelle.silva@uqconnect.edu.au	Wilson, Lewis J/F-3023-2011; Walter, Gimme/AAC-3635-2019; Furlong, Michael J/A-3314-2013	Wilson, Lewis J/0000-0002-3532-0309; Walter, Gimme/0000-0003-1025-7101; Furlong, Michael J/0000-0002-1465-8087	Cruiser Research and Development Fund	Cruiser Research and Development Fund	This research was funded by the Cruiser Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-97; Addesso KM, 2011, ENTOMOL EXP APPL, V138, P1, DOI 10.1111/j.1570-7458.2010.01070.x; Agrawal AA, 2000, ECOL ENTOMOL, V25, P493, DOI 10.1046/j.1365-2311.2000.00283.x; Agrawal AA, 2000, J ANIM ECOL, V69, P525, DOI 10.1046/j.1365-2656.2000.00416.x; Agrawal AA, 1999, ECOLOGY, V80, P518, DOI 10.1890/0012-9658(1999)080[0518:IOPAAI]2.0.CO;2; Agrawal AA, 2001, ANN ENTOMOL SOC AM, V94, P71, DOI 10.1603/0013-8746(2001)094[0071:IPRAST]2.0.CO;2; Anderson P, 1999, ENTOMOL EXP APPL, V92, P45, DOI 10.1023/A:1003749730428; Anderson P, 2011, BEHAV ECOL, V22, P1272, DOI 10.1093/beheco/arr124; Bernasconi ML, 1998, ENTOMOL EXP APPL, V87, P133, DOI 10.1023/A:1003200108763; Bruinsma M, 2007, J CHEM ECOL, V33, P655, DOI 10.1007/s10886-006-9245-2; Buteler M, 2009, ENVIRON ENTOMOL, V38, P1707, DOI 10.1603/022.038.0624; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; De Vries EJ, 2006, EUR J ENTOMOL, V103, P779, DOI 10.14411/eje.2006.106; Delphia CM, 2007, J CHEM ECOL, V33, P997, DOI 10.1007/s10886-007-9273-6; Frey M, 2000, P NATL ACAD SCI USA, V97, P14801, DOI 10.1073/pnas.260499897; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; Harmel N, 2007, INSECT SCI, V14, P57, DOI 10.1111/j.1744-7917.2007.00126.x; HEARD TA, 1995, ENTOMOL EXP APPL, V76, P203, DOI 10.1007/BF02383219; Hern A, 2002, ENTOMOL EXP APPL, V102, P145, DOI 10.1023/A:1015814215460; Hilker M, 2010, BIOL REV, V85, P267, DOI 10.1111/j.1469-185X.2009.00100.x; Huang CH, 2009, INSECT SCI, V16, P311, DOI 10.1111/j.1744-7917.2009.01257.x; Hunt-Joshi TR, 2005, OECOLOGIA, V142, P554, DOI 10.1007/s00442-004-1747-4; Johnson MTJ, 2011, FUNCT ECOL, V25, P305, DOI 10.1111/j.1365-2435.2011.01838.x; KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331, DOI 10.1146/annurev.es.20.110189.001555; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2011, FUNCT ECOL, V25, P348, DOI 10.1111/j.1365-2435.2010.01818.x; LANDOLT PJ, 1993, ENTOMOL EXP APPL, V67, P79, DOI 10.1007/BF02382720; Lin L, 2008, J CHEM ECOL, V34, P353, DOI 10.1007/s10886-008-9439-x; Lu YB, 2004, ECOL LETT, V7, P337, DOI 10.1111/j.1461-0248.2004.00582.x; Matthews GA, 1994, INSECT PESTS COTTON; Mayer RT, 2002, ARCH INSECT BIOCHEM, V51, P151, DOI 10.1002/arch.10065; Milne JR, 1996, ENTOMOL EXP APPL, V78, P271, DOI 10.1111/j.1570-7458.1996.tb00791.x; Milne M, 1997, ECOL ENTOMOL, V22, P74, DOI 10.1046/j.1365-2311.1997.00034.x; Ohgushi T, 2008, ENTOMOL EXP APPL, V128, P217, DOI 10.1111/j.1570-7458.2008.00705.x; Oluwafemi S, 2011, J CHEM ECOL, V37, P40, DOI 10.1007/s10886-010-9891-2; Omer AD, 2001, INT J PEST MANAGE, V47, P49, DOI 10.1080/09670870150215595; Poelman EH, 2008, MOL ECOL, V17, P3352, DOI 10.1111/j.1365-294X.2008.03838.x; Reddy GVP, 2004, BIOL CONTROL, V29, P270, DOI 10.1016/S1049-9644(03)00162-2; Rodriguez-Saona C, 2005, OECOLOGIA, V143, P566, DOI 10.1007/s00442-005-0006-7; Rojas JC, 1999, ENVIRON ENTOMOL, V28, P588, DOI 10.1093/ee/28.4.588; Rostas M, 2002, ENTOMOL EXP APPL, V103, P267, DOI 10.1023/A:1021155703691; Sadras VO, 1998, CROP SCI, V38, P399, DOI 10.2135/cropsci1998.0011183X003800020022x; Shiojiri K, 2002, ECOL LETT, V5, P186, DOI 10.1046/j.1461-0248.2002.00292.x; Shiojiri K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012161; Silva R, 2012, ENTOMOL EXP APPL, V143, P218, DOI 10.1111/j.1570-7458.2012.01255.x; Soler R, 2010, ENTOMOL EXP APPL, V136, P191, DOI 10.1111/j.1570-7458.2010.01015.x; Soler R, 2009, ECOL ENTOMOL, V34, P339, DOI 10.1111/j.1365-2311.2008.01082.x; Spence KO, 2007, ENVIRON ENTOMOL, V36, P623, DOI 10.1603/0046-225X(2007)36[623:FOFAPI]2.0.CO;2; StatView, 1999, STATVIEW US GUID VER; Tabuchi K, 2010, ECOSCIENCE, V17, P379, DOI 10.2980/17-4-3354; Tebayashi SI, 2007, BIOSCI BIOTECH BIOCH, V71, P1521, DOI 10.1271/bbb.70033; TRICHILO PJ, 1986, ENVIRON ENTOMOL, V15, P821, DOI 10.1093/ee/15.4.821; Underwood N, 2000, ECOLOGY, V81, P1565, DOI 10.1890/0012-9658(2000)081[1565:TEOHPG]2.0.CO;2; van Dam NM, 2009, PHYTOCHEM REV, V8, P171, DOI 10.1007/s11101-008-9101-9; Viswanathan DV, 2008, ECOL ENTOMOL, V33, P86, DOI 10.1111/j.1365-2311.2007.00943.x; Viswanathan DV, 2005, ECOLOGY, V86, P886, DOI 10.1890/04-0313; Voelckel C, 2004, ECOL LETT, V7, P770, DOI 10.1111/j.1461-0248.2004.00633.x; Williams S., 2011, PESTS BENEFICIAL AUS, P96; Wilson LJ, 1996, B ENTOMOL RES, V86, P297, DOI 10.1017/S0007485300052597; Wilson LJ, 1994, P 7 AUSTR COTT C BRO, P113; Wise MJ, 2002, ECOL ENTOMOL, V27, P115, DOI 10.1046/j.0307-6946.2001.00383.x	63	14	14	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63611	10.1371/journal.pone.0063611	http://dx.doi.org/10.1371/journal.pone.0063611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691075	Green Submitted, gold, Green Published			2022-12-25	WOS:000319107400069
J	Ullen, A; Singewald, E; Konya, V; Fauler, G; Reicher, H; Nusshold, C; Hammer, A; Kratky, D; Heinemann, A; Holzer, P; Malle, E; Sattler, W				Uellen, Andreas; Singewald, Evelin; Konya, Viktoria; Fauler, Guenter; Reicher, Helga; Nusshold, Christoph; Hammer, Astrid; Kratky, Dagmar; Heinemann, Akos; Holzer, Peter; Malle, Ernst; Sattler, Wolfgang			Myeloperoxidase-Derived Oxidants Induce Blood-Brain Barrier Dysfunction In Vitro and In Vivo	PLOS ONE			English	Article							N-TERMINAL KINASE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; BACTERIAL-MENINGITIS; CEREBRAL-ISCHEMIA; JUNCTION PROTEINS; EXPRESSION; ACID; NEUTROPHILS; TARGETS	Peripheral leukocytes can exacerbate brain damage by release of cytotoxic mediators that disrupt blood-brain barrier (BBB) function. One of the oxidants released by activated leukocytes is hypochlorous acid (HOCl) formed via the myeloperoxidase (MPO)-H2O2-Cl- system. In the present study we examined the role of leukocyte activation, leukocyte-derived MPO and MPO-generated oxidants on BBB function in vitro and in vivo. In a mouse model of lipopolysaccharide (LPS)-induced systemic inflammation, neutrophils that had become adherent released MPO into the cerebrovasculature. In vivo, LPS-induced BBB dysfunction was significantly lower in MPO-deficient mice as compared to wild-type littermates. Both, fMLP-activated leukocytes and the MPO-H2O2-Cl- system inflicted barrier dysfunction of primary brain microvascular endothelial cells (BMVEC) that was partially rescued with the MPO inhibitor 4-aminobenzoic acid hydrazide. BMVEC treatment with the MPO-H2O2-Cl- system or activated neutrophils resulted in the formation of plasmalogen-derived chlorinated fatty aldehydes. 2-chlorohexadecanal (2-ClHDA) severely compromised BMVEC barrier function and induced morphological alterations in tight and adherens junctions. In situ perfusion of rat brain with 2-ClHDA increased BBB permeability in vivo. 2-ClHDA potently activated the MAPK cascade at physiological concentrations. An ERK1/2 and JNK antagonist (PD098059 and SP600125, respectively) protected against 2-ClHDA-induced barrier dysfunction in vitro. The current data provide evidence that interference with the MPO pathway could protect against BBB dysfunction under (neuro) inflammatory conditions.	[Uellen, Andreas; Reicher, Helga; Nusshold, Christoph; Kratky, Dagmar; Malle, Ernst; Sattler, Wolfgang] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Singewald, Evelin; Konya, Viktoria; Heinemann, Akos; Holzer, Peter] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria; [Fauler, Guenter] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Hammer, Astrid] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Sattler, W (corresponding author), Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria.	wolfgang.sattler@medunigraz.at	Kratky, Dagmar/ABF-5699-2021; Holzer, Peter/F-7578-2011; Malle, Ernst/D-3071-2013	Holzer, Peter/0000-0002-5754-395X; Heinemann, Akos/0000-0002-8554-2372; Kratky, Dagmar/0000-0003-1357-7573; Konya, Viktoria/0000-0002-7999-9093	Austrian Science Fund (FWF) [SFB LIPOTOX F3007, DK-MCD-W1226, DK-MOLIN-W1241]; Austrian Nationalbank (Anniversary Fund) [14534]; Austrian Research Promotion Agency (FFG) [P820107]; Austrian Science Fund (FWF) [F 3004, F 3007] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Nationalbank (Anniversary Fund); Austrian Research Promotion Agency (FFG); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Financial support was provided by the Austrian Science Fund (FWF; http://www.fwf.ac.at/; SFB LIPOTOX F3007, DK-MCD-W1226 and DK-MOLIN-W1241), the Austrian Nationalbank (Anniversary Fund, http://www.oenb.at/de/ueber_die_oenb/foerderung/jubilaeumsfonds/jubilaeumsfonds.jsp; project number 14534), and the Austrian Research Promotion Agency (FFG; http://www.ffg.at/; grant No. Bridge P820107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shanti N, 2008, J ENDOCRINOL, V198, P243, DOI 10.1677/JOE-08-0151; Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008; Baldus S, 2001, J CLIN INVEST, V108, P1759; Berdyshev EV, 2011, BBA-MOL CELL BIOL L, V1811, P680, DOI 10.1016/j.bbalip.2011.08.018; Blasig IE, 2011, ANTIOXID REDOX SIGN, V15, P1195, DOI 10.1089/ars.2010.3542; Breckwoldt MO, 2008, P NATL ACAD SCI USA, V105, P18584, DOI 10.1073/pnas.0803945105; Chang CY, 2011, AM J PATHOL, V179, P964, DOI 10.1016/j.ajpath.2011.04.033; Chen JW, 2008, BRAIN, V131, P1123, DOI 10.1093/brain/awn004; Choi DK, 2005, J NEUROSCI, V25, P6594, DOI 10.1523/JNEUROSCI.0970-05.2005; Christen S, 2001, FREE RADICAL BIO MED, V31, P754, DOI 10.1016/S0891-5849(01)00642-6; Coisne C, 2011, ANTIOXID REDOX SIGN, V15, P1285, DOI 10.1089/ars.2011.3929; Dodelet-Devillers A, 2009, J MOL MED, V87, P765, DOI 10.1007/s00109-009-0488-6; Ehrnfelt C, 2003, TRANSPLANTATION, V76, P1112, DOI 10.1097/01.TP.0000079305.60271.96; Fischer S, 2005, EUR J CELL BIOL, V84, P687, DOI 10.1016/j.ejcb.2005.03.002; Forghani R, 2012, RADIOLOGY, V263, P451, DOI 10.1148/radiol.12111593; Freeman LR, 2012, BBA-MOL BASIS DIS, V1822, P822, DOI 10.1016/j.bbadis.2011.12.009; Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gonzalez-Mariscal L, 2011, ANTIOXID REDOX SIGN, V15, P1235, DOI 10.1089/ars.2011.3913; Haegens A, 2009, J IMMUNOL, V182, P7990, DOI 10.4049/jimmunol.0800377; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hermann DM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002886; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Klinke A, 2011, BLOOD, V117, P1350, DOI 10.1182/blood-2010-05-284513; Konya V, 2011, EUR J IMMUNOL, V41, P2379, DOI 10.1002/eji.201141460; Maddahi A, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-56; Maki RA, 2009, J BIOL CHEM, V284, P3158, DOI 10.1074/jbc.M807731200; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Messner MC, 2008, LIPIDS, V43, P581, DOI 10.1007/s11745-008-3189-y; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Miric D, 2010, CLIN BIOCHEM, V43, P246, DOI 10.1016/j.clinbiochem.2009.09.023; Nito C, 2008, J CEREBR BLOOD F MET, V28, P1686, DOI 10.1038/jcbfm.2008.60; Nussbaum C, 2013, ANTIOXID REDOX SIGN, V18, P692, DOI 10.1089/ars.2012.4783; Palmer LJ, 2012, CLIN EXP IMMUNOL, V167, P261, DOI 10.1111/j.1365-2249.2011.04518.x; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; RAUSCH PG, 1975, BLOOD, V46, P913; Rudolph TK, 2010, INT J CARDIOL, V140, P42, DOI 10.1016/j.ijcard.2008.10.035; Schuligoi R, 2009, J LEUKOCYTE BIOL, V85, P136, DOI 10.1189/jlb.0608387; Skaff O, 2008, BIOCHEMISTRY-US, V47, P8237, DOI 10.1021/bi800786q; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Stefanova N, 2012, NEUROTOX RES, V21, P393, DOI 10.1007/s12640-011-9294-3; Sugamata R, 2012, MICROBIOL IMMUNOL, V56, P171, DOI 10.1111/j.1348-0421.2011.00424.x; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Thukkani AK, 2005, AM J PHYSIOL-HEART C, V288, pH2955, DOI 10.1152/ajpheart.00834.2004; Thukkani AK, 2003, CIRCULATION, V108, P3128, DOI 10.1161/01.CIR.0000104564.01539.6A; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ullen A, 2012, FREE RADICAL BIO MED, V53, P1770, DOI 10.1016/j.freeradbiomed.2012.08.575; Ullen A, 2010, FREE RADICAL BIO MED, V49, P1655, DOI 10.1016/j.freeradbiomed.2010.08.025; Usatyuk PV, 2012, MICROVASC RES, V83, P45, DOI 10.1016/j.mvr.2011.04.012; Usatyuk PV, 2004, J BIOL CHEM, V279, P11789, DOI 10.1074/jbc.M311184200; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Wallace BK, 2012, AM J PHYSIOL-CELL PH, V302, pC505, DOI 10.1152/ajpcell.00261.2011; Wildsmith KR, 2006, CHEM PHYS LIPIDS, V139, P157, DOI 10.1016/j.chemphyslip.2005.12.003; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yatsushige H, 2007, J NEUROSCI RES, V85, P1436, DOI 10.1002/jnr.21281; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	59	57	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64034	10.1371/journal.pone.0064034	http://dx.doi.org/10.1371/journal.pone.0064034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691142	gold, Green Submitted, Green Published			2022-12-25	WOS:000319107400097
J	Benowitz-Fredericks, ZM; Kitaysky, AS; Welcker, J; Hatch, SA				Benowitz-Fredericks, Z. M.; Kitaysky, Alexander S.; Welcker, Jorg; Hatch, Scott A.			Effects of Food Availability on Yolk Androgen Deposition in the Black-Legged Kittiwake (Rissa tridactyla), a Seabird with Facultative Brood Reduction	PLOS ONE			English	Article							TESTOSTERONE LEVELS; MATERNAL CONDITION; STRESS HORMONES; EGGS; IMMUNITY; GROWTH; CONSEQUENCES; AGGRESSION; ASYMMETRY; MECHANISM	In birds with facultative brood reduction, survival of the junior chick is thought to be regulated primarily by food availability. In black-legged kittiwakes (Rissa tridactyla) where parents and chicks are provided with unlimited access to supplemental food during the breeding season, brood reduction still occurs and varies interannually. Survival of the junior chick is therefore affected by factors in addition to the amount of food directly available to them. Maternally deposited yolk androgens affect competitive dynamics within a brood, and may be one of the mechanisms by which mothers mediate brood reduction in response to a suite of environmental and physiological cues. The goal of this study was to determine whether food supplementation during the pre-lay period affected patterns of yolk androgen deposition in free-living kittiwakes in two years (2003 and 2004) that varied in natural food availability. Chick survival was measured concurrently in other nests where eggs were not collected. In both years, supplemental feeding increased female investment in eggs by increasing egg mass. First-laid ("A") eggs were heavier but contained less testosterone and androstenedione than second-laid ("B") eggs across years and treatments. Yolk testosterone was higher in 2003 (the year with higher B chick survival) across treatments. The difference in yolk testosterone levels between eggs within a clutch varied among years and treatments such that it was relatively small when B chick experienced the lowest and the highest survival probabilities, and increased with intermediate B chick survival probabilities. The magnitude of testosterone asymmetry in a clutch may allow females to optimize fitness by either predisposing a brood for reduction or facilitating survival of younger chicks.	[Benowitz-Fredericks, Z. M.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Kitaysky, Alexander S.; Welcker, Jorg] Univ Alaska Fairbanks, Dept Biol & Wildlife, Inst Arctic Biol, Fairbanks, AK USA; [Welcker, Jorg] Norwegian Polar Res Inst, Tromso, Norway; [Hatch, Scott A.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA	Bucknell University; University of Alaska System; University of Alaska Fairbanks; Norwegian Polar Institute; United States Department of the Interior; United States Geological Survey	Benowitz-Fredericks, ZM (corresponding author), Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA.	zmbf001@bucknell.edu	Benowitz-Fredericks, Morgan/AAV-3931-2021	Benowitz-Fredericks, Morgan/0000-0002-9265-3169	United States Geological Survey; National Science Foundation (NSF); Alaska EPSCoR (NSF) [EPS-0346770]	United States Geological Survey(United States Geological Survey); National Science Foundation (NSF)(National Science Foundation (NSF)); Alaska EPSCoR (NSF)	This research was supported by the United States Geological Survey (to SAH), a National Science Foundation (NSF) pre doctoral fellowship (to ZMBF), and Alaska EPSCoR (to ASK and ZMBF; NSF #EPS-0346770). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison B, 2008, GEN COMP ENDOCR, V158, P5, DOI 10.1016/j.ygcen.2008.05.020; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Andersson S, 2004, J EVOLUTION BIOL, V17, P501, DOI 10.1111/j.1420-9101.2004.00706.x; [Anonymous], 2009, R LANG ENV STAT COMP; BRAUN BM, 1983, AUK, V100, P469, DOI 10.1093/auk/100.2.469; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cam E, 1998, ECOLOGY, V79, P2917, DOI 10.1890/0012-9658(1998)079[2917:AANPPT]2.0.CO;2; Cam E, 2003, J ANIM ECOL, V72, P411, DOI 10.1046/j.1365-2656.2003.00708.x; Cook MI, 2000, BEHAV ECOL, V11, P282, DOI 10.1093/beheco/11.3.282; Dentressangle F, 2008, BEHAV ECOL SOCIOBIOL, V62, P1899, DOI 10.1007/s00265-008-0620-6; Drummond H, 2003, BEHAV ECOL SOCIOBIOL, V53, P287, DOI 10.1007/s00265-002-0571-2; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Eising CM, 2003, J EXP BIOL, V206, P3211, DOI 10.1242/jeb.00552; Eising CM, 2003, ANIM BEHAV, V66, P1027, DOI 10.1006/anbe.2003.2287; Elf PK, 2002, J EXP ZOOL, V293, P594, DOI 10.1002/jez.10169; Erikstad KE, 1998, ECOLOGY, V79, P1781; FORBES LS, 1991, OIKOS, V62, P325, DOI 10.2307/3545497; FORBES LS, 1990, J THEOR BIOL, V147, P345, DOI 10.1016/S0022-5193(05)80492-8; French JB, 2001, COMP BIOCHEM PHYS C, V128, P91, DOI 10.1016/S1532-0456(00)00181-2; Gasparini J, 2007, J EVOLUTION BIOL, V20, P874, DOI 10.1111/j.1420-9101.2007.01315.x; Gill V, 2002, IBIS; Gill VA, 2002, J AVIAN BIOL, V33, P113, DOI 10.1034/j.1600-048X.2002.330201.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Guillemain M, 2008, IBIS, V150, P172; Hatch SA, 2013, MAR ECOL PROG SER, V477, P271, DOI 10.3354/meps10161; Hinde CA, 2010, SCIENCE, V327, P1373, DOI 10.1126/science.1186056; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Kitaysky AS, 2006, P ROY SOC B-BIOL SCI, V273, P445, DOI 10.1098/rspb.2005.3351; Lack D., 1954, P343; Lipar JL, 2001, J AVIAN BIOL, V32, P231, DOI 10.1111/j.0908-8857.2001.320305.x; Love OP, 2009, GEN COMP ENDOCR, V163, P169, DOI 10.1016/j.ygcen.2008.10.001; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; Machmer MM, 1998, CAN J ZOOL, V76, P181, DOI 10.1139/cjz-76-1-181; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; MOCK DW, 1986, EVOLUTION, V40, P459, DOI 10.1111/j.1558-5646.1986.tb00499.x; MOCK DW, 1995, TRENDS ECOL EVOL, V10, P130, DOI 10.1016/S0169-5347(00)89014-X; Muller MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047763; Muller W, 2007, AM NAT, V169, pE84, DOI 10.1086/511962; Muller W, 2010, BEHAV ECOL, V21, P493, DOI 10.1093/beheco/arq010; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; Okuliarova M, 2007, ACTA VET BRNO, V76, P325, DOI 10.2754/avb200776030325; Okuliarova M, 2011, AM NAT, V177, P824, DOI 10.1086/659996; Paitz RT, 2011, P ROY SOC B-BIOL SCI, V278, P99, DOI 10.1098/rspb.2010.0813; Phillips RA, 1996, IBIS, V138, P410, DOI 10.1111/j.1474-919X.1996.tb08059.x; Pilz KM, 2004, HORM BEHAV, V46, P179, DOI 10.1016/j.yhbeh.2004.03.004; Pilz KM, 2004, FUNCT ECOL, V18, P58, DOI 10.1111/j.1365-2435.2004.00811.x; Pilz KM, 2003, ANIM BEHAV, V65, P841, DOI 10.1006/anbe.2003.2094; Poisbleau M, 2011, BIOL LETTERS, V7, P605, DOI 10.1098/rsbl.2010.1134; Reed WL, 2001, OECOLOGIA, V128, P164, DOI 10.1007/s004420100642; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P344, DOI 10.1007/s00265-005-0057-0; Rutstein AN, 2005, BEHAV ECOL, V16, P62, DOI 10.1093/beheco/arh123; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Shultz MT, 2009, MAR ECOL PROG SER, V393, P247, DOI 10.3354/meps08136; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Tschirren B, 2009, AM NAT, V174, P557, DOI 10.1086/605379; Verboven N, 2003, P ROY SOC B-BIOL SCI, V270, P2223, DOI 10.1098/rspb.2003.2496; White J, 2010, ANIM BEHAV, V79, P1095, DOI 10.1016/j.anbehav.2010.02.003; Williams TD, 2004, GEN COMP ENDOCR, V136, P346, DOI 10.1016/j.ygcen.2004.01.010	60	19	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62949	10.1371/journal.pone.0062949	http://dx.doi.org/10.1371/journal.pone.0062949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675443	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100024
J	Eyase, FL; Akala, HM; Ingasia, L; Cheruiyot, A; Omondi, A; Okudo, C; Juma, D; Yeda, R; Andagalu, B; Wanja, E; Kamau, E; Schnabel, D; Bulimo, W; Waters, NC; Walsh, DS; Johnson, JD				Eyase, Fredrick L.; Akala, Hoseah M.; Ingasia, Luiser; Cheruiyot, Agnes; Omondi, Angela; Okudo, Charles; Juma, Dennis; Yeda, Redemptah; Andagalu, Ben; Wanja, Elizabeth; Kamau, Edwin; Schnabel, David; Bulimo, Wallace; Waters, Norman C.; Walsh, Douglas S.; Johnson, Jacob D.			The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008-2011	PLOS ONE			English	Article							RESISTANCE TRANSPORTER GENE; TIME QUANTITATIVE PCR; PLASMODIUM-FALCIPARUM; ARTEMETHER-LUMEFANTRINE; IN-VIVO; SULFADOXINE-PYRIMETHAMINE; MOLECULAR ANALYSIS; MALARIA; ARTEMISININ; ARTESUNATE	Single Nucleotide Polymorphisms (SNPs) in the Pfmdr1, and Pfcrt, genes of Plasmodium falciparum may confer resistance to a number of anti-malaria drugs. Pfmdr1 86Y and haplotypes at Pfcrt 72-76 have been linked to chloroquine (CQ) as well as amodiaquine (AQ) resistance. mefloquine (MQ) and lumefantrine (LU) sensitivities are linked to Pfmdr1 86Y. Additionally, Pfcrt K76 allele carrying parasites have shown tolerance to LU. We investigated the association between Pfmdr1 86/Pfcrt 7276 and P. falciparum resistance to CQ, AQ, MQ and LU using field samples collected during 2008-2011 from malaria endemic sites in western Kenya. Genomic DNA from these samples was genotyped to examine SNPs and haplotypes in Pfmdr1 and Pfcrt respectively. Additionally, immediate ex vivo and in vitro drug sensitivity profiles were assessed using the malaria SYBR Green I fluorescence-based assay. We observed a rapid but steady percent increase in wild-type parasites with regard to both Pfmdr1 and Pfcrt between 2008 and 2011 (p<0.0001). Equally, a significant reciprocate decrease in AQ and CQ median IC50 values occurred (p<0.0001) during the same period. Thus, the data in this study point to a significantly rapid change in parasite response to AQ and CQ in the study period. This may be due to releasing of drug pressure on the parasite from reduced use of AQ in the face of increased Artemisinin (ART) Combination Therapy (ACT) administration following the intervention of the Global Fund in 2008. LU has been shown to select for 76K genotypes, thus the observed increase in 76K genotypes coupled with significant cross resistance between LU and MQ, may herald emergence of tolerance against both drugs in future.	[Eyase, Fredrick L.; Akala, Hoseah M.; Ingasia, Luiser; Cheruiyot, Agnes; Omondi, Angela; Okudo, Charles; Juma, Dennis; Yeda, Redemptah; Andagalu, Ben; Wanja, Elizabeth; Kamau, Edwin; Bulimo, Wallace; Johnson, Jacob D.] USAMRU K, Dept Emerging Infect Dis Global Emerging Infect S, Nairobi, Kenya; [Waters, Norman C.] US Mil Acad, New York, NY USA; [Walsh, Douglas S.] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Schnabel, David] Walter Reed Army Inst Res, Silver Spring, MD USA	United States Department of Defense; United States Army; United States Military Academy; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Eyase, FL (corresponding author), USAMRU K, Dept Emerging Infect Dis Global Emerging Infect S, Nairobi, Kenya.	fredrickeyase@yahoo.com	Eyase, Fredrick/AHA-7545-2022; Bulimo, Wallace/B-1982-2014	Bulimo, Wallace/0000-0001-8475-0586; Olubayo, Luicer Anne Ingasia/0000-0002-7370-7272; Akala, Hoseah/0000-0001-8584-2706	Armed Forces Health Surveillance Center (AFHSC-GEIS)	Armed Forces Health Surveillance Center (AFHSC-GEIS)	This work was funded by the Armed Forces Health Surveillance Center (AFHSC-GEIS). The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Abuya TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008937; Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; Akala HM, 2011, AM J TROP MED HYG, V85, P34, DOI 10.4269/ajtmh.2011.10-0674; Alifrangis M, 2006, J INFECT DIS, V193, P1738, DOI 10.1086/504269; Alker AP, 2007, AM J TROP MED HYG, V76, P641, DOI 10.4269/ajtmh.2007.76.641; Amin AA, 2005, J CLIN PHARM THER, V30, P559, DOI 10.1111/j.1365-2710.2005.00685.x; Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; Babiker HA, 2001, J INFECT DIS, V183, P1535, DOI 10.1086/320195; Baliraine FN, 2011, J INFECT DIS, V204, P1120, DOI 10.1093/infdis/jir486; Chen NH, 2002, J INFECT DIS, V185, P405, DOI 10.1086/338470; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Echeverry DF, 2006, MEM I OSWALDO CRUZ, V101, P341, DOI 10.1590/S0074-02762006000300022; Ferreira ID, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-1; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Gama BE, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-174; Gama BE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-156; Holmgren G, 2006, INFECT GENET EVOL, V6, P309, DOI 10.1016/j.meegid.2005.09.001; Holmgren G, 2007, INFECT GENET EVOL, V7, P562, DOI 10.1016/j.meegid.2007.03.005; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Lekana-Douki JB, 2011, INFECT GENET EVOL, V11, P512, DOI 10.1016/j.meegid.2011.01.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayxay M, 2004, CLIN INFECT DIS, V39, P1139, DOI 10.1086/424512; Mbaisi A, 2004, ANTIMICROB AGENTS CH, V48, P3598, DOI 10.1128/AAC.48.9.3598-3601.2004; Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09; Mwai L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-106; Ngo T, 2003, AM J TROP MED HYG, V68, P350, DOI 10.4269/ajtmh.2003.68.350; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Olliaro P., 2003, COCHRANE DB SYST REV, V2, pCD000016; Olliaro P L, 2004, J Postgrad Med, V50, P40; Phompradit P, 2011, ACTA TROP, V120, P130, DOI 10.1016/j.actatropica.2011.07.003; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Sa JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-374; Sirima SB, 2007, EXPERT OPIN INV DRUG, V16, P1079, DOI 10.1517/13543784.16.7.1079; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Spalding MD, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-338; Thwing JI, 2009, TROP MED INT HEALTH, V14, P294, DOI 10.1111/j.1365-3156.2009.02222.x; WILSON CM, 1993, MOL BIOCHEM PARASIT, V57, P151, DOI 10.1016/0166-6851(93)90252-S	45	62	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e64299	10.1371/journal.pone.0064299	http://dx.doi.org/10.1371/journal.pone.0064299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675533	gold, Green Published			2022-12-25	WOS:000319036100061
J	Sarute, N; Calderon, MG; Perez, R; La Torre, J; Hernandez, M; Francia, L; Panzera, Y				Sarute, Nicolas; Gallo Calderon, Marina; Perez, Ruben; La Torre, Jose; Hernandez, Martin; Francia, Lourdes; Panzera, Yanina			The Fusion Protein Signal-Peptide-Coding Region of Canine Distemper Virus: A Useful Tool for Phylogenetic Reconstruction and Lineage Identification	PLOS ONE			English	Article							HN GENE; RT-PCR; DOGS; CARNIVORES; STRAINS; CDV	Canine distemper virus (CDV; Paramyxoviridae, Morbillivirus) is the etiologic agent of a multisystemic infectious disease affecting all terrestrial carnivore families with high incidence and mortality in domestic dogs. Sequence analysis of the hemagglutinin (H) gene has been widely employed to characterize field strains, permitting the identification of nine CDV lineages worldwide. Recently, it has been established that the sequences of the fusion protein signal-peptide (Fsp) coding region are extremely variable, suggesting that analysis of its sequence might be useful for strain characterization studies. However, the divergence of Fsp sequences among worldwide strains and its phylogenetic resolution has not yet been evaluated. We constructed datasets containing the Fsp-coding region and H gene sequences of the same strains belonging to eight CDV lineages. Both datasets were used to evaluate their phylogenetic resolution. The phylogenetic analysis revealed that both datasets clustered the same strains into eight different branches, corresponding to CDV lineages. The inter-lineage amino acid divergence was fourfold greater for the Fsp peptide than for the H protein. The likelihood mapping revealed that both datasets display strong phylogenetic signals in the region of well-resolved topologies. These features indicate that Fsp-coding region sequence analysis is suitable for evolutionary studies as it allows for straightforward identification of CDV lineages.	[Sarute, Nicolas; Perez, Ruben; Hernandez, Martin; Francia, Lourdes; Panzera, Yanina] Univ Republica, Secc Genet Evolut, Inst Biol, Fac Ciencias, Montevideo, Uruguay; [Gallo Calderon, Marina; La Torre, Jose] Inst Ciencia & Tecnol Dr Cesar Milstein, Ctr Virol Anim, Buenos Aires, DF, Argentina	Universidad de la Republica, Uruguay	Panzera, Y (corresponding author), Univ Republica, Secc Genet Evolut, Inst Biol, Fac Ciencias, Montevideo, Uruguay.	ypanzera@fcien.edu.uy	Sarute, Nicolas/AAK-4259-2020; Perez, Ruben/AAU-1516-2020	Perez, Ruben/0000-0003-4961-4743; Sarute, Nicolas/0000-0001-6432-1880	"Programa de Desarrollo de las Ciencias Basicas" (PEDECIBA); Agencia Nacional de Investigacion e Innovacion (ANII); Programa Amsud-Pasteur from Uruguay	"Programa de Desarrollo de las Ciencias Basicas" (PEDECIBA); Agencia Nacional de Investigacion e Innovacion (ANII); Programa Amsud-Pasteur from Uruguay	This study was supported in part by "Programa de Desarrollo de las Ciencias Basicas" (PEDECIBA), Agencia Nacional de Investigacion e Innovacion (ANII) and Programa Amsud-Pasteur from Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DJ, 2008, VET MICROBIOL, V132, P389, DOI 10.1016/j.vetmic.2008.05.025; BLIXENKRONEMOLLER M, 1993, VET MICROBIOL, V37, P163, DOI 10.1016/0378-1135(93)90190-I; Bolt G, 1997, J GEN VIROL, V78, P367, DOI 10.1099/0022-1317-78-2-367; Calderon MG, 2007, VET MICROBIOL, V125, P341, DOI 10.1016/j.vetmic.2007.05.020; Nava AFD, 2008, ECOHEALTH, V5, P513, DOI 10.1007/s10393-008-0207-8; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; Frolich K, 2000, VET MICROBIOL, V74, P283, DOI 10.1016/S0378-1135(00)00192-9; Gebara CMS, 2004, ARQ BRAS MED VET ZOO, V56, P480, DOI 10.1590/S0102-09352004000400009; Gemma T, 1996, J VET MED SCI, V58, P547, DOI 10.1292/jvms.58.547; Hirama K, 2004, J VET MED SCI, V66, P1575, DOI 10.1292/jvms.66.1575; Iwatsuki K, 1997, J GEN VIROL, V78, P373, DOI 10.1099/0022-1317-78-2-373; Iwatsuki K, 2000, VET MICROBIOL, V71, P281, DOI 10.1016/S0378-1135(99)00172-8; Keller SM, 2012, J WILDLIFE DIS, V48, P1035, DOI 10.7589/2011-12-350; Kindermann J, 2001, ARCH VIROL, V146, P1021, DOI 10.1007/s007050170133; Lan NT, 2006, VET MICROBIOL, V115, P32, DOI 10.1016/j.vetmic.2006.01.010; Lednicky JA, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-2; LEE M, 2008, CAN LITERATURE SUM, P183; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Mahmood S, 2010, AVIAN PATHOL, V39, P453, DOI 10.1080/03079457.2010.517514; Martella V, 2006, VET MICROBIOL, V116, P301, DOI 10.1016/j.vetmic.2006.04.019; Martella V, 2008, VET CLIN N AM-SMALL, V38, P787, DOI 10.1016/j.cvsm.2008.02.007; Martella V, 2007, VET MICROBIOL, V122, P32, DOI 10.1016/j.vetmic.2007.01.005; Martella V, 2010, EMERG INFECT DIS, V16, P2007, DOI 10.3201/eid1612.100579; Muller A, 2011, J WILDLIFE DIS, V47, P725, DOI 10.7589/0090-3558-47.3.725; Origgi FC, 2012, VET PATHOL, V49, P913, DOI 10.1177/0300985812436743; Panzera Y, 2012, VIRUS RES, V163, P401, DOI 10.1016/j.virusres.2011.10.008; ROTA JS, 1992, VIROLOGY, V188, P135, DOI 10.1016/0042-6822(92)90742-8; Sarute N., 2011, Veterinaria (Montevideo), V47, P7; Schmidt H.A., 2007, CURR PROTOC BIOINFOR, V17, p6.6.1, DOI [10.1002/0471250953.bi0606s17, DOI 10.1002/0471250953.BI0606S17]; Shi JW, 2011, VIRUS GENES, V43, P319, DOI 10.1007/s11262-011-0638-0; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Sultan S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-157; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Woma TY, 2010, VET MICROBIOL, V143, P126, DOI 10.1016/j.vetmic.2009.11.013; Zhao JJ, 2010, VET MICROBIOL, V140, P34, DOI 10.1016/j.vetmic.2009.07.010	35	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63595	10.1371/journal.pone.0063595	http://dx.doi.org/10.1371/journal.pone.0063595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675493	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100043
J	Xin, LJ; Yamujala, R; Wang, YH; Wang, H; Wu, WH; Lawton, MA; Long, CL; Di, R				Xin, Lijuan; Yamujala, Ritupriya; Wang, Yuehu; Wang, Huan; Wu, Wen-Hsuan; Lawton, Michael A.; Long, Chunlin; Di, Rong			Acetylcholineestarase-Inhibiting Alkaloids from Lycoris radiata Delay Paralysis of Amyloid Beta-Expressing Transgenic C. elegans CL4176	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; ALZHEIMERS-DISEASE; ACETYLCHOLINESTERASE INHIBITORS; AMARYLLIDACEAE ALKALOIDS; OXIDATIVE STRESS; PEPTIDE; GENES; PEROXIDE; HYPOTHESIS; HUPERZINE	The limited symptom relief and side effects of current Alzheimer's disease (AD) medications warrant urgent discovery and study of new anti-AD agents. The "cholinergic hypothesis'' of AD prompts us to search for plant-derived acetylcholineesterase (AChE) inhibitors such as galanthamine that has been licensed in Europe for AD treatment. We used the unique amyloid beta-expressing transgenic C. elegans CL4176, which exhibits paralysis when human A(beta 1-42) is induced, to study two natural benzylphenethylamine alkaloids isolated from Lycoris radiata (L' Her.) Herb, galanthamine and haemanthidine, and their synthetic derivatives 1,2-Di-O-acetyllycorine and 1-O-acetyllycorine for their anti-paralysis effects. Our data indicate that these Lycoris compounds effectively delay the paralysis of CL4176 worms upon temperature up-shift, and prolong the lives of these transgenic worms. Lycoris compounds were shown to significantly inhibit the gene expression of ace-1 and ace-2. Additionally, the Lycoris compounds may modulate inflammatory and stress-related gene expressions to combat the A beta-toxicity in C. elegans.	[Xin, Lijuan; Long, Chunlin] Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China; [Yamujala, Ritupriya; Wu, Wen-Hsuan] Rutgers State Univ, New Brunswick Grad Sch, New Brunswick, NJ 08903 USA; [Wang, Yuehu; Wang, Huan; Long, Chunlin] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Beijing 100864, Peoples R China; [Xin, Lijuan; Lawton, Michael A.; Di, Rong] Rutgers State Univ, Sch Environm & Biol Sci, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Minzu University of China; Rutgers State University New Brunswick; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Rutgers State University New Brunswick	Long, CL (corresponding author), Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China.	long@mail.kib.ac.cn; di@aesop.rutgers.edu	WANG, YUE/GWQ-9256-2022	Wang, Yue-Hu/0000-0002-5327-457X; Long, Chunlin/0000-0002-6573-6049	National Natural Science Foundation of China [31161140345, 31070288, 20972166]; Ministry of Education of China [B08044, MUC985-9, MUC98506-01000101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was partially funded by the National Natural Science Foundation of China (31161140345, 31070288, 20972166), and Ministry of Education of China through its 111 and 985 programs (B08044, MUC985-9, MUC98506-01000101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya U, 2009, EXP GERONTOL, V44, P462, DOI 10.1016/j.exger.2009.02.010; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Combes D, 2003, EUR J NEUROSCI, V18, P497, DOI 10.1046/j.1460-9568.2003.02749.x; Combes D, 2001, INT REV CYTOL, V209, P207; Culetto E, 1999, J MOL BIOL, V290, P951, DOI 10.1006/jmbi.1999.2937; Dostal V., 2010, J VIS EXP, V1, P2252, DOI [10.3791/2252, DOI 10.3791/2252]; Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7; Elgorashi EE, 2004, PLANTA MED, V70, P260, DOI 10.1055/s-2004-818919; Evidente A, 2009, PHYTOCHEM REV, V8, P449, DOI 10.1007/s11101-008-9119-z; Evidente A, 2009, PLANTA MED, V75, P501, DOI 10.1055/s-0029-1185340; Giunta B, 2004, BRAIN RES BULL, V64, P165, DOI 10.1016/j.brainresbull.2004.06.008; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gutierrez-Zepeda A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-54; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hatters DM, 2011, DIAGNOSTICS AMYLOID; Howes MJR, 2003, PHARMACOL BIOCHEM BE, V75, P513, DOI 10.1016/S0091-3057(03)00128-X; Lee SS, 2007, BIOORGAN MED CHEM, V15, P1034, DOI 10.1016/j.bmc.2006.10.026; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Link CD, 2006, EXP GERONTOL, V41, P1007, DOI 10.1016/j.exger.2006.06.059; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McGleenon BM, 1999, BRIT J CLIN PHARMACO, V48, P471; Monsonego A, 2001, P NATL ACAD SCI USA, V98, P10273, DOI 10.1073/pnas.191118298; NAKAGAWA Y, 1956, CHEM IND-LONDON, P1238; Reale M, 2005, EXP GERONTOL, V40, P165, DOI 10.1016/j.exger.2004.12.003; Selkirk ME, 2005, CHEM-BIOL INTERACT, V157, P263, DOI 10.1016/j.cbi.2005.10.039; Tabet N, 2006, AGE AGEING, V35, P336, DOI 10.1093/ageing/afl027; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Huan, 2011, Chinese Herbal Medicines, V3, P60; Wang L, 2009, CHEM PHARM BULL, V57, P610, DOI 10.1248/cpb.57.610; Wang R, 2002, MOL BRAIN RES, V107, P1, DOI 10.1016/S0169-328X(02)00402-3; Wenk GL, 2000, LIFE SCI, V66, P1079, DOI 10.1016/S0024-3205(00)00411-2; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Xiao XQ, 2000, J NEUROSCI RES, V61, P564; Zhang HY, 2000, NEUROSCI LETT, V292, P41, DOI 10.1016/S0304-3940(00)01433-6; 耿中峰, 2008, [中草药, Chinese Traditional and Herbal Drugs], V39, P543	37	44	44	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63874	10.1371/journal.pone.0063874	http://dx.doi.org/10.1371/journal.pone.0063874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675513	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100053
J	Shi, F; Wang, L; Peng, ZW; Wee, CY; Shen, DG				Shi, Feng; Wang, Li; Peng, Ziwen; Wee, Chong-Yaw; Shen, Dinggang			Altered Modular Organization of Structural Cortical Networks in Children with Autism	PLOS ONE			English	Article							SPECTRUM DISORDERS; BRAIN-DEVELOPMENT; CEREBRAL-CORTEX; THICKNESS; MRI; VOLUME; SCHIZOPHRENIA; CONNECTIVITY; NEUROANATOMY; ANATOMY	Autism is a complex developmental disability that characterized by deficits in social interaction, language skills, repetitive stereotyped behaviors and restricted interests. Although great heterogeneity exists, previous findings suggest that autism has atypical brain connectivity patterns and disrupted small-world network properties. However, the organizational alterations in the autistic brain network are still poorly understood. We explored possible organizational alterations of 49 autistic children and 51 typically developing controls, by investigating their brain network metrics that are constructed upon cortical thickness correlations. Three modules were identified in controls, including cortical regions associated with brain functions of executive strategic, spatial/auditory/visual, and self-reference/episodic memory. There are also three modules found in autistic children with similar patterns. Compared with controls, autism demonstrates significantly reduced gross network modularity, and a larger number of inter-module connections. However, the autistic brain network demonstrates increased intra-and inter-module connectivity in brain regions including middle frontal gyrus, inferior parietal gyrus, and cingulate, suggesting one underlying compensatory mechanism associated with brain functions of self-reference and episodic memory. Results also show that there is increased correlation strength between regions inside frontal lobe, as well as impaired correlation strength between frontotemporal and frontoparietal regions. This alteration of correlation strength may contribute to the organization alteration of network structures in autistic brains.	[Shi, Feng; Wang, Li; Peng, Ziwen; Wee, Chong-Yaw; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA; [Shi, Feng; Wang, Li; Peng, Ziwen; Wee, Chong-Yaw; Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC USA; [Peng, Ziwen] S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; South China Normal University; Korea University	Shen, DG (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Shen, Dinggang/ABF-6812-2020; wang, li/O-1425-2015	Shen, Dinggang/0000-0002-7934-5698; wang, li/0000-0001-8927-6772	National Institutes of Health (NIH) [EB006733, EB008374, EB009634, AG041721]; National Natural Science Foundation of China [81201049]; University of North Carolina at Chapel Hill's Libraries; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008374, R01EB009634, R01EB006733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041721] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of North Carolina at Chapel Hill's Libraries; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (NIH) grants EB006733, EB008374, EB009634, AG041721, and National Natural Science Foundation of China (81201049). The University of North Carolina at Chapel Hill's Libraries provided support for open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Anagnostou E, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-4; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Baron-Cohen S., 2005, LOST SELF PATHOLOGIE, P166, DOI [10.1093/acprof:oso/9780195173413.003.0011, DOI 10.1093/ACPROF:OSO/9780195173413.003.0011]; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Ben Shalom D, 2006, J AUTISM DEV DISORD, V36, P395, DOI 10.1007/s10803-006-0077-2; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; Cohen J, 2003, APPL MULTIPLE REGRES, V3rd, DOI DOI 10.4324/9780203774441; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; COURCHESNE E, 1993, AM J ROENTGENOL, V160, P387, DOI 10.2214/ajr.160.2.8424359; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dawson G, 2002, DEV PSYCHOPATHOL, V14, P581, DOI 10.1017/S0954579402003103; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; FERRER I, 1995, NEUROSCIENCE, V66, P189, DOI 10.1016/0306-4522(94)00584-R; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gong GL, 2012, NEUROIMAGE, V59, P1239, DOI 10.1016/j.neuroimage.2011.08.017; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hall Dan, 2012, Neuroinformatics, V10, P331, DOI 10.1007/s12021-012-9151-4; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hardan AY, 2009, BIOL PSYCHIAT, V66, P320, DOI 10.1016/j.biopsych.2009.04.024; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; HUGHES C, 1994, NEUROPSYCHOLOGIA, V32, P477, DOI 10.1016/0028-3932(94)90092-2; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kana RK, 2011, PHYS LIFE REV; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kwon H, 2004, DEV MED CHILD NEUROL, V46, P760, DOI 10.1017/S0012162204001306; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Lind SE, 2010, J ABNORM PSYCHOL, V119, P896, DOI 10.1037/a0020631; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Ramachandran V. S., 2007, SCI AM, V17, P20; Raznahan A, 2010, CEREB CORTEX, V20, P1332, DOI 10.1093/cercor/bhp198; Redies C, 2001, BIOESSAYS, V23, P1100, DOI 10.1002/bies.10014; Rojas DC, 2005, J AUTISM DEV DISORD, V35, P479, DOI 10.1007/s10803-005-5038-7; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shi F, 2012, NEUROIMAGE, V62, P1622, DOI 10.1016/j.neuroimage.2012.05.026; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Tsatsanis KD, 2003, BIOL PSYCHIAT, V53, P121, DOI 10.1016/S0006-3223(02)01530-5; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Wallace GL, 2010, BRAIN, V133, P3745, DOI 10.1093/brain/awq279; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	59	35	37	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63131	10.1371/journal.pone.0063131	http://dx.doi.org/10.1371/journal.pone.0063131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675456	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400024
J	Yang, X; Kendrick, KM; Wu, QZ; Chen, TL; Lama, S; Cheng, BC; Li, SG; Huang, XQ; Gong, QY				Yang, Xun; Kendrick, Keith Maurice; Wu, Qizhu; Chen, Taolin; Lama, Sunima; Cheng, Bochao; Li, Shiguang; Huang, Xiaoqi; Gong, Qiyong			Structural and Functional Connectivity Changes in the Brain Associated with Shyness but Not with Social Anxiety	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; VOXEL-BASED MORPHOMETRY; PERSONALLY FAMILIAR FACES; SUPERIOR TEMPORAL SULCUS; RESTING STATE NETWORKS; PREFRONTAL CORTEX; GENETIC INFLUENCES; CHINESE VERSION; RHESUS-MONKEY; FEARFUL FACES	Shyness and social anxiety are correlated to some extent and both are associated with hyper-responsivity to social stimuli in the frontal cortex and limbic system. However to date no studies have investigated whether common structural and functional connectivity differences in the brain may contribute to these traits. We addressed this issue in a cohort of 61 healthy adult subjects. Subjects were first assessed for their levels of shyness (Cheek and Buss Shyness scale) and social anxiety (Liebowitz Social Anxiety scale) and trait anxiety. They were then given MRI scans and voxel-based morphometry and seed-based, resting-state functional connectivity analysis investigated correlations with shyness and anxiety scores. Shyness scores were positively correlated with gray matter density in the cerebellum, bilateral superior temporal gyri and parahippocampal gyri and right insula. Functional connectivity correlations with shyness were found between the superior temporal gyrus, parahippocampal gyrus and the frontal gyri, between the insula and precentral gyrus and inferior parietal lobule, and between the cerebellum and precuneus. Additional correlations were found for amygdala connectivity with the medial frontal gyrus, superior frontal gyrus and inferior parietal lobule, despite the absence of any structural correlation. By contrast no structural or functional connectivity measures correlated with social or trait anxiety. Our findings show that shyness is specifically associated with structural and functional connectivity changes in cortical and limbic regions involved with processing social stimuli. These associations are not found with social or trait anxiety in healthy subjects despite some behavioral correlations with shyness.	[Yang, Xun; Kendrick, Keith Maurice; Wu, Qizhu; Chen, Taolin; Lama, Sunima; Cheng, Bochao; Li, Shiguang; Huang, Xiaoqi; Gong, Qiyong] Sichuan Univ, West China Hosp, Dept Radiol, Huaxi MR Res Ctr, Chengdu 610064, Peoples R China; [Yang, Xun] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Psychiat, Chengdu 610064, Peoples R China; [Kendrick, Keith Maurice] Univ Elect Sci & Technol China, Key Lab Neuroinformat, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	Sichuan University; Sichuan University; University of Electronic Science & Technology of China	Gong, QY (corresponding author), Sichuan Univ, West China Hosp, Dept Radiol, Huaxi MR Res Ctr, Chengdu 610064, Peoples R China.	qiyonggong@hmrrc.org.cn	Gong, Qiyong/W-3052-2019; Chen, Taolin/AAG-1561-2019; Huang, Xiaoqi/O-7904-2017	Gong, Qiyong/0000-0002-5912-4871; Chen, Taolin/0000-0003-0877-4943; Huang, Xiaoqi/0000-0001-8686-5010; Kendrick, Keith/0000-0002-0371-5904; Cheng, Bochao/0000-0002-9923-5509	National Natural Science Foundation [81030027, 81227002, 81220108013, 30900362, 81171488, 91132720]; National Key Technologies R&D Program of China [2012BAI01B03]; CMB Distinguished Professorship Award [F510000/G16916411]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program); CMB Distinguished Professorship Award	This study was supported by the National Natural Science Foundation (Grant Nos. 81030027, 81227002, 81220108013, 30900362, 81171488 and 91132720) and National Key Technologies R&D Program of China (Program No. 2012BAI01B03). Dr. Qiyong Gong acknowledges the support from his CMB Distinguished Professorship Award (Award No. F510000/G16916411) administered by the Institute of International Education, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027633; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baldacara L, 2008, REV BRAS PSIQUIATR, V30, P281, DOI 10.1590/S1516-44462008000300016; Barnes LLB, 2002, EDUC PSYCHOL MEAS, V62, P603, DOI 10.1177/0013164402062004005; Battaglia M, 2005, ARCH GEN PSYCHIAT, V62, P85, DOI 10.1001/archpsyc.62.1.85; Beaton EA, 2008, BEHAV NEUROSCI, V122, P704, DOI 10.1037/0735-7044.122.3.704; Beaton EA, 2010, PERS INDIV DIFFER, V49, P755, DOI 10.1016/j.paid.2010.06.021; Beaton EA, 2009, SOC NEUROSCI-UK, V4, P308, DOI 10.1080/17470910902801021; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonne O, 2003, BIOL PSYCHIAT, V54, P1077, DOI 10.1016/S0006-3223(03)00525-0; Booth JR, 2003, NEUROIMAGE, V20, P737, DOI 10.1016/S1053-8119(03)00404-X; BRUCH MA, 1989, J PERS SOC PSYCHOL, V57, P904, DOI 10.1037/0022-3514.57.5.904; Bruhl AB, 2011, BRAIN RES, V1378, P72, DOI 10.1016/j.brainres.2010.12.084; Brunetti M, 2010, NEUROSCIENCE, V168, P670, DOI 10.1016/j.neuroscience.2010.04.024; Bryant RA, 2008, HUM BRAIN MAPP, V29, P517, DOI 10.1002/hbm.20415; Chavira DA, 2002, J ANXIETY DISORD, V16, P585, DOI 10.1016/S0887-6185(02)00124-X; Cheek J.M., 1990, HDB SOCIAL EVALUATIO, P47; CHEEK JM, 1981, J PERS SOC PSYCHOL, V41, P330, DOI 10.1037/0022-3514.41.2.330; Cheek JM, 1983, REVIESD CHEEK UNPUB; Chen SH, 2012, NEUROIMAGE, V60, P299, DOI 10.1016/j.neuroimage.2011.11.092; Chou KL, 2005, AGING MENT HEALTH, V9, P456, DOI 10.1080/13607860500142820; Cox CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012296; Crozier WR, 2005, PERS INDIV DIFFER, V38, P1947, DOI 10.1016/j.paid.2004.12.002; Davis F.C., 2012, CEREB CORTEX; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Denissen JJA, 2008, J PERS, V76, P67, DOI 10.1111/j.1467-6494.2007.00480.x; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Fernandez M, 2001, NEUROSCI LETT, V297, P101, DOI 10.1016/S0304-3940(00)01674-8; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fox NA, 2005, PSYCHOL SCI, V16, P921, DOI 10.1111/j.1467-9280.2005.01637.x; Freitas-Ferrari MC, 2010, PROG NEURO-PSYCHOPH, V34, P565, DOI 10.1016/j.pnpbp.2010.02.028; Fresco DM, 2001, PSYCHOL MED, V31, P1025, DOI 10.1017/S0033291701004056; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Gong YX, 1984, PSYCHOL SCI NEWSLETT, V4, P11; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Heiser NA, 2009, J ANXIETY DISORD, V23, P469, DOI 10.1016/j.janxdis.2008.10.002; Henderson HA, 2010, DEV NEUROPSYCHOL, V35, P177, DOI 10.1080/87565640903526538; Henderson L, 2002, PERS INDIV DIFFER, V32, P79, DOI 10.1016/S0191-8869(01)00007-1; Hirsch CR, 2004, CLIN PSYCHOL REV, V24, P799, DOI 10.1016/j.cpr.2004.07.005; Hoehn M, 2012, EXP NEUROL; Iancu I, 2011, COMPR PSYCHIAT, V52, P708, DOI 10.1016/j.comppsych.2010.11.011; Irle E, 2010, J PSYCHIATR NEUROSCI, V35, P126, DOI 10.1503/jpn.090041; Jetha MK, 2009, INT J NEUROSCI, V119, P847, DOI 10.1080/00207450701242966; Kaasinen V, 2005, NEUROIMAGE, V24, P315, DOI 10.1016/j.neuroimage.2004.09.017; Kanai R, 2012, P ROY SOC B-BIOL SCI, V279, P1327, DOI 10.1098/rspb.2011.1959; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Klumpp H, 2012, BIOL PSYCHOL, V89, P273, DOI 10.1016/j.biopsycho.2011.10.010; Kosaka H, 2010, NEUROIMAGE, V50, P1357, DOI 10.1016/j.neuroimage.2010.01.085; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Majak K, 2003, EUR J NEUROSCI, V18, P1652, DOI 10.1046/j.1460-9568.2003.02854.x; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Miskovic V, 2012, NEUROSCI BIOBEHAV R, V36, P459, DOI 10.1016/j.neubiorev.2011.08.002; Mukherjee P, 2012, SCHIZOPHR RES, V134, P118, DOI 10.1016/j.schres.2011.09.033; [潘集阳 PAN Jiyang], 2006, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V32, P206; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; POTTS NLS, 1994, PSYCHIAT RES, V52, P35, DOI 10.1016/0165-1781(94)90118-X; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Raj BA, 2001, MED CLIN N AM, V85, P711, DOI 10.1016/S0025-7125(05)70337-0; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; SCHMAHMANN JD, 1991, J COMP NEUROL, V308, P224, DOI 10.1002/cne.903080209; Schmidt LA, 1999, PSYCHOL SCI, V10, P316, DOI 10.1111/1467-9280.00161; Schmidt LA, 2008, PEDIATRICS, V122, pE181, DOI 10.1542/peds.2007-3747; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; SHEK DTL, 1993, J CLIN PSYCHOL, V49, P349, DOI 10.1002/1097-4679(199305)49:3<349::AID-JCLP2270490308>3.0.CO;2-J; SHEK DTL, 1988, J PSYCHOPATHOL BEHAV, V10, P303, DOI 10.1007/BF00960624; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Simmons WK, 2012, SOC COGN AFFECT NEUR, V7, P467, DOI 10.1093/scan/nsr018; Suomi S. J., 2004, RES HUMAN DEV, V1, P205, DOI DOI 10.1207/S15427617RHD0103_5; Thomas AG, 2009, NEUROIMAGE, V48, P117, DOI 10.1016/j.neuroimage.2009.05.097; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Tillfors M, 2002, BIOL PSYCHIAT, V52, P1113, DOI 10.1016/S0006-3223(02)01396-3; Van Schuerbeek P, 2011, BRAIN RES, V1371, P32, DOI 10.1016/j.brainres.2010.11.073; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Wong D. F. K., 2006, HONG KONG J PSYCHIAT, V16, P50; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Zimbardo P. G., 1977, SHYNESS WHAT IS IT W	97	12	16	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63151	10.1371/journal.pone.0063151	http://dx.doi.org/10.1371/journal.pone.0063151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143FO	23675458	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400026
J	Agrelo, R; Kishimoto, H; Novatchkova, M; Peraza, V; Paolino, M; Souabni, A; Wutz, A				Agrelo, R.; Kishimoto, H.; Novatchkova, M.; Peraza, V.; Paolino, M.; Souabni, A.; Wutz, A.			SATB1 collaborates with loss of p16 in cellular transformation	ONCOGENE			English	Article						senescence; SATB1; p16; tumor; cell cycle; RB; E2F	BINDING PROTEIN-1 SATB1; RETINOBLASTOMA PROTEIN; GASTRIC-CANCER; T-CELLS; EXPRESSION; GENE; CHROMATIN; SENESCENCE; GROWTH; DIFFERENTIATION	Tumor progression is associated with invasiveness and metastatic potential. The special AT-rich binding protein 1 (SATB1) has been identified as a key factor in the progression of breast cancer cells to a malignant phenotype and is associated with progression of human tumors. In normal development, SATB1 coordinates gene expression of progenitor cells by functioning as a genome organizer. In contrast to progenitor and tumor cells, SATB1 expression in nontransformed cells is not compatible with proliferation. Here we show that SATB1 expression in mouse embryonic fibroblasts induces cell cycle arrest and senescence that is associated with elevated p16 protein levels. Deletion of p16 overcomes the SATB1-induced senescence. We further provide evidence for an interaction of SATB1 with the retinoblastoma (RB)/E2F pathway downstream of p16. A combined deletion of the RB proteins, RB, p107 and p130 (triple-mutant; TM), prevents SATB1-induced G1 arrest, which is restored upon the reintroduction of RB into SATB1-expressing TM fibroblasts. SATB1 interacts with the E2F/RB complex and regulates the cyclin E promoter in an E2F-dependent manner. These findings demonstrate that p16 and the RB/E2F pathway are critical for SATB1-induced cell cycle arrest. In the absence of p16, SATB1 causes anchorage-independent growth and invasive phenotype in fibroblasts. Our data illustrate that p16 mutations collaborate with the oncogenic activity of SATB1. Consistent with our finding, a literature survey shows that deletion of p16 is generally associated with SATB1 expressing human cell lines and tumors.	[Agrelo, R.; Peraza, V.] Inst Pasteur Montevideo, Epigenet Canc & Aging Lab, Montevideo 11400, Uruguay; [Agrelo, R.; Kishimoto, H.; Novatchkova, M.; Paolino, M.; Souabni, A.; Wutz, A.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Kishimoto, H.] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan; [Kishimoto, H.; Wutz, A.] Univ Cambridge, Dept Biochem, Wellcome Trust, Cambridge CB2 1QW, England; [Kishimoto, H.; Wutz, A.] Univ Cambridge, Med Res Council Stem Cell Inst, Cambridge CB2 1QW, England; [Wutz, A.] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Tsukuba; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Swiss Federal Institutes of Technology Domain; ETH Zurich	Agrelo, R (corresponding author), Inst Pasteur Montevideo, Epigenet Canc & Aging Lab, Mataojo 2020, Montevideo 11400, Uruguay.	agrelo@pasteur.edu.uy		Paolino, Magdalena/0000-0001-9724-9029	IMP; Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF); ANII (Program ) INNOVA URU-European Union; Wellcome Trust [087530/Z/08/A]	IMP; Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ANII (Program ) INNOVA URU-European Union; Wellcome Trust(Wellcome TrustEuropean Commission)	We thank M Saltik, MH Idarraga, G Stengl and P Pasierbek for technical assistance, V Bhaskara for helpful discussions, S Galande, JM Peters, H Beug and R Foisner for reagents and advice. This research was supported by the IMP, the Vienna Science and Technology Fund (WWTF), and the Austrian Science Fund (FWF). RA is supported by ANII (Program INNOVA URUGUAY-DCI-ALA/2007/19.040 URU-European Union). AW is supported by a Wellcome Trust Senior Research Fellowship (Grant reference 087530/Z/08/A).	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Alvarez JD, 2000, GENE DEV, V14, P521; Asanoma K, 2012, J BIOL CHEM, V287, P2257, DOI 10.1074/jbc.M111.287128; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Conklin JF, 2009, J CELL BIOCHEM, V108, P1023, DOI 10.1002/jcb.22342; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; Fiorentino FP, 2009, CELL RES, V19, P1044, DOI 10.1038/cr.2009.96; Geng Y, 1996, ONCOGENE, V12, P1173; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hanker LC, 2011, BREAST, V20, P309, DOI 10.1016/j.breast.2010.10.002; Harb G, 2009, DIABETES, V58, P1852, DOI 10.2337/db08-0759; Iorns E, 2010, JNCI-J NATL CANCER I, V102, P1284, DOI 10.1093/jnci/djq243; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Kim H, 2001, ONCOGENE, V20, P3306, DOI 10.1038/sj.onc.1204423; Kim M, 2000, CELL DEATH DIFFER, V7, P706, DOI 10.1038/sj.cdd.4400703; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kohwi-Shigematsu T, 2010, J NATL CANCER I, V102, P1879, DOI 10.1093/jnci/djq440; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; McInnes N, 2012, ONCOGENE, V31, P1045, DOI 10.1038/onc.2011.293; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Odell A, 2010, AGING-US, V2, P160, DOI 10.18632/aging.100129; Ordinario E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051786; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Purbey PK, 2009, MOL CELL BIOL, V29, P1321, DOI 10.1128/MCB.00822-08; Quesnel B, 1996, BRIT J HAEMATOL, V95, P291, DOI 10.1046/j.1365-2141.1996.d01-1913.x; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Takahashi A, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-10; Tan JAT, 2008, J BIOL CHEM, V283, P18124, DOI 10.1074/jbc.M800512200; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Yamayoshi A, 2011, OLIGONUCLEOTIDES, V21, P115, DOI 10.1089/oli.2010.0277; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhao XD, 2010, ORL-J OTO-RHIN-LARYN, V72, P1, DOI 10.1159/000264777	45	15	16	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 28	2013	32	48					5492	5500		10.1038/onc.2013.158	http://dx.doi.org/10.1038/onc.2013.158			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	263BE	23686316	Green Published, hybrid			2022-12-25	WOS:000327780800006
J	Akhatib, B; Onnerfjord, P; Gawri, R; Ouellet, J; Jarzem, P; Heinegard, D; Mort, J; Roughley, P; Haglund, L				Akhatib, Bashar; Onnerfjord, Patrik; Gawri, Rahul; Ouellet, Jean; Jarzem, Peter; Heinegard, Dick; Mort, John; Roughley, Peter; Haglund, Lisbet			Chondroadherin Fragmentation Mediated by the Protease HTRA1 Distinguishes Human Intervertebral Disc Degeneration from Normal Aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-BACK-PAIN; SERINE-PROTEASE; EXTRACELLULAR-MATRIX; CATHEPSIN-K; ARTICULAR-CARTILAGE; PROTEOGLYCANS; EXPRESSION; AGGRECAN; PROTEINS; COLLAGEN	Chondroadherin, a member of the leucine-rich repeat family, has previously been demonstrated to be fragmented in some juveniles with idiopathic scoliosis. This observation led us to investigate adults with disc degeneration. Immunoblotting analysis demonstrated that non-degenerate discs from three different age groups show no chondroadherin fragmentation. Furthermore, the chondroadherin fragments in adult degenerate disc and the juvenile scoliotic disc were compared via immunoblot analysis and appeared to have a similar size. We then investigated whether or not chondroadherin fragmentation increases with the severity of disc degeneration. Three different samples with different severities were chosen from the same disc, and chondroadherin fragmentation was found to be more abundant with increasing severity of degeneration. This observation led us to the creation of a neoepitope antibody to the cleavage site observed. We then observed that the cleavage site in adult degenerate discs and juvenile scoliotic discs was identical as confirmed by the neoepitope antibody. Consequently, investigation of the protease capable of cleaving chondroadherin at this site was necessary. In vitro digests of disc tissue demonstrated that ADAMTS-4 and -5; cathepsins K, B, and L; and MMP-3, -7, -12, and -13 were incapable of cleavage of chondroadherin at this site and that HTRA1 was indeed the only protease capable. Furthermore, increased protein levels of the processed form of HTRA1 were demonstrated in degenerate disc tissues via immunoblotting. The results suggest that chondroadherin fragmentation can be used as a biomarker to distinguish the processes of disc degeneration from normal aging.	[Akhatib, Bashar; Gawri, Rahul; Haglund, Lisbet] McGill Univ, Orthopaed Res Lab, Montreal, PQ H3G 1A4, Canada; [Onnerfjord, Patrik; Ouellet, Jean; Jarzem, Peter; Heinegard, Dick] Lund Univ, Biomed Ctr C12, Dept Clin Sci, Lund Sect Rheumatol, SE-22184 Lund, Sweden; [Ouellet, Jean; Jarzem, Peter] McGill Scoliosis & Spine Grp, Montreal, PQ H3A 1A1, Canada; [Mort, John; Roughley, Peter] Shriners Hosp Children, Genet Unit, Montreal, PQ H3G 1A6, Canada	McGill University; Lund University; McGill University	Haglund, L (corresponding author), McGill Univ, Orthopaed Res Lab, 1650 Cedar Ave,Rm C-9173, Montreal, PQ H3G 1A4, Canada.	lisbet.haglund@orl.mcgill.ca	Gawri, Rahul/I-3784-2019; Onnerfjord, Patrik/R-3131-2019; Haglund, Lisbet/N-3095-2013	Gawri, Rahul/0000-0001-9415-1739; Onnerfjord, Patrik/0000-0002-2345-2937; Haglund, Lisbet/0000-0002-1288-2149	AO Foundation Switzerland Research Grants [S-09-108, S-11-92H]; Scoliosis Research Society	AO Foundation Switzerland Research Grants; Scoliosis Research Society	This work was supported by AO Foundation Switzerland Research Grants S-09-108 and S-11-92H and the Scoliosis Research Society.	Ariga K, 2001, SPINE, V26, P2666, DOI 10.1097/00007632-200112150-00007; Bachmeier BE, 2009, EUR SPINE J, V18, P1573, DOI 10.1007/s00586-009-1031-8; Bertram H, 2006, BIOCHEM BIOPH RES CO, V342, P963, DOI 10.1016/j.bbrc.2006.02.048; Billington CJ, 2000, BIOCHEM BIOPH RES CO, V276, P924, DOI 10.1006/bbrc.2000.3553; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P20613; Brown S, 2012, EUR SPINE J, V21, pS154, DOI 10.1007/s00586-012-2179-1; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Chamberland A, 2009, J BIOL CHEM, V284, P27352, DOI 10.1074/jbc.M109.037051; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Crean JKG, 1997, SPINE, V22, P2877, DOI 10.1097/00007632-199712150-00010; Danfelter M, 2007, J BIOL CHEM, V282, P36933, DOI 10.1074/jbc.M702491200; Durigova M, 2011, MATRIX BIOL, V30, P145, DOI 10.1016/j.matbio.2010.10.007; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; FISHER LW, 1989, J BIOL CHEM, V264, P4571; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Gruber HE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3454; Haglund L, 2013, J BIOL CHEM, V288, P995, DOI 10.1074/jbc.M112.430512; Haglund L, 2009, SPINE, V34, P1513, DOI 10.1097/BRS.0b013e3181a8d001; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; JOHNSTONE B, 1995, SPINE, V20, P674, DOI 10.1097/00007632-199503150-00008; LARSSON T, 1991, J BIOL CHEM, V266, P20428; Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652; Le Maitre CL, 2006, BIOTECH HISTOCHEM, V81, P125, DOI 10.1080/10520290601005298; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; Lotz JC, 1998, SPINE, V23, P2493, DOI 10.1097/00007632-199812010-00004; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Mizuno M, 1996, CALCIFIED TISSUE INT, V59, P163, DOI 10.1007/s002239900103; Nie GY, 2005, DEV DYNAM, V233, P1102, DOI 10.1002/dvdy.20399; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; Onnerfjord P, 2012, J BIOL CHEM, V287, P18913, DOI 10.1074/jbc.M111.298968; Peferoen M, 1988, Methods Mol Biol, V3, P395, DOI 10.1385/0-89603-126-8:395; Polur I, 2010, HISTOL HISTOPATHOL, V25, P599, DOI 10.14670/HH-25.599; Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007; Roughley PJ, 2002, BIOCHEM SOC T, V30, P869, DOI 10.1042/BST0300869; Shen ZX, 1998, BIOCHEM J, V330, P549, DOI 10.1042/bj3300549; Singh N, 2011, ARCH BIOCHEM BIOPHYS, V516, P85, DOI 10.1016/j.abb.2011.10.007; Sivan SS, 2006, J BIOL CHEM, V281, P13009, DOI 10.1074/jbc.M600296200; Struglics A, 2012, BIOCHEM J, V446, P213, DOI 10.1042/BJ20120274; Sztrolovics R, 1997, BIOCHEM J, V326, P235, DOI 10.1042/bj3260235; Tiaden AN, 2012, J BIOL CHEM, V287, P21335, DOI 10.1074/jbc.M112.341032; Tiaden AN, 2013, AM J PATHOL, V182, P1482, DOI 10.1016/j.ajpath.2013.02.003; Yu J, 2005, SPINE, V30, P1815, DOI 10.1097/01.brs.0000173899.97415.5b; Yurube T, 2010, J ORTHOP RES, V28, P1026, DOI 10.1002/jor.21116	44	33	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19280	19287		10.1074/jbc.M112.443010	http://dx.doi.org/10.1074/jbc.M112.443010			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23673665	Green Published, hybrid			2022-12-25	WOS:000321335800060
J	Otto, CC; Haydel, SE				Otto, Caitlin C.; Haydel, Shelley E.			Exchangeable Ions Are Responsible for the In Vitro Antibacterial Properties of Natural Clay Mixtures	PLOS ONE			English	Article							TOXICITY; PH; ELEMENTS; COPPER	We have identified a natural clay mixture that exhibits in vitro antibacterial activity against a broad spectrum of bacterial pathogens. We collected four samples from the same source and demonstrated through antibacterial susceptibility testing that these clay mixtures have markedly different antibacterial activity against Escherichia coli and methicillin-resistant Staphylococcus aureus (MRSA). Here, we used X-ray diffraction (XRD) and inductively coupled plasma - optical emission spectroscopy (ICP-OES) and - mass spectrometry (ICP-MS) to characterize the mineralogical and chemical features of the four clay mixture samples. XRD analyses of the clay mixtures revealed minor mineralogical differences between the four samples. However, ICP analyses demonstrated that the concentrations of many elements, Fe, Co, Cu, Ni, and Zn, in particular, vary greatly across the four clay mixture leachates. Supplementation of a non-antibacterial leachate containing lower concentrations of Fe, Co, Ni, Cu, and Zn to final ion concentrations and a pH equivalent to that of the antibacterial leachate generated antibacterial activity against E. coli and MRSA, confirming the role of these ions in the antibacterial clay mixture leachates. Speciation modeling revealed increased concentrations of soluble Cu2+ and Fe2+ in the antibacterial leachates, compared to the non-antibacterial leachates, suggesting these ionic species specifically are modulating the antibacterial activity of the leachates. Finally, linear regression analyses comparing the log(10) reduction in bacterial viability to the concentration of individual ion species revealed positive correlations with Zn2+ and Cu2+ and antibacterial activity, a negative correlation with Fe3+, and no correlation with pH. Together, these analyses further indicate that the ion concentration of specific species (Fe2+, Cu2+, and Zn2+) are responsible for antibacterial activity and that killing activity is not solely attributed to pH.	[Otto, Caitlin C.; Haydel, Shelley E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Haydel, Shelley E.] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Haydel, SE (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Shelley.Haydel@asu.edu		Haydel, Shelley/0000-0001-5542-5469	Public Health Service grant from the NIH National Center for Complementary and Alternative Medicine [AT004690]; Science Foundation Arizona; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004690] Funding Source: NIH RePORTER	Public Health Service grant from the NIH National Center for Complementary and Alternative Medicine; Science Foundation Arizona; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research was supported by Public Health Service grant AT004690 to S. E. Haydel from the NIH National Center for Complementary and Alternative Medicine (http://nccam.nih.gov/). Graduate research fellowship support was partially provided by Science Foundation Arizona to C. C. Otto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; BABICH H, 1978, ENVIRON RES, V15, P405, DOI 10.1016/0013-9351(78)90121-4; Carretero MI, 2006, DEV CLAY SCI, V1, P717, DOI 10.1016/S1572-4352(05)01024-X; Cunningham TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009456; De Schamphelaere KAC, 2003, ENVIRON TOXICOL CHEM, V22, P2454, DOI 10.1897/02-499; Diekema DJ, 2004, CLIN INFECT DIS, V38, P78, DOI 10.1086/380457; Eberl D. D., 2003, 0378 US GEOL SURV; Franklin NM, 2000, AQUAT TOXICOL, V48, P275, DOI 10.1016/S0166-445X(99)00042-9; GUTHRIE GD, 1992, AM MINERAL, V77, P225; Haydel SE, 2008, J ANTIMICROB CHEMOTH, V61, P353, DOI 10.1093/jac/dkm468; Hewson A, 1872, EARTH TOPICAL APPL S; Hillier S., 1995, ORIGIN MINERALOGY CL; Janney PE, 1996, J GEOPHYS RES-SOL EA, V101, P2875, DOI 10.1029/95JB03119; Klute A., 1986, METHODS SOIL ANAL 1; Mascolo N, 1999, APPL CLAY SCI, V15, P491, DOI 10.1016/S0169-1317(99)00037-X; MCLAREN AD, 1963, SCIENCE, V141, P1141, DOI 10.1126/science.141.3586.1141; Moberly JG, 2010, ENVIRON SCI TECHNOL, V44, P7302, DOI 10.1021/es100117f; Nunn JF., 2002, ANCIENT EGYPTIAN MED; Reinbacher W.R., 1999, CLAY MINERALS SOC NE, V11, P22; Solidum RU, 2002, THESIS U CALIFORNIA; Tateo F, 2009, APPL CLAY SCI, V44, P83, DOI 10.1016/j.clay.2009.02.004; Van Nostrand JD, 2005, ENVIRON TOXICOL CHEM, V24, P2742, DOI 10.1897/04-335R.1; Williams LB, 2008, CLAY CLAY MINER, V56, P437, DOI 10.1346/CCMN.2008.0560405; World Health Organization, 2002, 5 WHO ADV GROUP M BU	24	45	46	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64068	10.1371/journal.pone.0064068	http://dx.doi.org/10.1371/journal.pone.0064068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691149	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900076
J	Qu, GZ; Zheng, TC; Liu, GF; Wang, WJ; Zang, LN; Liu, HZ; Yang, CP				Qu, Guan-Zheng; Zheng, Tangchun; Liu, Guifeng; Wang, Wenjie; Zang, Lina; Liu, Huanzhen; Yang, Chuanping			Overexpression of a MADS-Box Gene from Birch (Betula platyphylla) Promotes Flowering and Enhances Chloroplast Development in Transgenic Tobacco	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; SHOOT DEVELOPMENT; TIME CONTROL; APETALA1; PLANTS; TRANSFORMATION; CHLOROPHYLLS; EXTRACTION; EXPRESSION; INITIATION	In this study, a MADS-box gene (BpMADS), which is an ortholog of AP1 from Arabidopsis, was isolated from birch (Betula platyphylla). Transgenic Arabidopsis containing a BpMADS promoter::GUS construct was produced, which exhibited strong GUS staining in sepal tissues. Ectopic expression of BpMADS significantly enhanced the flowering of tobacco (35S::BpMADS). In addition, the chloroplasts of transgenic tobacco exhibited much higher growth and division rates, as well rates of photosynthesis, than wild-type. A grafting experiment demonstrated that the flowering time of the scion was not affected by stock that overexpressed BpMADS. In addition, the overexpression of BpMADS resulted in the upregulation of some flowering-related genes in tobacco.	[Qu, Guan-Zheng; Zheng, Tangchun; Liu, Guifeng; Zang, Lina; Liu, Huanzhen; Yang, Chuanping] Northeast Forestry Univ, State Key Lab Forest Tree Genet & Breeding, Harbin, Peoples R China; [Wang, Wenjie] Northeast Forestry Univ, Key Lab Forest Plant Ecol, Harbin, Peoples R China	Northeast Forestry University - China; Northeast Forestry University - China	Yang, CP (corresponding author), Northeast Forestry Univ, State Key Lab Forest Tree Genet & Breeding, Harbin, Peoples R China.	liuguifeng@126.com; yangchuanpingnefu@yahoo.com			Fundamental Research Funds for the Central Universities [DL12EA02]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding was provided by Fundamental Research Funds for the Central Universities (DL12EA02). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES JD, 1992, ENVIRON EXP BOT, V32, P85, DOI 10.1016/0098-8472(92)90034-Y; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Elo A, 2001, PHYSIOL PLANTARUM, V112, P95, DOI 10.1034/j.1399-3054.2001.1120113.x; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jang S, 1999, MOL CELLS, V9, P576; Jang SH, 2002, PLANT CELL PHYSIOL, V43, P230, DOI 10.1093/pcp/pcf015; Jefferson RA, 1987, EMBO J, V6, P3909; Kwon KC, 2008, PLANT J, V55, P428, DOI 10.1111/j.1365-313X.2008.03523.x; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma GY, 2011, PLANT MOL BIOL REP, V29, P573, DOI 10.1007/s11105-010-0263-4; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; MANDEL MA, 1995, NATURE, V377, P522, DOI 10.1038/377522a0; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Ng M, 2001, PLANT CELL, V13, P739, DOI 10.1105/tpc.13.4.739; Niwa Y., 2003, PLANT BIOTECHNOL-NAR, V20, P1, DOI [10.5511/plantbiotechnology.20.1, DOI 10.5511/PLANTBIOTECHNOLOGY.20.1]; Pomar F, 2002, PROTOPLASMA, V220, P17, DOI 10.1007/s00709-002-0030-y; Reeves PH, 2001, PLANT PHYSIOL, V126, P1085, DOI 10.1104/pp.126.3.1085; Shinano T, 1996, PHOTOSYNTHETICA, V32, P409; Smykal P, 2007, PLANT MOL BIOL, V65, P233, DOI 10.1007/s11103-007-9211-6; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; SUNG ZR, 1992, SCIENCE, V258, P1645, DOI 10.1126/science.258.5088.1645; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Wang Q, 2004, PLANT PHYSIOL, V136, P3594, DOI 10.1104/pp.104.049841; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; Wu XL, 2003, DEVELOPMENT, V130, P3735, DOI 10.1242/dev.00577; YANG CH, 1995, DEV BIOL, V169, P421, DOI 10.1006/dbio.1995.1158	31	11	14	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63398	10.1371/journal.pone.0063398	http://dx.doi.org/10.1371/journal.pone.0063398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691043	Green Submitted, gold, Green Published			2022-12-25	WOS:000319107900043
J	Bryce, NS; Reynolds, AB; Koleske, AJ; Weaver, AM				Bryce, Nicole S.; Reynolds, Albert B.; Koleske, Anthony J.; Weaver, Alissa M.			WAVE2 Regulates Epithelial Morphology and Cadherin Isoform Switching through Regulation of Twist and Abl	PLOS ONE			English	Article							CELL-CELL ADHESION; APICAL JUNCTIONAL COMPLEX; KINASE INHIBITOR STI571; ACTIN-BASED MOTILITY; MESENCHYMAL TRANSITION; ADHERENS JUNCTIONS; TYROSINE PHOSPHORYLATION; MOLECULAR-MECHANISMS; BREAST-CANCER; DIFFERENTIAL ROLES	Background: Epithelial morphogenesis is a dynamic process that involves coordination of signaling and actin cytoskeletal rearrangements. Principal Findings: We analyzed the contribution of the branched actin regulator WAVE2 in the development of 3dimensional (3D) epithelial structures. WAVE2-knockdown (WAVE2-KD) cells formed large multi-lobular acini that continued to proliferate at an abnormally late stage compared to control acini. Immunostaining of the cell-cell junctions of WAVE2-KD acini revealed weak and heterogeneous E-cadherin staining despite little change in actin filament localization to the same junctions. Analysis of cadherin expression demonstrated a decrease in E-cadherin and an increase in N-cadherin protein and mRNA abundance in total cell lysates. In addition, WAVE2-KD cells exhibited an increase in the mRNA levels of the epithelialmesenchymal transition (EMT)-associated transcription factor Twist1. KD of Twist1 expression in WAVE2-KD cells reversed the cadherin switching and completely rescued the aberrant 3D morphological phenotype. Activity of the WAVE2 complex binding partner Abl kinase was also increased in WAVE2-KD cells, as assessed by tyrosine phosphorylation of the Abl substrate CrkL. Inhibition of Abl with STI571 rescued the multi-lobular WAVE2-KD 3D phenotype whereas overexpression of Abl kinase phenocopied the WAVE2-KD phenotype. Conclusions: The WAVE2 complex regulates breast epithelial morphology by a complex mechanism involving repression of Twist1 expression and Abl kinase activity. These data reveal a critical role for WAVE2 complex in regulation of cellular signaling and epithelial morphogenesis.	[Bryce, Nicole S.; Reynolds, Albert B.; Weaver, Alissa M.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA; [Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	Vanderbilt University; Yale University	Weaver, AM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA.	alissa.weaver@vanderbilt.edu		Bryce, Nicole/0000-0001-9799-7393	NIH [R01GM075126, R01CA133346, R01NS39475, P30-CA068485, RO1 CA111947, U54CA113007, 5P50CA098131]; AHA postdoctoral fellowship [0525430B]; NATIONAL CANCER INSTITUTE [P30CA068485, U54CA113007, P30CA016359, R01CA133346, R01CA111947, P50CA098131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075126, R01GM100411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039475] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA postdoctoral fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants R01GM075126 (AMW), R01CA133346 and R01NS39475 (AJK), P30-CA068485 (VICC), RO1 CA111947 (ABR), U54CA113007 (PI Quaranta), 5P50CA098131 (pilot project, PI Arteaga), and AHA postdoctoral fellowship 0525430B (NSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Allington TM, 2009, FASEB J, V23, P4231, DOI 10.1096/fj.09-138412; Baranwal S, 2009, BIOCHEM BIOPH RES CO, V384, P6, DOI 10.1016/j.bbrc.2009.04.051; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Bell P B Jr, 1978, Birth Defects Orig Artic Ser, V14, P177; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Dahl JP, 2003, J NEUROSCI, V23, P3343; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DEJONG R, 1995, ONCOGENE, V11, P1469; Dubielecka PM, 2011, P NATL ACAD SCI USA, V108, P7022, DOI 10.1073/pnas.1016811108; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Escobar B, 2010, CANCER RES, V70, P9349, DOI 10.1158/0008-5472.CAN-09-4491; Feigin ME, 2009, CURR OPIN CELL BIOL, V21, P694, DOI 10.1016/j.ceb.2009.07.003; FISHER HW, 1967, SCIENCE, V155, P581, DOI 10.1126/science.155.3762.581; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Hajra KM, 2002, CANCER RES, V62, P1613; Harmon B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000956; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Krystal GW, 2000, CLIN CANCER RES, V6, P3319; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Lin TY, 2009, DEVELOPMENT, V136, P3099, DOI 10.1242/dev.033324; Liu R, 2009, DEVELOPMENT, V136, P2849, DOI 10.1242/dev.035246; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Ly KT, 2009, INFECT IMMUN, V77, P60, DOI 10.1128/IAI.00639-08; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McGary EC, 2002, CLIN CANCER RES, V8, P3584; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nishimura T, 2009, CURR TOP DEV BIOL, V89, P33, DOI 10.1016/S0070-2153(09)89002-9; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; Shi J, 2005, J BIOL CHEM, V280, P29849, DOI 10.1074/jbc.M500617200; Silva JM, 2009, CELL, V137, P1047, DOI 10.1016/j.cell.2009.04.013; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Sossey-Alaoui K, 2003, MAMM GENOME, V14, P314, DOI 10.1007/s00335-002-2247-7; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suetsugu S, 2006, J CELL BIOL, V173, P571, DOI 10.1083/jcb.200509067; Takahashi Y, 2004, EXP CELL RES, V293, P144, DOI 10.1016/j.yexcr.2003.09.024; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Verma S, 2012, MOL BIOL CELL, V23, P4601, DOI 10.1091/mbc.E12-08-0574; Wang BL, 2006, WORLD J GASTROENTERO, V12, P966, DOI 10.3748/wjg.v12.i6.966; Werth M, 2010, DEVELOPMENT, V137, P3835, DOI 10.1242/dev.055483; Yae K, 2006, MOL CELL BIOL, V26, P6185, DOI 10.1128/MCB.00018-06; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu D, 2010, EXP CELL RES, V316, P848, DOI 10.1016/j.yexcr.2009.11.018; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104	77	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64533	10.1371/journal.pone.0064533	http://dx.doi.org/10.1371/journal.pone.0064533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691243	Green Submitted, gold, Green Published			2022-12-25	WOS:000319052700106
J	Cala, O; Remy, MH; Guillet, V; Merdes, A; Mourey, L; Milon, A; Czaplicki, G				Cala, Olivier; Remy, Marie-Helene; Guillet, Valerie; Merdes, Andreas; Mourey, Lionel; Milon, Alain; Czaplicki, Georges			Virtual and Biophysical Screening Targeting the gamma-Tubulin Complex - A New Target for the Inhibition of Microtubule Nucleation	PLOS ONE			English	Article							SPINDLE POLE BODY; PROTEIN-PROTEIN INTERACTIONS; SMALL-MOLECULE INHIBITORS; RING COMPLEX; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; CRYSTAL-STRUCTURE; CENTROSOME; RECRUITMENT; DISCOVERY	Microtubules are the main constituents of mitotic spindles. They are nucleated in large amounts during spindle assembly, from multiprotein complexes containing gamma-tubulin and associated gamma-tubulin complex proteins (GCPs). With the aim of developing anti-cancer drugs targeting these nucleating complexes, we analyzed the interface between GCP4 and gamma-tubulin proteins usually located in a multiprotein complex named gamma-TuRC (gamma-Tubulin Ring Complex). 10 ns molecular dynamics simulations were performed on the heterodimers to obtain a stable complex in silico and to analyze the residues involved in persistent protein-protein contacts, responsible for the stability of the complex. We demonstrated in silico the existence of a binding pocket at the interface between the two proteins upon complex formation. By combining virtual screening using a fragment-based approach and biophysical screening, we found several small molecules that bind specifically to this pocket. Sub-millimolar fragments have been experimentally characterized on recombinant proteins using differential scanning fluorimetry (DSF) for validation of these compounds as inhibitors. These results open a new avenue for drug development against microtubule-nucleating gamma-tubulin complexes.	[Cala, Olivier; Guillet, Valerie; Mourey, Lionel; Milon, Alain; Czaplicki, Georges] Univ Toulouse, UPS, UMR CNRS 5089, Inst Pharmacol & Biol Struct, Toulouse, France; [Remy, Marie-Helene; Merdes, Andreas] CNRS, Ctr Dev Biol, Toulouse, France; [Cala, Olivier; Remy, Marie-Helene; Guillet, Valerie; Merdes, Andreas; Mourey, Lionel; Milon, Alain; Czaplicki, Georges] Univ Toulouse, UPS, Fac Sci & Ingn, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Czaplicki, G (corresponding author), Univ Toulouse, UPS, UMR CNRS 5089, Inst Pharmacol & Biol Struct, Toulouse, France.	Georges.Czaplicki@ipbs.fr	MILON, Alain/B-3767-2010; Czaplicki, Georges/ABC-7047-2020; Mourey, Lionel/B-5662-2009; Cala, Olivier/AAE-8065-2019	MILON, Alain/0000-0001-5692-8201; Czaplicki, Georges/0000-0001-5348-4107; Mourey, Lionel/0000-0002-8259-1259; Cala, Olivier/0000-0003-3579-0973	Agence Nationale de la Recherche [ANR-08-BLAN-0281]; Fondation RITC	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation RITC	This work was funded in part by 'Agence Nationale de la Recherche' ANR-08-BLAN-0281), and by a grant from 'Fondation RITC'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Barbosa V, 2000, GENE DEV, V14, P3126, DOI 10.1101/gad.182800; Barelier S, 2011, CURR OPIN CHEM BIOL, V15, P469, DOI 10.1016/j.cbpa.2011.02.020; Bottegoni G, 2012, DRUG DISCOV TODAY, V17, P23, DOI 10.1016/j.drudis.2011.08.002; Bouissou A, 2009, J CELL BIOL, V187, P327, DOI 10.1083/jcb.200905060; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Colornbie N, 2006, MOL BIOL CELL, V17, P272, DOI 10.1091/mbc.e05-08-0722; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; Cuschieri L, 2006, MOL BIOL CELL, V17, P4420, DOI 10.1091/mbc.E06-03-0245; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Friesen DE, 2012, CHEM BIOL DRUG DES, V79, P639, DOI 10.1111/j.1747-0285.2012.01340.x; Geissler S, 1996, EMBO J, V15, P3899, DOI 10.1002/j.1460-2075.1996.tb00764.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Guillet V, 2011, NAT STRUCT MOL BIOL, V18, P915, DOI 10.1038/nsmb.2083; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hendrickson TW, 2001, MOL BIOL CELL, V12, P2469, DOI 10.1091/mbc.12.8.2469; Hildebrand PW, 2009, NUCLEIC ACIDS RES, V37, pW571, DOI 10.1093/nar/gkp338; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; JOSHI HC, 1992, NATURE, V356, P80, DOI 10.1038/356080a0; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kollman JM, 2008, MOL BIOL CELL, V19, P207, DOI 10.1091/mbc.E07-09-0879; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Law R, 2009, J COMPUT AID MOL DES, V23, P459, DOI 10.1007/s10822-009-9284-1; Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019; Masuda H, 2006, GENES CELLS, V11, P337, DOI 10.1111/j.1365-2443.2006.00947.x; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moudjou M, 1996, J CELL SCI, V109, P875; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Paluh JL, 2000, MOL BIOL CELL, V11, P1225, DOI 10.1091/mbc.11.4.1225; Pieraccini S, 2011, CHEM PHYS LETT, V517, P217, DOI 10.1016/j.cplett.2011.10.044; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Prigozhina NL, 2004, MOL BIOL CELL, V15, P1374, DOI 10.1091/mbc.E03-06-0405; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Strub Caroline, 2004, BMC Biochemistry, V5, P9, DOI 10.1186/1471-2091-5-9; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUNKEL CE, 1995, EMBO J, V14, P28, DOI 10.1002/j.1460-2075.1995.tb06972.x; Tange Y, 2004, GENETICS, V167, P1095, DOI 10.1534/genetics.104.027946; Tillement V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-10; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Wang YS, 2010, J MED CHEM, V53, P942, DOI 10.1021/jm901472u; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569; Zimmerman S, 2005, MOL BIOL CELL, V16, P2719, DOI 10.1091/mbc.E04-08-0676	57	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63908	10.1371/journal.pone.0063908	http://dx.doi.org/10.1371/journal.pone.0063908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691113	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700066
J	Drechsler, C; Kollerits, B; Meinitzer, A; Marz, W; Ritz, E; Konig, P; Neyer, U; Pilz, S; Wanner, C; Kronenberg, F				Drechsler, Christiane; Kollerits, Barbara; Meinitzer, Andreas; Maerz, Winfried; Ritz, Eberhard; Koenig, Paul; Neyer, Ulrich; Pilz, Stefan; Wanner, Christoph; Kronenberg, Florian		MMKD Study Grp	Homoarginine and Progression of Chronic Kidney Disease: Results from the Mild to Moderate Kidney Disease Study	PLOS ONE			English	Article							INDUCED INSULIN-RELEASE; NITRIC-OXIDE; CARDIOVASCULAR EVENTS; ALKALINE-PHOSPHATASE; CREATINE SYNTHESIS; RENAL-FUNCTION; HEART-FAILURE; RAT-KIDNEY; L-ARGININE; RISK	Background: Homoarginine is an amino acid derivative mainly synthesized in the kidney. It is suggested to increase nitric oxide availability, enhance endothelial function and to protect against cardiovascular diseases. We aimed to investigate the relation between homoarginine, kidney function and progression of chronic kidney disease (CKD). Methods: We measured plasma homoarginine concentrations in baseline samples of the Mild to Moderate Kidney Disease (MMKD) Study, a prospective cohort study of 227 patients with CKD in Europe. Homoarginine concentrations were available in 182 of the baseline samples and in 139 of the prospectively-followed patients. We correlated homoarginine concentrations to parameters of kidney function. The association between homoarginine and progression of CKD was assessed during a follow-up of up to seven years (median 4.45 years, interquartile range 2.54-5.19) using Cox regression analysis. Progression of CKD was defined as doubling of baseline serum creatinine and/or end-stage renal disease. Results: Study participants were at baseline on average 47 +/- 13 years old and 65% were male. Mean +/- standard deviation of homoarginine concentrations were 2.5 +/- 1.1 mu mol/L and concentrations were incrementally lower at lower levels of GFR with mean concentrations of 2.90 +/- 1.02 mu mol/L (GFR. 90 ml/min), 2.64 +/- 1.06 mu mol/L (GFR 60-90 ml/min), 2.52 +/- 1.24 mu mol/L (GFR 30-60 ml/min) and 2.05 +/- 0.78 mmol/L (GFR, 30 ml/min), respectively (p = 0.002). The age-and sex-adjusted risk to reach the renal endpoint was significantly higher by 62% with each decrease by one standard deviation (1.1 mu mol/L) of homoarginine (HR 1.62, 95% CI 1.16-2.27, p = 0.005). This association was independent of proteinuria (HR 1.56, 95% CI 1.11-2.20, p = 0.01), and was slightly attenuated when adjusting for GFR (HR 1.40 (95% CI 0.98-1.98, p = 0.06). Conclusions: Homoarginine concentrations are directly correlated with kidney function and are significantly associated with the progression of CKD. Low homoarginine concentrations might be an early indicator of kidney failure and a potential target for the prevention of disease progression which needs further investigations.	[Drechsler, Christiane; Wanner, Christoph] Univ Wurzburg, Dept Med, Div Nephrol, D-97070 Wurzburg, Germany; [Kollerits, Barbara; Kronenberg, Florian] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Meinitzer, Andreas] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Maerz, Winfried] Heidelberg Univ, Mannheim Med Fac, Dept Publ Hlth Social & Prevent Med, Mannheim, Germany; [Ritz, Eberhard] Heidelberg Univ, Dept Internal Med, Div Nephrol, Heidelberg, Germany; [Koenig, Paul] Univ Innsbruck Hosp, Dept Clin Nephrol, A-6020 Innsbruck, Austria; [Neyer, Ulrich] Acad Teaching Hosp, Dept Nephrol & Dialysis, Feldkirch, Austria; [Pilz, Stefan] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Pilz, Stefan] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria	University of Wurzburg; Medical University of Innsbruck; Medical University of Graz; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Medical University of Innsbruck; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Medical University of Graz	Kronenberg, F (corresponding author), Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria.	Florian.Kronenberg@i-med.ac.at	Kronenberg, Florian/B-1736-2008	Kronenberg, Florian/0000-0003-2229-1120; Pilz, Stefan/0000-0002-7959-1311	"Genomics of Lipid-associated Disorders -GOLD" of the "Austrian Genome Research Programme GEN-AU"; Medical Faculty of the University of Wurzburg (Habilitationsstipendium)	"Genomics of Lipid-associated Disorders -GOLD" of the "Austrian Genome Research Programme GEN-AU"; Medical Faculty of the University of Wurzburg (Habilitationsstipendium)	Parts of this work were supported by the "Genomics of Lipid-associated Disorders -GOLD" of the "Austrian Genome Research Programme GEN-AU" to F. Kronenberg. The work was furthermore supported by a fellowship grant from the Medical Faculty of the University of Wurzburg (Habilitationsstipendium) to C. Drechsler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Banchaabouchi M, 2001, METABOLISM, V50, P1418, DOI 10.1053/meta.2001.26763; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Bauersachs J, 2008, PHARMACOL REP, V60, P119; Becker B, 2005, J AM SOC NEPHROL, V16, P1091, DOI 10.1681/ASN.2004090742; BELL EA, 1962, BIOCHEM J, V85, P91, DOI 10.1042/bj0850091; BLACHIER F, 1989, ENDOCRINOLOGY, V124, P134, DOI 10.1210/endo-124-1-134; Borsook H, 1940, SCIENCE, V91, P551, DOI 10.1126/science.91.2371.551; Bostom AG, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022011.35035.F3; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; CHEN PY, 1993, HYPERTENSION, V22, P812, DOI 10.1161/01.HYP.22.6.812; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cullen ME, 2006, CIRCULATION, V114, pI16, DOI 10.1161/CIRCULATIONAHA.105.000448; Davids M, 2012, FEBS LETT, V586, P3653, DOI 10.1016/j.febslet.2012.08.020; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Henningsson R, 1998, AM J PHYSIOL-ENDOC M, V275, pE500, DOI 10.1152/ajpendo.1998.275.3.E500; HRABAK A, 1994, BIOCHEM BIOPH RES CO, V198, P206, DOI 10.1006/bbrc.1994.1029; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kollerits B, 2007, KIDNEY INT, V71, P1279, DOI 10.1038/sj.ki.5002191; Kozlenkov A, 2004, J BONE MINER RES, V19, P1862, DOI 10.1359/JBMR.040608; Kronenberg F, 2000, J AM SOC NEPHROL, V11, P105, DOI 10.1681/ASN.V111105; Kronenberg F, 2009, NAT REV NEPHROL, V5, P677, DOI 10.1038/nrneph.2009.173; Marz W, 2010, CIRCULATION, V122, P967, DOI 10.1161/CIRCULATIONAHA.109.908988; Magnusson P, 2002, CALCIFIED TISSUE INT, V71, P508, DOI 10.1007/s00223-001-1137-4; Meinitzer A, 2007, CLIN CHIM ACTA, V384, P141, DOI 10.1016/j.cca.2007.07.006; Pilz S, 2012, OSTEOPOROSIS INT, V23, P2731, DOI 10.1007/s00198-012-1904-2; Pilz S, 2012, OSTEOPOROS INT; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P5193, DOI 10.1073/pnas.87.13.5193; RAO SLN, 1963, BIOCHEMISTRY-US, V2, P298, DOI 10.1021/bi00902a019; RYAN WL, 1969, ARCH BIOCHEM BIOPHYS, V131, P521, DOI 10.1016/0003-9861(69)90425-1; RYAN WL, 1964, SCIENCE, V144, P1122, DOI 10.1126/science.144.3622.1122; Taal MW, 2006, KIDNEY INT, V70, P1694, DOI 10.1038/sj.ki.5001794; Tangri N, 2012, J AM SOC NEPHROL, V23, P351, DOI 10.1681/ASN.2011070663; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; TOFUKU Y, 1985, NEPHRON, V41, P174, DOI 10.1159/000183576; US Renal Data System, 2008, USRDS 2008 ANN DAT R; Valtonen P, 2008, CIRC J, V72, P1879, DOI 10.1253/circj.CJ-08-0240; Yang ZH, 2006, CURR HYPERTENS REP, V8, P54, DOI 10.1007/s11906-006-0041-8	39	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63560	10.1371/journal.pone.0063560	http://dx.doi.org/10.1371/journal.pone.0063560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691067	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700048
J	van Arnhem, LA; Bunders, MJ; Scherpbier, HJ; Majoie, CBLM; Reneman, L; Frinking, O; Poll-The, BT; Kuijpers, TW; Pajkrt, D				van Arnhem, Lotus A.; Bunders, Madeleine J.; Scherpbier, Henriette J.; Majoie, Charles B. L. M.; Reneman, Liesbeth; Frinking, Olivier; Poll-The, Bwee Tien; Kuijpers, Taco W.; Pajkrt, Dasja			Neurologic Abnormalities in HIV-1 Infected Children in the Era of Combination Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; HIV ENCEPHALOPATHY; MANIFESTATIONS; OUTCOMES; IMPACT; AIDS	Background: Pediatric HIV-1 infection is associated with neurologic abnormalities. In recent years, the neurological outcome of HIV-1 infected children has substantially improved with combination antiretroviral therapy (cART). However, data regarding the long-term effect of cART and neurologic outcome are limited. Methods: In the Pediatric Amsterdam Cohort on HIV-1 study, 59 perinatally HIV-1 infected children were evaluated from 1992-2010. All children underwent neurological examination and neuro-imaging studies, including CT-scan and/or MRI imaging. Fisher exact and Kruskal-Wallis tests were used to compare clinical deviations of neuro-imaging studies with HIV-1 related parameters, including CD4(+) T cell count, HIV-1 viral load in blood and cerebrospinal fluid (CSF), and duration of cART as well as neurological examination. Results: Abnormal neurologic examinations in these HIV-1 infected children included language impairment (22%), abnormal muscle tone (hyper/hypotonia) (14%) and delay in reaching developmental milestones (12%). Ventricular enlargement and sulcal widening (29%) and white matter lesions (38%) were prominent findings. White matter lesions were positively correlated with HIV-1 viral load levels. In a small follow-up sub study white matter lesions did not improve while children with ventricular enlargement and sulcal widening showed improvements whilst being treated with cART. Conclusions: In the current era of cART HIV-1 infected children still frequently show neurological impairments together with abnormal neuro-imaging.	[van Arnhem, Lotus A.; Bunders, Madeleine J.; Scherpbier, Henriette J.; Frinking, Olivier; Kuijpers, Taco W.; Pajkrt, Dasja] Emma Childrens Hosp, Acad Med Ctr AMC, Dept Pediat Hematol Immunol & Infect Dis, Amsterdam, Netherlands; [Majoie, Charles B. L. M.; Reneman, Liesbeth] AMC, Dept Radiol, Amsterdam, Netherlands; [Poll-The, Bwee Tien] Emma Childrens Hosp, AMC, Dept Pediat Neurol, Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Pajkrt, D (corresponding author), Emma Childrens Hosp, Acad Med Ctr AMC, Dept Pediat Hematol Immunol & Infect Dis, Amsterdam, Netherlands.	d.pajkrt@amc.uva.nl		Poll-The, Bwee Tien/0000-0002-8118-5419; Reneman, Liesbeth/0000-0002-5912-9971				Angelini L, 2000, NEUROL SCI, V21, P135, DOI 10.1007/s100720070088; CHAMBERLAIN MC, 1991, PEDIATR NEUROL, V7, P357, DOI 10.1016/0887-8994(91)90066-T; Chiriboga CA, 2005, J PEDIATR-US, V146, P402, DOI 10.1016/j.jpeds.2004.10.021; Cooper ER, 1998, J PEDIATR-US, V132, P808, DOI 10.1016/S0022-3476(98)70308-7; Eden A, 2010, J INFECT DIS, V202, P1819, DOI 10.1086/657342; EPSTEIN LG, 1986, PEDIATRICS, V78, P678; EPSTEIN LG, 1985, ANN NEUROL, V17, P488, DOI 10.1002/ana.410170512; Johann-Liang R, 1998, PEDIATR INFECT DIS J, V17, P753, DOI 10.1097/00006454-199808000-00019; Johnson VA, 2013, TOP ANTIVIR MED, V21, P4; Kieck JR, 2004, SAMJ S AFR MED J, V94, P628; Laughton B, 2012, AIDS, V26, P1685, DOI 10.1097/QAD.0b013e328355d0ce; Letendre Scott L, 2010, Top HIV Med, V18, P45; Patel K, 2009, AIDS, V23, P1893, DOI 10.1097/QAD.0b013e32832dc041; Raskino C, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.3.e32; Sanchez-Ramon S, 2003, PEDIATR NEUROL, V29, P218, DOI 10.1016/S0887-8994(03)00210-8; Scherpbier HJ, 2007, PEDIATRICS, V119, pE705, DOI 10.1542/peds.2006-1367; Scherpbier HJ, 2006, PEDIATRICS, V117, pE528, DOI 10.1542/peds.2005-1272; SCHMITT B, 1991, DEV MED CHILD NEUROL, V33, P535; Shanbhag MC, 2005, ARCH PEDIAT ADOL MED, V159, P651, DOI 10.1001/archpedi.159.7.651; Smurzynski M, 2011, AIDS, V25, P357, DOI 10.1097/QAD.0b013e32834171f8; Thao VP, 2012, ANTIVIR THER, V17, P905, DOI 10.3851/IMP2092; UNAIDS, 2010, AIDS EP UPD; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Visrutaratna P., 2002, SMJ Singapore Medical Journal, V43, P377; Wilmshurst JM, 2006, J CHILD NEUROL, V21, P788, DOI 10.1177/08830738060210091901; Wood SM, 2009, AIDS, V23, P1859, DOI 10.1097/QAD.0b013e32832d924f	26	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64398	10.1371/journal.pone.0064398	http://dx.doi.org/10.1371/journal.pone.0064398			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691211	Green Submitted, gold, Green Published			2022-12-25	WOS:000319052700093
J	Clark, CR; Ommerborn, MJ; Hickson, DA; Grooms, KN; Sims, M; Taylor, HA; Albert, MA				Clark, Cheryl R.; Ommerborn, Mark J.; Hickson, DeMarc A.; Grooms, Kya N.; Sims, Mario; Taylor, Herman A.; Albert, Michelle A.			Neighborhood Disadvantage, Neighborhood Safety and Cardiometabolic Risk Factors in African Americans: Biosocial Associations in the Jackson Heart Study	PLOS ONE			English	Article							METABOLIC-SYNDROME; ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; PREVALENCE; DISPARITIES; HAZARDS; GLUCOSE; INCOME; ADULTS	Objective: We examined associations between neighborhood socioeconomic disadvantage, perceived neighborhood safety and cardiometabolic risk factors, adjusting for health behaviors and socioeconomic status (SES) among African Americans. Methods: Study participants were non-diabetic African Americans (n = 3,909) in the baseline examination (2000-2004) of the Jackson Heart Study. We measured eight risk factors: the metabolic syndrome, its five components, insulin resistance and cardiovascular inflammation. We assessed neighborhood socioeconomic disadvantage with US Census 2000 data. We assessed perceived neighborhood safety, health behaviors and SES via survey. We used generalized estimating equations to estimate associations with a random intercept model for neighborhood effects. Results: After adjustment for health behaviors and SES, neighborhood socioeconomic disadvantage was associated with the metabolic syndrome in women (PR 1.13, 95% CI 1.01, 1.27). Lack of perceived safety was associated with elevated glucose (OR 1.36, 95% CI 1.03, 1.80) and waist circumference (PR 1.06, 95% CI 1.02, 1.11) among women, and with elevated glucose (PR 1.30, 95% CI 1.02, 1.66) and insulin resistance (PR 1.25, 95% CI 1.08, 1.46) among men. Conclusions: Neighborhood socioeconomic disadvantage and perceived safety should be considered as targets for intervention to reduce cardiometabolic risks among African Americans.	[Clark, Cheryl R.] Brigham & Womens Faulkner Hospitalist Program, Div Gen Med & Primary Care, Boston, MA USA; [Clark, Cheryl R.; Ommerborn, Mark J.; Grooms, Kya N.] Brigham & Womens Hosp, Ctr Community Hlth & Hlth Equ, Boston, MA 02115 USA; [Hickson, DeMarc A.] Jackson State Univ, Jackson Heart Study, Jackson, MS USA; [Sims, Mario; Taylor, Herman A.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Albert, Michelle A.] Howard Univ, Div Cardiovasc Med, Washington, DC 20059 USA	Harvard University; Brigham & Women's Hospital; Jackson State University; University of Mississippi; University of Mississippi Medical Center; Howard University	Clark, CR (corresponding author), Brigham & Womens Faulkner Hospitalist Program, Div Gen Med & Primary Care, Boston, MA USA.	crclark@partners.org			National Institute on Aging of the National Institutes of Health [K08AG032357]; National Heart, Lung, and Blood Institute [K01HL08468-05]; National Center for Minority Health and Health Disparities [N01-HC-95170, N01-HC-95171, N01-HC-95172]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095172, N01HC095170, N01HC095171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032357] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging of the National Institutes of Health (K08AG032357). The Jackson Heart Study (JHS) was supported by the National Heart, Lung, and Blood Institute and the National Center for Minority Health and Health Disparities (contracts N01-HC-95170, N01-HC-95171, and N01-HC-95172). This research was also supported by a grant from the National Heart, Lung, and Blood Institute to Dr. MS (award number K01HL08468-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin T, 2008, AM J PUBLIC HEALTH, V98, P1664, DOI 10.2105/AJPH.2007.125138; Burdette AM, 2008, SOC SCI MED, V67, P38, DOI 10.1016/j.socscimed.2008.03.029; Carithers TC, 2009, J AM DIET ASSOC, V109, P1184, DOI 10.1016/j.jada.2009.04.005; Carpenter MA, 2004, AM J MED SCI, V328, P131, DOI 10.1097/00000441-200409000-00001; Chichlowska KL, 2008, PSYCHOSOM MED, V70, P986, DOI 10.1097/PSY.0b013e318183a491; Clark CR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-162; Dallongeville J, 2005, DIABETES CARE, V28, P409, DOI 10.2337/diacare.28.2.409; Daniel M, 2008, HEALTH PLACE, V14, P117, DOI 10.1016/j.healthplace.2007.05.003; Dubbert PM, 2005, ETHNIC DIS, V15, pS56; Fleury J, 2006, AM J COMMUN PSYCHOL, V37, P129, DOI 10.1007/s10464-005-9002-7; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fuqua SR, 2005, ETHNIC DIS, V15, pS18; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hall WD, 2003, ETHNIC DIS, V13, P414; Hickson DA, 2011, AM J PUBLIC HEALTH, V101, pS301, DOI 10.2105/AJPH.2010.300006; Hickson DA, 2011, AM J EPIDEMIOL, V173, P110, DOI 10.1093/aje/kwq317; Hunt KJ, 2012, J GEN INTERN MED, V27, P893, DOI 10.1007/s11606-012-2023-7; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Laraia BA, 2012, SOC SCI MED, V74, P1082, DOI 10.1016/j.socscimed.2011.11.036; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Morland K, 2002, AM J PUBLIC HEALTH, V92, P1761, DOI 10.2105/AJPH.92.11.1761; *NAT RES COUN, 2008, BIOS SURV; Osei K, 2004, DIABETES CARE, V27, P1439, DOI 10.2337/diacare.27.6.1439; PARKER RN, 1983, SOC FORCES, V61, P872, DOI 10.2307/2578140; Raudenbush SW, 1999, SOCIOL METHODOL, V29, P1, DOI 10.1111/0081-1750.00059; Rehkopf DH, 2010, EPIDEMIOLOGY, V21, P38, DOI 10.1097/EDE.0b013e3181c30b89; Roux AVD, 2002, DIABETES CARE, V25, P1976, DOI 10.2337/diacare.25.11.1976; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; TAYLOR HA, 2005, ETHN DIS S6, V15, pS6; Taylor H, 2008, DIABETES CARE, V31, P1248, DOI 10.2337/dc07-1810; Tucker KL, 2005, PUBLIC HEALTH NUTR, V8, P87, DOI [10.1079/PHN2004663, 10.1079/PHN2005663]; *UNI STAT DEP AGR, 2010, DIET GUID AM 2010; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325	41	48	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63254	10.1371/journal.pone.0063254	http://dx.doi.org/10.1371/journal.pone.0063254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RE	23691005	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400039
J	Garcia-Carreras, B; Reuman, DC				Garcia-Carreras, Bernardo; Reuman, Daniel C.			Are Changes in the Mean or Variability of Climate Signals More Important for Long-Term Stochastic Growth Rate?	PLOS ONE			English	Article							POPULATION-DYNAMICS; PRECIPITATION VARIABILITY; TEMPERATURE-DEPENDENCE; VARIABLE ENVIRONMENTS; TRENDS; ELASTICITIES; COLOR; ECTOTHERMS; DEMOGRAPHY; RANGES	Population dynamics are affected by changes in both the mean and standard deviation of climate, e. g., changes in average temperature are likely to affect populations, but so are changes in the strength of year-to-year temperature variability. The impacts of increases in average temperature are extensively researched, while the impacts of changes in climate variability are less studied. Is the greater attention given to changes in mean environment justified? To help answer this question we developed a simple population model, explicitly linked to an environmental process. We used the model to compare the sensitivities of a population's long-term stochastic growth rate, a measure of fitness, to changes in the mean and standard deviation of the environment. Results are interpreted in light of a comparative analysis of the relative magnitudes of change in means and standard deviations of biologically relevant climate variables in the United States. Results show that changes in the variability of the environment can be more important for many populations. Changes in mean conditions are likely to have a greater impact than changes in variability on populations far from their ideal environment, for example, populations near species range boundaries and potentially of conservation concern. Populations near range centres and close to their ideal environment are more likely to be affected by changes in variability. Among pest and insect disease vectors, as well as species of commercial value, populations likely to be of greatest economic and public health significance are those near species range centers, living in a near-ideal environment for the species. Observed changes in the variability of climate variables may benefit these populations.	[Garcia-Carreras, Bernardo; Reuman, Daniel C.] Univ London Imperial Coll Sci Technol & Med, Ascot, Berks, England; [Reuman, Daniel C.] Rockefeller Univ, Lab Populat, New York, NY 10021 USA	Imperial College London; Rockefeller University	Garcia-Carreras, B (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England.	bgarciacarreras@gmail.com; d.reuman@imperial.ac.uk	Garcia-Carreras, Bernardo/H-3234-2011	Garcia-Carreras, Bernardo/0000-0002-0714-300X	United Kingdom Natural Environment Research Council (NERC) [NE/G523447/1]; NERC [NE/H020705/1, NE/I010963/1, NE/I011889/1]; Natural Environment Research Council [NE/I010963/1, NE/I011889/1, NE/H020705/1] Funding Source: researchfish	United Kingdom Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	BGC was supported by a United Kingdom Natural Environment Research Council (NERC) Ph.D. studentship grant NE/G523447/1, and DCR was partly supported by the NERC grants NE/H020705/1, NE/I010963/1, and NE/I011889/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2012, AM NAT, V179, P178, DOI 10.1086/663677; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Atkinson D, 1997, TRENDS ECOL EVOL, V12, P235, DOI 10.1016/S0169-5347(97)01058-6; Begon M., 1996, ECOLOGY; Boer GJ, 2009, J CLIMATE, V22, P3098, DOI 10.1175/2008JCLI2835.1; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Boyles JG, 2011, INTEGR COMP BIOL, V51, P676, DOI 10.1093/icb/icr053; Campbell RD, 2012, GLOBAL CHANGE BIOL, V18, P2730, DOI 10.1111/j.1365-2486.2012.02739.x; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x; Chesson PL., 1986, COMMUNITY ECOL; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Coulson T, 2011, SCIENCE, V334, P1275, DOI 10.1126/science.1209441; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Drake JM, 2005, P ROY SOC B-BIOL SCI, V272, P1823, DOI 10.1098/rspb.2005.3148; Ezard THG, 2008, AM NAT, V172, P424, DOI 10.1086/589897; Ezard THG, 2010, ECOL MODEL, V221, P191, DOI 10.1016/j.ecolmodel.2009.09.017; Facelli JM, 2005, ECOLOGY, V86, P2998, DOI 10.1890/05-0304; Forster J, 2011, AM NAT, V178, P668, DOI 10.1086/662174; Garcia-Carreras B, 2011, J ANIM ECOL, V80, P1042, DOI 10.1111/j.1365-2656.2011.01833.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; GULLAND JA, 1982, J THEOR BIOL, V97, P69, DOI 10.1016/0022-5193(82)90277-6; Hairston Nelson G. Jr., 1996, P109; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Haridas CV, 2005, AM NAT, V166, P481, DOI 10.1086/444444; HUEY RB, 1979, AM ZOOL, V19, P357; Huey RB, 2001, AM NAT, V158, P204, DOI 10.1086/321314; Hunt BG, 2004, ATMOS OCEAN, V42, P145, DOI 10.3137/ao.420301; Jenouvrier S, 2012, GLOBAL CHANGE BIOL, V18, P2756, DOI 10.1111/j.1365-2486.2012.02744.x; Jonzen N, 2010, J ANIM ECOL, V79, P109, DOI 10.1111/j.1365-2656.2009.01601.x; KARL TR, 1995, NATURE, V377, P217, DOI 10.1038/377217a0; Laakso J, 2001, OIKOS, V92, P119, DOI 10.1034/j.1600-0706.2001.920114.x; LANDE R, 1988, P NATL ACAD SCI USA, V85, P7418, DOI 10.1073/pnas.85.19.7418; Lande R., 2003, OXFORD SERIES ECOLOG; LEVINS R, 1979, AM NAT, V114, P765, DOI 10.1086/283527; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Menne MJ, 2009, B AM METEOROL SOC, V90, P993, DOI 10.1175/2008BAMS2613.1; Michaels PJ, 1998, CLIMATE RES, V10, P27, DOI 10.3354/cr010027; Morris W. F., 2002, QUANTITATIVE CONSERV; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; National Climatic Data Center National Oceanic and Atmospheric Adminis- tration, 2011, USHCN VERS 2 SER MON; PARKER DE, 1994, J GEOPHYS RES-ATMOS, V99, P14373, DOI 10.1029/94JD00548; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Raisanen J, 2002, J CLIMATE, V15, P2395, DOI 10.1175/1520-0442(2002)015<2395:CICIIT>2.0.CO;2; Reuman DC, 2008, ECOL LETT, V11, P820, DOI 10.1111/j.1461-0248.2008.01194.x; Reuman DC, 2006, P NATL ACAD SCI USA, V103, P18860, DOI 10.1073/pnas.0608571103; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Sakai D, 2009, J METEOROL SOC JPN, V87, P721, DOI 10.2151/jmsj.87.721; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; SCHOENER TW, 1992, AM NAT, V139, P1176, DOI 10.1086/285381; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stouffer RJ, 2007, J CLIMATE, V20, P5455, DOI 10.1175/2007JCLI1384.1; Sun FB, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043323; Svoma BM, 2010, PHYS GEOGR, V31, P307, DOI 10.2747/0272-3646.31.4.307; Tews Joerg, 2004, BMC Ecology, V4, P17, DOI 10.1186/1472-6785-4-17; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; Tuljapurkar S, 2003, AM NAT, V162, P489, DOI 10.1086/378648; Tuljapurkar S.D., 1990, POPULATION DYNAMICS; TULJAPURKAR SD, 1982, THEOR POPUL BIOL, V21, P141, DOI 10.1016/0040-5809(82)90010-7; van de Pol M, 2006, THESIS U GRONINGEN; van de Pol M, 2011, P ROY SOC B-BIOL SCI, V278, P3713, DOI 10.1098/rspb.2011.0487; van de Pol M, 2010, ECOLOGY, V91, P1192, DOI 10.1890/09-0410.1; Vinnikov KY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014025	67	20	20	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63974	10.1371/journal.pone.0063974	http://dx.doi.org/10.1371/journal.pone.0063974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691131	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400094
J	Liu, WT; Liang, ZS; Wang, XH; Sibbald, S; Hunter, D; Tian, LN				Liu, Wenting; Liang, Zongsuo; Wang, Xinhua; Sibbald, Susan; Hunter, David; Tian, Lining			Preservation and Faithful Expression of Transgene via Artificial Seeds in Alfalfa	PLOS ONE			English	Article							MEDICAGO-SATIVA L; DIRECT SOMATIC EMBRYOGENESIS; DESICCATION TOLERANCE; ABSCISIC-ACID; PLANTS; PROMOTER; EMBRYOS; GROWTH; INDUCTION; TECHNOLOGY	Proper preservation of transgenes and transgenic materials is important for wider use of transgenic technology in plants. Here, we report stable preservation and faithful expression of a transgene via artificial seed technology in alfalfa. DNA constructs containing the uid reporter gene coding for beta-glucuronidase (GUS) driven by a 35S promoter or a tCUP promoter were introduced into alfalfa via Agrobacterium-mediated genetic transformation. Somatic embryos were subsequently induced from transgenic alfalfa plants via in vitro technology. These embryos were treated with abscisic acid to induce desiccation tolerance and were subjected to a water loss process. After the desiccation procedure, the water content in dried embryos, or called artificial seeds, was about 12-15% which was equivalent to that in true seeds. Upon water rehydration, the dried somatic embryos showed high degrees of viability and exhibited normal germination. Full plants were subsequently developed and recovered in a greenhouse. The progeny plants developed from artificial seeds showed GUS enzyme activity and the GUS expression level was comparable to that of plants developed from somatic embryos without the desiccation process. Polymerase chain reaction analysis indicated that the transgene was well retained in the plants and Southern blot analysis showed that the transgene was stably integrated in plant genome. The research showed that the transgene and the new trait can be well preserved in artificial seeds and the progeny developed. The research provides a new method for transgenic germplasm preservation in different plant species.	[Liu, Wenting; Liang, Zongsuo] Northwest A & F Univ, Coll Life Sci, Shaanxi, Peoples R China; [Liu, Wenting; Wang, Xinhua; Sibbald, Susan; Tian, Lining] Agr & Agri Food Canada, Southern Crop Protect & Food Res Ctr, London, ON, Canada; [Hunter, David] Agr & Agri Food Canada, Southern Crop Protect & Food Res Ctr, Vineland Stn, ON, Canada	Northwest A&F University - China; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Tian, LN (corresponding author), Agr & Agri Food Canada, Southern Crop Protect & Food Res Ctr, London, ON, Canada.	lining.tian@agr.gc.ca	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	Knowledge Innovation Project of Chinese Academy of Science [KZCX2-YW-443]	Knowledge Innovation Project of Chinese Academy of Science(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supportted by Knowledge Innovation Project of Chinese Academy of Science (KZCX2-YW-443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirato P.V., 1983, HDB PLANT CELL CULTU, V1, P82; ANANDARAJAH K, 1990, PLANT CELL REP, V9, P451, DOI 10.1007/BF00232271; Bavage AD, 2002, EUPHYTICA, V124, P333, DOI 10.1023/A:1015799901176; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; BENNETZEN JL, 1993, CRIT REV PLANT SCI, V12, P57, DOI 10.1080/713608042; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; BLAYDES DF, 1966, PHYSIOL PLANTARUM, V19, P748, DOI 10.1111/j.1399-3054.1966.tb07060.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cangahuala-Inocente GC, 2007, SCI HORTIC-AMSTERDAM, V111, P228, DOI 10.1016/j.scienta.2006.10.030; CHEE PP, 1990, HORTSCIENCE, V25, P792, DOI 10.21273/HORTSCI.25.7.792; CONNER AJ, 1994, BIOCONTROL SCI TECHN, V4, P463, DOI 10.1080/09583159409355358; Devendra B. N., 2011, International Journal of Botany, V7, P216, DOI 10.3923/ijb.2011.216.222; Foster E, 1999, PLANT MOL BIOL, V41, P45, DOI 10.1023/A:1006229501860; FUJIMURA T, 1975, PLANT SCI LETT, V5, P359, DOI 10.1016/0304-4211(75)90001-2; GOLDBERG RB, 1994, SCIENCE, V266, P605, DOI 10.1126/science.266.5185.605; GRAY DJ, 1991, CRIT REV PLANT SCI, V10, P33, DOI 10.1080/07352689109382306; Hoshino T, 2005, ENV DESIGN CONSIDERA, P25; Ipekci Z, 2003, PLANT CELL REP, V22, P16, DOI 10.1007/s00299-003-0650-5; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kohli A, 1999, PLANTA, V208, P88, DOI 10.1007/s004250050538; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Maqbool SB, 1999, MOL BREEDING, V5, P471, DOI 10.1023/A:1009634226797; MCKERSIE BD, 1989, IN VITRO CELL DEV B, V25, P1183, DOI 10.1007/BF02621272; McKersie BD, 1996, SEED SCI RES, V6, P109, DOI 10.1017/S0960258500003135; Meza TJ, 2001, TRANSGENIC RES, V10, P53, DOI 10.1023/A:1008903026579; Murashige T., 1962, REVISED MEDIUM RAPID; Pintos B, 2008, PLANT CELL TISS ORG, V95, P217, DOI 10.1007/s11240-008-9435-4; Puspasree Puhan, 2012, Research Journal of Medicinal Plant, V6, P346, DOI 10.3923/rjmp.2012.346.369; Qiao H, 2004, PLANT CELL, V16, P2307, DOI 10.1105/tpc.104.024919; Redenbaugh K, 1991, CELL CULTURE SOMATIC, P62; Reinert J, 1973, PLANT TISSUE CELL CU, P31; SCHENK RU, 1972, CAN J BOTANY, V50, P199, DOI 10.1139/b72-026; SENARATNA T, 1989, PLANT SCI, V65, P253, DOI 10.1016/0168-9452(89)90072-1; SENARATNA T, 1990, IN VITRO CELL DEV B, V26, P85, DOI 10.1007/BF02624160; Sharma P, 2004, J PLANT PHYSIOL, V161, P1269, DOI 10.1016/j.jplph.2004.01.015; SHETTY K, 1993, PLANT SCI, V88, P185, DOI 10.1016/0168-9452(93)90090-M; Slade D, 1989, J TISSUE CULTURE MET, V12, P179; Sundararaj SG, 2010, SCI HORTIC-AMSTERDAM, V125, P761, DOI 10.1016/j.scienta.2010.06.001; Tian L, 2002, PLANT CELL REP, V20, P1181, DOI 10.1007/s00299-002-0459-7; Tsai C. J., 1999, Journal of Sugar Beet Research, V36, P11, DOI 10.5274/jsbr.36.4.11; Vdovitchenko MY, 2011, MOSCOW U BIOL SCI B, V66, P48; Wang ML, 2009, IN VITRO CELL DEV-PL, V45, P112, DOI 10.1007/s11627-009-9208-8; Wu K, 2001, MOL GENET GENOMICS, V265, P763, DOI 10.1007/s004380100478; Yan LP, 2012, PLANT CELL TISS ORG, V108, P191, DOI 10.1007/s11240-011-0027-3	44	4	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e56699	10.1371/journal.pone.0056699	http://dx.doi.org/10.1371/journal.pone.0056699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690914	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400002
J	Luo, XY; Stock, C; Burwinkel, B; Brenner, H				Luo, Xiaoya; Stock, Christian; Burwinkel, Barbara; Brenner, Hermann			Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer	PLOS ONE			English	Article							OCCULT BLOOD-TESTS; CIRCULATING MICRORNAS; CROSS-VALIDATION; EXPRESSION; MARKERS; MIR-143; BIOMARKERS; CARCINOMA; ADENOMA; MIR-21	Background: Colorectal cancer (CRC) is one of the most commonly diagnosed cancers. Circulating microRNAs (miRNAs) have been suggested as potentially promising markers for early detection of CRC. We aimed to identify and evaluate a panel of miRNAs that might be suitable for CRC early detection. Methods: MiRNAs were profiled by TaqMan MicroRNA Array and screened for differential expression in 5 pools of plasma samples of CRC patients (N = 50) and 5 pools of neoplasm-free controls (N = 50). Additional miRNAs were selected from a literature review. Identified candidates were evaluated in independent validation samples with respect to discrimination of CRC patients (N = 80) or advanced adenoma patients (N = 50) and neoplasm-free controls (N = 194). Diagnostic performance of the panel of miRNAs was assessed by multiple logistic regression, using bootstrap analysis to correct for over-optimism. Results: Five miRNAs identified to be differentially expressed from TaqMan MicroRNA Array (miR-29a, -106b, -133a, -342-3p, -532-3p), and seven miRNAs reported to be differentially expressed in the literature (miR-18a, -20a, -21, -92a, -143, -145, 181b) were selected for validation. Nine of the twelve miRNAs (miR-18a, -20a, -21, -29a, -92a, -106b, -133a, -143, -145) were found to be differentially expressed in CRC patients and controls in the validation samples. The optimism-corrected area under the curve was 0.745 (95% confidence interval: 0.708-0.846). None of the selected miRNAs showed significant differential expression between advanced adenoma patients and neoplasm-free controls. Conclusion: The identified panel of miRNAs could be of potential use in the development of a multi-marker blood based test for early detection of CRC. Impact: The study underscores the high potential of plasma miRNAs for the improvement of current offers of non-invasive CRC screening.	[Luo, Xiaoya; Stock, Christian; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Luo, Xiaoya] Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Burwinkel, Barbara] Heidelberg Univ, Dept Gynecol & Obstet, Div Mol Biol Breast Canc, Heidelberg, Germany; [Burwinkel, Barbara] German Canc Res Ctr, Mol Epidemiol Grp, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Capital Medical University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.	h.brenner@dkfz.de	Stock, Christian/F-6180-2015; Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017	Stock, Christian/0000-0002-3493-3234; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572				Adler W, 2009, COMPUT STAT DATA AN, V53, P718, DOI 10.1016/j.csda.2008.09.023; Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Ali S, 2011, AM J TRANSL RES, V3, P28; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bihrer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026971; Brenner H, 2011, J CLIN ONCOL, V29, P3761, DOI 10.1200/JCO.2011.35.9307; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brenner H, 2010, JAMA-J AM MED ASSOC, V304, P2513, DOI 10.1001/jama.2010.1773; Brenner H, 2010, INT J CANCER, V127, P1643, DOI 10.1002/ijc.25154; Canty, 2021, BOOT BOOTSTRAP R S P; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Cui LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027071; Diosdado B, 2009, BRIT J CANCER, V101, P707, DOI 10.1038/sj.bjc.6605037; Earle JSL, 2010, J MOL DIAGN, V12, P433, DOI 10.2353/jmoldx.2010.090154; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; Gupta AK, 2008, MOL DIAGN THER, V12, P77, DOI 10.1007/BF03256273; Huang JJ, 2012, MED ONCOL, V29, P2402, DOI 10.1007/s12032-012-0210-3; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Hundt S, 2009, ANN INTERN MED, V150, P162, DOI 10.7326/0003-4819-150-3-200902030-00005; Hundt S, 2007, CANCER EPIDEM BIOMAR, V16, P1935, DOI 10.1158/1055-9965.EPI-06-0994; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kulda V, 2010, CANCER GENET CYTOGEN, V200, P154, DOI 10.1016/j.cancergencyto.2010.04.015; Luo XY, 2011, CANCER EPIDEM BIOMAR, V20, P1272, DOI 10.1158/1055-9965.EPI-11-0035; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Pawa N, 2011, NAT REV GASTRO HEPAT, V8, P711, DOI 10.1038/nrgastro.2011.205; Potapov S, 2012, DAIM DIAGNOSTIC ACCU; Pu XX, 2010, J GASTROEN HEPATOL, V25, P1674, DOI 10.1111/j.1440-1746.2010.06417.x; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schmitz KJ, 2009, VIRCHOWS ARCH, V455, P49, DOI 10.1007/s00428-009-0804-0; Shigoka M, 2010, PATHOL INT, V60, P351, DOI 10.1111/j.1440-1827.2010.02526.x; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Tao S, 2012, BRIT J CANCER, V106, P1424, DOI 10.1038/bjc.2012.104; Tao S, 2011, AM J GASTROENTEROL, V106, P242, DOI 10.1038/ajg.2010.393; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wei Juan, 2011, Chin J Cancer, V30, P407; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	53	131	138	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62880	10.1371/journal.pone.0062880	http://dx.doi.org/10.1371/journal.pone.0062880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690963	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400023
J	Seidl, S; Braun, U; Roos, N; Li, SH; Ludtke, THW; Kispert, A; Leitges, M				Seidl, Sebastian; Braun, Ursula; Roos, Norbert; Li, Shaohua; Luedtke, Timo H-W; Kispert, Andreas; Leitges, Michael			Phenotypical Analysis of Atypical PKCs In Vivo Function Display a Compensatory System at Mouse Embryonic Day 7.5	PLOS ONE			English	Article							PROTEIN-KINASE-C; ZETA-PKC; EXPRESSION PATTERN; LAMBDA/IOTA-PKC; ELEGANS EMBRYOS; MESSENGER-RNA; CELL-POLARITY; GENE; APKC; ESTABLISHMENT	Background: The atypical protein kinases C (PKC) isoforms iota/lambda and zeta play crucial roles in many cellular processes including development, cell proliferation, differentiation and cell survival. Possible redundancy between the two isoforms has always been an issue since most biochemical tools do not differentiate between the two proteins. Thus, much effort has been made during the last decades to characterize the functions of aPKCs using gene targeting approaches and depletion studies. However, little is known about the specific roles of each isoform in mouse development. Methodology/Principal Findings: To evaluate the importance of PKC iota in mouse development we designed PKC iota deletion mutants using the gene targeting approach. We show that the deletion of PKC iota, results in a reduced size of the amniotic cavity at E7.5 and impaired growth of the embryo at E8.5 with subsequent absorption of the embryo. Our data also indicate an impaired localization of ZO-1 and disorganized structure of the epithelial tissue in the embryo. Importantly, using electron microscopy, embryoid body formation and immunofluorescence analysis, we found, that in the absence of PKC iota, tight junctions and apico-basal polarity were still established. Finally, our study points to a non-redundant PKC iota function at E9.5, since expression of PKC zeta is able to rescue the E7.5 phenotype, but could not prevent embryonic lethality at a later time-point (E9.5). Conclusion: Our data show that PKC iota is crucial for mouse embryogenesis but is dispensable for the establishment of polarity and tight junction formation. We present a compensatory function of PKC zeta at E7.5, rescuing the phenotype. Furthermore, this study indicates at least one specific, yet unknown, PKC iota function that cannot be compensated by the overexpression of PKC zeta at E9.5.	[Seidl, Sebastian; Braun, Ursula; Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Roos, Norbert] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Li, Shaohua] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08903 USA; [Luedtke, Timo H-W; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany	University of Oslo; University of Oslo; Rutgers State University New Brunswick; Rutgers State University Medical Center; Hannover Medical School	Leitges, M (corresponding author), Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway.	michael.leitges@biotek.uio.no	Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995	University of Oslo, Molecular Life Science	University of Oslo, Molecular Life Science	Sebastian Seidl has been funded by the University of Oslo, Molecular Life Science (MLS, https://www.uio.no/forskning/tverrfak/mls/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMOTO K, 1994, J BIOL CHEM, V269, P12677; Bandyopadhyay G, 2004, MOL ENDOCRINOL, V18, P373, DOI 10.1210/me.2003-0087; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; Burgess R, 1995, DEV BIOL; Cha SW, 2011, DEVELOPMENT, V138, P3989, DOI 10.1242/dev.068866; Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6; COOPER AR, 1983, DEV BIOL, V96, P467, DOI 10.1016/0012-1606(83)90183-5; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Delorme B, 1997, CIRC RES, V81, P423, DOI 10.1161/01.RES.81.3.423; DiazMeco MT, 1996, MOL CELL BIOL, V16, P105; DOMINGUEZ I, 1992, MOL CELL BIOL, V12, P3776, DOI 10.1128/MCB.12.9.3776; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; Frutos S, 1999, J BIOL CHEM, V274, P10765, DOI 10.1074/jbc.274.16.10765; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Helfrich I, 2007, J INVEST DERMATOL, V127, P782, DOI 10.1038/sj.jid.5700621; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hirano Y, 2004, J BIOL CHEM, V279, P31883, DOI 10.1074/jbc.M403092200; Hirose T, 2006, DEVELOPMENT, V133, P1389, DOI 10.1242/dev.02294; Huber TB, 2009, J AM SOC NEPHROL, V20, P798, DOI 10.1681/ASN.2008080871; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Ishiuchi T, 2011, NAT CELL BIOL, V13, P860, DOI 10.1038/ncb2274; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Joyner AL, 1993, GENE TARGETING PRACT; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Komura H, 2008, GENES CELLS, V13, P79, DOI 10.1111/j.1365-2443.2007.01150.x; Kovac J, 2007, GENE EXPR PATTERNS, V7, P187, DOI 10.1016/j.modgep.2006.07.002; Kraus F, 2001, MECH DEVELOP, V100, P87, DOI 10.1016/S0925-4773(00)00499-8; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Li Shaohua, 2006, V329, P113; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Martin P, 2002, EMBO J, V21, P4049, DOI 10.1093/emboj/cdf407; Monaghan AP, 1995, MOUSE HOMOLOG ORPHAN; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Murray NR, 2009, CANCER RES, V69, P656, DOI 10.1158/0008-5472.CAN-08-3001; Murray P, 2000, J CELL BIOL; Nakanishi H, 1993, J BIOL CHEM; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; Oster H, 2004, MOL BRAIN RES, V127, P79, DOI 10.1016/j.molbrainres.2004.05.009; Pauken CM, 1999, AID MRD5 3 0 CO 2 A; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; ROWITCH DH, 1995, MECH DEVELOP, V52, P3, DOI 10.1016/0925-4773(95)00380-J; Sambrook J., 2001, MOL CLONING; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SELBIE LA, 1993, J BIOL CHEM, V268, P24296; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tabuse Y, 2002, J BIOCHEM, V132, P519, DOI 10.1093/oxfordjournals.jbchem.a003251; Torres RM, 1997, LAB PROTOCOLS CONDIT; Watts JL, 1996, DEVELOPMENT, V122, P3133; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wu XW, 2007, DEV DYNAM, V236, P2767, DOI 10.1002/dvdy.21309; Yang JQ, 2009, P NATL ACAD SCI USA, V106, P1099, DOI 10.1073/pnas.0805907106	68	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62756	10.1371/journal.pone.0062756	http://dx.doi.org/10.1371/journal.pone.0062756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690951	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400016
J	Setten, L; Soto, G; Mozzicafreddo, M; Fox, AR; Lisi, C; Cuccioloni, M; Angeletti, M; Pagano, E; Diaz-Paleo, A; Ayub, ND				Setten, Lorena; Soto, Gabriela; Mozzicafreddo, Matteo; Romina Fox, Ana; Lisi, Christian; Cuccioloni, Massimiliano; Angeletti, Mauro; Pagano, Elba; Diaz-Paleo, Antonio; Daniel Ayub, Nicolas			Engineering Pseudomonas protegens Pf-5 for Nitrogen Fixation and its Application to Improve Plant Growth under Nitrogen-Deficient Conditions	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; KLEBSIELLA-PNEUMONIAE; FLUORESCENS CHA0; CULTURABLE FUNGI; GENE-TRANSFER; HOST-RANGE; SP-NOV.; STUTZERI; AZOSPIRILLUM; STRAIN	Nitrogen is the second most critical factor for crop production after water. In this study, the beneficial rhizobacterium Pseudomonas protegens Pf-5 was genetically modified to fix nitrogen using the genes encoding the nitrogenase of Pseudomonas stutzeri A1501 via the X940 cosmid. Pf-5 X940 was able to grow in L medium without nitrogen, displayed high nitrogenase activity and released significant quantities of ammonium to the medium. Pf-5 X940 also showed constitutive expression and enzymatic activity of nitrogenase in ammonium medium or in nitrogen-free medium, suggesting a constitutive nitrogen fixation. Similar to Pseudomonas protegens Pf-5, Pseudomonas putida, Pseudomonas veronii and Pseudomonas taetrolens but not Pseudomonas balearica and Pseudomonas stutzeri transformed with cosmid X940 showed constitutive nitrogenase activity and high ammonium production, suggesting that this phenotype depends on the genome context and that this technology to obtain nitrogen-fixing bacteria is not restricted to Pf-5. Interestingly, inoculation of Arabidopsis, alfalfa, tall fescue and maize with Pf-5 X940 increased the ammonium concentration in soil and plant productivity under nitrogen-deficient conditions. In conclusion, these results open the way to the production of effective recombinant inoculants for nitrogen fixation on a wide range of crops.	[Setten, Lorena; Soto, Gabriela; Lisi, Christian; Pagano, Elba; Diaz-Paleo, Antonio; Daniel Ayub, Nicolas] Inst Genet Ewald A Favret CICVyA INTA, Buenos Aires, DF, Argentina; [Soto, Gabriela; Romina Fox, Ana; Daniel Ayub, Nicolas] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Mozzicafreddo, Matteo; Cuccioloni, Massimiliano; Angeletti, Mauro] Univ Camerino, Sch Biosci & Biotechnol, I-62032 Camerino, MC, Italy	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Camerino	Ayub, ND (corresponding author), Inst Genet Ewald A Favret CICVyA INTA, Buenos Aires, DF, Argentina.	nayub@cnia.inta.gov.ar	Angeletti, Mauro/AAC-5597-2019; Cuccioloni, Massimiliano/X-7188-2019; Fox, Ana R/K-3985-2014; Angeletti, Mauro/C-2960-2014; Mozzicafreddo, M./AAW-2816-2021	Angeletti, Mauro/0000-0001-6719-5517; Fox, Ana R/0000-0002-7852-4539; Angeletti, Mauro/0000-0001-6719-5517; Mozzicafreddo, M./0000-0001-9835-8446; Ayub, Nicolas/0000-0001-5012-240X; Cuccioloni, Massimiliano/0000-0002-6025-1990; Soto, Gabriela/0000-0002-3492-1268; Setten, Lorena Maria/0000-0001-9750-9302	Instituto Nacional de Tecnologia Agropecuaria [3425]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011-1325]	Instituto Nacional de Tecnologia Agropecuaria; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Instituto Nacional de Tecnologia Agropecuaria (grant AEGR#3425 to ADP) and Agencia Nacional de Promocion Cientifica y Tecnologica (grant PICT 2011-1325 to NA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGLE JS, 1995, APPL ENVIRON MICROB, V61, P2835, DOI 10.1128/AEM.61.8.2835-2839.1995; Anzai Y, 1997, INT J SYST BACTERIOL, V47, P249, DOI 10.1099/00207713-47-2-249; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Ayub ND, 2009, EXTREMOPHILES, V13, P59, DOI 10.1007/s00792-008-0197-z; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Baudoin E, 2010, RES MICROBIOL, V161, P219, DOI 10.1016/j.resmic.2010.01.005; Bennasar A, 1996, INT J SYST BACTERIOL, V46, P200, DOI 10.1099/00207713-46-1-200; Beyeler M, 1999, FEMS MICROBIOL ECOL, V28, P225, DOI 10.1111/j.1574-6941.1999.tb00578.x; BODDEY RM, 1991, PLANT SOIL, V137, P111, DOI 10.1007/BF02187441; BODDEY RM, 1995, CRIT REV PLANT SCI, V14, P263, DOI 10.1080/713608118; BODDEY RM, 1988, PLANT SOIL, V108, P53, DOI 10.1007/BF02370099; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANEY AL, 1962, CLIN CHEM, V8, P130; Cummings SP, 2009, ENVIRON MICROBIOL, V11, P2510, DOI 10.1111/j.1462-2920.2009.01975.x; Dean D.R., 1992, BIOL NITROGEN FIXATI, P763; Desnoues N, 2003, MICROBIOL-SGM, V149, P2251, DOI 10.1099/mic.0.26270-0; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; DIXON RA, 1972, NATURE, V237, P102, DOI 10.1038/237102a0; DIXON RA, 1971, NATURE, V234, P47, DOI 10.1038/234047a0; Dobbelaere S, 1999, PLANT SOIL, V212, P155, DOI 10.1023/A:1004658000815; DOBEREINER J, 1993, CURR PLANT SCI BIOT, V17, P671; Dos Santos PC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-162; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Elomari M, 1996, INT J SYST BACTERIOL, V46, P1138, DOI 10.1099/00207713-46-4-1138; GALIMAND M, 1989, J GEN MICROBIOL, V135, P1047; Gehringer MM, 2010, MOL PLANT MICROBE IN, V23, P811, DOI 10.1094/MPMI-23-6-0811; Girlanda M, 2001, APPL ENVIRON MICROB, V67, P1851, DOI 10.1128/AEM.67.4.1851-1864.2001; Gyaneshwar P, 2011, MOL PLANT MICROBE IN, V24, P1276, DOI 10.1094/MPMI-06-11-0172; Hamilton TL, 2011, J BACTERIOL, V193, P4477, DOI 10.1128/JB.05099-11; Hatayama K, 2005, INT J SYST EVOL MICR, V55, P1539, DOI 10.1099/ijs.0.63586-0; HOWELL CR, 1979, PHYTOPATHOLOGY, V69, P480, DOI 10.1094/Phyto-69-480; James EK, 2000, FIELD CROP RES, V65, P197, DOI 10.1016/S0378-4290(99)00087-8; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kechris KJ, 2006, P NATL ACAD SCI USA, V103, P9584, DOI 10.1073/pnas.0603534103; Kersters K, 1996, SYST APPL MICROBIOL, V19, P465, DOI 10.1016/S0723-2020(96)80020-8; KROM MD, 1980, ANALYST, V105, P305, DOI 10.1039/an9800500305; Ladha J. K., 1995, Geojournal, V35, P363, DOI 10.1007/BF00989144; Latysheva N, 2012, BIOINFORMATICS, V28, P603, DOI 10.1093/bioinformatics/bts008; LOBO AL, 1988, APPL ENVIRON MICROB, V54, P1656, DOI 10.1128/AEM.54.7.1656-1661.1988; Loper JE, 2007, PHYTOPATHOLOGY, V97, P233, DOI 10.1094/PHYTO-97-2-0233; Markel E, 2011, J BACTERIOL, V193, P5775, DOI 10.1128/JB.05114-11; MARTINEZ E, 1987, J BACTERIOL, V169, P2828, DOI 10.1128/jb.169.6.2828-2834.1987; Martinez-Argudo I, 2005, BIOCHEM SOC T, V33, P152, DOI 10.1042/BST0330152; Mavrodi DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8; MERRICK MJ, 1993, CURR PLANT SCI BIOT, V17, P43; Mirza MS, 2006, BIOL FERT SOILS, V43, P163, DOI 10.1007/s00374-006-0074-9; Mozzicafreddo M, 2009, J CHEM INF MODEL, V49, P401, DOI 10.1021/ci800235m; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Newton WE, 2007, BIOLOGY OF THE NITROGEN CYCLE, P109, DOI 10.1016/B978-044452857-5.50009-6; Op den Camp RHM, 2012, MOL PLANT MICROBE IN, V25, P954, DOI 10.1094/MPMI-11-11-0304; Ozen AI, 2012, MICROB ECOL, V63, P239, DOI 10.1007/s00248-011-9914-8; Palleroni NJ, 2003, MICROBIOL-SGM, V149, P1, DOI 10.1099/mic.0.25952-0; Palleroni Norberto J., 2008, P1; Palus JA, 1996, PLANT SOIL, V186, P135, DOI 10.1007/BF00035067; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pawlowski K, 2012, PROTOPLASMA, V249, P967, DOI 10.1007/s00709-012-0388-4; Peters JW, 2006, CURR OPIN CHEM BIOL, V10, P101, DOI 10.1016/j.cbpa.2006.02.019; POSTGATE JR, 1987, J GEN MICROBIOL, V133, P2563; Rai AN, 2002, CYANOBACTERIA IN SYMBIOSIS, P97; Ramette A, 2011, SYST APPL MICROBIOL, V34, P180, DOI 10.1016/j.syapm.2010.10.005; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Rediers H, 2004, MICROBIOL-SGM, V150, P1117, DOI 10.1099/mic.0.27096-0; Reis VM, 1998, ARCH MICROBIOL, V171, P13, DOI 10.1007/s002030050672; Satoshi Y, 1995, APPL ENVIRON MICROB, V61, P1104; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shah Z, 2003, FIELD CROP RES, V83, P1, DOI 10.1016/S0378-4290(03)00005-4; Shaukat SS, 2003, J APPL MICROBIOL, V95, P1039, DOI 10.1046/j.1365-2672.2003.02074.x; Soto G, 2008, FEBS LETT, V582, P4077, DOI 10.1016/j.febslet.2008.11.002; Soto G, 2011, J EXP BOT, V62, P5699, DOI 10.1093/jxb/err287; Soto G, 2010, PLANT J, V64, P1038, DOI 10.1111/j.1365-313X.2010.04395.x; Spaepen S, 2008, PLANT SOIL, V312, P15, DOI 10.1007/s11104-008-9560-1; Spaepen S, 2007, J BACTERIOL, V189, P7626, DOI 10.1128/JB.00830-07; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; STREICHER S, 1971, P NATL ACAD SCI USA, V68, P1174, DOI 10.1073/pnas.68.6.1174; Sullivan JT, 1998, P NATL ACAD SCI USA, V95, P5145, DOI 10.1073/pnas.95.9.5145; SULLIVAN JT, 1995, P NATL ACAD SCI USA, V92, P8985, DOI 10.1073/pnas.92.19.8985; Sullivan JT, 1996, APPL ENVIRON MICROB, V62, P2818, DOI 10.1128/AEM.62.8.2818-2825.1996; Tan ZY, 2001, APPL ENVIRON MICROB, V67, P3655, DOI 10.1128/AEM.67.8.3655-3664.2001; Triplett EW, 1996, PLANT SOIL, V186, P29, DOI 10.1007/BF00035052; WHEATLEY RE, 1989, BIOL FERT SOILS, V8, P189, DOI 10.1007/BF00257765; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P769, DOI DOI 10.1007/978-94-011-0227-8_27; Wood CC, 2001, AUST J PLANT PHYSIOL, V28, P969, DOI 10.1071/PP01036; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Yan YL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-405, 10.1186/1471-2164-11-11]; Young JM, 2007, INT J SYST EVOL MICR, V57, P2894, DOI 10.1099/ijs.0.64969-0; Young J. P. W., 1992, BIOL NITROGEN FIXATI, V1544, P43; Yu HY, 2011, J BACTERIOL, V193, P3422, DOI 10.1128/JB.05039-11; Zhang T, 2012, RES MICROBIOL, V163, P332, DOI 10.1016/j.resmic.2012.05.002; Zhang XJ, 2012, BIOTECHNOL LETT, V34, P287, DOI 10.1007/s10529-011-0760-z; Zhang YP, 2000, J BACTERIOL, V182, P983, DOI 10.1128/JB.182.4.983-992.2000	90	57	63	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63666	10.1371/journal.pone.0063666	http://dx.doi.org/10.1371/journal.pone.0063666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675499	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100045
J	Kuppu, S; Mishra, N; Hu, RB; Sun, L; Zhu, XL; Shen, GX; Blumwald, E; Payton, P; Zhang, H				Kuppu, Sundaram; Mishra, Neelam; Hu, Rongbin; Sun, Li; Zhu, Xunlu; Shen, Guoxin; Blumwald, Eduardo; Payton, Paxton; Zhang, Hong			Water-Deficit Inducible Expression of a Cytokinin Biosynthetic Gene IPT Improves Drought Tolerance in Cotton	PLOS ONE			English	Article							DELAYED LEAF SENESCENCE; INCREASES FIBER YIELD; TOBACCO PLANTS; ISOPENTENYLTRANSFERASE GENE; AGROBACTERIUM-TUMEFACIENS; MOISTURE STATUS; ABSCISIC-ACID; STRESS; PHOTOSYNTHESIS; GROWTH	Water-deficit stress is a major environmental factor that limits agricultural productivity worldwide. Recent episodes of extreme drought have severely affected cotton production in the Southwestern USA. There is a pressing need to develop cotton varieties with improved tolerance to water-deficit stress for sustainable production in water-limited regions. One approach to engineer drought tolerance is by delaying drought-induced senescence via up-regulation of cytokinin biosynthesis. The isopentenyltransferase gene (IPT) that encodes a rate limiting enzyme in cytokinin biosynthesis, under the control of a water-deficit responsive and maturation specific promoter P-SARK was introduced into cotton and the performance of the P-SARK::IPT transgenic cotton plants was analyzed in the greenhouse and growth chamber conditions. The data indicate that P-SARK::IPT-transgenic cotton plants displayed delayed senescence under water deficit conditions in the greenhouse. These plants produced more root and shoot biomass, dropped fewer flowers, maintained higher chlorophyll content, and higher photosynthetic rates under reduced irrigation conditions in comparison to wild-type and segregated non-transgenic lines. Furthermore, P-SARK::IPT-transgenic cotton plants grown in growth chamber condition also displayed greater drought tolerance. These results indicate that water-deficit induced expression of an isopentenyltransferase gene in cotton could significantly improve drought tolerance.	[Kuppu, Sundaram; Mishra, Neelam; Hu, Rongbin; Sun, Li; Zhu, Xunlu; Zhang, Hong] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Shen, Guoxin] Zhejiang Acad Agr Sci, Hangzhou, Zhejiang, Peoples R China; [Blumwald, Eduardo] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Payton, Paxton] ARS, USDA, Cropping Syst Res Lab, Lubbock, TX USA	Texas Tech University System; Texas Tech University; Zhejiang Academy of Agricultural Sciences; University of California System; University of California Davis; United States Department of Agriculture (USDA)	Zhang, H (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	hong.zhang@ttu.edu	HU, RONGBIN/B-2225-2017; Blumwald, Eduardo/Y-2751-2019; Shen, Guoxin/GPT-2191-2022; MISHRA, NEELAM/ABD-3008-2021	MISHRA, NEELAM/0000-0001-6191-5392; HU, RONGBIN/0000-0001-5921-6891				ANTONY AK, 1975, INDIAN J AGR SCI, V45, P199; BadenochJones J, 1996, PLANT CELL ENVIRON, V19, P504, DOI 10.1111/j.1365-3040.1996.tb00384.x; BARRY GF, 1984, P NATL ACAD SCI-BIOL, V81, P4776, DOI 10.1073/pnas.81.15.4776; BAYLEY C, 1992, THEOR APPL GENET, V83, P645, DOI 10.1007/BF00226910; Bogeat-Triboulot MB, 2007, PLANT PHYSIOL, V143, P876, DOI 10.1104/pp.106.088708; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BUCHMANN I, 1985, EMBO J, V4, P853, DOI 10.1002/j.1460-2075.1985.tb03710.x; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; CHAVES MM, 1991, J EXP BOT, V42, P1, DOI 10.1093/jxb/42.1.1; Chen LFO, 2001, MOL BREEDING, V7, P243, DOI 10.1023/A:1011357320259; Cornic G, 2000, TRENDS PLANT SCI, V5, P187, DOI 10.1016/S1360-1385(00)01625-3; Cowan AK, 2005, PLANTA, V221, P801, DOI 10.1007/s00425-005-1489-5; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; Dennis ES, 2007, CURR OPIN PLANT BIOL, V10, P520, DOI 10.1016/j.pbi.2007.06.009; Ennahli S, 2005, CROP SCI, V45, P2374, DOI 10.2135/cropsci2005.0147; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI [10.1007/978-90-481-2666-8_12, 10.1051/agro:2008021]; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fernandes J, 2008, PLANT BIOTECHNOL J, V6, P782, DOI 10.1111/j.1467-7652.2008.00360.x; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Frederick JR, 2001, CROP SCI, V41, P759, DOI 10.2135/cropsci2001.413759x; Galmes J, 2007, NEW PHYTOL, V175, P81, DOI 10.1111/j.1469-8137.2007.02087.x; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Guillemaut P, 1992, PLANT MOL BIOL REP, V10, P60, DOI 10.1007/BF02669265; GUINN G, 1984, AGRON J, V76, P90, DOI 10.2134/agronj1984.00021962007600010023x; GUINN G, 1984, AGRON J, V76, P94, DOI 10.2134/agronj1984.00021962007600010024x; Hajouj T, 2000, PLANT PHYSIOL, V124, P1305, DOI 10.1104/pp.124.3.1305; He CX, 2005, PLANT CELL PHYSIOL, V46, P1848, DOI 10.1093/pcp/pci201; HE JX, 1995, PHYSIOL PLANTARUM, V93, P771, DOI 10.1111/j.1399-3054.1995.tb05130.x; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Jordi W, 2000, PLANT CELL ENVIRON, V23, P279, DOI 10.1046/j.1365-3040.2000.00544.x; KIRSCHBAUM MUF, 1988, PLANT CELL ENVIRON, V11, P685, DOI 10.1111/j.1365-3040.1988.tb01151.x; Kudoyarova GR, 2007, J EXP BOT, V58, P161, DOI 10.1093/jxb/erl116; Lawlor DW, 2009, ANN BOT-LONDON, V103, P561, DOI [10.1093/aob/mcn244, 10.1093/aob/mcn256]; Lin YJ, 2002, ACTA BOT SIN, V44, P1333; Liu XH, 2002, CROP SCI, V42, P457, DOI 10.2135/cropsci2002.0457; MARTINEAU B, 1994, PLANT J, V5, P11, DOI 10.1046/j.1365-313X.1994.5010011.x; McCabe MS, 2001, PLANT PHYSIOL, V127, P505, DOI 10.1104/pp.010244; Meyer S, 1998, PLANT PHYSIOL, V116, P947, DOI 10.1104/pp.116.3.947; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; NAQVI SSM, 1995, HDB PLANT CROP PHYSL, P645; Ort DR, 2001, PLANT PHYSIOL, V125, P29, DOI 10.1104/pp.125.1.29; Pasapula V, 2011, PLANT BIOTECHNOL J, V9, P88, DOI 10.1111/j.1467-7652.2010.00535.x; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Pettigrew WT, 2004, CROP SCI, V44, P1265, DOI 10.2135/cropsci2004.1265; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qin H, 2011, PLANT CELL PHYSIOL, V52, P1904, DOI 10.1093/pcp/pcr125; RICHMOND AE, 1957, SCIENCE, V125, P650, DOI 10.1126/science.125.3249.650-a; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Rivero RM, 2010, PLANT CELL PHYSIOL, V51, P1929, DOI 10.1093/pcp/pcq143; Sakakibara H, 2005, P NATL ACAD SCI USA, V102, P9972, DOI 10.1073/pnas.0500793102; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; SMART CM, 1991, PLANT CELL, V3, P647, DOI 10.1105/tpc.3.7.647; STRABALA TJ, 1989, MOL GEN GENET, V216, P388, DOI 10.1007/BF00334380; Sykorova B, 2008, J EXP BOT, V59, P377, DOI 10.1093/jxb/erm319; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Xu P, 2004, P NATL ACAD SCI USA, V101, P15805, DOI 10.1073/pnas.0407094101; Yang JC, 2002, PLANTA, V215, P645, DOI 10.1007/s00425-002-0789-2	63	68	70	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e64190	10.1371/journal.pone.0064190	http://dx.doi.org/10.1371/journal.pone.0064190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675526	Green Submitted, gold, Green Published			2022-12-25	WOS:000318852400062
J	Garcia-Fontana, C; Reyes-Darias, JA; Munoz-Martinez, F; Alfonso, C; Morel, B; Ramos, JL; Krell, T				Garcia-Fontana, Cristina; Antonio Reyes-Darias, Jose; Munoz-Martinez, Francisco; Alfonso, Carlos; Morel, Bertrand; Ramos, Juan Luis; Krell, Tino			High Specificity in CheR Methyltransferase Function CheR2 OF PSEUDOMONAS PUTIDA IS ESSENTIAL FOR CHEMOTAXIS, WHEREAS CheR1 IS INVOLVED IN BIOFILM FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; LIGAND-BINDING REGIONS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; BACTERIAL CHEMOTAXIS; CHEMOSENSORY SYSTEM; SIGNAL-TRANSDUCTION; COVALENT MODIFICATION; S-ADENOSYLMETHIONINE; TWITCHING MOTILITY	Chemosensory pathways are a major signal transduction mechanism in bacteria. CheR methyltransferases catalyze the methylation of the cytosolic signaling domain of chemoreceptors and are among the core proteins of chemosensory cascades. These enzymes have primarily been studied Escherichia coli and Salmonella typhimurium, which possess a single CheR involved in chemotaxis. Many other bacteria possess multiple cheR genes. Because the sequences of chemoreceptor signaling domains are highly conserved, it remains to be established with what degree of specificity CheR paralogues exert their activity. We report here a comparative analysis of the three CheR paralogues of Pseudomonas putida. Isothermal titration calorimetry studies show that these paralogues bind the product of the methylation reaction, S-adenosylhomocysteine, with much higher affinity (K-D of 0.14-2.2 mu M) than the substrate S-adenosylmethionine (K-D of 22-43 mu M), which indicates product feedback inhibition. Product binding was particularly tight for CheR2. Analytical ultracentrifugation experiments demonstrate that CheR2 is monomeric in the absence and presence of S-adenosylmethionine or S-adenosylhomocysteine. Methylation assays show that CheR2, but not the other paralogues, methylates the McpS and McpT chemotaxis receptors. The mutant in CheR2 was deficient in chemotaxis, whereas mutation of CheR1 and CheR3 had either no or little effect on chemotaxis. In contrast, biofilm formation of the CheR1 mutant was largely impaired but not affected in the other mutants. We conclude that CheR2 forms part of a chemotaxis pathway, and CheR1 forms part of a chemosensory route that controls biofilm formation. Data suggest that CheR methyltransferases act with high specificity on their cognate chemoreceptors.	[Garcia-Fontana, Cristina; Antonio Reyes-Darias, Jose; Munoz-Martinez, Francisco; Ramos, Juan Luis; Krell, Tino] CSIC, Estn Expt Zaidin, Environm Protect Dept, E-18008 Granada, Spain; [Antonio Reyes-Darias, Jose] Poligono Ind Juncaril, Bioiliberis R&D, Granada 18210, Spain; [Alfonso, Carlos] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Morel, Bertrand] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain; [Morel, Bertrand] Univ Granada, Fac Ciencias, Inst Biotecnol, E-18071 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Granada; University of Granada	Krell, T (corresponding author), CSIC, Estn Expt Zaidin, C Prof Albareda 1, E-18008 Granada, Spain.	tino.krell@eez.csic.es	Fontana, Cristina Garcia/AAJ-4536-2021; Alfonso, Carlos/K-1316-2014; Krell, Tino/G-7296-2015; Fontana, Cristina Garcia/L-8184-2014	Fontana, Cristina Garcia/0000-0002-9328-6022; Alfonso, Carlos/0000-0001-7165-4800; Krell, Tino/0000-0002-9040-3166; Fontana, Cristina Garcia/0000-0002-9328-6022; Morel, Bertrand/0000-0002-2708-8589; Munoz-Martinez, Francisco/0000-0001-8416-0092; Ramos, Juan L./0000-0002-8731-7435	FEDER; Fondo Social Europeo through Junta de Andalucia [P09-RNM-4509, CVI-7335]; Spanish Ministry for Economy and Competitiveness [Bio2010-16937, BIO2010-17227]	FEDER(European Commission); Fondo Social Europeo through Junta de Andalucia; Spanish Ministry for Economy and Competitiveness(Spanish Government)	This work was supported by FEDER funds and Fondo Social Europeo through Junta de Andalucia Grants P09-RNM-4509 and CVI-7335 (to T. K.) and Spanish Ministry for Economy and Competitiveness Grants Bio2010-16937 (to T. K.) and BIO2010-17227 (to J. L. R.).	Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906; BINSTOCK J, 1984, METHOD ENZYMOL, V106, P310; Blaszczyk U, 2003, J PROTEIN CHEM, V22, P285, DOI 10.1023/A:1025024604677; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; CAMPILLO JE, 1982, FEBS LETT, V138, P71, DOI 10.1016/0014-5793(82)80397-9; DARZINS A, 1994, MOL MICROBIOL, V11, P137, DOI 10.1111/j.1365-2958.1994.tb00296.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Djordjevic S, 1998, NAT STRUCT BIOL, V5, P446, DOI 10.1038/nsb0698-446; Djordjevic S, 1997, STRUCTURE, V5, P545, DOI 10.1016/S0969-2126(97)00210-4; Duque E, 2004, ENVIRON MICROBIOL, V6, P1021, DOI 10.1111/j.1462-2920.2004.00621.x; ELY B, 1986, GENETICS, V114, P717; Espinosa-Urgel M, 2004, APPL ENVIRON MICROB, V70, P5190, DOI 10.1128/AEM.70.9.5190-5198.2004; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Ferrandez A, 2002, J BACTERIOL, V184, P4374, DOI 10.1128/JB.184.16.4374-4383.2002; Fillet S, 2011, P NATL ACAD SCI USA, V108, P15372, DOI 10.1073/pnas.1018894108; Fulcher NB, 2010, MOL MICROBIOL, V76, P889, DOI 10.1111/j.1365-2958.2010.07135.x; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Hamer R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-3; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; JONES KS, 1992, J BIOL CHEM, V267, P16037; Kanungpean D, 2011, MICROBIOL-SGM, V157, P1279, DOI 10.1099/mic.0.047399-0; Kato J, 1999, BIOSCI BIOTECH BIOCH, V63, P155, DOI 10.1271/bbb.63.155; Kearns DB, 2001, J BACTERIOL, V183, P763, DOI 10.1128/JB.183.2.763-767.2001; Kedracka-Krok S, 2003, EUR J BIOCHEM, V270, P4564, DOI 10.1046/j.1432-1033.2003.03856.x; Krell T, 2011, ENVIRON MICROBIOL, V13, P1115, DOI 10.1111/j.1462-2920.2010.02383.x; Krell T, 2008, MICROB BIOTECHNOL, V1, P126, DOI 10.1111/j.1751-7915.2007.00013.x; Lacal J, 2013, J APPL MICROBIOL, V114, P923, DOI 10.1111/jam.12076; Lacal J, 2011, ENVIRON MICROBIOL, V13, P1733, DOI 10.1111/j.1462-2920.2011.02493.x; Lacal J, 2011, J MOL RECOGNIT, V24, P378, DOI 10.1002/jmr.1101; Lacal J, 2010, ENVIRON MICROBIOL, V12, P2873, DOI 10.1111/j.1462-2920.2010.02325.x; Lacal J, 2010, J BIOL CHEM, V285, P23124, DOI 10.1074/jbc.M110.110403; Lazova MD, 2011, P NATL ACAD SCI USA, V108, P13870, DOI 10.1073/pnas.1108608108; LeMoual H, 1996, J MOL BIOL, V261, P568, DOI 10.1006/jmbi.1996.0483; Li GY, 2000, CELL, V100, P357, DOI 10.1016/S0092-8674(00)80671-6; Llamas MA, 2003, J BACTERIOL, V185, P4707, DOI 10.1128/JB.185.16.4707-4716.2003; MASDUKI A, 1995, J BACTERIOL, V177, P948, DOI 10.1128/jb.177.4.948-952.1995; Min TJL, 2012, P NATL ACAD SCI USA, V109, P9869, DOI 10.1073/pnas.1120218109; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Molina L, 2011, ENVIRON MICROBIOL, V13, P2315, DOI 10.1111/j.1462-2920.2011.02492.x; Munoz-Martinez F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045810; Muppirala UK, 2009, PROTEIN SCI, V18, P1702, DOI 10.1002/pro.170; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; O'Connor JR, 2012, MOL MICROBIOL, V86, P720, DOI 10.1111/mmi.12013; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Pineda-Molina E, 2012, P NATL ACAD SCI USA, V109, P18926, DOI 10.1073/pnas.1201400109; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; Ramos JL, 2009, CURR OPIN MICROBIOL, V12, P215, DOI 10.1016/j.mib.2009.02.001; Rodriguez-Herva JJ, 2007, ENVIRON MICROBIOL, V9, P1550, DOI 10.1111/j.1462-2920.2007.01276.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiomi D, 2002, J BIOL CHEM, V277, P42325, DOI 10.1074/jbc.M202001200; SIMMS SA, 1991, J BIOL CHEM, V266, P12741; SIMMS SA, 1987, J BIOL CHEM, V262, P8537; Sourjik V, 2012, CURR OPIN CELL BIOL, V24, P262, DOI 10.1016/j.ceb.2011.11.008; STOCK JB, 1981, CELL, V27, P37, DOI 10.1016/0092-8674(81)90358-5; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TERWILLIGER TC, 1984, J BIOL CHEM, V259, P7719; Timmis KN, 2002, ENVIRON MICROBIOL, V4, P779, DOI 10.1046/j.1462-2920.2002.00365.x; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Vladimirov N, 2009, BIOL CHEM, V390, P1097, DOI 10.1515/BC.2009.130; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Yi X, 2002, BBA-PROTEIN STRUCT M, V1596, P28, DOI 10.1016/S0167-4838(01)00314-4; Yuan JH, 2012, NATURE, V484, P233, DOI 10.1038/nature10964; Zhulin IB, 2001, ADV MICROB PHYSIOL, V45, P157, DOI 10.1016/S0065-2911(01)45004-1	67	25	29	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18987	18999		10.1074/jbc.M113.472605	http://dx.doi.org/10.1074/jbc.M113.472605			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23677992	Green Published, hybrid			2022-12-25	WOS:000321335800035
J	Gu, L; Liu, C; Guo, ZF				Gu, Lei; Liu, Cong; Guo, Zhefeng			Structural Insights into A beta 42 Oligomers Using Site-directed Spin Labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA OLIGOMERS; AGGREGATION BEHAVIOR; ALZHEIMERS-DISEASE; SIDE-CHAINS; PROTEIN; SHEET; MOTION; FIBRIL; EPR; STABILIZATION	Oligomerization of the 42-residue peptide A beta 42 plays a key role in the pathogenesis of Alzheimer disease. Despite great academic and medical interest, the structures of these oligomers have not been well characterized. Site-directed spin labeling combined with electron paramagnetic resonance spectroscopy is a powerful approach for studying structurally ill-defined systems, but its application in amyloid oligomer structure study has not been systematically explored. Here we report a comprehensive structural study on a toxic A beta 42 oligomer, called globulomer, using site-directed spin labeling complemented by other techniques. Transmission electron microscopy shows that these oligomers are globular structures with diameters of similar to 7-8 nm. Circular dichroism shows primarily beta-structures. X-ray powder diffraction suggests a highly ordered intrasheet hydrogen-bonding network and a heterogeneous intersheet packing. Residue-level mobility analysis on spin labels introduced at 14 different positions shows a structured state and a disordered state at all labeling sites. Side chain mobility analysis suggests that structural order increases from N- to C-terminal regions. Intermolecular distance measurements at 14 residue positions suggest that C-terminal residues Gly-29-Val-40 form a tightly packed core with intermolecular distances in a narrow range of 11.5-12.5 angstrom. These intermolecular distances rule out the existence of fibril-like parallel in-register beta-structures and strongly suggest an antiparallel beta-sheet arrangement in A beta 42 globulomers.	[Gu, Lei; Guo, Zhefeng] Univ Calif Los Angeles, Dept Neurol, Brain Res Inst, Inst Mol Biol, Los Angeles, CA 90095 USA; [Liu, Cong] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Guo, ZF (corresponding author), Univ Calif Los Angeles, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	zhefeng@ucla.edu	Guo, Zhefeng/A-2069-2013; Gu, Lei/GWQ-6785-2022	Guo, Zhefeng/0000-0003-1992-7255; 	Alzheimer's Association [NIRG-09-133555]; American Health Assistance Foundation [A2010362]	Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation	This work was supported by the Alzheimer's Association (Grant NIRG-09-133555) and American Health Assistance Foundation (Grant A2010362).	Agopian A, 2012, BIOCHEM J, V447, P43, DOI 10.1042/BJ20120034; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Cunningham TF, 2012, BIOCHEMISTRY-US, V51, P6350, DOI 10.1021/bi300328w; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Fanucci GE, 2006, CURR OPIN STRUC BIOL, V16, P644, DOI 10.1016/j.sbi.2006.08.008; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gu L, 2012, J BIOL CHEM, V287, P9081, DOI 10.1074/jbc.M111.292086; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lietzow MA, 2004, BIOCHEMISTRY-US, V43, P3137, DOI 10.1021/bi0360962; Liu C, 2011, J AM CHEM SOC, V133, P6736, DOI 10.1021/ja200222n; Lopez CJ, 2012, BIOCHEMISTRY-US, V51, P6568, DOI 10.1021/bi3005686; Ma BY, 2011, J BIOL CHEM, V286, P34244, DOI 10.1074/jbc.M111.241141; Ma BY, 2010, J BIOL CHEM, V285, P37102, DOI 10.1074/jbc.M110.133488; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Morgado I, 2012, P NATL ACAD SCI USA, V109, P12503, DOI 10.1073/pnas.1206433109; Ngo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047248; Ngo S, 2011, BIOCHEM BIOPH RES CO, V414, P512, DOI 10.1016/j.bbrc.2011.09.097; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Sarroukh R, 2011, CELL MOL LIFE SCI, V68, P1429, DOI 10.1007/s00018-010-0529-x; Schneider D. J., 1989, SPIN LABELING THEORY, P1; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shafrir Y, 2010, PROTEINS, V78, P3458, DOI 10.1002/prot.22832; Shahnawaz M, 2007, BIOCHEM BIOPH RES CO, V359, P801, DOI 10.1016/j.bbrc.2007.05.186; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Vandersteen A, 2012, FEBS LETT, V586, P4088, DOI 10.1016/j.febslet.2012.10.022; Veluraja K, 2011, BIOCHEM BIOPH RES CO, V406, P570, DOI 10.1016/j.bbrc.2011.02.092; Yamamoto N, 2004, J NEUROCHEM, V90, P62, DOI 10.1111/j.1471-4159.2004.02459.x; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904	59	57	59	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18673	18683		10.1074/jbc.M113.457739	http://dx.doi.org/10.1074/jbc.M113.457739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23687299	Green Published, hybrid			2022-12-25	WOS:000321335800004
J	Hazra, A; Gu, F; Aulakh, A; Berridge, C; Eriksen, JL; Ziburkus, J				Hazra, Anupam; Gu, Feng; Aulakh, Ahmad; Berridge, Casey; Eriksen, Jason L.; Ziburkus, Jokubas			Inhibitory Neuron and Hippocampal Circuit Dysfunction in an Aged Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; PROTEIN-TAU TAU; AMYLOID-BETA; COGNITIVE IMPAIRMENTS; DENTATE GYRUS; EPILEPSY; CALCIUM; SEIZURES; PLAQUES; NETWORK	In Alzheimer's disease (AD), a decline in explicit memory is one of the earliest signs of disease and is associated with hippocampal dysfunction. Amyloid protein exerts a disruptive impact on neuronal function, but the specific effects on hippocampal network activity are not well known. In this study, fast voltage-sensitive dye imaging and extracellular and whole-cell electrophysiology were used on entorhinal cortical-hippocampal slice preparations to characterize hippocampal network activity in 12-16 month old female APPswe/PSEN1DeltaE9 (APdE9 mice) mice. Aged APdE9 mice exhibited profound disruptions in dentate gyrus circuit activation. High frequency stimulation of the perforant pathway in the dentate gyrus (DG) area of APdE9 mouse tissue evoked abnormally large field potential responses corresponding to the wider neural activation maps. Whole-cell patch clamp recordings of the identified inhibitory interneurons in the molecular layer of DG revealed that they fail to reliably fire action potentials. Taken together, abnormal DG excitability and an inhibitory neuron failure to generate action potentials are suggested to be important contributors to the underlying cellular mechanisms of early-stage Alzheimer's disease pathophysiology.	[Hazra, Anupam; Gu, Feng; Aulakh, Ahmad; Ziburkus, Jokubas] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Berridge, Casey; Eriksen, Jason L.] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Eriksen, JL (corresponding author), Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA.	jeriksen@central.uh.edu; jziburkus@uh.edu	Eriksen, Jason/A-8054-2008; Hazra, Anupam/GOP-1864-2022; Hazra, Anupam/ABD-6774-2020	Eriksen, Jason/0000-0003-1549-4165; Hazra, Anupam/0000-0002-3679-7950; Ziburkus, Jokubas/0000-0002-1701-4367	Alzheimer's Association [NIRG-08-92033, NIRG-12-242527]; United States National Institutes of Health (NIH)/NIA [1R15AG039008]; Epilepsy Foundation of America Research Grant; NATIONAL INSTITUTE ON AGING [R15AG039008] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); United States National Institutes of Health (NIH)/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation of America Research Grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by funding from the Alzheimer's Association (J.E.; NIRG-08-92033; J.Z. NIRG-12-242527), United States National Institutes of Health (NIH)/NIA (J.E., J.E., 1R15AG039008), and the Epilepsy Foundation of America Research Grant (J.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; Armstrong C, 2011, J COMP NEUROL, V519, P1476, DOI 10.1002/cne.22577; Avoli M, 1996, J PHYSIOL-LONDON, V493, P707, DOI 10.1113/jphysiol.1996.sp021416; Ben-Ari Y, 2012, KAINATE TEMPORAL LOB; Bordji K, 2011, REV NEUROSCIENCE, V22, P285, DOI 10.1515/RNS.2011.029; Brown JT, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.025; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Buzsaki G., 2006, RHYTHMS BRAIN; Carlson GC, 2008, NAT PROTOC, V3, P249, DOI 10.1038/nprot.2007.539; Chakroborty S, 2012, J NEUROSCI, V32, P8341, DOI 10.1523/JNEUROSCI.0936-12.2012; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cloyd J, 2006, EPILEPSY RES, V68, pS39, DOI 10.1016/j.eplepsyres.2005.07.016; Coulter DA, 2011, J PHYSIOL-LONDON, V589, P1893, DOI 10.1113/jphysiol.2010.202184; Culmone V, 2012, FRONT COMPUT NEUROSC, V6, P1, DOI 10.3389/fncom.2012.00052; D'Amelio M, 2012, PROG NEUROBIOL; Dulla CG, 2009, NAT NEUROSCI, V12, P959, DOI 10.1038/nn0809-959; Eriksen JL, 2007, BEHAV GENET, V37, P79, DOI 10.1007/s10519-006-9118-z; Ferreira IL, 2011, CELL CALCIUM; Gengler S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009764; Gleichmann M, 2010, NEUROMOL MED, V12, P44, DOI 10.1007/s12017-009-8100-3; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hazra A, 2012, J NEUROPHYSIOL, V108, P658, DOI 10.1152/jn.00708.2011; Hsu D, 2007, PROG BRAIN RES, V163, P601, DOI 10.1016/S0079-6123(07)63032-5; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lee SH, 2012, J NEUROSCI, V32, P5953, DOI 10.1523/JNEUROSCI.0465-12.2012; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Malinow R, 2011, CURR OPIN NEUROBIOL; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Noebels J, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2010.02909.x; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Otsu Y, 2000, J NEUROPHYSIOL, V83, P2421, DOI 10.1152/jn.2000.83.4.2421; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2011, METHODS MOL BIOL, V670, P245, DOI 10.1007/978-1-60761-744-0_17; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Palop JJ, 2010, NEUROMOL MED, V12, P48, DOI 10.1007/s12017-009-8097-7; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Petrou S., 2012, GABAAGAMMA2 R43Q MOU; Poulin B, 2010, P NATL ACAD SCI USA, V107, P9440, DOI 10.1073/pnas.0914801107; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sachse CC, 2013, FASEB J; Scharfman HE, 2012, FUTUR NEUROL, V7, P177, DOI 10.2217/FNL.12.8; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sloviter R. S., 2012, JASPERS BASIC MECH E; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Thibault O, 2012, BBA-MOL BASIS DIS, V1822, P546, DOI 10.1016/j.bbadis.2012.01.004; Timofeev I, 2004, NEUROSCIENCE, V123, P299, DOI 10.1016/j.neuroscience.2003.08.051; Tominaga T, 2000, J NEUROSCI METH, V102, P11, DOI 10.1016/S0165-0270(00)00270-3; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Volianskis A, 2010, NEUROBIOL AGING, V31, P1173, DOI 10.1016/j.neurobiolaging.2008.08.005; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wilcock DM, 2009, NEUROSCIENCE, V159, P1055, DOI 10.1016/j.neuroscience.2009.01.023; Wu JY, 2008, NEUROSCIENTIST, V14, P487, DOI 10.1177/1073858408317066; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zecevic D, 2003, CURR PROTOC NEUROSCI; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003	71	56	57	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64318	10.1371/journal.pone.0064318	http://dx.doi.org/10.1371/journal.pone.0064318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691195	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900093
J	Rao, SAM; Arimappamagan, A; Pandey, P; Santosh, V; Hegde, AS; Chandramouli, BA; Somasundaram, K				Rao, Soumya Alige Mahabala; Arimappamagan, Arivazhagan; Pandey, Paritosh; Santosh, Vani; Hegde, Alangar Sathyaranjandas; Chandramouli, Bangalore Ashwathnarayanara; Somasundaram, Kumaravel			miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma	PLOS ONE			English	Article							MICRORNAS	Glioblastoma is one of the common types of primary brain tumors with a median survival of 12-15 months. The receptor tyrosine kinase (RTK) pathway is known to be deregulated in 88% of the patients with glioblastoma. 45% of GBM patients show amplifications and activating mutations in EGFR gene leading to the upregulation of the pathway. In the present study, we demonstrate that a brain specific miRNA, miR-219-5p, repressed EGFR by directly binding to its 3'-UTR. The expression of miR-219-5p was downregulated in glioblastoma and the overexpression of miR-219-5p in glioma cell lines inhibited the proliferation, anchorage independent growth and migration. In addition, miR-219-5p inhibited MAPK and PI3K pathways in glioma cell lines in concordance with its ability to target EGFR. The inhibitory effect of miR-219-5p on MAPK and PI3K pathways and glioma cell migration could be rescued by the overexpression of wild type EGFR and vIII mutant of EGFR (both lacking 3'-UTR and thus being insensitive to miR-219-5p) suggesting that the inhibitory effects of miR-219-5p were indeed because of its ability to target EGFR. We also found significant negative correlation between miR-219-5p levels and total as well as phosphorylated forms of EGFR in glioblastoma patient samples. This indicated that the downregulation of miR-219-5p in glioblastoma patients contribute to the increased activity of the RTK pathway by the upregulation of EGFR. Thus, we have identified and characterized miR-219-5p as the RTK regulating novel tumor suppressor miRNA in glioblastoma.	[Rao, Soumya Alige Mahabala; Somasundaram, Kumaravel] Indian Inst Sci, Bangalore 560012, Karnataka, India; [Arimappamagan, Arivazhagan; Pandey, Paritosh; Chandramouli, Bangalore Ashwathnarayanara] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India; [Santosh, Vani] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore, Karnataka, India; [Hegde, Alangar Sathyaranjandas] Sri SatyaSai Inst Higher Med Sci, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India	Somasundaram, K (corresponding author), Indian Inst Sci, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in			Department of Biotechnology, Government of India; CSIR	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The study is funded by Department of Biotechnology, Government of India. SAR gratefully acknowledges Senior Research Fellowship from CSIR. KS is a J. C. Bose Fellow of the Department of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2011, J EXP MED, V208, P689, DOI 10.1084/jem.20102099; *CBTRUS, 2000, CBTRUS STAT REP PRIM; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Das S, 2005, CANCER GENE THER, V12, P417, DOI 10.1038/sj.cgt.7700803; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Huang N, 2012, FEBS LETT, V586, P884, DOI 10.1016/j.febslet.2012.02.017; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380; Rao SAM, 2010, MODERN PATHOL, V23, P1404, DOI 10.1038/modpathol.2010.135; Reardon DA, 2006, ONCOLOGIST, V11, P152, DOI 10.1634/theoncologist.11-2-152; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; SOMASUNDARAM K, 2011, MOL TARGETS CNS TUMO, DOI DOI 10.5772/1047; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Suvasini R, 2011, J BIOL CHEM, V286, P25882, DOI 10.1074/jbc.M110.178012; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wajapeyee N, 2006, J BIOL CHEM, V281, P16207, DOI 10.1074/jbc.M600539200; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhang Q, 2011, BLOOD, V118, P3062, DOI 10.1182/blood-2011-01-332916; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; ZHI F, 2012, INT J CANC	29	62	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63164	10.1371/journal.pone.0063164	http://dx.doi.org/10.1371/journal.pone.0063164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690991	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000319107900025
J	Tecchio, S; van Oevelen, D; Soetaert, K; Navarro, J; Ramirez-Llodra, E				Tecchio, Samuele; van Oevelen, Dick; Soetaert, Karline; Navarro, Joan; Ramirez-Llodra, Eva			Trophic Dynamics of Deep-Sea Megabenthos Are Mediated by Surface Productivity	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; STABLE-ISOTOPE RATIOS; FEEDING-HABITS; CARBON; COMMUNITY; NITROGEN; WESTERN; ECOSYSTEM; ATLANTIC; PACIFIC	Most deep-sea benthic ecosystems are food limited and, in the majority of cases, are driven by the organic matter falling from the surface or advected downslope. Species may adapt to this scarceness by applying a wide variety of responses, such as feeding specialisation, niche width variation, and reduction in metabolic rates. The Mediterranean Sea hosts a gradient of food availability at the deep seafloor over its wide longitudinal transect. In the Mediterranean, broad regional studies on trophic habits are almost absent, and the response of deep-sea benthos to different trophic conditions is still speculative. Here, we show that both primary and secondary production processes taking place at surface layers are key drivers of deepsea food web structuring. By employing an innovative statistical tool, we interpreted bulk-tissue delta(13) C and delta(15) N isotope ratios in benthic megafauna, and associated surface and mesopelagic components from the 3 basins of the Mediterranean Sea at 3 different depths (1200, 2000, and 3000 m). The trophic niche width and the amplitude of primary carbon sources were positively correlated with both primary and secondary surface production indicators. Moreover, mesopelagic organic matter utilization processes showed an intermediate position between surface and deep benthic components. These results shed light on the understanding of deep-sea ecosystems functioning and, at the same time, they demand further investigation.	[Tecchio, Samuele; Navarro, Joan; Ramirez-Llodra, Eva] CSIC, Inst Ciencies Mar, Barcelona, Spain; [van Oevelen, Dick; Soetaert, Karline] Royal Netherlands Inst Sea Res, Yerseke, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Tecchio, S (corresponding author), CSIC, Inst Ciencies Mar, Barcelona, Spain.	tecchio@icm.csic.es	Soetaert, Karline E/A-9839-2011; Navarro, Joan/C-2119-2009; Tecchio, Samuele/A-4043-2013	Soetaert, Karline E/0000-0003-4603-7100; Navarro, Joan/0000-0002-5756-9543; Tecchio, Samuele/0000-0001-9905-7717; Ramirez-Llodra, Eva/0000-0003-0137-1906	European Science Foundation BIOFUN project [CTM2007-28739-E]; Spanish Ministry of Science and Innovation PROMETEO project [CTM2007-66316-C02/MAR]; JAE-PRE CSIC grant; ERL; JAE-DOC CSIC postdoctoral grant; European Social Fund; post-doc contract of the "Juan de la Cierva'' program	European Science Foundation BIOFUN project; Spanish Ministry of Science and Innovation PROMETEO project; JAE-PRE CSIC grant; ERL; JAE-DOC CSIC postdoctoral grant; European Social Fund(European Social Fund (ESF)); post-doc contract of the "Juan de la Cierva'' program	This study was supported by the European Science Foundation BIOFUN project (CTM2007-28739-E), and the Spanish Ministry of Science and Innovation PROMETEO project (CTM2007-66316-C02/MAR). ST was funded by a JAE-PRE CSIC grant, and ERL was supported by a JAE-DOC CSIC postdoctoral grant, both with co-funding from the European Social Fund. JN was supported by a post-doc contract of the "Juan de la Cierva'' program (Spanish Ministry of Economy and Competitiveness). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZOV Y, 1991, MAR POLLUT BULL, V23, P225, DOI 10.1016/0025-326X(91)90679-M; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Carrasson M, 2002, MAR ECOL PROG SER, V241, P41, DOI 10.3354/meps241041; Carrasson M, 1998, J MAR BIOL ASSOC UK, V78, P1295, DOI 10.1017/S0025315400044507; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; Costalago D, 2012, MAR ECOL PROG SER, V460, P169, DOI 10.3354/meps09751; Danovaro R, 1999, PROG OCEANOGR, V44, P287, DOI 10.1016/S0079-6611(99)00030-0; Danovaro R, 2008, ECOGRAPHY, V31, P231, DOI 10.1111/j.0906-7590.2008.5484.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Drazen JC, 2008, LIMNOL OCEANOGR, V53, P2644, DOI 10.4319/lo.2008.53.6.2644; Fanelli E, 2009, DEEP-SEA RES PT I, V56, P1504, DOI 10.1016/j.dsr.2009.04.004; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gage JD, 2003, ECOSY WORLD, V28, P313; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Iken K, 2001, PROG OCEANOGR, V50, P383, DOI 10.1016/S0079-6611(01)00062-3; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Jeffreys RM, 2011, DEEP-SEA RES PT I, V58, P415, DOI 10.1016/j.dsr.2011.02.002; Jeffreys RM, 2009, DEEP-SEA RES PT I, V56, P1816, DOI 10.1016/j.dsr.2009.05.001; LAMPITT RS, 1985, DEEP-SEA RES, V32, P885, DOI 10.1016/0198-0149(85)90034-2; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Madurell T, 2008, J MARINE SYST, V71, P336, DOI 10.1016/j.jmarsys.2007.03.006; Margalef R., 1985, W MEDITERRANEAN; Massuti E, 2004, SCI MAR, V68, P101, DOI 10.3989/scimar.2004.68s3101; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mees Jan, 1997, Oceanography and Marine Biology an Annual Review, V35, P221; Nadon MO, 2006, LIMNOL OCEANOGR, V51, P2828, DOI 10.4319/lo.2006.51.6.2828; Navarro J, 2011, J EXP MAR BIOL ECOL, V401, P97, DOI 10.1016/j.jembe.2011.02.040; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Polunin NVC, 2001, MAR ECOL PROG SER, V220, P13; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Ramirez-Llodra E, 2010, MAR ECOL-EVOL PERSP, V31, P167, DOI 10.1111/j.1439-0485.2009.00336.x; Sabates A, 2010, HYDROBIOLOGIA, V645, P153, DOI 10.1007/s10750-010-0221-z; Sanchez-Vidal A, 2009, LIMNOL OCEANOGR, V54, P1488, DOI 10.4319/lo.2009.54.5.1488; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; Sarda F, 1998, FISHERIES SCI, V64, P492, DOI 10.2331/fishsci.64.492; Sarda F, 2004, SCI MAR, V68, P7, DOI 10.3989/scimar.2004.68s37; Smith CR, 2006, DEEP-SEA RES PT II, V53, P875, DOI 10.1016/j.dsr2.2006.02.001; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; SMITH KL, 1994, LIMNOL OCEANOGR, V39, P1101, DOI 10.4319/lo.1994.39.5.1101; Smith KL, 1998, DEEP-SEA RES PT II, V45, P573, DOI 10.1016/S0967-0645(97)00094-5; Tecchio S, 2013, DEEP-SEA RES PT I, V75, P1, DOI 10.1016/j.dsr.2013.01.003; Tecchio S, 2011, MAR ECOL PROG SER, V439, P181, DOI 10.3354/meps09333; Tecchio S, 2011, SCI MAR, V75, P341, DOI 10.3989/scimar.2011.75n2341; Tyler PA, 2003, ECOSY WORLD, V28, P261; Zintzen V, 2011, ECOGRAPHY, V34, P306, DOI 10.1111/j.1600-0587.2010.06546.x; Zuniga D, 2009, PROG OCEANOGR, V82, P239, DOI 10.1016/j.pocean.2009.07.002	57	24	24	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63796	10.1371/journal.pone.0063796	http://dx.doi.org/10.1371/journal.pone.0063796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691098	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107900060
J	Smallegange, RC; van Gemert, GJ; van de Vegte-Bolmer, M; Gezan, S; Takken, W; Sauerwein, RW; Logan, JG				Smallegange, Renate C.; van Gemert, Geert-Jan; van de Vegte-Bolmer, Marga; Gezan, Salvador; Takken, Willem; Sauerwein, Robert W.; Logan, James G.			Malaria Infected Mosquitoes Express Enhanced Attraction to Human Odor	PLOS ONE			English	Article								There is much evidence that some pathogens manipulate the behaviour of their mosquito hosts to enhance pathogen transmission. However, it is unknown whether this phenomenon exists in the interaction of Anopheles gambiae sensu stricto with the malaria parasite, Plasmodium falciparum - one of the most important interactions in the context of humanity, with malaria causing over 200 million human cases and over 770 thousand deaths each year. Here we demonstrate, for the first time, that infection with P. falciparum causes alterations in behavioural responses to host-derived olfactory stimuli in host-seeking female An. gambiae s.s. mosquitoes. In behavioural experiments we showed that P. falciparum-infected An. gambiae mosquitoes were significantly more attracted to human odors than uninfected mosquitoes. Both P. falciparum-infected and uninfected mosquitoes landed significantly more on a substrate emanating human skin odor compared to a clean substrate. However, significantly more infected mosquitoes landed and probed on a substrate emanating human skin odor than uninfected mosquitoes. This is the first demonstration of a change of An. gambiae behaviour in response to olfactory stimuli caused by infection with P. falciparum. The results of our study provide vital information that could be used to provide better predictions of how malaria is transmitted from human being to human being by An. gambiae s.s. females. Additionally, it highlights the urgent need to investigate this interaction further to determine the olfactory mechanisms that underlie the differential behavioural responses. In doing so, new attractive compounds could be identified which could be used to develop improved mosquito traps for surveillance or trapping programmes that may even specifically target P. falciparum-infected An. gambiae s.s. females.	[Smallegange, Renate C.; Takken, Willem] Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands; [Smallegange, Renate C.; Takken, Willem] Res Ctr, Wageningen, Netherlands; [Smallegange, Renate C.; Logan, James G.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [van Gemert, Geert-Jan; van de Vegte-Bolmer, Marga; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Gezan, Salvador] Univ Florida, Inst Food & Agr Sci, Dept Stat, Gainesville, FL 32611 USA	Wageningen University & Research; University of London; London School of Hygiene & Tropical Medicine; Radboud University Nijmegen; State University System of Florida; University of Florida	Smallegange, RC (corresponding author), Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands.	renate.smallegange@gmail.com; james.logan@lshtm.ac.uk	Sauerwein, Robert/C-8519-2013; Smallegange, Renate C./L-1566-2019	Smallegange, Renate C./0000-0002-6946-9777				Anderson RA, 1999, P ROY SOC B-BIOL SCI, V266, P1729, DOI 10.1098/rspb.1999.0839; Hurd H, 2010, ECOL CONT VECTOR-BOR, V2, P349; Koella JC, 1989, P ROY SOC LOND B BIO, V265, P763; Lefevre T, 2007, PROTEOMICS, V7, P1908, DOI 10.1002/pmic.200601021; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; ROSSIGNOL PA, 1986, AM J TROP MED HYG, V35, P277, DOI 10.4269/ajtmh.1986.35.277; Smallegange RC, 2010, J MED ENTOMOL, V47, P338, DOI 10.1603/ME09015; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Verhulst NO, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020497, 10.1371/journal.pone.0028991]	11	65	66	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63602	10.1371/journal.pone.0063602	http://dx.doi.org/10.1371/journal.pone.0063602			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691073	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000319052700052
J	Zhao, ZJ; Zhang, J; Wei, J; Li, Z; Wang, T; Yi, SQ; Shen, JL; Yang, TB; Hide, G; Lun, ZR				Zhao, Zhi-Jun; Zhang, Jia; Wei, Jun; Li, Zhi; Wang, Tao; Yi, Si-Qi; Shen, Ji-Long; Yang, Ting-Bao; Hide, Geoff; Lun, Zhao-Rong			Lower Expression of Inducible Nitric Oxide Synthase and Higher Expression of Arginase in Rat Alveolar Macrophages Are Linked to Their Susceptibility to Toxoplasma gondii Infection	PLOS ONE			English	Article							PERITONEAL-MACROPHAGES; PULMONARY TOXOPLASMOSIS; MURINE MACROPHAGES; BRONCHOALVEOLAR LAVAGE; GAMMA-INTERFERON; POLYAMINE LEVELS; REACTIVE OXYGEN; PNEUMONIA; ARGININE; CELLS	Rats are naturally resistant to Toxoplasma gondii infection, particularly the RH strain, while mice are not. Previous studies have demonstrated that inducible nitric oxide synthase (iNOS) and arginase-1 of rodent peritoneal macrophages are linked to the mechanism of resistance. As an increasing number of studies on human and animal infections are showing that pulmonary toxoplasmosis is one of the most severe clinical signs from T. gondii infection, we are interested to know whether T. gondii infection in alveolar macrophages of rats is also linked to the levels of iNOS and arginase-1 activity. Our results demonstrate that T. gondii could grow and proliferate in rat alveolar macrophages, both in vitro and in vivo, at levels higher than resistant rat peritoneal macrophages and at comparable levels to sensitive mouse peritoneal macrophages. Lower activity and expression levels of iNOS and higher activity and expression levels of arginase-1 in rat alveolar macrophages were found to be linked to the susceptibility of T. gondii infection in these cells. These novel findings could aid a better understanding of the pathogenesis of clinical pulmonary toxoplasmosis in humans and domestic animals.	[Zhao, Zhi-Jun; Zhang, Jia; Li, Zhi; Wang, Tao; Yi, Si-Qi; Yang, Ting-Bao; Lun, Zhao-Rong] Sun Yat Sen Univ, Sch Life Sci, Ctr Parasit Organisms, State Key Lab Biocontrol, Guangzhou, Peoples R China; [Zhao, Zhi-Jun; Zhang, Jia; Li, Zhi; Wang, Tao; Yi, Si-Qi; Yang, Ting-Bao; Lun, Zhao-Rong] Sun Yat Sen Univ, Zhongshan Sch Med, Key Lab Trop Dis & Control, Minist Educ, Guangzhou, Peoples R China; [Zhao, Zhi-Jun; Wei, Jun] Ningxia Med Univ, Gen Hosp, Yinchuan, Peoples R China; [Shen, Ji-Long] Anhui Med Univ, Prov Lab Microbiol & Parasitol, Hefei, Anhui, Peoples R China; [Shen, Ji-Long] Anhui Med Univ, Dept Parasitol, Key Lab Zoonoses Anhui, Hefei, Anhui, Peoples R China; [Hide, Geoff; Lun, Zhao-Rong] Univ Salford, Ecosystems & Environm Res Ctr, Salford M5 4WT, Lancs, England; [Hide, Geoff; Lun, Zhao-Rong] Univ Salford, Sch Environm & Life Sci, Biomed Res Ctr, Salford M5 4WT, Lancs, England	Sun Yat Sen University; Sun Yat Sen University; Ningxia Medical University; Anhui Medical University; Anhui Medical University; University of Salford; University of Salford	Lun, ZR (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Ctr Parasit Organisms, State Key Lab Biocontrol, Guangzhou, Peoples R China.	lsslzr@mail.sysu.edu.cn		Hide, Geoff/0000-0002-3608-0175	National Basic Research Program of China (973 Program) [2010CB530000]; National Special Research Programs for Non-Profit Trades (Agriculture) [200803017]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Special Research Programs for Non-Profit Trades (Agriculture)	The work was supported by National Basic Research Program of China (973 Program) (No. 2010CB530000) and the National Special Research Programs for Non-Profit Trades (Agriculture) (No. 200803017), http://www.973.gov.cn/English/Index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallahi OMS, 2001, CELL MOL LIFE SCI, V58, P1350, DOI 10.1007/PL00000947; ADAMS LB, 1990, J IMMUNOL, V144, P2725; Alexander J, 1997, PHILOS T ROY SOC B, V352, P1355, DOI 10.1098/rstb.1997.0120; BADGER AM, 1988, J INTERFERON RES, V8, P251, DOI 10.1089/jir.1988.8.251; BADGER AM, 1987, J LEUKOCYTE BIOL, V42, P447, DOI 10.1002/jlb.42.5.447; BOLTZNITULESCU G, 1979, IMMUNOLOGY, V38, P621; Bossi P, 1998, J CLIN MICROBIOL, V36, P3724, DOI 10.1128/JCM.36.12.3724-3725.1998; Bossi P, 2004, LANCET, V364, P579, DOI 10.1016/S0140-6736(04)16841-4; Brunet LR, 2001, INT IMMUNOPHARMACOL, V1, P1457, DOI 10.1016/S1567-5769(01)00090-X; Bunn HJ, 2002, CLIN EXP IMMUNOL, V128, P313, DOI 10.1046/j.1365-2249.2002.01848.x; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; CANDOLFI E, 1993, J INFECTION, V26, P79, DOI 10.1016/0163-4453(93)96968-V; Carme B, 2002, VECTOR-BORNE ZOONOT, V2, P11, DOI 10.1089/153036602760260733; Carme B, 2009, EMERG INFECT DIS, V15, P656, DOI 10.3201/eid1504.081306; CATTERALL JR, 1986, AM REV RESPIR DIS, V133, P704; CATTERALL JR, 1986, J EXP MED, V163, P1113, DOI 10.1084/jem.163.5.1113; CATTERALL JR, 1987, INFECT IMMUN, V55, P1635, DOI 10.1128/IAI.55.7.1635-1640.1987; CHINCHILLA M, 1982, J PARASITOL, V68, P952, DOI 10.2307/3281014; CHINCHILLA M, 1978, INFECT IMMUN, V19, P999, DOI 10.1128/IAI.19.3.999-1012.1978; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; DARCY F, 1993, RES IMMUNOL, V144, P16, DOI 10.1016/S0923-2494(05)80091-4; Das P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000899; Delhaes L, 2010, BONE MARROW TRANSPL, V45, P580, DOI 10.1038/bmt.2009.167; DING AH, 1988, J IMMUNOL, V141, P2407; Dorger M, 2001, EXP LUNG RES, V27, P65, DOI 10.1080/019021401459770; Dubey JP, 1998, VET PARASITOL, V77, P1, DOI 10.1016/S0304-4017(97)00227-6; Dubey JP, 1999, J PARASITOL, V85, P657, DOI 10.2307/3285739; Dubremetz JF, 2012, MICROBES INFECT, V14, P1403, DOI 10.1016/j.micinf.2012.09.005; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; FELS AOS, 1986, J APPL PHYSIOL, V60, P353, DOI 10.1152/jappl.1986.60.2.353; FERGUSON HW, 1979, VET REC, V104, P392, DOI 10.1136/vr.104.17.392; Foster SF, 2004, J FELINE MED SURG, V6, P167, DOI 10.1016/j.jfms.2003.11.006; Freyre A, 2008, EXP PARASITOL, V120, P142, DOI 10.1016/j.exppara.2008.06.007; Freyre A, 2008, EXP PARASITOL, V119, P252, DOI 10.1016/j.exppara.2008.02.007; Gobert AP, 2002, J IMMUNOL, V168, P6002, DOI 10.4049/jimmunol.168.12.6002; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; HERSCOWITZ HB, 1985, ANN ALLERGY, V55, P634; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Hrabak A, 2006, INFLAMM RES, V55, P23, DOI 10.1007/s00011-005-0004-6; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Jurankova J, 2013, VET PARASITOL, V193, P95, DOI 10.1016/j.vetpar.2012.11.016; Kempf MC, 1999, MED MICROBIOL IMMUN, V187, P137, DOI 10.1007/s004300050085; KNANI L, 1990, ANN MED INTERNE, V141, P469; Koschorreck S, 2003, EUR J PHARMACOL, V471, P229, DOI 10.1016/S0014-2999(03)01830-2; Kovari H, 2010, INFECTION, V38, P141, DOI 10.1007/s15010-009-9367-5; KRAHENBUHL JL, 1975, EXP PARASITOL, V37, P83, DOI 10.1016/0014-4894(75)90055-7; LACRAZ S, 1992, J CLIN INVEST, V90, P382, DOI 10.1172/JCI115872; Lambrecht BN, 2006, IMMUNITY, V24, P366, DOI 10.1016/j.immuni.2006.03.008; LANGERMANS JAM, 1992, J IMMUNOL, V148, P568; Leal FE, 2007, CLIN INFECT DIS, V44, pE62, DOI 10.1086/511871; Li ZR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035834, 10.1371/journal.pone.0051597]; LOVCHIK JA, 1995, AM J RESP CELL MOL, V13, P116, DOI 10.1165/ajrcmb.13.1.7598935; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; Luong ML, 2010, CURR OPIN INFECT DIS, V23, P578, DOI 10.1097/QCO.0b013e32833f9f93; MENDELSON MH, 1987, SCAND J INFECT DIS, V19, P703, DOI 10.3109/00365548709117209; Monaco SE, 2012, DIAGN CYTOPATHOL, V40, P629, DOI 10.1002/dc.21646; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mullner N, 2002, INT J BIOCHEM CELL B, V34, P1080, DOI 10.1016/S1357-2725(02)00028-6; Munder M, 1999, J IMMUNOL, V163, P3771; Munder M, 1998, J IMMUNOL, V160, P5347; Murakami Y, 2012, CYTOKINE, V59, P245, DOI 10.1016/j.cyto.2012.04.022; MYRVIK QN, 1961, J IMMUNOL, V86, P128; Naito M, 2008, PATHOL INT, V58, P143, DOI 10.1111/j.1440-1827.2007.02203.x; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; OKSENHENDLER E, 1990, AM J MED, V88, pN18; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; POMEROY C, 1992, CLIN INFECT DIS, V14, P863, DOI 10.1093/clinids/14.4.863; Qualls JE, 2009, J IMMUNOL, V182; Carrera NJR, 2009, REV BIOL TROP, V57, P13; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Rottenberg GT, 1997, CLIN RADIOL, V52, P472, DOI 10.1016/S0009-9260(97)80012-8; RUSKIN J, 1976, ANN INTERN MED, V84, P193, DOI 10.7326/0003-4819-84-2-193; SANTORO F, 1987, CR ACAD SCI III-VIE, V304, P297; SCHNEEMANN M, 1993, J INFECT DIS, V167, P1358, DOI 10.1093/infdis/167.6.1358; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Seabra SH, 2004, J PARASITOL, V90, P455, DOI 10.1645/GE-179R; Seabra SJ, 2002, EXP PARASITOL, V100, P62, DOI 10.1006/expr.2001.4675; Simanaityte D, 2010, MED MALADIES INFECT, V40, P713, DOI 10.1016/j.medmal.2010.03.013; SIMON LM, 1977, J CLIN INVEST, V59, P443, DOI 10.1172/JCI108658; Thiptara A, 2006, ANN NY ACAD SCI, V1081, P336, DOI 10.1196/annals.1373.047; TOURANI JM, 1985, LANCET, V1, P989; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053483; WANG WW, 1995, BIOCHEM BIOPH RES CO, V210, P1009, DOI 10.1006/bbrc.1995.1757; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Zenner L, 1998, EXP PARASITOL, V90, P86, DOI 10.1006/expr.1998.4301; Zenner L, 1999, PATHOL RES PRACT, V195, P475, DOI 10.1016/S0344-0338(99)80051-X	87	7	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63650	10.1371/journal.pone.0063650	http://dx.doi.org/10.1371/journal.pone.0063650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691079	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700055
J	Bronner, A; Henaux, V; Vergne, T; Vinard, JL; Morignat, E; Hendrikx, P; Calavas, D; Gay, E				Bronner, Anne; Henaux, Viviane; Vergne, Timothee; Vinard, Jean-Luc; Morignat, Eric; Hendrikx, Pascal; Calavas, Didier; Gay, Emilie			Assessing the Mandatory Bovine Abortion Notification System in France Using Unilist Capture-Recapture Approach	PLOS ONE			English	Article							SCRAPIE SURVEILLANCE; MODELS; SIMULATION; CATTLE	The mandatory bovine abortion notification system in France aims to detect as soon as possible any resurgence of bovine brucellosis. However, under-reporting seems to be a major limitation of this system. We used a unilist capture-recapture approach to assess the sensitivity, i.e. the proportion of farmers who reported at least one abortion among those who detected such events, and representativeness of the system during 2006-2011. We implemented a zero-inflated Poisson model to estimate the proportion of farmers who detected at least one abortion, and among them, the proportion of farmers not reporting. We also applied a hurdle model to evaluate the effect of factors influencing the notification process. We found that the overall surveillance sensitivity was about 34%, and was higher in beef than dairy cattle farms. The observed increase in the proportion of notifying farmers from 2007 to 2009 resulted from an increase in the surveillance sensitivity in 2007/2008 and an increase in the proportion of farmers who detected at least one abortion in 2008/2009. These patterns suggest a raise in farmers' awareness in 2007/2008 when the Bluetongue Virus (BTV) was detected in France, followed by an increase in the number of abortions in 2008/2009 as BTV spread across the country. Our study indicated a lack of sensitivity of the mandatory bovine abortion notification system, raising concerns about the ability to detect brucellosis outbreaks early. With the increasing need to survey the zoonotic Rift Valley Fever and Q fever diseases that may also cause bovine abortions, our approach is of primary interest for animal health stakeholders to develop information programs to increase abortion notifications. Our framework combining hurdle and ZIP models may also be applied to estimate the completeness of other clinical surveillance systems.	[Bronner, Anne; Henaux, Viviane; Vinard, Jean-Luc; Morignat, Eric; Calavas, Didier; Gay, Emilie] Agence Natl Securite Sanit Alimentat Environm & T, Unite Epidemiol Lab Lyon, Lyon, France; [Vergne, Timothee] Ctr Cooperat Int Rech Agron Dev Cirad, Dept ES, UR22, TA E C22, Montpellier, France; [Vergne, Timothee] Agence Natl Securite Sanit Alimentat Environm & T, Lab Sante Anim Maisons Alfort, Maisons Alfort, France; [Hendrikx, Pascal] Agence Natl Securite Sanit Alimentat Environm & T, Unite Surveillance Epidemiol Survepi, Direct Sci Labs, Maisons Alfort, France	CIRAD; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); Ecole Nationale Veterinaire d'Alfort (ENVA)	Bronner, A (corresponding author), Agence Natl Securite Sanit Alimentat Environm & T, Unite Epidemiol Lab Lyon, Lyon, France.	anne.bronner@anses.fr	Vergne, Timothée/ABH-4185-2020	Vergne, Timothée/0000-0002-1146-9256	French Ministry of Agriculture	French Ministry of Agriculture	This work was partially supported by the French Ministry of Agriculture (http://agriculture.gouv.fr/), who provided the data. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, OP SCI PAN AN HLTH W, V130, P130; [Anonymous], 2012, ARRETE 13 AOUT 2012; [Anonymous], 1965, ARTICLE R 223 79 COD; [Anonymous], R LANG ENV STAT COMP; [Anonymous], PRINC CHEPT SEL LEUR; Boucher JP, 2008, RISK CLASSIFICATION; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; CDC, 2001, UPD GUID EV PUBL HLT; Chao A, 2001, STAT MED, V20, P3123, DOI 10.1002/sim.996.abs; Dagnelie P, 1998, STAT DESCRIPTIVE BAS, V1; Dubey J, 2011, VET PARASITOL; Elbers ARW, 2010, REV SCI TECH OIE, V29, P435, DOI 10.20506/rst.29.3.1988; Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4; England T, 2004, PREV VET MED, V63, P63, DOI 10.1016/j.prevetmed.2004.01.009; Fediaevsky A., 2011, B EPIDEMIOL SANTE AN, V46, P10; Figueiras A, 2004, PUBLIC HEALTH, V118, P521, DOI 10.1016/j.puhe.2003.12.015; FORAR AL, 1995, THERIOGENOLOGY, V43, P989, DOI 10.1016/0093-691X(95)00063-E; Gallay A, 2000, AM J EPIDEMIOL, V152, P171, DOI 10.1093/aje/152.2.171; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Hadfield J., 2019, PACKAGE MCMCGLMM; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hadorn DC, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-52; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Hovingh E, 2009, ABORTION DAIRY CATTL; JOHNSON MH, 1987, J ANIM SCI, V65, P68, DOI 10.2527/jas1987.65168x; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Moutou F, 2002, COMP IMMUNOL MICROB, V25, P321, DOI 10.1016/S0147-9571(02)00029-2; Nusinovici S, 2012, THERIOGENOL IN PRESS; OIE website, COUNTR REP; Pioz M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-60; Rodrigues-Motta M, 2007, J DAIRY SCI, V90, P5306, DOI 10.3168/jds.2006-898; Stengel B, 1995, EPIDEMIOLOGIE PRINCI; Trivedi Cameron A, 1998, REGRESSION ANAL COUN; Vergne T, 2012, PREV VET MED, V105, P127, DOI 10.1016/j.prevetmed.2012.02.014; Vilas VJD, 2008, PREV VET MED, V85, P253, DOI 10.1016/j.prevetmed.2008.02.003; Weinstein MC, 1980, CLIN DECISION ANAL; ZORN C, 1996, EVALUATING ZERO INFL	38	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63246	10.1371/journal.pone.0063246	http://dx.doi.org/10.1371/journal.pone.0063246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691004	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400038
J	Guo, DJ; Zeng, LH; Brody, DL; Wong, M				Guo, Dongjun; Zeng, Linghui; Brody, David L.; Wong, Michael			Rapamycin Attenuates the Development of Posttraumatic Epilepsy in a Mouse Model of Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; TEMPORAL-LOBE EPILEPSY; TUBEROUS SCLEROSIS COMPLEX; MAMMALIAN TARGET; STATUS EPILEPTICUS; SEIZURES; EPILEPTOGENESIS; THERAPY; INHIBITION; PREVENTION	Posttraumatic epilepsy is a major source of disability following traumatic brain injury (TBI) and a common cause of medically-intractable epilepsy. Previous attempts to prevent the development of posttraumatic epilepsy with treatments administered immediately following TBI have failed. Recently, the mammalian target of rapamycin complex 1 (mTORC1) pathway has been implicated in mechanisms of epileptogenesis and the mTORC1 inhibitor, rapamycin, has been proposed to have antiepileptogenic effects in preventing some types of epilepsy. In this study, we have tested the hypothesis that rapamycin has antiepileptogenic actions in preventing the development of posttraumatic epilepsy in an animal model of TBI. A detailed characterization of posttraumatic epilepsy in the mouse controlled cortical impact model was first performed using continuous video-EEG monitoring for 16 weeks following TBI. Controlled cortical impact injury caused immediate hyperactivation of the mTORC1 pathway lasting at least one week, which was reversed by rapamycin treatment. Rapamycin decreased neuronal degeneration and mossy fiber sprouting, although the effect on mossy fiber sprouting was reversible after stopping rapamycin and did not directly correlate with inhibition of epileptogenesis. Most posttraumatic seizures occurred greater than 10 weeks after TBI, and rapamycin treatment for one month after TBI decreased the seizure frequency and rate of developing posttraumatic epilepsy during the entire 16 week monitoring session. These results suggest that rapamycin may represent a rational treatment for preventing posttraumatic epilepsy in patients with TBI.	[Guo, Dongjun; Brody, David L.; Wong, Michael] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Guo, Dongjun; Brody, David L.; Wong, Michael] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Zeng, Linghui] Zhejiang Univ City Coll, Dept Pharm, Hangzhou 310003, Zhejiang, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); Zhejiang University City College	Wong, M (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	wong_m@wustl.edu	Ritter, Stefanie L/D-9312-2012		National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS056872, NS057105]; Pfizer Inc. (Washington University/Pfizer Biomedical Research Agreement); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056872, P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Pfizer Inc. (Washington University/Pfizer Biomedical Research Agreement); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	1) National Institutes of Health/National Institute of Neurological Disorders and Stroke: NS056872, NS057105. 2) Pfizer Inc. (Washington University/Pfizer Biomedical Research Agreement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Chachua T, 2012, EPILEPSIA, V53, P2015, DOI 10.1111/j.1528-1167.2012.03674.x; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Galanopoulou AS, 2012, EPILEPSIA, V53, P1119, DOI 10.1111/j.1528-1167.2012.03506.x; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Hartman AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045156; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Langlois J.A., 2006, TRAUMATIC BRAIN INJU; Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Raffo E, 2011, NEUROBIOL DIS, V43, P322, DOI 10.1016/j.nbd.2011.03.021; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Russo E, 2012, NEUROPHARM      1022; Sliwa A, 2012, NEUROSCI LETT, V509, P105, DOI 10.1016/j.neulet.2011.12.051; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Talos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035885; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; van Vliet EA, 2012, EPILEPSIA, V53, P1254, DOI 10.1111/j.1528-1167.2012.03513.x; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009	42	132	143	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64078	10.1371/journal.pone.0064078	http://dx.doi.org/10.1371/journal.pone.0064078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691153	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400100
J	Huang, HX; Liang, LF; Liu, P; Wei, H; Sachs, F; Niu, WZ; Wang, W				Huang, Haixia; Liang, Lifang; Liu, Ping; Wei, Hua; Sachs, Frederick; Niu, Weizhen; Wang, Wei			Mechanical Effects on K-ATP Channel Gating in Rat Ventricular Myocytes	PLOS ONE			English	Article							MECHANOSENSITIVE ION CHANNELS; ACTIVATED POTASSIUM CHANNELS; ATRIAL	Cardiac K-ATP channels link metabolism with electrical activity. They are implicated in arrhythmias, secretion of atrial natriuretic peptide and protection of the heart from hypertrophy and failure. These processes may involve mechanosensitivity. K-ATP channels can be activated by mechanical stimulation and disrupting the cortical actin increases the activity. We propose that K-ATP channels are modulated by local bilayer tension and this tension is affected by cortical F-actin. Here we measured K-ATP background activity and stretch sensitivity with inside-out patches of rat ventricular myocytes before and after disrupting F-actin. Disrupting F-actin potentiated background activity but did not influence the slope sensitivity in the semilog relationship of NPo vs. suction that is a measure of the change in dimensions between closed and open states. Thus actin alters prestress on the channel probably by parallel elastic sharing of mean cortical tension with the bilayer.	[Huang, Haixia; Liang, Lifang; Liu, Ping; Wei, Hua; Niu, Weizhen; Wang, Wei] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Sachs, Frederick] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	Capital Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wang, W (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.	wangwei@ccmu.edu.cn			National Natural Science Foundation of China [30770790, 30800377, 31171105]; National Institutes of Health	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from National Natural Science Foundation of China (30770790, 30800377, 31171105) and the National Institutes of Health to F.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev AE, 2012, J MOL CELL CARDIOL, V52, P401, DOI 10.1016/j.yjmcc.2011.06.007; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Corey D, 2003, J CELL SCI, V116, P1, DOI 10.1242/jcs.00101; Cunha SR, 2011, SEMIN CELL DEV BIOL, V22, P166, DOI 10.1016/j.semcdb.2010.09.013; Diaz RJ, 2003, J MOL CELL CARDIOL, V35, P45, DOI 10.1016/S0022-2828(02)00277-8; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Flagg TP, 2008, CIRC RES, V103, P1458, DOI 10.1161/CIRCRESAHA.108.178186; Hashmi S, 2013, INT J CLIN EXP PATHO, V6, P249; Kane GC, 2005, J MOL CELL CARDIOL, V38, P937, DOI 10.1016/j.yjmcc.2005.02.026; Kline CF, 2009, P NATL ACAD SCI USA, V106, P16669, DOI 10.1073/pnas.0907138106; Korchev YE, 2000, NAT CELL BIOL, V2, P616, DOI 10.1038/35023563; Li JD, 2010, J BIOL CHEM, V285, P28723, DOI 10.1074/jbc.M110.147868; Link MS, 1999, CIRCULATION, V100, P413, DOI 10.1161/01.CIR.100.4.413; Liu XX, 2008, J MEMBRANE BIOL, V226, P17, DOI 10.1007/s00232-008-9135-3; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Naruse K, 2009, BIOCHEM BIOPH RES CO, V385, P634, DOI 10.1016/j.bbrc.2009.05.105; NICHOLS CG, 1990, J PHYSIOL-LONDON, V423, P91, DOI 10.1113/jphysiol.1990.sp018013; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Saavedra WF, 2002, BRIT J PHARMACOL, V135, P657, DOI 10.1038/sj.bjp.0704510; SACKIN H, 1989, P NATL ACAD SCI USA, V86, P1731, DOI 10.1073/pnas.86.5.1731; Saegusa N, 2005, CARDIOVASC RES, V67, P60, DOI 10.1016/j.cardiores.2005.03.011; Shi L, 2009, PHYSIOL RES, V58, P645, DOI 10.33549/physiolres.931594; SINGER JJ, 1987, PFLUG ARCH EUR J PHY, V408, P98, DOI 10.1007/BF00581337; Suchyna TM, 2007, J PHYSIOL-LONDON, V581, P369, DOI 10.1113/jphysiol.2006.125021; Sukharev S, 2002, BIOPHYS J, V83, P290, DOI 10.1016/S0006-3495(02)75169-2; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Terzic A, 1996, J PHYSIOL-LONDON, V492, P395, DOI 10.1113/jphysiol.1996.sp021316; VANWAGONER DR, 1993, CIRC RES, V72, P973, DOI 10.1161/01.RES.72.5.973; VANWAGONER DR, 1994, ANN NY ACAD SCI, V723, P392; Wang W, 2010, AM J PHYSIOL-GASTR L, V299, pG1231, DOI 10.1152/ajpgi.00268.2010; WEISS JN, 1992, J PHYSIOL-LONDON, V447, P649, DOI 10.1113/jphysiol.1992.sp019022; Yamada S, 2006, J PHYSIOL-LONDON, V577, P1053, DOI 10.1113/jphysiol.2006.119511	34	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63337	10.1371/journal.pone.0063337	http://dx.doi.org/10.1371/journal.pone.0063337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691027	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400054
J	Johnson, NR; Wang, YD				Johnson, Noah Ray; Wang, Yadong			Controlled Delivery of Sonic Hedgehog Morphogen and Its Potential for Cardiac Repair	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; FIBROBLAST GROWTH FACTOR-2; AMERICAN-HEART-ASSOCIATION; GENE-THERAPY; MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; SIGNALING PATHWAYS; BONE-MARROW; ANGIOGENESIS	The morphogen Sonic hedgehog (Shh) holds great promise for repair or regeneration of tissues suffering ischemic injury, however clinical translation is limited by its short half-life in the body. Here, we describe a coacervate delivery system which incorporates Shh, protects it from degradation, and sustains its release for at least 3 weeks. Shh released from the coacervate stimulates cardiac fibroblasts to upregulate the expression of multiple trophic factors including VEGF, SDF-1 alpha, IGF-1, and Shh itself, for at least 48 hours. Shh coacervate also demonstrates cytoprotective effects for cardiomyocytes in a hydrogen peroxide-induced oxidative stress environment. In each of these studies the bioactivity of the Shh coacervate is enhanced compared to free Shh. These results warrant further investigation of the in vivo efficacy of Shh coacervate for cardiac repair.	[Johnson, Noah Ray; Wang, Yadong] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Johnson, Noah Ray; Wang, Yadong] McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Wang, Yadong] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA; [Wang, Yadong] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, YD (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	yaw20@pitt.edu	Wang, Yadong/AAC-3381-2020	Wang, Yadong/0000-0003-2067-382X	National Science Foundation [DMR 1005766]; American Heart Association [12EIA9020016]	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association)	This work was supported by grants from the National Science Foundation (#DMR 1005766) and the American Heart Association (#12EIA9020016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RPH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008576; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Cencioni C, 2012, CARDIOVASC RES, V94, P400, DOI 10.1093/cvr/cvs132; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chang H, 2010, INT J BIOCHEM CELL B, V42, P1462, DOI 10.1016/j.biocel.2010.04.016; Chang SC, 2011, J BIOL CHEM, V286, P44391, DOI 10.1074/jbc.M111.285361; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Chu HH, 2013, BIOMATERIALS, V34, P1747, DOI 10.1016/j.biomaterials.2012.11.019; Chu HH, 2012, BIOTECHNOL PROGR, V28, P257, DOI 10.1002/btpr.728; Chu HH, 2011, P NATL ACAD SCI USA, V108, P13444, DOI 10.1073/pnas.1110121108; Chu HH, 2011, J CONTROL RELEASE, V150, P157, DOI 10.1016/j.jconrel.2010.11.025; Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453; Fu JR, 2006, ACTA PHARMACOL SIN, V27, P685, DOI 10.1111/j.1745-7254.2006.00335.x; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Houser SR, 2012, CIRC RES, V111, P131, DOI 10.1161/RES.0b013e3182582523; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang ZS, 2004, CARDIOVASC RES, V62, P154, DOI 10.1016/j.cardiores.2004.01.009; Johnson NR, 2013, J CONTROL RELEASE, V166, P124, DOI 10.1016/j.jconrel.2012.11.004; Kajstura J, 2001, DIABETES, V50, P1414, DOI 10.2337/diabetes.50.6.1414; Kicheva A, 2012, CURR OPIN GENET DEV, V22, P527, DOI 10.1016/j.gde.2012.08.004; Kucia M, 2004, CIRC RES, V95, P1191, DOI 10.1161/01.RES.0000150856.47324.5b; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Kusano KF, 2004, ARTERIOSCL THROM VAS, V24, P2102, DOI 10.1161/01.ATV.0000144813.44650.75; Lavine KJ, 2008, TRENDS GENET, V24, P33, DOI 10.1016/j.tig.2007.10.007; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Mark RJ, 1997, BRAIN RES, V756, P205, DOI 10.1016/S0006-8993(97)00196-0; Nakamura K, 2010, J SYN ORG CHEM JPN, V68, P1, DOI 10.5059/yukigoseikyokaishi.68.1; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Palladino M, 2011, MOL THER, V19, P658, DOI 10.1038/mt.2010.292; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Pola R, 2003, CIRCULATION, V108, P479, DOI 10.1161/01.CIR.0000080338.60981.FA; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Renault MA, 2010, J MOL CELL CARDIOL, V49, P490, DOI 10.1016/j.yjmcc.2010.05.003; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Roncalli J, 2011, J AM COLL CARDIOL, V57, P2444, DOI 10.1016/j.jacc.2010.11.069; Soleti R, 2012, FREE RADICAL BIO MED, V53, P2159, DOI 10.1016/j.freeradbiomed.2012.09.021; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Unzek S, 2007, CELL TRANSPLANT, V16, P879, DOI 10.3727/096368907783338271; Wang ZG, 2012, TOXICOL LETT, V212, P137, DOI 10.1016/j.toxlet.2012.05.006; Welch S, 2002, CIRC RES, V90, P641, DOI 10.1161/01.RES.0000013780.77774.75; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38	49	38	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63075	10.1371/journal.pone.0063075	http://dx.doi.org/10.1371/journal.pone.0063075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690982	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000319107400030
J	Rasigade, JP; Trouillet-Assant, S; Ferry, T; Diep, BA; Sapin, A; Lhoste, Y; Ranfaing, J; Badiou, C; Benito, Y; Bes, M; Couzon, F; Tigaud, S; Lina, G; Etienne, J; Vandenesch, F; Laurent, F				Rasigade, Jean-Philippe; Trouillet-Assant, Sophie; Ferry, Tristan; Diep, Binh An; Sapin, Anais; Lhoste, Yannick; Ranfaing, Jeremy; Badiou, Cedric; Benito, Yvonne; Bes, Michele; Couzon, Florence; Tigaud, Sylvestre; Lina, Gerard; Etienne, Jerome; Vandenesch, Francois; Laurent, Frederic			PSMs of Hypervirulent Staphylococcus aureus Act as Intracellular Toxins That Kill Infected Osteoblasts	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; VIRULENCE DETERMINANTS; CYTOLYTIC PEPTIDES; ALPHA-HEMOLYSIN; EXPRESSION; PROTEIN; OSTEOMYELITIS; EPIDEMIOLOGY; APOPTOSIS	Epidemic community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is associated with more severe and acute forms of osteomyelitis than healthcare-associated (HA-) MRSA. Although S. aureus is now recognized as a facultative intracellular pathogen, the contribution of osteoblast invasion by CA-MRSA to the pathogenesis of osteomyelitis is unknown. Using an ex vivo model of intracellular infection of human osteoblasts, we demonstrated that CA-MRSA strains of diverse lineages share an enhanced ability to kill infected osteoblasts compared to HA-MRSA. Cytotoxicity comparisons of CA-MRSA isogenic deletion mutants revealed that phenol-soluble modulins (PSMs), a class of membrane-damaging exoproteins that are expressed at higher levels in CA-MRSA than in HA-MRSA, are involved in this osteoblast killing, whereas other major CA-MRSA virulence determinants, the Panton-Valentine leukocidin and alpha-toxin, are not involved. Similarly, functional agr and sarA regulators, which control the expression of PSMs and alpha-toxin, were required for the expression of the intracellular cytotoxic phenotype by CA-MRSA, whereas the saeRS regulator, which controls the expression of alphatoxin but not PSMs, had no impact on cytotoxicity. Finally, PSM transcript levels determined by quantitative reverse-transcriptase PCR were significantly higher in CA-MRSA than in HA-MRSA strains and associated with cell damage in MRSA-infected osteoblasts. These findings provide new insights into the pathogenesis of severe CA-MRSA osteomyelitis and unravel a novel virulence strategy of CA-MRSA, based on the invasion and subsequent killing of osteoblasts by PSMs acting as intracellular toxins.	[Rasigade, Jean-Philippe; Trouillet-Assant, Sophie; Ferry, Tristan; Ranfaing, Jeremy; Badiou, Cedric; Couzon, Florence; Lina, Gerard; Etienne, Jerome; Vandenesch, Francois; Laurent, Frederic] Univ Lyon, INSERM U1111, Lyon, France; [Rasigade, Jean-Philippe; Benito, Yvonne; Bes, Michele; Lina, Gerard; Etienne, Jerome; Vandenesch, Francois; Laurent, Frederic] Hosp Civils Lyon, Natl Reference Ctr Staphylococci, Bron, France; [Rasigade, Jean-Philippe; Sapin, Anais; Lhoste, Yannick; Tigaud, Sylvestre; Laurent, Frederic] Hosp Civils Lyon, Northern Hosp Grp, Dept Clin Microbiol, Bron, France; [Diep, Binh An] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU Lyon; University of California System; University of California San Francisco	Rasigade, JP (corresponding author), Univ Lyon, INSERM U1111, Lyon, France.	jean-philippe.rasigade@chu-lyon.fr	Ferry, Tristan/M-5108-2014; Rasigade, Jean-Philippe/AAE-1667-2021; trouillet-assant, sophie/L-9400-2014; Laurent, Frederic/M-4719-2014; ETIENNE, Jerome/C-5471-2014; LAURENT, Frederic/AGM-0706-2022; Lina, Gerard J/L-9352-2014; Rasigade, Jean-Philippe/L-9320-2014; Vandenesch, Francois/C-7209-2014	ETIENNE, Jerome/0000-0002-3348-3315; Rasigade, Jean-Philippe/0000-0002-8264-0452; Vandenesch, Francois/0000-0001-9412-7106; laurent, frederic/0000-0003-0609-9091; Lina, Gerard/0000-0002-9236-7998; ferry, tristan/0000-0003-3082-7001	French Ministry of Health; French Ministry of Education; Institut National de la Sante et de la Recherche Medicale (Inserm)	French Ministry of Health; French Ministry of Education; Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the French Ministry of Health, the French Ministry of Education and the Institut National de la Sante et de la Recherche Medicale (Inserm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arnold SR, 2006, J PEDIATR ORTHOPED, V26, P703, DOI 10.1097/01.bpo.0000242431.91489.b4; Badiou C, 2008, CLIN MICROBIOL INFEC, V14, P1180, DOI 10.1111/j.1469-0691.2008.02105.x; Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Claro T, 2012, PLOS ONE, V6; Claro T, 2013, MICROBIOL-SGM, V159, P147, DOI 10.1099/mic.0.063016-0; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Dauwalder O, 2008, J CLIN MICROBIOL, V46, P3454, DOI 10.1128/JCM.01050-08; Daver NG, 2007, J INFECTION, V54, P539, DOI 10.1016/j.jinf.2006.11.011; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Dohin B, 2007, PEDIATR INFECT DIS J, V26, P1042, DOI 10.1097/INF.0b013e318133a85e; Ellington JK, 2006, J ORTHOP RES, V24, P87, DOI 10.1002/jor.20003; Ellington JK, 2003, J BONE JOINT SURG BR, V85B, P918, DOI 10.1302/0301-620X.85B6.13509; Fraunholz M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00043; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gerber JS, 2009, CLIN INFECT DIS, V49, P65, DOI 10.1086/599348; Giese B, 2011, CELL MICROBIOL, V13, P316, DOI 10.1111/j.1462-5822.2010.01538.x; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Gwynne-Jones DP, 1999, J PEDIATR ORTHOPED, V19, P413, DOI 10.1097/00004694-199905000-00025; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; Have KLV, 2009, J PEDIATR ORTHOPED, V29, P927, DOI 10.1097/BPO.0b013e3181bd1e0c; Jevon M, 1999, INFECT IMMUN, V67, P2677, DOI 10.1128/IAI.67.5.2677-2681.1999; JEVONS MP, 1963, LANCET, V1, P904; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Martinez-Aguilar G, 2004, PEDIATR INFECT DIS J, V23, P701, DOI 10.1097/01.inf.0000133044.79130.2a; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; NESIN M, 1990, ANTIMICROB AGENTS CH, V34, P2273, DOI 10.1128/AAC.34.11.2273; Nygaard TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036532; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Perret M, 2012, CELL MICROBIOL, V14, P1019, DOI 10.1111/j.1462-5822.2012.01772.x; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; Said-Salim B, 2005, J CLIN MICROBIOL, V43, P3373, DOI 10.1128/JCM.43.7.3373-3379.2005; SaraviaOtten P, 1997, J BACTERIOL, V179, P5259, DOI 10.1128/jb.179.17.5259-5263.1997; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; SJOSTROM JE, 1973, J BACTERIOL, V113, P576; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Trouillet S, 2011, J MICROBIOL METH, V86, P145, DOI 10.1016/j.mimet.2011.04.012; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Webb Lawrence X, 2007, J Surg Orthop Adv, V16, P73; Widaa A, 2011, PLOS ONE, V7; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	62	72	75	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63176	10.1371/journal.pone.0063176	http://dx.doi.org/10.1371/journal.pone.0063176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690994	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400035
J	Buque, A; Aresti, U; Calvo, B; Muhialdin, JS; Munoz, A; Carrera, S; Azkona, E; Rubio, I; Lopez-Vivanco, G				Buque, Aitziber; Aresti, Unai; Calvo, Begona; Muhialdin, Jangi Sh.; Munoz, Alberto; Carrera, Sergio; Azkona, Eider; Rubio, Itziar; Lopez-Vivanco, Guillermo			Thymidylate Synthase Expression Determines Pemetrexed Targets and Resistance Development in Tumour Cells	PLOS ONE			English	Article							SYNERGISTIC INTERACTION; MAMMALIAN TARGET; IN-VITRO; CANCER; CISPLATIN; GROWTH; AMPK; INHIBITION; RAPAMYCIN; PATHWAYS	Although treatment options for cancer patients are increasing every year, the drug resistance problem remains very present. It is very difficult to find a drug that acts equally on tumours of the same histology as the individual's genetic characteristics often determine the response to treatment. Furthermore, tumours that initially respond to anti-tumour therapy are able to adapt and develop resistance to the drug, while others do not. In addition, this usually implies resistance development to agents to which the cells have not been exposed, a phenomenon called cross-resistance or multidrug resistance. Given this situation, it has been suggested that the most appropriate treatment would be able to act in parallel on multiple pathways constitutively altered in tumour cells. Pemetrexed is a multitargeted antifolate that exerts its activity against folate-dependent enzymes involved in de novo pyrimidine and purine synthesis. It is currently in use in combination with cisplatin against malignant pleural mesothelioma and non-squamous non-small cell lung cancer with favourable results. By real-time RT-PCR gene expression assays and restoration viability assays we demonstrated that Pemetrexed targets folate-dependent enzymes involved in de novo biosynthesis of purines differently depending on the intrinsic genetic characteristics of the tumour. These differences did not, however, interfere either with the initial response to the drug or with the activation of apoptotic pathways. In addition, these genetic fingerprints can differentiate two groups of tumours: those capable of developing resistance to antifolate, and not capable. These results may be useful to employ targets gene expression as resistance markers, a valuable tool for identifying patients likely to receive combination therapy to prevent the development of resistance.	[Buque, Aitziber; Aresti, Unai; Calvo, Begona; Muhialdin, Jangi Sh.] Cruces Univ Hosp, Med Oncol Res Lab, Bizkaia, Spain; [Munoz, Alberto; Carrera, Sergio; Azkona, Eider; Rubio, Itziar; Lopez-Vivanco, Guillermo] Cruces Univ Hosp, Dept Med Oncol, Bizkaia, Spain	Hospital Universitario Cruces; Hospital Universitario Cruces	Buque, A (corresponding author), Cruces Univ Hosp, Med Oncol Res Lab, Bizkaia, Spain.	aitziber.buquemartinez@osakidetza.net	Lopez, Guillermo/F-3435-2012	, Aitziber/0000-0002-7698-8778				Adjei Alex A, 2004, Clin Lung Cancer, V5 Suppl 2, pS51; Beckers A, 2006, MOL CANCER THER, V5, P2211, DOI 10.1158/1535-7163.MCT-06-0001; Buque A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-25; Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571; Giovannetti E, 2005, MOL PHARMACOL, V68, P110, DOI 10.1124/mol.104.009373; Gonen N, 2012, DRUG RESIST UPDATE, V15, P183, DOI 10.1016/j.drup.2012.07.002; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hanauske AR, 2007, INVEST NEW DRUG, V25, P417, DOI 10.1007/s10637-007-9060-9; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Lasithiotakis KG, 2008, J INVEST DERMATOL, V128, P2013, DOI 10.1038/jid.2008.44; Meier F, 2007, BRIT J DERMATOL, V156, P1204, DOI 10.1111/j.1365-2133.2007.07821.x; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Nannizzi S, 2010, CANCER CHEMOTH PHARM, V66, P547, DOI 10.1007/s00280-009-1195-2; Ozasa H, 2010, CANCER SCI, V101, P161, DOI 10.1111/j.1349-7006.2009.01358.x; Persidis A, 2000, NAT BIOTECHNOL, V18, pIT18; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Racanelli AC, 2009, CANCER RES, V69, P5467, DOI 10.1158/0008-5472.CAN-08-4979; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Rothbart SB, 2010, CANCER RES, V70, P10299, DOI 10.1158/0008-5472.CAN-10-1873; Sen T, 2011, CANCER RES, V71, P1167, DOI 10.1158/0008-5472.CAN-10-1481; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Tekle C, 2008, BRIT J CANCER, V99, P750, DOI 10.1038/sj.bjc.6604566; Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425	24	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63338	10.1371/journal.pone.0063338	http://dx.doi.org/10.1371/journal.pone.0063338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675481	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100040
J	Martorell, P; Bataller, E; Llopis, S; Gonzalez, N; Alvarez, B; Monton, F; Ortiz, P; Ramon, D; Genoves, S				Martorell, Patricia; Bataller, Esther; Llopis, Silvia; Gonzalez, Nuria; Alvarez, Beatriz; Monton, Fernando; Ortiz, Pepa; Ramon, Daniel; Genoves, Salvador			A Cocoa Peptide Protects Caenorhabditis elegans from Oxidative Stress and beta-Amyloid Peptide Toxicity	PLOS ONE			English	Article							THEOBROMA-CACAO L.; ALZHEIMERS-DISEASE; ANTIOXIDATIVE PEPTIDES; MODEL; GENE; ENDOPEPTIDASE; EXPRESSION; CHOCOLATE; EXTRACT; FOOD	Background: Cocoa and cocoa-based products contain different compounds with beneficial properties for human health. Polyphenols are the most frequently studied, and display antioxidant properties. Moreover, protein content is a very interesting source of antioxidant bioactive peptides, which can be used therapeutically for the prevention of age-related diseases. Methodology/Principal Findings: A bioactive peptide, 13L (DNYDNSAGKWWVT), was obtained from a hydrolyzed cocoa by-product by chromatography. The in vitro inhibition of prolyl endopeptidase (PEP) was used as screening method to select the suitable fraction for peptide identification. Functional analysis of 13L peptide was achieved using the transgenic Caenorhabditis elegans strain CL4176 expressing the human A beta(1-42) peptide as a pre-clinical in vivo model for Alzheimer's disease. Among the peptides isolated, peptide 13L (1 mg/mL) showed the highest antioxidant activity (P <= 0.001) in the wildtype strain (N2). Furthermore, 13L produced a significant delay in body paralysis in strain CL4176, especially in the 24-47 h period after A beta(1-42) peptide induction (P <= 0.0001). This observation is in accordance with the reduction of A beta deposits in CL4176 by western blot. Finally, transcriptomic analysis in wild-type nematodes treated with 13L revealed modulation of the proteosomal and synaptic functions as the main metabolic targets of the peptide. Conclusions/Significance: These findings suggest that the cocoa 13L peptide has antioxidant activity and may reduce A beta deposition in a C. elegans model of Alzheimer's disease; and therefore has a putative therapeutic potential for prevention of age-related diseases. Further studies in murine models and humans will be essential to analyze the effectiveness of the 13L peptide in higher animals.	[Martorell, Patricia; Bataller, Esther; Llopis, Silvia; Gonzalez, Nuria; Monton, Fernando; Ortiz, Pepa; Ramon, Daniel; Genoves, Salvador] Biopolis SL, Cell Biol Lab, Dept Food Biotechnol, Valencia, Spain; [Alvarez, Beatriz] Biopolis SL, Mol Biol Lab, Microbial Biotechnol Dept, Valencia, Spain		Genoves, S (corresponding author), Biopolis SL, Cell Biol Lab, Dept Food Biotechnol, Valencia, Spain.	salvador.genoves@biopolis.es	Martorell, Patricia/ABC-8717-2021; Bataller, Esther/Z-4687-2019	Bataller, Esther/0000-0003-3903-2918; Martorell, Patricia/0000-0001-5689-8399	Biopolis SL. from the Spanish Ministry of Science and Innovation; Biopolis SL	Biopolis SL. from the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Biopolis SL	This work was funded by Biopolis SL. within the framework of the e-CENIT Project SENIFOOD from the Spanish Ministry of Science and Innovation(http://www.cdti.es). The funders played a role as all authors are employees of Biopolis SL.; All authors are employees of the commercial funder of this research, Biopolis SL. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Arya U, 2009, EXP GERONTOL, V44, P462, DOI 10.1016/j.exger.2009.02.010; Barelli H, 1999, BIOCHEM BIOPH RES CO, V257, P657, DOI 10.1006/bbrc.1999.0366; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Calahorro F, 2011, INVERTEBR NEUROSCI, V11, P73, DOI 10.1007/s10158-011-0126-1; Checler F, 2000, BBA-MOL BASIS DIS, V1502, P133, DOI 10.1016/S0925-4439(00)00039-9; Chou JL, 2011, J PROTEOMICS, V74, P466, DOI 10.1016/j.jprot.2010.12.012; Dillinger TL, 2000, J NUTR, V130, p2057S, DOI 10.1093/jn/130.8.2057S; Dostal V, 2010, GENETICS, V186, P857, DOI 10.1534/genetics.110.120436; Ewald CY, 2010, BRAIN STRUCT FUNCT, V214, P263, DOI 10.1007/s00429-009-0235-3; Galleano M, 2009, J CARDIOVASC PHARM, V54, P483, DOI 10.1097/FJC.0b013e3181b76787; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gutierrez-Zepeda A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-54; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hare EE, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-24; Hassan WM, 2009, HUM MOL GENET, V18, P2739, DOI 10.1093/hmg/ddp209; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Imahori K, 2010, P JPN ACAD B-PHYS, V86, P54, DOI 10.2183/pjab.86.54; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Katz DL, 2011, ANTIOXID REDOX SIGN, V15, P2779, DOI 10.1089/ars.2010.3697; Kim SK, 2001, J AGR FOOD CHEM, V49, P1984, DOI 10.1021/jf000494j; Klompong V, 2009, J FOOD SCI, V74, pC126, DOI 10.1111/j.1750-3841.2009.01047.x; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Luo Y, 2006, LIFE SCI, V78, P2066, DOI 10.1016/j.lfs.2005.12.004; Martorell P, 2012, J AGR FOOD CHEM, V60, P11071, DOI 10.1021/jf3031138; Martorell P, 2011, J AGR FOOD CHEM, V59, P2077, DOI 10.1021/jf104217g; Montaner D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010348; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morales R, 2011, MOL PSYCHIATR, DOI [10.1038/mp.2011.120, DOI 10.1038/MP.2011.120.[]; Nehlig A, 2012, BR J CLIN PHARM, V10, DOI [10.1111/j.1365-2125.2012.04378.x, DOI 10.1111/J.1365-2125.2012.04378.X.[]; Oxenkrug GF, 2010, ANN NY ACAD SCI, V1199, P1, DOI 10.1111/j.1749-6632.2009.05356.x; Phelps ME, 2010, P NATL ACAD SCI USA, V107, P17459, DOI 10.1073/pnas.1012684107; Preza AM, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-61; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Rusconi M, 2010, PHARMACOL RES, V61, P5, DOI 10.1016/j.phrs.2009.08.008; Sarmadi BH, 2010, PEPTIDES, V31, P1949, DOI 10.1016/j.peptides.2010.06.020; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Summa C, 2008, MOL NUTR FOOD RES, V52, P342, DOI 10.1002/mnfr.200700403; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Teschendorf D, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-38; Verri M, 2012, INT J IMMUNOPATH PH, V25, P345, DOI 10.1177/039463201202500204; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; YOSHIMOTO T, 1987, J PHARMACOBIO-DYNAM, V10, P730, DOI 10.1248/bpb1978.10.730; YOSHIMOTO T, 1980, J BIOL CHEM, V255, P4786	53	53	59	2	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63283	10.1371/journal.pone.0063283	http://dx.doi.org/10.1371/journal.pone.0063283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675471	Green Submitted, Green Published, gold			2022-12-25	WOS:000319036100034
J	Beck, A; Speicher, T; Stoerger, C; Sell, T; Dettmer, V; Jusoh, SA; Abdulmughni, A; Cavalie, A; Philipp, SE; Zhu, MX; Helms, V; Wissenbach, U; Flockerzi, V				Beck, Andreas; Speicher, Tilman; Stoerger, Christof; Sell, Thomas; Dettmer, Viviane; Jusoh, Siti A.; Abdulmughni, Ammar; Cavalie, Adolfo; Philipp, Stephan E.; Zhu, Michael X.; Helms, Volkhard; Wissenbach, Ulrich; Flockerzi, Veit			Conserved Gating Elements in TRPC4 and TRPC5 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OF-FUNCTION MUTATIONS; S4-S5 LINKER; TRPV3; PREDICTION; KV1.2; GENE	TRPC4 and TRPC5 proteins share 65% amino acid sequence identity and form Ca2+ -permeable nonselective cation channels. They are activated by stimulation of receptors coupled to the phosphoinositide signaling cascade. Replacing a conserved glycine residue within the cytosolic S4-S5 linker of both proteins by a serine residue forces the channels into an open conformation. Expression of the TRPC4(G503S) and TRPC5(G504S) mutants causes cell death, which could be prevented by buffering the Ca2+ of the culture medium. Current- voltage relationships of the TRPC4G(503S) and TRPC5(G504S) mutant ion channels resemble that of fully activated TRPC4 and TRPC5 wild- type channels, respectively. Modeling the structure of the transmembrane domains and the pore region (S4-S6) of TRPC4 predicts a conserved serine residue within the C- terminal sequence of the predicted S6 helix as a potential interaction site. Introduction of a second mutation (S623A) into TRPC4(G503S) suppressed the constitutive activation and partially rescued its function. These results indicate that the S4-S5 linker is a critical constituent of TRPC4/C5 channel gating and that disturbance of its sequence allows channel opening independent of any sensor domain.	[Cavalie, Adolfo; Philipp, Stephan E.] Univ Saarland, D-66421 Homburg, Germany; [Jusoh, Siti A.; Abdulmughni, Ammar; Helms, Volkhard] Univ Saarland, Zentrum Bioinformat, D-66123 Saarbrucken, Germany; [Jusoh, Siti A.] Univ Teknol MARA, Fac Pharm, Bandar Puncak Alam 42300, Malaysia; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Saarland University; Saarland University; University of Texas System; University of Texas Health Science Center Houston		andreas.beck@uniklinikum-saarland.de	Jusoh, Siti Azma/A-3646-2010; Philipp, Stephan/AAR-7519-2020	Jusoh, Siti Azma/0000-0002-9028-5681; Helms, Volkhard/0000-0002-2180-9154; Philipp, Stephan/0000-0003-1959-9167; Sell, Thomas/0000-0002-5138-3967; Abdulmughni, Ammar/0000-0002-5837-5943	Deutsche Forschungsgemeinschaft [SFB894]; Homburg Forschungsforderungsprogramm HOMFOR; Forschungskommission der Universitat des Saarlandes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Homburg Forschungsforderungsprogramm HOMFOR; Forschungskommission der Universitat des Saarlandes	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB894 (to A. B., S. E. P., and V. F.), the Homburg Forschungsforderungsprogramm HOMFOR (to A. B., C. S., and S. E. P.), and the Forschungskommission der Universitat des Saarlandes (to A. B., S. E. P., U. W., and V. F.).	Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Gross SA, 2009, J BIOL CHEM, V284, P34423, DOI 10.1074/jbc.M109.018192; Hong YS, 2002, J BIOL CHEM, V277, P33884, DOI 10.1074/jbc.M204075200; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kalia J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01523; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Lai-Cheong JE, 2012, BRIT J DERMATOL, V167, P440, DOI 10.1111/j.1365-2133.2012.11115.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li MH, 2011, ADV EXP MED BIOL, V704, P1, DOI 10.1007/978-94-007-0265-3_1; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; McKay RR, 2000, BIOCHEM J, V351, P735, DOI 10.1042/0264-6021:3510735; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; Myers BR, 2008, J GEN PHYSIOL, V132, P481, DOI 10.1085/jgp.200810104; Obukhov AG, 2005, J NEUROSCI, V25, P1234, DOI 10.1523/JNEUROSCI.4451-04.2005; Obukhov AG, 2008, J CELL PHYSIOL, V216, P162, DOI 10.1002/jcp.21388; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; Su ZW, 2007, P NATL ACAD SCI USA, V104, P19607, DOI 10.1073/pnas.0708584104; Tsvilovskyy VV, 2009, GASTROENTEROLOGY, V137, P1415, DOI 10.1053/j.gastro.2009.06.046; Verma P, 2010, CHANNELS, V4, P319, DOI 10.4161/chan.4.4.12905; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xiao R, 2008, CELL CALCIUM, V43, P334, DOI 10.1016/j.ceca.2007.06.004; Zimmermann K, 2011, P NATL ACAD SCI USA, V108, P18114, DOI 10.1073/pnas.1115387108	40	37	37	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19471	19483		10.1074/jbc.M113.478305	http://dx.doi.org/10.1074/jbc.M113.478305			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23677990	hybrid, Green Published			2022-12-25	WOS:000321515800015
J	Jiang, LL; Che, MX; Zhao, J; Zhou, CJ; Xie, MY; Li, HY; He, JH; Hu, HY				Jiang, Lei-Lei; Che, Mei-Xia; Zhao, Jian; Zhou, Chen-Jie; Xie, Mu-Yun; Li, Hai-Yin; He, Jian-Hua; Hu, Hong-Yu			Structural Transformation of the Amyloidogenic Core Region of TDP-43 Protein Initiates Its Aggregation and Cytoplasmic Inclusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS A-BETA-42 PEPTIDE; HUMAN ALPHA-SYNUCLEIN; FIBRIL FORMATION; SPLICING REGULATION; TERMINAL FRAGMENTS; RNA DEPLETION; HUMAN-DISEASE; MUTATIONS	TDP-43 (TAR DNA-binding protein of 43 kDa) is a major deposited protein in amyotrophic lateral sclerosis and frontotemporal dementia with ubiquitin. A great number of genetic mutations identified in the flexible C-terminal region are associated with disease pathologies. We investigated the molecular determinants of TDP-43 aggregation and its underlying mechanisms. We identified a hydrophobic patch (residues 318-343) as the amyloidogenic core essential for TDP-43 aggregation. Biophysical studies demonstrated that the homologous peptide formed a helix-turn-helix structure in solution, whereas it underwent structural transformation from an alpha-helix to a beta-sheet during aggregation. Mutation or deletion of this core region significantly reduced the aggregation and cytoplasmic inclusions of full-length TDP-43 (or TDP-35 fragment) in cells. Thus, structural transformation of the amyloidogenic core initiates the aggregation and cytoplasmic inclusion formation of TDP-43. This particular core region provides a potential therapeutic target to design small-molecule compounds for mitigating TDP-43 proteinopathies.	[Jiang, Lei-Lei; Che, Mei-Xia; Zhao, Jian; Zhou, Chen-Jie; Li, Hai-Yin; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Xie, Mu-Yun; He, Jian-Hua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201204, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	hyhu@sibcb.ac.cn	Che, Meixia/Q-2119-2019; Hu, Hong-Yu/AAQ-2633-2020	Che, Meixia/0000-0002-4515-1414; 	National Basic Research Program of China [2012CB911003, 2011CB911104]; National Natural Science Foundation of China [31270773, 10979070]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2012CB911003 and 2011CB911104 and National Natural Science Foundation of China Grants 31270773 and 10979070.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Barmada SJ, 2010, REV NEUROSCIENCE, V21, P251; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Borroni B, 2009, HUM MUTAT, V30, pE974, DOI 10.1002/humu.21100; Budini M, 2012, J BIOL CHEM, V287, P7512, DOI 10.1074/jbc.M111.288720; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gsponer J, 2012, CELL REP, V2, P1425, DOI 10.1016/j.celrep.2012.09.036; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hu HY, 2001, BIOPOLYMERS, V62, P15, DOI 10.1002/1097-0282(2001)62:1<15::AID-BIP30>3.0.CO;2-J; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Kroth H, 2012, J BIOL CHEM, V287, P34786, DOI 10.1074/jbc.M112.357665; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Li HT, 2002, BIOPOLYMERS, V64, P221, DOI 10.1002/bip.10179; Neary D, 2000, J NEUROL SCI, V180, P15, DOI 10.1016/S0022-510X(00)00425-1; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wurth C, 2002, J MOL BIOL, V319, P1279, DOI 10.1016/S0022-2836(02)00399-6; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang T, 2012, J BIOL CHEM, V287, P8371, DOI 10.1074/jbc.M111.311977; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	46	89	91	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19614	19624		10.1074/jbc.M113.463828	http://dx.doi.org/10.1074/jbc.M113.463828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689371	Green Published, hybrid			2022-12-25	WOS:000321515800027
J	Pearson, EL; Moore, CL				Pearson, Erika L.; Moore, Claire L.			Dismantling Promoter-driven RNA Polymerase II Transcription Complexes in Vitro by the Termination Factor Rat1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; ELONGATION COMPLEX; EXONUCLEASE XRN2; BUDDING YEAST; NASCENT RNA; GENE; SITE; INITIATION; PROTEIN	Proper RNA polymerase II (Pol II) transcription termination is essential to generate stable transcripts, to prevent interference at downstream loci, and to recycle Pol II back to the promoter (1-3). As such, termination is an intricately controlled process that is tightly regulated by a variety of different cis- and trans-acting factors (4, 5). Although many eukaryotic termination factors have been identified to date, the details of the precise molecular mechanisms governing termination remain to be elucidated. We devised an in vitro transcription system to study specific Pol II termination. We show for the first time that the exonucleolytic Rat1.Rai1 complex can elicit the release of stalled Pol II in vitro and can do so in the absence of other factors. We also find that Rtt103, which interacts with the Pol II C-terminal domain (CTD) and with Rat1, can rescue termination activity of an exonucleolytically deficient Rat1 mutant. In light of our findings, we posit a model whereby functional nucleolytic activity is not the feature of Rat1 that ultimately promotes termination. Degradation of the nascent transcript allows Rat1 to pursue Pol II in a guided fashion and arrive at the site of RNA exit from Pol II. Upon this arrival, however, it is perhaps the specific and direct contact between Rat1 and Pol II that transmits the signal to terminate transcription.	[Pearson, Erika L.; Moore, Claire L.] Tufts Univ, Dept Mol Biol & Microbiol, Sch Med, Boston, MA 02111 USA	Tufts University	Moore, CL (corresponding author), Tufts Univ, Dept Mol Biol & Microbiol, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	claire.moore@tufts.edu			National Institutes of Health [GM68887]; National Science Foundation [MCB-1244043]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068887] Funding Source: NIH RePORTER; Direct For Biological Sciences [1244043] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health Grant GM68887 and National Science Foundation Grant MCB-1244043 (to C. L. M.).	AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; Dengl S, 2009, J BIOL CHEM, V284, P21270, DOI 10.1074/jbc.M109.013847; Domecq C, 2010, PROTEIN EXPRES PURIF, V69, P83, DOI 10.1016/j.pep.2009.06.016; Epshtein V, 2010, NATURE, V463, P245, DOI 10.1038/nature08669; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Gu WG, 1996, P NATL ACAD SCI USA, V93, P6935, DOI 10.1073/pnas.93.14.6935; Hammell CM, 2002, MOL CELL BIOL, V22, P6441, DOI 10.1128/MCB.22.18.6441-6457.2002; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Hogan BP, 2002, J BIOL CHEM, V277, P967, DOI 10.1074/jbc.M108737200; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Jimeno-Gonzalez S, 2010, MOL CELL, V37, P580, DOI 10.1016/j.molcel.2010.01.019; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; KENNA M, 1993, MOL CELL BIOL, V13, P341, DOI 10.1128/MCB.13.1.341; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; LUE NF, 1989, SCIENCE, V246, P661, DOI 10.1126/science.2510298; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Mukundan B, 2011, J BIOL CHEM, V286, P37053, DOI 10.1074/jbc.C111.295915; PLATT T, 1994, MOL MICROBIOL, V11, P983, DOI 10.1111/j.1365-2958.1994.tb00376.x; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Sikorski TW, 2012, J BIOL CHEM, V287, P35397, DOI 10.1074/jbc.M112.391581; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; SNYDER M, 1988, MOL CELL BIOL, V8, P2184, DOI 10.1128/MCB.8.5.2184; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TANAKA S, 1994, NUCLEIC ACIDS RES, V22, P3904, DOI 10.1093/nar/22.19.3904; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; WOONTNER M, 1990, J BIOL CHEM, V265, P8979; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Zhang ZQ, 2005, GENE DEV, V19, P1572, DOI 10.1101/gad.1296305	41	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19750	19759		10.1074/jbc.M112.434985	http://dx.doi.org/10.1074/jbc.M112.434985			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689372	Green Published, hybrid			2022-12-25	WOS:000321515800044
J	Korsholm, KS; Karlsson, I; Tang, ST; Brandt, L; Agger, EM; Aagaard, C; Andersen, P; Fomsgaard, A				Korsholm, Karen S.; Karlsson, Ingrid; Tang, Sheila T.; Brandt, Lea; Agger, Else Marie; Aagaard, Claus; Andersen, Peter; Fomsgaard, Anders			Broadening of the T-Cell Repertoire to HIV-1 Gag p24 by Vaccination of HLA-A2/DR Transgenic Mice with Overlapping Peptides in the CAF05 Adjuvant	PLOS ONE			English	Article							LYMPHOCYTE RESPONSES; IMMUNE-RESPONSE; ESAT-6 ANTIGEN; CORD FACTOR; EPITOPES; INFECTION; IMMUNODOMINANCE; IMMUNIZATION; INDUCTION; AIDS	Induction of broad T-cell immune responses is regarded as critical for vaccines against the human immunodeficiency virus type 1 (HIV-1) which exhibit high diversity and, therefore, focus has been on inducing cytotoxic CD8 T-cell responses against the more conserved parts of the virus, such as the Gag protein. Herein, we have used the p24 protein which contains a range of conserved T-cell epitopes. We demonstrate that a vaccine of HIV-1 subtype B consensus group-specific antigen (Gag) p24 protein with the CD8-inducing liposomal cationic adjuvant formulation (CAF) 05, induces both CD4 and CD8 T-cell responses in CB6F1 mice. The adjuvanted vaccine also induced functional antigen-specific cytotoxicity in vivo. Furthermore, we found that when fragmenting the Gag p24 protein into overlapping Gag p24 peptides, a broader T-cell epitope specificity was induced in the humanized human leukocyte antigen (HLA)-A2/DR-transgenic mouse model. Thus, combining overlapping Gag p24 peptides with CAF05 appears to be a promising and simple strategy for inducing broader T-cell responses to multiple conserved epitopes which will be relevant for both prophylactic and therapeutic HIV-1 vaccines.	[Korsholm, Karen S.; Agger, Else Marie; Aagaard, Claus; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Karlsson, Ingrid; Tang, Sheila T.; Brandt, Lea; Fomsgaard, Anders] Statens Serum Inst, Dept Virol, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Statens Serum Institut	Korsholm, KS (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	kkn@ssi.dk; afo@ssi.dk		Andersen, Peter/0000-0002-5869-2551; Fomsgaard, Anders/0000-0003-4304-0603	Danish National Advanced Technology Foundation	Danish National Advanced Technology Foundation	This work has been supported by the Danish National Advanced Technology Foundation (EpiExpose project) who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard CS, 2009, J IMMUNOL, V183, P2659, DOI 10.4049/jimmunol.0900947; Amara RR, 2002, J VIROL, V76, P6138, DOI 10.1128/JVI.76.12.6138-6146.2002; [Anonymous], 2012, LOS ALAMOS HIV MOL I; Barouch DH, 2001, J VIROL, V75, P2462, DOI 10.1128/JVI.75.5.2462-2467.2001; Benlahrech A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048038; Brander C, 1999, J VIROL, V73, P10191, DOI 10.1128/JVI.73.12.10191-10198.1999; Brandt L, 1996, J IMMUNOL, V157, P3527; Chea S, 2005, J VIROL, V79, P3748, DOI 10.1128/JVI.79.6.3748-3757.2005; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Daucher M, 2008, J VIROL, V82, P4102, DOI 10.1128/JVI.02212-07; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; De Rose R, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000055; Fomsgaard A, 2011, VACCINE, V29, P7067, DOI 10.1016/j.vaccine.2011.07.025; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Fujimoto C, 2004, INT IMMUNOL, V16, P55, DOI 10.1093/intimm/dxh025; Garcia F, 2011, VACCINE, V29, P6454, DOI 10.1016/j.vaccine.2011.07.043; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Hansen J, 2012, CANCER IMMUNOL IMMUN, V61, P893, DOI 10.1007/s00262-011-1156-6; Harcourt GC, 1998, J EXP MED, V188, P1785, DOI 10.1084/jem.188.10.1785; Holten-Andersen L, 2004, INFECT IMMUN, V72, P1608, DOI 10.1128/IAI.72.3.1608-1617.2004; Hudson CP, 2009, LANCET, V373, P805, DOI 10.1016/S0140-6736(09)60471-2; Karlsson I, 2012, AIDS RES HUM RETROV, V28, P1434, DOI [10.1089/aid.2012.0081, 10.1089/AID.2012.0081]; Karlsson I, 2013, CLIN IMMUNOL, V146, P120, DOI 10.1016/j.clim.2012.12.005; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kloverpris H, 2009, AIDS, V23, P1329, DOI 10.1097/QAD.0b013e32832d9b00; Kloverpris HN, 2009, APMIS, V117, P849, DOI 10.1111/j.1600-0463.2009.02544.x; Koeppe JR, 2006, JAIDS-J ACQ IMM DEF, V41, P140, DOI 10.1097/01.qai.0000195608.32885.38; KOHLER H, 1992, J ACQ IMMUN DEF SYND, V5, P1158; Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5; Lazaro E, 2005, AIDS RES HUM RETROV, V21, P586, DOI 10.1089/aid.2005.21.586; Liu Y, 2011, VACCINE, V29, P2582, DOI 10.1016/j.vaccine.2011.01.049; Malhotra U, 2001, J CLIN INVEST, V107, P505, DOI 10.1172/JCI11275; Mason RD, 2009, J VIROL, V83, P1501, DOI 10.1128/JVI.02119-08; Moodie Z, 2010, CANCER IMMUNOL IMMUN, V59, P1489, DOI 10.1007/s00262-010-0875-4; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; Nordly P, 2011, J CONTROL RELEASE, V150, P307, DOI 10.1016/j.jconrel.2010.11.021; Pajot A, 2004, EUR J IMMUNOL, V34, P3060, DOI 10.1002/eji.200425463; Palmowski MJ, 2002, J IMMUNOL, V168, P4391, DOI 10.4049/jimmunol.168.9.4391; Payne RP, 2010, J VIROL, V84, P10543, DOI 10.1128/JVI.00793-10; Pettersen FO, 2010, CLIN EXP IMMUNOL, V161, P315, DOI 10.1111/j.1365-2249.2010.04179.x; Pion S, 1999, BLOOD, V93, P952, DOI 10.1182/blood.V93.3.952.403k33_952_962; POWELL MF, 1992, J PHARM SCI, V81, P731, DOI 10.1002/jps.2600810802; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; Richmond M, 2011, J VIROL, V85, P1275, DOI 10.1128/JVI.01707-10; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Roy-Proulx G, 2001, EUR J IMMUNOL, V31, P2284, DOI 10.1002/1521-4141(200108)31:8<2284::AID-IMMU2284>3.0.CO;2-E; Rugg D, 2009, JAIDS-J ACQ IMM DEF, V52, pS69, DOI 10.1097/QAI.0b013e3181baec7c; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Stratov I, 2005, J VIROL, V79, P7728, DOI 10.1128/JVI.79.12.7728-7737.2005; Vanham G, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-72; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Wilson CC, 2001, J VIROL, V75, P4195, DOI 10.1128/JVI.75.9.4195-4207.2001; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zaks K, 2006, J IMMUNOL, V176, P7335, DOI 10.4049/jimmunol.176.12.7335	57	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63575	10.1371/journal.pone.0063575	http://dx.doi.org/10.1371/journal.pone.0063575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691069	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900049
J	Plasterer, HL; Deutsch, EC; Belmonte, M; Egan, E; Lynch, DR; Rusche, JR				Plasterer, Heather L.; Deutsch, Eric C.; Belmonte, Matthew; Egan, Elizabeth; Lynch, David R.; Rusche, James R.			Development of Frataxin Gene Expression Measures for the Evaluation of Experimental Treatments in Friedreich's Ataxia	PLOS ONE			English	Article							PROTEIN; MOUSE; ERYTHROPOIETIN; IMMUNOASSAY; FEATURES; TRIAL	Background: Friedreich ataxia is a progressive neurodegenerative disorder caused by GAA triplet repeat expansions or point mutations in the FXN gene and, ultimately, a deficiency in the levels of functional frataxin protein. Heterozygous carriers of the expansion express approximately 50% of normal frataxin levels yet manifest no clinical symptoms, suggesting that therapeutic approaches that increase frataxin may be effective even if frataxin is raised only to carrier levels. Small molecule HDAC inhibitor compounds increase frataxin mRNA and protein levels, and have beneficial effects in animal models of FRDA. Methodology/Principal Findings: To gather data supporting the use of frataxin as a therapeutic biomarker of drug response we characterized the intra-individual stability of frataxin over time, determined the contribution of frataxin from different components of blood, compared frataxin measures in different cell compartments, and demonstrated that frataxin increases are achieved in peripheral blood mononuclear cells. Frataxin mRNA and protein levels were stable with repeated sampling over four and 15 weeks. In the 15-week study, the average CV was 15.6% for protein and 18% for mRNA. Highest levels of frataxin in blood were in erythrocytes. As erythrocytes are not useful for frataxin assessment in many clinical trial situations, we confirmed that PBMCs and buccal swabs have frataxin levels equivalent to those of whole blood. In addition, a dose-dependent increase in frataxin was observed when PBMCs isolated from patient blood were treated with HDACi. Finally, higher frataxin levels predicted less severe neurological dysfunction and were associated with slower rates of neurological change. Conclusions/Significance: Our data support the use of frataxin as a biomarker of drug effect. Frataxin levels are stable over time and as such a 1.5 to 2-fold change would be detectable over normal biological fluctuations. Additionally, our data support buccal cells or PBMCs as sources for measuring frataxin protein in therapeutic trials.	[Plasterer, Heather L.; Belmonte, Matthew; Egan, Elizabeth; Rusche, James R.] Repligen Corp, Waltham, MA USA; [Deutsch, Eric C.; Lynch, David R.] Univ Penn, Perelman Sch Med, Dept Neurol & Pediat, Philadelphia, PA 19104 USA; [Deutsch, Eric C.; Lynch, David R.] Univ Penn, Childrens Hosp Philadelphia, Div Neurol & Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Lynch, DR (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurol & Pediat, Philadelphia, PA 19104 USA.	lynchd@mail.med.upenn.edu; jrusche@repligen.com			Muscular Dystrophy Association (MDA); Friedreich's Ataxia Research Alliance (FARA); Penwest Pharmaceutical; GoFAR	Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Friedreich's Ataxia Research Alliance (FARA); Penwest Pharmaceutical(Johnson & Johnson); GoFAR	This work was supported by grants from Muscular Dystrophy Association (MDA), from Friedreich's Ataxia Research Alliance (FARA), and from Penwest Pharmaceutical to DRL; from FARA and GoFAR to Repligen Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A representative of FARA and of GoFAR assisted in the collection of blood samples used in the study.	Boesch S, 2008, MOVEMENT DISORD, V23, P1940, DOI 10.1002/mds.22294; Boesch S, 2007, ANN NEUROL, V62, P521, DOI 10.1002/ana.21177; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; Delatycki MB, 2000, J MED GENET, V37, P1, DOI 10.1136/jmg.37.1.1; Deutsch EC, 2010, MOL GENET METAB, V101, P238, DOI 10.1016/j.ymgme.2010.07.001; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Filla A, 1996, AM J HUM GENET, V59, P554; Friedman LS, 2010, MOVEMENT DISORD, V25, P426, DOI 10.1002/mds.22912; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Jiralerspong S, 1997, NEUROBIOL DIS, V4, P103, DOI 10.1006/nbdi.1997.0139; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Lynch DR, 2012, MOVEMENT DISORD, V27, P1026, DOI 10.1002/mds.25058; Lynch DR, 2006, NEUROLOGY, V66, P1711, DOI 10.1212/01.wnl.0000218155.46739.90; Mariotti C, 2012, MOVEMENT DISORD, V27, P446, DOI 10.1002/mds.24066; Nachbauer W, 2011, CEREBELLUM, V10, P763, DOI 10.1007/s12311-011-0287-9; Nachbauer W, 2011, MOVEMENT DISORD, V26, P1935, DOI 10.1002/mds.23789; Pandolfo M, 1999, SEMIN NEUROL, V19, P311, DOI 10.1055/s-2008-1040847; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Sacca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017627; Sacca F, 2011, MOVEMENT DISORD, V26, P739, DOI 10.1002/mds.23435; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Selak MA, 2011, MITOCHONDRION, V11, P342, DOI 10.1016/j.mito.2010.12.003; Steinkellner H, 2010, ANAL CHIM ACTA, V659, P129, DOI 10.1016/j.aca.2009.11.036; Willis JH, 2008, MOL GENET METAB, V94, P491, DOI 10.1016/j.ymgme.2008.03.019; Wilson Robert B, 2006, Semin Pediatr Neurol, V13, P166, DOI 10.1016/j.spen.2006.08.005	32	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63958	10.1371/journal.pone.0063958	http://dx.doi.org/10.1371/journal.pone.0063958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691127	gold, Green Published			2022-12-25	WOS:000319107900070
J	Xiong, EH; Wu, XL; Shi, J; Wang, XY; Wang, W				Xiong, Erhui; Wu, Xiaolin; Shi, Jiang; Wang, Xiaoyan; Wang, Wei			Proteomic Identification of Differentially Expressed Proteins between Male and Female Plants in Pistacia chinensis	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; RESPONSES; LEAF; ARABIDOPSIS; EXTRACTION; ALLOCATION; DROUGHT; BIOMASS; STRESS; GROWTH	Pistacia chinensis is a strict dioecious plant with male and female flowers in individuals. In China, P. chinensis is widely planted for biodiesel oil due to high oil content in seeds. In practice it requires to grow more female plants for biodiesel production. At present, there are still no reliable methods for sex determination during the long juvenile stage of this species. In order to develop protein molecular markers for sex determination in P. chinensis, proteomic approach was used to identify differentially expressed proteins between male and female plants. Vegetative organs (leaf and stem) rather than reproductive organs/tissues were used for protein extraction so as to develop protein markers which can be used in siblings before flowering. Protein was extracted using a phenol-based protocol. By using two-dimensional electrophoresis, a total of 10 protein spots were found to be differentially expressed in leaf and stem between both sexes, of which 7 were successfully identified by mass spectrometry and matched to 6 functional proteins such as NB-ARC domain containing protein, light harvesting chlorophyll a/b binding protein, asorbate peroxidase (APX), eukaryotic translation initiation factor 5A2, temperature-induced lipocalin (TIL) and phosphoglycerate kinase (PGK). The sex-related difference displayed in a tissue-specific way, especially in stem. PGK existed in high abundance in stem phloem in the female, but was almost not detected in the male; APX and two TIL species were highly abundant in the stem of male plants, while their abundance was much lower in female plants. Moreover, these abundance differences were further confirmed in individual plants. Hence, it is assumed that APX, PGK and TIL might be promising candidates to serve as protein molecular markers for sex determination in P. chinensis. Our results form the basis for a further understanding of the biochemical mechanisms of sex determination in P. chinensis.	[Xiong, Erhui; Wu, Xiaolin; Wang, Wei] Henan Agr Univ, Coll Life Sci, Dept Plant Sci, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China; [Shi, Jiang; Wang, Xiaoyan] Henan Univ Sci & Technol, Coll Agron, Dept Bot, Luoyang, Peoples R China	Henan Agricultural University; Henan University of Science & Technology	Wang, W (corresponding author), Henan Agr Univ, Coll Life Sci, Dept Plant Sci, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	wangwei@henau.edu.cn	Wang, Wei/R-7323-2016	Wang, Wei/0000-0002-3711-5181				AGREN J, 1988, ECOLOGY, V69, P962, DOI 10.2307/1941251; Ainsworth C, 2000, ANN BOT-LONDON, V86, P211, DOI 10.1006/anbo.2000.1201; Charron JBF, 2005, PLANT PHYSIOL, V139, P2017, DOI 10.1104/pp.105.070466; Charron JBF, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-86; Chen LH, 2010, PLANT CELL ENVIRON, V33, P1767, DOI 10.1111/j.1365-3040.2010.02182.x; Chi WT, 2009, PLANT CELL ENVIRON, V32, P917, DOI 10.1111/j.1365-3040.2009.01972.x; Christensen JH, 1998, PLANT PHYSIOL, V118, P125, DOI 10.1104/pp.118.1.125; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Esfandiyari B, 2012, EUPHYTICA, V185, P227, DOI 10.1007/s10681-011-0527-6; Feng HZ, 2007, PLANT PHYSIOL, V144, P1531, DOI 10.1104/pp.107.098079; Guttman DS, 1998, NATURE, V393, P263, DOI 10.1038/30492; Hashimoto M, 2007, PROTEOMICS, V7, P1293, DOI 10.1002/pmic.200600921; HORMAZA JI, 1994, THEOR APPL GENET, V89, P9, DOI 10.1007/BF00226975; Kim HB, 2010, AFR J BIOTECHNOL, V9, P6684; KOPKESECUNDO E, 1990, PLANT PHYSIOL, V93, P40, DOI 10.1104/pp.93.1.40; Korpelainen H, 2008, J HERED, V99, P581, DOI 10.1093/jhered/esn036; Kumar N, 2006, BIOL PLANTARUM, V50, P705, DOI 10.1007/s10535-006-0111-4; Li CY, 2007, TREE PHYSIOL, V27, P399, DOI 10.1093/treephys/27.3.399; Liu Q, 1999, J HENAN FORESTRY SCI, V19, P2; [马丽媛 Ma Liyuan], 2012, [河北农业大学学报, Journal of Agricultural University of Hebei], V35, P48; Navrot N, 2011, J PROTEOMICS, V74, P1450, DOI 10.1016/j.jprot.2011.03.008; Negrutiu I, 2001, PLANT PHYSIOL, V127, P1418, DOI 10.1104/pp.010711; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; POPP JW, 1988, AM J BOT, V75, P1732, DOI 10.2307/2444688; Renuse S, 2012, J PROTEOMICS, V75, P5793, DOI 10.1016/j.jprot.2012.08.003; Seifert, 2000, AUSTR GEOGRAPHICAL S, V38, P263, DOI [https://doi.org/10.1111/1467-8470.00115, DOI 10.1111/1467-8470.00115]; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Wang W, 2003, ELECTROPHORESIS, V24, P2369, DOI 10.1002/elps.200305500; Wang W, 2006, ELECTROPHORESIS, V27, P2782, DOI 10.1002/elps.200500722; [王晓茹 Wang Xiaoru], 2011, [植物学报, Chinese Bulletin of Botany], V46, P665; Wladimir ILT, 2006, PLANT PHYSL, V140; Wu XL, 2011, ACTA PHYSIOL PLANT, V33, P181, DOI 10.1007/s11738-010-0536-4; Xu X, 2007, CHINESE J APPL ECOLO, V18, P2626; Xu X, 2008, PLANT CELL ENVIRON, V31, P850, DOI 10.1111/j.1365-3040.2008.01799.x; Xu YH, 2012, J EXP BOT, V63, P1095, DOI 10.1093/jxb/err315; Yakubov B, 2005, SCI HORTIC-AMSTERDAM, V103, P473, DOI 10.1016/j.scienta.2004.06.008; Yu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022903; Zluvova J, 2006, P NATL ACAD SCI USA, V103, P18854, DOI 10.1073/pnas.0606622103	38	16	17	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64276	10.1371/journal.pone.0064276	http://dx.doi.org/10.1371/journal.pone.0064276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691188	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900090
J	Colca, JR; McDonald, WG; Cavey, GS; Cole, SL; Holewa, DD; Brightwell-Conrad, AS; Wolfe, CL; Wheeler, JS; Coulter, KR; Kilkuskie, PM; Gracheva, E; Korshunova, Y; Trusgnich, M; Karr, R; Wiley, SE; Divakaruni, AS; Murphy, AN; Vigueira, PA; Finck, BN; Kletzien, RF				Colca, Jerry R.; McDonald, William G.; Cavey, Gregory S.; Cole, Serena L.; Holewa, Danielle D.; Brightwell-Conrad, Angela S.; Wolfe, Cindy L.; Wheeler, Jean S.; Coulter, Kristin R.; Kilkuskie, Peter M.; Gracheva, Elena; Korshunova, Yulia; Trusgnich, Michelle; Karr, Robert; Wiley, Sandra E.; Divakaruni, Ajit S.; Murphy, Anne N.; Vigueira, Patrick A.; Finck, Brian N.; Kletzien, Rolf F.			Identification of a Mitochondrial Target of Thiazolidinedione Insulin Sensitizers (mTOT)-Relationship to Newly Identified Mitochondrial Pyruvate Carrier Proteins	PLOS ONE			English	Article							MEMBRANE PROTEIN; PPAR-GAMMA; 2FE-2S CLUSTER; FATTY LIVER; TCA CYCLE; MITONEET; RESISTANCE; PIOGLITAZONE; DROSOPHILA; OBESITY	Thiazolidinedione (TZD) insulin sensitizers have the potential to effectively treat a number of human diseases, however the currently available agents have dose-limiting side effects that are mediated via activation of the transcription factor PPAR gamma. We have recently shown PPAR gamma-independent actions of TZD insulin sensitizers, but the molecular target of these molecules remained to be identified. Here we use a photo-catalyzable drug analog probe and mass spectrometry-based proteomics to identify a previously uncharacterized mitochondrial complex that specifically recognizes TZDs. These studies identify two well-conserved proteins previously known as brain protein 44 (BRP44) and BRP44 Like (BRP44L), which recently have been renamed Mpc2 and Mpc1 to signify their function as a mitochondrial pyruvate carrier complex. Knockdown of Mpc1 or Mpc2 in Drosophila melanogaster or pre-incubation with UK5099, an inhibitor of pyruvate transport, blocks the crosslinking of mitochondrial membranes by the TZD probe. Knockdown of these proteins in Drosophila also led to increased hemolymph glucose and blocked drug action. In isolated brown adipose tissue (BAT) cells, MSDC-0602, a PPAR gamma-sparing TZD, altered the incorporation of C-13-labeled carbon from glucose into acetyl CoA. These results identify Mpc1 and Mpc2 as components of the mitochondrial target of TZDs (mTOT) and suggest that understanding the modulation of this complex, which appears to regulate pyruvate entry into the mitochondria, may provide a viable target for insulin sensitizing pharmacology.	[Colca, Jerry R.; McDonald, William G.; Cole, Serena L.; Holewa, Danielle D.; Brightwell-Conrad, Angela S.; Wolfe, Cindy L.; Wheeler, Jean S.; Coulter, Kristin R.; Kilkuskie, Peter M.; Kletzien, Rolf F.] Metab Solut Dev Co, Kalamazoo, MI USA; [Cavey, Gregory S.] Southwest Michigan Innovat Ctr, Kalamazoo, MI USA; [Gracheva, Elena; Korshunova, Yulia; Trusgnich, Michelle; Karr, Robert] Medros Inc, St Louis, MO USA; [Wiley, Sandra E.; Divakaruni, Ajit S.; Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Vigueira, Patrick A.; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University of California System; University of California San Diego; Washington University (WUSTL)	Colca, JR (corresponding author), Metab Solut Dev Co, Kalamazoo, MI USA.	jcolca@msdRx.com	Murphy, Anne N/H-3217-2016	Murphy, Anne N/0000-0002-5222-9902; Finck, Brian/0000-0001-5411-3674; Wiley, Sandra/0000-0003-3979-2474	National Institutes of Health (NIH) [DK081298, DK84596, AA21228]; Michigan Economic Development Corporation; Metabolic Solutions Development Company; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R42DK081298, R41DK084596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R42AA021228] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Economic Development Corporation; Metabolic Solutions Development Company; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research reported in this publication was supported in part by the following National Institutes of Health (NIH) grants: DK081298, DK84596, and AA21228. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors also acknowledge support from the Michigan Economic Development Corporation for their financial support of the Southwest Michigan Innovation Center's Core Lab which provided mass spectrometry analysis for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Elena Gracheva, Yulia Korshunova, Michelle Trusgnich, and Robert Karr are employed by Medros. Medros performed the experiments in Drosophila under contract to Metabolic Solutions Development Company. This fact did not influence their interpretation of the results and they have no other conflicts in this regard. The authors confirm that this does not alter their adherence to all PLOS ONE policies on sharing data and materials.	BENGA G, 1979, J CELL SCI, V35, P417; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brun RP, 1997, J ENDOCRINOL, V155, P217, DOI 10.1677/joe.0.1550217; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Colca JR, 2013, CLIN PHARMACOL THER, V93, P352, DOI 10.1038/clpt.2013.10; Colca JR, 2006, EXPERT OPIN INV DRUG, V15, P205, DOI 10.1517/13543784.15.3.205; Colca JR, 2004, COMB CHEM HIGH T SCR, V7, P699; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; DeFronzo RA, 2011, DIABETES CARE, V34, pS202, DOI 10.2337/dc11-s221; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P77; FoellmiAdams LA, 1996, BIOCHEM PHARMACOL, V52, P693, DOI 10.1016/0006-2952(96)00345-0; Halestrap AP, 2012, CELL METAB, V16, P141, DOI 10.1016/j.cmet.2012.07.013; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Kahn BB, 2010, NEW ENGL J MED, V363, P2667, DOI 10.1056/NEJMcibr1012075; Kusminski CM, 2012, NAT MED; Loren MA, 2011, ANAL CHEM, V8, P3406; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008; Ryder R.E.J., 2011, BR J DIABETES VASC D, V11, P113, DOI [10.1177/1474651411412658, DOI 10.1177/1474651411412658]; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Sauermann M, 2007, J BIOMOL SCREEN, V12, P510, DOI 10.1177/1087057107301271; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Zuris JA, 2012, J BIOL CHEM, V287, P11649, DOI 10.1074/jbc.M111.319731	30	115	127	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e61551	10.1371/journal.pone.0061551	http://dx.doi.org/10.1371/journal.pone.0061551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690925	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700006
J	Morzaria-Luna, HN; Ainsworth, CH; Kaplan, IC; Levin, PS; Fulton, EA				Morzaria-Luna, Hem Nalini; Ainsworth, Cameron H.; Kaplan, Isaac C.; Levin, Phillip S.; Fulton, Elizabeth A.			Indirect Effects of Conservation Policies on the Coupled Human-Natural Ecosystem of the Upper Gulf of California	PLOS ONE			English	Article							FISHERIES MANAGEMENT; MARINE ECOSYSTEMS; SEABIRD BYCATCH; PROTECTED AREAS; SHRIMP FISHERY; SEA-TURTLE; VAQUITA; MODELS; POPULATIONS; CHALLENGES	High bycatch of non-target species and species of conservation concern often drives the implementation of fisheries policies. However, species-or fishery-specific policies may lead to indirect consequences, positive or negative, for other species or fisheries. We use an Atlantis ecosystem model of the Northern Gulf of California to evaluate the effects of fisheries policies directed at reducing bycatch of vaquita (Phocoena sinus) on other species of conservation concern, priority target species, and metrics of ecosystem function and structure. Vaquita, a Critically Endangered porpoise endemic to the Upper Gulf of California, are frequently entangled by finfish gillnets and shrimp driftnets. We tested five fishery management scenarios, projected over 30 years (2008 to 2038), directed at vaquita conservation. The scenarios consider progressively larger spatial restrictions for finfish gillnets and shrimp driftnets. The most restrictive scenario resulted in the highest biomass of species of conservation concern; the scenario without any conservation measures in place resulted in the lowest. Vaquita experienced the largest population increase of any functional group; their biomass increased 2.7 times relative to initial (2008) levels under the most restrictive spatial closure scenario. Bycatch of sea lions, sea turtles, and totoaba decreased. 80% in shrimp driftnets and at least 20% in finfish gillnet fleets under spatial management. We found indirect effects on species and ecosystem function and structure as a result of vaquita management actions. Biomass and catch of forage fish declined, which could affect lower-trophic level fisheries, while other species such as skates, rays, and sharks increased in both biomass and catch. When comparing across performance metrics, we found that scenarios that increased ecosystem function and structure resulted in lower economic performance indicators, underscoring the need for management actions that consider ecological and economic tradeoffs as part of the integrated management of the Upper Gulf of California.	[Morzaria-Luna, Hem Nalini; Ainsworth, Cameron H.] Marine Resources Assessment Grp Amer Inc, Seattle, WA USA; [Kaplan, Isaac C.; Levin, Phillip S.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA; [Fulton, Elizabeth A.] Commonwealth Sci & Ind Res Org Wealth Oceans Flag, Div Marine & Atmospher Res, Hobart, Tas, Australia	National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Morzaria-Luna, HN (corresponding author), Marine Resources Assessment Grp Amer Inc, Seattle, WA USA.	HemNalini.MorzariaLuna@noaa.gov	Fulton, Beth/A-2871-2008	Fulton, Beth/0000-0002-5904-7917	David and Lucile Packard Foundation; Gordon and Betty Moore Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This project was supported by the David and Lucile Packard Foundation. Atlantis code development was supported by the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KE, 2007, CAN J FISH AQUAT SCI, V64, P1595, DOI 10.1139/F07-125; Aburto-Oropeza O., 2008, CIENCIA CONSERVACION, P1; Ainsworth CH, 2012, MAR POLICY, V36, P1275, DOI 10.1016/j.marpol.2012.03.016; Ainsworth C.H., 2011, NMFSNWFSC110 NOAA US; Ainsworth CH, 2006, ECOL INDIC, V6, P623, DOI 10.1016/j.ecolind.2005.08.024; Ainsworth CH, 2012, J APPL ECOL, V49, P63, DOI 10.1111/j.1365-2664.2011.02064.x; Aragon-Noriega EA, 2010, INT J SUST DEV WORLD, V17, P410, DOI 10.1080/13504509.2010.500823; Aragon-Noriega E. Alberto, 2009, International Journal of Biodiversity Science & Management, V5, P208, DOI 10.1080/17451591003709371; Aswani S, 2012, MAR POLICY, V36, P1, DOI 10.1016/j.marpol.2011.02.014; Avila-Forcada S, 2012, MAR POLICY, V36, P613, DOI 10.1016/j.marpol.2011.10.012; Bache SJ, 2003, OCEAN COAST MANAGE, V46, P103, DOI 10.1016/S0964-5691(02)00123-0; Bakun A, 2010, REV FISH BIOL FISHER, V20, P9, DOI 10.1007/s11160-009-9118-1; Bizzarro JJ, 2009, FISH RES, V97, P103, DOI 10.1016/j.fishres.2009.01.009; Bobadilla M, 2011, ENVIRON SCI POLICY, V14, P998, DOI 10.1016/j.envsci.2011.06.003; Brand EJ, 2007, TMNMFSNWFSC84 NOAA U; Brusca Richard C., 2005, P179; Bull LS, 2007, FISH FISH, V8, P31, DOI 10.1111/j.1467-2979.2007.00234.x; C?lix M., 2018, EUROPEAN RED LIST SA; Christensen V, 2004, B MAR SCI, V74, P549; Cinti A, 2010, MAR POLICY, V34, P1322, DOI 10.1016/j.marpol.2010.06.005; Cinti A, 2010, MAR POLICY, V34, P328, DOI 10.1016/j.marpol.2009.08.002; CIRVA, 2012, 4 M INT COMM REC VAQ; Cisneros-Mata Miguel A., 2010, P119; Coggins LG, 2007, FISH FISH, V8, P196, DOI 10.1111/j.1467-2679.2007.00247.x; CONANP, 2007, PROGR CONS MAN RES B; CONAPESCA, 2011, PROYECT ESTR RET VOL; Cudney-Bueno R., 1998, PESCANDO ENTRE MAREA; Diario Oficial de la Federacion (DOF), 2005, DIARIO OFICIAL FEDER; DOF, 1993, DIARIO OFICIAL FEDER; Erisman BE, 2011, ICES J MAR SCI, V68, P564, DOI 10.1093/icesjms/fsq179; Felger R.S., 2005, SEA TURTLES NW MEXIC, P405; Fulton E.A., 2001, THESIS U TASMANIA; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Fulton EA, 2004, ECOL MODEL, V174, P267, DOI 10.1016/j.ecolmodel.2003.09.027; Fulton EA, 2004, ECOL MODEL, V173, P371, DOI 10.1016/j.ecolmodel.2003.09.024; Fulton EA, 2007, ALTERNATIVE MANAGEME; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Garcia-Caudillo JM, 2000, BIOL CONSERV, V92, P199, DOI 10.1016/S0006-3207(99)00053-1; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE101, DOI 10.1111/j.1748-7692.2010.00449.x; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE79, DOI 10.1111/j.1748-7692.2010.00438.x; Gilman E, 2007, BIOL CONSERV, V139, P19, DOI 10.1016/j.biocon.2007.06.002; Hall SJ, 2005, FISH FISH, V6, P134, DOI 10.1111/j.1467-2979.2005.00183.x; Heredia-Quevedo JA, 2001, THESIS UN U REVKJAVI; Hernandez A, 2003, OCEAN COAST MANAGE, V46, P507, DOI 10.1016/S0964-5691(03)00032-2; INAPESCA, 2011, EV BIOT RED ARR PROT; INAPESCA NMFS, 2012, FISH TECHN RES COLL; INAPESCA WWF, 2010, TECN RED CAPT INC PE; INE WWF, 2006, CONS VAQ HAB ALT GOL; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jaramillo-Legorreta AM, 1999, MAR MAMMAL SCI, V15, P957, DOI 10.1111/j.1748-7692.1999.tb00872.x; Jurado-Molina J, 2002, CAN J FISH AQUAT SCI, V59, P1941, DOI 10.1139/F02-160; Kaiser MJ, 2002, FISH FISH, V3, P114, DOI 10.1046/j.1467-2979.2002.00079.x; Kaiser MJ, 2000, J ANIM ECOL, V69, P494, DOI 10.1046/j.1365-2656.2000.00412.x; Kaplan IC, 2012, PROG OCEANOGR, V102, P5, DOI 10.1016/j.pocean.2012.03.009; Kellner JB, 2011, CONSERV LETT, V4, P21, DOI 10.1111/j.1755-263X.2010.00132.x; Lercari D, 2007, FISH RES, V86, P136, DOI 10.1016/j.fishres.2007.05.010; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Leslie HM, 2009, ECOL RES, V24, P505, DOI 10.1007/s11284-009-0603-8; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Link JS, 2012, PROG OCEANOGR, V102, P102, DOI 10.1016/j.pocean.2012.03.008; Link JS, 2010, PROG OCEANOGR, V87, P214, DOI 10.1016/j.pocean.2010.09.020; Link JS, 2002, FISHERIES, V27, P10, DOI 10.1577/1548-8446(2002)027<0010:ECIFM>2.0.CO;2; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; Lluch-Cota SE, 2010, PROG OCEANOGR, V87, P114, DOI 10.1016/j.pocean.2010.09.007; Martell SJD, 2005, CAN J FISH AQUAT SCI, V62, P1320, DOI 10.1139/F05-114; Meltzer L, 2006, OCEAN COAST MANAGE, V49, P222, DOI 10.1016/j.ocecoaman.2006.02.009; Meltzer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035609; Micheli F, 1999, SCIENCE, V285, P1396, DOI 10.1126/science.285.5432.1396; Moore JE, 2009, MAR POLICY, V33, P435, DOI 10.1016/j.marpol.2008.09.003; Moreno-Baez M, 2010, B MAR SCI, V86, P339; Morzaria-Luna HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042917; Nava-Romo JM, 1994, THESIS I TECHNOLOGIC; NMFS, 2005, ESS FISH HAB DES MIN, P137; ORTIZ I, 2002, THESIS U WASHINGTON; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Peguero-Icaza M, 2011, J PLANKTON RES, V33, P517, DOI 10.1093/plankt/fbq107; Perez-Ramirez M, 2010, INTERCIENCIA, V35, P855; Perez-Valencia S, 2011, MANIFESTACION IMPACT; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Rodriguez-Quiroz G, 2008, SOC PESCA CONSERVACI; Rodriguez-Valencia JA, 2006, CAPTURA INCIDENTAL F; Rojas-Bracho L, 2006, MAMMAL REV, V36, P179, DOI 10.1111/j.1365-2907.2006.00088.x; Rose KA, 2010, MAR COAST FISH, V2, P115, DOI 10.1577/C09-059.1; Rowell K, 2008, BIOL CONSERV, V141, P1138, DOI 10.1016/j.biocon.2008.02.013; Ruckelshaus M, 2013, MAR POLICY, V40, P154, DOI 10.1016/j.marpol.2013.01.009; Ruiz-Lopez DM, 2009, THESIS CTR INTERDISC; Saenz-Arroyo A, 2006, FISH FISH, V7, P128, DOI 10.1111/j.1467-2979.2006.00214.x; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Salomon AK, 2010, CONSERV BIOL, V24, P382, DOI 10.1111/j.1523-1739.2009.01436.x; Samhouri JF, 2009, ECOSYSTEMS, V12, P1283, DOI 10.1007/s10021-009-9286-9; SEMARNAT, 2008, PROGR ACC CONS ESP V; Sumaila UR, 2000, ICES J MAR SCI, V57, P752, DOI 10.1006/jmsc.2000.0732; SZTEREN D, 2006, POPULATION STATUS TR; Underwood JG, 2008, CONSERV BIOL, V22, P701, DOI 10.1111/j.1523-1739.2008.00919.x; van Ginkel R., 1999, J ENVIRON POL PLAN, V1, P223, DOI [DOI 10.1080/714038537, 10.1080/714038537]; Velarde E, 2004, ECOL APPL, V14, P607, DOI 10.1890/02-5320; [No title captured]	99	14	14	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64085	10.1371/journal.pone.0064085	http://dx.doi.org/10.1371/journal.pone.0064085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145XK	23691155	gold, Green Submitted, Green Published			2022-12-25	WOS:000319052700079
J	Puente-Rolon, AR; Reynolds, RG; Revell, LJ				Puente-Rolon, Alberto R.; Reynolds, R. Graham; Revell, Liam J.			Preliminary Genetic Analysis Supports Cave Populations as Targets for Conservation in the Endemic Endangered Puerto Rican Boa (Boidae: Epicrates inornatus)	PLOS ONE			English	Article							ECOLOGY; PHYLOGEOGRAPHY; DIVERGENCE; PROGRAM; SNAKE; SIZE	The endemic Puerto Rican boa (Epicrates inornatus) has spent 42 years on the Endangered Species List with little evidence for recovery. One significant impediment to effective conservation planning has been a lack of knowledge of the distribution of genetic variability in the species. It has previously been suggested that boas might best be protected around caves that harbor large populations of bats. Prior study has found Puerto Rican boas at relatively high densities in and around bat caves, which they use both to feed and seek shelter. However, it is unknown whether these behaviorally distinctive populations represent a distinct evolutionary lineage, or (conversely) whether caves harbor representative genetic diversity for the species across the island. We provide the first genetic study of the Puerto Rican boa, and we examine and compare genetic diversity and divergence among two cave populations and two surface populations of boas. We find three haplogroups and an apparent lack of phylogeographic structure across the island. In addition, we find that the two cave populations appear no less diverse than the two surface populations, and harbor multiple mtDNA lineages. We discuss the conservation implications of these findings, including a call for the immediate protection of the remaining cave-associated populations of boas.	[Puente-Rolon, Alberto R.] Univ Interamer Puerto Rico, Dept Ciencias & Tecnol, Arecibo, PR USA; [Reynolds, R. Graham; Revell, Liam J.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	Inter American University of Puerto Rico-San German; University of Massachusetts System; University of Massachusetts Boston	Reynolds, RG (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	rgraham.reynolds@umb.edu	Revell, Liam J/AAF-1151-2019	Revell, Liam J/0000-0003-0767-4713; Reynolds, Robert Graham/0000-0002-0056-8304	University of Massachusetts Boston; U.S. Fish and Wildlife Service Endangered Species Recovery Implementation Grant	University of Massachusetts Boston; U.S. Fish and Wildlife Service Endangered Species Recovery Implementation Grant	Funding was provided by the University of Massachusetts Boston and by a 2012 U.S. Fish and Wildlife Service Endangered Species Recovery Implementation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 2006, CONSERVATION GENETIC; Bird-Pico FJ, 1994, FINAL REPORT EPICRAT; Booth W, 2011, J HERED, V102, P759, DOI 10.1093/jhered/esr080; Booth W, 2011, BIOL LETTERS, V7, P253, DOI 10.1098/rsbl.2010.0793; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Draper G., 1987, J GEOLOGICAL SOC JAM, P151; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fitzpatrick BM, 2009, MOL ECOL, V18, P3961, DOI 10.1111/j.1365-294X.2009.04314.x; Frankham Richard, 2006, P502; Henderson R.W., 2009, NATURAL HIST W INDIA; Janzen FJ, 2002, MOL ECOL, V11, P1739, DOI 10.1046/j.1365-294X.2002.01571.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lugo AE, 2001, WO65 US FOR SERV; Maddison WP, 2011, MESQUITE MODULAR SYS; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Puente-Rolon AR, 2004, CARIBB J SCI, V40, P343; Puente-Rolon AR, 2012, THESIS U PUERTO RICO; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REAGAN D P, 1984, Caribbean Journal of Science, V20, P119; Reynolds RG, 2012, J HERPETOL, V46, P578, DOI 10.1670/11-079; Reynolds RG, 2011, CONSERVATION OF CARIBBEAN ISLAND HERPETOFAUNAS, VOL 2: REGIONAL ACCOUNTS OF THE WEST INDIES, P377; Reynolds RG, 2011, HERPETOLOGICA, V67, P477, DOI 10.1655/HERPETOLOGICA-D-11-00014.1; Rivero J.A., 1998, ANFIBIOS REPTILES PU; RODRIGUEZ GA, 1984, COPEIA, P219; Rodriguez-Robles JA, 2010, MOL ECOL, V19, P1860, DOI 10.1111/j.1365-294X.2010.04616.x; RodriguezDuran A, 1996, J HERPETOL, V30, P533, DOI 10.2307/1565698; Tolson PJ, 2011, CONSERVATION OF CARIBBEAN ISLAND HERPETOFAUNAS, VOL 1: CONSERVATION BIOLOGY AND THE WIDER CARIBBEAN, P49; Tzika AC, 2008, MOL ECOL, V17, P533, DOI [10.1111/j.1365-294X.2008.03967.x, 10.1111/j.1365-294X.2007.03588.x]; Tzika AC, 2009, CONSERV GENET, V10, P69, DOI 10.1007/s10592-008-9519-z; U.S. Fish and Wildlife Service, 2011, PUERT RIC BOA EP IN; *US FISH WILDL SER, 1986, PUERT RIC BOA REC PL; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wiley JW, 2003, CARIBB J SCI, V39, P189; Wunderle JM, 2004, BIOTROPICA, V36, P555, DOI 10.1646/1592	38	5	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63899	10.1371/journal.pone.0063899	http://dx.doi.org/10.1371/journal.pone.0063899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691110	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700064
J	Sriramula, S; Cardinale, JP; Francis, J				Sriramula, Srinivas; Cardinale, Jeffrey P.; Francis, Joseph			Inhibition of TNF in the Brain Reverses Alterations in RAS Components and Attenuates Angiotensin II-Induced Hypertension	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PARAVENTRICULAR NUCLEUS; HEART-FAILURE; RENIN; INFLAMMATION; ACTIVATION; SYMPATHOEXCITATION; CYTOKINES; RESPONSES; SYSTEM	Dysfunction of brain renin-angiotensin system (RAS) components is implicated in the development of hypertension. We previously showed that angiotensin (Ang) II-induced hypertension is mediated by increased production of proinflammatory cytokines (PIC), including tumor necrosis factor (TNF), in brain cardiovascular regulatory centers such as the paraventricular nucleus (PVN). Presently, we tested the hypothesis that central TNF blockade prevents dysregulation of brain RAS components and attenuates Ang II-induced hypertension. Male Sprague-Dawley rats were implanted with radio-telemetry transmitters to measure mean arterial pressure (MAP) and subjected to intracerebroventricular (ICV) infusion of etanercept (10 mg/kg/day) with/without concurrent subcutaneous 4-week Ang II (200 ng/kg/min) infusion. Chronic Ang II infusion resulted in a significant increase in MAP and cardiac hypertrophy, which was attenuated by inhibition of brain TNF with etanercept. Etanercept treatment also attenuated Ang II-induced increases in PIC and decreases in IL-10 expression in the PVN. Additionally, Ang II infusion increased expression of pro-hypertensive RAS components (ACE and AT(1)R), while decreasing anti-hypertensive RAS components (ACE2, Mas, and AT(2) receptors), within the PVN. ICV etanercept treatment reversed these changes. Ang II-infusion was associated with increased oxidative stress as indicated by increased NAD(P) H oxidase activity and super oxide production in the PVN, which was prevented by inhibition of TNF. Moreover, brain targeted TNF blockade significantly reduced Ang II-induced NOX-2 and NOX-4 mRNA and protein expression in the PVN. These findings suggest that chronic TNF blockade in the brain protects rats against Ang II-dependent hypertension and cardiac hypertrophy by restoring the balance between pro-and anti-hypertensive RAS axes and inhibiting PIC and oxidative stress genes and proteins in the PVN.	[Sriramula, Srinivas; Cardinale, Jeffrey P.; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA; [Sriramula, Srinivas] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA; [Sriramula, Srinivas] Louisiana State Univ, Hlth Sci Ctr, Cardiovasc Ctr Excellence, New Orleans, LA USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Francis, J (corresponding author), Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA.	jfrancis@lsu.edu	Sriramula, Srinivas/N-1297-2019	Sriramula, Srinivas/0000-0001-9937-1589	National Institutes of Health [HL80544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant (HL80544) to JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; Arenas IA, 2004, AM J PHYSIOL-CELL PH, V286, pC779, DOI 10.1152/ajpcell.00398.2003; Bader M, 2002, CIRC RES, V90, P8, DOI 10.1161/res.90.1.8; Baltatu OC, 2011, PEPTIDES, V32, P1083, DOI 10.1016/j.peptides.2011.02.008; BRUNER CA, 1986, AM J PHYSIOL, V250, pH52, DOI 10.1152/ajpheart.1986.250.1.H52; Davisson RL, 2003, AM J PHYSIOL-REG I, V285, pR498, DOI 10.1152/ajpregu.00190.2003; Elmarakby AA, 2006, HYPERTENSION, V47, P557, DOI 10.1161/01.HYP.0000198545.01860.90; FINK GD, 1987, HYPERTENSION, V9, P355, DOI 10.1161/01.HYP.9.4.355; Francis J, 2003, AM J PHYSIOL-REG I, V284, pR328, DOI 10.1152/ajpregu.00376.2002; Fujita M, 2007, HYPERTENSION, V50, P360, DOI 10.1161/HYPERTENSIONAHA.107.091009; Gao L, 2004, CIRC RES, V95, P937, DOI 10.1161/01.RES.0000146676.04359.64; Goffe B, 2003, J AM ACAD DERMATOL, V49, pS105, DOI 10.1016/mjd.2003.554; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Kang YM, 2009, CARDIOVASC RES, V82, P503, DOI 10.1093/cvr/cvp073; Lu Y, 2009, NEUROL RES, V31, P420, DOI 10.1179/174313208X353677; MARTIN DS, 1991, HYPERTENSION, V18, P48, DOI 10.1161/01.HYP.18.1.48; Marvar PJ, 2010, CIRC RES, V107, P263, DOI 10.1161/CIRCRESAHA.110.217299; McKinley MJ, 2003, INT J BIOCHEM CELL B, V35, P901, DOI 10.1016/S1357-2725(02)00306-0; Muller DN, 2002, AM J PATHOL, V161, P1679, DOI 10.1016/S0002-9440(10)64445-8; Nishiyama A, 2001, HYPERTENSION, V37, P77, DOI 10.1161/01.HYP.37.1.77; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Sakai K, 2005, CURR HYPERTENS REP, V7, P135, DOI 10.1007/s11906-005-0088-y; Sasamura H, 1997, HYPERTENSION, V30, P35, DOI 10.1161/01.HYP.30.1.35; Shi P, 2010, HYPERTENSION, V56, P297, DOI 10.1161/HYPERTENSIONAHA.110.150409; SIMPSON JB, 1981, NEUROENDOCRINOLOGY, V32, P248, DOI 10.1159/000123167; Sriramula S, 2008, HYPERTENSION, V51, P1345, DOI 10.1161/HYPERTENSIONAHA.107.102152; Sriramula S, 2011, CARDIOVASC RES, V92, P401, DOI 10.1093/cvr/cvr242; Turnbull AV, 1997, J NEUROSCI, V17, P3262; Veerasingham SJ, 2003, BRIT J PHARMACOL, V139, P191, DOI 10.1038/sj.bjp.0705262; Xia HJ, 2009, HYPERTENSION, V53, P210, DOI 10.1161/HYPERTENSIONAHA.108.123844; Xu P, 2011, AM J PHYSIOL-REG I, V300, pR804, DOI 10.1152/ajpregu.00222.2010; Xue BJ, 2012, AM J PHYSIOL-HEART C, V302, pH733, DOI 10.1152/ajpheart.00873.2011; Yu Y, 2007, CIRC RES, V101, P304, DOI 10.1161/CIRCRESAHA.107.148940; Zhang CH, 2006, J MOL CELL CARDIOL, V40, P247, DOI 10.1016/j.yjmcc.2005.11.010; Zhu GQ, 2004, J APPL PHYSIOL, V97, P1746, DOI 10.1152/japplphysiol.00573.2004; Zubcevic J, 2011, HYPERTENSION, V57, P1026, DOI 10.1161/HYPERTENSIONAHA.111.169748	38	99	101	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63847	10.1371/journal.pone.0063847	http://dx.doi.org/10.1371/journal.pone.0063847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691105	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700062
J	Vredenburg, VT; Felt, SA; Morgan, EC; McNally, SVG; Wilson, S; Green, SL				Vredenburg, Vance T.; Felt, Stephen A.; Morgan, Erica C.; McNally, Samuel V. G.; Wilson, Sabrina; Green, Sherril L.			Prevalence of Batrachochytrium dendrobatidis in Xenopus Collected in Africa (1871-2000) and in California (2001-2010)	PLOS ONE			English	Article							CHYTRIDIOMYCOSIS; AMPHIBIANS; EXTINCTION; DISEASE; FROGS	International trade of the invasive South African clawed frog (Xenopus laevis), a subclinical carrier of the fungal pathogen Batrachochytrium dendrobatis (Bd) has been proposed as a major means of introduction of Bd into naive, susceptible amphibian populations. The historical presence of Bd in the indigenous African population of Xenopus is well documented. However, there are no reports documenting the presence of Bd in wild Xenopus populations in the US, particularly in California where introduced populations are well-established after intentional or accidental release. In this report, a survey was conducted on 178 archived specimens of 6 species of Xenopus collected in Africa from 1871-2000 and on 23 archived specimens (all wild-caught Xenopus laevis) collected in California, USA between 2001 and 2010. The overall prevalence rate of Bd in the tested Xenopus was 2.8%. The earliest positive specimen was X. borealis collected in Kenya in 1934. The overall prevalence of Bd in the X. laevis collected in California was 13% with 2 positive specimens from 2001 and one positive specimen from 2003. The positive Xenopus (3/23) collected in California were collected in 2001 (2/3) and 2003 (1/3). These data document the presence of Bd-infected wild Xenopus laevis in California. The findings reported here support the prevailing hypothesis that Bd was present as a stable, endemic infection in Xenopus populations in Africa prior to their worldwide distribution likely via international live-amphibian trade.	[Vredenburg, Vance T.; McNally, Samuel V. G.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Vredenburg, Vance T.] Calif Acad Sci, San Francisco, CA 94118 USA; [Vredenburg, Vance T.] Museum Vertebrate Zool Berkeley, Berkeley, CA USA; [Felt, Stephen A.; Morgan, Erica C.; Wilson, Sabrina; Green, Sherril L.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA	California State University System; San Francisco State University; California Academy of Sciences; Stanford University	Vredenburg, VT (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	vancev@sfsu.edu		Felt, Stephen/0000-0001-7030-717X; McNally, Sam/0000-0003-4577-9700; Vredenburg, Vance/0000-0002-9682-1190	Stanford's Undergraduate Research Program; National Science Foundation [1120283]; Direct For Biological Sciences [1120283] Funding Source: National Science Foundation	Stanford's Undergraduate Research Program; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by a grant from Stanford's Undergraduate Research Program to Erica Morgan and Sherril Green, and by the National Science Foundation (grant #1120283) to Vance Vredenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; BURY R B, 1976, Biological Conservation, V10, P1; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; DEUCHAR EM, 1972, BIOL REV, V47, P37, DOI 10.1111/j.1469-185X.1972.tb00970.x; Green S.L, 2009, LAB XENOPUS SP; Green SL, 2009, LAB XENOPUS SP, P19; Longo AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059499; MCCOID M J, 1980, Bulletin Southern California Academy of Sciences, V79, P82; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; ST AMANT JA, 1973, CALIF FISH GAME, V59, P151; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804	17	35	36	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63791	10.1371/journal.pone.0063791	http://dx.doi.org/10.1371/journal.pone.0063791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691097	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700061
J	Santaolalla, R; Sussman, DA; Ruiz, JR; Davies, JM; Pastorini, C; Espana, CL; Sotolongo, J; Burlingame, O; Bejarano, PA; Philip, S; Ahmed, MM; Ko, J; Dirisina, R; Barrett, TA; Shang, LM; Lira, SA; Fukata, M; Abreu, MT				Santaolalla, Rebeca; Sussman, Daniel A.; Ruiz, Jose R.; Davies, Julie M.; Pastorini, Cristhine; Espana, Cecilia L.; Sotolongo, John; Burlingame, Oname; Bejarano, Pablo A.; Philip, Sakhi; Ahmed, Mansoor M.; Ko, Jeffrey; Dirisina, Ramanarao; Barrett, Terrence A.; Shang, Limin; Lira, Sergio A.; Fukata, Masayuki; Abreu, Maria T.			TLR4 Activates the beta-catenin Pathway to Cause Intestinal Neoplasia	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; COLORECTAL-CANCER; STEM-CELLS; COLON-CANCER; MURINE MODEL; EXPRESSION; GENE; PROLIFERATION; TUMORIGENESIS; PREVENTION	Colonic bacteria have been implicated in the development of colon cancer. We have previously demonstrated that toll-like receptor 4 (TLR4), the receptor for bacterial lipopolysaccharide (LPS), is over-expressed in humans with colitis-associated cancer. Genetic epidemiologic data support a role for TLR4 in sporadic colorectal cancer (CRC) as well, with over-expression favoring more aggressive disease. The goal of our study was to determine whether TLR4 played a role as a tumor promoter in sporadic colon cancer. Using immunofluorescence directed to TLR4, we found that a third of sporadic human colorectal cancers over-express this marker. To mechanistically investigate this observation, we used a mouse model that overexpresses TLR4 in the intestinal epithelium (villin-TLR4 mice). We found that these transgenic mice had increased epithelial proliferation as measured by BrdU labeling, longer colonic crypts and an expansion of Lgr5+ crypt cells at baseline. In addition, villin-TLR4 mice developed spontaneous duodenal dysplasia with age, a feature that is not seen in any wild-type (WT) mice. To model human sporadic CRC, we administered the genotoxic agent azoxymethane (AOM) to villin-TLR4 and WT mice. We found that villin-TLR4 mice showed an increased number of colonic tumors compared to WT mice as well as increased beta-catenin activation in non-dysplastic areas. Biochemical studies in colonic epithelial cell lines revealed that TLR4 activates beta-catenin in a PI3K-dependent manner, increasing phosphorylation of beta-catenin(Ser552), a phenomenon associated with activation of the canonical Wnt pathway. Our results suggest that TLR4 can trigger a neoplastic program through activation of the Wnt/beta-catenin pathway. Our studies highlight a previously unexplored link between innate immune signaling and activation of oncogenic pathways, which may be targeted to prevent or treat CRC.	[Santaolalla, Rebeca; Sussman, Daniel A.; Ruiz, Jose R.; Davies, Julie M.; Pastorini, Cristhine; Espana, Cecilia L.; Sotolongo, John; Fukata, Masayuki; Abreu, Maria T.] Univ Miami, Leonard Miller Sch Med, Dept Med, Div Gastroenterol, Miami, FL 33152 USA; [Burlingame, Oname; Bejarano, Pablo A.] Univ Miami, Leonard Miller Sch Med, Dept Pathol, Miami, FL USA; [Philip, Sakhi; Ahmed, Mansoor M.] Univ Miami, Leonard Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Radiat Oncol, Miami, FL USA; [Ko, Jeffrey; Dirisina, Ramanarao; Barrett, Terrence A.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Gastroenterol, Chicago, IL 60611 USA; [Shang, Limin; Lira, Sergio A.] Mt Sinai Sch Med, Inst Immunol, New York, NY USA	University of Miami; University of Miami; University of Miami; Northwestern University; Feinberg School of Medicine; Icahn School of Medicine at Mount Sinai	Abreu, MT (corresponding author), Univ Miami, Leonard Miller Sch Med, Dept Med, Div Gastroenterol, Miami, FL 33152 USA.	MAbreu1@med.miami.edu	Ahmed, Mansoor/AAK-5988-2020; Davies, Julie/AAU-7129-2021	Davies, Julie/0000-0003-4035-6047; Abreu, Maria T./0000-0002-7294-0574; Barrett, Terrence/0000-0001-6428-3271; Ruiz, Jose/0000-0001-9938-7943	National Institutes of Health [CA137869]; Crohn's and Colitis Foundation of America (CCFA) Research Fellowship Award; CCFA Senior Investigator Award; Bankhead Coley Team Science Grant; NATIONAL CANCER INSTITUTE [R01CA137869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America (CCFA) Research Fellowship Award; CCFA Senior Investigator Award; Bankhead Coley Team Science Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by a National Institutes of Health CA137869 grant to M.T.A., a Crohn's and Colitis Foundation of America (CCFA) Research Fellowship Award to R.S., a CCFA Senior Investigator Award to M.T.A., and a Bankhead Coley Team Science Grant to M.T.A. and D.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Khalek Feras J, 2010, Gastrointest Cancer Res, pS16; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bissahoyo A, 2005, TOXICOL SCI, V88, P340, DOI 10.1093/toxsci/kfi313; Brown JB, 2011, INFECT IMMUN, V79, P1863, DOI 10.1128/IAI.01025-10; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Earl TM, 2009, ANN SURG ONCOL, V16, P1043, DOI 10.1245/s10434-009-0325-8; EYKING A, 2011, GASTROENTEROLOGY; Fan XS, 2010, INT J COLORECTAL DIS, V25, P583, DOI 10.1007/s00384-010-0903-z; FERLAY J, 2010, IRC CANCERBASE; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Fukata M, 2011, INFLAMM BOWEL DIS, V17, P1464, DOI 10.1002/ibd.21527; Hernandez Y, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-82; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; HSU D, 2010, LAB INVEST; Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Ihle NT, 2011, CURR CANCER DRUG TAR, V11, P190; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; KALER P, 2009, CANC MICROENVIRON; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lee G, 2010, GASTROENTEROLOGY, V139, P869, DOI 10.1053/j.gastro.2010.05.037; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Meunier C, 2010, ONCOGENE, V29, P647, DOI 10.1038/onc.2009.369; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Neal MD, 2012, J BIOL CHEM, V287, P37296, DOI 10.1074/jbc.M112.375881; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; RAMANATHAN V, 2012, P53 GENE MUTATION IN; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shang LM, 2008, GASTROENTEROLOGY, V135, P529, DOI 10.1053/j.gastro.2008.04.020; SLATTERY ML, 2011, INT J CANC J INT CAN; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Soubeyran P, 2001, ONCOGENE, V20, P4180, DOI 10.1038/sj.onc.1204551; Sun Jun, 2010, Cancers (Basel), V3, P285, DOI 10.3390/cancers3010285; Takeda K, 2011, ANTICANCER RES, V31, P263; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	67	76	81	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63298	10.1371/journal.pone.0063298	http://dx.doi.org/10.1371/journal.pone.0063298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691015	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400046
J	Baker, M; Reynolds, LE; Robinson, SD; Lees, DM; Parsons, M; Elia, G; Hodivala-Dilke, K				Baker, Marianne; Reynolds, Louise E.; Robinson, Stephen D.; Lees, Delphine M.; Parsons, Maddy; Elia, George; Hodivala-Dilke, Kairbaan			Stromal Claudin14-Heterozygosity, but Not Deletion, Increases Tumour Blood Leakage without Affecting Tumour Growth	PLOS ONE			English	Article							TIGHT JUNCTION; VE-CADHERIN; SUBCELLULAR-LOCALIZATION; CLAUDIN-5 EXPRESSION; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; ANGIOGENESIS; CANCER; GENE; MICE	The maintenance of endothelial cell-cell junctions is vital for the control of blood vessel leakage and is known to be important in the growth and maturation of new blood vessels during angiogenesis. Here we have investigated the role of a tight junction molecule, Claudin14, in tumour blood vessel leakage, angiogenesis and tumour growth. Using syngeneic tumour models our results showed that genetic ablation of Claudin14 was not sufficient to affect tumour blood vessel morphology or function. However, and surprisingly, Claudin14-heterozygous mice displayed several blood vessel-related phenotypes including: disruption of ZO-1-positive cell-cell junctions in tumour blood vessels; abnormal distribution of basement membrane laminin around tumour blood vessels; increased intratumoural leakage and decreased intratumoural hypoxia. Additionally, although total numbers of tumour blood vessels were increased in Claudin14-heterozygous mice, and in VEGF-stimulated angiogenesis ex vivo, the number of lumenated vessels was not changed between genotypes and this correlated with no difference in syngeneic tumour growth between wild-type, Claudin14-heterozygous and Claudin14-null mice. Lastly, Claudin14-heterozygosity, but not complete deficiency, also enhanced endothelial cell proliferation significantly. These data establish a new role for Claudin14 in the regulation of tumour blood vessel integrity and angiogenesis that is evident only after the partial loss of this molecule in Claudin14-heterozyous mice but not in Claudin14-null mice.	[Baker, Marianne; Reynolds, Louise E.; Lees, Delphine M.; Elia, George; Hodivala-Dilke, Kairbaan] Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, London, England; [Robinson, Stephen D.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of London; Queen Mary University London; University of East Anglia; University of London; King's College London	Hodivala-Dilke, K (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, London, England.	k.hodivala-dilke@qmul.ac.uk	Parsons, Maddy/B-2203-2013	Parsons, Maddy/0000-0002-2021-8379; Robinson, Stephen/0000-0002-6606-7588; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; Lees, Delphine M/0000-0002-2119-3978	Cancer Research UK [C8218/A12007]; Medical Research Council [G0901609]; Cancer Research UK [12007] Funding Source: researchfish; Worldwide Cancer Research [12-1068] Funding Source: researchfish; MRC [G0901609] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Cancer Research UK, C8218/A12007 and the Medical Research Council G0901609. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrass CK, 2010, AM J PATHOL, V176, P839, DOI 10.2353/ajpath.2010.090570; Aurrand-Lions M, 2001, BLOOD, V98, P3699, DOI 10.1182/blood.V98.13.3699; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Belguith H, 2009, BIOCHEM BIOPH RES CO, V385, P1, DOI 10.1016/j.bbrc.2009.02.125; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Chouaib S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00021; Delbaldo C, 2012, THER ADV MED ONCOL, V4, P9, DOI 10.1177/1758834011428147; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Dudley AC, 2012, COLD SPRING HARB PER, V2, P1; Gavard J, 2008, NAT CELL BIOL, V10, P883, DOI 10.1038/ncb0808-883; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Glienke J, 2000, EUR J BIOCHEM, V267, P2820, DOI 10.1046/j.1432-1327.2000.01325.x; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Hall AP, 2006, TOXICOL PATHOL, V34, P763, DOI 10.1080/01926230600936290; Hou JH, 2012, ANN NY ACAD SCI, V1258, P185, DOI 10.1111/j.1749-6632.2012.06529.x; Kohler K, 2005, BIOL CELL, V97, P659; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; LESERVE AW, 1972, BRIT MED J, V1, P597, DOI 10.1136/bmj.1.5800.597; Liebner S, 2000, ACTA NEUROPATHOL, V100, P323, DOI 10.1007/s004010000180; Mandel I, 2012, J CELL MOL MED, V16, P765, DOI 10.1111/j.1582-4934.2011.01380.x; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Osada T, 2011, J CEREBR BLOOD F MET, V31, P1972, DOI 10.1038/jcbfm.2011.99; Peters K, 2002, MICROVASC RES, V64, P334, DOI 10.1006/mvre.2002.2438; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Reynolds LE, 2006, METH MOLEC MED, V120, P503; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Thomlinson R H, 1977, J Clin Pathol Suppl (R Coll Pathol), V11, P105; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Amerongen GPV, 2007, ARTERIOSCL THROM VAS, V27, P2332, DOI 10.1161/ATVBAHA.107.152322; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Zicha D, 1997, Methods Mol Biol, V75, P449	44	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62516	10.1371/journal.pone.0062516	http://dx.doi.org/10.1371/journal.pone.0062516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675413	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100004
J	Chen, XM; Ding, GP; Gao, QH; Sun, J; Zhang, QQ; Du, LJ; Qiu, ZN; Wang, CJ; Zheng, F; Sun, BW; Ni, J; Feng, ZQ; Zhu, J				Chen, Ximin; Ding, Guipeng; Gao, Qihe; Sun, Jian; Zhang, Qianqian; Du, Lijian; Qiu, Zhenning; Wang, Changjun; Zheng, Feng; Sun, Bowang; Ni, Jian; Feng, Zhenqing; Zhu, Jin			A Human Anti-c-Met Fab Fragment Conjugated with Doxorubicin as Targeted Chemotherapy for Hepatocellular Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DRUG CONJUGATE; MONOCLONAL-ANTIBODY; CANCER-THERAPY; DELIVERY; EXPRESSION; LIPOSOMES; IMMUNOCONJUGATE; CONSTRUCTION; INHIBITOR	c-Met is over-expressed in hepatocellular carcinoma(HCC) but is absent or expressed at low levels in normal tissues. Therefore we generated a novel conjugate of a human anti-c-Met Fab fragment (MetFab) with doxorubicin (DOX) and assessed whether it had targeted antitumor activity against HCC and reduced the side-effects of DOX. The MetFab was screened from human phage library, conjugated with DOX via chemical synthesis, and the conjugation MetFab-DOX was confirmed by HPLC. The drug release patterns, the binding efficacy, and cellular distribution of MetFab-DOX were assessed. MetFab-DOX was stable at pH7.2 PBS while release doxorubicin quickly at pH4.0, the binding efficacy of MetFab-DOX was similarly as MetFab, and the cellular distribution of the MetFab-DOX is distinct from free DOX. The cytotoxicity of MetFab-DOX was analyzed by the MTT method and the nude mouse HCC model. The MetFab-DOX demonstrated cytotoxic effects on c-Met expressing-tumor cells, but not on the cells without c-Met expression. MetFab-DOX exerted anti-tumor effect and significantly reduced the side effect of free DOX in mice model. Furthermore, the localization of conjugate was confirmed by immunofluorescence staining of tumor tissue sections and optical tumor imaging, respectively, and the tissue-distribution of drug was compared between free DOX and MetFab-DOX treatment by spectrofluorometer. MetFab-DOX can localize to the tumor tissue, and the concentration of doxorubicin in the tumor was higher after MetFab-DOX administration than after DOX administration. In summary, MetFab-DOX can target c-Met expressing HCC cells effectively and have obvious antitumor activity with decreased side-effects in preclinical models of HCC.	[Chen, Ximin; Ding, Guipeng; Zhang, Qianqian; Du, Lijian; Qiu, Zhenning; Feng, Zhenqing; Zhu, Jin] Nanjing Med Univ, Key Lab Antibody Tech, Minist Hlth, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Wang, Changjun; Zheng, Feng; Zhu, Jin] Huadong Med Inst Biotech, Nanjing, Jiangsu, Peoples R China; [Gao, Qihe; Sun, Jian; Sun, Bowang] Southeast Univ, Sch Chem & Chem Engn, Nanjing, Jiangsu, Peoples R China; [Ni, Jian] Nanjing Med Univ, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Feng, Zhenqing] Nanjing Med Univ, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China; Nanjing Medical University; Nanjing Medical University	Feng, ZQ (corresponding author), Nanjing Med Univ, Key Lab Antibody Tech, Minist Hlth, Dept Pathol, Nanjing, Jiangsu, Peoples R China.	fengzhenqing@njmu.edu.cn; zjsimmons@yahoo.com.cn			State Major Basic Research Development Program of China (973 Project) [2010CB933902]; Health Department of Jiangsu Province [H200938]	State Major Basic Research Development Program of China (973 Project)(National Basic Research Program of China); Health Department of Jiangsu Province	This work was supported by a grant from State Major Basic Research Development Program of China (973 Project, No. 2010CB933902) and a grant from Health Department of Jiangsu Province (H200938). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD I, 1993, CANCER RES, V53, P1484; Alley SC, 2010, CURR OPIN CHEM BIOL, V14, P529, DOI 10.1016/j.cbpa.2010.06.170; Ayla Sule, 2011, Int J Cell Biol, V2011, P390238, DOI 10.1155/2011/390238; Blanc V, 2011, CLIN CANCER RES, V17, P6448, DOI 10.1158/1078-0432.CCR-11-0485; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Cardillo TM, 2011, CLIN CANCER RES, V17, P3157, DOI 10.1158/1078-0432.CCR-10-2939; Carter PJ, 2008, CANCER J, V14, P154, DOI 10.1097/PPO.0b013e318172d704; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Choueiri TK, 2013, J CLIN ONCOL, V31, P181, DOI 10.1200/JCO.2012.43.3383; de Claro RA, 2012, CLIN CANCER RES, V18, P5845, DOI 10.1158/1078-0432.CCR-12-1803; DiJoseph JF, 2005, CANCER IMMUNOL IMMUN, V54, P11, DOI 10.1007/s00262-004-0572-2; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Erickson HK, 2010, BIOCONJUGATE CHEM, V21, P84, DOI 10.1021/bc900315y; Etrych T, 2007, J CONTROL RELEASE, V122, P31, DOI 10.1016/j.jconrel.2007.06.007; Feldman DR, 2013, INVEST NEW DRUGS; Fiume L, 2005, J HEPATOL, V43, P645, DOI 10.1016/j.jhep.2005.02.045; Goyal L, 2013, CLIN CANC RES; Hao HY, 2006, ANTICANCER RES, V26, P1947; Hay RV, 2005, CLIN CANCER RES, V11, p7064S, DOI 10.1158/1078-0432.CCR-1004-0014; Huan ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044116; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; Inoh K, 2006, JPN J CLIN ONCOL, V36, P207, DOI 10.1093/jjco/hyl004; Iyer U, 2011, J PHARMACOL TOX MET, V64, P207, DOI 10.1016/j.vascn.2011.07.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Knudsen BS, 2009, APPL IMMUNOHISTO M M, V17, P57, DOI 10.1097/PAI.0b013e3181816ae2; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HS, 1998, J BIOMED SCI, V5, P180, DOI 10.1159/000025329; Lee RJ, 2013, CANCER J, V19, P90, DOI 10.1097/PPO.0b013e318281e280; Liao YJ, 2005, MOL BIOTECHNOL, V31, P41, DOI 10.1385/MB:31:1:041; Lindegren S, 2011, CURR RADIOPHARM, V4, P248, DOI 10.2174/1874471011104030248; Liu XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019848; Liu Z, 2013, IMMUNOL LETT, V149, P30, DOI 10.1016/j.imlet.2012.09.006; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lukyanov AN, 2004, J CONTROL RELEASE, V100, P135, DOI 10.1016/j.jconrel.2004.08.007; Mathew J, 2011, CURR OPIN ONCOL, V23, P594, DOI 10.1097/CCO.0b013e32834b895c; Matsudaira H, 2010, INT J ONCOL, V36, P77, DOI 10.3892/ijo_00000477; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petruzzi NJ, 2013, J VASC INTERV RADIOL, V24, P266, DOI 10.1016/j.jvir.2012.10.025; Polakis P, 2005, CURR OPIN PHARMACOL, V5, P382, DOI 10.1016/j.coph.2005.04.008; Polson AG, 2010, LEUKEMIA, V24, P1566, DOI 10.1038/leu.2010.141; Prajapati HJ, 2012, J VASC INTERV RADIOL, V23, P1286, DOI 10.1016/j.jvir.2012.07.003; Qin LX, 2004, J CANCER RES CLIN, V130, P497, DOI 10.1007/s00432-004-0572-9; Qin W, 2010, J BIOMED RES, V24, P145, DOI 10.1016/S1674-8301(10)60023-1; Qin YL, 2012, ANTI-CANCER DRUG, V23, P1047, DOI 10.1097/CAD.0b013e3283569759; Rodon J, 2008, CANCER CHEMOTH PHARM, V62, P911, DOI 10.1007/s00280-007-0672-8; Ross HJ, 2006, LUNG CANCER, V54, P69, DOI 10.1016/j.lungcan.2006.05.020; Sharkey RM, 2012, MOL CANCER THER, V11, P224, DOI 10.1158/1535-7163.MCT-11-0632; Steiner M, 2011, CLIN CANCER RES, V17, P6406, DOI 10.1158/1078-0432.CCR-11-0483; Sun B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030143; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wan JY, 2008, ACTA U MED NANJING N, V6, P697; Wang SW, 2007, CANCER LETT, V257, P87, DOI 10.1016/j.canlet.2007.07.002; Wang SY, 2004, J HEPATOL, V41, P267, DOI 10.1016/j.jhep.2004.04.013; Wang XN, 2011, MOL CANCER THER, V10, P1728, DOI 10.1158/1535-7163.MCT-11-0191; Weyergang A, 2011, LASER SURG MED, V43, P721, DOI 10.1002/lsm.21084; Zeglis BM, 2011, BIOCONJUGATE CHEM, V22, P2048, DOI 10.1021/bc200288d; Zhou XJ, 2012, INT J NANOMED, V7, P5465, DOI 10.2147/IJN.S33965; Zhu J, 2007, PROG BIOCHEM BIOPHYS, V34, P73	60	22	22	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63093	10.1371/journal.pone.0063093	http://dx.doi.org/10.1371/journal.pone.0063093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675455	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100028
J	Kermani, N; Abu-Hassan, ZA; Dieng, H; Ismail, NF; Attia, M; Ghani, IA				Kermani, Nadia; Abu-Hassan, Zainal-Abidin; Dieng, Hamady; Ismail, Noor Farehan; Attia, Mansour; Ghani, Idris Abd			Pathogenicity of Nosema sp (Microsporidia) in the Diamondback Moth, Plutella xylostella (Lepidoptera: Plutellidae)	PLOS ONE			English	Article							LYMANTRIA-DISPAR; GYPSY-MOTH; IMPACT; RESISTANCE; PYRAUSTA; HATCH; PESTS	Biological control using pathogenic microsporidia could be an alternative to chemical control of the diamondback moth (DBM) Plutella xylostella (Lepidoptera: Plutellidae). The microsporidium Nosema bombycis (NB) is one of the numerous pathogens that can be used in the Integrated Pest Management (IPM) of DBM. However, its pathogenicity or effectiveness can be influenced by various factors, particularly temperature. This study was therefore conducted to investigate the effect of temperature on NB infection of DBM larvae. Second-instar larvae at different doses (spore concentration: 0, 1x10(2),1x10(3),1x10(4), and 1x10(5)) at 15 degrees, 20 degrees, 25 degrees, 30 degrees and 35 degrees C and a relative humidity(RH) of 65% and light dark cycle (L: D) of 12:12. Larval mortality was recorded at 24 h intervals until the larvae had either died or pupated. The results showed that the spore concentration had a significant negative effect on larval survival at all temperatures, although this effect was more pronounced (92%) at 35 degrees C compared with that at 20 and 30 degrees C (similar or equal to 50%) and 25 degrees C (26%). Histological observations showed that Nosema preferentially infected the adipose tissue and epithelial cells of the midgut, resulting in marked vacuolization of the cytoplasm. These findings suggest that Nosema damaged the midgut epithelial cells. Our results suggest that Nosema had a direct adverse effect on DBM, and could be utilized as an important biopesticide alternative to chemical insecticides in IPM.	[Kermani, Nadia; Ismail, Noor Farehan; Attia, Mansour; Ghani, Idris Abd] Univ Kebangsaan Malaysia, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia; [Abu-Hassan, Zainal-Abidin] Univ Teknol MARA, Fac Med, Shah Alam, Selangor, Malaysia; [Dieng, Hamady] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia	Universiti Kebangsaan Malaysia; Universiti Teknologi MARA; Universiti Sains Malaysia	Ghani, IA (corresponding author), Univ Kebangsaan Malaysia, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia.	idrisgh@ukm.my	KERMANI, NADIA/ABH-4897-2020	KERMANI, NADIA/0000-0003-1914-1068	Ministry of Sciences, Technology and Innovation, Malaysia (MOSTI) [02-01-02 -SF0601, 05-01-02-SF1019]; Research University Grant (OUP) [OUP-2012-043, OUP-2013-043]	Ministry of Sciences, Technology and Innovation, Malaysia (MOSTI); Research University Grant (OUP)	This research was funded by grant No. (02-01-02 -SF0601) and (05-01-02-SF1019) from the Ministry of Sciences, Technology and Innovation, Malaysia (MOSTI) and Research University Grant (OUP): OUP-2012-043, OUP-2013-043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal A. K., 1997, SERICOLOGIA, V37, P11; BAUER LS, 1989, ENVIRON ENTOMOL, V18, P261, DOI 10.1093/ee/18.2.261; Becnel James J., 1999, P447; Becnel JJ, 2000, BIOL CONTROL, V18, P39, DOI 10.1006/bcon.1999.0805; Bruck DJ, 2001, J INVERTEBR PATHOL, V78, P210, DOI 10.1006/jipa.2001.5062; CANTWELL G E, 1970, American Bee Journal, V110, P222; Diss AL, 1996, OECOLOGIA, V106, P470, DOI 10.1007/BF00329704; Finney D.J., 1971, PROBIT ANAL; FUXA JR, 1981, J ECON ENTOMOL, V74, P99, DOI 10.1093/jee/74.1.99; Goertz D, 2004, J INVERTEBR PATHOL, V87, P105, DOI 10.1016/j.jip.2004.07.006; Goertz D, 2008, BIOCONTROL SCI TECHN, V18, P419, DOI 10.1080/09583150801993212; Haque MA, 1999, B ENTOMOL RES, V89, P147, DOI 10.1017/S0007485399000231; Humason G., 1967, ANIMAL TISSUE TECHNI; Idris AB, 2004, MANAGEMENT OF DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P295; Inglis GD, 2003, J ECON ENTOMOL, V96, P12, DOI 10.1603/0022-0493-96.1.12; Jolly M.S., 1972, Indian Journal of Sericulture, V11, P52; Lakshmi Velide, 2011, Journal of Applied Biosciences, V44, P2994; Rath SS, 2003, J INVERTEBR PATHOL, V83, P1, DOI 10.1016/S0022-2011(03)00038-7; Remadevi O. K., 2010, International Journal of Tropical Insect Science, V30, P138, DOI 10.1017/S1742758410000214; Salkeld EH, 1951, J CAN ENT, P8339; Shabir Ahmad B, 2009, AFRICAN J AGR RES, V13, P1519; SHELTON AM, 1993, J ECON ENTOMOL, V86, P11, DOI 10.1093/jee/86.1.11; SOLTER LF, 1990, J INVERTEBR PATHOL, V55, P337, DOI 10.1016/0022-2011(90)90076-I; Undeen Albert H., 1997, P117, DOI 10.1016/B978-012432555-5/50010-5; Wiwat C, 2000, J INVERTEBR PATHOL, V76, P270, DOI 10.1006/jipa.2000.4976; Yu CG, 1997, APPL ENVIRON MICROB, V63, P532, DOI 10.1128/AEM.63.2.532-536.1997; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhao JZ, 2002, J ECON ENTOMOL, V95, P430, DOI 10.1603/0022-0493-95.2.430	28	15	17	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62884	10.1371/journal.pone.0062884	http://dx.doi.org/10.1371/journal.pone.0062884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675435	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100016
J	Muthuramu, I; Jacobs, F; Singh, N; Gordts, SC; De Geest, B				Muthuramu, Ilayaraja; Jacobs, Frank; Singh, Neha; Gordts, Stephanie C.; De Geest, Bart			Selective Homocysteine Lowering Gene Transfer Improves Infarct Healing, Attenuates Remodelling, and Enhances Diastolic Function after Myocardial Infarction in Mice	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; INNATE IMMUNE-RESPONSES; APO A-I; NITRIC-OXIDE; HEART-FAILURE; HYPERHOMOCYSTEINEMIA LEADS; IMPAIRS ANGIOGENESIS; PLASMA HOMOCYSTEINE; MURINE MODEL; STRESS	Background and aims: Homocysteine levels predict heart failure incidence in prospective epidemiological studies and correlate with severity of heart failure in cross-sectional surveys. The objective of this study was to evaluate whether a selective homocysteine lowering intervention beneficially affects cardiac remodelling and cardiac function after myocardial infarction (MI) in a murine model of combined hypercholesterolemia and hyperhomocysteinemia. Methodology and principal findings: A selective homocysteine lowering gene transfer strategy was evaluated in female C57BL/6 low density lipoprotein receptor (Ldlr)(-/-) cystathionine-beta-synthase (Cbs)(+/-) deficient mice fed a hyperhomocysteinemic and high saturated fat/high cholesterol diet using an E1E3E4-deleted hepatocyte-specific adenoviral vector expressing Cbs (AdCBS). MI was induced by permanent ligation of the left anterior descending coronary artery 14 days after saline injection or gene transfer. AdCBS gene transfer resulted in a persistent more than 5-fold (p < 0.01) decrease of plasma homocysteine levels and significantly improved endothelial progenitor cell function. Selective homocysteine lowering enhanced infarct healing as indicated by a 21% (p, 0.01) reduction of infarct length at day 28 after MI and by an increased number of capillaries and increased collagen content in the infarct zone. Adverse remodelling was attenuated in AdCBS MI mice as evidenced by a 29% (p < 0.05) reduction of left ventricular cavity area at day 28, by an increased capillary density in the remote myocardium, and by reduced interstitial collagen. The peak rate of isovolumetric relaxation was increased by 19% (p < 0.05) and the time constant of left ventricular relaxation was reduced by 21% (p < 0.05) in AdCBS MI mice compared to control MI mice, indicating improved diastolic function. Conclusion/significance: Selective homocysteine lowering gene transfer improves infarct healing, attenuates remodelling, and significantly enhances diastolic function post-MI in female C57BL/6 Ldlr(-/-) Cbs(+/-) mice. The current study corroborates the view that hyperhomocysteinemia exerts direct effects on the myocardium and may potentiate the development of heart failure.	[Muthuramu, Ilayaraja; Jacobs, Frank; Singh, Neha; Gordts, Stephanie C.; De Geest, Bart] Catholic Univ Louvain, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium	Universite Catholique Louvain	De Geest, B (corresponding author), Catholic Univ Louvain, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium.	bart.degeest@med.kuleuven.be	Muthuramu, Ilayaraja/R-2199-2018; De Geest, Bart/AHB-0394-2022; Jacobs, Frank/GSD-3616-2022	Muthuramu, Ilayaraja/0000-0003-3550-7672; De Geest, Bart/0000-0001-5580-686X	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0599.09N]; Onderzoekstoelagen of the K.U. Leuven [OT/11/083]	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Onderzoekstoelagen of the K.U. Leuven	This work was supported by grant G.0599.09N the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen and by Onderzoekstoelagen OT/11/083 of the K.U. Leuven. Frank Jacobs is a postdoctoral fellow of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. Stephanie C. Gordts is a Research Assistant of the Agentschap voor Innovatie door Wetenschap en Technologie (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bosch-Marce M, 2005, VASC MED, V10, P15, DOI 10.1191/1358863x05vm585oa; De Geest B, 2005, HUM GENE THER, V16, P1439; Duan JL, 2000, ARTERIOSCL THROM VAS, V20, P2579, DOI 10.1161/01.ATV.20.12.2579; Feng Y, 2008, ARTERIOSCL THROM VAS, V28, P278, DOI 10.1161/ATVBAHA.107.158741; Feng YM, 2009, BLOOD, V113, P755, DOI 10.1182/blood-2008-06-161794; Gordts SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046849; Herrmann M, 2007, AM J CLIN NUTR, V85, P117, DOI 10.1093/ajcn/85.1.117; Herrmann M, 2006, EUR J HEART FAIL, V8, P571, DOI 10.1016/j.ejheart.2005.11.016; Jacobs F, 2008, GENE THER, V15, P594, DOI 10.1038/sj.gt.3303096; Jacobs F, 2011, J MOL MED, V89, P1051, DOI 10.1007/s00109-011-0778-7; Jacobs F, 2008, ATHEROSCLEROSIS, V201, P289, DOI 10.1016/j.atherosclerosis.2008.02.023; Joseph J, 2003, AM J PHYSIOL-HEART C, V285, pH679, DOI 10.1152/ajpheart.00145.2003; Joseph J, 2002, AM J PHYSIOL-HEART C, V283, pH2567, DOI 10.1152/ajpheart.00475.2002; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kundu S, 2009, J CELL BIOCHEM, V106, P119, DOI 10.1002/jcb.21982; Loscalzo J, 1996, J CLIN INVEST, V98, P5, DOI 10.1172/JCI118776; Lu F, 2007, J MOL CELL CARDIOL, V43, P535, DOI 10.1016/j.yjmcc.2007.06.011; Nasir K, 2007, CIRCULATION, V115, P180, DOI 10.1161/CIRCULATIONAHA.106.633750; Raaf L, 2011, MOL CELL BIOCHEM, V347, P63, DOI 10.1007/s11010-010-0612-5; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; Shimizu I, 2010, J CLIN INVEST, V120, P1506, DOI 10.1172/JCI40096; Sood HS, 2002, ANTIOXID REDOX SIGN, V4, P799, DOI 10.1089/152308602760598954; Suematsu N, 2007, CIRCULATION, V115, P255, DOI 10.1161/CIRCULATIONAHA.106.652693; Sundstroma J, 2004, EUR HEART J, V25, P523, DOI 10.1016/j.ehj.2004.01.008; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Topal G, 2004, FREE RADICAL BIO MED, V36, P1532, DOI 10.1016/j.freeradbiomed.2004.03.019; Van Craeyveld E, 2012, GENE THER, V19, P860, DOI 10.1038/gt.2011.147; Van Craeyveld E, 2011, J MOL MED, V89, P555, DOI 10.1007/s00109-011-0722-x; Van Linthout S, 2002, GENE THER, V9, P1520, DOI 10.1038/sj.gt.3301824; Vasan RS, 2003, JAMA-J AM MED ASSOC, V289, P1251, DOI 10.1001/jama.289.10.1251; Velagaleti RS, 2009, CIRCULATION, V120, P2345, DOI 10.1161/CIRCULATIONAHA.109.830984; Wang TD, 1998, AM J CARDIOL, V81, P531, DOI 10.1016/S0002-9149(97)00974-0; WEISS JL, 1976, J CLIN INVEST, V58, P751, DOI 10.1172/JCI108522; Wollert KC, 2002, HYPERTENSION, V39, P87, DOI 10.1161/hy1201.097292; Wu JC, 2003, J AM SOC ECHOCARDIOG, V16, P1158, DOI 10.1067/S0894-7317(03)00648-5; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002	38	8	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63710	10.1371/journal.pone.0063710	http://dx.doi.org/10.1371/journal.pone.0063710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675503	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100047
J	Dai, CY; Sun, FF; Zhu, CP; Hu, X				Dai, Chunyan; Sun, Feifei; Zhu, Chunpeng; Hu, Xun			Tumor Environmental Factors Glucose Deprivation and Lactic Acidosis Induce Mitotic Chromosomal Instability - An Implication in Aneuploid Human Tumors	PLOS ONE			English	Article							CHECKPOINT GENES BUB1; IN-SITU HYBRIDIZATION; CENTROSOME AMPLIFICATION; MULTIPLE CENTROSOMES; CANCER-CELLS; LOW PH; OVEREXPRESSION; LACTATE; RISK; TUMORIGENESIS	Mitotic chromosomal instability (CIN) plays important roles in tumor progression, but what causes CIN is incompletely understood. In general, tumor CIN arises from abnormal mitosis, which is caused by either intrinsic or extrinsic factors. While intrinsic factors such as mitotic checkpoint genes have been intensively studied, the impact of tumor microenvironmental factors on tumor CIN is largely unknown. We investigate if glucose deprivation and lactic acidosis - two tumor microenvironmental factors - could induce cancer cell CIN. We show that glucose deprivation with lactic acidosis significantly increases CIN in 4T1, MCF-7 and HCT116 scored by micronuclei, or aneuploidy, or abnormal mitosis, potentially via damaging DNA, up-regulating mitotic checkpoint genes, and/or amplifying centrosome. Of note, the feature of CIN induced by glucose deprivation with lactic acidosis is similar to that of aneuploid human tumors. We conclude that tumor environmental factors glucose deprivation and lactic acidosis can induce tumor CIN and propose that they are potentially responsible for human tumor aneuploidy.	[Dai, Chunyan; Zhu, Chunpeng; Hu, Xun] Zhejiang Univ, Inst Canc, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Feifei] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Zhejiang University; State Key Lab Oncology South China; Sun Yat Sen University	Hu, X (corresponding author), Zhejiang Univ, Inst Canc, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	huxun@zju.edu.cn		Zhu, Chunpeng/0000-0003-4861-985X	National 863 project [2007AA02Z143]; China Natural Sciences Foundation [30772544, 81071802]; Fundamental Research Funds for the Central Universities, National Ministry of Education, China	National 863 project(National High Technology Research and Development Program of China); China Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, National Ministry of Education, China	This work was supported in part by National 863 project (2007AA02Z143), China Natural Sciences Foundation projects (30772544, 81071802), and the Fundamental Research Funds for the Central Universities, National Ministry of Education, China, to X Hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibaldi A, 2010, CURR OPIN CLIN NUTR, V13, P466, DOI 10.1097/MCO.0b013e32833a5577; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Borel F, 2002, P NATL ACAD SCI USA, V99, P9819, DOI 10.1073/pnas.152205299; Brendle A, 2009, EUR J CANCER, V45, P435, DOI 10.1016/j.ejca.2008.10.001; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Camps J, 2005, FASEB J, V19, P828, DOI 10.1096/fj.04-2276fje; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chen JLY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000293; Choi CM, 2009, LUNG CANCER, V64, P66, DOI 10.1016/j.lungcan.2008.07.016; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fleming RA HK, 2008, EORTC NCI AACR INT C; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gergely F, 2008, GENE DEV, V22, P2291, DOI 10.1101/gad.1715208; Grabsch H, 2003, J PATHOL, V200, P16, DOI 10.1002/path.1324; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; HOLROYDE CP, 1979, CANCER RES, V39, P4900; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Karpinets TV, 2005, CARCINOGENESIS, V26, P1323, DOI 10.1093/carcin/bgi079; LEVINE DS, 1991, GASTROENTEROLOGY, V101, P1198, DOI 10.1016/0016-5085(91)90068-V; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; MORITA T, 1992, MUTAT RES, V268, P297, DOI 10.1016/0027-5107(92)90235-T; MORITA T, 1995, MUTAT RES-ENVIR MUTA, V334, P301, DOI 10.1016/0165-1161(95)90067-5; Pihan GA, 2003, CANCER RES, V63, P1398; Pihan GA, 1998, CANCER RES, V58, P3974; Pinto M, 2008, CELL ONCOL, V30, P389, DOI 10.3233/CLO-2008-0439; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; REID BJ, 1987, GASTROENTEROLOGY, V93, P1; Reynolds TY, 1996, CANCER RES, V56, P5754; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; SKINNER SA, 1990, CANCER RES, V50, P2411; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; THISTLETHWAITE AJ, 1985, INT J RADIAT ONCOL, V11, P1647, DOI 10.1016/0360-3016(85)90217-2; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; van Sluis R, 1999, MAGN RESON MED, V41, P743, DOI 10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z; VORAVUD N, 1993, CANCER RES, V53, P2874; Wada N, 2008, ANTICANCER RES, V28, P139; WALDMAN FM, 1991, CANCER RES, V51, P3807; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; Walenta S, 2000, CANCER RES, V60, P916; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wu H, 2012, J PATHOL, V227, P189, DOI 10.1002/path.3978; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001	56	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63054	10.1371/journal.pone.0063054	http://dx.doi.org/10.1371/journal.pone.0063054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675453	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400022
J	Wang, H; Li, NN; Zhu, HD; Xu, SM; Lu, H; Feng, ZC				Wang, Heng; Li, NianNian; Zhu, Haidi; Xu, Shuman; Lu, Hua; Feng, ZhanChun			Prescription Pattern and Its Influencing Factors in Chinese County Hospitals: A Retrospective Cross-Sectional Study	PLOS ONE			English	Article							RATIONAL DRUG-USE; FACILITIES; CARE	Objective: This study aimed to investigate prescription patterns and influencing factors in Chinese county hospitals. Methods: Prescription quality was evaluated by five indicators proposed by WHO/INRUD. A questionnaire for doctors was designed by our research group. All internists, surgeons, obstetricians, gynecologists and pediatricians from 10 county hospitals in Anhui province were asked to fill the questionnaire. Their prescriptions from May 2011 to April 2012 were analyzed. Results: Three-hundred and thirty-seven doctors completed valid questionnaires, and 5099 prescriptions were analyzed. The average number of drugs per prescription was 3.52+/-2.31; the average percentage of generic drugs, antibiotic usage, injection drug usage, and drugs prescribed from the national essential drug list were 96.12%, 29.90%, 20.02% and 48.85%, respectively. Differences in final academic degree and specialty led to differences in all of the five prescription quality indicators. The older doctors tended to use more antibiotics. Doctors with more education, more training on rational drug use, and better acquisition of medicine knowledge prescribe a lower percentage of generic drugs. Moreover, the more supportive the doctor's attitude to national essential medicine policy, the higher the percentage of generic drugs were prescribed. A higher level of medical knowledge was associated with a higher percentage of drugs prescribed from the essential drugs list. Conclusions: Promoting the education of medical knowledge on doctors, reinforcing the publicity of rational drug use to doctors, and initiating the performance evaluation for doctors are effective ways for improving prescription quality in Chinese county hospitals.	[Wang, Heng; Zhu, Haidi; Feng, ZhanChun] Huazhong Univ Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Wang, Heng; Li, NianNian] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Xu, Shuman; Lu, Hua] Anhui Med Univ, Social Sci & Hlth Management Sch, Hefei, Anhui, Peoples R China	Huazhong University of Science & Technology; Anhui Medical University; Anhui Medical University	Feng, ZC (corresponding author), Huazhong Univ Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	zcfeng@mails.tjmu.edu.cn			soft science planning project of Anhui province [12020503084]; Humanities Social Science Planning Project of Ministry of Education [12YJA630121]	soft science planning project of Anhui province; Humanities Social Science Planning Project of Ministry of Education	This study was supported by grants from soft science planning project of Anhui province (12020503084) (http://www.ahkjt.gov.cn/) and the Humanities Social Science Planning Project of Ministry of Education (12YJA630121), (http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo ET, 2010, ANN AFR MED, V9, P152, DOI 10.4103/1596-3519.68366; Andersen M, 2006, JAMA-J AM MED ASSOC, V295, P2759, DOI 10.1001/jama.295.23.2759; Bashrahil K. A., 2010, Eastern Mediterranean Health Journal, V16, P151; Daohai C, 2012, EVALUATION ANAL DRUG, V12, P373; Figueiras A, 2001, J EVAL CLIN PRACT, V7, P223, DOI 10.1046/j.1365-2753.2001.00234.x; GREENHALGH T, 1987, SOC SCI MED, V25, P307, DOI 10.1016/0277-9536(87)90233-4; HOGERZEIL HV, 1995, BRIT J CLIN PHARMACO, V39, P1; HOGERZEIL HV, 1993, LANCET, V342, P1408, DOI 10.1016/0140-6736(93)92760-Q; Hua L, 2009, EVALUATION ANAL DRUG, V9, P280; Irshaid YM, 2004, SAUDI MED J, V25, P1864; Keohavong B, 2006, PHARMACOEPIDEM DR S, V15, P344, DOI 10.1002/pds.1169; Kun Y, 2002, CHIN J HOSP ADM, V18, P92; Lianzhen C, 2003, CHINA PHARM, V14, P156; Mahajan R, 2010, J PHARM BIOALLIED SC, V2, P132, DOI 10.4103/0975-7406.67008; MELVILLE A, 1980, SOC SCI MED-MED SOC, V14, P495, DOI 10.1016/0160-7979(80)90050-8; Menik HL, 2011, J PHARM BIOALLIED SC, V3, P165, DOI 10.4103/0975-7406.76502; Orzella L, 2010, HEALTH POLICY, V95, P236, DOI 10.1016/j.healthpol.2009.12.005; Trap B, 2002, HEALTH POLICY PLANN, V17, P288, DOI 10.1093/heapol/17.3.288; Uzochukwu BS, 2002, HEALTH POLICY PLANN, V17, P378, DOI 10.1093/heapol/17.4.378; Vallano A, 2004, EUR J CLIN PHARMACOL, V60, P725, DOI 10.1007/s00228-004-0802-8; Weihui D, 2009, ANAL INFLUENCE FACTO; WHO, 1993, ACT PROGR ESS DRUGS, P1; WHO, 2003, WHO TECH REP SER, V914; WHO Website, 2010, WHO WEBS 10 FACTS ES; World Health Organization, 2004, EQ ACC ESS MED FRAM; World Health Organization, 2011, WORLD MED SIT 2011 M; Xinyi Z, 2010, CHINESE J PHARMACOVI, V7, P755; Younis MZ, 2009, PHARMACOECONOMICS OU, V9, P243	28	33	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63225	10.1371/journal.pone.0063225	http://dx.doi.org/10.1371/journal.pone.0063225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143FO	23675465	Green Submitted, Green Published, gold			2022-12-25	WOS:000318852400031
J	Wood, EM; Pidgeon, AM; Radeloff, VC; Keuler, NS				Wood, Eric M.; Pidgeon, Anna M.; Radeloff, Volker C.; Keuler, Nicholas S.			Image Texture Predicts Avian Density and Species Richness	PLOS ONE			English	Article							VEGETATION STRUCTURE; GRASSLAND BIRDS; HABITAT SELECTION; SATELLITE IMAGERY; AIRBORNE LIDAR; BIODIVERSITY; DIVERSITY; PATTERNS; ENCROACHMENT; ASSOCIATIONS	For decades, ecologists have measured habitat attributes in the field to understand and predict patterns of animal distribution and abundance. However, the scale of inference possible from field measured data is typically limited because large-scale data collection is rarely feasible. This is problematic given that conservation and management typical require data that are fine grained yet broad in extent. Recent advances in remote sensing methodology offer alternative tools for efficiently characterizing wildlife habitat across broad areas. We explored the use of remotely sensed image texture, which is a surrogate for vegetation structure, calculated from both an air photo and from a Landsat TM satellite image, compared with field-measured vegetation structure, characterized by foliage-height diversity and horizontal vegetation structure, to predict avian density and species richness within grassland, savanna, and woodland habitats at Fort McCoy Military Installation, Wisconsin, USA. Image texture calculated from the air photo best predicted density of a grassland associated species, grasshopper sparrow (Ammodramus savannarum), within grassland habitat (R-2 = 0.52, p-value <0.001), and avian species richness among habitats (R-2 = 0.54, p-value <0.001). Density of field sparrow (Spizella pusilla), a savanna associated species, was not particularly well captured by either field-measured or remotely sensed vegetation structure variables, but was best predicted by air photo image texture (R-2 = 0.13, p-value = 0.002). Density of ovenbird (Seiurus aurocapillus), a woodland associated species, was best predicted by pixel-level satellite data (mean NDVI, R-2 = 0.54, p-value <0.001). Surprisingly and interestingly, remotely sensed vegetation structure measures (i.e., image texture) were often better predictors of avian density and species richness than field-measured vegetation structure, and thus show promise as a valuable tool for mapping habitat quality and characterizing biodiversity across broad areas.	[Wood, Eric M.; Pidgeon, Anna M.; Radeloff, Volker C.; Keuler, Nicholas S.] Univ Wisconsin Madison, Dept Forest & Wildlife Ecol, Madison, WI USA; [Keuler, Nicholas S.] Univ Wisconsin Madison, Dept Stat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wood, EM (corresponding author), Univ Wisconsin Madison, Dept Forest & Wildlife Ecol, Madison, WI USA.	emwood@wisc.edu	Radeloff, Volker C/B-6124-2016	Radeloff, Volker C/0000-0001-9004-221X; Wood, Eric/0000-0003-2787-6451	U.S. Strategic Environmental Research and Development Program [RC-1438]	U.S. Strategic Environmental Research and Development Program	Eric Wood and Anna Pidgeon received financial support from the U.S. Strategic Environmental Research and Development Program, Project RC-1438 (http://www.serdp.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGUST PV, 1983, ECOLOGY, V64, P1495, DOI 10.2307/1937504; Bellis LM, 2008, ECOL APPL, V18, P1956, DOI 10.1890/07-0243.1; Bergen KM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000883; BEST LB, 1977, CONDOR, V79, P192, DOI 10.2307/1367162; Bestelmeyer BT, 2001, ECOL APPL, V11, P1123, DOI 10.1890/1051-0761(2001)011[1123:ABISLM]2.0.CO;2; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bock CE, 2004, FRONT ECOL ENVIRON, V2, P403, DOI 10.2307/3868428; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Buckland S.T., 2001, pi; Burley F.W., 1988, P227; California USA, 2006, ARCGIS 9 1; Canty A, 2011, J AM STAT ASSOC, V88, P486; Clawges R, 2008, REMOTE SENS ENVIRON, V112, P2064, DOI 10.1016/j.rse.2007.08.023; Cody M.L., 1985, HABITATS SELECTION B; CODY ML, 1981, BIOSCIENCE, V31, P107, DOI 10.2307/1308252; Coops NC, 2009, J BIOGEOGR, V36, P905, DOI 10.1111/j.1365-2699.2008.02053.x; Culbert PD, 2012, REMOTE SENS ENVIRON, V118, P140, DOI 10.1016/j.rse.2011.11.004; Curtis JT, 1959, VEGETATION WISCONSIN; Estades CF, 1997, CONDOR, V99, P719, DOI 10.2307/1370483; Estes LD, 2008, REMOTE SENS ENVIRON, V112, P2033, DOI 10.1016/j.rse.2008.01.004; Estes LD, 2010, REMOTE SENS ENVIRON, V114, P792, DOI 10.1016/j.rse.2009.11.016; GAUSMAN HW, 1977, REMOTE SENS ENVIRON, V6, P1, DOI 10.1016/0034-4257(77)90015-3; GREENSTONE MH, 1984, OECOLOGIA, V62, P299, DOI 10.1007/BF00384260; Grundel R, 2007, AUK, V124, P969, DOI 10.1642/0004-8038(2007)124[969:DUAVOM]2.0.CO;2; Hall-Beyer M., 2007, GLCM TUTORIAL HOME P; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hepinstall JA, 1997, PHOTOGRAMM ENG REM S, V63, P1231; Hothorn T, 2011, ECOL MONOGR, V81, P329, DOI 10.1890/10-0602.1; Hudak AT, 1998, REMOTE SENS ENVIRON, V66, P317, DOI 10.1016/S0034-4257(98)00078-9; Hudak AT, 2001, INT J REMOTE SENS, V22, P2731, DOI 10.1080/01431160152518660; HUTTO RL, 1986, AUK, V103, P593, DOI 10.1093/auk/103.3.593; Johnson DH, 2001, AUK, V118, P24, DOI 10.1642/0004-8038(2001)118[0024:AROGBA]2.0.CO;2; KARR JR, 1971, AM NAT, V105, P423, DOI 10.1086/282735; Laurent EJ, 2005, REMOTE SENS ENVIRON, V97, P249, DOI 10.1016/j.rse.2005.04.015; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; MAC NALLY RC, 1990, AUST J ECOL, V15, P321, DOI 10.1111/j.1442-9993.1990.tb01036.x; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Martin T. E., 1997, BBIRD FIELD PROTOCOL; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; MURDOCH WW, 1972, ECOLOGY, V53, P819, DOI 10.2307/1934297; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Pasher J, 2007, REMOTE SENS ENVIRON, V107, P471, DOI 10.1016/j.rse.2006.09.022; Patterson MP, 1996, AM MIDL NAT, V135, P153, DOI 10.2307/2426881; Pidgeon AM, 2001, CONSERV BIOL, V15, P1772, DOI 10.1046/j.1523-1739.2001.00073.x; R Core Team, 2012, LANG ENV STAT COMP; RALPH CJ, 1995, MONITORING BIRD POPU, P161; Ribic CA, 2001, AM MIDL NAT, V146, P105, DOI 10.1674/0003-0031(2001)146[0105:AOGBWL]2.0.CO;2; Ribic CA, 2009, AUK, V126, P233, DOI 10.1525/auk.2009.1409; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROTENBERRY JT, 1985, OECOLOGIA, V67, P213, DOI 10.1007/BF00384286; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; ROUGHGARDEN J, 1991, ECOLOGY, V72, P1918, DOI 10.2307/1941546; St-Louis V, 2006, REMOTE SENS ENVIRON, V105, P299, DOI 10.1016/j.rse.2006.07.003; St-Louis V, 2009, ECOGRAPHY, V32, P468, DOI 10.1111/j.1600-0587.2008.05512.x; STENGER JUDITH, 1958, AUK, V75, P335; STOMS DM, 1993, INT J REMOTE SENS, V14, P1839, DOI 10.1080/01431169308954007; Sutherland W., 2000, CONSERVATION HDB RES; SZARO RC, 1996, BIODIVERSITY MANAGED; Thomas L., 2004, DISTANCE 4 1 RELEASE; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Tuttle EM, 2006, GLOBAL ECOL BIOGEOGR, V15, P349, DOI 10.1111/j.1466-822x.2006.00232.x; Vie J-C, 2009, WILDLIFE CHANGING WO; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; WIENS JA, 1981, ECOL MONOGR, V51, P21, DOI 10.2307/2937305; WIENS JA, 1973, ECOLOGY, V54, P877, DOI 10.2307/1935683; WILLIAMS PH, 1994, BIOL CONSERV, V67, P211, DOI 10.1016/0006-3207(94)90612-2; Wood EM, 2012, REMOTE SENS ENVIRON, V121, P516, DOI 10.1016/j.rse.2012.01.003; Wood EM, 2011, BIOL CONSERV, V144, P3117, DOI 10.1016/j.biocon.2011.10.010	70	47	49	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63211	10.1371/journal.pone.0063211	http://dx.doi.org/10.1371/journal.pone.0063211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675463	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400029
J	Floss, DM; Mrotzek, S; Klocker, T; Schroder, J; Grotzinger, J; Rose-John, S; Scheller, J				Floss, Doreen M.; Mrotzek, Simone; Kloecker, Tobias; Schroeder, Jutta; Groetzinger, Joachim; Rose-John, Stefan; Scheller, Juergen			Identification of Canonical Tyrosine-dependent and Non-canonical Tyrosine-independent STAT3 Activation Sites in the Intracellular Domain of the Interleukin 23 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; CYTOKINE; IL-23; CELLS; IL-12; ROLES; EXPRESSION; RESPONSES; IMMUNITY; ANTIBODY	Signaling of interleukin 23 (IL-23) via the IL-23 receptor (IL-23R) and the shared IL-12 receptor beta 1 (IL-12R beta 1) controls innate and adaptive immune responses and is involved in the differentiation and expansion of IL-17-producing CD4(+) T helper (T(H)17) cells. Activation of signal transducer and activator of transcription 3 (STAT3) appears to be the major signaling pathway of IL-23, and STAT binding sites were predicted in the IL-23R but not in the IL-12R beta 1 chain. Using site-directed mutagenesis and deletion variants of the murine and human IL-23R, we showed that the predicted STAT binding sites (pYXXQ; including Tyr-504 and Tyr-626 in murine IL-23R and Tyr-484 and Tyr-611 in human IL-23R) mediated STAT3 activation. Furthermore, we identified two uncommon STAT3 binding/activation sites within the murine IL-23R. First, the murine IL-23R carried the Y(542)PNFQ sequence, which acts as an unusual Src homology 2 (SH2) domain-binding protein activation site of STAT3. Second, we identified a non-canonical, phosphotyrosine-independent STAT3 activation motif within the IL-23R. A third predicted site, Tyr-416 in murine and Tyr-397 in human IL-23R, is involved in the activation of PI3K/Akt and the MAPK pathway leading to STAT3-independent proliferation of Ba/F3 cells upon stimulation with IL-23. In contrast to IL-6-induced short term STAT3 phosphorylation, cellular activation by IL-23 resulted in a slower but long term STAT3 phosphorylation, indicating that the IL-23R might not be a major target of negative feedback inhibition by suppressor of cytokine signaling (SOCS) proteins. In summary, we characterized IL-23-dependent signal transduction with a focus on STAT3 phosphorylation and identified canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the IL-23R.	[Floss, Doreen M.; Mrotzek, Simone; Kloecker, Tobias; Schroeder, Jutta; Scheller, Juergen] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany; [Groetzinger, Joachim; Rose-John, Stefan] Univ Kiel, Inst Biochem, Fac Med, D-24118 Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel	Scheller, J (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015; Rose-John, Stefan/A-7998-2010	Rose-John, Stefan/0000-0002-7519-3279	Deutsche Forschungsgemeinschaft (Bonn, Germany) [SCHE 907/2-1]; Forschungskommission of Heinrich-Heine-University Dusseldorf (Medical Faculty) [08/2011]	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Forschungskommission of Heinrich-Heine-University Dusseldorf (Medical Faculty)	This work was supported by Deutsche Forschungsgemeinschaft (Bonn, Germany) Grants SCHE 907/2-1 and by Forschungskommission of Heinrich-Heine-University Dusseldorf (Medical Faculty) Grant 08/2011.	Althoff K, 2001, BIOCHEM J, V353, P663, DOI 10.1042/0264-6021:3530663; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; CASE RD, 1994, J BIOL CHEM, V269, P10467; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Cocco C, 2010, BLOOD, V116, P3887, DOI 10.1182/blood-2009-10-248245; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; de Paus RA, 2008, MOL IMMUNOL, V45, P3889, DOI 10.1016/j.molimm.2008.06.029; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; Dumoutier L, 2009, J BIOL CHEM, V284, P26377, DOI 10.1074/jbc.M109.007955; Eulenfeld R, 2012, EUR J CELL BIOL, V91, P486, DOI 10.1016/j.ejcb.2011.09.010; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Naeger LK, 1999, J BIOL CHEM, V274, P1875, DOI 10.1074/jbc.274.4.1875; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pidasheva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025038; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Sarin R, 2011, P NATL ACAD SCI USA, V108, P9560, DOI 10.1073/pnas.1017854108; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Suthaus J, 2010, MOL BIOL CELL, V21, P2797, DOI 10.1091/mbc.E10-03-0240; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Ward AC, 1999, BLOOD, V93, P113, DOI 10.1182/blood.V93.1.113.401k33_113_124; Wiederkehr-Adam M, 2003, J BIOL CHEM, V278, P16117, DOI 10.1074/jbc.M300261200; Yao BB, 1999, ARCH BIOCHEM BIOPHYS, V368, P147, DOI 10.1006/abbi.1999.1302; Zheng Y, 2011, BLOOD, V118, P156, DOI 10.1182/blood-2010-01-266320	53	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19386	19400		10.1074/jbc.M112.432153	http://dx.doi.org/10.1074/jbc.M112.432153			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23673666	hybrid, Green Published			2022-12-25	WOS:000321515800008
J	Tagami, T; Yamashita, K; Okuyama, M; Mori, H; Yao, M; Kimura, A				Tagami, Takayoshi; Yamashita, Keitaro; Okuyama, Masayuki; Mori, Haruhide; Yao, Min; Kimura, Atsuo			Molecular Basis for the Recognition of Long-chain Substrates by Plant alpha-Glucosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTASE-GLUCOAMYLASE; SUBSITE AFFINITIES; SPECIFICITY; SEEDS; CONSERVATION; PURIFICATION; FORMS	Sugar beet alpha-glucosidase (SBG), a member of glycoside hydrolase family 31, shows exceptional long-chain specificity, exhibiting higher k(cat)/K-m values for longer malto-oligosaccharides. However, its amino acid sequence is similar to those of other short chain-specific alpha-glucosidases. To gain structural insights into the long-chain substrate recognition of SBG, a crystal structure complex with the pseudotetrasaccharide acarbose was determined at 1.7 angstrom resolution. The active site pocket of SBG is formed by a (beta/alpha)(8) barrel domain and a long loop (N-loop) bulging from the N-terminal domain similar to other related enzymes. Two residues (Phe-236 and Asn-237) in the N-loop are important for the long-chain specificity. Kinetic analysis of an Asn-237 mutant enzyme and a previous study of a Phe-236 mutant enzyme demonstrated that these residues create subsites +2 and +3. The structure also indicates that Phe-236 and Asn-237 guide the reducing end of long substrates to subdomain b2, which is an additional element inserted into the (beta/alpha)(8) barrel domain. Subdomain b2 of SBG includes Ser-497, which was identified as the residue at subsite +4 by site-directed mutagenesis.	[Tagami, Takayoshi; Okuyama, Masayuki; Mori, Haruhide; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Yamashita, Keitaro; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Okuyama, M (corresponding author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	okuyama@abs.agr.hokudai.ac.jp; kimura@abs.agr.hokudai.ac.jp	yao, min/F-5287-2011; Okuyama, Masayuki/D-8739-2012; Mori, Haruhide/AAV-6374-2021; Mori, Haruhide/B-7777-2012; Tagami, Takayoshi/Q-3953-2019	yao, min/0000-0003-1687-5904; Okuyama, Masayuki/0000-0001-7013-6032; Mori, Haruhide/0000-0001-7346-9131; Yamashita, Keitaro/0000-0002-5442-7582; Tagami, Takayoshi/0000-0002-4004-1558				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHIBA S, 1979, AGR BIOL CHEM TOKYO, V43, P237, DOI 10.1080/00021369.1979.10863439; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; HIZUKURI S, 1978, CARBOHYD RES, V63, P261, DOI 10.1016/S0008-6215(00)80950-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; IM H, 1995, CARBOHYD RES, V277, P145, DOI 10.1016/0008-6215(95)00212-C; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; Imperiali B, 1995, BIOORGAN MED CHEM, V3, P1565, DOI 10.1016/0968-0896(95)00142-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KITA A, 1991, AGR BIOL CHEM TOKYO, V55, P2327, DOI 10.1080/00021369.1991.10870952; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATSUI H, 1978, AGR BIOL CHEM TOKYO, V42, P1855, DOI 10.1080/00021369.1978.10863265; Nakai H, 2007, J BIOCHEM, V142, P491, DOI 10.1093/jb/mvm174; Nakai H, 2007, BIOCHIMIE, V89, P49, DOI 10.1016/j.biochi.2006.09.014; Okuyama M, 2005, ENZYME MICROB TECH, V37, P472, DOI 10.1016/j.enzmictec.2004.06.018; Quezada-Calvillo R, 2007, J NUTR, V137, P1725, DOI 10.1093/jn/137.7.1725; Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3; Sato F, 2005, BIOSCI BIOTECH BIOCH, V69, P1905, DOI 10.1271/bbb.69.1905; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; SUGIMOTO M, 1995, BIOSCI BIOTECH BIOCH, V59, P673, DOI 10.1271/bbb.59.673; Tagami T, 2013, BBA-PROTEINS PROTEOM, V1834, P329, DOI 10.1016/j.bbapap.2012.08.007; Tan KM, 2010, FASEB J, V24, P3939, DOI 10.1096/fj.10-156257; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Yu SK, 2008, IUBMB LIFE, V60, P798, DOI 10.1002/iub.125	33	66	67	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19296	19303		10.1074/jbc.M113.465211	http://dx.doi.org/10.1074/jbc.M113.465211			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23687304	Green Published, hybrid			2022-12-25	WOS:000321335800062
J	Capellini, VK; Restini, CBA; Bendhack, LM; Evora, PRB; Celotto, AC				Capellini, Verena K.; Restini, Carolina B. A.; Bendhack, Lusiane M.; Evora, Paulo R. B.; Celotto, Andrea C.			The Effect of Extracellular pH Changes on Intracellular pH and Nitric Oxide Concentration in Endothelial and Smooth Muscle Cells from Rat Aorta	PLOS ONE			English	Article							ACIDOSIS; VASODILATION; ACTIVATION; SYNTHASE; RELAXATION; TENSION; NO	Aims: It has been known for more than a century that pH changes can alter vascular tone. However, there is no consensus about the effects of pH changes on vascular response. In this study, we investigated the effects of extracellular pH (pH(o)) changes on intracellular pH (pH(i)) and intracellular nitric oxide concentration ([NO](i)) in freshly isolated endothelial cells and cross sections from rat aorta. Main Methods: The HCl was used to reduce the pH(o) from 7.4 to 7.0 and from 7.4 to 6.5; the NaOH was used to increase the pHo from 7.4 to 8.0 and from 7.4 to 8.5. The fluorescent dyes 5-(and-6)-carboxy SNARF-1, acetoxymethyl ester, acetate (SNARF-1) and diaminofluorescein-FM diacetate (DAF-FM DA) were employed to measure the pH(i) and [NO](i), respectively. The fluorescence intensity was measured in freshly isolated endothelial cells by flow cytometry and in freshly obtained aorta cross sections by confocal microscopy. Key Findings: The endothelial and vascular smooth muscle pH(i) was increased at pH(o) 8.5. The extracellular acidification did not change the endothelial pH(i), but the smooth muscle pH(i) was reduced at pH(o) 7.0. At pH(o) 8.5 and pH(o) 6.5, the endothelial [NO](i) was increased. Both extracellular alkalinization and acidification increased the vascular smooth muscle [NO](i). Significance: Not all changes in pH(o) did result in pH(i) changes, but disruption of acid-base balance in both directions induced NO synthesis in the endothelium and/or vascular smooth muscle.	[Capellini, Verena K.; Evora, Paulo R. B.; Celotto, Andrea C.] Univ Sao Paulo, Sch Med, Dept Surg & Anat, Lab Endothelial Funct, BR-14049 Ribeirao Preto, SP, Brazil; [Restini, Carolina B. A.; Bendhack, Lusiane M.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Chem & Phys, Pharmacol Lab, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Celotto, AC (corresponding author), Univ Sao Paulo, Sch Med, Dept Surg & Anat, Lab Endothelial Funct, BR-14049 Ribeirao Preto, SP, Brazil.	acarla_c@yahoo.com	Bendhack, Lusiane/J-6158-2015; Evora, Paulo Roberto/C-3351-2013; Celotto, Andrea/G-2370-2012	Celotto, Andrea/0000-0003-0037-7468	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA/HCFMRP/USP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA/HCFMRP/USP)	The authors are grateful to Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA/HCFMRP/USP) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICKIN CC, 1984, J PHYSIOL-LONDON, V349, P571, DOI 10.1113/jphysiol.1984.sp015174; AUSTIN C, 1993, J PHYSIOL-LONDON, V466, P1; Austin C, 1996, BIOCHEM BIOPH RES CO, V222, P537, DOI 10.1006/bbrc.1996.0779; Bond J, 2005, CYTOM PART A, V64A, P43, DOI 10.1002/cyto.a.20066; Celotto AC, 2010, NITRIC OXIDE-BIOL CH, V23, P269, DOI 10.1016/j.niox.2010.07.008; Celotto AC, 2011, EUR J PHARMACOL, V656, P88, DOI 10.1016/j.ejphar.2011.01.053; Celotto C, 2008, BRAZ J MED BIOL RES, V41, P439, DOI 10.1590/S0100-879X2008005000026; Crimi E, 2011, J CRITICAL CARE; Dabertrand F, 2011, CIRC RES; FLEMING I, 1994, CIRC RES, V74, P1220, DOI 10.1161/01.RES.74.6.1220; Gaskell W H, 1880, J Physiol, V3, P48; GUREVICIUS J, 1995, AM J PHYSIOL-HEART C, V268, pH39, DOI 10.1152/ajpheart.1995.268.1.H39; Hattori K, 2002, LIFE SCI, V71, P1439, DOI 10.1016/S0024-3205(02)01914-8; HEINZEL B, 1992, BIOCHEM J, V281, P627, DOI 10.1042/bj2810627; IGNARRO LJ, 1989, FASEB J, V3, P31, DOI 10.1096/fasebj.3.1.2642868; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Lindauer U, 2003, J CEREBR BLOOD F MET, V23, P1227, DOI 10.1097/01.WCB.0000088764.02615.B7; MITCHELL JA, 1991, BRIT J PHARMACOL, V103, P1295, DOI 10.1111/j.1476-5381.1991.tb09783.x; Mizuno S, 2002, AM J PHYSIOL-LUNG C, V283, pL113, DOI 10.1152/ajplung.00436.2001; Modin A, 2001, ACTA PHYSIOL SCAND, V171, P9, DOI 10.1046/j.1365-201x.2001.171001009.x; Nagy S, 2006, ACTA PAEDIATR, V95, P814, DOI 10.1080/08035250500462083; Nakamura K, 2012, ARTERIOSCL THROM VAS, V32, P2670, DOI 10.1161/ATVBAHA.112.254946; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; Peng HL, 1998, AM J PHYSIOL-HEART C, V274, pH655, DOI 10.1152/ajpheart.1998.274.2.H655; Rohra DK, 2005, EUR J PHARMACOL, V514, P175, DOI 10.1016/j.ejphar.2005.02.041; Smith G, 1998, SIGHT SOUND, V8, P38; TAGGART M, 1994, J PHYSIOL-LONDON, V475, P285, DOI 10.1113/jphysiol.1994.sp020069; WRAY S, 1988, AM J PHYSIOL, V254, pC213; Zhang YF, 2002, AM J PHYSIOL-REG I, V282, pR400, DOI 10.1152/ajpregu.00256.2001	29	32	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e62887	10.1371/journal.pone.0062887	http://dx.doi.org/10.1371/journal.pone.0062887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690964	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107900016
J	Kim, CS; Joo, SY; Lee, KE; Choi, JS; Bae, EH; Ma, SK; Kim, SH; Lee, J; Kim, SW				Kim, Chang Seong; Joo, Soo Yeon; Lee, Ko Eun; Choi, Joon Seok; Bae, Eun Hui; Ma, Seong Kwon; Kim, Suhn Hee; Lee, JongUn; Kim, Soo Wan			Paricalcitol Attenuates 4-Hydroxy-2-Hexenal-Induced Inflammation and Epithelial-Mesenchymal Transition in Human Renal Proximal Tubular Epithelial Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; FIBROSIS; TRANSCRIPTION; APOPTOSIS; PROGRESSION; INDUCTION; KINASE; INJURY	4-Hydroxy-2-hexenal (HHE), the aldehyde product of lipid peroxidation, may be responsible for the pathogenesis of progressive renal disease. Recently, paricalcitol (19-nor-1,25-dihydroxyvitamin D2) was shown to be renoprotective through its anti-inflammatory and antifibrotic effects in various experimental nephropathy models. In this study, we investigated the effects of paricalcitol on inflammation and epithelial-mesenchymal transition (EMT) after HHE-induced renal tubular epithelial cell injury. To investigate the molecular mechanisms underlying HHE-induced renal tubular cell injury, the human proximal tubular epithelial (HK-2) cells cultured with 10 mu M HHE in the presence or absence of paricalcitol. In HK-2 cells, paricalcitol attenuated the HHE-induced expression of extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase, and prevented nuclear factor-kappa B (NF-kappa B) activation. The expression of the inflammatory proteins inducible nitric oxide synthase and cyclooxygenase-2 was attenuated by paricalcitol pretreatment. In addition, HHE increased the expression of the transforming growth factor (TGF)-beta/Smad signaling proteins and fibrotic proteins, such as asmooth muscle actin and connective tissue growth factor; this inducible expression was suppressed by pretreatment with paricalcitol. Treatment with HHE resulted in the activation of the beta-catenin signaling pathway, and paricalcitol pretreatment reduced the expression of b-catenin in HHE-treated HK-2 cells. Coimmunoprecipitation shows that paricalcitol induced vitamin D receptor (VDR)/beta-catenin complex formation in HK-2 cells. Also immunofluorescence staining revealed that colocalization of VDR and beta-catenin in the nuclei. ICG-001, an inhibitor of beta-catenin, decreased the expression of TGF-beta 1 and attenuated HHE-induced tubular EMT. These results show that paricalcitol attenuated HHE-induced renal tubular cell injury by suppressing inflammation and EMT process through inhibition of the NF-kappa B, TGF-beta/Smad, and beta-catenin signaling pathways.	[Kim, Chang Seong; Lee, Ko Eun; Choi, Joon Seok; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Sch Med, Dept Physiol, Kwangju, South Korea; [Joo, Soo Yeon; Lee, JongUn] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Kim, Suhn Hee] Chonbuk Natl Univ, Sch Med, Dept Physiol, Jeonju, South Korea	Chonnam National University; Chonnam National University; Jeonbuk National University	Kim, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Physiol, Kwangju, South Korea.	skimw@chonnam.ac.kr			Ministry of Science and Technology (MoST)/Korea Science and Engineering Foundation (KOSEF) [20100021808]; Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation grant at Chonnam National University, Chonnam National University Hospital Research Institute of Clinical Medicine [2012-0009448, CRI12053-21]; Korean Society of Nephrology	Ministry of Science and Technology (MoST)/Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation grant at Chonnam National University, Chonnam National University Hospital Research Institute of Clinical Medicine; Korean Society of Nephrology	This work was supported by a grant from the Ministry of Science and Technology (MoST)/Korea Science and Engineering Foundation (KOSEF) (20100021808), the Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation grant (2012-0009448) at Chonnam National University, Chonnam National University Hospital Research Institute of Clinical Medicine (CRI12053-21), and the Korean Society of Nephrology (2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarikwu SO, 2012, BASIC CLIN PHARMACOL, V110, P441, DOI 10.1111/j.1742-7843.2011.00834.x; Bae EH, 2011, NEPHROL DIAL TRANSPL, V26, P3866, DOI 10.1093/ndt/gfr386; Bodur C, 2012, J CELL PHYSL; Boor P, 2007, NEPHROL DIAL TRANSPL, V22, P3391, DOI 10.1093/ndt/gfm393; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Canty TG, 1999, CIRCULATION, V100, P361; Chung ACK, 2010, J AM SOC NEPHROL, V21, P249, DOI 10.1681/ASN.2009010018; Dai CS, 2006, J AM SOC NEPHROL, V17, P2164, DOI 10.1681/ASN.2006010033; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Je JH, 2004, FEBS LETT, V566, P183, DOI 10.1016/j.febslet.2004.04.037; Kim J, 2009, AM J PHYSIOL-RENAL, V297, pF461, DOI 10.1152/ajprenal.90735.2008; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee JY, 2004, EUR J BIOCHEM, V271, P1339, DOI 10.1111/j.1432-1033.2004.04042.x; Li FF, 2009, BIOCHEM BIOPH RES CO, V386, P289, DOI 10.1016/j.bbrc.2009.05.084; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Mizobuchi M, 2007, J AM SOC NEPHROL, V18, P1796, DOI 10.1681/ASN.2006091028; Ozbek E, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/465897; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Park JW, 2010, KIDNEY INT, V77, P1076, DOI 10.1038/ki.2010.69; Rosenau C, 2004, J BIOMOL SCREEN, V9, P334, DOI 10.1177/1087057103261446; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Tan XY, 2006, J AM SOC NEPHROL, V17, P3382, DOI 10.1681/ASN.2006050520; TOYOKUNI S, 1994, P NATL ACAD SCI USA, V91, P2616, DOI 10.1073/pnas.91.7.2616; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	35	30	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63186	10.1371/journal.pone.0063186	http://dx.doi.org/10.1371/journal.pone.0063186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690997	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900028
J	Woodman, MM; Jirsa, VK				Woodman, M. Marmaduke; Jirsa, Viktor K.			Emergent Dynamics from Spiking Neuron Networks through Symmetry Breaking of Connectivity	PLOS ONE			English	Article							MODEL; OSCILLATIONS; ORGANIZATION; EXCITATOR; CURVES	Low-dimensional attractive manifolds with flows prescribing the evolution of state variables are commonly used to capture the lawful behavior of behavioral and cognitive variables. Neural network dynamics underlie many of the mechanistic explanations of function and demonstrate the existence of such low-dimensional attractive manifolds. In this study, we focus on exploring the network mechanisms due to asymmetric couplings giving rise to the emergence of arbitrary flows in low dimensional spaces. Here we use a spiking neural network model, specifically the theta neuron model and simple synaptic dynamics, to show how a qualitatively identical set of basic behaviors arises from different combinations of couplings with broken symmetry, in fluctuations of both firing rate and spike timing. We further demonstrate how such network dynamics can be combined to create more complex processes. These results suggest that 1) asymmetric coupling is not always a variance to be averaged over, 2) different networks may produce the same dynamics by different dynamical routes and 3) complex dynamics may be formed by simpler dynamics through a combination of couplings.	[Woodman, M. Marmaduke; Jirsa, Viktor K.] Aix Marseille Univ, Inst Neurosci Syst, INSERM, UMR 1106, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Jirsa, VK (corresponding author), Aix Marseille Univ, Inst Neurosci Syst, INSERM, UMR 1106, Marseille, France.	viktor.jirsa@univ-amu.fr	Woodman, M Marmaduke/AAY-2324-2021; Jirsa, Viktor/M-4630-2016	Woodman, M Marmaduke/0000-0002-8410-4581; Jirsa, Viktor/0000-0002-8251-8860	French government; Brain Network Recovery Group through the James S. McDonnell Foundation; FP7-ICT BrainScales	French government; Brain Network Recovery Group through the James S. McDonnell Foundation; FP7-ICT BrainScales	The research reported here was supported by a graduate fellowship from the French government, by the Brain Network Recovery Group through the James S. McDonnell Foundation and the FP7-ICT BrainScales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Bressler SL, 2004, NEUROINFORMATICS, V2, P227, DOI 10.1385/NI:2:2:227; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brette R, 2005, J NEUROPHYSIOL; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Canavier C, 2005, BURSTING: THE GENESIS OF RHYTHM IN THE NERVOUS SYSTEM, P175, DOI 10.1142/9789812703231_0007; Canavier CC, 1999, BIOL CYBERN, V80, P87, DOI 10.1007/s004220050507; CRAWFORD JD, 1995, PHYS REV LETT, V74, P4341, DOI 10.1103/PhysRevLett.74.4341; De Luca C, 2010, J NEUROSCI, V30, P3167, DOI 10.1523/JNEUROSCI.2673-09.2010; Deco G, 2010, P NATL ACAD SCI USA, V107, P7545, DOI 10.1073/pnas.1002333107; DITZINGER T, 1989, BIOL CYBERN, V61, P279, DOI 10.1007/BF00203175; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Erlhagen W, 2002, PSYCHOL REV, V109, P545, DOI 10.1037//0033-295X.109.3.545; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; ERMENTROUT GB, 1991, J MATH BIOL, V29, P195, DOI 10.1007/BF00160535; Fink PW, 2009, J MOTOR BEHAV, V41, P147, DOI 10.3200/JMBR.41.2.147-157; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Fuchs A, 2000, HUM MOVEMENT SCI, V19, P425, DOI 10.1016/S0167-9457(00)00025-7; Galan RF, 2006, NEUROCOMPUTING, V69, P1112, DOI 10.1016/j.neucom.2005.12.055; GALAN RF, 2009, COORDINATED ACTIVITY, V2, P65, DOI DOI 10.1007/978-0-387-93797-7_4; Graziano M, 2006, ANNU REV NEUROSCI, V29, P105, DOI 10.1146/annurev.neuro.29.051605.112924; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Gutkin BS, 2005, J NEUROPHYSIOL, V94, P1623, DOI 10.1152/jn.00359.2004; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haken H., 2002, SPRINGER SERIES SYNE; Hatsopoulos NG, 2007, J NEUROSCI, V27, P5105, DOI 10.1523/JNEUROSCI.3570-06.2007; Hoppensteadt F. C., 1997, APPL MATH SCI, V126; Huys R, 2010, P ROY SOC B-BIOL SCI, V277, P1179, DOI 10.1098/rspb.2009.1954; Huys R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000061; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jirsa VK, 2005, J MOTOR BEHAV, V37, P35, DOI 10.3200/JMBR.37.1.35-51; Jirsa VK, 1998, NEURAL COMPUT, V10, P2019, DOI 10.1162/089976698300016954; Koch C., 2004, BIOPHYSICS COMPUTATI; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Mayville JM, 1999, EXP BRAIN RES, V127, P371, DOI 10.1007/s002210050805; McIntosh AR, 2000, NEURAL NETWORKS, V13, P861, DOI 10.1016/S0893-6080(00)00059-9; Memmesheimer RM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188101; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Nakao H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.184101; Nowotny T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128106; Perdikis D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002198; Perdikis D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016589; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Roy D, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051909; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Saleh M, 2010, NEURON, V65, P461, DOI 10.1016/j.neuron.2010.02.001; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Stephen DG, 2009, J EXP PSYCHOL HUMAN, V35, P1811, DOI 10.1037/a0014510; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; van Mourik AM, 2006, BIOL CYBERN, V94, P233, DOI 10.1007/s00422-005-0041-9; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006	53	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64339	10.1371/journal.pone.0064339	http://dx.doi.org/10.1371/journal.pone.0064339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691200	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900095
J	Sarafidou, T; Stamatis, C; Kalozoumi, G; Spyrou, V; Fthenakis, GC; Billinis, C; Mamuris, Z				Sarafidou, Theologia; Stamatis, Costas; Kalozoumi, Georgia; Spyrou, Vassiliki; Fthenakis, George C.; Billinis, Charalambos; Mamuris, Zissis			Toll Like Receptor 9 (TLR9) Polymorphism G520R in Sheep Is Associated with Seropositivity for Small Ruminant Lentivirus	PLOS ONE			English	Article							PARATUBERCULOSIS INFECTION; IMMUNE-RESPONSES; RESISTANCE; MUTATIONS; GENES; SUSCEPTIBILITY; TRANSMISSION; RECOGNITION; EXPRESSION; DISEASE	Infectious diseases of sheep are of major economic importance causing direct and indirect losses. Among the major sheep infectious agents are Small Ruminant Lentivirus, Chlamydophila abortus and Mycobacterium avium subsp. paratuberculosis infections, mainly due to their worldwide distribution and economic impact that they cause. Based on the differential susceptibility to infectious diseases between and within breeds and on the recent findings regarding the putative involvement of TLR9 in disease susceptibility, the aim of this study was to evaluate the levels of nucleotide variation of TLR9 and its mediator MyD88 in three sheep flocks originated from different breeds and assess their possible association with seropositivity/seronegativity for different infectious agents. The analysis indicated that the change of G to R at codon 520 of TLR9 polypeptide shows a significant association with Small Ruminant Lentivirus seropositivity. This amino-acid substitution, which can result in polarity change, might influence structure and function of LRR17, interfering with ligand binding and thus could be used in studies investigating susceptibility/resistance to Small Ruminant Lentivirus infections in sheep.	[Sarafidou, Theologia; Stamatis, Costas; Kalozoumi, Georgia; Mamuris, Zissis] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Spyrou, Vassiliki] Inst Educ Technol, Dept Anim Prod, Larisa, Greece; [Fthenakis, George C.; Billinis, Charalambos] Univ Thessaly, Fac Vet Med, Kardhitsa, Greece	University of Thessaly; University of Thessaly	Mamuris, Z (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece.	zmamur@bio.uth.gr	Mamuris, Zissis/AAN-2576-2021		Department of Biochemistry and Biotechnology, University of Thessaly, Greece	Department of Biochemistry and Biotechnology, University of Thessaly, Greece	This work was supported by the postgraduate programs "Biotechnology-Quality Assessment in Nutrition and the Environment" and "Molecular Biology and Genetics Applications - Diagnostic Markers" of the Department of Biochemistry and Biotechnology (http://www.bio.uth.gr/), University of Thessaly, Greece. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken ID, 1993, RICKETTSIAL CHLAMYDI, P349; Belkhir K., 1999, 9060 CNRS UPR U MONT; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bhide MR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-21; Bochud PY, 2003, J IMMUNOL, V170, P3451, DOI 10.4049/jimmunol.170.7.3451; Chang JS, 2009, VET IMMUNOL IMMUNOP, V127, P94, DOI 10.1016/j.vetimm.2008.09.026; Christodoulopoulos G, 2005, P 6 INT SHEEP VET C, P161; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Fisher CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027744; Fragkou IA, 2007, J DAIRY RES, V74, P349, DOI 10.1017/S0022029907002518; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Fthenakis GC, 2001, VET CLIN N AM-FOOD A, V27, pxxiii; GREEN EP, 1989, NUCLEIC ACIDS RES, V17, P9063, DOI 10.1093/nar/17.22.9063; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Juste RA, 2011, VET CLIN N AM-FOOD A, V27, P127, DOI 10.1016/j.cvfa.2010.10.020; Koets A, 2010, PREV VET MED, V93, P305, DOI 10.1016/j.prevetmed.2009.11.008; Kostoulas P, 2006, PREV VET MED, V76, P121, DOI 10.1016/j.prevetmed.2006.04.008; Koutsogiannouli EA, 2009, MOL ECOL, V18, P4631, DOI 10.1111/j.1365-294X.2009.04394.x; Mikula I, 2011, DEV COMP IMMUNOL, V35, P182, DOI 10.1016/j.dci.2010.09.008; Mucha R, 2009, VET IMMUNOL IMMUNOP, V128, P381, DOI 10.1016/j.vetimm.2008.12.007; Nalubamba K, 2008, MICROBES INFECT, V10, P598, DOI 10.1016/j.micinf.2008.02.005; Oliveira S. C., 2010, Open Veterinary Science Journal, V4, P102, DOI 10.2174/1874318801004010102; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peterhans E, 2004, VET RES, V35, P257, DOI 10.1051/vetres:2004014; Pine SO, 2009, AIDS, V23, P2387, DOI 10.1097/QAD.0b013e328330b489; Ruiz-Larranaga O, 2011, J DAIRY SCI, V94, P3635, DOI 10.3168/jds.2010-3788; Scanga CA, 2004, INFECT IMMUN, V72, P2400, DOI 10.1128/IAI.72.4.2400-2404.2004; Shah C, 2004, VIROLOGY, V319, P12, DOI 10.1016/j.virol.2003.09.047; Shinkai H, 2011, MOL IMMUNOL, V48, P1114, DOI 10.1016/j.molimm.2011.02.004; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Subharat S, 2012, VET IMMUNOL IMMUNOP, V145, P471, DOI 10.1016/j.vetimm.2011.10.008; Taylor DL, 2008, VET IMMUNOL IMMUNOP, V124, P132, DOI 10.1016/j.vetimm.2008.02.021; Zhong L, 2009, VET IMMUNOL IMMUNOP, V131, P177, DOI 10.1016/j.vetimm.2009.04.007; Zhou H, 2008, VET IMMUNOL IMMUNOP, V121, P140, DOI 10.1016/j.vetimm.2007.07.001	35	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63901	10.1371/journal.pone.0063901	http://dx.doi.org/10.1371/journal.pone.0063901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691111	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700065
J	Cordier, AG; Leveille, P; Dupont, C; Tarrade, A; Picone, O; Larcher, T; Dahirel, M; Poumerol, E; Mandon-Pepin, B; Levy, R; Chavatte-Palmer, P				Cordier, Anne-Gael; Leveille, Pauline; Dupont, Charlotte; Tarrade, Anne; Picone, Olivier; Larcher, Thibaut; Dahirel, Michele; Poumerol, Elodie; Mandon-Pepin, Beatrice; Levy, Rachel; Chavatte-Palmer, Pascale			Dietary Lipid and Cholesterol Induce Ovarian Dysfunction and Abnormal LH Response to Stimulation in Rabbits	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; ADVERSELY AFFECT; LUTEINIZING-HORMONE; FOLLICULAR-FLUID; OXIDATIVE STRESS; GENE-EXPRESSION; MENSTRUAL-CYCLE; FETAL-GROWTH; OBESE WOMEN	Background/Aim: Excess of fat intake is dramatically increasing in women of childbearing age and results in numerous health complications, including reproductive disorders. Using rabbit does as a biomedical model, the aim of this study was to evaluate onset of puberty, endocrine responses to stimulation and ovarian follicular maturation in females fed a high fat high cholesterol diet (HH diet) from 10 weeks of age (i.e., 2 weeks before normal onset of puberty) or a control diet (C diet). Methodology/Principal Findings: Three experiments were performed, each including 8 treated (HH group) and 8 control (C group) does. In experiment 1, the endocrine response to Gonadotropin releasing hormone (GnRH) was evaluated at 13, 18 and 22 weeks of age. In experiment 2, the follicular population was counted in ovaries of adult females (18 weeks of age). In experiment 3, the LH response to mating and steroid profiles throughout gestation were evaluated at 18 weeks of age. Fetal growth was monitored by ultrasound and offspring birth weight was recorded. Data showed a significantly higher Luteinizing hormone (LH) response after induction of ovulation at 13 weeks of age in the HH group. There was no difference at 18 weeks, but at 22 weeks, the LH response to GnRH was significantly reduced in the HH group. The number of atretic follicles was significantly increased and the number of antral follicles significantly reduced in HH does vs. controls. During gestation, the HH diet induced intra-uterine growth retardation (IUGR). Conclusion: The HH diet administered from before puberty onwards affected onset of puberty, follicular growth, hormonal responses to breeding and GnRH stimulation in relation to age and lead to fetal IUGR.	[Cordier, Anne-Gael; Leveille, Pauline; Dupont, Charlotte; Tarrade, Anne; Picone, Olivier; Dahirel, Michele; Poumerol, Elodie; Mandon-Pepin, Beatrice; Chavatte-Palmer, Pascale] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Cordier, Anne-Gael] Hosp Antoine Beclere, APHP, Serv Gynecol Obstet & Med Reprod, Clamart, France; [Leveille, Pauline; Dupont, Charlotte; Levy, Rachel] Univ Paris 13, Unite Rech Epidemiol Nutr, Sorbonne Paris Cite, Bobigny, France; [Leveille, Pauline; Dupont, Charlotte; Levy, Rachel] Hop Jean Verdier, APHP, Bondy, France; [Tarrade, Anne; Dahirel, Michele; Chavatte-Palmer, Pascale] PremUp Fdn, Paris, France; [Larcher, Thibaut] INRA, UMR APEX 703, Oniris, F-44026 Nantes, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Antoine-Beclere - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Jean-Verdier - APHP; UDICE-French Research Universities; Universite Paris Cite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Chavatte-Palmer, P (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	pascale.chavatte@jouy.inra.fr	PICONE, Olivier/ABF-7916-2020; Chavatte-Palmer, Pascale/K-7349-2012; Larcher, Thibaut/M-9160-2013; Larcher, Thibaut/X-8500-2019; Dupont, Charlotte/AAL-8780-2020	PICONE, Olivier/0000-0001-8421-9971; Chavatte-Palmer, Pascale/0000-0002-4581-6092; Larcher, Thibaut/0000-0002-0396-3190; Mandon-Pepin, Beatrice/0000-0002-5424-0822; Couturier-Tarrade, Anne/0000-0003-1559-5476; Leveille, Pauline/0000-0003-1870-8501	INRA	INRA	No current external funding sources was obtained for this study. The work was entirely financed through internal INRA funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Ahima RS, 1997, J CLIN INVEST, V99, P391, DOI 10.1172/JCI119172; Akamine EH, 2010, J ENDOCRINOL, V206, P65, DOI 10.1677/JOE-09-0461; Arias-Alvarez M, 2009, THERIOGENOLOGY, V72, P612, DOI 10.1016/j.theriogenology.2009.04.017; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Balasubramanian P, 2012, J NEUROENDOCRINOL, V24, P748, DOI 10.1111/j.1365-2826.2011.02276.x; Balen AH, 2006, BJOG-INT J OBSTET GY, V113, P1195, DOI 10.1111/j.1471-0528.2006.01034.x; Bellver J, 2006, REPROD BIOMED ONLINE, V12, P562, DOI 10.1016/S1472-6483(10)61181-9; Berkey CS, 2000, AM J EPIDEMIOL, V152, P446, DOI 10.1093/aje/152.5.446; Bodensteiner KJ, 2004, TOXICOL SCI, V80, P83, DOI 10.1093/toxsci/kfh135; Caron E, 2012, J NEUROSCI, V32, P11486, DOI 10.1523/JNEUROSCI.6074-11.2012; Charles MA, 2009, OBEPI 2009; Chavatte-Palmer P, 2008, THERIOGENOLOGY, V69, P859, DOI 10.1016/j.theriogenology.2007.12.013; CRAMER DW, 1995, AM J OBSTET GYNECOL, V172, P568, DOI 10.1016/0002-9378(95)90574-X; De Lorenzo A, 2007, AM J CLIN NUTR, V85, P40, DOI 10.1093/ajcn/85.1.40; Dearth RK, 2000, PEPTIDES, V21, P387, DOI 10.1016/S0196-9781(00)00157-1; Dechaud H, 2006, EUR J OBSTET GYN R B, V127, P88, DOI 10.1016/j.ejogrb.2005.12.009; Di Renzo L, 2010, OBESITY, V18, P2125, DOI 10.1038/oby.2010.50; Fischer B, 2012, REPRODUCTIO IN PRESS; Fortun-Lamothe L, 2002, LIVEST PROD SCI, V78, P133, DOI 10.1016/S0301-6226(02)00087-8; Freedman DS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e43; Gonzalez-Anover P, 2011, REPROD DOMEST ANIM, V46, P1011, DOI 10.1111/j.1439-0531.2011.01776.x; GRENMAN S, 1986, J CLIN ENDOCR METAB, V63, P1257, DOI 10.1210/jcem-63-6-1257; Hamm ML, 2004, BIOL REPROD, V71, P66, DOI 10.1095/biolreprod.104.027292; Hutchinson IA, 2012, THERIOGENOLOGY, V78, P12, DOI 10.1016/j.theriogenology.2011.12.031; Jain A, 2007, J CLIN ENDOCR METAB, V92, P2468, DOI 10.1210/jc.2006-2274; Jungheim ES, 2011, FERTIL STERIL, V95, P1970, DOI 10.1016/j.fertnstert.2011.01.154; Jungheim ES, 2010, ENDOCRINOLOGY, V151, P4039, DOI 10.1210/en.2010-0098; Kajihara T, 2009, MED MOL MORPHOL, V42, P216, DOI 10.1007/s00795-009-0466-7; KRANZFELDER D, 1984, CELL TISSUE RES, V238, P611, DOI 10.1007/BF00219879; La Vignera S, 2011, EUR REV MED PHARMACO, V15, P267; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Lashen H, 1999, HUM REPROD, V14, P712, DOI 10.1093/humrep/14.3.712; Lea RG, 2007, REPRODUCTION, V133, P785, DOI 10.1530/REP-06-0294; Li XF, 2012, ENDOCRINOLOGY, V153, P4422, DOI 10.1210/en.2012-1223; Lof M., 2009, BMC WOMENS HLTH, V9, P10, DOI DOI 10.1186/1472-6874-9-10; Lund SA, 1999, BIOL REPROD, V61, P388, DOI 10.1095/biolreprod61.2.388; MACLURE M, 1991, AM J CLIN NUTR, V54, P649, DOI 10.1093/ajcn/54.4.649; Maheshwari A, 2007, HUM REPROD UPDATE, V13, P433, DOI 10.1093/humupd/dmm017; Martinuzzi K, 2008, J ASSIST REPROD GEN, V25, P169, DOI 10.1007/s10815-008-9213-6; MERZENICH H, 1993, AM J EPIDEMIOL, V138, P217, DOI 10.1093/oxfordjournals.aje.a116850; MOISAN J, 1990, AM J EPIDEMIOL, V132, P953, DOI 10.1093/oxfordjournals.aje.a115738; Ozdemir O, 2004, MATURITAS, V49, P211, DOI 10.1016/j.maturitas.2004.01.013; Picone O, 2011, THERIOGENOLOGY, V75, P287, DOI 10.1016/j.theriogenology.2010.08.015; Pierce MB, 2005, AM J CLIN NUTR, V82, P733, DOI 10.1093/ajcn/82.4.733; Robker RL, 2009, J CLIN ENDOCR METAB, V94, P1533, DOI 10.1210/jc.2008-2648; Rogers IS, 2010, PUBLIC HEALTH NUTR, V13, P2052, DOI 10.1017/S1368980010001461; Rommers JM, 2004, ANIM SCI, V79, P255, DOI 10.1017/S1357729800090111; Sagae SC, 2012, PHYSIOL BEHAV, V105, P1104, DOI 10.1016/j.physbeh.2011.12.002; Santoro N, 2004, J CLIN ENDOCR METAB, V89, P2622, DOI 10.1210/jc.2003-031578; Serke H, 2012, INT J OBESITY, V36, P1047, DOI 10.1038/ijo.2011.220; SHERMAN BM, 1974, J CLIN ENDOCR METAB, V39, P145, DOI 10.1210/jcem-39-1-145; Soulis G, 2005, CELL MOL NEUROBIOL, V25, P869, DOI 10.1007/s10571-005-4943-9; Terasawa E, 2012, ENDOCRINOLOGY, V153, P1696, DOI 10.1210/en.2011-1970; Yeung EH, 2012, INT J OBES LOND; Ying SJ, 2011, REPRODUCTION, V142, P699, DOI 10.1530/REP-11-0229; Zachut M, 2010, J DAIRY SCI, V93, P529, DOI 10.3168/jds.2009-2167; Zheng H, 2009, EXP CLIN ENDOCR DIAB, V117, P400, DOI 10.1055/s-0028-1102918	59	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63101	10.1371/journal.pone.0063101	http://dx.doi.org/10.1371/journal.pone.0063101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690983	Green Submitted, gold, Green Published			2022-12-25	WOS:000319107400031
J	Edmund, GHC; Lewis, DFV; Howlin, BJ				Edmund, Grace H. C.; Lewis, David F. V.; Howlin, Brendan J.			Modelling Species Selectivity in Rat and Human Cytochrome P450 2D Enzymes	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; NUCLEIC-ACIDS; CLUSTAL-W; BINDING; SERVER; MICROSOMES	Updated models of the Rat Cytochrome P450 2D enzymes are produced based on the recent x-ray structures of the Human P450 2D6 enzyme both with and without a ligand bound. The differences in species selectivity between the epimers quinine and quinidine are rationalised using these models and the results are discussed with regard to previous studies. A close approach to the heme is not observed in this study. The x-ray structure of the enzyme with a ligand bound is shown to be a better model for explaining the observed experimental binding of quinine and quinidine. Hence models with larger closed binding sites are recommended for comparative docking studies. This is consistent with molecular recognition in Cytochrome P450 enzymes being the result of a number of non-specific interactions in a large binding site.	[Edmund, Grace H. C.; Lewis, David F. V.; Howlin, Brendan J.] Univ Surrey, Dept Chem, Fac Engn & Phys Sci, Guildford GU2 5XH, Surrey, England	University of Surrey	Howlin, BJ (corresponding author), Univ Surrey, Dept Chem, Fac Engn & Phys Sci, Guildford GU2 5XH, Surrey, England.	b.howlin@surrey.ac.uk	Howlin, Brendan J/F-3343-2011	Howlin, Brendan J/0000-0002-9398-7152	Grundy Educational Trust	Grundy Educational Trust	The authors would like to thank the Grundy Educational Trust for support for (GHCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathelt CM, 2008, J PHYS CHEM A, V112, P13149, DOI 10.1021/jp8016908; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; CONNOLLY ML, 1996, NET SCI; EDELSBRUNNER H, 1995, MEASURING PROTEINS V, P256; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Kumar GN, 1996, J PHARMACOL EXP THER, V277, P423; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis DFV, 2010, J ENZYM INHIB MED CH, V25, P679, DOI 10.3109/14756360903514149; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Molecular Operating Environment (MOE), 2009, MOL OP ENV MOE, pH3A 2R7; Nakashima D, 2007, J CLIN PHARMACOL, V47, P1311, DOI 10.1177/0091270007304103; Paris BL, 2009, DRUG METAB DISPOS, V37, P2045, DOI 10.1124/dmd.109.028274; POLLASTRI G, BIOINFORMATICS, V21, P1719; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Sethian J., 1998, ACTA MATH U COMENIAN, V67, P3; Tanczos AC, 2004, COMPUT BIOL CHEM, V28, P375, DOI 10.1016/j.compbiolchem.2004.09.009; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Umeda S, 2005, BIOL PHARM BULL, V28, P212, DOI 10.1248/bpb.28.212; *UNIPROT CONS, 2011, NUCLEIC ACIDS RES, pD214; Venhorst J, 2003, J MED CHEM, V46, P74, DOI 10.1021/jm0209578; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Zhang T, 2012, MOL INFORM, V31, P53, DOI 10.1002/minf.201100052; 2010, SIT FIND 2010	26	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63335	10.1371/journal.pone.0063335	http://dx.doi.org/10.1371/journal.pone.0063335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691026	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400053
J	Sun, YY; Zang, ZH; Zhong, L; Wu, M; Su, Q; Gao, XR; Zan, W; Lin, D; Zhao, Y; Zhang, ZL				Sun, Yiyi; Zang, Zhihe; Zhong, Ling; Wu, Min; Su, Qing; Gao, Xiurong; Zan, Wang; Lin, Dong; Zhao, Yan; Zhang, Zhonglin			Identification of Adiponectin Receptor Agonist Utilizing a Fluorescence Polarization Based High Throughput Assay	PLOS ONE			English	Article							BREAST-CANCER CELLS; ELEUTHEROCOCCUS-SENTICOSUS; INSULIN-RESISTANCE; RATS; SYRINGIN; GROWTH; INHIBITION; INDUCTION; APOPTOSIS; RESPONSES	Adiponectin, the adipose-derived hormone, plays an important role in the suppression of metabolic disorders that can result in type 2 diabetes, obesity, and atherosclerosis. It has been shown that up-regulation of adiponectin or adiponectin receptor has a number of therapeutic benefits. Given that it is hard to convert the full size adiponectin protein into a viable drug, adiponectin receptor agonists could be designed or identified using high-throughput screening. Here, we report on the development of a two-step screening process to identify adiponectin agonists. First step, we developed a high throughput screening assay based on fluorescence polarization to identify adiponectin ligands. The fluorescence polarization assay reported here could be adapted to screening against larger small molecular compound libraries. A natural product library containing 10,000 compounds was screened and 9 hits were selected for validation. These compounds have been taken for the second-step in vitro tests to confirm their agonistic activity. The most active adiponectin receptor 1 agonists are matairesinol, arctiin, (-)-arctigenin and gramine. The most active adiponectin receptor 2 agonists are parthenolide, taxifoliol, deoxyschizandrin, and syringin. These compounds may be useful drug candidates for hypoadiponectin related diseases.	[Sun, Yiyi; Zang, Zhihe; Zhong, Ling; Wu, Min; Su, Qing; Gao, Xiurong; Zan, Wang; Zhao, Yan; Zhang, Zhonglin] Chengdu Med Coll, Sch Pharm, Chengdu, Sichuan Provinc, Peoples R China; [Lin, Dong] Chengdu Lang Guan Technol Co Ltd, Chengdu, Sichuan Provinc, Peoples R China	Chengdu Medical College	Zhang, ZL (corresponding author), Chengdu Med Coll, Sch Pharm, Chengdu, Sichuan Provinc, Peoples R China.	zhangzhonglin2@live.com			Sichuan Provincial Education Department [09ZB013]; Administration of Traditional Chinese Medicine of Sichuan Province, China; Chengdu Qingyang District Science and Technology Bureau [2011JHKJ108430K-047]	Sichuan Provincial Education Department; Administration of Traditional Chinese Medicine of Sichuan Province, China; Chengdu Qingyang District Science and Technology Bureau	This is a project supported by Scientific Research Fund of Sichuan Provincial Education Department (09ZB013), Administration of Traditional Chinese Medicine of Sichuan Province, China (2010-92), and Chengdu Qingyang District Science and Technology Bureau (2011JHKJ108430K-047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; D'Anneo A, 2012, J CELL PHYSL; Dalamaga M, 2012, ENDOCR REV; Delaigle AM, 2004, ENDOCRINOLOGY, V145, P5589, DOI 10.1210/en.2004-0503; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Dos Santos E, 2008, ONCOL REP, V20, P971, DOI 10.3892/or_00000098; Fayad R, 2007, GASTROENTEROLOGY, V132, P601, DOI 10.1053/j.gastro.2006.11.026; Grossmann ME, 2008, BRIT J CANCER, V98, P370, DOI 10.1038/sj.bjc.6604166; Hivert MF, 2008, J CLIN ENDOCR METAB, V93, P3165, DOI 10.1210/jc.2008-0425; Hong Y, 2009, AQUAT TOXICOL, V91, P262, DOI 10.1016/j.aquatox.2008.11.014; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kang K, 2007, BIOL PHARM BULL, V30, P2352, DOI 10.1248/bpb.30.2352; Kaser S, 2005, GUT, V54, P117, DOI 10.1136/gut.2003.037010; Katsiougiannis S, 2006, ARTHRITIS RHEUM, V54, P2295, DOI 10.1002/art.21944; Ke SY, 2012, EUR J MED CHEM, V54, P248, DOI 10.1016/j.ejmech.2012.05.003; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kim SL, 2012, INT J ONCOL; Liu KY, 2008, NEUROSCI LETT, V434, P195, DOI 10.1016/j.neulet.2008.01.054; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Niu HS, 2008, PLANTA MED, V74, P109, DOI 10.1055/s-2008-1034275; Nkhata KJ, 2009, ONCOL REP, V21, P1611, DOI 10.3892/or_00000395; Opletal L, 2004, J CHROMATOGR B, V812, P357, DOI 10.1016/j.jchromb.2004.07.040; Otvos L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-90; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Pfeiler GH, 2008, ONCOL REP, V19, P787; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Shoeb M, 2006, PHYTOCHEMISTRY, V67, P2370, DOI 10.1016/j.phytochem.2006.08.012; Song Yuan-yuan, 2010, Yaoxue Xuebao, V45, P1006; Sun YY, 2011, MOL BIOL REP, V38, P199, DOI 10.1007/s11033-010-0095-1; Sun YY, 2010, BIOFACTORS, V36, P179, DOI 10.1002/biof.83; Sun YY, 2009, ANTI-CANCER DRUG, V20, P757, DOI 10.1097/CAD.0b013e328330d95b; Sun YY, 2009, CARDIOVASC THER, V27, P59, DOI 10.1111/j.1755-5922.2008.00069.x; Tsuchida A, 2004, J BIOL CHEM, V279, P30817, DOI 10.1074/jbc.M402367200; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Ziemke F, 2010, AM J CLIN NUTR, V91, p258S, DOI 10.3945/ajcn.2009.28449C	38	40	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63354	10.1371/journal.pone.0063354	http://dx.doi.org/10.1371/journal.pone.0063354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691032	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400059
J	Lai, PS; Hofmann, O; Baron, RM; Cernadas, M; Meng, QR; Bresler, HS; Brass, DM; Yang, IV; Schwartz, DA; Christiani, DC; Hide, W				Lai, Peggy S.; Hofmann, Oliver; Baron, Rebecca M.; Cernadas, Manuela; Meng, Quanxin Ryan; Bresler, Herbert S.; Brass, David M.; Yang, Ivana V.; Schwartz, David A.; Christiani, David C.; Hide, Winston			Integrating Murine Gene Expression Studies to Understand Obstructive Lung Disease Due to Chronic Inhaled Endotoxin	PLOS ONE			English	Article							CIGARETTE-SMOKE; PULMONARY-DISEASE; FOLLOW-UP; COPD; ASTHMA; LIPOPOLYSACCHARIDE; RISK; EMPHYSEMA; EXPOSURE; ACCUMULATION	Rationale: Endotoxin is a near ubiquitous environmental exposure that that has been associated with both asthma and chronic obstructive pulmonary disease (COPD). These obstructive lung diseases have a complex pathophysiology, making them difficult to study comprehensively in the context of endotoxin. Genome-wide gene expression studies have been used to identify a molecular snapshot of the response to environmental exposures. Identification of differentially expressed genes shared across all published murine models of chronic inhaled endotoxin will provide insight into the biology underlying endotoxin-associated lung disease. Methods: We identified three published murine models with gene expression profiling after repeated low-dose inhaled endotoxin. All array data from these experiments were re-analyzed, annotated consistently, and tested for shared genes found to be differentially expressed. Additional functional comparison was conducted by testing for significant enrichment of differentially expressed genes in known pathways. The importance of this gene signature in smoking-related lung disease was assessed using hierarchical clustering in an independent experiment where mice were exposed to endotoxin, smoke, and endotoxin plus smoke. Results: A 101-gene signature was detected in three murine models, more than expected by chance. The three model systems exhibit additional similarity beyond shared genes when compared at the pathway level, with increasing enrichment of inflammatory pathways associated with longer duration of endotoxin exposure. Genes and pathways important in both asthma and COPD were shared across all endotoxin models. Mice exposed to endotoxin, smoke, and smoke plus endotoxin were accurately classified with the endotoxin gene signature. Conclusions: Despite the differences in laboratory, duration of exposure, and strain of mouse used in three experimental models of chronic inhaled endotoxin, surprising similarities in gene expression were observed. The endotoxin component of tobacco smoke may play an important role in disease development.	[Lai, Peggy S.; Christiani, David C.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Lai, Peggy S.; Hofmann, Oliver; Christiani, David C.; Hide, Winston] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Baron, Rebecca M.; Cernadas, Manuela] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Meng, Quanxin Ryan; Bresler, Herbert S.] Battelle Mem Inst, Columbus, OH USA; [Brass, David M.] Duke Univ, Med Ctr, Dept Pediat Neonatol, Durham, NC USA; [Yang, Ivana V.; Schwartz, David A.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO USA; [Yang, Ivana V.; Schwartz, David A.] Univ Colorado, Dept Med, Aurora, CO USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Battelle Memorial Institute; Duke University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Lai, PS (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	plai@partners.org	Hide, Winston/R-3815-2019; Yang, Ivana V/P-3059-2018; Hide, Winston A/V-2727-2017; Hide, Winston Hide/C-7217-2009; Hofmann, Oliver/F-1800-2013	Hide, Winston/0000-0002-8621-3271; Yang, Ivana V/0000-0002-1018-489X; Hide, Winston A/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Hofmann, Oliver/0000-0002-7738-1513; Lai, Peggy/0000-0001-9501-8606	National Institute of Environmental Health Sciences [ES00002, P30 ES00002, P01 ES18181, F32 ES020082]; Battelle Memorial Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018181, P30ES000002, F32ES020082] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Battelle Memorial Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support was provided by ES00002, P30 ES00002, and P01 ES18181 from the National Institute of Environmental Health Sciences for generation of primary microarray data for the Lai and Brass et al studies, Battelle Memorial Institute's Corporate Science & Technology Program for generation of microarray data for the Meng et al study, and F32 ES020082 from the National Institute of Environmental Health Sciences to PL as a career development award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Environmental Health Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; BENDITT EP, 1989, J EXP MED, V169, P1841, DOI 10.1084/jem.169.5.1841; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Brass DM, 2008, AM J RESP CELL MOL, V39, P584, DOI 10.1165/rcmb.2007-0448OC; Brass DM, 2008, IMMUNOGENETICS, V60, P353, DOI 10.1007/s00251-008-0293-3; Brass DM, 2003, AM J PHYSIOL-LUNG C, V285, pL755, DOI 10.1152/ajplung.00001.2003; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Espinassous Q, 2009, J IMMUNOL, V183, P1446, DOI 10.4049/jimmunol.0803067; Gaschler Gordon J., 2007, V14, P126, DOI 10.1159/000107059; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Lai PS, 2012, AM J RESP CELL MOL, V47, P209, DOI 10.1165/rcmb.2011-0447OC; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; LANTZ RC, 1985, EXP MOL PATHOL, V43, P305, DOI 10.1016/0014-4800(85)90068-1; Leclerc O, 2006, EUR RESPIR J, V27, P1102, DOI 10.1183/09031936.06.00076905; Liebers V, 2008, ARCH TOXICOL, V82, P203, DOI 10.1007/s00204-008-0290-1; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Matesic LE, 1999, GENOMICS, V62, P34, DOI 10.1006/geno.1999.5986; Meng QR, 2006, INHAL TOXICOL, V18, P555, DOI 10.1080/08958370600686226; MILTON DK, 1990, AM REV RESPIR DIS, V142, P184, DOI 10.1164/ajrccm/142.1.184; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; RYLANDER R, 1976, BRIT J IND MED, V33, P175; Rylander R, 1985, INFLAMMATION RES; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Schromm AB, 1998, J IMMUNOL, V161, P5464; Semple S, 2010, ENVIRON HEALTH PERSP, V118, P988, DOI 10.1289/ehp.0901605; Shi J, 2010, AM J RESP CRIT CARE, V182, P200, DOI 10.1164/rccm.200903-0329OC; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; STOLK J, 1992, J PATHOL, V167, P349, DOI 10.1002/path.1711670314; Thorne PS, 2005, AM J RESP CRIT CARE, V172, P1371, DOI 10.1164/rccm.200505-758OC; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vassallo R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-45; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Yang HN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003724	51	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62910	10.1371/journal.pone.0062910	http://dx.doi.org/10.1371/journal.pone.0062910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675439	Green Submitted, Green Published, gold			2022-12-25	WOS:000319036100020
J	Mpagama, SG; Heysell, SK; Ndusilo, ND; Kumburu, HH; Lekule, IA; Kisonga, RM; Gratz, J; Boeree, MJ; Houpt, ER; Kibiki, GS				Mpagama, Stellah G.; Heysell, Scott K.; Ndusilo, Nora D.; Kumburu, Happiness H.; Lekule, Isack A.; Kisonga, Riziki M.; Gratz, Jean; Boeree, Martin J.; Houpt, Eric R.; Kibiki, Gibson S.			Diagnosis and Interim Treatment Outcomes from the First Cohort of Multidrug-Resistant Tuberculosis Patients in Tanzania	PLOS ONE			English	Article							RURAL SOUTH-AFRICA; MDR-TB; HIV; COMMUNITY	Setting: Kibong'oto National Tuberculosis Hospital (KNTH), Kilimanjaro, Tanzania. Objective: Characterize the diagnostic process and interim treatment outcomes from patients treated for multidrug-resistant tuberculosis (MDR-TB) in Tanzania. Design: A retrospective cohort study was performed among all patients treated at KNTH for pulmonary MDR-TB between November 2009 and September 2011. Results: Sixty-one culture-positive MDR-TB patients initiated therapy, 60 (98%) with a prior history of TB treatment. Forty-one (67%) were male and 9 (14%) were HIV infected with a mean CD4 count of 424 (+/- 106) cells/mu l. The median time from specimen collection to MDR-TB diagnosis and from diagnosis to initiation of MDR-TB treatment was 138 days (IQR 101-159) and 131 days (IQR 32-233), respectively. Following treatment initiation four (7%) patients died (all HIV negative), 3 (5%) defaulted, and the remaining 54 (89%) completed the intensive phase. Most adverse drug reactions were mild to moderate and did not require discontinuation of treatment. Median time to culture conversion was 2 months (IQR 1-3) and did not vary by HIV status. In 28 isolates available for additional second-line drug susceptibility testing, fluoroquinolone, aminoglycoside and para-aminosalicylic acid resistance was rare yet ethionamide resistance was present in 9 (32%). Conclusion: The majority of MDR-TB patients from this cohort had survived a prolonged referral process, had multiple episodes of prior TB treatment, but did not have advanced AIDS and converted to culture negative early while completing an intensive inpatient regimen without serious adverse event. Further study is required to determine the clinical impact of second-line drug susceptibility testing and the feasibility of alternatives to prolonged hospitalization.	[Mpagama, Stellah G.; Lekule, Isack A.; Kisonga, Riziki M.] Kibongoto Natl TB Hosp, Kilimanjaro, Tanzania; [Mpagama, Stellah G.; Ndusilo, Nora D.; Kumburu, Happiness H.; Gratz, Jean; Kibiki, Gibson S.] Kilimanjaro Christian Med Ctr, Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Heysell, Scott K.; Gratz, Jean; Houpt, Eric R.] Univ Virginia, Charlottesville, VA USA; [Boeree, Martin J.] UCCZ Dekkerswald, UMC St Radboud, Nijmegen, Netherlands	Kilimanjaro Christian Medical Centre; University of Virginia; Radboud University Nijmegen	Mpagama, SG (corresponding author), Kibongoto Natl TB Hosp, Kilimanjaro, Tanzania.	s.mpagama@kcri.ac.tz	Boeree, Martin J./G-6132-2010		Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA); National Institutes of Health/Fogarty training grant [D43 TW008270]; National Institutes of Health [R01AI093358, K23AI099019]; Virginia Department of Health; Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene; FOGARTY INTERNATIONAL CENTER [D43TW008270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI099019, R01AI093358, T32AI007046] Funding Source: NIH RePORTER	Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA); National Institutes of Health/Fogarty training grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Department of Health; Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene(Burroughs Wellcome Fund); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SGM was supported by an award from the Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA) and the National Institutes of Health/Fogarty training grant (D43 TW008270) awarded to ERH and GSK. ERH was also supported in part by National Institutes of Health grant R01AI093358 and the Virginia Department of Health. SKH was supported by National Institutes of Health grant K23AI099019 and the Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Brust JCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015841; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Dhingra V K, 2008, Indian J Tuberc, V55, P15; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; [Francis J Curry National Tuberculosis Center California Department of Health], 2008, DRUG RES TUB SURV GU, P86; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Heysell SK, 2011, ANTIMICROB AGENTS CH, V55, P5819, DOI 10.1128/AAC.05561-11; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Kibiki GS, 2007, CLIN EXP IMMUNOL, V148, P254, DOI 10.1111/j.1365-2249.2007.03330.x; Kruuner A, 2003, ANTIMICROB AGENTS CH, V47, P2971, DOI 10.1128/AAC.47.9.2971-2973.2003; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; *MIN HLTH TANZ, 2009, HLTH SECT STRAT PLAN; Ministry of Health Tanzania, 2010, OP GUID MAN DRUG RES; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; Satti H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046943; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shenoi S, 2009, CURR OPIN INFECT DIS, V22, P11, DOI 10.1097/QCO.0b013e3283210020; Thomas TA, 2010, INT J TUBERC LUNG D, V14, P1244; Torun T, 2005, INT J TUBERC LUNG D, V9, P1373; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2010, GLOB TUB CONTR	25	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62034	10.1371/journal.pone.0062034	http://dx.doi.org/10.1371/journal.pone.0062034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675411	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100002
J	Tymofiyeva, O; Hess, CP; Ziv, E; Lee, PN; Glass, HC; Ferriero, DM; Barkovich, AJ; Xu, D				Tymofiyeva, Olga; Hess, Christopher P.; Ziv, Etay; Lee, Patricia N.; Glass, Hannah C.; Ferriero, Donna M.; Barkovich, A. James; Xu, Duan			A DTI-Based Template-Free Cortical Connectome Study of Brain Maturation	PLOS ONE			English	Article							STRUCTURAL CONNECTIVITY; NETWORKS; TRACTOGRAPHY	Improved understanding of how the human brain is "wired" on a macroscale may now be possible due to the emerging field of MRI connectomics. However, mapping the rapidly developing infant brain networks poses challenges. In this study, we applied an automated template-free "baby connectome" framework using diffusion MRI to non-invasively map the structural brain networks in subjects of different ages, including premature neonates, term-born neonates, six-month-old infants, and adults. We observed increasing brain network integration and decreasing segregation with age in term-born subjects. We also explored how the equal area nodes can be grouped into modules without any prior anatomical information - an important step toward a fully network-driven registration and analysis of brain connectivity.	[Tymofiyeva, Olga; Hess, Christopher P.; Ziv, Etay; Lee, Patricia N.; Barkovich, A. James; Xu, Duan] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Glass, Hannah C.; Ferriero, Donna M.; Barkovich, A. James] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Glass, Hannah C.; Ferriero, Donna M.; Barkovich, A. James] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Xu, D (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	Duan.Xu@ucsf.edu	Xu, Duan/B-3197-2013; Xu, Duan/GMW-4195-2022	Xu, Duan/0000-0003-0550-4235; Hess, Christopher/0000-0002-5132-5302	National Institutes of Health (NIH) [UL1RR024131, R01 HD072074, R01 NS35902, NS46432, EB009756];  [K23NS066137]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072074] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS035902, K23NS066137, R01NS046432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health (NIH) grants UL1RR024131 (UCSF-CTSI), R01 HD072074, R01 NS35902, NS46432 and EB009756 (www.nih.gov). H. C. G. is supported by K23NS066137 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball G, 2012, CORTEX; Batalle D, 2012, NEUROIMAGE, V60, P1352, DOI 10.1016/j.neuroimage.2012.01.059; Bells S, 2011, P INT SOC MAG RESON; Brodmann, 1909, VERGLEICHENDE LOKALI; Brodmann K, 1905, J PSYCHOL NEUROL LEI, V4, P177; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; Dennis EL, 2013, NEUROIMAGE, V64, P671, DOI 10.1016/j.neuroimage.2012.09.004; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Khundrakpam BS, 2013, CEREB CORTEX, V23, P2072, DOI 10.1093/cercor/bhs187; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Leopardi P, 2006, ELECTRON T NUMER ANA, V25, P309; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; March of Dimes PMNCH Save The Children WHO, 2012, GLOB ACT REP PRET BI, DOI DOI 10.1016/S0140-6736(12)61970-9; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Sporns O., 2010, NETWORKS BRAIN; Tymofiyeva O, P OHBM 2012; Tymofiyeva O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031029; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yap PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024678; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	31	53	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63310	10.1371/journal.pone.0063310	http://dx.doi.org/10.1371/journal.pone.0063310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675475	Green Published, gold			2022-12-25	WOS:000319036100036
J	Dai, ZQ; Wu, F; Chen, J; Xu, HJ; Wang, HH; Guo, FM; Tan, YJ; Ding, B; Wang, JF; Wan, YM; Li, YH				Dai, Zhongquan; Wu, Feng; Chen, Jian; Xu, Hongjie; Wang, Honghui; Guo, Feima; Tan, Yingjun; Ding, Bai; Wang, Jinfu; Wan, Yumin; Li, Yinghui			Actin Microfilament Mediates Osteoblast Cbfa1 Responsiveness to BMP2 under Simulated Microgravity	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEINS; GENE-EXPRESSION; OSTEOGENIC DIFFERENTIATION; MODELED MICROGRAVITY; MAPK PATHWAY; TGF-BETA; RUNX2; INDUCTION; BINDING	Microgravity decreases osteoblastic activity, induces actin microfilament disruption and inhibits the responsiveness of osteoblast to cytokines, but the mechanisms remains enigmatic. The F-actin cytoskeleton has previously been implicated in manifold changes of cell shape, function and signaling observed under microgravity. Here we investigate the involvement of microfilament in mediating the effects of microgravity and BMP2 induction on Cbfa1 activity. For this purpose we constructed a fluorescent reporter cell line (OSE-MG63) of Cbfa1 activity by stably transfecting MG63 cells with a reporter consisting of six tandem copies of OSE2 and a minimal mOG2 promoter upstream of enhanced green fluorescent protein (EGFP). The fluorescence intensity of OSE-MG63 showed responsiveness to bone-related cytokines (IGF-I, vitamin D3 and BMP2) and presented an accordant tendency with alkaline phosphatase (ALP) activity. Using OSE-MG63 reporter fluorescence, we performed a semi-quantitative analysis of Cbfa1 activity after treatment with simulated microgravity, microfilament-disrupting agent (cytochalasin B, CB), microfilament-stabilizing agent (Jasplakinolide, JAS) or any combination thereof. In parallel, ALP activity, DNA binding activity of Cbfa1 to OSE2 (ChIP), F-actin structure (immunofluorescence) and EGFP mRNA expression (RT-qPCR) were analyzed. Simulated microgravity inhibited Cbfa1 activity, affected the responsiveness of Cbfa1 to cytokine BMP2, and caused a thinning and dispersed distribution of microfilament. Under normal gravity, CB significantly attenuated BMP2 induction to Cbfa1 activity as well as DNA binding activity of Cbfa1 to OSE2. The addition of JAS reversed the inhibitory effects of microgravity on the responsiveness of Cbfa1 to BMP2. Our study demonstrates that disrupting the microfilament organization by CB or simulated microgravity attenuates the responsiveness of Cbfa1 to BMP2. A stabilization of the microfilament organization by JAS reverses this inhibition. Taken together, these results suggest that actin microfilament participates in BMP2's induction to Cbfa1 activity and that their disruption might be an important contributor to microgravity's inhibition on BMP2' s osteogenic induction.	[Dai, Zhongquan; Li, Yinghui] Fourth Mil Med Univ, Fac Aerosp Med, Xian, Peoples R China; [Dai, Zhongquan; Wu, Feng; Chen, Jian; Xu, Hongjie; Wang, Honghui; Guo, Feima; Tan, Yingjun; Ding, Bai; Wan, Yumin; Li, Yinghui] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Chen, Jian; Wang, Jinfu] Zhejiang Univ, Coll Life Sci, Inst Cell & Dev Biol, Hangzhou 310003, Zhejiang, Peoples R China	Air Force Military Medical University; Zhejiang University	Dai, ZQ (corresponding author), Fourth Mil Med Univ, Fac Aerosp Med, Xian, Peoples R China.	daizhq77@163.com; yinghuidd@vip.sina.com	Zhongquan, Dai/AAF-9331-2020; xu, hong/GSD-8903-2022		National Basic Research Program of China (973 Program) [2011CB707704]; National Key Technology RD Program [2009BAK59B01]; State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center [SMFA200908, SMFA2012B02]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center	This study was supported by a grant from the National Basic Research Program of China (973 Program No. 2011CB707704); National Key Technology R&D Program (no. 2009BAK59B01) and the State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center (SMFA200908, SMFA2012B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Caillot-Augusseau A, 1998, CLIN CHEM, V44, P578; Cao Xin-sheng, 2003, Space Med Med Eng (Beijing), V16, P269; Carmeliet G, 1997, J BONE MINER RES, V12, P786, DOI 10.1359/jbmr.1997.12.5.786; Carmeliet G, 1998, BONE, V22, p139S, DOI 10.1016/S8756-3282(98)00007-6; Cohen MM, 2002, AM J MED GENET, V109, P87, DOI 10.1002/ajmg.10289; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Dai ZQ, 2007, CELL PROLIFERAT, V40, P671, DOI 10.1111/j.1365-2184.2007.00461.x; Dai ZQ, 2006, ADV SPACE RES, V38, P1159, DOI 10.1016/j.asr.2006.02.060; Day JR, 1998, J APPL PHYSIOL, V85, P716, DOI 10.1152/jappl.1998.85.2.716; Dehority W, 1999, AM J PHYSIOL-ENDOC M, V276, pE62; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Frendo JL, 1998, J BIOL CHEM, V273, P30509, DOI 10.1074/jbc.273.46.30509; Fu C J, 2001, Space Med Med Eng (Beijing), V14, P295; Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; Guignandon A, 2001, FASEB J, V15, P2036, DOI 10.1096/fj.00-0837fje; Guo Feima, 2011, Chinese Journal of Space Science, V31, P627; Higashibata Akira, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-19; Higuchi C, 2009, J BONE MINER METAB, V27, P158, DOI 10.1007/s00774-009-0037-y; Huang HY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002691; Hughes-Fulford Millie, 2002, J Gravit Physiol, V9, pP257; Javed A, 2009, CELLS TISSUES ORGANS, V189, P133, DOI 10.1159/000151719; Jun JH, 2010, J BIOL CHEM, V285, P36410, DOI 10.1074/jbc.M110.142307; Kacena MA, 2004, MICROGRAVITY SCI TEC, V15, P28, DOI 10.1007/BF02870949; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kostenuik PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE1133; Lai CF, 2005, J BONE MINER RES, V20, P330, DOI 10.1359/JBMR.041013; LAJEUNESSE D, 1990, J BONE MINER RES, V5, P915, DOI 10.1002/jbmr.5650050904; Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.3.CO;2-5; Lewis ML, 2004, GRAVIT SPACE BIOL, V17, P1; LORENZI G, 1990, BIOL CELL, V68, P259, DOI 10.1016/0248-4900(90)90317-V; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Meyers VE, 2004, J CELL BIOCHEM, V93, P697, DOI 10.1002/jcb.20229; Morita S, 2004, ANN NY ACAD SCI, V1030, P158, DOI 10.1196/annals.1329.020; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; Ontiveros C, 2003, J CELL BIOCHEM, V88, P427, DOI 10.1002/jcb.10410; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pan Z, 2008, STEM CELLS DEV, V17, P795, DOI 10.1089/scd.2008.0254; Pardo SJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1211, DOI 10.1152/ajpcell.00222.2004; Park SJ, 2011, BONE, V49, P428, DOI 10.1016/j.bone.2011.05.012; Patel MJ, 2009, J CELL BIOCHEM, V106, P306, DOI 10.1002/jcb.22007; Pei Y, 2003, ACTA PHARMACOL SIN, V24, P975; Roberts WE., 1981, PHYSIOLOGIST, V24, pS75; Rosner H, 2006, PROTOPLASMA, V229, P225, DOI 10.1007/s00709-006-0202-2; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Sato M, 1999, J BONE MINER RES, V14, P1084, DOI 10.1359/jbmr.1999.14.7.1084; Saxena R, 2007, ANN NY ACAD SCI, V1116, P494, DOI 10.1196/annals.1402.033; Schwartz Z, 2008, J ORTHOP RES, V26, P1250, DOI 10.1002/jor.20591; Selvamurugan N, 2004, J BIOL CHEM, V279, P27764, DOI 10.1074/jbc.M312870200; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Sun LW, 2008, ACTA ASTRONAUT, V63, P968, DOI 10.1016/j.actaastro.2007.12.008; TILTON FE, 1980, AVIAT SPACE ENVIR MD, V51, P1209; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Wang B, 2006, ZHONGGUO LINCHUANG K, V10, P155; Wang Bing, 2004, Space Med Med Eng (Beijing), V17, P176; Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yotsumoto N, 2010, TOHOKU J EXP MED, V221, P221, DOI 10.1620/tjem.221.221; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Zayzafoon M, 2004, ENDOCRINOLOGY, V145, P2421, DOI 10.1210/en.2003-1156; Zhang ZJ, 2006, BIOCHEM BIOPH RES CO, V348, P421, DOI 10.1016/j.bbrc.2006.07.073; Zheng L, 2007, J CELL BIOL, V178, P121, DOI 10.1083/jcb.200703113; Zheng Q, 2007, BIOL CHEM, V388, P755, DOI 10.1515/BC.2007.082	69	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63661	10.1371/journal.pone.0063661	http://dx.doi.org/10.1371/journal.pone.0063661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675497	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400049
J	Guy, L; Jernberg, C; Norling, JA; Ivarsson, S; Hedenstrom, I; Melefors, O; Liljedahl, U; Engstrand, L; Andersson, SGE				Guy, Lionel; Jernberg, Cecilia; Norling, Jenny Arven; Ivarsson, Sofie; Hedenstrom, Ingela; Melefors, Ojar; Liljedahl, Ulrika; Engstrand, Lars; Andersson, Siv G. E.			Adaptive Mutations and Replacements of Virulence Traits in the Escherichia coli O104:H4 Outbreak Population	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; HEMOLYTIC-UREMIC SYNDROME; E.-COLI; GENOMIC ANALYSIS; READ ALIGNMENT; RNA GENES; SEQUENCE; O104/H4; K-12; ANNOTATION	The sequencing of highly virulent Escherichia coli O104:H4 strains isolated during the outbreak of bloody diarrhea and hemolytic uremic syndrome in Europe in 2011 revealed a genome that contained a Shiga toxin encoding prophage and a plasmid encoding enteroaggregative fimbriae. Here, we present the draft genome sequence of a strain isolated in Sweden from a patient who had travelled to Tunisia in 2010 (E112/10) and was found to differ from the outbreak strains by only 38 SNPs in non-repetitive regions, 16 of which were mapped to the branch to the outbreak strain. We identified putatively adaptive mutations in genes for transporters, outer surface proteins and enzymes involved in the metabolism of carbohydrates. A comparative analysis with other historical strains showed that E112/10 contained Shiga toxin prophage genes of the same genotype as the outbreak strain, while these genes have been replaced by a different genotype in two otherwise very closely related strains isolated in the Republic of Georgia in 2009. We also present the genome sequences of two enteroaggregative E. coli strains affiliated with phylogroup A (C43/90 and C48/93) that contain the agg genes for the AAF/I-type fimbriae characteristic of the outbreak population. Interestingly, C43/90 also contained a tet/mer antibiotic resistance island that was nearly identical in sequence to that of the outbreak strain, while the corresponding island in the Georgian strains was most similar to E. coli strains of other serotypes. We conclude that the pan-genome of the outbreak population is shared with strains of the A phylogroup and that its evolutionary history is littered with gene replacement events, including most recently independent acquisitions of antibiotic resistance genes in the outbreak strains and its nearest neighbors. The results are summarized in a refined evolutionary model for the emergence of the O104:H4 outbreak population.	[Guy, Lionel; Norling, Jenny Arven; Andersson, Siv G. E.] Uppsala Univ, Dept Mol Evolut Cell & Mol Biol, Sci Life Lab, Biomed Ctr, Uppsala, Sweden; [Jernberg, Cecilia; Ivarsson, Sofie; Hedenstrom, Ingela; Melefors, Ojar; Engstrand, Lars] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden; [Melefors, Ojar; Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Liljedahl, Ulrika] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Uppsala University	Andersson, SGE (corresponding author), Uppsala Univ, Dept Mol Evolut Cell & Mol Biol, Sci Life Lab, Biomed Ctr, Uppsala, Sweden.	siv.andersson@icm.uu.se	Guy, Lionel/B-4501-2008; Melefors, Öjar/N-6164-2015	Guy, Lionel/0000-0001-8354-2398; Melefors, Öjar/0000-0003-4115-1190	Swiss National Science Foundation [PA00P3_131491]; Swedish Research Council; Science for Life Laboratory	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Science for Life Laboratory	This work was supported by grants from the Swiss National Science Foundation (grant PA00P3_131491 to L. G.), the Swedish Research Council (to L. E. and S. G. E. A) and Science for Life Laboratory (to S. G. E. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048228; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Brondijk THC, 2004, BIOCHEM J, V379, P47, DOI 10.1042/BJ20031115; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chibba A, 2012, ORG BIOMOL CHEM, V10, P7103, DOI 10.1039/c2ob26105g; European Centre for Disease Prevention and Control and European Food Safety Authority, 2011, SHIG TOX VER PROD ES; Ferrandez A, 1997, J BACTERIOL, V179, P2573, DOI 10.1128/jb.179.8.2573-2581.1997; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Guy L, 2012, P NATL ACAD SCI USA, V109, pE3627, DOI 10.1073/pnas.1206246110; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kupferschmidt K, 2011, SCIENCE, V332, P1249, DOI 10.1126/science.332.6035.1249; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; L'Abee-Lund TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031413; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Sadowsky MJ, 1998, J BACTERIOL, V180, P152, DOI 10.1128/JB.180.1.152-158.1998; Scheutz F, 2011, EURO SURVEILL, V16; Schiffer G, 1999, J BIOL CHEM, V274, P32031, DOI 10.1074/jbc.274.45.32031; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart AC, 2009, BIOINFORMATICS, V25, P962, DOI 10.1093/bioinformatics/btp097; Tau NP, 2012, EMERG INFECT DIS, V18, P1314, DOI 10.3201/eid1808.111616; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vanderpool CK, 2007, CURR OPIN MICROBIOL, V10, P146, DOI 10.1016/j.mib.2007.03.011; Yang KC, 2009, J BACTERIOL, V191, P4667, DOI 10.1128/JB.00235-09; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	43	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63027	10.1371/journal.pone.0063027	http://dx.doi.org/10.1371/journal.pone.0063027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675451	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400020
J	Wang, JP; Ai, XL; Mei, H; Fu, Y; Chen, B; Yu, ZN; He, J				Wang, Jieping; Ai, Xulu; Mei, Han; Fu, Yang; Chen, Bo; Yu, Ziniu; He, Jin			High-Throughput Identification of Promoters and Screening of Highly Active Promoter-5 '-UTR DNA Region with Different Characteristics from Bacillus thuringiensis	PLOS ONE			English	Article							TRANSCRIPTION START SITES; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; RNA-POLYMERASE; EXPRESSION; SUBTILIS; SPORULATION; PROTEIN; RECOGNITION; SECRETION	In bacteria, both promoters and 5'-untranslated regions (5'-UTRs) of mRNAs play vital regulatory roles in gene expression. In this study, we identified 1203 active promoter candidates in Bacillus thuringiensis through analysis of the genome-wide TSSs based on the transcriptome data. There were 11 types of sigma-factor and 34 types of transcription factor binding sites found in 723 and 1097 active promoter candidates, respectively. Moreover, within the 1203 transcriptional units (TUs), most (52%) of the 5'-UTRs were 10-50 nucleotides in length, 12.8% of the TUs had a long 5'-UTR greater than 100 nucleotides in length, and 16.3% of the TUs were leaderless. We then selected 20 active promoter candidates combined with the corresponding 5'-UTR DNA regions to screen the highly active promoter-5'-UTR DNA region complexes with different characteristics. Our results demonstrate that among the 20 selected complexes, six were able to exert their functions throughout the life cycle, six were specifically induced during the early-stationary phase, and four were specifically activated during the mid-stationary phase. We found a direct corresponding relationship between sigma-factor-recognized consensus sequences and complex activity features: the great majority of complexes acting throughout the life cycle possess sigma(A)-like consensus sequences; the maximum activities of the sigma(F)-, sigma-(E), sigma(G)-, and sigma(K)-dependent complexes appeared at 10, 14, 16, and 22 h under our experimental conditions, respectively. In particular, complex Phj3 exhibited the strongest activity. Several lines of evidence showed that complex Phj3 possessed three independent promoter regions located at -251 similar to-98, -113 similar to-31, and -54 similar to+14, and that the 5'-UTR +1 similar to+118 DNA region might be particularly beneficial to both the stability and translation of its downstream mRNA. Moreover, Phj3 successfully overexpressed the active beta-galactosidase and turbo-RFP, indicating that Phj3 could be a proper regulatory element for overexpression of proteins in B. thuringiensis. Therefore, our efforts contribute to molecular biology research and the biotechnological application of B. thuringiensis.	[Wang, Jieping; Ai, Xulu; Mei, Han; Fu, Yang; Chen, Bo; Yu, Ziniu; He, Jin] Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	He, J (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	hejin@mail.hzau.edu.cn		Mei, Han/0000-0002-2567-5464	Chinese National Natural Science Funds [31270105, 30930004]; National Basic Research Program of China (973 Program) [2010CB126105]; National High-tech R&D Program of China [2011AA10A205]; Fundamental Research Funds for Central Universities of China [2011PY092]	Chinese National Natural Science Funds(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High-tech R&D Program of China(National High Technology Research and Development Program of China); Fundamental Research Funds for Central Universities of China	This work was supported by the Chinese National Natural Science Funds (grants 31270105 and 30930004), the National Basic Research Program of China (973 Program, grant 2010CB126105), the National High-tech R&D Program of China (No. 2011AA10A205) and the Fundamental Research Funds for Central Universities of China (grant 2011PY092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 2011, FOOD MICROBIOL, V28, P199, DOI 10.1016/j.fm.2010.03.015; AGAISSE H, 1994, J BACTERIOL, V176, P4734, DOI 10.1128/JB.176.15.4734-4741.1994; Aronson A, 2002, CELL MOL LIFE SCI, V59, P417, DOI 10.1007/s00018-002-8434-6; Berg L, 2012, J BIOTECHNOL, V158, P224, DOI 10.1016/j.jbiotec.2011.07.012; Bongrand C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032862; Bron S, 1998, J BIOTECHNOL, V64, P3, DOI 10.1016/S0168-1656(98)00099-6; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; De Lay N, 2012, MOL MICROBIOL, V86, P524, DOI 10.1111/j.1365-2958.2012.08209.x; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Gutierrez-Preciado A, 2009, MICROBIOL MOL BIOL R, V73, P36, DOI 10.1128/MMBR.00026-08; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; He J, 2011, J BACTERIOL, V193, P3407, DOI 10.1128/JB.05085-11; He J, 2010, J BACTERIOL, V192, P4074, DOI 10.1128/JB.00562-10; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Ibrahim Mohamed A, 2010, Bioeng Bugs, V1, P31, DOI 10.4161/bbug.1.1.10519; Kang JoongNam, 2005, International Journal of Industrial Entomology, V11, P125; Lale R, 2011, APPL ENVIRON MICROB, V77, P2648, DOI 10.1128/AEM.02091-10; Lioliou E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002782; Loh E, 2012, NUCLEIC ACIDS RES, V40, P1818, DOI 10.1093/nar/gkr850; Mathew R, 2006, TRENDS MICROBIOL, V14, P450, DOI 10.1016/j.tim.2006.08.002; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; Miller JH., 1972, EXPT MOL GENETICS; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; NICKERSON KW, 1974, APPL MICROBIOL, V28, P129, DOI 10.1128/AEM.28.1.129-132.1974; Paredes-Sabja D, 2011, TRENDS MICROBIOL, V19, P85, DOI 10.1016/j.tim.2010.10.004; Peng D, 2009, J APPL MICROBIOL, V106, P1849, DOI 10.1111/j.1365-2672.2009.04151.x; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Sachs R, 2012, RNA, V18, P65, DOI 10.1261/rna.02809212; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; Wang JP, 2013, MOL CELL PROTEOMICS, V12, P1363, DOI 10.1074/mcp.M112.023986; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; WONG SL, 1995, CURR OPIN BIOTECH, V6, P517, DOI 10.1016/0958-1669(95)80085-9; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zhong CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016025; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	27	30	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62960	10.1371/journal.pone.0062960	http://dx.doi.org/10.1371/journal.pone.0062960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675447	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400017
J	Chiara, DC; Jayakar, SS; Zhou, XJ; Zhang, X; Savechenkov, PY; Bruzik, KS; Miller, KW; Cohen, JB				Chiara, David C.; Jayakar, Selwyn S.; Zhou, Xiaojuan; Zhang, Xi; Savechenkov, Pavel Y.; Bruzik, Karol S.; Miller, Keith W.; Cohen, Jonathan B.			Specificity of Intersubunit General Anesthetic-binding Sites in the Transmembrane Domain of the Human alpha 1 beta 3 gamma 2 gamma-Aminobutyric Acid Type A (GABA(A)) Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SUBUNIT INTERFACES; BETA-3 SUBUNIT; ETOMIDATE; PROPOFOL; IDENTIFICATION; POTENCIES; PHARMACOLOGY; ACTIVATION; MECHANISMS	GABA type A receptors (GABA(A)R), the brain's major inhibitory neurotransmitter receptors, are the targets for many general anesthetics, including volatile anesthetics, etomidate, propofol, and barbiturates. Howsuch structurally diverse agents can act similarly as positive allosteric modulators of GABA(A) Rs remains unclear. Previously, photoreactive etomidate analogs identified two equivalent anesthetic-binding sites in the transmembrane domain at the beta(+)-alpha(-) subunit interfaces, which also contain the GABA-binding sites in the extracellular domain. Here, we used R-[H-3]5-allyl-1-methyl-5-(m-trifluoromethyl-diazirynylphenyl) barbituric acid (R-mTFD-MPAB), a potent stereospecific barbiturate anesthetic, to photolabel expressed human alpha 1 beta 3 gamma 2 GABA(A)Rs. Protein microsequencing revealed that R-[3H]mTFD-MPAB did not photolabel the etomidate sites at the alpha(+) -beta(-) subunit interfaces. Instead, it photolabeled sites at the alpha(+) -beta(-) and gamma(+) -beta(-) subunit interfaces in the transmembrane domain. On the (similar to)-side, alpha 1M3 was labeled at Ala-291 and Tyr294 and gamma 2M3 at Ser-301, and on the (-)-side, beta 3M1 was labeled at Met-227. These residues, like those in the etomidate site, are located at subunit interfaces near the synaptic side of the transmembrane domain. The selectivity of R-etomidate for the beta(+) -alpha(-) interface relative to the alpha(+) -beta(-)/gamma(+)-beta(-) interfaces was > 100-fold, whereas that of R-mTFD-MPAB for its sites was > 50-fold. Each ligand could enhance photoincorporation of the other, demonstrating allosteric interactions between the sites. The structural heterogeneity of barbiturate, etomidate, and propofol derivatives is accommodated by varying selectivities for these two classes of sites. Wehypothesize that binding at any of these homologous intersubunit sites is sufficient for anesthetic action and that this explains to some degree the puzzling structural heterogeneity of anesthetics.	[Chiara, David C.; Jayakar, Selwyn S.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Miller, Keith W.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhou, Xiaojuan; Zhang, Xi; Miller, Keith W.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Savechenkov, Pavel Y.; Bruzik, Karol S.] Univ Illinois, Deparment Med Chem & Pharmacognosy, Chicago, IL 60612 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu		Jayakar, Selwyn/0000-0002-5792-6408; Zhang, Xi/0000-0003-2755-7901	National Institutes of Health, USPHS [GM-58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448, P01GM055876] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-58448 from USPHS.	Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Chen ZW, 2012, MOL PHARMACOL, V82, P408, DOI 10.1124/mol.112.078410; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; CRIMMINS DL, 1990, ANAL BIOCHEM, V187, P27, DOI 10.1016/0003-2697(90)90412-3; DODSON BA, 1990, BRIT J PHARMACOL, V101, P710, DOI 10.1111/j.1476-5381.1990.tb14145.x; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; Drexler B, 2011, CAN J ANESTH, V58, P178, DOI 10.1007/s12630-010-9414-1; FIRESTONE LL, 1986, MOL CELLULAR MECH AN, P455; Forman SA, 2012, CURR OPIN ANESTHESIO, V25, P411, DOI 10.1097/ACO.0b013e328354feea; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Greenfield LJ, 2002, NEUROPHARMACOLOGY, V42, P502, DOI 10.1016/S0028-3908(01)00196-4; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Husain SS, 2006, J MED CHEM, V49, P4818, DOI 10.1021/jm051207b; Husain SS, 2010, J MED CHEM, V53, P6432, DOI 10.1021/jm100498u; Husain SS, 1999, J MED CHEM, V42, P3300, DOI 10.1021/jm9806300; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kamiya Y, 1999, ANESTHESIOLOGY, V90, P1704, DOI 10.1097/00000542-199906000-00028; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; LEESON S, 1975, J PHARMACOL EXP THER, V195, P251; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Li GD, 2009, J BIOL CHEM, V284, P11771, DOI 10.1074/jbc.C900016200; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Meyer H, 1901, ARCH EXP PATHOL PHAR, V46, P338, DOI 10.1007/BF01978064; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Overton C. E., 1991, STUDIES NARCOSIS CON; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Ruesch D, 2012, ANESTHESIOLOGY, V116, P47, DOI 10.1097/ALN.0b013e31823d0c36; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Serafini R, 2000, J PHYSIOL-LONDON, V524, P649, DOI 10.1111/j.1469-7793.2000.00649.x; Sieghart W, 2012, BRIT J PHARMACOL, V166, P476, DOI 10.1111/j.1476-5381.2011.01779.x; Siegwart Roberta, 2003, BMC Pharmacol, V3, P13, DOI 10.1186/1471-2210-3-13; Sigel E, 2005, MED CHEM REV ONLINE, V2, P251, DOI [10.2174/1567203054065673, DOI 10.2174/1567203054065673]; Stewart DS, 2011, J MED CHEM, V54, P8124, DOI 10.1021/jm200943f; TICKU MK, 1985, EUR J PHARMACOL, V112, P1, DOI 10.1016/0014-2999(85)90232-8; TURNER DM, 1989, J PHARMACOL EXP THER, V248, P960; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Zeller A, 2007, MOL PHARMACOL, V71, P852, DOI 10.1124/mol.106.030049; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	55	111	111	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19343	19357		10.1074/jbc.M113.479725	http://dx.doi.org/10.1074/jbc.M113.479725			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23677991	Green Published, hybrid			2022-12-25	WOS:000321515800005
J	Baty, F; Putora, PM; Isenring, B; Blum, T; Brutsche, M				Baty, Florent; Putora, Paul Martin; Isenring, Bruno; Blum, Torsten; Brutsche, Martin			Comorbidities and Burden of COPD: A Population Based Case-Control Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; SYSTEMIC MANIFESTATIONS; GLOBAL BURDEN; MORTALITY; PREVALENCE; PROJECTIONS; DISABILITY; RISK	COPD is associated with a relevant burden of disease and a high mortality worldwide. Only recently, the importance of comorbidities of COPD has been recognized. Studies postulated an association with inflammatory conditions potentially sharing pathogenic pathways and worsening overall prognosis. More evidence is required to estimate the role of comorbidities of COPD. Our aim was to investigate the prevalence and clustering of comorbidities associated with COPD, and to estimate their impact on clinically relevant outcomes. In this population-based case-control study, a nation-wide database provided by the Swiss Federal Office for Statistics enclosing every hospital entry covering the years 2002-2010 (n = 12'888'075) was analyzed using MySQL and R statistical software. Statistical methods included non-parametric hypothesis testing by means of Fisher's exact test and Wilcoxon rank sum test, as well as linear models with generalized estimating equation to account for intra-patient variability. Exploratory multivariate approaches were also used for the identification of clusters of comorbidities in COPD patients. In 2.6% (6.3% in patients aged >70 years) of all hospitalization cases an active diagnosis of COPD was recorded. In 21% of these cases, COPD was the main reason for hospitalization. Patients with a diagnosis of COPD had more comorbidities (7 [IQR 4-9] vs. 3 [IQR 1-6]; p<0: 001), were more frequently rehospitalized (annual hospitalization rate 0.33 [IQR 0.20-0.67] vs. 0.25 [IQR 0.14-0.43]/year; p<0: 001), had a longer hospital stay (9 [IQR 4-15] vs. 5 [IQR 2-11] days; p<0: 001), and had higher in-hospital mortality (5.9% [95% CI 5.8%-5.9%] vs. 3.4% [95% CI 3.3%-3.5%]; p<0: 001) compared to matched controls. A set of comorbidities was associated with worse outcome. We could identify COPD-related clusters of COPD-comorbidities.	[Baty, Florent; Brutsche, Martin] Cantonal Hosp, Div Pulm Med, St Gallen, Switzerland; [Putora, Paul Martin] Cantonal Hosp, Dept Radiat Oncol, St Gallen, Switzerland; [Isenring, Bruno] Univ Zurich Hosp, Clin Pulm Med, CH-8091 Zurich, Switzerland; [Blum, Torsten] Lung Clin Heckeshorn, Dept Pulm Med, Berlin, Germany	Kantonsspital St. Gallen; Kantonsspital St. Gallen; University of Zurich; University Zurich Hospital	Brutsche, M (corresponding author), Cantonal Hosp, Div Pulm Med, St Gallen, Switzerland.	martin.brutsche@kssg.ch	Blum, Torsten/W-6011-2019	Blum, Torsten/0000-0003-1216-2157; Brutsche, Martin/0000-0002-1612-3609	Takeda Pharma AG, Switzerland	Takeda Pharma AG, Switzerland	Unconditional support for costs related to the elaboration of this manuscript was granted by Takeda Pharma AG, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Baty F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-422; Burgel PR, 2012, AM J RESP CRIT CARE, V186, P936, DOI 10.1164/rccm.201209-1634ED; Calverley Peter M A, 2006, COPD, V3, P233; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Culhane AC, 2002, BIOINFORMATICS, V18, P1600, DOI 10.1093/bioinformatics/18.12.1600; Decramer M, 2008, COPD, V5, P235, DOI 10.1080/15412550802237531; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Greenacre M., 2010, BIPLOTS PRACTICE; Hansell AL, 2003, EUR RESPIR J, V22, P809, DOI 10.1183/09031936.03.00031403; Hartman Jorine E, 2010, Expert Rev Respir Med, V4, P735, DOI 10.1586/ers.10.76; Katz P, 2011, J CARDIOPULM REHABIL, V31, P193, DOI 10.1097/HCR.0b013e3181fc09b7; Lindberg A, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-1; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nussbaumer-Ochsner Y, 2011, CHEST, V139, P165, DOI 10.1378/chest.10-1252; Oksanen, 2010, MULTIVARIATE ANAL EC; Patel ARC, 2011, EXPERT REV RESP MED, V5, P647, DOI [10.1586/ERS.11.62, 10.1586/ers.11.62]; Pena VS, 2000, CHEST, V118, P981, DOI 10.1378/chest.118.4.981; R Development Core Team, 2012, R LANG ENV STAT COMP; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Smit RNV, 2010, EUR RESPIR J, V35, P27, DOI 10.1183/09031936.00072909; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; Thomsen RW, 2011, RESP MED, V105, P1063, DOI 10.1016/j.rmed.2011.01.012; Tinkelman DG, 2006, J ASTHMA, V43, P75, DOI 10.1080/02770900500448738; van Eeden SF, 2008, RESPIRATION, V75, P224, DOI 10.1159/000111820; VESTBO J, 2012, AM J RESP C IN PRESS; Viegi G, 2007, EUR RESPIR J, V30, P993, DOI 10.1183/09031936.00082507; Wedzicha JA, 2000, THORAX, V55, P631, DOI 10.1136/thorax.55.8.631; Ye YM, 2010, ALLERGY ASTHMA IMMUN, V2, P260, DOI 10.4168/aair.2010.2.4.260	37	71	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63285	10.1371/journal.pone.0063285	http://dx.doi.org/10.1371/journal.pone.0063285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691009	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900032
J	Scafoglio, C; Smolka, M; Zhou, HL; Perissi, V; Rosenfeld, MG				Scafoglio, Claudio; Smolka, Marcus; Zhou, Huilin; Perissi, Valentina; Rosenfeld, Michael G.			The Co-Repressor SMRT Delays DNA Damage-Induced Caspase Activation by Repressing Pro-Apoptotic Genes and Modulating the Dynamics of Checkpoint Kinase 2 Activation	PLOS ONE			English	Article							NF-KAPPA-B; NUCLEAR RECEPTOR COREPRESSOR; CELL-CYCLE PROGRESSION; TUMOR-NECROSIS-FACTOR; CHK2; EXPRESSION; P53; PHOSPHORYLATION; TRANSCRIPTION; COMPLEX	Checkpoint kinase 2 (Chk2) is a major regulator of DNA damage response and can induce alternative cellular responses: cell cycle arrest and DNA repair or programmed cell death. Here, we report the identification of a new role of Chk2 in transcriptional regulation that also contributes to modulating the balance between survival and apoptosis following DNA damage. We found that Chk2 interacts with members of the NCoR/SMRT transcriptional co-regulator complexes and serves as a functional component of the repressor complex, being required for recruitment of SMRT on the promoter of proapoptotic genes upon DNA damage. Thus, the co-repressor SMRT exerts a critical protective action against genotoxic stress-induced caspase activation, repressing a functionally important cohort of pro-apoptotic genes. Amongst them, SMRT is responsible for basal repression of Wip1, a phosphatase that de-phosphorylates and inactivates Chk2, thus affecting a feedback loop responsible for licensing the correct timing of Chk2 activation and the proper execution of the DNA repair process.	[Scafoglio, Claudio; Perissi, Valentina; Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Scafoglio, Claudio; Perissi, Valentina; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Scafoglio, Claudio] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Smolka, Marcus; Zhou, Huilin; Rosenfeld, Michael G.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Smolka, Marcus; Zhou, Huilin; Rosenfeld, Michael G.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Smolka, Marcus] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY USA; [Perissi, Valentina] Boston Univ, Sch Med, Boston, MA 02118 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Cornell University; Boston University	Scafoglio, C (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	cscafoglio@mednet.ucla.edu; mrosenfeld@ucsd.edu		Perissi, Valentina/0000-0002-3716-0003; Zhou, Huilin/0000-0002-1350-4430; Scafoglio, Claudio/0000-0003-1188-8124	National Institutes of Health [NS34934, DK018477, CA097134, HL065445, R25T CA098010]; American Italian Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA097134, R25CA098010] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Italian Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	work was supported by National Institutes of Health grants NS34934, DK018477, CA097134, HL065445 and R25T CA098010, and by the American Italian Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chehab NH, 2000, GENE DEV, V14, P278; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Ghosh JC, 2006, CANCER RES, V66, P11576, DOI 10.1158/0008-5472.CAN-06-3095; Guenther MG, 2000, GENE DEV, V14, P1048; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hiom K, 2010, DNA REPAIR, V9, P1256, DOI 10.1016/j.dnarep.2010.09.018; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hoffman B, 1998, ONCOGENE, V17, P3351, DOI 10.1038/sj.onc.1202592; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Jang SW, 2009, J BIOL CHEM, V284, P24512, DOI 10.1074/jbc.M109.026237; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lazzaro F, 2009, DNA REPAIR, V8, P1055, DOI 10.1016/j.dnarep.2009.04.022; Le Guezennec X, 2010, TRENDS BIOCHEM SCI, V35, P109, DOI 10.1016/j.tibs.2009.09.005; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Li J, 2005, J BIOL CHEM, V280, P37948, DOI 10.1074/jbc.M509299200; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Lowe JM, 2010, J BIOL CHEM, V285, P5249, DOI 10.1074/jbc.M109.034579; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Pajak B, 2005, J Physiol Pharmacol, V56 Suppl 3, P101; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Stolz A, 2011, CLIN CANCER RES, V17, P401, DOI 10.1158/1078-0432.CCR-10-1215; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Takeuchi K, 2001, J BIOL CHEM, V276, P26077, DOI 10.1074/jbc.M102704200; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; You MJ, 1997, MOL CELL BIOL, V17, P7328, DOI 10.1128/MCB.17.12.7328; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108	71	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e59986	10.1371/journal.pone.0059986	http://dx.doi.org/10.1371/journal.pone.0059986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690919	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900002
J	Bell, PR; Coria, RA				Bell, Phil R.; Coria, Rodolfo A.			Palaeopathological Survey of a Population of Mapusaurus (Theropoda: Carcharodontosauridae) from the Late Cretaceous Huincul Formation, Argentina	PLOS ONE			English	Article							DINOSAUR; PATHOLOGY; BEHAVIOR; CLUES	Paleoepidemiology (the study of disease and trauma in prehistoric populations) provides insight into the distribution of disease and can have implications for interpreting behavior in extinct organisms. A monospecific bonebed of the giant carcharodontosaurid Mapusaurus (minimum number of individuals = 9) from the Canadon del Gato site, Neuquen Province, Argentina (Cenomanian) provides a rare opportunity to investigate disease within a single population of this important apex predator. Visual inspection of 176 skeletal elements belonging to a minimum of nine individuals yielded a small number of abnormalities on a cervical vertebra, two ribs, pedal phalanx, and an ilium. These are attributed to traumatic (two cases), infectious (two cases) and anomalous (one case) conditions in a minimum of one individual. The emerging picture for large theropod (abelisaurids, allosaurids, carcharodontosaurids, tyrannosaurids) populations suggests that 1) osseous abnormalities were relatively rare (7-19% of individuals) but consistently present, and 2) trauma was a leading factor in the frequency of pathological occurrences, evidence of an active, often perilous lifestyle.	[Bell, Phil R.] Pipestone Creek Dinosaur Initiat, Clairmont, AB, Canada; [Coria, Rodolfo A.] Univ Nacl Rio Negro, Gral Roca, Rio Negro, Argentina		Bell, PR (corresponding author), Pipestone Creek Dinosaur Initiat, Cty Grande Prairie 1, Clairmont, AB, Canada.	pbell@countygp.ab.ca						Anonymous, 2006, Bulletin of the New Mexico Museum of Natural History and Science, P1; Bell PR, 2010, CAN J EARTH SCI, V47, P1263, DOI 10.1139/E10-030; Chure Daniel J., 1995, P103; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; Coria RA, 2006, GEODIVERSITAS, V28, P71; Currie P, 2008, J VERTEBR PALEONTOL, V28, p67A; Currie Philip J., 2006, Journal of the Paleontological Society of Korea, V22, P173; Currie PJ, 2010, CAN J EARTH SCI, V47, P1277, DOI 10.1139/E10-072; Currie PJ, 2005, LIFE O PAST, P313; Eberth David A., 2000, Journal of Vertebrate Paleontology, V20, p39A; Farke AA, 2007, J VERTEBR PALEONTOL, V27, P180, DOI 10.1671/0272-4634(2007)27[180:PIMCTA]2.0.CO;2; Hanna RR, 2002, J VERTEBR PALEONTOL, V22, P76, DOI 10.1671/0272-4634(2002)022[0076:MIAIIA]2.0.CO;2; Hershkovitz I, 1998, AM J PHYS ANTHROPOL, V106, P47, DOI 10.1002/(SICI)1096-8644(199805)106:1<47::AID-AJPA4>3.0.CO;2-A; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; Larson PL, 1995, AUSTR NATURE, V25, P46; Molnar R.E., 2001, P337; Moore MJ, 2004, SCIENCE, V306, P2215, DOI 10.1126/science.1105452; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Raath M. A., 1977, THESIS RHODES U GRAH; Resnick D., 2002, DIAGNOSIS BONE JOINT; Resnick D., 1988, DIAGNOSIS BONE JOINT; Rothschild B, 2005, LIFE O PAST, P351; Rothschild BM, 2003, J VERTEBR PALEONTOL, V23, P324, DOI 10.1671/0272-4634(2003)023[0324:DSIPSR]2.0.CO;2; Rothschild BM, 1998, AM J PHYS ANTHROPOL, V105, P241, DOI 10.1002/(SICI)1096-8644(199802)105:2<241::AID-AJPA10>3.0.CO;2-0; Rothschild Bruce, 2007, P171; Rowe T., 1989, Journal of Vertebrate Paleontology, V9, P125; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Tykoski R.S., 1998, THESIS U TEXAS AUSTI; VARRICCHIO DJ, 1995, PALAEOGEOGR PALAEOCL, V114, P297, DOI 10.1016/0031-0182(94)00084-L; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19	31	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63409	10.1371/journal.pone.0063409	http://dx.doi.org/10.1371/journal.pone.0063409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691045	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700035
J	Catterson, JH; Heck, MMS; Hartley, PS				Catterson, James H.; Heck, Margarete M. S.; Hartley, Paul S.			Fermitins, the Orthologs of Mammalian Kindlins, Regulate the Development of a Functional Cardiac Syncytium in Drosophila melanogaster	PLOS ONE			English	Article							CELL-MATRIX ADHESION; DILATED CARDIOMYOPATHY; MUTATIONS; GENE; MORPHOGENESIS; COMPONENT; VINCULIN; PROTEIN	The vertebrate Kindlins are an evolutionarily conserved family of proteins critical for integrin signalling and cell adhesion. Kindlin-2 (KIND2) is associated with intercalated discs in mice, suggesting a role in cardiac syncytium development; however, deficiency of Kind2 leads to embryonic lethality. Morpholino knock-down of Kind2 in zebrafish has a pleiotropic effect on development that includes the heart. It therefore remains unclear whether cardiomyocyte Kind2 expression is required for cardiomyocyte junction formation and the development of normal cardiac function. To address this question, the expression of Fermitin 1 and Fermitin 2 (Fit1, Fit2), the two Drosophila orthologs of Kind2, was silenced in Drosophila cardiomyocytes. Heart development was assessed in adult flies by immunological methods and videomicroscopy. Silencing both Fit1 and Fit2 led to a severe cardiomyopathy characterised by the failure of cardiomyocytes to develop as a functional syncytium and loss of synchrony between cardiomyocytes. A null allele of Fit1 was generated but this had no impact on the heart. Similarly, the silencing of Fit2 failed to affect heart function. In contrast, the silencing of Fit2 in the cardiomyocytes of Fit1 null flies disrupted syncytium development, leading to severe cardiomyopathy. The data definitively demonstrate a role for Fermitins in the development of a functional cardiac syncytium in Drosophila. The findings also show that the Fermitins can functionally compensate for each other in order to control syncytium development. These findings support the concept that abnormalities in cardiomyocyte KIND2 expression or function may contribute to cardiomyopathies in humans.	[Catterson, James H.; Heck, Margarete M. S.; Hartley, Paul S.] Univ Edinburgh, British Heart Fdn Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Hartley, PS (corresponding author), Univ Edinburgh, British Heart Fdn Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	P.S.Hartley@ed.ac.uk		Catterson, James/0000-0003-4231-0114; Hartley, Paul/0000-0003-2782-0490	British Heart Foundation Centre of Research Excellence (CoRE); 4-year BHF PhD award; BHF CoRE Transitional Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	British Heart Foundation Centre of Research Excellence (CoRE); 4-year BHF PhD award; BHF CoRE Transitional Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a British Heart Foundation Centre of Research Excellence (CoRE) award to the University of Edinburgh. JHC is supported by a 4-year BHF PhD award, and PSH is supported by a BHF CoRE Transitional Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alayari NN, 2009, JOVE-J VIS EXP, pe1423, DOI DOI 10.3791/1423; Anastasi G, 2009, INT J MOL MED, V23, P149, DOI 10.3892/ijmm_00000112; Bai JW, 2008, DEVELOPMENT, V135, P1439, DOI 10.1242/dev.012849; Basso C, 2006, EUR HEART J, V27, P1847, DOI 10.1093/eurheartj/ehl095; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; BROWER DL, 1984, P NATL ACAD SCI-BIOL, V81, P7485, DOI 10.1073/pnas.81.23.7485; Cammarato A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018497; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Di Mauro D, 2009, FOLIA HISTOCHEM CYTO, V47, P605, DOI 10.2478/v10042-009-0114-z; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Ehler E, 2001, J CELL BIOL, V153, P763, DOI 10.1083/jcb.153.4.763; Kim IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007132; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Knox J, 2011, DEV BIOL, V356, P279, DOI 10.1016/j.ydbio.2011.04.006; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Lehmacher C, 2012, ARTHROPOD STRUCT DEV, V41, P459, DOI 10.1016/j.asd.2012.02.002; MacMullin A, 2006, DEV BIOL, V293, P154, DOI 10.1016/j.ydbio.2006.01.027; Medioni C, 2008, J CELL BIOL, V182, P249, DOI 10.1083/jcb.200801100; Medioni C, 2009, CURR OPIN GENET DEV, V19, P518, DOI 10.1016/j.gde.2009.07.004; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Ocorr K, 2009, J VIS EXP, V32, P1423; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Perriard JC, 2003, TRENDS CARDIOVAS MED, V13, P30, DOI 10.1016/S1050-1738(02)00209-8; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Togel M, 2008, DEV BIOL, V318, P29, DOI 10.1016/j.ydbio.2008.02.043; Vanderploeg J, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-8; Vasile VC, 2006, BIOCHEM BIOPH RES CO, V345, P998, DOI 10.1016/j.bbrc.2006.04.151; Vogler G, 2009, JOVE-J VIS EXP; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; White SJ, 2005, J DERMATOL SCI, V38, P169, DOI 10.1016/j.jdermsci.2004.12.026; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e62958	10.1371/journal.pone.0062958	http://dx.doi.org/10.1371/journal.pone.0062958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690969	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000319052700015
J	Esquivel-Solis, H; Vallecillo, AJ; Benitez-Guzman, A; Adams, LG; Lopez-Vidal, Y; Gutierrez-Pabello, JA				Esquivel-Solis, Hugo; Vallecillo, Antonio J.; Benitez-Guzman, Alejandro; Adams, L. Garry; Lopez-Vidal, Yolanda; Gutierrez-Pabello, Jose A.			Nitric Oxide Not Apoptosis Mediates Differential Killing of Mycobacterium bovis in Bovine Macrophages	PLOS ONE			English	Article							BRUCELLA-ABORTUS; NRAMP1 GENE; MONONUCLEAR PHAGOCYTES; INTRACELLULAR SURVIVAL; NATURAL-RESISTANCE; TNF-ALPHA; TUBERCULOSIS; INFECTION; REPLICATION; INDUCTION	To identify the resistance phenotype against Mycobacterium bovis in cattle, we used a bactericidal assay that has been considered a marker of this trait. Three of 24 cows (12.5%) were phenotyped as resistant and 21 as susceptible. Resistance of bovine macrophages (M Phi) to BCG challenge was evaluated for its association with SLC11A1 GT microsatellite polymorphisms within 3'UTR region. Twenty-three cows (95.8%) had a GT(13) genotype, reported as resistant, consequently the SLC11A1 polymorphism was not in agreement with our bactericidal assay results. M Phi of cows with resistant or susceptible phenotype were challenged in vitro with virulent M. bovis field strain or BCG, and nitric oxide production, bacterial killing and apoptosis induction were measured in resting and LPS-primed states. M. bovis field strain induced more apoptosis than BCG, although the difference was not significant. Resistant M Phi controlled better the replication of M. bovis (P<0.01), produced more nitric oxide (P<0.05) and were slightly more prone to undergo apoptosis than susceptible cells. LPS pretreatment of M Phi enhanced all the functional parameters analyzed. Inhibition of nitric oxide production with n(G)-monomethyl-L-arginine monoacetate enhanced replication of M. bovis but did not modify apoptosis rates in both resistant and susceptible M Phi. We conclude that nitric oxide production not apoptosis is a major determinant of macrophage resistance to M. bovis infection in cattle and that the influence of SLC11A1 gene 3'UTR polymorphism is not associated with this event.	[Esquivel-Solis, Hugo; Vallecillo, Antonio J.; Benitez-Guzman, Alejandro; Gutierrez-Pabello, Jose A.] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Dept Microbiol & Inmunol, Lab Invest TB Bovina, Mexico City 04510, DF, Mexico; [Esquivel-Solis, Hugo] Ctr Invest & Asistencia Tecnol Diseno Estado Jali, Unidad Biotecnol Med & Farmaceut, Guadalajara, Jalisco, Mexico; [Adams, L. Garry] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Lopez-Vidal, Yolanda] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Programa Inmunol Mol Microbiana, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Texas A&M University System; Texas A&M University College Station; Universidad Nacional Autonoma de Mexico	Gutierrez-Pabello, JA (corresponding author), Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Dept Microbiol & Inmunol, Lab Invest TB Bovina, Mexico City 04510, DF, Mexico.	jagp@unam.mx	Benítez-Guzmán, Alejandro/ABD-4646-2020; López-Vidal, Yolanda/ABE-9501-2021; Esquivel-Solís, Hugo/I-8327-2017	López-Vidal, Yolanda/0000-0001-7111-8813; Esquivel-Solís, Hugo/0000-0002-3685-3094; Vallecillo, Antonio J./0000-0001-9141-0176	Universidad Nacional Autonoma de Mexico [PAPIIT IN-219999]; CONACYT (Consejo Nacional de Ciencia y Tecnologia) [34833-B]; Texas A&M-CONACYT Collaborative Research Grant Program [3-051002-7]	Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); CONACYT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Texas A&M-CONACYT Collaborative Research Grant Program	This work was supported by grants: PAPIIT IN-219999 from the Universidad Nacional Autonoma de Mexico, 34833-B from CONACYT (Consejo Nacional de Ciencia y Tecnologia) and 3-051002-7 from the Texas A&M-CONACYT Collaborative Research Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina JE, 1998, CANCER METAST REV, V17, P39, DOI 10.1023/A:1005904704618; Arcila ML, 2007, CELL IMMUNOL, V249, P80, DOI 10.1016/j.cellimm.2007.11.006; Arias M, 1997, J INFECT DIS, V176, P1552, DOI 10.1086/514154; Barthel R, 2000, AM J VET RES, V61, P1140, DOI 10.2460/ajvr.2000.61.1140; Barthel R, 2001, INFECT IMMUN, V69, P3110, DOI 10.1128/IAI.69.5.3110-3119.2001; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bosca L, 1999, CELL SIGNAL, V11, P239, DOI 10.1016/S0898-6568(98)00064-3; CAMPBELL GA, 1992, VET IMMUNOL IMMUNOP, V34, P291, DOI 10.1016/0165-2427(92)90171-L; Cassidy JP, 2006, VET MICROBIOL, V112, P151, DOI 10.1016/j.vetmic.2005.11.031; Castillo-Velazquez U, 2011, VET MICROBIOL, V151, P51, DOI 10.1016/j.vetmic.2011.02.025; Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349; Denis M, 2005, IMMUNOL CELL BIOL, V83, P643, DOI 10.1111/j.1440-1711.2005.01386.x; Denis M, 2005, VET IMMUNOL IMMUNOP, V107, P189, DOI 10.1016/j.vetimm.2005.04.010; Denis M, 2007, TUBERCULOSIS, V87, P53, DOI 10.1016/j.tube.2006.03.005; Fairbairn IP, 2001, J IMMUNOL, V167, P3300, DOI 10.4049/jimmunol.167.6.3300; Feng JW, 1996, GENOME RES, V6, P956, DOI 10.1101/gr.6.10.956; Ferguson JS, 1997, CURR OPIN INFECT DIS, V10, P190, DOI 10.1097/00001432-199706000-00006; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gil DP, 2004, J INFECT DIS, V189, P2120, DOI 10.1086/386369; Gutierrez-Pabello JA, 2002, INFECT IMMUN, V70, P2121, DOI 10.1128/IAI.70.4.2121-2127.2002; Horin P, 1999, EUR J IMMUNOGENET, V26, P311, DOI 10.1046/j.1365-2370.1999.00148.x; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kumar N, 2005, VET MICROBIOL, V111, P139, DOI 10.1016/j.vetmic.2005.09.012; Laochumroonvorapong P, 1996, INFECT IMMUN, V64, P452, DOI 10.1128/IAI.64.2.452-459.1996; Liebana E, 2008, VET J, V176, P354, DOI 10.1016/j.tvjl.2007.07.001; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; McNair J, 2007, VACCINE, V25, P5504, DOI 10.1016/j.vaccine.2007.02.037; Paixao TA, 2007, INFECT IMMUN, V75, P2493, DOI 10.1128/IAI.01855-06; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Piercy J, 2007, TUBERCULOSIS, V87, P415, DOI 10.1016/j.tube.2007.06.001; Placido R, 1997, J PATHOL, V181, P31, DOI 10.1002/(SICI)1096-9896(199701)181:1<31::AID-PATH722>3.0.CO;2-G; Pollock JM, 2005, VET IMMUNOL IMMUNOP, V108, P37, DOI 10.1016/j.vetimm.2005.08.012; PRICE RE, 1990, INFECT IMMUN, V58, P879, DOI 10.1128/IAI.58.4.879-886.1990; PRITCHARD DG, 1988, J COMP PATHOL, V99, P357, DOI 10.1016/0021-9975(88)90058-8; Qureshi T, 1996, VET IMMUNOL IMMUNOP, V50, P55, DOI 10.1016/0165-2427(95)05492-8; Randhawa AK, 2008, CELL MICROBIOL, V10, P2105, DOI 10.1111/j.1462-5822.2008.01194.x; Rodrigues MF, 2009, IMMUNOLOGY, V128, pe691, DOI 10.1111/j.1365-2567.2009.03062.x; Rojas M, 1997, J IMMUNOL, V159, P1352; Sanchez MD, 2006, MICROBES INFECT, V8, P2492, DOI 10.1016/j.micinf.2006.06.005; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Vega-Manriquez X, 2007, INFECT IMMUN, V75, P1223, DOI 10.1128/IAI.01047-06; Waters WR, 2001, CLIN DIAGN LAB IMMUN, V8, P1204, DOI 10.1128/CDLI.8.6.1204-1212.2001; Widdison S, 2007, VET IMMUNOL IMMUNOP, V117, P302, DOI 10.1016/j.vetimm.2007.01.016; Zinsstag J., 2006, MYCOBACTERIUM BOVIS, P68, DOI DOI 10.1002/9780470344538.CH9	47	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63464	10.1371/journal.pone.0063464	http://dx.doi.org/10.1371/journal.pone.0063464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691050	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700037
J	Pittman, M; Gatesy, SM; Upchurch, P; Goswami, A; Hutchinson, JR				Pittman, Michael; Gatesy, Stephen M.; Upchurch, Paul; Goswami, Anjali; Hutchinson, John R.			Shake a Tail Feather: The Evolution of the Theropod Tail into a Stiff Aerodynamic Surface	PLOS ONE			English	Article							ROTATIONAL INERTIA; LIMB FUNCTION; AVIAN FLIGHT; MORPHOLOGY; PERFORMANCE; MECHANICS; DINOSAURS; SIZE; MICRORAPTOR; LENGTH	Theropod dinosaurs show striking morphological and functional tail variation; e.g., a long, robust, basal theropod tail used for counterbalance, or a short, modern avian tail used as an aerodynamic surface. We used a quantitative morphological and functional analysis to reconstruct intervertebral joint stiffness in the tail along the theropod lineage to extant birds. This provides new details of the tail's morphological transformation, and for the first time quantitatively evaluates its biomechanical consequences. We observe that both dorsoventral and lateral joint stiffness decreased along the non-avian theropod lineage (between nodes Theropoda and Paraves). Our results show how the tail structure of non-avian theropods was mechanically appropriate for holding itself up against gravity and maintaining passive balance. However, as dorsoventral and lateral joint stiffness decreased, the tail may have become more effective for dynamically maintaining balance. This supports our hypothesis of a reduction of dorsoventral and lateral joint stiffness in shorter tails. Along the avian theropod lineage (Avialae to crown group birds), dorsoventral and lateral joint stiffness increased overall, which appears to contradict our null expectation. We infer that this departure in joint stiffness is specific to the tail's aerodynamic role and the functional constraints imposed by it. Increased dorsoventral and lateral joint stiffness may have facilitated a gradually improved capacity to lift, depress, and swing the tail. The associated morphological changes should have resulted in a tail capable of producing larger muscular forces to utilise larger lift forces in flight. Improved joint mobility in neornithine birds potentially permitted an increase in the range of lift force vector orientations, which might have improved flight proficiency and manoeuvrability. The tail morphology of modern birds with tail fanning capabilities originated in early ornithuromorph birds. Hence, these capabilities should have been present in the early Cretaceous, with incipient tail-fanning capacity in the earliest pygostylian birds.	[Pittman, Michael; Upchurch, Paul; Goswami, Anjali] UCL, Dept Earth Sci, London, England; [Gatesy, Stephen M.] Brown Univ, Dept Ecol & Evolut Biol, Providence, RI 02912 USA; [Goswami, Anjali] UCL, Dept Genet Evolut & Environm, London, England; [Hutchinson, John R.] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, Struct & Motion Lab, Hatfield, Herts, England	University of London; University College London; Brown University; University of London; University College London; University of London; University of London Royal Veterinary College	Pittman, M (corresponding author), Univ Hong Kong, Dept Earth Sci, Pokfulam, Hong Kong, Peoples R China.	mpittman@hku.hk	Pittman, Michael/F-9779-2012; Upchurch, Paul/C-1654-2008; Hutchinson, John/AAH-1593-2020	Pittman, Michael/0000-0002-6149-3078; Hutchinson, John/0000-0002-6767-7038	University College London Graduate School Research Projects Fund; Student Conference Fund; Doris O. and Samuel P. Welles Research Fund; Jurassic Foundation; Gloyne Outdoor Geological Research Fund of the Geological Society of London; Jackson School of Geosciences Student Member Travel Grant; Department of Veterinary Basic Sciences (The Royal Veterinary College); Natural Environment Research Council [NE/G005877/1]; University College London Earth Sciences; NERC [NE/G005877/1] Funding Source: UKRI	University College London Graduate School Research Projects Fund; Student Conference Fund; Doris O. and Samuel P. Welles Research Fund; Jurassic Foundation; Gloyne Outdoor Geological Research Fund of the Geological Society of London; Jackson School of Geosciences Student Member Travel Grant; Department of Veterinary Basic Sciences (The Royal Veterinary College); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University College London Earth Sciences; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors are grateful for support from the University College London Graduate School Research Projects Fund and Student Conference Fund, University College London Earth Sciences, The Doris O. and Samuel P. Welles Research Fund, The Jurassic Foundation, The Gloyne Outdoor Geological Research Fund of the Geological Society of London and The Jackson School of Geosciences Student Member Travel Grant. Additional support was provided by the Department of Veterinary Basic Sciences (The Royal Veterinary College) and Natural Environment Research Council grant NE/G005877/1 to JRH, awarded in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1988, BIOL J LINN SOC, V34, P363, DOI 10.1111/j.1095-8312.1988.tb01969.x; Alexander DE, 2010, P NATL ACAD SCI USA, V107, P2972, DOI 10.1073/pnas.0911852107; Allen TT, 1962, MYOLOGY LIMPKIN; Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Andersson Malte, 1994; Autodesk, 2011, AUT MAYA 2011; BARNETT SA, 1965, Q J EXP PHYSIOL CMS, V50, P417, DOI 10.1113/expphysiol.1965.sp001807; Barsbold R, 2000, NATURE, V403, P155, DOI 10.1038/35003103; BAUMEL JJ, 1988, ADV ANAT EMBRYOL CEL, V110, P1; BERGER ANDREW J., 1956, CONDOR, V58, P433, DOI 10.2307/1365098; Bock W.J., 1986, Memoirs of the California Academy of Sciences, P57; Boszczyk BM, 2001, ANAT RECORD, V264, P157, DOI 10.1002/ar.1156; Brana F, 2000, J EXP ZOOL, V286, P422, DOI 10.1002/(SICI)1097-010X(20000301)286:4<422::AID-JEZ10>3.0.CO;2-D; Burnham DA, 2004, LIFE O PAST, P67; Carpenter K, CARNIVOROUS DINOSAUR, P238; Carrier DR, 2001, J EXP BIOL, V204, P3917; Cavallini P, 1995, ANN ZOOL FENN, V32, P421; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Chiappe LM, 2002, ANNU REV ECOL SYST, V33, P91, DOI 10.1146/annurev.ecolsys.33.010802.150517; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Clarke JA, 2006, J ANAT, V208, P287, DOI 10.1111/j.1469-7580.2006.00534.x; Czerkas Stephen A., 2002, Dinosaur Museum Journal, V1, P63; Czerkas Stephen A., 2002, Dinosaur Museum Journal, V1, P97; Denny M. W., 1988, BIOL MECH WAVE SWEPT; Dickey JP, 2003, MED ENG PHYS, V25, P221, DOI 10.1016/S1350-4533(02)00152-2; Eldredge N., 1972, P82; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Fooden J, 1999, INT J PRIMATOL, V20, P431, DOI 10.1023/A:1020556922189; Gao CL, 2008, PALAEONTOLOGY, V51, P775, DOI 10.1111/j.1475-4983.2008.00793.x; Gatesy SM, 1996, EVOLUTION, V50, P2037, DOI 10.1111/j.1558-5646.1996.tb03590.x; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; GATESY SM, 1993, J EXP BIOL, V176, P55; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Gatesy SM, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P333; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gillis GB, 2009, J EXP BIOL, V212, P604, DOI 10.1242/jeb.024349; Hall J, 2012, J VERTEBR PALEONTOL, p105A; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; He Tao, 2008, Vertebrata Palasiatica, V46, P178; HEILMANN G, 1926, ORIGIN BIRDS; Henderson DM, 2004, P ROY SOC B-BIOL SCI, V271, pS57, DOI 10.1098/rsbl.2003.0097; Hone DWE, 2012, J VERTEBR PALEONTOL, V32, P1082, DOI 10.1080/02724634.2012.680998; Hukins DWL, 2000, AM ZOOL, V40, P42, DOI 10.1668/0003-1569(2000)040[0042:RBSAMF]2.0.CO;2; Hutchinson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026037; Hutchinson JR, 2011, ANAT REC, V294, P756, DOI 10.1002/ar.21356; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Hutchinson JR, 2005, PALEOBIOLOGY, V31, P676; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Koehl MAR, 2011, INTEGR COMP BIOL, V51, P1002, DOI 10.1093/icb/icr112; Koob TJ, 2000, AM ZOOL, V40, P1, DOI 10.1668/0003-1569(2000)040[0001:TVBAEA]2.0.CO;2; Kubo K, 2002, SCAND J MED SCI SPOR, V12, P3, DOI 10.1034/j.1600-0838.2002.120102.x; Kurochkin EN, 2008, BIOL BULL+, V35, P1, DOI 10.1134/S1062359008010019; Lerner IM, 1954, GENETIC HOMEOSTASIS; Li QG, 2012, SCIENCE, V335, P1215, DOI 10.1126/science.1213780; Libby T, 2012, NATURE, V481, P181, DOI 10.1038/nature10710; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Lloyd DG, 1996, J BIOMECH ENG-T ASME, V118, P367, DOI 10.1115/1.2796019; Long JH, 1997, J EXP BIOL, V200, P65; LONG JH, 1992, J EXP BIOL, V162, P131; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Maddison WP, 2017, MESQUITE MODULAR SYS; Mallison H, 2011, PALAEONTOL ELECTRON, V14, p10A; Manter JT, 1940, J EXP ZOOL, V83, P345, DOI 10.1002/jez.1400830302; Mayr E., 1954, EVOLUTION PROCESS, P157; Mayr G, 2006, SCIENCE, V313, DOI 10.1126/science.1130964; MCGILL SM, 1992, J BIOMECH, V25, P395, DOI 10.1016/0021-9290(92)90259-4; Newman B. H., 1970, Biol. J. Linn. Soc., V2, P119, DOI 10.1111/j.1095-8312.1970.tb01707.x; Norell Mark A., 1999, American Museum Novitates, V3282, P1; O'Connor JK, 2012, HIST BIOL, V24, P29, DOI 10.1080/08912963.2011.552720; O'Connor JK, 2010, J VERTEBR PALEONTOL, V30, P311, DOI 10.1080/02724631003617498; Olshevsky G, 1994, OMNI, V16, P34; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Paul G., 1988, PREDATORY DINOSAURS; Paul G. S., 2002, DINOSAURS AIR EVOLUT; Persons WS, 2014, ACTA PALAEONTOL POL, V59, P553, DOI 10.4202/app.2012.0093; Persons WS, 2012, ACTA GEOL SIN-ENGL, V86, P1402, DOI 10.1111/1755-6724.12009; Persons WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025763; Persons WS, 2011, ANAT REC, V294, P119, DOI 10.1002/ar.21290; Pittman M, 2012, EVOLUTION BIOMECHANI; Rayner JMV, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P363; Rockwell H, 1938, J MORPHOL, V63, P87, DOI 10.1002/jmor.1050630105; RUSSELL DA, 1972, CAN J EARTH SCI, V9, P375, DOI 10.1139/e72-031; SANZ JL, 1992, PALAEONTOLOGY, V35, P829; Schilling N, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-4; Schluter D, 2000, ECOLOGY ADAPTIVE RAD, P10; Seebacher F, 2003, AUST J ZOOL, V51, P15, DOI 10.1071/ZO02036; Senter P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036790; Simon H, 1977, COURTSHIP BIRDS; Slijper E. J., 1946, Verh K nod Akad Wet Amsterdam (2), V42, P1; SMITH JM, 1952, EVOLUTION, V6, P127, DOI 10.2307/2405510; Sternberg CM, 1951, NATIONAL MUSEUM CANA, V123, P225; THOMAS ALR, 1993, PHILOS T ROY SOC B, V340, P361, DOI 10.1098/rstb.1993.0079; TUCKER VA, 1992, J EXP BIOL, V165, P21; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Tyson Amanda R., 1997, Journal of Vertebrate Paleontology, V17, p82A; Valentin S, 2012, J BIOMECH, V45, P2506, DOI 10.1016/j.jbiomech.2012.07.022; Washburn S, 1952, AM J PHYS ANTHROPOL, V10, P251; WHITSON M, 1975, Living Bird, V14, P215; Willey JS, 2004, J EXP BIOL, V207, P553, DOI 10.1242/jeb.00774; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Zhang FC, 2002, NATURWISSENSCHAFTEN, V89, P394, DOI 10.1007/s00114-002-0353-8; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	106	24	26	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63115	10.1371/journal.pone.0063115	http://dx.doi.org/10.1371/journal.pone.0063115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690987	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700020
J	Axmacher, JC; Sang, WG				Axmacher, Jan C.; Sang, Weiguo			Plant Invasions in China - Challenges and Chances	PLOS ONE			English	Article							EASTERN NORTH-AMERICA; UNITED-STATES; BIOLOGICAL INVASIONS; ALIEN PLANTS; ECONOMIC-DEVELOPMENT; DIVERSITY; PATTERNS; FUTURE; GLOBALIZATION; BIODIVERSITY	Invasive species cause serious environmental and economic harm and threaten global biodiversity. We set out to investigate how quickly invasive plant species are currently spreading in China and how their resulting distribution patterns are linked to socio-economic and environmental conditions. A comparison of the invasive plant species density (log species/log area) reported in 2008 with current data shows that invasive species were originally highly concentrated in the wealthy, southeastern coastal provinces of China, but they are currently rapidly spreading inland. Linear regression models based on the species density and turnover of invasive plants as dependent parameters and principal components representing key socio-economic and environmental parameters as predictors indicate strong positive links between invasive plant density and the overall phytodiversity and associated climatic parameters. Principal components representing socio-economic factors and endemic plant density also show significant positive links with invasive plant density. Urgent control and eradication measures are needed in China's coastal provinces to counteract the rapid inland spread of invasive plants. Strict controls of imports through seaports need to be accompanied by similarly strict controls of the developing horticultural trade and underpinned by awareness campaigns for China's increasingly affluent population to limit the arrival of new invaders. Furthermore, China needs to fully utilize its substantial native phytodiversity, rather than relying on exotics, in current large-scale afforestation projects and in the creation of urban green spaces.	[Axmacher, Jan C.] UCL, UCL Dept Geog, London, England; [Sang, Weiguo] Chinese Acad Sci, Inst Bot, Key Lab Vegetat & Environm Change, Beijing, Peoples R China	University of London; University College London; Chinese Academy of Sciences; Institute of Botany, CAS	Sang, WG (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	swg@ibcas.ac.cn	Axmacher, Jan/C-4412-2008	Axmacher, Jan/0000-0003-1406-928X	Chinese Academy of Sciences' Fellowship for International Scientists [2011T2S18]; '111 Program' of the Bureau of China Foreign Experts and Ministry of Education [2008-B08044]; 'Public Environment Benefits Programme' of the Ministry of Environment Protection [201209027-2]	Chinese Academy of Sciences' Fellowship for International Scientists; '111 Program' of the Bureau of China Foreign Experts and Ministry of Education; 'Public Environment Benefits Programme' of the Ministry of Environment Protection	The authors' research was financially supported by the Chinese Academy of Sciences' Fellowship for International Scientists (Fellowship Number 2011T2S18) the '111 Program' of the Bureau of China Foreign Experts and Ministry of Education (contract No. 2008-B08044) and the 'Public Environment Benefits Programme' of the Ministry of Environment Protection (201209027-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FLOR CHIN; Cao SX, 2009, J APPL ECOL, V46, P536, DOI 10.1111/j.1365-2664.2008.01605.x; Davies KF, 2005, ECOLOGY, V86, P1602, DOI 10.1890/04-1196; Davis MA, 2003, BIOSCIENCE, V53, P481, DOI 10.1641/0006-3568(2003)053[0481:BGDCFI]2.0.CO;2; Ding J.Q., 1998, INVASIVE ALIEN SPECI; Ding JQ, 2008, BIOSCIENCE, V58, P317, DOI 10.1641/B580407; Editorial Board of the Flora Republicae Popularis Sinicae, 2008, FLORA REIPUBLICAE PO; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Feng JM, 2010, BIODIVERS CONSERV, V19, P3489, DOI 10.1007/s10531-010-9909-7; Gilbert B, 2005, ECOLOGY, V86, P1848, DOI 10.1890/04-09997; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Huang DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031734; Huang JH, 2012, DIVERS DISTRIB, V18, P673, DOI 10.1111/j.1472-4642.2011.00845.x; Huang QQ, 2011, WEED RES, V51, P534, DOI 10.1111/j.1365-3180.2011.00868.x; Huang QQ, 2010, BIODIVERS CONSERV, V19, P1251, DOI 10.1007/s10531-009-9751-y; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jenkins PT, 2006, BIOL INVASIONS, V8, P1589, DOI 10.1007/s10530-005-5852-z; Jiang H, 2011, BIODIVERS CONSERV, V20, P1545, DOI 10.1007/s10531-011-0044-x; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Lambrinos JG, 2001, J ECOL, V89, P88, DOI 10.1046/j.1365-2745.2001.00524.x; Li Z., 2002, INVASIVE ALIEN SPECI; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Liu J, 2005, DIVERS DISTRIB, V11, P341, DOI 10.1111/j.1366-9516.2005.00162.x; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu J, 2006, BIOL INVASIONS, V8, P1461, DOI 10.1007/s10530-005-5838-x; [刘全儒 Liu Quanru], 2002, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University], V38, P399; Lu ZJ, 2006, WEED SCI, V54, P1068, DOI 10.1614/WS-06-040R1.1; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; National Bureau of Statistics of China, 2001, CHIN NAT STAT YB; Nianyong Han, 2001, Journal of Sustainable Tourism, V9, P228, DOI 10.1080/09669580108667400; Normile D, 2004, SCIENCE, V306, P968, DOI 10.1126/science.306.5698.968; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Qian H, 2005, ECOL LETT, V8, P15, DOI 10.1111/j.1461-0248.2004.00682.x; Qian H, 2004, J ECOL, V92, P253, DOI 10.1111/j.0022-0477.2004.00868.x; Qiang Sheng, 2000, Journal of Plant Resources and Environment, V9, P34; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Rouget M, 2003, BIOL CONSERV, V112, P63, DOI 10.1016/S0006-3207(02)00395-6; Sang WG, 2011, BIOSCIENCE, V61, P720, DOI 10.1525/bio.2011.61.9.11; Sang WG, 2010, BIOL INVASIONS, V12, P1721, DOI 10.1007/s10530-009-9584-3; Sax DF, 2002, DIVERS DISTRIB, V8, P193, DOI 10.1046/j.1472-4642.2002.00147.x; Sax DF, 2001, J BIOGEOGR, V28, P139, DOI 10.1046/j.1365-2699.2001.00536.x; Shuiliang Guo, 1995, WEED SCI, V2, P4; Stohlgren TJ, 2005, ECOLOGY, V86, P2298, DOI 10.1890/04-1195; Stohlgren TJ, 2003, FRONT ECOL ENVIRON, V1, P11; TIAN JY, 2004, SHANDONG INVASIVE AL; Weber E, 2008, BIOL INVASIONS, V10, P1411, DOI 10.1007/s10530-008-9216-3; Weber E, 2008, BIOSCIENCE, V58, P437, DOI 10.1641/B580511; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wu Shan-Huah, 2004, Taiwania, V49, P16; Wu SH, 2010, BIOL INVASIONS, V12, P2179, DOI 10.1007/s10530-009-9620-3; Wu Xiao-Wen, 2006, Zhiwu Shengtai Xuebao, V30, P576; Xie Y, 2001, BIODIVERS CONSERV, V10, P1317, DOI 10.1023/A:1016695609745; Xu HG, 2006, BIODIVERS CONSERV, V15, P2893, DOI 10.1007/s10531-005-2575-5; XU HG, 2004, ALIEN SPECIES INVASI; Xu HG., 2004, CATALOG INVASIVE SPE; [No title captured]	57	23	30	5	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64173	10.1371/journal.pone.0064173	http://dx.doi.org/10.1371/journal.pone.0064173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691164	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400101
J	Chmarra, MK; Hansen, R; Marvik, R; Lango, T				Chmarra, Magdalena K.; Hansen, Rune; Marvik, Ronald; Lango, Thomas			Multimodal Phantom of Liver Tissue	PLOS ONE			English	Article							ULTRASOUND; EQUIVALENT; SCATTERING; CRYOGEL; BAND	Medical imaging plays an important role in patients' care and is continuously being used in managing health and disease. To obtain the maximum benefit from this rapidly developing technology, further research is needed. Ideally, this research should be done in a patient-safe and environment-friendly manner; for example, on phantoms. The goal of this work was to develop a protocol and manufacture a multimodal liver phantom that is suitable for ultrasound, computed tomography, and magnetic resonance imaging modalities. The proposed phantom consists of three types of mimicked soft tissues: liver parenchyma, tumors, and portal veins, that are made of six ingredients: candle gel, sephadex (R), agarose, glycerol, distilled water, and silicone string. The entire procedure is advantageous, since preparation of the phantom is simple, rather cost-effective, and reasonably quick - it takes around 2 days. Besides, most of the phantom's parts can be reused to manufacture a new phantom. Comparison of ultrasound images of real patient's liver and the developed phantom shows that the phantom's liver tissue and its structures are well simulated.	[Chmarra, Magdalena K.; Hansen, Rune] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Hansen, Rune; Lango, Thomas] SINTEF Technol & Soc, Dept Med Technol, Trondheim, Norway; [Marvik, Ronald] Univ Trondheim Hosp, St Olavs Hosp, Dept Gastrointestinal Surg, Trondheim, Norway; [Marvik, Ronald] Univ Trondheim Hosp, St Olavs Hosp, Natl Ctr Adv Laparoscop Surg, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); SINTEF; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Chmarra, MK (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway.	mchmarra@gmail.com		Lango, Thomas/0000-0002-2824-6120	European Community [238802]; SINTEF (Trondheim, Norway); Ministry of Health and Social Affairs of Norway through the National Centre of Competence for Ultrasound and Image-Guided Therapy (Trondheim, Norway); eMIT (enhanced Minimally Invasive Therapy) in the FRIMED program of the Research Council of Norway [196726/V50]	European Community(European Commission); SINTEF (Trondheim, Norway)(SINTEF); Ministry of Health and Social Affairs of Norway through the National Centre of Competence for Ultrasound and Image-Guided Therapy (Trondheim, Norway); eMIT (enhanced Minimally Invasive Therapy) in the FRIMED program of the Research Council of Norway	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 238802 (IIIOS project); SINTEF (Trondheim, Norway); the Ministry of Health and Social Affairs of Norway through the National Centre of Competence for Ultrasound and Image-Guided Therapy (Trondheim, Norway); and the project 196726/V50 eMIT (enhanced Minimally Invasive Therapy) in the FRIMED program of the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askeland C, 2011, MIDAS J SYSTEMS ARCH; Bates J., 2004, ABDOMINAL ULTRASOUND; Bays R, 1997, LASER SURG MED, V21, P227, DOI 10.1002/(SICI)1096-9101(1997)21:3<227::AID-LSM2>3.0.CO;2-S; Brunetti A, 2008, EUR J NUCL MED MOL I, V35, P1749, DOI 10.1007/s00259-008-0861-7; Culjat MO, 2010, ULTRASOUND MED BIOL, V36, P861, DOI 10.1016/j.ultrasmedbio.2010.02.012; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; FLOCK ST, 1992, LASER SURG MED, V12, P510, DOI 10.1002/lsm.1900120510; FREDFELDT KE, 1986, J ULTRAS MED, V5, P295; Fromageau J, 2003, IEEE T ULTRASON FERR, V50, P1318, DOI 10.1109/TUFFC.2003.1244748; Hall TJ, 1997, IEEE T ULTRASON FERR, V44, P1355, DOI 10.1109/58.656639; Hansen R, 2010, J ACOUST SOC AM, V127, P579, DOI 10.1121/1.3257584; Hendee W. R., 2003, MED IMAGING PHYS; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Kato H, 2005, MED PHYS, V32, P3199, DOI 10.1118/1.2047807; Kondo T, 2005, ULTRASON, P1664; Lazebnik M, 2005, PHYS MED BIOL, V50, P4245, DOI 10.1088/0031-9155/50/18/001; LINFORD J, 1986, MED PHYS, V13, P869, DOI 10.1118/1.595948; MADSEN E L, 1982, Magnetic Resonance Imaging, V1, P135, DOI 10.1016/0730-725X(82)90204-1; MADSEN E L, 1978, Medical Physics (Woodbury), V5, P391, DOI 10.1118/1.594483; Mazzara GP, 1996, MAGN RESON IMAGING, V14, P639, DOI 10.1016/0730-725X(96)00054-9; MITIC G, 1994, APPL OPTICS, V33, P6699, DOI 10.1364/AO.33.006699; MOES CJM, 1989, APPL OPTICS, V28, P2292, DOI 10.1364/AO.28.002292; Pogue BW, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2335429; Schwaiger J, 2011, INT J COMPUT ASS RAD, V6, P785, DOI 10.1007/s11548-011-0557-5; Surry KJM, 2004, PHYS MED BIOL, V49, P5529, DOI 10.1088/0031-9155/49/24/009; VANSTAVEREN HJ, 1991, APPL OPTICS, V30, P4507, DOI 10.1364/AO.30.004507; Waterworth Michael D., 1995, Australasian Physical and Engineering Sciences in Medicine, V18, P39; Zell K, 2007, PHYS MED BIOL, V52, pN475, DOI 10.1088/0031-9155/52/20/N02	28	32	34	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64180	10.1371/journal.pone.0064180	http://dx.doi.org/10.1371/journal.pone.0064180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691165	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400102
J	Johnson, RM; Kerr, MS; Slaven, JE				Johnson, Raymond M.; Kerr, Micah S.; Slaven, James E.			Perforin Is Detrimental to Controllinc gamma C. muridarum Replication In Vitro, but Not In Vivo	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; NITRIC-OXIDE SYNTHASE; CD8(+) T-CELLS; GENITAL-TRACT; EPITHELIAL-CELLS; IMMUNE MICE; SUSCEPTIBILITY; EPIDEMIOLOGY; REINFECTION; MECHANISMS	CD4 T cells are critical for clearing experimental Chlamydia muridarum genital tract infections. Two independent in vitro CD4 T cell mechanisms have been identified for terminating Chlamydia replication in epithelial cells. One mechanism, requiring IFN-gamma and T cell-epithelial cell contact, terminates infection by triggering epithelial production of nitric oxide to chlamydiacidal levels; the second is dependent on T cell degranulation. We recently demonstrated that there are two independent in vivo clearance mechanisms singly sufficient for clearing genital tract infections within six weeks; one dependent on iNOS, the other on Plac8. Redundant genital tract clearance mechanisms bring into question negative results in single-gene knockout mice. Two groups have shown that perforin-knockout mice were not compromised in their ability to clear C. muridarum genital tract infections. Because cell lysis would be detrimental to epithelial nitric oxide production we hypothesized that perforin was not critical for iNOS-dependent clearance, but posited that perforin could play a role in Plac8-dependent clearance. We tested whether the Plac8-dependent clearance was perforin-dependent by pharmacologically inhibiting iNOS in perforin-knockout mice. In vitro we found that perforin was detrimental to iNOS-dependent CD4 T cell termination of Chlamydia replication in epithelial cells. In vivo, unexpectedly, clearance in perforin knockout mice was delayed to the end of week 7 regardless of iNOS status. The discordant in vitro/in vivo results suggest that the perforin's contribution to bacterial clearance in vivo is not though enhancing CD4 T cell termination of Chlamydia replication in epithelial cells, but likely via a mechanism independent of T cell-epithelial cell interactions.	[Johnson, Raymond M.; Kerr, Micah S.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46204 USA; [Slaven, James E.] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Johnson, RM (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46204 USA.	raymjohn@iupui.edu			NIH [R01AI070514]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070514] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by an NIH grant R01AI070514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SEX TRANSM DIS SURV; Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Bode J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050327; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; Brunham RC, 2008, SEX TRANSM DIS, V35, P53, DOI 10.1097/OLQ.0b013e31815e41a3; HALL RT, 1993, INFECT IMMUN, V61, P1829, DOI 10.1128/IAI.61.5.1829-1834.1993; Hawkins RA, 2002, INFECT IMMUN, V70, P5132, DOI 10.1128/IAI.70.9.5132-5139.2002; Hook CE, 2004, CLIN EXP IMMUNOL, V138, P54, DOI 10.1111/j.1365-2249.2004.02596.x; Ibana JA, 2012, FEMS IMMUNOL MED MIC, V65, P32, DOI 10.1111/j.1574-695X.2012.00930.x; Igietseme JU, 2009, J INFECT DIS, V200, P926, DOI 10.1086/605411; Igietseme JU, 1996, IMMUNOLOGY, V87, P1; Igietseme JU, 1998, INFECT IMMUN, V66, P1282, DOI 10.1128/IAI.66.4.1282-1286.1998; Igietseme JU, 1996, J LEUKOCYTE BIOL, V59, P656, DOI 10.1002/jlb.59.5.656; Jayarapu K, 2010, J IMMUNOL, V185, P6911, DOI 10.4049/jimmunol.1002596; Jayarapu K, 2009, INFECT IMMUN, V77, P4469, DOI 10.1128/IAI.00491-09; Johnson RM, 2012, INFECT IMMUN, V80, P2204, DOI 10.1128/IAI.06339-11; Johnson RM, 2012, J IMMUNOL, V188, P1896, DOI 10.4049/jimmunol.1102764; Johnson RM, 2004, INFECT IMMUN, V72, P3951, DOI 10.1128/IAI.72.7.3951-3960.2004; Johnson RM, 2012, PROKARYOTES; Kinnunen AH, 2002, HUM REPROD, V17, P2073, DOI 10.1093/humrep/17.8.2073; LIN JSL, 1992, INFECT IMMUN, V60, P2547, DOI 10.1128/IAI.60.6.2547-2550.1992; Moore T, 2002, IMMUNOLOGY, V105, P213, DOI 10.1046/j.0019-2805.2001.01354.x; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; Morrison SG, 2001, INFECT IMMUN, V69, P2643, DOI 10.1128/IAI.69.4.2643-2649.2001; Murthy AK, 2011, INFECT IMMUN, V79, P2928, DOI 10.1128/IAI.05022-11; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; Perry LL, 1999, INFECT IMMUN, V67, P1379, DOI 10.1128/IAI.67.3.1379-1385.1999; Ramsey KH, 1998, INFECT IMMUN, V66, P835, DOI 10.1128/IAI.66.2.835-838.1998; Rekart ML, 2008, SEX TRANSM INFECT, V84, P87, DOI 10.1136/sti.2007.027938; SCHACHTER J, 1985, REV INFECT DIS, V7, P713; WILLIAMS DM, 1984, INFECT IMMUN, V45, P674, DOI 10.1128/IAI.45.3.674-678.1984; Yu H, 2011, J IMMUNOL, V186, P3615, DOI 10.4049/jimmunol.1002952	34	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63340	10.1371/journal.pone.0063340	http://dx.doi.org/10.1371/journal.pone.0063340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691028	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400055
J	Shi, XL; Zhao, Y; Jiao, YD; Shi, TR; Yang, XB				Shi, Xiaolong; Zhao, Yan; Jiao, Yadong; Shi, Tengrui; Yang, Xingbin			ROS-Dependent Mitochondria Molecular Mechanisms Underlying Antitumor Activity of Pleurotus abalonus Acidic Polysaccharides in Human Breast Cancer MCF-7 Cells	PLOS ONE			English	Article							BETA-GLUCAN; APOPTOSIS; MUSHROOM; PATHWAYS; ANTIOXIDANT; OSTREATUS; RESISTANCE; INDUCTION; PROTECTS; THERAPY	Background: A greater reduction in cancer risk associated with mushroom diet rich in fungus polysaccharides is generally accepted. Meanwhile, edible Pleurotus abalonus as a member of Abalone mushroom family is a popular nutritional supplement that purportedly prevents cancer occurrence. However, these anecdotal claims are supported by limited studies describing tumor-inhibitory responses to the promising polysaccharides, and the molecular mechanisms underlying these properties have not yet been elucidated. Methodology/Principal Findings: We here fractionated the crude polysaccharide preparation from the fruiting bodies of P. abalonus into three fractions, namely PAP-1, PAP-2 and PAP-3, and tested these fractions for antiproliferative activity in human breast cancer MCF-7 cells. The largest PAP-3, an acidic polysaccharide fraction with a molecular mass of 3.68x10(5) Da, was the most active in inhibiting MCF-7 cancer cells with an IC50 of 193 mu g/mL. The changes in cell normal morphology were observed by DAPI staining and the PAP-3-induced apoptosis was confirmed by annexin V/propidium iodide staining. The apoptosis was involved in mitochondria-mediated pathway including the loss of mitochondrial membrane potential (Delta psi m), the increase of Bax/Bcl-2 ratio, caspase-9/3 activation, and poly(ADP-ribose) polymerase (PARP) degradation, as well as intracellular ROS production. PAP-3 also induced up-regulation of p53, and cell cycle arrest at the S phase. The incubation of MCF-7 cells with antioxidant superoxide dismutase (SOD) and N-acetylcysteine (NAC) significantly attenuated the ROS generation and apoptosis caused by PAP-3, indicating that intracellular ROS plays a pivotal role in cell death. Conclusions/Significance: These findings suggest that the polysaccharides, especially acidic PAP-3, are very important nutritional ingredients responsible for, at least in part, the anticancer health benefits of P. abalonus via ROS-mediated mitochondrial apoptotic pathway. It is a major breakthrough bringing new insight of the potential use of the polysaccharides as health-care food or medicine to provide significant natural defense against human cancer.	[Shi, Xiaolong; Jiao, Yadong; Shi, Tengrui; Yang, Xingbin] Shaanxi Normal Univ, Key Lab Med Resources & Nat Pharmaceut Chem, Minist Educ, Xian, Peoples R China; [Shi, Xiaolong; Jiao, Yadong; Shi, Tengrui; Yang, Xingbin] Shaanxi Normal Univ, Natl Engn Lab Resource Developing Endangered Chin, Coll Food Engn & Nutrit Sci, Xian, Peoples R China; [Zhao, Yan] Fourth Mil Med Univ, Sch Pharm, Xian 710032, Peoples R China	Shaanxi Normal University; Shaanxi Normal University; Air Force Military Medical University	Yang, XB (corresponding author), Shaanxi Normal Univ, Key Lab Med Resources & Nat Pharmaceut Chem, Minist Educ, Xian, Peoples R China.	xbyang@snnu.edu.cn	shi, teng/GSE-5879-2022		National Natural Science Foundation of China [C31171678]; Innovation Funds of Graduate Programs of Shaanxi Normal University [201210781121]; Fundamental Research Funds for the Central Universities of Shaanxi Normal University, China [GK201103004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Funds of Graduate Programs of Shaanxi Normal University; Fundamental Research Funds for the Central Universities of Shaanxi Normal University, China	The National Natural Science Foundation of China (C31171678); http://www.nsfc.gov.cn/Portal0/default152.htm. 2. Innovation Funds of Graduate Programs of Shaanxi Normal University (201210781121); http://kjc.snnu.edu.cn/. 3. the Fundamental Research Funds for the Central Universities of Shaanxi Normal University, China (GK201103004); http://jkw.mof.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MM, 2002, J BIOL CHEM, V277, P2234, DOI 10.1074/jbc.M110168200; Bobek P, 2001, NAHRUNG, V45, P360, DOI 10.1002/1521-3803(20011001)45:5&lt;360::AID-FOOD360&gt;3.0.CO;2-C; Chen XY, 2009, CARBOHYD POLYM, V78, P581, DOI 10.1016/j.carbpol.2009.05.019; Cooi VE, CURR MED CHEM, V7, P715; Denicourt C, 2004, SCIENCE, V305, P1411, DOI 10.1126/science.1102974; Dixon AS, 2011, J BIOL CHEM, V286, P27751, DOI 10.1074/jbc.M111.264903; FEIG DI, 1994, CANCER RES, V54, pS1890; Flora SJS, 2011, FREE RADICAL BIO MED, V51, P257, DOI 10.1016/j.freeradbiomed.2011.04.008; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Gan D, 2011, CARBOHYD POLYM, V84, P997, DOI 10.1016/j.carbpol.2010.12.058; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gohrbandt S, 2011, J GEN VIROL, V92, P1843, DOI 10.1099/vir.0.031591-0; He NW, 2013, J AGR FOOD CHEM, V61, P579, DOI 10.1021/jf3036929; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Jeong YT, 2008, PHYTOTHER RES, V22, P614, DOI 10.1002/ptr.2294; Jose N, 2000, CURR SCI INDIA, V79, P941; Ko HG, 2005, BIORESOURCE TECHNOL, V96, P1439, DOI 10.1016/j.biortech.2004.12.009; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lavi I, 2006, CANCER LETT, V244, P61, DOI 10.1016/j.canlet.2005.12.007; Lee JY, 2006, TOXICOL LETT, V166, P212, DOI 10.1016/j.toxlet.2006.07.305; Li N, 2012, BIOSCIENCE REP, V32, P221, DOI 10.1042/BSR20110012; Li YG, 2010, INORG CHEM, V49, P4, DOI 10.1021/ic901970b; Maity P, 2008, J BIOL CHEM, V283, P14391, DOI 10.1074/jbc.M800414200; Manzi P, 1999, FOOD CHEM, V65, P477, DOI 10.1016/S0308-8146(98)00212-X; Mao QQ, 2010, MOL NUTR FOOD RES, V54, P1574, DOI 10.1002/mnfr.200900392; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Moungjaroen J, 2006, J PHARMACOL EXP THER, V319, P1062, DOI 10.1124/jpet.106.110965; Murthy KNC, 2011, J AGR FOOD CHEM, V59, P2314, DOI 10.1021/jf104498p; Qiu PJ, 2011, MOL NUTR FOOD RES, V55, P613, DOI 10.1002/mnfr.201000269; Russell JL, 2002, MOL CELL BIOL, V22, P1360, DOI 10.1128/MCB.22.5.1360-1368.2002; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Siemens N, 2011, J BIOL CHEM, V286, P21612, DOI 10.1074/jbc.M110.202671; Wang CR, 2011, J PHARM PHARMACOL, V63, P825, DOI 10.1111/j.2042-7158.2011.01274.x; Wang HX, 1998, MYCOL RES, V102, P897, DOI 10.1017/S0953756298006200; Wang JC, 2005, APPL MICROBIOL BIOT, V67, P759, DOI 10.1007/s00253-004-1833-x; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; Wong JH, 2009, BIOSCIENCE REP, V29, P321, DOI 10.1042/BSR20080153; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yang XB, 2010, J AGR FOOD CHEM, V58, P6075, DOI 10.1021/jf101061y; Yerlikaya A, 2012, TUMOR BIOL, V33, P1385, DOI 10.1007/s13277-012-0386-3; YOSHIOKA Y, 1985, CARBOHYD RES, V140, P93, DOI 10.1016/0008-6215(85)85052-7; Zhang HS, 2012, FOOD CHEM TOXICOL, V50, P1589, DOI 10.1016/j.fct.2012.01.025; Zhang M, 2006, TRENDS FOOD SCI TECH, V18, P4, DOI 10.1016/j.tifs.2006.07.013; ZHUANG C, 1993, BIOSCI BIOTECH BIOCH, V57, P901, DOI 10.1271/bbb.57.901; Zong AZ, 2012, CARBOHYD POLYM, V90, P1395, DOI 10.1016/j.carbpol.2012.07.026	46	61	65	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64266	10.1371/journal.pone.0064266	http://dx.doi.org/10.1371/journal.pone.0064266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691187	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400114
J	Sosa, LJ; Bergman, J; Estrada-Bernal, A; Glorioso, TJ; Kittelson, JM; Pfenninger, KH				Sosa, Lucas J.; Bergman, Jared; Estrada-Bernal, Adriana; Glorioso, Thomas J.; Kittelson, John M.; Pfenninger, Karl H.			Amyloid Precursor Protein Is an Autonomous Growth Cone Adhesion Molecule Engaged in Contact Guidance	PLOS ONE			English	Article							INTERFERENCE REFLECTION MICROSCOPY; APP FAMILY-MEMBERS; FETAL-RAT-BRAIN; COLLAGEN TYPE-I; NEURITE OUTGROWTH; ALZHEIMERS-DISEASE; CELL-ADHESION; EXTRACELLULAR-MATRIX; SUBSTRATE CONTACTS; DOWN-REGULATION	Amyloid precursor protein (APP), a transmembrane glycoprotein, is well known for its involvement in the pathogenesis of Alzheimer disease of the aging brain, but its normal function is unclear. APP is a prominent component of the adult as well as the developing brain. It is enriched in axonal growth cones (GCs) and has been implicated in cell adhesion and motility. We tested the hypothesis that APP is an extracellular matrix adhesion molecule in experiments that isolated the function of APP from that of well-established adhesion molecules. To this end we plated wild-type, APP-, or beta 1-integrin (Itgb1)-misexpressing mouse hippocampal neurons on matrices of either laminin, recombinant L1, or synthetic peptides binding specifically to Itgb1 s or APP. We measured GC adhesion, initial axonal outgrowth, and substrate preference on alternating matrix stripes and made the following observations: Substrates of APP-binding peptide alone sustain neurite outgrowth; APP dosage controls GC adhesion to laminin and APP-binding peptide as well as axonal outgrowth in Itgb1 - independent manner; and APP directs GCs in contact guidance assays. It follows that APP is an independently operating cell adhesion molecule that affects the GC's phenotype on APP-binding matrices including laminin, and that it is likely to affect axon pathfinding in vivo.	[Sosa, Lucas J.; Bergman, Jared; Estrada-Bernal, Adriana; Pfenninger, Karl H.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Sosa, Lucas J.; Bergman, Jared; Estrada-Bernal, Adriana; Pfenninger, Karl H.] Univ Colorado, Sch Med, Colorado Intellectual & Dev Disabil Res Ctr, Aurora, CO USA; [Glorioso, Thomas J.; Kittelson, John M.] Univ Colorado, Anschutz Med Ctr, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Pfenninger, KH (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA.	Karl.pfenninger@ucdenver.edu		Sosa, Lucas/0000-0002-9153-7537	NIH/NINDS [R01 NS061940]; Anna and John J. Sie Foundation; Linda Crnic Institute for Down Syndrome, Denver CO; Colorado Children's Hospital Research Institute; NIH/NCATS Colorado CTSI Grant [UL1 TR000154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061940] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Anna and John J. Sie Foundation; Linda Crnic Institute for Down Syndrome, Denver CO; Colorado Children's Hospital Research Institute; NIH/NCATS Colorado CTSI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH/NINDS (R01 NS061940), The Anna and John J. Sie Foundation and the Linda Crnic Institute for Down Syndrome, Denver CO, and The Colorado Children's Hospital Research Institute. Further support was provided by NIH/NCATS Colorado CTSI Grant UL1 TR000154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Caceres J, 1997, J CELL BIOCHEM, V65, P145, DOI 10.1002/(SICI)1097-4644(199705)65:2<145::AID-JCB2>3.0.CO;2-U; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; Coulson EJ, 1997, BRAIN RES, V770, P72, DOI 10.1016/S0006-8993(97)00757-9; CURTIS ASG, 1964, J CELL BIOL, V20, P199, DOI 10.1083/jcb.20.2.199; De Strooper B, 2000, J CELL SCI, V113, P1857; Dewji NN, 2006, P NATL ACAD SCI USA, V103, P1540, DOI 10.1073/pnas.0509899103; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Drazba J, 1997, DEV BRAIN RES, V100, P183, DOI 10.1016/S0165-3806(97)00041-2; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Estrada-Bernal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031858; Gatlin JC, 2006, MOL BIOL CELL, V17, P5115, DOI 10.1091/mbc.E05-12-1183; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; GUNDERSEN RW, 1988, J NEUROSCI RES, V21, P298, DOI 10.1002/jnr.490210222; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Howell BW, 1999, MOL CELL BIOL, V19, P5179; IZZARD CS, 1976, J CELL SCI, V21, P129; KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150; Kim JM, 2005, EXP CELL RES, V304, P317, DOI 10.1016/j.yexcr.2004.11.009; Knoll B, 2007, NAT PROTOC, V2, P1216, DOI 10.1038/nprot.2007.157; Korte M, 2012, EXP BRAIN RES, V217, P435, DOI 10.1007/s00221-011-2894-6; LEMMON V, 1992, J NEUROSCI, V12, P818; Limozin L, 2009, CHEMPHYSCHEM, V10, P2752, DOI 10.1002/cphc.200900601; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; LOCKERBIE RO, 1991, J CELL BIOL, V112, P1215, DOI 10.1083/jcb.112.6.1215; Lohse K, 1996, DEV BRAIN RES, V96, P83, DOI 10.1016/0165-3806(96)00076-4; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; Mikule K, 2002, J NEUROSCI, V22, P4932, DOI 10.1523/JNEUROSCI.22-12-04932.2002; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; PFENNINGER KH, 1983, CELL, V35, P573, DOI 10.1016/0092-8674(83)90191-5; PFENNINGER KH, 1981, J CELL BIOL, V89, P536, DOI 10.1083/jcb.89.3.536; Pierres A, 2003, BIOPHYS J, V84, P2058, DOI 10.1016/S0006-3495(03)75013-9; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Selhuber-Unkel C, 2008, BIOPHYS J, V95, P5424, DOI 10.1529/biophysj.108.139584; SMALL DH, 1994, J NEUROSCI, V14, P2117; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Song P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034209; Stipp CS, 2000, J CELL SCI, V113, P1871; Storey E, 1996, BRAIN RES, V735, P217, DOI 10.1016/0006-8993(96)00608-7; Streicher P, 2009, BBA-BIOMEMBRANES, V1788, P2291, DOI 10.1016/j.bbamem.2009.07.025; TASHIRO K, 1989, J BIOL CHEM, V264, P16174; Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Von Philipsborn AC, 2006, NAT PROTOC, V1, P1322, DOI 10.1038/nprot.2006.251; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; Yamazaki T, 1997, J NEUROSCI, V17, P1004; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	70	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64521	10.1371/journal.pone.0064521	http://dx.doi.org/10.1371/journal.pone.0064521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691241	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400131
J	Giuraniuc, CV; MacPherson, M; Saka, Y				Giuraniuc, Claudiu V.; MacPherson, Murray; Saka, Yasushi			Gateway Vectors for Efficient Artificial Gene Assembly In Vitro and Expression in Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							ONE-HYBRID ASSAYS; FLUORESCENT PROTEIN; MAMMALIAN-CELLS; SYSTEM; CASSETTES; CLONING; DIVERSITY; FRAMEWORK; NETWORKS; CIRCUITS	Construction of synthetic genetic networks requires the assembly of DNA fragments encoding functional biological parts in a defined order. Yet this may become a time-consuming procedure. To address this technical bottleneck, we have created a series of Gateway shuttle vectors and an integration vector, which facilitate the assembly of artificial genes and their expression in the budding yeast Saccharomyces cerevisiae. Our method enables the rapid construction of an artificial gene from a promoter and an open reading frame (ORF) cassette by one-step recombination reaction in vitro. Furthermore, the plasmid thus created can readily be introduced into yeast cells to test the assembled gene's functionality. As flexible regulatory components of a synthetic genetic network, we also created new versions of the tetracycline-regulated transactivators tTA and rtTA by fusing them to the auxin-inducible degron (AID). Using our gene assembly approach, we made yeast expression vectors of these engineered transactivators, AIDtTA and AIDrtTA and then tested their functions in yeast. We showed that these factors can be regulated by doxycycline and degraded rapidly after addition of auxin to the medium. Taken together, the method for combinatorial gene assembly described here is versatile and would be a valuable tool for yeast synthetic biology.	[Giuraniuc, Claudiu V.; MacPherson, Murray; Saka, Yasushi] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen, Scotland	University of Aberdeen	Saka, Y (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen, Scotland.	y.saka@abdn.ac.uk		Giuraniuc, Claudiu Vasile/0000-0001-7127-2642	SULSA (Scottish Universities Life Sciences Alliance); CNRS, France [CNRS USR3078]	SULSA (Scottish Universities Life Sciences Alliance); CNRS, France(Centre National de la Recherche Scientifique (CNRS))	This work was funded by SULSA (Scottish Universities Life Sciences Alliance; http://www.sulsa.ac.uk/). The work was also supported in part by CNRS, France (CNRS USR3078) for the early stage of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC., 2005, METHODS YEAST GENETI; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Deplancke B, 2004, GENOME RES, V14, P2093, DOI 10.1101/gr.2445504; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Gallia GL, 1998, ONCOGENE, V16, P1879, DOI 10.1038/sj.onc.1201706; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Kubota T, 2013, MOL CELL; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lohmueller JJ, 2012, NUCLEIC ACIDS RES, V40, P5180, DOI 10.1093/nar/gks142; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; Murakami CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024530; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1059, DOI [10.1038/NMETH.1748, 10.1038/nmeth.1748]; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1050, DOI [10.1038/NMETH.1764, 10.1038/nmeth.1764]; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109; Sadowski I, 2007, YEAST, V24, P447, DOI 10.1002/yea.1469; Sasaki Y, 2004, J BIOTECHNOL, V107, P233, DOI 10.1016/j.jbiotec.2003.10.001; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; SIKORSKI RS, 1989, GENETICS, V122, P19; Suzuki Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni103; Tagwerker C, 2012, NUCLEIC ACIDS RES, V40, P10375, DOI 10.1093/nar/gks823	34	11	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e64419	10.1371/journal.pone.0064419	http://dx.doi.org/10.1371/journal.pone.0064419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675537	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400069
J	Kandasamy, K; Bezavada, L; Escue, RB; Parthasarathi, K				Kandasamy, Kathirvel; Bezavada, Lavanya; Escue, Rachel B.; Parthasarathi, Kaushik			Lipopolysaccharide Induces Endoplasmic Store Ca2+-Dependent Inflammatory Responses in Lung Microvessels	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED CYTOKINE PRODUCTION; ENDOTHELIAL-CELLS; PROINFLAMMATORY RESPONSES; CALCIUM OSCILLATION; SIGNALING PATHWAY; GENE-EXPRESSION; ACTIVATION; RECEPTOR; PROTEIN	The pulmonary microvasculature plays a critical role in endotoxin-induced acute lung injury. However, the relevant signaling remain unclear. Specifically the role of endothelial Ca2+ in the induction of endotoxin-mediated responses in lung microvessels remains undefined. Toward elucidating this, we used the isolated blood-perfused rat lung preparation. We loaded microvessels with the Ca2+ indicator, Fura 2 AM and then determined Ca2+ responses to infusions of lipopolysaccharide (LPS) into the microvessels. LPS induced a more than two-fold increase in the amplitude of cytosolic Ca2+ oscillations. Inhibiting inositol 1,4,5 trisphosphate receptors on endoplasmic reticulum (ER) Ca2+ stores with Xestospongin C (XeC), blocked the LPS-induced increase in the Ca2+ oscillation amplitude. However, XeC did not affect entry of external Ca2+ via plasma membrane Ca2+ channels in lung microvascular endothelial cells. This suggested that LPS augmented the oscillations via release of Ca2+ from ER stores. In addition, XeC also blocked LPS-mediated activation and nuclear translocation of nuclear factor-kappa B in lung microvessels. Further, inhibiting ER Ca2+ release blunted increases in intercellular adhesion molecule-1 expression and retention of naive leukocytes in LPS-treated microvessels. Taken together, the data suggest that LPS-mediated Ca2+ release from ER stores underlies nuclear factor-kappa B activation and downstream inflammatory signaling in lung microvessels. Thus, we show for the first time a role for inositol 1,4,5 trisphosphate-mediated ER Ca2+ release in the induction of LPS responses in pulmonary microvascular endothelium. Mechanisms that blunt this signaling may mitigate endotoxin-induced morbidity.	[Kandasamy, Kathirvel; Bezavada, Lavanya; Escue, Rachel B.; Parthasarathi, Kaushik] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Parthasarathi, Kaushik] Univ Tennessee, Ctr Hlth Sci, Dept Orthoped Surg & Biomed Engn, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Parthasarathi, K (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA.	kparthas@uthsc.edu		Kandasamy, Kathirvel/0000-0002-4966-4604; Helms, Rachel/0000-0001-5027-7153; Bezavada, Lavanya/0000-0001-8434-3323	National Heart, Lung, and Blood Institute, National Institutes of Health [HL75503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075503] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, grant number HL75503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 1997, HEPATOLOGY, V26, P295, DOI 10.1002/hep.510260207; Antonsson A, 2003, MOL CELL BIOL, V23, P1418, DOI 10.1128/MCB.23.4.1418-1427.2003; Aul R, 2012, BRIT J CLIN PHARMACO, V74, P1023, DOI 10.1111/j.1365-2125.2012.04287.x; BADER MF, 1994, GLIA, V11, P336, DOI 10.1002/glia.440110406; Beck A, 2008, J PHYSIOL-LONDON, V586, P427, DOI 10.1113/jphysiol.2007.145151; Berendji-Grun D, 2001, MOL MED, V7, P748, DOI 10.1007/BF03401964; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Chin ER, 2005, J APPL PHYSIOL, V99, P414, DOI 10.1152/japplphysiol.00015.2005; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Guo F, 2012, CYTOKINE, V57, P417, DOI 10.1016/j.cyto.2011.12.009; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Hu QH, 2002, BIOCHEM BIOPH RES CO, V292, P325, DOI 10.1006/bbrc.2002.6675; Hughes K, 2001, J BIOL CHEM, V276, P36008, DOI 10.1074/jbc.M106125200; Ichimura H, 2003, J CLIN INVEST, V111, P691, DOI 10.1172/JCI200317271; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kandasamy K, 2012, MICROVASC RES, V83, P323, DOI 10.1016/j.mvr.2012.01.006; Karpurapu M, 2011, BLOOD, V118, P5255, DOI 10.1182/blood-2011-03-341123; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Kiefmann R, 2009, AM J PHYSIOL-LUNG C, V296, pL901, DOI 10.1152/ajplung.90549.2008; Kojima S, 2000, BLOOD, V95, P1309; Lai DZ, 2009, P NATL ACAD SCI USA, V106, P1169, DOI 10.1073/pnas.0811274106; Lawson C, 1999, J IMMUNOL, V162, P2990; Lowry MAR, 1999, DEV COMP IMMUNOL, V23, P253, DOI 10.1016/S0145-305X(99)00004-X; Lu ZY, 2012, ARTERIOSCL THROM VAS, V32, P1696, DOI 10.1161/ATVBAHA.112.251181; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Otterson MF, 2012, LIFE SCI, V91, P771, DOI 10.1016/j.lfs.2012.08.018; Parthasarathi K, 2002, J IMMUNOL, V169, P7078, DOI 10.4049/jimmunol.169.12.7078; Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605; Rahman A, 2000, AM J PHYSIOL-CELL PH, V279, pC906, DOI 10.1152/ajpcell.2000.279.4.C906; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Scharbrodt W, 2009, J CEREBR BLOOD F MET, V29, P57, DOI 10.1038/jcbfm.2008.87; SCHUMANN MA, 1993, J BIOL CHEM, V268, P2134; Segura BJ, 2005, MOL BRAIN RES, V133, P325, DOI 10.1016/j.molbrainres.2004.10.016; Shinji H, 1997, J IMMUNOL, V158, P1370; Song YX, 2013, EUR J PHARMACOL, V705, P49, DOI 10.1016/j.ejphar.2013.02.008; Stevens Troy, 2011, Proc Am Thorac Soc, V8, P453, DOI 10.1513/pats.201101-004MW; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Thompson PW, 2002, J IMMUNOL, V169, P1007, DOI 10.4049/jimmunol.169.2.1007; Thor D, 2012, VASCUL PHARM, V53, P230; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Valdes JA, 2007, AM J PHYSIOL-CELL PH, V292, pC1960, DOI 10.1152/ajpcell.00320.2006; Wang Q, 2005, AM J PHYSIOL-LUNG C, V288, pL359, DOI 10.1152/ajplung.00292.2004; Wehrhahn J, 2010, J IMMUNOL, V184, P2386, DOI 10.4049/jimmunol.0902474; Wildner O, 1992, Exp Dermatol, V1, P191, DOI 10.1111/j.1600-0625.1992.tb00188.x; Wurster AL, 2011, MOL IMMUNOL, V48, P2178, DOI 10.1016/j.molimm.2011.07.016; Xie YC, 1997, J LEUKOCYTE BIOL, V61, P745, DOI 10.1002/jlb.61.6.745; Yamashiro K, 2010, BIOCHEM BIOPH RES CO, V398, P284, DOI 10.1016/j.bbrc.2010.06.082; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	54	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63465	10.1371/journal.pone.0063465	http://dx.doi.org/10.1371/journal.pone.0063465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675486	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400041
J	Wildeman, MA; Fles, R; Herdini, C; Indrasari, RS; Vincent, AD; Tjokronagoro, M; Stoker, S; Kurnianda, J; Karakullukcu, B; Taroeno-Hariadi, KW; Hamming-Vrieze, O; Middeldorp, JM; Hariwiyanto, B; Haryana, SM; Tan, IB				Wildeman, Maarten A.; Fles, Renske; Herdini, Camelia; Indrasari, Rai S.; Vincent, Andrew D.; Tjokronagoro, Maesadji; Stoker, Sharon; Kurnianda, Johan; Karakullukcu, Baris; Taroeno-Hariadi, Kartika W.; Hamming-Vrieze, Olga; Middeldorp, Jaap M.; Hariwiyanto, Bambang; Haryana, Sofia M.; Tan, I. Bing			Primary Treatment Results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; IMMUNOGLOBULIN-G IGG; HIGH-RISK POPULATION; ANTIBODY-LEVELS; CONCURRENT CHEMORADIOTHERAPY; DIAGNOSTIC DELAYS; MESSENGER-RNA; ESTRO-QUARTS; NECK-CANCER; DNA LOAD	Introduction: Nasopharyngeal Carcinoma (NPC) is a major health problem in southern and eastern Asia. In Indonesia NPC is the most frequent cancer in the head and neck area. NPC is very sensitive to radiotherapy resulting in 3-year disease-free and overall survival of approximately 70% and 80%, respectively. Here we present routine treatment results in a prospective study on NPC in a top referral; university hospital in Indonesia. Methods: All NPC patients presenting from September 2008 till January 2011 at the ear, nose and throat (ENT) department of the Dr. Sardjito General Hospital, Universitas Gadjah Mada, Yogyakarta, Indonesia, were possible candidates. Patients were included if the biopsy was a histological proven NPC without distant metastasis and were assessed during counselling sessions prior to treatment, as being able to complete the entire treatment. Results: In total 78 patients were included for treatment analysis. The median time between diagnosis and start of radiotherapy is 120 days. Forty-eight (62%) patients eventually finished all fractions of radiotherapy. The median duration of the radiotherapy is 62 days for 66 Gy. Median overall survival is 21 months (95% CI 18-35) from day of diagnosis. Conclusion: The results presented here reveal that currently the treatment of NPC at an Indonesian hospital is not sufficient and cannot be compared to the treatment results in literature. Main reasons for these poor treatment results are (1) a long waiting time prior to the start of radiotherapy, (2) the extended overall duration of radiotherapy and (3) the advanced stage of disease at presentation.	[Wildeman, Maarten A.; Fles, Renske; Stoker, Sharon; Karakullukcu, Baris; Tan, I. Bing] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands; [Herdini, Camelia; Indrasari, Rai S.; Hariwiyanto, Bambang; Tan, I. Bing] Univ Gadjah Mada, Dr Sardjito Gen Hosp, Fac Med, Dept Otorhinolaryngol, Yogyakarta, Indonesia; [Vincent, Andrew D.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Biometr, Amsterdam, Netherlands; [Tjokronagoro, Maesadji] Univ Gadjah Mada, Dr Sardjito Gen Hosp, Fac Med, Dept Radiotherapy, Yogyakarta, Indonesia; [Kurnianda, Johan; Taroeno-Hariadi, Kartika W.] Univ Gadjah Mada, Dr Sardjito Gen Hosp, Fac Med, Div Med Oncol,Dept Internal Med, Yogyakarta, Indonesia; [Hamming-Vrieze, Olga] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands; [Middeldorp, Jaap M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Haryana, Sofia M.] Univ Gadjah Mada, Fac Med, Dept Histol Cell & Tumour Biol, Yogyakarta, Indonesia; [Tan, I. Bing] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1105 AZ Amsterdam, Netherlands	Netherlands Cancer Institute; Gadjah Mada University; Netherlands Cancer Institute; Gadjah Mada University; Gadjah Mada University; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Gadjah Mada University; University of Amsterdam; Academic Medical Center Amsterdam	Tan, IB (corresponding author), Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands.	i.tan@nki.nl	Taroeno-Hariadi, Kartika/AHD-4364-2022; Kurnianda, Johan/GOV-3648-2022	Middeldorp, Jaap Michiel/0000-0002-0765-4125; Taroeno-Hariadi, Kartika/0000-0002-7791-9010	KWF, the Dutch Cancer Foundation	KWF, the Dutch Cancer Foundation	The study was funded by the KWF, the Dutch Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2012, CHIN J CANC; Akimoto T, 1997, JPN J CLIN ONCOL, V27, P240, DOI 10.1093/jjco/27.4.240; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Alho OP, 2006, CAN MED ASSOC J, V174, P779, DOI 10.1503/cmaj.050623; [Anonymous], 2021, CANC INCIDENCE 5 CON; Bentzen SM, 2005, RADIOTHER ONCOL, V75, P355, DOI 10.1016/j.radonc.2004.12.007; Boyle P, 2008, WORLD CANC REPORT 20; CEVENINI R, 1986, J INFECTION, V12, P127, DOI 10.1016/S0163-4453(86)93558-9; CHEN JY, 1987, J MED VIROL, V23, P11, DOI 10.1002/jmv.1890230103; DEVATHAIRE F, 1988, INT J CANCER, V42, P176, DOI 10.1002/ijc.2910420206; Devi BCR, 2007, ANN ONCOL, V18, P1172, DOI 10.1093/annonc/mdm105; Fachiroh J, 2008, J CLIN MICROBIOL, V46, P1374, DOI 10.1128/JCM.01368-07; Fachiroh J, 2006, J CLIN MICROBIOL, V44, P1459, DOI 10.1128/JCM.44.4.1459-1467.2006; Fachiroh J, 2004, J INFECT DIS, V190, P53, DOI 10.1086/421245; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fles R, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-81; Gondhowiardjo Sa, 2008, Biomed Imaging Interv J, V4, pe42, DOI 10.2349/biij.4.3.e42; Gulley ML, 2010, J MOL DIAGNOSIS; Hutajulu SH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-48; Ji MF, 2007, BRIT J CANCER, V96, P623, DOI 10.1038/sj.bjc.6603609; Ji Ming-fang, 2011, Chin J Cancer, V30, P120; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Koivunen P, 2001, CANCER, V92, P2885, DOI 10.1002/1097-0142(20011201)92:11<2885::AID-CNCR10119>3.0.CO;2-G; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; Lee N, 2007, HEAD NECK-J SCI SPEC, V29, P387, DOI 10.1002/hed.20332; Levendag PC, 2002, INT J RADIAT ONCOL, V52, P755, DOI 10.1016/S0360-3016(01)02719-5; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Nyst HJ, 2012, PHOTODIAGN PHOTODYN, V9, P274, DOI 10.1016/j.pdpdt.2012.07.002; Paramita DK, 2007, J MED VIROL, V79, P1710, DOI 10.1002/jmv.20987; Paramita DK, 2009, CLIN VACCINE IMMUNOL, V16, P706, DOI 10.1128/CVI.00425-08; Prasad U, 2000, Med J Malaysia, V55, P230; Sloan F.A., 2007, I MED US COMMITTEE C; Slotman BJ, 2005, RADIOTHER ONCOL, V75, P349, DOI 10.1016/j.radonc.2004.12.005; Stevens SJC, 2006, INT J CANCER, V119, P608, DOI 10.1002/ijc.21914; Stevens SJC, 2005, J CLIN MICROBIOL, V43, P3066, DOI 10.1128/JCM.43.7.3066-3073.2005; TAMADA A, 1984, CANCER, V53, P430, DOI 10.1002/1097-0142(19840201)53:3<430::AID-CNCR2820530311>3.0.CO;2-Z; Teppo H, 2003, HEAD NECK-J SCI SPEC, V25, P389, DOI 10.1002/hed.10208; Tong JHM, 2002, CLIN CANCER RES, V8, P2612; Tune CE, 1999, JNCI-J NATL CANCER I, V91, P796, DOI 10.1093/jnci/91.9.796; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Wildeman MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032756; Wildeman MA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-190; Zhang L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-558	44	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63706	10.1371/journal.pone.0063706	http://dx.doi.org/10.1371/journal.pone.0063706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675501	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400051
J	Ravn, P; Madhurantakam, C; Kunze, S; Matthews, E; Priest, C; O'Brien, S; Collinson, A; Papworth, M; Fritsch-Fredin, M; Jermutus, L; Benthem, L; Gruetter, M; Jackson, RH				Ravn, Peter; Madhurantakam, Chaithanya; Kunze, Susan; Matthews, Evelyn; Priest, Claire; O'Brien, Siobhan; Collinson, Andie; Papworth, Monika; Fritsch-Fredin, Maria; Jermutus, Lutz; Benthem, Lambertus; Gruetter, Markus; Jackson, Ronald H.			Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; PROTEIN-COUPLED-RECEPTOR; HIGH-FAT DIET; GLUCAGON RECEPTOR; PHAGE DISPLAY; IN-VITRO; AFFINITY MATURATION; RIBOSOME DISPLAY; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE	Glucose-dependent insulinotropic polypeptide (GIP) is an endogenous hormonal factor (incretin) that, upon binding to its receptor (GIPr; a class B G-protein-coupled receptor), stimulates insulin secretion by beta cells in the pancreas. There has been a lack of potent inhibitors of the GIPr with prolonged in vivo exposure to support studies on GIP biology. Here we describe the generation of an antagonizing antibody to the GIPr, using phage and ribosome display libraries. Gipg013 is a specific competitive antagonist with equally high potencies to mouse, rat, dog, and human GIP receptors with a K-i of 7 nM for the human GIPr. Gipg013 antagonizes the GIP receptor and inhibits GIP-induced insulin secretion in vitro and in vivo. A crystal structure of Gipg013 Fab in complex with the human GIPr extracellular domain (ECD) shows that the antibody binds through a series of hydrogen bonds from the complementarity-determining regions of Gipg013 Fab to the N-terminal alpha-helix of GIPr ECD as well as to residues around its highly conserved glucagon receptor subfamily recognition fold. The antibody epitope overlaps with the GIP binding site on the GIPr ECD, ensuring competitive antagonism of the receptor. This well characterized antagonizing antibody to the GIPr will be useful as a tool to further understand the biological roles of GIP.	[Ravn, Peter; Kunze, Susan; Matthews, Evelyn; O'Brien, Siobhan; Collinson, Andie; Papworth, Monika; Jermutus, Lutz; Jackson, Ronald H.] MedImmune, Dept Antibody Discovery & Prot Engn, Cambridge CB21 6GH, England; [Madhurantakam, Chaithanya; Gruetter, Markus] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Priest, Claire] AstraZeneca R&D Alderley Pk, Discovery Sci, Alderley Pk SK10 4GT, Cheshire, England; [Fritsch-Fredin, Maria; Benthem, Lambertus] AstraZeneca R&D, Biosci, S-43183 Molndal, Sweden	AstraZeneca; Medimmune; University of Zurich; AstraZeneca; AstraZeneca	Ravn, P (corresponding author), MedImmune, Dept Antibody Discovery & Prot Engn, Milstein Bldg,Granta Pk, Cambridge CB21 6GH, England.	ravnp@medimmune.com	Madhurantakam, Chaithanya/AAP-5197-2020; Madhurantakam, Chaithanya/F-3652-2010; Jermutus, Lutz/AAU-2047-2020	Collinson, Andie/0000-0001-7465-8313; Madhurantakam, Chaithanya/0000-0002-1967-8538				Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Bazarsuren A, 2002, BIOPHYS CHEM, V96, P305, DOI 10.1016/S0301-4622(02)00023-6; Brubaker PL, 2007, TRENDS ENDOCRIN MET, V18, P240, DOI 10.1016/j.tem.2007.06.005; Buggy J, 1996, HORM METAB RES, V28, P215, DOI 10.1055/s-2007-979167; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Edwards BM, 2003, J MOL BIOL, V334, P103, DOI 10.1016/j.jmb.2003.09.054; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finlay WJ, 2009, J MOL BIOL, V388, P541, DOI 10.1016/j.jmb.2009.03.019; Flatt PR, 2008, DIABETIC MED, V25, P759, DOI 10.1111/j.1464-5491.2008.02455.x; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Fulurija A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003163; Gault VA, 2002, J ENDOCRINOL, V175, P525, DOI 10.1677/joe.0.1750525; Gault VA, 2002, BIOCHEM BIOPH RES CO, V290, P1420, DOI 10.1006/bbrc.2002.6364; Gelling RW, 1997, REGUL PEPTIDES, V69, P151, DOI 10.1016/S0167-0115(97)00009-8; Getty-Kaushik L, 2006, OBESITY, V14, P1124, DOI 10.1038/oby.2006.129; Groves M, 2006, J IMMUNOL METHODS, V313, P129, DOI 10.1016/j.jim.2006.04.002; Gu W, 2010, AM J PHYSIOL-ENDOC M, V299, pE624, DOI 10.1152/ajpendo.00102.2010; Hansotia T, 2004, DIABETES, V53, P1326, DOI 10.2337/diabetes.53.5.1326; Harris GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035129; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Hinke SA, 2001, BBA-PROTEIN STRUCT M, V1547, P143, DOI 10.1016/S0167-4838(01)00181-9; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Irwin N, 2009, BIOL CHEM, V390, P75, DOI 10.1515/BC.2009.002; Irwin N, 2012, BRIT J NUTR, V108, P46, DOI 10.1017/S0007114511005228; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040156; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019682; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lewis JT, 2000, ENDOCRINOLOGY, V141, P3710, DOI 10.1210/en.141.10.3710; Liu LM, 2011, BIOLOGICALS, V39, P205, DOI 10.1016/j.biologicals.2011.06.002; Lloyd C, 2009, PROTEIN ENG DES SEL, V22, P159, DOI 10.1093/protein/gzn058; MCCAFFERTY J, 1994, APPL BIOCHEM BIOTECH, V47, P157, DOI 10.1007/BF02787932; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKnight A, 1997, J VIROL, V71, P1692, DOI 10.1128/JVI.71.2.1692-1696.1997; Meier JJ, 2002, REGUL PEPTIDES, V107, P1, DOI 10.1016/S0167-0115(02)00039-3; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nakamura T, 2012, DIABETES OBES METAB, V14, P511, DOI 10.1111/j.1463-1326.2011.01555.x; Nauck MA, 2009, EUR J INTERN MED, V20, pS303, DOI 10.1016/j.ejim.2009.05.012; Osbourn JK, 1998, NAT BIOTECHNOL, V16, P778, DOI 10.1038/nbt0898-778; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Ravn P, 2004, J MOL BIOL, V343, P985, DOI 10.1016/j.jmb.2004.08.052; Ravn P, 2012, METHODS MOL BIOL, V805, P213, DOI 10.1007/978-1-61779-379-0_12; Tschop MH, 2012, DIABETES, V61, P1309, DOI 10.2337/db12-0272; Tseng CC, 1996, J CLIN INVEST, V98, P2440, DOI 10.1172/JCI119060; Ugleholdt R, 2011, J BIOL CHEM, V286, P44632, DOI 10.1074/jbc.M111.311779; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Villemagne D, 2006, J IMMUNOL METHODS, V313, P140, DOI 10.1016/j.jim.2006.04.001; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; West AP, 2001, P NATL ACAD SCI USA, V98, P3744, DOI 10.1073/pnas.051625298; WHEELER MB, 1995, ENDOCRINOLOGY, V136, P4629, DOI 10.1210/en.136.10.4629; Wright LM, 2000, ACTA CRYSTALLOGR D, V56, P573, DOI 10.1107/S090744490000233X; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009	58	61	76	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19760	19772		10.1074/jbc.M112.426288	http://dx.doi.org/10.1074/jbc.M112.426288			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689510	Green Published, hybrid			2022-12-25	WOS:000321515800045
J	Habermannova, J; Bogusch, P; Straka, J				Habermannova, Jana; Bogusch, Petr; Straka, Jakub			Flexible Host Choice and Common Host Switches in the Evolution of Generalist and Specialist Cuckoo Bees (Anthophila: Sphecodes)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; PLANT SPECIALIZATION; CLEPTOPARASITIC BEES; NUCLEAR GENES; ARMS RACES; RED QUEEN; HYMENOPTERA; GENUS; HALICTIDAE; APOIDEA	Specialization makes resource use more efficient and should therefore be a common process in animal evolution. However, this process is not as universal in nature as one might expect. Our study shows that Sphecodes (Halictidae) cuckoo bees frequently change their host over the course of their evolution. To test the evolutionary scenario of host specialization in cuckoo bees, we constructed well-supported phylogenetic trees based on partial sequences of five genes for subtribe Sphecodina (Halictini). We detected up to 17 host switches during Sphecodes evolution based on 37 ingroup species subject to mapping analysis of the hosts associated with the cuckoo bee species. We also examine the direction of evolution of host specialization in Sphecodes using the likelihood ratio test and obtain results to support the bidirectional evolutionary scenario in which specialists can arise from generalists, and vice versa. We explain the existence of generalist species in Sphecodes based on their specialization at the individual level, which is recently known in two species. Our findings suggest flexible host choice and frequent host switches in the evolution of Sphecodes cuckoo bees. This scenario leads us to propose an individual choice constancy hypothesis based on the individual specialization strategy in cuckoo bees. Choice constancy has a close relationship to flower constancy in bees and might be an extension of the latter. Our analysis also shows relationships among the genera Microsphecodes, Eupetersia, Sphecodes and Austrosphecodes, a formerly proposed Sphecodes subgenus. Austrosphecodes species form a basal lineage of the subtribe, and Microsphecodes makes it paraphyletic.	[Habermannova, Jana; Straka, Jakub] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Bogusch, Petr] Univ Hradec Kralove, Dept Biol, Hradec Kralove, Czech Republic	Charles University Prague; University of Hradec Kralove	Straka, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	jakub.straka@aculeataresearch.com	Bogusch, Petr/AAN-6667-2020; Bogusch, Petr/Q-6111-2016; Straka, Jakub/A-7215-2012	Bogusch, Petr/0000-0002-4554-6141; Straka, Jakub/0000-0002-8987-1245	Czech Science Foundation [206/09/0522]; SVV poject Integrative Animal Biology from Ministry of Education, youth and sports [SVV-2012-265206]	Czech Science Foundation(Grant Agency of the Czech Republic); SVV poject Integrative Animal Biology from Ministry of Education, youth and sports	This project was supported by grant from Czech Science Foundation (www.gacr.cz/), project no. 206/09/0522 and SVV poject Integrative Animal Biology no. SVV-2012-265206 from Ministry of Education, youth and sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; Agosta SJ, 2010, ZOOLOGIA-CURITIBA, V27, P151, DOI 10.1590/S1984-46702010000200001; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almeida EAB, 2012, J BIOGEOGR, V39, P526, DOI 10.1111/j.1365-2699.2011.02624.x; Begon M., 2009, ECOLOGY INDIVIDUALS; BERNAYS EA, 1994, Q REV BIOL, V69, P187, DOI 10.1086/418539; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bluthgen P., 1934, Zeitschrift fuer Wissenschaftliche Insektenbiologie Berlin, V27, P33; Bogusch P, 2003, BIOL SELECTED KLEPTO; Bogusch P, 2006, BEHAV ECOL SOCIOBIOL, V60, P422, DOI 10.1007/s00265-006-0182-4; Bogusch P, 2012, ZOOTAXA, P1; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Cardinal S, 2010, P NATL ACAD SCI USA, V107, P16207, DOI 10.1073/pnas.1006299107; CARPENTER JM, 1993, CLADISTICS, V9, P129, DOI 10.1111/j.1096-0031.1993.tb00214.x; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Cope ED, 1903, PRIMARY FACTORS ORGA, P547; Crespi BJ, 2000, J EVOLUTION BIOL, V13, P249, DOI 10.1046/j.1420-9101.2000.00164.x; Danforth BN, 2003, SYST BIOL, V52, P23, DOI 10.1080/10635150390132687; Danforth BN, 1999, SYST ENTOMOL, V24, P377, DOI 10.1046/j.1365-3113.1999.00087.x; Danforth BN, 2006, MOL PHYLOGENET EVOL, V39, P358, DOI 10.1016/j.ympev.2005.09.022; Danforth BN, 2004, SYST BIOL, V53, P309, DOI 10.1080/10635150490423737; DANFORTH BN, 1989, J KANSAS ENTOMOL SOC, V62, P59; Danforth BN, 2002, P NATL ACAD SCI USA, V99, P286, DOI 10.1073/pnas.012387999; Danforth BN, 1999, MOL PHYLOGENET EVOL, V13, P605, DOI 10.1006/mpev.1999.0670; Danforth BN, 2001, SYST BIOL, V50, P268; Danforth BN, 2008, APIDOLOGIE, V39, P86, DOI 10.1051/apido:2008002; Danforth BN, 2006, P NATL ACAD SCI USA, V103, P15118, DOI 10.1073/pnas.0604033103; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Desdevises Y, 2002, BIOL J LINN SOC, V77, P431, DOI 10.1046/j.1095-8312.2002.00114.x; EICKWORT G C, 1977, Journal of the Kansas Entomological Society, V50, P577; Emery C, 1909, AMEISEN BIOL CENTALB, V29, P352; Engel Michael S., 2006, Acta Zoologica Cracoviensia, V49B, P1, DOI 10.3409/000000006783995300; Favret C, 2004, MOL PHYLOGENET EVOL, V32, P139, DOI 10.1016/j.ympev.2003.12.005; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gibbs J, 2012, MOL PHYLOGENET EVOL, V65, P926, DOI 10.1016/j.ympev.2012.08.013; Gibbs J, 2012, CLADISTICS, V28, P195, DOI 10.1111/j.1096-0031.2011.00373.x; Griekspoor A., 2006, 4PEAKS; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hoberg EP, 2008, J BIOGEOGR, V35, P1533, DOI 10.1111/j.1365-2699.2008.01951.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Johnson KP, 2003, SYST BIOL, V52, P37, DOI 10.1080/10635150390132704; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kawecki TJ, 1998, AM NAT, V152, P635, DOI 10.1086/286195; Kumar S, 2009, BMC BIOINFORMATICS, P10; Lopez-Vaamonde C, 2003, EVOLUTION, V57, P1804, DOI 10.1111/j.0014-3820.2003.tb00588.x; Maddison WP, 2011, MESQUITE MODULAR SYS; MICHENER C D, 1978, University of Kansas Science Bulletin, V51, P291; Michener C.D., 2007, BEES WORLD, Vsecond; MICHENER CHARLES D., 1956, UNIV KANSAS SCI BULL, V37, P645; Michez D, 2008, APIDOLOGIE, V39, P146, DOI 10.1051/apido:2007048; Muller A, 1996, ECOL MONOGR, V66, P235, DOI 10.2307/2963476; PACKER L, 1995, BIOCHEM GENET, V33, P97, DOI 10.1007/BF00557948; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pedersen BV, 1996, MOL PHYLOGENET EVOL, V5, P289, DOI 10.1006/mpev.1996.0024; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poulin R, 2006, INT J PARASITOL, V36, P185, DOI 10.1016/j.ijpara.2005.09.017; Poulin R, 2003, PARASITOLOGY, V126, P473, DOI 10.1017/S0031182003002993; Poulin R, 2007, EVOLUTIONARY ECOLOGY; Praz CJ, 2008, ECOLOGY, V89, P795, DOI 10.1890/07-0751.1; Rambaut A, 2014, TRACER V1 6; Rasmussen C, 2011, ZOOKEYS, P61, DOI 10.3897/zookeys.127.1670; Rezkova K, 2012, J INSECT BEHAV, V25, P24, DOI 10.1007/s10905-011-9274-8; Robertson C., 1903, Entomological News Philadelphia, Vxiv, P103; Robinson BW, 1998, AM NAT, V151, P223, DOI 10.1086/286113; ROHDE K, 1980, EXPERIENTIA, V36, P1369, DOI 10.1007/BF01960103; Ronquist F, 2001, EVOLUTION, V55, P2503; Rozen JG, 1965, AM MUS NOVIT, P2224; Scheffer SJ, 2000, MOL PHYLOGENET EVOL, V17, P244, DOI 10.1006/mpev.2000.0830; Schulmeister S, 2003, BIOL J LINN SOC, V79, P245, DOI 10.1046/j.1095-8312.2003.00233.x; Sedivy C, 2008, EVOLUTION, V62, P2487, DOI 10.1111/j.1558-5646.2008.00465.x; Sedivy C, 2011, FUNCT ECOL, V25, P718, DOI 10.1111/j.1365-2435.2010.01828.x; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; SICK M, 1994, J INSECT BEHAV, V7, P101, DOI 10.1007/BF01989830; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Soucy SL, 2002, EVOLUTION, V56, P330, DOI 10.1111/j.0014-3820.2002.tb01343.x; Straka J, 2007, SYST ENTOMOL, V32, P700, DOI 10.1111/j.1365-3113.2007.00394.x; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; WESTRICH P, 2008, EUCERA, V1, P17; Westrich P., 1990, WILDBIENEN BADEN WUR; Whitlock MC, 1996, AM NAT, V148, pS65, DOI 10.1086/285902; Williams NM, 2003, OECOLOGIA, V134, P228, DOI 10.1007/s00442-002-1104-4; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	91	23	23	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64537	10.1371/journal.pone.0064537	http://dx.doi.org/10.1371/journal.pone.0064537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691244	Green Published, gold			2022-12-25	WOS:000319107900109
J	Schuler, N; Rube, CE				Schuler, Nadine; Ruebe, Claudia E.			Accumulation of DNA Damage-Induced Chromatin Alterations in Tissue-Specific Stem Cells: The Driving Force of Aging?	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; REPAIR; HETEROCHROMATIN; CARCINOGENESIS; CANCER; BULGE; MICE; KU	Accumulation of DNA damage leading to stem cell exhaustion has been proposed to be a principal mechanism of aging. Using 53BP1-foci as a marker for DNA double-strand breaks (DSBs), hair follicle stem cells (HFSCs) in mouse epidermis were analyzed for age-related DNA damage response (DDR). We observed increasing amounts of 53BP1-foci during the natural aging process independent of telomere shortening and after protracted low-dose radiation, suggesting substantial accumulation of DSBs in HFSCs. Electron microscopy combined with immunogold-labeling showed multiple small 53BP1 clusters diffusely distributed throughout the highly compacted heterochromatin of aged HFSCs, but single large 53BP1 clusters in irradiated HFSCs. These remaining 53BP1 clusters did not colocalize with core components of non-homologous end-joining, but with heterochromatic histone modifications. Based on these results we hypothesize that these lesions were not persistently unrepaired DSBs, but may reflect chromatin rearrangements caused by the repair or misrepair of DSBs. Flow cytometry showed increased activation of repair proteins and damage-induced chromatin modifications, triggering apoptosis and cellular senescence in irradiated, but not in aged HFSCs. These results suggest that accumulation of DNA damage-induced chromatin alterations, whose structural dimensions reflect the complexity of the initial genotoxic insult, may lead to different DDR events, ultimately determining the biological outcome of HFSCs. Collectively, our findings support the hypothesis that aging might be largely the remit of structural changes to chromatin potentially leading to epigenetically induced transcriptional deregulation.	[Schuler, Nadine; Ruebe, Claudia E.] Univ Saarland, Dept Radiat Oncol, Homburg, Germany	Saarland University	Rube, CE (corresponding author), Univ Saarland, Dept Radiat Oncol, Homburg, Germany.	claudia.ruebe@uks.eu			Deutsche Forschungsgemeinschaft [RU 821/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (RU 821/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneke S, 2007, NUCLEIC ACIDS RES, V35, P7456, DOI 10.1093/nar/gkm735; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Boehnke K, 2012, CARCINOGENESIS, V33, P1247, DOI 10.1093/carcin/bgs136; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016; Gannon HS, 2011, DEV BIOL, V353, P1, DOI 10.1016/j.ydbio.2011.02.007; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Goodarzi AA, 2009, BIOCHEM SOC T, V37, P569, DOI 10.1042/BST0370569; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Lorat Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038165; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; O'Sullivan RJ, 2012, TRENDS BIOCH SCI; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Peuscher MH, 2011, NAT CELL BIOL, V13, P1139, DOI 10.1038/ncb2326; Rube CE, 2008, INT J RADIAT ONCOL, V72, P1180, DOI 10.1016/j.ijrobp.2008.07.017; Rube CE, 2008, CLIN CANCER RES, V14, P6546, DOI 10.1158/1078-0432.CCR-07-5147; Rube CE, 2011, DNA REPAIR, V10, P427, DOI 10.1016/j.dnarep.2011.01.012; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Rube CE, 2011, DNA REPAIR, V10, P159, DOI 10.1016/j.dnarep.2010.10.007; Rube CE, 2010, INT J RADIAT ONCOL, V76, P1206, DOI 10.1016/j.ijrobp.2009.10.009; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Tamaru H, 2010, GENE DEV, V24, P1465, DOI 10.1101/gad.1941010; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumpel S, 2012, ANN NY ACAD SCI, V1266, P28, DOI 10.1111/j.1749-6632.2012.06547.x; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Woodbine L, 2011, NUCLEIC ACIDS RES, V39, P6986, DOI 10.1093/nar/gkr331	33	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63932	10.1371/journal.pone.0063932	http://dx.doi.org/10.1371/journal.pone.0063932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691119	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107900067
J	Naish, S; Mengersen, K; Hu, WB; Tong, SL				Naish, Suchithra; Mengersen, Kerrie; Hu, Wenbiao; Tong, Shilu			Forecasting the Future Risk of Barmah Forest Virus Disease under Climate Change Scenarios in Queensland, Australia	PLOS ONE			English	Article								Background: Mosquito-borne diseases are climate sensitive and there has been increasing concern over the impact of climate change on future disease risk. This paper projected the potential future risk of Barmah Forest virus (BFV) disease under climate change scenarios in Queensland, Australia. Methods/Principal Findings: We obtained data on notified BFV cases, climate (maximum and minimum temperature and rainfall), socio-economic and tidal conditions for current period 2000-2008 for coastal regions in Queensland. Grid-data on future climate projections for 2025, 2050 and 2100 were also obtained. Logistic regression models were built to forecast the otential risk of BFV disease distribution under existing climatic, socio-economic and tidal conditions. The model was applied to estimate the potential geographic distribution of BFV outbreaks under climate change scenarios. The predictive model had good model accuracy, sensitivity and specificity. Maps on potential risk of future BFV disease indicated that disease would vary significantly across coastal regions in Queensland by 2100 due to marked differences in future rainfall and temperature projections. Conclusions/Significance: We conclude that the results of this study demonstrate that the future risk of BFV disease would vary across coastal regions in Queensland. These results may be helpful for public health decision making towards developing effective risk management strategies for BFV disease control and prevention programs in Queensland.	[Naish, Suchithra; Hu, Wenbiao; Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; [Mengersen, Kerrie] Queensland Univ Technol, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Naish, S (corresponding author), Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia.	s.naish@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	Hu, Wenbiao/0000-0001-6422-9240; Mengersen, Kerrie/0000-0001-8625-9168	Queensland University of Technology	Queensland University of Technology	Funding institution: Queensland University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, SPSS 18 0 GUIDE DATA; Australian Bureau of Meteorology, 2011, DAT OBT NAT CLIM CTR; Australian Bureau of Statistics, 2011, CENS POP HOUS BAS CO; Australian Bureau of Statistics, 2008, MESH BLOCKS DIG BOUN; Australian Bureau of Statistics, 2008, POP AG SEX AUSTR STA, V3201; Australian Department of Health and Ageing, 2012, COMM DIS SURV HIGHL; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CSIRO, 2011, OZCLIM CLIM CHANG SC; Dale P, 2009, AUSTRALIAN SALTMARSH ECOLOGY, P167; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; I.P.C.C, 2011, CONTRIBUTION WORKING; I.P.C.C, 2001, CLIM CHANG 2001 IMP; I.P.C.C, 2011, INT PAN CLIM CHANG P; Jacups SP, 2011, J MED ENTOMOL, V48, P453, DOI 10.1603/ME10193; Lloyd CD., 2010, SPATIAL DATA ANAL; McMichael AJ, 2008, CLIMATE CHANGE INFEC, P378; Naish S, 2006, ENVIRON HEALTH PERSP, V114, P678, DOI 10.1289/ehp.8568; Naish S, 2011, TROP MED INT HEALTH, V16, P884, DOI 10.1111/j.1365-3156.2011.02775.x; Naish S, 2011, EMERGING METHODS USI; Naish S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025688; Naish S, 2009, TROP MED INT HEALTH, V14, P247, DOI 10.1111/j.1365-3156.2008.02217.x; Queensland Department of Transport and Main Roads, 2009, MAR SAF QUEENSL TID; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Russell RC, 2009, AUST J ENTOMOL, V48, P1, DOI 10.1111/j.1440-6055.2008.00677.x; WHO, 2004, US CLIM PRED INF DIS, P55; Young J, 2009, STRATEGIC DIRECTIONS, P9; Zeng N, 2010, NESUG P HLTH CARE LI	27	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e62843	10.1371/journal.pone.0062843	http://dx.doi.org/10.1371/journal.pone.0062843			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690959	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700013
J	Sahores, A; Luque, GM; Wargon, V; May, M; Molinolo, A; Becu-Villalobos, D; Lanari, C; Lamb, CA				Sahores, Ana; Luque, Guillermina M.; Wargon, Victoria; May, Maria; Molinolo, Alfredo; Becu-Villalobos, Damasia; Lanari, Claudia; Lamb, Caroline A.			Novel, Low Cost, Highly Effective, Handmade Steroid Pellets for Experimental Studies	PLOS ONE			English	Article							BREAST-CANCER; PROGESTERONE-RECEPTORS; OVARIECTOMIZED RATS; SILASTIC IMPLANTS; ESTROGEN-RECEPTOR; GROWTH; 17-BETA-ESTRADIOL; PROLACTIN; ESTRADIOL; HORMONES	The basic component of Silastic (R) glue (Dow Corning) used to prepare Silastic (R) pellets is polydimethylsiloxane. This compound is also present in other commercial adhesives such as FASTIX (R) (Akapol SA) that are available in any store for that category. In the present study we developed low cost, easy to prepare handmade steroid pellets (HMSP) by mixing 17 beta-estradiol, progesterone or other synthetic steroids with FASTIX (R) adhesive. We assessed serum levels of 17 beta-estradiol, progesterone, prolactin and luteinizing hormone in ovariectomized mice treated for 24 and 48 h or 7, 14 and 28 days with 20 mu g or 5 mg of 17 beta-estradiol or 5 mg progesterone HMSP. We found a time dependent and significant increase in the levels of both natural hormones, and a downregulation of serum luteinizing hormone levels, while both 17 beta-estradiol doses increased serum prolactin. Uterine weights at sacrifice and histological examination of the uteri and the mammary glands correlated with estrogen or progestin action. Finally, we evaluated the biological effects of HMSP compared to commercial pellets or daily injections in the stimulation or inhibition of hormone dependent mammary tumor growth, and found that HMSP were as effective as the other methods of hormone administration. These data show that HMSP represent a useful, low cost, easily accessible method for administering steroids to mice.	[Sahores, Ana; Luque, Guillermina M.; Wargon, Victoria; May, Maria; Becu-Villalobos, Damasia; Lanari, Claudia; Lamb, Caroline A.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt IBYME, Buenos Aires, DF, Argentina; [Molinolo, Alfredo] Natl Inst Dent & Craniofacial Res, NIH, Oral & Pharyngeal Canc Branch, Bethesda, MD USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Lamb, CA (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt IBYME, Buenos Aires, DF, Argentina.	carolinealamb@gmail.com	Luque, Guillermina/M-9237-2019	Luque, Guillermina/0000-0002-2745-8236	Fundacion Sales; Secretaia de Ciencia y Tecnologia [989, 459]; PIP [692]; intramural Research Program, National Institute of Dental and Craniofacial Research-National Institutes of Health	Fundacion Sales; Secretaia de Ciencia y Tecnologia; PIP; intramural Research Program, National Institute of Dental and Craniofacial Research-National Institutes of Health	This work was supported by Fundacion Sales (Specific Grant 2010-2012), Secretaia de Ciencia y Tecnologia (PICT 2008 No989; PICT 2010 No459), PIP 2010-2012 No692. AM is supported by the intramural Research Program, National Institute of Dental and Craniofacial Research-National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aupperlee MD, 2007, ENDOCRINOLOGY, V148, P2290, DOI 10.1210/en.2006-1721; BRONSON FH, 1976, BIOL REPROD, V15, P147, DOI 10.1095/biolreprod15.2.147; Chang K, 2008, REPROD SCI, V15, P336, DOI 10.1177/1933719108317975; COHEN PE, 1993, J REPROD FERTIL, V99, P219, DOI 10.1530/jrf.0.0990219; Cristina C, 2005, ENDOCRINOLOGY, V146, P2952, DOI 10.1210/en.2004-1445; DZIUK PJ, 1966, ENDOCRINOLOGY, V78, P208, DOI 10.1210/endo-78-1-208; ELSAESSER F, 1989, Steroids, V54, P159, DOI 10.1016/0039-128X(89)90091-3; Gadducci A, 1997, EUR J GYNAECOL ONCOL, V18, P371; GARDNER W. U., 1939, YALE JOUR BIOL AND MED, V12, P213; Girard GM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1660; Giulianelli S, 2012, CANCER RES, V72, P2416, DOI 10.1158/0008-5472.CAN-11-3290; Ingberg E, 2012, GEN COMP ENDOCR, V175, P188, DOI 10.1016/j.ygcen.2011.11.014; Institute of Laboratory Animal Resources CoLS National Research Council, 1996, GUIDE CARE USE LAB A; KIVISAARI J, 1973, AM J SURG, V125, P623, DOI 10.1016/0002-9610(73)90149-9; Lacau-Mengido IM, 2000, J ANIM SCI, V78, P817; Lamb CA, 2005, BREAST CANCER RES, V7, pR1111, DOI 10.1186/bcr1345; Lanari C, 2009, ENDOCR-RELAT CANCER, V16, P333, DOI 10.1677/ERC-08-0244; Li JJ, 2004, P NATL ACAD SCI USA, V101, P18123, DOI 10.1073/pnas.0408273101; Luque GM, 2011, J PHARMACOL EXP THER, V337, P766, DOI 10.1124/jpet.110.177790; Mejia M, 1999, J ANIM SCI, V77, P1329; SABA N, 1975, J REPROD FERTIL, V44, P59, DOI 10.1530/jrf.0.0440059; Salem HF, 2010, INT J NANOMED, V5, P943, DOI 10.2147/IJN.S12947; SINHA YN, 1972, ENDOCRINOLOGY, V91, P1045, DOI 10.1210/endo-91-4-1045; Strom JO, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-39; Strom JO, 2008, SCAND J CLIN LAB INV, V68, P814, DOI 10.1080/00365510802409703; Suarez C, 2002, J ENDOCRINOL, V174, P447, DOI 10.1677/joe.0.1740447; SYMONS AM, 1974, J REPROD FERTIL, V41, P475, DOI 10.1530/jrf.0.0410475; Theodorsson A, 2005, SCAND J CLIN LAB INV, V65, P699, DOI 10.1080/00365510500375206; Tibbetts TA, 1998, BIOL REPROD, V59, P1143, DOI 10.1095/biolreprod59.5.1143; Vanzulli SI, 2005, CARCINOGENESIS, V26, P1055, DOI 10.1093/carcin/bgi060; WANG SQ, 1990, ENDOCRINOLOGY, V127, P2183, DOI 10.1210/endo-127-5-2183; Wargon V, 2009, BREAST CANCER RES TR, V116, P449, DOI 10.1007/s10549-008-0150-y	32	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64049	10.1371/journal.pone.0064049	http://dx.doi.org/10.1371/journal.pone.0064049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691144	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700074
J	Shcherbakov, D; Knorzer, A; Espenhahn, S; Hilbig, R; Haas, U; Blum, M				Shcherbakov, Denis; Knoerzer, Alexandra; Espenhahn, Svenja; Hilbig, Reinhard; Haas, Ulrich; Blum, Martin			Sensitivity Differences in Fish Offer Near-Infrared Vision as an Adaptable Evolutionary Trait	PLOS ONE			English	Article							VISUAL PIGMENTS; SPECTRAL SENSITIVITY; OPTICAL-PROPERTIES; NILE TILAPIA; VA OPSIN; WATER; MELANOPSIN; CICHLIDAE; BEHAVIOR; INDEXES	Near-infrared (NIR) light constitutes an integrated part of solar radiation. The principal ability to sense NIR under laboratory conditions has previously been demonstrated in fish. The availability of NIR in aquatic habitats, and thus its potential use as a cue for distinct behaviors such as orientation and detection of prey, however, depends on physical and environmental parameters. In clear water, blue and green light represents the dominating part of the illumination. In turbid waters, in contrast, the relative content of red and NIR radiation is enhanced, due to increased scattering and absorption of short and middle range wavelengths by suspended particles and dissolved colored materials. We have studied NIR detection thresholds using a phototactic swimming assay in five fish species, which are exposed to different NIR conditions in their natural habitats. Nile and Mozambique tilapia, which inhabit waters with increased turbidity, displayed the highest spectral sensitivity, with thresholds at wavelengths above 930 nm. Zebrafish, guppy and green swordtail, which prefer clearer waters, revealed significantly lower thresholds of spectral sensitivity with 825-845 nm for green swordtail and 845-910 nm for zebrafish and guppy. The present study revealed a clear correlation between NIR sensation thresholds and availability of NIR in the natural habitats, suggesting that NIR vision, as an integral part of the whole spectrum of visual abilities, can serve as an evolutionarily adaptable trait in fish.	[Shcherbakov, Denis; Knoerzer, Alexandra; Espenhahn, Svenja; Hilbig, Reinhard; Haas, Ulrich; Blum, Martin] Univ Hohenheim, Inst Zool, Stuttgart, Germany	University Hohenheim	Shcherbakov, D (corresponding author), Univ Hohenheim, Inst Zool, Stuttgart, Germany.	denis.scherbakov@uni-hohenheim.de		Espenhahn, Svenja/0000-0002-4460-3853				Anstis S, 1998, VISION RES, V38, P45, DOI 10.1016/S0042-6989(97)00159-4; Batschelet E, 1981, CIRCULAR STAT BIOL; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Borowiak D, 2009, LIMNOL REV, V9, P141; Bowmaker JK, 1995, PROG RETIN EYE RES, V15, P1; Bowmaker JK, 2008, SENSES COMPREHENSIVE, V1, P53; BRUTON MN, 1975, J FISH BIOL, V7, P423, DOI 10.1111/j.1095-8649.1975.tb04618.x; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; CERRI RD, 1983, ANIM BEHAV, V31, P736, DOI 10.1016/S0003-3472(83)80230-9; Chervinski J., 1982, ICLARM Conference Proceedings, P119; Chinen A, 2003, GENETICS, V163, P663; Cronin W, 2008, SENSES COMPREHENSIVE, V1, P211; Doron M, 2011, REMOTE SENS ENVIRON, V115, P1617, DOI 10.1016/j.rse.2011.01.015; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Endo M, 2002, NIPPON SUISAN GAKK, V68, P887; Espinosa-Lemus V, 2009, HIDROBIOLOGICA, V19, P95; FERNALD RD, 1980, VISION RES, V20, P857, DOI 10.1016/0042-6989(80)90066-8; Franck D, 2001, BEHAVIOUR, V138, P467, DOI 10.1163/156853901750382115; Gaile G. L., 1980, DIRECTIONAL STAT; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Hepher B., 1982, ICLARM C P, P185; IRVINE WM, 1968, ICARUS, V8, P324, DOI 10.1016/0019-1035(68)90083-3; Jenkins A, 2003, CURR BIOL, V13, P1269, DOI 10.1016/S0960-9822(03)00509-8; Kempkes M, 2010, GUPPIES; Kobayashi R, 2002, NIPPON SUISAN GAKK, V68, P646, DOI 10.2331/suisan.68.646; Kondrashev SL, 2008, VISION RES, V48, P2269, DOI 10.1016/j.visres.2008.07.004; KOU LH, 1993, APPL OPTICS, V32, P3531, DOI 10.1364/AO.32.003531; Kusmic C, 2000, MICRON, V31, P183, DOI 10.1016/S0968-4328(99)00081-5; Lavender SJ, 2005, CONT SHELF RES, V25, P539, DOI 10.1016/j.csr.2004.10.007; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; Lisney TJ, 2010, J EXP BIOL, V213, P1453, DOI 10.1242/jeb.036897; LYTHGOE JN, 1984, VISION RES, V24, P1539, DOI 10.1016/S0042-6989(84)80003-6; MALTHUS TJ, 1995, ENVIRON INT, V21, P221, DOI 10.1016/0160-4120(95)00012-7; Matsumoto T, 2005, FISHERIES SCI, V71, P350, DOI 10.1111/j.1444-2906.2005.00971.x; MCFARLAND WN, 1994, VISION RES, V34, P1393, DOI 10.1016/0042-6989(94)90138-4; MERKEL FW, 1980, ORIENTIERUNG TIERREI; Meuthen D, 2012, NATURWISSENSCHAFTEN, V99, P1063, DOI 10.1007/s00114-012-0980-7; Meyer-Rochow V. Benno, 2006, Neuroembryology and Aging, V4, P112, DOI 10.1159/000103585; Michiels Nico K., 2008, BMC Ecology, V8, P16, DOI 10.1186/1472-6785-8-16; MOOIJ JEM, 1983, VISION RES, V23, P701, DOI 10.1016/0042-6989(83)90211-0; NIWA H, 1979, COMP BIOCHEM PHYS A, V64, P581; PALMER KF, 1974, J OPT SOC AM, V64, P1107, DOI 10.1364/JOSA.64.001107; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Philippart J.-C., 1982, ICLARM Conference Proceedings, P15; Philp AR, 2000, J EXP BIOL, V203, P1925; Reinart A, 2003, J SEA RES, V49, P357, DOI 10.1016/S1385-1101(03)00019-4; RIORDAN CJ, 1986, SOL CELLS, V18, P223, DOI 10.1016/0379-6787(86)90121-3; Schmitter-Soto JJ, 2011, SCI TOTAL ENVIRON, V409, P844, DOI 10.1016/j.scitotenv.2010.11.017; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shcherbakov D, 2012, ZOOLOGY, V115, P233, DOI 10.1016/j.zool.2012.01.005; Shcherbakov D, 2010, CONTRIB ZOOL, V79, P33, DOI 10.1163/18759866-07901002; Takeuchi T, 2008, SPACE UTILIZ RES, V24, P251; Thiemann S, 2002, REMOTE SENS ENVIRON, V81, P228, DOI 10.1016/S0034-4257(01)00345-5; Wetzel RG, 2001, LIMNOLOGY, Vthird, P331	54	26	28	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64429	10.1371/journal.pone.0064429	http://dx.doi.org/10.1371/journal.pone.0064429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691215	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700094
J	Yang, H; Yang, S; Park, G				Yang, Hwajin; Yang, Sujin; Park, Giho			Her Voice Lingers on and Her Memory Is Strategic: Effects of Gender on Directed Forgetting	PLOS ONE			English	Article							SEX-DIFFERENCES; EMOTIONAL WORDS; RECOGNITION MEMORY; VERBAL MEMORY; SPOKEN WORDS; IDENTIFICATION; PERCEPTION; BENEFITS; INFANTS; PROSODY	The literature on directed forgetting has employed exclusively visual words. Thus, the potentially interesting aspects of a spoken utterance, which include not only vocal cues (e.g., prosody) but also the speaker and the listener, have been neglected. This study demonstrates that prosody alone does not influence directed-forgetting effects, while the sex of the speaker and the listener significantly modulate directed-forgetting effects for spoken utterances. Specifically, forgetting costs were attenuated for female-spoken items compared to male-spoken items, and forgetting benefits were eliminated among female listeners but not among male listeners. These results suggest that information conveyed in a female voice draws attention to its distinct perceptual attributes, thus interfering with retention of the semantic meaning, while female listeners' superior capacity for processing the surface features of spoken utterances may predispose them to spontaneously employ adaptive strategies to retain content information despite distraction by perceptual features. Our findings underscore the importance of sex differences when processing spoken messages in directed forgetting.	[Yang, Hwajin] Singapore Management Univ, Sch Social Sci, Singapore, Singapore; [Yang, Sujin] Cathol Univ Korea, Sch Med, Seoul, South Korea; [Park, Giho] Singapore MIT Alliance Res & Technol, Singapore, Singapore	Singapore Management University; Catholic University of Korea; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Yang, H (corresponding author), Singapore Management Univ, Sch Social Sci, Singapore, Singapore.	hjyang@smu.edu.sg	YANG, Hwajin/F-9093-2010	Yang, Hwajin/0000-0002-0762-7194	 [C242026]		This research was supported by a research grant to Hwajin Yang (C242026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2001, WILDLIFE SOC B, V29, P311; Bauml KH, 2009, PSYCHON B REV, V16, P93, DOI 10.3758/PBR.16.1.93; Barnier AJ, 2007, J EXP PSYCHOL GEN, V136, P301, DOI 10.1037/0096-3445.136.2.301; BJORK RA, 1970, J VERB LEARN VERB BE, V9, P255, DOI 10.1016/S0022-5371(70)80059-7; BLEECKER ML, 1988, J CLIN PSYCHOL, V44, P403, DOI 10.1002/1097-4679(198805)44:3<403::AID-JCLP2270440315>3.0.CO;2-0; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P206, DOI 10.3758/BF03206883; Brend RM, 1975, STUDIES TONE INTONAT; CHURCH BA, 1994, J EXP PSYCHOL LEARN, V20, P521, DOI 10.1037/0278-7393.20.3.521; Clement S, 1997, J ACOUST SOC AM, V106, P2805; DURLACH NI, 1969, J ACOUST SOC AM, V46, P372, DOI 10.1121/1.1911699; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; Floyd K., 2003, WESTERM J COMMUN, V67, P56, DOI [10.1080/10570310309374758, DOI 10.1080/10570310309374758, DOI 10.1080/10570]; GEISELMAN RE, 1983, J EXP PSYCHOL GEN, V112, P58, DOI 10.1037/0096-3445.112.1.58; Huber JE, 1999, J ACOUST SOC AM, V106, P1532, DOI 10.1121/1.427150; Hunt R. R., 2006, DISTINCTIVENESS MEMO; Huron D, 2006, EMPIR MUSICOL REV, V1, P170, DOI 10.18061/1811/24068; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; JACOBY LL, 1984, PSYCHOL LEARN MOTIV, V18, P1, DOI 10.1016/S0079-7421(08)60358-8; Kaushanskaya M, 2011, ACTA PSYCHOL, V137, P24, DOI 10.1016/j.actpsy.2011.02.002; KAUSLER DH, 1981, J GERONTOL, V36, P44, DOI 10.1093/geronj/36.1.44; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; KRAMER JH, 1988, J CLIN PSYCHOL, V44, P907, DOI 10.1002/1097-4679(198811)44:6<907::AID-JCLP2270440610>3.0.CO;2-8; Kuhl BA, 2007, NAT NEUROSCI, V10, P908, DOI 10.1038/nn1918; Lattner S, 2005, HUM BRAIN MAPP, V24, P11, DOI 10.1002/hbm.20065; Lavner Y, 2000, SPEECH COMMUN, V30, P9, DOI 10.1016/S0167-6393(99)00028-X; MacLeod CM, 1998, INTENTIONAL FORGETTING: INTERDISCIPLINARY APPROACHES, P1; MILLER CL, 1983, INFANT BEHAV DEV, V6, P313, DOI 10.1016/S0163-6383(83)80040-X; Minnema MT, 2008, EMOTION, V8, P643, DOI 10.1037/a0013441; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; PALMERI TJ, 1993, J EXP PSYCHOL LEARN, V19, P309, DOI 10.1037/0278-7393.19.2.309; Pastotter B, 2012, MEM COGNITION, V40, P861, DOI 10.3758/s13421-012-0206-4; Paulmann S, 2008, BRAIN LANG, V105, P59, DOI 10.1016/j.bandl.2007.11.005; Payne BK, 2007, J EXP SOC PSYCHOL, V43, P780, DOI 10.1016/j.jesp.2006.07.005; Pell MD, 2011, COGNITION EMOTION, V25, P834, DOI 10.1080/02699931.2010.516915; Pinkham JR, 1994, CRANIOFACIAL CHANGES; Pittam J, 1993, HDB EMOTIONS; Sahakyan L, 2005, J EXP PSYCHOL LEARN, V31, P789, DOI 10.1037/0278-7393.31.4.789; Sahakyan L, 2003, J MEM LANG, V48, P195, DOI 10.1016/S0749-596X(02)00524-7; Scherer K.R., 1981, SPEECH EVALUATION PS, P189; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schirmer A, 2013, COGN AFFECT BEHAV NE, V13, P80, DOI 10.3758/s13415-012-0132-8; Schirmer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009080; Spence MJ, 2002, J SPEECH LANG HEAR R, V45, P214, DOI 10.1044/1092-4388(2002/016); STANGOR C, 1992, PSYCHOL BULL, V111, P42, DOI 10.1037/0033-2909.111.1.42; Trahan D E, 1990, Arch Clin Neuropsychol, V5, P325, DOI 10.1016/0887-6177(90)90012-E; Wessel I, 2006, COGNITION EMOTION, V20, P129, DOI 10.1080/02699930500260195; Wilding J, 2000, PERCEPT MOTOR SKILL, V91, P535, DOI 10.2466/PMS.91.6.535-538	50	5	5	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64030	10.1371/journal.pone.0064030	http://dx.doi.org/10.1371/journal.pone.0064030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145XK	23691141	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700073
J	Dai, SQ; An, X; Wang, F; Shao, Q; Chen, YC; Kong, YN; Chen, C; Li, C; Luo, HY; Liang, Y; Wang, FH; Xu, RH; Li, YH				Dai, Shu-Qin; An, Xin; Wang, Fang; Shao, Qiong; Chen, Yong-Chang; Kong, Ya-Nan; Chen, Cui; Li, Cong; Luo, Hui-Yan; Liang, Ying; Wang, Feng-Hua; Xu, Rui-Hua; Li, Yu-Hong			Serum HER 2 Extracellular Domain Level Is Correlated with Tissue HER 2 Status in Metastatic Gastric or Gastro-Oesophageal Junction Adenocarcinoma	PLOS ONE			English	Article							BREAST-CANCER; PROGNOSTIC VALUE; HER2 STATUS; AMPLIFICATION; VALIDATION; RECEPTOR	Background: To explore the association between serum human epidermal growth factor receptor 2 (HER 2) extracellular domain (ECD) levels and tissue HER 2 status in metastatic gastric cancer. Patients and Methods: HER 2 status was retrospectively analyzed in 219 advanced gastric or gastroesophageal junction (GEJ) patients. Serum HER 2 ECD was measured by chemiluminescent assay and tissue HER 2 was assessed by fluorescent in situ hybridisation (FISH) and immunohistochemistry (IHC) assay. Results: Significant associations were found between serum HER 2 ECD levels and tissue HER 2 status. Twenty-four patients had HER 2 ECD levels > 16.35 ng/mL, which has a sensitivity of 51.4% and a specificity of 97.3% to predict tissue HER 2 status. When the cut-off value was increased to 22 ng/mL, then all 12 patients with serum HER 2 ECD levels > 22 ng/mL were tissue HER 2 positive, corresponding to a specificity of 100% and a sensitivity of 32.4%. High serum HER 2 ECD levels were strongly associated with the intestinal histological type (Lauren's classification), liver metastasis, multiple metastasis (>2) and increased LDH levels, but not with overall survival. Conclusions: The high specificity of the serum HER 2 ECD assay in predicting tissue HER 2 status suggests its potential as a surrogate marker of the HER 2 status in gastric cancer.	[Dai, Shu-Qin; An, Xin; Wang, Fang; Shao, Qiong; Chen, Yong-Chang; Kong, Ya-Nan; Chen, Cui; Li, Cong; Luo, Hui-Yan; Liang, Ying; Wang, Feng-Hua; Xu, Rui-Hua; Li, Yu-Hong] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Dai, Shu-Qin] Sun Yat Sen Univ, Ctr Canc, Dept Med Examinat, Guangzhou 510275, Guangdong, Peoples R China; [An, Xin; Chen, Yong-Chang; Chen, Cui; Li, Cong; Luo, Hui-Yan; Liang, Ying; Wang, Feng-Hua; Xu, Rui-Hua; Li, Yu-Hong] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Fang; Shao, Qiong] Sun Yat Sen Univ, Ctr Canc, Dept Mol Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Kong, Ya-Nan] Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, YH (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	liyh@mail.sysucc.org.cn	xu, rui/GRX-5734-2022; Xu, Rui-Hua/AAW-4766-2021; li, Yu/HCI-9086-2022; wang, fang/GYD-4295-2022; li, yu/HGL-9518-2022; 骆, 卉妍/GWR-3383-2022; Li, yu/HHZ-5236-2022	Xu, Rui-Hua/0000-0001-9771-8534; 骆, 卉妍/0000-0001-6312-9299; Kong, Yanan/0000-0002-3145-5492	Chinese Gastrointestinal Oncology Group [CGOG20130101015]	Chinese Gastrointestinal Oncology Group	This work was supported by the Chinese Gastrointestinal Oncology Group (grant no. CGOG20130101015). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Asgeirsson KS, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1788; Bang YJ, 2010, LANCET, V376, P1302; Bramwell VHC, 2009, BREAST CANCER RES TR, V114, P503, DOI 10.1007/s10549-008-0033-2; Di Lorenzo G, 2004, TUMORI J, V90, P163, DOI 10.1177/030089160409000201; Dresse M, 2009, J CLIN ONCOL, V27; Fehm T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1783; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Jorgensen JT, 2012, J CANCER, V3, P137, DOI 10.7150/jca.4090; Kong SY, 2006, CLIN CHEM, V52, P1510, DOI 10.1373/clinchem.2006.067512; Li YH, 2011, CLIN CANCER RES, V17, P382, DOI 10.1158/1078-0432.CCR-10-0208; Ludovini V, 2008, ANN ONCOL, V19, P883, DOI 10.1093/annonc/mdm585; Marx AH, 2009, HUM PATHOL, V40, P769, DOI 10.1016/j.humpath.2008.11.014; Molina R, 2010, TUMOR BIOL, V31, P171, DOI 10.1007/s13277-010-0025-9; Muller V, 2003, INT J BIOL MARKER, V18, P13, DOI 10.1177/172460080301800103; Nahta R., 2009, Current Pharmacogenomics & Personalized Medicine, V7, P263; Ruschoff J, 2010, PATHOLOGE, V31, P208, DOI 10.1007/s00292-010-1278-1; Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2; Saghatchian M, 2004, INT J BIOL MARKER, V19, P14, DOI 10.1177/172460080401900102; Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Tse C, 2005, CLIN CHEM, V51, P1093, DOI 10.1373/clinchem.2004.044305; Witzel I, 2010, BREAST CANCER RES TR, V123, P437, DOI 10.1007/s10549-010-1030-9; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	24	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63458	10.1371/journal.pone.0063458	http://dx.doi.org/10.1371/journal.pone.0063458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691049	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400064
J	Hunter, KE; Quick, ML; Sadanandam, A; Hanahan, D; Joyce, JA				Hunter, Karen E.; Quick, Marsha L.; Sadanandam, Anguraj; Hanahan, Douglas; Joyce, Johanna A.			Identification and Characterization of Poorly Differentiated Invasive Carcinomas in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis	PLOS ONE			English	Article							BETA-CELL; GROWTH-FACTOR; TUMOR-GROWTH; CANCER; ANGIOGENESIS; PROGRESSION; METASTASIS; EXPRESSION; RECEPTOR; THERAPY	Pancreatic neuroendocrine tumors (PanNETs) are a relatively rare but clinically challenging tumor type. In particular, high grade, poorly-differentiated PanNETs have the worst patient prognosis, and the underlying mechanisms of disease are poorly understood. In this study we have identified and characterized a previously undescribed class of poorly differentiated PanNETs in the RIP1-Tag2 mouse model. We found that while the majority of tumors in the RIP1-Tag2 model are well-differentiated insulinomas, a subset of tumors had lost multiple markers of beta-cell differentiation and were highly invasive, leading us to term them poorly differentiated invasive carcinomas (PDICs). In addition, we found that these tumors exhibited a high mitotic index, resembling poorly differentiated (PD)-PanNETs in human patients. Interestingly, we identified expression of Id1, an inhibitor of DNA binding gene, and a regulator of differentiation, specifically in PDIC tumor cells by histological analysis. The identification of PDICs in this mouse model provides a unique opportunity to study the pathology and molecular characteristics of PD-PanNETs.	[Hunter, Karen E.; Quick, Marsha L.; Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Hunter, Karen E.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10021 USA; [Sadanandam, Anguraj] Swiss Inst Bioinformat, Lausanne, Switzerland; [Sadanandam, Anguraj; Hanahan, Douglas] Swiss Fed Inst Technol Lausanne EPFL, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Joyce, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	joycej@mskcc.org		Sadanandam, Anguraj/0000-0001-8485-5150	Cycle for Survival; National Cancer Institute [R01 CA125162]; Grayer Fellowship; NATIONAL CANCER INSTITUTE [R01CA125162] Funding Source: NIH RePORTER	Cycle for Survival; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grayer Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by Cycle for Survival and the National Cancer Institute R01 CA125162 (JAJ). Karen Hunter was supported in part by a Grayer Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KR, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-65; Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; Bergers G, 1998, INT J DEV BIOL, V42, P995; Chiu CW, 2010, J CLIN ONCOL, V28, P4425, DOI 10.1200/JCO.2010.28.0198; Davies Karen, 2009, Curr Gastroenterol Rep, V11, P119; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hu Wenwei, 2010, Genes Cancer, V1, P360; Klimstra DS, 2010, PANCREAS, V39, P707, DOI 10.1097/MPA.0b013e3181ec124e; Lardon J, 2004, VIRCHOWS ARCH, V444, P61, DOI 10.1007/s00428-003-0930-z; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Mashima H, 1996, ENDOCRINOLOGY, V137, P3969, DOI 10.1210/en.137.9.3969; MOERTEL CG, 1991, CANCER, V68, P227, DOI 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Reidy DL, 2009, NAT CLIN PRACT ONCOL, V6, P143, DOI 10.1038/ncponc1326; Reidy-Lagunes DL, 2012, J NATL COMPR CANC NE, V10, P777, DOI 10.6004/jnccn.2012.0077; Sadanandam A, 2010, INT J CANCER, V127, P1373, DOI 10.1002/ijc.25166; Tang LH, 2012, CLIN CANCER RES, V18, P4612, DOI 10.1158/1078-0432.CCR-11-3264; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tuveson D, 2011, NATURE, V471, P316, DOI 10.1038/471316a; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2007, ANN SURG ONCOL, V14, P3492, DOI 10.1245/s10434-007-9566-6; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290	28	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64472	10.1371/journal.pone.0064472	http://dx.doi.org/10.1371/journal.pone.0064472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691228	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400129
J	Sharifov, OF; Xu, X; Gaggar, A; Grizzle, WE; Mishra, VK; Honavar, J; Litovsky, SH; Palgunachari, MN; White, CR; Anantharamaiah, GM; Gupta, H				Sharifov, Oleg F.; Xu, Xin; Gaggar, Amit; Grizzle, William E.; Mishra, Vinod K.; Honavar, Jaideep; Litovsky, Silvio H.; Palgunachari, Mayakonda N.; White, C. Roger; Anantharamaiah, G. M.; Gupta, Himanshu			Anti-Inflammatory Mechanisms of Apolipoprotein A-I Mimetic Peptide in Acute Respiratory Distress Syndrome Secondary to Sepsis	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ACUTE LUNG INJURY; APOA-I; INFLAMMATORY RESPONSES; IMPROVES SURVIVAL; SEPTIC SHOCK; ENDOTOXIN; 4F; EXPRESSION; CHOLESTEROL	Acute respiratory distress syndrome (ARDS) due to sepsis has a high mortality rate with limited treatment options. High density lipoprotein (HDL) exerts innate protective effects in systemic inflammation. However, its role in ARDS has not been well studied. Peptides such as L-4F mimic the secondary structural features and functions of apolipoprotein (apo) A-I, the major protein component of HDL. We set out to measure changes in HDL in sepsis-mediated ARDS patients, and to study the potential of L-4F to prevent sepsis-mediated ARDS in a rodent model of lipopolysaccharide (LPS)-mediated acute lung injury, and a combination of primary human leukocytes and human ARDS serum. We also analyzed serum from non-lung disease intubated patients (controls) and sepsis-mediated ARDS patients. Compared to controls, ARDS demonstrates increased serum endotoxin and IL-6 levels, and decreased HDL, apoA-I and activity of anti-oxidant HDL-associated paraoxanase-1. L-4F inhibits the activation of isolated human leukocytes and neutrophils by ARDS serum and LPS in vitro. Further, L-4F decreased endotoxin activity and preserved anti-oxidant properties of HDL both in vitro and in vivo. In a rat model of severe endotoxemia, L-4F significantly decreased mortality and reduces lung and liver injury, even when administered 1 hour post LPS. Our study suggests the protective role of the apoA-I mimetic peptide L-4F in ARDS and gram-negative endotoxemia and warrant further clinical evaluation. The main protective mechanisms of L-4F are due to direct inhibition of endotoxin activity and preservation of HDL anti-oxidant activity.	[Sharifov, Oleg F.; Xu, Xin; Gaggar, Amit; Mishra, Vinod K.; Honavar, Jaideep; Palgunachari, Mayakonda N.; White, C. Roger; Gupta, Himanshu] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Gaggar, Amit; Gupta, Himanshu] US Dept Vet Affairs Med Ctr, Med Serv, Birmingham, AL USA; [Grizzle, William E.; Litovsky, Silvio H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Anantharamaiah, G. M.] Univ Alabama Birmingham, Dept Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Gupta, H (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	hgupta@uab.edu	Mishra, Vinod/S-1151-2019; Sharifov, Oleg F/AAO-1812-2021	Mishra, Vinod/0000-0002-4527-1512; Sharifov, Oleg F/0000-0003-4799-3903	NIH [NHLBI K08HL085282, R01 HL102371, 5R01GM 082952, NHLBI HL 34343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034343, K08HL085282, R01HL102371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082952] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants NHLBI K08HL085282 (H.G.), R01 HL102371 (A.G.), 5R01GM 082952 (C.R.W.), and NHLBI HL 34343 (G.M.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Bannerman DD, 2003, AM J PHYSIOL-LUNG C, V284, pL899, DOI 10.1152/ajplung.00338.2002; Bashtovyy D, 2011, J LIPID RES, V52, P435, DOI 10.1194/jlr.R012658; Baumgarten G, 2006, SHOCK, V25, P43, DOI 10.1097/01.shk.0000196498.57306.a6; Bloedon LT, 2008, J LIPID RES, V49, P1344, DOI 10.1194/jlr.P800003-JLR200; Bouros Demosthenes, 2004, BMC Pulm Med, V4, P6, DOI 10.1186/1471-2466-4-6; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Calkins CM, 2001, J SURG RES, V101, P232, DOI 10.1006/jsre.2001.6274; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dai LJ, 2010, J LIPID RES, V51, P2695, DOI 10.1194/jlr.M008086; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Datta G, 2001, J LIPID RES, V42, P1096; Draganov D, 2010, ADV EXP MED BIOL, V660, P89, DOI 10.1007/978-1-60761-350-3_9; FEINGOLD KR, 1995, INFECT IMMUN, V63, P2041, DOI 10.1128/IAI.63.5.2041-2046.1995; Ferretti G, 2010, OBESITY, V18, P1079, DOI 10.1038/oby.2009.338; Floer M, 2010, AM J PATHOL, V176, P146, DOI 10.2353/ajpath.2010.080639; FOWLER AA, 1985, AM REV RESPIR DIS, V132, P472; Gaggar A, 2006, CLIN CHIM ACTA, V372, P24, DOI 10.1016/j.cca.2006.04.019; Garber DW, 2000, J LIPID RES, V41, P1020; Garber DW, 2001, J LIPID RES, V42, P545; Garin MCB, 2006, J LIPID RES, V47, P515, DOI 10.1194/jlr.M500281-JLR200; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Gupta H, 2005, CIRC RES, V97, P236, DOI 10.1161/01.RES.0000176530.66400.48; HADDAD IA, 1986, J BIOL CHEM, V261, P3268; Imaizumi Satoshi, 2010, Drug Metab Lett, V4, P139; Iovine NM, 1997, P NATL ACAD SCI USA, V94, P10973, DOI 10.1073/pnas.94.20.10973; Kitchens RL, 2003, J LIPID RES, V44, P2339, DOI 10.1194/jlr.M300228-JLR200; Kwon WY, 2012, J TRAUMA ACUTE CARE, V72, P1576, DOI 10.1097/TA.0b013e3182493ab4; Levels JH, 2001, INFECT IMMUN, V71, P3280; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; McDonald MC, 2003, SHOCK, V20, P551, DOI 10.1097/01.shk.0000097249.97298.a3; MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062; Mishra VK, 1998, BIOCHEMISTRY-US, V37, P10313, DOI 10.1021/bi980042o; Morishima A, 2003, J BIOL CHEM, V278, P38188, DOI 10.1074/jbc.M306336200; Munford RS, 2006, ANNU REV PATHOL-MECH, V1, P467, DOI 10.1146/annurev.pathol.1.110304.100200; Murphy AJ, 2011, ARTERIOSCL THROM VAS, V31, P1333, DOI 10.1161/ATVBAHA.111.226258; Nandedkar SD, 2011, J LIPID RES, V52, P499, DOI 10.1194/jlr.M012724; Navab M, 2004, CURR OPIN LIPIDOL, V15, P645, DOI 10.1097/00041433-200412000-00004; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Novak F, 2010, CLIN EXP MED, V10, P21, DOI 10.1007/s10238-009-0059-8; Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202; Pajkrt D, 1996, J EXP MED, V184, P1601, DOI 10.1084/jem.184.5.1601; READ TE, 1993, INFECT IMMUN, V61, P3496, DOI 10.1128/IAI.61.8.3496-3502.1993; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sharifov OF, 2012, AM J RESP CRIT CARE, V185, pA2213; Siore AM, 2005, AM J PHYSIOL-LUNG C, V289, pL769, DOI 10.1152/ajplung.00137.2005; Smythies LE, 2010, AM J PHYSIOL-CELL PH, V298, pC1538, DOI 10.1152/ajpcell.00467.2009; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Vakili L, 2010, ADV EXP MED BIOL, V660, P167, DOI 10.1007/978-1-60761-350-3_15; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; Van Lenten BJ, 2008, J LIPID RES, V49, P2302, DOI 10.1194/jlr.M800075-JLR200; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Watson CE, 2011, J LIPID RES, V52, P361, DOI 10.1194/jlr.M011098; White CR, 2012, ARTERIOSCL THROM VAS, V32, P2631, DOI 10.1161/ATVBAHA.112.300167; White CR, 2012, J LIPID RES, V53, P1576, DOI 10.1194/jlr.M026278; Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781; Yan YJ, 2006, LIFE SCI, V79, P210, DOI 10.1016/j.lfs.2006.02.011; Zhang ZH, 2009, AM J PHYSIOL-HEART C, V297, pH866, DOI 10.1152/ajpheart.01232.2008	61	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64486	10.1371/journal.pone.0064486	http://dx.doi.org/10.1371/journal.pone.0064486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691230	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400130
J	Vogan, AA; Khankhet, J; Xu, JP				Vogan, Aaron A.; Khankhet, Jordan; Xu, Jianping			Evidence for Mitotic Recombination within the Basidia of a Hybrid Cross of Cryptococcus neoformans	PLOS ONE			English	Article							SEROTYPE AD; LIFE-CYCLE; FILOBASIDIELLA-NEOFORMANS; SACCHAROMYCES-CEREVISIAE; AGARICUS-BISPORUS; MATING-TYPE; STRAINS; NONDISJUNCTION; MORPHOGENESIS; INHERITANCE	In the majority of diploid eukaryotes, each meiotic process generates four haploid gametes with each containing a single recombinant nucleus. In some species and/or some meiotic processes, aneuploid or diploid gametes can also be generated due to chromosomal non-disjunction and/or the co-packaging of two of the four haploid nuclei into the same gamete. Here we show that another process is involved in generating genotypes of sexual progeny from a hybrid cross between two divergent lineages of the human fungal pathogen Cryptococcus neoformans. Through micro-dissection of 1358 basidiospores from 194 basidia and genotyping using 33 co-dominant genetic markers, the genotypes of all 230 germinated basidiospores from 94 basidia were obtained. The minimum haploid genotypes required to constitute the observed genotypes from each basidium were then inferred. Our results demonstrated that more than four haploid nuclear genotypes are required to explain the observed genotypes of basidiospores in seven of the 94 basidia. Our results suggest that mitotic recombination within basidia must be involved to produce the observed genotypes in these seven basidia. The mitotic recombination likely includes both chromosomal loss and crossing over. This novel recombination process could play an important role in generating the genotypic and phenotypic diversities of this important human pathogen.	[Vogan, Aaron A.; Khankhet, Jordan] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Xu, Jianping] Cent South Univ Forestry & Technol, Coll Forestry, Changsha, Hunan, Peoples R China	McMaster University; Central South University of Forestry & Technology	Xu, JP (corresponding author), Cent South Univ Forestry & Technol, Coll Forestry, Changsha, Hunan, Peoples R China.	jpxu@mcmaster.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada; Ontario Graduate Scholarship fund	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship fund(Ontario Graduate Scholarship)	This study is supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada (JX) and Ontario Graduate Scholarship fund (AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2012, MYCOPATHOLOGIA, V173, P435, DOI 10.1007/s11046-012-9524-0; Brandt ME, 1996, J INFECT DIS, V174, P812, DOI 10.1093/infdis/174.4.812; Brandt ME, 1996, J CLIN MICROBIOL, V34, P912, DOI 10.1128/JCM.34.4.912-917.1996; Chiavarino AM, 2000, GENETICS, V155, P889; Fredslund J, 2005, NUCLEIC ACIDS RES, V33, pW516, DOI 10.1093/nar/gki425; HAMOIR G, 1992, INT J DEV BIOL, V36, P9; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; HERSKOWITZ I, 1988, MICROBIOL REV, V52, P536, DOI 10.1128/MMBR.52.4.536-553.1988; Hertwig O., 1875, MORPHOL JB, V1, P347, DOI [10.2307/1411521, DOI 10.2307/1411521]; Idnurm A, 2010, GENETICS, V185, P153, DOI 10.1534/genetics.109.113027; IKEDA R, 1982, J CLIN MICROBIOL, V16, P22, DOI 10.1128/JCM.16.1.22-29.1982; KERRIGAN RW, 1994, EXP MYCOL, V18, P193, DOI 10.1006/emyc.1994.1020; KWONCHUNG KJ, 1980, MYCOLOGIA, V72, P418, DOI 10.2307/3759266; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P821, DOI 10.2307/3758800; Lengeler KB, 2001, INFECT IMMUN, V69, P115, DOI 10.1128/IAI.69.1.115-122.2001; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Poss KD, 2004, GENE DEV, V18, P1527, DOI 10.1101/gad.1182604; RAPER CA, 1972, MYCOLOGIA, V64, P1088, DOI 10.2307/3758075; RAPER CA, 1966, GENETICS, V54, P1151; SORA S, 1982, GENETICS, V101, P17; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; SUMMERBELL RC, 1989, GENETICS, V123, P293; Sun S, 2007, GENETICS, V177, P1475, DOI 10.1534/genetics.107.078923; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Xu JP, 2000, CURR MICROBIOL, V40, P269, DOI 10.1007/s002849910053; Xu JP, 2003, MICROBIOL-SGM, V149, P2147, DOI 10.1099/mic.0.26180-0; Xu JP, 2002, MICROBIOL-SGM, V148, P203, DOI 10.1099/00221287-148-1-203; Yan Z, 2003, GENETICS, V163, P1315	29	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62790	10.1371/journal.pone.0062790	http://dx.doi.org/10.1371/journal.pone.0062790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690954	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400019
J	Huang, WH; Yu, MC; Huang, JY; Lai, PC				Huang, Wen-Hung; Yu, Mei-Ching; Huang, Jeng-Yi; Lai, Ping-Chin			Impact of Hepatitis C Virus Infection on Bone Mineral Density in Renal Transplant Recipients	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; VITAMIN-D; LIVER-DISEASE; OSTEOCLAST DIFFERENTIATION; SECONDARY HYPERPARATHYROIDISM; OSTEOPROTEGERIN LIGAND; PARATHYROID-HORMONE; DENDRITIC-CELL; OSTEOPOROSIS; FRACTURES	Background: The average prevalence of hepatitis C virus (HCV) infection in renal transplant recipients is 10%. Studies of these patients with HCV infection usually focuses on long-term graft survival and patient survival. Studies of the correlation between HCV infection and bone mineral density (BMD) in renal transplant patients are limited. The aim of this study was to investigate whether HCV infection is a risk factor for BMD change during a short follow-up period. Methods: Seventy-six renal transplant recipients underwent 2 separate dual-energy X-ray absorptiometry (DXA) scans during a mean period of 14 months. Fifteen patients were HCV infection. First bone mineral density (BMD) at the lumbar spine, hip, and femoral neck was determined using dual-energy X-ray absorptiometry (DXA) between September 2008 and March 2009. After that, 34 patients took alendronate sodium 70 mg per week. Subgroups risk factors analysis was also performed into with or without alendronate. Immunosuppressive agents, bisphosphonates, patient characteristics, and biochemical factors were analyzed to identify associations with BMD. Results: After 14 months, in 76 patients, BMD of the lumbar spine had significantly increased (from 0.9 g/cm(2) to 0.92 g/cm(2), p < 0.001), whereas BMD of the hip and femoral neck had not. Multiple linear regression analysis showed that HCV infection was negatively associated with BMD change in the lumbar spine (beta: -0.247, 95% CI, -0.035 to -0.002; p = 0.028). Moreover, in subgroup analysis, among 42 patients without alendronate, multiple linear regression analysis showed HCV infection was a risk factor for adverse BMD change of the lumbar spine (beta: -0.371, 95% CI, -0.043 to -0.003; p = 0.023). Conclusion: HCV infection in renal transplant recipients was a negative risk factor for BMD change in the lumbar spine. Moreover, alendronate may be able to reverse the negative effect of HCV infection on bone in renal transplant recipients.	[Huang, Wen-Hung; Huang, Jeng-Yi; Lai, Ping-Chin] Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan; [Yu, Mei-Ching] Chang Gung Childrens Hosp, Dept Paediat Nephrol, Linkou, Taiwan; [Huang, Wen-Hung; Yu, Mei-Ching; Huang, Jeng-Yi; Lai, Ping-Chin] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lai, PC (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan.	williammaxima@gmail.com	huang, wen/GXW-0661-2022					Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arase Y, 2010, J MED VIROL, V82, P390, DOI 10.1002/jmv.21691; Aroldi A, 1997, TRANSPLANTATION, V63, P380, DOI 10.1097/00007890-199702150-00009; Arteh J, 2010, DIGEST DIS SCI, V55, P2624, DOI 10.1007/s10620-009-1069-9; Barone A, 2007, J AM GERIATR SOC, V55, P752, DOI 10.1111/j.1532-5415.2007.01161.x; Bruchfeld A, 2004, TRANSPLANTATION, V78, P745, DOI 10.1097/01.TP.0000131948.29742.24; Carey EJ, 2003, LIVER TRANSPLANT, V9, P1166, DOI 10.1053/jlts.2003.50242; Collin F, 2009, AIDS, V23, P1021, DOI 10.1097/QAD.0b013e3283292195; Deane A, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-3; Dunstan CR, 2000, ENDOCRINOLOGIST, V10, P18, DOI 10.1097/00019616-200010010-00005; El-Maouche D, 2011, J HEPATOL, V55, P770, DOI 10.1016/j.jhep.2011.01.035; Fabrega E, 2005, LIVER INT, V25, P305, DOI 10.1111/j.1478-3231.2005.01073.x; Fabrizi F, 2006, ALIMENT PHARM THER, V24, P1413, DOI 10.1111/j.1365-2036.2006.03151.x; Fabrizi F, 2005, AM J TRANSPLANT, V5, P1452, DOI 10.1111/j.1600-6143.2005.00864.x; Fabrizi F, 2002, HEPATOLOGY, V36, P3, DOI 10.1053/jhep.2002.34613; George J, 2009, WORLD J GASTROENTERO, V15, P3516, DOI 10.3748/wjg.15.3516; Gutierrez JA, 2011, SEMIN LIVER DIS, V31, P387, DOI 10.1055/s-0031-1297927; Hansen ABE, 2012, AIDS, V26, P285, DOI 10.1097/QAD.0b013e32834ed8a7; Hay J Eileen, 2005, Clin Liver Dis, V9, P747, DOI 10.1016/j.cld.2005.07.003; HEPNER GW, 1976, AM J DIG DIS, V21, P527, DOI 10.1007/BF01464758; Huang WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048481; Huang WH, 2011, RENAL FAILURE, V33, P776, DOI 10.3109/0886022X.2011.599914; Hung CJ, 1996, TRANSPLANT P, V28, P1548; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; Kodras K, 2006, EUR J CLIN INVES S75, V36; Kokado Y, 2000, TRANSPL INT S5, V13; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036576; Loria I, 2010, TRANSPL P, V42, P1191, DOI 10.1016/j.transproceed.2010.03.096; Mitwalli AH, 2006, NEPHRON CLIN PRACT, V102, P72, DOI 10.1159/000089090; Morales JM, 2004, NEPHROL DIAL TRAN S6, V19; Moschen AR, 2005, J HEPATOL, V43, P973, DOI 10.1016/j.jhep.2005.05.034; PERIERA BJG, 1995, TRANSPLANTATION, V60, P799, DOI 10.1097/00007890-199510270-00007; Rostami Z, 2011, HEPAT MON, V11, P247; ROTH D, 1995, AM J KIDNEY DIS, V25, P3, DOI 10.1016/0272-6386(95)90617-7; Schiefke I, 2005, WORLD J GASTROENTERO, V11, P1843, DOI 10.3748/wjg.v11.i12.1843; Sigurdsson G, 2000, OSTEOPOROSIS INT, V11, P1031, DOI 10.1007/s001980070024; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Szalay F, 2003, J HEPATOL, V38, P395, DOI 10.1016/S0168-8278(02)00435-X; van der Merwe SW, 2006, WORLD J GASTROENTERO, V12, P4504, DOI 10.3748/wjg.v12.i28.4504; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; von Muhlen DG, 2005, OSTEOPOROSIS INT, V16, P1721, DOI 10.1007/s00198-005-1910-8; Vosnides GG, 1997, KIDNEY INT, V52, P843, DOI 10.1038/ki.1997.403; Westenfeld R, 2011, NEPHROL DIAL TRANSPL, V26, P4115, DOI 10.1093/ndt/gfr214; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1999, J LEUKOCYTE BIOL, V65, P715, DOI 10.1002/jlb.65.6.715; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Young B, 2011, CLIN INFECT DIS, V52, P1061, DOI 10.1093/cid/ciq242	50	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63263	10.1371/journal.pone.0063263	http://dx.doi.org/10.1371/journal.pone.0063263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675468	Green Submitted, Green Published, gold			2022-12-25	WOS:000319036100032
J	Zabouri, N; Haverkamp, S				Zabouri, Nawal; Haverkamp, Silke			Calcium Channel-Dependent Molecular Maturation of Photoreceptor Synapses	PLOS ONE			English	Article							STATIONARY NIGHT BLINDNESS; DEVELOPING MOUSE RETINA; SYNAPTIC VESICLE PROTEINS; ROD BIPOLAR CELLS; RIBBON SYNAPSES; MAMMALIAN RETINA; CONE PHOTORECEPTORS; CA2+ CHANNELS; IMMUNOCYTOCHEMICAL LOCALIZATION; HAIR-CELLS	Several studies have shown the importance of calcium channels in the development and/or maturation of synapses. The Ca(V)1.4(alpha(1F)) knockout mouse is a unique model to study the role of calcium channels in photoreceptor synapse formation. It features abnormal ribbon synapses and aberrant cone morphology. We investigated the expression and targeting of several key elements of ribbon synapses and analyzed the cone morphology in the Ca(V)1.4(alpha(1F)) knockout retina. Our data demonstrate that most abnormalities occur after eye opening. Indeed, scaffolding proteins such as Bassoon and RIM2 are properly targeted at first, but their expression and localization are not maintained in adulthood. This indicates that either calcium or the Ca(V)1.4 channel, or both are necessary for the maintenance of their normal expression and distribution in photoreceptors. Other proteins, such as Veli3 and PSD-95, also display abnormal expression in rods prior to eye opening. Conversely, vesicle related proteins appear normal. Our data demonstrate that the Ca(V)1.4 channel is important for maintaining scaffolding proteins in the ribbon synapse but less vital for proteins related to vesicular release. This study also confirms that in adult retinae, cones show developmental features such as sprouting and synaptogenesis. Overall we present evidence that in the absence of the Ca(V)1.4 channel, photoreceptor synapses remain immature and are unable to stabilize.	[Zabouri, Nawal; Haverkamp, Silke] Max Planck Inst Brain Res, Frankfurt, Germany	Max Planck Society	Zabouri, N (corresponding author), Max Planck Inst Brain Res, Frankfurt, Germany.	nawal.zabouri@brain.mpg.de			Behrens-Weise-Stiftung	Behrens-Weise-Stiftung	This work was supported by a grant of the Behrens-Weise-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsen WM, 2009, MOL CELL NEUROSCI, V41, P156, DOI 10.1016/j.mcn.2009.02.003; Aartsen WM, 2006, HUM MOL GENET, V15, P1291, DOI 10.1093/hmg/ddl047; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Bayley PR, 2007, J COMP NEUROL, V500, P286, DOI 10.1002/cne.21188; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bello OD, 2012, EXP CELL RES, V318, P478, DOI 10.1016/j.yexcr.2012.01.002; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Cote PD, 2005, J NEUROSCI, V25, P5046, DOI 10.1523/JNEUROSCI.4692-04.2005; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Dieck ST, 2012, J NEUROSCI, V32, P12192, DOI 10.1523/JNEUROSCI.0752-12.2012; Doering CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002538; Elferink LA, 1995, PROG BRAIN RES, V105, P79; Fei YJ, 2002, MOL VIS, V8, P306; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Haverkamp S, 2006, J NEUROSCI, V26, P5248, DOI 10.1523/JNEUROSCI.4483-05.2006; Heck N, 2008, CEREB CORTEX, V18, P1335, DOI 10.1093/cercor/bhm165; Hombrebueno JR, 2010, BRAIN RES, V1321, P60, DOI 10.1016/j.brainres.2010.01.051; Hu SSJ, 2010, J COMP NEUROL, V518, P3848, DOI 10.1002/cne.22429; Johnson J, 2003, J NEUROSCI, V23, P518, DOI 10.1523/JNEUROSCI.23-02-00518.2003; Kersten FFJ, 2010, INVEST OPHTH VIS SCI, V51, P2338, DOI 10.1167/iovs.09-4650; Koulen P, 1998, J NEUROSCI, V18, P10136; Kulbatski I, 2004, J NEUROTRAUM, V21, P357, DOI 10.1089/089771504322972130; Landgraf I, 2012, EUR J NEUROSCI; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; Lodha N, 2010, ADV EXP MED BIOL, V664, P549, DOI 10.1007/978-1-4419-1399-9_63; Lv CX, 2012, MICROSC MICROANAL, V18, P745, DOI 10.1017/S1431927612000268; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Mercer AJ, 2011, VISUAL NEUROSCI, V28, P453, DOI 10.1017/S0952523811000356; Michalakis S, 2012, CELL MOL LIFE SCI; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; NEGISHI K, 1988, NEUROSCI LETT, V94, P247, DOI 10.1016/0304-3940(88)90025-0; Nishimune H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038029; OLNEY JW, 1968, INVEST OPHTH VISUAL, V7, P250; Omori Y, 2012, J NEUROSCI, V32, P6126, DOI 10.1523/JNEUROSCI.0322-12.2012; Peng YW, 2000, NAT NEUROSCI, V3, P1121, DOI 10.1038/80639; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Puller C, 2011, J COMP NEUROL, V519, P467, DOI 10.1002/cne.22528; Raven MA, 2008, J COMP NEUROL, V506, P745, DOI 10.1002/cne.21526; Regus-Leidig H, 2009, J COMP NEUROL, V512, P814, DOI 10.1002/cne.21915; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2009, J CELL SCI, V122, P1352, DOI 10.1242/jcs.045401; Rich KA, 1997, J COMP NEUROL, V388, P47; Santos MS, 2009, NEUROSCIENCE, V158, P189, DOI 10.1016/j.neuroscience.2008.03.029; Schiviz AN, 2008, J COMP NEUROL, V507, P1336, DOI 10.1002/cne.21626; Sheets L, 2012, J NEUROSCI, V32, P17273, DOI 10.1523/JNEUROSCI.3005-12.2012; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Specht D, 2007, EUR J NEUROSCI, V26, P2506, DOI 10.1111/j.1460-9568.2007.05886.x; Stohr H, 2005, J COMP NEUROL, V481, P31, DOI 10.1002/cne.20367; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; von Kriegstein K, 2003, CELL TISSUE RES, V311, P159, DOI 10.1007/s00441-002-0674-0; von Kriegstein K, 1999, EUR J NEUROSCI, V11, P1335, DOI 10.1046/j.1460-9568.1999.00542.x; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wassle H, 2006, J COMP NEUROL, V496, P544, DOI 10.1002/cne.20942; Wei T, 2012, J NEUROSCI, V32, P6981, DOI 10.1523/JNEUROSCI.6432-11.2012; Wu JA, 2007, J NEUROPHYSIOL, V97, P3731, DOI 10.1152/jn.00146.2007; Xiao HL, 2007, MOL VIS, V13, P764; Xing W, 2012, ADV EXP MED BIOL, V723, P739, DOI 10.1007/978-1-4614-0631-0_94; Zhang HB, 2003, INVEST OPHTH VIS SCI, V44, P2858, DOI 10.1167/iovs.03-0072	71	56	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63853	10.1371/journal.pone.0063853	http://dx.doi.org/10.1371/journal.pone.0063853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675510	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100050
J	Perez-Cervera, Y; Dehennaut, V; Gil, MA; Guedri, K; Mata, CJS; Olivier-Van Stichelen, S; Michalski, JC; Foulquier, F; Lefebvre, T				Perez-Cervera, Yobana; Dehennaut, Vanessa; Aquino Gil, Moyira; Guedri, Katia; Solorzano Mata, Carlos Josue; Olivier-Van Stichelen, Stephanie; Michalski, Jean-Claude; Foulquier, Francois; Lefebvre, Tony			Insulin signaling controls the expression of O-GlcNAc transferase and its interaction with lipid microdomains	FASEB JOURNAL			English	Article						lipid rafts; OGT; PI3K pathway	N-ACETYLGLUCOSAMINE TRANSFERASE; PROTEIN MODIFICATION; GLCNACYLATION; RESISTANCE; PHOSPHORYLATION; RECEPTOR; PATHWAY; CELLS; RAFTS; GLYCOSYLATION	Lipid microdomains (rafts) are cholesterol-enriched dynamic ordered lipid domains belonging to cell membranes involved in diverse cellular functions, including signal transduction, membrane trafficking, and infection. Many studies have reported relationships between insulin signaling and lipid rafts. Likewise, links between insulin signaling and O-GlcNAcylation have also been described. However, the potential connection between O-GlcNAc and raft dynamics remains unexplored. Here we show that O-GlcNAc and the enzyme that creates this modification, O-GlcNAc transferase (OGT), are localized in rafts. On insulin stimulation, we observe time-dependent increases in OGT expression and localization within rafts. We show that these processes depend on activation of the phosphatidylinositol 3-kinase (PI3K) pathway. Inhibition of OGT does not significantly affect cholesterol synthesis and raft building but decreases insulin receptor expression and PI3K and mitogen-activated protein kinase pathway activation. Taken together, these findings indicate that O-GlcNAcylation, lipid rafts, and signaling pathways are spatiotemporally coordinated to enable fundamental cellular functions.Perez-Cervera, Y., Dehennaut, V., Aquino Gil, M., Guedri, K., Solorzano Mata, C. J., Olivier-Van Stichelen, S., Michalski, J.-C., Foulquier, F., Lefebvre, T. Insulin signaling controls the expression of O-GlcNAc transferase and its interaction with lipid microdomains.	[Perez-Cervera, Yobana; Dehennaut, Vanessa; Guedri, Katia; Solorzano Mata, Carlos Josue; Olivier-Van Stichelen, Stephanie; Michalski, Jean-Claude; Foulquier, Francois; Lefebvre, Tony] Univ Lille 1, IFR 147, Unit Struct & Funct Glycobiol, CNRS,UMR 8576, F-59655 Villeneuve Dascq, France; [Perez-Cervera, Yobana; Aquino Gil, Moyira; Solorzano Mata, Carlos Josue] UABJO, UNAM, Ctr Multidisciplinario Invest, Oaxaca, Mexico	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universidad Autonoma Benito Juarez de Oaxaca; Universidad Nacional Autonoma de Mexico	Lefebvre, T (corresponding author), Univ Lille 1, IFR 147, Unit Struct & Funct Glycobiol, CNRS,UMR 8576, F-59655 Villeneuve Dascq, France.	tony.lefebvre@univ-lille1.fr	olivier-van stichelen, Stephanie/AAH-9328-2021; dehennaut, vanessa/I-7435-2018; Perez-Cervera, Yobana/C-4700-2018; Lefebvre, Tony/AAZ-1724-2021; FOULQUIER, FRANCOIS/AAI-1182-2021; foulquier, francois/ABE-5886-2020; Lefebvre, Tony/AAW-9169-2021	olivier-van stichelen, Stephanie/0000-0002-2033-5241; dehennaut, vanessa/0000-0001-6421-0793; Lefebvre, Tony/0000-0001-9883-2240; foulquier, francois/0000-0002-6551-3240; Foulquier, Francois/0000-0001-5084-4015; GUEDRI-IDJOUADIENE, Katia/0000-0001-8417-5489	University of Lille 1; Centre National de la Recherche Scientifique (CNRS); Franco-Mexican exchange program ECOS NORD [M09S02]; Rosalind Franklin fellowship (Instituto de Ciencia y Tecnologia del Distrito Federal)	University of Lille 1; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Franco-Mexican exchange program ECOS NORD; Rosalind Franklin fellowship (Instituto de Ciencia y Tecnologia del Distrito Federal)	The authors thank Dr. Andrew J. Thompson for his expert advice in the preparation of DRMs, Jennifer Stallars for her technical assistance, Professor Edgar Zenteno and Dr. Xiaoyong Yang for helpful discussion and continual support, the Bioimaging Core Facility of Lille, Institut de Recherche Interdisciplinaire CNRS, Dr. Tarik Issad and Professor Ralph Schwarz for critical reading of the manuscript, and Dr. David Vocadlo (Simon Fraser University, Burnaby, BC, Canada) for English editing the manuscript and for providing Ac-5SGlcNAc. This work was supported by the University of Lille 1, the Centre National de la Recherche Scientifique (CNRS), and the Franco-Mexican exchange program ECOS NORD No. M09S02. Y.P.C. is the recipient of a Rosalind Franklin fellowship (Instituto de Ciencia y Tecnologia del Distrito Federal). The authors declare no conflicts of interest.	Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Dehennaut V, 2008, MOL CELL PROTEOMICS, V7, P2229, DOI 10.1074/mcp.M700494-MCP200; Dehennaut V, 2008, BIOCHEM BIOPH RES CO, V369, P539, DOI 10.1016/j.bbrc.2008.02.063; Dehennaut V, 2007, J BIOL CHEM, V282, P12527, DOI 10.1074/jbc.M700444200; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Guinez C, 2006, GLYCOBIOLOGY, V16, P22, DOI 10.1093/glycob/cwj041; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Inokuchi J, 2007, YAKUGAKU ZASSHI, V127, P579, DOI 10.1248/yakushi.127.579; JARETT L, 1980, SCIENCE, V210, P1127, DOI 10.1126/science.7003710; Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; Majumdar G, 2004, DIABETES, V53, P3184, DOI 10.2337/diabetes.53.12.3184; Olivier-Van Stichelen S, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.36; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; Robinson KA, 2007, AM J PHYSIOL-ENDOC M, V292, pE884, DOI 10.1152/ajpendo.00569.2006; Sekine O, 2010, J BIOL CHEM, V285, P38684, DOI 10.1074/jbc.M110.155192; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; SKIBBENS JE, 1989, J CELL BIOL, V108, P821, DOI 10.1083/jcb.108.3.821; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Thompson AJ, 2009, PROTEOMICS, V9, P3022, DOI 10.1002/pmic.200900006; Uhles S, 2003, J CELL BIOL, V163, P1327, DOI 10.1083/jcb.200306093; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; VAN MEER G, 1988, J CELL BIOCHEM, V36, P51, DOI 10.1002/jcb.240360106; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008	41	38	38	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3478	3486		10.1096/fj.12-217984	http://dx.doi.org/10.1096/fj.12-217984			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23689613				2022-12-25	WOS:000328840500008
J	Johnen, G; Rozynek, P; von der Gathen, Y; Bryk, O; Zdrenka, R; Johannes, C; Weber, DG; Igwilo-Okuefuna, O; Raiko, I; Hippler, J; Bruning, T; Dopp, E				Johnen, Georg; Rozynek, Peter; von der Gathen, Yvonne; Bryk, Oleksandr; Zdrenka, Ricarda; Johannes, Christian; Weber, Daniel G.; Igwilo-Okuefuna, O'Brien; Raiko, Irina; Hippler, Joerg; Bruening, Thomas; Dopp, Elke			Cross-Contamination of a UROtsa Stock with T24 Cells - Molecular Comparison of Different Cell Lines and Stocks	PLOS ONE			English	Article							HUMAN UROTHELIAL CELLS; URINARY-BLADDER CARCINOMA; INDUCED MALIGNANT-TRANSFORMATION; ABERRANT PROMOTER METHYLATION; TO-MESENCHYMAL TRANSITION; DNA METHYLATION; MONOMETHYLARSONOUS ACID; VOIDED URINE; IN-VITRO; SQUAMOUS METAPLASIA	Background: UROtsa is an authentic, immortalized human urothelial cell line that is used to study the effects of metals and other toxic substances, mostly in the context of bladder cancer carcinogenesis. Unusual properties on the molecular level of a provided UROtsa cell line stock prompted us to verify its identity. Methods: UROtsa cell line stocks from different sources were tested on several molecular levels and compared with other cell lines. MicroRNA and mRNA expression was determined by Real-Time PCR. Chromosome numbers were checked and PCR of different regions of the large T-antigen was performed. DNA methylation of RARB, PGR, RASSF1, CDH1, FHIT, ESR1, C1QTNF6, PTGS2, SOCS3, MGMT, and LINE1 was analyzed by pyrosequencing and compared with results from the cell lines RT4, T24, HeLa, BEAS-2B, and HepG2. Finally, short tandem repeat (STR) profiling was applied. Results: All tested UROtsa cell line stocks lacked large T-antigen. STR analysis unequivocally identified our main UROtsa stock as the bladder cancer cell line T24, which was different from two authentic UROtsa stocks that served as controls. Analysis of DNA methylation patterns and RNA expression confirmed their differences. Methylation pattern and mRNA expression of the contaminating T24 cell line showed moderate changes even after long-term culture of up to 56 weeks, whereas miRNAs and chromosome numbers varied markedly. Conclusions: It is important to check the identity of cell lines, especially those that are not distributed by major cell banks. However, for some cell lines STR profiles are not available. Therefore, new cell lines should either be submitted to cell banks or at least their STR profile determined and published as part of their initial characterization. Our results should help to improve the identification of UROtsa and other cells on different molecular levels and provide information on the use of urothelial cells for long-term experiments.	[Johnen, Georg; Rozynek, Peter; von der Gathen, Yvonne; Bryk, Oleksandr; Weber, Daniel G.; Raiko, Irina; Bruening, Thomas] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany; [Zdrenka, Ricarda; Igwilo-Okuefuna, O'Brien; Dopp, Elke] Univ Hosp Essen, Inst Hyg & Occupat Med, Essen, Germany; [Johannes, Christian] Univ Duisburg Essen, Dept Genet, Essen, Germany; [Hippler, Joerg] Univ Duisburg Essen, Inst Environm Analyt Chem, Essen, Germany; [Dopp, Elke] Univ Duisburg Essen, Zentrum Wasser & Umweltforsch, Essen, Germany	Ruhr University Bochum; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Johnen, G (corresponding author), Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany.	johnen@ipa-dguv.de	Brüning, Thomas/G-8120-2015; Johnen, Georg/AFG-8027-2022	Brüning, Thomas/0000-0001-9560-5464; Johnen, Georg/0000-0002-3773-5946	DFG (Deutsche Forschungsgemeinschaft) [JO 753/2-1, DO 332/8-1]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was in part supported by a grant of the DFG (Deutsche Forschungsgemeinschaft, www.dfg.de) to GJ (JO 753/2-1) and ED (DO 332/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Adhim Z, 2011, BRIT J CANCER, V105, P393, DOI 10.1038/bjc.2011.262; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Aparicio A, 2009, EPIGENETICS-US, V4, P176, DOI 10.4161/epi.4.3.8694; Apodaca G, 2004, TRAFFIC, V5, P117, DOI 10.1046/j.1600-0854.2003.00156.x; Bertino L, 1996, DEV BRAIN RES, V95, P38, DOI 10.1016/0165-3806(96)00059-4; Brait M, 2008, CANCER EPIDEM BIOMAR, V17, P2786, DOI 10.1158/1055-9965.EPI-08-0192; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; Buehring GC, 2004, IN VITRO CELL DEV-AN, V40, P211; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Chan MWY, 2002, CLIN CANCER RES, V8, P464; Chan MWY, 2003, INT J CANCER, V104, P611, DOI 10.1002/ijc.10971; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chen LM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-377; Chen PC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-45; Chiong E, 2009, J UROLOGY, V181, P2737, DOI 10.1016/j.juro.2009.01.108; CHRISTIAN BJ, 1987, CANCER RES, V47, P6066; da Silva GN, 2011, MOL BIOL REP, V38, P4159, DOI 10.1007/s11033-010-0536-x; Dirks WG, 2010, INT J CANCER, V126, P303, DOI 10.1002/ijc.24999; Drobna Z, 2005, TOXICOL APPL PHARM, V207, P147, DOI 10.1016/j.taap.2004.12.007; Dube E, 2010, BIOL REPROD, V82, P1119, DOI 10.1095/biolreprod.109.083196; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eblin KE, 2008, TOXICOLOGY, V248, P67, DOI 10.1016/j.tox.2008.03.020; Eblin KE, 2009, TOXICOLOGY, V255, P107, DOI 10.1016/j.tox.2008.10.007; Escudero-Lourdes C, 2010, TOXICOL APPL PHARM, V244, P162, DOI 10.1016/j.taap.2009.12.029; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Freshney RI, 2010, INT J CANCER, V126, P302, DOI 10.1002/ijc.24998; Gabriel U, 2010, CANCER GENET CYTOGEN, V203, P253, DOI 10.1016/j.cancergencyto.2010.07.135; Gabriel U, 2008, ONCOL REP, V20, P1419, DOI 10.3892/or_00000161; Gildea JJ, 2000, GENE CHROMOSOME CANC, V27, P252, DOI 10.1002/(SICI)1098-2264(200003)27:3<252::AID-GCC5>3.0.CO;2-9; Hester SD, 2009, HUM EXP TOXICOL, V28, P49, DOI 10.1177/0960327109102368; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; Jensen TJ, 2008, CARCINOGENESIS, V29, P1500, DOI 10.1093/carcin/bgn102; Jensen TJ, 2009, TOXICOL APPL PHARM, V241, P221, DOI 10.1016/j.taap.2009.08.019; Johnen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035363; Cabello MJ, 2011, J MOL DIAGN, V13, P29, DOI 10.1016/j.jmoldx.2010.11.008; KATO T, 1978, TOHOKU J EXP MED, V124, P339, DOI 10.1620/tjem.124.339; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Kenney PA, 2011, BJU INT, V107, P656, DOI 10.1111/j.1464-410X.2010.09489.x; Kim J, 2011, IN VITRO CELL DEV-AN, V47, P2, DOI 10.1007/s11626-010-9350-y; Kim MS, 2005, CANCER GENET CYTOGEN, V163, P17, DOI 10.1016/j.cancergencyto.2005.04.010; Kunze E, 2006, INT J MOL MED, V18, P547; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Liang FX, 2005, J CELL BIOL, V171, P835, DOI 10.1083/jcb.200505035; Liang G, 2002, CANCER RES, V62, P961; MacLeod RAF, 1999, INT J CANCER, V83, P555; MacLeod RAF, 2013, INT J CANCER, V132, P1232, DOI 10.1002/ijc.27752; MALKOVSKY M, 1977, NEOPLASMA, V24, P319; Maruyama R, 2001, CANCER RES, V61, P8659; Masters JR, 2012, NATURE, V492, P186, DOI 10.1038/492186a; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Masters JR, 2002, CYTOTECHNOLOGY, V39, P69, DOI 10.1023/A:1022908930937; Medeiros M, 2012, TOXICOLOGY, V291, P102, DOI 10.1016/j.tox.2011.11.002; Novakovic B, 2011, MOL HUM REPROD, V17, P344, DOI 10.1093/molehr/gar005; Petzoldt JL, 1995, UROL RES, V23, P377, DOI 10.1007/BF00698738; Phuchareon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006040; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Salewski H, 1999, CANCER RES, V59, P1980; Sanchez-Carbayo M, 2002, CANCER RES, V62, P6973; Scriven SD, 2001, J MATER SCI-MATER M, V12, P991, DOI 10.1023/A:1012869318205; SENGER DR, 1988, P NATL ACAD SCI USA, V85, P5107, DOI 10.1073/pnas.85.14.5107; Sens DA, 2004, TOXICOL SCI, V79, P56, DOI 10.1093/toxsci/kfh086; Simeonova PP, 2000, CANCER RES, V60, P3445; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Stone R, 2010, CANCER PREV RES, V3, P776, DOI 10.1158/1940-6207.CAPR-09-0189; Styblo M, 2000, ARCH TOXICOL, V74, P289, DOI 10.1007/s002040000134; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Varley CL, 2004, AM J PATHOL, V164, P1789, DOI 10.1016/S0002-9440(10)63737-6; WHO, 2001, ENV HLTH CRIT, V224, P521; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wnek SM, 2010, TOXICOL SCI, V116, P44, DOI 10.1093/toxsci/kfq106; Wolff EM, 2008, CANCER RES, V68, P6208, DOI 10.1158/0008-5472.CAN-07-6616; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Zhu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028223	78	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64139	10.1371/journal.pone.0064139	http://dx.doi.org/10.1371/journal.pone.0064139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691160	gold, Green Published			2022-12-25	WOS:000319107900081
J	Qi, XJ; Vargas, E; Larsen, L; Knapp, W; Hatfield, GW; Lathrop, R; Sandmeyer, S				Qi, Xiaojie; Vargas, Edwin; Larsen, Liza; Knapp, Whitney; Hatfield, G. Wesley; Lathrop, Richard; Sandmeyer, Suzanne			Directed DNA Shuffling of Retrovirus and Retrotransposon Integrase Protein Domains	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TARGET SITE SELECTION; RNA-POLYMERASE-III; MULTIPLE SEQUENCE ALIGNMENT; STRUCTURE PREDICTION SERVER; TRANSCRIPTION FACTOR IIIB; TATA-BINDING PROTEIN; GENOME-WIDE ANALYSIS; HIV-1 INTEGRASE; STRAND TRANSFER	Chimeric proteins are used to study protein domain functions and to recombine protein domains for novel or optimal functions. We used a library of chimeric integrase proteins to study DNA integration specificity. The library was constructed using a directed shuffling method that we adapted from fusion PCR. This method easily and accurately shuffles multiple DNA gene sequences simultaneously at specific base-pair positions, such as protein domain boundaries. It produced all 27 properly-ordered combinations of the amino-terminal, catalytic core, and carboxyl-terminal domains of the integrase gene from human immunodeficiency virus, prototype foamy virus, and Saccharomyces cerevisiae retrotransposon Ty3. Retrotransposons can display dramatic position-specific integration specificity compared to retroviruses. The yeast retrotransposon Ty3 integrase interacts with RNA polymerase III transcription factors to target integration at the transcription initiation site. In vitro assays of the native and chimeric proteins showed that human immunodeficiency virus integrase was active with heterologous substrates, whereas prototype foamy virus and Ty3 integrases were not. This observation was consistent with a lower substrate specificity for human immunodeficiency virus integrase than for other retrovirus integrases. All eight chimeras containing the Ty3 integrase carboxyl-terminal domain, a candidate targeting domain, failed to target strand transfer in the presence of the targeting protein, suggesting that multiple domains of the Ty3 integrase cooperate in this function.	[Qi, Xiaojie; Knapp, Whitney; Sandmeyer, Suzanne] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA; [Vargas, Edwin; Lathrop, Richard] Univ Calif Irvine, Sch Informat & Comp Sci, Dept Comp Sci, Irvine, CA USA; [Vargas, Edwin; Larsen, Liza; Hatfield, G. Wesley; Lathrop, Richard; Sandmeyer, Suzanne] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA USA; [Hatfield, G. Wesley; Sandmeyer, Suzanne] Univ Calif Irvine, Sch Engn, Dept Chem Engn & Mat Sci, Irvine, CA USA; [Hatfield, G. Wesley; Sandmeyer, Suzanne] Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Hatfield, G. Wesley; Lathrop, Richard] Univ Calif Irvine, Sch Engn, Dept Biomed Engn, Irvine, CA USA; [Hatfield, G. Wesley; Lathrop, Richard] CODA Genom Inc, Laguna Hills, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Sandmeyer, S (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA.	sbsandme@uci.edu			National Science Foundation [0450159]; Public Health Service grants [GM33281]; Public Health Service STTR subcontract [AI076658]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033281] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Public Health Service grants(United States Department of Health & Human ServicesUnited States Public Health Service); Public Health Service STTR subcontract; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funds from the National Science Foundation grant 0450159 and Public Health Service GM33281 grants to S.S., and Public Health Service STTR subcontract to G.W.H. from grant AI076658 to CODA Genomics Inc., Laguna Hills, California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.092301; Appa RS, 2001, J BIOL CHEM, V276, P45848, DOI 10.1074/jbc.M107365200; Baronio R, 2010, NUCLEIC ACIDS RES, V38, P7079, DOI 10.1093/nar/gkq571; Behrens R, 2000, NUCLEIC ACIDS RES, V28, P4709, DOI 10.1093/nar/28.23.4709; Berger N, 2001, J GEN VIROL, V82, P139, DOI 10.1099/0022-1317-82-1-139; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Craigie R, 2001, J BIOL CHEM, V276, P23213, DOI 10.1074/jbc.R100027200; Devine SE, 1996, GENE DEV, V10, P620, DOI 10.1101/gad.10.5.620; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Gao X, 2008, GENOME RES, V18, P359, DOI 10.1101/gr.7146408; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; HICKMAN AB, 1994, J BIOL CHEM, V269, P29279; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kassavetis GA, 2005, P NATL ACAD SCI USA, V102, P15406, DOI 10.1073/pnas.0507653102; Katzman M, 2000, VIRUS RES, V66, P87, DOI 10.1016/S0168-1702(99)00126-4; KATZMAN M, 1995, J VIROL, V69, P5687, DOI 10.1128/JVI.69.9.5687-5696.1995; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kordis D, 2005, GENE, V347, P161, DOI 10.1016/j.gene.2004.12.017; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Larsen Liza S Z, 2008, Int J Bioinform Res Appl, V4, P324, DOI 10.1504/IJBRA.2008.019578; Lee HS, 2005, MOL CELLS, V19, P246; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Malik HS, 1999, J VIROL, V73, P5186, DOI 10.1128/JVI.73.6.5186-5190.1999; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morita K, 2001, VIROLOGY, V287, P417, DOI 10.1006/viro.2001.1048; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; Qi XJ, 2012, J BIOL CHEM, V287, P18589, DOI 10.1074/jbc.M111.326025; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; Shibagaki Y, 1997, J BIOL CHEM, V272, P8361, DOI 10.1074/jbc.272.13.8361; Singleton TL, 2002, EUKARYOT CELL, V1, P44, DOI 10.1128/EC.01.1.44-55.2002; SKALKA AM, 1993, GENE, V135, P175, DOI 10.1016/0378-1119(93)90063-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Wassman CD, 2004, NUCLEIC ACIDS RES, V32, P6407, DOI 10.1093/nar/gkh977; Xie WW, 2001, MOL CELL BIOL, V21, P6606, DOI 10.1128/MCB.21.19.6606-6614.2001; Yieh L, 2000, J BIOL CHEM, V275, P29800, DOI 10.1074/jbc.M003149200; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zhou HY, 2009, PROTEINS, V77, P123, DOI 10.1002/prot.22501; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	61	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63957	10.1371/journal.pone.0063957	http://dx.doi.org/10.1371/journal.pone.0063957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691126	Green Published, gold			2022-12-25	WOS:000319107900069
J	Zango, A; Dube, K; Kelbert, S; Meque, I; Cumbe, F; Chen, PL; Ferro, JJ; Feldblum, PJ; van de Wijgert, J				Zango, Arlinda; Dube, Karine; Kelbert, Silvia; Meque, Ivete; Cumbe, Fidelina; Chen, Pai Lien; Ferro, Josefo J.; Feldblum, Paul J.; van de Wijgert, Janneke			Determinants of Prevalent HIV Infection and Late HIV Diagnosis among Young Women with Two or More Sexual Partners in Beira, Mozambique	PLOS ONE			English	Article							MALE CIRCUMCISION; PREVENTION; MEN; RISK	Background: The prevalence and determinants of HIV and late diagnosis of HIV in young women in Beira, Mozambique, were estimated in preparation for HIV prevention trials. Methods: An HIV prevalence survey was conducted between December 2009 and October 2012 among 1,018 women aged 18-35 with two or more sexual partners in the last month. Participants were recruited in places thought by recruitment officers to be frequented by women at higher-risk, such as kiosks, markets, night schools, and bars. Women attended the research center and underwent a face-to-face interview, HIV counseling and testing, pregnancy testing, and blood sample collection. Results: HIV prevalence was 32.6% (95% confidence interval (CI) 29.7%-35.5%). Factors associated with being HIV infected in the multivariable analysis were older age (p < 0.001), lower educational level (p < 0.001), self-reported genital symptoms in the last 3 months (adjusted odds ratio (aOR) = 1.4; CI 1.1-2.0), more than one lifetime HIV test (aOR = 0.4; CI 0.3-0.6), and not knowing whether the primary partner has ever been tested for HIV (aOR = 1.7; CI 1.1-2.5). About a third (32.3%) of participants who tested HIV-positive had a CD4 lymphocyte count of <350 cells/mu l at diagnosis. Factors associated with late diagnosis in multivariable analyses were: not knowing whether the primary partner has ever been tested for HIV (aOR = 2.2; CI 1.1-4.2) and having had a gynecological pathology in the last year (aOR = 3.7; CI 1.2-12.0). Conclusions: HIV prevalence and late diagnosis of HIV infection were high in our study population of young women with sexual risk behavior in Beira, Mozambique. HIV prevention programs should be strengthened, health care providers should be sensitized, and regular HIV testing should be encouraged to enroll people living with HIV into care and treatment programs sooner.	[Zango, Arlinda; Meque, Ivete; Cumbe, Fidelina; Ferro, Josefo J.] UCM, CIDI, Beira, Mozambique; [Dube, Karine; Chen, Pai Lien; Feldblum, Paul J.] FHI 360, Dept Clin Sci, Durham, NC USA; [Dube, Karine] Henry M Jackson Fdn Adv Mil Med Inc HJF, US Mil HIV Res Program MHRP, Clin Operat Off, Bethesda, MD USA; [Kelbert, Silvia] London Sch Hyg & Trop Med, London WC1, England; [van de Wijgert, Janneke] Univ Amsterdam, AIGHD, Amsterdam, Netherlands; [van de Wijgert, Janneke] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	FHI 360; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool	Dube, K (corresponding author), FHI 360, Dept Clin Sci, Durham, NC USA.	kdube@hivresearch.org		van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	U.S. Agency for International Development (USAID) [GPO-A-00-05-00022-00]; Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) Program [GHO-A-00-09-00016-00]; Preventive Technologies Agreement (PTA); European and Developing Countries Clinical Trials Partnership (EDCTP); Fogarty International Center; National Institutes of Health [3 D43 TW01038]; FOGARTY INTERNATIONAL CENTER [D43TW001038] Funding Source: NIH RePORTER	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) Program; Preventive Technologies Agreement (PTA); European and Developing Countries Clinical Trials Partnership (EDCTP); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The UCM/CIDI site development project and the HIV incidence study were partly funded by the U.S. Agency for International Development (USAID), under Cooperative Agreement No. GPO-A-00-05-00022-00, the Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) Program, and Cooperative Agreement No. GHO-A-00-09-00016-00, the Preventive Technologies Agreement (PTA). The study also received funding from the European and Developing Countries Clinical Trials Partnership (EDCTP) through the AfrEVacc project. SK was partially supported by the Fogarty International Center, National Institutes of Health (3 D43 TW01038 to the University of Pittsburgh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha S, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-20; Audet CM, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-15; Auvert B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002679; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bandali S, 2012, J INT ASS PHYS AIDS, V00, P1; Bandali S, 2011, CULT HEALTH SEX, V13, P575, DOI 10.1080/13691058.2011.561500; Braunstein SL, 2011, PLOS ONE, V6; da Saude Ministerio, 2009, GUIA TRATAMENTO ANTI; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE) e ICF Macro, 2010, NAT SURV PREV BEH RI; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2011, WORLD AIDS DAY REP G; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Macia M, 2011, CULT HEALTH SEX, V13, P1181, DOI 10.1080/13691058.2011.611537; McEnery R, 2012, NEW TOOLS STRATEGIES; UNAIDS, 2010, GLOB REP UNAIDS REP; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; WHO, 2010, ANT THER HIV INF AD; Zachariah R, 2009, LANCET INFECT DIS, V9, P711, DOI 10.1016/S1473-3099(09)70229-4	20	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63427	10.1371/journal.pone.0063427	http://dx.doi.org/10.1371/journal.pone.0063427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691046	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900045
J	Baier, DB; Gatesy, SM; Dial, KP				Baier, David B.; Gatesy, Stephen M.; Dial, Kenneth P.			Three-Dimensional, High-Resolution Skeletal Kinematics of the Avian Wing and Shoulder during Ascending Flapping Flight and Uphill Flap-Running	PLOS ONE			English	Article							MECHANICAL POWER OUTPUT; QUAIL COTURNIX-CHINENSIS; PECTORALIS-MUSCLE FORCE; BLACK-BILLED MAGPIES; IN-VIVO MEASUREMENT; NEUROMUSCULAR CONTROL; INTERMITTENT FLIGHT; COLUMBA-LIVIA; EMG ACTIVITY; BIRD FLIGHT	Past studies have shown that birds use their wings not only for flight, but also when ascending steep inclines. Uphill flap-running or wing-assisted incline running (WAIR) is used by both flight-incapable fledglings and flight-capable adults to retreat to an elevated refuge. Despite the broadly varying direction of travel during WAIR, level, and descending flight, recent studies have found that the basic wing path remains relatively invariant with reference to gravity. If so, joints undergo disparate motions to maintain a consistent wing path during those specific flapping modes. The underlying skeletal motions, however, are masked by feathers and skin. To improve our understanding of the form-functional relationship of the skeletal apparatus and joint morphology with a corresponding locomotor behavior, we used XROMM (X-ray Reconstruction of Moving Morphology) to quantify 3-D skeletal kinematics in chukars (Alectoris chukar) during WAIR (ascending with legs and wings) and ascending flight (AF, ascending with wings only) along comparable trajectories. Evidence here from the wing joints demonstrates that the glenohumeral joint controls the vast majority of wing movements. More distal joints are primarily involved in modifying wing shape. All bones are in relatively similar orientations at the top of upstroke during both behaviors, but then diverge through downstroke. Total excursion of the wing is much smaller during WAIR and the tip of the manus follows a more vertical path. The WAIR stroke appears "truncated" relative to ascending flight, primarily stemming from ca. 50% reduction in humeral depression. Additionally, the elbow and wrist exhibit reduced ranges of angular excursions during WAIR. The glenohumeral joint moves in a pattern congruent with being constrained by the acrocoracohumeral ligament. Finally, we found pronounced lateral bending of the furcula during the wingbeat cycle during ascending flight only, though the phasic pattern in chukars is opposite of that observed in starlings (Sturnus vulgaris).	[Baier, David B.] Providence Coll, Dept Biol, Providence, RI 02918 USA; [Gatesy, Stephen M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Dial, Kenneth P.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Providence College; Brown University; University of Montana System; University of Montana	Baier, DB (corresponding author), Providence Coll, Dept Biol, Providence, RI 02918 USA.	dbaier@providence.edu			National Science Foundation [0919799, 0552051]; W.M. Keck Foundation	National Science Foundation(National Science Foundation (NSF)); W.M. Keck Foundation(W.M. Keck Foundation)	Funding was provided by the National Science Foundation grant entitled "Ontogeny of Avian Locomotion: Aerodynamics, Skeletal Kinematics, and Neuromuscular Control", award number 0919799, the W.M. Keck Foundation grant entitled "A Proposal to Design and Build a Dynamic 3-D Skeletal Imaging System" and the NSF grant entitled "IDBR: Hardware and Software Development for 3D Visualization of Rapid Skeletal Motion in Vertebrate Animals", award number 0552051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew GN, 2001, J EXP BIOL, V204, P3601; Askew GN, 2001, J EXP BIOL, V204, P3587; Baier DB, 2007, NATURE, V445, P307, DOI 10.1038/nature05435; Baier DB, 2012, J EXP ZOOL PART A, V317A, P83, DOI 10.1002/jez.724; BAILEY JP, 1991, CAN J ZOOL, V69, P2751, DOI 10.1139/z91-387; Bannasch R., 1986, Gegenbaurs Morphologisches Jahrbuch, V132, P757; Bannasch R, 1994, MECH PHYSL ANIMAL SW; BANZETT RB, 1992, RESP PHYSIOL, V89, P27, DOI 10.1016/0034-5687(92)90068-8; Berg AM, 2008, J EXP BIOL, V211, P1120, DOI 10.1242/jeb.010413; Berg AM, 2010, J EXP BIOL, V213, P1651, DOI 10.1242/jeb.038109; BIEWENER AA, 1992, J EXP BIOL, V164, P1; Biewener AA, 1998, J EXP BIOL, V201, P3293; BIEWENER AA, 1995, J MORPHOL, V225, P61, DOI 10.1002/jmor.1052250106; BOGGS DF, 1993, J MORPHOL, V218, P43, DOI 10.1002/jmor.1052180104; Boggs DF, 1997, J EXP BIOL, V200, P1403; Brainerd EL, 2010, J EXP ZOOL PART A, V313A, P262, DOI 10.1002/jez.589; BROWN RHJ, 1951, IBIS, V93, P333, DOI 10.1111/j.1474-919X.1951.tb05439.x; Bundle MW, 2003, J EXP BIOL, V206, P4553, DOI 10.1242/jeb.00673; Crisco JJ, 1998, J BIOMECH, V31, P97, DOI 10.1016/S0021-9290(97)00108-5; Dial KP, 2008, NATURE, V451, P985, DOI 10.1038/nature06517; Dial KP, 2006, BIOSCIENCE, V56, P437, DOI 10.1641/0006-3568(2006)056[0437:WUIHAW]2.0.CO;2; Dial KP, 2003, AUK, V120, P941, DOI 10.1642/0004-8038(2003)120[0941:EOALCO]2.0.CO;2; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; DIAL KP, 1991, J MORPHOL, V207, P327, DOI 10.1002/jmor.1052070309; DIAL KP, 1992, J EXP ZOOL, V262, P357, DOI 10.1002/jez.1402620402; DIAL KP, 1987, AM ZOOL, V27, pA23; Gatesy SM, 2005, PALEOBIOLOGY, V31, P382, DOI 10.1666/0094-8373(2005)031[0382:TOOTAF]2.0.CO;2; Gatesy SM, 2010, J EXP ZOOL PART A, V313A, P244, DOI 10.1002/jez.588; GOSLOW GE, 1990, BIOSCIENCE, V40, P108, DOI 10.2307/1311343; GOSLOW GE, 1987, AM ZOOL, V27, pA23; GOSLOW GE, 1989, AM ZOOL, V29, P287; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Hedrick TL, 2002, J EXP BIOL, V205, P1389; Hedrick TL, 2012, P ROY SOC B-BIOL SCI, V279, P1986, DOI 10.1098/rspb.2011.2238; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Heers AM, 2012, TRENDS ECOL EVOL, V27, P296, DOI 10.1016/j.tree.2011.12.003; Jackson BE, 2011, J EXP BIOL, V214, P2354, DOI 10.1242/jeb.052829; Jackson BE, 2011, J EXP BIOL, V214, P452, DOI 10.1242/jeb.046789; Jackson BE, 2009, P ROY SOC B-BIOL SCI, V276, P3457, DOI 10.1098/rspb.2009.0794; JENKINS FA, 1988, SCIENCE, V241, P1495, DOI 10.1126/science.241.4872.1495; JENKINS FA, 1993, AM J SCI, V293A, P253, DOI 10.2475/ajs.293.A.253; Piazza SJ, 2000, J BIOMECH, V33, P1029, DOI 10.1016/S0021-9290(00)00056-7; Ros IG, 2011, P NATL ACAD SCI USA, V108, P19990, DOI 10.1073/pnas.1107519108; Simpson SF, 1983, J ZOOL, V200, P425; Sullivan C, 2010, P ROY SOC B-BIOL SCI, V277, P2027, DOI 10.1098/rspb.2009.2281; Sy M., 1936, Journal fuer Ornithologie Berlin, V84, P199, DOI 10.1007/BF01906709; Tashman S, 2003, J BIOMECH ENG-T ASME, V125, P238, DOI 10.1115/1.1559896; Tobalske BW, 2007, J EXP BIOL, V210, P1742, DOI 10.1242/jeb.001701; Tobalske BW, 1996, J EXP BIOL, V199, P263; Tobalske BW, 2003, J AVIAN BIOL, V34, P177, DOI 10.1034/j.1600-048X.2003.03006.x; TOBALSKE BW, 1995, J EXP BIOL, V198, P1259; TOBALSKE BW, 1994, J EXP BIOL, V187, P1; VAZQUEZ RJ, 1994, ZOOMORPHOLOGY, V114, P59, DOI 10.1007/BF00574915; VAZQUEZ RJ, 1992, J MORPHOL, V211, P259, DOI 10.1002/jmor.1052110303; Warrick DR, 1998, J EXP BIOL, V201, P655; You BM, 2001, IEEE T MED IMAGING, V20, P514, DOI 10.1109/42.929617	56	38	38	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63982	10.1371/journal.pone.0063982	http://dx.doi.org/10.1371/journal.pone.0063982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691132	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700068
J	Borel, JC; Tamisier, R; Dias-Domingos, S; Sapene, M; Martin, F; Stach, B; Grillet, Y; Muir, JF; Levy, P; Series, F; Pepin, JL				Borel, Jean Christian; Tamisier, Renaud; Dias-Domingos, Sonia; Sapene, Marc; Martin, Francis; Stach, Bruno; Grillet, Yves; Muir, Jean Francois; Levy, Patrick; Series, Frederic; Pepin, Jean-Louis		Sci Council Sleep Registry French	Type of Mask May Impact on Continuous Positive Airway Pressure Adherence in Apneic Patients	PLOS ONE			English	Article							OBSTRUCTIVE-SLEEP-APNEA; HYPERTENSIVE PATIENTS; DAYTIME SLEEPINESS; BLOOD-PRESSURE; NASAL; CPAP; INTERFACE; TITRATION; HYPOPNEA; EFFICACY	Rationale: In obstructive sleep apnea patients (OSA), continuous positive airway pressure (CPAP) adherence is crucial to improve symptoms and cardiometabolic outcomes. The choice of mask may influence CPAP adherence but this issue has never been addressed properly. Objective: To evaluate the impact of nasal pillows, nasal and oronasal masks on CPAP adherence in a cohort of OSA. Methods: Newly CPAP treated OSA participating in "Observatoire Sommeil de la Federation de Pneumologie'', a French national prospective cohort, were included between March 2009 and December 2011. Anthropometric data, medical history, OSA severity, sleepiness, depressive status, treatment modalities (auto-CPAP versus fixed pressure, pressure level, interface type, use of humidifiers) and CPAP-related side effects were included in multivariate analysis to determine independent variables associated with CPAP adherence. Results: 2311 OSA (age = 57(12) years, apnea+hypopnea index = 41(21)/h, 29% female) were included. Nasal masks, oronasal masks and nasal pillows were used by 62.4, 26.2 and 11.4% of the patients, respectively. In univariate analysis, oronasal masks and nasal pillows were associated with higher risk of CPAP non-adherence. CPAP non-adherence was also associated with younger age, female gender, mild OSA, gastroesophageal reflux, depression status, low effective pressure and CPAP-related side effects. In multivariate analysis, CPAP non-adherence was associated with the use of oronasal masks (OR = 2.0; 95% CI = 1.6; 2.5), depression, low effective pressure, and side effects. Conclusion: As oronasal masks negatively impact on CPAP adherence, a nasal mask should be preferred as the first option. Patients on oronasal masks should be carefully followed.	[Tamisier, Renaud; Dias-Domingos, Sonia; Levy, Patrick; Pepin, Jean-Louis] Univ Grenoble Alpes, HP2 Lab, INSERM, U 1042, Grenoble, France; [Tamisier, Renaud; Dias-Domingos, Sonia; Muir, Jean Francois; Levy, Patrick; Pepin, Jean-Louis] Hop Albert Michallon, Grenoble, France; [Borel, Jean Christian] AGIRadom, Dept Res & Dev, Meylan, France; [Muir, Jean Francois] Rouen Univ Hosp, Pneumol & Resp Intens Care U, Rouen, France; [Series, Frederic] Univ Laval, Inst Univ Pneumol & Cardiol Quebec, Quebec City, PQ, Canada; [Sapene, Marc] Polyclin Bordeaux Cauderan, Unite Sommeil & Vigilance, Bordeaux, France; [Martin, Francis] Ctr Hosp Compiegne, Unite Pathol Sommeil, Compiegne, France; [Stach, Bruno] Cabinet Med St Michel, Valenciennes, France; [Grillet, Yves] Cabinet Med, Valence, France; [Sci Council Sleep Registry French] FFP, Sci Council Sleep Registry, Paris, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; CHU de Rouen; Laval University	Borel, JC (corresponding author), AGIRadom, Dept Res & Dev, Meylan, France.	j.borel@agiradom.com; jpepin@chu-grenoble.fr	Lévy, Patrick/M-6903-2014; Tamisier, Renaud/M-6858-2014; PEPIN, Jean-Louis/M-6549-2014; Borel, Jean Christian/AAC-5950-2019; LEVY, Patrick/AAX-2802-2020; Borel, Jean Christian JC/M-7135-2014	Lévy, Patrick/0000-0003-3632-1327; Tamisier, Renaud/0000-0003-1128-6529; Borel, Jean Christian/0000-0003-4140-6210; LEVY, Patrick/0000-0003-3174-7935; Pepin, Jean Louis/0000-0003-3832-2358	RESMED; GSK; Philips; Fisher-Paykel; Boehringer/General elctrics/breas; Chiesi; Boehringer; Breas	RESMED; GSK(GlaxoSmithKline); Philips; Fisher-Paykel; Boehringer/General elctrics/breas; Chiesi(Chiesi Pharmaceuticals Inc); Boehringer(Boehringer Ingelheim); Breas	Dr. Borel is employed by AGIR a dom, a home-care provider delivering CPAP treatment. Dr. Tamisier received grants/payment for lecture and consultant fees from RESMED. Dr. Muir received grants from GSK; board membership fees from Boehringer/General elctrics/breas; payment for lectures from Chiesi and Boehringer; payment for educational presentation from Breas and Boehringer; travel/accomodations from Boehringer, Astra, GSK. Dr. Levy received consultant fees from Resmed, Philips, Fisher-Paykel; grants from Resmed, Philips, Fisher-Paykel and payment for lectures from Resmed and Philips. Dr. Pepin received consultant fees from Resmed, Philips, Fisher-Paykel; grants from Resmed, Philips, Fisher-Paykel and payment for lectures from Resmed and Philips. Mrs. Dias-Domingos, Dr. Sapene, Dr. Martin, Dr. Stach, Dr. Grillet and Dr. Series declare no conflict of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anderson FE, 2003, SLEEP, V26, P721, DOI 10.1093/sleep/26.6.721; Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; Bachour A, 2004, CHEST, V126, P1248, DOI 10.1378/chest.126.4.1248; Bakker JP, 2012, SLEEP BREATH, V16, P709, DOI 10.1007/s11325-011-0564-3; Baltzan MA, 2009, SLEEP MED, V10, P198, DOI 10.1016/j.sleep.2007.12.005; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; Beecroft J, 2003, CHEST, V124, P2200, DOI 10.1378/chest.124.6.2200; Belge C, 2012, AM J RESP CRIT CARE, V185, P112, DOI 10.1164/ajrccm.185.1.112; Borel JC, 2012, RESP PHYSIOL NEUROBI, V183, P170, DOI 10.1016/j.resp.2012.06.018; Chai CL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005308.pub2; Ebben MR, 2012, SLEEP MED, V13, P645, DOI 10.1016/j.sleep.2012.02.004; El-Solh AA, 2011, SLEEP BREATH, V15, P203, DOI 10.1007/s11325-010-0437-1; Gagnadoux F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022503; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; GUELFI JD, 1988, CLIN NEUROPHARMACOL, V11, pS59; Haentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757; Hedner J, 2011, EUR RESPIR J, V38, P635, DOI 10.1183/09031936.00046710; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Khanna R, 2003, SLEEP MED, V4, P333, DOI 10.1016/S1389-9457(03)00063-7; Kohler M, 2010, THORAX, V65, P829, DOI 10.1136/thx.2010.135848; Laaban JP, 2010, RESP MED, V104, P1063, DOI 10.1016/j.rmed.2010.02.021; Lindberg E, 2006, SLEEP MED, V7, P553, DOI 10.1016/j.sleep.2005.12.010; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Massie CA, 2003, CHEST, V123, P1112, DOI 10.1378/chest.123.4.1112; Mortimore IL, 1998, THORAX, V53, P290, DOI 10.1136/thx.53.4.290; Pepin JL, 2010, AM J RESP CRIT CARE, V182, P954, DOI 10.1164/rccm.200912-1803OC; Pepin JL, 2009, CHEST, V136, P490, DOI 10.1378/chest.08-2646; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; Poulet C, 2009, SLEEP MED, V10, P993, DOI 10.1016/j.sleep.2009.01.007; Rossi VA, 2012, EUR HEART J, V33, P2206, DOI 10.1093/eurheartj/ehs073; Schorr F, 2012, EUR RESPIR J, V40, P503, DOI 10.1183/09031936.00145111; Sharma SK, 2011, NEW ENGL J MED, V365, P2277, DOI 10.1056/NEJMoa1103944; Smith I, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003531.pub3; SULLIVAN CE, 1981, LANCET, V1, P862; Teo M, 2011, SLEEP, V34, P951, DOI 10.5665/SLEEP.1134; Valentin A, 2011, SLEEP, V34, P801, DOI 10.5665/SLEEP.1054; Veale D, 2000, EUR RESPIR J, V15, P326, DOI 10.1034/j.1399-3003.2000.15b18.x; Wang H, 2003, ENCY BIOPHARMACEUTIC, DOI [10.1081/E-EBS 120007637, DOI 10.1081/E-EBS]; Weaver TE, 2007, SLEEP, V30, P711, DOI 10.1093/sleep/30.6.711; Wild MR, 2004, EUR RESPIR J, V24, P461, DOI 10.1183/09031936.04.00114603	42	90	92	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64382	10.1371/journal.pone.0064382	http://dx.doi.org/10.1371/journal.pone.0064382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691209	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700092
J	Bouby, L; Figueiral, I; Bouchette, A; Rovira, N; Ivorra, S; Lacombe, T; Pastor, T; Picq, S; Marinval, P; Terral, JF				Bouby, Laurent; Figueiral, Isabel; Bouchette, Anne; Rovira, Nuria; Ivorra, Sarah; Lacombe, Thierry; Pastor, Thierry; Picq, Sandrine; Marinval, Philippe; Terral, Jean-Frederic			Bioarchaeological Insights into the Process of Domestication of Grapevine (Vitis vinifera L.) during Roman Times in Southern France	PLOS ONE			English	Article							MULTIPLE ORIGINS; SSP. SILVESTRIS; WINE GRAPE; WILD; CULTIVATION; EVOLUTION; PARENTAGE; EXPLOITATION; BEGINNINGS; SELECTION	Grapevine (Vitis vinifera), one of the most important fruit species in the Classical Mediterranean world, is thought to have been domesticated first in South-Western Asia, during the Neolithic. However, the domestication process remains largely unknown. Crucial unanswered questions concern the duration of the process (rapid or slow?) and the related geographical area (single or multiple-origins?). Seeds from domesticated grapevine and from its wild ancestor are reported to differ according to shape. Our work aims, first, to confirm this difference and secondly to identify the extent of domestication in the grapes cultivated by Romans in Southern France during the period 50 BCE-500 CE. We had the opportunity to analyze uncharred waterlogged grape pips from 17 archaeological sites. Based on an extended reference sample of modern wild grapevines and cultivars our work shows that both subspecies can be discriminated using simple measurements. The elongation gradient of the pip's body and stalk may be regarded as an indicator of the strength of the selection pressures undergone by domesticated grapes. Grapevines cultivated during the Roman period included a mix of morphotypes comprising wild, intermediate and moderately selected domesticated forms. Our data point to a relative shift towards more selected types during the Roman period. Domestication of the grapevine appears to have been a slow process. This could result from the recurrent incorporation into cultivation of plants originating from sexual reproduction, when grape cultivation essentially relies on vegetative propagation.	[Bouby, Laurent; Ivorra, Sarah] CNRS, Ctr Bioarcheol & Ecol CBAE, UMR 5059, Montpellier, France; [Figueiral, Isabel] INRAP Mediterranee, Ctr Bioarcheol & Ecol CBAE, UMR 5059, Montpellier, France; [Bouchette, Anne] INRAP Mediterranee, Archeol Soc Mediterraneennes, UMR 5140, Lattes, France; [Rovira, Nuria] Univ Montpellier 3, Archeol Soc Mediterraneennes, UMR 5140, Lattes, France; [Lacombe, Thierry; Picq, Sandrine] INRA, Montpellier SupAgro, UMR AGAP, Equipe Divers & Adaptat Vigne & Especes Mediterra, F-34060 Montpellier, France; [Pastor, Thierry; Picq, Sandrine; Terral, Jean-Frederic] Univ Montpellier 2, Ctr Bioarcheol & Ecol CBAE, UMR 5059, Montpellier, France; [Marinval, Philippe] CNRS, Archeol Soc Mediterraneennes, UMR 5140, Lattes, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Paul-Valery; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Bouby, L (corresponding author), CNRS, Ctr Bioarcheol & Ecol CBAE, UMR 5059, Montpellier, France.	laurent.bouby@univ-montp2.fr	Rovira, Nuria/AAA-8243-2019	Bouby, Laurent/0000-0002-3633-9829; Rovira, Nuria/0000-0001-8139-7000; TERRAL, Jean-Frederic/0000-0003-1921-2161	CNRS; ATIP program; Archaeo-Vitis; Agence Nationale de la Recherche (ANR); programme blanc; FRUCTIMEDHIS	CNRS(Centre National de la Recherche Scientifique (CNRS)); ATIP program; Archaeo-Vitis; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); programme blanc; FRUCTIMEDHIS	The work was supported by the following: CNRS, ATIP program, Archaeo-Vitis (J.-F. Terral dir.); and Agence Nationale de la Recherche (ANR)(http://www.agence-nationale-recherche.fr/), programme blanc, FRUCTIMEDHIS (A. Durand dir.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEWELDT G, 1988, THEOR APPL GENET, V75, P669, DOI 10.1007/BF00265585; Andre J, 1952, REV ETUD LATIN, V30, P126; Arnold C, 2005, BIODIVERS CONSERV, V14, P1507, DOI 10.1007/s10531-004-9789-9; Arnold C, 1998, VITIS, V37, P159; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Barnard H, 2011, J ARCHAEOL SCI, V38, P977, DOI 10.1016/j.jas.2010.11.012; Bouby L, 2001, GALLIA, V58, P13, DOI DOI 10.3406/GALIA.2001.3171; Boursiquot JM, 2009, AUST J GRAPE WINE R, V15, P144, DOI 10.1111/j.1755-0238.2008.00041.x; BOURSIQUOT JM, 1987, AGRONOMIE, V7, P13, DOI 10.1051/agro:19870102; Bowers J, 1999, SCIENCE, V285, P1562, DOI 10.1126/science.285.5433.1562; Bowers JE, 1997, NAT GENET, V16, P84, DOI 10.1038/ng0597-84; Branas J., 1974, VITICULTURE; Brothwell D, 1969, FOOD ANTIQUITY SURVE; Brun J.P., 2004, ARCHEOLOGIE VIN LHUI; Brun JP, 2011, COMMENT GAULES DEVIN, P231; Brun JP, 2005, ARCHEOLOGIE VIN PHUI; Capdevila RBI, 1996, ANTIQUITY, V70, P393, DOI 10.1017/S0003598X00083344; Casanova A, 1998, ARBORICULTURE SOC ME; Castelletti L, 1996, 13 INT C PREH PROT S, P11; Costantini L, 2006, VAZI GHVINO, V1-2, P62; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.2307/2336077; de Candolle A., 1886, ORIGIN CULTIVATED PL, VXLIX, P376; DIETLER M, 1990, J ANTHROPOL ARCHAEOL, V9, P352, DOI 10.1016/0278-4165(90)90011-2; Dietler M, 2007, CAMBRIDGE ECONOMIC HISTORY OF THE GRECO-ROMAN WORLD, P242, DOI 10.1017/CHOL9780521780537.010; Fall PL, 1998, ANN ASSOC AM GEOGR, V88, P107, DOI 10.1111/1467-8306.00087; Figueiral I, 2010, J ARCHAEOL SCI, V37, P139, DOI 10.1016/j.jas.2009.09.024; Fuller DQ, 2011, WORLD ARCHAEOL, V43, P628, DOI 10.1080/00438243.2011.624747; Galet P, 2000, DICT ENCY CEPAGES; GILMAN A, 1981, CURR ANTHROPOL, V22, P1, DOI 10.1086/202600; Grassi F, 2003, THEOR APPL GENET, V107, P1315, DOI 10.1007/s00122-003-1321-1; HANSEN J, 1978, NATURE, V271, P349, DOI 10.1038/271349a0; Jacquat C, 1999, VEG HIST ARCHAEOBOT, V8, P25, DOI 10.1007/BF02042839; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; Lacombe T, 2003, ACTA HORTIC, P553, DOI 10.17660/ActaHortic.2003.603.73; Lacombe T, 2013, THEOR APPL GENET, V126, P401, DOI 10.1007/s00122-012-1988-2; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; Lopes MS, 2009, GENOME, V52, P790, DOI [10.1139/g09-048, 10.1139/G09-048]; Mangafa M, 1996, J ARCHAEOL SCI, V23, P409, DOI 10.1006/jasc.1996.0036; Margaritis E, 2006, J ARCHAEOL SCI, V33, P784, DOI 10.1016/j.jas.2005.10.021; Marinval P, 1997, HIST VIN HIST RITES, P137; MARTINOLI D., 2004, PALEORIENT, V30, P61, DOI [10.3406/paleo.2004.1011, DOI 10.3406/PALEO.2004.1011]; McGovern PE, 1996, NATURE, V381, P480, DOI 10.1038/381480a0; McGovern PE, 1995, ORIGINS ANCIENT HIST; McGovern PE, 2003, ANCIENT WINE SEARCH; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Miller NF, 2008, ANTIQUITY, V82, P937, DOI 10.1017/S0003598X00097696; MOSIMANN JE, 1979, EVOLUTION, V33, P444, DOI 10.1111/j.1558-5646.1979.tb04697.x; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Negrul A., 1946, AMPELOGRAPHY USSR, V1, P159; NUNEZ DR, 1989, REV PALAEOBOT PALYNO, V61, P205, DOI 10.1016/0034-6667(89)90033-X; Ocete R., 1997, Plant Genetic Resources Newsletter, P5; Ocete R, 2008, AGR ECOSYST ENVIRON, V123, P95, DOI 10.1016/j.agee.2007.05.009; Olmo H. P., 1976, Evolution of crop plants., P294; Olmo HP, 1995, ORIGINS ANCIENT HIST, P31; Ozenda P., 1975, DOCUMENT CARTOGR ECO, VXVI, P1; Picq S, 2012, THESIS MONTPELLIER 2; Purugganan MD, 2011, EVOLUTION, V65, P171, DOI 10.1111/j.1558-5646.2010.01093.x; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Renfrew C, 1972, ERMERGENCE CIVILISAT; Renfrew JM, 1995, ORIGINS ANCIENT HIST, V11, P255; SMITH H, 1990, J ARCHAEOL SCI, V17, P317, DOI 10.1016/0305-4403(90)90026-2; Stummer A, 1911, MITTEILUNGEN ANTHR G, V61, P283; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Tchernia A., 1986, BIBLIOTHEQUE ECOLES; TERPO A, 1977, ACTA BOT HUNG, V23, P247; Terral JF, 2010, ANN BOT-LONDON, V105, P443, DOI 10.1093/aob/mcp298; Terral JF, 2004, J BIOGEOGR, V31, P63, DOI 10.1046/j.0305-0270.2003.01019.x; Terral JF, 2000, J ARCHAEOL SCI, V27, P127, DOI 10.1006/jasc.1999.0444; Terral JF, 1996, QUATERNARY RES, V46, P176, DOI 10.1006/qres.1996.0057; This P, 2001, GENET SEL EVOL, V33, pS289, DOI 10.1186/BF03500885; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Valamoti SM, 2007, ANTIQUITY, V81, P54, DOI 10.1017/S0003598X00094837; VANZEIST W, 1983, J ARCHAEOL SCI, V10, P351, DOI 10.1016/0305-4403(83)90072-9; Vaquer J, 1986, OXFORD J ARCHAEOL, V5, P1, DOI [10.1111/j.1468-0092.1986.tb00127.x, DOI 10.1111/J.1468-0092.1986.TB00127.X]; Vavilov N. I., 1930, Report. and Proc. 9th Int. Hort. Congr., P271; Vivier MA, 2002, TRENDS BIOTECHNOL, V20, P472, DOI 10.1016/S0167-7799(02)02058-9; Vouillamoz JF, 2006, HEREDITY, V97, P102, DOI 10.1038/sj.hdy.6800842; Weiss E, 2004, P NATL ACAD SCI USA, V101, P9551, DOI 10.1073/pnas.0402362101; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary D, 2004, ECON BOT, V58, P5, DOI 10.1663/0013-0001(2004)058[0005:USATEO]2.0.CO;2; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319; ZOHARY D, 1995, ORIGINS ANCIENT HIST, P23	83	68	69	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63195	10.1371/journal.pone.0063195	http://dx.doi.org/10.1371/journal.pone.0063195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	145XK	23690998	Green Published, gold			2022-12-25	WOS:000319052700024
J	Shaikh, A; Bentley, A; Kamerman, PR				Shaikh, Asma; Bentley, Alison; Kamerman, Peter R.			Symptomatology of Peripheral Neuropathy in an African Language	PLOS ONE			English	Article							DIAGNOSTIC QUESTIONNAIRE DN4; LEEDS ASSESSMENT; PAIN SCALE; SCREENING TOOLS; VALIDATION; SYMPTOMS; SIGNS; RELIABILITY; MANAGEMENT; VALIDITY	The terminology used to describe neuropathic pain appears to be conserved across languages, which facilitates the translation of validated neuropathic pain screening tools into other languages. However, this assumption has not been assessed in an African language. Therefore we investigated the terminology used by 54 patients whose native language was isiZulu, a major Bantu language of Africa, when describing their symptomatic HIV-associated sensory neuropathy. Also, because English is a commonly spoken second-language in the region, we assessed these patients' knowledge and understanding of 21 English terms commonly used to describe neuropathic pain. English translations of the most commonly used isiZulu symptom descriptors included: "hot/burning" (50%), "cramping" (35%), "painful/sore/aching" (32%), "itching" (22%), "numb" (22%), "cold/freezing" (17%), and "stabbing/pricking/pins-and-needles" (13%). Thus, the isiZulu terminology to describe neuropathic pain was very similar to that used in non-African languages. However, knowledge and understanding of English neuropathic pain descriptors by these non-native English speakers was highly variable. For example, knowledge of English terms ranged from>98% ("hot", "cold/freezing", "cramping") to <25% ("pricking", "radiating", "throbbing"), and true understanding of English terms ranged from>90% ("hot", "burning", "cramping") to <35% ("tingling", "jumping", "shooting", "radiating"). In conclusion, we show significant similarity in the terms used to describe neuropathic pain in isiZulu compared to non-African languages, thus indicating that translation of existing neuropathic pain screening tools into this, and possibly other Bantu languages, is a viable option. However, the usefulness of English-language screening tools in this non-native English speaking population may be limited.	[Shaikh, Asma; Bentley, Alison; Kamerman, Peter R.] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Brain Funct Res Grp, Johannesburg, South Africa	University of Witwatersrand	Kamerman, PR (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Brain Funct Res Grp, Johannesburg, South Africa.	peter.kamerman@wits.ac.za	Shaikh-Kader, Asma/AAM-1988-2020; Kamerman, Peter/L-8645-2015	Shaikh-Kader, Asma/0000-0002-4396-4788; Kamerman, Peter/0000-0002-3103-5295	Faculty of Health Sciences, University of the Witwatersrand, South Africa	Faculty of Health Sciences, University of the Witwatersrand, South Africa	This research project received financial support from the Faculty of Health Sciences, University of the Witwatersrand, South Africa. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attal N, 2011, EUR J PAIN, V15, P441, DOI 10.1016/j.ejpain.2011.03.005; Attal N, 2010, PAIN MED, V11, P985, DOI 10.1111/j.1526-4637.2010.00893.x; Baron R, 2012, LANCET NEUROL, V11, P999, DOI 10.1016/S1474-4422(12)70189-8; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Bouhassira D, 2011, PAIN, V152, pS74, DOI 10.1016/j.pain.2010.11.027; Chaudakshetrin Pongparadee, 2007, Journal of the Medical Association of Thailand, V90, P1860; Cherry CL, 2005, NEUROLOGY, V65, P1778, DOI 10.1212/01.wnl.0000187119.33075.41; Chetty S, 2012, SAMJ S AFR MED J, V102, P312, DOI 10.7196/SAMJ.5472; DUBUISSON D, 1976, EXP NEUROL, V51, P480, DOI 10.1016/0014-4886(76)90271-5; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; Harifi G, 2011, PAIN PRACT, V11, P139, DOI 10.1111/j.1533-2500.2010.00399.x; Koc R, 2010, PAIN MED, V11, P1107, DOI 10.1111/j.1526-4637.2010.00837.x; Krause SJ, 2003, CLIN J PAIN, V19, P306, DOI 10.1097/00002508-200309000-00004; Lasch K, 2002, PAIN CLIN UPDATES, P1; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Maritz J, 2010, MUSCLE NERVE, V41, P599, DOI 10.1002/mus.21535; MASSON EA, 1989, PAIN, V38, P25, DOI 10.1016/0304-3959(89)90068-7; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Narayan MC, 2010, AM J NURS, V110, P38, DOI 10.1097/01.NAJ.0000370157.33223.6d; Portenoy R, 2006, CURR MED RES OPIN, V22, P1555, DOI 10.1185/030079906X115702; Scholz J, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000047; Smith BH, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-29; Wadley AL, 2011, J PAIN SYMPTOM MANAG, V41, P700, DOI 10.1016/j.jpainsymman.2010.07.006; Yucel A, 2004, J PAIN, V5, P427, DOI 10.1016/j.jpain.2004.07.001	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63986	10.1371/journal.pone.0063986	http://dx.doi.org/10.1371/journal.pone.0063986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691133	gold, Green Published, Green Submitted			2022-12-25	WOS:000319052700069
J	Singh, MI; Jain, V				Singh, Manika Indrajit; Jain, Vikas			Tagging the Expressed Protein with 6 Histidines: Rapid Cloning of an Amplicon with Three Options	PLOS ONE			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; ESCHERICHIA-COLI; BIOCHEMICAL FUNDAMENTALS; COMMERCIAL SYSTEMS; CLONED GENES; CHROMATOGRAPHY; DEHYDROGENASE; VECTOR; TAG	We report the designing of three expression vectors that can be used for rapid cloning of any blunt-end DNA segment. Only a single set of oligonucleotides are required to perform the amplification of the target DNA and its cloning in all three vectors simultaneously. The DNA thus cloned can express a protein either with or without a hexa-histidine tag depending upon the vector used. The expression occurs from T7 promoter when transformed into E. coli BL21(DE3). Two of the three plasmids have been designed to provide the expressed protein with either N- or C-terminus 6 histidine amino acids in tandem. The third plasmid, however, does not add any tag to the expressed protein. The cloning is achieved quickly with the requirement of phosphorylation of PCR product without any restriction digestion. Additionally, the generated clones can be confirmed with a single step PCR reaction carried out from bacterial colonies (generally termed as "colony PCR"). We show the cloning, expression and purification of Green Fluorescent Protein (GFP) as proof-of-concept. Additionally, we also show the cloning and expression of four sigma factors from Mycobacterium tuberculosis further demonstrating the utility of the designed plasmids. We strongly believe that the vectors and the strategy that we have developed will facilitate the rapid cloning and expression of any gene in E. coli BL21(DE3) with or without a hexa-histidine tag.	[Singh, Manika Indrajit; Jain, Vikas] Indian Inst Sci Educ & Res, Dept Biol Sci, Microbiol & Mol Biol Lab, Bhopal, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Jain, V (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Microbiol & Mol Biol Lab, Bhopal, India.	vikas@iiserb.ac.in	JAIN, VIKAS/B-3142-2008	JAIN, VIKAS/0000-0003-0238-8144; Singh, Manika Indrajit/0000-0001-9784-7969	Council of Scientific and Industrial Research, Govt. of India; Department of Biotechnology, Govt. of India	Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	Manika I. Singh wishes to acknowledge Council of Scientific and Industrial Research, Govt. of India for the fellowship. The work has been supported by a grant from the Department of Biotechnology, Govt. of India to Vikas Jain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brizio C, 2004, PROTEIN EXPRES PURIF, V37, P434, DOI 10.1016/j.pep.2004.06.011; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; CALOS MP, 1978, NATURE, V274, P762, DOI 10.1038/274762a0; Choudhary RK, 2004, PROTEIN EXPRES PURIF, V36, P249, DOI 10.1016/j.pep.2004.03.016; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; Erijman A, 2011, J STRUCT BIOL, V175, P171, DOI 10.1016/j.jsb.2011.04.005; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; Halliwell CM, 2001, ANAL BIOCHEM, V295, P257, DOI 10.1006/abio.2001.5182; Hunt I, 2005, PROTEIN EXPRES PURIF, V40, P1, DOI 10.1016/j.pep.2004.10.018; Jungbauer A, 2004, CURR OPIN BIOTECH, V15, P487, DOI 10.1016/j.copbio.2004.08.009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 2009, PROTEIN EXPRES PURIF, V63, P58, DOI 10.1016/j.pep.2008.09.005; Neely A, 2004, J BIOL CHEM, V279, P21689, DOI 10.1074/jbc.M312675200; Oganesyan Natalia, 2005, Journal of Structural and Functional Genomics, V6, P177, DOI 10.1007/s10969-005-2827-3; Parr RD, 2003, PLASMID, V49, P179, DOI 10.1016/S0147-619X(02)00148-8; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Sambrook J, 2001, MOL CLONING LAB MANU; Stevens RC, 2000, STRUCTURE, V8, pR177, DOI 10.1016/S0969-2126(00)00193-3; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; WEINER MP, 1994, PCR METH APPL, V4, pS131; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131	25	22	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63922	10.1371/journal.pone.0063922	http://dx.doi.org/10.1371/journal.pone.0063922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691118	Green Submitted, gold, Green Published			2022-12-25	WOS:000319052700067
J	Berepiki, A; Read, ND				Berepiki, Adokiye; Read, Nick D.			Septins Are Important for Cell Polarity, Septation and Asexual Spore Formation in Neurospora crassa and Show Different Patterns of Localisation at Germ Tube Tips	PLOS ONE			English	Article							RICE BLAST FUNGUS; BUDDING YEAST; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; CONIDIOPHORE DEVELOPMENT; MAGNAPORTHE-ORYZAE; FILAMENT FORMATION; MAMMALIAN SEPTINS; ASHBYA-GOSSYPII	Septins are GTP-binding cytoskeletal proteins that contribute to cell polarity, vesicle trafficking, cytokinesis and cell morphogenesis. Here we have characterised the six septins encoded by the genome of the model filamentous fungus Neurospora crassa. Analysis of septin null mutants demonstrated that septins limit the sites of emergence of germ tubes and are important for septation and conidiation in N. crassa. Septins constituted a range of different higher-order structures in N. crassa - rings, loops, fibres, bands, and caps - which can co-exist within the same cell. They showed different patterns of localisation at germ tube tips, with GFP-CDC-10 and CDC-11-GFP forming a subapical collar with lower signal intensity at the tip apex, CDC-3-GFP and CDC-12-GFP organized as a cap at the tip apex and GFP-ASP-1 forming an extended subapical collar. Purification of the septin complex and mass spectrometry of isolated proteins revealed that the septin complex consists predominantly of CDC-3, CDC-10, CDC-11 and CDC-12. Immunoprecipitation of the putative septin ASP-1 revealed that this protein interacts with the core septin complex.	[Berepiki, Adokiye] Univ Exeter, Exeter, Devon, England; [Read, Nick D.] Univ Edinburgh, Inst Cell Biol, Fungal Cell Biol Grp, Edinburgh, Midlothian, Scotland	University of Exeter; University of Edinburgh	Read, ND (corresponding author), Univ Edinburgh, Inst Cell Biol, Fungal Cell Biol Grp, Edinburgh, Midlothian, Scotland.	Nick.Read@ed.ac.uk		Read, Nick/0000-0002-2286-2862; Berepiki, Adokiye/0000-0003-3881-0503	Biotechnology and Biological Sciences Research Council [BB/E010741/1]; BBSRC [BB/E010741/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this project was provided by a Biotechnology and Biological Sciences Research Council grant (# BB/E010741/1) to NDR and a Biotechnology and Biological Sciences Research Council Research Studentship to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Tabares I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012933; An HB, 2004, MOL BIOL CELL, V15, P5551, DOI 10.1091/mbc.E04-07-0640; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Berepiki A, 2011, NAT REV MICROBIOL, V9, P876, DOI 10.1038/nrmicro2666; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Berlin A, 2003, J CELL BIOL, V160, P1083, DOI 10.1083/jcb.200212016; Boyce KJ, 2005, EUKARYOT CELL, V4, P2044, DOI 10.1128/EC.4.12.2044-2056.2005; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Calvert MEK, 2011, J CELL BIOL, V195, P799, DOI 10.1083/jcb.201101055; Chaga G, 1999, J CHROMATOGR A, V864, P247; Collopy PD, 2010, METHODS MOL BIOL, V638, P33, DOI 10.1007/978-1-60761-611-5_3; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; Davis RH, 2000, NEUROSPORA CONTRIBUT, Vxii; Demay BS, 2009, MOL BIOL CELL, V20, P2311, DOI 10.1091/mbc.E08-12-1169; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Garcia G, 2011, J CELL BIOL, V195, P993, DOI 10.1083/jcb.201107123; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; Gladfelter AS, 2010, CURR OPIN MICROBIOL, V13, P720, DOI 10.1016/j.mib.2010.09.012; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Helfer H, 2006, MOL BIOL CELL, V17, P4494, DOI 10.1091/mbc.E06-03-0215; Hernandez-Rodriguez Y, 2012, EUKARYOT CELL, V11, P311, DOI 10.1128/EC.05164-11; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Juvvadi PR, 2011, BIOCHEM BIOPH RES CO, V405, P238, DOI 10.1016/j.bbrc.2011.01.017; Kaufmann A, 2009, MOL CELL BIOL, V29, P771, DOI 10.1128/MCB.01150-08; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kozubowski L, 2010, MOL MICROBIOL, V75, P658, DOI 10.1111/j.1365-2958.2009.06983.x; Kuck U, 2010, FUNGAL GENET NEWSL, V53, P9; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Lindsey R, 2010, EUKARYOT CELL, V9, P155, DOI 10.1128/EC.00269-09; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Margolin BS, 1997, FUNGAL GENET NEWSL, V44, P112; Martin SW, 2005, EUKARYOT CELL, V4, P1191, DOI 10.1128/EC.4.7.1191-1202.2005; McMurray MA, 2011, DEV CELL, V20, P540, DOI 10.1016/j.devcel.2011.02.004; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Nishihama R, 2011, BIOL CHEM, V392, P681, DOI 10.1515/BC.2011.086; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Orlando K, 2011, MOL BIOL CELL, V22, P624, DOI 10.1091/mbc.E10-06-0484; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.e04-08-0734; Saunders DGO, 2010, PLANT CELL, V22, P2417, DOI 10.1105/tpc.110.074492; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; SIKORSKI RS, 1989, GENETICS, V122, P19; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2012, TRAFFIC, V13, P195, DOI 10.1111/j.1600-0854.2011.01268.x; SPRINGER ML, 1989, GENE DEV, V3, P559, DOI 10.1101/gad.3.4.559; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tasto JJ, 2003, J CELL BIOL, V160, P1093, DOI 10.1083/jcb.200211126; Vrabioiu AM, 2006, NATURE, V443, P466, DOI 10.1038/nature05109; Warenda AJ, 2003, INFECT IMMUN, V71, P4045, DOI 10.1128/IAI.71.7.4045-4051.2003; Warenda AJ, 2002, MOL BIOL CELL, V13, P2732, DOI 10.1091/mbc.E02-01-0013; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Westfall PJ, 2002, MOL BIOL CELL, V13, P110, DOI 10.1091/mbc.01-06-0312; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wu JQ, 2010, GENETICS, V186, P897, DOI 10.1534/genetics.110.119842	65	30	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63843	10.1371/journal.pone.0063843	http://dx.doi.org/10.1371/journal.pone.0063843			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691103	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400081
J	Chen, J; Qian, HH; Horai, R; Chan, CC; Caspi, RR				Chen, Jun; Qian, Haohua; Horai, Reiko; Chan, Chi-Chao; Caspi, Rachel R.			Use of Optical Coherence Tomography and Electroretinography to Evaluate Retinal Pathology in a Mouse Model of Autoimmune Uveitis	PLOS ONE			English	Article							MACULAR EDEMA; UVEORETINITIS; DISEASE; SYSTEM; MICE	Experimental autoimmune uveoretinitis (EAU) in mice is a model for human autoimmune uveitis. Longitudinal follow-up is only possible by non-invasive techniques, but the information obtained by visual fundus examination can be limited. We therefore evaluated the efficacy of optical coherence tomography (OCT) and electroretinography (ERG) to monitor pathological and functional changes of the retina in vivo. OCT imaging and ERG recording as a measure of visual function were compared with visual fundoscopic imaging and histology findings in the same mouse. Our results showed that OCT imaging of the retina was well correlated with clinical and histological observations in mice during EAU. However, OCT imaging was more sensitive than fundoscopic imaging in detecting the cell infiltrates at the early phase of disease onset. Furthermore, by allowing multi-layer cross-and horizontal-sectional visualizations of retinal lesions longitudinally in a noninvasive fashion, OCT added information that could not be obtained by fundoscopic and histological examinations. Lastly, retinal thickness obtained by OCT imaging provided a key indicator reflecting disease activity, which showed a close association with visual dysfunction as measured by ERG recordings in EAU mice. Thus, our findings demonstrate that OCT is a highly sensitive and reliable technique, and a valuable method for the semi-quantitative evaluation of retinal inflammation in vivo in the mouse.	[Chen, Jun; Horai, Reiko; Chan, Chi-Chao; Caspi, Rachel R.] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Qian, Haohua] NEI, Vis Funct Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Chen, J (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	chenju@mail.nih.gov; caspir@mail.nih.gov		Chen, Jun/0000-0002-4059-3512; Caspi, Rachel/0000-0002-7140-7671	NIH-National Eye Institute Intramural funding [EY000184]; NATIONAL EYE INSTITUTE [ZICEY000461, ZIAEY000222, ZIAEY000184, ZICEY000503] Funding Source: NIH RePORTER	NIH-National Eye Institute Intramural funding; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH-National Eye Institute Intramural funding, grant # EY000184. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwall RK SP, 2012, AUTOIMMUNITY METHODS, V900, P443; CASPI RR, 1990, CURR EYE RES, V9, P169, DOI 10.3109/02713689008999438; CASPI RR, 1988, J IMMUNOL, V140, P1490; Caspi RR, 1996, J IMMUNOL, V157, P2668; Caspi RR, 1997, CURRENT PROTOCOLS IM, P16; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; Chong GT, 2012, CURR OPIN OPHTHALMOL, V23, P79, DOI 10.1097/ICU.0b013e32834ff431; Comyn O, 2012, INVEST OPHTH VIS SCI, V53, P7754, DOI 10.1167/iovs.12-10895; Copland DA, 2008, INVEST OPHTH VIS SCI, V49, P5458, DOI 10.1167/iovs.08-2348; Drexler W, 2001, NAT MED, V7, P502, DOI 10.1038/86589; Fernandes DB, 2012, OPHTHALMOLOGY; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; FORRESTER JV, 1992, CURR EYE RES, V11, P33, DOI 10.3109/02713689208999509; FORRESTER JV, 1990, CURR EYE RES, V9, P75, DOI 10.3109/02713689008999424; Gadjanski I, 2011, EXP EYE RES, V93, P82, DOI 10.1016/j.exer.2011.04.012; Gallagher MJ, 2007, BRIT J OPHTHALMOL, V91, P1680, DOI 10.1136/bjo.2007.124099; Grajewski RS, 2006, J EXP MED, V203, P851, DOI 10.1084/jem.20050429; HAMASAKI DI, 1993, INVEST OPHTH VIS SCI, V34, P1861; Haq E, 2007, J OCUL PHARMACOL TH, V23, P221, DOI 10.1089/jop.2007.0023; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Markomichelakis NN, 2004, OPHTHALMOLOGY, V111, P946, DOI 10.1016/j.ophtha.2003.08.037; Nakayama M, 2012, RETINA-J RET VIT DIS, V32, P2061, DOI 10.1097/IAE.0b013e318256205a; O'Leary N, 2012, EYE LOND; Toth CA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1425, DOI 10.1001/archopht.1997.01100160595012; van Velthoven MEJ, 2006, AM J OPHTHALMOL, V141, P972, DOI 10.1016/j.ajo.2005.12.050; WALDREP J C, 1990, Regional Immunology, V3, P247; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012	28	20	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63904	10.1371/journal.pone.0063904	http://dx.doi.org/10.1371/journal.pone.0063904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691112	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400085
J	Gao, X; Su, Y; Guan, LP; Yuan, YY; Huang, SS; Lu, Y; Wang, GJ; Han, MY; Yu, F; Song, YS; Zhu, QY; Wu, J; Dai, P				Gao, Xue; Su, Yu; Guan, Li-Ping; Yuan, Yong-Yi; Huang, Sha-Sha; Lu, Yu; Wang, Guo-Jian; Han, Ming-Yu; Yu, Fei; Song, Yue-Shuai; Zhu, Qing-Yan; Wu, Jing; Dai, Pu			Novel Compound Heterozygous TMC1 Mutations Associated with Autosomal Recessive Hearing Loss in a Chinese Family	PLOS ONE			English	Article							CAUSE OVARIAN DYSGENESIS; PERRAULT SYNDROME; READ ALIGNMENT; DEAFNESS; DOMINANT; PROTEIN; DFNA36; GENE; IMPAIRMENT; DFNB7/11	Hereditary nonsyndromic hearing loss is highly heterogeneous and most patients with a presumed genetic etiology lack a specific diagnosis. It has been estimated that several hundred genes may be associated with this sensory deficit in humans. Here, we identified compound heterozygous mutations in the TMC1 gene as the cause of recessively inherited sensorineural hearing loss by using whole-exome sequencing in a family with two deaf siblings. Sanger sequencing confirmed that both siblings inherited a missense mutation, c.589G>A p.G197R (maternal allele), and a nonsense mutation, c.1171C>T p.Q391X (paternal allele), in TMC1. We also used DNA from 50 Chinese familial patients with ARNSHL and 208 ethnicity-matched negative samples to perform extended variants analysis. Both variants co-segregated in family 1953, which had the hearing loss phenotype, but were absent in 50 patients and 208 ethnicity-matched controls. Therefore, we concluded that the hearing loss in this family was caused by novel compound heterozygous mutations in TMC1.	[Gao, Xue; Su, Yu; Yuan, Yong-Yi; Huang, Sha-Sha; Lu, Yu; Wang, Guo-Jian; Han, Ming-Yu; Yu, Fei; Song, Yue-Shuai; Dai, Pu] Peoples Liberat Army Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China; [Gao, Xue; Han, Ming-Yu; Song, Yue-Shuai; Dai, Pu] Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Otorhinolaryngol, Sanya, Peoples R China; [Gao, Xue] Second Artillery Gen Hosp, Dept Otorhinolaryngol, Beijing, Peoples R China; [Guan, Li-Ping; Zhu, Qing-Yan] BGI Shenzhen, Shenzhen, Peoples R China; [Wu, Jing] BGI Tianjin, Tianjin, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI)	Dai, P (corresponding author), Peoples Liberat Army Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China.	daipu301@vip.sina.com		Yuan, Yongyi/0000-0002-7936-4776	National Natural Science Foundation of China [30801285, 31071099, 81230020, 81200751, 81070792, 81000414, 81000415]; State 863 High Technology R&D Key Project of China [2011AA02A112]; Natural Science Foundation of Beijing [7122172]; Minister of Science and Technology of China [2012BAI09B02]; Minister of Health of China [201202005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State 863 High Technology R&D Key Project of China(National High Technology Research and Development Program of China); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Minister of Science and Technology of China; Minister of Health of China	This work was supported by grants from the Project of the National Natural Science Foundation of China (Grant Nos. 30801285, 31071099, 81230020, 81200751, 81070792, 81000414, 81070792, 81000415), a grant from State 863 High Technology R&D Key Project of China (2011AA02A112), a grant from Natural Science Foundation of Beijing (Grant No 7122172), a grant from Minister of Science and Technology of China (2012BAI09B02) and a grant from Minister of Health of China (201202005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownstein Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-245; de Heer AMR, 2011, AUDIOL NEURO-OTOL, V16, P93, DOI 10.1159/000313282; Delmaghani S, 2012, HUM MOL GENET, V21, P3835, DOI 10.1093/hmg/dds212; Hanlon MR, 2002, BIOCHEMISTRY-US, V41, P2886, DOI 10.1021/bi0119565; Hilgert N, 2008, CLIN GENET, V74, P223, DOI 10.1111/j.1399-0004.2008.01053.x; Kalay E, 2005, Hum Mutat, V26, P591, DOI 10.1002/humu.9384; Keresztes G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-24; Kitajiri S, 2007, CLIN GENET, V71, P148, DOI 10.1111/j.1399-0004.2007.00739.x; Kitajiri SI, 2007, CLIN GENET, V72, P546, DOI 10.1111/j.1399-0004.2007.00895.x; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li Y, 2010, AM J HUM GENET, V86, P479, DOI 10.1016/j.ajhg.2010.02.003; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Makishima T, 2004, OTOL NEUROTOL, V25, P714, DOI 10.1097/00129492-200409000-00011; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer Christian G, 2005, Hum Mutat, V25, P100, DOI 10.1002/humu.9302; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Santos Regie Lyn P, 2005, Hum Mutat, V26, P396, DOI 10.1002/humu.9374; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Shearer AE, 2011, HEARING RES, V282, P1, DOI 10.1016/j.heares.2011.10.001; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Sirmaci A, 2009, INT J PEDIATR OTORHI, V73, P699, DOI 10.1016/j.ijporl.2009.01.005; Tlili A, 2008, AUDIOL NEURO-OTOL, V13, P213, DOI 10.1159/000115430; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Zheng J, 2011, P NATL ACAD SCI USA, V108, P4218, DOI 10.1073/pnas.1005842108	32	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63026	10.1371/journal.pone.0063026	http://dx.doi.org/10.1371/journal.pone.0063026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690975	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400027
J	Quintana, MI; Andreoli, SB; Moreira, FG; Ribeiro, WS; Feijo, MM; Bressan, RA; Coutinho, ESF; Mari, JJ				Quintana, Maria Ines; Andreoli, Sergio B.; Moreira, Fernanda G.; Ribeiro, Wagner S.; Feijo, Marcelo M.; Bressan, Rodrigo A.; Coutinho, Evandro S. F.; Mari, Jair J.			Epidemiology of Psychotropic Drug Use in Rio de Janeiro, Brazil: Gaps in Mental Illness Treatments	PLOS ONE			English	Article							INTERVIEW CIDI 2.1; POSTTRAUMATIC-STRESS-DISORDER; GENERAL-POPULATION; MEDICATION USE; PRIMARY-CARE; SAO-PAULO; PATTERNS; PREVALENCE; CANADA; COMMUNITY	Objective: Estimate the prevalence of psychotropic drugs use in the city of Rio de Janeiro, Brazil, and establish its relationship with the presence of mental disorders. Methods: A probabilistic sample of non-institutionalized individuals, from the general population of Rio de Janeiro (n = 1208; turn out:81%), 15 years or older, who were interviewed using the Composite International Diagnostic Interview 2.1 (depression, anxiety-phobia, OCD\PTSD, alcoholism sections), and asked about their psychotropic use during a 12 and one-month period before the interview. Data were collected between June/2007-February/2008. The prevalence was estimated with a confidence interval of 95%. The associations between psychotropics use and mental disorders were analyzed through a logistic regression model (Odds Ration - OR). Results: The one-month prevalence of psychotropic drug use was 6.55%, 3.19% for men and 9.13% for women. Antidepressants were the most frequently used drug (2.78%), followed by anorectics (1.65%), tranquilizers (1.61%) and mood stabilizers (1.23%). General practitioners issued the highest number of prescriptions (46.3%), followed by psychiatrists (29.3%); 86.6% of the psychotropic drugs used were paid for by the patient himself. Individuals with increased likelihood of using psychotropic drugs were those that had received a psychiatric diagnosis during a one-month period before the study (OR:3.93), females (OR:1.82), separated/divorced (OR:2.23), of increased age (OR:1.03), with higher income (OR:2.96), and family history of mental disorder (OR:2.59); only 16% of the individuals with a current DSM IV diagnosis were using a psychotropic drug; 17% among individuals with a depression-related diagnosis and 8% with Phobic Anxiety Disorders-related diagnosis used psychotropics. Conclusion: Approximately 84% of individuals displaying some mental disorder did not use psychotropic drugs, which indicates an important gap between demand and access to treatment. A significant failure is evident in the health system for patients with mental disorders; this could be due to health workers' inability to recognize mental disorders among individuals.	[Quintana, Maria Ines; Moreira, Fernanda G.; Ribeiro, Wagner S.; Feijo, Marcelo M.; Bressan, Rodrigo A.; Mari, Jair J.] Univ Fed Sao Paulo, Paulista Med Sch, Sao Paulo, Brazil; [Andreoli, Sergio B.] Univ Fed Sao Paulo, Paulista Med Sch, Dept Psychiat, Sao Paulo, Brazil; [Andreoli, Sergio B.] Santos Catholic Univ, Santos, Brazil; [Coutinho, Evandro S. F.] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Catolica de Santos; Fundacao Oswaldo Cruz	Quintana, MI (corresponding author), Univ Fed Sao Paulo, Paulista Med Sch, Sao Paulo, Brazil.	inesquintana@uol.com.br	Andreoli, Sergio Baxter/D-9568-2012; Ribeiro, Wagner Silva/O-2927-2018; Bressan, Rodrigo A/E-9178-2010; de Jesus Mari, Jair/A-7309-2008; Andreoli, Sergio Baxter/M-7112-2019; Quintana, Maria Ines/F-6320-2012	Andreoli, Sergio Baxter/0000-0002-1976-0881; Ribeiro, Wagner Silva/0000-0001-6735-3861; Bressan, Rodrigo A/0000-0002-0868-4449; de Jesus Mari, Jair/0000-0002-5403-0112; Andreoli, Sergio Baxter/0000-0002-1976-0881; Goncalves Moreira, Fernanda/0000-0002-4884-2229; Quintana, Maria Ines/0000-0002-3808-8189; Coutinho, Evandro/0000-0002-4649-7353	State of Sao Paulo Support and Research Foundation (FAPESP) [420122/2005-2]; CNPQ [420122/2005-2]; Edital MCT/CNPq [01/2005]	State of Sao Paulo Support and Research Foundation (FAPESP); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Edital MCT/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project received grants from the State of Sao Paulo Support and Research Foundation (FAPESP) process number 420122/2005-2 and CNPQ process number 420122/2005-2; Edital MCT/CNPq 01/2005 - Millennium Institute 2005-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida L M, 1994, Cad Saude Publica, V10, P5; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P55; Andreoli SB, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-34; Aparasu RR, 2003, J AM GERIATR SOC, V51, P671, DOI 10.1034/j.1600-0579.2003.00212.x; ASHTON H, 1991, BRIT J PSYCHIAT, V158, P30, DOI 10.1192/S0007125000291964; Beck CA, 2005, SOC PSYCH PSYCH EPID, V40, P799, DOI 10.1007/s00127-005-0968-0; Beck CA, 2005, CAN J PSYCHIAT, V50, P605, DOI 10.1177/070674370505001006; Carrasco-Garrido P, 2007, PHARMACOEPIDEM DR S, V16, P449, DOI 10.1002/pds.1344; de Lima MM, 1999, REV PSIQUIATRIA CLIN, V26, P225; De Lima MS, 1999, SOC PSYCH PSYCH EPID, V34, P316, DOI 10.1007/s001270050150; Dealberto MJ, 1997, J CLIN EPIDEMIOL, V50, P357, DOI 10.1016/S0895-4356(96)00339-3; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Galduróz José Carlos F., 2005, Rev. Latino-Am. Enfermagem, V13, P888, DOI 10.1590/S0104-11692005000700017; Goldney Robert, 2006, Australas Psychiatry, V14, P379, DOI 10.1111/j.1440-1665.2006.02308.x; Hemels MEH, 2002, ANN PHARMACOTHER, V36, P1375, DOI 10.1345/aph.1A331; Hoexter MQ, 2012, PSYCHOPHARMACOLOGY, V224, P337, DOI 10.1007/s00213-012-2755-4; HOHMANN AA, 1989, MED CARE, V27, P478, DOI 10.1097/00005650-198905000-00004; Kish L, 1949, J AM STAT ASS, V44; MARI JD, 1993, PSYCHOL MED, V23, P467; Ohayon MM, 1998, J CLIN EPIDEMIOL, V51, P273, DOI 10.1016/S0895-4356(97)00238-2; Ohayon MM, 2002, J CLIN PSYCHIAT, V63, P817, DOI 10.4088/JCP.v63n0912; Paulose-Ram R, 2004, J CLIN EPIDEMIOL, V57, P309, DOI 10.1016/j.jclinepi.2003.05.001; Paulose-Ram R, 2007, PHARMACOEPIDEM DR S, V16, P560, DOI 10.1002/pds.1367; Pearce N, 2004, ENVIRON HEALTH PERSP, V112, P1047, DOI 10.1289/ehp.6927; Pini S, 1999, J AFFECT DISORDERS, V56, P37, DOI 10.1016/S0165-0327(99)00141-X; Quintana MI, 2007, REV BRAS PSIQUIATR, V29, P18, DOI 10.1590/S1516-44462007000100007; Quintana MI, 2012, CAD SAUDE PUBLICA, V28, P1312, DOI 10.1590/S0102-311X2012000700009; Quintana MI, 2004, BRAZ J MED BIOL RES, V37, P1739, DOI 10.1590/S0100-879X2004001100020; Reichenheim ME, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-66; Rodrigues MAP, 2006, REV SAUDE PUBL, V40, P107, DOI 10.1590/S0034-89102006000100017; Rojas G, 2005, J MENTAL HLTH, V14, P407, DOI DOI 10.1080/09638230500195221; Tancredi FB, 1979, THESIS U SAO PAULO, P1; UHLENHUTH EH, 1983, ARCH GEN PSYCHIAT, V40, P1167; VAZQUEZBARQUERO JL, 1989, BRIT J PSYCHIAT, V155, P633; Voyer Philippe, 2004, BMC Nurs, V3, P3, DOI 10.1186/1472-6955-3-3; Zuvekas SH, 2005, HEALTH AFFAIR, V24, P195, DOI 10.1377/hlthaff.24.1.195	36	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62270	10.1371/journal.pone.0062270	http://dx.doi.org/10.1371/journal.pone.0062270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RE	23690934	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400010
J	Ahmad, R; Al-Mass, A; Al-Ghawas, D; Shareif, N; Zghoul, N; Melhem, M; Hasan, A; Al-Ghimlas, F; Dermime, S; Behbehani, K				Ahmad, Rasheed; Al-Mass, Anfal; Al-Ghawas, Dalal; Shareif, Nada; Zghoul, Nadia; Melhem, Motasem; Hasan, Amal; Al-Ghimlas, Fahad; Dermime, Said; Behbehani, Kazem			Interaction of Osteopontin with IL-18 in Obese Individuals: Implications for Insulin Resistance	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; MACROPHAGE INFILTRATION; INTERLEUKIN-18 LEVELS; GENE-EXPRESSION; INFLAMMATION; PLASMA; INDUCTION; CELLS; ACCUMULATION	Background/Objective: Osteopontin (OPN) and IL-18 are known inflammatory mediators and both participate in a wide range of biological processes linked to immunological disorders. Since an interaction between OPN and IL-18 has not been studied in obesity, we investigated whether: (i) their levels were simultaneously elevated in obese individuals; (ii) OPN was associated with IL-18 in obese individuals and (iii) their levels associated with fasting blood glucose (FBG) and BMI. Subjects and Methods: PBMCs and plasma samples were isolated from 60 individuals including lean as well as overweight and obese individuals. Subcutaneous adipose tissue samples were obtained. OPN and IL-18 were measured by ELISA. OPN and IL-18 mRNA expression was quantified by real time quantitative RT-PCR. Results: Obese individuals exhibited significantly increased circulating OPN levels as compared with lean individuals (obese 2865 +/- 101; lean 1681 +/- 116 pg/ml; P<0.0001). IL-18 levels were also high in obese individuals (obese 491 +/- 39, lean 301 +/- 26 pg/ml; P = 0.0009). OPN and IL-18 expression were simultaneously up-regulated (OPN: 5.4-Fold; IL-18: 8.9-Fold; P<0.05) in PBMCs from obese individuals compared to lean group. Adipose tissue from obese individuals had high expression of OPN (7.3-Fold) and IL-18 (9.6-Fold). Plasma OPN levels correlated positively with FBG levels (r = 0.32, P = 0.02). Similarly, IL-18 correlated positively with FBG levels (r = 0.406, P = 0.0042). Stepwise multiple regression analysis showed an independent association of BMI with OPN and IL-18. Interestingly, OPN levels increased progressively with an increase in IL-18 levels (r = 0.52, P = 0.0004). We also examined the regulatory role of IL-18 in OPN secretion from PBMCs. Neutralizing anti-IL-18R alpha mAb reduced OPN secretion. Conclusion: These findings represent the first observation that plasma, PBMC and adipose tissue OPN and IL-18 are simultaneously increased and correlate with each other in overweight/obese individuals which may trigger the development of obesity-associated insulin resistance. Moreover, these results provide the direct evidence that IL-18 regulates OPN production in PBMCs.	[Ahmad, Rasheed; Al-Mass, Anfal; Al-Ghawas, Dalal; Shareif, Nada; Zghoul, Nadia; Hasan, Amal; Dermime, Said] Dasman Diabet Inst, Immunol & Innovat Cell Therapy Unit, Kuwait, Kuwait; [Melhem, Motasem] Dasman Diabet Inst, Genet & Genom Unit, Kuwait, Kuwait; [Al-Ghimlas, Fahad] Dasman Diabet Inst, Fitness & Rehabil Ctr, Kuwait, Kuwait; [Behbehani, Kazem] Dasman Diabet Inst, Kuwait, Kuwait		Ahmad, R (corresponding author), Dasman Diabet Inst, Immunol & Innovat Cell Therapy Unit, Kuwait, Kuwait.	rasheed.ahmad@dasmaninstitute.org	Dermime, Said/P-2448-2019; Hasan, Amal/V-3944-2019	Dermime, Said/0000-0002-5526-7496; Hasan, Amal/0000-0002-1793-7794; , Nadia/0000-0002-9455-9846; Alam-Eldin, Nada/0000-0002-4766-8839	Kuwait Foundation for the Advancement of Sciences (KFAS)	Kuwait Foundation for the Advancement of Sciences (KFAS)(Kuwait Foundation for the Advancement of Sciences (KFAS))	This work was financially supported by the Kuwait Foundation for the Advancement of Sciences (KFAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2000, AIDS, V14, P744, DOI 10.1097/00002030-200004140-00015; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Blackburn P, 2006, OBESITY, V14, P1747, DOI 10.1038/oby.2006.201; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Bruun JM, 2007, EUR J ENDOCRINOL, V157, P465, DOI 10.1530/EJE-07-0206; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; Esposito K, 2002, J CLIN ENDOCR METAB, V87, P3864, DOI 10.1210/jc.2002-????; Giachelli CM, 1998, AM J PATHOL, V152, P353; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Greene CM, 2000, J IMMUNOL, V165, P4718, DOI 10.4049/jimmunol.165.8.4718; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; Hak AE, 2001, J CLIN ENDOCR METAB, V86, P4398, DOI 10.1210/jc.86.9.4398; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hung J, 2005, ARTERIOSCL THROM VAS, V25, P1268, DOI 10.1161/01.ATV.0000163843.70369.12; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kawamura K, 2005, CLIN DIAGN LAB IMMUN, V12, P206, DOI 10.1128/CDLI.12.1.206-212.2005; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Leick L, 2007, OBESITY, V15, P356, DOI 10.1038/oby.2007.528; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; MURRY CE, 1994, AM J PATHOL, V145, P1450; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Nystrom T, 2007, EXP CELL RES, V313, P1149, DOI 10.1016/j.yexcr.2006.12.026; Ogawa D, 2005, CIRC RES, V96, P59, DOI 10.1161/01.RES.0000163630.86796.17; Osborn O, 2008, SWISS MED WKLY, V138, P665, DOI /aop/smw-aop12276; PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145; Reddy VS, 2010, AM J PHYSIOL-HEART C, V299, pH1242, DOI 10.1152/ajpheart.00451.2010; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Sahar S, 2005, CIRC RES, V96, P1064, DOI 10.1161/01.RES.0000168210.10358.f4; Schack L, 2009, J IMMUNOL, V182, P6943, DOI 10.4049/jimmunol.0900065; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sodek J, 2006, J DENT RES, V85, P404, DOI 10.1177/154405910608500503; Sun LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018104; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yu QL, 2009, AM J PHYSIOL-HEART C, V297, pH76, DOI 10.1152/ajpheart.01285.2008; Zeyda M, 2011, ENDOCRINOLOGY, V152, P2219, DOI 10.1210/en.2010-1328; Zhang YF, 2006, ENDOCRINE, V29, P419, DOI 10.1385/ENDO:29:3:419; Zhao W, 2011, J IMMUNOL, V186, P3173, DOI 10.4049/jimmunol.1003626	45	45	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63944	10.1371/journal.pone.0063944	http://dx.doi.org/10.1371/journal.pone.0063944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675517	Green Submitted, Green Published, gold			2022-12-25	WOS:000319036100054
J	Lee, W; Park, J; Lee, GS; Lee, S; Akimoto, S				Lee, Wonhoon; Park, Jongsun; Lee, Gwan-Seok; Lee, Seunghwan; Akimoto, Shin-ichi			Taxonomic Status of the Bemisia tabaci Complex (Hemiptera: Aleyrodidae) and Reassessment of the Number of Its Constituent Species	PLOS ONE			English	Article							IDENTIFICATION; TRANSMISSION; POPULATIONS; WHITEFLIES; APHIDIDAE; BIOTYPES; GENUS	Bemisia tabaci (Hemiptera: Aleyrodidae) is one of the most important insect pests in the world. In the present study, the taxonomic status of B. tabaci and the number of species composing the B. tabaci complex were determined based on 1059 COI sequences of B. tabaci and 509 COI sequences of 153 hemipteran species. The genetic divergence within B. tabaci was conspicuously higher (on average, 11.1%) than interspecific genetic divergence within the respective genera of the 153 species (on average, 6.5%). This result indicates that B. tabaci is composed of multiple species that may belong to different genera or subfamilies. A phylogenetic tree constructed based on 212 COI sequences without duplications revealed that the B. tabaci complex is composed of a total of 31 putative species, including a new species, JpL. However, genetic divergence within six species (Asia II 1, Asia II 7, Australia, Mediterranean, New World, and Sub Saharan Africa 1) was higher than 3.5%, which has been used as a threshold of species boundaries within the B. tabaci complex. These results suggest that it is necessary to increase the threshold for species boundaries up to 4% to distinguish the constituent species in the B. tabaci complex.	[Lee, Wonhoon; Akimoto, Shin-ichi] Hokkaido Univ, Lab Systemat Entomol, Dept Systemat & Ecol, Grad Sch Agr,Kita Ku, Sapporo, Hokkaido, Japan; [Park, Jongsun] Stronghold Innovat Ctr, Seoul, South Korea; [Lee, Gwan-Seok] RDA, Crop Protect Div, Natl Acad Agr Sci, Gyongi Do, South Korea; [Lee, Seunghwan] Seoul Natl Univ, Insect Biosystemat Lab, Res Inst Agr & Life Sci, Seoul, South Korea	Hokkaido University; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU)	Lee, S (corresponding author), Seoul Natl Univ, Insect Biosystemat Lab, Res Inst Agr & Life Sci, Seoul, South Korea.	seung@snu.ac.kr; akimoto@res.agr.hokudai.ac.jp	Lee, Seunghwan/E-4992-2011	Park, Jongsun/0000-0003-0786-4701	Japan Society for the Promotion of Science [P.11079, 23370037]; Agricultural R&D Promotion Center, Korea	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agricultural R&D Promotion Center, Korea	This research was supported by a Grant-in-Aid for Scientific Research (No. P.11079 for Postdoctoral Fellowship for Foreign Researchers and No. 23370037 to SA) from the Japan Society for the Promotion of Science. This research was also supported by a grant from the Agricultural R&D Promotion Center, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemandri V, 2012, J ECON ENTOMOL, V105, P48, DOI 10.1603/EC11161; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BEDFORD ID, 1994, ANN APPL BIOL, V125, P311, DOI 10.1111/j.1744-7348.1994.tb04972.x; BROWER AV, 1994, MOL PHYLOGENET EVOL, V3, P159, DOI 10.1006/mpev.1994.1018; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Brown JK, 2000, VIRUS RES, V71, P233, DOI 10.1016/S0168-1702(00)00221-5; Brown JK, 1990, FAO PLANT PROTECT B, V39, P5; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Calvert LA, 2001, ANN ENTOMOL SOC AM, V94, P512, DOI 10.1603/0013-8746(2001)094[0512:MAMDMA]2.0.CO;2; CAMPBELL BC, 1993, SCIENCE, V261, P1333, DOI 10.1126/science.8257524; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chowda-Reddy RV, 2012, J INTEGR AGR, V11, P235, DOI 10.1016/S2095-3119(12)60008-2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COSTA HS, 1991, ENTOMOL EXP APPL, V61, P211, DOI 10.1007/BF00187724; De Barro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025579; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2000, MOL PHYLOGENET EVOL, V16, P29, DOI 10.1006/mpev.1999.0768; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dubey AK, 2009, ZOOL STUD, V48, P539; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Howard D.J., 1998, ENDLESS FORMS SPECIE; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lee WH, 2012, J ASIA-PAC ENTOMOL, V15, P363, DOI 10.1016/j.aspen.2012.01.008; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Lee W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-148; Mayr E, 1940, AM NAT, V74, P249, DOI 10.1086/280892; Nylander JAA, 2004, MRMODELTEST 2 0; PERRING TM, 1993, SCIENCE, V261, P1334, DOI 10.1126/science.261.5126.1334; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ueda S, 2009, J APPL ENTOMOL, V133, P355, DOI 10.1111/j.1439-0418.2008.01379.x	39	92	103	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63817	10.1371/journal.pone.0063817	http://dx.doi.org/10.1371/journal.pone.0063817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675507	Green Submitted, Green Published, gold			2022-12-25	WOS:000319036100049
J	Wong, PY; Leo, VI; Low, M; Mak, TW; Zhang, XD; Reilly, PT				Wong, Peiyan; Leo, Vonny I.; Low, Meijun; Mak, Tak W.; Zhang, Xiaodong; Reilly, Patrick T.			Targeted ANP32E Mutant Mice Do Not Demonstrate Obvious Movement Defects	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; HISTONE ACETYLATION; INHAT; TRANSCRIPTION; PP32; PHOSPHORYLATION; MAPMODULIN; I-1(PP2A); CASPASE-3; PATHOLOGY	Background: The ANP32 family of proteins have been implicated in neuronal function through biochemical and cellular biology studies in neurons, as well as by recent behavioural studies of a gene-trapped loss-of-function mutation of Anp32e in mice, particularly with respect to fine motor function. A second targeted allele of the Anp32e, however, did not appear to demonstrate neurological phenotypes. Methodology/Principal Findings: Using a stringently controlled cohort of ten-generation backcrossed, co-caged, sex-matched, littermate pairs, we assayed for potential motor defects in the targeted ANP32E-deficient mice. We found no phenotypic difference in any assays. Conclusion: Since it is unlikely that the gene-trap is a more complete loss-of-function, our results suggest that ANP32E has no appreciable effect on motor functions and that genetic background differences most likely account for the gene-trap phenomena.	[Wong, Peiyan; Zhang, Xiaodong] Duke NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore, Singapore; [Leo, Vonny I.; Low, Meijun; Mak, Tak W.; Reilly, Patrick T.] Natl Canc Ctr Singapore, Lab Inflammat Biol, Div Cellular & Mol Res, Singapore, Singapore; [Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Zhang, Xiaodong] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Zhang, Xiaodong] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA	National University of Singapore; National Cancer Centre Singapore (NCCS); University of Toronto; University Toronto Affiliates; University Health Network Toronto; National University of Singapore; Duke University	Reilly, PT (corresponding author), Natl Canc Ctr Singapore, Lab Inflammat Biol, Div Cellular & Mol Res, Singapore, Singapore.	patrick.reilly@nccs.com.sg		Wong, Peiyan/0000-0003-3734-2461	Singhealth Research Foundation; National Cancer Centre Singapore	Singhealth Research Foundation; National Cancer Centre Singapore	This work was supported by funding from the Singhealth Research Foundation and the National Cancer Centre Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beare JE, 2009, J NEUROTRAUM, V26, P2045, DOI 10.1089/neu.2009.0914; Chen S, 2008, J BIOL CHEM, V283, P10513, DOI 10.1074/jbc.M709852200; Cheng L, 2012, BRAIN DEV; Costanzo RV, 2006, EUR J NEUROSCI, V23, P309, DOI 10.1111/j.1460-9568.2005.04555.x; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Cvetanovic M, 2007, EMBO REP, V8, P671, DOI 10.1038/sj.embor.7400983; Cvetanovic M, 2012, NEUROBIOL DIS, V48, P526, DOI 10.1016/j.nbd.2012.07.024; Fan Z, 2006, CELL DEATH DIFFER, V13, P1485, DOI 10.1038/sj.cdd.4401825; Fries B, 2007, J BIOL CHEM, V282, P4504, DOI 10.1074/jbc.M608849200; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Guyenet S.J., 2010, J VIS EXP; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Higashino F, 2005, J CELL BIOL, V170, P15, DOI 10.1083/jcb.200405112; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Homma D, 2011, J BIOL CHEM, V286, P1445, DOI 10.1074/jbc.M110.159426; Itin C, 1999, MOL BIOL CELL, V10, P2191, DOI 10.1091/mbc.10.7.2191; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kular RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012649; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Maddatu TP, 2012, NUCLEIC ACIDS RES, V40, pD887, DOI 10.1093/nar/gkr1061; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Radrizzani M, 2001, BRAIN RES, V907, P162, DOI 10.1016/S0006-8993(01)02351-4; Reilly PT, 2011, P NATL ACAD SCI USA, V108, P10243, DOI 10.1073/pnas.1106211108; Reilly PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013597; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; Santa-Coloma TA, 2003, CEREBELLUM, V2, P310, DOI 10.1080/14734220310017212; Schneider R, 2004, J BIOL CHEM, V279, P23859, DOI 10.1074/jbc.C400151200; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shen SM, 2010, CARCINOGENESIS, V31, P419, DOI 10.1093/carcin/bgp320; Sun W, 2006, BIOCHEM BIOPH RES CO, V342, P817, DOI 10.1016/j.bbrc.2006.02.026; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tochio N, 2010, J MOL BIOL, V401, P97, DOI 10.1016/j.jmb.2010.06.005; Ulitzur N, 1997, P NATL ACAD SCI USA, V94, P5084, DOI 10.1073/pnas.94.10.5084	40	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63815	10.1371/journal.pone.0063815	http://dx.doi.org/10.1371/journal.pone.0063815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675506	Green Submitted, Green Published, gold			2022-12-25	WOS:000319036100048
J	Garbuzova-Davis, S; Rodrigues, MCO; Hernandez-Ontiveros, DG; Tajiri, N; Frisina-Deyo, A; Boffeli, SM; Abraham, JV; Pabon, M; Wagner, A; Ishikawa, H; Shinozuka, K; Haller, E; Sanberg, PR; Kaneko, Y; Borlongan, CV				Garbuzova-Davis, Svitlana; Rodrigues, Maria C. O.; Hernandez-Ontiveros, Diana G.; Tajiri, Naoki; Frisina-Deyo, Aric; Boffeli, Sean M.; Abraham, Jerry V.; Pabon, Mibel; Wagner, Andrew; Ishikawa, Hiroto; Shinozuka, Kazutaka; Haller, Edward; Sanberg, Paul R.; Kaneko, Yuji; Borlongan, Cesario V.			Blood-Brain Barrier Alterations Provide Evidence of Subacute Diaschisis in an Ischemic Stroke Rat Model	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; CROSSED CEREBELLAR DIASCHISIS; TRANSHEMISPHERIC DIASCHISIS; HEMORRHAGIC TRANSFORMATION; RISK-FACTORS; PERMEABILITY; AUTOPHAGY; INFLAMMATION; REPERFUSION; MECHANISMS	Background: Comprehensive stroke studies reveal diaschisis, a loss of function due to pathological deficits in brain areas remote from initial ischemic lesion. However, blood-brain barrier (BBB) competence in subacute diaschisis is uncertain. The present study investigated subacute diaschisis in a focal ischemic stroke rat model. Specific focuses were BBB integrity and related pathogenic processes in contralateral brain areas. Methodology/Principal Findings: In ipsilateral hemisphere 7 days after transient middle cerebral artery occlusion (tMCAO), significant BBB alterations characterized by large Evans Blue (EB) parenchymal extravasation, autophagosome accumulation, increased reactive astrocytes and activated microglia, demyelinization, and neuronal damage were detected in the striatum, motor and somatosensory cortices. Vascular damage identified by ultrastuctural and immunohistochemical analyses also occurred in the contralateral hemisphere. In contralateral striatum and motor cortex, major ultrastructural BBB changes included: swollen and vacuolated endothelial cells containing numerous autophagosomes, pericyte degeneration, and perivascular edema. Additionally, prominent EB extravasation, increased endothelial autophagosome formation, rampant astrogliosis, activated microglia, widespread neuronal pyknosis and decreased myelin were observed in contralateral striatum, and motor and somatosensory cortices. Conclusions/Significance: These results demonstrate focal ischemic stroke-induced pathological disturbances in ipsilateral, as well as in contralateral brain areas, which were shown to be closely associated with BBB breakdown in remote brain microvessels and endothelial autophagosome accumulation. This microvascular damage in subacute phase likely revealed ischemic diaschisis and should be considered in development of treatment strategies for stroke.	[Garbuzova-Davis, Svitlana; Hernandez-Ontiveros, Diana G.; Tajiri, Naoki; Frisina-Deyo, Aric; Boffeli, Sean M.; Abraham, Jerry V.; Pabon, Mibel; Wagner, Andrew; Ishikawa, Hiroto; Shinozuka, Kazutaka; Sanberg, Paul R.; Kaneko, Yuji; Borlongan, Cesario V.] Univ S Florida, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.; Kaneko, Yuji; Borlongan, Cesario V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL USA; [Garbuzova-Davis, Svitlana] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA; [Rodrigues, Maria C. O.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Internal Med, Sao Paulo, Brazil; [Sanberg, Paul R.] Univ S Florida, Morsani Coll Med, Dept Psychiat, Tampa, FL USA; [Haller, Edward] Univ S Florida, Dept Integrat Biol, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Universidade de Sao Paulo; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Garbuzova-Davis, S (corresponding author), Univ S Florida, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	sgarbuzo@health.usf.edu	Kaneko, Yuji/J-6447-2012; Borlongan, Cesar/I-5696-2012; Rodrigues, Maria Carolina Oliveira/A-2302-2012; Tajiri, Naoki/K-1230-2012; Garbuzova-Davis, Svitlana/Q-3687-2019; CTC USP, CEPID 13 18/J-8951-2014	Borlongan, Cesar/0000-0002-2966-9782; Rodrigues, Maria Carolina Oliveira/0000-0003-0691-2222; Tajiri, Naoki/0000-0003-2189-662X; Shinozuka, Kazutaka/0000-0002-6435-4460; Haller, Edward/0000-0002-8535-2181; CTC USP, CEPID 13 18/0000-0002-7123-9524; Sanberg, Paul/0000-0001-9130-4592; Ishikawa, Hiroto/0000-0003-0760-7203	National Institutes of Health [1RO1NS071956-01A1]; James and Easter King Biomedical Research Program [1KG01-33966]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Easter King Biomedical Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health (1RO1NS071956-01A1) and the James and Easter King Biomedical Research Program (1KG01-33966). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Abo-Ramadan U, 2009, EXP NEUROL, V219, P328, DOI 10.1016/j.expneurol.2009.06.002; ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Balduini W, 2009, AUTOPHAGY, V5, P221, DOI 10.4161/auto.5.2.7363; BARON JC, 1991, CEREBROVASC DIS, V1, P22, DOI 10.1159/000108877; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Borlongan CV, 2010, STEM CELLS DEV, V19, P439, DOI 10.1089/scd.2009.0340; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cumming TB, 2011, INT J STROKE, V6, P416, DOI 10.1111/j.1747-4949.2011.00666.x; Dankbaar JW, 2011, J NEURORADIOLOGY, V38, P161, DOI 10.1016/j.neurad.2010.08.001; De Deyn PP, 1999, PHARMACOPSYCHIATRY, V32, P17, DOI 10.1055/s-2007-979232; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Dhamoon MS, 2006, NEUROLOGY, V66, P641, DOI 10.1212/01.wnl.0000201253.93811.f6; Dihne M, 2002, STROKE, V33, P3006, DOI 10.1161/01.STR.0000039406.64644.CB; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DOBBIN J, 1989, J CEREBR BLOOD F MET, V9, P71, DOI 10.1038/jcbfm.1989.10; DOBKIN JA, 1989, ARCH NEUROL-CHICAGO, V46, P1333, DOI 10.1001/archneur.1989.00520480077023; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Erkinjuntti Timo, 2007, Cerebrovasc Dis, V24 Suppl 1, P189, DOI 10.1159/000107395; Fisher Mark, 2008, Rev Neurol Dis, V5 Suppl 1, pS4; Garbuzova-Davis S, 2007, BRAIN RES, V1157, P126, DOI 10.1016/j.brainres.2007.04.044; Gerriets T, 2009, J NEUROSURG, V111, P1036, DOI 10.3171/2009.3.JNS081040; Gonzalez-Aguado E, 2000, REV NEUROLOGIA, V30, P941, DOI 10.33588/rn.3010.99579; Gu Yong, 2011, Front Biosci (Schol Ed), V3, P1216; Haberg AK, 2009, J NEUROCHEM, V109, P174, DOI 10.1111/j.1471-4159.2009.05940.x; Hayasaka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032342; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kalaria RN, 2012, PANMINERVA MED, V54, P139; Kaneko Y, 2010, CELL MED, V1, P137, DOI 10.3727/215517910X552818; Kochanek KD, 2011, NATL VITAL STAT REP, V60; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; Lim JS, 1998, J NUCL MED, V39, P2044; Liu Y, 2007, J CEREBR BLOOD F MET, V27, P1724, DOI 10.1038/sj.jcbfm.9600467; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lorberboym M, 2006, BRAIN RES, V1103, P13, DOI 10.1016/j.brainres.2006.05.073; Matsukawa N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-126; MEYER JS, 1993, NEUROL RES, V15, P362; NAGASAWA H, 1989, STROKE, V20, P1037, DOI 10.1161/01.STR.20.8.1037; Neumann-Haefelin T, 2000, J CEREBR BLOOD F MET, V20, P45, DOI 10.1097/00004647-200001000-00008; Nguyen DK, 1998, CAN J NEUROL SCI, V25, P5, DOI 10.1017/S0317167100033424; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Pinkston JB, 2009, NEUROL RES, V31, P824, DOI 10.1179/016164109X12445505689643; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; PRESTON E, 1993, NEUROSCI LETT, V149, P75, DOI 10.1016/0304-3940(93)90351-K; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Reinecke S, 1999, NEUROSCI LETT, V261, P85, DOI 10.1016/S0304-3940(99)00014-2; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Sadoshima J, 2008, AUTOPHAGY, V4, P402, DOI 10.4161/auto.5924; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Seitz RJ, 1999, STROKE, V30, P1844, DOI 10.1161/01.STR.30.9.1844; Shen J, 2012, J CEREBR BLOOD F MET, V32, P353, DOI 10.1038/jcbfm.2011.136; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Takasawa M, 2002, AM J NEURORADIOL, V23, P189; Terruso V, 2009, NEUROEPIDEMIOLOGY, V33, P261, DOI 10.1159/000229781; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Wang CX, 2007, PROG NEUROBIOL, V83, P140, DOI 10.1016/j.pneurobio.2007.07.006; Wang XY, 2003, MOL NEUROBIOL, V28, P229, DOI 10.1385/MN:28:3:229; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; Witte OW, 2000, J CEREBR BLOOD F MET, V20, P1149, DOI 10.1097/00004647-200008000-00001; World Health Organization, WORLD HLTH REP 2000; YANG GY, 1994, STROKE, V25, P1658, DOI 10.1161/01.STR.25.8.1658; Yang GY, 1994, STROKE, P25, DOI DOI 10.1161/01.STR.25.8.1658; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011; Young CC, 2013, CEREB CORTEX, V23, P647, DOI 10.1093/cercor/bhs049	77	51	55	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63553	10.1371/journal.pone.0063553	http://dx.doi.org/10.1371/journal.pone.0063553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675488	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400043
J	Shen, ZJ; Hu, J; Ali, A; Pastor, J; Shiizaki, K; Blank, RD; Kuro-o, M; Malter, JS				Shen, Zhong-Jian; Hu, Jie; Ali, Aktar; Pastor, Johanne; Shiizaki, Kazuhiro; Blank, Robert D.; Kuro-o, Makoto; Malter, James S.			Pin1 Null Mice Exhibit Low Bone Mass and Attenuation of BMP Signaling	PLOS ONE			English	Article							PROLYL ISOMERASE PIN1; RECEPTOR; PROTEIN; GASTRULATION; EOSINOPHILS	Bone is constantly formed and resorbed throughout life by coordinated actions of osteoblasts and osteoclasts. However, the molecular mechanisms involved in osteoblast function remain incompletely understood. Here we show, for the first time, that the peptidyl-prolyl isomerase PIN1 controls the osteogenic activity of osteoblasts. Pin1 null mice exhibited an age-dependent decrease in bone mineral density and trabecular bone formation without alteration in cortical bone. Further analysis identified a defect in BMP signaling in Pin1 null osteoblasts but normal osteoclast function. PIN1 interacted with SMAD5 and was required for the expression by primary osteoblasts of osteoblast specific transcription factors (CBFA1 and OSX), ECM (collagen I and OCN) and the formation of bone nodules. Our results thus uncover a novel aspect of the molecular underpinning of osteoblast function and identify a new therapeutic target for bone diseases.	[Shen, Zhong-Jian; Hu, Jie; Pastor, Johanne; Shiizaki, Kazuhiro; Kuro-o, Makoto; Malter, James S.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Ali, Aktar] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Blank, Robert D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Wisconsin System; University of Wisconsin Madison	Shen, ZJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.	zhong.shen@UTSouthwestern.edu	Blank, Robert D./V-5995-2019	Blank, Robert D./0000-0003-2950-1944	National Institutes of Health [R01HL087950, P01HL088594, P30HD03352, AR54753, R01DK091392]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594, R01HL087950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health to J.S.M. (R01HL087950, P01HL088594 and P30HD03352), R. D. B. (AR54753) and M. K. (R01DK091392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Caetano-Lopes J, 2007, ACTA REUMATOL PORT, V32, P103; Christoulas D, 2009, EXPERT REV HEMATOL, V2, P385, DOI 10.1586/ehm.09.36; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Morinobu M, 2005, J EXP MED, V201, P961, DOI 10.1084/jem.20041097; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Shen ZJ, 2012, J BIOL CHEM, V287, P23294, DOI 10.1074/jbc.M111.313684; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Shen ZJ, 2002, J BIOL CHEM, V277, P29840, DOI 10.1074/jbc.M203157200; Uchida K, 2012, EXP ANIM TOKYO, V61, P59, DOI 10.1538/expanim.61.59; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	23	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63565	10.1371/journal.pone.0063565	http://dx.doi.org/10.1371/journal.pone.0063565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675491	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400045
J	Shu, CC; Lee, P; Lin, JW; Huang, CT; Chang, YC; Yu, CJ; Wang, HC				Shu, Chin-Chung; Lee, Peilin; Lin, Jou-Wei; Huang, Chun-Ta; Chang, Yeun-Chung; Yu, Chong-Jen; Wang, Hao-Chien			The Use of Sub-Mental Ultrasonography for Identifying Patients with Severe Obstructive Sleep Apnea	PLOS ONE			English	Article							UPPER AIRWAY; METABOLIC SYNDROME; CHINESE; RISK; POLYSOMNOGRAPHY; INFLAMMATION; POPULATION; ULTRASOUND; PHARYNX; OSA	Objective: This study aimed to explore the association between obstructive sleep apnea (OSA) severity and pharyngeal parameters using sub-mental ultrasonography (US), and investigate the accuracy of US for identifying severe OSA patients. Methods: One hundred and five consecutive referrals for suspected OSA were enrolled. The diameters of the retro-glossal (RG) and retro-palatal (RP) regions were measured via sub-mental US upon expiration during tidal breathing, forced inspiration, and Muller maneuver (MM). Independent factors associated with severe OSA identified from two-thirds of randomly-selected patients (model-development group) were used to construct a model for predicting severe OSA. The accuracy of the model was validated in the remaining one-third of patients (validation group). Results: Fifty severe OSA patients, 30 with mild-moderate OSA, and 25 without OSA were enrolled. Compared to non-OSA and mild-moderate OSA patients, those with severe OSA had narrower RP diameter in all three maneuvers. Using the prediction model constructed with changes of RP diameters at MM and neck circumference, the independent predictors of severe OSA in the model-development group had 100% sensitivity and 65% specificity. Conclusion: Sub-mental US can accurately discriminate the severity of OSA and be used to identify patients with severe OSA.	[Shu, Chin-Chung; Huang, Chun-Ta] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Shu, Chin-Chung; Lee, Peilin; Huang, Chun-Ta; Yu, Chong-Jen; Wang, Hao-Chien] Natl Taiwan Univ, Sch Med, Coll Med, Taipei 10764, Taiwan; [Lee, Peilin; Yu, Chong-Jen; Wang, Hao-Chien] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lee, Peilin; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Ctr Sleep Disorder, Taipei, Taiwan; [Lin, Jou-Wei] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Yunlin Cty, Taiwan; [Chang, Yeun-Chung] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Wang, HC (corresponding author), Natl Taiwan Univ, Sch Med, Coll Med, Taipei 10764, Taiwan.	haochienwang@gmail.com	Lee, Pei-Lin/L-5564-2019	Lee, Pei-Lin/0000-0002-6883-9502; Wang, Hao-Chien/0000-0002-7528-7494; HUANG, CHUN-TA/0000-0002-5234-4986; CHANG, YEUN-CHUNG/0000-0001-9984-5713; Yu, Chong-Jen/0000-0001-5664-9392; SHU, CHIN-CHUNG/0000-0003-0311-5148				Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; [Anonymous], 1998, RECOMMENDATIONS CRIT; Chen NH, 2002, LARYNGOSCOPE, V112, P721, DOI 10.1097/00005537-200204000-00023; Ciscar MA, 2001, EUR RESPIR J, V17, P79, DOI 10.1183/09031936.01.17100790; Coughlin SR, 2007, EUR RESPIR J, V29, P720, DOI 10.1183/09031936.00043306; Ding LW, 2006, EUR RESPIR J, V27, P384, DOI 10.1183/09031936.06.00029605; Gold AR, 2008, SLEEP MED, V9, P675, DOI 10.1016/j.sleep.2007.08.013; Gozal D, 2008, AM J RESP CRIT CARE, V177, P1142, DOI 10.1164/rccm.200711-1670OC; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gurubhagavatula I, 2001, AM J RESP CRIT CARE, V164, P1904, DOI 10.1164/ajrccm.164.10.2103039; Jager L, 1998, AM J NEURORADIOL, V19, P1205; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Lahav Y, 2009, ANN OTO RHINOL LARYN, V118, P179, DOI 10.1177/000348940911800304; Lee PL, 2009, CHEST, V135, P537, DOI 10.1378/chest.08-1664; Lin JW, 2009, DIABETES CARE, V32, P2294, DOI 10.2337/dc09-0694; Liu KH, 2007, SLEEP, V30, P1503, DOI 10.1093/sleep/30.11.1503; Liu YH, 2000, AM J ORTHOD DENTOFAC, V117, P479, DOI 10.1016/S0889-5406(00)70169-7; Magalang UJ, 2003, CHEST, V124, P1694, DOI 10.1378/chest.124.5.1694; McNicholas WT, 2007, EUR RESPIR J, V29, P156, DOI 10.1183/09031936.00027406; Ritter CT, 1999, LARYNGOSCOPE, V109, P954, DOI 10.1097/00005537-199906000-00022; Ryan S, 2007, THORAX, V62, P509, DOI 10.1136/thx.2006.066720; Segal Y, 2008, SLEEP BREATH, V12, P311, DOI 10.1007/s11325-008-0191-9; Siegel H, 2000, NEUROLOGY, V54, P1872, DOI 10.1212/WNL.54.9.1872; Stuck BA, 2008, SLEEP MED REV, V12, P411, DOI 10.1016/j.smrv.2007.08.009; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Thakkar K, 2007, OTOLARYNG CLIN N AM, V40, P785, DOI 10.1016/j.otc.2007.04.005; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	27	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62848	10.1371/journal.pone.0062848	http://dx.doi.org/10.1371/journal.pone.0062848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675433	gold, Green Published, Green Submitted			2022-12-25	WOS:000318852400015
J	Ieguchi, K; Tomita, T; Omori, T; Komatsu, A; Deguchi, A; Masuda, J; Duffy, SL; Coulthard, MG; Boyd, A; Maru, Y				Ieguchi, K.; Tomita, T.; Omori, T.; Komatsu, A.; Deguchi, A.; Masuda, J.; Duffy, S. L.; Coulthard, M. G.; Boyd, A.; Maru, Y.			ADAM12-cleaved ephrin-A1 contributes to lung metastasis	ONCOGENE			English	Article						Eph; tyrosine kinase; cell adhesion; permeability	EPH RECEPTORS; TYROSINE KINASE; CELL-PROLIFERATION; TUMOR-CELLS; ADAM12; CANCER; EXPRESSION; LIGAND; MIGRATION; BINDING	Eph receptor tyrosine kinases and their ephrin ligands have been implicated in neuronal development and neovascularization. Overexpression of ephrin-A1 has been implicated in tumor progression and poor prognosis. However, the mechanisms are not clear. Here, we report a role of the Eph/ephrin system in a cell adhesion mechanism. Clustered erythropoietin-producing hepatocellular receptor A1 ( EphA1)/ephrin-A1 complexes on the plasma membrane did not undergo endocytosis, and the cell remained adherent to one another. The cell-cell contacts were maintained in an Eph tyrosine kinase activity-independent manner even in the absence of E-cadherin. EphA1 and ephrin-A1 co-localized in pulmonary endothelial cells, and regulated vascular permeability and metastasis in the lungs. We identified ADAM12 ( A disintegrin and metalloproteinase 12) as an EphA1-binding partner by yeast two-hybrid screening and found that ADAM12 enhanced ephrin-A1 cleavage in response to transforming growth factor-b1 in primary tumors. Released soluble ephrin-A1 in the serum deteriorated the EphA1/ephrin-A1-mediated cell adhesion in the lungs in an endocrine manner, causing lung hyperpermeability that facilitated tumor cell entry into the lungs. Depletion of soluble ephrin-A1 by its neutralizing antibody significantly inhibited lung metastasis.	[Ieguchi, K.; Tomita, T.; Omori, T.; Komatsu, A.; Deguchi, A.; Masuda, J.; Maru, Y.] Tokyo Womens Med Univ, Dept Pharmacol, Tokyo 1828666, Japan; [Duffy, S. L.] Inst Curie, CNRS, UMR 144, Lab Morphogenese & Signalisat Cellulaires, F-75231 Paris, France; [Coulthard, M. G.; Boyd, A.] Queensland Inst Med Res, Leukemia Fdn Res Lab, Brisbane, Qld 4006, Australia	Tokyo Women's Medical University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Maru, Y (corresponding author), Tokyo Womens Med Univ, Dept Pharmacol, 8-1 Kawadacho, Tokyo 1828666, Japan.	ymaru@research.twmu.ac.jp	Coulthard, Mark Graeme/E-9444-2010; Coulthard, Mark G/AAT-7735-2021	Coulthard, Mark Graeme/0000-0001-7400-5582; Coulthard, Mark G/0000-0001-7400-5582; Tomita, Takeshi/0000-0001-6815-2244	Ministry of Education, Culture, Sports, Science and Technology of Japan [21117008, 23590347, 25122716, 25870760]; Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine from Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine from Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr Yoichiro Iwakura at the University of Tokyo for providing EphA2-KO mice, Dr Ulla Wewer at the University of Copenhagen for providing human ADAM12 cDNA clones and Ms. Helen Jeays at the Queensland Institute of Medical Research for proofreading. This work was supported by grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, grant nos. 21117008 (to YM), 23590347 (to TT), 25122716 and 25870760 (to KI), and the Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine from Japan.	Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; Alford S, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-41; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; Beauchamp A, 2012, MOL CELL BIOL, V32, P3253, DOI 10.1128/MCB.06791-11; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Brantley-Sieders DM, 2005, FASEB J, V19, P1884, DOI 10.1096/fj.05-4038fje; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Carpenter TC, 2012, AM J RESP CELL MOL, V46, P40, DOI 10.1165/rcmb.2011-0044OC; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Duffy SL, 2008, GENESIS, V46, P553, DOI 10.1002/dvg.20434; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Frohlich C, 2011, MOL CANCER RES, V9, P1449, DOI 10.1158/1541-7786.MCR-11-0100; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hiratsuka S, 2011, P NATL ACAD SCI USA, V108, P3725, DOI 10.1073/pnas.1100446108; HOLZMAN LB, 1990, MOL CELL BIOL, V10, P5830, DOI 10.1128/MCB.10.11.5830; Ieguchi K, 2007, J BIOL CHEM, V282, P23296, DOI 10.1074/jbc.M700950200; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Larson J, 2008, AM J PHYSIOL-LUNG C, V295, pL431, DOI 10.1152/ajplung.90256.2008; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Masuda J, 2008, J BIOL CHEM, V283, P13148, DOI 10.1074/jbc.M702164200; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Naruse-Nakajima C, 2001, MECH DEVELOP, V102, P95, DOI 10.1016/S0925-4773(01)00290-8; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Okazaki T, 2009, AM J PATHOL, V174, P2388, DOI 10.2353/ajpath.2009.080949; Orsulic S, 2000, J CELL SCI, V113, P1793; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Shiomi T, 2003, CANCER METAST REV, V22, P145, DOI 10.1023/A:1023039230052; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Yamazaki T, 2009, J CELL SCI, V122, P243, DOI 10.1242/jcs.036467; Yoon S, 2012, ONCOGENE, V31, P3467, DOI 10.1038/onc.2011.517	50	43	44	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2014	33	17					2179	2190		10.1038/onc.2013.180	http://dx.doi.org/10.1038/onc.2013.180			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF8WJ	23686306				2022-12-25	WOS:000334996000004
J	He, WJ; Mazumder, A; Wilder, T; Cronstein, BN				He, Wenjie; Mazumder, Amitabha; Wilder, Tuere; Cronstein, Bruce N.			Adenosine regulates bone metabolism via A(1), A(2A), and A(2B) receptors in bone marrow cells from normal humans and patients with multiple myeloma	FASEB JOURNAL			English	Article						osteoclast differentiation; osteoblast differentiation; osteolytic bone disease	INFLAMMATORY PROTEIN (MIP)-1-ALPHA; NUCLEOSIDE TRANSPORTER 1; PATHOLOGICAL FRACTURES; MACROPHAGE; EXPRESSION; LESIONS; ALPHA; DIFFERENTIATION; OSTEOBLASTS; MECHANISMS	Multiple myeloma (MM) is characterized by osteolytic bone lesions with uncoupled bone remodeling. In this study, we examined the effects of adenosine and its receptors (A(1)R, A(2A)R, A(2B)R, and A(3)R) on osteoblast and osteoclast differentiation of cells derived from patients with MM and healthy control subjects. Mesenchymal stem cells and bone marrow-derived mononuclear cells were isolated from bone marrow and differentiated into osteoblasts and osteoclasts, respectively. A(1)R antagonist rolofylline and A(2B)R agonist BAY60-6583 inhibit osteoclast differentiation of cells from patients with MM in a dose-dependent manner, as shown by TRAP staining (IC50: 10 and approximate to 10 nM, respectively). BAY60-6583 and dipyridamole, a nucleoside transport inhibitor, stimulate osteoblast differentiation of cells from patients with MM, as measured by ALP activity at d 14 and Alizarin Red staining at d 21 (by 1.57 +/- 0.03- and 1.71 +/- 0.45-fold, respectively), which can be blocked by A(2B)R antagonist MRS1754. Consistently, real-time PCR showed a significant increase of mRNA of osteocalcin and osterix at d 14. The effect of adenosine and its receptors is consistent in patients with MM and healthy subjects, suggesting an intrinsic mechanism that is important in both MM bone metabolism and normal physiology. Furthermore, the effect of dipyridamole on osteoblast differentiation is diminished in both A(2B)R- and CD39-knockout mice. These results indicate that adenosine receptors may be useful targets for the treatment of MM-induced bone disease.He, W., Mazumder, A., Wilder, T., Cronstein. B. N. Adenosine regulates bone metabolism via A(1), A(2A), and A(2B) receptors in bone marrow cells from normal humans and patients with multiple myeloma.	[He, Wenjie; Wilder, Tuere; Cronstein, Bruce N.] NYU, Sch Med, New York, NY 10016 USA; [Mazumder, Amitabha] NYU, Ctr Canc, New York, NY 10016 USA	New York University; New York University	Cronstein, BN (corresponding author), NYU, Sch Med, 550 1st Ave, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Cronstein, Bruce N/D-4678-2011	Cronstein, Bruce N/0000-0002-4295-7383	U.S. National Institutes of Health [AR56672, AR56672S1, AR54897]; New York University-Health and Hospitals Corporation (NYU-HHC) Clinical and Translational Science Institute [UL1RR029893]; Vilcek Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056672, R01AR054897, R56AR056672] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University-Health and Hospitals Corporation (NYU-HHC) Clinical and Translational Science Institute; Vilcek Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the U.S. National Institutes of Health (AR56672, AR56672S1 and AR54897), the New York University-Health and Hospitals Corporation (NYU-HHC) Clinical and Translational Science Institute (UL1RR029893), and the Vilcek Foundation.	Costa MA, 2011, J CELL PHYSIOL, V226, P1353, DOI 10.1002/jcp.22458; BARILLE S, 1995, BLOOD, V86, P3151; BATAILLE R, 1989, J CLIN ONCOL, V7, P1909, DOI 10.1200/JCO.1989.7.12.1909; Carroll SH, 2012, J BIOL CHEM, V287, P15718, DOI 10.1074/jbc.M112.344994; Eckle T, 2013, FASEB J; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Evans BAJ, 2006, J BONE MINER RES, V21, P228, DOI 10.1359/JBMR.051021; Filella X, 1996, CANCER DETECT PREV, V20, P52; Gharibi B, 2012, INT J OBESITY, V36, P397, DOI 10.1038/ijo.2011.129; Gharibi B, 2011, J BONE MINER RES, V26, P2112, DOI 10.1002/jbmr.424; Goranova-Marinova V, 2007, HAEMATOLOGICA, V92, P1000, DOI 10.3324/haematol.10943; Grenz A, 2012, J CLIN INVEST, V122, P693, DOI 10.1172/JCI60214; Hashimoto T, 2004, BRIT J HAEMATOL, V125, P38, DOI 10.1111/j.1365-2141.2004.04864.x; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; He W, 2012, PURINERG SIGNAL, V8, P327, DOI 10.1007/s11302-012-9292-9; Hideshima T, 2001, SEMIN ONCOL, V28, P607, DOI 10.1053/sonc.2001.28608; Kara FM, 2010, FASEB J, V24, P2325, DOI 10.1096/fj.09-147447; Kara FM, 2010, ARTHRITIS RHEUM-US, V62, P534, DOI 10.1002/art.27219; Khoa ND, 2003, J IMMUNOL, V171, P3991, DOI 10.4049/jimmunol.171.8.3991; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Lai FPL, 2004, BRIT J HAEMATOL, V126, P192, DOI 10.1111/j.1365-2141.2004.05018.x; Lust JA, 1999, HEMATOL ONCOL CLIN N, V13, P1117, DOI 10.1016/S0889-8588(05)70115-5; Mediero A., 2012, SCI TRANSL MED, V4; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Melton LJ, 2005, J BONE MINER RES, V20, P487, DOI 10.1359/JBMR.041131; Mitsiades CS, 2006, EUR J CANCER, V42, P1564, DOI 10.1016/j.ejca.2005.12.025; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Oyajobi BO, 2003, BLOOD, V102, P311, DOI 10.1182/blood-2002-12-3905; Pellegatti P, 2011, FASEB J, V25, P1264, DOI 10.1096/fj.10-169854; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Saad F, 2007, CANCER-AM CANCER SOC, V110, P1860, DOI 10.1002/cncr.22991; Sati HIA, 1999, BRIT J HAEMATOL, V104, P350, DOI 10.1046/j.1365-2141.1999.01193.x; Sonmez M, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-11; SUBBARAO K, 1977, J CLIN INVEST, V60, P936, DOI 10.1172/JCI108848; Szabo C, 1998, BRIT J PHARMACOL, V125, P379, DOI 10.1038/sj.bjp.0702040; Takedachi M, 2012, J CELL PHYSIOL, V227, P2622, DOI 10.1002/jcp.23001; TAUBE T, 1992, EUR J HAEMATOL, V49, P192; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Uneda S, 2003, BRIT J HAEMATOL, V120, P53, DOI 10.1046/j.1365-2141.2003.04040.x; VALENTINOPRAN A, 1982, BRIT J HAEMATOL, V52, P601, DOI 10.1111/j.1365-2141.1982.tb03936.x; Warraich S, 2013, J BONE MINER RES, V28, P1135, DOI 10.1002/jbmr.1826; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]	45	60	61	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3446	3454		10.1096/fj.13-231233	http://dx.doi.org/10.1096/fj.13-231233			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23682121	Green Published			2022-12-25	WOS:000328840500005
J	Garzon, D; Anselmi, C; Bond, PJ; Faraldo-Gomez, JD				Garzon, Diana; Anselmi, Claudio; Bond, Peter J.; Faraldo-Gomez, Jose D.			Dynamics of the Antigen-binding Grooves in CD1 Proteins REVERSIBLE HYDROPHOBIC COLLAPSE IN THE LIPID-FREE STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; PRESENTING MOLECULES; TAPASIN DEPENDENCE; BOUND LIGANDS; FORCE-FIELD; T-CELLS; SIMULATION; TRAFFICKING; ANGSTROM	CD1 proteins mediate the presentation of endogenous and foreign lipids on the cell surface for recognition by T cell receptors. To sample a diverse antigen pool, CD1 proteins are repeatedly internalized and recycled, assisted, in some cases, by lipid transfer proteins such as saposins. The specificity of each CD1 isoform is, therefore, conferred in part by its intracellular pathway but also by distinct structural features of the antigen-binding domain. Crystal structures of CD1-lipid complexes reveal hydrophobic grooves and pockets within these binding domains that appear to be specialized for different lipids. However, the mechanism of lipid loading and release remains to be characterized. Here we gain insights into this mechanism through a meta-analysis of the five human CD1 isoforms, in the lipid-bound and lipid-free states, using all-atom molecular dynamics simulations. Strikingly, for isoforms CD1b through CD1e, our simulations show the near-complete collapse of the hydrophobic cavities in the absence of the antigen. This event results from the spontaneous closure of the binding domain entrance, flanked by two alpha-helices. Accordingly, we show that the anatomy of the binding cavities is restored if these alpha-helices are repositioned extrinsically, suggesting that helper proteins encountered during recycling facilitate lipid exchange allosterically. By contrast, we show that the binding cavity of CD1a is largely preserved in the unliganded state because of persistent electrostatic interactions that keep the portal alpha-helices at a constant separation. The robustness of this binding groove is consistent with the observation that lipid exchange in CD1a is not dependent on cellular internalization.	[Garzon, Diana; Anselmi, Claudio; Faraldo-Gomez, Jose D.] Max Planck Inst Biophys, Theoret Mol Biophys Grp, D-60438 Frankfurt, Germany; [Bond, Peter J.] Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Cambridge CB2 1EW, England	Max Planck Society; University of Cambridge	Bond, PJ (corresponding author), Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Lensfield Rd, Cambridge CB2 1EW, England.	pjb91@cam.ac.uk; jose.faraldo@biophys.mpg.de	Faraldo-Gomez, Jose/H-7127-2016; Anselmi, Claudio/D-6244-2012	Anselmi, Claudio/0000-0002-3017-5085; Bond, Peter/0000-0003-2900-098X	German Research Foundation Cluster of Excellence Grant [EXC115]; IMPReS fellowship of the Max Planck Institute of Biophysics	German Research Foundation Cluster of Excellence Grant; IMPReS fellowship of the Max Planck Institute of Biophysics	This work was supported in part by German Research Foundation Cluster of Excellence Grant EXC115 (to J. D. F. G.) and by an IMPReS fellowship of the Max Planck Institute of Biophysics (to D. G.).	Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bauer A, 1997, EUR J IMMUNOL, V27, P1366, DOI 10.1002/eji.1830270611; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUTKIEWICZ RR, 1995, J EXP MED, V182, P1913, DOI 10.1084/jem.182.6.1913; Cernadas M, 2010, J IMMUNOL, V184, P1235, DOI 10.4049/jimmunol.0804140; Cheng TY, 2006, EMBO J, V25, P2989, DOI 10.1038/SJ.EMBOJ.7601185; De Libero G, 2005, NAT REV IMMUNOL, V5, P485, DOI 10.1038/nri1631; De Libero G, 2012, TRENDS IMMUNOL, V33, P103, DOI 10.1016/j.it.2012.01.005; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Eswar N., 2006, CURR PROTOC PROT SCI, V50, P291; Feller SE, 1997, BIOPHYS J, V73, P2269, DOI 10.1016/S0006-3495(97)78259-6; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Garcia-Alles LF, 2006, EMBO J, V25, P3684, DOI 10.1038/sj.emboj.7601244; Garcia-Alles LF, 2011, P NATL ACAD SCI USA, V108, P13230, DOI 10.1073/pnas.1105627108; Garstka MA, 2011, FASEB J, V25, P3989, DOI 10.1096/fj.11-190249; Garzon D, 2009, MOL IMMUNOL, V47, P253, DOI 10.1016/j.molimm.2009.09.029; Girardi E, 2010, J IMMUNOL, V185, P376, DOI 10.4049/jimmunol.1000042; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huttinger R, 1999, INT IMMUNOL, V11, P1615, DOI 10.1093/intimm/11.10.1615; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manolova V, 2006, EUR J IMMUNOL, V36, P1083, DOI 10.1002/eji.200535544; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Moody DB, 2001, IMMUNITY, V15, P861, DOI 10.1016/S1074-7613(01)00250-3; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porcelli SA, 1998, IMMUNOL TODAY, V19, P362, DOI 10.1016/S0167-5699(98)01289-4; Relloso M, 2008, IMMUNITY, V28, P774, DOI 10.1016/j.immuni.2008.04.017; Salamero J, 2001, J INVEST DERMATOL, V116, P401, DOI 10.1046/j.1523-1747.2001.01264.x; Salio M, 2010, CURR OPIN IMMUNOL, V22, P81, DOI 10.1016/j.coi.2009.12.008; Scharf L, 2010, IMMUNITY, V33, P853, DOI 10.1016/j.immuni.2010.11.026; Sieker F, 2008, MOL IMMUNOL, V45, P3714, DOI 10.1016/j.molimm.2008.06.009; Sieker F, 2007, PROTEIN SCI, V16, P299, DOI 10.1110/ps.062568407; Silk JD, 2008, ANNU REV CELL DEV BI, V24, P369, DOI 10.1146/annurev.cellbio.24.110707.175359; Sugita M, 2000, TRAFFIC, V1, P295, DOI 10.1034/j.1600-0854.2000.010401.x; Sugita M, 1997, J IMMUNOL, V159, P2358; Sugita M, 2004, CURR OPIN IMMUNOL, V16, P90, DOI 10.1016/j.coi.2003.11.014; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104; Zajonc DM, 2007, CURR TOP MICROBIOL, V314, P27; Zajonc DM, 2008, P NATL ACAD SCI USA, V105, P17925, DOI 10.1073/pnas.0809814105; Zajonc DM, 2005, IMMUNITY, V22, P209, DOI 10.1016/j.immuni.2004.12.009; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	51	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19528	19536		10.1074/jbc.M113.470179	http://dx.doi.org/10.1074/jbc.M113.470179			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23677998	hybrid, Green Published			2022-12-25	WOS:000321515800019
J	Horlick, RA; Macomber, JL; Bowers, PM; Neben, TY; Tomlinson, GL; Krapf, IP; Dalton, JL; Verdino, P; King, DJ				Horlick, Robert A.; Macomber, John L.; Bowers, Peter M.; Neben, Tamlyn Y.; Tomlinson, Geoffery L.; Krapf, Irina P.; Dalton, Jennifer L.; Verdino, Petra; King, David J.			Simultaneous Surface Display and Secretion of Proteins from Mammalian Cells Facilitate Efficient in Vitro Selection and Maturation of Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC HYPERMUTATION; MESSENGER-RNAS; 3 ENDS; MEMBRANE; EVOLUTION; VECTORS; CHAINS; DIFFER	A mammalian expression system has been developed that permits simultaneous cell surface display and secretion of the same protein through alternate splicing of pre-mRNA. This enables a flexible system for in vitro protein evolution in mammalian cells where the displayed protein phenotype remains linked to genotype, but with the advantage of soluble protein also being produced without the requirement for any further recloning to allow a wide range of assays, including biophysical and cell-based functional assays, to be used during the selection process. This system has been used for the simultaneous surface presentation and secretion of IgG during antibody discovery and maturation. Presentation and secretion of monomeric Fab can also be achieved to minimize avidity effects. Manipulation of the splice donor site sequence enables control of the relative amounts of cell surface and secreted antibody. Multi-domain proteins may be presented and secreted in different formats to enable flexibility in experimental design, and secreted proteins may be produced with epitope tags to facilitate high-throughput testing. This system is particularly useful in the context of in situ mutagenesis, as in the case of in vitro somatic hypermutation.	[Horlick, Robert A.; Macomber, John L.; Bowers, Peter M.; Neben, Tamlyn Y.; Tomlinson, Geoffery L.; Krapf, Irina P.; Dalton, Jennifer L.; Verdino, Petra; King, David J.] AnaptysBio Inc, San Diego, CA 92121 USA		Horlick, RA (corresponding author), AnaptysBio Inc, Dept Mol Biol, 10421 Pacific Ctr Ct,Ste 200, San Diego, CA 92121 USA.	rhorlick@anaptysbio.com						ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bowers PM, 2011, P NATL ACAD SCI USA, V108, P20455, DOI 10.1073/pnas.1114010108; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; DAMJANOVICH S, 1983, P NATL ACAD SCI-BIOL, V80, P5985, DOI 10.1073/pnas.80.19.5985; Elkina Y, 2011, J CACHEXIA SARCOPENI, V2, P143, DOI 10.1007/s13539-011-0035-5; Gur H, 1999, CELL IMMUNOL, V191, P105, DOI 10.1006/cimm.1998.1417; Horlick RA, 2000, GENE, V243, P187, DOI 10.1016/S0378-1119(99)00561-2; HUANG MTF, 1990, MOL CELL BIOL, V10, P1805, DOI 10.1128/MCB.10.4.1805; KEHRY M, 1980, CELL, V21, P393, DOI 10.1016/0092-8674(80)90476-6; Lipovsek D, 2007, CHEM BIOL, V14, P1176, DOI 10.1016/j.chembiol.2007.09.008; Majors BS, 2012, PROTEIN ENG DES SEL, V25, P27, DOI 10.1093/protein/gzr052; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; McConnell AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049458; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; ROGERS J, 1980, CELL, V20, P303, DOI 10.1016/0092-8674(80)90616-9; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Vendel MC, 2012, ARCH BIOCHEM BIOPHYS, V526, P188, DOI 10.1016/j.abb.2011.12.018; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101	22	23	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19861	19869		10.1074/jbc.M113.452482	http://dx.doi.org/10.1074/jbc.M113.452482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689374	Green Published, hybrid			2022-12-25	WOS:000321515800053
J	Bround, MJ; Wambolt, R; Luciani, DS; Kulpa, JE; Rodrigues, B; Brownsey, RW; Allard, MF; Johnson, JD				Bround, Michael J.; Wambolt, Rich; Luciani, Dan S.; Kulpa, Jerzy E.; Rodrigues, Brian; Brownsey, Roger W.; Allard, Michael F.; Johnson, James D.			Cardiomyocyte ATP Production, Metabolic Flexibility, and Survival Require Calcium Flux through Cardiac Ryanodine Receptors in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESSURE-OVERLOAD; ENDOPLASMIC-RETICULUM; MITOCHONDRIAL CA2+; PPAR-ALPHA; HEART; GENE; STRESS; EXPRESSION; ADULT; MICE	Ca2+ fluxes between adjacent organelles are thought to control many cellular processes, including metabolism and cell survival. In vitro evidence has been presented that constitutive Ca2+ flux from intracellular stores into mitochondria is required for basal cellular metabolism, but these observations have not been made in vivo. We report that controlled in vivo depletion of cardiac RYR2, using a conditional gene knock-out strategy (cRyr2KO mice), is sufficient to reduce mitochondrial Ca2+ and oxidative metabolism, and to establish a pseudo-hypoxic state with increased autophagy. Dramatic metabolic reprogramming was evident at the transcriptional level via Sirt1/Foxo1/Pgc1 alpha, Atf3, and Klf15 gene networks. Ryr2 loss also induced a non-apoptotic form of programmed cell death associated with increased calpain-10 but not caspase-3 activation or endoplasmic reticulum stress. Remarkably, cRyr2KO mice rapidly exhibited many of the structural, metabolic, and molecular characteristics of heart failure at a time when RYR2 protein was reduced 50%, a similar degree to that which has been reported in heart failure. RYR2-mediated Ca2+ fluxes are therefore proximal controllers of mitochondrial Ca2+, ATP levels, and a cascade of transcription factors controlling metabolism and survival.	[Bround, Michael J.; Johnson, James D.] Univ British Columbia, Inst Life Sci, Cardiovasc Res Grp, Vancouver, BC V6T 1Z3, Canada; [Bround, Michael J.; Kulpa, Jerzy E.; Brownsey, Roger W.; Johnson, James D.] Univ British Columbia, Inst Life Sci, Diabet Res Grp, Vancouver, BC V6T 1Z3, Canada; [Bround, Michael J.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Bround, Michael J.; Luciani, Dan S.; Johnson, James D.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1Z3, Canada; [Wambolt, Rich; Allard, Michael F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Y6, Canada; [Wambolt, Rich; Allard, Michael F.] St Pauls Hosp, James Hogg Res Ctr, Vancouver, BC V6T 1Y6, Canada; [Luciani, Dan S.] Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Kulpa, Jerzy E.; Brownsey, Roger W.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Rodrigues, Brian] Univ British Columbia, Dept Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; Child & Family Research Institute; University of British Columbia; University of British Columbia	Johnson, JD (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Cardiovasc Res Grp, 5358 Life Sci Bldg,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	James.D.Johnson@ubc.ca		Luciani, Dan/0000-0002-4318-4159; Rodrigues, Brian/0000-0002-0129-4261	Canadian Institutes for Health Research; Canadian Diabetes Association; Michael Smith Foundation for Health Research; Carlsberg Foundation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Carlsberg Foundation(Carlsberg Foundation)	This work was supported by a Canadian Institutes for Health Research operating grant to J. D. J.; Supported by postdoctoral fellowships from the Canadian Diabetes Association, the Michael Smith Foundation for Health Research, and the Carlsberg Foundation.	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; ALLY A, 1992, J CHROMATOGR-BIOMED, V575, P19, DOI 10.1016/0378-4347(92)80499-G; Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; Assayag P, 1998, CARDIOVASC RES, V38, P169, DOI 10.1016/S0008-6363(97)00283-6; Belke DD, 1999, AM J PHYSIOL-REG I, V277, pR1210, DOI 10.1152/ajpregu.1999.277.4.R1210; Bidasse KR, 2001, MOL PHARMACOL, V60, P1356, DOI 10.1124/mol.60.6.1356; BRILLANTES AM, 1992, CIRC RES, V71, P18, DOI 10.1161/01.RES.71.1.18; Bround MJ, 2012, CARDIOVASC RES, V96, P372, DOI 10.1093/cvr/cvs260; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Croquelois A, 2008, J EXP MED, V205, P3173, DOI 10.1084/jem.20081427; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Dror V, 2008, J BIOL CHEM, V283, P9909, DOI 10.1074/jbc.M710601200; Ferrari R, 2009, CIRC J, V73, P1973, DOI 10.1253/circj.CJ-09-0573; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Igwe EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-408; Johnson JD, 2012, PROTOPLASMA, V249, pS49, DOI 10.1007/s00709-011-0349-3; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Kandilci HB, 2011, J PHYSIOL BIOCHEM, V67, P317, DOI 10.1007/s13105-011-0077-3; Kettlewell S, 2009, J MOL CELL CARDIOL, V46, P891, DOI 10.1016/j.yjmcc.2009.02.016; Khairallah M, 2004, AM J PHYSIOL-HEART C, V286, pH1461, DOI 10.1152/ajpheart.00942.2003; Koh IU, 2010, FEBS J, V277, P2304, DOI 10.1111/j.1742-4658.2010.07646.x; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Liao RL, 2002, CIRCULATION, V106, P2125, DOI 10.1161/01.CIR.0000034049.61181.F3; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Lukyanenko V, 2007, J PHYSIOL-LONDON, V583, P251, DOI 10.1113/jphysiol.2007.136549; MATSUI H, 1995, AM J PHYSIOL-CELL PH, V268, pC252, DOI 10.1152/ajpcell.1995.268.1.C252; NAUDIN V, 1991, FEBS LETT, V285, P135, DOI 10.1016/0014-5793(91)80743-M; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Okamoto Y, 2001, AM J PATHOL, V159, P639, DOI 10.1016/S0002-9440(10)61735-X; Pacher P, 2002, P NATL ACAD SCI USA, V99, P2380, DOI 10.1073/pnas.032423699; Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Rutter GA, 1996, P NATL ACAD SCI USA, V93, P5489, DOI 10.1073/pnas.93.11.5489; Salnikov V, 2009, J MUSCLE RES CELL M, V30, P161, DOI 10.1007/s10974-009-9186-9; Santiago D. J., 2010, BIOPHYS J; Santiago DJ, 2010, BIOPHYS J, V98, P2111, DOI 10.1016/j.bpj.2010.01.042; Schaeffer PJ, 2004, J BIOL CHEM, V279, P39593, DOI 10.1074/jbc.M403649200; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; WAN B, 1989, J BIOL CHEM, V264, P13430; Yamaguchi N, 2011, AM J PHYSIOL-HEART C, V300, pH2187, DOI 10.1152/ajpheart.00719.2010; Yamamoto K, 2010, BIOCHEM BIOPH RES CO, V400, P175, DOI 10.1016/j.bbrc.2010.08.039; Zou YZ, 2011, HYPERTENSION, V58, P1099, DOI 10.1161/HYPERTENSIONAHA.111.173500	60	58	64	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18975	18986		10.1074/jbc.M112.427062	http://dx.doi.org/10.1074/jbc.M112.427062			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23678000	Green Published, hybrid			2022-12-25	WOS:000321335800034
J	Pang, YH; Kurella, S; Voisset, C; Samanta, D; Banerjee, D; Schabe, A; Das Gupta, C; Galons, H; Blondel, M; Sanyal, S				Pang, Yanhong; Kurella, Sriram; Voisset, Cecile; Samanta, Dibyendu; Banerjee, Debapriya; Schabe, Ariane; Das Gupta, Chanchal; Galons, Herve; Blondel, Marc; Sanyal, Suparna			The Antiprion Compound 6-Aminophenanthridine Inhibits the Protein Folding Activity of the Ribosome by Direct Competition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RIBOSOME; IN-VITRO; DOMAIN-V; DENATURED PROTEINS; MAMMALIAN PRIONS; 50S SUBUNIT; RNA; DRUGS; GUANABENZ; VIVO	Domain V of the 23S/25S/28S rRNA of the large ribosomal subunit constitutes the active center for the protein folding activity of the ribosome (PFAR). Using in vitro transcribed domain V rRNAs from Escherichia coli and Saccharomyces cerevisiae as the folding modulators and human carbonic anhydrase as a model protein, we demonstrate that PFAR is conserved from prokaryotes to eukaryotes. It was shown previously that 6-aminophenanthridine (6AP), an antiprion compound, inhibits PFAR. Here, using UV cross-linking followed by primer extension, we show that the protein substrates and 6AP interact with a common set of nucleotides on domain V of 23S rRNA. Mutations at the interaction sites decreased PFAR and resulted in loss or change of the binding pattern for both the protein substrates and 6AP. Moreover, kinetic analysis of human carbonic anhydrase refolding showed that 6AP decreased the yield of the refolded protein but did not affect the rate of refolding. Thus, we conclude that 6AP competitively occludes the protein substrates from binding to rRNA and thereby inhibits PFAR. Finally, we propose a scheme clarifying the mechanism by which 6AP inhibits PFAR.	[Pang, Yanhong; Kurella, Sriram; Banerjee, Debapriya; Schabe, Ariane; Sanyal, Suparna] Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; [Voisset, Cecile; Blondel, Marc] Univ Bretagne Occidentale, Ctr Hosp Reg Univ CHRU Brest, Fac Med & Sci Sante,INSERM,UMR 1078, Etab Francais Sang EFS Bretagne,Hop Morvan,Lab Ge, F-29200 Brest, France; [Samanta, Dibyendu; Das Gupta, Chanchal] Univ Calcutta, Dept Biophys Mol Biol & Genet, Kolkata 700009, W Bengal, India; [Galons, Herve] Univ Paris 05, CNRS, UMR 8601, Lab Chim Organ 2, F-75270 Paris 6, France	Uppsala University; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; University of Calcutta; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Sanyal, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden.	suparna.sanyal@icm.uu.se	Voisset, Cecile/AAK-1636-2020; Blondel, Marc/AAJ-9049-2020	Blondel, Marc/0000-0003-4897-2995; Pang, Yanhong/0000-0002-5167-4174; Voisset, Cecile/0000-0001-7505-1927	Swedish Research Council (M section); Swedish Research Council (NT section); Swedish Research Council (VR-SIDA); Carl Tryggers Stiftelse; Wenner Gren Stiftelse; Knut and Wallice Wallenberg Foundation; Vinnova/DBT (India); SSF-Dalen (Sweden-France Bilateral Collaboration) Program; Chinese Scholarship Council; INSERM; CRITT Sante Bretagne (Region Bretagne); ANR "Blanche" of the French Government	Swedish Research Council (M section)(Swedish Research Council); Swedish Research Council (NT section)(Swedish Research Council); Swedish Research Council (VR-SIDA)(Swedish Research Council); Carl Tryggers Stiftelse; Wenner Gren Stiftelse; Knut and Wallice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Vinnova/DBT (India); SSF-Dalen (Sweden-France Bilateral Collaboration) Program; Chinese Scholarship Council(China Scholarship Council); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CRITT Sante Bretagne (Region Bretagne); ANR "Blanche" of the French Government(French National Research Agency (ANR))	This work was supported by the Swedish Research Council (individual grants from the M and NT sections, VR-SIDA (Swedish Research Link), and a Linnaeus grant to the Uppsala RNA Research Center); the Carl Tryggers Stiftelse; a postdoctoral stipendium from the Wenner Gren Stiftelse (to D. B.); the Knut and Wallice Wallenberg Foundation (to RiboCORE), Vinnova/DBT (India), and the SSF-Dalen (Sweden-France Bilateral Collaboration) Program (to S. S.); a scholarship from the Chinese Scholarship Council (to Y. P.); and INSERM, CRITT Sante Bretagne (Region Bretagne), and ANR "Blanche" of the French Government (to M. B. and C. V.).	Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; Barbezier N, 2011, EMBO MOL MED, V3, P35, DOI 10.1002/emmm.201000109; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P598, DOI 10.1016/j.bbrc.2007.11.143; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P592, DOI 10.1016/j.bbrc.2007.11.142; BERA AK, 1994, CURR SCI INDIA, V66, P230; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Chattopadhyay S, 1999, BBA-PROTEIN STRUCT M, V1429, P293, DOI 10.1016/S0167-4838(98)00179-4; Chowdhury S, 2002, NUCLEIC ACIDS RES, V30, P1278, DOI 10.1093/nar/30.5.1278; Das A, 2011, J BIOL CHEM, V286, P43771, DOI 10.1074/jbc.M111.263574; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das D, 2012, J BIOL CHEM, V287, P37508, DOI 10.1074/jbc.M112.396127; Das Debasis, 2008, Biotechnology Journal, V3, P999, DOI 10.1002/biot.200800098; Dos Reis S, 2011, BIOCHIMIE, V93, P1047, DOI 10.1016/j.biochi.2011.03.002; Gomes MPB, 2012, WIRES RNA, V3, P415, DOI 10.1002/wrna.118; Gug F, 2010, BIOCONJUGATE CHEM, V21, P279, DOI 10.1021/bc900314n; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; LEWIS ME, 1986, P NATL ACAD SCI USA, V83, P5419, DOI 10.1073/pnas.83.15.5419; Macedo B, 2012, BIOCHEMISTRY-US, V51, P5402, DOI 10.1021/bi300440e; Pal D, 1997, NUCLEIC ACIDS RES, V25, P5047, DOI 10.1093/nar/25.24.5047; Pal S, 1999, J BIOL CHEM, V274, P32771, DOI 10.1074/jbc.274.46.32771; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; Sanyal SC, 2002, NUCLEIC ACIDS RES, V30, P2390, DOI 10.1093/nar/30.11.2390; Silva JL, 2011, METHODS, V53, P306, DOI 10.1016/j.ymeth.2010.12.002; Sulijoadikusumo I, 2001, BIOCHEMISTRY-US, V40, P11559, DOI 10.1021/bi015526q; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002174; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Voisset C, 2011, BIOTECHNOL J, V6, P668, DOI 10.1002/biot.201100021; Voisset Cecile, 2008, Biotechnology Journal, V3, P1033, DOI 10.1002/biot.200800134	29	24	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19081	19089		10.1074/jbc.M113.466748	http://dx.doi.org/10.1074/jbc.M113.466748			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23673663	Green Published, hybrid			2022-12-25	WOS:000321335800043
J	Tanifuji, S; Funakoshi-Tago, M; Ueda, F; Kasahara, T; Mochida, S				Tanifuji, Shota; Funakoshi-Tago, Megumi; Ueda, Fumihito; Kasahara, Tadashi; Mochida, Sumiko			Dynamin Isoforms Decode Action Potential Firing for Synaptic Vesicle Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FROG NEUROMUSCULAR JUNCTION; RAT SYMPATHETIC NEURONS; CA2+ SENSOR PROTEINS; TRANSMITTER RELEASE; CA(V)2.1 CHANNELS; ENDOCYTOSIS; SYNAPSES; EXOCYTOSIS; PLASTICITY; MEMBRANE	Presynaptic nerve terminals must maintain stable neurotransmission via synaptic vesicle membrane recycling despite encountering wide fluctuations in the number and frequency of incoming action potentials (APs). However, the molecular mechanism linking variation in neuronal activity to vesicle trafficking is unknown. Here, we combined genetic knockdown and direct physiological measurements of synaptic transmission from paired neurons to show that three isoforms of dynamin, an essential endocytic protein, work individually to match vesicle reuse pathways, having distinct rate and time constants with physiological AP frequencies. Dynamin 3 resupplied the readily releasable pool with slow kinetics independently of the AP frequency but acted quickly, within 20 ms of the incoming AP. Under high-frequency firing, dynamin 1 regulated recycling to the readily releasable pool with fast kinetics in a slower time window of greater than 50 ms. Dynamin 2 displayed a hybrid response between the other isoforms. Collectively, our findings show how dynamin isoforms select appropriate vesicle reuse pathways associated with specific neuronal firing patterns.	[Tanifuji, Shota; Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan; [Tanifuji, Shota; Funakoshi-Tago, Megumi; Ueda, Fumihito; Kasahara, Tadashi] Keio Univ, Dept Biochem, Minato Ku, Tokyo 1058512, Japan	Tokyo Medical University; Keio University	Mochida, S (corresponding author), Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan.	mochida@tokyo-med.ac.jp		Ueda, Fumihito/0000-0003-1241-1643				ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; Leal K, 2012, P NATL ACAD SCI USA, V109, P17069, DOI 10.1073/pnas.1215172109; LIBET B, 1988, BRAIN RES, V473, P271, DOI 10.1016/0006-8993(88)90856-6; Lou XL, 2012, P NATL ACAD SCI USA, V109, pE515, DOI 10.1073/pnas.1121626109; Lu WB, 2009, J BIOL CHEM, V284, P1930, DOI 10.1074/jbc.M803691200; MOCHIDA S, 1994, MICROSC RES TECHNIQ, V29, P94, DOI 10.1002/jemt.1070290206; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Mochida S, 2011, NEUROSCI RES, V70, P16, DOI 10.1016/j.neures.2011.03.005; Park H, 2012, SCIENCE, V335, P1362, DOI 10.1126/science.1216937; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Wenzel EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038188; Wu LG, 2004, TRENDS NEUROSCI, V27, P548, DOI 10.1016/j.tins.2004.07.001; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Ying Y, 2012, FEBS LETT, V586, P3674, DOI 10.1016/j.febslet.2012.08.025; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024	33	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19050	19059		10.1074/jbc.M112.445874	http://dx.doi.org/10.1074/jbc.M112.445874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23687302	Green Published, hybrid			2022-12-25	WOS:000321335800040
J	Elliott, DT; Pierson, JJ; Roman, MR				Elliott, David T.; Pierson, James J.; Roman, Michael R.			Predicting the Effects of Coastal Hypoxia on Vital Rates of the Planktonic Copepod Acartia tonsa Dana	PLOS ONE			English	Article							GULF-OF-MEXICO; CALANOID COPEPODS; DYNAMIC ACTION; EGG-PRODUCTION; COMMUNITY STRUCTURE; MARINE ZOOPLANKTON; CHESAPEAKE BAY; OXYGEN LEVELS; TEMPERATURE; RESPONSES	We describe a model predicting the effects of low environmental oxygen on vital rates (egg production, somatic growth, and mortality) of the coastal planktonic copepod Acartia tonsa. Hypoxic conditions can result in respiration rate being directly limited by oxygen availability. We hypothesized that A. tonsa egg production, somatic growth, and ingestion rates would all respond in a similar manner to low oxygen conditions, as a result of oxygen dependent changes in respiration rate. Rate data for A. tonsa egg production, somatic growth, and ingestion under low environmental oxygen were compiled from the literature and from supplementary experiments. The response of these rates to oxygen was compared by converting all to the analogous units in terms of oxygen utilization, which we termed analogous respiration rate. These analogous respiration rates, along with published measurements of respiration rates, were used to parameterize and evaluate the relationship between A. tonsa respiration rate and environmental oxygen. At 18 degrees C, our results suggest that A. tonsa experiences sub-lethal effects of hypoxia below an oxygen partial pressure of 8.1 kPa (similar to 3.1 mg L-1 = 2.3 mL L-1). The results of this study can be used to predict the effects of hypoxia on A. tonsa growth and mortality as related to environmental temperature and oxygen partial pressure. Such predictions will be useful as a way to incorporate the effects of coastal hypoxia into population, community, or ecosystem level models that include A. tonsa. This approach can also be used to characterize the effects of hypoxia on other aquatic organisms.	[Elliott, David T.; Pierson, James J.; Roman, Michael R.] Univ Maryland, Ctr Environm Sci UMCES, Horn Point Lab, Cambridge, MD USA	University System of Maryland; University of Maryland Center for Environmental Science	Elliott, DT (corresponding author), Virginia Commonwealth Univ, Ctr Environm Studies, Richmond, VA 23284 USA.	delliott@umces.edu	Pierson, James J/B-7278-2008; Roman, Michael/F-9390-2013; Elliott, David/G-2161-2012	Pierson, James J/0000-0002-5248-5850; 	U.S. National Science Foundation (NSF) Ocean Sciences award [OCE-0961942]; National Oceanic and Atmospheric Administration (NOAA) award [NA09NOS4780198]; Division Of Ocean Sciences [0961942] Funding Source: National Science Foundation	U.S. National Science Foundation (NSF) Ocean Sciences award(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); National Oceanic and Atmospheric Administration (NOAA) award; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by U.S. National Science Foundation (NSF) Ocean Sciences award OCE-0961942 and National Oceanic and Atmospheric Administration (NOAA) award NA09NOS4780198 to J.J.P and M.R.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELMAN BW, 1979, MAR BIOL, V50, P275, DOI 10.1007/BF00394209; Besiktepe S, 2002, MAR ECOL PROG SER, V229, P151, DOI 10.3354/meps229151; Breitburg DL, 2009, ANNU REV MAR SCI, V1, P329, DOI 10.1146/annurev.marine.010908.163754; Broglio E, 2003, AQUAT MICROB ECOL, V31, P267, DOI 10.3354/ame031267; Childress JJ, 1998, J EXP BIOL, V201, P1223; Dam HG, 2013, ANNU REV MAR SCI, V5, P349, DOI 10.1146/annurev-marine-121211-172229; Decker MB, 2003, ECOL APPL, V13, P1104, DOI 10.1890/1051-0761(2003)13[1104:GDIBRT]2.0.CO;2; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Elliott DT, 2012, J PLANKTON RES, V34, P602, DOI 10.1093/plankt/fbs029; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Gaudy R, 2000, J EXP MAR BIOL ECOL, V247, P51, DOI 10.1016/S0022-0981(00)00139-8; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; GONZALEZ JG, 1974, MAR BIOL, V27, P219, DOI 10.1007/BF00391947; HEISEY D, 1977, LIMNOL OCEANOGR, V22, P839, DOI 10.4319/lo.1977.22.5.0839; Hubareva E, 2008, ESTUAR COAST SHELF S, V76, P131, DOI 10.1016/j.ecss.2007.06.009; HUGHES GM, 1973, AM ZOOL, V13, P475; Keister JE, 2000, MAR ECOL PROG SER, V205, P43, DOI 10.3354/meps205043; Kimmel DG, 2010, J PLANKTON RES, V32, P1185, DOI 10.1093/plankt/fbp136; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; LUTZ RV, 1994, MAR BIOL, V119, P199, DOI 10.1007/BF00349557; Marcus NH, 2004, J EXP MAR BIOL ECOL, V301, P111, DOI 10.1016/j.jembe.2003.09.016; Mauchline J, 1998, ADV MAR BIOL, V33, P1; MILLER CB, 1977, LIMNOL OCEANOGR, V22, P326, DOI 10.4319/lo.1977.22.2.0326; Parsons T.R., 1984, BIOL OCEANOGRAPHIC P, V3rd; Pierson JJ, 2009, J EXP MAR BIOL ECOL, V381, pS74, DOI 10.1016/j.jembe.2009.07.013; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Richmond C, 2006, J EXP MAR BIOL ECOL, V328, P177, DOI 10.1016/j.jembe.2005.07.004; ROMAN MR, 1993, LIMNOL OCEANOGR, V38, P1603, DOI 10.4319/lo.1993.38.8.1603; Sedlacek C, 2005, J EXP MAR BIOL ECOL, V318, P183, DOI 10.1016/j.jembe.2004.12.012; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Stalder LC, 1997, MAR BIOL, V127, P599, DOI 10.1007/s002270050050; Thor P, 2002, J PLANKTON RES, V24, P293, DOI 10.1093/plankt/24.4.293; Thor P, 2000, J EXP MAR BIOL ECOL, V245, P171, DOI 10.1016/S0022-0981(99)00159-8; Vanderploeg HA, 2009, J EXP MAR BIOL ECOL, V381, pS108, DOI 10.1016/j.jembe.2009.07.015; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9	37	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63987	10.1371/journal.pone.0063987	http://dx.doi.org/10.1371/journal.pone.0063987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691134	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900072
J	Yin, L; Cai, WJ; Liu, CX; Chen, YZ; Hu, JM; Jiang, JF; Li, HA; Cui, XB; Chang, XY; Zhang, WJ; Sun, K; Li, F				Yin, Liang; Cai, Wei-Juan; Liu, Chun-Xia; Chen, Yun-Zhao; Hu, Jian-Ming; Jiang, Jin-Fang; Li, Hong-An; Cui, Xiao-Bin; Chang, Xiang-Yun; Zhang, Wen Jie; Sun, Kan; Li, Feng			Analysis of PTEN Methylation Patterns in Soft Tissue Sarcomas by MassARRAY Spectrometry	PLOS ONE			English	Article							CELL LUNG-CANCER; PROMOTER METHYLATION; TUMOR-SUPPRESSOR; PROSTATE-CANCER; GENE; HYPERMETHYLATION; PHOSPHATASE; SURVIVAL; LEUKEMIA; BREAST	Soft tissue sarcomas (STSs) are a rare and fascinating group of diseases that can be subdivided into specific reciprocal translocations in STSs (SRTSs) and nonspecific reciprocal translocations in STSs (NRTSs). PTEN mutations are rare in STSs, suggesting that PTEN expression may be lost by alternative mechanisms such as methylation. In order to reveal whether aberrant PTEN methylation occurs in STSs, MassARRAY Spectrometry was carried to detect methylation patterns of PTEN in STSs. We evaluated methylation levels in 41 CpG sites from -2,515 to -2,186 bp (amplicon A) and -1,786 to -1,416 bp (amplicon B) relative to the translation initiation site in 110 different cases (46 cases of SRTSs, 40 cases of NRTSs, and 24 cases of normal controls). In addition, immunohistochemistry (IHC) was used to detect the loss of PTEN to determine whether PTEN alterations were responsible for decreased PTEN expression. Our data showed that expression of PTEN was diminished in 49 (57%) STSs, whereas the remaining cases (43%) were classified as high expression. Our previous results found that only 2 of 86 cases (2.3%) had a PTEN mutation suggesting that PTEN may be mainly downregulated in STSs by methylation, but not by mutation of PTEN itself. We observed that amplicon A was hypermethylated in STSs with low PTEN expression, whereas normal controls had low methylation levels (P<0.0001), which was not present in amplicon B (P>0.05), nor were there significant differences in the methylation levels in PTEN between SRTS and NRTS cases. The majority of individual CpG units within two amplicons was demonstrated to be hypermethylated. These findings indicate that PTEN hypermethylation is a common event in STSs suggesting that the inactivation of PTEN may be due to hypermethylation in the promoter of PTEN. The aberrant methylation of the CpG sites within PTEN promoter may serve as a potential candidate biomarker for STSs.	[Yin, Liang; Liu, Chun-Xia; Chen, Yun-Zhao; Hu, Jian-Ming; Jiang, Jin-Fang; Li, Hong-An; Cui, Xiao-Bin; Zhang, Wen Jie; Li, Feng] Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Yin, Liang; Liu, Chun-Xia; Chen, Yun-Zhao; Hu, Jian-Ming; Jiang, Jin-Fang; Li, Hong-An; Cui, Xiao-Bin; Zhang, Wen Jie; Li, Feng] Shihezi Univ, Sch Med, Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [Yin, Liang; Chang, Xiang-Yun; Sun, Kan] Shihezi Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Sch Med, Shihezi, Xinjiang, Peoples R China; [Cai, Wei-Juan] Shihezi Univ, Affiliated Hosp 1, Dept Clin Lab, Sch Med, Shihezi, Xinjiang, Peoples R China	Shihezi University; Shihezi University; Shihezi University; Shihezi University	Sun, K (corresponding author), Shihezi Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Sch Med, Shihezi, Xinjiang, Peoples R China.	sunkan_shz@126.com; lifeng7855@yahoo.com.cn			National Natural Science Foundation of China [30560169, 81160322/H1624]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by National Natural Science Foundation of China under the grant No. 30560169 and 81160322/H1624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bullinger L, 2010, BLOOD, V115, P636, DOI 10.1182/blood-2009-03-211003; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Ehrich M, 2006, CANCER RES, V66, P10911, DOI 10.1158/0008-5472.CAN-06-0400; Fletcher CDM, 2002, WHO CLASSIFICATION T; Furuta J, 2004, CANCER SCI, V95, P962, DOI 10.1111/j.1349-7006.2004.tb03184.x; Hino R, 2009, CANCER RES, V69, P2766, DOI 10.1158/0008-5472.CAN-08-3070; JOSEPH S, 2001, MOL CLONING LAB MANU, P461; Kawaguchi K, 2006, MODERN PATHOL, V19, P106, DOI 10.1038/modpathol.3800502; Kawaguchi K, 2005, HUM PATHOL, V36, P357, DOI 10.1016/j.humpath.2005.01.017; Kotilingam D, 2006, CA-CANCER J CLIN, V56, P282, DOI 10.3322/canjclin.56.5.282; Li HG, 2007, CANCER LETT, V253, P215, DOI 10.1016/j.canlet.2007.01.020; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Mertens F, 2010, VIRCHOWS ARCH, V456, P129, DOI 10.1007/s00428-009-0736-8; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Olk-Batz C, 2011, BLOOD, V117, P4871, DOI 10.1182/blood-2010-08-298968; Radpour R, 2008, MOL CANCER RES, V6, P1702, DOI 10.1158/1541-7786.MCR-08-0262; Saito T, 2003, INT J CANCER, V104, P175, DOI 10.1002/ijc.10918; Sjoling A, 2003, GENE CHROMOSOME CANC, V36, P70, DOI 10.1002/gcc.10143; Soria JC, 2002, CLIN CANCER RES, V8, P1178; Vanaja DK, 2009, CANCER INVEST, V27, P549, DOI 10.1080/07357900802620794; Yin L, 2012, MOL MED REP, V5, P457, DOI 10.3892/mmr.2011.660; Zhu Y, 2001, NATL MED J CHINA, V81, P715; Zysman MA, 2002, AM J PATHOL, V160, P795, DOI 10.1016/S0002-9440(10)64902-4	23	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e62971	10.1371/journal.pone.0062971	http://dx.doi.org/10.1371/journal.pone.0062971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690972	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900020
J	You, YB; Bai, LJ; Dai, RW; Cheng, H; Liu, ZY; Wei, WJ; Tian, J				You, Youbo; Bai, Lijun; Dai, Ruwei; Cheng, Hao; Liu, Zhenyu; Wei, Wenjuan; Tian, Jie			Altered Hub Configurations within Default Mode Network following Acupuncture at ST36: A Multimodal Investigation Combining fMRI and MEG	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; FUNCTIONAL MRI DATA; BRAIN ACTIVITY; CONNECTIVITY PATTERNS; TEMPORAL CORRELATIONS; CORTEX; STATE; MAGNETOENCEPHALOGRAPHY; SYNCHRONIZATION; ORGANIZATION	Acupuncture, an externally somatosensory stimulation in the Traditional Chinese Medicine, has been proposed about its modulations on the brain's default mode network (DMN). However, it is still unknown on how the internal brain resting networks are modulated and what inferences can be made about the physiological processes underlying these changes. Combining high spatial resolution of functional magnetic resonance imaging (fMRI) with high temporal resolution of magnetoencephalography (MEG), in the current multimodal study, we sought to explore spatiotemporally whether or not band- specific DMN hub configurations would be induced by verum acupuncture, compared with sham control. Spatial independent component analysis was applied to fMRI data, followed by the discrete regional sources seeded into MEG data. Partial correlation analysis was further adopted to estimate the intrinsic functional connectivity and network hub configurations. One of the most striking findings is that the posterior cingulate cortex is not only validated as a robust DMN hub, but served as a hub only within the delta and gamma bands following the verum acupuncture, compared with its consistently being a DMN hub in sham control group. Our preliminary results may provide a new perspective to lend support for the specificity of neural mechanism underlying acupuncture.	[You, Youbo; Bai, Lijun; Dai, Ruwei; Liu, Zhenyu; Wei, Wenjuan; Tian, Jie] Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging & Funct Imaging, Beijing, Peoples R China; [Tian, Jie] Xidian Univ, Sch Elect Engn, Life Sci Res Ctr, Xian, Saarbrucken, Peoples R China; [Cheng, Hao] Capital Med Univ, Beijing Ditan Hosp, Dept Anesthesiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Xidian University; Capital Medical University	Bai, LJ (corresponding author), Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging & Funct Imaging, Beijing, Peoples R China.	bailj4152615@gmail.com; tian@ieee.org	Tian, Jie/H-1190-2011; tian, jie/M-6336-2013; Bai, Lijun/C-5119-2015; Liu, Zhenyu/G-8444-2018	Tian, Jie/0000-0003-0498-0432; Bai, Lijun/0000-0001-8790-5424; Liu, Zhenyu/0000-0001-7559-8519	National Basic Research Program of China (973 Program) [2011CB707700]; National Natural Science Foundation of China [81227901, 61231004, 30970771, 81000640, 81171314, 30970769, 81071217]; Fundamental Research Funds for the Central Universities [2011JBM226]; NIH [R01HD046526, R01HD060595]; Beijing Nova program [Z111101054511116]; Beijing Natural Science Foundation [4122082]; Chinese Academy of Sciences [2010Y2GA03, 2012T1G0036, 2010T2G36, 2012T1G0039]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060595, R01HD046526] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beijing Nova program(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This paper is supported by the National Basic Research Program of China (973 Program) under Grant 2011CB707700, the National Natural Science Foundation of China under Grant No. 81227901, 61231004, 30970771, 81000640, 81171314, 30970769, 81071217, the Fundamental Research Funds for the Central Universities (2011JBM226) and NIH (R01HD046526 & R01HD060595), the Beijing Nova program (grant number Z111101054511116), and Beijing Natural Science Foundation (grant number 4122082), the Fellowship for Young International Scientists of the Chinese Academy of Sciences under Grant No. 2010Y2GA03, the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists under Grant No. 2012T1G0036, 2010T2G36, 2012T1G0039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; ANDERSON KL, 2011, NEUROSCIENCE; Bai LJ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-73; Bai LJ, 2009, HUM BRAIN MAPP, V30, P3445, DOI 10.1002/hbm.20769; Bai LJ, 2009, BRAIN RES, V1279, P37, DOI 10.1016/j.brainres.2009.04.056; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Benjamini Y, 2001, ANN STAT, V29, P1165; Birch S., 2003, CLIN ACUPUNCT ORIENT, V4, P59, DOI DOI 10.1016/S1461-1449(03)00025-2; Brinkhaus B, 2006, ARCH INTERN MED, V166, P450; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Castelli F, 2006, P NATL ACAD SCI USA, V103, P4693, DOI 10.1073/pnas.0600444103; Chen L, 1998, ANESTH ANALG, V87, P1129, DOI 10.1097/00000539-199811000-00028; Cho ZH, 1998, P NATL ACAD SCI USA, V95, P2670, DOI 10.1073/pnas.95.5.2670; COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; Del Gratta C, 2002, NEUROIMAGE, V17, P1373, DOI 10.1006/nimg.2002.1253; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Douw L, 2011, NEUROSCIENCE, V175, P169, DOI 10.1016/j.neuroscience.2010.11.039; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friston K., 2007, STAT PARAMETRIC MAPP, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; GHUMAN AS, 2011, NEUROIMAGE; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hahn A, 2012, P NATL ACAD SCI USA, V109, P2619, DOI 10.1073/pnas.1117104109; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Han JS, 2011, PAIN, V152, pS41, DOI 10.1016/j.pain.2010.10.012; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Hui KKS, 2009, BRAIN RES, V1287, P84, DOI 10.1016/j.brainres.2009.06.061; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Hyvarinen A, 2009, COMPUT IMAGING VIS, V39, P151; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Keil A, 2009, HUM BRAIN MAPP, V30, P532, DOI 10.1002/hbm.20521; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; Lewith GT, 2005, EVID-BASED COMPL ALT, V2, P315, DOI 10.1093/ecam/neh110; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Linde K, 2005, JAMA-J AM MED ASSOC, V293, P2118, DOI 10.1001/jama.293.17.2118; Liu AK, 1998, P NATL ACAD SCI USA, V95, P8945, DOI 10.1073/pnas.95.15.8945; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039342; Liu P, 2009, NEUROSCI LETT, V462, P183, DOI 10.1016/j.neulet.2009.07.015; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; Marrelec G, 2007, MAGN RESON IMAGING, V25, P1181, DOI 10.1016/j.mri.2007.02.012; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayer DJ, 2000, ANNU REV MED, V51, P49, DOI 10.1146/annurev.med.51.1.49; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; Melchart D, 2005, BMJ-BRIT MED J, V331, P376, DOI 10.1136/bmj.38512.405440.8F; Miao XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025546; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Nihashi T, 2001, NEUROIMAGE, V13, P295, DOI 10.1006/nimg.2000.0695; Qin W, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-19; Qin W, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-55; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; RICHARDSON P, 1986, PAIN; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Scherg Michael, 1992, Brain Topography, V5, P103, DOI 10.1007/BF01129037; Sherman KJ, 2002, J ALTERN COMPLEM MED, V8, P11, DOI 10.1089/107555302753507140; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stoffers D, 2007, BRAIN, V130, P1847, DOI 10.1093/brain/awm034; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Whittaker J., 1990, GRAPHICAL MODELS APP; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; WITT CM, 2012, PLOS ONE, P7; XING C, 1987, CHINESE ACUPUNCTURE; You YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049250; Zhang Y, 2010, J COGNITIVE NEUROSCI, V22, P307, DOI 10.1162/jocn.2009.21247	91	21	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64509	10.1371/journal.pone.0064509	http://dx.doi.org/10.1371/journal.pone.0064509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691237	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900105
J	Deitloff, J; Johnson, VM; Guyer, C				Deitloff, Jennifer; Johnson, Valerie M.; Guyer, Craig			Bold Colors in a Cryptic Lineage: Do Eastern Indigo Snakes Exhibit Color Dimorphism?	PLOS ONE			English	Article							SEXUAL DICHROMATISM; CAROTENOID-PIGMENTS; GENETIC-BASIS; GARTER SNAKE; EVOLUTION; POLYMORPHISM; POPULATIONS; DIVERGENCE; MUTATIONS; SERPENTES	Many species exhibit variation in the color of their scales, feathers, or fur. Various forms of natural selection, such as mimicry, crypsis, and species recognition, as well as sexual selection, can influence the evolution of color. Eastern Indigo Snakes (Drymarchon couperi), a federally threatened species, have coloration on the sides of the head and the chin that can vary from black to red or cream. Despite significant conservations efforts for this species, little is known about its biology in the field. Past researchers have proposed that the color variation on the head and chin is associated with the sex of the individual. Alternatively, color might vary among individuals because it is controlled by genes that are under natural selection or neutral evolution. We tested these alternative hypotheses by examining whether coloration of the sublabial, submaxillary, and ventral scales of this species differed by sex or among clutches. We used color spectrometry to characterize important aspects of color in two ways: by examining overall color differences across the entire color spectrum and by comparing differences within the ultraviolet, yellow, and red colorbands. We found that Eastern Indigo Snakes do not exhibit sexual dichromatism, but their coloration does vary among clutches; therefore, the pattern of sexual selection leading to sexual dichromatism observed in many squamates does not appear to play a role in the evolution and maintenance of color variation in Eastern Indigo Snakes. We suggest that future studies should focus on determining whether color variation in these snakes is determined by maternal effects or genetic components and if color is influenced by natural selection or neutral evolutionary processes. Studying species that exhibit bright colors within lineages that are not known for such coloration will contribute greatly to our understanding of the evolutionary and ecological factors that drive these differences.	[Deitloff, Jennifer; Johnson, Valerie M.; Guyer, Craig] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Deitloff, Jennifer] Iowa State Univ, Dept Entomol, Ames, IA USA	Auburn University System; Auburn University; Iowa State University	Deitloff, J (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	jenneymd@gmail.com						Andersson Malte, 1994; Apesteguia S, 2006, NATURE, V440, P1037, DOI 10.1038/nature04413; Baiao PC, 2007, J HERED, V98, P287, DOI 10.1093/jhered/esm030; BECHTEL HB, 1985, J HERED, V76, P7, DOI 10.1093/oxfordjournals.jhered.a110026; BECHTEL HB, 1989, J HERED, V80, P272, DOI 10.1093/oxfordjournals.jhered.a110853; Blount JD, 2004, P ROY SOC B-BIOL SCI, V271, pS79, DOI 10.1098/rsbl.2003.0104; Boback SM, 2010, J HERPETOL, V44, P506, DOI 10.1670/09-026.1; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Caprette CL, 2004, BIOL J LINN SOC, V81, P469, DOI 10.1111/j.1095-8312.2003.00305.x; Cooper W.E. Jr, 1992, P298; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Farallo VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030316; Fleishman Leo J., 2000, P209; GARRETT CM, 1994, ZOO BIOL, V13, P45, DOI 10.1002/zoo.1430130106; Grill CP, 2000, BIOL J LINN SOC, V69, P121, DOI 10.1006/bijl.1999.0360; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Heinsohn R, 2005, SCIENCE, V309, P617, DOI 10.1126/science.1112774; Hill G. E., 2006, BIRD COLORATION, V2; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Houde A.E., 1997, SEX COLOR MATE CHOIC; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Hyslop N. L., 2007, MOVEMENTS HABITAT US; JACOB J S, 1977, Journal of Herpetology, V11, P81, DOI 10.2307/1563295; Kikuchi DW, 2012, CURR ZOOL, V58, P658, DOI 10.1093/czoolo/58.4.658; Lindell LE, 1996, CAN J ZOOL, V74, P2254, DOI 10.1139/z96-256; Macedonia JM, 2004, J HERPETOL, V38, P340, DOI 10.1670/183-03A; Macedonia JM, 2000, J HERPETOL, V34, P99, DOI 10.2307/1565245; Manier MK, 2007, J EVOLUTION BIOL, V20, P1705, DOI 10.1111/j.1420-9101.2007.01401.x; McGraw K.J., 2006, BIRD COLORATION, P354; McGraw KJ, 2005, NATURWISSENSCHAFTEN, V92, P375, DOI 10.1007/s00114-005-0003-z; Montgomerie Robert, 2006, P90; Moulis R, 1976, HERP B NEW YORK HERP, V12, P14; Mount R. H., 1975, REPTILES AMPHIBIANS; Nicholson KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000274; O'Neill EM, 2010, J HERED, V101, P703, DOI 10.1093/jhered/esq082; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; RALPH CL, 1969, AM ZOOL, V9, P521; ROBINSON M D, 1978, Madoqua, V11, P81; Rosenblum EB, 2004, EVOLUTION, V58, P1794, DOI 10.1111/j.0014-3820.2004.tb00462.x; SHINE R, 1994, J HERPETOL, V28, P114, DOI 10.2307/1564692; Shine R, 1998, OECOLOGIA, V116, P113, DOI 10.1007/s004420050569; Shine Richard, 1993, P49; Siefferman L, 2005, EVOLUTION, V59, P1819, DOI 10.1111/j.0014-3820.2005.tb01828.x; Siefferman L, 2003, BEHAV ECOL, V14, P855, DOI 10.1093/beheco/arg063; Siefferman L, 2005, ANIM BEHAV, V69, P67, DOI 10.1016/j.anbehav.2003.12.026; Sillman AJ, 1997, J COMP PHYSIOL A, V181, P89, DOI 10.1007/s003590050096; Skarstein F, 1996, OIKOS, V76, P359, DOI 10.2307/3546208; Steffen JE, 2007, COMP BIOCHEM PHYS B, V146, P42, DOI 10.1016/j.cbpb.2006.08.017; Steffen JE, 2010, COPEIA, P239, DOI 10.1643/CP-09-067; Steffen JE, 2009, COMP BIOCHEM PHYS B, V154, P334, DOI 10.1016/j.cbpb.2009.07.009; Stuart-Fox DM, 2004, P ROY SOC B-BIOL SCI, V271, P2249, DOI 10.1098/rspb.2004.2802; Tanaka K, 2008, ACTA ZOOL-STOCKHOLM, V89, P211, DOI 10.1111/j.1463-6395.2007.00309.x; Tansley K., 1965, pi; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; Wilson D, 2007, BIOL LETT-UK, V3, P40, DOI 10.1098/rsbl.2006.0574; Zaidan III F, 2001, HERPETOL NAT HIST, V8, P77; Zuffi MAL, 2008, AMPHIBIA-REPTILIA, V29, P229, DOI 10.1163/156853808784124929	58	4	4	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64538	10.1371/journal.pone.0064538	http://dx.doi.org/10.1371/journal.pone.0064538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691245	gold, Green Published, Green Submitted			2022-12-25	WOS:000319052700107
J	Dusane, DH; Damare, SR; Nancharaiah, YV; Ramaiah, N; Venugopalan, VP; Kumar, AR; Zinjarde, SS				Dusane, Devendra H.; Damare, Samir R.; Nancharaiah, Yarlagadda V.; Ramaiah, N.; Venugopalan, Vayalam P.; Kumar, Ameeta Ravi; Zinjarde, Smita S.			Disruption of Microbial Biofilms by an Extracellular Protein Isolated from Epibiotic Tropical Marine Strain of Bacillus licheniformis	PLOS ONE			English	Article							PURIFICATION; BACTERIOCIN; MICROORGANISMS; METABOLITES; ORGANISMS; COMPOUND; FUNGAL	Background: Marine epibiotic bacteria produce bioactive compounds effective against microbial biofilms. The study examines antibiofilm ability of a protein obtained from a tropical marine strain of Bacillus licheniformis D1. Methodology/Principal Findings: B. licheniformis strain D1 isolated from the surface of green mussel, Perna viridis showed antimicrobial activity against pathogenic Candida albicans BH, Pseudomonas aeruginosa PAO1 and biofouling Bacillus pumilus TiO1 cultures. The antimicrobial activity was lost after treatment with trypsin and proteinase K. The protein was purified by ultrafiltration and size-exclusion chromatography. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and matrix assisted laser desorption/ionization-time of flight (MALDI-TOF) analysis revealed the antimicrobial agent to be a 14 kDa protein designated as BL-DZ1. The protein was stable at 75uC for 30 min and over a pH range of 3.0 to 11.0. The sequence alignment of the MALDI-fingerprint showed homology with the NCBI entry for a hypothetical protein (BL00275) derived from B. licheniformis ATCC 14580 with the accession number gi52082584. The protein showed minimum inhibitory concentration (MIC) value of 1.6 mg/ml against C. albicans. Against both P. aeruginosa and B. pumilus the MIC was 3.12 mg/ml. The protein inhibited microbial growth, decreased biofilm formation and dispersed pre-formed biofilms of the representative cultures in polystyrene microtiter plates and on glass surfaces. Conclusion/Significance: We isolated a protein from a tropical marine strain of B. licheniformis, assigned a function to the hypothetical protein entry in the NCBI database and described its application as a potential antibiofilm agent.	[Dusane, Devendra H.; Kumar, Ameeta Ravi; Zinjarde, Smita S.] Univ Pune, Inst Bioinformat & Biotechnol, Pune, Maharashtra, India; [Damare, Samir R.; Ramaiah, N.] Natl Inst Oceanog, Gene Lab, Panaji, Goa, India; [Nancharaiah, Yarlagadda V.; Venugopalan, Vayalam P.] BARC Facil, Water & Steam Chem Div, Biofouling & Biofilm Proc Sect, Kalpakkam, Tamil Nadu, India	Savitribai Phule Pune University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Bhabha Atomic Research Center (BARC)	Zinjarde, SS (corresponding author), Univ Pune, Inst Bioinformat & Biotechnol, Pune, Maharashtra, India.	smita@unipune.ac.in	Dusane, PhD, Devendra/AAZ-9820-2021; Dusane, Devendra/P-9829-2018; Damare, Samir R/C-3493-2009; Ramaiah, Nagappa/AAV-3530-2021; Yarlagadda, Venkata Nancharaiah/B-2036-2012	Dusane, Devendra/0000-0003-4340-6214; Damare, Samir/0000-0002-4201-4844; Yarlagadda, Nancharaiah/0000-0002-6443-7661	BARC-UOP program; University Grants Commission-UPE Phase II	BARC-UOP program(Department of Atomic Energy (DAE)); University Grants Commission-UPE Phase II	This study was supported by a grant of the BARC-UOP program and University Grants Commission-UPE Phase II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Bahry S, 2012, ASIAN PAC J TROP MED, V5, P265, DOI 10.1016/S1995-7645(12)60037-6; Asaduzzaman SM, 2009, J BIOSCI BIOENG, V107, P475, DOI 10.1016/j.jbiosc.2009.01.003; Bernan VS, 1997, ADV APPL MICROBIOL, V43, P57, DOI 10.1016/S0065-2164(08)70223-5; BRYERS JD, 1982, BIOTECHNOL BIOENG, V24, P2451, DOI 10.1002/bit.260241111; D'Arezzo Silvia, 2012, BMC Res Notes, V5, P43, DOI 10.1186/1756-0500-5-43; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; de Carvalho CCCR, 2010, MAR DRUGS, V8, P705, DOI 10.3390/md8030705; Dheilly A, 2010, APPL ENVIRON MICROB, V76, P3452, DOI 10.1128/AEM.02632-09; Dischinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006788; Dobretsov S, 2006, BIOFOULING, V22, P43, DOI 10.1080/08927010500504784; Dobretsov S, 2009, BIOFOULING, V25, P413, DOI 10.1080/08927010902853516; Dusane DH, 2008, LETT APPL MICROBIOL, V47, P374, DOI 10.1111/j.1472-765X.2008.02440.x; Dusane Devendra H, 2011, Biofouling, V27, P645, DOI 10.1080/08927014.2011.594883; Dusane DH, 2011, CURR MICROBIOL, V62, P974, DOI 10.1007/s00284-010-9812-1; Dusane DH, 2010, COLLOID SURFACE B, V81, P242, DOI 10.1016/j.colsurfb.2010.07.013; He LL, 2006, MICROBIOL RES, V161, P321, DOI 10.1016/j.micres.2005.12.002; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Holmstrom C, 1998, INT J SYST BACTERIOL, V48, P1205, DOI 10.1099/00207713-48-4-1205; Iken K. B., 2000, Journal of Phycology, V36, P33, DOI 10.1046/j.1529-8817.1999.00001-99.x; Jamal MT, 2006, MAR BIOTECHNOL, V8, P587, DOI 10.1007/s10126-005-6160-4; James SG, 1996, APPL ENVIRON MICROB, V62, P2783, DOI 10.1128/AEM.62.8.2783-2788.1996; JENSEN PR, 1994, ANNU REV MICROBIOL, V48, P559, DOI 10.1146/annurev.mi.48.100194.003015; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P1490; Jiang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018514; Kayalvizhi N, 2008, LETT APPL MICROBIOL, V47, P600, DOI 10.1111/j.1472-765X.2008.02473.x; Kayalvizhi N, 2010, BIOTECHNOL BIOPROC E, V15, P365, DOI 10.1007/s12257-009-0164-2; Kiran GS, 2010, FEMS IMMUNOL MED MIC, V59, P432, DOI 10.1111/j.1574-695X.2010.00698.x; Korenblum E, 2008, APPL MICROBIOL BIOT, V79, P97, DOI 10.1007/s00253-008-1401-x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTIN D, 1993, J EXP MAR BIOL ECOL, V173, P11, DOI 10.1016/0022-0981(93)90205-3; Martirani L, 2002, MICROB CELL FACT, V1, DOI 10.1186/1475-2859-1-1; Miao L, 2005, AQUAT MICROB ECOL, V38, P231, DOI 10.3354/ame038231; Mtolera M.S.P., 1996, CURRENT TRENDS MARIN, P211; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015668; Nithya C, 2011, BIOFOULING, V27, P519, DOI 10.1080/08927014.2011.586127; Nithya C, 2010, APPL MICROBIOL BIOT, V88, P341, DOI 10.1007/s00253-010-2777-y; Pattnaik P, 2001, J APPL MICROBIOL, V91, P636, DOI 10.1046/j.1365-2672.2001.01429.x; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; RITTSCHOF D, 1986, B MAR SCI, V39, P376; Rivardo F, 2009, APPL MICROBIOL BIOT, V83, P541, DOI 10.1007/s00253-009-1987-7; Rogers SA, 2010, CHEMBIOCHEM, V11, P396, DOI 10.1002/cbic.200900617; Sapna Sharma, 2010, Journal of Microbiology and Antimicrobials, V2, P127; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tendulkar SR, 2007, J APPL MICROBIOL, V103, P2331, DOI 10.1111/j.1365-2672.2007.03501.x; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; WAHL M, 1994, MAR ECOL PROG SER, V110, P45, DOI 10.3354/meps110045	49	33	34	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64501	10.1371/journal.pone.0064501	http://dx.doi.org/10.1371/journal.pone.0064501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691235	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700103
J	Ma, J; Dankulich-Nagrudny, L; Lowe, G				Ma, Jie; Dankulich-Nagrudny, Luba; Lowe, Graeme			Cholecystokinin: An Excitatory Modulator of Mitral/Tufted Cells in the Mouse Olfactory Bulb	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INTRABULBAR ASSOCIATIONAL SYSTEM; EXTERNAL TUFTED CELLS; RAT-BRAIN; MITRAL CELLS; BINDING-SITES; GUINEA-PIG; AUTORADIOGRAPHIC LOCALIZATION; B-RECEPTOR; MOLECULAR HETEROGENEITY	Cholecystokinin (CCK) is widely distributed in the brain as a sulfated octapeptide (CCK-8S). In the olfactory bulb, CCK-8S is concentrated in two laminae: an infraglomerular band in the external plexiform layer, and an inframitral band in the internal plexiform layer (IPL), corresponding to somata and terminals of superficial tufted cells with intrabulbar projections linking duplicate glomerular maps of olfactory receptors. The physiological role of CCK in this circuit is unknown. We made patch clamp recordings of CCK effects on mitral cell spike activity in mouse olfactory bulb slices, and applied immunohistochemistry to localize CCKB receptors. In cell-attached recordings, mitral cells responded to 300 nM -1 mu M CCK-8S by spike excitation, suppression, or mixed excitation-suppression. Antagonists of GABA(A) and ionotropic glutamate receptors blocked suppression, but excitation persisted. Whole-cell recordings revealed that excitation was mediated by a slow inward current, and suppression by spike inactivation or inhibitory synaptic input. Similar responses were elicited by the CCKB receptor-selective agonist CCK-4 (1 mM). Excitation was less frequent but still occurred when CCKB receptors were blocked by LY225910, or disrupted in CCKB knockout mice, and was also observed in CCKA knockouts. CCKB receptor immunoreactivity was detected on mitral and superficial tufted cells, colocalized with Tbx21, and was absent from granule cells and the IPL. Our data indicate that CCK excites mitral cells postsynaptically, via both CCKA and CCKB receptors. We hypothesize that extrasynaptic CCK released from tufted cell terminals in the IPL may diffuse to and directly excite mitral cell bodies, creating a positive feedback loop that can amplify output from pairs of glomeruli receiving sensory inputs encoded by the same olfactory receptor. Dynamic plasticity of intrabulbar projections suggests that this could be an experience-dependent amplification mechanism for tuning and optimizing olfactory bulb signal processing in different odor environments.	[Ma, Jie; Dankulich-Nagrudny, Luba; Lowe, Graeme] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Lowe, G (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	loweg@monell.org		Ma, Jie/0000-0001-7386-5214	U.S. Public Health Service Grants from the National Institute of Deafness and other Communication Disorders; National Institutes of Health U.S. Department of Health & Human Services, U.S.A. [5R01DC004208-09]; ARRA (Core Center for Chemical Senses) [R01DC004208-062S1, 1P30DC011735-01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC011735, R01DC004208] Funding Source: NIH RePORTER	U.S. Public Health Service Grants from the National Institute of Deafness and other Communication Disorders; National Institutes of Health U.S. Department of Health & Human Services, U.S.A.; ARRA (Core Center for Chemical Senses); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Work reported here was supported by U.S. Public Health Service Grants from the National Institute of Deafness and other Communication Disorders (http://www.nidcd.nih.gov), National Institutes of Health, U.S. Department of Health & Human Services, U.S.A.: 5R01DC004208-09 (GL), ARRA award R01DC004208-062S1 (GL) and 1P30DC011735-01 (Core Center for Chemical Senses). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott L. F., 2001, THEORETICAL NEUROSCI; Angelo K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00050; Baltanas FC, 2011, J NEUROSCI RES, V89, P35, DOI 10.1002/jnr.22521; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; CARLBERG M, 1992, EUR J NEUROSCI, V4, P563, DOI 10.1111/j.1460-9568.1992.tb00906.x; Carlson GC, 2000, J NEUROSCI, V20, P2011; Chung L, 2009, BRAIN RES, V1282, P10, DOI 10.1016/j.brainres.2009.05.061; Chung L, 2009, J NEUROPHYSIOL, V102, P272, DOI 10.1152/jn.90769.2008; COX CL, 1995, J NEUROPHYSIOL, V74, P990, DOI 10.1152/jn.1995.74.3.990; Cummings DM, 2010, J NEUROSCI, V30, P9172, DOI 10.1523/JNEUROSCI.1717-10.2010; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Deng PY, 2010, J NEUROSCI, V30, P5136, DOI 10.1523/JNEUROSCI.5711-09.2010; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; DIETL MM, 1987, SYNAPSE, V1, P169, DOI 10.1002/syn.890010205; Driesang RB, 2000, NEUROREPORT, V11, P1703, DOI 10.1097/00001756-200006050-00022; DURIEUX C, 1988, NEUROPEPTIDES, V12, P141, DOI 10.1016/0143-4179(88)90045-5; Faedo A, 2002, MECH DEVELOP, V116, P157, DOI 10.1016/S0925-4773(02)00114-4; FALLON JH, 1985, ANN NY ACAD SCI, V448, P121, DOI 10.1111/j.1749-6632.1985.tb29912.x; Fletcher ML, 2009, J NEUROPHYSIOL, V102, P817, DOI 10.1152/jn.00020.2009; Fossa AA, 1997, J PHARMACOL EXP THER, V281, P180; Gire DH, 2012, J NEUROSCI, V32, P2964, DOI 10.1523/JNEUROSCI.5580-11.2012; Gutierrez-Mecinas M, 2005, J COMP NEUROL, V489, P467, DOI 10.1002/cne.20649; Hays W.L., 1963, STAT PSYCHOLOGISTS; Heyward P, 2001, J NEUROSCI, V21, P5311, DOI 10.1523/JNEUROSCI.21-14-05311.2001; HONDA T, 1993, MOL CELL NEUROSCI, V4, P143, DOI 10.1006/mcne.1993.1018; Hosoya O, 2004, J PHARM PHARMACOL, V56, P1501, DOI 10.1211/0022357044878; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; INGRAM SM, 1989, J COMP NEUROL, V287, P260, DOI 10.1002/cne.902870209; INNIS RB, 1979, P NATL ACAD SCI USA, V76, P521, DOI 10.1073/pnas.76.1.521; Kosaka T, 2007, NEUROSCI RES, V57, P165, DOI 10.1016/j.neures.2006.10.005; Kosaka T, 2012, NEUROSCI RES, V73, P24, DOI 10.1016/j.neures.2012.02.013; Langhans N, 1997, GASTROENTEROLOGY, V112, P280, DOI 10.1016/S0016-5085(97)90000-7; LARSSON LI, 1979, BRAIN RES, V165, P201, DOI 10.1016/0006-8993(79)90554-7; Lee SY, 2011, J NEUROSCI, V31, P10993, DOI 10.1523/JNEUROSCI.1970-11.2011; Lee SY, 2011, DEV NEUROBIOL, V71, P83, DOI 10.1002/dneu.20815; LIU WL, 1994, J COMP NEUROL, V346, P541, DOI 10.1002/cne.903460407; Lodovichi C, 2003, NEURON, V38, P265, DOI 10.1016/S0896-6273(03)00194-6; Ma J, 2007, NEUROSCIENCE, V144, P1094, DOI 10.1016/j.neuroscience.2006.10.041; Ma J, 2004, J NEUROSCI, V24, P9341, DOI 10.1523/JNEUROSCI.1782-04.2004; Ma J, 2010, NEUROSCIENCE, V169, P1715, DOI 10.1016/j.neuroscience.2010.06.033; MACRIDES F, 1982, J COMP NEUROL, V208, P419, DOI 10.1002/cne.902080410; Marks CA, 2006, J NEUROSCI, V26, P11257, DOI 10.1523/JNEUROSCI.2805-06.2006; MATSUTANI S, 1988, J COMP NEUROL, V272, P331, DOI 10.1002/cne.902720304; Meis S, 2007, MOL CELL NEUROSCI, V35, P356, DOI 10.1016/j.mcn.2007.03.012; Mercer LD, 2000, NEUROSCI LETT, V293, P167, DOI 10.1016/S0304-3940(00)01504-4; Mercer LD, 2004, NEUROSCI LETT, V359, P109, DOI 10.1016/j.neulet.2004.01.045; Mercer LD, 1997, NEUROSCI LETT, V225, P97, DOI 10.1016/S0304-3940(97)00197-3; MICELI MO, 1989, EUR J PHARMACOL, V169, P215, DOI 10.1016/0014-2999(89)90018-6; Mitsui S, 2011, NEURAL SYSTEMS CIRCU, V1, P1; Mohammad S, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416214; MORENCY MA, 1991, PROG NEURO-PSYCHOPH, V15, P291, DOI 10.1016/0278-5846(91)90095-I; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Nassel DR, 2009, INVERTEBR NEUROSCI, V9, P57, DOI 10.1007/s10158-009-0090-1; NIEHOFF DL, 1989, PEPTIDES, V10, P265, DOI 10.1016/0196-9781(89)90029-6; Noble F, 1999, PROG NEUROBIOL, V58, P349, DOI 10.1016/S0301-0082(98)00090-2; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Rasband WS, 1997, IMAGEJ; Rehfeld JF, 2007, CURR TOP MED CHEM, V7, P1154; REHFELD JF, 1978, J BIOL CHEM, V253, P4022; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; ROBBERECHT P, 1978, P NATL ACAD SCI USA, V75, P524, DOI 10.1073/pnas.75.1.524; Rubin DB, 2006, J NEUROPHYSIOL, V96, P555, DOI 10.1152/jn.00264.2006; SCHIFFMANN SN, 1991, J COMP NEUROL, V304, P219, DOI 10.1002/cne.903040206; SCHOENFELD TA, 1985, J COMP NEUROL, V235, P503, DOI 10.1002/cne.902350408; SEROOGY KB, 1985, J COMP NEUROL, V239, P373, DOI 10.1002/cne.902390403; Shao ZY, 2012, J NEUROPHYSIOL, V108, P782, DOI 10.1152/jn.00119.2012; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; SumanChauhan N, 1996, REGUL PEPTIDES, V65, P37, DOI 10.1016/0167-0115(96)00070-5; Tsujino N, 2005, J NEUROSCI, V25, P7459, DOI 10.1523/JNEUROSCI.1193-05.2005; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VANDERHAEGHEN JJ, 1975, NATURE, V257, P604, DOI 10.1038/257604a0; VANDERHAEGHEN JJ, 1980, P NATL ACAD SCI-BIOL, V77, P1190, DOI 10.1073/pnas.77.2.1190; VANDIJK A, 1984, J NEUROSCI, V4, P1021; Wang SP, 2011, J NEUROPHYSIOL, V106, P1515, DOI 10.1152/jn.00025.2011; Wank SA, 1998, AM J PHYSIOL-GASTR L, V274, pG607, DOI 10.1152/ajpgi.1998.274.4.G607; WANK SA, 1994, ANN NY ACAD SCI, V713, P49, DOI 10.1111/j.1749-6632.1994.tb44052.x; ZARBIN MA, 1983, J NEUROSCI, V3, P877; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhou ZS, 2008, J NEUROSCI, V28, P9920, DOI 10.1523/JNEUROSCI.3082-08.2008; Zhou ZS, 2012, CELL REP, V2, P1143, DOI 10.1016/j.celrep.2012.09.035; Zibman S, 2011, NEUROSCIENCE, V189, P51, DOI 10.1016/j.neuroscience.2011.05.039	82	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64170	10.1371/journal.pone.0064170	http://dx.doi.org/10.1371/journal.pone.0064170			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691163	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700083
J	Mobley, A; Linder, SK; Braeuer, R; Ellis, LM; Zwelling, L				Mobley, Aaron; Linder, Suzanne K.; Braeuer, Russell; Ellis, Lee M.; Zwelling, Leonard			A Survey on Data Reproducibility in Cancer Research Provides Insights into Our Limited Ability to Translate Findings from the Laboratory to the Clinic	PLOS ONE			English	Article								Background: The pharmaceutical and biotechnology industries depend on findings from academic investigators prior to initiating programs to develop new diagnostic and therapeutic agents to benefit cancer patients. The success of these programs depends on the validity of published findings. This validity, represented by the reproducibility of published findings, has come into question recently as investigators from companies have raised the issue of poor reproducibility of published results from academic laboratories. Furthermore, retraction rates in high impact journals are climbing. Methods and Findings: To examine a microcosm of the academic experience with data reproducibility, we surveyed the faculty and trainees at MD Anderson Cancer Center using an anonymous computerized questionnaire; we sought to ascertain the frequency and potential causes of non-reproducible data. We found that, similar to 50% of respondents had experienced at least one episode of the inability to reproduce published data; many who pursued this issue with the original authors were never able to identify the reason for the lack of reproducibility; some were even met with a less than "collegial'' interaction. Conclusions: These results suggest that the problem of data reproducibility is real. Biomedical science needs to establish processes to decrease the problem and adjudicate discrepancies in findings when they are discovered.	[Mobley, Aaron; Braeuer, Russell; Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Linder, Suzanne K.] Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Houston, TX 77030 USA; [Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Zwelling, Leonard] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ellis, LM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	lellis@mdanderson.org; lzwellin@mdanderson.org						Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Fang FC, 2012, P NATL ACAD SCI USA, V109, P17028, DOI 10.1073/pnas.1212247109; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Neaves W., 2012, NATURE, V488, P121, DOI DOI 10.1038/NJ7409-121A; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Zimmer C, 2012, NY TIMES	6	98	99	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63221	10.1371/journal.pone.0063221	http://dx.doi.org/10.1371/journal.pone.0063221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691000	gold, Green Published			2022-12-25	WOS:000319052700026
J	Drexler, M; Ainsworth, CH				Drexler, Michael; Ainsworth, Cameron H.			Generalized Additive Models Used to Predict Species Abundance in the Gulf of Mexico: An Ecosystem Modeling Tool	PLOS ONE			English	Article							MARINE ECOSYSTEM; FISH; BATHYMETRY; HABITAT	Spatially explicit ecosystem models of all types require an initial allocation of biomass, often in areas where fisheries independent abundance estimates do not exist. A generalized additive modelling (GAM) approach is used to describe the abundance of 40 species groups (i.e. functional groups) across the Gulf of Mexico (GoM) using a large fisheries independent data set (SEAMAP) and climate scale oceanographic conditions. Predictor variables included in the model are chlorophyll a, sediment type, dissolved oxygen, temperature, and depth. Despite the presence of a large number of zeros in the data, a single GAM using a negative binomial distribution was suitable to make predictions of abundance for multiple functional groups. We present an example case study using pink shrimp (Farfantepenaeus duroarum) and compare the results to known distributions. The model successfully predicts the known areas of high abundance in the GoM, including those areas where no data was inputted into the model fitting. Overall, the model reliably captures areas of high and low abundance for the large majority of functional groups observed in SEAMAP. The result of this method allows for the objective setting of spatial distributions for numerous functional groups across a modeling domain, even where abundance data may not exist.	[Drexler, Michael; Ainsworth, Cameron H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA	State University System of Florida; University of South Florida	Drexler, M (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	mdrexler@mail.usf.edu			Florida Sea Grant; Gulf of Mexico Research Initiative; C-IMAGE (Center for Integrated Modeling and Analysis of the Gulf Ecosystem) consortium; National Marine Fisheries Service/USF College of Marine Science Marine Resource Assessment fellowship	Florida Sea Grant; Gulf of Mexico Research Initiative; C-IMAGE (Center for Integrated Modeling and Analysis of the Gulf Ecosystem) consortium; National Marine Fisheries Service/USF College of Marine Science Marine Resource Assessment fellowship	The authors would like thank the funding sources: Florida Sea Grant, Gulf of Mexico Research Initiative, C-IMAGE (Center for Integrated Modeling and Analysis of the Gulf Ecosystem) consortium, and the National Marine Fisheries Service/USF College of Marine Science Marine Resource Assessment fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth C.H., 2011, NMFSNWFSC110 NOAA US; Aitchison J, 1996, LOG NORMAL DISTRIBUT; Barry SC, 2002, ECOL MODEL, V157, P179, DOI 10.1016/S0304-3800(02)00194-1; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Bielsa L. M, 1983, FWSOBS821117 US ARM; Boyer T. P., 2009, NOAA ATLAS NESDIS, V66; Buczkowski B.J., 2006, US GEOL SURV DATA SE; ESRI, 2011, ARCGIS DESKT REL 10; Fulton EA, 2004, ECOL MODEL, V173, P371, DOI 10.1016/j.ecolmodel.2003.09.024; Fulton EA, 2007, ALTERNATIVE MANAGEME; GMFMC, 2006, OPT PAP AM 15 SHRIMP; GSMFC, 2011, SEAMAP ENV BIOL ATL; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hastie T.J., 2017, STAT SCI; Jenkins C., 2011, DOMINANT BOTTOM TYPE; Katsanevakis S, 2009, FISHERIES SCI, V75, P13, DOI 10.1007/s12562-008-0033-5; Maravelias CD, 1999, CAN J FISH AQUAT SCI, V56, P437, DOI 10.1139/cjfas-56-3-437; Minami M, 2007, FISH RES, V84, P210, DOI 10.1016/j.fishres.2006.10.019; Moisen GG, 2002, ECOL MODEL, V157, P209, DOI 10.1016/S0304-3800(02)00197-7; Mulholland R., 1984, FWSOBS821076; NOAA, 2010, ANN COMM LAND STAT N; NOS, 2008, GULF MEX GLANC US NA; PENNINGTON M, 1983, BIOMETRICS, V39, P281, DOI 10.2307/2530830; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Rester J. K., 2011, SEAMAP ENV BIOL ATLA; Sherman K., 2009, UNEP REGIONAL SEAS R, V182, P255; Stefansson G, 1996, ICES J MAR SCI, V53, P577, DOI 10.1006/jmsc.1996.0079; Stoner AW, 2001, MAR ECOL PROG SER, V213, P253, DOI 10.3354/meps213253; Vidal L, 2004, OCEAN COAST MANAGE, V47, P709, DOI 10.1016/j.ocecoaman.2004.12.009; Walsh WA, 2001, FISH RES, V53, P115, DOI 10.1016/S0165-7836(00)00306-4; Warton DI, 2005, ENVIRONMETRICS, V16, P275, DOI 10.1002/env.702; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170; [No title captured]	34	87	89	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64458	10.1371/journal.pone.0064458	http://dx.doi.org/10.1371/journal.pone.0064458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691223	Green Published, gold			2022-12-25	WOS:000319107400127
J	Setterfield, SA; Rossiter-Rachor, NA; Douglas, MM; Wainger, L; Petty, AM; Barrow, P; Shepherd, IJ; Ferdinands, KB				Setterfield, Samantha A.; Rossiter-Rachor, Natalie A.; Douglas, Michael M.; Wainger, Lisa; Petty, Aaron M.; Barrow, Piers; Shepherd, Ian J.; Ferdinands, Keith B.			Adding Fuel to the Fire: The Impacts of Non-Native Grass Invasion on Fire Management at a Regional Scale	PLOS ONE			English	Article							GAYANUS GAMBA GRASS; TROPICAL SAVANNAS; NORTHERN; AGREEMENT; DYNAMICS; PLANTS; CYCLE	Background: Widespread invasion by non-native plants has resulted in substantial change in fire-fuel characteristics and fire-behaviour in many of the world's ecosystems, with a subsequent increase in the risk of fire damage to human life, property and the environment. Models used by fire management agencies to assess fire risk are dependent on accurate assessments of fuel characteristics but there is little evidence that they have been modified to reflect landscape-scale invasions. There is also a paucity of information documenting other changes in fire management activities that have occurred to mitigate changed fire regimes. This represents an important limitation in information for both fire and weed risk management. Methodology/Principal Findings: We undertook an aerial survey to estimate changes to landscape fuel loads in northern Australia resulting from invasion by Andropogon gayanus (gamba grass). Fuel load within the most densely invaded area had increased from 6 to 10 t ha(-1) in the past two decades. Assessment of the effect of calculating the Grassland Fire Danger Index (GFDI) for the 2008 and 2009 fire seasons demonstrated that an increase from 6 to 10 t ha(-1) resulted in an increase from five to 38 days with fire risk in the 'severe' category in 2008 and from 11 to 67 days in 2009. The season of severe fire weather increased by six weeks. Our assessment of the effect of increased fuel load on fire management practices showed that fire management costs in the region have increased markedly (similar to 9 times) in the past decade due primarily to A. gayanus invasion. Conclusions/Significance: This study demonstrated the high economic cost of mitigating fire impacts of an invasive grass. This study demonstrates the need to quantify direct and indirect invasion costs to assess the risk of further invasion and to appropriately fund fire and weed management strategies.	[Setterfield, Samantha A.; Rossiter-Rachor, Natalie A.; Douglas, Michael M.; Petty, Aaron M.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Wainger, Lisa] Univ Maryland, Ctr Environm Sci, Solomons, MD USA; [Barrow, Piers; Ferdinands, Keith B.] Northern Terr Dept Land Resource Management, Weed Management Branch, Darwin, NT, Australia; [Shepherd, Ian J.] Australian Bur Meteorol, Casuarina, NT, Australia	Charles Darwin University; University System of Maryland; University of Maryland Center for Environmental Science; Bureau of Meteorology - Australia	Setterfield, SA (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	samantha.setterfield@cdu.edu.au	Rossiter-Rachor, Natalie A/N-2204-2013; Douglas, Michael M/I-3149-2012; Wainger, Lisa A/H-7640-2012; Setterfield, Samantha/ABD-1481-2021	Douglas, Michael M/0000-0003-3650-3374; Wainger, Lisa A/0000-0002-3983-8850; Rossiter-Rachor, Natalie/0000-0002-1098-9428; Setterfield, Samantha/0000-0002-7470-4997	Land and Water Australia [PN22423]; Commonwealth Environmental Research Fund; Australian Weeds Research Centre [AWRC08-10]	Land and Water Australia; Commonwealth Environmental Research Fund; Australian Weeds Research Centre	Funding was provided by Land and Water Australia (Project PN22423), the Commonwealth Environmental Research Fund and the Australian Weeds Research Centre (AWRC08-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AN, 2005, AUSTRAL ECOL, V30, P155, DOI 10.1111/j.1442-9993.2005.01441.x; Andison R, 1990, DARWIN; [Anonymous], 2008, NO REGIONAL MANAGEME; [Anonymous], 2009, LISTING ADVICE KEY T; Australian Emergency Management Committee (AEMC) National Bushfires Warnings Taskforce, 2009, RESP75000010001 VICT; Balch Jennifer K., 2009, P481, DOI 10.1007/978-3-540-77381-8_17; Barrow P, 1995, ECOLOGY MANAGEMENT G; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; BOWMAN DMJS, 1988, J BIOGEOGR, V15, P807, DOI 10.2307/2845341; Brooks KJ, 2010, RESTOR ECOL, V18, P188, DOI 10.1111/j.1526-100X.2008.00470.x; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Bureau of Meteorology, 2010, FIRE WEATHER WARNING; CHENEY NP, 1993, INT J WILDLAND FIRE, V3, P31, DOI 10.1071/WF9930031; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cook GD, 2003, ECOL STU AN, V169, P47; D'Antonio Carla M., 2009, V5, P123; D'Antonio CM, 2004, FRONT ECOL ENVIRON, V2, P513; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Erdody TL, 2010, REMOTE SENS ENVIRON, V114, P725, DOI 10.1016/j.rse.2009.11.002; Flores TA, 2005, AUST J BOT, V53, P243, DOI 10.1071/BT03154; Foxcroft LC, 2010, BIOL INVASIONS, V12, P3913, DOI 10.1007/s10530-010-9823-7; Garden G, 2006, SIMPLE METHODS CALCU; Gill AM, 2010, INT J WILDLAND FIRE, V19, P338, DOI 10.1071/WF09023; Hulme PE, 2012, J APPL ECOL, V49, P10, DOI 10.1111/j.1365-2664.2011.02069.x; Hutley L. B., 2008, ENCY ECOLOGY, V4, P3143, DOI DOI 10.1016/B978-008045405-4.00358-X; Kean L, 2003, BIOLOGY, V8, P1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lippincott CL, 2000, NAT AREA J, V20, P140; Luke R.H., 1978, BUSHFIRES AUSTR; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; McArthur A, 1973, GRASSLAND FIRE DANGE; McNaught I, 2006, FIELD MANUAL SURVEYI; Northern Territory Government, 2009, WEEK RISK ASS REP AN; Northern Territory Government, 2010, BUSHF NT STAND OP PR; ORAM R, 1987, J AUST I AGR SCI, V53, P123; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Petty AM, 2012, J APPL ECOL, V49, P742, DOI 10.1111/j.1365-2664.2012.02128.x; Price O, 2003, NATURAL RESOURCE STR; Purton C, 1982, EQUATIONS MCARTHUR M; Rossiter NA, 2003, DIVERS DISTRIB, V9, P169, DOI 10.1046/j.1472-4642.2003.00020.x; Rossiter-Rachor NA, 2009, ECOL APPL, V19, P1546, DOI 10.1890/08-0265.1; Russell-Smith J, 2003, ECOL MONOGR, V73, P349, DOI 10.1890/01-4021; Setterfield SA, 2010, DIVERS DISTRIB, V16, P854, DOI 10.1111/j.1472-4642.2010.00688.x; Varga TA, 2008, ECOL APPL, V18, P613, DOI 10.1890/07-1280.1; Whitehead PJ, 2008, PUBLIC ADMIN DEVELOP, V28, P374, DOI 10.1002/pad.512; Williams Richard J., 2002, P281; Williams RJ, 2003, ECOL STU AN, V169, P33; Woinarski J, 2007, NATURE OF NORTHERN AUSTRALIA: NATURAL VALUES, ECOLOGICAL PROCESSES AND FUTURE PROSPECTS, P1	50	46	50	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e59144	10.1371/journal.pone.0059144	http://dx.doi.org/10.1371/journal.pone.0059144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690917	Green Published, gold			2022-12-25	WOS:000319107400003
J	Barros, S; Mencia, N; Rodriguez, L; Oleaga, C; Santos, C; Noe, V; Ciudad, CJ				Barros, Susana; Mencia, Nuria; Rodriguez, Laura; Oleaga, Carlota; Santos, Conceicao; Noe, Veronique; Ciudad, Carlos J.			The Redox State of Cytochrome C Modulates Resistance to Methotrexate in Human MCF7 Breast Cancer Cells	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; ANTICANCER DRUG-RESISTANCE; DIHYDROFOLATE-REDUCTASE; INDUCED APOPTOSIS; DEPENDENT ENZYMES; MECHANISM; RELEASE; MITOCHONDRIA; CARDIOLIPIN; LEUKEMIA	Background: Methotrexate is a chemotherapeutic agent used to treat a variety of cancers. However, the occurrence of resistance limits its effectiveness. Cytochrome c in its reduced state is less capable of triggering the apoptotic cascade. Thus, we set up to study the relationship among redox state of cytochrome c, apoptosis and the development of resistance to methotrexate in MCF7 human breast cancer cells. Results: Cell incubation with cytochrome c-reducing agents, such as tetramethylphenylenediamine, ascorbate or reduced glutathione, decreased the mortality and apoptosis triggered by methotrexate. Conversely, depletion of glutathione increased the apoptotic action of methotrexate, showing an involvement of cytochrome c redox state in methotrexate-induced apoptosis. Methotrexate-resistant MCF7 cells showed increased levels of endogenous reduced glutathione and a higher capability to reduce exogenous cytochrome c. Using functional genomics we detected the overexpression of GSTM1 and GSTM4 in methotrexate-resistant MCF7 breast cancer cells, and determined that methotrexate was susceptible of glutathionylation by GSTs. The inhibition of these GSTM isoforms caused an increase in methotrexate cytotoxicity in sensitive and resistant cells. Conclusions: We conclude that overexpression of specific GSTMs, GSTM1 and GSTM4, together with increased endogenous reduced glutathione levels help to maintain a more reduced state of cytochrome c which, in turn, would decrease apoptosis, thus contributing to methotrexate resistance in human MCF7 breast cancer cells.	[Barros, Susana; Mencia, Nuria; Rodriguez, Laura; Oleaga, Carlota; Noe, Veronique; Ciudad, Carlos J.] Univ Barcelona, Dept Biochem & Mol Biol, Sch Pharm, Barcelona, Spain; [Barros, Susana; Santos, Conceicao] Univ Aveiro, Dept Biol, CESAM, P-3800 Aveiro, Portugal	University of Barcelona; Universidade de Aveiro	Ciudad, CJ (corresponding author), Univ Barcelona, Dept Biochem & Mol Biol, Sch Pharm, Barcelona, Spain.	cciudad@ub.edu	Santos, Conceição/ABE-6172-2020; Noe, Veronique/K-3615-2014; Santos, Conceição LV/A-8651-2008; santos, conceição/GQQ-7378-2022; Ciudad, Carlos J./D-7917-2014; Oleaga, Carlota/N-9276-2019	Santos, Conceição/0000-0003-4129-6381; Noe, Veronique/0000-0001-7937-8038; Santos, Conceição LV/0000-0003-4129-6381; Ciudad, Carlos J./0000-0002-7855-392X; Oleaga, Carlota/0000-0002-2146-9671; MENCIA TRINCHANT, Nuria/0000-0003-1376-8708	"Plan Nacional de Investigacion Cientifica" (Spain) [SAF2011-23582]	"Plan Nacional de Investigacion Cientifica" (Spain)	The work was supported by grant SAF2011-23582 from "Plan Nacional de Investigacion Cientifica" (Spain). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif Y, 2007, CELL CALCIUM, V41, P429, DOI 10.1016/j.ceca.2006.08.004; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; ALT FW, 1978, J BIOL CHEM, V253, P1357; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; AUPETIT B, 1986, BIOCHIM BIOPHYS ACTA, V884, P270, DOI 10.1016/0304-4165(86)90173-X; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; BLAKLEY RL, 1984, BIOCHEMISTRY-US, V23, P2377, DOI 10.1021/bi00306a009; Borutaite V, 2007, J BIOL CHEM, V282, P31124, DOI 10.1074/jbc.M700322200; Bracht K, 2006, ANTI-CANCER DRUG, V17, P41, DOI 10.1097/01.cad.0000190280.60005.05; Brown GC, 2008, BBA-BIOENERGETICS, V1777, P877, DOI 10.1016/j.bbabio.2008.03.024; CHEN G, 1994, BIOCHEM PHARMACOL, V47, P1079, DOI 10.1016/0006-2952(94)90420-0; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Chu E, 1996, STEM CELLS, V14, P41, DOI 10.1002/stem.140041; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; de Almagro MC, 2011, HUM GENE THER, V22, P451, DOI 10.1089/hum.2010.102; de Almagro MC, 2011, BIOCHEM PHARMACOL, V81, P60, DOI 10.1016/j.bcp.2010.09.008; de Almagro MC, 2009, J BIOL CHEM, V284, P11579, DOI 10.1074/jbc.M900981200; Deng HT, 2006, BIOCHEM BIOPH RES CO, V342, P73, DOI 10.1016/j.bbrc.2006.01.108; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; EVERSE J, 1979, BIOCHEMISTRY-US, V18, P2668, DOI 10.1021/bi00579a037; Fan MY, 2001, DRUG RESIST UPDATE, V4, P253, DOI 10.1054/drup.2001.0214; Ghibelli L, 1999, FASEB J, V13, P2031, DOI 10.1096/fasebj.13.14.2031; Gorlick R, 1997, BLOOD, V89, P1013, DOI 10.1182/blood.V89.3.1013; HABER DA, 1981, J BIOL CHEM, V256, P9501; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Han I, 2011, PROTEOMICS, V11, P352, DOI 10.1002/pmic.201000475; Hancock JT, 2003, ANN NY ACAD SCI, V1010, P446, DOI 10.1196/annals.1299.081; Hancock JT, 2001, FREE RADICAL BIO MED, V31, P697, DOI 10.1016/S0891-5849(01)00646-3; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hosono N, 2010, CANCER SCI, V101, P767, DOI 10.1111/j.1349-7006.2009.01432.x; Huang CC, 2005, APOPTOSIS, V10, P895, DOI 10.1007/s10495-005-2947-z; Ip SW, 2008, IN VIVO, V22, P237; JOLIVET J, 1983, NEW ENGL J MED, V309, P1094, DOI 10.1056/NEJM198311033091805; Jordan J, 2002, BRIT J PHARMACOL, V137, P993, DOI 10.1038/sj.bjp.0704953; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Li M, 2008, PROTEIN PEPTIDE LETT, V15, P200; Li TS, 2009, CANCER CHEMOTH PHARM, V63, P873, DOI 10.1007/s00280-008-0809-4; Liani E, 2003, INT J CANCER, V103, P587, DOI 10.1002/ijc.10829; Luo W, 2009, ONCOGENE, V28, P4126, DOI 10.1038/onc.2009.262; McLellan LI, 1999, DRUG RESIST UPDATE, V2, P153, DOI 10.1054/drup.1999.0083; Mencia N, 2011, BIOCHEM PHARMACOL, V82, P1572, DOI 10.1016/j.bcp.2011.08.009; Mencia N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-250; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moyer AM, 2010, CANCER EPIDEM BIOMAR, V19, P811, DOI 10.1158/1055-9965.EPI-09-0871; Nishimura G, 2001, FEBS LETT, V505, P399, DOI 10.1016/S0014-5793(01)02859-9; NOE V, 1995, ANAL BIOCHEM, V224, P600, DOI 10.1006/abio.1995.1093; Ott M, 2007, CELL DEATH DIFFER, V14, P1243, DOI 10.1038/sj.cdd.4402135; Pasello M, 2011, ANAL CELL PATHOL, V34, P131, DOI [10.1155/2011/414985, 10.3233/ACP-2011-012]; PERRY RR, 1993, CANCER, V72, P783, DOI 10.1002/1097-0142(19930801)72:3<783::AID-CNCR2820720325>3.0.CO;2-U; Ripple MO, 2010, APOPTOSIS, V15, P563, DOI 10.1007/s10495-010-0455-2; SARTI P, 1992, ARCH BIOCHEM BIOPHYS, V299, P8, DOI 10.1016/0003-9861(92)90237-Q; SARTI P, 1992, BIOCHEM J, V284, P123, DOI 10.1042/bj2840123; Selga E, 2008, BIOCHEM PHARMACOL, V75, P414, DOI 10.1016/j.bcp.2007.08.034; Selga E, 2009, GENOME MED, V1, DOI 10.1186/gm83; Selga E, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-35; Silva AM, 2012, METHODS MOL BIOL, V810, P7, DOI 10.1007/978-1-61779-382-0_2; SIROTNAK FM, 1981, CANCER RES, V41, P4447; Suto D, 2005, BIOCHEM J, V392, P399, DOI 10.1042/BJ20050580; Tang SC, 2011, CANCER-AM CANCER SOC, V117, P3209, DOI 10.1002/cncr.25875; TEW KD, 1994, CANCER RES, V54, P4313; TEW KD, 2012, ANTIOXID REDOX SIGNA; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wang CH, 2011, J MED CHEM, V54, P8574, DOI 10.1021/jm201131n	67	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63276	10.1371/journal.pone.0063276	http://dx.doi.org/10.1371/journal.pone.0063276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675469	Green Published, gold			2022-12-25	WOS:000319036100033
J	Burgers, TA; Hoffmann, MF; Collins, CJ; Zahatnansky, J; Alvarado, MA; Morris, MR; Sietsema, DL; Mason, JJ; Jones, CB; Ploeg, HL; Williams, BO				Burgers, Travis A.; Hoffmann, Martin F.; Collins, Caitlyn J.; Zahatnansky, Juraj; Alvarado, Martin A.; Morris, Michael R.; Sietsema, Debra L.; Mason, James J.; Jones, Clifford B.; Ploeg, Heidi L.; Williams, Bart O.			Mice Lacking Pten in Osteoblasts Have Improved Intramembranous and Late Endochondral Fracture Healing	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; BONE; REPAIR; PATHWAY; CELLS; MODEL	The failure of an osseous fracture to heal (development of a non-union) is a common and debilitating clinical problem. Mice lacking the tumor suppressor Pten in osteoblasts have dramatic and progressive increases in bone volume and density throughout life. Since fracture healing is a recapitulation of bone development, we investigated the process of fracture healing in mice lacking Pten in osteoblasts (Ocn-cret(g/+;)Pten(flox/flox)). Mid-diaphyseal femoral fractures induced in wild-type and Ocn-cre(tg/+;)Pten(flox/flox) mice were studied via micro-computed tomography (mu CT) scans, biomechanical testing, histological and histomorphometric analysis, and protein expression analysis. Ocn-cre(tg/+;)Pten(flox/flox) mice had significantly stiffer and stronger intact bones relative to controls in all cohorts. They also had significantly stiffer healing bones at day 28 post-fracture (PF) and significantly stronger healing bones at days 14, 21, and 28 PF. At day 7 PF, the proximal and distal ends of the Pten mutant calluses were more ossified. By day 28 PF, Pten mutants had larger and more mineralized calluses. Pten mutants had improved intramembranous bone formation during healing originating from the periosteum. They also had improved endochondral bone formation later in the healing process, after mature osteoblasts are present in the callus. Our results indicate that the inhibition of Pten can improve fracture healing and that the local or short-term use of commercially available Pten-inhibiting agents may have clinical application for enhancing fracture healing.	[Burgers, Travis A.; Zahatnansky, Juraj; Mason, James J.; Williams, Bart O.] Van Andel Res Inst, Ctr Skeletal Dis Res, Grand Rapids, MI USA; [Hoffmann, Martin F.] Grand Rapids Med Educ Partners, Grand Rapids, MI USA; [Hoffmann, Martin F.; Sietsema, Debra L.; Jones, Clifford B.] Orthopaed Associates Michigan, Ctr Trauma, Grand Rapids, MI USA; [Collins, Caitlyn J.; Ploeg, Heidi L.] Univ Wisconsin, Dept Mech Engn, Madison, WI 53706 USA; [Alvarado, Martin A.] Creston High Sch, Grand Rapids, MI USA; [Alvarado, Martin A.] Grand Rapids Area Precoll Engn Program, Grand Rapids, MI USA; [Morris, Michael R.; Sietsema, Debra L.; Jones, Clifford B.] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA	Van Andel Institute; University of Wisconsin System; University of Wisconsin Madison; Michigan State University; Michigan State University College of Human Medicine	Williams, BO (corresponding author), Van Andel Res Inst, Ctr Skeletal Dis Res, Grand Rapids, MI USA.	bart.williams@vai.org	Williams, Bart/A-3539-2013; Hoffmann, Martin F./AAE-5064-2019; ploeg, heidi-lynn/GPC-5429-2022	Williams, Bart/0000-0002-5261-5301; Hoffmann, Martin F./0000-0003-0194-1497; ploeg, heidi-lynn/0000-0003-3317-7817; Burgers, Travis/0000-0002-4912-6136; Collins, Caitlyn/0000-0003-0181-878X	Van Andel Research Institute; United States National Institutes of Health [AR053293]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053293] Funding Source: NIH RePORTER	Van Andel Research Institute; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by the Van Andel Research Institute and was supported by United States National Institutes of Health grant AR053293 (BOW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyangar AK, 2010, MED ENG PHYS, V32, P1116, DOI 10.1016/j.medengphy.2010.08.001; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Burgers Travis A., 2009, International Journal of Experimental and Computational Biomechanics, V1, P23, DOI 10.1504/IJECB.2009.022857; Burgers TA, 2008, J BIOMECH, V41, P1077, DOI 10.1016/j.jbiomech.2007.11.018; Cai ZP, 2008, FASEB J, V22, P4248, DOI 10.1096/fj.08-105940; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Conradas KA, 2005, MOL CELL PROTEOMICS, V4, P1284, DOI 10.1074/mcp.M500082-MCP200; Coulibaly MO, 2010, CRIT REV EUKAR GENE, V20, P105, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.20; Court-Brown CM, 2008, J TRAUMA, V64, P1517, DOI 10.1097/TA.0b013e3181469840; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Ferguson CM, 1998, ANN NY ACAD SCI, V857, P33, DOI 10.1111/j.1749-6632.1998.tb10105.x; Gaur T, 2009, J CELL PHYSIOL, V220, P174, DOI 10.1002/jcp.21747; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hugunin KMS, 2010, SHOCK, V34, P250, DOI 10.1097/SHK.0b013e3181cdc412; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Komatsu DE, 2010, J ORTHOP RES, V28, P928, DOI 10.1002/jor.21078; La Harrysson O, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-91; Lai JP, 2009, BRIT J PHARMACOL, V156, P189, DOI 10.1111/j.1476-5381.2008.00020.x; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Paez Juan, 2003, Cancer Treat Res, V115, P145; Parker MJ, 2007, CLIN ORTHOP RELAT R, P175, DOI 10.1097/BLO.0b013e3180325a42; Phieffer LS, 2006, J BONE JOINT SURG AM, V88A, P206, DOI 10.2106/00004623-200601000-00026; Phillips AM, 2005, INJURY, V36, P5, DOI 10.1016/j.injury.2005.07.027; RHO JY, 1995, MED ENG PHYS, V17, P347, DOI 10.1016/1350-4533(95)97314-F; Rosivatz E, 2007, BIOCHEM SOC T, V35, P257, DOI 10.1042/BST0350257; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Takeda S, 2005, J APPL PHYSIOL, V99, P999, DOI 10.1152/japplphysiol.00234.2005; Thompson Z, 2002, J ORTHOPAED RES, V20, P1091, DOI 10.1016/S0736-0266(02)00017-7; Ushiku C, 2010, J ORTHOP RES, V28, P1338, DOI 10.1002/jor.21105; Valdes MA, 2009, ARCH ORTHOP TRAUM SU, V129, P1651, DOI 10.1007/s00402-009-0850-8; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	37	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63857	10.1371/journal.pone.0063857	http://dx.doi.org/10.1371/journal.pone.0063857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675511	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100051
J	Khan, P; Drobic, B; Perez-Cadahia, B; Healy, S; He, SH; Davie, JR				Khan, Protiti; Drobic, Bojan; Perez-Cadahia, Beatriz; Healy, Shannon; He, Shihua; Davie, James R.			Mitogen- and Stress-Activated Protein Kinases 1 and 2 Are Required for Maximal Trefoil Factor 1 Induction	PLOS ONE			English	Article							BREAST-CANCER CELLS; ESTROGEN-RECEPTOR-ALPHA; HISTONE H3; INDUCED PHOSPHORYLATION; NUCLEOSOMAL RESPONSE; GENE-EXPRESSION; PS2 GENE; MSK1; CHROMATIN; PROMOTER	Mitogen- and stress-activated protein kinases 1 and 2 (MSK1 and MSK2), activated downstream of the ERK- and p38-mitogen-activated protein kinase pathways are involved in cell survival, proliferation and differentiation. Following mitogenic or stress stimuli, they mediate the nucleosomal response, which includes phosphorylation of histone H3 at serine 10 (H3S10ph) coupled with transcriptional activation of immediate-early genes. While MSK1 and MSK2 are closely related, their relative roles may vary with cellular context and/or stimuli. However, our knowledge of MSK2 recruitment to immediate-early genes is limited, as research has primarily focused on MSK1. Here, we demonstrate that both MSK1 and MSK2, regulate the phorbol ester 12-O-tetradecanoylphorbol-13-acetate induced expression of the breast cancer marker gene, trefoil factor 1 (TFF1), by phosphorylating H3S10 at its 59 regulatory regions. The MSK-mediated phosphorylation of H3S10 promotes the recruitment of 14-3-3 isoforms and BRG1, the ATPase subunit of the BAF/PBAF remodeling complex, to the enhancer and upstream promoter elements of TFF1. The recruited chromatin remodeling activity leads to the RNA polymerase II carboxy-terminal domain phosphorylation at the TFF1 promoter, initiating TFF1 expression in MCF-7 breast cancer cells. Moreover, we show that MSK1 or MSK2 is recruited to TFF1 regulatory regions, but as components of different multiprotein complexes.	[Khan, Protiti; Drobic, Bojan; Perez-Cadahia, Beatriz; Healy, Shannon; He, Shihua; Davie, James R.] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB, Canada	University of Manitoba	Davie, JR (corresponding author), Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB, Canada.	davie@cc.umanitoba.ca		Davie, James/0000-0002-0420-6888	Canadian Cancer Society [2010 700323]; Canadian Breast Cancer Foundation; Canadian Institute of Health Research [MOP-9186]; Canada Research Chair; UMGF/CancerCare Manitoba Studentship Award; Canadian Cancer Society Research Institute Terry Fox Foundation studentship; Manitoba Health Research Council	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); UMGF/CancerCare Manitoba Studentship Award; Canadian Cancer Society Research Institute Terry Fox Foundation studentship; Manitoba Health Research Council	This work was supported with funding from Canadian Cancer Society [2010 700323] (http://www.cancer.ca/), a Canadian Breast Cancer Foundation (http://www.cbcf.org/), and a Canadian Institute of Health Research [MOP-9186] (http://www.cihr-irsc.gc.ca/) to J.R.D., a Canada Research Chair (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) to J.R.D., a UMGF/CancerCare Manitoba (http://www.cancercare.mb.ca/home/) Studentship Award to P. K., a Canadian Cancer Society Research Institute Terry Fox Foundation studentship to B. D., and Manitoba Health Research Council (http://mhrc.mb.ca/) Fellowships to B. P-C and S. H. The authors acknowledge the strong support of the Manitoba Institute of Child Health and CancerCare Manitoba Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry N, 2009, ENDOCRINOLOGY, V150, P4473, DOI 10.1210/en.2009-0066; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bougen NM, 2013, CANCER LETT, V332, P19, DOI 10.1016/j.canlet.2012.12.012; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chandramohan Y, 2008, EUR J NEUROSCI, V27, P2701, DOI 10.1111/j.1460-9568.2008.06230.x; Chang S, 2011, CANCER INVEST, V29, P240, DOI 10.3109/07357907.2010.550594; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corte MD, 2006, BREAST CANCER RES TR, V96, P63, DOI 10.1007/s10549-005-9041-7; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Espino PS, 2006, CANCER RES, V66, P4610, DOI 10.1158/0008-5472.CAN-05-4251; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Healy S, 2012, BIOCHEM CELL BIOL, V90, P39, DOI [10.1139/o11-092, 10.1139/O11-092]; Hsu YL, 2012, ONCOGENE; Jacks KA, 2010, J BIOL CHEM, V285, P1661, DOI 10.1074/jbc.M109.083808; Kim J, 2000, J STEROID BIOCHEM, V74, P157, DOI 10.1016/S0960-0760(00)00119-9; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Li L, 2008, J CELL BIOCHEM, V105, P365, DOI 10.1002/jcb.21832; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Perez-Cadahia B, 2011, J BIOL CHEM, V286, P42, DOI 10.1074/jbc.M110.156687; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Rodrigues S, 2003, FASEB J, V17, P7, DOI 10.1096/fj.02-0201com; Rodrigues S, 2003, ONCOGENE, V22, P4488, DOI 10.1038/sj.onc.1206685; Roze E, 2008, FASEB J, V22, P1083, DOI 10.1096/fj.07-9814; Sewack GF, 1997, J BIOL CHEM, V272, P31118, DOI 10.1074/jbc.272.49.31118; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Vicent GP, 2008, J STEROID BIOCHEM, V109, P344, DOI 10.1016/j.jsbmb.2008.03.015; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; WALTER W, 2008, MOL CELL BIOL; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Yuen HF, 2011, J PATHOL, V224, P78, DOI 10.1002/path.2859	47	12	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63189	10.1371/journal.pone.0063189	http://dx.doi.org/10.1371/journal.pone.0063189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675462	Green Submitted, Green Published, gold			2022-12-25	WOS:000319036100030
J	Vielfort, K; Weyler, L; Soderholm, N; Engelbrecht, M; Lofmark, S; Aro, H				Vielfort, Katarina; Weyler, Linda; Soderholm, Niklas; Engelbrecht, Mattias; Lofmark, Sonja; Aro, Helena			Lactobacillus Decelerates Cervical Epithelial Cell Cycle Progression	PLOS ONE			English	Article							VAGINAL LACTOBACILLI; RHAMNOSUS-GG; POLYAMINE METABOLISM; CANCER; PROLIFERATION	We investigated cell cycle progression in epithelial cervical ME-180 cells during colonization of three different Lactobacillus species utilizing live cell microscopy, bromodeoxyuridine incorporation assays, and flow cytometry. The colonization of these ME-180 cells by L. rhamnosus and L. reuteri, originating from human gastric epithelia and saliva, respectively, was shown to reduce cell cycle progression and to cause host cells to accumulate in the G1 phase of the cell cycle. The G1 phase accumulation in L. rhamnosus-colonized cells was accompanied by the up-regulation and nuclear accumulation of p21. By contrast, the vaginal isolate L. crispatus did not affect cell cycle progression. Furthermore, both the supernatants from the lactic acid-producing L. rhamnosus colonies and lactic acid added to cell culture media were able to reduce the proliferation of ME-180 cells. In this study, we reveal the diversity of the Lactobacillus species to affect host cell cycle progression and demonstrate that L. rhamnosus and L. reuteri exert anti-proliferative effects on human cervical carcinoma cells.	[Vielfort, Katarina; Weyler, Linda; Soderholm, Niklas; Engelbrecht, Mattias; Aro, Helena] Stockholm Univ, Wenner Grens Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Lofmark, Sonja] Swedish Inst Communicable Dis Control, Solna, Sweden	Stockholm University; Swedish Institute for Infectious Disease Control	Aro, H (corresponding author), Stockholm Univ, Wenner Grens Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	Helena.Aro@su.se		Vielfort, Katarina/0000-0002-9988-6336	Cancerfonden [CAN 2011/671]; Stockholm University; Carl Tryggers Stiftelse; Ake Wibergs Stiftelse; Harald Jeanssons Stiftelse; Petrus och Augusta Hedlunds Stiftelse; Marcus Borgstroms stiftelse; Granholms Stiftelse; Ellen AB; John Soderbergs stipendiestiftelse	Cancerfonden(Swedish Cancer Society); Stockholm University; Carl Tryggers Stiftelse; Ake Wibergs Stiftelse; Harald Jeanssons Stiftelse; Petrus och Augusta Hedlunds Stiftelse; Marcus Borgstroms stiftelse; Granholms Stiftelse; Ellen AB; John Soderbergs stipendiestiftelse	This work was supported by Cancerfonden [grant number CAN 2011/671], Stockholm University, Carl Tryggers Stiftelse, Ake Wibergs Stiftelse, Harald Jeanssons Stiftelse, Petrus och Augusta Hedlunds Stiftelse, Marcus Borgstroms stiftelse, and Granholms Stiftelse. KV was supported by Ellen AB. LW was supported by John Soderbergs stipendiestiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hsiao YP, 2009, J DERMATOL SCI, V54, P175, DOI 10.1016/j.jdermsci.2009.02.012; Kumar RS, 2012, APPL BIOCHEM BIOTECH, V166, P620, DOI 10.1007/s12010-011-9453-2; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Orlando A, 2009, IMMUNOPHARM IMMUNOT, V31, P108, DOI 10.1080/08923970802443631; Pavlova SI, 2002, J APPL MICROBIOL, V92, P451, DOI 10.1046/j.1365-2672.2002.01547.x; Pi W, 2011, KOREAN J PARASITOL, V49, P295, DOI 10.3347/kjp.2011.49.3.295; Rodriguez-Vilarrupla A, 2002, FEBS LETT, V531, P319, DOI 10.1016/S0014-5793(02)03549-4; Russo F, 2007, NUTR CANCER, V59, P106, DOI 10.1080/01635580701365084; Seow SW, 2010, CANCER SCI, V101, P751, DOI 10.1111/j.1349-7006.2009.01426.x; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Thirabunyanon M, 2009, BIOTECHNOL LETT, V31, P571, DOI 10.1007/s10529-008-9902-3; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vielfort K, 2008, MICROBES INFECT, V10, P1325, DOI 10.1016/j.micinf.2008.07.032; Zarate G, 2006, LETT APPL MICROBIOL, V43, P174, DOI 10.1111/j.1472-765X.2006.01934.x	15	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63592	10.1371/journal.pone.0063592	http://dx.doi.org/10.1371/journal.pone.0063592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675492	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400046
J	Wang, Y; Du, HX; Xia, MR; Ren, L; Xu, M; Xie, T; Gong, GL; Xu, NY; Yang, HZ; He, Y				Wang, Yu; Du, Haixiao; Xia, Mingrui; Ren, Ling; Xu, Mo; Xie, Teng; Gong, Gaolang; Xu, Ningyi; Yang, Huazhong; He, Yong			A Hybrid CPU-GPU Accelerated Framework for Fast Mapping of High-Resolution Human Brain Connectome	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; CORTICAL NETWORKS; MODULAR ORGANIZATION; ANATOMICAL NETWORKS; ARCHITECTURE; PARCELLATION; STABILITY; PATTERNS	Recently, a combination of non-invasive neuroimaging techniques and graph theoretical approaches has provided a unique opportunity for understanding the patterns of the structural and functional connectivity of the human brain (referred to as the human brain connectome). Currently, there is a very large amount of brain imaging data that have been collected, and there are very high requirements for the computational capabilities that are used in high-resolution connectome research. In this paper, we propose a hybrid CPU-GPU framework to accelerate the computation of the human brain connectome. We applied this framework to a publicly available resting-state functional MRI dataset from 197 participants. For each subject, we first computed Pearson's Correlation coefficient between any pairs of the time series of gray-matter voxels, and then we constructed unweighted undirected brain networks with 58 k nodes and a sparsity range from 0.02% to 0.17%. Next, graphic properties of the functional brain networks were quantified, analyzed and compared with those of 15 corresponding random networks. With our proposed accelerating framework, the above process for each network cost 80 similar to 150 minutes, depending on the network sparsity. Further analyses revealed that high-resolution functional brain networks have efficient small-world properties, significant modular structure, a power law degree distribution and highly connected nodes in the medial frontal and parietal cortical regions. These results are largely compatible with previous human brain network studies. Taken together, our proposed framework can substantially enhance the applicability and efficacy of high-resolution (voxel-based) brain network analysis, and have the potential to accelerate the mapping of the human brain connectome in normal and disease states.	[Wang, Yu; Du, Haixiao; Ren, Ling; Xu, Mo; Yang, Huazhong] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China; [Xia, Mingrui; Xie, Teng; Gong, Gaolang; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Xu, Ningyi] Microsoft Res Asia, Beijing, Peoples R China	Tsinghua University; Beijing Normal University; Microsoft; Microsoft Research Asia	He, Y (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	yong.he@bnu.edu.cn	He, Yong/C-2161-2009; WANG, Yu/B-7985-2011; Xia, Mingrui/J-3267-2019; He, Yong/Q-5756-2018; , Teng/AAC-1774-2022	WANG, Yu/0000-0001-6108-5157; Xia, Mingrui/0000-0003-4615-9132; , Teng/0000-0002-3708-5189; He, Yong/0000-0002-7039-2850	Microsoft Research Asia, National Basic Research Program of China (973) [2013CB531004]; Beijing Natural Science Foundation [Z111107067311036]; Natural Science Foundation of China [81030028]; National Science Fund for Distinguished Young Scholars [81225012]	Microsoft Research Asia, National Basic Research Program of China (973); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the Microsoft Research Asia, National Basic Research Program of China (973) (Grant No. 2013CB531004), Beijing Natural Science Foundation (Grant No. Z111107067311036), Natural Science Foundation of China (Grant No. 81030028) and National Science Fund for Distinguished Young Scholars (Grant No. 81225012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bell M G H, 1997, Q APPL MATH, P17, DOI 10.1090/qam/102435; Brodmann, 1909, VERGLEICHENDE LOKALI; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cecchi GA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-S1-S5; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; D'Alberto P, 2007, ALGORITHMICA, V47, P203, DOI 10.1007/s00453-006-1224-z; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; JOHNSON DB, 1977, J ACM, V24, P1, DOI 10.1145/321992.321993; Kotter R, 2003, NEURAL NETWORKS, V16, P1261, DOI 10.1016/j.neunet.2003.06.002; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matsumoto K, 2011, BLOCKED ALL PAIRS SH, P145; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Mohsen A., 1978, Proceedings of the 8th European Microwave Conference, P433; Nath R, 2010, INT J HIGH PERFORM C, V24, P511, DOI 10.1177/1094342010385729; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Owens JD, 2007, COMPUT GRAPH FORUM, V26, P80, DOI 10.1111/j.1467-8659.2007.01012.x; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rixner S, 1998, BANDWIDTH EFFICIENT, P3; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stam CJ, 2010, J NEUROL SCI, V289, P128, DOI 10.1016/j.jns.2009.08.028; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valencia M, 2009, CHAOS, V19, DOI 10.1063/1.3129783; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Venkatamaran G, 2003, ACM J EXPT ALGORITHM, V8; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; WARSHALL S, 1962, J ACM, V9, P11, DOI 10.1145/321105.321107; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Wu D, 2010, P 2010 IEEE 16 INT C; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Xia MR, 2011, BRAIN CONNECT, V1, P349, DOI 10.1089/brain.2011.0062; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yap PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024678; Yuan K, 2010, NEUROSCI LETT, V477, P37, DOI 10.1016/j.neulet.2010.04.032; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhu CY, 2011, CLIN NEUROPHYSIOL, V122, P278, DOI 10.1016/j.clinph.2010.06.016; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2011, NETWORK CENTRALITY H	79	210	211	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62789	10.1371/journal.pone.0062789	http://dx.doi.org/10.1371/journal.pone.0062789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675425	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400010
J	Liebau, MC; Braun, F; Hopker, K; Weitbrecht, C; Bartels, V; Muller, RU; Brodesser, S; Saleem, MA; Benzing, T; Schermer, B; Cybulla, M; Kurschat, CE				Liebau, Max C.; Braun, Fabian; Hoepker, Katja; Weitbrecht, Claudia; Bartels, Valerie; Mueller, Roman-Ulrich; Brodesser, Susanne; Saleem, Moin A.; Benzing, Thomas; Schermer, Bernhard; Cybulla, Markus; Kurschat, Christine E.			Dysregulated Autophagy Contributes to Podocyte Damage in Fabry's Disease	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISEASES; ALPHA-GALACTOSIDASE; GLOBOTRIAOSYL CERAMIDE; DIABETIC-NEPHROPATHY; REPLACEMENT THERAPY; RENAL PATHOLOGY; SLIT DIAPHRAGM; MICE; INHIBITION; BINDING	Fabry's disease results from an inborn error of glycosphingolipid metabolism that is due to deficiency of the lysosomal hydrolase alpha-galactosidase A. This X-linked defect results in the accumulation of enzyme substrates with terminally alpha-glycosidically bound galactose, mainly the neutral glycosphingolipid Globotriaosylceramide (Gb3) in various tissues, including the kidneys. Although end-stage renal disease is one of the most common causes of death in hemizygous males with Fabry's disease, the pathophysiology leading to proteinuria, hematuria, hypertension, and kidney failure is not well understood. Histological studies suggest that the accumulation of Gb3 in podocytes plays an important role in the pathogenesis of glomerular damage. However, due to the lack of appropriate animal or cellular models, podocyte damage in Fabry's disease could not be directly studied yet. As murine models are insufficient, a human model is needed. Here, we developed a human podocyte model of Fabry's disease by combining RNA interference technology with lentiviral transduction of human podocytes. Knockdown of alpha-galactosidase A expression resulted in diminished enzymatic activity and slowly progressive accumulation of intracellular Gb3. Interestingly, these changes were accompanied by an increase in autophagosomes as indicated by an increased abundance of LC3-II and a loss of mTOR kinase activity, a negative regulator of the autophagic machinery. These data suggest that dysregulated autophagy in alpha-galactosidase A-deficient podocytes may be the result of deficient mTOR kinase activity. This finding links the lysosomal enzymatic defect in Fabry's disease to deregulated autophagy pathways and provides a promising new direction for further studies on the pathomechanism of glomerular injury in Fabry patients.	[Liebau, Max C.; Braun, Fabian; Hoepker, Katja; Weitbrecht, Claudia; Bartels, Valerie; Mueller, Roman-Ulrich; Benzing, Thomas; Schermer, Bernhard; Kurschat, Christine E.] Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany; [Liebau, Max C.; Braun, Fabian; Hoepker, Katja; Weitbrecht, Claudia; Bartels, Valerie; Mueller, Roman-Ulrich; Benzing, Thomas; Schermer, Bernhard; Kurschat, Christine E.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Liebau, Max C.] Univ Cologne, Dept Pediat, D-50931 Cologne, Germany; [Brodesser, Susanne] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Mueller, Roman-Ulrich; Brodesser, Susanne; Benzing, Thomas; Schermer, Bernhard; Kurschat, Christine E.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Mueller, Roman-Ulrich; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Syst Biol Ageing Cologne, D-50931 Cologne, Germany; [Saleem, Moin A.] Univ Bristol, Southmead Hosp, Sch Clin Sci, Acad & Childrens Renal Unit, Bristol, Avon, England; [Cybulla, Markus] Univ Hosp Freiburg, Div Renal, Freiburg, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Southmead Hospital; University of Bristol; University of Freiburg	Kurschat, CE (corresponding author), Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany.	christine.kurschat@uk-koeln.de	Schermer, Bernhard/E-9972-2014; Müller, Roman-Ulrich/AAK-3493-2021; Benzing, Thomas/X-5476-2019; Liebau, Max Christoph/K-3470-2019	Schermer, Bernhard/0000-0002-5194-9000; Müller, Roman-Ulrich/0000-0001-6910-0745; Liebau, Max Christoph/0000-0003-0494-9080; Saleem, Moin/0000-0002-9808-4518; Braun, Fabian/0000-0002-4742-050X	Deutsche Forschungsgemeinschaft [DFG SFB 635, DFG SFB 829]; Deutsche Nierenstiftung; Koln Fortune; Shire	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Nierenstiftung; Koln Fortune; Shire	This study was supported by the Deutsche Forschungsgemeinschaft (grants DFG SFB 635, DFG SFB 829 to T.B.), by Koln Fortune (grant to F.B. and K.H.), by Deutsche Nierenstiftung (grant to K.H.) and by Shire (Grant to T.B. and M.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2000, J CLIN INVEST, V105, P1563, DOI 10.1172/JCI9711; Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Chark D, 2004, EUR J BIOCHEM, V271, P405, DOI 10.1046/j.1432-1033.2003.03941.x; Chevrier M, 2010, AUTOPHAGY, P6; Christensen EI, 2007, J AM SOC NEPHROL, V18, P698, DOI 10.1681/ASN.2006080822; Cina DP, 2012, J AM SOC NEPHROL, V23, P412, DOI 10.1681/ASN.2011070690; D'Agati VD, 2008, CURR OPIN NEPHROL HY, V17, P271, DOI 10.1097/MNH.0b013e3282f94a96; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Feriozzi S, 2012, CLIN J AM SOC NEPHRO, V7, P60, DOI 10.2215/CJN.03130411; Fogo AB, 2010, NEPHROL DIAL TRANSPL, V25, P2168, DOI 10.1093/ndt/gfp528; Gbadegesin R, 2011, PEDIATR NEPHROL, V26, P1001, DOI 10.1007/s00467-010-1692-x; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; KUSIAK JW, 1978, J BIOL CHEM, V253, P184; Lin HY, 2009, CIRC-CARDIOVASC GENE, V2, P450, DOI 10.1161/CIRCGENETICS.109.862920; LINGWOOD CA, 1994, NEPHRON, V66, P21, DOI 10.1159/000187761; Mattocks M, 2006, FEBS J, V273, P2064, DOI 10.1111/j.1742-4658.2006.05223.x; Mehta A, 2009, LANCET, V374, P1986, DOI 10.1016/S0140-6736(09)61493-8; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; MOMOI T, 1976, BIOCHIM BIOPHYS ACTA, V441, P488; Najafian B, 2011, KIDNEY INT, V79, P663, DOI 10.1038/ki.2010.484; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Prabakaran T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025065; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rutjes NWP, 2002, KIDNEY INT, V62, P832, DOI 10.1046/j.1523-1755.2002.00502.x; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schermer B, 2009, J AM SOC NEPHROL, V20, P473, DOI 10.1681/ASN.2008070694; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2009, PHARMACOL THERAPEUT, V122, P65, DOI 10.1016/j.pharmthera.2009.01.003; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; YAO JK, 1985, ANAL BIOCHEM, V150, P111, DOI 10.1016/0003-2697(85)90447-6	37	72	79	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63506	10.1371/journal.pone.0063506	http://dx.doi.org/10.1371/journal.pone.0063506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691056	Green Submitted, gold, Green Published			2022-12-25	WOS:000319107900046
J	Lugli, L; Baroni, G; Anelli, F; Borghi, AM; Nicoletti, R				Lugli, Luisa; Baroni, Giulia; Anelli, Filomena; Borghi, Anna M.; Nicoletti, Roberto			Counting Is Easier while Experiencing a Congruent Motion	PLOS ONE			English	Article							NUMBER; MAGNITUDE; SPACE; TIME; REPRESENTATIONS; SHIFTS	Several studies suggest that numerical and spatial representations are intrinsically linked. Recent findings demonstrate that also motor actions interact with number magnitude processing, showing a motor-to-semantic effect. The current study assesses whether calculation processes can be modulated by motions performed with the whole body. Participants were required to make additions or subtractions while performing (on-line condition) or after having experienced (off-line condition) an ascending or descending motion through a passive (i.e., taking the elevator) or an active (i.e., taking the stairs) mode. Results show a congruency effect between the type of calculation and the direction of the motion depending on: a) the off-line or on-line condition, b) the passive or active mode and c) the real or imagined task. Implications of the results for an embodied and grounded perspective view will be discussed.	[Lugli, Luisa; Baroni, Giulia; Anelli, Filomena; Nicoletti, Roberto] Univ Bologna, Dept Philosophy & Commun Studies, Bologna, Italy; [Lugli, Luisa] Univ Modena & Reggio Emilia, Dept Commun & Econ, Reggio Emilia, Italy; [Anelli, Filomena] Univ Bologna, Dept Educ Sci, Bologna, Italy; [Borghi, Anna M.] Univ Bologna, Dept Psychol, Bologna, Italy; [Borghi, Anna M.] Inst Cognit Sci & Technol, Natl Res Council, Rome, Italy	University of Bologna; Universita di Modena e Reggio Emilia; University of Bologna; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Lugli, L (corresponding author), Univ Bologna, Dept Philosophy & Commun Studies, Bologna, Italy.	l.lugli@unibo.it	Anelli, Filomena/K-1468-2016; Lugli, Luisa/AAG-1408-2021	Anelli, Filomena/0000-0002-3971-0101; Borghi, Anna M./0000-0001-9455-8408	MIUR; European Community; Emergence of Communication in Robots through Sensorimotor and Social Interaction	MIUR(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission); Emergence of Communication in Robots through Sensorimotor and Social Interaction	This work was supported by MIUR (PRIN 2008) and by the European Community, FP7 project ROSSI (www.rossiproject.eu), Emergence of Communication in Robots through Sensorimotor and Social Interaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres M, 2008, CURR DIR PSYCHOL SCI, V17, P313, DOI 10.1111/j.1467-8721.2008.00597.x; Andres M, 2008, CORTEX, V44, P414, DOI 10.1016/j.cortex.2007.08.007; Badets A, 2007, EXP BRAIN RES, V180, P525, DOI 10.1007/s00221-007-0870-y; Badets A, 2012, EXP BRAIN RES, V221, P43, DOI 10.1007/s00221-012-3145-1; Badets A, 2011, EXP PSYCHOL, V58, P287, DOI 10.1027/1618-3169/a000095; Badets A, 2010, COGNITION, V115, P46, DOI 10.1016/j.cognition.2009.11.007; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2003, LANG COGNITIVE PROC, V18, P513, DOI 10.1080/01690960344000026; Bonato M, 2012, NEUROSCI BIOBEHAV R, V36, P2257, DOI 10.1016/j.neubiorev.2012.08.007; Borghi A. M., 2005, GROUNDING COGNITION, P8, DOI DOI 10.1017/CBO9780511499968.002; Borghi AM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00187; Borghi AM, 2010, NEUROPSYCHOLOGIA, V48, P763, DOI 10.1016/j.neuropsychologia.2009.10.029; Chiou RYC, 2009, EXP BRAIN RES, V194, P553, DOI 10.1007/s00221-009-1730-8; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Fischer MH, 2012, COGN PROCESS, V13, pS161, DOI 10.1007/s10339-012-0477-5; Fischer MH, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00260; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Fischer MH, 2003, VIS COGN, V10, P493, DOI 10.1080/13506280244000186; Gallese Vittorio, 2010, EMBODIED SELF DIMENS; Gevers W, 2006, ACTA PSYCHOL, V122, P221, DOI 10.1016/j.actpsy.2005.11.004; Hartmann M, 2012, COGN PROCESS, V13, pS189, DOI 10.1007/s10339-012-0484-6; Hartmann M, 2012, J EXP PSYCHOL HUMAN, V38, P1416, DOI 10.1037/a0026706; Holmes KJ, 2012, Q J EXP PSYCHOL, V65, P1044, DOI 10.1080/17470218.2012.685079; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Jirak D, 2010, CONSCIOUS COGN, V19, P711, DOI 10.1016/j.concog.2010.06.020; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Knops A, 2009, ATTEN PERCEPT PSYCHO, V71, P803, DOI 10.3758/APP.71.4.803; Lindemann O, 2007, J EXP PSYCHOL HUMAN, V33, P1400, DOI 10.1037/0096-1523.33.6.1400; Loetscher T, 2008, CURR BIOL, V18, pR60, DOI 10.1016/j.cub.2007.11.015; Loetscher T, 2010, CURR BIOL, V20, pR264, DOI 10.1016/j.cub.2010.01.015; Miles LK, 2010, PSYCHOL SCI, V21, P222, DOI 10.1177/0956797609359333; Nicholls MER, 2008, PSYCHON B REV, V15, P413, DOI 10.3758/PBR.15.2.413; Pecher D., 2005, GROUNDING COGNITION; Pecher D, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00121; Pecher D, 2011, PSYCHOL LEARN MOTIV, V54, P217, DOI 10.1016/B978-0-12-385527-5.00007-3; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; Ranzini M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00147; Schwarz W, 2004, PERCEPT PSYCHOPHYS, V66, P651, DOI 10.3758/BF03194909; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wood G., 2008, PSYCHOL SCI Q, V50, P489; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	42	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64500	10.1371/journal.pone.0064500	http://dx.doi.org/10.1371/journal.pone.0064500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145XK	23691234	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700102
J	Pujol-Autonell, I; Ampudia, RM; Planas, R; Marin-Gallen, S; Carrascal, J; Sanchez, A; Marin, A; Puig-Domingo, M; Pujol-Borrell, R; Verdaguer, J; Vives-Pi, M				Pujol-Autonell, Irma; Ampudia, Rosa-Maria; Planas, Raquel; Marin-Gallen, Silvia; Carrascal, Jorge; Sanchez, Alex; Marin, Ana; Puig-Domingo, Manuel; Pujol-Borrell, Ricardo; Verdaguer, Joan; Vives-Pi, Marta			Efferocytosis Promotes Suppressive Effects on Dendritic Cells through Prostaglandin E2 Production in the Context of Autoimmunity	PLOS ONE			English	Article							CD4(+) T-CELLS; ACTIVATED RECEPTOR-GAMMA; ANTIGEN-PRESENTING CELLS; NONOBESE DIABETIC MICE; APOPTOTIC CELLS; NOD MICE; GENE-EXPRESSION; CYTOKINE PRODUCTION; IN-VIVO; BETA	Introduction: Efferocytosis is a crucial process by which apoptotic cells are cleared by phagocytes, maintaining immune tolerance to self in the absence of inflammation. Peripheral tolerance, lost in autoimmune processes, may be restored by the administration of autologous dendritic cells loaded with islet apoptotic cells in experimental type 1 diabetes. Objective: To evaluate tolerogenic properties in dendritic cells induced by the clearance of apoptotic islet cells, thus explaining the re-establishment of tolerance in a context of autoimmunity. Methods: Bone marrow derived dendritic cells from non-obese diabetic mice, a model of autoimmune diabetes, were generated and pulsed with islet apoptotic cells. The ability of these cells to induce autologous T cell proliferation and to suppress mature dendritic cell function was assessed, together with cytokine production. Microarray experiments were performed using dendritic cells to identify differentially expressed genes after efferocytosis. Results: Molecular and functional changes in dendritic cells after the capture of apoptotic cells were observed. 1) Impaired ability of dendritic cells to stimulate autologous T cell proliferation after the capture of apoptotic cells even after proinflammatory stimuli, with a cytokine profile typical for immature dendritic cells. 2) Suppressive ability of mature dendritic cell function. 3) Microarray-based gene expression profiling of dendritic cells showed differential expression of genes involved in antigen processing and presentation after efferocytosis. 4) Prostaglandin E2 increased production was responsible for immunosuppressive mechanism of dendritic cells after the capture of apoptotic cells. Conclusions: The tolerogenic behaviour of dendritic cells after islet cells efferocytosis points to a mechanism of silencing potential autoreactive T cells in the microenvironment of autoimmunity. Our results suggest that dendritic cells may be programmed to induce specific immune tolerance using apoptotic cells; this is a viable strategy for a variety of autoimmune diseases.	[Pujol-Autonell, Irma; Ampudia, Rosa-Maria; Planas, Raquel; Marin-Gallen, Silvia; Vives-Pi, Marta] Autonomous Univ Barcelona, Germans Trias Pujol Res Inst, Dept Immunol, Badalona, Spain; [Carrascal, Jorge; Verdaguer, Joan] Univ Lleida & IRBLleida, Dept Ciencies Basiques Med, Immunol Unit, Lleida, Spain; [Sanchez, Alex; Marin, Ana; Pujol-Borrell, Ricardo] Univ Hosp Vall Hebron, Res Inst Vall Hebron, Barcelona, Spain; [Puig-Domingo, Manuel] Univ Hosp Germans Trias Pujol, Endocrinol & Nutr Sect, Badalona, Spain	Autonomous University of Barcelona; Universitat de Lleida; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Vives-Pi, M (corresponding author), Autonomous Univ Barcelona, Germans Trias Pujol Res Inst, Dept Immunol, Badalona, Spain.	mvives.liradbst.germanstrias@gencat.cat	Autonell, Joan Verdaguer/A-2059-2010; Planas, Raquel/B-6092-2019; Marín-Sánchez, Ana/M-1231-2019; Puig-Domingo, Manel/S-2169-2019; Sánchez-Pla, Alex/H-8310-2015; Vives-Pi, Marta/AAM-8158-2020; Pujol-Borrell, Ricardo/N-3415-2013	Autonell, Joan Verdaguer/0000-0003-1768-9310; Planas, Raquel/0000-0002-2478-997X; Marín-Sánchez, Ana/0000-0003-2873-456X; Puig-Domingo, Manel/0000-0002-6744-7195; Sánchez-Pla, Alex/0000-0002-8673-7737; Vives-Pi, Marta/0000-0003-3735-0779; Pujol-Borrell, Ricardo/0000-0001-7833-675X	Fondo de Investigaciones Sanitarias of the Carlos III Institute of Health [PS09/00253, PI12/00195]; Instituto de Salud Carlos III of the Spanish National Institute of Health [FIS05/00418]; Miguel Servet biomedical researchers; Instituto de Salud Carlos III; Direccio d'Estrategia i Coordinacio, Health Dept. of the Catalonian Government	Fondo de Investigaciones Sanitarias of the Carlos III Institute of Health; Instituto de Salud Carlos III of the Spanish National Institute of Health; Miguel Servet biomedical researchers; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Direccio d'Estrategia i Coordinacio, Health Dept. of the Catalonian Government	This work was supported by grants from the Fondo de Investigaciones Sanitarias (PS09/00253 and PI12/00195) of the Carlos III Institute of Health, www.isciii.es. RP was supported by the Instituto de Salud Carlos III of the Spanish National Institute of Health (FIS05/00418). MVP is funded by the stabilization program of Miguel Servet biomedical researchers and RMA by the program of research technicians of the Instituto de Salud Carlos III and Direccio d'Estrategia i Coordinacio, Health Dept. of the Catalonian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blacher NE, 2005, PLOS BIOL, V3, P1070, DOI 10.1371/journal.pbio.0030185; Brandmaier AG, 2009, J IMMUNOTHER, V32, P677, DOI 10.1097/CJI.0b013e3181ab1824; Chung EY, 2006, CELL RES, V16, P154, DOI 10.1038/sj.cr.7310021; Cortesini NSF, 2001, HUM IMMUNOL, V62, P1065, DOI 10.1016/S0198-8859(01)00310-X; Creusot RJ, 2009, BLOOD, V113, P6638, DOI 10.1182/blood-2009-02-204321; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Erwig LP, 2007, AM J PATHOL, V171, P2, DOI 10.2353/ajpath.2007.070135; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Faleo G, 2012, DIABETES, V61, P1769, DOI 10.2337/db11-0516; FORMBY B, 1990, P NATL ACAD SCI USA, V87, P2438, DOI 10.1073/pnas.87.7.2438; GOODWIN JS, 1983, J CLIN IMMUNOL, V3, P295, DOI 10.1007/BF00915791; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Hanig J, 2008, J IMMUNOL, V180, P1405, DOI 10.4049/jimmunol.180.3.1405; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; HANCOCK WW, 1995, AM J PATHOL, V147, P1193; Hilkens CMU, 2010, INT REV IMMUNOL, V29, P156, DOI 10.3109/08830180903281193; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jozefowski S, 2005, IMMUNOLOGY, V116, P418, DOI 10.1111/j.1365-2567.2005.02241.x; Keino H, 2006, INVEST OPHTH VIS SCI, V47, P1047, DOI 10.1167/iovs.05-0110; Knip M, 2008, AUTOIMMUN REV, V7, P550, DOI 10.1016/j.autrev.2008.04.008; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Kushwah R, 2010, EUR J IMMUNOL, V40, P1022, DOI 10.1002/eji.200939782; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lee M, 2000, J KOREAN MED SCI, V15, P217, DOI 10.3346/jkms.2000.15.2.217; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LO D, 1993, EUR J IMMUNOL, V23, P1693, DOI 10.1002/eji.1830230744; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Marin-Gallen S, 2010, CLIN EXP IMMUNOL, V160, P207, DOI 10.1111/j.1365-2249.2009.04082.x; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Miles K, 2012, P NATL ACAD SCI USA, V109, P887, DOI 10.1073/pnas.1109173109; Morel PA, 2011, J LEUKOCYTE BIOL, V90, P539, DOI 10.1189/jlb.0311126; Morelli AE, 2010, APOPTOSIS, V15, P1083, DOI 10.1007/s10495-010-0469-9; Muthuswamy R, 2010, BLOOD, V116, P1454, DOI 10.1182/blood-2009-12-258038; Nencioni A, 2003, CRIT REV IMMUNOL, V23, P1, DOI 10.1615/CritRevImmunol.v23.i12.10; O'Brien BA, 2006, J AUTOIMMUN, V26, P104, DOI 10.1016/j.jaut.2005.11.006; Peakman M, 2010, DIABETES, V59, P2087, DOI 10.2337/db10-0630; Phillips B, 2009, EXPERT REV CLIN IMMU, V5, P325, DOI 10.1586/ECI.09.8; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Ruggeri P, 2000, IMMUNOPHARM IMMUNOT, V22, P117, DOI 10.3109/08923970009016410; Sandahl M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-122; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Strid J, 2001, CLIN EXP IMMUNOL, V123, P375, DOI 10.1046/j.1365-2249.2001.01473.x; Torres-Aguilar H, 2010, AUTOIMMUN REV, V10, P8, DOI 10.1016/j.autrev.2010.07.015; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Van Elssen CHMJ, 2011, BLOOD, V118, P2473, DOI 10.1182/blood-2010-09-307835; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022	51	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63296	10.1371/journal.pone.0063296	http://dx.doi.org/10.1371/journal.pone.0063296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691013	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700028
J	Torres, CAA; Varian, KD; Canan, CH; Davis, JP; Janssen, PML				Torres, Carlos A. A.; Varian, Kenneth D.; Canan, Cynthia H.; Davis, Jonathan P.; Janssen, Paul M. L.			The Positive Inotropic Effect of Pyruvate Involves an Increase in Myofilament Calcium Sensitivity	PLOS ONE			English	Article							FREQUENCY-DEPENDENT ACCELERATION; CARDIAC-MUSCLE CONTRACTION; TROPONIN-C CONSTRUCTS; INTRACORONARY PYRUVATE; RELAXATION; CA2+; FORCE; PHOSPHORYLATION; RABBIT; HEART	Pyruvate is a metabolic fuel that is a potent inotropic agent. Despite its unique inotropic and antioxidant properties, the molecular mechanism of its inotropic mechanism is still largely unknown. To examine the inotropic effect of pyruvate in parallel with intracellular calcium handling under near physiological conditions, we measured pH, myofilament calcium sensitivity, developed force, and calcium transients in ultra thin rabbit heart trabeculae at 37 degrees C loaded iontophoretically with the calcium indicator bis-fura-2. By contrasting conditions of control versus sarcoplasmic reticulum block (with either cyclopiazonic acid and ryanodine or with thapsigargin) we were able to characterize and isolate the effects of pyruvate on sarcoplasmic reticulum calcium handling and developed force. A potassium contracture technique was subsequently utilized to assess the force-calcium relationship and thus the myofilament calcium sensitivity. Pyruvate consistently increased developed force whether or not the sarcoplasmic reticulum was blocked (16.8 +/- 3.5 to 24.5 +/- 5.1 vs. 6.9 +/- 2.6 to 12.5 +/- 4.4 mN/mm(2), non-blocked vs. blocked sarcoplasmic reticulum respectively, p<0.001, n = 9). Furthermore, the sensitizing effect of pyruvate on the myofilaments was demonstrated by potassium contractures (EC50 at baseline versus 20 minutes of pyruvate infusion (peak force development) was 701 +/- 94 vs. 445 +/- 65 nM, p<0.01, n = 6). This study is the first to demonstrate that a leftward shift in myofilament calcium sensitivity is an important mediator of the inotropic effect of pyruvate. This finding can have important implications for future development of therapeutic strategies in the management of heart failure.	[Torres, Carlos A. A.; Varian, Kenneth D.; Canan, Cynthia H.; Davis, Jonathan P.; Janssen, Paul M. L.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Janssen, PML (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	janssen.10@osu.edu	Janssen, Paul ML/E-3307-2011; Torres, Carlos/GRS-7240-2022	Janssen, Paul/0000-0002-9682-3014	Emergency Medicine Foundation (CAAT); National Heart, Lung, and Blood Institute [R01 073816]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091986] Funding Source: NIH RePORTER	Emergency Medicine Foundation (CAAT); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a career development grant from the Emergency Medicine Foundation (CAAT); and by a National Heart, Lung, and Blood Institute [Grant R01 073816] (PMLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	BACKX PH, 1993, AM J PHYSIOL, V264, pH1098, DOI 10.1152/ajpheart.1993.264.4.H1098; Bassenge E, 2000, AM J PHYSIOL-HEART C, V279, pH2431, DOI 10.1152/ajpheart.2000.279.5.H2431; BLATTER LA, 1991, CIRC RES, V68, P150, DOI 10.1161/01.RES.68.1.150; BUNGER R, 1989, EUR J BIOCHEM, V180, P221, DOI 10.1111/j.1432-1033.1989.tb14637.x; de Tombe PP, 2003, J BIOMECH, V36, P721, DOI 10.1016/S0021-9290(02)00450-5; DEBOER LWV, 1993, AM J PHYSIOL, V265, pH1571, DOI 10.1152/ajpheart.1993.265.5.H1571; DEHEMPTINNE A, 1983, AM J PHYSIOL, V245, pC178, DOI 10.1152/ajpcell.1983.245.3.C178; DeSantiago J, 2002, J MOL CELL CARDIOL, V34, P975, DOI 10.1006/jmcc.2002.2034; EBUS JP, 1994, J PHYSIOL-LONDON, V476, P501, DOI 10.1113/jphysiol.1994.sp020150; Hasenfuss G, 2002, CIRCULATION, V105, P194, DOI 10.1161/hc0202.102238; Hermann HP, 2004, EUR J HEART FAIL, V6, P213, DOI 10.1016/j.ejheart.2003.10.001; Hermann HP, 2002, CARDIOVASC RES, V53, P116, DOI 10.1016/S0008-6363(01)00437-0; Hermann HP, 1999, LANCET, V353, P1321, DOI 10.1016/S0140-6736(98)06423-X; Hermann HP, 2000, AM J PHYSIOL-HEART C, V279, pH702, DOI 10.1152/ajpheart.2000.279.2.H702; HOFMANN PA, 1994, CIRC RES, V74, P718, DOI 10.1161/01.RES.74.4.718; Janssen PML, 2010, AM J PHYSIOL-HEART C, V299, pH1741, DOI 10.1152/ajpheart.00759.2010; Janssen PML, 2010, AM J PHYSIOL-HEART C, V299, pH1092, DOI 10.1152/ajpheart.00417.2010; Janssen PML, 2002, AM J PHYSIOL-HEART C, V282, pH499, DOI 10.1152/ajpheart.00595.2001; KENTISH JC, 1986, J PHYSIOL-LONDON, V370, P585, DOI 10.1113/jphysiol.1986.sp015952; Keweloh B, 2007, EUR J HEART FAIL, V9, P754, DOI 10.1016/j.ejheart.2007.03.011; LAUGHLIN MR, 1993, AM J PHYSIOL, V264, pH2068, DOI 10.1152/ajpheart.1993.264.6.H2068; Li L, 2000, AM J PHYSIOL-HEART C, V278, pH769, DOI 10.1152/ajpheart.2000.278.3.H769; LIEDTKE AJ, 1978, CIRC RES, V43, P189, DOI 10.1161/01.RES.43.2.189; Liu B, 2012, J BIOL CHEM, V287, P20027, DOI 10.1074/jbc.M111.334953; Luo Y, 2002, J PHYSIOL-LONDON, V545, P887, DOI 10.1113/jphysiol.2002.031757; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Mallet RT, 2005, EXP BIOL MED, V230, P435; Mallet RT, 1999, CARDIOVASC RES, V42, P149, DOI 10.1016/S0008-6363(98)00300-9; Martin BJ, 1998, AM J PHYSIOL-HEART C, V274, pH8, DOI 10.1152/ajpheart.1998.274.1.H8; METZGER JM, 1992, BIOPHYS J, V63, P460, DOI 10.1016/S0006-3495(92)81614-4; Monasky MM, 2009, J COMP PHYSIOL B, V179, P469, DOI 10.1007/s00360-008-0331-3; Norman C, 2007, AM J PHYSIOL-HEART C, V293, pH2580, DOI 10.1152/ajpheart.00039.2007; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; Raman S, 2006, PFLUG ARCH EUR J PHY, V451, P625, DOI 10.1007/s00424-005-1500-9; RODRIGUEZ EK, 1992, AM J PHYSIOL, V263, pH293, DOI 10.1152/ajpheart.1992.263.1.H293; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Roof SR, 2011, AM J PHYSIOL-HEART C, V301, pH1570, DOI 10.1152/ajpheart.00402.2011; Schillinger W, 2011, CLIN RES CARDIOL, V100, P433, DOI 10.1007/s00392-010-0261-4; SCHOUTEN VJA, 1986, PFLUG ARCH EUR J PHY, V407, P14, DOI 10.1007/BF00580714; Slovin PN, 2001, RESUSCITATION, V50, P109, DOI 10.1016/S0300-9572(01)00325-2; STRANG KT, 1994, CIRC RES, V74, P542, DOI 10.1161/01.RES.74.3.542; Stull LB, 2002, J MOL CELL CARDIOL, V34, P1367, DOI 10.1006/jmcc.2002.2065; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2002, BIOCHEMISTRY-US, V41, P6697, DOI 10.1021/bi011763h; Varian KD, 2006, AM J PHYSIOL-HEART C, V290, pH2092, DOI 10.1152/ajpheart.01241.2005; Varian KD, 2007, AM J PHYSIOL-HEART C, V292, pH2212, DOI 10.1152/ajpheart.00778.2006; Zima AV, 2003, J PHYSIOL-LONDON, V550, P765, DOI 10.1113/jphysiol.2003.040345; ZWEIER JL, 1987, J BIOL CHEM, V262, P8015	48	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63608	10.1371/journal.pone.0063608	http://dx.doi.org/10.1371/journal.pone.0063608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691074	Green Submitted, gold, Green Published			2022-12-25	WOS:000319052700053
J	Burns, EM; Tober, KL; Riggenbach, JA; Kusewitt, DF; Young, GS; Oberyszyn, TM				Burns, Erin M.; Tober, Kathleen L.; Riggenbach, Judith A.; Kusewitt, Donna F.; Young, Gregory S.; Oberyszyn, Tatiana M.			Differential Effects of Topical Vitamin E and C E Ferulic (R) Treatments on Ultraviolet Light B-Induced Cutaneous Tumor Development in Skh-1 Mice	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; INDUCED OXIDATIVE DAMAGE; ALPHA-TOCOPHEROL; SKIN-CANCER; BETA-CAROTENE; MOUSE SKIN; GLUTATHIONE-PEROXIDASE; ANTIOXIDANT VITAMINS; MICROVESSEL DENSITY; MALIGNANT-MELANOMA	Because of the ever-increasing incidence of ultraviolet light B (UVB)-induced skin cancer, considerable attention is being paid to prevention through the use of both sunscreens and after sun treatments, many of which contain antioxidants. Vitamin E is included as an antioxidant in many sunscreens and lotions currently on the market. Studies examining the efficacy of vitamin E as a topical preventative agent for UVB-induced skin cancer have yielded conflicting results. A likely contributor to differences in study outcome is the stability of vitamin E in the particular formulation being tested. In the current study we examined the effects of topical vitamin E alone as well as vitamin E combined with vitamin C and ferulic acid in a more stable topical formula (C E Ferulic (R)). Mice were exposed to UVB for 10 weeks in order to induce skin damage. Then, before the appearance of any cutaneous lesions, mice were treated for 15 weeks with a topical antioxidant, without any further UVB exposure. We found that topical C E Ferulic decreased tumor number and tumor burden and prevented the development of malignant skin tumors in female mice with chronically UVB-damaged skin. In contrast, female mice chronically exposed to UVB and treated topically with vitamin E alone showed a trend towards increased tumor growth rate and exhibited increased levels of overall DNA damage, cutaneous proliferation, and angiogenesis compared to vehicle-treated mice. Thus, we have demonstrated that topical 5% alpha tocopherol may actually promote carcinogenesis when applied on chronically UVB-damaged skin while treating with a more stable antioxidant compound may offer therapeutic benefits.	[Burns, Erin M.; Tober, Kathleen L.; Riggenbach, Judith A.; Oberyszyn, Tatiana M.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Kusewitt, Donna F.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Young, Gregory S.] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University	Oberyszyn, TM (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	oberyszyn.1@osu.edu	Oberyszyn, Tatiana/E-3774-2011	Oberyszyn, Tatiana/0000-0002-5308-0855	National Institutes of Health [R01 CA133629]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA133629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health grant R01 CA133629 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaq F, 2001, J PHOTOCH PHOTOBIO B, V63, P61, DOI 10.1016/S1011-1344(01)00217-2; ASANOMA M, 1994, CARCINOGENESIS, V15, P2069, DOI 10.1093/carcin/15.9.2069; Bath-Hextall F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005414.pub2; Berton TR, 1998, MOL CARCINOGEN, V23, P175, DOI 10.1002/(SICI)1098-2744(199811)23:3<175::AID-MC6>3.0.CO;2-B; BISSETT DL, 1990, PHOTODERMATOL PHOTO, V7, P56; BRESLOW RA, 1995, CANCER EPIDEM BIOMAR, V4, P837; Burns EM, 2013, CARCINOGENESIS, V34, P370, DOI 10.1093/carcin/bgs349; CHAN AC, 1993, CAN J PHYSIOL PHARM, V71, P725, DOI 10.1139/y93-109; Chen LL, 2012, PHOTODERMATOL PHOTO, V28, P228, DOI 10.1111/j.1600-0781.2012.00674.x; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Daghini E, 2007, AM J PHYSIOL-RENAL, V293, pF371, DOI 10.1152/ajprenal.00475.2006; DARR D, 1992, BRIT J DERMATOL, V127, P247, DOI 10.1111/j.1365-2133.1992.tb00122.x; Dorgan JF, 2004, CANCER EPIDEM BIOMAR, V13, P1276; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Fazary AE, 2007, ACTA BIOCH BIOPH SIN, V39, P811, DOI 10.1111/j.1745-7270.2007.00348.x; FOX SB, 1993, CANCER RES, V53, P4161; FUCHS J, 1989, J INVEST DERMATOL, V93, P769, DOI 10.1111/1523-1747.ep12284412; FUCHS J, 1989, PHOTOCHEM PHOTOBIOL, V50, P739, DOI 10.1111/j.1751-1097.1989.tb02904.x; Fung TT, 2003, INT J CANCER, V103, P110, DOI 10.1002/ijc.10798; GENSLER HL, 1991, NUTR CANCER, V15, P97, DOI 10.1080/01635589109514117; Gensler HL, 1996, NUTR CANCER, V26, P183, DOI 10.1080/01635589609514474; Gouaze V, 2002, J BIOL CHEM, V277, P42867, DOI 10.1074/jbc.M203067200; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 2007, J NUTR, V137, P2098, DOI 10.1093/jn/137.9.2098; Hsu J. C, 1992, J COMPUTATIONAL STAT, V1, P151, DOI DOI 10.2307/1390839; HUANG MT, 1988, CANCER RES, V48, P5941; Ichihashi M, 1999, ANTICANCER RES, V19, P3769; Karagas MR, 1997, CANCER EPIDEM BIOMAR, V6, P25; KEANEY JF, 1994, J CLIN INVEST, V93, P844, DOI 10.1172/JCI117039; Kontush A, 1996, J LIPID RES, V37, P1436; KUNE GA, 1992, NUTR CANCER, V18, P237, DOI 10.1080/01635589209514224; Kuwabara M, 2006, J PHYSIOL SCI, V56, P95, DOI 10.2170/physiolsci.RP002305; Lin FH, 2005, J INVEST DERMATOL, V125, P826, DOI 10.1111/j.0022-202X.2005.23768.x; Lin JY, 2003, J AM ACAD DERMATOL, V48, P866, DOI 10.1067/mjd.2003.425; Lopez-Torres M, 1998, BRIT J DERMATOL, V138, P207; Lu YP, 1997, CANCER RES, V57, P1468; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Mattern J, 1996, BRIT J CANCER, V73, P931, DOI 10.1038/bjc.1996.166; MCBRIDE TJ, 1991, BIOCHEMISTRY-US, V30, P207, DOI 10.1021/bi00215a030; Murakami A, 2002, CANCER LETT, V180, P121, DOI 10.1016/S0304-3835(01)00858-8; Murakami A, 2000, CANCER LETT, V157, P77, DOI 10.1016/S0304-3835(00)00478-X; Neuzil J, 1997, FREE RADICAL BIO MED, V22, P57, DOI 10.1016/S0891-5849(96)00224-9; Nishigori C, 2004, ANTIOXID REDOX SIGN, V6, P561, DOI 10.1089/152308604773934314; Pauling L, 1982, Int J Vitam Nutr Res Suppl, V23, P53; Ratnasinghe D, 2000, CANCER RES, V60, P6381; Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267; Rebel H, 2001, CANCER RES, V61, P977; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Rojas A, 2006, ARCH MED RES, V37, P436, DOI 10.1016/j.arcmed.2005.11.012; Sander CS, 2004, INT J DERMATOL, V43, P326, DOI 10.1111/j.1365-4632.2004.02222.x; Sander CS, 2002, J INVEST DERMATOL, V118, P618, DOI 10.1046/j.1523-1747.2002.01708.x; Sander CS, 2003, BRIT J DERMATOL, V148, P913, DOI 10.1046/j.1365-2133.2003.05303.x; Sauer H, 2005, ANTIOXID REDOX SIGN, V7, P1423, DOI 10.1089/ars.2005.7.1423; SHINDO Y, 1995, ARCH DERMATOL RES, V287, P747, DOI 10.1007/BF01105800; SHINDO Y, 1993, J INVEST DERMATOL, V100, P260, DOI 10.1111/1523-1747.ep12469048; SHINDO Y, 1994, J INVEST DERMATOL, V102, P470, DOI 10.1111/1523-1747.ep12373027; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Sullivan NJ, 2012, J INVEST DERMATOL, V132, P695, DOI 10.1038/jid.2011.329; Thomas-Ahner JM, 2007, CANCER RES, V67, P3468, DOI 10.1158/0008-5472.CAN-06-3798; van der Pols JC, 2009, CANCER EPIDEM BIOMAR, V18, P1167, DOI 10.1158/1055-9965.EPI-08-1211; VERMEULEN PB, 1995, ANN ONCOL, V6, P59, DOI 10.1093/oxfordjournals.annonc.a059043; Versari D, 2006, HYPERTENSION, V47, P475, DOI 10.1161/01.HYP.0000201445.77125.26; Walaszek Z, 2004, CHEST, V125, p128S, DOI 10.1378/chest.125.5_suppl.128S-a; Wilgus TA, 2003, MOL CARCINOGEN, V38, P49, DOI 10.1002/mc.10141; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200	67	22	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63809	10.1371/journal.pone.0063809	http://dx.doi.org/10.1371/journal.pone.0063809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691100	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400080
J	He, HL; Li, W; Wu, DY; Nagy, R; Liyanarachchi, S; Akagi, K; Jendrzejewski, J; Jiao, H; Hoag, K; Wen, B; Srinivas, M; Waidyaratne, G; Wang, R; Wojcicka, A; Lattimer, IR; Stachlewska, E; Czetwertynska, M; Dlugosinska, J; Gierlikowski, W; Ploski, R; Krawczyk, M; Jazdzewski, K; Kere, J; Symer, DE; Jin, V; Wang, QB; de la Chapelle, A				He, Huiling; Li, Wei; Wu, Dayong; Nagy, Rebecca; Liyanarachchi, Sandya; Akagi, Keiko; Jendrzejewski, Jaroslaw; Jiao, Hong; Hoag, Kevin; Wen, Bernard; Srinivas, Mukund; Waidyaratne, Gavisha; Wang, Rui; Wojcicka, Anna; Lattimer, Ilene R.; Stachlewska, Elzbieta; Czetwertynska, Malgorzata; Dlugosinska, Joanna; Gierlikowski, Wojciech; Ploski, Rafal; Krawczyk, Marek; Jazdzewski, Krystian; Kere, Juha; Symer, David E.; Jin, Victor; Wang, Qianben; de la Chapelle, Albert			Ultra-Rare Mutation in Long-Range Enhancer Predisposes to Thyroid Carcinoma with High Penetrance	PLOS ONE			English	Article							FIRST-DEGREE RELATIVES; CANCER-RISK; SUSCEPTIBILITY LOCUS; COLORECTAL-CANCER; LINKAGE ANALYSIS; GENE-EXPRESSION; ANAPLASTIC TRANSFORMATION; COMMON VARIANTS; PROSTATE-CANCER; HUMAN-DISEASE	Thyroid cancer shows high heritability but causative genes remain largely unknown. According to a common hypothesis the genetic predisposition to thyroid cancer is highly heterogeneous; being in part due to many different rare alleles. Here we used linkage analysis and targeted deep sequencing to detect a novel single-nucleotide mutation in chromosome 4q32 (4q32A>C) in a large pedigree displaying non-medullary thyroid carcinoma (NMTC). This mutation is generally ultra-rare; it was not found in 38 NMTC families, in 2676 sporadic NMTC cases or 2470 controls. The mutation is located in a long-range enhancer element whose ability to bind the transcription factors POU2F and YY1 is significantly impaired, with decreased activity in the presence of the C-allele compared with the wild type A-allele. An enhancer RNA (eRNA) is transcribed in thyroid tissue from this region and is greatly downregulated in NMTC tumors. We suggest that this is an example of an ultra-rare mutation predisposing to thyroid cancer with high penetrance.	[He, Huiling; Li, Wei; Nagy, Rebecca; Liyanarachchi, Sandya; Akagi, Keiko; Jendrzejewski, Jaroslaw; Hoag, Kevin; Wen, Bernard; Srinivas, Mukund; Waidyaratne, Gavisha; Lattimer, Ilene R.; Jazdzewski, Krystian; Symer, David E.; de la Chapelle, Albert] Ohio State Univ, Human Canc Genet Program, Wexner Med Ctr, Columbus, OH 43210 USA; [He, Huiling; Li, Wei; Nagy, Rebecca; Liyanarachchi, Sandya; Akagi, Keiko; Jendrzejewski, Jaroslaw; Hoag, Kevin; Wen, Bernard; Srinivas, Mukund; Waidyaratne, Gavisha; Lattimer, Ilene R.; Jazdzewski, Krystian; Symer, David E.; de la Chapelle, Albert] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Wexner Med Ctr, Columbus, OH 43210 USA; [He, Huiling; Li, Wei; Wu, Dayong; Nagy, Rebecca; Liyanarachchi, Sandya; Akagi, Keiko; Jendrzejewski, Jaroslaw; Hoag, Kevin; Wen, Bernard; Srinivas, Mukund; Waidyaratne, Gavisha; Wang, Rui; Lattimer, Ilene R.; Jazdzewski, Krystian; Symer, David E.; Jin, Victor; Wang, Qianben; de la Chapelle, Albert] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Li, Wei; Wang, Qianben] Ohio State Univ, Dept Mol & Cellular Biochem, Wexner Med Ctr, Columbus, OH 43210 USA; [Nagy, Rebecca; Lattimer, Ilene R.; Symer, David E.] Ohio State Univ, Dept Internal Med, Wexner Med Ctr, Columbus, OH 43210 USA; [Wang, Rui; Symer, David E.; Jin, Victor] Ohio State Univ, Dept Biomed Informat, Wexner Med Ctr, Columbus, OH 43210 USA; [Jiao, Hong; Kere, Juha] Karolinska Inst, Clin Res Ctr, Dept Biosci & Nutr, Stockholm, Sweden; [Jiao, Hong; Kere, Juha] Karolinska Inst, Sci Life Lab, Stockholm, Sweden; [Stachlewska, Elzbieta] Maria Sklodowska Curie Mem Canc Ctr, Dept Endocrine Surg, Warsaw, Poland; [Stachlewska, Elzbieta; Czetwertynska, Malgorzata; Dlugosinska, Joanna] Inst Oncol, Warsaw, Poland; [Czetwertynska, Malgorzata; Dlugosinska, Joanna] Maria Sklodowska Curie Mem Canc Ctr, Dept Nucl Med & Endocrine Oncol, Warsaw, Poland; [Wojcicka, Anna] Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Wojcicka, Anna; Gierlikowski, Wojciech; Krawczyk, Marek; Jazdzewski, Krystian] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Warsaw, Poland; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Kere, Juha] Univ Helsinki, Res Programs Unit, Helsinki, Finland	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Karolinska Institutet; Karolinska Institutet; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Centre of Postgraduate Medical Education - Poland; Medical University of Warsaw; Medical University of Warsaw; University of Helsinki	He, HL (corresponding author), Ohio State Univ, Human Canc Genet Program, Wexner Med Ctr, Columbus, OH 43210 USA.	huiling.he@osumc.edu; albert.delachapelle@osumc.edu	Nagy, Rebecca Shrigley/E-4088-2011; Jazdzewski, Krystian/A-2938-2008; Wang, Qianben/E-4267-2011; Symer, David E./E-4173-2011; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008; Gierlikowski, Wojciech/M-3215-2018; Wojcicka, Anna/K-4134-2012	Jazdzewski, Krystian/0000-0001-5327-6332; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Gierlikowski, Wojciech/0000-0002-1706-4436; Wojcicka, Anna/0000-0001-5803-6397; Ploski, Rafal/0000-0001-6286-5526; Jendrzejewski, Jaroslaw/0000-0002-9717-5880; Eva, Joanna/0000-0001-7634-2056	National Cancer Institute [P30CA16058, P01CA124570]; Polish Ministry of Science and Higher Education [NN401 584838]; NATIONAL CANCER INSTITUTE [R01CA151979, P01CA124570, P30CA016058] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Grants P30CA16058 and P01CA124570 (http://www.nih.gov/) and by the Polish Ministry of Science and Higher Education Grant NN401 584838 (http://www.nauka.gov.pl/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Bignell GR, 1997, AM J HUM GENET, V61, P1123, DOI 10.1086/301610; Bingle CD, 1996, BIOCHEM J, V319, P669, DOI 10.1042/bj3190669; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bodmer W, 2010, CURR OPIN GENET DEV, V20, P262, DOI 10.1016/j.gde.2010.04.016; Canzian F, 1998, AM J HUM GENET, V63, P1743, DOI 10.1086/302164; Carvajal-Carmona LG, 2010, CURR OPIN GENET DEV, V20, P277, DOI 10.1016/j.gde.2010.05.005; Cavaco BM, 2008, J CLIN ENDOCR METAB, V93, P4426, DOI 10.1210/jc.2008-0449; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; CLARK ME, 1995, MOL CELL BIOL, V15, P6169; Dong CH, 2001, INT J CANCER, V92, P144; Epstein Douglas J., 2009, Briefings in Functional Genomics & Proteomics, V8, P310, DOI 10.1093/bfgp/elp021; Fagin JA, 1997, J CLIN ENDOCR METAB, V82, P342, DOI 10.1210/jc.82.2.342; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frich L, 2001, CANCER EPIDEM BIOMAR, V10, P113; Glinskii AB, 2011, CELL CYCLE, V10, P3571, DOI 10.4161/cc.10.20.17842; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gruber SB, 2007, CANCER BIOL THER, V6, P1143, DOI 10.4161/cbt.6.7.4704; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; He HL, 2009, CANCER RES, V69, P625, DOI 10.1158/0008-5472.CAN-08-1071; Howlader N, 2011, SEER CANC STAT REV 1; Hunt JL, 2003, AM J SURG PATHOL, V27, P1559, DOI 10.1097/00000478-200312000-00009; Im Hogune, 2004, Methods Mol Biol, V284, P129; Jarinova O, 2012, HUM MUTAT, V33, P1021, DOI 10.1002/humu.22083; Jendrzejewski J, 2012, P NATL ACAD SCI USA, V109, P8646, DOI 10.1073/pnas.1205654109; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Loh KC, 1997, THYROID, V7, P107, DOI 10.1089/thy.1997.7.107; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Malchoff CD, 2000, J CLIN ENDOCR METAB, V85, P1758, DOI 10.1210/jc.85.5.1758; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Mazeh H, 2013, THYROID, V23, P1049, DOI 10.1089/thy.2013.0079; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McKay JD, 2001, AM J HUM GENET, V69, P440, DOI 10.1086/321979; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Nose V, 2011, MODERN PATHOL, V24, pS19, DOI 10.1038/modpathol.2010.147; Pal T, 2001, J CLIN ENDOCR METAB, V86, P5307, DOI 10.1210/jc.86.11.5307; Palin K, 2006, NAT PROTOC, V1, P368, DOI 10.1038/nprot.2006.56; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Schneider AB, 2005, NAT CLIN PRACT ENDOC, V1, P82, DOI 10.1038/ncpendmet0022; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Smith A, 2007, J MED GENET, V44, P10, DOI 10.1136/jmg.2006.043091; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Suh I, 2009, SURGERY, V146, P1073, DOI 10.1016/j.surg.2009.09.012; Tuupanen S, 2012, CANCER GENET-NY, V205, P25, DOI 10.1016/j.cancergen.2012.01.005; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wiseman SM, 2003, ARCH OTOLARYNGOL, V129, P96, DOI 10.1001/archotol.129.1.96; Xu L, 2012, CANCER-AM CANCER SOC, V118, P1228, DOI 10.1002/cncr.26398; Zhang X, 2012, EXP THER MED, V3, P9, DOI 10.3892/etm.2011.367	55	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e61920	10.1371/journal.pone.0061920	http://dx.doi.org/10.1371/journal.pone.0061920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690926	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400006
J	Khandelwal, P; Blanco-Mezquita, T; Emami, P; Lee, HS; Reyes, NJ; Mathew, R; Huang, R; Saban, DR				Khandelwal, Payal; Blanco-Mezquita, Tomas; Emami, Parisa; Lee, Hyun Soo; Reyes, Nancy J.; Mathew, Rose; Huang, Randy; Saban, Daniel R.			Ocular Mucosal CD11b+and CD103+Mouse Dendritic Cells under Normal Conditions and in Allergic Immune Responses	PLOS ONE			English	Article							CROSS-PRESENTATION; ANTIGEN; SUBSETS	Steady state dendritic cells (DC) found in non-lymphoid tissue sites under normal physiologic conditions play a pivotal role in triggering T cell responses upon immune provocation. CD11b+ and CD103+ DC have received considerable attention in this regard. However, still unknown is whether such CD11b+ and CD103+ DC even exist in the ocular mucosa, and if so, what functions they have in shaping immune responses. We herein identified in the ocular mucosa of normal wild-type (WT) and Flt3-/- mice the presence of a CD11b+ DC (i.e., CD11c+ MHCII+ CD11b+ CD103-F4/80+ Sirp-a+). CD103+ DC (i.e. CD11c+ MHCII+ CD11b low CD103+ CD8a+ DEC205+ Langerin+) were also present in WT, but not in Flt3-/- mice. These CD103+ DC expressed high levels of Id2 and Flt3 mRNA; whereas CD11b+ DC expressed high Irf4, Csfr, and Cx3cr1 mRNA. Additionally, the functions of these DC differed in response to allergic immune provocation. This was assessed utilizing a previously validated model, which includes transferring specific populations of exogenous DC into the ocular mucosa of ovalbumin (OVA)/alum-primed mice. Interestingly, in such mice, topical OVA instillation following engraftment of exogenous CD11b+ DC led to dominant allergic T cell responses and clinical signs of ocular allergy relative to those engrafted with CD103+ DC. Thus, although CD11b+ and CD103+ DC are both present in the normal ocular mucosa, the CD11b+ DC subset plays a dominant role in a mouse model of ocular allergy.	[Khandelwal, Payal; Emami, Parisa; Lee, Hyun Soo; Huang, Randy] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Schepens Eye Res Inst, Boston, MA 02114 USA; [Blanco-Mezquita, Tomas; Reyes, Nancy J.; Mathew, Rose; Saban, Daniel R.] Duke Univ, Sch Med, Duke Eye Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Saban, Daniel R.] Duke Univ, Sch Med, Dept Immunol, Durham, NC USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Duke University; Duke University	Saban, DR (corresponding author), Duke Univ, Sch Med, Duke Eye Ctr, Dept Ophthalmol, Durham, NC 27710 USA.	daniel.saban@duke.edu		Emami, Parisa/0000-0002-4494-7517	NIH [R01EY021798]; NATIONAL EYE INSTITUTE [R01EY021798] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this work came exclusively from NIH grant R01EY021798 awarded to DRS, the PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; D'Agostino PM, 2012, P NATL ACAD SCI USA, V109, P6175, DOI 10.1073/pnas.1203941109; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hattori T, 2012, J LEUKOCYTE BIOL, V91, P621, DOI 10.1189/jlb.1011500; Hattori T, 2011, INVEST OPHTH VIS SCI, V52, P4598, DOI 10.1167/iovs.10-6741; Ho AWS, 2011, J IMMUNOL, V187, P6011, DOI 10.4049/jimmunol.1100987; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maldonado-Lopez R, 2001, J IMMUNOL, V167, P4345, DOI 10.4049/jimmunol.167.8.4345; Manzouri B, 2008, OCUL SURF, V6, P70, DOI 10.1016/S1542-0124(12)70270-7; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Medoff BD, 2009, J IMMUNOL, V182, P623, DOI 10.4049/jimmunol.182.1.623; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Ohbayashl M, 2007, EXP MOL PATHOL, V83, P216, DOI 10.1016/j.yexmp.2007.04.007; Raymond M, 2009, J ALLERGY CLIN IMMUN, V124, P1333, DOI 10.1016/j.jaci.2009.07.021; Sathe P, 2011, J IMMUNOL, V186, P5184, DOI 10.4049/jimmunol.1002683; Schlereth S, 2012, AM J PATHOL, V180, P2351, DOI 10.1016/j.ajpath.2012.02.015; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025	23	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64193	10.1371/journal.pone.0064193	http://dx.doi.org/10.1371/journal.pone.0064193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691170	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400104
J	Lyu, YN; Tian, LL; Zhang, LQ; Dou, XF; Wang, XM; Li, WH; Zhang, XC; Sun, YL; Guan, ZZ; Li, XY; Wang, QY				Lyu, Yanning; Tian, Lili; Zhang, Liqin; Dou, Xiangfeng; Wang, Xiaomei; Li, Weihong; Zhang, Xiuchun; Sun, Yulan; Guan, Zengzhi; Li, Xinyu; Wang, Quanyi			A Case-Control Study of Risk Factors Associated with Scrub Typhus Infection in Beijing, China	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; RICKETTSIAL DISEASES; EPIDEMIOLOGY; THAILAND	To investigate the risk factors of scrub typhus infection in Beijing, China, a case-control study was carried out. Cases (n = 56) were defined as persons who were diagnosed by PCR and serological method within three years. Three neighborhood control subjects were selected by matching for age and occupation. Living at the edge of the village, living in the houses near grassland, vegetable field or ditch, house yard without cement floor, piling weeds in the house or yard, all of these were risk factors for scrub typhus infection. Working in vegetable fields and hilly areas, and harvesting in autumn posed the highest risks, with odds ratios (ORs) and 95% confidence intervals (CIs) of 3.7 (1.1-11.9), 8.2 (1.4-49.5), and 17.2 (5.1-57.9), respectively. These results would be useful for the establishment of a detail control strategy for scrub typhus infection in Beijing, China.	[Lyu, Yanning; Tian, Lili; Dou, Xiangfeng; Wang, Xiaomei; Li, Weihong; Zhang, Xiuchun; Sun, Yulan; Guan, Zengzhi; Li, Xinyu; Wang, Quanyi] Beijing Ctr Dis Prevent & Control, Inst Infect Dis & Endem Dis Prevent & Control, Beijing, Peoples R China; [Zhang, Liqin] Ctr Dis Prevent & Control Pinggu Dist, Dept Infect Dis & Endem Dis Prevent & Control, Beijing, Peoples R China		Wang, QY (corresponding author), Beijing Ctr Dis Prevent & Control, Inst Infect Dis & Endem Dis Prevent & Control, Beijing, Peoples R China.	bjcdcxm@126.com			National Key Program for Infectious Disease of China [2012ZX10004215-003-001]	National Key Program for Infectious Disease of China	This work was supported by grants from the National Key Program for Infectious Disease of China (2012ZX10004215-003-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavaro Mary F, 2005, Mil Med, V170, P49; BROWN GW, 1976, T ROY SOC TROP MED H, V70, P444, DOI 10.1016/0035-9203(76)90127-9; Cao M, 2006, EMERG INFECT DIS, V12, P1463, DOI 10.3201/eid1209.060257; Ebisawa I, 1995, J Travel Med, V2, P218, DOI 10.1111/j.1708-8305.1995.tb00662.x; FAN MY, 1987, REV INFECT DIS, V9, P823; Fu XiuPing, 2011, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V22, P137; Jensenius M, 2006, SCAND J INFECT DIS, V38, P200, DOI 10.1080/00365540500277342; Jensenius M, 2009, EMERG INFECT DIS, V15, P1791, DOI 10.3201/eid1511.090677; Kelly DJ, 2002, CLIN INFECT DIS, V34, pS145, DOI 10.1086/339908; Kim DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022731; Lee YS, 2006, JPN J INFECT DIS, V59, P235; Lewis MD, 2003, EMERG INFECT DIS, V9, P1638, DOI 10.3201/eid0912.030212; Matsui T, 2002, JPN J INFECT DIS, V55, P197; Phongmany S, 2006, EMERG INFECT DIS, V12, P256; Rosenberg R, 1997, PARASITOL TODAY, V13, P131, DOI 10.1016/S0169-4758(97)01020-X; Silpapojakul Khachornsakdi, 1997, Annals Academy of Medicine Singapore, V26, P794; STRICKMAN D, 1994, AM J TROP MED HYG, V51, P149, DOI 10.4269/ajtmh.1994.51.149; Su JingJing, 2012, Chinese Journal of Hygienic Insecticides & Equipments, V18, P160; Tian LL, 2011, DIS SURVEILLANCE, V26, P211; WATT G, 1994, CLIN INFECT DIS, V18, P624, DOI 10.1093/clinids/18.4.624; Watt G, 2003, CURR OPIN INFECT DIS, V16, P429, DOI 10.1097/00001432-200310000-00009; Watt G, 1996, LANCET, V348, P86, DOI 10.1016/S0140-6736(96)02501-9; Wu GH, 2005, CHIN J VECTOR BIO CO, V16, P485; YI KS, 1993, MIL MED, V158, P269, DOI 10.1093/milmed/158.4.269; Yu C, 1992, Zhonghua Liu Xing Bing Xue Za Zhi, V13, P212; Zhao YH, 2010, OCCUP HLTH, V26, P2991	26	24	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63668	10.1371/journal.pone.0063668	http://dx.doi.org/10.1371/journal.pone.0063668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691083	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400072
J	Sailer, M; Dahlhoff, C; Giesbertz, P; Eidens, MK; de Wit, N; Rubio-Aliaga, I; Boekschoten, MV; Muller, M; Daniel, H				Sailer, Manuela; Dahlhoff, Christoph; Giesbertz, Pieter; Eidens, Mena K.; de Wit, Nicole; Rubio-Aliaga, Isabel; Boekschoten, Mark V.; Mueller, Michael; Daniel, Hannelore			Increased Plasma Citrulline in Mice Marks Diet-Induced Obesity and May Predict the Development of the Metabolic Syndrome	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; SKELETAL-MUSCLE CELLS; ARGININE BIOAVAILABILITY RATIOS; HIGH-FAT DIET; INSULIN-RESISTANCE; L-ALANINE; PROTEIN; LIVER; SECRETION; MECHANISM	In humans, plasma amino acid concentrations of branched-chain amino acids (BCAA) and aromatic amino acids (AAA) increase in states of obesity, insulin resistance and diabetes. We here assessed whether these putative biomarkers can also be identified in two different obesity and diabetic mouse models. C57BL/6 mice with diet-induced obesity (DIO) mimic the metabolic impairments of obesity in humans characterized by hyperglycemia, hyperinsulinemia and hepatic triglyceride accumulation. Mice treated with streptozotocin (STZ) to induce insulin deficiency were used as a type 1 diabetes model. Plasma amino acid profiling of two high fat (HF) feeding trials revealed that citrulline and ornithine concentrations are elevated in obese mice, while systemic arginine bioavailability (ratio of plasma arginine to ornithine + citrulline) is reduced. In skeletal muscle, HF feeding induced a reduction of arginine levels while citrulline levels were elevated. However, arginine or citrulline remained unchanged in their key metabolic organs, intestine and kidney. Moreover, the intestinal conversion of labeled arginine to ornithine and citrulline in vitro remained unaffected by HF feeding excluding the intestine as prime site of these alterations. In liver, citrulline is mainly derived from ornithine in the urea cycle and DIO mice displayed reduced hepatic ornithine levels. Since both amino acids share an antiport mechanism for mitochondrial import and export, elevated plasma citrulline may indicate impaired hepatic amino acid handling in DIO mice. In the insulin deficient mice, plasma citrulline and ornithine levels also increased and additionally these animals displayed elevated BCAA and AAA levels like insulin resistant and diabetic patients. Therefore, type 1 diabetic mice but not DIO mice show the "diabetic fingerprint'' of plasma amino acid changes observed in humans. Additionally, citrulline may serve as an early indicator of the obesity-dependent metabolic impairments.	[Sailer, Manuela; Dahlhoff, Christoph; Giesbertz, Pieter; Eidens, Mena K.; Rubio-Aliaga, Isabel; Daniel, Hannelore] Tech Univ Munich, Res Ctr Nutr & Food Sci, Mol Nutr Unit, Freising Weihenstephan, Germany; [Dahlhoff, Christoph] Tech Univ Munich, PhD Grad Sch Epigenet Imprinting & Nutr, Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany; [de Wit, Nicole; Boekschoten, Mark V.; Mueller, Michael] Wageningen Univ, Netherlands Nutrigen Ctr, TI Food & Nutr, NL-6700 AP Wageningen, Netherlands; [de Wit, Nicole; Boekschoten, Mark V.; Mueller, Michael] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Technical University of Munich; Technical University of Munich; Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research	Daniel, H (corresponding author), Tech Univ Munich, Res Ctr Nutr & Food Sci, Mol Nutr Unit, Freising Weihenstephan, Germany.	hannelore.daniel@tum.de	Boekschoten, Mark/AAS-4597-2021; Daniel, Hannelore/B-8982-2009; Muller, Michael/B-5795-2008; Muller, Michael/M-5724-2019	Boekschoten, Mark/0000-0002-2139-0795; Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Rubio-Aliaga, Isabel/0000-0003-1051-9511	European Nutrigenomics Organisation, an EC-funded Network of Excellence [FOOD-2004-506360]	European Nutrigenomics Organisation, an EC-funded Network of Excellence	The study was funded by the European Nutrigenomics Organisation, an EC-funded Network of Excellence (Grant No. FOOD-2004-506360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Baccini M, 2008, GENES NUTR, V3, P147, DOI 10.1007/s12263-008-0102-5; Boirie Y, 2001, DIABETES, V50, P2652, DOI 10.2337/diabetes.50.12.2652; Brennan L, 2002, DIABETES, V51, P1714, DOI 10.2337/diabetes.51.6.1714; CEBALLOS I, 1990, CLIN CHIM ACTA, V188, P101, DOI 10.1016/0009-8981(90)90154-K; CLOSS EI, 1993, J BIOL CHEM, V268, P7538; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4; de Wit NJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019145; Dixon G, 2003, J ENDOCRINOL, V179, P447, DOI 10.1677/joe.0.1790447; Drummond MJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1011, DOI 10.1152/ajpendo.00690.2009; Erdely A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015253; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gameiro A, 2005, J PHYSIOL-LONDON, V569, P761, DOI 10.1113/jphysiol.2005.098962; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Gu SM, 2005, J BIOL CHEM, V280, P26055, DOI 10.1074/jbc.M504401200; Guihot G, 1997, JPEN-PARENTER ENTER, V21, P316, DOI 10.1177/0148607197021006316; Hyde R, 2002, J BIOL CHEM, V277, P13628, DOI 10.1074/jbc.M108609200; Indiveri C, 1997, BIOCHEM J, V327, P349, DOI 10.1042/bj3270349; Kashiwagi H, 2009, AMINO ACIDS, V36, P219, DOI 10.1007/s00726-008-0050-9; Lambertucci RH, 2012, CELL PHYSIOL BIOCHEM, V30, P1169, DOI 10.1159/000343307; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; Levillain O, 1997, METABOLISM, V46, P611, DOI 10.1016/S0026-0495(97)90002-0; Mochida T, 2011, MOL GENET METAB, V103, P406, DOI 10.1016/j.ymgme.2011.05.002; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nissim I, 1999, J BIOL CHEM, V274, P28958, DOI 10.1074/jbc.274.41.28958; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Noguchi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012057; Obici S, 2012, CELL BIOCH FUNCT; Patti ME, 1999, ANN NY ACAD SCI, V892, P187, DOI 10.1111/j.1749-6632.1999.tb07796.x; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; POZEFSKY T, 1976, J CLIN INVEST, V57, P444, DOI 10.1172/JCI108295; RDC T, 2008, R LANG ENV STAT COMP; Reimann F, 2004, DIABETOLOGIA, V47, P1592, DOI 10.1007/s00125-004-1498-0; Rubio-Aliaga I, 2011, PHYSIOL GENOMICS, V43, P408, DOI 10.1152/physiolgenomics.00179.2010; Rubio-Aliaga I, 2011, METABOLOMICS, V7, P375, DOI 10.1007/s11306-010-0255-2; Schmid GM, 2004, PROTEOMICS, V4, P2270, DOI 10.1002/pmic.200300810; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; Song SM, 2001, AM J PHYSIOL-ENDOC M, V281, pE275, DOI 10.1152/ajpendo.2001.281.2.E275; Sourij H, 2011, ATHEROSCLEROSIS, V218, P220, DOI 10.1016/j.atherosclerosis.2011.04.041; STEELE RD, 1982, METABOLISM, V31, P318, DOI 10.1016/0026-0495(82)90106-8; STEELE RD, 1984, J NUTR, V114, P701, DOI 10.1093/jn/114.4.701; Stoll B, 1998, J NUTR, V128, P606, DOI 10.1093/jn/128.3.606; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Sutherland LN, 2008, AM J PHYSIOL-ENDOC M, V295, pE1076, DOI 10.1152/ajpendo.90408.2008; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tripolt NJ, 2012, DIABETIC MED, V29, pe365, DOI 10.1111/j.1464-5491.2012.03743.x; van de Poll MCG, 2007, AM J CLIN NUTR, V85, P167, DOI 10.1093/ajcn/85.1.167; VANNINI P, 1982, DIABETOLOGIA, V22, P217, DOI 10.1007/BF00283757; Verdam FJ, 2011, J CLIN ENDOCR METAB, V96, pE379, DOI 10.1210/jc.2010-1333; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; Wileman SM, 2003, BRIT J PHARMACOL, V140, P179, DOI 10.1038/sj.bjp.0705407; WINDMUELLER HG, 1976, ARCH BIOCHEM BIOPHYS, V175, P670, DOI 10.1016/0003-9861(76)90558-0; WINDMUELLER HG, 1981, AM J PHYSIOL, V241, pE473, DOI 10.1152/ajpendo.1981.241.6.E473; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1	59	49	50	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63950	10.1371/journal.pone.0063950	http://dx.doi.org/10.1371/journal.pone.0063950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691124	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400090
J	Xi, P; Ding, DQ; Zhou, JZ; Wang, M; Cong, YS				Xi, Peng; Ding, Deqiang; Zhou, Junzhi; Wang, Miao; Cong, Yu-Sheng			DDRGK1 Regulates NF-kappa B Activity by Modulating I kappa B alpha Stability	PLOS ONE			English	Article							PROTEIN; COMPLEX; TRANSLOCATION; LEUKEMIA; CANCER; LZAP	NF-kappa B is a ubiquitously expressed transcription factor that regulates a large number of genes in response to diverse physiological and pathological stimuli. The regulation of the transcriptional activity of NF-kappa B is often dependent on its interaction with I kappa B alpha. Proteins that bind to I kappa B alpha are critical regulators of NF-kappa B activity. DDRGK1 is a member of the DDRGK domain-containing protein family with unknown function. In this study, we showed that the depletion of DDRGK1 inhibits cell proliferation and invasion. Microarray analysis indicated that the expression of NF-kappa B target genes showed the most significant decrease after depleting of DDRGK1, suggesting that DDRGK1 may play an important role in the NF-kappa B signaling pathway. We further demonstrated that DDRGK1 interacts with I kappa B alpha and regulates its stability, thereby regulates the NF-kappa B transcriptional activity. Our findings identify DDRGK1 as an important regulator of the NF-kappa B pathway.	[Xi, Peng; Ding, Deqiang; Zhou, Junzhi] Beijing Normal Univ, Coll Life Sci, Key Lab Cell Proliferat & Regulat Biol, Minist Educ,Inst Cell Biol, Beijing 100875, Peoples R China; [Xi, Peng; Ding, Deqiang; Zhou, Junzhi; Wang, Miao; Cong, Yu-Sheng] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China	Beijing Normal University; Hangzhou Normal University	Cong, YS (corresponding author), Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China.	yscong@hznu.edu.cn	Xi, Peng/A-9768-2012	Xi, Peng/0000-0001-6626-4840	National Natural Science Foundation of China [31071200, 31171320]; National Basic Research Program of China [2012CB911203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by grants from the National Natural Science Foundation of China [31071200, 31171320] and the National Basic Research Program of China [2012CB911203]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim TH, 2001, TRENDS PLANT SCI, V6, P379, DOI 10.1016/S1360-1385(01)02015-5; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Neziri D, 2010, BBA-GEN SUBJECTS, V1800, P430, DOI 10.1016/j.bbagen.2009.12.004; Tanaka Y, 2011, HUM MOL GENET, V20, P3507, DOI 10.1093/hmg/ddr249; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Taylor JA, 1999, J MOL BIOL, V290, P839, DOI 10.1006/jmbi.1999.2912; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Xue YQ, 1997, BRIT J HAEMATOL, V98, P733, DOI 10.1046/j.1365-2141.1997.2693088.x; Yamamoto K, 1998, CANCER GENET CYTOGEN, V101, P89, DOI 10.1016/S0165-4608(97)00251-3	18	30	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e64231	10.1371/journal.pone.0064231	http://dx.doi.org/10.1371/journal.pone.0064231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675531	gold, Green Published, Green Submitted			2022-12-25	WOS:000318852400065
J	Lu, D; Insel, PA				Lu, David; Insel, Paul A.			Hydrolysis of Extracellular ATP by Ectonucleoside Triphosphate Diphosphohydrolase (ENTPD) Establishes the Set Point for Fibrotic Activity of Cardiac Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-INFARCTION; NUCLEOTIDE RECEPTORS; P2Y(2) RECEPTORS; A(2B) RECEPTORS; EXPRESSION; ADENOSINE; INJURY; CD39; ACTIVATION; FIBROSIS	The establishment of set points for cellular activities is essential in regulating homeostasis. Here, we demonstrate key determinants of the fibrogenic set point of cardiac fibroblasts (CFs) by focusing on the pro-fibrotic activity of ATP, which is released by CFs. We tested the hypothesis that the hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolases (ENTPDs) regulates pro-fibrotic nucleotide signaling. We detected two ENTPD isoforms, ENTPD-1 and -2, in adult rat ventricular CFs. Partial knockdown of ENTPD-1 and -2 with siRNA increased basal extracellular ATP concentration and enhanced the pro-fibrotic effect of ATP stimulation. Sodium polyoxotungstate-1, an ENTPD inhibitor, not only enhanced the pro-fibrotic effects of exogenously added ATP but also increased basal expression of alpha-smooth muscle actin, plasminogen activator inhibitor-1 and transforming growth factor (TGF)-beta, collagen synthesis, and gel contraction. Furthermore, we found that adenosine, a product of ATP hydrolysis by ENTPD, acts via A2(B) receptors to counterbalance the pro-fibrotic response to ATP. Removal of extracellular adenosine or inhibition of A2(B) receptors enhanced pro-fibrotic ATP signaling. Together, these results demonstrate the contribution of basally released ATP in establishing the set point for fibrotic activity in adult rat CFs and identify a key role for the modulation of this activity by hydrolysis of released ATP by ENTPDs. These findings also imply that cellular homeostasis and fibrotic response involve the integration of signaling that is pro-fibrotic by ATP and anti-fibrotic by adenosine and that is regulated by ENTPDs.	[Lu, David; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr,0636, La Jolla, CA 92093 USA.	pinsel@ucsd.edu			National Institutes of Health [1R01HL091071-01, GM066232, 1F31AG039992-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM066232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG039992] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01HL091071-01 and GM066232 (to P. A. I.) and 1F31AG039992-01 (to D. L.).	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Ayata CK, 2012, GASTROENTEROLOGY, V143, P1620, DOI 10.1053/j.gastro.2012.08.049; Bagatini MD, 2011, CLIN CHIM ACTA, V412, P159, DOI 10.1016/j.cca.2010.09.033; Braun OO, 2010, J MOL CELL CARDIOL, V49, P362, DOI 10.1016/j.yjmcc.2010.05.001; Cai M, 2011, J MOL CELL CARDIOL, V51, P927, DOI 10.1016/j.yjmcc.2011.09.003; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chen YH, 2004, AM J PHYSIOL-HEART C, V287, pH2478, DOI 10.1152/ajpheart.00217.2004; Clayton A, 2011, J IMMUNOL, V187, P676, DOI 10.4049/jimmunol.1003884; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001; Dobaczewski M, 2010, CIRC RES, V107, P418, DOI 10.1161/CIRCRESAHA.109.216101; Dranoff JA, 2004, AM J PHYSIOL-GASTR L, V287, pG417, DOI 10.1152/ajpgi.00294.2003; Dubey RK, 2001, HYPERTENSION, V37, P716, DOI 10.1161/01.HYP.37.2.716; El-Omar MM, 2005, THROMB RES, V116, P199, DOI 10.1016/j.thromres.2004.11.024; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Epperson SA, 2009, AM J PHYSIOL-CELL PH, V296, pC1171, DOI 10.1152/ajpcell.00290.2008; Fausther M, 2012, AM J PHYSIOL-GASTR L, V302, pG447, DOI [10.1152/ajpgi.00165.2011., 10.1152/ajpgi.00165.2011]; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Goldsmith EC, 2013, AM J PHYSIOL-CELL PH, V304, pC393, DOI 10.1152/ajpcell.00347.2012; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Jhandier MN, 2005, J BIOL CHEM, V280, P22986, DOI 10.1074/jbc.M412371200; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Kauffenstein G, 2010, CARDIOVASC RES, V85, P204, DOI 10.1093/cvr/cvp265; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lu D, 2012, FASEB J, V26, P2580, DOI 10.1096/fj.12-204677; Maleckar MM, 2009, BIOPHYS J, V97, P2179, DOI [10.1016/j.bpj.2009.07.054, 10.1016/j.bpj.2009.07.0.54]; Marcus AJ, 2003, J PHARMACOL EXP THER, V305, P9, DOI 10.1124/jpet.102.043729; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Muller CE, 2006, BIOORG MED CHEM LETT, V16, P5943, DOI 10.1016/j.bmcl.2006.09.003; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Takeshita K, 2004, AM J PATHOL, V164, P449, DOI 10.1016/S0002-9440(10)63135-5; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wall MJ, 2008, NEUROPHARMACOLOGY, V55, P1251, DOI 10.1016/j.neuropharm.2008.08.005; Yamamoto K, 2011, J CELL SCI, V124, P3477, DOI 10.1242/jcs.087221; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; Zeisberg EM, 2010, CIRC RES, V107, P1304, DOI 10.1161/CIRCRESAHA.110.231910; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	49	24	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19040	19049		10.1074/jbc.M113.466102	http://dx.doi.org/10.1074/jbc.M113.466102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23677997	hybrid, Green Published			2022-12-25	WOS:000321335800039
J	Fang, ZQ; Tang, YQ; Fang, JJ; Zhou, ZL; Xing, ZQ; Guo, ZX; Guo, XY; Wang, WC; Jiao, W; Xu, ZH; Liu, ZX				Fang, Zhiqing; Tang, Yueqing; Fang, Juanjuan; Zhou, Zunlin; Xing, Zhaoquan; Guo, Zhaoxin; Guo, Xiaoyu; Wang, Weichang; Jiao, Wei; Xu, Zhonghua; Liu, Zhaoxu			Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway	PLOS ONE			English	Article							COA REDUCTASE INHIBITORS; STATINS; THERAPY; PROLIFERATION; INFLAMMATION; APOPTOSIS; INTERLEUKIN-6; NEOADJUVANT; CARCINOMA; IMMUNITY	Renal cell carcinoma (RCC) is the most lethal type of genitourinary cancer due to its occult onset and resistance to chemotherapy and radiation. Recently, accumulating evidence has suggested stains, inhibitors of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase, were associated with the risk reduction of cancer. In the present study, we aimed to investigate the potential effects of simvastatin on RCC cells and the underlying mechanisms by which simvastatin exerted its actions. With cell viability, colony formation, and flow cytometric apoptosis assays, we found that simvastatin potently suppressed cell growth of A498 and 786-O cells in a time- and dose- dependent manner. Consistently, the xenograft model performed in nude mice exhibited reduced tumor growth with simvastatin treatment. In addition, the inhibitory effects of simvastatin on migration and invasion were also observed in vitro. Mechanically, we presented that simvastatin could suppress the proliferation and motility of RCC cells via inhibiting the phosphorylation of AKT, mTOR, and ERK in a time- and dose- dependent manner. Further investigation of the underlying mechanism revealed simvastatin could exert the anti-tumor effects by suppressing IL-6-induced phosphorylation of JAK2 and STAT3. In conclusion, these findings suggested that simvastatin-induced apoptosis and its anti-metastasis activity in RCC cells were accompanied by inhibition of AKT/mTOR, ERK, and JAK2/STAT3 pathways, which imply that simvastatin may be a potential therapeutic agent for the treatment of RCC patients.	[Fang, Zhiqing; Tang, Yueqing; Zhou, Zunlin; Xing, Zhaoquan; Guo, Zhaoxin; Wang, Weichang; Jiao, Wei; Xu, Zhonghua; Liu, Zhaoxu] Shandong Univ, Qilu Hosp, Dept Urol, Jinan, Shandong, Peoples R China; [Fang, Zhiqing] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [Fang, Zhiqing] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan, Shandong, Peoples R China; [Fang, Juanjuan] Wucheng Peoples Hosp, Dept Anesthesiol, Wucheng, Shandong, Peoples R China; [Guo, Xiaoyu; Liu, Zhaoxu] Shandong Univ, Sch Nursing, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Liu, ZX (corresponding author), Shandong Univ, Qilu Hosp, Dept Urol, Jinan, Shandong, Peoples R China.	zhaoxvl@sdu.edu.cn			National Natural Science Foundation of China [81172435]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81172435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso M, 2010, UROL ONCOL-SEMIN ORI, V28, P121, DOI 10.1016/j.urolonc.2009.04.015; Bex A, 2010, EUR UROL, V58, P819, DOI 10.1016/j.eururo.2010.08.029; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; BLAY JY, 1992, CANCER RES, V52, P3317; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Bocci G, 2005, BRIT J CANCER, V93, P319, DOI 10.1038/sj.bjc.6602720; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brown M, 2012, BRIT J CANCER, V106, P1689, DOI 10.1038/bjc.2012.138; Campese VM, 2007, KIDNEY INT, V71, P1215, DOI 10.1038/sj.ki.5002174; Cho SJ, 2008, INT J CANCER, V123, P951, DOI 10.1002/ijc.23593; Clendening JW, 2012, ONCOGENE, V31, P4967, DOI 10.1038/onc.2012.6; Coon JT, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14020; COON JT, 2010, HEALTH TECHNOL ASSES, V14, pR3; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fried LF, 2008, KIDNEY INT, V74, P571, DOI 10.1038/ki.2008.231; Goc A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-409; Gopalan A, 2013, CANCER LETT, V329, P9, DOI 10.1016/j.canlet.2012.08.031; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herrmann E, 2010, WORLD J UROL, V28, P303, DOI 10.1007/s00345-010-0519-5; Hoque A, 2008, CANCER EPIDEM BIOMAR, V17, P88, DOI 10.1158/1055-9965.EPI-07-0531; Jiang JT, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-4; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Johnson MD, 2002, J NEURO-ONCOL, V56, P133, DOI 10.1023/A:1014588214966; Karp I, 2008, AM J MED, V121, P302, DOI 10.1016/j.amjmed.2007.12.011; Katz MS, 2005, INT J RADIAT ONCOL, V62, P1363, DOI 10.1016/j.ijrobp.2004.12.033; Khanzada UK, 2006, ONCOGENE, V25, P877, DOI 10.1038/sj.onc.1209117; Khurana V, 2008, UROLOGY, V71, P118, DOI 10.1016/j.urology.2007.08.039; Kochuparambil ST, 2011, J PHARMACOL EXP THER, V336, P496, DOI 10.1124/jpet.110.174870; Kotamraju S, 2007, CANCER RES, V67, P7386, DOI 10.1158/0008-5472.CAN-07-0993; Lam JS, 2005, WORLD J UROL, V23, P202, DOI 10.1007/s00345-004-0466-0; Linehan WM, 2004, CANCER CELL, V6, P223, DOI 10.1016/j.ccr.2004.09.006; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Menter DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028813; Miyake H, 2013, INT J CLIN ONCOL, V18, P1054, DOI 10.1007/s10147-012-0492-7; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Osmak M, 2012, CANCER LETT, V324, P1, DOI 10.1016/j.canlet.2012.04.011; Pelaia G, 2012, CELL PROLIFERAT, V45, P557, DOI 10.1111/j.1365-2184.2012.00846.x; Relja B, 2010, INT J MOL MED, V26, P733, DOI 10.3892/ijmm_00000520; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roy M, 2011, AM J CANCER RES, V1, P542; Sanchez CA, 2008, CANCER INVEST, V26, P698, DOI 10.1080/07357900701874658; Sassano A, 2008, CANCER LETT, V260, P11, DOI 10.1016/j.canlet.2007.11.036; Savas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018306; Schonbeck U, 2004, CIRCULATION, V109, P18, DOI 10.1161/01.CIR.0000129505.34151.23; Sekine Y, 2008, BIOCHEM BIOPH RES CO, V372, P356, DOI 10.1016/j.bbrc.2008.05.043; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; Takahashi H K, 2007, Curr Oncol, V14, P246; Thillai K, 2012, EXPERT REV ANTICANC, V12, P765, DOI [10.1586/ERA.12.56, 10.1586/era.12.56]; Thurnher M, 2012, CLIN CANCER RES, V18, P3524, DOI 10.1158/1078-0432.CCR-12-0489; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055790; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang J, 2013, INT J BIOCHEM CELL B, V45, P745, DOI 10.1016/j.biocel.2012.11.001; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110	58	118	122	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e62823	10.1371/journal.pone.0062823	http://dx.doi.org/10.1371/journal.pone.0062823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690956	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900013
J	Lv, A; Li, ZW; Tian, XY; Guan, XY; Zhao, M; Dong, B; Hao, CY				Lv, Ang; Li, Zhongwu; Tian, Xiuyun; Guan, Xiaoya; Zhao, Min; Dong, Bin; Hao, Chunyi			SKP2 High Expression, KIT Exon 11 Deletions, and Gastrointestinal Bleeding as Predictors of Poor Prognosis in Primary Gastrointestinal Stromal Tumors	PLOS ONE			English	Article							C-KIT; MUTATIONS; RISK; P27(KIP1); ASSOCIATION; RECURRENCE; INHIBITOR; MESYLATE; STOMACH	Background and Aims: Considering the indication of adjuvant therapy, the recurrence risk for primary gastrointestinal stromal tumor (GIST) after surgery needs to be accurately estimated. However, current risk stratification schemes may still have room for improvement. This study seeks to analyze prognostic factors for primary GISTs from 3 aspects, including clinicopathological parameters, immunohistochemical biomarkers, and gene mutational status, and attempts to find novel valuable factors predicting the malignancy potential of GISTs. Methods: Retrospective data from 114 primary GIST patients after R0 resection were collected. Clinicopathological data was obtained from medical records and re-evaluated. Immunohistochemical analysis was performed using the Tissue Microarray method for Ki67, p16, p27, p53, SKP2, CD133, and actin. KIT gene exons 9, 11, 13, and 17 and PDGFR alpha gene exons 12 and 18 were tested for mutations using PCR. Results: Univariate analysis revealed the following factors as poor prognostic indicators for relapse-free survival with a median follow-up of 50 months: male gender, gastrointestinal bleeding, mitotic index >5/50HPFs, tumor size >5 cm, non-gastric site, necrosis, epithelioid or mixed cell type, surrounding tissue invasion, Ki67>5%, p16>20%, p53 index >10, SKP2>10%, and KIT exon 11 deletion. Besides mitotic index, tumor size and site, SKP2 high expression (RR = 2.91, 95% CI: 1.41-5.99, P = 0.004) and KIT exon 11 deletion (RR = 2.73, 95% CI: 1.04-7.16, P = 0.041) were also independent risk factors in multivariate analysis, with gastrointestinal bleeding also showing a trend towards significance (RR = 1.88, 95% CI: 0.98-3.64, P = 0.059). In addition, gastrointestinal bleeding and SKP2 high expression showed a good ability to stratify high-risk patients further. Conclusion: Our results show that gastrointestinal bleeding, SKP2 high expression, and KIT exon 11 deletions may be useful indicators of high recurrence risk for primary GIST patients.	[Lv, Ang; Tian, Xiuyun; Guan, Xiaoya; Hao, Chunyi] Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Hepatopancreatobiliary Surg, Minist Educ,Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China; [Li, Zhongwu] Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Pathol, Minist Educ,Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China; [Zhao, Min; Dong, Bin] Peking Univ, Key Lab Carcinogenesis & Translat Res, Ctr Lab, Minist Educ,Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Hao, CY (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Hepatopancreatobiliary Surg, Minist Educ,Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China.	haochunyi@126.com			National Natural Science Funding [81272765]; Capital Characteristic Clinical Application Research [Z121107001012083]; Key Project of Capital Medical Development Fund [2009-2095]; Beijing Municipal Natural Science Foundation [7122030]; Beijing's Outstanding Talents Subsidy Scheme (215 Program) [2009-2-18]; Beijing Municipal Science and Technology Commission NOVA Program [2010 B033]; Funding of Beijing Cancer Hospital [10-04]	National Natural Science Funding(National Natural Science Foundation of China (NSFC)); Capital Characteristic Clinical Application Research; Key Project of Capital Medical Development Fund; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Beijing's Outstanding Talents Subsidy Scheme (215 Program); Beijing Municipal Science and Technology Commission NOVA Program; Funding of Beijing Cancer Hospital	This study was supported by National Natural Science Funding (approval #: 81272765), Capital Characteristic Clinical Application Research (approval #: Z121107001012083), Key Project of Capital Medical Development Fund (approval #: 2009-2095), Beijing Municipal Natural Science Foundation (approval #: 7122030), Beijing's Outstanding Talents Subsidy Scheme (215 Program: 2009-2-18), Grants from Beijing Municipal Science and Technology Commission NOVA Program (NO. 2010 B033) and Funding of Beijing Cancer Hospital (approval #: 10-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2006, GASTROENTEROLOGY, V130, P1573, DOI 10.1053/j.gastro.2006.01.043; Antonescu CR, 2003, CLIN CANCER RES, V9, P3329; Arne G, 2011, INT J CANCER, V129, P1149, DOI 10.1002/ijc.25755; Neto RA, 2012, ACTA CIR BRAS, V27, P315, DOI 10.1590/S0102-86502012000500007; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cates JMM, 2010, INT J EXP PATHOL, V91, P335, DOI 10.1111/j.1365-2613.2010.00711.x; Cerski MR, 2011, PATHOL RES PRACT, V207, P701, DOI 10.1016/j.prp.2011.09.008; DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Di Vizio D, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-134; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Fujimoto Yoshiya, 2003, Gastric Cancer, V6, P39, DOI 10.1007/s101200300005; Gelen T, 2003, JPN J CLIN ONCOL, V33, P346, DOI 10.1093/jjco/hyg071; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hershko DD, 2006, CANCER-AM CANCER SOC, V107, P668, DOI 10.1002/cncr.22073; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; Lasota J, 2003, MODERN PATHOL, V16, P1257, DOI 10.1097/01.MP.0000097365.72526.3E; Lasota J, 2004, LAB INVEST, V84, P874, DOI 10.1038/labinvest.3700122; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Martin J, 2005, J CLIN ONCOL, V23, P6190, DOI 10.1200/JCO.2005.19.554; Meara RS, 2007, CYTOPATHOLOGY, V18, P283, DOI 10.1111/j.1365-2303.2007.00505.x; Miettinen M, 2005, AM J SURG PATHOL, V29, P52, DOI 10.1097/01.pas.0000146010.92933.de; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Mucciarini C, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-230; Nakamura N, 2005, HUM PATHOL, V36, P828, DOI 10.1016/j.humpath.2005.03.012; Nilsson B, 2005, CANCER-AM CANCER SOC, V103, P821, DOI 10.1002/cncr.20862; Oliveira AM, 2003, J CLIN ONCOL, V21, P722, DOI 10.1200/JCO.2003.05.112; Penin RM, 2002, MODERN PATHOL, V15, P1227, DOI 10.1097/01.MP.0000036589.99516.D6; Perrone F, 2005, CANCER-AM CANCER SOC, V104, P159, DOI 10.1002/cncr.21113; Romeo S, 2009, CLIN CANCER RES, V15, P4191, DOI 10.1158/1078-0432.CCR-08-3297; Ruiz-Tovar J, 2010, AM SURGEON, V76, P1244; Schneider-Stock R, 2005, CLIN CANCER RES, V11, P638; Shirin H, 2007, DIGESTION, V75, P4, DOI 10.1159/000101457; Sorbye SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047068; Steigen SE, 2008, MODERN PATHOL, V21, P46, DOI 10.1038/modpathol.3800976; Steigen SE, 2007, APMIS, V115, P289, DOI 10.1111/j.1600-0463.2007.apm_587.x; Tazawa K, 1999, PATHOL INT, V49, P786, DOI 10.1046/j.1440-1827.1999.00947.x; Wong NACS, 2003, HISTOPATHOLOGY, V43, P118, DOI 10.1046/j.1365-2559.2003.01665.x; Zong L, 2012, EJSO-EUR J SURG ONC, V38, P189, DOI 10.1016/j.ejso.2011.12.012	41	29	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e62951	10.1371/journal.pone.0062951	http://dx.doi.org/10.1371/journal.pone.0062951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690967	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900018
J	Wataya-Kaneda, M; Tanaka, M; Hamasaki, T; Katayama, I				Wataya-Kaneda, Mari; Tanaka, Mari; Hamasaki, Toshimitsu; Katayama, Ichiro			Trends in the Prevalence of Tuberous Sclerosis Complex Manifestations: An Epidemiological Study of 166 Japanese Patients	PLOS ONE			English	Article							ACQUIRED PERIUNGUAL FIBROKERATOMA; MUTATIONAL ANALYSIS; MENTAL-RETARDATION; CLINICAL-FEATURES; UTERINE LEIOMYOMA; EPILEPSY; LYMPHANGIOLEIOMYOMATOSIS; CHILDREN; TSC1; PATHOGENESIS	Tuberous sclerosis complex (TSC) is an autosomal dominant disorder with multi-system involvement and variable manifestations. There has been significant progress in TSC research and the development of technologies used to diagnose this disorder. As a result, individuals with mild TSC are now being diagnosed, including many older adults who have not developed seizures or cognitive abnormalities. We conducted a statistical analysis of the frequency of TSC manifestations in a population of Japanese adults and children, comparing our findings with historical data. The chi-square test was used to examine the frequency of each manifestation by age. A total of 166 outpatients at the Department of Dermatology of Osaka University Hospital during the period from January 2001 to March 2011 were included in the study. Compared to previous reports, the frequency of neurologic manifestations (excepting autism) was lower in this cohort, and the frequency of skin manifestations (excepting hypomelanotic macules) was higher in this cohort. The frequencies of pulmonary lymphangioleiomyomatosis and renal manifestations were not significantly different from those previously reported. Regarding the association of each manifestation with age, the frequency of neurologic manifestations (excepting subependymal giant cell astrocytoma) was significantly higher in younger patients than in older patients. The frequency of skin manifestations and renal angiomyolipoma were significantly higher in older patients than in younger patients. Because of their high frequency and visibility, skin manifestations are useful in the diagnosis of TSC. Moreover, uterine perivascular epithelioid cell tumor was also characterized as a new findings associated with TSC.	[Wataya-Kaneda, Mari; Tanaka, Mari; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka, Japan; [Hamasaki, Toshimitsu] Osaka Univ, Grad Sch Med, Dept Biomed Stat, Suita, Osaka, Japan	Osaka University; Osaka University	Wataya-Kaneda, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka, Japan.	mkaneda@derma.med.osaka-u.ac.jp	Hamasaki, Toshimitsu/N-3851-2015	Hamasaki, Toshimitsu/0000-0002-4928-1160; yi lang, pian shan/0000-0002-3270-1085	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the grant from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen MEAPM, 2011, CLIN RADIOL, V66, P625, DOI 10.1016/j.crad.2011.02.009; Aldrich SL, 2010, J AM ACAD DERMATOL, V63, P244, DOI 10.1016/j.jaad.2009.08.042; An KS, 2007, GENET MED, V9, P88, DOI 10.1097/GIM.0b013e31803068c7; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Baskin HJ, 2008, PEDIATR RADIOL, V38, P936, DOI 10.1007/s00247-008-0832-y; BERNSTEIN J, 1991, ANN NY ACAD SCI, V615, P36; CAHN RL, 1977, ARCH DERMATOL, V113, P1564, DOI 10.1001/archderm.113.11.1564; Carlson RM, 2007, CUTIS, V80, P137; Cass H, 2006, CHILD CARE HLTH DEV, V32, P521, DOI 10.1111/j.1365-2214.2006.00630.x; Castagnetti M, 2007, J UROLOGY, V178, P2155, DOI 10.1016/j.juro.2007.07.058; CASTRO M, 1995, CHEST, V107, P189, DOI 10.1378/chest.107.1.189; Chopra M, 2011, J PAEDIATR CHILD H, V47, P711, DOI 10.1111/j.1440-1754.2011.02038.x; Chou Ping-Chen, 2004, Acta Neurol Taiwan, V13, P10; Chu-Shore CJ, 2010, EPILEPSIA, V51, P1236, DOI 10.1111/j.1528-1167.2009.02474.x; Cui LH, 2011, FERTIL STERIL, V95, P1805, DOI 10.1016/j.fertnstert.2010.11.028; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; de Vries PJ, 2007, EUR CHILD ADOLES PSY, V16, P16, DOI 10.1007/s00787-006-0570-3; Devlin LA, 2006, DEV MED CHILD NEUROL, V48, P495, DOI 10.1017/S0012162206001058; Ewalt DH, 1998, J UROLOGY, V160, P141, DOI 10.1016/S0022-5347(01)63072-6; Franz DN, 2010, NEUROPEDIATRICS, V41, P199, DOI 10.1055/s-0030-1269906; Hake S, 2011, OCHSNER J, V10, P200; Hallett L, 2011, CURR MED RES OPIN, V27, P1571, DOI 10.1185/03007995.2011.586687; Hancock E, 2002, RESP MED, V96, P1, DOI 10.1053/rmed.2001.1207; Holmes GL, 2007, EPILEPSIA, V48, P617, DOI 10.1111/j.1528-1167.2007.01035.x; Hong CH, 2009, NEUROEPIDEMIOLOGY, V33, P335, DOI 10.1159/000254569; HUNT A, 1993, J AUTISM DEV DISORD, V23, P323, DOI 10.1007/BF01046223; Jansen FE, 2008, NEUROLOGY, V70, P916, DOI 10.1212/01.wnl.0000280579.04974.c0; Joinson C, 2003, PSYCHOL MED, V33, P335, DOI 10.1017/S0033291702007092; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; Jozwiak D, 2008, AM J DERMATOPATH, V30, P256, DOI 10.1097/DAD.0b013e31816e22a5; Jozwiak S, 1998, ARCH NEUROL-CHICAGO, V55, P379, DOI 10.1001/archneur.55.3.379; Jozwiak S, 2000, J CHILD NEUROL, V15, P652, DOI 10.1177/088307380001501003; Jozwiak S, 1998, INT J DERMATOL, V37, P911; Jozwiak S, 2006, PEDIATRICS, V118, pE1146, DOI 10.1542/peds.2006-0504; Jozwiak S, 2011, EUR J PAEDIATR NEURO, V15, P424, DOI 10.1016/j.ejpn.2011.03.010; Juvet SC, 2007, AM J RESP CELL MOL, V36, P398, DOI 10.1165/rcmb.2006-0372TR; Kotulska K, 2009, PEDIATR DEVEL PATHOL, V12, P89, DOI 10.2350/06-11-0191.1; Lim GSD, 2011, INT J GYNECOL PATHOL, V30, P121, DOI 10.1097/PGP.0b013e3181fa5a99; Luciano AA, 2009, CLIN OBSTET GYNECOL, V52, P362, DOI 10.1097/GRF.0b013e3181b0bdcd; Osborne JP, 2000, LANCET, V355, P1698, DOI 10.1016/S0140-6736(00)02247-9; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; PEROU ML, 1960, J UROLOGY, V83, P240, DOI 10.1016/S0022-5347(17)65698-2; Piecha G, 2008, EUR J INTERN MED, V19, P99, DOI 10.1016/j.ejim.2007.08.004; Rakowski SK, 2006, KIDNEY INT, V70, P1777, DOI 10.1038/sj.ki.5001853; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Sancak O, 2005, EUR J HUM GENET, V13, P731, DOI 10.1038/sj.ejhg.5201402; Sasongko Teguh Haryo, 2008, Kobe J Med Sci, V54, pE73; Schwartz RA, 2007, J AM ACAD DERMATOL, V57, P189, DOI 10.1016/j.jaad.2007.05.004; SHEPHERD CW, 1992, DEV MED CHILD NEUROL, V34, P766; SMALLEY SL, 1992, J AUTISM DEV DISORD, V22, P339, DOI 10.1007/BF01048239; Sogut A, 2002, TURKISH J PEDIATR, V44, P98; Staley BA, 2011, PEDIATRICS, V127, pE117, DOI 10.1542/peds.2010-0192; Sun XF, 2005, CHINESE MED J-PEKING, V118, P215; Thiele EA, 2004, J CHILD NEUROL, V19, P680, DOI 10.1177/08830738040190090801; Torrelo A, 2012, J AM ACAD DERMATOL, V66, P617, DOI 10.1016/j.jaad.2011.04.002; Urban T, 1999, MEDICINE, V78, P321, DOI 10.1097/00005792-199909000-00004; Vanderhooft SL, 1996, J PEDIATR-US, V129, P355, DOI 10.1016/S0022-3476(96)70066-5; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Walker CL, 2003, GENE CHROMOSOME CANC, V38, P349, DOI 10.1002/gcc.10281; Webb DW, 1996, BRIT J DERMATOL, V135, P1; WEBB DW, 1991, J MED GENET, V28, P395, DOI 10.1136/jmg.28.6.395; Yamakado K, 2002, RADIOLOGY, V225, P78, DOI 10.1148/radiol.2251011477; Yates JR, 2011, ARCH DIS CHILD; ZELLER J, 1995, ARCH DERMATOL, V131, P1465	65	64	69	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63910	10.1371/journal.pone.0063910	http://dx.doi.org/10.1371/journal.pone.0063910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RJ	23691114	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900064
J	Chegou, NN; Detjen, AK; Thiart, L; Walters, E; Mandalakas, AM; Hesseling, AC; Walzl, G				Chegou, Novel N.; Detjen, Anne K.; Thiart, Lani; Walters, Elisabetta; Mandalakas, Anna M.; Hesseling, Anneke C.; Walzl, Gerhard			Utility of Host Markers Detected in Quantiferon Supernatants for the Diagnosis of Tuberculosis in Children in a High-Burden Setting	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GAMMA RELEASE ASSAYS; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; PULMONARY TUBERCULOSIS; ALPHA-INTERFERON; DISEASE-ACTIVITY; WHOLE-BLOOD; INFECTION; RESPONSES	Background: The diagnosis of childhood tuberculosis (TB) disease remains a challenge especially in young and HIV-infected children. Recent studies have identified potential host markers which, when measured in Quantiferon (QFT-IT) supernatants, show promise in discriminating between Mycobacterium tuberculosis (M.tb) infection states. In this study, the utility of such markers was investigated in children screened for TB in a setting with high TB incidence. Methodology and Principal Findings: 76 children (29% HIV-infected) with or without active TB provided blood specimens collected directly into QFT-IT tubes. After overnight incubation, culture supernatants were harvested, aliquoted and frozen for future immunological research purposes. Subsequently, the levels of 12 host markers previously identified as potential TB diagnostic markers were evaluated in these supernatants for their ability to discriminate between M.tb infection and disease states using the Luminex platform. Of the 76 children included, 19 (25%) had culture confirmed TB disease; 26 (46%) of the 57 without TB had positive markers of M.tb infection defined by a positive QFT-IT test. The potentially most useful analytes for diagnosing TB disease included IFN-alpha 2, IL-1Ra, sCD40L and VEGF and the most useful markers for discriminating between QFT-IT positive children as TB or latent infection included IL-1Ra, IP-10 and VEGF. When markers were used in combinations of four, 84% of all children were accurately classified into their respective groups (TB disease or no TB), after leave-one-out cross validation. Conclusions: Measurement of the levels of IFN-alpha 2, IL-1Ra, sCD40L, IP-10 and VEGF in QFT-IT supernatants may be a useful method for diagnosing TB disease and differentiating between active TB disease and M.tb infection in children. Our observations warrant further investigation in larger well-characterized clinical cohorts.	[Chegou, Novel N.; Thiart, Lani; Walzl, Gerhard] Univ Stellenbosch, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, ZA-7505 Tygerberg, South Africa; [Chegou, Novel N.; Thiart, Lani; Walzl, Gerhard] Univ Stellenbosch, Fac Med & Hlth Sci, MRC,Ctr Mol & Cellular Biol, Dept Biomed Sci,Div Mol Biol & Human Genet, ZA-7505 Tygerberg, South Africa; [Detjen, Anne K.; Walters, Elisabetta; Hesseling, Anneke C.] Univ Stellenbosch, Fac Med & Hlth Sci, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa; [Detjen, Anne K.] Int Union TB & Lung Dis, North Amer Off, New York, NY USA; [Mandalakas, Anna M.] Baylor Coll Med, Dept Pediat, Sect Retrovirol & Global Hlth, Houston, TX 77030 USA	National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; Stellenbosch University; Baylor College of Medicine	Chegou, NN (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, ZA-7505 Tygerberg, South Africa.	novel@sun.ac.za	; Walzl, Gerhard/N-6371-2016	Chegou, Novel N/0000-0002-8690-1699; Walzl, Gerhard/0000-0003-2487-125X	EDCTP [IP_2009_32040]; Claude Leon Foundation; South African MRC; Alexander von Humboldt Foundation (Feodor Lynen Fellowship); Norwegian Cooperation for Higher Education (NUFU)	EDCTP; Claude Leon Foundation; South African MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alexander von Humboldt Foundation (Feodor Lynen Fellowship)(Alexander von Humboldt Foundation); Norwegian Cooperation for Higher Education (NUFU)	This study was supported by the EDCTP, grant number IP_2009_32040. N.N. Chegou received financial assistance from the Claude Leon Foundation and the South African MRC. A.K. Detjen received funding from the Alexander von Humboldt Foundation (Feodor Lynen Fellowship). A.C. Hesseling received funding from the Norwegian Cooperation for Higher Education (NUFU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RK, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-41; Alatas F, 2004, CHEST, V125, P2156, DOI 10.1378/chest.125.6.2156; Alsleben N, 2012, SCAND J INFECT DIS, V44, P256, DOI 10.3109/00365548.2011.632644; [Anonymous], 2011, AUT REAL TIM NUCL AC; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Bermudez LE, 1996, INFECT IMMUN, V64, P2917, DOI 10.1128/IAI.64.8.2917-2922.1996; Chegou NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038501; Chegou NN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-10; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Desem N, 1998, CLIN DIAGN LAB IMMUN, V5, P531, DOI 10.1128/CDLI.5.4.531-536.1998; Detjen AK, 2009, CLIN VACCINE IMMUNOL, V16, P1170, DOI 10.1128/CVI.00168-09; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; GOIN JE, 1982, PATTERN RECOGN, V15, P263, DOI 10.1016/0031-3203(82)90077-2; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Husain N, 2008, J INFECTION, V56, P114, DOI 10.1016/j.jinf.2007.11.004; Jones GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1946, DOI 10.1128/CVI.00377-10; Juffermans NP, 1998, AM J RESP CRIT CARE, V157, P1328, DOI 10.1164/ajrccm.157.4.9709126; Kabeer BSA, 2010, AIDS, V24, P323, DOI 10.1097/QAD.0b013e328334895e; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Kabeer BSA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005718; Kellar KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026545; Kiropoulos TS, 2005, CHEST, V128, P468, DOI 10.1378/chest.128.1.468; Lighter-Fisher J, 2010, INT J TUBERC LUNG D, V14, P1548; Lu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024290; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631; Marais BJ, 2011, PAEDIATR RESPIR REV, V12, P39, DOI 10.1016/j.prrv.2010.09.002; Marais BJ, 2006, CLIN INFECT DIS, V42, pE69, DOI 10.1086/502652; Marais BJ, 2004, PEDIATR RADIOL, V34, P886, DOI 10.1007/s00247-004-1238-0; Mariotti S, 2004, INFECT IMMUN, V72, P4385, DOI 10.1128/IAI.72.8.4385-4392.2004; Mizusawa M, 2008, CLIN VACCINE IMMUNOL, V15, P544, DOI 10.1128/CVI.00355-07; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Parker AE, 2000, MICROB PATHOGENESIS, V28, P135, DOI 10.1006/mpat.1999.0335; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; Prabhakar S, 2003, INFECT IMMUN, V71, P2487, DOI 10.1128/IAI.71.5.2487-2497.2003; Rubbo PA, 2012, J CLIN MICR IN PRESS; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Sakai H, 2012, INT IMMUNOL, V24, P5, DOI 10.1093/intimm/dxr088; Sartain MJ, 2006, MOL CELL PROTEOMICS, V5, P2102, DOI 10.1074/mcp.M600089-MCP200; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Su WL, 2010, CLIN VACCINE IMMUNOL, V17, P771, DOI 10.1128/CVI.00526-09; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Tanaka T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-71; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; van Ingen J, 2009, J BACTERIOL, V191, P5865, DOI 10.1128/JB.00683-09; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051338; Webb EA, 2009, INT J TUBERC LUNG D, V13, P868; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; World Health Organization, 2010, GUID NAT TUB HIV PRO; World Health Organization, 2011, US TUB INT GAMM REL; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2	60	56	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64226	10.1371/journal.pone.0064226	http://dx.doi.org/10.1371/journal.pone.0064226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691173	gold, Green Published, Green Submitted			2022-12-25	WOS:000319052700084
J	Heseler, K; Schmidt, SK; Spekker, K; Sinzger, C; Sorg, RV; Quambusch, M; Zimmermann, A; Meisel, R; Daubener, W				Heseler, Kathrin; Schmidt, Silvia K.; Spekker, Katrin; Sinzger, Christian; Sorg, Rudiger V.; Quambusch, Marc; Zimmermann, Albert; Meisel, Roland; Daeubener, Walter			Cytomegalovirus Impairs the Induction of Indoleamine 2,3-Dioxygenase Mediated Antimicrobial and Immunoregulatory Effects in Human Fibroblasts	PLOS ONE			English	Article							LIVER-TRANSPLANT RECIPIENTS; MESENCHYMAL STEM-CELLS; NITRIC-OXIDE SYNTHASE; IFN-GAMMA; TYROSINE PHOSPHORYLATION; TRYPTOPHAN-METABOLITES; ALLOGRAFT SURVIVAL; TOXOPLASMA-GONDII; ENDOTHELIAL-CELLS; DENDRITIC CELLS	Human fibroblasts provide immunosuppressive functions that are partly mediated by the tryptophan-catabolizing enzyme indoleamine-2,3-dioxygenase (IDO). Moreover, upon stimulation with inflammatory cytokines human fibroblasts exhibit broad-spectrum antimicrobial effector functions directed against various clinically relevant pathogens and these effects are also IDO-dependent. Therefore human fibroblasts are suggested to be involved in the control of immune reactions during infectious diseases. As human cytomegalovirus (HCMV) represents a pathogen frequently found in immunocompromised hosts and IDO is involved in the control of HCMV growth, we here investigated the impact of HCMV infection on IDO-mediated antimicrobial and immunoregulatory effects. We show that infection with HCMV substantially impairs IFN-cinduced IDO-activity in human fibroblasts in a dose and time dependent fashion. Consequently, these cells are no longer able to restrict bacterial and parasitic growth and, furthermore, loose their IDO-mediated immunosuppressive capacity. Our results may have significant implications for the course of HCMV infection during solid organ transplantation: we suggest that loss of IDO-mediated antimicrobial and immunoregulatory functions during a HCMV infection might at least in part explain the enhanced risk of organ rejection and infections observed in patients with HCMV reactivation after solid organ transplantation.	[Heseler, Kathrin; Schmidt, Silvia K.; Spekker, Katrin; Quambusch, Marc; Daeubener, Walter] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Heseler, Kathrin; Schmidt, Silvia K.; Spekker, Katrin; Quambusch, Marc; Daeubener, Walter] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany; [Sinzger, Christian] Univ Ulm, Med Ctr, Inst Virol, D-89069 Ulm, Germany; [Sorg, Rudiger V.] Univ Dusseldorf, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany; [Zimmermann, Albert] Univ Dusseldorf, Inst Virol, D-40225 Dusseldorf, Germany; [Meisel, Roland] Univ Dusseldorf, Ctr Child & Adolescent Hlth, Clin Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Ulm University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Daubener, W (corresponding author), Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany.	daeubene@uni-duesseldorf.de			German Federal Ministry of Education and Research (BMBF) [01GN0951, 01KI1002E, 01GN0990, 01GM0873]; German Research Concil (DFG) [RU 729]; Elterninitiative Kinderkrebsklinik Dusseldorf e.V.	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Concil (DFG); Elterninitiative Kinderkrebsklinik Dusseldorf e.V.	This study was supported by German Federal Ministry of Education and Research (BMBF) grants no. 01GN0951 (WD, RVS), no. 01KI1002E (WD), no. 01GN0990 (RM), no. 01GM0873 (RM), German Research Concil (DFG) grant no. RU 729 (WD) and the "Elterninitiative Kinderkrebsklinik Dusseldorf e.V.'' (RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjogble KDZ, 2004, INT J PARASITOL, V34, P1255, DOI 10.1016/j.ijpara.2004.07.011; Adler B, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL I, P297; Babic M, 2011, TRENDS MOL MED, V17, P677, DOI 10.1016/j.molmed.2011.07.003; Baron M, 2008, J IMMUNOL, V181, P5530, DOI 10.4049/jimmunol.181.8.5530; Basta S, 2003, VIRAL IMMUNOL, V16, P231, DOI 10.1089/088282403322396064; Beam E, 2012, CURR INFECT DIS REP, V14, P633, DOI 10.1007/s11908-012-0292-2; Beutelspacher SC, 2006, EUR J IMMUNOL, V36, P690, DOI 10.1002/eji.200535238; Bodaghi B, 1999, J IMMUNOL, V162, P957; Daubener W, 2009, THROMB HAEMOSTASIS, V102, P1110, DOI 10.1160/TH09-04-0250; DAUBENER W, 1994, J IMMUNOL METHODS, V168, P39, DOI 10.1016/0022-1759(94)90207-0; Dzabic M, 2011, CLIN INFECT DIS, V53, P969, DOI 10.1093/cid/cir619; ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4; Falagas ME, 1996, CLIN INFECT DIS, V23, P468, DOI 10.1093/clinids/23.3.468; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; George MJ, 1997, AM J MED, V103, P106, DOI 10.1016/S0002-9343(97)80021-6; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Harari A, 2004, HUM IMMUNOL, V65, P500, DOI 10.1016/j.humimm.2004.02.012; Le VTK, 2008, J GEN VIROL, V89, P2416, DOI 10.1099/vir.0.2008/001669-0; Limaye AP, 2006, TRANSPLANTATION, V81, P1645, DOI 10.1097/01.tp.0000226071.12562.1a; Lopez H, 2011, PLACENTA, V32, P522, DOI 10.1016/j.placenta.2011.04.016; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Meisel R, 2011, LEUKEMIA, V25, P648, DOI 10.1038/leu.2010.310; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Miki T, 2001, TRANSPLANT P, V33, P129, DOI 10.1016/S0041-1345(00)02792-5; Miller DM, 1998, J EXP MED, V187, P675, DOI 10.1084/jem.187.5.675; Muller A, 2009, J CELL MOL MED, V13, P1125, DOI 10.1111/j.1582-4934.2008.00542.x; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Sadeghi M, 2012, HUM IMMUNOL, V73, P186, DOI 10.1016/j.humimm.2011.11.002; Schmidt SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044797; Schroten H, 2001, NEUROPEDIATRICS, V32, P206, DOI 10.1055/s-2001-17375; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Vermijlen D, 2010, J EXP MED, V207, P807, DOI 10.1084/jem.20090348	35	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64442	10.1371/journal.pone.0064442	http://dx.doi.org/10.1371/journal.pone.0064442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691219	gold, Green Published, Green Submitted			2022-12-25	WOS:000319052700097
J	Le Grand, JN; Bon, K; Fraichard, A; Zhang, JH; Jouvenot, M; Risold, PY; Boyer-Guittaut, M; Delage-Mourroux, R				Le Grand, Jaclyn Nicole; Bon, Karine; Fraichard, Annick; Zhang, Jianhua; Jouvenot, Michele; Risold, Pierre-Yves; Boyer-Guittaut, Michael; Delage-Mourroux, Regis			Specific Distribution of the Autophagic Protein GABARAPL1/GEC1 in the Developing and Adult Mouse Brain and Identification of Neuronal Populations Expressing GABARAPL1/GEC1	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GABA(A) RECEPTOR; MESSENGER-RNAS; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; IN-VIVO; GEC1; MICE; DEGRADATION; INTERACTS	Macroautophagy is a highly conserved cellular degradation process, regulated by autophagy-related (atg) factors, in which a double membrane autophagosome engulfs cytoplasmic components to target them for degradation. In yeast, the Atg8 protein is indispensable for autophagosome formation. In mammals, this is complicated by the presence of six Atg8 homologues grouped into the GABARAP and MAP1LC3 subfamilies. Although these proteins share a high similarity, their transcript expression, regulation and protein interactions differ, suggesting they may display individual properties and specific functions. GABARAPL1/GEC1 is a member of the GABARAP subfamily and its mRNA is the most highly expressed Atg8 homologue in the central nervous system. Consequently, we performed an in depth study of GABARAPL1 distribution in the developing and adult murine brain. Our results show that GABARAPL1 brain expression is visible as early as embryonic day 11 and progressively increases to a maximum level in the adult. Immunohistochemical staining was detected in both fibers and immature neurons in embryos but was restrained to neurons in adult tissue. By E17, intense punctate-like structures were visible and these accumulated in cortical primary neurons treated with the autophagosome/lysosome fusion inhibitor Bafilomycin A1 (Baf A1), suggesting that they represent autophagosomes. Finally, GABARAPL1 expression was particularly intense in motoneurons in the embryo and in neurons involved in somatomotor and neuroendocrine functions in the adult, particularly in the substantia nigra pars compacta, a region affected in Parkinson's disease. Our study of cerebral GABARAPL1 protein expression provides insight into its role in the development and homeostasis of the mouse brain.	[Le Grand, Jaclyn Nicole; Bon, Karine; Fraichard, Annick; Jouvenot, Michele; Risold, Pierre-Yves; Boyer-Guittaut, Michael; Delage-Mourroux, Regis] Univ Franche Comte, UFR Sci & Tech, Estrogenes Express Gen & Pathol Syst Nerveux Cent, Lab Biochim,SFR IBCT FED 4234, F-25030 Besancon, Doubs, France; [Zhang, Jianhua] Univ Alabama Birmingham, Dept Pathol, Ctr Free Radical Biol, Birmingham, AL 35294 USA; [Zhang, Jianhua] Birmingham VA Med Ctr, Dept Vet Affairs, Birmingham, AL 35294 USA	Universite de Franche-Comte; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Delage-Mourroux, R (corresponding author), Univ Franche Comte, UFR Sci & Tech, Estrogenes Express Gen & Pathol Syst Nerveux Cent, Lab Biochim,SFR IBCT FED 4234, F-25030 Besancon, Doubs, France.	regis.delage-mourroux@univ-fcomte.fr	Risold, Pierre-Yves/AAJ-9535-2021; Guittaut, Michael/ABE-4274-2021; Risold, Pierre-Yves/M-7730-2018; DELAGE-MOURROUX, Régis/ABE-1424-2021; fraichard, annick/ABE-1289-2021	Guittaut, Michael/0000-0001-9540-5593; Risold, Pierre-Yves/0000-0001-6801-591X; DELAGE-MOURROUX, Régis/0000-0002-7145-5948; fraichard, annick/0000-0001-6936-138X; Zhang, Jianhua/0000-0002-2128-9574	Ministere de l'Enseignement Superieur et de la Recherche (MESR); VA merit award;  [NIHR01-NS064090]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064090] Funding Source: NIH RePORTER	Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France); VA merit award(US Department of Veterans Affairs); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	JNLG is supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche (MESR) and Dr. JZ was supported by NIHR01-NS064090 and a VA merit award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourque M, 2009, FRONT NEUROENDOCRIN, V30, P142, DOI 10.1016/j.yfrne.2009.04.014; Brischoux F, 2001, EUR J NEUROSCI, V13, P1733, DOI 10.1046/j.0953-816x.2001.01552.x; Cann GM, 2008, DEV DYNAM, V237, P187, DOI 10.1002/dvdy.21392; Chakrama FZ, 2010, AUTOPHAGY, V6, P495, DOI 10.4161/auto.6.4.11819; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Friedman LG, 2012, J NEUROSCI, V32, P7585, DOI 10.1523/JNEUROSCI.5809-11.2012; Griswold AJ, 2012, HUM MOL GENET; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Larsen KB, 2010, AUTOPHAGY, V6, P784, DOI 10.4161/auto.6.6.12510; Le Grand JN, 2011, AUTOPHAGY, V7, P1302, DOI 10.4161/auto.7.11.16723; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; MANN SS, 1994, J BIOL CHEM, V269, P11492; Mansuy V, 2004, BIOCHEM BIOPH RES CO, V325, P639, DOI 10.1016/j.bbrc.2004.10.072; Mansuy-Schlick V, 2006, BRAIN RES, V1073, P83, DOI 10.1016/j.brainres.2005.11.004; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nemos C, 2003, MOL BRAIN RES, V119, P216, DOI 10.1016/j.molbrainres.2003.09.011; O'Sullivan GA, 2005, EUR J NEUROSCI, V22, P2644, DOI 10.1111/j.1460-9568.2005.04448.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; PELLERIN I, 1993, MOL CELL ENDOCRINOL, V90, pR17, DOI 10.1016/0303-7207(93)90161-C; Peng C, 2012, J BIOL CHEM, V287, P32861, DOI 10.1074/jbc.M112.384305; Rannals MD, 2011, J NEUROSCI, V31, P17701, DOI 10.1523/JNEUROSCI.4476-11.2011; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Schnack C, 2008, NEUROSCIENCE, V154, P1450, DOI 10.1016/j.neuroscience.2008.02.049; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Storvik M, 2010, NEUROBIOL DIS, V38, P386, DOI 10.1016/j.nbd.2010.02.008; Tolle F, 2008, BRAIN RES, V1210, P103, DOI 10.1016/j.brainres.2008.02.077; Vernier-Magnin S, 2001, BIOCHEM BIOPH RES CO, V284, P118, DOI 10.1006/bbrc.2001.4908; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; Wang Y, 2006, NEUROSCIENCE, V140, P1265, DOI 10.1016/j.neuroscience.2006.03.013; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	43	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63133	10.1371/journal.pone.0063133	http://dx.doi.org/10.1371/journal.pone.0063133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690988	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700021
J	McEvoy, MA; Schofield, PW; Smith, WT; Agho, K; Mangoni, AA; Soiza, RL; Peel, R; Hancock, SJ; Carru, C; Zinellu, A; Attia, JR				McEvoy, Mark A.; Schofield, Peter W.; Smith, Wayne T.; Agho, Kingsley; Mangoni, Arduino A.; Soiza, Roy L.; Peel, Roseanne; Hancock, Stephen J.; Carru, Ciriaco; Zinellu, Angelo; Attia, John R.			Serum Methylarginines and Spirometry-Measured Lung Function in Older Adults	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CORONARY-HEART-DISEASE; ASYMMETRIC DIMETHYLARGININE; IN-VIVO; RISK; INHIBITORS; MODULATION; ASTHMA	Rationale: Methylarginines are endogenous nitric oxide synthase inhibitors that have been implicated in animal models of lung disease but have not previously been examined for their association with spirometric measures of lung function in humans. Objectives: This study measured serum concentrations of asymmetric and symmetric dimethylarginine in a representative sample of older community-dwelling adults and determined their association with spirometric lung function measures. Methods: Data on clinical, lifestyle, and demographic characteristics, methylated arginines, and L-arginine (measured using LC-MS/MS) were collected from a population-based sample of older Australian adults from the Hunter Community Study. The five key lung function measures included as outcomes were Forced Expiratory Volume in 1 second, Forced Vital Capacity, Forced Expiratory Volume in 1 second to Forced Vital Capacity ratio, Percent Predicted Forced Expiratory Volume in 1 second, and Percent Predicted Forced Vital Capacity. Measurements and Main Results: In adjusted analyses there were statistically significant independent associations between a) higher asymmetric dimethylarginine, lower Forced Expiratory Volume in 1 second and lower Forced Vital Capacity; and b) lower L-arginine/asymmetric dimethylarginine ratio, lower Forced Expiratory Volume in 1 second, lower Percent Predicted Forced Expiratory Volume in 1 second and lower Percent Predicted Forced Vital Capacity. By contrast, no significant associations were observed between symmetric dimethylarginine and lung function. Conclusions: After adjusting for clinical, demographic, biochemical, and pharmacological confounders, higher serum asymmetric dimethylarginine was independently associated with a reduction in key measures of lung function. Further research is needed to determine if methylarginines predict the decline in lung function.	[McEvoy, Mark A.; Peel, Roseanne; Hancock, Stephen J.; Attia, John R.] Univ Newcastle, Sch Med & Publ Hlth, Hunter Med Res Inst, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia; [Schofield, Peter W.] Univ Newcastle, Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia; [Smith, Wayne T.] New South Wales Dept Hlth, Environm Hlth Branch, Gladesville, NSW, Australia; [Agho, Kingsley] Univ Western Sydney, Sch Med, Sci Mental Hlth & Advers Unit, Parramatta, NSW, Australia; [Mangoni, Arduino A.; Soiza, Roy L.] Univ Aberdeen, Sch Med & Dent, Div Appl Med, Aberdeen, Scotland; [Mangoni, Arduino A.; Soiza, Roy L.] NHS Grampian, Woodend Hosp, Dept Med Elderly, Aberdeen, Scotland; [Carru, Ciriaco; Zinellu, Angelo] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Attia, John R.] John Hunter Hosp, Dept Gen Med, Newcastle, NSW, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Western Sydney University; University of Aberdeen; University of Sassari; John Hunter Hospital	McEvoy, MA (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Hunter Med Res Inst, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia.	mark.mcevoy@newcastle.edu.au; john.attia@newcastle.edu.au	Peel, Roseanne/G-7726-2013; Attia, John R/F-5376-2013; , roysoiza/Q-3525-2019; Agho, Kingsley/AAE-9971-2020; Agho, Kingsley/AAW-5622-2021; Carru, Ciriaco/AAI-9996-2021; Schofield, Peter/J-7133-2013; Mangoni, Arduino Aleksander/I-5109-2019	Peel, Roseanne/0000-0001-9912-3198; Attia, John R/0000-0001-9800-1308; , roysoiza/0000-0002-1397-4272; Agho, Kingsley/0000-0003-4111-3207; Mangoni, Arduino Aleksander/0000-0001-8699-1412; Carru, Ciriaco/0000-0002-6985-4907; McEvoy, Mark/0000-0002-5505-5557; Schofield, Peter/0000-0001-8298-8590; Zinellu, Angelo/0000-0002-8396-0968	University of Newcastle Strategic Initiative Fund; University of Newcastle	University of Newcastle Strategic Initiative Fund; University of Newcastle	Funding provided by the University of Newcastle Strategic Initiative Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to The University of Newcastle for funding and to the men and women of the Hunter region who provided the information recorded.	Ahmad T, 2010, AM J RESP CELL MOL, V42, P3, DOI 10.1165/rcmb.2009-0137RC; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Barnes PJ, 2010, CHEST, V138, P682, DOI 10.1378/chest.09-2090; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Brindicci C, 2007, CHEST, V132, P581, DOI 10.1378/chest.06-3046; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Bulau P, 2007, AM J PHYSIOL-LUNG C, V292, pL18, DOI 10.1152/ajplung.00076.2006; Caplin B, 2012, ARTERIOSCL THROM VAS, V32, P1343, DOI 10.1161/ATVBAHA.112.247726; Cardounel AJ, 2005, J BIOL CHEM, V280, P7540, DOI 10.1074/jbc.M410241200; Fliser D, 2005, EUR J CLIN INVEST, V35, P71, DOI 10.1111/j.1365-2362.2005.01457.x; GORE CJ, 1995, EUR RESPIR J, V8, P773; Grasemann H, 1997, PEDIATR PULM, V24, P173, DOI 10.1002/(SICI)1099-0496(199709)24:3<173::AID-PPUL2>3.0.CO;2-O; Hole DJ, 1996, BRIT MED J, V313, P711; KIPS JC, 1995, AM J RESP CRIT CARE, V151, P1165; Koarai A, 2002, EUR RESPIR J, V20, P609, DOI 10.1183/09031936.02.00274902; Lara A, 2008, AM J RESP CRIT CARE, V178, P673, DOI 10.1164/rccm.200710-1542OC; Mangoni AA, 2009, ADV CLIN CHEM, V48, P73, DOI 10.1016/S0065-2423(09)48003-X; McEvoy M, 2010, INT J EPIDEMIOL, V39, P1452, DOI 10.1093/ije/dyp343; NIJKAMP FP, 1993, AM REV RESPIR DIS, V148, P727, DOI 10.1164/ajrccm/148.3.727; PERSSON MG, 1993, EUR J PHARMACOL, V249, pR7, DOI 10.1016/0014-2999(93)90532-M; Pullamsetti S, 2005, FASEB J, V19, P1175, DOI 10.1096/fj.04-3223fje; Ricciardolo FLM, 1996, LANCET, V348, P374, DOI 10.1016/S0140-6736(96)04450-9; Ricciardolo FLM, 2004, PHYSIOL REV, V84, P731, DOI 10.1152/physrev.00034.2003; ROBBINS RA, 1994, BIOCHEM BIOPH RES CO, V203, P209, DOI 10.1006/bbrc.1994.2169; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Scott JA, 2011, AM J RESP CRIT CARE, V184, P779, DOI 10.1164/rccm.201011-1810OC; Segarra G, 2001, AM J HYPERTENS, V14, P1142, DOI 10.1016/S0895-7061(01)02208-7; Segarra G, 1999, STROKE, V30, P2206, DOI 10.1161/01.STR.30.10.2206; Selley ML, 2004, J NEUROSCI RES, V77, P90, DOI 10.1002/jnr.20070; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Ten Broeke R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-58; TOCKMAN MS, 1995, AM J RESP CRIT CARE, V151, P390, DOI 10.1164/ajrccm.151.2.7842197; Tulic MK, 2000, EUR RESPIR J, V15, P870, DOI 10.1183/09031936.00.15587000; Wanner A, 2010, AM J RESP CRIT CARE, V182, P1344, DOI 10.1164/rccm.201001-0038PP; WARD JK, 1993, J CLIN INVEST, V92, P736, DOI 10.1172/JCI116644; Wells SM, 2009, AM J RESP CELL MOL, V40, P179, DOI 10.1165/rcmb.2008-0148OC	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e58390	10.1371/journal.pone.0058390	http://dx.doi.org/10.1371/journal.pone.0058390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690915	gold, Green Published			2022-12-25	WOS:000319052700002
J	Barker, JM; Charlier, TD; Ball, GF; Balthazart, J				Barker, Jennifer M.; Charlier, Thierry D.; Ball, Gregory F.; Balthazart, Jacques			A New Method for In Vitro Detection of Bromodeoxyuridine in Serum: A Proof of Concept in a Songbird Species, the Canary	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; TRITIATED-THYMIDINE; ADULT; FEMALE; ESTRADIOL; SURVIVAL; NEURONS; BRAIN; DEATH; FATE	Systemic injection of a thymidine analogue such as bromodeoxyuridine (BrdU) in vertebrates is commonly used to detect and study cell production during development, adulthood, and pathology, particularly in studies of adult neurogenesis. Although researchers are applying this technique to multiple species in various physiological conditions, the rate of BrdU clearance from the serum remains unknown in most cases. Changes in this clearance rate as a function of the species, sex or endocrine condition could however profoundly affect the interpretation of the results. We describe a rapid, sensitive, but simple bioassay for post-injection detection and quantification of BrdU in serum. This procedure was shown to be suitable for determining the length of time a thymidine analogue remains in the bloodstream of one avian species and seems applicable to any vertebrate provided sufficiently large blood samples can be collected. This technique was used to demonstrate that, in canaries, BrdU injected at a dose of 100 mg/kg is no longer available for incorporation into DNA between 30 and 60 min post-injection, a delay shorter than anticipated based on the available literature. Preliminary data suggest a similar fast clearance in Japanese quail and mice.	[Barker, Jennifer M.; Charlier, Thierry D.; Balthazart, Jacques] Univ Liege, Res Grp Behav Neuroendocrinol, GIGA Neurosci, Liege, Belgium; [Ball, Gregory F.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD USA	University of Liege; Johns Hopkins University	Barker, JM (corresponding author), Univ Liege, Res Grp Behav Neuroendocrinol, GIGA Neurosci, Liege, Belgium.	jenn.barker@utoronto.ca	Charlier, Thierry/J-4668-2015; Balthazart, Jacques/H-6865-2019	Balthazart, Jacques/0000-0001-9492-2126; Ball, Gregory/0000-0002-4784-0520	NIH NINDS [RO1-NS035467]; University of Liege; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035467] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Liege(University of Liege); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided by NIH NINDS RO1-NS035467 (JB and GFB) and by a Postdoctoral Fellowship for Foreign Researchers from the University of Liege (JMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JM, 2008, NEUROSCIENCE, V152, P888, DOI 10.1016/j.neuroscience.2007.10.071; Bauer S, 2005, J CELL BIOL, V171, P641, DOI 10.1083/jcb.200505072; Burns KA, 2005, EUR J NEUROSCI, V21, P803, DOI 10.1111/j.1460-9568.2005.03907.x; Cavanagh BL, 2011, MOLECULES, V16, P7980, DOI 10.3390/molecules16097980; Charalampopoulos I, 2008, TRENDS ENDOCRIN MET, V19, P300, DOI 10.1016/j.tem.2008.07.004; Dalla C, 2009, P NATL ACAD SCI USA, V106, P2927, DOI 10.1073/pnas.0809650106; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Huang LY, 1998, J NEUROBIOL, V36, P410, DOI 10.1002/(SICI)1097-4695(19980905)36:3<410::AID-NEU8>3.0.CO;2-Z; Kempermann G., 2011, ADULT NEUROGENESIS, V2nd ed.; KRISS JP, 1962, CANCER RES, V22, P254; Kuhn HG, 2007, CURR PHARM BIOTECHNO, V8, P127; NOTTEBOHM F, 1989, SCI AM, V260, P74, DOI 10.1038/scientificamerican0289-74; NOWAKOWSKI RS, 1974, CELL TISSUE KINET, V7, P189, DOI 10.1111/j.1365-2184.1974.tb00411.x; Packard D S Jr, 1973, Differentiation, V1, P397, DOI 10.1111/j.1432-0436.1973.tb00137.x; PHUPHANICH S, 1985, CANCER RES, V45, P2387; Qiu Lin, 2007, Neurosci Bull, V23, P46, DOI 10.1007/s12264-007-0007-0; RUBINI JR, 1960, J CLIN INVEST, V39, P909, DOI 10.1172/JCI104111; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Spritzer MD, 2007, DEV NEUROBIOL, V67, P1321, DOI 10.1002/dneu.20457; STAROSCIK RN, 1964, NATURE, V202, P456, DOI 10.1038/202456a0; STETSON PL, 1985, J CHROMATOGR, V341, P217, DOI 10.1016/S0378-4347(00)84032-3; Strand CR, 2007, DEV NEUROBIOL, V67, P827, DOI 10.1002/dneu.20400; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092	30	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63692	10.1371/journal.pone.0063692	http://dx.doi.org/10.1371/journal.pone.0063692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691086	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400075
J	Chu, CJ; Herrmann, P; Carvalho, LS; Liyanage, SE; Bainbridge, JWB; Ali, RR; Dick, AD; Luhmann, UFO				Chu, Colin J.; Herrmann, Philipp; Carvalho, Livia S.; Liyanage, Sidath E.; Bainbridge, James W. B.; Ali, Robin R.; Dick, Andrew D.; Luhmann, Ulrich F. O.			Assessment and In Vivo Scoring of Murine Experimental Autoimmune Uveoretinitis Using Optical Coherence Tomography	PLOS ONE			English	Article							GRIFFONIA-SIMPLICIFOLIA; CELLULAR INFILTRATE; INFLAMMATION; MODEL; MACROPHAGES; MECHANISMS; RECEPTOR; CELLS	Despite advances in clinical imaging and grading our understanding of retinal immune responses and their morphological correlates in experimental autoimmune uveoretinitis (EAU), has been hindered by the requirement for post-mortem histology. To date, monitoring changes occurring during EAU disease progression and evaluating the effect of therapeutic intervention in real time has not been possible. We wanted to establish whether optical coherence tomography (OCT) could detect intraretinal changes during inflammation and to determine its utility as a tool for accurate scoring of EAU. EAU was induced in C57BL/6J mice and animals evaluated after 15, 26, 36 and 60 days. At each time-point, contemporaneous Spectralis-OCT scanning, topical endoscopic fundal imaging (TEFI), fundus fluorescein angiography (FFA) and CD45-immunolabelled histology were performed. OCT features were further characterised on retinal flat-mounts using immunohistochemistry and 3D reconstruction. Optic disc swelling and vitreous opacities detected by OCT corresponded to CD45+ cell infiltration on histology. Vasculitis identified by FFA and OCT matched perivascular myeloid and T-cell infiltrates and could be differentiated from unaffected vessels. Evolution of these changes could be followed over time in the same eye. Retinal folds were visible and found to encapsulate mixed populations of activated myeloid cells, T-cells and microglia. Using these features, an OCT-based EAU scoring system was developed, with significant correlation to validated histological (Pearson r(2) = 0.6392, P<0.0001, n = 31 eyes) and TEFI based scoring systems (r(2) = 0.6784, P<0.0001). OCT distinguishes the fundamental features of murine EAU in vivo, permits dynamic assessment of intraretinal changes and can be used to score disease severity. As a result, it allows tissue synchronisation with subsequent cellular and functional assessment and greater efficiency of animal usage. By relating OCT signals with immunohistochemistry in EAU, our findings offer the opportunity to inform the interpretation of OCT changes in human uveitis.	[Chu, Colin J.; Herrmann, Philipp; Carvalho, Livia S.; Liyanage, Sidath E.; Bainbridge, James W. B.; Ali, Robin R.; Luhmann, Ulrich F. O.] UCL Inst Ophthalmol, Dept Genet, London, England; [Bainbridge, James W. B.; Ali, Robin R.; Dick, Andrew D.] Moorfields Eye Hosp, NIHR Biomed Res Ctr Ophthalmol, London, England; [Dick, Andrew D.] Univ Bristol, Sch Clin Sci, Unit Ophthalmol, Bristol, Avon, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Bristol	Dick, AD (corresponding author), Moorfields Eye Hosp, NIHR Biomed Res Ctr Ophthalmol, London, England.	a.dick@bristol.ac.uk; u.luhmann@ucl.ac.uk		Dick, Andrew/0000-0002-0742-3159; Carvalho, Livia/0000-0002-3909-5778; Ali, Robin/0000-0003-3126-6517; Chu, Colin/0000-0003-2088-8310; Bainbridge, James/0000-0003-1318-8201	MRC [G1100383]; Fight for Sight [MR/K003003/1]; German Research Foundation [DFG He 6175/1-1]; Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; NIHR Moorfields Biomedical Research Centre; NIHR; MRC [MR/K003003/1] Funding Source: UKRI; Medical Research Council [G1100383, MR/K003003/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-003, NF-SI-0508-10130] Funding Source: researchfish; Fight for Sight [1371/72, 1333/34] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fight for Sight; German Research Foundation(German Research Foundation (DFG)); Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital(National Institute for Health Research (NIHR)); NIHR Moorfields Biomedical Research Centre; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	CJC and SEL are joint MRC and Fight for Sight clinical research training fellows (G1100383 and MR/K003003/1 respectively). PH is a fellow of the German Research Foundation (DFG He 6175/1-1). RRA is partly funded by the Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital. ADD is partly funded as the theme lead for inflammation and immunotherapy at the NIHR Moorfields Biomedical Research Centre. JB is supported by a NIHR Research Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calder CJ, 2005, J IMMUNOL, V175, P6286, DOI 10.4049/jimmunol.175.10.6286; Caspi RR, 2008, OPHTHAL RES, V40, P169, DOI 10.1159/000119871; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; CASPI RR, 1992, J IMMUNOL, V148, P2384; Chen M, 2012, AM J PATHOL, V180, P235, DOI 10.1016/j.ajpath.2011.09.020; Copland DA, 2012, AM J PATHOL, V180, P672, DOI 10.1016/j.ajpath.2011.10.008; Copland DA, 2008, INVEST OPHTH VIS SCI, V49, P5458, DOI 10.1167/iovs.08-2348; DICK AD, 1994, EYE, V8, P52, DOI 10.1038/eye.1994.10; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Forooghian F, 2010, OCUL IMMUNOL INFLAMM, V18, P470, DOI 10.3109/09273948.2010.506973; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312; Gadjanski I, 2011, EXP EYE RES, V93, P82, DOI 10.1016/j.exer.2011.04.012; Gallagher MJ, 2007, BRIT J OPHTHALMOL, V91, P1680, DOI 10.1136/bjo.2007.124099; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Jaissle GB, 2010, GRAEF ARCH CLIN EXP, V248, P1063, DOI 10.1007/s00417-009-1253-9; Jiang HR, 1999, INVEST OPHTH VIS SCI, V40, P3177; Keane PA, 2012, SURV OPHTHALMOL, V57, P389, DOI 10.1016/j.survophthal.2012.01.006; Kerr EC, 2008, J AUTOIMMUN, V31, P354, DOI 10.1016/j.jaut.2008.08.006; Luhmann UFO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035551; MADDOX DE, 1982, P NATL ACAD SCI-BIOL, V79, P166, DOI 10.1073/pnas.79.1.166; National Centre for the Replacement Refinement and Reduction of Animals in Research, 2008, RESP US AN BIOSC RES; PETRYNIAK J, 1986, ARCH BIOCHEM BIOPHYS, V244, P57, DOI 10.1016/0003-9861(86)90094-9; Raveney BJE, 2009, J IMMUNOL, V183, P2321, DOI 10.4049/jimmunol.0901340; Schewitz-Bowers LP, 2010, EXPERT REV OPHTHALMO, V5, P43, DOI 10.1586/EOP.09.68; Vance SK, 2011, RETINA-J RET VIT DIS, V31, P717, DOI 10.1097/IAE.0b013e318203c1ef; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wojtkowski M, 2012, OPTOMETRY VISION SCI, V89, P524, DOI 10.1097/OPX.0b013e31824eecb2; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012	29	46	47	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63002	10.1371/journal.pone.0063002	http://dx.doi.org/10.1371/journal.pone.0063002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690973	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400026
J	Simone, R; Pesce, G; Antola, P; Merlo, DF; Bagnasco, M; Saverino, D				Simone, Rita; Pesce, Giampaola; Antola, Princey; Merlo, Domenico F.; Bagnasco, Marcello; Saverino, Daniele			Serum LAIR-2 Is Increased in Autoimmune Thyroid Diseases	PLOS ONE			English	Article							INHIBITORY RECEPTOR; COLLAGENS	Leukocyte-associated Ig-like receptor (LAIR) is a small family-receptor able to inhibit immune cell function via collagen binding. It exists as both membrane-bound and soluble forms. LAIR-1 functions as an inhibitory receptor on natural killer cells, T lymphocytes and monocytes. In addition to LAIR-1, the human genome encodes LAIR-2, a soluble homolog. Several studies have focused on LAIR-1, whereas few investigations concentrate on the expression and function of LAIR-2. We demonstrate the presence of high LAIR-2 levels in 74/80 sera from patients with autoimmune thyroid diseases (both Graves' disease and autoimmune thyroiditis). LAIR-2 levels seemed not to be related to specific clinical manifestations, such as thyroid functions (hypo-or hyperthyroidism), or specific clinical features (such as ophtalmopathy). In addition, serum LAIR-2 is able, in vitro, to bind its natural ligand, collagen. Since LAIR-2 has been found to have higher affinity for collagens than LAIR-1 did, we hypothesize a potential regulating capability of serum LAIR-2 in finally regulating the inhibitory capability of LAIR-1.	[Simone, Rita; Saverino, Daniele] Univ Genoa, Sect Human Anat, Dept Expt Med, Genoa, Italy; [Simone, Rita] N Shore Univ Hosp, Dept Med, Manhasset, NY USA; [Simone, Rita] N Shore Univ Hosp, Dept Cell Biol, Manhasset, NY USA; [Pesce, Giampaola; Antola, Princey; Bagnasco, Marcello] Univ Genoa, Dept Internal Med, Autoimmun Unit, I-16126 Genoa, Italy; [Merlo, Domenico F.] IST Ist Nazl Ric Canc, IRCCS AOU San Martino, Genoa, Italy	University of Genoa; Northwell Health; North Shore University Hospital; Northwell Health; North Shore University Hospital; University of Genoa; University of Genoa; IRCCS AOU San Martino IST	Saverino, D (corresponding author), Univ Genoa, Sect Human Anat, Dept Expt Med, Genoa, Italy.	daniele.saverino@unige.it	Merlo, Domenico Franco/ABI-1345-2020; Saverino, Daniele/I-4741-2014	Merlo, Domenico Franco/0000-0002-1832-4754; Pesce, Giampaola/0000-0002-6294-9110	Fondazione CARIGE	Fondazione CARIGE(Fondazione Carige)	This work was supported by grants from Fondazione CARIGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Bellis A, 2005, CLIN ENDOCRINOL, V62, P24, DOI 10.1111/j.1365-2265.2004.02167.x; Diaz-Pena R, 2012, ANN RHEUM DIS, V71, P714, DOI 10.1136/annrheumdis-2011-200661; Founds SA, 2010, PLACENTA, V31, P880, DOI 10.1016/j.placenta.2010.07.005; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Lebbink RJ, 2008, J IMMUNOL, V180, P1662, DOI 10.4049/jimmunol.180.3.1662; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lebbink RJ, 2009, MATRIX BIOL, V28, P202, DOI 10.1016/j.matbio.2009.03.005; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lenting PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012174; Levine SJ, 2004, J IMMUNOL, V173, P5343, DOI 10.4049/jimmunol.173.9.5343; Merlo A, 2005, CLIN DIAGN LAB IMMUN, V12, P705, DOI 10.1128/CDLI.12.6.705-712.2005; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Meyaard L, 1999, J IMMUNOL, V162, P5800; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nordkamp MJMO, 2011, ARTHRITIS RHEUM-US, V63, P3749, DOI 10.1002/art.30612; Ouyang WM, 2004, J IMMUNOL METHODS, V292, P109, DOI 10.1016/j.jim.2004.06.005; Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510	18	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63282	10.1371/journal.pone.0063282	http://dx.doi.org/10.1371/journal.pone.0063282			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691008	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400041
J	Zhu, WL; Zhao, YL; Xu, YQ; Sun, Y; Wang, Z; Yuan, W; Du, ZM				Zhu, Wenliang; Zhao, Yilei; Xu, Yingqi; Sun, Yong; Wang, Zhe; Yuan, Wei; Du, Zhimin			Dissection of Protein Interactomics Highlights MicroRNA Synergy	PLOS ONE			English	Article							EXPRESSION; MODULARITY; RESOURCE; CANCER	Despite a large amount of microRNAs (miRNAs) have been validated to play crucial roles in human biology and disease, there is little systematic insight into the nature and scale of the potential synergistic interactions executed by miRNAs themselves. Here we established an integrated parameter synergy score to determine miRNA synergy, by combining the two mechanisms for miRNA-miRNA interactions, miRNA-mediated gene co-regulation and functional association between target gene products, into one single parameter. Receiver operating characteristic (ROC) analysis indicated that synergy score accurately identified the gene ontology-defined miRNA synergy (AUC = 0.9415, p<0.001). Only a very small portion of the random miRNA-miRNA combinations generated potent synergy, implying poor expectancy of widespread synergy. However, targeting more key genes made two miRNAs more likely to act synergistically. Compared to other miRNAs, miR-21 was a highly exceptional case due to frequent appearance in the top synergistic miRNA pairs. This result highlighted its essential role in coordinating or strengthening physiological and pathological functions of other miRNAs. The synergistic effect of miR-21 and miR-1 were functionally validated for their significant influences on myocardial apoptosis, cardiac hypertrophy and fibrosis. The novel approach established in this study enables easy and effective identification of condition-restricted potent miRNA synergy simply by concentrating the available protein interactomics and miRNA-target interaction data into a single parameter synergy score. Our results may be important for understanding synergistic gene regulation by miRNAs and may have significant implications for miRNA combination therapy of cardiovascular disease.	[Zhu, Wenliang; Zhao, Yilei; Xu, Yingqi; Sun, Yong; Wang, Zhe; Yuan, Wei; Du, Zhimin] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China	Harbin Medical University	Du, ZM (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China.	dzm1956@126.com		Xu, Yingqi/0000-0001-6879-639X	Funds for Creative Research Groups [81121003]; National Natural Science Foundation of China [81072639]; Major Program of National Natural Science Foundation of China [81230081]	Funds for Creative Research Groups(Science Fund for Creative Research Groups); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Funds for Creative Research Groups (81121003), the National Natural Science Foundation of China (81072639) and Major Program of National Natural Science Foundation of China (81230081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boettger T, 2012, CIRC RES, V110, P1000, DOI 10.1161/CIRCRESAHA.111.247742; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Gamazon ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013534; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Han M, 2011, CURR OPIN CARDIOL, V26, P181, DOI 10.1097/HCO.0b013e328345983d; Hu SJ, 2011, CIRCULATION, V124, pS27, DOI 10.1161/CIRCULATIONAHA.111.017954; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikeda S, 2010, CURR DRUG TARGETS, V11, P913, DOI 10.2174/138945010791591304; Jazbutyte V, 2010, CURR DRUG TARGETS, V11, P926, DOI 10.2174/138945010791591403; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ritchie W, 2010, BIOINFORMATICS, V26, P223, DOI 10.1093/bioinformatics/btp649; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Su WL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.23; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-528; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291; Zhu WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025394; Zhu WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014736	44	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63342	10.1371/journal.pone.0063342	http://dx.doi.org/10.1371/journal.pone.0063342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691029	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400056
J	Ding, H; Gao, YS; Hu, C; Wang, Y; Wang, CG; Yin, JM; Sun, Y; Zhang, CQ				Ding, Hao; Gao, You-Shui; Hu, Chen; Wang, Yang; Wang, Chuan-Gui; Yin, Ji-Min; Sun, Yuan; Zhang, Chang-Qing			HIF-1 alpha Transgenic Bone Marrow Cells Can Promote Tissue Repair in Cases of Corticosteroid-Induced Osteonecrosis of the Femoral Head in Rabbits	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HYPOXIA-INDUCIBLE FACTORS; CONSTITUTIVELY ACTIVE FORM; ENGINEERED BONE; STROMAL CELLS; EXPRESSION; ANGIOGENESIS; IMPLANTATION; INDUCTION; PROTECTS	Although corticosteroid-induced osteonecrosis of the femoral head (ONFH) is common, the treatment for it remains limited and largely ineffective. We examined whether implantation of hypoxia inducible factor-1 alpha (HIF-1 alpha) transgenic bone marrow cells (BMCs) can promote the repair of the necrotic area of corticosteroid-induced ONFH. In this study, we confirmed that HIF-1 alpha gene transfection could enhance mRNA expression of osteogenic genes in BMCs in vitro. Alkaline phosphatase activity assay and alizarin red-S staining indicated HIF-1 alpha transgenic BMCs had enhanced osteogenic differentiation capacity in vitro. Furthermore, enzyme linked immunosorbent assay (ELISA) for VEGF revealed HIF-1 alpha transgenic BMCs secreted more VEGF as compared to normal BMCs. An experimental rabbit model of early-stage corticosteroid-induced ONFH was established and used for an evaluation of cytotherapy. Transplantation of HIF-1 alpha transgenic BMCs dramatically improved the bone regeneration of the necrotic area of the femoral head. The number and volume of blood vessel were significantly increased in the necrotic area of the femoral head compared to the control groups. These results support HIF-1 alpha transgenic BMCs have enhanced osteogenic and angiogenic activity in vitro and in vivo. Transplantation of HIF-1 alpha transgenic BMCs can potentially promote the repair of the necrotic area of corticosteroid-induced ONFH.	[Ding, Hao; Gao, You-Shui; Wang, Yang; Yin, Ji-Min; Sun, Yuan; Zhang, Chang-Qing] Shanghai Jiao Tong Univ, Dept Orthoped Surg, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Hu, Chen; Wang, Chuan-Gui] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Sch Life Sci, Shanghai 200062, Peoples R China	Shanghai Jiao Tong University; East China Normal University	Zhang, CQ (corresponding author), Shanghai Jiao Tong Univ, Dept Orthoped Surg, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China.	zcqgk@yahoo.cn	GAO, YOUSHUI/U-8349-2019	zhang, changqing/0000-0002-7408-4126	National Natural Science Foundation of China [81101368, 81272003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81101368 and 81272003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATSUMI T, 1992, CLIN ORTHOP RELAT R, P22; Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chiu KH, 1997, J ARTHROPLASTY, V12, P683, DOI 10.1016/S0883-5403(97)90142-X; Dadon-Nachum M, 2011, STEM CELL REV REP, V7, P664, DOI 10.1007/s12015-010-9227-1; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; Deckers MM, 2010, ENDOCRINOLOGY, V141, P1667; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Gangji V, 2004, J BONE JOINT SURG AM, V86A, P1153, DOI 10.2106/00004623-200406000-00006; Gangji V, 2011, BONE, V49, P1005, DOI 10.1016/j.bone.2011.07.032; Hang DH, 2012, CELLS TISSUES ORGANS, V195, P495, DOI 10.1159/000329502; JONES JP, 1993, CLIN ORTHOP RELAT R, P294; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Lieberman Jay R, 2003, Instr Course Lect, V52, P337; Loinard C, 2009, CIRCULATION, V120, P50, DOI 10.1161/CIRCULATIONAHA.108.813303; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; Mazumdar J, 2009, J CELL MOL MED, V13, P4319, DOI 10.1111/j.1582-4934.2009.00963.x; Nagano M, 2010, STEM CELLS DEV, V19, P1195, DOI 10.1089/scd.2009.0447; Qin L, 2006, BONE, V39, P863, DOI 10.1016/j.bone.2006.04.018; Qu D, 2011, J BIOMED MATER RES A, V96A, P543, DOI 10.1002/jbm.a.33009; Riddle RC, 2009, J MOL MED, V87, P583, DOI 10.1007/s00109-009-0477-9; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Shomento SH, 2010, J CELL BIOCHEM, V109, P196, DOI 10.1002/jcb.22396; Sun Y, 2009, JOINT BONE SPINE, V76, P685, DOI 10.1016/j.jbspin.2009.04.002; Takaku M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042964; Tang TT, 2007, J BONE JOINT SURG BR, V89B, P127, DOI 10.1302/0301-620X.89B1.18350; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tzaribachev N, 2008, ISR MED ASSOC J, V10, P232; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wen Q, 2008, GENE THER, V15, P1523, DOI 10.1038/gt.2008.110; Yan ZQ, 2009, J ORTHOP RES, V27, P442, DOI 10.1002/jor.20759; Yang Y, 2011, J BIOMED MATER RES A, V99A, P74, DOI 10.1002/jbm.a.33155; Yoon TR, 2001, INT ORTHOP, V24, P316, DOI 10.1007/s002640000186; Ziche M, 1997, LAB INVEST, V76, P517; Zou D, 2011, CELL PROLIFERAT, V44, P234, DOI 10.1111/j.1365-2184.2011.00747.x; Zou DH, 2012, BIOMATERIALS, V33, P2097, DOI 10.1016/j.biomaterials.2011.11.053	42	47	51	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63628	10.1371/journal.pone.0063628	http://dx.doi.org/10.1371/journal.pone.0063628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675495	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100044
J	Holcombe, A; Howorko, A; Powell, RA; Schalomon, M; Hamilton, TJ				Holcombe, Adam; Howorko, Adam; Powell, Russell A.; Schalomon, Melike; Hamilton, Trevor J.			Reversed Scototaxis during Withdrawal after Daily-Moderate, but Not Weekly-Binge, Administration of Ethanol in Zebrafish	PLOS ONE			English	Article							EXCESSIVE ALCOHOL-DRINKING; LIGHT/DARK PREFERENCE TEST; BEHAVIOR GENETIC MODEL; DANIO-RERIO; EXPOSURE; ANXIETY; SYSTEM; FISH; INJECTIONS; ADDICTION	Alcohol abuse can lead to severe psychological and physiological damage. Little is known, however, about the relative impact of a small, daily dose of alcohol (daily-moderate schedule) versus a large, once per week dose (weekly-binge schedule). In this study, we examined the effect of each of these schedules on behavioural measures of anxiety in zebrafish (Danio rerio). Adult wild-type zebrafish were administered either 0.2% ethanol on a daily-moderate schedule or 1.4% ethanol on a weekly-binge schedule for a period of 21 days, and then tested for scototaxis (preference for darkness) during withdrawal. Compared to a control group with no alcohol exposure, the daily-moderate group spent significantly more time on the light side of the arena (indicative of decreased anxiety) on day two of withdrawal, but not day 9 of withdrawal. The weekly-binge group was not significantly different from the control group on either day of withdrawal and showed no preference for either the light or dark zones. Our results indicate that even a small dose of alcohol on a daily basis can cause significant, though reversible, changes in behaviour.	[Holcombe, Adam; Howorko, Adam; Powell, Russell A.; Schalomon, Melike; Hamilton, Trevor J.] Grant MacEwan Univ, Dept Psychol, Edmonton, AB, Canada		Hamilton, TJ (corresponding author), Grant MacEwan Univ, Dept Psychol, Edmonton, AB, Canada.	hamiltont9@macewan.ca			Grant MacEwan University; MacEwan Research Office	Grant MacEwan University; MacEwan Research Office	Funding was provided internally by Grant MacEwan University and the MacEwan Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Bardag-Gorce F, 2009, ALCOHOL CLIN EXP RES, V33, P684, DOI 10.1111/j.1530-0277.2008.00885.x; Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Blaser RE, 2011, PHYSIOL BEHAV, V104, P831, DOI 10.1016/j.physbeh.2011.07.029; Blaser RE, 2010, BEHAV BRAIN RES, V208, P56, DOI 10.1016/j.bbr.2009.11.009; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Chakraborty C, 2009, CURR DRUG METAB, V10, P116, DOI 10.2174/138920009787522197; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; Chiva-Blanch G, 2013, ALCOHOL ALCOHOLISM, V48, P270, DOI 10.1093/alcalc/agt007; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Dlugos CA, 2003, PHARMACOL BIOCHEM BE, V74, P471, DOI 10.1016/S0091-3057(02)01026-2; Domjan M., 2010, PRINCIPLES LEARNING; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Gebauer DL, 2011, PHARMACOL BIOCHEM BE, V99, P480, DOI 10.1016/j.pbb.2011.04.021; George O, 2012, P NATL ACAD SCI USA, V109, P18156, DOI 10.1073/pnas.1116523109; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gerlai R, 2009, GENES BRAIN BEHAV, V8, P586, DOI 10.1111/j.1601-183X.2009.00488.x; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Harper C, 2007, HUM EXP TOXICOL, V26, P251, DOI 10.1177/0960327107070499; Hayton SJ, 2012, ALCOHOL CLIN EXP RES, V36, P594, DOI 10.1111/j.1530-0277.2011.01668.x; Hoeppner BB, 2012, J STUD ALCOHOL DRUGS, V73, P613, DOI 10.15288/jsad.2012.73.613; Holmes A, 2012, NAT NEUROSCI, V15, P1359, DOI 10.1038/nn.3204; Kily LJM, 2008, J EXP BIOL, V211, P1623, DOI 10.1242/jeb.014399; Klee EW, 2012, HUM GENET, V131, P977, DOI 10.1007/s00439-011-1128-0; Kroener S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037541; Langheinrich U, 2003, BIOESSAYS, V25, P904, DOI 10.1002/bies.10326; Le AD, 1999, NEUROPSYCHOPHARMACOL, V21, P435, DOI 10.1016/S0893-133X(99)00024-X; LEBLANC AE, 1969, J PHARMACOL EXP THER, V168, P244; Liu S, 2011, ANNU REV PATHOL-MECH, V6, P71, DOI 10.1146/annurev-pathol-011110-130330; Mathur P, 2011, BEHAV BRAIN RES, V219, P234, DOI 10.1016/j.bbr.2011.01.019; Mathur P, 2011, BEHAV BRAIN RES, V217, P128, DOI 10.1016/j.bbr.2010.10.015; Maximino C, 2011, PROG NEURO-PSYCHOPH, V35, P624, DOI 10.1016/j.pnpbp.2011.01.006; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; Miller NY, 2011, REV NEUROSCIENCE, V22, P17, DOI 10.1515/RNS.2011.004; Ninkovic J, 2006, METHODS, V39, P262, DOI 10.1016/j.ymeth.2005.12.007; Pham J, 2009, J NEUROSCI METH, V178, P323, DOI 10.1016/j.jneumeth.2008.12.021; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-130; Renninger SL, 2011, NEUROGENETICS, V12, P97, DOI 10.1007/s10048-011-0273-x; Sackerman James, 2010, Int J Comp Psychol, V23, P43; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Serra EL, 1999, BRAZ J MED BIOL RES, V32, P1551, DOI 10.1590/S0100-879X1999001200016; Silvers JM, 2003, ALCOHOL CLIN EXP RES, V27, P1606, DOI 10.1097/01.ALC.0000090141.66526.22; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Steenbergen PJ, 2011, BEHAV BRAIN RES, V222, P15, DOI 10.1016/j.bbr.2011.03.025; Tierney KB, 2011, BBA-MOL BASIS DIS, V1812, P381, DOI 10.1016/j.bbadis.2010.10.011; Ward RJ, 2009, ALCOHOL ALCOHOLISM, V44, P128, DOI 10.1093/alcalc/agn100; Wen XJ, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110204; World Health Organization, 2011, GLOB STAT REP ALC HL	50	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63319	10.1371/journal.pone.0063319	http://dx.doi.org/10.1371/journal.pone.0063319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675478	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100038
J	Kasmati, AR; Topel, M; Khan, NZ; Patel, R; Ling, QH; Karim, S; Aronsson, H; Jarvis, P				Kasmati, Ali Reza; Toepel, Mats; Khan, Nadir Zaman; Patel, Ramesh; Ling, Qihua; Karim, Sazzad; Aronsson, Henrik; Jarvis, Paul			Evolutionary, Molecular and Genetic Analyses of Tic22 Homologues in Arabidopsis thaliana Chloroplasts	PLOS ONE			English	Article							INNER ENVELOPE MEMBRANE; PROTEIN IMPORT RECEPTOR; IN-VIVO; INTERMEMBRANE SPACE; COMPONENTS; CHAPERONE; DATABASE; GENEVESTIGATOR; LOCALIZATION; TRANSLOCON	The Tic22 protein was previously identified in pea as a putative component of the chloroplast protein import apparatus. It is a peripheral protein of the inner envelope membrane, residing in the intermembrane space. In Arabidopsis, there are two Tic22 homologues, termed atTic22-III and atTic22-IV, both of which are predicted to localize in chloroplasts. These two proteins defined clades that are conserved in all land plants, which appear to have evolved at a similar rates since their separation >400 million years ago, suggesting functional conservation. The atTIC22-IV gene was expressed several-fold more highly than atTIC22-III, but the genes exhibited similar expression profiles and were expressed throughout development. Knockout mutants lacking atTic22-IV were visibly normal, whereas those lacking atTic22-III exhibited moderate chlorosis. Double mutants lacking both isoforms were more strongly chlorotic, particularly during early development, but were viable and fertile. Double-mutant chloroplasts were small and under-developed relative to those in wild type, and displayed inefficient import of precursor proteins. The data indicate that the two Tic22 isoforms act redundantly in chloroplast protein import, and that their function is non-essential but nonetheless required for normal chloroplast biogenesis, particularly during early plant development.	[Kasmati, Ali Reza; Toepel, Mats; Patel, Ramesh; Ling, Qihua; Jarvis, Paul] Univ Leicester, Dept Biol, Leicester, Leics, England; [Khan, Nadir Zaman; Karim, Sazzad; Aronsson, Henrik] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Leicester; University of Gothenburg	Jarvis, P (corresponding author), Univ Leicester, Dept Biol, Leicester, Leics, England.	rpj3@le.ac.uk	Zaman, Nadir/ABE-6560-2020	Zaman, Nadir/0000-0003-0405-2724; Ling, Qihua/0000-0002-6984-9921; Topel, Mats/0000-0001-7989-696X; Jarvis, Paul/0000-0003-2127-5671; Kasmati, Ali Reza/0000-0001-9694-8987	Swedish Research Council VR; Carl Tryggers Foundation; University of Malakand; Biotechnology and Biological Sciences Research Council (BBSRC); Royal Society Rosenheim Research Fellowship; BBSRC [BBS/B/03629, BBS/C006348/1, BB/D016541/1, BB/F020325/1, BB/H008039/1]; BBSRC [BB/J017256/1, BB/J009369/1, BB/J009369/2, BB/J017256/2, BB/K018442/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009369/2, BB/D016541/1, BB/H008039/1, BB/F020325/1, BB/K018442/1, BBS/B/03629, BB/J017256/1, BB/J017256/2, BB/J009369/1] Funding Source: researchfish	Swedish Research Council VR(Swedish Research Council); Carl Tryggers Foundation; University of Malakand; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Rosenheim Research Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Swedish Research Council VR (http://vr.se/) (to H. A.), the Carl Tryggers Foundation (http://www.carltryggersstiftelse.se/) (to H. A., M. T. and S. K.), by a PhD student fellowship from University of Malakand (to N.Z.), and by a Biotechnology and Biological Sciences Research Council (BBSRC; http://www.bbsrc.ac.uk/) PhD studentship, the Royal Society Rosenheim Research Fellowship (http://royalsociety.org/), and BBSRC grants BBS/B/03629, BBS/C006348/1, BB/D016541/1, BB/F020325/1 and BB/H008039/1 (to P.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Aronsson H, 2007, PLANT J, V52, P53, DOI 10.1111/j.1365-313X.2007.03207.x; Aronsson H, 2011, METHODS MOL BIOL, V774, P281, DOI 10.1007/978-1-61779-234-2_17; Aronsson H, 2010, PLANT J, V63, P297, DOI 10.1111/j.1365-313X.2010.04242.x; Baldwin A, 2005, PLANT PHYSIOL, V138, P715, DOI 10.1104/pp.105.063289; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Becker T, 2004, MOL BIOL CELL, V15, P5130, DOI 10.1091/mbc.E04-05-0405; Bedard J, 2007, J BIOL CHEM, V282, P21404, DOI 10.1074/jbc.M611545200; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; DAHLIN C, 1991, PLANT CELL, V3, P1131, DOI 10.1105/tpc.3.10.1131; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; Garcia C, 2010, PLANT J, V63, P73, DOI 10.1111/j.1365-313X.2010.04225.x; Glaser S, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405100; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang WH, 2011, PLANT PHYSIOL, V157, P147, DOI 10.1104/pp.111.181891; Jackson-Constan D, 2001, PLANT PHYSIOL, V125, P1567, DOI 10.1104/pp.125.4.1567; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Kaneko T, 1996, DNA Res, V3, P109; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kasmati AR, 2011, PLANT J, V66, P877, DOI 10.1111/j.1365-313X.2011.04551.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kouranov A, 1997, J CELL BIOL, V139, P1677, DOI 10.1083/jcb.139.7.1677; Kouranov A, 1999, J BIOL CHEM, V274, P25181, DOI 10.1074/jbc.274.35.25181; Kovacheva S, 2005, PLANT J, V41, P412, DOI 10.1111/j.1365-313X.2004.02307.x; Kovacheva S, 2007, PLANT J, V50, P364, DOI 10.1111/j.1365-313X.2007.03060.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Li M, 2006, J CELL BIOL, V175, P249, DOI 10.1083/jcb.200605162; Ling QH, 2012, SCIENCE, V338, P655, DOI 10.1126/science.1225053; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Rambaut A, 2007, TRACER V 1 4; Reumann S, 1999, TRENDS PLANT SCI, V4, P302, DOI 10.1016/S1360-1385(99)01449-1; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Rudolf M, 2013, MOL PLANT, V6, P817, DOI 10.1093/mp/sss114; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Shi LX, 2013, BBA-MOL CELL RES, V1833, P314, DOI 10.1016/j.bbamcr.2012.10.002; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Stanga JP, 2009, PLANT PHYSIOL, V149, P1896, DOI 10.1104/pp.109.135301; Topel M, 2012, PLANT SIGNAL BEHAV, V7, P161, DOI 10.4161/psb.18677; Tripp J, 2007, PLANT J, V52, P824, DOI 10.1111/j.1365-313X.2007.03279.x; Tripp J, 2012, J BIOL CHEM, V287, P24164, DOI 10.1074/jbc.M112.341644; Vojta L, 2007, FEBS J, V274, P5043, DOI 10.1111/j.1742-4658.2007.06023.x; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Wu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030288; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	60	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63863	10.1371/journal.pone.0063863	http://dx.doi.org/10.1371/journal.pone.0063863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675512	Green Submitted, Green Published, gold			2022-12-25	WOS:000319036100052
J	Guo, X; Zhang, ZZ; Zhang, F; Tao, YL; An, P; Wu, Q; Wang, CY; Knutson, MD; Wang, FD				Guo, Xin; Zhang, Zhuzhen; Zhang, Fan; Tao, Yunlong; An, Peng; Wu, Qian; Wang, Chia-Yu; Knutson, Mitchell D.; Wang, Fudi			Fine-Mapping and Genetic Analysis of the Loci Affecting Hepatic Iron Overload in Mice	PLOS ONE			English	Article							V-ATPASE; METABOLISM; EXPRESSION; HOMEOSTASIS; PARAMETERS; TRANSPORT; FERRITIN; DELIVERY; CELLS; MON1A	The liver, as the major organ for iron storage and production of hepcidin, plays pivotal roles in maintaining mammalian iron homeostasis. A previous study showed that Quantitative Trait Loci (QTLs) on chromosome 7 (Chr7) and 16 (Chr16) may control hepatic non-heme iron overload in an F2 intercross derived from C57BL/6J (B6) and SWR/J (SWR) mice. In this study, we aimed to validate the existence of these loci and identify the genes responsible for the phenotypic variations by generating congenic mice carrying SWR chromosome segments expanding these QTLs (D7Mit68-D7Mit71 and D16Mit125-D16Mit185, respectively). We excluded involvement of Chr7 based on the lack of iron accumulation in congenic mice. In contrast, liver iron accumulation was observed in Chr16 congenic mice. Through use of a series of subcongenic murine lines the interval on Chr16 was further fine-mapped to a 0.8 Mb segment spanning 11 genes. We found that the mRNA expression pattern in the liver remained unchanged for all 11 genes tested. Most importantly, we detected 4 missense mutations in 3 candidate genes including Sidt1 (P172R), Spice1(R708S), Boc (Q1051R) and Boc (S450-insertion in B6 allele) in the liver of SWR homozygous congenic mice. To further delineate potential modifier gene(s), we reconstituted seven candidate genes, Sidt1, Boc, Zdhhc23, Gramd1c, Atp6v1a, Naa50 and Gtpbp8, in mouse liver through hydrodynamic transfection. However, we were unable to detect significant changes in liver iron levels upon reconstitution of these candidate genes. Taken together, our work provides strong genetic evidence of the existence of iron modifiers on Chr16. Moreover, we were able to delineate the phenotypically responsible region to a 0.8 Mb region containing 11 coding genes, 3 of which harbor missense mutations, using a series of congenic mice.	[Guo, Xin; Zhang, Zhuzhen; Zhang, Fan; Tao, Yunlong; An, Peng; Wu, Qian] Chinese Acad Sci, Shanghai Key Lab Pediat Gastroenterol & Nutr, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China; [Guo, Xin; Zhang, Zhuzhen; Zhang, Fan; Tao, Yunlong; An, Peng; Wu, Qian; Wang, Fudi] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Publ Hlth, Dept Nutr,Inst Nutr & Food Safety, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Chia-Yu; Knutson, Mitchell D.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; State University System of Florida; University of Florida	Wang, FD (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Publ Hlth, Dept Nutr,Inst Nutr & Food Safety, Hangzhou 310003, Zhejiang, Peoples R China.	fwang@zju.edu.cn	Tao, Yunlong/I-8328-2019; Wang, Fudi/L-7888-2018; Wang, Chia-Yu/ABF-1758-2020; An, Peng/GWZ-9176-2022	Tao, Yunlong/0000-0003-0377-7133; Wang, Fudi/0000-0001-8730-0003; Wang, Chia-Yu/0000-0003-3679-6453; An, Peng/0000-0002-0421-0035; Zhang, Zhuzhen/0000-0001-6787-3920; Wu, Qian/0000-0003-3934-0128	Ministry of Science and Technology of China (973 Program) [2009CB941404, 2011CB966200, 2012BAD33B05]; National Natural Science Foundation of China [31225013, 31030039, 10979071, 30970665]; Science & Technology Commission of Shanghai Municipality [10JC1416800]	Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the research grants from the Ministry of Science and Technology of China (973 Program) (grant numbers 2009CB941404, 2011CB966200, 2012BAD33B05); The National Natural Science Foundation of China (grant numbers 31225013, 31030039, 10979071, 30970665); Science & Technology Commission of Shanghai Municipality grant (grant number 10JC1416800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Ajioka RS, 2007, BLOOD CELL MOL DIS, V39, P199, DOI 10.1016/j.bcmd.2007.03.007; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Bartnikas TB, 2012, MAMM GENOME, V23, P356, DOI 10.1007/s00335-012-9393-3; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; Bensaid M, 2004, GASTROENTEROLOGY, V126, P1400, DOI 10.1053/j.gastro.2004.01.021; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P483, DOI 10.1016/S0968-0004(00)01664-9; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Gao L, 2012, ACTA VIROL, V56, P25, DOI 10.4149/av_2012_01_25; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Gorman N, 1999, BIOCHEM PHARMACOL, V58, P375, DOI 10.1016/S0006-2952(99)00088-X; Grant GR, 2006, HEPATOLOGY, V44, P174, DOI 10.1002/hep.21233; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Horng JL, 2007, AM J PHYSIOL-REG I, V292, pR2068, DOI 10.1152/ajpregu.00578.2006; Jones BC, 2007, AM J PHYSIOL-REG I, V293, pR116, DOI 10.1152/ajpregu.00608.2006; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Mackenzie, 1999, BIOMEMBRANE TRANSPOR, P327; McCreedy RA, 2009, NUTR REV, V67, P607, DOI 10.1111/j.1753-4887.2009.00233.x; McLachlan S, 2011, PHYSIOL GENOMICS, V43, P136, DOI 10.1152/physiolgenomics.00025.2010; Nieland TJF, 2004, TRAFFIC, V5, P478, DOI 10.1111/j.1398-9219.2004.00193.x; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Pei JM, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-37; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Pratt AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033607; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Smith AG, 1997, BLOOD, V89, P1045, DOI 10.1182/blood.V89.3.1045; Stam LF, 1996, GENETICS, V144, P1559; Straud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011629; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Vanoaica L, 2010, CELL METAB, V12, P273, DOI 10.1016/j.cmet.2010.08.003; Wang FD, 2007, NAT GENET, V39, P1025, DOI 10.1038/ng2059; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Zhang Z, 2012, HEPATOLOGY; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324	48	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63280	10.1371/journal.pone.0063280	http://dx.doi.org/10.1371/journal.pone.0063280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675470	gold, Green Published, Green Submitted			2022-12-25	WOS:000318852400033
J	Main, H; Radenkovic, J; Jin, SB; Lendahl, U; Andersson, ER				Main, Heather; Radenkovic, Jelena; Jin, Shao-bo; Lendahl, Urban; Andersson, Emma R.			Notch Signaling Maintains Neural Rosette Polarity	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; RADIAL GLIAL IDENTITY; BINDING PROTEIN; TUBE CLOSURE; SELF-RENEWAL; APICAL CONSTRICTION; ASYMMETRIC DIVISION; VERTEBRATE EMBRYO	Formation of the metazoan body plan requires a complex interplay of morphological changes and patterning, and central to these processes is the establishment of apical/basal cell polarity. In the developing nervous system, apical/basal cell polarity is essential for neural tube closure and maintenance of the neural stem cell population. In this report we explore how a signaling pathway important for nervous system development, Notch signaling, impacts on apical/basal cell polarity in neural differentiation. CSL-/- mouse embryos, which are devoid of canonical Notch signaling, demonstrated a neural tube phenotype consistent with cell polarity and convergent extension defects, including deficiencies in the restricted expression of apical polarity markers in the neuroepithelium. CSL-/- mouse embryonic stem (ES) cells, cultured at low density, behaved as wild-type in the establishment of neural progenitors and apical specification, though progression through rosette formation, an in vitro correlate of neurulation, required CSL for correct maintenance of rosette structure and regulation of neuronal differentiation. Similarly, acute pharmacological inhibition of Notch signaling led to the breakdown of neural rosettes and accelerated neuronal differentiation. In addition to functional Notch signaling, rosette integrity was found to require actin polymerization and Rho kinase (ROCK) activity. Disruption of rosettes through inhibition of actin polymerization or ROCK activity, however, had no effect on neuronal differentiation, indicating that rosette maintenance is not a prerequisite for normal neuronal differentiation. In conclusion, our data indicate that Notch signaling plays a role not only in differentiation, but also in organization and maintenance of polarity during development of the early nervous system.	[Main, Heather; Radenkovic, Jelena; Jin, Shao-bo; Lendahl, Urban; Andersson, Emma R.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet	Main, H (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	h.main@physics.usyd.edu.au; emma.andersson@ki.se	Andersson, Emma R/J-4236-2012; Andersson, Emma/AAB-8532-2019	Andersson, Emma R/0000-0002-8608-625X; Andersson, Emma/0000-0002-8608-625X; Lendahl, Urban/0000-0001-9543-8141	Karolinska Institutet KID; Swedish Cancer Society; Swedish Research Council (DBRM); Swedish Research Council (Strategic Research Initiative in Stem Cells and Regenerative Medicine); EC project EuroSyStem; EC project NotchIT; Karolinska Institutet; Knut och Alice Wallenbergs Stiftelse (WIRM)	Karolinska Institutet KID; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council (DBRM)(Swedish Research Council); Swedish Research Council (Strategic Research Initiative in Stem Cells and Regenerative Medicine)(Swedish Research Council); EC project EuroSyStem; EC project NotchIT; Karolinska Institutet(Karolinska Institutet); Knut och Alice Wallenbergs Stiftelse (WIRM)(Knut & Alice Wallenberg Foundation)	This work was financially supported by Karolinska Institutet KID funding (HM), the Swedish Cancer Society, the Swedish Research Council (DBRM; the Strategic Research Initiative in Stem Cells and Regenerative Medicine), the EC projects EuroSyStem and NotchIT, Karolinska Institutet and Knut och Alice Wallenbergs Stiftelse (WIRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; ARTAVANISTSAKONAS S, 1983, P NATL ACAD SCI-BIOL, V80, P1977, DOI 10.1073/pnas.80.7.1977; Barsi JC, 2005, MECH DEVELOP, V122, P1106, DOI 10.1016/j.mod.2005.06.005; Boroviak T, 2010, STEM CELLS; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Chen YC, 2012, J NEUROSCI RES, V90, P1382, DOI 10.1002/jnr.23030; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Corbeil D, 2010, FEBS LETT, V584, P1659, DOI 10.1016/j.febslet.2010.01.050; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; De Marco P, 2011, BIOFACTORS; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; DESMOND ME, 1986, J EMBRYOL EXP MORPH, V97, P25; Doudney K, 2005, AM J MED GENET C, V135C, P42, DOI 10.1002/ajmg.c.30052; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Dunwoodie SL, 2002, DEVELOPMENT, V129, P1795; Egger B, 2011, FLY, V5, P237, DOI 10.4161/fly.5.3.15640; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Guzman-Ayala M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004268; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Ishiuchi T, 2011, NAT CELL BIOL, V13, P860, DOI 10.1038/ncb2274; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kinoshita N, 2008, MOL BIOL CELL, V19, P2289, DOI 10.1091/mbc.E07-12-1286; Kobayashi NR, 2010, MOL PSYCHIATR, V15, P672, DOI 10.1038/mp.2009.131; LEE H, 1985, TERATOLOGY, V31, P119, DOI 10.1002/tera.1420310114; Lee JD, 2007, DEVELOPMENT, V134, P2007, DOI 10.1242/dev.000885; Letizia A, 2011, J CELL SCI, V124, P240, DOI 10.1242/jcs.073601; Li T, 2003, J NEUROSCI, V23, P3272; Liu HA, 2010, J CLIN BIOCHEM NUTR, V47, P174, DOI 10.3164/jcbn.10-47; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Main H, 2010, EXP CELL RES, V316, P1610, DOI 10.1016/j.yexcr.2009.12.012; Malicki J, 1999, DEVELOPMENT, V126, P1235; Marthiens V, 2009, EMBO REP, V10, P515, DOI 10.1038/embor.2009.36; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Mitchell KJ, 2011, CURR OPIN NEUROBIOL, V21, P197, DOI 10.1016/j.conb.2010.08.009; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Ohata S, 2011, NEURON, V69, P215, DOI 10.1016/j.neuron.2010.12.026; OKA C, 1995, DEVELOPMENT, V121, P3291; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Ossipova O, 2009, DEV CELL, V17, P222, DOI 10.1016/j.devcel.2009.06.010; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Sathananthan AH, 2011, MICROSC MICROANAL, V17, P520, DOI 10.1017/S1431927611000584; Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wilson PG, 2006, STEM CELL REV, V2, P67, DOI 10.1385/SCR:2:1:67; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Ybot-Gonzalez P, 1999, DEV DYNAM, V215, P273, DOI 10.1002/(SICI)1097-0177(199907)215:3<273::AID-AJA9>3.0.CO;2-H; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Zecchini V, 1999, CURR BIOL, V9, P460, DOI 10.1016/S0960-9822(99)80211-5; Zhang XM, 2008, J NUTR SCI VITAMINOL, V54, P353, DOI 10.3177/jnsv.54.353; Zhang XM, 2012, NUTR NEUROSCI, V15, P55, DOI 10.1179/1476830511Y.0000000025	79	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62959	10.1371/journal.pone.0062959	http://dx.doi.org/10.1371/journal.pone.0062959			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675446	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400016
J	Xu, D; Zheng, H; Yu, WM; Qu, CK				Xu, Dan; Zheng, Hong; Yu, Wen-Mei; Qu, Cheng-Kui			Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder	PLOS ONE			English	Article							OF-FUNCTION MUTATION; GROWTH-FACTOR RECEPTOR; HEMATOPOIETIC STEM; MOUSE MODEL; LEUKEMIA; BINDING; GENE; MITOCHONDRIA; CHECKPOINT; DISTINCT	Gain of function (GOF) mutations in protein tyrosine phosphatase Ptpn11 have been identified in childhood leukemias, and these mutations are sufficient to drive the development of myeloproliferative disorder and malignant leukemias in mice. However, the molecular mechanisms by which Ptpn11 mutations induce these malignancies are not completely understood. Here we report that Ptpn11 GOF mutations cause cytokine hypersensitivity in hematopoietic cells partly by enhancing the production of reactive oxygen species (ROS). GOF mutations D61G or E76K in Ptpn11 increased ROS levels in myeloid progenitors but not in hematopoietic stem cells. Increased ROS enhanced cellular responses to cytokines by promoting cytokine signaling. Treatment with an antioxidant partially corrected cytokine hypersensitivity in Ptpn11 mutant progenitors. Further analyses demonstrated that Ptpn11 mutations increased mitochondrial aerobic metabolism by interacting with a novel substrate in the mitochondria. This study provides new insights into the pathogenic effects of GOF mutations of Ptpn11 and implies that antioxidants may have a therapeutic benefit for the leukemic patients with these mutations.	[Xu, Dan; Zheng, Hong; Yu, Wen-Mei; Qu, Cheng-Kui] Case Western Reserve Univ, Dept Med, Ctr Stem Cell & Regenerat Med, Div Hematol & Oncol,Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University	Qu, CK (corresponding author), Case Western Reserve Univ, Dept Med, Ctr Stem Cell & Regenerat Med, Div Hematol & Oncol,Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	cxq6@case.edu			National Institutes of Health [HL068212, DK092722]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants HL068212 and DK092722 (to C. K. Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, J BIOL CHEM, V278, P13952, DOI 10.1074/jbc.M210670200; Arachiche A, 2008, J BIOL CHEM, V283, P24406, DOI 10.1074/jbc.M709217200; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Araki T, 2009, P NATL ACAD SCI USA, V106, P4736, DOI 10.1073/pnas.0810053106; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Birnbaum RA, 2000, MOL CELL, V5, P189, DOI 10.1016/S1097-2765(00)80415-3; Carcamo JM, 2002, BLOOD, V99, P3205, DOI 10.1182/blood.V99.9.3205; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan G, 2011, BLOOD, V117, P4253, DOI 10.1182/blood-2010-11-319517; Chan G, 2009, BLOOD, V113, P4414, DOI 10.1182/blood-2008-10-182626; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Chughtai N, 2002, J BIOL CHEM, V277, P31107, DOI 10.1074/jbc.M200156200; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Gu HH, 1997, J BIOL CHEM, V272, P16421, DOI 10.1074/jbc.272.26.16421; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Jakob S, 2008, J BIOL CHEM, V283, P33155, DOI 10.1074/jbc.M805138200; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Lee I, 2010, BBA-MOL BASIS DIS, V1802, P275, DOI 10.1016/j.bbadis.2009.10.005; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Loh ML, 2004, LEUKEMIA, V18, P1831, DOI 10.1038/sj.leu.2403492; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Qu CK, 1998, MOL CELL BIOL, V18, P6075, DOI 10.1128/MCB.18.10.6075; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Salvi M, 2004, CELL MOL LIFE SCI, V61, P2393, DOI 10.1007/s00018-004-4211-z; Sattler M, 1999, BLOOD, V93, P2928; Shen JH, 2011, MOL CELL BIOL, V31, P4902, DOI 10.1128/MCB.05629-11; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wu TR, 2002, J BIOL CHEM, V22, P22; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Xu D, 2011, J EXP MED, V208, P1977, DOI 10.1084/jem.20110450; Xu D, 2010, BLOOD, V116, P3611, DOI 10.1182/blood-2010-01-265652; Yu WM, 2006, J BIOL CHEM, V281, P5426, DOI 10.1074/jbc.M507622200; Yu WM, 2003, ONCOGENE, V22, P5995, DOI 10.1038/sj.onc.1206846; Yuan LP, 2003, J BIOL CHEM, V278, P42812, DOI 10.1074/jbc.M305075200; Yuan LP, 2003, J BIOL CHEM, V278, P15208, DOI 10.1074/jbc.M211327200; Zhu HH, 2011, BLOOD, V117, P5350, DOI 10.1182/blood-2011-01-333476	47	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63152	10.1371/journal.pone.0063152	http://dx.doi.org/10.1371/journal.pone.0063152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675459	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400027
J	Bagchi, M; Kim, LA; Boucher, J; Walshe, TE; Kahn, CR; D'Amore, PA				Bagchi, Mandrita; Kim, Leo A.; Boucher, Jeremie; Walshe, Tony E.; Kahn, C. Ronald; D'Amore, Patricia A.			Vascular endothelial growth factor is important for brown adipose tissue development and maintenance	FASEB JOURNAL			English	Article						sFlt1; apoptosis; mitochondria; proliferation	MESSENGER-RNA EXPRESSION; VEGF-A; ADIPOCYTE DIFFERENTIATION; ANGIOGENESIS; INSULIN; CELLS; FAT; GENE; IDENTIFICATION; ACTIVATION	Vascular endothelial growth factor (VEGF) is critical for angiogenesis, but also has pleiotropic effects on several nonvascular cells. Our aim was to investigate the role of VEGF in brown adipose tissue (BAT). We show that VEGF expression increases 2.5-fold during differentiation of cultured murine brown adipocytes and that VEGF receptor-2 is phosphorylated, indicating VEGF signaling. VEGF increased proliferation in brown preadipocytes in vitro by 70%, and blockade of VEGF signaling using anti-VEGFR2 antibody DC101 increased brown adipocyte apoptosis, as determined by cell number and activation of caspase 3. Systemic VEGF neutralization in mice, accomplished by adenoviral expression of soluble Flt1, resulted in 7-fold increase in brown adipocyte apoptosis, mitochondrial degeneration, and increased mitophagy compared to control mice expressing a null adenovirus. Absence of the heparan sulfate-binding VEGF isoforms, VEGF164 and VEGF188, resulted in abnormal BAT development in mice at E15.5, with fewer brown adipocytes and lower mitochondrial protein compared to wild-type littermates. These results suggest a role for VEGF in brown adipocytes and preadipocytes to promote survival, proliferation, and normal mitochondria and development.Bagchi, M., Kim, L A., Boucher, J., Walshe, T. E., Kahn, C. R., D'Amore, P. A. Vascular endothelial growth factor is important for brown adipose tissue development and maintenance.	[Bagchi, Mandrita; D'Amore, Patricia A.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Dept Pathol, Boston, MA 02115 USA; [Kim, Leo A.; D'Amore, Patricia A.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Dept Ophthalmol, Boston, MA 02115 USA; [Boucher, Jeremie; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02115 USA; [Bagchi, Mandrita; Kim, Leo A.; Walshe, Tony E.; D'Amore, Patricia A.] Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	D'Amore, PA (corresponding author), Massachusetts Eye & Ear, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	patricia_damore@meei.harvard.edu	D'Amore, Patricia A/G-5660-2017; Kim, Leo/Y-3323-2018; Walshe, Tony/AAJ-8833-2020; Kahn, Ronald/AAY-2435-2021; Boucher, Jeremie/G-6602-2015	D'Amore, Patricia A/0000-0001-9652-8974; Kim, Leo/0000-0001-9106-6416; Kahn, Ronald/0000-0002-7583-9228; 	U.S. National Institutes of Health [EY15435, K12-EY16335]; NATIONAL EYE INSTITUTE [K12EY016335, R01EY015435] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health grants EY15435 (to P. A. D.) and K12-EY16335 (to L. K.). The authors acknowledge Dhanesh Amarnani for his technical assistance in the sFlt1 experiments.	Asano A, 2001, MOL CELL ENDOCRINOL, V174, P71, DOI 10.1016/S0303-7207(00)00450-0; Asano A, 1997, BIOCHEM J, V328, P179, DOI 10.1042/bj3280179; BARNARD T, 1969, J ULTRA MOL STRUCT R, V29, P311, DOI 10.1016/S0022-5320(69)90109-9; Boucher J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001173; BOUILLAUD F, 1994, EMBO J, V13, P1990, DOI 10.1002/j.1460-2075.1994.tb06468.x; Bryan BA, 2008, MOL BIOL CELL, V19, P994, DOI 10.1091/mbc.E07-09-0856; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; CIGOLINI M, 1986, J ANAT, V145, P207; Cinti S, 2007, ADIPOSE TISSUE ADIPO, P3, DOI [10.1007/978-1-59745-370-7_1, DOI 10.1007/978-1-59745-370-7_1]; CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Cypess AM, 2010, CURR OPIN PEDIATR, V22, P478, DOI 10.1097/MOP.0b013e32833a8d6e; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; dela Paz NG, 2009, CELL TISSUE RES, V335, P5, DOI 10.1007/s00441-008-0706-5; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ford KM, 2011, INVEST OPHTH VIS SCI, V52, P9478, DOI 10.1167/iovs.11-8353; Fredriksson JM, 2005, FEBS LETT, V579, P5680, DOI 10.1016/j.febslet.2005.09.044; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Jimenez M, 2002, FEBS LETT, V530, P37, DOI 10.1016/S0014-5793(02)03387-2; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Korac A, 2008, HISTOL HISTOPATHOL, V23, P441, DOI 10.14670/HH-23.441; Kuhn A, 2002, J INVEST DERMATOL, V119, P1388, DOI 10.1046/j.1523-1747.2002.19647.x; Maharaj ASR, 2008, J EXP MED, V205, P491, DOI 10.1084/jem.20072041; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Milosevic M., 2008, EMC 2008 14 EUR MICR, V3, P113; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Miranda S, 2010, CELL SIGNAL, V22, P645, DOI 10.1016/j.cellsig.2009.11.019; Miyazawa-Hoshimoto S, 2005, AM J PHYSIOL-ENDOC M, V288, pE1128, DOI 10.1152/ajpendo.00003.2004; NAPOLITANO L, 1963, J CELL BIOL, V18, P663, DOI 10.1083/jcb.18.3.663; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Ng YS, 2001, DEV DYNAM, V220, P112, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nieves BJ, 2009, BIOFACTORS, V35, P332, DOI 10.1002/biof.46; Nisoli E, 1997, CELL DEATH DIFFER, V4, P771, DOI 10.1038/sj.cdd.4400292; Patel-Hett S, 2011, INT J DEV BIOL, V55, P353, DOI 10.1387/ijdb.103213sp; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Seale P, 2009, DIABETES, V58, P1482, DOI 10.2337/db09-0622; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tonello C, 1999, FEBS LETT, V442, P167, DOI 10.1016/S0014-5793(98)01627-5; Xue Y, 2008, P NATL ACAD SCI USA, V105, P10167, DOI 10.1073/pnas.0802486105; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhang L, 2003, BIOCHEM BIOPH RES CO, V303, P1169, DOI 10.1016/S0006-291X(03)00495-9; Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983	61	60	64	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3257	3271		10.1096/fj.12-221812	http://dx.doi.org/10.1096/fj.12-221812			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23682123	Bronze, Green Published			2022-12-25	WOS:000329877600031
J	Eyre, DW; Walker, AS; Freeman, J; Baines, SD; Fawley, WN; Chilton, CH; Griffiths, D; Vaughan, A; Crook, DW; Peto, TEA; Wilcox, MH				Eyre, David W.; Walker, A. Sarah; Freeman, Jane; Baines, Simon D.; Fawley, Warren N.; Chilton, Caroline H.; Griffiths, David; Vaughan, Alison; Crook, Derrick W.; Peto, Tim E. A.; Wilcox, Mark H.			Short-Term Genome Stability of Serial Clostridium difficile Ribotype 027 Isolates in an Experimental Gut Model and Recurrent Human Disease	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; CHANGING EPIDEMIOLOGY; INFECTION; STRAINS	Background: Clostridium difficile whole genome sequencing has the potential to identify related isolates, even among otherwise indistinguishable strains, but interpretation depends on understanding genomic variation within isolates and individuals. Methods: Serial isolates from two scenarios were whole genome sequenced. Firstly, 62 isolates from 29 timepoints from three in vitro gut models, inoculated with a NAP1/027 strain. Secondly, 122 isolates from 44 patients (2-8 samples/patient) with mostly recurrent/on-going symptomatic NAP-1/027 C. difficile infection. Reference-based mapping was used to identify single nucleotide variants (SNVs). Results: Across three gut model inductions, two with antibiotic treatment, total 137 days, only two new SNVs became established. Pre-existing minority SNVs became dominant in two models. Several SNVs were detected, only present in the minority of colonies at one/two timepoints. The median (inter-quartile range) [ range] time between patients' first and last samples was 60 (29.5-118.5) [ 0-561] days. Within-patient C. difficile evolution was 0.45 SNVs/called genome/year (95% CI 0.00-1.28) and within-host diversity was 0.28 SNVs/called genome (0.05-0.53). 26/28 gut model and patient SNVs were non-synonymous, affecting a range of gene targets. Conclusions: The consistency of whole genome sequencing data from gut model C. difficile isolates, and the high stability of genomic sequences in isolates from patients, supports the use of whole genome sequencing in detailed transmission investigations.	[Eyre, David W.; Walker, A. Sarah; Griffiths, David; Vaughan, Alison; Crook, Derrick W.; Peto, Tim E. A.] John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 9DU, Oxon, England; [Freeman, Jane; Baines, Simon D.; Fawley, Warren N.; Chilton, Caroline H.; Wilcox, Mark H.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England	University of Oxford; University of Leeds	Eyre, DW (corresponding author), John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 9DU, Oxon, England.	david.eyre@ndm.ox.ac.uk	Eyre, David W/P-6887-2016; Walker, Sarah/HDM-8717-2022	Eyre, David W/0000-0001-5095-6367; peto, tim/0000-0003-3477-8307; Freeman, Jane/0000-0001-9580-4586	NIHR Oxford Biomedical Research Centre; UKCRC Modernising Medical Microbiology Consortium; UKCRC Translational Infection Research Initiative; Medical Research Council, Biotechnology and Biological Sciences Research Council; National Institute for Health Research on behalf of the Department of Health [G0800778]; Wellcome Trust [087646/Z/08/Z, 090532/Z/09/Z]; Optimer Pharmaceuticals; Actelion; Astellas; Biomerieux; Cubist; Pfizer; Summit; Medicines Company; MRC [G0800778] Funding Source: UKRI; Medical Research Council [G0800778] Funding Source: researchfish; National Institute for Health Research [DRF-2010-03-40, NF-SI-0508-10279, NF-SI-0512-10047] Funding Source: researchfish	NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); UKCRC Modernising Medical Microbiology Consortium; UKCRC Translational Infection Research Initiative; Medical Research Council, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research on behalf of the Department of Health; Wellcome Trust(Wellcome TrustEuropean Commission); Optimer Pharmaceuticals; Actelion; Astellas(Astellas Pharmaceuticals); Biomerieux; Cubist; Pfizer(Pfizer); Summit; Medicines Company; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the NIHR Oxford Biomedical Research Centre and the UKCRC Modernising Medical Microbiology Consortium, the latter funded under the UKCRC Translational Infection Research Initiative supported by Medical Research Council, Biotechnology and Biological Sciences Research Council and the National Institute for Health Research on behalf of the Department of Health [Grant G0800778] and the Wellcome Trust [Grant 087646/Z/08/Z]. The authors acknowledge the support of Wellcome Trust core funding [Grant 090532/Z/09/Z]. TEAP and DWC are NIHR Senior Investigators. DWE is a NIHR Doctoral Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The institution of DWC and TEAP received per-case funding from Optimer Pharmaceuticals to support fidaxomicin trial patient expenses. DWC and TEAP also received honoraria from Optimer Pharmaceuticals for participation in additional meetings related to investigative planning for fidaxomicin. MHW has received research support from Actelion, Astellas, Biomerieux, Cubist, Pfizer, Summit and The Medicines Company have funded research in the past 2 years. MHW has received consultancies and/or lecture honoraria in the past 2 years from Actelion, Astellas, Astra-Zeneca, Bayer, Cubist, Durata, J&J, Merck, Nabriva, Novacta, Novartis, Optimer, Pfizer, Sanofi-Pasteur, The Medicines Company, VH Squared, Viropharma. No other author has any conflict of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baines SD, 2012, 52 INT C ANT AG CHEM; Baines SD, 2009, J ANTIMICROB CHEMOTH, V63, P520, DOI 10.1093/jac/dkn502; Bakker D, 2010, J CLIN MICROBIOL, V48, P3744, DOI 10.1128/JCM.01171-10; Baldoni D, 2012, 52 INT C ANT AG CHEM; Best EL, 2012, GUT MICROBES, V3, P145, DOI 10.4161/gmic.19526; Chilton CH, 2012, J ANTIMICROB CHEMOTH, V67, P951, DOI 10.1093/jac/dkr584; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Dingle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019993; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Eyre DW, 2013, PLOS COMPUT IN PRESS; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Hensgens MPM, 2012, CLIN MICROBIOL INFEC, V18, P635, DOI 10.1111/j.1469-0691.2012.03853.x; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Lemee L, 2004, J CLIN MICROBIOL, V42, P2609, DOI 10.1128/JCM.42.6.2609-2617.2004; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; NEI M, 1986, MOL BIOL EVOL, V3, P418; Oliver A, 2010, CLIN MICROBIOL INFEC, V16, P798, DOI 10.1111/j.1469-0691.2010.03250.x; Prunier AL, 2005, J BACTERIOL, V187, P3455, DOI 10.1128/JB.187.10.3455-3464.2005; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rodrigo AG, 1999, EVOLUTION OF HIV, P233; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Walker AS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001172; Wilcox MH, 2012, CLIN INFECT DIS, V55, P1056, DOI 10.1093/cid/cis614	30	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63540	10.1371/journal.pone.0063540	http://dx.doi.org/10.1371/journal.pone.0063540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691061	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700044
J	Umeno, A; Shichiri, M; Ishida, N; Hashimoto, Y; Abe, K; Kataoka, M; Yoshino, K; Hagihara, Y; Aki, N; Funaki, M; Asada, Y; Yoshida, Y				Umeno, Aya; Shichiri, Mototada; Ishida, Noriko; Hashimoto, Yoshiko; Abe, Kaori; Kataoka, Masatoshi; Yoshino, Kohzoh; Hagihara, Yoshihisa; Aki, Nanako; Funaki, Makoto; Asada, Yasuhiko; Yoshida, Yasukazu			Singlet Oxygen Induced Products of Linoleates, 10-and 12-(Z,E)- Hydroxyoctadecadienoic Acids (HODE), Can Be Potential Biomarkers for Early Detection of Type 2 Diabetes	PLOS ONE			English	Article							PEROXIDATION IN-VIVO; HYDROXY FATTY-ACIDS; LIPID-PEROXIDATION; OXIDATIVE STRESS; GLUCOSE-INTOLERANCE; BETA-CELLS; PLASMA; ALPHA; ERYTHROCYTES; MELLITUS	Current diagnostic tests such as glycemic indicators have limitations for early detection of impaired glucose tolerance (IGT), which leads to diabetes. Oxidative stress induced by various oxidants in a random and destructive manner is considered to play an important role in the pathophysiology of a number of human disorders and diseases such as impaired glucose tolerance. We have developed an improved method for the measurement of in vivo lipid peroxidation, where the presence of 8-iso-prostaglandin F-2 alpha (8-iso-PGF(2 alpha)), hydroxyoctadecadienoic acids (HODEs), hydroxyeicosatetraenoic acids (HETEs), and 7-hydroxycholesterol (7-OHCh), as well as their parent molecules, linoleic acid (LA) and cholesterol (Ch), was determined by performing LC-MS/MS (for 8-iso-PGF(2 alpha), HODE, and HETE) and GC-MS (for 7-OHCh, LA, and Ch) after reduction with triphenyl phosphine and saponification by potassium hydroxide. We then applied this method to volunteers (n = 57), including normal type (n = 43), "high-normal'' (fasting plasma glucose, 100-109 mg/dL, n = 7), pre-diabetic type (IGT, n = 5), and diabetic type (n = 2) subjects who are diagnosed by performing oral glucose tolerance tests (OGTTs). Several biomarkers in plasma, such as insulin, leptin, adiponectin, interleukin-6, tumor necrosis factor-a, high sensitivity-C-reactive protein, HbA1c, and glucose levels were measured during OGTT. We found that the fasting levels of (10- and 12-(Z,E)-HODE)/LA increased significantly with increasing levels of HbA1c and glucose during OGTT and with insulin secretion and resistance index. In conclusion, 10-and 12-(Z,E)-HODE may be prominent biomarkers for the early detection of IGT and "high-normal'' type without OGTT.	[Umeno, Aya; Hashimoto, Yoshiko; Abe, Kaori; Kataoka, Masatoshi; Yoshida, Yasukazu] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa, Japan; [Shichiri, Mototada; Ishida, Noriko; Yoshino, Kohzoh; Hagihara, Yoshihisa] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka, Japan; [Aki, Nanako; Funaki, Makoto] Tokushima Univ Hosp, Clin Res Ctr Diabet, Tokushima, Japan; [Asada, Yasuhiko] Kagawa Univ, Fac Agr, Depertment Appl Biol Sci, Kita, Kagawa, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Tokushima University; Kagawa University	Shichiri, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka, Japan.	mototada-shichiri@aist.go.jp; yoshida-ya@aist.go.jp	Kataoka, Masatoshi/M-6925-2018; YOSHIDA, YASUKAZU/H-8510-2016; Shichiri, Mototada/L-9276-2018; HAGIHARA, Yoshihisa/K-4996-2016	Kataoka, Masatoshi/0000-0001-9779-8319; YOSHIDA, YASUKAZU/0000-0001-6034-2502; Shichiri, Mototada/0000-0003-1108-7597; HAGIHARA, Yoshihisa/0000-0002-5980-1764	Ministry of Education, Science, Sports and Culture [22300242]	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Science, Sports and Culture (22300242, 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Atli T, 2004, ARCH GERONTOL GERIAT, V39, P269, DOI 10.1016/j.archger.2004.04.065; Bachi A, 1996, FREE RADICAL BIO MED, V20, P619, DOI 10.1016/0891-5849(95)02087-X; Badway JA, 1988, J BIOL CHEM, V263, P9692; Basu S, 2004, FREE RADICAL RES, V38, P105, DOI 10.1080/10715760310001646895; Cho H, 2003, ANAL BIOCHEM, V318, P47, DOI 10.1016/S0003-2697(03)00140-4; Elbekai RH, 2006, PHARMACOL THERAPEUT, V112, P564, DOI 10.1016/j.pharmthera.2005.05.011; Ferderbar S, 2007, DIABETES-METAB RES, V23, P35, DOI 10.1002/dmrr.645; Fessel JP, 2002, P NATL ACAD SCI USA, V99, P16713, DOI 10.1073/pnas.252649099; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Georgiou HM, 2008, ACTA DIABETOL, V45, P157, DOI 10.1007/s00592-008-0037-8; Gniwotta C, 1997, ARTERIOSCL THROM VAS, V17, P3236, DOI 10.1161/01.ATV.17.11.3236; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hirashima Y, 2012, NEUROSURGERY, V70, P602, DOI 10.1227/NEU.0b013e3182333c69; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Inouye M, 1999, BBA-MOL CELL BIOL L, V1438, P204, DOI 10.1016/S1388-1981(99)00052-9; Jira W, 1998, CHEM PHYS LIPIDS, V91, P1, DOI 10.1016/S0009-3084(97)00095-9; Kadowaki Takashi, 2008, Journal of the Japan Diabetes Society, V51, P281; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; KANOFSKY JR, 1988, J BIOL CHEM, V263, P14171; Kitano S, 2007, ANAL CHIM ACTA, V585, P86, DOI 10.1016/j.aca.2006.12.032; Liu W, 2010, CHEM RES TOXICOL, V23, P986, DOI 10.1021/tx1000943; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Minami Y, 2008, FREE RADICAL RES, V42, P197, DOI 10.1080/10715760801948088; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; Miyamoto S, 2005, INTERNAL MED, V44, P1127, DOI 10.2169/internalmedicine.44.1127; Montine TJ, 2002, FREE RADICAL BIO MED, V33, P620, DOI 10.1016/S0891-5849(02)00807-9; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; MORROW JD, 1990, ANAL BIOCHEM, V184, P1, DOI 10.1016/0003-2697(90)90002-Q; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Obata T, 2000, J CHROMATOGR B, V746, P11, DOI 10.1016/S0378-4347(00)00182-1; Pereira EC, 2008, CLIN BIOCHEM, V41, P1454, DOI 10.1016/j.clinbiochem.2008.08.074; Pratico D, 1997, J CLIN INVEST, V100, P2028, DOI 10.1172/JCI119735; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Schwarzer E, 2003, BLOOD, V101, P722, DOI 10.1182/blood-2002-03-0979; Shichiri M, 2011, FREE RADICAL BIO MED, V50, P1801, DOI 10.1016/j.freeradbiomed.2011.03.023; Tanito M, 2007, INVEST OPHTH VIS SCI, V48, P396, DOI 10.1167/iovs.06-0872; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Wang MH, 1999, AM J PHYSIOL-RENAL, V276, pF246, DOI 10.1152/ajprenal.1999.276.2.F246; Yoshida Y, 2007, LIPIDS, V42, P439, DOI 10.1007/s11745-007-3037-5; Yoshida Y, 2006, BBA-GEN SUBJECTS, V1760, P1558, DOI 10.1016/j.bbagen.2006.06.007; Yoshida Y, 2006, BIOFACTORS, V27, P195, DOI 10.1002/biof.5520270117; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112; Yoshida Y, 2009, NEUROBIOL AGING, V30, P174, DOI 10.1016/j.neurobiolaging.2007.06.012	44	40	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63542	10.1371/journal.pone.0063542	http://dx.doi.org/10.1371/journal.pone.0063542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691063	gold, Green Published, Green Submitted			2022-12-25	WOS:000319052700045
J	Jia, YM; Li, RS; Cong, RH; Yang, XJ; Sun, QW; Parvizi, N; Zhao, RQ				Jia, Yimin; Li, Runsheng; Cong, Rihua; Yang, Xiaojing; Sun, Qinwei; Parvizi, Nahid; Zhao, Ruqian			Maternal Low-Protein Diet Affects Epigenetic Regulation of Hepatic Mitochondrial DNA Transcription in a Sex-Specific Manner in Newborn Piglets Associated with GR Binding to Its Promoter	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; INSULIN-RESISTANCE; METABOLIC-SYNDROME; GENE-EXPRESSION; SKELETAL-MUSCLE; RNA-SYNTHESIS; PREGNANT RATS; BIRTH-WEIGHT; IN-VIVO; LIVER	Mitochondrial oxidative phosphorylation (OXPHOS) plays an important role in energy homeostasis by controlling electron transfer and ATP generation. Maternal malnutrition during pregnancy affects mitochondrial (mt) DNA-encoded OXPHOS activity in offspring, yet it is unknown whether epigenetic mechanism is involved in the transcriptional regulation of mtDNA-encoded OXPHOS genes. In this study, 14 primiparous purebred Meishan sows were fed either standard-(SP, 12% crude protein) or low-protein (LP; 6% crude protein) diets throughout gestation, and the hepatic expression and transcriptional regulation of mtDNA-encoded OXPHOS genes were analyzed in newborn piglets. Maternal low protein diet decreased hepatic mtDNA copy number in males, but not in females. LP male piglets had significantly higher hepatic AMP concentration and low energy charge, which was accompanied by enhanced mRNA expression of NADH dehydrogenase subunits 6, cytochrome c oxidase subunit 1, 2, 3 and cytochrome b, as well as increased cytochrome c oxidase enzyme activity. In contrast, LP female piglets showed significantly lower hepatic AMP concentrations and higher energy charge with no alterations in OXPHOS gene expression. Moreover, LP males demonstrated higher glucocorticoid receptor (GR) binding to the mtDNA promoter compared with SP males, which was accompanied by lower cytosine methylation and hydroxymethylation on mtDNA promoter. Interestingly, opposite changes were seen in females, which showed diminished GR binding and enriched cytosine methylation and hydroxymethylation on mtDNA promoter. These results suggest that maternal low protein diet during pregnancy causes sex-dependent epigenetic alterations in mtDNA-encoded OXPHOS gene expression, possibly GR is involved in mtDNA transcription regulation.	[Jia, Yimin; Li, Runsheng; Cong, Rihua; Yang, Xiaojing; Sun, Qinwei; Zhao, Ruqian] Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China; [Cong, Rihua] Northwest A&F Univ, Coll Vet Med, Yangling, Shannxi, Peoples R China; [Parvizi, Nahid] FLI, Inst Anim Genet, Dept Funct Genom & Bioregulat, Neustadt, Germany	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Northwest A&F University - China; Friedrich Loeffler Institute	Zhao, RQ (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	zhao.ruqian@gmail.com	LI, Runsheng/AFR-9519-2022	LI, Runsheng/0000-0003-1563-1844	National Basic Research Program of China [2012CB124703]; Special Fund for Agro-scientific Research in the Public Interest [201003011]; National "948'' project [2013-S13]; Fundamental Research Funds for the Central Universities [KYZ200913]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; National "948'' project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions	This project was supported by the National Basic Research Program of China (2012CB124703), the Special Fund for Agro-scientific Research in the Public Interest (201003011), the National "948'' project (2013-S13), the Fundamental Research Funds for the Central Universities (KYZ200913) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Buchner DA, 2011, OBESITY, V19, P917, DOI 10.1038/oby.2010.214; Casas F, 1999, MOL CELL BIOL, V19, P7913; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Coletta DK, 2009, DIABETOLOGIA, V52, P723, DOI 10.1007/s00125-008-1256-9; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Delghingaro-Augusto V, 2004, J NUTR, V134, P321, DOI 10.1093/jn/134.2.321; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; Faulk C, 2011, EPIGENETICS-US, V6, P791, DOI 10.4161/epi.6.7.16209; Fernandez-Twinn DS, 2006, PHYSIOL BEHAV, V88, P234, DOI 10.1016/j.physbeh.2006.05.039; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gemma C, 2006, OBESITY, V14, P2193, DOI 10.1038/oby.2006.257; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Guevara R, 2009, FREE RADICAL BIO MED, V46, P169, DOI 10.1016/j.freeradbiomed.2008.09.035; Isganaitis E, 2009, DIABETES, V58, P1192, DOI 10.2337/db08-1266; James AM, 2012, TRENDS ENDOCRIN MET, V23, P429, DOI 10.1016/j.tem.2012.06.008; Jia YM, 2012, J NUTR, V142, P1659, DOI 10.3945/jn.112.160341; Jorgensen W, 2009, AM J PHYSIOL-ENDOC M, V297, pE1349, DOI 10.1152/ajpendo.00505.2009; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lattuada D, 2008, PLACENTA, V29, P1029, DOI 10.1016/j.placenta.2008.09.012; Burgueno AL, 2013, J NUTR BIOCHEM, V24, P6, DOI 10.1016/j.jnutbio.2011.12.008; Legato Marianne J, 2006, Gend Med, V3, P131, DOI 10.1016/S1550-8579(06)80202-0; Lesage J, 2001, ENDOCRINOLOGY, V142, P1692, DOI 10.1210/en.142.5.1692; Lillycrop KA, J NUTR, V135, P1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd LJ, 2012, J PHYSIOL-LONDON, V590, P377, DOI 10.1113/jphysiol.2011.220186; MANSOUR AM, 1970, NATURE, V228, P665, DOI 10.1038/228665a0; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; Misiak M, 2010, BBA-BIOENERGETICS, V1797, P1178, DOI 10.1016/j.bbabio.2010.04.009; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Nadal-Casellas A, 2010, CELL PHYSIOL BIOCHEM, V26, P291, DOI 10.1159/000320552; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; Nijland MJ, 2010, J PHYSIOL-LONDON, V588, P1349, DOI 10.1113/jphysiol.2009.184168; ONTKO JA, 1973, J LIPID RES, V14, P78; Oster M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021691; Pajuelo D, 2012, BRIT J NUTR, V107, P170, DOI 10.1017/S0007114511002728; Park HK, 2004, ANN NY ACAD SCI, V1011, P205, DOI 10.1196/annals.1293.021; Park KS, 2003, J NUTR, V133, P3085, DOI 10.1093/jn/133.10.3085; Piechota J, 2006, ACTA BIOCHIM POL, V53, P485; POND WG, 1969, J NUTR, V99, P61, DOI 10.1093/jn/99.1.61; POND WG, 1991, J NUTR, V121, P504, DOI 10.1093/jn/121.4.504; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Psarra AMG, 2011, BBA-MOL CELL RES, V1813, P1814, DOI 10.1016/j.bbamcr.2011.05.014; Razmara A, 2008, J PHARMACOL EXP THER, V325, P782, DOI 10.1124/jpet.107.134072; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; Rehfeldt C, 2011, J ANIM SCI, V89, P329, DOI 10.2527/jas.2010-2970; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; SANGILD PT, 1995, EXP PHYSIOL, V80, P147, DOI 10.1113/expphysiol.1995.sp003830; Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; SILVER M, 1989, Q J EXP PHYSIOL CMS, V74, P197, DOI 10.1113/expphysiol.1989.sp003255; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; SMITH DJ, 1976, J BIOL CHEM, V251, P4165; Theys N, 2009, AM J PHYSIOL-REG I, V297, pR1516, DOI 10.1152/ajpregu.00280.2009; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; VANITALLIE CM, 1988, MOL ENDOCRINOL, V2, P332, DOI 10.1210/mend-2-4-332; VERHOEVEN AJ, 1985, BIOCHEM J, V226, P183, DOI 10.1042/bj2260183; Vial G, 2010, ACTA BIOCHIM POL, V57, P389; Yamagata Y, 2009, HUM REPROD, V24, P1126, DOI 10.1093/humrep/dep015; YU FL, 1970, BIOCHIM BIOPHYS ACTA, V213, P134, DOI 10.1016/0005-2787(70)90014-6; Yuzefovych LV, 2012, ENDOCRINOLOGY, V153, P92, DOI 10.1210/en.2011-1442	64	37	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63855	10.1371/journal.pone.0063855	http://dx.doi.org/10.1371/journal.pone.0063855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691106	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400083
J	Liu, N; Wang, MX; Deng, W; Schmidt, CS; Qin, WH; Leonhardt, H; Spada, F				Liu, Nan; Wang, Mengxi; Deng, Wen; Schmidt, Christine S.; Qin, Weihua; Leonhardt, Heinrich; Spada, Fabio			Intrinsic and Extrinsic Connections of Tet3 Dioxygenase with CXXC Zinc Finger Modules	PLOS ONE			English	Article							ACTIVE DNA DEMETHYLATION; GENE-EXPRESSION; NUCLEAR FACTOR; SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; PROTEINS; BINDING; DOMAIN; 5-METHYLCYTOSINE; METHYLATION	Tet proteins are emerging as major epigenetic modulators of cell fate and plasticity. However, little is known about how Tet proteins are targeted to selected genomic loci in distinct biological contexts. Previously, a CXXC-type zinc finger domain in Tet1 was shown to bind CpG-rich DNA sequences. Interestingly, in human and mouse the Tet2 and Tet3 genes are adjacent to Cxxc4 and Cxxc10-1, respectively. The CXXC domains encoded by these loci, together with those in Tet1 and Cxxc5, identify a distinct homology group within the CXXC domain family. Here we provide evidence for alternative mouse Tet3 transcripts including the Cxxc10-1 sequence (Tet3 CXXC) and for an interaction between Tet3 and Cxxc4. In vitro Cxxc4 and the isolated CXXC domains of Tet1 and Tet3 CXXC bind DNA substrates with similar preference towards the modification state of cytosine at a single CpG site. In vivo Tet1 and Tet3 isoforms with and without CXXC domain hydroxylate genomic 5-methylcytosine with similar activity. Relative transcript levels suggest that distinct ratios of Tet3 CXXC isoforms and Tet3-Cxxc4 complex may be present in adult tissues. Our data suggest that variable association with CXXC modules may contribute to context specific functions of Tet proteins.	Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; Univ Munich, CIPSM, Planegg Martinsried, Germany	University of Munich; University of Munich	Spada, F (corresponding author), Univ Munich, Fac Chem & Pharm, Munich, Germany.	Fabio.Spada@cup.uni-muenchen.de	Leonhardt, Heinrich/B-2791-2014; Spada, Fabio/J-4354-2013; Deng, Wen/GQH-3160-2022	Spada, Fabio/0000-0002-7148-9013; Deng, Wen/0000-0003-3062-7843	Deutsche Forschungsgemeinschaft (DFG) [SFB 684, SPP 1463]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, SFB 684, and SPP 1463, http://www.dfg.de/en/index.jsp) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2009, J BIOL CHEM, V284, P3672, DOI 10.1074/jbc.M808119200; [Anonymous], 2005, Nat Methods, V2, P629; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dambacher S, 2012, NUCLEUS-PHILA, V3, P101, DOI 10.4161/nucl.18955; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016627; Frauer C, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1029; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; HANDYSIDE AH, 1989, ROUX ARCH DEV BIOL, V198, P48, DOI 10.1007/BF00376370; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Huang T, 2011, J BIOL CHEM, V286, P37399, DOI 10.1074/jbc.M111.251165; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Itoh K, 2005, J BIOL, V4; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Kallin EM, 2012, MOL CELL, V48, P266, DOI 10.1016/j.molcel.2012.08.007; Katoh M, 2004, INT J ONCOL, V25, P1193; Kim WT, 2012, EMBO J, V31, P3384, DOI 10.1038/emboj.2012.181; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Konstandin N, 2011, LEUKEMIA, V25, P1649, DOI 10.1038/leu.2011.134; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Mancini M, 2012, J CELL BIOCHEM, V113, P2765, DOI 10.1002/jcb.24154; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Michiue T, 2004, DEV DYNAM, V230, P79, DOI 10.1002/dvdy.20037; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nichols Jennifer, 2006, V329, P91; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Pendino F, 2009, BLOOD, V113, P3172, DOI 10.1182/blood-2008-07-170035; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200	64	34	36	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62755	10.1371/journal.pone.0062755	http://dx.doi.org/10.1371/journal.pone.0062755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690950	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400015
J	Seth, H; Grans, A; Sandblom, E; Olsson, C; Wiklander, K; Johnsson, JI; Axelsson, M				Seth, Henrik; Grans, Albin; Sandblom, Erik; Olsson, Catharina; Wiklander, Kerstin; Johnsson, Jorgen I.; Axelsson, Michael			Metabolic Scope and Interspecific Competition in Sculpins of Greenland Are Influenced by Increased Temperatures Due to Climate Change	PLOS ONE			English	Article							GLOBAL CLIMATE; PHYSIOLOGY; FISH; COVER; TELEOSTS; BEHAVIOR; ECOLOGY; SALMON	Ongoing climate change has led to an increase in sea surface temperatures of 2-4 degrees C on the west coast of Greenland. Since fish are ectothermic, metabolic rate increases with ambient temperature. This makes these animals particularly sensitive to changes in temperature; subsequently any change may influence their metabolic scope, i.e. the physiological capacity to undertake aerobically challenging activities. Any temperature increase may thus disrupt species-specific temperature adaptations, at both the molecular level as well as in behavior, and concomitant species differences in the temperature sensitivity may shift the competitive balance among coexisting species. We investigated the influence of temperature on metabolic scope and competitive ability in three species of marine sculpin that coexist in Greenland coastal waters. Since these species have different distribution ranges, we hypothesized that there should be a difference in their physiological response to temperature; hence we compared their metabolic scope at three temperatures (4, 9 and 14 degrees C). Their competitive ability at the ambient temperature of 9 degrees C was also tested in an attempt to link physiological capacity with behaviour. The Arctic staghorn sculpin, the species with the northernmost distribution range, had a lower metabolic scope in the higher temperature range compared to the other two species, which had similar metabolic scope at the three temperatures. The Arctic staghorn sculpin also had reduced competitive ability at 9 degrees C and may thus already be negatively affected by the current ocean warming. Our results suggest that climate change can have effects on fish physiology and interspecific competition, which may alter the species composition of the Arctic fish fauna.	[Seth, Henrik; Grans, Albin; Sandblom, Erik; Olsson, Catharina; Johnsson, Jorgen I.; Axelsson, Michael] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Wiklander, Kerstin] Univ Gothenburg, Dept Math Sci, Gothenburg, Sweden; [Seth, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Neurosci & Physiol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Seth, H (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	henrik.seth@bioenv.gu.se	Axelsson, Michael/D-1412-2009	Axelsson, Michael/0000-0002-7839-3233; Grans, Albin/0000-0003-0268-1199	Goteborg University Research Platform on Integrative Physiology (GRIP); Swedish Research Council; Helge Ax:son Johnsons foundation; Royal Society of Arts and Sciences; Wilhelm and Martina Lundgrens foundation	Goteborg University Research Platform on Integrative Physiology (GRIP); Swedish Research Council(Swedish Research CouncilEuropean Commission); Helge Ax:son Johnsons foundation; Royal Society of Arts and Sciences; Wilhelm and Martina Lundgrens foundation	This research was supported by Goteborg University Research Platform on Integrative Physiology (GRIP), the Swedish Research Council (www.VR.se), the Helge Ax:son Johnsons foundation, the Royal Society of Arts and Sciences and the Wilhelm and Martina Lundgrens foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDDOW TA, 1995, J EXP BIOL, V198, P203; Bradbury Jack W., 1998, pi; BRETT JR, 1971, AM ZOOL, V11, P99; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CLAIREAUX G, 1995, J EXP BIOL, V198, P49; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Clarke A, 2010, BIOL REV, V85, P703, DOI 10.1111/j.1469-185X.2010.00122.x; Erwin DH, 2009, CURR BIOL, V19, pR575, DOI 10.1016/j.cub.2009.05.047; Farrell AP, 2009, CAN J ZOOL, V87, P835, DOI 10.1139/Z09-092; Farrell AP, 1996, GLOBAL WARMING IMPLI, P135; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Folland CK, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P99; Hardewig I, 2004, J COMP PHYSIOL B, V174, P149, DOI 10.1007/s00360-003-0399-8; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Johnsson JI, 2004, BEHAV ECOL SOCIOBIOL, V56, P388, DOI 10.1007/s00265-004-0791-8; Killen SS, 2007, P ROY SOC B-BIOL SCI, V274, P431, DOI 10.1098/rspb.2006.3741; Magnuson JJ, 2002, FISHERIES CHANGING C, P283; MCLEAN EB, 1989, OIKOS, V55, P281, DOI 10.2307/3565586; Moring JR, 2001, NORTHEAST NAT, V8, P207, DOI 10.1656/1092-6194(2001)008[0207:AAPHOT]2.0.CO;2; Morris DW, 2011, P R SOC B, V278, P1; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; PRECHT H, 1955, TEMPERATUR LEBEN; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Reinhardt UG, 1997, CAN J ZOOL, V75, P1642, DOI 10.1139/z97-791; Richards JG, 2011, J EXP BIOL, V214, P191, DOI 10.1242/jeb.047951; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; STEFFENSEN JF, 1994, POLAR BIOL, V14, P49; Stegen JC, 2009, ECOL LETT, V12, P1001, DOI 10.1111/j.1461-0248.2009.01358.x; Temple GK, 1998, J EXP BIOL, V201, P317; White CR, 2011, P R SOC BIOL SCI, V7, P1740; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378	34	20	20	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62859	10.1371/journal.pone.0062859	http://dx.doi.org/10.1371/journal.pone.0062859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690960	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400021
J	Liu, Y; Guo, YB; An, S; Kuang, YY; He, X; Ma, HJ; Li, JF; Lv, J; Zhang, N; Jiang, C				Liu, Yang; Guo, Yubo; An, Sai; Kuang, Yuyang; He, Xi; Ma, Haojun; Li, Jianfeng; Lv, Jing; Zhang, Ning; Jiang, Chen			Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							ACTIVATION; MICROGLIA; APOPTOSIS; SYSTEM; DEATH	The activation of caspase-3 is an important hallmark in Parkinson's disease. It could induce neuron death by apoptosis and microglia activation by inflammation. As a result, inhibition the activation of caspase-3 would exert synergistic dual effect in brain in order to prevent the progress of Parkinson's disease. Silencing caspase-3 genes by RNA interference could inhibit the activation of caspase-3. We developed a brain-targeted gene delivery system based on non-viral gene vector, dendrigraft poly-L-lysines. A rabies virus glycoprotein peptide with 29 amino-acid linked to dendrigraft poly-L-lysines could render gene vectors the ability to get across the blood brain barrier by specific receptor mediated transcytosis. The resultant brain-targeted vector was complexed with caspase-3 short hairpin RNA coding plasmid DNA, yielding nanoparticles. In vivo imaging analysis indicated the targeted nanoparticles could accumulate in brain more efficiently than non-targeted ones. A multiple dosing regimen by weekly intravenous administration of the nanoparticles could reduce activated casapse-3 levels, significantly improve locomotor activity and rescue dopaminergic neuronal loss and in Parkinson's disease rats' brain. These results indicated the rabies virus glycoprotein peptide modified brain-targeted nanoparticles were promising gene delivery system for RNA interference to achieve anti-apoptotic and anti-inflammation synergistic therapeutic effects by down-regulation the expression and activation of caspase-3.	[Liu, Yang; Guo, Yubo; An, Sai; Kuang, Yuyang; He, Xi; Ma, Haojun; Li, Jianfeng; Jiang, Chen] Fudan Univ, Minist Educ, Key Lab Smart Drug Delivery, Shanghai 200433, Peoples R China; [Liu, Yang; Guo, Yubo; An, Sai; Kuang, Yuyang; He, Xi; Ma, Haojun; Li, Jianfeng; Jiang, Chen] Fudan Univ, Sch Pharm, PLA, Shanghai 200433, Peoples R China; [Lv, Jing; Zhang, Ning] Caliper, Dept Life Sci & Technol, Alameda, CA USA	Fudan University; Fudan University	Jiang, C (corresponding author), Fudan Univ, Minist Educ, Key Lab Smart Drug Delivery, Shanghai 200433, Peoples R China.	jiangchen@shmu.edu.cn	An, Sai/N-3596-2017		National Natural Foundation of China [30973652]; Program for New Century Excellent Talents in University;  [20110071110048]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 	This work was supported by the grant from National Natural Foundation of China (30973652), Program for New Century Excellent Talents in University and Funding for doctoral discipline in high education university (20110071110048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouz M, 2002, J NEUROSCI, V22, P10302; Bashkatova V, 2004, EXP NEUROL, V186, P235, DOI 10.1016/j.expneurol.2003.12.005; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bjorklund A, 2010, PROG BRAIN RES, V184, P237, DOI 10.1016/S0079-6123(10)84013-0; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Burke RE, 2010, PROG BRAIN RES, V183, P79, DOI 10.1016/S0079-6123(10)83005-5; Carvey PM, 2006, CELL TRANSPLANT, V15, P239, DOI 10.3727/000000006783981990; Cottet H, 2007, BIOMACROMOLECULES, V8, P3235, DOI 10.1021/bm070268j; Denyer R, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/757305; Fahn S, 2006, J NEURAL TRANSM-SUPP, P1; Gao Y, 2011, BIOMATERIALS, V32, P1738, DOI 10.1016/j.biomaterials.2010.11.001; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; Huang RQ, 2010, J NEUROL SCI, V290, P123, DOI 10.1016/j.jns.2009.09.032; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Liu Y, 2012, J CONTROL RELEASE, V163, P203, DOI 10.1016/j.jconrel.2012.09.001; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Lou JN, 1998, EUR J IMMUNOL, V28, P3989, DOI 10.1002/(SICI)1521-4141(199812)28:12&lt;3989::AID-IMMU3989&gt;3.0.CO;2-X; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Ravenstijn PGM, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-4; Sherer TB, 2003, NEUROSCI LETT, V341, P87, DOI 10.1016/S0304-3940(03)00172-1; Sherer TB, 2002, NEUROSCIENTIST, V8, P192, DOI 10.1177/1073858402008003004; Sherer TB, 2002, J NEUROSCI, V22, P7006; Tsogas I, 2007, BIOMACROMOLECULES, V8, P3263, DOI 10.1021/bm700668w; Wood MJA, 2003, HUM MOL GENET, V12, pR279, DOI 10.1093/hmg/ddg275; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhao XW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046302, 10.1371/journal.pone.0029935]	28	43	44	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62905	10.1371/journal.pone.0062905	http://dx.doi.org/10.1371/journal.pone.0062905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675438	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100019
J	Lu, SG; Le, S; Tan, YL; Zhu, JM; Li, M; Rao, XC; Zou, LY; Li, S; Wang, J; Jin, XL; Huang, GT; Zhang, L; Zhao, X; Hu, FQ				Lu, Shuguang; Le, Shuai; Tan, Yinling; Zhu, Junmin; Li, Ming; Rao, Xiancai; Zou, Lingyun; Li, Shu; Wang, Jing; Jin, Xiaolin; Huang, Guangtao; Zhang, Lin; Zhao, Xia; Hu, Fuquan			Genomic and Proteomic Analyses of the Terminally Redundant Genome of the Pseudomonas aeruginosa Phage PaP1: Establishment of Genus PaP1-Like Phages	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; BACTERIOPHAGE; DATABASE; THERAPY; GENES; DNA; RESEMBLES; COREGENES; TOOL	We isolated and characterized a new Pseudomonas aeruginosa myovirus named PaP1. The morphology of this phage was visualized by electron microscopy and its genome sequence and ends were determined. Finally, genomic and proteomic analyses were performed. PaP1 has an icosahedral head with an apex diameter of 68-70 nm and a contractile tail with a length of 138-140 nm. The PaP1 genome is a linear dsDNA molecule containing 91,715 base pairs (bp) with a G+C content of 49.36% and 12 tRNA genes. A strategy to identify the genome ends of PaP1 was designed. The genome has a 1190 bp terminal redundancy. PaP1 has 157 open reading frames (ORFs). Of these, 143 proteins are homologs of known proteins, but only 38 could be functionally identified. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and high-performance liquid chromatography-mass spectrometry allowed identification of 12 ORFs as structural protein coding genes within the PaP1 genome. Comparative genomic analysis indicated that the Pseudomonas aeruginosa phage PaP1, JG004, PAK_P1 and vB_PaeM_C2-10_Ab1 share great similarity. Besides their similar biological characteristics, the phages contain 123 core genes and have very close phylogenetic relationships, which distinguish them from other known phage genera. We therefore propose that these four phages be classified as PaP1-like phages, a new phage genus of Myoviridae that infects Pseudomonas aeruginosa.	[Lu, Shuguang; Le, Shuai; Tan, Yinling; Zhu, Junmin; Li, Ming; Rao, Xiancai; Zou, Lingyun; Li, Shu; Wang, Jing; Jin, Xiaolin; Huang, Guangtao; Zhang, Lin; Zhao, Xia; Hu, Fuquan] Third Mil Med Univ, Coll Basic Med Sci, Dept Microbiol, Chongqing, Peoples R China	Army Medical University	Hu, FQ (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Microbiol, Chongqing, Peoples R China.	hufuquan2009@yahoo.cn	Rao, Xiancai/F-3033-2012	Rao, Xiancai/0000-0002-9905-760X; Le, Shuai/0000-0003-3748-5454	National Natural Science Foundation of China [31070153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 31070153 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon S, 2011, ADV APPL MICROBIOL, V77, P1, DOI 10.1016/B978-0-12-387044-5.00001-7; Ackermann HW, 2012, ARCH VIROL, V157, P1843, DOI 10.1007/s00705-012-1383-y; Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bamford DH, 2005, CURR OPIN STRUC BIOL, V15, P655, DOI 10.1016/j.sbi.2005.10.012; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Bonomo RA, 2006, CLIN INFECT DIS, V43, pS49, DOI 10.1086/504477; BOWDEN DW, 1985, J BIOL CHEM, V260, P6999; BRAVO A, 1990, NUCLEIC ACIDS RES, V18, P2881, DOI 10.1093/nar/18.10.2881; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Casas V, 2007, METHOD ENZYMOL, V421, P259, DOI 10.1016/S0076-6879(06)21020-6; Casjens S, 1992, SEMINARS VIROLOGY, V3, P383; Ceyssens PJ, 2008, VIROLOGY, V377, P233, DOI 10.1016/j.virol.2008.04.038; Ceyssens PJ, 2010, FUTURE MICROBIOL, V5, P1041, DOI 10.2217/FMB.10.66; Ceyssens PJ, 2009, ENVIRON MICROBIOL, V11, P2874, DOI 10.1111/j.1462-2920.2009.02030.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Ciprandi G, 2008, INT IMMUNOPHARMACOL, V8, P1622, DOI 10.1016/j.intimp.2008.07.007; d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373; de la Bastide Melissa, 2007, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1104s17; Debarbieux L, 2008, MED MALADIES INFECT, V38, P421, DOI 10.1016/j.medmal.2008.06.014; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; Diard M, 2010, J BACTERIOL, V192, P4885, DOI 10.1128/JB.00804-10; Eyer L, 2007, PROTEOMICS, V7, P64, DOI 10.1002/pmic.200600280; Garbe J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-301; Garbe J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-102; Govind R, 2006, J BACTERIOL, V188, P2568, DOI 10.1128/JB.188.7.2568-2577.2006; Grigoriev A, 1999, VIRUS RES, V60, P1, DOI 10.1016/S0168-1702(98)00139-7; Hendrix RW, 2003, CURR OPIN MICROBIOL, V6, P506, DOI 10.1016/j.mib.2003.09.004; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hertveldt K, 2005, J MOL BIOL, V354, P536, DOI 10.1016/j.jmb.2005.08.075; JUST W, 1990, J GEN VIROL, V71, P2157, DOI 10.1099/0022-1317-71-9-2157; Keppel F, 1988, STRATEGIES BACTERIOP, P145; Kimelman A, 2012, GENOME RES, V22, P802, DOI 10.1101/gr.133850.111; Klumpp J, 2008, J BACTERIOL, V190, P5753, DOI 10.1128/JB.00461-08; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006; Lima-Mendez G, 2007, VIROLOGY, V365, P241, DOI 10.1016/j.virol.2007.03.047; Mahadevan Padmanabhan, 2009, International Journal of Computational Biology and Drug Design, V2, P100; Manoharadas S, 2009, J BIOTECHNOL, V139, P118, DOI 10.1016/j.jbiotec.2008.09.003; Mesyanzhinov VV, 2002, J MOL BIOL, V317, P1, DOI 10.1006/jmbi.2001.5396; Moak M, 2004, MOL MICROBIOL, V51, P1169, DOI 10.1046/j.1365-2958.2003.03894.x; Monod C, 1997, J MOL BIOL, V267, P237, DOI 10.1006/jmbi.1996.0867; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Nakayama K, 1999, MOL MICROBIOL, V31, P399, DOI 10.1046/j.1365-2958.1999.01158.x; Pajunen MI, 2001, J BACTERIOL, V183, P1928, DOI 10.1128/JB.183.6.1928-1937.2001; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rosseel T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041967; Sambrook J, 2001, MOL CLONING LAB MANU; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Skurnik M, 2006, INT J MED MICROBIOL, V296, P5, DOI 10.1016/j.ijmm.2005.09.002; Som A, 2009, MOL PHYLOGENET EVOL, V52, P846, DOI 10.1016/j.ympev.2009.05.025; Stewart CR, 1998, VIROLOGY, V246, P329, DOI 10.1006/viro.1998.9197; Sun WZ, 2010, AFR J MICROBIOL RES, V4, P933; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan YL, 2007, CELL MICROBIOL, V9, P479, DOI 10.1111/j.1462-5822.2006.00804.x; Twort A, 1993, FOCUS OUT STEP BIOGR, Vxi; Uchiyama J, 2012, ARCH VIROL, V157, P733, DOI 10.1007/s00705-011-1210-x; Welker M, 2007, J MASS SPECTROM, V42, P1062, DOI 10.1002/jms.1237; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Williams EA, 2009, MOL ECOL, V18, P4434, DOI 10.1111/j.1365-294X.2009.04371.x; Wu HY, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-54; WU R, 1971, J MOL BIOL, V57, P491, DOI 10.1016/0022-2836(71)90105-7; Zafar N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-12; Zhang YZ, 2007, J VIROL, V81, P7662, DOI 10.1128/JVI.00186-07; Zheng ZL, 2011, NAT PROTOC, V6, P1367, DOI 10.1038/nprot.2011.369	66	50	61	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62933	10.1371/journal.pone.0062933	http://dx.doi.org/10.1371/journal.pone.0062933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675441	Green Submitted, Green Published, gold			2022-12-25	WOS:000319036100022
J	Minato, Y; Fassio, SR; Hase, CC				Minato, Yusuke; Fassio, Sara R.; Haese, Claudia C.			Malonate Inhibits Virulence Gene Expression in Vibrio cholerae	PLOS ONE			English	Article							CARBON METABOLISM; TOXR REGULON; PROTEIN; COLONIZATION; ACTIVATION; SEQUENCE; ACETATE; CASCADE; APHA	We previously found that inhibition of the TCA cycle, either through mutations or chemical inhibition, increased toxT transcription in Vibrio cholerae. In this study, we found that the addition of malonate, an inhibitor of succinate dehydrogenase (SDH), decreased toxT transcription in V. cholerae, an observation inconsistent with the previous pattern observed. Unlike another SDH inhibitor, 2-thenoyltrifluoroacetone (TTFA), which increased toxT transcription and slightly inhibited V. cholerae growth, malonate inhibited toxT transcription in both the wild-type strain and TCA cycle mutants, suggesting malonate-mediated inhibition of virulence gene expression is independent to TCA cycle activity. Addition of malonate also inhibited ctxB and tcpA expressions but did not affect aphA, aphB, tcpP and toxR expressions. Malonate inhibited cholera toxin (CT) production in both V. cholerae classical biotype strains O395N1 and CA401, and El Tor biotype strain, N16961. Consistent with previous reports, we confirmed that these strains of V. cholerae did not utilize malonate as a primary carbon source. However, we found that the addition of malonate to the growth medium stimulated V. cholerae growth. All together, these results suggest that metabolizing malonate as a nutrient source negatively affects virulence gene expression in V. cholerae.	[Minato, Yusuke; Haese, Claudia C.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Fassio, Sara R.; Haese, Claudia C.] Oregon State Univ, Dept Microbiol, Coll Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Hase, CC (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	hasec@science.oregonstate.edu	Minato, Yusuke/B-9510-2018	Minato, Yusuke/0000-0002-0888-8564	National Institutes of Health [AI-063121-02]; Medical Research Foundation (MRF) from OHSU Foundation; Undergraduate Research, Innovation, Scholarship & Creativity fund; OSU Howard Hughes Medical Institute Summer Undergraduate Research Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Foundation (MRF) from OHSU Foundation; Undergraduate Research, Innovation, Scholarship & Creativity fund; OSU Howard Hughes Medical Institute Summer Undergraduate Research Program	This research was supported by grants from the National Institutes of Health to C. C. H. (AI-063121-02) and by the Medical Research Foundation (MRF) from OHSU Foundation. S. R. F. was partially supported by the Undergraduate Research, Innovation, Scholarship & Creativity fund and the OSU Howard Hughes Medical Institute Summer Undergraduate Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Bogard RW, 2012, MBIO, V3, DOI 10.1128/mBio.00236-12; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; CHIANG SL, 1995, MOL MICROBIOL, V17, P1133, DOI 10.1111/j.1365-2958.1995.mmi_17061133.x; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Dimroth P, 1997, MOL MICROBIOL, V25, P3, DOI 10.1046/j.1365-2958.1997.4611824.x; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; GARDEL CL, 1994, METHOD ENZYMOL, V235, P517; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Hase CC, 1998, P NATL ACAD SCI USA, V95, P730, DOI 10.1073/pnas.95.2.730; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Hoenke S, 1997, EUR J BIOCHEM, V246, P530, DOI 10.1111/j.1432-1033.1997.00530.x; IWANAGA M, 1987, J CLIN MICROBIOL, V25, P2314, DOI 10.1128/JCM.25.12.2314-2316.1987; IWANAGA M, 1985, J CLIN MICROBIOL, V22, P405, DOI 10.1128/JCM.22.3.405-408.1985; Kim YS, 2002, J BIOCHEM MOL BIOL, V35, P443; Kovacikova G, 1999, J BACTERIOL, V181, P4250, DOI 10.1128/JB.181.14.4250-4256.1999; Lee KM, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394932; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Minato Y, 2013, MICROBIOLOG IN PRESS; Minato Y, 2011, J BACTERIOL, V193, P5850, DOI 10.1128/JB.05222-11; Patra T, 2012, J BACTERIOL, V194, P3377, DOI 10.1128/JB.06379-11; PETERSON KM, 1988, INFECT IMMUN, V56, P2822, DOI 10.1128/IAI.56.11.2822-2829.1988; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; Ray S, 2011, INFECT IMMUN, V79, P258, DOI 10.1128/IAI.00663-10; Rogosa M., 1984, BERGEYS MANUAL SYSTE; ROSE IA, 1954, J BIOL CHEM, V211, P737; SCHNEIDER DR, 1978, J INFECT DIS, V138, P143, DOI 10.1093/infdis/138.2.143; SHAW CE, 1990, INFECT IMMUN, V58, P3042, DOI 10.1128/IAI.58.9.3042-3049.1990; Skorupski K, 1999, MOL MICROBIOL, V31, P763, DOI 10.1046/j.1365-2958.1999.01215.x; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Vanden Broeck D, 2007, INT J BIOCHEM CELL B, V39, P1771, DOI 10.1016/j.biocel.2007.07.005; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002	35	7	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63336	10.1371/journal.pone.0063336	http://dx.doi.org/10.1371/journal.pone.0063336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675480	gold, Green Submitted, Green Published			2022-12-25	WOS:000319036100039
J	Freeman, EE; Roy-Gagnon, MH; Samson, E; Haddad, S; Aubin, MJ; Vela, C; Zunzunegui, MV				Freeman, Ellen E.; Roy-Gagnon, Marie-Helene; Samson, Elodie; Haddad, Slim; Aubin, Marie-Josee; Vela, Claudia; Zunzunegui, Maria Victoria			The Global Burden of Visual Difficulty in Low, Middle, and High Income Countries	PLOS ONE			English	Article							EYE CARE UTILIZATION; IMPAIRMENT; RISK; CATARACT; PREVALENCE; HEALTH; IMPACT	Purpose: Using a world-wide, population-based dataset of adults, we sought to determine the frequency of far visual difficulty and its associated risk factors. Methods: The World Health Survey (WHS) was conducted in 70 countries throughout the world in 2003 using a random, multi-stage, stratified, cluster sampling design of adults ages 18 years and older. Far vision was assessed by asking "In the last 30 days, how much difficulty did you have in seeing and recognizing a person you know across the road (i.e. from a distance of about 20 meters)?". Responses included none, mild, moderate, severe, or extreme/unable. The income status of countries was estimated using gross national income per capita data from 2003 from the World Bank. Prevalence and regression estimates were adjusted to account for the complex sample design. Results: 21% of adults reported any visual difficulty. The rate varied by the income status of the country with the percentage who had any visual difficulty being 24%, 23%, and 13% in low, middle, and high income countries, respectively. Five percent of people reported severe or extreme visual difficulty with rates in low, middle, and high income countries of 6%, 5%, and 2% respectively. Risk factors for visual difficulty included older age, female sex, poorer socioeconomic status, little to no formal education, and diabetes (P<0.05). Conclusions: One out of five adults in the WHS reported some degree of far visual difficulty. Given the importance of vision to living an independent life, better access to quality eye care services and life course factors affecting vision health (e. g. repeated eye infections, diet lacking vitamin A) must receive adequate attention and resources, especially in low and middle income countries.	[Freeman, Ellen E.; Aubin, Marie-Josee] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada; [Freeman, Ellen E.; Roy-Gagnon, Marie-Helene; Samson, Elodie; Aubin, Marie-Josee; Vela, Claudia] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada; [Haddad, Slim; Zunzunegui, Maria Victoria] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Freeman, EE (corresponding author), Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada.	eefreeman@gmail.com	Aubin, Marie-Josée/AAI-9745-2020	Roy-Gagnon, Marie-Helene/0000-0001-8747-0846; Freeman, Ellen/0000-0002-1403-8427; Zunzunegui, Maria-Victoria/0000-0003-0827-2804	CIHR [MOP 106533]; Department of Ophthalmology at Universite de Montreal	CIHR(Canadian Institutes of Health Research (CIHR)); Department of Ophthalmology at Universite de Montreal	This work was supported by CIHR grant MOP 106533 and funds from the Department of Ophthalmology at Universite de Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Bank W, 2003, GNI PER CAPITA; Cho EY, 2004, ARCH OPHTHALMOL-CHIC, V122, P883, DOI 10.1001/archopht.122.6.883; Christen WG, 2005, AM J CLIN NUTR, V81, P1417; Cockburn N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030718; Coffeng LE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002032; Eusebio C, 2007, BRIT J OPHTHALMOL, V91, P1588, DOI 10.1136/bjo.2007.119123; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Freeman EE, 2007, OPHTHALMOLOGY; Freeman EE, 2010, OPHTHAL EPIDEMIOL, V17, P301, DOI 10.3109/09286586.2010.508354; Glover SJ, 2012, BRIT J OPHTHALMOL, V96, P156, DOI 10.1136/bjo.2010.196071; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Hosseinpoor AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042843; Jacques PF, 2001, ARCH OPHTHALMOL-CHIC, V119, P1009, DOI 10.1001/archopht.119.7.1009; Janz NK, 2001, OPHTHALMOLOGY, V108, P887, DOI 10.1016/S0161-6420(00)00624-2; Klein B E, 1999, Ophthalmic Epidemiol, V6, P49; Lamoureux EL, 2011, CURR OPIN OPHTHALMOL, V22, P19, DOI 10.1097/ICU.0b013e3283414284; Loerbroks A, 2012, INT J EPIDEMIOL, V41, P1436, DOI 10.1093/ije/dys123; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227; Mechakra-Tahiri SD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-598; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Ojofeitimi E. O., 1999, Nutrition and Health (Bicester), V13, P61; Orr P, 1999, OPHTHALMOLOGY, V106, P904, DOI 10.1016/S0161-6420(99)00508-4; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Roba AA, 2011, J EPIDEMIOL COMMUN H, V65, P626, DOI 10.1136/jech.2009.094763; Schaumberg DA, 2000, MED CARE, V38, P638, DOI 10.1097/00005650-200006000-00005; Shankar AV, 1996, AM J CLIN NUTR, V64, P242, DOI 10.1093/ajcn/64.2.242; Sherwin JC, 2012, T ROY SOC TROP MED H, V106, P205, DOI 10.1016/j.trstmh.2012.01.004; UNDP, 2009, HUM DEV REP; Vela C, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-5; Woldeyes Alemayehu, 2008, Ethiop Med J, V46, P211; World Health Organization, 2009, WORLD HLTH SURV	34	64	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63315	10.1371/journal.pone.0063315	http://dx.doi.org/10.1371/journal.pone.0063315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675477	gold, Green Submitted, Green Published			2022-12-25	WOS:000318852400036
J	Janowski, K; Kurpas, D; Kusz, J; Mroczek, B; Jedynak, T				Janowski, Konrad; Kurpas, Donata; Kusz, Joanna; Mroczek, Bozena; Jedynak, Tomasz			Health-Related Behavior, Profile of Health Locus of Control and Acceptance of Illness in Patients Suffering from Chronic Somatic Diseases	PLOS ONE			English	Article							QUALITY-OF-LIFE; PREDICTORS; MORTALITY; ADHERENCE; BELIEFS; SEEKING; CARE; AGE	Purpose: The purpose of the study was to determine health-related behaviors, profile of health locus of control (HLC), and to assess the relationships between these constructs among patients suffering from chronic somatic diseases. Material and Methods: Three-hundred adult patients suffering from various chronic diseases participated in the study. The patients' mean age was 54.6 years (SD = 17.57). Results: No statistically significant differences were found between the different clinical groups in health-related behavior, acceptance of illness, internal HLC or chance HLC. Patients with neurologic conditions showed slightly lower powerful others HLC than did some other clinical groups. Health-related behavior was significantly positively related to all three categories of HLC, with most prominent associations observed with powerful others HLC. Only one type of health-related behavior - preventive behavior - correlated significantly and negatively with acceptance of illness. Differences in the frequency of health-related behavior were also found due to gender (women showing more healthy nutritional habits than men), age (older subjects showing more frequent health-promoting behavior), education (higher education was associated with less frequent health-promoting behavior) and marital status (widowed subjects reporting more frequent health-promoting behavior). Conclusions: Health-related behavior in patients with chronic diseases seems to be unrelated to a specific diagnosis; however it shows associations with both internal and external HLC. Sociodemographic factors are also crucial factors determining frequency of health-related behavior in such patients.	[Janowski, Konrad] Univ Finance & Management, Dept Psychol, Warsaw, Poland; [Kurpas, Donata] Med Univ, Dept Family Med, Wroclaw, Poland; [Kurpas, Donata] Publ Higher Med Profess Sch, Opole, Poland; [Kusz, Joanna] Med Univ, Dept Hlth Sci Nursing, Wroclaw, Poland; [Mroczek, Bozena] Pomeranian Med Univ, Dept Hlth Sci, Publ Hlth Div, Szczecin, Poland; [Jedynak, Tomasz] John Paul II Catholic Univ Lublin, Fac Social Sci, Dept Clin Psychol, Lublin, Poland	University of Finance & Management Warsaw; Wroclaw Medical University; Wroclaw Medical University; Pomeranian Medical University; Catholic University of Lublin	Kurpas, D (corresponding author), Med Univ, Dept Family Med, Wroclaw, Poland.	dkurpas@hotmail.com	Kurpas, Donata/I-7054-2013; Mroczek, Bożena BM/I-2488-2014	Kurpas, Donata/0000-0002-6996-8920; Mroczek, Bożena BM/0000-0002-6745-4942; Janowski, Konrad/0000-0003-0838-9754	Polish Ministry of Science and Higher Education	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	A part of this work was done by Dr. Janowski when he was receiving a scholarship from the Polish Ministry of Science and Higher Education.	Ali SM, 2006, EUR J PUBLIC HEALTH, V16, P324, DOI 10.1093/eurpub/cki187; Bodecs T, 2011, MATERN CHILD HLTH J, V15, P1316, DOI 10.1007/s10995-010-0698-0; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Brug J, 2004, PATIENT EDUC COUNS, V52, P249, DOI 10.1016/S0738-3991(03)00099-5; Burke V, 2007, PREV MED, V44, P135, DOI 10.1016/j.ypmed.2006.09.008; Chen YC, 2010, J CLIN NURS, V19, P3031, DOI 10.1111/j.1365-2702.2010.03280.x; Christensen AJ, 1996, COGNITIVE THER RES, V20, P411, DOI 10.1007/BF02228042; Cohen SM, 2009, NURS FORUM, V44, P25, DOI 10.1111/j.1744-6198.2009.00124.x; Coombs John B, 2004, South Med J, V97, P560, DOI 10.1097/00007611-200406000-00010; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Dijkstra A., 2008, J APPL BIOBEHAVIORAL, V12, P119, DOI [10.1111/j.1751-9861.2008.00018.x, DOI 10.1111/J.1751-9861.2008.00018.X]; FELTON BJ, 1984, SOC SCI MED, V18, P889, DOI 10.1016/0277-9536(84)90158-8; Gochman David S., 1988, HLTH BEHAV EMERGING, P3; Gore-Felton C, 2008, PSYCHOSOM MED, V70, P569, DOI 10.1097/PSY.0b013e318177353e; Greene CA, 2013, AM J HEALTH BEHAV, V37, P227, DOI 10.5993/AJHB.37.2.10; Grotz M, 2011, PSYCHOL HEALTH MED, V16, P129, DOI 10.1080/13548506.2010.521570; Henshaw EJ, 2009, CLIN PSYCHOL-SCI PR, V16, P420, DOI 10.1111/j.1468-2850.2009.01181.x; Heth JT, 2004, ADV PSY RES, V28, P43; Jackson ES, 2007, J AM COLL HEALTH, V56, P69, DOI 10.3200/JACH.56.1.69-74; Janowski K, 2012, ARCH DERMATOL RES, V304, P421, DOI 10.1007/s00403-012-1235-3; Juczynski Z, 2009, NARZEDZIA POMIARU PR; Karampampa K, 2012, MULT SCLER J, V18, P7, DOI 10.1177/1352458512441566; Kostas TI, 2010, J VASC SURG, V51, P900, DOI 10.1016/j.jvs.2009.10.119; Kuwahara A, 2004, TOHOKU J EXP MED, V203, P37, DOI 10.1620/tjem.203.37; Laaksonen M, 2008, EUR J PUBLIC HEALTH, V18, P38, DOI 10.1093/eurpub/ckm051; LemosGiraldez S, 1997, EUR J PERSONALITY, V11, P197, DOI 10.1002/(SICI)1099-0984(199709)11:3<197::AID-PER283>3.0.CO;2-H; LEVENTHAL EA, 1986, J AM GERIATR SOC, V34, P185; Lewko J, 2007, Adv Med Sci, V52 Suppl 1, P144; Mannion AF, 2009, EUR SPINE J, V18, P1881, DOI 10.1007/s00586-009-1093-7; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; Martin LG, 2012, DISS ABSTR INT B, V72, P5594; McConnell TR, 2010, J CARDIOPULM REHABIL, V30, P299, DOI 10.1097/HCR.0b013e3181d6fb82; Morrison T, 2009, J ASTHMA, V46, P751, DOI 10.3109/02770900903144686; Narayanaswami P, 2009, J NEUROL SCI, V276, P175, DOI 10.1016/j.jns.2008.09.036; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Norman P, 1998, J Health Psychol, V3, P171, DOI 10.1177/135910539800300202; Nyland J, 2006, ARTHROSCOPY, V22, P1225, DOI 10.1016/j.arthro.2006.05.034; Ono R, 2008, CLIN J PAIN, V24, P725, DOI 10.1097/AJP.0b013e3181759261; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Steptoe A, 2001, BRIT J PSYCHOL, V92, P659, DOI 10.1348/000712601162400; Stuifbergen AK, 2000, NURS RES, V49, P122, DOI 10.1097/00006199-200005000-00002; SUTTON S, 1994, J EPIDEMIOL COMMUN H, V48, P65, DOI 10.1136/jech.48.1.65; Tacon AM, 2004, FAMILIES SYSTEMS HLT, V22, P193, DOI DOI 10.1037/1091-7527.22.2.193; Telford K, 2006, J ADV NURS, V55, P457, DOI 10.1111/j.1365-2648.2006.03942.x; Vogel JJ, 2008, OTOL NEUROTOL, V29, P839, DOI 10.1097/MAO.0b013e3181820246; WALLSTON BS, 1978, HEALTH EDUC QUART, V6, P107; WALLSTON BS, 1976, J CONSULT CLIN PSYCH, V44, P580, DOI 10.1037/0022-006X.44.4.580; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; WALLSTON KA, 1976, J RES PERS, V10, P215, DOI 10.1016/0092-6566(76)90074-X; Westenhoefer J, 2005, FORUM NUTR, V57, P44, DOI 10.1159/000083753; Whitehead K, 2013, EPILEPSIA, V54, P708, DOI 10.1111/epi.12087; Winkleby MA, 2004, AM J HEALTH PROMOT, V19, P19, DOI 10.4278/0890-1171-19.1.19	52	38	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63920	10.1371/journal.pone.0063920	http://dx.doi.org/10.1371/journal.pone.0063920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143FO	23675516	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400058
J	Maiti, GP; Mondal, P; Mukherjee, N; Ghosh, A; Ghosh, S; Dey, S; Chakrabarty, J; Roy, A; Biswas, J; Roychoudhury, S; Panda, CK				Maiti, Guru Prasad; Mondal, Pinaki; Mukherjee, Nupur; Ghosh, Amlan; Ghosh, Susmita; Dey, Sanjib; Chakrabarty, Jayanta; Roy, Anup; Biswas, Jaydip; Roychoudhury, Susanta; Panda, Chinmay Kumar			Overexpression of EGFR in Head and Neck Squamous Cell Carcinoma Is Associated with Inactivation of SH3GL2 and CDC25A Genes	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; COPY NUMBER; LOCI; METHYLATION; EXPRESSION; DELETIONS; LESIONS; HPV	The aim of this study is to understand the mechanism of EGFR overexpression in head and neck squamous cell carcinoma (HNSCC). For this reason, expression/mutation of EGFR were analyzed in 30 dysplastic head and neck lesions and 148 HNSCC samples of Indian patients along with 3 HNSCC cell lines. In addition, deletion/methylation/mutation/expression of SH3GL2 (associated with EGFR degradation) and CDC25A (associated with dephosphorylation of EGFR) were analyzed in the same set of samples. Our study revealed high frequency of EGFR overexpression (66-84%), low frequency of gene amplification (10-32.5%) and absence of functional mutation in the dysplastic lesions and HNSCC samples. No correlation was found between protein overexpression and mRNA expression/gene amplification status of EGFR. On the other hand, frequent alterations (deletion/methylation) of SH3GL2 (63-77%) and CDC25A (37-64%) were seen in the dysplastic and HNSCC samples. Two novel single nucleotide polymorphism (SNPs) were found in the promoter region of SH3GL2. Reduced expression of these genes showed concordance with their alterations. Overexpression of EGFR and p-EGFR were significantly associated with reduced expression and alterations of SH3GL2 and CDC25A respectively. In-vitro demethylation experiment by 5-aza-2'-deoxycytidine (5-aza-dC) showed upregulation of SH3GL2 and CDC25A and downregulation of EGFR expression in Hep2 cell line. Poor patient outcome was predicted in the cases with alterations of SH3GL2 and CDC25A in presence of human papilloma virus (HPV) infection. Also, low SH3GL2 and high EGFR expression was a predictor of poor patient survival. Thus, our data suggests that overexpression of EGFR due to its reduced degradation and dephosphorylation is needed for development of HNSCC.	[Maiti, Guru Prasad; Mukherjee, Nupur; Ghosh, Amlan; Ghosh, Susmita; Panda, Chinmay Kumar] Chittaranjan Natl Canc Inst, Dept Oncogene Regulat, Kolkata, India; [Mondal, Pinaki; Dey, Sanjib; Roychoudhury, Susanta] CSIR, Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India; [Ghosh, Amlan] Presidency Univ, Dept Zool, Kolkata, India; [Ghosh, Susmita] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Chakrabarty, Jayanta; Biswas, Jaydip] Chittaranjan Natl Canc Inst, Dept Surg Oncol, Kolkata, India; [Roy, Anup] North Bengal Med Coll, Darjeeling, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Presidency University, Kolkata; Johns Hopkins University; Johns Hopkins Medicine	Panda, CK (corresponding author), Chittaranjan Natl Canc Inst, Dept Oncogene Regulat, Kolkata, India.	ckpanda.cnci@gmail.com	Maiti, Prasad/M-7729-2014; Mondal, Pinaki/AAB-8998-2022; Roychoudhury, Susanta/AAD-7946-2021	Maiti, Prasad/0000-0003-1936-363X; 	Department of Biotechnology, Government of India [BT/PR/5524/Med/14/649/2004]; Council for Scientific and Industrial Research-Project, Government of India [IAP-001]; CSIR-SRF Fellowship [09/30 (0053)2k9-EMR-I]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research-Project, Government of India; CSIR-SRF Fellowship(Council of Scientific & Industrial Research (CSIR) - India)	Financial support for this work was provided by grants from Department of Biotechnology, (BT/PR/5524/Med/14/649/2004), Government of India, to Dr. CK Panda and Dr. S Roychoudhury, Council for Scientific and Industrial Research-Project (IAP-001), Government of India to Dr. S Roychoudhury and CSIR-SRF Fellowship (grant no. 09/30 (0053)2k9-EMR-I) to Mr. GP Maiti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya N, 2009, J ORAL PATHOL MED, V38, P759, DOI 10.1111/j.1600-0714.2009.00781.x; Chau NG, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-11; Choi SH, 2007, ONCOGENE, V26, P1567, DOI 10.1038/sj.onc.1209957; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Dasgupta S, 2002, ORAL ONCOL, V38, P6, DOI 10.1016/S1368-8375(00)00131-7; Dasgupta S, 2013, J MOL MED, V91, P381, DOI 10.1007/s00109-012-0955-3; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Farrell WE, 1997, CANCER RES, V57, P2703; Ghosh A, 2009, J PATHOL, V217, P408, DOI 10.1002/path.2464; Ghosh S, 2008, DEUT VIER LIT GEIST, V82, P3; Ghosh S, 2009, HUM GENET, V125, P189, DOI 10.1007/s00439-008-0610-9; Giordani L, 2002, CANCER GENET CYTOGEN, V135, P42, DOI 10.1016/S0165-4608(01)00640-9; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Mitra S, 2010, GENE CHROMOSOME CANC, V49, P155, DOI 10.1002/gcc.20726; Nath S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.160671; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Perrone F, 2006, CLIN CANCER RES, V12, P6643, DOI 10.1158/1078-0432.CCR-06-1759; Potter N, 2008, NEOPLASIA, V10, P757, DOI 10.1593/neo.07914; Ray D, 2008, CANCER RES, V68, P1251, DOI 10.1158/0008-5472.CAN-07-5983; Shang C, 2007, CHINESE MED J-PEKING, V120, P385, DOI 10.1097/00029330-200703010-00007; Shang C, 2010, MED SCI MONITOR, V16, pBR168; Sinha S, 2008, ANN SURG ONCOL, V15, P1070, DOI 10.1245/s10434-007-9790-0; Tripathi A, 2003, INT J GYNECOL CANCER, V13, P472, DOI 10.1046/j.1525-1438.2003.13330.x; Wang ZQ, 2002, J BIOL CHEM, V277, P19470, DOI 10.1074/jbc.M201097200; Xu YR, 2010, MOL BIOL CELL, V21, P29, DOI 10.1091/mbc.E09-08-0710; Zhang BY, 2005, ONCOGENE, V24, P2585, DOI 10.1038/sj.onc.1208453	27	54	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63440	10.1371/journal.pone.0063440	http://dx.doi.org/10.1371/journal.pone.0063440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675485	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400040
J	Thakur, S; Garg, N; Adamo, ML				Thakur, Sachin; Garg, Neha; Adamo, Martin L.			Deficiency of Insulin-Like Growth Factor-1 Receptor Confers Resistance to Oxidative Stress in C2C12 Myoblasts	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; TUMOR-CELLS; SIGNALING PATHWAYS; INDUCED APOPTOSIS; MYOGENIC CELLS; PHOSPHORYLATION; AKT; ACTIVATION; 3-KINASE; DEATH	IGF-1 receptor (IGF-1R) signaling regulates cell growth, transformation and survival. Haploinsufficiency of the IGF-1R is reported to paradoxically confer resistance to oxidative stress in vivo and in cells cultured from Igf1r(+/-) mice. In order to determine whether IGF-1R deficiency directly confers resistance to oxidative stress in specific cell types, an siRNA-mediated approach was applied to reduce IGF-1R in C2C12 myoblasts, NIH3T3 fibroblasts and MC3T3-E1 osteoblasts. Treating the IGF-1R deficient myoblasts with H2O2 resulted in significantly higher phosphorylation of Akt as compared to cells having normal expression of IGF-1R. Similar results were obtained with UV treatment, another inducer of oxidative stress. This enhanced activation of Akt was associated with reduced level of cleaved caspase-3 and PARP. Moreover, in the IGF-1R knockdown myoblasts, phosphorylation of the Akt substrate Bad was enhanced after peroxide treatment. However, in NIH-3T3 fibroblasts and MC3T3-E1 osteoblasts, the loss of IGF-1R by siRNA directed knockdown was associated with reduced levels of phosphorylated Akt on treatment with H2O2 or UV as compared to control cells and these cells showed more apoptosis. These results suggest a novel mechanism of cell type specific differential regulation of resistance to oxidative stress induced apoptosis by reduced levels of IGF-1R.	[Thakur, Sachin; Garg, Neha; Adamo, Martin L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Adamo, Martin L.] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Adamo, ML (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	adamo@biochem.uthscsa.edu			NIA (National Institute on Aging) [RO1AG026012]; ARRA (American Recovery and Reinvestment Act) Supplement [3R01-AG026012-04S1]; University of Texas System's Graduate Programs Initiative: Translational Science Training Across Disciplines; NATIONAL INSTITUTE ON AGING [R01AG026012] Funding Source: NIH RePORTER	NIA (National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ARRA (American Recovery and Reinvestment Act) Supplement; University of Texas System's Graduate Programs Initiative: Translational Science Training Across Disciplines; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIA (National Institute on Aging) grant RO1AG026012 to MLA, ARRA (American Recovery and Reinvestment Act) Supplement 3R01-AG026012-04S1 to MLA for support of ST and the University of Texas System's Graduate Programs Initiative: Translational Science Training Across Disciplines to NG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azar ZM, 2007, CAN J PHYSIOL PHARM, V85, P105, DOI 10.1139/Y06-101; Boucher J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001173; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chakravarti A, 2002, CANCER RES, V62, P200; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Esposito F, 2003, J BIOL CHEM, V278, P20828, DOI 10.1074/jbc.M211841200; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Heidegger I, 2011, CANCER BIOL THER, V11, P701, DOI 10.4161/cbt.11.8.14689; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hongo A, 1998, CANCER RES, V58, P2477; Huang CS, 2001, J BIOL CHEM, V276, P40234, DOI 10.1074/jbc.M103684200; Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835; Jiang BM, 2005, CELL STRESS CHAPERON, V10, P252, DOI 10.1379/CSC-124R.1; Jiang BM, 2005, FREE RADICAL BIO MED, V39, P658, DOI 10.1016/j.freeradbiomed.2005.04.018; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kooijman R, 2006, CYTOKINE GROWTH F R, V17, P305, DOI 10.1016/j.cytogfr.2006.02.002; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Liu YM, 1998, CANCER RES, V58, P570; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Niesler CU, 2000, J ENDOCRINOL, V167, P165, DOI 10.1677/joe.0.1670165; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Parrizas M, 1997, J BIOL CHEM, V272, P154; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pollak Michael, 2007, V174, P49; Purdom S, 2005, J PHARMACOL EXP THER, V312, P1179, DOI 10.1124/jpet.104.077057; RESNICOFF M, 1995, CANCER RES, V55, P2463; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sutherland BW, 2008, CANCER RES, V68, P3495, DOI 10.1158/0008-5472.CAN-07-6531; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Xiong L, 2007, J CELL BIOL, V178, P995, DOI 10.1083/jcb.200703044	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63838	10.1371/journal.pone.0063838	http://dx.doi.org/10.1371/journal.pone.0063838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675509	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400055
J	Waisberg, M; Lin, CK; Huang, CY; Pena, M; Orandle, M; Bolland, S; Pierce, SK				Waisberg, Michael; Lin, Christina K.; Huang, Chiung-Yu; Pena, Mirna; Orandle, Marlene; Bolland, Silvia; Pierce, Susan K.			The Impact of Genetic Susceptibility to Systemic Lupus Erythematosus on Placental Malaria in Mice	PLOS ONE			English	Article							FALCIPARUM-MALARIA; CEREBRAL MALARIA; PROGNOSTIC-SIGNIFICANCE; CLINICAL-IMPLICATIONS; AUTOIMMUNE DISEASE; THROMBOCYTOPENIA; INFECTION; POPULATIONS; PROTECTION; COMPLEMENT	Severe malaria, including cerebral malaria (CM) and placental malaria (PM), have been recognized to have many of the features of uncontrolled inflammation. We recently showed that in mice genetic susceptibility to the lethal inflammatory autoimmune disease, systemic lupus erythematosus (SLE), conferred resistance to CM. Protection appeared to be mediated by immune mechanisms that allowed SLE-prone mice, prior to the onset of overt SLE symptoms, to better control their inflammatory response to Plasmodium infection. Here we extend these findings to ask does SLE susceptibility have 1) a cost to reproductive fitness and/or 2) an effect on PM in mice? The rates of conception for WT and SLE susceptible (SLEs) mice were similar as were the number and viability of fetuses in pregnant WT and SLEs mice indicating that SLE susceptibility does not have a reproductive cost. We found that Plasmodium chabaudi AS (Pc) infection disrupted early stages of pregnancy before the placenta was completely formed resulting in massive decidual necrosis 8 days after conception. Pc-infected pregnant SLEs mice had significantly more fetuses (similar to 1.8 fold) but SLE did not significantly affect fetal viability in infected animals. This was despite the fact that Pc-infected pregnant SLEs mice had more severe symptoms of malaria as compared to Pc-infected pregnant WT mice. Thus, although SLE susceptibility was not protective in PM in mice it also did not have a negative impact on reproductive fitness.	[Waisberg, Michael; Lin, Christina K.; Pena, Mirna; Bolland, Silvia; Pierce, Susan K.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Huang, Chiung-Yu] NIAID, Biostat Res Branch, NIH, Rockville, MD USA; [Orandle, Marlene] NIAID, Comparat Med Branch, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Waisberg, M (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	waisberg@gmail.com		Lin, Christina/0000-0001-9728-6591	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001064, ZIGAI001047, ZIAAI000912] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SC, 1998, ARTHRITIS RHEUM-US, V41, P2091, DOI 10.1002/1529-0131(199812)41:12<2091::AID-ART2>3.3.CO;2-4; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; BURROWS RF, 1993, NEW ENGL J MED, V329, P1463, DOI 10.1056/NEJM199311113292005; BUTCHER GA, 1990, PARASITOL TODAY, V6, P259, DOI 10.1016/0169-4758(90)90186-8; Crocker I, 1999, CLIN DIAGN LAB IMMUN, V6, P587, DOI 10.1128/CDLI.6.4.587-593.1999; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; GREENWOO.BM, 1968, LANCET, V2, P380; Greenwood B, 2001, LANCET, V358, P1182, DOI 10.1016/S0140-6736(01)06281-X; GREENWOOD BM, 1970, T ROY SOC TROP MED H, V64, P7; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; HENTATI B, 1994, EUR J IMMUNOL, V24, P8, DOI 10.1002/eji.1830240103; Jallouli M, 2012, LUPUS, V21, P682, DOI 10.1177/0961203312438630; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; Lee SW, 2012, MOD RHEUMATOL; Molokhia M, 2006, LUPUS, V15, P827, DOI 10.1177/0961203306070007; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; PHANUPHAK P, 1985, CLIN EXP IMMUNOL, V59, P571; Poovassery J, 2006, INFECT IMMUN, V74, P2839, DOI 10.1128/IAI.74.5.2839-2848.2006; REST JR, 1982, T ROY SOC TROP MED H, V76, P410, DOI 10.1016/0035-9203(82)90203-6; Sturfelt G, 2005, RHEUMATOLOGY, V44, P1227, DOI 10.1093/rheumatology/keh719; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Waisberg M, 2011, P NATL ACAD SCI USA, V108, P1122, DOI 10.1073/pnas.1017996108; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Wu SA, 2013, LUPUS, V22, P279, DOI 10.1177/0961203312474704; Ziakas PD, 2005, ANN RHEUM DIS, V64, P1366, DOI 10.1136/ard.2004.033100	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62820	10.1371/journal.pone.0062820	http://dx.doi.org/10.1371/journal.pone.0062820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675429	Green Submitted, gold, Green Published			2022-12-25	WOS:000318852400012
J	Xia, LG; Zhang, ML; Chang, Q; Wang, LZ; Zeng, DL; Zhang, XL; Zhang, ZY; Jiang, XQ				Xia, Lunguo; Zhang, Maolin; Chang, Qing; Wang, Lizhen; Zeng, Deliang; Zhang, Xiuli; Zhang, Zhiyuan; Jiang, Xinquan			Enhanced Dentin-Like Mineralized Tissue Formation by AdShh-Transfected Human Dental Pulp Cells and Porous Calcium Phosphate Cement	PLOS ONE			English	Article							MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; TOOTH DEVELOPMENT; MATRIX PROTEIN-1; ENGINEERED BONE; GENE-THERAPY; HEDGEHOG; PROLIFERATION; SCAFFOLD	The aim of the present study was to investigate the effect of Sonic hedgehog (Shh) on human dental pulp cells (hDPCs) and the potential of complexes with Shh gene modified hDPCs and porous calcium phosphate cement (CPC) for mineralized tissue formation. hDPCs were cultured and transfected with adenoviral mediated human Shh gene (AdShh). Overexpression of Shh and cell proliferation was tested by real-time PCR analysis, western blotting analysis, and MTT analysis, respectively. The odontoblastic differentiation was assessed by alkaline phosphatase (ALP) activity and real-time PCR analysis on markers of Patched-1 (Ptc-1), Smoothened (Smo), Gli 1, Gli 2, Gli 3, osteocalcin (OCN), dentin matrix protein-1 (DMP-1), and dentin sialophosphoprotein (DSPP). Finally, AdShh-transfected hDPCs were combined with porous CPC and placed subcutaneously in nude mice for 8 and 12 weeks, while AdEGFP-transfected and untransfected hDPCs were treated as control groups. Results indicated that Shh could promote proliferation and odontoblastic differentiation of hDPCs, while Shh/Gli 1 signaling pathway played a key role in this process. Importantly, more mineralized tissue formation was observed in combination with AdShh transfected hDPCs and porous CPC, moreover, the mineralized tissue exhibited dentin-like features such as structures similar to dentin-pulp complex and the positive staining for DSPP protein similar to the tooth tissue. These results suggested that the constructs with AdShh-transfected hDPCs and porous CPC might be a better alternative for dental tissue regeneration.	[Xia, Lunguo; Zhang, Maolin; Zhang, Zhiyuan] Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial Surg, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Xia, Lunguo; Zhang, Maolin; Chang, Qing; Zeng, Deliang; Zhang, Xiuli; Zhang, Zhiyuan; Jiang, Xinquan] Shanghai Jiao Tong Univ, Oral Bioengn Lab, Shanghai Peoples Hosp 9, Shanghai Res Inst Stomatol,Sch Med, Shanghai 200030, Peoples R China; [Zeng, Deliang; Jiang, Xinquan] Shanghai Jiao Tong Univ, Dept Prosthodont, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Wang, Lizhen] Shanghai Jiao Tong Univ, Dept Oral Pathol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, ZY (corresponding author), Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial Surg, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China.	zhzhy@omschina.org.cn; xinquanj@yahoo.cn	zhang, zhiyuan/GRS-2141-2022		National Basic Research Program of China (973 Program) [2012CB933600(4)]; National Natural Science Foundation of China [30973342, 81170939]; Science and Technology Commission of Shanghai Municipality [12 nm0501600, 10ZR1418100]; Biomedical Engineering Cross Research Foundation of Shanghai Jiao Tong University School [YG2012MS29]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Biomedical Engineering Cross Research Foundation of Shanghai Jiao Tong University School	This work was supported by National Basic Research Program of China (973 Program, 2012CB933600(4)), National Natural Science Foundation of China (30973342, 81170939), Science and Technology Commission of Shanghai Municipality (12 nm0501600, 10ZR1418100), and Biomedical Engineering Cross Research Foundation of Shanghai Jiao Tong University School (YG2012MS29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliot-Licht B, 2005, CELL TISSUE RES, V321, P391, DOI 10.1007/s00441-005-1115-7; Alsanea R, 2011, J ENDODONT, V37, P1092, DOI 10.1016/j.joen.2011.05.019; Cai JQ, 2012, CELL BIOL INT, V36, P349, DOI 10.1042/CBI20110284; Cobourne MT, 2004, DEVELOPMENT, V131, P2875, DOI 10.1242/dev.01163; Dassule HR, 2000, DEVELOPMENT, V127, P4775; DICKENSVENZ SH, 1994, DENT MATER, V10, P100, DOI 10.1016/0109-5641(94)90048-5; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Jackman WR, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-119; James AW, 2010, TISSUE ENG PT A, V16, P2605, DOI [10.1089/ten.tea.2010.0048, 10.1089/ten.TEA.2010.0048]; Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526; Jiang X, 2006, INT J ORAL MAX SURG, V35, P1133, DOI 10.1016/j.ijom.2006.07.005; Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021; Kang R, 2000, CLIN ORTHOP RELAT R, P324; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee SK, 2010, J ENDODONT, V36, P1537, DOI 10.1016/j.joen.2010.04.027; Li Y, 2011, Adv Dent Res, V23, P280, DOI 10.1177/0022034511405387; Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039; Lopez-Cazaux S, 2006, EUR CELLS MATER, V11, P35, DOI 10.22203/eCM.v011a05; Lu KG, 2012, CELL BIOL INT, V36, P119, DOI 10.1042/CBI20100848; Lye KW, 2009, TISSUE ENG PART B-RE, V15, P485, DOI 10.1089/ten.TEB.2009.0139; MacDougall M, 1996, CONNECT TISSUE RES, V35, P267, DOI 10.3109/03008209609029200; Martinez C, 2011, J DENT RES, V90, P483, DOI 10.1177/0022034510391797; Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5; Nakatomi M, 2006, J DENT RES, V85, P427, DOI 10.1177/154405910608500506; Neumann CJ, 2005, CELL CYCLE, V4, P1139, DOI 10.4161/cc.4.9.1999; Reiser J, 2005, EXPERT OPIN BIOL TH, V5, P1571, DOI 10.1517/14712598.5.12.1571; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Stagg J, 2004, HUM GENE THER, V15, P597, DOI 10.1089/104303404323142042; Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048; Takahashi S, 2007, BIOCHEM BIOPH RES CO, V353, P405, DOI 10.1016/j.bbrc.2006.12.053; Tonomura A, 2007, CONNECT TISSUE RES, V48, P229, DOI 10.1080/03008200701507909; Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034; Xia LU, 2011, CELLS TISSUES ORGANS, V194, P481, DOI 10.1159/000323918; Xia LG, 2011, CALCIFIED TISSUE INT, V89, P53, DOI 10.1007/s00223-011-9493-1; Yang B, 2012, BIOMATERIALS, V33, P2449, DOI 10.1016/j.biomaterials.2011.11.074; Yang X, 2009, J DENT RES, V88, P1020, DOI 10.1177/0022034509346258; Zhang L, 2008, J MOL HISTOL, V39, P87, DOI 10.1007/s10735-007-9132-3; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299; Zou DR, 2012, TISSUE ENG PT A, V18, P1464, DOI [10.1089/ten.tea.2011.0501, 10.1089/ten.TEA.2011.0501]	40	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62645	10.1371/journal.pone.0062645	http://dx.doi.org/10.1371/journal.pone.0062645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675415	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400007
J	Liu, C; Guo, LQ; Menon, S; Jin, D; Pick, E; Wang, XJ; Deng, XW; Wei, N				Liu, Cheng; Guo, Li-Quan; Menon, Suchithra; Jin, Dan; Pick, Elah; Wang, Xuejun; Deng, Xing Wang; Wei, Ning			COP9 Signalosome Subunit Csn8 Is Involved in Maintaining Proper Duration of the G(1) Phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; CELL-CYCLE CONTROL; ARABIDOPSIS COP9; COP9/SIGNALOSOME SUBUNITS; PROLIFERATION; COMPLEX; YEAST; SCF; DIFFERENTIATION; DENEDDYLATION	The COP9 signalosome (CSN) is a conserved protein complex known to be involved in developmental processes of eukaryotic organisms. Genetic disruption of a CSN gene causes arrest during early embryonic development in mice. The Csn8 subunit is the smallest and the least conserved subunit, being absent from the CSN complex of several fungal species. Nevertheless, Csn8 is an integral component of the CSN complex in higher eukaryotes, where it is essential for life. By characterizing the mouse embryonic fibroblasts (MEFs) that express Csn8 at a low level, we found that Csn8 plays an important role in maintaining the proper duration of the G(1) phase of the cell cycle. A decreased level of Csn8, either in Csn8 hypomorphic MEFs or following siRNA-mediated knockdown in HeLa cells, accelerated cell growth rate. Csn8 hypomorphic MEFs exhibited a shortened G1 duration and affected expression of G(1) regulators. In contrast to Csn8, down-regulation of Csn5 impaired cell proliferation. Csn5 proteins were found both as a component of the CSN complex and outside of CSN (Csn5-f), and the amount of Csn5-f relative to CSN was increased in the Csn8 hypomorphic cells. We conclude that CSN harbors both positive and negative regulators of the cell cycle and therefore is poised to influence the fate of a cell at the crossroad of cell division, differentiation, and senescence.	[Liu, Cheng; Guo, Li-Quan; Menon, Suchithra; Jin, Dan; Pick, Elah; Deng, Xing Wang; Wei, Ning] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Wang, Xuejun] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA	Yale University; University of South Dakota	Wei, N (corresponding author), Yale Univ, Dept MCDB, Osborn Mem Labs, Room 451,POB 208104, New Haven, CT 06520 USA.	ning.wei@yale.edu	Wang, Xuejun/K-8874-2013; Deng, Xing Wang/ABF-4107-2020; Wang, Xuejun/AAT-9490-2021; Pick, Elah/G-6137-2018	Wang, Xuejun/0000-0001-9267-1343; Wang, Xuejun/0000-0001-9267-1343; Pick, Elah/0000-0002-6591-2217; Wei, Ning/0000-0001-8827-1320	National Institutes of Health [R01HL085629, GM47850]; National Science Foundation (NSF) [MCB-0929100]; "New Century Excellent Talents" program of Ministry of Education, China [NCET-10-0153]; China Postdoctoral Visiting-Scholar Fellowship [201104519, 20100481042]; China Scholarship Council (CSC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072166, R01HL085629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047850, R01GM047850, R29GM047850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); "New Century Excellent Talents" program of Ministry of Education, China; China Postdoctoral Visiting-Scholar Fellowship; China Scholarship Council (CSC)(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL085629 (to X. J. W. and N. W,) and GM47850 (to X. W. D.). This work was also supported by the National Science Foundation (NSF) 2010 Program MCB-0929100 (to X. W. D.).; Supported by the "New Century Excellent Talents" program of Ministry of Education, China (Grant NCET-10-0153) and China Postdoctoral Visiting-Scholar Fellowship (Grants 201104519 and 20100481042).; Supported by the China Scholarship Council (CSC) of 2011.	Adler AS, 2008, CANCER RES, V68, P506, DOI 10.1158/0008-5472.CAN-07-3060; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; Choi HH, 2011, ONCOGENE, V30, P4791, DOI 10.1038/onc.2011.192; Cope Gregory A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-1; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Dohmann EMN, 2008, DEVELOPMENT, V135, P2013, DOI 10.1242/dev.020743; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Fukumoto A, 2006, FEBS LETT, V580, P5836, DOI 10.1016/j.febslet.2006.09.042; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Lei D, 2011, CELL DEATH DIFFER, V18, P259, DOI 10.1038/cdd.2010.98; Lim S, 2012, STEM CELLS, V30, P1509, DOI 10.1002/stem.1114; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Luke-Glaser S, 2007, MOL CELL BIOL, V27, P4526, DOI 10.1128/MCB.01724-06; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Mori M, 2008, J BIOL CHEM, V283, P29011, DOI 10.1074/jbc.M804539200; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; Oren-Giladi P, 2008, GENES CELLS, V13, P221, DOI 10.1111/j.1365-2443.2008.01164.x; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Oron E, 2002, DEVELOPMENT, V129, P4399; Panattoni M, 2008, J EXP MED, V205, P465, DOI 10.1084/jem.20070725; Peth Andreas, 2007, BMC Biochemistry, V8, P27, DOI 10.1186/1471-2091-8-27; Pick E, 2007, MOL CELL BIOL, V27, P4708, DOI 10.1128/MCB.02432-06; Pick E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043980; Rosel D, 2006, EUR J CELL BIOL, V85, P1023, DOI 10.1016/j.ejcb.2006.04.006; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schwechheimer C, 2010, EUR J CELL BIOL, V89, P157, DOI 10.1016/j.ejcb.2009.11.021; Serino G, 2003, PLANT CELL, V15, P719, DOI 10.1105/tpc.009092; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; Su HB, 2011, CIRCULATION, V124, P2117, DOI 10.1161/CIRCULATIONAHA.111.048934; Su HB, 2011, CIRC RES, V108, P40, DOI 10.1161/CIRCRESAHA.110.230607; Su HB, 2009, INT J BIOCHEM CELL B, V41, P615, DOI 10.1016/j.biocel.2008.07.008; Tanguy G, 2008, BBA-MOL CELL RES, V1783, P1189, DOI 10.1016/j.bbamcr.2008.01.010; Tian L, 2010, ONCOGENE, V29, P6125, DOI 10.1038/onc.2010.345; Tomoda K, 2005, BLOOD, V105, P775, DOI 10.1182/blood-2004-04-1242; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Wang JY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001232; Wang XP, 2009, PLANT J, V58, P655, DOI 10.1111/j.1365-313X.2009.03805.x; Wee S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-15; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Yoneda-Kato N, 2005, EMBO J, V24, P1739, DOI 10.1038/sj.emboj.7600656; Yoshida A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01054; Zhao RY, 2011, J CLIN INVEST, V121, P851, DOI 10.1172/JCI44111; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9; Zhou ZP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002712	61	15	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20443	20452		10.1074/jbc.M113.468959	http://dx.doi.org/10.1074/jbc.M113.468959			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23689509	Green Published, hybrid			2022-12-25	WOS:000321715100032
J	Dai, C; Shi, DD; Gu, W				Dai, Chao; Shi, Dingding; Gu, Wei			Negative Regulation of the Acetyltransferase TIP60-p53 Interplay by UHRF1 (Ubiquitin-like with PHD and RING Finger Domains 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLTRANSFERASE-1 DNMT1 PROTEIN; HEMI-METHYLATED DNA; CELL-CYCLE ARREST; HISTONE-ACETYLTRANSFERASE; BINDING-PROTEIN; SRA DOMAIN; TRANSCRIPTIONAL REGULATION; CANCER PROGRESSION; COLORECTAL-CANCER; LIGASE ACTIVITY	Numerous studies indicate the importance of acetylation in p53-mediated stress responses upon DNA damage. We and others previously showed that TIP60 (Tat-interacting protein of 60 kDa)-mediated acetylation of p53 at K120 is crucial for p53-dependent apoptotic responses. Nevertheless, it remains unclear how TIP60-mediated effects on p53 are dynamically regulated in vivo. Here, we report that UHRF1 (ubiquitin-like with PHD and RING finger domains 1) interacts with TIP60 both in vitro and in vivo and induces degradation-independent ubiquitination of TIP60. Moreover, UHRF1 expression markedly suppresses the ability of TIP60 to acetylate p53. In contrast, RNAi-mediated knockdown of UHRF1 increases the endogenous levels of p53 acetylation at K120 and p53-mediated apoptosis is significantly enhanced in UHRF1-depleted cells. To elucidate the mechanisms of this regulation, we found that the interaction between TIP60 and p53 is severely inhibited in the presence of UHRF1, suggesting that UHRF1 modulates TIP60-mediated functions in both K120 acetylation-dependent and -independent manners. Consistent with this notion, UHRF1 knockdown promotes activation of p21 and PUMA but not MDM2. These findings demonstrate that UHRF1 is a critical negative regulator of TIP60 and suggest that UHRF1-mediated effects on p53 may contribute, at least in part, to its role in tumorigenesis.	[Dai, Chao; Shi, Dingding; Gu, Wei] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Gu, Wei] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Dai, Chao; Shi, Dingding; Gu, Wei] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Dai, Chao] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, Dept Pathol & Cell Biol, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu			NCI, National Institutes of Health [5R01 CA172023, 5R01 CA085533, 2P01 CA080058]; NATIONAL CANCER INSTITUTE [T32CA009503, P01CA080058, R01CA085533, R01CA172023] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants 5R01 CA172023, 5R01 CA085533, and 2P01 CA080058 (to W. G.).	Achour M, 2009, BIOCHEM BIOPH RES CO, V390, P523, DOI 10.1016/j.bbrc.2009.09.131; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Babbio F, 2012, ONCOGENE, V31, P4878, DOI 10.1038/onc.2011.641; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bhoumik A, 2008, J BIOL CHEM, V283, P17605, DOI 10.1074/jbc.M802030200; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Charvet C, 2011, MOL CELL, V42, P584, DOI 10.1016/j.molcel.2011.03.033; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Creaven M, 1999, BIOCHEMISTRY-US, V38, P8826, DOI 10.1021/bi9907274; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Dai C, 2011, P NATL ACAD SCI USA, V108, P18937, DOI 10.1073/pnas.1110988108; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Fujimori A, 1998, MAMM GENOME, V9, P1032, DOI 10.1007/s003359900920; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Guan D., 2012, ONCOGENE; Gupta A., 2012, ONCOGENE, DOI [10.1038/onc.2012.534, DOI 10.1038/0NC.2012.534.[]; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hopfner R, 2000, CANCER RES, V60, P121; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Kofunato Y, 2012, ONCOL REP, V28, P1997, DOI 10.3892/or.2012.2064; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lorenzato M, 2005, HUM PATHOL, V36, P1101, DOI 10.1016/j.humpath.2005.07.016; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; Oba-Shinjo SM, 2005, MOL BRAIN RES, V140, P25, DOI 10.1016/j.molbrainres.2005.06.015; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Peng DF, 2005, CANCER SCI, V96, P403, DOI 10.1111/j.1349-7006.2005.00071.x; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Sabatino L, 2012, ONCOGENE, V31, P5061, DOI 10.1038/onc.2012.3; Sawada M, 2007, CANCER LETT, V251, P211, DOI 10.1016/j.canlet.2006.11.023; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Unoki M, 2009, BRIT J CANCER, V101, P98, DOI 10.1038/sj.bjc.6605123; Unoki M, 2011, RECENT PAT ANTI-CANC, V6, P116, DOI 10.2174/157489211793980024; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Witt O, 2009, CANCER LETT, V280, P123, DOI 10.1016/j.canlet.2009.02.038; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595	57	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19581	19592		10.1074/jbc.M113.476606	http://dx.doi.org/10.1074/jbc.M113.476606			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23677994	hybrid, Green Published			2022-12-25	WOS:000321515800024
J	Callejo, G; Giblin, JP; Gasull, X				Callejo, Gerard; Giblin, Jonathan P.; Gasull, Xavier			Modulation of TRESK Background K+ Channel by Membrane Stretch	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; POTASSIUM CHANNEL; SENSORY NEURONS; RAT SKIN; TRAAK; NOCICEPTORS; ACTIVATION; PRESSURE; TREK-2; SENSITIZATION	The two-pore domain K+ channel TRESK is expressed in dorsal root ganglion and trigeminal sensory neurons where it is a major contributor to background K+ current. TRESK acts as a break to prevent excessive sensory neuron activation and decreases in its expression or function have been involved in neuronal hyperexcitability after injury/inflammation, migraine or altered sensory perception (tingling, cooling and pungent burning sensations). All these effects have implicated this channel in nociception and mechanotransduction. To determine the role of TRESK in sensory transduction, we studied its sensitivity to changes in membrane tension (stretch) in heterologous systems, F-11 cells and trigeminal neurons. Laminar shear stress increased TRESK currents by 22-30%. An increase in membrane tension induced by cell swelling (hypotonic medium) produced a reversible elevation of TRESK currents (39.9%). In contrast, cell shrinkage (hypertonic solution) produced the opposite effect. Membrane crenators or cup-formers produced equivalent effects. In trigeminal sensory neurons, TRESK channels were mechanically stimulated by negative pressure, which led to a 1.51-fold increase in channel open probability. TRESK-like currents in trigeminal neurons were additively inhibited by arachidonic acid, acidic pH and hypertonic stimulation, conditions usually found after tissue inflammation. Our results show that TRESK is modulated by changes in cell membrane tension and/or cell volume. Several key players released during inflammation or tissue injury could modulate sensory neuron activation through small changes in membrane tension.	[Callejo, Gerard; Giblin, Jonathan P.; Gasull, Xavier] Univ Barcelona, Sch Med, Dept Physiol Sci 1, Neurophysiol Lab, Barcelona, Spain; [Callejo, Gerard; Giblin, Jonathan P.; Gasull, Xavier] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Gasull, X (corresponding author), Univ Barcelona, Sch Med, Dept Physiol Sci 1, Neurophysiol Lab, Barcelona, Spain.	xgasull@ub.edu	Martín, Gerard Callejo/F-8757-2019; Gasull, Xavier/T-9630-2017	Martín, Gerard Callejo/0000-0003-4366-0482; Gasull, Xavier/0000-0002-6154-8323	Ministerio de Sanidad of Spain [FIS 08/0014, FIS PI11/01601]; RETIC (Red de Patologia ocular del envejecimiento, calidad visual y calidad de vida) [RD07/0062/0006, RD12/0034/0003]; Generalitat de Catalunya [2009SGR869]; Ramon y Cajal fellowship from the Ministerio de Economia y competitividad of Spain [RYC-2011-08589]	Ministerio de Sanidad of Spain; RETIC (Red de Patologia ocular del envejecimiento, calidad visual y calidad de vida); Generalitat de Catalunya(Generalitat de Catalunya); Ramon y Cajal fellowship from the Ministerio de Economia y competitividad of Spain	This work was supported by grants from the Ministerio de Sanidad of Spain: FIS 08/0014; FIS PI11/01601; RETIC (Red de Patologia ocular del envejecimiento, calidad visual y calidad de vida; RD07/0062/0006 and RD12/0034/0003) and 2009SGR869 from Generalitat de Catalunya. JPG is supported by a Ramon y Cajal fellowship from the Ministerio de Economia y competitividad of Spain (RYC-2011-08589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009520; Andres-Enguix I, 2012, SCI REP-UK, V2, DOI 10.1038/srep00237; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Baciu M, 2007, J PHYS CHEM B, V111, P909, DOI 10.1021/jp066595n; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Bautista DM, 2011, J GEN PHYSIOL, V138, P291, DOI 10.1085/jgp.201110637; Bhattacharya MRC, 2008, P NATL ACAD SCI USA, V105, P20015, DOI 10.1073/pnas.0810801105; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; Braun G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028119; Brickley SG, 2007, J NEUROSCI, V27, P9329, DOI 10.1523/JNEUROSCI.1427-07.2007; Brierley SM, 2011, J PHYSIOL-LONDON, DOI [10.1113/jphysiol.2011.206789, DOI 10.1113/JPHY-SI0L.2011.206789]; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Bryant BP, 1999, BRAIN RES, V842, P452, DOI 10.1016/S0006-8993(99)01878-8; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Delaunay A, 2012, P NATL ACAD SCI USA, V109, P13124, DOI 10.1073/pnas.1120350109; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Enyedi P, 2012, MOL CELL ENDOCRINOL, V353, P75, DOI 10.1016/j.mce.2011.11.009; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Folgering JHA, 2008, PROG BIOPHYS MOL BIO, V97, P180, DOI 10.1016/j.pbiomolbio.2008.02.006; FRANCEL PC, 1987, J NEUROCHEM, V48, P1624, DOI 10.1111/j.1471-4159.1987.tb05711.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hill K, 2007, J BIOL CHEM, V282, P7145, DOI 10.1074/jbc.M609600200; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kang D, 2005, J PHYSIOL-LONDON, V564, P103, DOI 10.1113/jphysiol.2004.081059; Kang D, 2008, BIOCHEM BIOPH RES CO, V367, P609, DOI 10.1016/j.bbrc.2008.01.008; Kang D, 2007, J PHYSIOL-LONDON, V583, P57, DOI 10.1113/jphysiol.2007.136150; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kim Y, 2001, PFLUG ARCH EUR J PHY, V442, P64, DOI 10.1007/s004240000496; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Klein AH, 2011, J NEUROPHYSIOL, V105, P1701, DOI 10.1152/jn.00922.2010; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Lennertz RC, 2010, J NEUROSCI, V30, P4353, DOI 10.1523/JNEUROSCI.4666-09.2010; Liu CH, 2004, ANESTH ANALG, V99, P1715, DOI 10.1213/01.ANE.0000136849.07384.44; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; Nilius B, 2012, TRENDS NEUROSCI, V35, P477, DOI 10.1016/j.tins.2012.04.002; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; SCHMIDT R, 1995, J NEUROSCI, V15, P333; Schmidt R, 2000, NEUROSCIENCE, V98, P793, DOI 10.1016/S0306-4522(00)00189-5; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Shelly M, 2011, DEV NEUROBIOL, V71, P508, DOI 10.1002/dneu.20884; STEEN KH, 1992, J NEUROSCI, V12, P86; STEEN KH, 1995, J NEUROSCI, V15, P3982; Sung B, 2007, PAIN, V131, P121, DOI 10.1016/j.pain.2006.12.020; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Tulleuda A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-30; VAKILI C, 1970, Surgical Forum (Chicago), V21, P227; Vilceanu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012177; Yamamoto Y, 2009, NEUROSCI LETT, V454, P129, DOI 10.1016/j.neulet.2009.02.069; Zhang XC, 2010, J NEUROSCI, V30, P8807, DOI 10.1523/JNEUROSCI.0511-10.2010	67	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64471	10.1371/journal.pone.0064471	http://dx.doi.org/10.1371/journal.pone.0064471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691227	gold, Green Published, Green Submitted			2022-12-25	WOS:000319052700099
J	Chadha, MS; Hirve, S; Dawood, FS; Lele, P; Deoshatwar, A; Sambhudas, S; Juvekar, S; LaFond, KE; Mott, JA; Lal, RB; Mishra, AC				Chadha, Mandeep S.; Hirve, Siddhivinayak; Dawood, Fatimah S.; Lele, Pallavi; Deoshatwar, Avinash; Sambhudas, Somnath; Juvekar, Sanjay; LaFond, Kathryn E.; Mott, Joshua A.; Lal, Renu B.; Mishra, Akhilesh C.			Burden of Seasonal and Pandemic Influenza-Associated Hospitalization during and after 2009 A(H1N1)pdm09 Pandemic in a Rural Community in India	PLOS ONE			English	Article							HONG-KONG; UNITED-STATES; PNEUMONIA; CHILDREN; MORTALITY; EPIDEMIOLOGY; IMPACT	Background: Influenza is vaccine-preventable; however, the burden of severe influenza in India remains unknown. We conducted a population-based study to estimate the incidence of laboratory confirmed influenza-associated hospitalizations in a rural community in western India. Methods: We conducted active surveillance for hospitalized patients with acute medical illnesses or acute chronic disease exacerbations in Pune during pandemic and post pandemic periods (May 2009-April 2011). Nasal and throat swabs were tested for influenza viruses. A community health utilization survey estimated the proportion of residents hospitalized with respiratory illness at non-study facilities and was used to adjust incidence estimates from facility-based surveillance. Results: Among 9,426 hospitalizations, 3,391 (36%) patients were enrolled; 665 of 3,179 (20.9%) tested positive for influenza. Of 665 influenza positives, 340 (51%) were pandemic A(H1N1)pdm09 and 327 (49%) were seasonal, including A/H3 (16%), A/H1 (3%) and influenza B (30%). The proportion of patients with influenza peaked during August 2009 (39%) and 2010 (42%). The adjusted annual incidence of influenza hospitalizations was 46.8/10,000 during pandemic and 40.5/10,000 during post-pandemic period with comparable incidence of A(H1N1) pdm09 during both periods (18.8 and 20.3, respectively). The incidence of both pH1N1 and seasonal hospitalized influenza disease was highest in the 5-29 year olds. Conclusions: We document the previously unrecognized burden of influenza hospitalization in a rural community following the emergence of influenza A(H1N1)pdm09 viruses in India. During peak periods of influenza activity circulation i.e during the monsoon period, 20% of all hospital admissions in the community had influenza positivity. These findings can inform development of influenza prevention and control strategies in India.	[Chadha, Mandeep S.; Deoshatwar, Avinash; Mishra, Akhilesh C.] Indian Council Med Res, Natl Inst Virol, Pune, Maharashtra, India; [Hirve, Siddhivinayak; Lele, Pallavi; Deoshatwar, Avinash; Sambhudas, Somnath; Juvekar, Sanjay] King Edward Mem Hosp Res Ctr, Vadu Rural Hlth Program, Pune, Maharashtra, India; [Dawood, Fatimah S.; LaFond, Kathryn E.; Mott, Joshua A.; Lal, Renu B.] Natl Ctr Immunizat & Resp Dis, Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Centers for Disease Control & Prevention - USA	Chadha, MS (corresponding author), Indian Council Med Res, Natl Inst Virol, Pune, Maharashtra, India.	acm1750@rediffmail.com; mscniv@hotmail.com		Sambhudas, Somnath/0000-0003-0140-4931	Centers for Disease Control and Prevention [1U01IP000206]; National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP000206] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Influenza Disease Burden, India Study was supported by a Centers for Disease Control and Prevention co-operative agreement # 1U01IP000206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; ASSAAD F, 1973, B WORLD HEALTH ORGAN, V49, P219; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; BARKER WH, 1986, AM J PUBLIC HEALTH, V76, P761, DOI 10.2105/AJPH.76.7.761; Broor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029129; CDC, 2009, CDC PROT REAL TIM RT; Census of India, 2012, RUR URB DISTR POP PR; Chadha MS, 2012, INFLUENZA OTHER RESP, V6, P196, DOI 10.1111/j.1750-2659.2011.00293.x; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Crighton EJ, 2004, EPIDEMIOL INFECT, V132, P1167, DOI 10.1017/S0950268804002924; Dawood FS, 2010, J PEDIATR-US, V157, P808, DOI 10.1016/j.jpeds.2010.05.012; Esposito S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-271; GLEZEN WP, 1982, EPIDEMIOL REV, V4, P25, DOI 10.1093/oxfordjournals.epirev.a036250; Gregg MB, 1976, INFLUENZA VIRUS VACC, P79; Griffin Marie R, 2004, Pediatr Infect Dis J, V23, pS188, DOI 10.1097/01.inf.0000144660.53024.64; Li CK, 2006, PUBLIC HEALTH, V120, P517, DOI 10.1016/j.puhe.2006.03.004; Mishra AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010540; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Ramamurty N, 2005, INDIAN J MED RES, V121, P776; RAO BL, 1993, B WORLD HEALTH ORGAN, V71, P177; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; *WHO, 2009, PRACT GUID HARM VIR; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; World Health Organization, GLOB INFL SURV RESP; World Health Organization, 2009, PRACT GUID DES COND; Yap FHY, 2004, J MED VIROL, V73, P617, DOI 10.1002/jmv.20135	30	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e55918	10.1371/journal.pone.0055918	http://dx.doi.org/10.1371/journal.pone.0055918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690913	gold, Green Published, Green Submitted			2022-12-25	WOS:000319052700001
J	Petrie, SM; Guarnaccia, T; Laurie, KL; Hurt, AC; McVernon, J; McCaw, JM				Petrie, Stephen M.; Guarnaccia, Teagan; Laurie, Karen L.; Hurt, Aeron C.; McVernon, Jodie; McCaw, James M.			Reducing Uncertainty in Within-Host Parameter Estimates of Influenza Infection by Measuring Both Infectious and Total Viral Load	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSE; A VIRUS-INFECTION; RESPIRATORY-TRACT; DYNAMICS; KINETICS; CULTURE; MODELS; SYSTEM; ASSAYS; MICE	For in vivo studies of influenza dynamics where within-host measurements are fit with a mathematical model, infectivity assays (e.g. 50% tissue culture infectious dose; TCID50) are often used to estimate the infectious virion concentration over time. Less frequently, measurements of the total (infectious and non-infectious) viral particle concentration (obtained using real-time reverse transcription-polymerase chain reaction; rRT-PCR) have been used as an alternative to infectivity assays. We investigated the degree to which measuring both infectious (via TCID50) and total (via rRT-PCR) viral load allows within-host model parameters to be estimated with greater consistency and reduced uncertainty, compared with fitting to TCID50 data alone. We applied our models to viral load data from an experimental ferret infection study. Best-fit parameter estimates for the "dual-measurement" model are similar to those from the TCID50-only model, with greater consistency in best-fit estimates across different experiments, as well as reduced uncertainty in some parameter estimates. Our results also highlight how variation in TCID50 assay sensitivity and calibration may hinder model interpretation, as some parameter estimates systematically vary with known uncontrolled variations in the assay. Our techniques may aid in drawing stronger quantitative inferences from in vivo studies of influenza virus dynamics.	[Petrie, Stephen M.; McVernon, Jodie; McCaw, James M.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Parkville, Vic 3052, Australia; [Guarnaccia, Teagan; Hurt, Aeron C.] Monash Univ, Churchill, Vic, Australia; [Guarnaccia, Teagan; Laurie, Karen L.; Hurt, Aeron C.] WHO, Collaborating Ctr Reference & Res Influenza, North Melbourne, Vic, Australia; [McVernon, Jodie; McCaw, James M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Vaccine & Immunisat Res Grp, Parkville, Vic 3052, Australia	University of Melbourne; Monash University; World Health Organization; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	McCaw, JM (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Parkville, Vic 3052, Australia.	jamesm@unimelb.edu.au		Laurie, Karen/0000-0001-5186-8342; McVernon, Jodie/0000-0001-9774-1961; Petrie, Stephen/0000-0002-8773-516X; McCaw, James/0000-0002-2452-3098; Hurt, Aeron/0000-0003-1826-4314	Australian Government Department of Health and Ageing	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The Melbourne World Health Organization Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; Beauchemin CAA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S7; Dobrovolny HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013811; Dobrovolny HM, 2011, J THEOR BIOL, V269, P234, DOI 10.1016/j.jtbi.2010.10.017; DONALDSON JR, 1987, TECHNOMETRICS, V29, P67, DOI 10.2307/1269884; Falsey AR, 2003, J CLIN MICROBIOL, V41, P4160, DOI 10.1128/JCM.41.9.4160-4165.2003; GINSBERG HS, 1954, J EXP MED, V100, P581, DOI 10.1084/jem.100.6.581; Handel A, 2007, PLOS COMPUT BIOL, V3, P2456, DOI 10.1371/journal.pcbi.0030240; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; Holder BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014767; Holder BP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S10; Holder BP, 2011, AUTOIMMUNITY, V44, P282, DOI 10.3109/08916934.2011.523267; HORSFALL FL, 1954, J EXP MED, V100, P135, DOI 10.1084/jem.100.2.135; Iwami S, 2012, RETROVIROLOGY, V9, DOI [10.1186/PREACCEPT-8502330256154242, 10.1186/1742-4690-9-18]; LARSON EW, 1976, INFECT IMMUN, V13, P438, DOI 10.1128/IAI.13.2.438-447.1976; Lee HY, 2009, J VIROL, V83, P7151, DOI 10.1128/JVI.00098-09; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P847, DOI 10.1098/rspb.2000.1572; Ma ZM, 2009, J VIROL, V83, P3288, DOI 10.1128/JVI.02423-08; Marcus PI, 2009, J VIROL, V83, P8122, DOI 10.1128/JVI.02680-08; Marriott AC, 2010, REV MED VIROL, V20, P51, DOI 10.1002/rmv.641; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Menache MG, 1997, J TOXICOL ENV HEALTH, V50, P475, DOI 10.1080/00984109708984003; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Pinilla LT, 2012, J VIROL, V86, P10651, DOI 10.1128/JVI.07244-11; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; Schulze-Horsel J, 2009, VACCINE, V27, P2712, DOI 10.1016/j.vaccine.2009.02.027; Schwaab M, 2008, CHEM ENG SCI, V63, P1542, DOI 10.1016/j.ces.2007.11.024; Smith AM, 2011, WIRES SYST BIOL MED, V3, P429, DOI 10.1002/wsbm.129; Smith AM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001081; Smith AM, 2010, CRIT REV IMMUNOL, V30, P291, DOI 10.1615/CritRevImmunol.v30.i3.60; Smith AM, 2010, J MATH BIOL, V60, P711, DOI 10.1007/s00285-009-0281-8; Tabuchi A, 2008, J MED VIROL, V80, P2064, DOI 10.1002/jmv.21320; Vaidya NK, 2010, J VIROL, V84, P4302, DOI 10.1128/JVI.02284-09; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Wood JM, 2012, VACCINE, V30, P210, DOI 10.1016/j.vaccine.2011.11.019; Yoshikawa T, 2004, J GEN VIROL, V85, P2339, DOI 10.1099/vir.0.79892-0	42	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64098	10.1371/journal.pone.0064098	http://dx.doi.org/10.1371/journal.pone.0064098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691157	gold, Green Published, Green Submitted			2022-12-25	WOS:000319052700080
J	Clark, CJ; Poulsen, JR; Levey, DJ				Clark, Connie J.; Poulsen, John R.; Levey, Doug J.			Roles of Seed and Establishment Limitation in Determining Patterns of Afrotropical Tree Recruitment	PLOS ONE			English	Article							DENSITY-DEPENDENCE; COEXISTENCE; NICHE; DISPERSAL; DIVERSITY; CONSEQUENCES; COMMUNITIES; MAINTENANCE; COMPETITION; MORTALITY	Quantifying the relative importance of the multiple processes that limit recruitment may hold the key to understanding tropical tree diversity. Here we couple theoretical models with a large-scale, multi-species seed-sowing experiment to assess the degree to which seed and establishment limitation shape patterns of tropical tree seedling recruitment in a central African forest. Of five randomly selected species (Pancovia laurentii, Staudtia kamerunensis, Manilkara mabokeensis, Myrianthus arboreas, and Entandophragma utile), seedling establishment and survival were low (means of 16% and 6% at 3 and 24 months, respectively), and seedling density increased with seed augmentation. Seedling recruitment was best explained by species identity and the interaction of site-by-species, suggesting recruitment probabilities vary among species and sites, and supporting the role of niche-based mechanisms. Although seed augmentation enhanced initial seedling density, environmental filtering and post-establishment mortality strongly limited seedling recruitment. The relative importance of seed and establishment limitation changed with seed and seedling density and through time. The arrival of seeds most strongly affected local recruitment when seeds were nearly absent from a site (similar to 1 seed m(2)), but was also important when seeds arrived in extremely high densities, overwhelming niche-based mortality factors. The strength of seed limitation and density-independent mortality decreased significantly over time, while density-dependent mortality showed the opposite trend. The varying strengths of seed and establishment limitation as a function of juvenile density and time emphasize the need to evaluate their roles through later stages of a tree's life cycle.	[Clark, Connie J.; Poulsen, John R.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Clark, Connie J.; Poulsen, John R.; Levey, Doug J.] Univ Florida, Dept Biol, Gainesville, FL USA; [Levey, Doug J.] Natl Sci Fdn, Arlington, VA 22230 USA	Duke University; State University System of Florida; University of Florida; National Science Foundation (NSF)	Clark, CJ (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	connie.j.clark@duke.edu	Poulsen, John/O-5332-2019	Poulsen, John/0000-0002-1532-9808	SNRE alumni fellowship; EPA STAR fellowship [91630801-0]; NSF [00074232]; Madelyn Lockhart Dissertation Fellowship; American Association of University Women Dissertation Fellowship	SNRE alumni fellowship; EPA STAR fellowship(United States Environmental Protection Agency); NSF(National Science Foundation (NSF)); Madelyn Lockhart Dissertation Fellowship; American Association of University Women Dissertation Fellowship	Financial support was provided by an SNRE alumni fellowship, EPA STAR fellowship (number 91630801-0), NSF dissertation improvement grant (number 00074232), the Madelyn Lockhart Dissertation Fellowship and an American Association of University Women Dissertation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; [Anonymous], ECOLOGY TROPICAL FOR; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; CHESSON PL, 1985, THEOR POPUL BIOL, V28, P263, DOI 10.1016/0040-5809(85)90030-9; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Clark CJ, 2012, ECOLOGY, V93, P554, DOI 10.1890/11-0894.1; Clark CJ, 2005, ECOLOGY, V86, P2684, DOI 10.1890/04-1325; Clark CJ, 2004, OECOLOGIA, V139, P66, DOI 10.1007/s00442-003-1483-1; Clark JS, 2009, TRENDS ECOL EVOL, V24, P8, DOI 10.1016/j.tree.2008.09.004; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; Congolaise Industrielle des Bois, 2006, PLAN DAM UN FOR KAB PLAN DAM UN FOR KAB, P2005; CONNELL J H, 1971, P298; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Harris D.J., 2002, VASCULAR PLANTS DZAN; HUBBELL SP, 1990, PHILOS T R SOC B, V330, P269, DOI 10.1098/rstb.1990.0198; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; Hubbell Stephen P., 2001, V32, pi; HURTT GC, 1995, J THEOR BIOL, V176, P1, DOI 10.1006/jtbi.1995.0170; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Karst J, 2005, ECOLOGY, V86, P2473, DOI 10.1890/04-1420; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Lanfranchi R, 1991, REMANIEMENTS SOLS PE; Makana JR, 2004, OIKOS, V106, P67, DOI 10.1111/j.0030-1299.2004.13084.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Metz MR, 2010, ECOLOGY, V91, P3675, DOI 10.1890/08-2323.1; Muller-Landau H. C., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P35, DOI 10.1079/9780851995250.0035; Muller-Landau HC, 2010, P NATL ACAD SCI USA, V107, P4242, DOI 10.1073/pnas.0911637107; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Norden N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001079; Norghauer JM, 2010, ECOLOGY, V91, P2303, DOI 10.1890/09-0071.1; Paine CET, 2008, BIOTROPICA, V40, P432, DOI 10.1111/j.1744-7429.2007.00390.x; Paine CET, 2009, OECOLOGIA, V160, P139, DOI 10.1007/s00442-008-1269-6; PLUMMER M, 2005, CODA OUTPUT ANAL DIA; Poulsen JR, 2007, AM NAT, V170, P167, DOI 10.1086/518945; Rupp S., 1998, RESOURCE USE TRINATI, P41; SAS Institute Inc, 2001, SAS STAT SOFTW CHANG; Shipley B, 2012, ECOLOGY, V93, P760, DOI 10.1890/11-0944.1; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Svenning JC, 2008, OECOLOGIA, V155, P143, DOI 10.1007/s00442-007-0884-y; Svenning JC, 2005, J ECOL, V93, P853, DOI 10.1111/j.1365-2745.2005.01016.x; THOMAS L, 2006, DISTANCE 5 0 RES UNI; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; Wright SJ, 2005, ECOLOGY, V86, P848, DOI 10.1890/03-0750; Zangato ME, 1999, AFRICAN ARCHAEOLOGY	57	16	18	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63330	10.1371/journal.pone.0063330	http://dx.doi.org/10.1371/journal.pone.0063330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691023	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400051
J	Giardi, MT; Rea, G; Lambreva, MD; Antonacci, A; Pastorelli, S; Bertalan, I; Johanningmeier, U; Mattoo, AK				Giardi, Maria Teresa; Rea, Giuseppina; Lambreva, Maya D.; Antonacci, Amina; Pastorelli, Sandro; Bertalan, Ivo; Johanningmeier, Udo; Mattoo, Autar K.			Mutations of Photosystem II D1 Protein That Empower Efficient Phenotypes of Chlamydomonas reinhardtii under Extreme Environment in Space	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; IONIZING-RADIATION; GAS-EXCHANGE; PHOTOSYNTHESIS; DYNAMICS; PLANTS; MICROGRAVITY; SENSITIVITY; EVOLUTION; SEQUENCE	Space missions have enabled testing how microorganisms, animals and plants respond to extra-terrestrial, complex and hazardous environment in space. Photosynthetic organisms are thought to be relatively more prone to microgravity, weak magnetic field and cosmic radiation because oxygenic photosynthesis is intimately associated with capture and conversion of light energy into chemical energy, a process that has adapted to relatively less complex and contained environment on Earth. To study the direct effect of the space environment on the fundamental process of photosynthesis, we sent into low Earth orbit space engineered and mutated strains of the unicellular green alga, Chlamydomonas reinhardtii, which has been widely used as a model of photosynthetic organisms. The algal mutants contained specific amino acid substitutions in the functionally important regions of the pivotal Photosystem II (PSII) reaction centre D1 protein near the Q(B) binding pocket and in the environment surrounding Tyr-161 (Y-Z) electron acceptor of the oxygen-evolving complex. Using real-time measurements of PSII photochemistry, here we show that during the space flight while the control strain and two D1 mutants (A250L and V160A) were inefficient in carrying out PSII activity, two other D1 mutants, I163N and A251C, performed efficient photosynthesis, and actively re-grew upon return to Earth. Mimicking the neutron irradiation component of cosmic rays on Earth yielded similar results. Experiments with I163N and A251C D1 mutants performed on ground showed that they are better able to modulate PSII excitation pressure and have higher capacity to reoxidize the Q(A)(-) state of the primary electron acceptor. These results highlight the contribution of D1 conformation in relation to photosynthesis and oxygen production in space.	[Giardi, Maria Teresa; Rea, Giuseppina; Lambreva, Maya D.; Antonacci, Amina; Pastorelli, Sandro] CNR, Natl Res Council Italy, Inst Crystallog, Rome, Italy; [Bertalan, Ivo; Johanningmeier, Udo] Univ Halle Wittenberg, Inst Plant Physiol, D-06108 Halle, Germany; [Mattoo, Autar K.] USDA, Henry A Wallace Beltsville Agr Res Ctr, ARS, Sustainable Agr Syst Lab, Beltsville, MD 20705 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Martin Luther University Halle Wittenberg; United States Department of Agriculture (USDA)	Mattoo, AK (corresponding author), USDA, Henry A Wallace Beltsville Agr Res Ctr, ARS, Sustainable Agr Syst Lab, Beltsville, MD 20705 USA.	autar.mattoo@ars.usda.gov	Antonacci, Amina/I-4374-2012; REA, GIUSEPPINA/B-9479-2015; Mattoo, Autar/U-9751-2019; Lambreva, Maya Dimova/D-6917-2017	Antonacci, Amina/0000-0002-3245-3739; REA, GIUSEPPINA/0000-0001-7353-727X; Mattoo, Autar/0000-0001-9226-7164; Lambreva, Maya Dimova/0000-0001-5750-0899; Giardi, Maria Teresa/0000-0002-7401-5905	Italian Space Agency; German Aerospace Research Establishmen (DLR); European Space Agency	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); German Aerospace Research Establishmen (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); European Space Agency(European Space AgencyEuropean Commission)	This work was supported by Italian Space Agency, German Aerospace Research Establishmen (DLR) and European Space Agency. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Belyavskaya NA, 2004, ADV SPACE RES-SERIES, V34, P1566, DOI 10.1016/j.asr.2004.01.021; Cano JB, 2011, RECENT PATENTS SPACE, V1, P18; Dauvillee D, 2004, PHOTOSYNTH RES, V79, P219, DOI 10.1023/B:PRES.0000015384.24958.a9; Edelman M, 2008, PHOTOSYNTH RES, V98, P609, DOI 10.1007/s11120-008-9342-x; Esposito D, 2006, MICROGRAVITY SCI TEC, V18, P215, DOI 10.1007/BF02870412; Eyal E, 2004, J COMPUT CHEM, V25, P712, DOI 10.1002/jcc.10420; Govindjee, 2002, PHOTOSYNTHETICA, V40, P1, DOI 10.1023/A:1020169502548; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Hakala-Yatkin M, 2011, PHYSIOL PLANTARUM, V142, P26, DOI 10.1111/j.1399-3054.2011.01453.x; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Ivanova PI, 2008, RADIAT ENVIRON BIOPH, V47, P169, DOI 10.1007/s00411-007-0139-7; JOHANNINGMEIER U, 1993, PLANT MOL BIOL, V22, P91, DOI 10.1007/BF00038998; JOHANNINGMEIER U, 1984, J BIOL CHEM, V259, P3541; Jovanic B., 2002, INT J ENVIRON STUD, V59, P599, DOI [10.1080/00207230212729, DOI 10.1080/00207230212729]; Kornyeyev D, 2010, FUNCT PLANT BIOL, V37, P943, DOI 10.1071/FP09276; Lardans A, 1998, J BIOL CHEM, V273, P11082, DOI 10.1074/jbc.273.18.11082; Lehto KA, 2006, RES MICROBIOL, V157, P69, DOI 10.1016/j.resmic.2005.07.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTOO AK, 1989, CELL, V56, P241, DOI 10.1016/0092-8674(89)90897-0; Melis A, 1998, J APPL PHYCOL, V10, P515, DOI 10.1023/A:1008076231267; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miroshnichenko L, 2003, RAD HAZARD SPACE; Monje O, 2005, PLANTA, V222, P336, DOI 10.1007/s00425-005-1529-1; Nedbal L, 1999, J PHOTOCH PHOTOBIO B, V48, P154, DOI 10.1016/S1011-1344(99)00032-9; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; Porterfield DM, 2002, J PLANT GROWTH REGUL, V21, P177, DOI 10.1007/s003440010054; Rea G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016216; Rea G, 2009, PROTEIN SCI, V18, P2139, DOI 10.1002/pro.228; Rea G, 2008, INT J RADIAT BIOL, V84, P867, DOI 10.1080/09553000802460149; Rochaix JD, 2001, PLANT PHYSIOL, V127, P1394, DOI 10.1104/pp.010628; Saakov V S, 2003, Dokl Biochem Biophys, V388, P22, DOI 10.1023/A:1022552328204; Sarghein S. Hosseini, 2008, International Journal of Botany, V4, P486; SCHAGGER H, 1985, FEBS LETT, V190, P89, DOI 10.1016/0014-5793(85)80434-8; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Schulze-Makuch D., 2008, LIFE UNIVERSE EXPECT; Shlyk-Kerner O, 2006, NATURE, V442, P827, DOI 10.1038/nature04947; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Stutte GW, 2005, PLANTA, V223, P46, DOI 10.1007/s00425-005-0066-2; TENHUNEN JD, 1984, PLANTA, V162, P193, DOI 10.1007/BF00397440; Toth SZ, 2007, PHOTOSYNTH RES, V93, P193, DOI 10.1007/s11120-007-9179-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tripathy BC, 1996, PLANT PHYSIOL, V110, P801, DOI 10.1104/pp.110.3.801; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wang GJ, 2004, HEILONGJIANG AGR SCI, P1; Wolff SA, 2013, ADV SPACE RES, V51, P465, DOI 10.1016/j.asr.2012.09.024; Yokthongwattana K, 2006, ADV PHOTO RESPIRAT, V21, P175	49	16	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64352	10.1371/journal.pone.0064352	http://dx.doi.org/10.1371/journal.pone.0064352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691201	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400119
J	Guo, JP; Tian, W; Shu, SK; Xin, Y; Shou, CC; Cheng, JQ				Guo, Jian-Ping; Tian, Wei; Shu, Shaokun; Xin, Yu; Shou, Chengchao; Cheng, Jin Q.			IKBKE Phosphorylation and Inhibition of FOXO3a: A Mechanism of IKBKE Oncogenic Function	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO3A; TUMOR-SUPPRESSOR CYLD; KAPPA-B ACTIVATION; IKK-EPSILON; BREAST-CANCER; PROMOTES TUMORIGENESIS; EMERGING ROLES; EXPRESSION; AKT; PROTEINS	Forkhead box O (FOXO) transcription factors are emerging as key regulators of cell survival and growth. The transcriptional activity and subcellular localization of FOXO are tightly regulated by post-translational modifications. Here we report that IKBKE regulates FOXO3a through phosphorylation of FOXO3a-Ser644. The phosphorylation of FOXO3a resulted in its degradation and nuclear-cytoplasmic translocation. Previous studies have shown that IKBKE directly activates Akt and that Akt inhibits FOXO3a by phosphorylation of Ser32, Ser253 and Ser315. However, the activity of Akt-nonphosphorytable FOXO3a-A3 (i.e., converting 3 serine residues to alanine) was inhibited by IKBKE. Furthermore, overexpression of IKBKE correlates with elevated levels of pFOXO3a-S644 in primary lung and breast tumors. IKBKE inhibits cellular function of FOXO3a and FOXO3a-A3 but, to a much less extent, of FOXO3a-S644A. These findings suggest that IKBKE regulates FOXO3a primarily through phosphorylation of SerS644 and that IKBKE exerts its cellular function, at least to some extent, through regulation of FOXO3a.	[Guo, Jian-Ping; Tian, Wei; Shou, Chengchao] Peking Univ, Canc Hosp & Inst, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Guo, Jian-Ping; Tian, Wei; Shu, Shaokun; Xin, Yu; Cheng, Jin Q.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Mol Oncol, Tampa, FL 33682 USA	Peking University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Shou, CC (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.	scc@bjcancer.org; jin.cheng@moffitt.org			National Institutes of Health (NIH) [CA137041, CA160455]; Florida James & Esther King Biomedical Research Program [1KG02, 10KD-04]; National 973 Program of China [2009CB521805]; NATIONAL CANCER INSTITUTE [R01CA160455, R01CA137041] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida James & Esther King Biomedical Research Program; National 973 Program of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grant CA137041, CA160455 and Florida James & Esther King Biomedical Research Program 1KG02 to JQC, 10KD-04 to JPG and National 973 Program of China (2009CB521805) to CCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chapuis N, 2010, BLOOD, V116, P4240, DOI 10.1182/blood-2009-12-260711; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Guo J, 2013, ONCOGENE, V32, P151, DOI 10.1038/onc.2012.39; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Guo JP, 2009, AM J PATHOL, V175, P324, DOI 10.2353/ajpath.2009.080767; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Heckman CA, 2002, ONCOGENE, V21, P3898, DOI 10.1038/sj.onc.1205483; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Keen JC, 2006, IMMUNOLOGY, V117, P29, DOI 10.1111/j.1365-2567.2005.02260.x; Khatri S, 2010, J BIOL CHEM, V285, P15960, DOI 10.1074/jbc.M110.121871; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Luron L, 2012, EUR J IMMUNOL, V42, P1030, DOI 10.1002/eji.201141969; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Onuma H, 2006, MOL ENDOCRINOL, V20, P2831, DOI 10.1210/me.2006-0085; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Shen RR, 2011, ONCOGENE, V30, P631, DOI 10.1038/onc.2010.493; Shiota M, 2010, CANCER SCI, V101, P1177, DOI 10.1111/j.1349-7006.2010.01503.x; Sun M, 2001, CANCER RES, V61, P5985; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, INT J ONCOL, V29, P643; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	42	34	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63636	10.1371/journal.pone.0063636	http://dx.doi.org/10.1371/journal.pone.0063636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691078	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400071
J	Walters, KA; Olsufka, R; Kuestner, RE; Cho, JH; Li, H; Zornetzer, GA; Wang, K; Skerrett, SJ; Ozinsky, A				Walters, Kathie-Anne; Olsufka, Rachael; Kuestner, Rolf E.; Cho, Ji Hoon; Li, Hong; Zornetzer, Gregory A.; Wang, Kai; Skerrett, Shawn J.; Ozinsky, Adrian			Francisella tularensis subsp tularensis Induces a Unique Pulmonary Inflammatory Response: Role of Bacterial Gene Expression in Temporal Regulation of Host Defense Responses	PLOS ONE			English	Article							LIVE-VACCINE-STRAIN; IMMUNE-RESPONSE; IN-VIVO; YERSINIA-PESTIS; NK CELLS; SCHU S4; GAMMA-INTERFERON; DENDRITIC CELLS; UNITED-STATES; VIRULENCE	Pulmonary exposure to Francisella tularensis is associated with severe lung pathology and a high mortality rate. The lack of induction of classical inflammatory mediators, including IL1-beta and TNF-alpha, during early infection has led to the suggestion that F. tularensis evades detection by host innate immune surveillance and/or actively suppresses inflammation. To gain more insight into the host response to Francisella infection during the acute stage, transcriptomic analysis was performed on lung tissue from mice exposed to virulent (Francisella tularensis ssp tularensis SchuS4). Despite an extensive transcriptional response in the lungs of animals as early as 4 hrs post-exposure, Francisella tularensis was associated with an almost complete lack of induction of immune-related genes during the initial 24 hrs post-exposure. This broad subversion of innate immune responses was particularly evident when compared to the pulmonary inflammatory response induced by other lethal (Yersinia pestis) and non-lethal (Legionella pneumophila, Pseudomonas aeruginosa) pulmonary infections. However, the unique induction of a subset of inflammation-related genes suggests a role for dysregulation of lymphocyte function and anti-inflammatory pathways in the extreme virulence of Francisella. Subsequent activation of a classical inflammatory response 48 hrs post-exposure was associated with altered abundance of Francisella-specific transcripts, including those associated with bacterial surface components. In summary, virulent Francisella induces a unique pulmonary inflammatory response characterized by temporal regulation of innate immune pathways correlating with altered bacterial gene expression patterns. This study represents the first simultaneous measurement of both host and Francisella transcriptome changes that occur during in vivo infection and identifies potential bacterial virulence factors responsible for regulation of host inflammatory pathways.	[Walters, Kathie-Anne; Kuestner, Rolf E.; Cho, Ji Hoon; Li, Hong; Zornetzer, Gregory A.; Wang, Kai; Ozinsky, Adrian] Inst Syst Biol, Seattle, WA USA; [Olsufka, Rachael; Skerrett, Shawn J.] Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle	Walters, KA (corresponding author), Inst Syst Biol, Seattle, WA USA.	Kathie.Walters@systemsbiology.org			Defense Threat Reduction Agency [HDTRA-1-08-C-0023]; Luxembourg Centre for Systems Biomedicine; University of Luxembourg	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Luxembourg Centre for Systems Biomedicine; University of Luxembourg	This work was supported by Defense Threat Reduction Agency contract HDTRA-1-08-C-0023, the Luxembourg Centre for Systems Biomedicine and the University of Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2002, J EXP MED, V196, P1253, DOI 10.1084/jem.20021183; Andersson H, 2006, GENES IMMUN, V7, P503, DOI 10.1038/sj.gene.6364321; Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Bannenberg GL, 2004, J EXP MED, V199, P515, DOI 10.1084/jem.20031325; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Bauler TJ, 2011, J IMMUNOL, V187, P1845, DOI 10.4049/jimmunol.1100377; Bell BL, 2010, INFECT IMMUN, V78, P2189, DOI 10.1128/IAI.00021-10; Berrington WR, 2010, EUR J IMMUNOL, V40, P3519, DOI 10.1002/eji.201040518; Bokhari SM, 2008, INFECT IMMUN, V76, P1379, DOI 10.1128/IAI.00745-07; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00009; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Bublitz DC, 2010, J IMMUNOL, V185, P1124, DOI 10.4049/jimmunol.0902429; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Chase JC, 2010, INFECT IMMUN, V78, P154, DOI 10.1128/IAI.00750-09; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Conlan JW, 2002, MICROB PATHOGENESIS, V32, P127, DOI 10.1006/mpat.2001.0489; Dai SP, 2012, INFECT IMMUN, V80, P1088, DOI 10.1128/IAI.06245-11; Dai S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00144; David J, 2012, MICROBES INFECT, V14, P369, DOI 10.1016/j.micinf.2011.11.006; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; De Pascalis R, 2008, INFECT IMMUN, V76, P4311, DOI 10.1128/IAI.00514-08; DIENST F T Jr, 1963, J La State Med Soc, V115, P114; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elkins KL, 2009, MICROBES INFECT, V11, P49, DOI 10.1016/j.micinf.2008.10.005; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; EVANS ME, 1985, MEDICINE, V64, P251, DOI 10.1097/00005792-198507000-00006; Faith SA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00126; Forslund AL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-227; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Garcia-Ramallo E, 2002, J IMMUNOL, V169, P6467, DOI 10.4049/jimmunol.169.11.6467; Gil H, 2006, P NATL ACAD SCI USA, V103, P12897, DOI 10.1073/pnas.0602582103; Gosselin EJ, 2005, HUM IMMUNOL, V66, P1039, DOI 10.1016/j.humimm.2005.08.240; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hinnebusch BJ, 2011, INFECT IMMUN, V79, P4984, DOI 10.1128/IAI.05307-11; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kingry LC, 2011, MICROBES INFECT, V13, P261, DOI 10.1016/j.micinf.2010.10.022; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Li Y, 2012, P NATL ACAD SCI US; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Lopez MC, 2004, CELL IMMUNOL, V232, P75, DOI 10.1016/j.cellimm.2005.02.001; Margolis JJ, 2010, APPL ENVIRON MICROB, V76, P596, DOI 10.1128/AEM.02037-09; Medina EA, 2010, J IMMUNOL, V185, P7562, DOI 10.4049/jimmunol.0903790; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Morris AE, 2009, AM J PHYSIOL-LUNG C, V297, pL1112, DOI 10.1152/ajplung.00155.2009; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Parsa KVL, 2008, MOL IMMUNOL, V45, P3428, DOI 10.1016/j.molimm.2008.04.006; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Platz GJ, 2010, INFECT IMMUN, V78, P1022, DOI 10.1128/IAI.00992-09; Porcu M, 2012, BLOOD; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Soundararajan V, 2011, INNATE IMMUN-LONDON, V17, P548, DOI 10.1177/1753425910377099; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Tang JJ, 2011, BLOOD, V118, P786, DOI 10.1182/blood-2010-11-321406; Thomas LD, 2010, INFECT DIS CLIN N AM, V24, P43, DOI 10.1016/j.idc.2009.10.012; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Yang HY, 2011, INFECT IMMUN, V79, P4413, DOI 10.1128/IAI.05622-11; Yang S, 2008, ACAD EMERG MED, V15, P388, DOI 10.1111/j.1553-2712.2008.00061.x; Zarrella TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022335	78	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62412	10.1371/journal.pone.0062412	http://dx.doi.org/10.1371/journal.pone.0062412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690939	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400012
J	Chen, YW; Xu, ZH; Baksh, ANH; Wang, JK; Chen, CY; Swanson, R; Olson, ST; Kataoka, H; Johnson, MD; Lin, CY				Chen, Ya-Wen; Xu, Zhenghong; Baksh, Adrienne N. H.; Wang, Jehng-Kang; Chen, Chiu-Yuan; Swanson, Richard; Olson, Steve T.; Kataoka, Hiroaki; Johnson, Michael D.; Lin, Chen-Yong			Antithrombin Regulates Matriptase Activity Involved in Plasmin Generation, Syndecan Shedding, and HGF Activation in Keratinocytes	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; SERINE-PROTEASE MATRIPTASE; EPIDERMAL BARRIER FUNCTION; MAMMARY EPITHELIAL-CELLS; HEPARIN-BINDING; PROTEOLYTIC CASCADE; ZYMOGEN ACTIVATION; CANCER-CELLS; HUMAN-MILK; INHIBITOR	Matriptase, a membrane-associated serine protease, plays an essential role in epidermal barrier function through activation of the glycosylphosphatidylinositol (GPI)-anchored serine protease prostasin. The matriptase-prostasin proteolytic cascade is tightly regulated by hepatocyte growth factor activator inhibitor (HAI)-1 such that matriptase autoactivation and prostasin activation occur simultaneously and are followed immediately by the inhibition of both enzymes by HAI-1. However, the mechanisms whereby matriptase acts on extracellular substrates remain elusive. Here we report that some active matriptase can escape HAI-1 inhibition by being rapidly shed from the cell surface. In the pericellular environment, shed active matriptase is able to activate hepatocyte growth factor (HGF), accelerate plasminogen activation, and shed syndecan 1. The amount of active matriptase shed is inversely correlated with the amount of antithrombin (AT) bound to the surface of the keratinocytes. Binding of AT to the surface of keratinocytes is dependent on a functional heparin binding site, Lys-125, and that the N-glycosylation site Asn-135 be unglycosylated. This suggests that beta-AT, and not alpha-AT, is responsible for regulation of pericellular matriptase activity in keratinocytes. Keratinocytes appear to rely on AT to regulate the level of pericellular active matriptase much more than breast and prostate epithelial cells in which AT regulation of matriptase activity occurs at much lower levels than keratinocytes. These results suggest that keratinocytes employ two distinct serine protease inhibitors to control the activation and processing of two different sets of matriptase substrates leading to different biological events: 1) HAI-1 for prostasin activation/inhibition, and 2) AT for the pericellular proteolysis involved in HGF activation, accelerating plasminogen activation, and shedding of syndecans.	[Chen, Ya-Wen; Xu, Zhenghong; Lin, Chen-Yong] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Chen, Ya-Wen] Univ Maryland, Grad Program Life Sci, Baltimore, MD 21201 USA; [Baksh, Adrienne N. H.] Univ Illinois, Dept Med, Chicago, IL USA; [Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Chen, Chiu-Yuan] Nanhua Univ, Grad Inst Nat Healing Sci, Chiayi, Taiwan; [Swanson, Richard; Olson, Steve T.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL USA; [Kataoka, Hiroaki] Miyazaki Univ, Fac Med, Dept Pathol, Miyazaki, Japan; [Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Defense Medical Center; Nanhua University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Miyazaki; Georgetown University	Lin, CY (corresponding author), Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA.	lincy@georgetown.edu		Chen, Ya-Wen/0000-0003-2382-8444; johnson, Michael/0000-0001-6260-7586	National Institutes of Health (NIH) [R01-CA-123223]; Maryland Cigarette Restitution Fund Program; NATIONAL CANCER INSTITUTE [R01CA123223] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Cigarette Restitution Fund Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) Grants R01-CA-123223 (MDJ and CL), and the Maryland Cigarette Restitution Fund Program (CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arocas V, 2001, J BIOL CHEM, V276, P43809, DOI 10.1074/jbc.M105294200; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Chen CJ, 2011, AM J PHYSIOL-CELL PH, V300, pC406, DOI 10.1152/ajpcell.00403.2010; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Chou FP, 2011, AM J PHYSIOL-CELL PH, V301, pC1093, DOI 10.1152/ajpcell.00122.2011; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; ECKERT RL, 1989, PHYSIOL REV, V69, P1316, DOI 10.1152/physrev.1989.69.4.1316; ELIAS PM, 1987, J INVEST DERMATOL, V88, P459, DOI 10.1111/1523-1747.ep12469885; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Green KA, 2008, J INVEST DERMATOL, V128, P2092, DOI 10.1038/jid.2008.54; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Kataoka H, 2000, J BIOL CHEM, V275, P40453, DOI 10.1074/jbc.M006412200; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Li Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016483; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Myerburg MM, 2008, AM J PHYSIOL-LUNG C, V294, pL932, DOI 10.1152/ajplung.00437.2007; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Opal SM, 2002, CRIT CARE MED, V30, pS325, DOI 10.1097/00003246-200205001-00024; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; PETERSON CB, 1985, J BIOL CHEM, V260, P610; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P12369, DOI 10.1021/bi020406j; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P4779, DOI 10.1021/bi012163l; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Swedenborg J, 1998, BLOOD COAGUL FIBRIN, V9, pS7; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tseng IC, 2008, AM J PHYSIOL-CELL PH, V295, pC423, DOI 10.1152/ajpcell.00164.2008; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; Zeeuwen PLJM, 2004, EUR J CELL BIOL, V83, P761, DOI 10.1078/0171-9335-00388	50	15	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62826	10.1371/journal.pone.0062826	http://dx.doi.org/10.1371/journal.pone.0062826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675430	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100014
J	Yamamoto, T; Mase, K; Sawada, H				Yamamoto, Takayuki; Mase, Keisuke; Sawada, Hiroshi			Diapause Prevention Effect of Bombyx mori by Dimethyl Sulfoxide	PLOS ONE			English	Article							EARLY EMBRYONIC-DEVELOPMENT; PROTEIN-KINASE CK2; SILKWORM; EGGS; CELLS; DIMETHYLSULFOXIDE; DIFFERENTIATION; LOCALIZATION; PERMEABILITY; TEMPERATURE	HCl treatment has been, for about 80 years, the primary method for the prevention of entry into embryonic diapauses of Bombyx mori. This is because no method is as effective as the HCl treatment. In this study, we discovered that dimethyl sulfoxide (DMSO) prevented entry into the diapause of the silkworm, Bombyx mori. The effect of diapause prevention was 78% as a result of treatment with 100% DMSO concentration, and the effect was comparable to that of the HCl treatment. In contrast, in the case of non-diapause eggs, hatchability was decreased by DMSO in a concentration-dependent manner. The effect of DMSO was restricted within 24 hours after oviposition of diapause eggs, and the critical period was slightly shorter than the effective period of the HCl treatment. DMSO analogs, such as dimethyl formamide (DMF) and dimethyl sulfide (DMS), did little preventive effect against the diapause. Furthermore, we also investigated the permeation effects of chemical compounds by DMSO. When treated with an inhibitor of protein kinase CK2 (CK2) dissolved in DMSO, the prevention rate of the diapause was less than 40%. This means that the inhibition effect by the CK2 inhibitor was the inhibition of embryonic development after diapause prevention by DMSO. These data suggest that DMSO has the effects of preventing from entering into the diapause and permeation of chemicals into diapause eggs.	[Yamamoto, Takayuki] Kitasato Univ, Coll Liberal Arts & Sci, Div Biol, Sagamihara, Kanagawa 228, Japan; [Mase, Keisuke; Sawada, Hiroshi] Nihon Univ, Coll Humanities & Sci, Setagaya Ku, Tokyo 156, Japan	Kitasato University; Nihon University	Sawada, H (corresponding author), Nihon Univ, Coll Humanities & Sci, Setagaya Ku, Tokyo 156, Japan.	sawada@chs.nihon-u.ac.jp			Japan Society for the Promotion of Science [21580068]; Grants-in-Aid for Scientific Research [25450489] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Japan Society for the Promotion of Science to HS, grant number 21580068. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHKONG QF, 1975, NATURE, V253, P194, DOI 10.1038/253194a0; COLLINS S, 1982, NATURE, V298, P679, DOI 10.1038/298679a0; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Fujiwara Y, 2006, INSECT BIOCHEM MOLEC, V36, P47, DOI 10.1016/j.ibmb.2005.10.005; GAILANI D, 1989, CANCER RES, V49, P5329; Gee DJ, 2012, BIOSCIENCE REP, V32, P375, DOI 10.1042/BSR20110109; Iwata K, 2005, J INSECT PHYSIOL, V51, P1306, DOI 10.1016/j.jinsphys.2005.07.009; Iwata KI, 2005, PHYSIOL ENTOMOL, V30, P317, DOI 10.1111/j.1365-3032.2005.00463.x; Kami D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002407; Miya K., 2003, EARLY EMBRYONIC DEV; Moribe Y, 2001, EUR J BIOCHEM, V268, P3432, DOI 10.1046/j.1432-1327.2001.02244.x; NAKAGAKI M, 1991, ROUX ARCH DEV BIOL, V200, P223, DOI 10.1007/BF00361341; Nijhout H.F., 1994, INSECT HORMONES; Notman R, 2007, BIOPHYS J, V93, P2056, DOI 10.1529/biophysj.107.104703; Pegg David E, 2007, Methods Mol Biol, V368, P39; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Sawada H, 2006, INSECT BIOCHEM MOLEC, V36, P911, DOI 10.1016/j.ibmb.2006.09.002; Sawada H, 2007, COMP BIOCHEM PHYS B, V146, P172, DOI 10.1016/j.cbpb.2006.10.101; Sawada H, 2012, ZOOL SCI, V29, P6, DOI 10.2108/zsj.29.6; SONOBE H, 1979, J INSECT PHYSIOL, V25, P381, DOI 10.1016/0022-1910(79)90003-9; SONOBE H, 1991, J INSECT PHYSIOL, V37, P727, DOI 10.1016/0022-1910(91)90106-A; Sonobe H, 2004, ZOOL SCI, V21, P503, DOI 10.2108/zsj.21.503; Takahashi Y, 1958, JAP J APPL ZOOL, V21, P158; Trang LTD, 2006, J BIOL RHYTHM, V21, P335, DOI 10.1177/0748730406291734; Tsurumaru S, 2010, J INSECT PHYSIOL, V56, P1721, DOI 10.1016/j.jinsphys.2010.07.004; Wang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033772; Wang XM, 2010, BIOCHEM BIOPH RES CO, V400, P613, DOI 10.1016/j.bbrc.2010.08.113; YAGINUMA T, 1990, J COMP PHYSIOL B, V160, P277, DOI 10.1007/BF00302593; Yamada R, 2005, ZOOL SCI, V22, P187, DOI 10.2108/zsj.22.187; Yamaguchi T, 1999, J BIOL CHEM, V274, P15575, DOI 10.1074/jbc.274.22.15575; Yamahama Y, 2003, J INSECT PHYSIOL, V49, P131, DOI 10.1016/S0022-1910(02)00257-3; Yamamoto T, 2005, DNA SEQUENCE, V16, P446, DOI 10.1080/10425170500287591; Yamamoto T, 2008, ZOOL SCI, V25, P799, DOI 10.2108/zsj.25.799; Yamashita O., 1985, P407; YOSHIMI T, 1990, Journal of Sericultural Science of Japan, V59, P14	36	9	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e64124	10.1371/journal.pone.0064124	http://dx.doi.org/10.1371/journal.pone.0064124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675522	Green Submitted, gold, Green Published			2022-12-25	WOS:000319036100056
J	Gerken, TA; Revoredo, L; Thome, JJC; Tabak, LA; Vester-Christensen, MB; Clausen, H; Gahlay, GK; Jarvis, DL; Johnson, RW; Moniz, HA; Moremen, K				Gerken, Thomas A.; Revoredo, Leslie; Thome, Joseph J. C.; Tabak, Lawrence A.; Vester-Christensen, Malene Bech; Clausen, Henrik; Gahlay, Gagandeep K.; Jarvis, Donald L.; Johnson, Roy W.; Moniz, Heather A.; Moremen, Kelley			Family of Glycosyltransferases (ppGalNAc Ts) Acts as a Switch Directing Glycopeptide Substrate Glycosylation in an N- or C-terminal Direction, Further Controlling Mucin Type O-Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; ACETYL-D-GALACTOSAMINE; NEIGHBORING RESIDUE GLYCOSYLATION; TRANSFERASE GENE FAMILY; UDP-GALNAC; LECTIN DOMAINS; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE-1; ACETYLGALACTOSAMINYLTRANSFERASES T1; TUMORAL CALCINOSIS; SUGAR RECOGNITION	Mucin type O-glycosylation is initiated by a large family of polypeptide GalNAc transferases (ppGalNAc Ts) that add alpha-GalNAc to the Ser and Thr residues of peptides. Of the 20 human isoforms, all but one are composed of two globular domains linked by a short flexible linker: a catalytic domain and a ricin-like lectin carbohydrate binding domain. Presently, the roles of the catalytic and lectin domains in peptide and glycopeptide recognition and specificity remain unclear. To systematically study the role of the lectin domain in ppGalNAc T glycopeptide substrate utilization, we have developed a series of novel random glycopeptide substrates containing a single GalNAc-O-Thr residue placed near either the N or C terminus of the glycopeptide substrate. Our results reveal that the presence and N- or C-terminal placement of the GalNAc-O-Thr can be important determinants of overall catalytic activity and specificity that differ between transferase isoforms. For example, ppGalNAc T1, T2, and T14 prefer C-terminally placed GalNAc-O-Thr, whereas ppGalNAc T3 and T6 prefer N-terminally placed GalNAc-O-Thr. Several transferase isoforms, ppGalNAc T5, T13, and T16, display equally enhanced N- or C-terminal activities relative to the nonglycosylated control peptides. This N-and/or C-terminal selectivity is presumably due to weak glycopeptide binding to the lectin domain, whose orientation relative to the catalytic domain is dynamic and isoform-dependent. Such N-or C-terminal glycopeptide selectivity provides an additional level of control or fidelity for the O-glycosylation of biologically significant sites and suggests that O-glycosylation may in some instances be exquisitely controlled.	[Gerken, Thomas A.; Thome, Joseph J. C.] Case Western Reserve Univ, Dept Pediat, WA Bernbaum Ctr Cyst Fibrosis Res, Cleveland, OH 44106 USA; [Gerken, Thomas A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Gerken, Thomas A.; Revoredo, Leslie] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Tabak, Lawrence A.] NIDCR, Sect Biol Chem, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Vester-Christensen, Malene Bech; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, CCG, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Vester-Christensen, Malene Bech; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, CCG, Dept Dent, DK-2200 Copenhagen N, Denmark; [Gahlay, Gagandeep K.; Jarvis, Donald L.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Johnson, Roy W.; Moniz, Heather A.; Moremen, Kelley] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Copenhagen; University of Copenhagen; University of Wyoming; University System of Georgia; University of Georgia	Gerken, TA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pediat, BRB 823,2109 Adelbert Rd, Cleveland, OH 44104 USA.	txg2@cwru.edu	Gahlay, Gagandeep/F-3975-2010; Moremen, Kelley/AAD-4661-2019; clausen, henrik/AAD-8016-2021; Gahlay, Gagandeep/AAO-7928-2020	Gahlay, Gagandeep/0000-0002-0058-2827; Clausen, Henrik/0000-0002-0915-5055; Jarvis, Donald/0000-0002-8104-7155	National Institutes of Health [R01-CA78834, P41-GM103390, P41-RR005351]; National Institutes of Health; NIDCR; Danish National Research Foundation Grant [DNRF107]; NATIONAL CANCER INSTITUTE [R01CA078834] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, U01GM113534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Danish National Research Foundation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA78834 (to T. A. G.) and P41-GM103390 and P41-RR005351 (to James Prestegard (Complex Carbohydrate Center, University of Georgia) and K. M. and D. L. J.) and a National Institutes of Health, NIDCR, intramural program grant (to L. A. T.). This work was also supported by Danish National Research Foundation Grant DNRF107 (to H. C.).	Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Berois N, 2006, J HISTOCHEM CYTOCHEM, V54, P317, DOI 10.1369/jhc.5A6783.2005; Berois N, 2013, CLIN CHEM, V59, P225, DOI 10.1373/clinchem.2012.192328; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Carmon A, 2007, GENETICS, V176, P309, DOI 10.1534/genetics.106.060897; Cheng LM, 2002, FEBS LETT, V531, P115, DOI 10.1016/S0014-5793(02)03399-9; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Fujimoto Z, 2000, J MOL BIOL, V300, P575, DOI 10.1006/jmbi.2000.3877; Garringer HJ, 2006, J CLIN ENDOCR METAB, V91, P4037, DOI 10.1210/jc.2006-0305; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gerken TA, 2004, BIOCHEMISTRY-US, V43, P9888, DOI 10.1021/bi049178e; Gerken TA, 2002, J BIOL CHEM, V277, P49850, DOI 10.1074/jbc.M205851200; Gerken TA, 2002, J BIOL CHEM, V277, P7736, DOI 10.1074/jbc.M111690200; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Hanisch FG, 2001, GLYCOBIOLOGY, V11, P731, DOI 10.1093/glycob/11.9.731; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; Herr P, 2008, DEVELOPMENT, V135, P1813, DOI 10.1242/dev.019323; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Imberty A, 1997, PROTEIN ENG, V10, P1353, DOI 10.1093/protein/10.12.1353; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kinlough CL, 2011, J BIOL CHEM, V286, P39072, DOI 10.1074/jbc.M111.289504; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Lee SH, 2010, J BIOL CHEM, V285, P37683, DOI 10.1074/jbc.M110.162735; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Maveyraud L, 2009, PROTEINS, V75, P89, DOI 10.1002/prot.22222; Nakayama Y, 2012, J BIOL CHEM, V287, P32222, DOI 10.1074/jbc.M112.370932; Park JH, 2011, NEOPLASIA, V13, P320, DOI 10.1593/neo.101440; Pedersen JW, 2011, J BIOL CHEM, V286, P32684, DOI 10.1074/jbc.M111.273722; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; RAJU TS, 1994, BIOCHEM BIOPH RES CO, V205, P402, DOI 10.1006/bbrc.1994.2679; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Simmons AD, 1999, HUM MOL GENET, V8, P2155, DOI 10.1093/hmg/8.12.2155; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Tani M, 2003, J BIOL CHEM, V278, P10523, DOI 10.1074/jbc.M207932200; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; Tenno M, 2002, J BIOL CHEM, V277, P47088, DOI 10.1074/jbc.M207369200; Tenno M, 2002, BIOCHEM BIOPH RES CO, V298, P755, DOI 10.1016/S0006-291X(02)02549-4; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; Tran DT, 2012, J BIOL CHEM, V287, P5243, DOI 10.1074/jbc.M111.306159; Vakhrushev S. Y., 2013, MOL CELL PR IN PRESS; Vester-Christensen M. B., 2013, METHODS MOL IN PRESS; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wakinaka T, 2013, GLYCOBIOLOGY, V23, P232, DOI 10.1093/glycob/cws142; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Wopereis S, 2006, CLIN CHEM, V52, P574, DOI 10.1373/clinchem.2005.063040; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Yoshimura Y, 2012, GLYCOBIOLOGY, V22, P429, DOI 10.1093/glycob/cwr159; Young WW, 2003, GLYCOBIOLOGY, V13, P549, DOI 10.1093/glycob/cwg062; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200	75	60	63	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19900	19914		10.1074/jbc.M113.477877	http://dx.doi.org/10.1074/jbc.M113.477877			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689369	hybrid, Green Published			2022-12-25	WOS:000321515800056
J	Takarada, T; Kou, M; Nakamichi, N; Ogura, M; Ito, Y; Fukumori, R; Kokubo, H; Acosta, GB; Hinoi, E; Yoneda, Y				Takarada, Takeshi; Kou, Miki; Nakamichi, Noritaka; Ogura, Masato; Ito, Yuma; Fukumori, Ryo; Kokubo, Hiroshi; Acosta, Gabriela B.; Hinoi, Eiichi; Yoneda, Yukio			Myosin VI Reduces Proliferation, but Not Differentiation, in Pluripotent P19 Cells	PLOS ONE			English	Article							TRAUMATIC STRESS; BINDING-PROTEIN; DENTATE GYRUS; MOTOR; NEURONS; ACID; NEUROGENESIS; EXPRESSION; RECEPTORS; GENES	Background: We have previously shown marked upregulation of the mRNA and corresponding protein for the cellular motor molecule myosin VI (Myo6) after an extremely traumatic stress experience, along with a delayed decrease in 5-bromo-2'-deoxyuridine incorporation in the murine hippocampus, a brain structure believed to undergo adult neurogenesis. In this study, we investigated the role of Myo6 in both proliferation and differentiation in pluripotent P19 cells by using stable transfection and RNA interference techniques. Methodology/Principal Findings: Stable overexpression of Myo6 not only led to significant inhibition of the reducing activity of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and the size of clustered aggregates in P19 cells, but also resulted in selectively decreased mRNA expression of the repressor type proneural gene Hes5 without affecting the expression of neuronal and astroglial marker proteins. In P19 cells transfected with Myo6 siRNA, by contrast, a significant increase was found in the size of aggregate and MTT reduction along with increased Sox2 protein levels, in addition to marked depletion of the endogenous Myo6 protein. In C6 glioma cells, however, introduction of Myo6 siRNA induced a drastic decrease in endogenous Myo6 protein levels without significantly affecting MTT reduction. The Ca2+ ionophore A23187 drastically increased the luciferase activity in P19 cells transfected with a Myo6 promoter reporter plasmid, but not in HEK293, Neuro2A and C6 glioma cells transfected with the same reporter. Conclusions/Significance: These results suggest that Myo6 may play a predominant pivotal role in the mechanism underlying proliferation without affecting differentiation to progeny lineages in pluripotent P19 cells.	[Takarada, Takeshi; Kou, Miki; Nakamichi, Noritaka; Ogura, Masato; Ito, Yuma; Fukumori, Ryo; Kokubo, Hiroshi; Acosta, Gabriela B.; Hinoi, Eiichi; Yoneda, Yukio] Kanazawa Univ, Grad Sch, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa, Japan; [Acosta, Gabriela B.] Univ Buenos Aires, CONICET, ININFA, Buenos Aires, DF, Argentina	Kanazawa University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Yoneda, Y (corresponding author), Kanazawa Univ, Grad Sch, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa, Japan.	yyoneda@p.kanazawa-u.ac.jp	Nakamichi, Noritaka/AAB-7388-2020; Ogura, Masato/AAK-1619-2020; Nakamichi, Noritaka/D-8403-2015; Yoneda, Yukio/ABI-1864-2020	Nakamichi, Noritaka/0000-0002-0283-3546; Yoneda, Yukio/0000-0002-4624-177X; Acosta, Gabriela/0000-0002-4794-9980; Ogura, Masato/0000-0001-9557-5023; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science and Technology, Japan [22500330, 24650196]; Grants-in-Aid for Scientific Research [24650196] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research to T. T. (No. 22500330) and Y.Y. (No. 24650196) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar V, 2010, EMBO MOL MED, V2, P338, DOI 10.1002/emmm.201000089; ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Boutin C, 2010, P NATL ACAD SCI USA, V107, P1201, DOI 10.1073/pnas.0909015107; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Casarosa S, 1999, DEVELOPMENT, V126, P525; Endo M, 2009, J BIOL CHEM, V284, P5107, DOI 10.1074/jbc.M807745200; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fukumori R, 2010, J PHARMACOL SCI, V112, P273, DOI 10.1254/jphs.09294FP; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Markakis EA, 1999, J COMP NEUROL, V406, P449; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Ogura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048270; Ogura M, 2011, NEUROCHEM INT, V58, P504, DOI 10.1016/j.neuint.2011.01.007; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rudnicki M.A., 1987, TERATOCARCINOMAS EMB; SAPOLSKY RM, 1988, BRAIN RES, V453, P367, DOI 10.1016/0006-8993(88)90180-1; Takarada T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046177; Takarada T, 2012, J BIOL CHEM, V287, P36081, DOI 10.1074/jbc.M112.408963; Takarada T, 2009, J NEUROCHEM, V110, P1457, DOI 10.1111/j.1471-4159.2009.06225.x; Tamaki K, 2008, J NEUROCHEM, V105, P1642, DOI 10.1111/j.1471-4159.2008.05253.x; Tamaki K, 2008, NEUROSCI LETT, V433, P183, DOI 10.1016/j.neulet.2007.12.062; Vreugde S, 2006, MOL CELL, V23, P749, DOI 10.1016/j.molcel.2006.07.005; WEIDMANN E, 1995, ANN HEMATOL, V70, P153, DOI 10.1007/s002770050049; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Wu HJ, 2002, J BIOL CHEM, V277, P30928, DOI 10.1074/jbc.M203735200; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; YONEDA Y, 1983, J NEUROCHEM, V40, P350, DOI 10.1111/j.1471-4159.1983.tb11289.x	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63947	10.1371/journal.pone.0063947	http://dx.doi.org/10.1371/journal.pone.0063947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691122	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900068
J	Zeilinger, S; Kuhnel, B; Klopp, N; Baurecht, H; Kleinschmidt, A; Gieger, C; Weidinger, S; Lattka, E; Adamski, J; Peters, A; Strauch, K; Waldenberger, M; Illig, T				Zeilinger, Sonja; Kuehnel, Brigitte; Klopp, Norman; Baurecht, Hansjoerg; Kleinschmidt, Anja; Gieger, Christian; Weidinger, Stephan; Lattka, Eva; Adamski, Jerzy; Peters, Annette; Strauch, Konstantin; Waldenberger, Melanie; Illig, Thomas			Tobacco Smoking Leads to Extensive Genome-Wide Changes in DNA Methylation	PLOS ONE			English	Article							PLACENTAL ALKALINE-PHOSPHATASE; HYDROCARBON RECEPTOR REPRESSOR; PROMOTER METHYLATION; LYMPHOBLASTS; EXPRESSION; PIPELINE; PLASMA; MARKER; HEALTH; CANCER	Environmental factors such as tobacco smoking may have long-lasting effects on DNA methylation patterns, which might lead to changes in gene expression and in a broader context to the development or progression of various diseases. We conducted an epigenome-wide association study (EWAs) comparing current, former and never smokers from 1793 participants of the population-based KORA F4 panel, with replication in 479 participants from the KORA F3 panel, carried out by the 450K BeadChip with genomic DNA obtained from whole blood. We observed wide-spread differences in the degree of site-specific methylation (with p-values ranging from 9.31E-08 to 2.54E-182) as a function of tobacco smoking in each of the 22 autosomes, with the percent of variance explained by smoking ranging from 1.31 to 41.02. Depending on cessation time and pack-years, methylation levels in former smokers were found to be close to the ones seen in never smokers. In addition, methylation-specific protein binding patterns were observed for cg05575921 within AHRR, which had the highest level of detectable changes in DNA methylation associated with tobacco smoking (-24.40% methylation; p = 2.54E-182), suggesting a regulatory role for gene expression. The results of our study confirm the broad effect of tobacco smoking on the human organism, but also show that quitting tobacco smoking presumably allows regaining the DNA methylation state of never smokers.	[Zeilinger, Sonja; Klopp, Norman; Kleinschmidt, Anja; Lattka, Eva; Peters, Annette; Waldenberger, Melanie; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Kuehnel, Brigitte; Gieger, Christian; Strauch, Konstantin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Klopp, Norman; Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Baurecht, Hansjoerg; Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol Allergol & Venerol, Kiel, Germany; [Baurecht, Hansjoerg] Tech Univ Munich, Grad Sch Informat Sci Hlth, D-80290 Munich, Germany; [Adamski, Jerzy] Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Chair Expt Genet, D-80290 Munich, Germany; [Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; University of Kiel; Schleswig Holstein University Hospital; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Waldenberger, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany.	waldenberger@helmholtz-muenchen.de	Reischl, Eva/B-9311-2013; Weidinger, Stephan/C-8461-2011; Waldenberger, Melanie/B-5355-2014; Peters, Annette/A-6117-2011; Baurecht, Hansjorg/C-4035-2013	Reischl, Eva/0000-0003-4055-8060; Weidinger, Stephan/0000-0003-3944-252X; Waldenberger, Melanie/0000-0003-0583-5093; Peters, Annette/0000-0001-6645-0985; Kunze, Sonja/0000-0002-9685-2675; Adamski, Jerzy/0000-0001-9259-0199; Gieger, Christian/0000-0001-6986-9554; Baurecht, Hansjorg/0000-0002-9265-5594	Helmholtz Zentrum Munchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF); State of Bavaria; Graduate School of Information Science in Health, Technische Universitat Munchen;  [DFG/Tr22-Z03]	Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Graduate School of Information Science in Health, Technische Universitat Munchen; 	The KORA study was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. This work was supported by the DFG/Tr22-Z03 and the Graduate School of Information Science in Health, Technische Universitat Munchen. The funders had no role in study design, data collection and analysis, decision to publish, or preperation of the manuscript.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Arsenescu R, 2011, INFLAMM BOWEL DIS, V17, P1149, DOI 10.1002/ibd.21463; Barrera V, 2012, NUCLEIC ACIDS RES, V40, P11490, DOI 10.1093/nar/gks928; Belinsky SA, 2002, CANCER RES, V62, P2370; Bosse Y, 2012, CANCER RES, V72, P3753, DOI 10.1158/0008-5472.CAN-12-1160; Breitling LP, 2012, EUR HEART J; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; BROCK DJH, 1988, BRIT J OBSTET GYNAEC, V95, P79, DOI 10.1111/j.1471-0528.1988.tb06484.x; Chen HT, 2010, J CELL PHYSIOL, V223, P737, DOI 10.1002/jcp.22083; Chiba T, 2012, J ALLERGY CAIRO; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Enokida H, 2006, CANCER-AM CANCER SOC, V106, P79, DOI 10.1002/cncr.21577; Eriksen M. P., 2012, TOBACCO ATLAS, Vfouth; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; FOX H, 1974, EUR J OBSTET GYN R B, V4, P45, DOI 10.1016/0028-2243(74)90008-2; Haarmann-Stemmann T, 2007, DRUG METAB DISPOS, V35, P2262, DOI 10.1124/dmd.107.016253; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Joubert BR, 2012, ENV HLTH PERSPECT; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kasai A, 2006, CANCER RES, V66, P7143, DOI 10.1158/0008-5472.CAN-05-4541; Koshida K, 1996, BRIT J UROL, V77, P138, DOI 10.1046/j.1464-410X.1996.74324.x; KOSHIDA K, 1990, UROL RES, V18, P169, DOI 10.1007/BF00295842; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS31, DOI 10.1055/s-2005-858241; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matthews Jason, 2006, Nucl Recept Signal, V4, pe016; MEYER RE, 1995, AM J OBSTET GYNECOL, V173, P181, DOI 10.1016/0002-9378(95)90187-6; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Moawad AH, 2002, AM J OBSTET GYNECOL, V186, P990, DOI 10.1067/mob.2002.121727; Monick MM, 2012, AM J MED GENET B, V159B, P141, DOI 10.1002/ajmg.b.32021; Mosbah Amira A Abd El-Rahman, 2011, J Egypt Soc Parasitol, V41, P745; Muensch H, 1984, Prog Clin Biol Res, V166, P317; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; NIELSEN OS, 1990, EUR J CANCER, V26, P1049, DOI 10.1016/0277-5379(90)90049-Y; Philibert RA, 2010, AM J MED GENET B, V153B, P619, DOI 10.1002/ajmg.b.31031; Pot C, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13592; Services USDoHaH, 2010, TOB SMOK CAUS DIS BI; Services USDoHaH, 2006, HLTH CONS INV EXP TO; Shenker NS, 2012, HUM MOL GENET; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Touleimat N, 2012, EPIGENOMICS-UK, V4, P325, DOI [10.2217/epi.12.21, 10.2217/EPI.12.21]; TUCKER DF, 1985, BRIT J CANCER, V51, P631, DOI 10.1038/bjc.1985.95; van der Maarel SM, 2008, ANN RHEUM DIS, V67, P97, DOI 10.1136/ard.2008.098392; Wan ES, 2012, HUM MOL GENET; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	53	508	518	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63812	10.1371/journal.pone.0063812	http://dx.doi.org/10.1371/journal.pone.0063812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691101	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107900061
J	Chuang, FC; Kuo, HC				Chuang, Fei-Chi; Kuo, Hann-Chorng			Increased Urothelial Cell Apoptosis and Chronic Inflammation Are Associated with Recurrent Urinary Tract Infection in Women	PLOS ONE			English	Article							GROWTH-FACTOR LEVELS; MAST-CELL; INTERSTITIAL CYSTITIS; BLADDER; ACTIVATION; PHOSPHORYLATION; INVOLVEMENT; TRYPTASE; KINASE; P53	Objective: This study was designed to investigate whether increased urothelial cell apoptosis and chronic inflammation might contribute to recurrent urinary tract infection (UTI) in women. Methods: The bladder biopsy specimens were collected from thirty women with recurrent UTI and ten controls. The bladder biopsies were performed at one to two months after UTI episode had been completely resolved and urine analysis and urine culture all showed negative. Immunofluorescence staining of the adhesive protein E-cadherin, mast cell and TUNEL were performed in all the bladder specimens. In addition, western blots were also performed to analyze the inflammatory proteins (phospho-p38, tryptase) and apoptotic protein (Bax) in the bladder mucosa specimens between patients with recurrent UTI and controls. Results: Immunofluorescence staining showed significantly lower E-cadherin in the recurrent UTI bladder tissue compared with the controls (25.4 +/- 8.9 v 42.4 +/- 16.7, p<0.0001). The mast cell expression was significantly stronger in the recurrent UTI bladder tissue compared with the controls (2.5 +/- 1.8 v 1.3 +/- 1.2, p = 0.046). TUNEL staining revealed a significantly higher numbers of apoptotic cells in the recurrent UTI bladder tissue compared with the control bladder tissue (1.5 +/- 1.8 v 0.08 +/- 0.3, p<0.0001). Western blot analysis also showed that the expressions of tryptase and Bax increased in five recurrent UTI specimens compared with two normal control specimens. Conclusion: Chronic inflammation, urothelial cell apoptosis and impairment of barrier function of urothelial cells might contribute to recurrent UTI in women.	[Chuang, Fei-Chi] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Chuang, Fei-Chi] Chang Gung Univ Coll Med, Dept Obstet & Gynecol, New Taipei, Taiwan; [Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Kuo, Hann-Chorng] Buddhist Tzu Chi Univ Coll Med, Dept Urol, Hualien, Taiwan	Chang Gung Memorial Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Chuang, FC (corresponding author), Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Obstet & Gynecol, Kaohsiung, Taiwan.	chuangfeichi@hotmail.com; hck@tzuchi.com.tw						Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; Chung SD, 2011, NEUROUROL URODYNAM, V30, P417, DOI 10.1002/nau.20938; Graham Emmanuel, 2006, Curr Urol Rep, V7, P440, DOI 10.1007/s11934-006-0051-8; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Janssen DAW, 2011, J UROLOGY, V186, P1121, DOI 10.1016/j.juro.2011.04.107; Jiang P, 2007, CELL RES, V17, P283, DOI 10.1038/cr.2007.19; Kaczmarek E, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P155; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Khan MA, 2002, UROL RES, V30, P79, DOI 10.1007/s00240-002-0233-x; Kuo Hann-Chorng, 2010, Rev Urol, V12, pe69; Liu HT, 2008, BJU INT, V102, P1440, DOI 10.1111/j.1464-410X.2008.07757.x; Liu HT, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.01.047; Liu HT, 2010, J FORMOS MED ASSOC, V109, P862, DOI 10.1016/S0929-6646(10)60133-7; Liu HT, 2009, BJU INT, V103, P1668, DOI 10.1111/j.1464-410X.2009.08380.x; Liu HT, 2009, EUR UROL, V56, P700, DOI 10.1016/j.eururo.2008.04.037; Lowe EM, 1997, BRIT J UROL, V79, P572, DOI 10.1046/j.1464-410X.1997.00097.x; LYNES WL, 1987, J UROLOGY, V138, P746, DOI 10.1016/S0022-5347(17)43359-3; Ma FY, 2007, AM J PHYSIOL-RENAL, V293, pF1556, DOI 10.1152/ajprenal.00010.2007; ROZNIECKI JJ, 1995, ANN NEUROL, V37, P63, DOI 10.1002/ana.410370112; Sant GR, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.08.1109; Shie JH, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.09.049; Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x; Sylvester PW, 2007, VITAM HORM, V76, P329, DOI 10.1016/S0083-6729(07)76012-0; Van De Merwe JP, 2000, BJU INT, V85, P995, DOI 10.1046/j.1464-410x.2000.00646.x; Wang HL, 2007, CELL BIOL INT, V31, P1027, DOI 10.1016/j.cellbi.2007.03.017; Zhang S, 2012, CELL PHYSIOL BIOCHEM, V29, P931, DOI 10.1159/000171029	27	36	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63760	10.1371/journal.pone.0063760	http://dx.doi.org/10.1371/journal.pone.0063760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691091	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700058
J	Fedorova, LV; Sodhi, K; Gatto-Weis, C; Puri, N; Hinds, TD; Shapiro, JI; Malhotra, D				Fedorova, Larisa V.; Sodhi, Komal; Gatto-Weis, Cara; Puri, Nitin; Hinds, Terry D., Jr.; Shapiro, Joseph I.; Malhotra, Deepak			Peroxisome Proliferator-Activated Receptor delta Agonist, HPP593, Prevents Renal Necrosis under Chronic Ischemia	PLOS ONE			English	Article							MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; TRANSCRIPTION FACTOR NRF2; FOCAL CEREBRAL-ISCHEMIA; AUTOPHAGIC CELL-DEATH; OXIDATIVE STRESS; KAPPA-B; MITOCHONDRIAL DYSFUNCTION; UP-REGULATION; BNIP3; EXPRESSION	The Goldblatt's 2 kidney 1 clip (2K1C) rat animal model of renovascular hypertension is characterized by ischemic nephropathy of the clipped kidney. 2K1C rats were treated with a specific peroxisome proliferator-activated receptor delta (PPAR delta) agonist, HPP593. Clipped kidneys from untreated rats developed tubular and glomerular necrosis and massive interstitial, periglomerular and perivascular fibrosis. HPP593 kidneys did not exhibit any histochemical features of necrosis; fibrotic lesions were present only in perivascular areas. Necrosis in the untreated clipped kidneys was associated with an increased oxidative stress, up regulation and mitochondrial translocation of the pro-death protein BNIP3 specifically in tubules. In the kidneys of HPP593-treated rats oxidative stress was attenuated and BNIP3 protein decreased notably in the mitochondrial fraction when compared to untreated animals. In untreated clipped kidneys, mitochondria were dysfunctional as revealed by perturbations in the levels of MCAD, COXIV, TFAM, and Parkin proteins and AMPK activation, while in HPP593-treated rats these proteins remained at the physiological levels. Nuclear amounts of oxidative stress-responsive proteins, NRF1 and NRF2 were below physiological levels in treated kidneys. Mitochondrial biogenesis and autophagy were inhibited similarly in both treated and untreated 2K1C kidneys as indicated by a decrease in PGC1-alpha and deficiency of the autophagy-essential proteins LC3-II and ATG5. However, HPP593 treatment resulted in increased accumulation of p62 protein, an autophagic substrate and an enhancer of NRF2 activity. Therefore, inhibition of BNIP3 activation by the preservation of mitochondrial function and control of oxidative stress by PPARd is the most likely mechanism to account for the prevention of necrotic death in the kidney under conditions of persistent ischemia.	[Fedorova, Larisa V.; Shapiro, Joseph I.; Malhotra, Deepak] Univ Toledo, Sch Med, Dept Med, Toledo, OH 43606 USA; [Sodhi, Komal; Puri, Nitin; Hinds, Terry D., Jr.] Univ Toledo, Sch Med, Dept Physiol & Pharmacol, Toledo, OH 43606 USA; [Gatto-Weis, Cara] Univ Toledo, Sch Med, Dept Pathol, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Fedorova, LV (corresponding author), Univ Toledo, Sch Med, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	Larisa.fedorova@utoledo.edu	Hinds, Terry/B-8495-2015	Hinds, Terry/0000-0002-7599-1529	NIH [263-MA-707136-1]; internal funds at the University of Toledo Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109015, U01HL071556] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); internal funds at the University of Toledo Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH contract # 263-MA-707136-1 (S.J.I. and D.M.) and internal funds at the University of Toledo Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus J, 2006, NEUROCHEM INT, V48, P687, DOI 10.1016/j.neuint.2005.12.008; Altieri P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046126; Arsenijevic D, 2006, J CEREBR BLOOD F MET, V26, P433, DOI 10.1038/sj.jcbfm.9600200; Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Baetz D, 2005, CIRCULATION, V112, P3777, DOI 10.1161/CIRCULATIONAHA.105.573899; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Benigni A, 2010, LANCET, V375, P1310, DOI 10.1016/S0140-6736(10)60237-1; Bishop-Bailey D, 2011, BIOCHEM SOC T, V39, P1601, DOI 10.1042/BST20110643; Bishop-Bailey D, 2008, PPAR RES, V2008, DOI 10.1155/2008/825970; Bishop-Bailey D, 2009, PHARMACOL THERAPEUT, V124, P141, DOI 10.1016/j.pharmthera.2009.06.011; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Boor P, 2011, KIDNEY INT, V80, P1182, DOI 10.1038/ki.2011.254; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; CAMADRO JM, 1985, ARCH BIOCHEM BIOPHYS, V242, P206, DOI 10.1016/0003-9861(85)90494-1; CANTIN M, 1979, AM J PATHOL, V96, P545; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chen HH, 2009, AM J PHYSIOL-RENAL, V297, pF1109, DOI 10.1152/ajprenal.00057.2009; Collino M, 2011, FREE RADICAL BIO MED, V50, P345, DOI 10.1016/j.freeradbiomed.2010.10.710; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; DENNIS SC, 1991, J MOL CELL CARDIOL, V23, P1077, DOI 10.1016/0022-2828(91)91642-5; Ding X, 2010, AUTOPHAGY, V6; Diwan A, 2007, J CLIN INVEST, V117, P2825, DOI 10.1172/JCI32490; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Fedorova L, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-15; Fedorova LV, 2009, AM J PHYSIOL-RENAL, V296, pF922, DOI 10.1152/ajprenal.90605.2008; Fogo AB, 2011, PEDIATR NEPHROL, V26, P347, DOI 10.1007/s00467-010-1602-2; Frazier DP, 2006, ANTIOXID REDOX SIGN, V8, P1625, DOI 10.1089/ars.2006.8.1625; Galvez AS, 2006, J BIOL CHEM, V281, P1442, DOI 10.1074/jbc.M509056200; Gamboa JL, 2010, AM J PHYSIOL-REG I, V298, pR575, DOI 10.1152/ajpregu.00320.2009; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glatz T, 2010, J HYPERTENS, V28, P1488, DOI 10.1097/HJH.0b013e3283396e4e; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; Gustafsson AB, 2011, PEDIATR CARDIOL, V32, P267, DOI 10.1007/s00246-010-9876-5; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Herzog C, 2012, AM J PHYSIOL-RENAL, V303, pF1239, DOI 10.1152/ajprenal.00659.2011; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Iwashita A, 2007, J PHARMACOL EXP THER, V320, P1087, DOI 10.1124/jpet.106.115758; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kapoor A, 2010, SHOCK, V34, P117, DOI 10.1097/SHK.0b013e3181cd86d6; Kennedy DJ, 2006, HYPERTENSION, V47, P488, DOI 10.1161/01.HYP.0000202594.82271.92; Kimura T, 2011, J AM SOC NEPHROL; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Kubl DA, 2007, BIOCHEM J, V405, P407, DOI 10.1042/BJ20070319; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Kurosu T, 2003, ONCOGENE, V22, P4459, DOI 10.1038/sj.onc.1206755; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee M, 2011, BIOCHEM BIOPH RES CO, V413, P122, DOI 10.1016/j.bbrc.2011.08.067; Lerman LO, 2009, PROG CARDIOVASC DIS, V52, P196, DOI 10.1016/j.pcad.2009.09.002; Lerman LO, 2001, HYPERTENSION, V37, P541, DOI 10.1161/01.HYP.37.2.541; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Letavernier E, 2005, J AM SOC NEPHROL, V16, P2395, DOI 10.1681/ASN.2004090802; Li SY, 2009, KIDNEY INT, V76, P1049, DOI 10.1038/ki.2009.330; Liu JA, 2011, HYPERTENSION, V57, P223, DOI 10.1161/HYPERTENSIONAHA.110.164590; Liu S, 2012, AUTOPHAGY, V8; Mazure NM, 2009, AUTOPHAGY, V5, P868, DOI 10.4161/auto.9042; Meissner M, 2011, ARCH DERMATOL RES, V303, P41, DOI 10.1007/s00403-010-1091-y; Metukuri MR, 2009, AM J PHYSIOL-GASTR L, V296, pG499, DOI 10.1152/ajpgi.90526.2008; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Moscat J, 2011, CELL, V147, P724, DOI 10.1016/j.cell.2011.10.021; NADASDY T, 1994, HUM PATHOL, V25, P22, DOI 10.1016/0046-8177(94)90166-X; Nakamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030767; Nezis IP, 2012, ANTIOXID REDOX SIGNA; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Ong SB, 2012, CARDIOVASC RES, V94, P190, DOI 10.1093/cvr/cvr312; Patel NSA, 2009, J PHARMACOL EXP THER, V328, P635, DOI 10.1124/jpet.108.146191; Pesant M, 2006, CARDIOVASC RES, V69, P440, DOI 10.1016/j.cardiores.2005.10.019; PFALLER W, 1980, INT J BIOCHEM, V12, P17, DOI 10.1016/0020-711X(80)90035-X; Pialat JB, 2007, NMR BIOMED, V20, P335, DOI 10.1002/nbm.1157; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Quinsay MN, 2010, J MOL CELL CARDIOL, V48, P1146, DOI 10.1016/j.yjmcc.2009.12.004; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Regula KM, 2002, CIRC RES, V91, P226, DOI 10.1161/01.RES.0000029232.42227.16; Regula KM, 2004, CIRCULATION, V110, P3795, DOI 10.1161/01.CIR.0000150537.59754.55; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Sanchez-Lopez E, 2005, ANTIOXID REDOX SIGN, V7, P1275, DOI 10.1089/ars.2005.7.1275; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Shanley PF, 1996, SEMIN NEPHROL, V16, P21; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Sivarajah A, 2003, AM J NEPHROL, V23, P267, DOI 10.1159/000072088; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Tanaka T, 2013, NAT REV NEPHROL; Thomas MC, 2012, PPAR RES, V2012, DOI 10.1155/2012/456529; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Wang PY, 2010, CIRC RES, V106, P911, DOI 10.1161/CIRCRESAHA.109.206185; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Willey James C., 2004, V258, P13; Yin KJ, 2011, ARTERIOSCL THROM VAS, V31, P574, DOI 10.1161/ATVBAHA.110.221267; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang J, 2011, ANTIOXID REDOX SIGN, V14, P1959, DOI 10.1089/ars.2010.3772; Zhang ZF, 2007, STROKE, V38, P1606, DOI 10.1161/STROKEAHA.106.475129	104	34	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64436	10.1371/journal.pone.0064436	http://dx.doi.org/10.1371/journal.pone.0064436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691217	gold, Green Submitted, Green Published			2022-12-25	WOS:000319052700095
J	Hagg, D; Eriksson, M; Sundstrom, A; Schmitt-Egenolf, M				Hagg, David; Eriksson, Marie; Sundstrom, Anders; Schmitt-Egenolf, Marcus			The Higher Proportion of Men with Psoriasis Treated with Biologics May Be Explained by More Severe Disease in Men	PLOS ONE			English	Article							SYSTEM; INDEX; AREA; RISK	Moderate to severe psoriasis, once regarded as merely a skin disease, is today seen as an inflammatory systemic disease. The sex ratio of the prevalence of psoriasis is balanced. In recent years several reports have documented that men receive more systemic or UV treatment than women, and different hypotheses were made. In PsoReg, the national registry for systemic treatment of psoriasis in Sweden, we have, like other European registries, observed a predominance of men (59%), especially of men treated with biologics (63%). Biologics are a relatively new group of very effective but high-priced drugs. The objective of this study was to analyse if women are discriminated by not having the same access to the high-priced biologics. Design: Population based cohort study using data from a nationwide quality register of psoriasis patients. Population: 2294 patients with moderate to severe psoriasis receiving systemic treatment from a specialist in dermatology. Main Outcome Measures: Time to initiation of biologic treatment. A multiple Cox proportional hazard's regression was performed, with time to initiating a biologic treatment as the outcome in order to assess the independent role of the patient's sex in initiating such therapy. The psoriasis severity was defined as a time-varying variable. Results: Men had more severe psoriasis than women according to the Psoriasis Area and Severity Index (PASI), regardless of age at enrolment, and throughout the study period. The analysis in the multiple Cox regression show that age, psoriasis severity and psoriasis arthropathy were relevant factors for initiating biologic therapy, whereas sex is not. Conclusions: Although as many women as men are believed to suffer from psoriasis, men seem to be more severely affected by psoriasis. The asymmetry in allocation of biologic therapy thereby probably reflects the differing disease activity between the sexes, and is not a discrimination against women per se.	[Hagg, David; Schmitt-Egenolf, Marcus] Umea Univ, Publ Hlth & Clin Med, Umea, Sweden; [Eriksson, Marie] USBE, Dept Stat, Umea, Sweden; [Sundstrom, Anders] Karolinska Univ Hosp, Ctr Pharmacoepidemiol CPE, Karolinska Inst, Stockholm, Sweden	Umea University; Karolinska Institutet; Karolinska University Hospital	Schmitt-Egenolf, M (corresponding author), Umea Univ, Publ Hlth & Clin Med, Umea, Sweden.	marcus.schmitt-egenolf@dermven.umu.se	Schmitt-Egenolf, Marcus/H-7310-2014; Eriksson, Marie/AAB-6215-2019; Eriksson, Marie/H-2452-2012	Schmitt-Egenolf, Marcus/0000-0002-3858-8474; Eriksson, Marie/0000-0003-3298-1555; Eriksson, Marie/0000-0003-3298-1555; Hagg, David/0000-0002-2610-5033	Swedish Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Vasterbotten County Council; Industrial Doctoral School for Research and Innovation; Umea University	Swedish Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Vasterbotten County Council; Industrial Doctoral School for Research and Innovation; Umea University	Funding came from the Swedish Board of Health and Welfare, Swedish Association of Local Authorities and Regions, Vasterbotten County Council, Industrial Doctoral School for Research and Innovation, and Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkema EV, 2012, ANN RHEUM DIS, V71, P1203, DOI 10.1136/annrheumdis-2011-200947; ENA P, 1985, ACTA CARDIOL, V40, P199; FARBER EM, 1961, CALIF MED, V95, P6; Feldman SR, 2005, ANN RHEUM DIS, V64, P65, DOI 10.1136/ard.2004.031237; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Hotard RS, 2000, J AM ACAD DERMATOL, V42, P620, DOI 10.1016/S0190-9622(00)90174-9; Langley RG, 2004, J AM ACAD DERMATOL, V51, P563, DOI 10.1016/j.jaad.2004.04.012; Lin HW, 2011, J AM ACAD DERMATOL, V64, P495, DOI 10.1016/j.jaad.2010.01.050; LOMHOLT GUNNAR, 1964, DANISH MED BULL, V11, P1; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225, DOI 10.1023/B:EJEP.0000020447.59150.f9; Nyberg F, 2008, INT J DERMATOL, V47, P144, DOI 10.1111/j.1365-4632.2008.03485.x; Ormerod AD, 2012, DERMATOLOGY, V224, P236, DOI 10.1159/000338572; Ragnarson Tennvall G, 2012, ACTA DERM VENEREOL; Rustin MHA, 2012, BRIT J DERMATOL, V167, P3, DOI 10.1111/j.1365-2133.2012.11208.x; Schafer I, 2010, EUR J DERMATOL, V20, P62, DOI 10.1684/ejd.2010.0815; Schmitt-Egenolf M, 2007, DERMATOLOGY, V214, P112, DOI 10.1159/000098568; TRAUPE H, 1992, AM J MED GENET, V42, P649, DOI 10.1002/ajmg.1320420504; White D, 2012, J EUR ACAD DERMATOL, V26, P126, DOI 10.1111/j.1468-3083.2011.04026.x	19	63	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63619	10.1371/journal.pone.0063619	http://dx.doi.org/10.1371/journal.pone.0063619			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691076	gold, Green Submitted, Green Published			2022-12-25	WOS:000319052700054
J	Lind, PA; Andersson, DI				Lind, Peter A.; Andersson, Dan I.			Fitness Costs of Synonymous Mutations in the rpsT Gene Can Be Compensated by Restoring mRNA Base Pairing	PLOS ONE			English	Article							ESCHERICHIA-COLI; CODON USAGE; SECONDARY STRUCTURE; EVOLUTION; SELECTION; BIAS; EXPRESSION; BACTERIA; MAMMALS; DISEASE	We previously reported that the distribution of fitness effects for non-synonymous and synonymous mutations in Salmonella typhimurium ribosomal proteins S20 and L1 are similar, suggesting that fitness constraints are present at the level of mRNA. Here we explore the hypothesis that synonymous mutations confer their fitness-reducing effect by alterating the secondary structure of the mRNA. To this end, we constructed a set of synonymous substitutions in the rpsT gene, encoding ribosomal protein S20, that are located in predicted paired regions in the mRNA and measured their effect on bacterial fitness. Our results show that for 3/9 cases tested, the reduced fitness conferred by a synonymous mutation could be fully or partly restored by introducing a second synonymous substitution that restore base pairing in a mRNA stem. In addition, random mutations in predicted paired regions had larger fitness effects than those in unpaired regions. Finally, we did not observe any correlation between fitness effects of the synonymous mutations and their rarity. These results suggest that for ribosomal protein S20, the deleterious effects of synonymous mutations are not generally due to codon usage effects, but that mRNA secondary structure is a major fitness constraint.	[Lind, Peter A.; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University	Andersson, DI (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	Dan.Andersson@imbim.uu.se		Lind, Peter/0000-0003-1510-8324; Andersson, Dan/0000-0001-6640-2174	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Berg OG, 1997, NUCLEIC ACIDS RES, V25, P1397, DOI 10.1093/nar/25.7.1397; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lind PA, 2010, SCIENCE, V330, P825, DOI 10.1126/science.1194617; Lind PA, 2010, MOL MICROBIOL, V75, P1078, DOI 10.1111/j.1365-2958.2009.07030.x; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	29	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63373	10.1371/journal.pone.0063373	http://dx.doi.org/10.1371/journal.pone.0063373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691039	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700032
J	Bjelic, S; Wieser, M; Frey, D; Stirnimann, CU; Chance, MR; Jaussi, R; Steinmetz, MO; Kammerer, RA				Bjelic, Sasa; Wieser, Mara; Frey, Daniel; Stirnimann, Christian U.; Chance, Mark R.; Jaussi, Rolf; Steinmetz, Michel O.; Kammerer, Richard A.			Structural Basis for the Oligomerization-State Switch from a Dimer to a Trimer of an Engineered Cortexillin-1 Coiled-Coil Variant	PLOS ONE			English	Article							SEDIMENTATION-VELOCITY; MOLECULAR-BASIS; TRIGGER SITE; PROTEINS; DESIGN; STABILITY; SEQUENCE; DOMAINS; MODEL	Coiled coils are well suited to drive subunit oligomerization and are widely used in applications ranging from basic research to medicine. The optimization of these applications requires a detailed understanding of the molecular determinants that control of coiled-coil formation. Although many of these determinants have been identified and characterized in great detail, a puzzling observation is that their presence does not necessarily correlate with the oligomerization state of a given coiled-coil structure. Thus, other determinants must play a key role. To address this issue, we recently investigated the unrelated coiled-coil domains from GCN4, ATF1 and cortexillin-1 as model systems. We found that well-known trimer-specific oligomerization-state determinants, such as the distribution of isoleucine residues at heptad-repeat core positions or the trimerization motif Arg-h-x-x-h-Glu (where h = hydrophobic amino acid; x = any amino acid), switch the peptide's topology from a dimer to a trimer only when inserted into the trigger sequence, a site indispensable for coiled-coil formation. Because high-resolution structural information could not be obtained for the full-length, three-stranded cortexillin-1 coiled coil, we here report the detailed biophysical and structural characterization of a shorter variant spanning the trigger sequence using circular dichroism, anatytical ultracentrifugation and x-ray crystallography. We show that the peptide forms a stable alpha-helical trimer in solution. We further determined the crystal structure of an optimised variant at a resolution of 1.65 angstrom, revealing that the peptide folds into a parallel, three-stranded coiled coil. The two complemented R-IxxIE trimerization motifs and the additional hydrophobic core isoleucine residue adopt the conformations seen in other extensively characterized parallel, three-stranded coiled coils. These findings not only confirm the structural basis for the switch in oligomerization state from a dimer to a trimer observed for the full-length cortexillin-1 coiled-coil domain, but also provide further evidence for a general link between oligomerization-state specificity and trigger-sequence function.	[Bjelic, Sasa; Wieser, Mara; Frey, Daniel; Jaussi, Rolf; Steinmetz, Michel O.; Kammerer, Richard A.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Bjelic, Sasa; Chance, Mark R.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Stirnimann, Christian U.] Paul Scherrer Inst, Swiss Light Source, Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Case Western Reserve University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Bjelic, S (corresponding author), Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland.	sasa.bjelic@case.edu; michel.steinmetz@psi.ch	Bjelic, Sasa/N-1348-2019; Bjelic, Sasa/G-6849-2011; Steinmetz, Michel O/AAA-3349-2022	Bjelic, Sasa/0000-0002-9805-3201; Bjelic, Sasa/0000-0002-9805-3201; Steinmetz, Michel O/0000-0001-6157-3687; Kammerer, Richard/0000-0003-4570-5197; Stirnimann, Christian/0000-0002-1030-8864	Swiss National Science Foundation [PA00P3_139673, 310030B_138659]; National Institute of Bioengineering and Biomedical [P30-EB-09998]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Bioengineering and Biomedical; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by fellowship PA00P3_139673 and grant 310030B_138659 from the Swiss National Science Foundation and P30-EB-09998 form the National Institute of Bioengineering and Biomedical (to SB, MOS and MRC respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Ciani B, 2010, P NATL ACAD SCI USA, V107, P19850, DOI 10.1073/pnas.1008502107; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Demeler B, 2010, MACROMOL BIOSCI, V10, P775, DOI 10.1002/mabi.200900481; Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101; Kammerer RA, 2005, P NATL ACAD SCI USA, V102, P13891, DOI 10.1073/pnas.0502390102; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Kammerer RA, 2001, J BIOL CHEM, V276, P13685, DOI 10.1074/jbc.M010492200; Kammerer RA, 2006, J STRUCT BIOL, V155, P146, DOI 10.1016/j.jsb.2006.01.017; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller M, 2012, ACTA CRYSTALLOGR D, V68, P42, DOI 10.1107/S0907444911049833; Olieric N, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-56; Painter J, TLSMD WEB SERVER GEN; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Sharma VA, 1998, CURR BIOL, V8, P823, DOI 10.1016/S0960-9822(98)70324-0; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; ZHOU NE, 1992, BIOCHEMISTRY-US, V31, P5739, DOI 10.1021/bi00140a008	35	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63370	10.1371/journal.pone.0063370	http://dx.doi.org/10.1371/journal.pone.0063370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691037	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400061
J	Mansouri, S; Wang, S; Frappier, L				Mansouri, Sheila; Wang, Shan; Frappier, Lori			A Role for the Nucleosome Assembly Proteins TAF-I beta and NAP1 in the Activation of BZLF1 Expression and Epstein-Barr Virus Reactivation	PLOS ONE			English	Article							LYTIC CYCLE; EPITHELIAL-CELLS; HISTONE ACETYLATION; DNA-REPLICATION; BINDING-PROTEIN; GENE-EXPRESSION; EBNA1 PROTEIN; INFECTION; SET; TRANSCRIPTION	The reactivation of Epstein-Barr virus (EBV) from latent to lytic infection begins with the expression of the viral BZLF1 gene, leading to a subsequent cascade of viral gene expression and amplification of the EBV genome. Using RNA interference, we show that nucleosome assembly proteins NAP1 and TAF-I positively contribute to EBV reactivation in epithelial cells through the induction of BZLF1 expression. In addition, overexpression of NAP1 or the beta isoform of TAF-I (TAF-I beta) in AGS cells latently infected with EBV was sufficient to induce BZLF1 expression. Chromatin immunoprecipitation experiments performed in AGS-EBV cells showed that TAF-I associated with the BZLF1 promoter upon lytic induction and affected local histone modifications by increasing H3K4 dimethylation and H4K8 acetylation. MLL1, the host protein known to dimethylate H3K4, was found to associate with the BZLF1 promoter upon lytic induction in a TAF-I- dependent manner, and MLL1 depletion decreased BZLF1 expression, confirming its contribution to lytic reactivation. The results indicate that TAF-I beta promotes BZLF1 expression and subsequent lytic infection by affecting chromatin at the BZLF1 promoter.	[Mansouri, Sheila; Wang, Shan; Frappier, Lori] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto	Frappier, L (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	lori.frappier@utoronto.ca			Canadian Cancer Society and the Canadian Institutes of Health Research [12477]; Canada Research Chairs program	Canadian Cancer Society and the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	This work was funded by operating grants to LF from the Canadian Cancer Society and the Canadian Institutes of Health Research (number 12477). LF is a Tier 1 Canada Research Chair in Molecular Virology and therefore receives salary support from the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS A, 1987, J VIROL, V61, P1743, DOI 10.1128/JVI.61.5.1743-1746.1987; Adler HT, 1997, J BIOL CHEM, V272, P28407, DOI 10.1074/jbc.272.45.28407; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Borza CM, NAT MED, V8, P594; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; Deng Z, 2005, J VIROL, V79, P4640, DOI 10.1128/JVI.79.8.4640-4650.2005; Diehl F, 2007, BLOOD, V109, P1472, DOI 10.1182/blood-2006-08-039651; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; DYSON PJ, 1985, J GEN VIROL, V66, P1931, DOI 10.1099/0022-1317-66-9-1931; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Feng WH, 2007, J VIROL, V81, P10113, DOI 10.1128/JVI.00692-07; Feng WH, 2002, CANCER RES, V62, P1920; FIXMAN ED, 1992, J VIROL, V66, P5030, DOI 10.1128/JVI.66.8.5030-5039.1992; Gao ZG, 1998, J VIROL, V72, P8559, DOI 10.1128/JVI.72.11.8559-8567.1998; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Holowaty MN, 2003, J BIOL CHEM, V278, P29987, DOI 10.1074/jbc.M303977200; Huang J, 2006, J VIROL, V80, P1098, DOI 10.1128/JVI.80.3.1098-1109.2006; Hutt-Fletcher LM, 2007, J VIROL, V81, P7825, DOI 10.1128/JVI.00445-07; ISHIMI Y, 1985, CELL STRUCT FUNCT, V10, P373, DOI 10.1247/csf.10.373; Jenkins PJ, 2000, J VIROL, V74, P710, DOI 10.1128/JVI.74.2.710-720.2000; Karetsou Z, 2005, BIOCHEM BIOPH RES CO, V335, P322, DOI 10.1016/j.bbrc.2005.06.210; Kawase H, 1996, GENES CELLS, V1, P1045, DOI 10.1046/j.1365-2443.1996.d01-223.x; KIEFF E, 2001, FIELDS VIROLOGY, P2511; LIEBERMAN PM, 1990, J VIROL, V64, P1143, DOI 10.1128/JVI.64.3.1143-1155.1990; Lin A, 2008, J VIROL, V82, P12009, DOI 10.1128/JVI.01680-08; Liu SF, 1997, VIROLOGY, V228, P11, DOI 10.1006/viro.1996.8371; MATSUMOTO K, 1993, J BIOL CHEM, V268, P10582; Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Miyaji-Yamaguchi M, 1999, J MOL BIOL, V290, P547, DOI 10.1006/jmbi.1999.2898; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Park YJ, 2006, BIOCHEM CELL BIOL, V84, P549, DOI 10.1139/O06-088; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Sarkari F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016598; SCHEPERS A, 1993, J VIROL, V67, P4237, DOI 10.1128/JVI.67.7.4237-4245.1993; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; SHAW JE, 1979, J VIROL, V29, P657, DOI 10.1128/JVI.29.2.657-665.1979; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Shimoyama T, 2005, FEBS LETT, V579, P757, DOI 10.1016/j.febslet.2004.12.064; Sivachandran N, 2012, J VIROL, V86, P6146, DOI 10.1128/JVI.00013-12; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; ThorleyLawson DA, 1996, TRENDS MICROBIOL, V4, P204, DOI 10.1016/S0966-842X(96)90020-7; Tsao SW, 2012, SEMIN CANCER BIOL, V22, P137, DOI 10.1016/j.semcancer.2012.02.004; Wang S, 2009, J VIROL, V83, P11704, DOI 10.1128/JVI.00931-09; Wen WR, 2007, J VIROL, V81, P1037, DOI 10.1128/JVI.01416-06; Wu FY, 2004, J VIROL, V78, P4847, DOI 10.1128/JVI.78.9.4847-4865.2004; Yu XM, 2007, PLOS PATHOG, V3, P1993, DOI 10.1371/journal.ppat.0030194; Yuan J, 2006, J VIROL, V80, P2548, DOI 10.1128/JVI.80.5.2548-2565.2006; Zhou J, 2009, J VIROL, V83, P2154, DOI 10.1128/JVI.02115-08	52	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63802	10.1371/journal.pone.0063802	http://dx.doi.org/10.1371/journal.pone.0063802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691099	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400079
J	Garenne, M; Kahn, K; Collinson, M; Gomez-Olive, X; Tollman, S				Garenne, Michel; Kahn, Kathleen; Collinson, Mark; Gomez-Olive, Xavier; Tollman, Stephen			Protective Effect of Pregnancy in Rural South Africa: Questioning the Concept of "Indirect Cause'' of Maternal Death	PLOS ONE			English	Article							SOCIAL TRANSITIONS; AGINCOURT HEALTH; MORTALITY; POPULATION; ANEMIA; TUBERCULOSIS; TRENDS; AREA; HIV	Background: Measurement of the level and composition of maternal mortality depends on the definition used, with inconsistencies leading to inflated rates and invalid comparisons across settings. This study investigates the differences in risk of death for women in their reproductive years during and outside the maternal risk period (pregnancy, delivery, puerperium), focusing on specific causes of infectious, non-communicable and external causes of death after separating out direct obstetrical causes. Methods: Data on all deaths of women aged 15-49 years that occurred in the Agincourt sub-district between 1992 and 2010 were obtained from the Agincourt health and socio-demographic surveillance system (HDSS) located in rural South Africa. Causes of death were assessed using a validated verbal autopsy instrument. Analysis included 2170 deaths, of which 137 occurred during the maternal risk period. Findings: Overall, women had significantly lower mortality during the maternal risk period than outside it (age-standardized RR = 0.75; 95% CI = 0.63-0.89). This was true in most age groups with the exception of adolescents aged 15-19 years where the risk of death was higher. Mortality from most causes, other than obstetric causes, was lower during the maternal risk period except for malaria, cardiovascular diseases and violence where there were no differences. Lower mortality was significant for HIV/AIDS (RR = 0.29, P<0.0001), cancers (RR = 0.10, P<0.023), and accidents (RR = 0, P<0.0001). Interpretation: In this rural setting typical of much of Southern Africa, pregnancy was largely protective against the risk of death, most likely because of a strong selection effect amongst those women who conceived successfully. The concept of indirect cause of maternal death needs to be re-examined.	[Garenne, Michel; Kahn, Kathleen; Collinson, Mark; Gomez-Olive, Xavier; Tollman, Stephen] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Garenne, Michel] Inst Pasteur, Paris, France; [Garenne, Michel] Ctr Ile France, UMI Resiliences, Inst Rech Dev, Bondy, France; [Kahn, Kathleen; Collinson, Mark; Tollman, Stephen] Umea Univ, Ctr Global Hlth Res, Umea, Sweden; [Kahn, Kathleen; Collinson, Mark; Gomez-Olive, Xavier; Tollman, Stephen] INDEPTH Network, Accra, Ghana	University of Witwatersrand; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD); Umea University; INDEPTH Network	Garenne, M (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa.	michel.garenne@pasteur.fr	Gómez-Olivé, Francesc Xavier/AAP-7673-2021	Gómez-Olivé, Francesc Xavier/0000-0002-4876-0848; Kahn, Kathleen/0000-0003-3339-3931; Tollman, Stephen/0000-0003-0744-7588	The Wellcome Trust, UK [058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z]	The Wellcome Trust, UK(Wellcome Trust)	The Agincourt health and socio-demographic surveillance system has been funded by The Wellcome Trust, UK (Grants 058893/Z/99/A; 069683/Z/02/Z; 085477/Z/08/Z), with important contributions from The William and Flora Hewlett Foundation, National Institute on Aging (NIA) of the National Institutes of Health, and The Andrew W. Mellon Foundation, USA. The School of Public Health and Faculty of Health Sciences, University of the Witwatersrand, and the Medical Research Council, South Africa, have provided vital support. The authors greatly value the involvement of community leaders, study participants, and district and provincial managers in health, education and other government sectors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, 31 WHO EIPGPEEBD; AYANGADE O, 1981, International Journal of Gynecology and Obstetrics, V19, P403, DOI 10.1016/0020-7292(81)90025-4; Cross S, 2010, B WORLD HEALTH ORGAN, V88, P147, DOI 10.2471/BLT.09.063537; FLEMING AF, 1989, T ROY SOC TROP MED H, V83, P441, DOI 10.1016/0035-9203(89)90241-1; Garenne M, 2000, J TROP PEDIATRICS, V46, P183, DOI 10.1093/tropej/46.3.183; Garenne M, 2011, STUD FAMILY PLANN, V42, P237, DOI 10.1111/j.1728-4465.2011.00287.x; Kahn K, 1999, TROP MED INT HEALTH, V4, P433, DOI 10.1046/j.1365-3156.1999.00415.x; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P8, DOI 10.1080/14034950701505031; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P26, DOI 10.1080/14034950701355668; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Khlat M, 2000, AM J EPIDEMIOL, V151, P300, DOI 10.1093/oxfordjournals.aje.a010206; Laibl VR, 2005, CLIN PERINATOL, V32, P727, DOI 10.1016/j.clp.2005.04.009; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; Menendez C, 2006, CURR MOL MED, V6, P269, DOI 10.2174/156652406776055186; Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044; Mnyani CN, 2011, BJOG-INT J OBSTET GY, V118, P226, DOI 10.1111/j.1471-0528.2010.02771.x; Mocroft A, 2005, AIDS, V19, P2117, DOI 10.1097/01.aids.0000194799.43799.ea; Ronsmans C, 2001, INT J EPIDEMIOL, V30, P467, DOI 10.1093/ije/30.3.467; Silver H M, 1998, Obstet Gynecol Surv, V53, P737, DOI 10.1097/00006254-199812000-00004; STECKLOV G, 1995, STUD FAMILY PLANN, V26, P33, DOI 10.2307/2138049; Suy A, 2006, AIDS, V20, P59, DOI 10.1097/01.aids.0000198090.70325.bd; Tollman SM, 1999, AIDS, V13, P1091, DOI 10.1097/00002030-199906180-00013; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; Tollman SM, 2007, SCAND J PUBLIC HEALT, V35, P4, DOI 10.1080/14034950701525906; Uneke Chigozie J, 2007, Yale J Biol Med, V80, P39; Uneke Chigozie J, 2007, Yale J Biol Med, V80, P95; Uneke Chigozie J, 2008, Yale J Biol Med, V81, P1; vandenBroek N, 1996, TROP DOCT, V26, P5, DOI 10.1177/004947559602600103; Watts DH, 2006, DRUG SAFETY, V29, P467, DOI 10.2165/00002018-200629060-00002; Weiner R, 2007, SAMJ S AFR MED J, V97, P944; WILLIAMS MD, 1992, MED CLIN N AM, V76, P631; World Health Organization, 1992, ICD 10 INT STAT CLAS; Zwang J, 2007, T ROY SOC TROP MED H, V101, P893, DOI 10.1016/j.trstmh.2007.04.023	34	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e64414	10.1371/journal.pone.0064414	http://dx.doi.org/10.1371/journal.pone.0064414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675536	gold, Green Submitted, Green Published			2022-12-25	WOS:000319036100062
J	Radovica, I; Fridmanis, D; Vaivade, I; Nikitina-Zake, L; Klovins, J				Radovica, Ilze; Fridmanis, Davids; Vaivade, Iveta; Nikitina-Zake, Liene; Klovins, Janis			The Association of Common SNPs and Haplotypes in CETP Gene with HDL Cholesterol Levels in Latvian Population	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; GENOME-WIDE ASSOCIATION; ESTER TRANSFER PROTEIN; SINGLE-NUCLEOTIDE POLYMORPHISMS; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; LIPID CONCENTRATIONS; LOCI; TRIGLYCERIDES; LIPASE	The heritability of high-density lipoprotein cholesterol (HDL-C) level is estimated at approximately 50%. Recent genome-wide association studies have identified genes involved in regulation of high-density lipoprotein cholesterol (HDL-C) levels. The precise genetic profile determining heritability of HDL-C however are far from complete and there is substantial room for further characterization of genetic profiles influencing blood lipid levels. Here we report an association study comparing the distribution of 139 SNPs from more than 30 genes between groups that represent extreme ends of HDL-C distribution. We genotyped 704 individuals that were selected from Genome Database of Latvian Population. 10 SNPs from CETP gene showed convincing association with low HDL-C levels (rs1800775, rs3764261, rs173539, rs9939224, rs711752, rs708272, rs7203984, rs7205804, rs11076175 and rs9929488) while 34 SNPs from 10 genes were nominally associated (p<0.05) with HDL-C levels. We have also identified haplotypes from CETP with distinct effects on determination of HDL-C levels. Our conclusion: So far the SNPs in CETP gene are identified as the most common genetic factor influencing HDL-C levels in the representative sample from Latvian population.	[Radovica, Ilze; Fridmanis, Davids; Vaivade, Iveta; Nikitina-Zake, Liene; Klovins, Janis] Latvian Biomed Res & Study Ctr, Riga, Latvia	Latvian Biomedical Research & Study Centre	Klovins, J (corresponding author), Latvian Biomed Res & Study Ctr, Riga, Latvia.	klovins@biomed.lu.lv	Radovica-Spalvina, Ilze/D-7859-2018; Klovins, Janis/C-5695-2011; Fridmanis, Davids/I-3292-2017	Radovica-Spalvina, Ilze/0000-0002-7104-8824; Fridmanis, Davids/0000-0003-0310-0448; Klovins, Janis/0000-0001-8362-5505	European Regional Development Fund [2010/0311/2DP/2.1.1.1.0/10/APIA/VIAA/022]	European Regional Development Fund(European Commission)	Our work was supported by European Regional Development Fund project No. 2010/0311/2DP/2.1.1.1.0/10/APIA/VIAA/022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiu L, PSYCHIAT RES; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barsh GS, PLOS GENET, V8; BRESLOW JL, 1982, P NATL ACAD SCI-BIOL, V79, P6861, DOI 10.1073/pnas.79.22.6861; BREWER HB, 1978, BIOCHEM BIOPH RES CO, V80, P623, DOI 10.1016/0006-291X(78)91614-5; Burkhardt R, 2008, ARTERIOSCL THROM VAS, V28, P2078, DOI 10.1161/ATVBAHA.108.172288; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Dachet C, 2000, ARTERIOSCL THROM VAS, V20, P507, DOI 10.1161/01.ATV.20.2.507; de Grooth GJ, 2004, J LIPID RES, V45, P1967, DOI 10.1194/jlr.R400007-JLR200; Edmondson AC, CIRC CARDIOVASC GENE, V4, P145; Edmondson AC, 2009, J CLIN INVEST, V119, P1042, DOI 10.1172/JCI37176; Gauderman W, 2009, QUANTO 1 1 COMPUTER; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Heid IM, 2008, CIRC-CARDIOVASC GENE, V1, P10, DOI 10.1161/CIRCGENETICS.108.776708; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; HIRANO K, 1995, ARTERIOSCL THROM VAS, V15, P1849, DOI 10.1161/01.ATV.15.11.1849; Hiura Y, 2009, CIRC J, V73, P1119, DOI 10.1253/circj.CJ-08-1101; Ignatovica V, MOL BIOL REP, V39, P1917; Ishida T, 2004, J BIOL CHEM, V279, P45085, DOI 10.1074/jbc.M406360200; Jee SH, AM J HUM GENET, V87, P545; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, CURR OPIN LIPIDOL, V19, P122, DOI 10.1097/MOL.0b013e3282f70296; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Khovidhunkit W., AM J CARDIOL; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; LO JY, 1995, BIOCHEM BIOPH RES CO, V206, P266, DOI 10.1006/bbrc.1995.1037; Ma L, BMC MED GENET, V11, P55; Martin S, 2003, BBA-MOL BASIS DIS, V1637, P217, DOI 10.1016/S0925-4439(03)00033-4; Natarajan P, J AM COLL CARDIOL, V55, P1283; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridker PM, 2009, CIRC-CARDIOVASC GENE, V2, P26, DOI 10.1161/CIRCGENETICS.108.817304; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Spirin V, 2007, AM J HUM GENET, V81, P1298, DOI 10.1086/522497; Teslovich TM, NATURE, V466, P707; Thompson JF, 2005, ATHEROSCLEROSIS, V181, P45, DOI 10.1016/j.atherosclerosis.2005.01.015; Thompson JF, 2004, CLIN GENET, V66, P223, DOI 10.1111/j.1399-0004.2004.00289.x; Thompson JF, 2007, J LIPID RES, V48, P434, DOI 10.1194/jlr.M600372-JLR200; Voight BF, LANCET, V380, P572; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Waterworth D. M., ARTERIOSCLER THROMB, V30, P2264; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	50	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e64191	10.1371/journal.pone.0064191	http://dx.doi.org/10.1371/journal.pone.0064191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675527	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100059
J	Farhana, L; Dawson, MI; Murshed, F; Das, JK; Rishi, AK; Fontana, JA				Farhana, Lulu; Dawson, Marcia I.; Murshed, Farhan; Das, Jayanta K.; Rishi, Arun K.; Fontana, Joseph A.			Upregulation of miR-150*and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R	PLOS ONE			English	Article							EXPRESSION PROFILES; TUMOR-SUPPRESSOR; MICRORNAS; GROWTH; MIR-150; PROLIFERATION; MOLECULES; PATHWAYS	MicroRNAs have been implicated in many critical cellular processes including apoptosis. We have previously found that apoptosis in pancreatic cancer cells was induced by adamantyl retinoid-related (ARR) molecule 3-Cl-AHPC. Here we report that 3-Cl-AHPC-dependent apoptosis involves regulating a number of microRNAs including miR-150* and miR-630. 3-Cl-AHPC stimulated miR-150* expression and caused decreased expression of c-Myb and IGF-1R in the pancreatic cancer cells. 3-Cl-AHPC-mediated reduction of c-Myb resulted in diminished binding of c-Myb with IGF-1R and Bcl-2 promoters, thereby causing repression of their transcription and protein expression. Over-expression of miR-150* also resulted in diminished levels of c-Myb and Bcl-2 proteins. Furthermore, the addition of the miRNA inhibitor 2'-O-methylated miR-150 blocked 3-Cl-AHPC-mediated increase in miR-150* levels and abrogated loss of c-Myb protein. Knockdown of c-Myb in PANC-1 cells resulted in enhanced apoptosis both in the presence or absence of 3-Cl-AHPC confirming the anti-apoptotic property of c-Myb. Overexpression of miR-630 also induced apoptosis in the pancreatic cancer cells and inhibited target protein IGF-1R mRNA and protein expression. Together these results implicate key roles for miR-150* and miR-630 and their targeting of IGF-1R to promote apoptosis in pancreatic cancer cells.	[Farhana, Lulu; Das, Jayanta K.; Rishi, Arun K.; Fontana, Joseph A.] Wayne Sate Univ, Dept Oncol, Detroit, MI USA; [Farhana, Lulu; Murshed, Farhan; Das, Jayanta K.; Rishi, Arun K.; Fontana, Joseph A.] John D Dingell VA Med Ctr, Detroit, MI USA; [Farhana, Lulu; Das, Jayanta K.; Rishi, Arun K.; Fontana, Joseph A.] Wayne State Univ, Detroit, MI USA; [Farhana, Lulu; Rishi, Arun K.; Fontana, Joseph A.] Karmanos Canc Inst, Detroit, MI USA; [Dawson, Marcia I.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Sanford Burnham Prebys Medical Discovery Institute	Fontana, JA (corresponding author), Wayne Sate Univ, Dept Oncol, Detroit, MI USA.	Joseph.Fontana@va.gov	DAS, JAYANTA/E-2596-2015	DAS, JAYANTA/0000-0002-2840-1645; Fontana, Joseph/0000-0003-3829-3358	Veterans Affairs Merit Review Grant; National Cancer Institute (NCI)	Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Veterans Affairs Merit Review Grant (JAF, MID) and National Cancer Institute (NCI) grants (JAF, MID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, CRIT REV THER DRUG, V28, P293, DOI 10.1615/CritRevTherDrugCarrierSyst.v28.i4.10; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Andrews GA, 2004, HEAD NECK-J SCI SPEC, V26, P870, DOI 10.1002/hed.20029; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bauer TW, 2006, MOL CANCER THER, V5, P1676, DOI 10.1158/1535-7163.MCT-05-0175; Beverly LJ, 2012, J CELL BIOCHEM, V113, P3, DOI 10.1002/jcb.23335; Bhardwaj Arun, 2010, Mol Cell Pharmacol, V2, P213; Bhayani MK, 2012, MUTAT RES-FUND MOL M, V731, P14, DOI 10.1016/j.mrfmmm.2011.10.014; Dawson MI, 2010, MINI-REV MED CHEM, V10, P455, DOI 10.2174/138955710791384045; Farhana L, 2007, CANCER RES, V67, P318, DOI 10.1158/0008-5472.CAN-06-2164; Farhana L, 2012, J ONCOL, V2012, DOI 10.1155/2012/796729; Fujita H, 2011, INT J ONCOL, V38, P629, DOI 10.3892/ijo.2011.908; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Haldar Subrata, 2011, Mol Cell Pharmacol, V3, P135; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Kota SK, 2010, DRUG DISCOV TODAY, V15, P733, DOI 10.1016/j.drudis.2010.07.003; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kunej T, 2011, MUTAT RES-FUND MOL M, V717, P77, DOI 10.1016/j.mrfmmm.2011.03.008; Lang G, 2005, ONCOGENE, V24, P1375, DOI 10.1038/sj.onc.1208301; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Lin MS, 2011, ONCOL REP, V25, P739, DOI 10.3892/or.2010.1112; Liu LX, 2012, FEBS J, V279, P3800, DOI 10.1111/j.1742-4658.2012.08741.x; McDermott AM, 2011, PHARM RES-DORDR, V28, P3016, DOI 10.1007/s11095-011-0550-2; Moser C, 2008, EUR J CANCER, V44, P1577, DOI 10.1016/j.ejca.2008.04.003; Mott JL, 2009, HEPATOLOGY, V50, P630, DOI 10.1002/hep.23010; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Park JY, 2011, WORLD J GASTROENTERO, V17, P817, DOI 10.3748/wjg.v17.i7.817; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272; Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhang J, 2012, INT J ONCOL, V40, P747, DOI 10.3892/ijo.2011.1242; Zhang YX, 2002, BLOOD, V100, P2917, DOI 10.1182/blood.V100.8.2917	39	77	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e61015	10.1371/journal.pone.0061015	http://dx.doi.org/10.1371/journal.pone.0061015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675407	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400003
J	Ivanova, C; Baath, JA; Seiboth, B; Kubicek, CP				Ivanova, Christa; Baath, Jenny A.; Seiboth, Bernhard; Kubicek, Christian P.			Systems Analysis of Lactose Metabolism in Trichoderma reesei Identifies a Lactose Permease That Is Essential for Cellulase Induction	PLOS ONE			English	Article							BIOMASS-DEGRADING ENZYMES; HYPOCREA-JECORINA; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; CELLULOLYTIC ENZYMES; BETA-GALACTOSIDASE; GENE-EXPRESSION; YEAST; TRANSFORMATION; XYLOGLUCAN	Trichoderma reesei colonizes predecayed wood in nature and metabolizes cellulose and hemicellulose from the plant biomass. The respective enzymes are industrially produced for application in the biofuel and biorefinery industry. However, these enzymes are also induced in the presence of lactose (1,4-0-beta-D-galactopyranosyl-D-glucose), a waste product from cheese manufacture or whey processing industries. In fact, lactose is the only soluble carbon source that induces these enzymes in T. reesei on an industrial level but the reason for this unique phenomenon is not understood. To answer this question, we used systems analysis of the T. reesei transcriptome during utilization of lactose. We found that the respective CAZome encoded all glycosyl hydrolases necessary for cellulose degradation and particularly for the attack of monocotyledon xyloglucan, from which beta-galactosides could be released that may act as the inducers of T. reesei's cellulases and hemicellulases. In addition, lactose also induces a high number of putative transporters of the major facilitator superfamily. Deletion of fourteen of them identified one gene that is essential for lactose utilization and lactose uptake, and for cellulase induction by lactose (but not sophorose) in pregrown mycelia of T. reesei. These data shed new light on the mechanism by which T. reesei metabolizes lactose and offers strategies for its improvement. They also illuminate the key role of beta-D-galactosides in habitat specificity of this fungus.	[Ivanova, Christa; Baath, Jenny A.; Seiboth, Bernhard; Kubicek, Christian P.] Vienna Univ Technol, Inst Chem Engn, A-1040 Vienna, Austria; [Baath, Jenny A.] Lund Univ, Lund, Sweden; [Seiboth, Bernhard; Kubicek, Christian P.] Vienna Univ Technol, Inst Chem Engn, Austrian Inst Ind Biotechnol ACIB GmBH, A-1040 Vienna, Austria	Technische Universitat Wien; Lund University; Austrian Centre of Industrial Biotechnology; Technische Universitat Wien	Kubicek, CP (corresponding author), Vienna Univ Technol, Inst Chem Engn, A-1040 Vienna, Austria.	ckubicek@mail.zserv.tuwien.ac.at		Arnling Baath, Jenny/0000-0001-7973-9577	Austrian Science Foundation [FWF P-19143, FWF P24219]	Austrian Science Foundation(Austrian Science Fund (FWF))	This work was supported by grants from the Austrian Science Foundation (FWF P-19143 and FWF P24219) to CPK and BS, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akel E, 2009, EUKARYOT CELL, V8, P1837, DOI 10.1128/EC.00162-09; Arvas M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-32; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Chang MCY, 2007, CURR OPIN CHEM BIOL, V11, P677, DOI 10.1016/j.cbpa.2007.08.039; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; Fekete E, 2012, FUNGAL GENET BIOL, V49, P415, DOI 10.1016/j.fgb.2012.03.001; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; GRUBER F, 1990, CURR GENET, V18, P71, DOI 10.1007/BF00321118; Guangtao Z, 2009, J BIOTECHNOL, V139, P146, DOI 10.1016/j.jbiotec.2008.10.007; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; Hayashi T, 2011, MOL PLANT, V4, P17, DOI 10.1093/mp/ssq063; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Liu D, 2000, J CLIN MICROBIOL, V38, P471; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Metz B, 2011, EUKARYOT CELL, V10, P1527, DOI 10.1128/EC.05014-11; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Penttila ME, 1998, HETEROLOGOUS PROTEIN; PERSSON I, 1991, PROCESS BIOCHEM, V26, P65, DOI 10.1016/0032-9592(91)80019-L; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Portnoy T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-269; Roelfsema WA, 2000, LACTOSE DERIVATIVES; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Saloheimo A, 2007, APPL MICROBIOL BIOT, V74, P1041, DOI 10.1007/s00253-006-0747-1; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmoll M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-127; Seiboth B, 2005, APPL ENVIRON MICROB, V71, P851, DOI 10.1128/AEM.71.2.851-857.2005; Seiboth B, 2007, MOL MICROBIOL, V66, P890, DOI 10.1111/j.1365-2958.2007.05953.x; Singh MV, 2002, ANAL BIOCHEM, V307, P13, DOI 10.1016/S0003-2697(02)00018-0; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stricker AR, 2006, EUKARYOT CELL, V5, P2128, DOI 10.1128/EC.00211-06; VAHERI MP, 1979, EUR J APPL MICROBIOL, V8, P73, DOI 10.1007/BF00510268; VANTILBEURGH H, 1982, FEBS LETT, V149, P152, DOI 10.1016/0014-5793(82)81092-2; Vincken JP, 1997, PLANT PHYSIOL, V114, P9, DOI 10.1104/pp.114.1.9; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10; Xu Q, 2009, CURR OPIN BIOTECH, V20, P364, DOI 10.1016/j.copbio.2009.05.006; Zeilinger S, 1998, J BIOL CHEM, V273, P34463, DOI 10.1074/jbc.273.51.34463	39	94	98	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62631	10.1371/journal.pone.0062631	http://dx.doi.org/10.1371/journal.pone.0062631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23690947	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600035
J	Bonito, NA; Drechsler, J; Stoecker, S; Carmo, CR; Seckl, MJ; Hermanns, HM; Costa-Pereira, AP				Bonito, N. A.; Drechsler, J.; Stoecker, S.; Carmo, C. R.; Seckl, M. J.; Hermanns, H. M.; Costa-Pereira, A. P.			Control of gp130 expression by the mitogen-activated protein kinase ERK2	ONCOGENE			English	Article						ERK; gp130; IL-6-type cytokines; JAK/STAT signalling; receptor expression	LEUKEMIA INHIBITORY FACTOR; CYTOKINE RECEPTOR GP130; INFLAMMATORY CYTOKINES; SIGNAL-TRANSDUCTION; CELL-PROLIFERATION; STAT3 ACTIVATION; CANCER; GROWTH; IL-6; TRANSFORMATION	Interleukin (IL)-6-type cytokines such as IL-6, oncostatin M (OSM) and leukaemia inhibitory factor (LIF) signal through receptor complexes that are critically dependent on gp130. The latter is the common signal-transducing molecule that couples these cytokines to their downstream effectors, Janus kinases (JAKs) and signal transducers and activators of transcription (STATs). IL-6-type cytokine signalling additionally involves the recruitment and activation of extracellular signal-regulated kinase (ERK) 1 and ERK2. Both STATs and ERKs regulate responses mediated by members of the IL-6 family. Here, we show that ERK2, but not ERK1, also controls the expression and function of gp130 per se, as silencing ERK2 in human osteosarcoma U2OS cells inhibits the expression of gp130. This does not simply reflect quantitative differences between ERK1 and ERK2, and the effects are not restricted to osteosarcoma cells, as they can be extended to several other cancer cell types analysed to date (such as breast, prostate, lung and cervical cancer cells). Importantly, ERK2 binds to the GP130 promoter, where it perhaps interacts with the transcriptional machinery. Indeed, its role in the transcriptional regulation of the GP130 gene was corroborated using luciferase reporter assays and messenger RNA stability experiments. Considering the pivotal role that gp130 has in cancer and inflammation these data thus identify novel non-overlapping functions for ERK1 and ERK2 that are biologically relevant.	[Bonito, N. A.; Stoecker, S.; Carmo, C. R.; Seckl, M. J.; Costa-Pereira, A. P.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Fac Med, London W12 0NN, England; [Drechsler, J.; Hermanns, H. M.] Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany; [Carmo, C. R.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Imperial College London; German Research Foundation (DFG); University of Wurzburg; Instituto Gulbenkian de Ciencia	Costa-Pereira, AP (corresponding author), Univ London Imperial Coll Sci Technol & Med, ICTEM, Dept Surg & Canc, Fac Med, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	a.costa-pereira@imperial.ac.uk	Costa-Pereira, Ana/AAE-8192-2020	Ramos do Carmo, Catarina/0000-0001-9717-6667; Costa-Pereira, Ana/0000-0001-8265-8065	Foundation for Science and Technology (FCT) ( Lisbon, Portugal), [SFRH/BD/61857/2009]; Cancer Treatment and Research Trust (CTRT); Cancer Research UK; Deutsche Forschungsgemeinschaft (DFG) [FZ82]; Elsie Widdowson Fellowship	Foundation for Science and Technology (FCT) ( Lisbon, Portugal),(Portuguese Foundation for Science and Technology); Cancer Treatment and Research Trust (CTRT); Cancer Research UK(Cancer Research UK); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Elsie Widdowson Fellowship	We are grateful to Dr Charles A O'Brien (University of Arkansas for Medical Sciences, Little Rock, USA) for control and full-length gp130 (p2433) luciferase constructs. Within Imperial College London, the authors are indebted to Dr Charlotte Bevan and her research team, Dr Rajat Roy, Mr Richard Schlegel and Dr Olivier Pardo for many helpful discussions, and Dr Anna Maria Tommasi for technical help. NB is funded by a PhD studentship (SFRH/BD/61857/2009) from the Foundation for Science and Technology (FCT) ( Lisbon, Portugal), and CRC is funded by Cancer Treatment and Research Trust (CTRT). APC-P and MJS are funded by Cancer Research UK and CTRT. JD and HMH are funded by the Deutsche Forschungsgemeinschaft (DFG, FZ82). APC-P is also the recipient of an Elsie Widdowson Fellowship.	Bourcier C, 2006, CANCER RES, V66, P2700, DOI 10.1158/0008-5472.CAN-05-3129; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Costa-Pereira AP, 2011, AM J CANCER RES, V1, P806; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Fasnacht N, 2008, SEMIN CELL DEV BIOL, V19, P379, DOI 10.1016/j.semcdb.2008.07.001; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hermanns HM, 2000, J BIOL CHEM, V275, P40742, DOI 10.1074/jbc.M005408200; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; Jain N, 1998, ONCOGENE, V17, P3157, DOI 10.1038/sj.onc.1202238; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Krens SFG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-196; Lavagni P, 2009, J MOL NEUROSCI, V37, P212, DOI 10.1007/s12031-008-9118-y; Lefloch R, 2008, MOL CELL BIOL, V28, P511, DOI 10.1128/MCB.00800-07; Marchetti A, 2004, CELL DEATH DIFFER, V11, P596, DOI 10.1038/sj.cdd.4401368; Marchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003873; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; OBrien CA, 1997, J BIOL CHEM, V272, P15003, DOI 10.1074/jbc.272.23.15003; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Radtke S, 2010, J CELL SCI, V123, P947, DOI 10.1242/jcs.065326; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rodriguez J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002324; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roy SK, 2002, P NATL ACAD SCI USA, V99, P7945, DOI 10.1073/pnas.122075799; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Santos CI, 2011, BBA-REV CANCER, V1816, P38, DOI 10.1016/j.bbcan.2011.03.003; Schiemann WP, 1997, J BIOL CHEM, V272, P16631, DOI 10.1074/jbc.272.26.16631; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Stuhlmann-Laeisz C, 2006, MOL BIOL CELL, V17, P2986, DOI 10.1091/mbc.E05-12-1129; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Voisin L, 2010, MOL CELL BIOL, V30, P2918, DOI 10.1128/MCB.00131-10; Watling D, 2008, P NATL ACAD SCI USA, V105, P6051, DOI 10.1073/pnas.0710814105; Yamanaka Y, 1996, EMBO J, V15, P1557, DOI 10.1002/j.1460-2075.1996.tb00500.x; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	53	15	15	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2014	33	17					2255	2263		10.1038/onc.2013.159	http://dx.doi.org/10.1038/onc.2013.159			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF8WJ	23686311				2022-12-25	WOS:000334996000011
J	Newhart, A; Rafalska-Metcalf, IU; Yang, T; Joo, LM; Powers, SL; Kossenkov, AV; Lopez-Jones, M; Singer, RH; Showe, LC; Skordalakes, E; Janicki, SM				Newhart, Alyshia; Rafalska-Metcalf, Ilona U.; Yang, Tian; Joo, Lucy M.; Powers, Sara Lawrence; Kossenkov, Andrew V.; Lopez-Jones, Melissa; Singer, Robert H.; Showe, Louise C.; Skordalakes, Emmanuel; Janicki, Susan M.			Single Cell Analysis of RNA-mediated Histone H3.3 Recruitment to a Cytomegalovirus Promoter-regulated Transcription Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-INDEPENDENT DEPOSITION; REPEAT-CONTAINING RNA; SIMPLEX-VIRUS TYPE-1; GENOME-WIDE ANALYSIS; VARIANT H3.3; MOLECULAR DISSECTION; CHROMATIN; HETEROCHROMATIN; CHAPERONE; DAXX	Unlike the core histones, which are incorporated into nucleosomes concomitant with DNA replication, histone H3.3 is synthesized throughout the cell cycle and utilized for replication-independent (RI) chromatin assembly. The RI incorporation of H3.3 into nucleosomes is highly conserved and occurs at both euchromatin and heterochromatin. However, neither the mechanism of H3.3 recruitment nor its essential function is well understood. Several different chaperones regulate H3.3 assembly at distinct sites. The H3.3 chaperone, Daxx, and the chromatin-remodeling factor, ATRX, are required for H3.3 incorporation and heterochromatic silencing at telomeres, pericentromeres, and the cytomegalovirus (CMV) promoter. By evaluating H3.3 dynamics at a CMV promoter-regulated transcription site in a genetic background in which RI chromatin assembly is blocked, we have been able to decipher the regulatory events upstream of RI nucleosomal deposition. We find that at the activated transcription site, H3.3 accumulates with sense and antisense RNA, suggesting that it is recruited through an RNA-mediated mechanism. Sense and antisense transcription also increases after H3.3 knockdown, suggesting that the RNA signal is amplified when chromatin assembly is blocked and attenuated by nucleosomal deposition. Additionally, we find that H3.3 is still recruited after Daxx knockdown, supporting a chaperone-independent recruitment mechanism. Sequences in the H3.3 N-terminal tail and alpha N helix mediate both its recruitment to RNA at the activated transcription site and its interaction with double-stranded RNA in vitro. Interestingly, the H3.3 gain-of-function pediatric glioblastoma mutations, G34R and K27M, differentially affect H3.3 affinity in these assays, suggesting that disruption of an RNA-mediated regulatory event could drive malignant transformation.	[Newhart, Alyshia; Rafalska-Metcalf, Ilona U.; Joo, Lucy M.; Powers, Sara Lawrence; Kossenkov, Andrew V.; Showe, Louise C.; Janicki, Susan M.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Skordalakes, Emmanuel] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA; [Yang, Tian] Univ Penn, Roy & Diana Vagelos Scholars Program Mol Life Sci, Philadelphia, PA 19104 USA; [Lopez-Jones, Melissa; Singer, Robert H.] Yeshiva Univ Albert Einstein Coll Med, Dept Anat, Bronx, NY 10461 USA; [Lopez-Jones, Melissa; Singer, Robert H.] Yeshiva Univ Albert Einstein Coll Med, Dept Biol Struct, Bronx, NY 10461 USA	The Wistar Institute; The Wistar Institute; University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Janicki, SM (corresponding author), Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA.	sjanicki@wistar.org	Skordalakes, Emmanuel/H-7071-2019	Skordalakes, Emmanuel/0000-0002-7600-2833	National Institutes of Health [R01 GM 093000-02, P30 CA10815]; Wistar Institute; Arnold and Mabel Beckman Foundation; Mallinckrodt Foundation; Emerald Foundation; March of Dimes Basil O'Connor Award; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088332, R01GM093000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wistar Institute; Arnold and Mabel Beckman Foundation; Mallinckrodt Foundation; Emerald Foundation; March of Dimes Basil O'Connor Award(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM 093000-02 and P30 CA10815 (Wistar Cancer Center Core Grant Facilities: Genomics, Bioinformatics, Protein Expression and Library Screening, Imaging, and Research Supply). This work was also supported by start-up funding from the Wistar Institute and grants from the Arnold and Mabel Beckman Foundation, the Mallinckrodt Foundation, and the Emerald Foundation, the March of Dimes Basil O'Connor Award.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Bonnefoy E, 2007, PLOS GENET, V3, P1991, DOI 10.1371/journal.pgen.0030182; Bower K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050062; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Campos EI, 2010, GENE DEV, V24, P1334, DOI 10.1101/gad.1946810; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Choi ES, 2005, NUCLEIC ACIDS RES, V33, P7102, DOI 10.1093/nar/gki1011; Cui BW, 2006, MOL CELL BIOL, V26, P7719, DOI 10.1128/MCB.01139-06; Delbarre E, 2013, GENOME RES, V23, P440, DOI 10.1101/gr.142703.112; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Elsaesser SJ, 2010, COLD SH Q B, V75, P27, DOI 10.1101/sqb.2010.75.008; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Everett RD, 2008, J VIROL, V82, P2661, DOI 10.1128/JVI.02308-07; Eymery A, 2009, INT J DEV BIOL, V53, P259, DOI 10.1387/ijdb.082673ae; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Femino AM, 2003, METHOD ENZYMOL, V361, P245; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Govin J, 2010, GENE DEV, V24, P1772, DOI 10.1101/gad.1954910; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Harada A, 2012, EMBO J, V31, P2994, DOI 10.1038/emboj.2012.136; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; HUANG RCC, 1965, P NATL ACAD SCI USA, V54, P960, DOI 10.1073/pnas.54.3.960; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jullien J, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-17; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Lin LJ, 2010, MOL CELL BIOL, V30, P1116, DOI 10.1128/MCB.01229-09; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lukashchuk V, 2010, J VIROL, V84, P4026, DOI 10.1128/JVI.02597-09; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; NELSON T, 1981, BIOCHEMISTRY-US, V20, P2594, DOI 10.1021/bi00512a035; Newhart A, 2013, MOL BIOL CELL, V24, P1454, DOI 10.1091/mbc.E12-09-0669; Newhart A, 2012, J CELL SCI, V125, P5489, DOI 10.1242/jcs.110148; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Ooi SL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1090; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Rafalska-Metcalf IU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010272; Rai TS, 2011, MOL CELL BIOL, V31, P4107, DOI 10.1128/MCB.05546-11; Raitskin O, 2001, P NATL ACAD SCI USA, V98, P6571, DOI 10.1073/pnas.111153798; ROHRBAUGH ML, 1985, MOL CELL BIOL, V5, P147, DOI 10.1128/MCB.5.1.147; Sakai A, 2009, CURR BIOL, V19, P1816, DOI 10.1016/j.cub.2009.09.021; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sioud M, 2007, ADV DRUG DELIVER REV, V59, P153, DOI 10.1016/j.addr.2007.03.006; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tamura T, 2009, J BIOL CHEM, V284, P12217, DOI 10.1074/jbc.M805651200; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; van der Heijden GW, 2007, NAT GENET, V39, P251, DOI 10.1038/ng1949; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; WAGNER RW, 1988, MOL CELL BIOL, V8, P770, DOI 10.1128/MCB.8.2.770; Waterborg JH, 2012, BIOCHEM CELL BIOL, V90, P79, DOI [10.1139/O11-036, 10.1139/o11-036]; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658; Wu B, 2010, J MOL BIOL, V398, P633, DOI 10.1016/j.jmb.2010.03.038; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501; Zaslavsky E, 2010, J IMMUNOL, V184, P2908, DOI 10.4049/jimmunol.0903453; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	90	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19882	19899		10.1074/jbc.M113.473181	http://dx.doi.org/10.1074/jbc.M113.473181			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689370	Green Published, hybrid			2022-12-25	WOS:000321515800055
J	Anton, AI; Cerezo-Manchado, JJ; Padilla, J; Perez-Andreu, V; Corral, J; Vicente, V; Roldan, V; Gonzalez-Conejero, R				Anton, Ana Isabel; Cerezo-Manchado, Juan J.; Padilla, Jose; Perez-Andreu, Virginia; Corral, Javier; Vicente, Vicente; Roldan, Vanessa; Gonzalez-Conejero, Rocio			Novel Associations of VKORC1 Variants with Higher Acenocoumarol Requirements	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; WARFARIN; POLYMORPHISM; RESISTANCE; GENE; PHARMACOGENETICS; MUTATIONS; ASP36TYR; CYP2C9; VARIABILITY	Background: Algorithms combining both clinical and genetic data have been developed to improve oral anticoagulant therapy. Three polymorphisms in two genes, VKORC1 and CYP2C9, are the main coumarin dose determinants and no additional polymorphisms of any relevant pharmacogenetic importance have been identified. Objectives: To identify new genetic variations in VKORC1 with relevance for oral anticoagulant therapy. Methods and Results: 3949 consecutive patients taking acenocoumarol were genotyped for the VKORC1 rs9923231 and CY2C9* polymorphisms. Of these, 145 patients with a dose outside the expected range for the genetic profile determined by these polymorphisms were selected. Clinical factors explained the phenotype in 88 patients. In the remaining 57 patients, all with higher doses than expected, we sequenced the VKORC1 gene and genetic changes were identified in 14 patients. Four patients carried VKORC1 variants previously related to high coumarin doses (L128R, N = 1 and D36Y, N = 3). Three polymorphisms were also detected: rs17878544 (N = 5), rs55894764 (N = 4) and rs7200749 (N = 2) which was in linkage disequilibrium with rs17878544. Finally, 2 patients had lost the rs9923231/rs9934438 linkage. The prevalence of these variations was higher in these patients than in the whole sample. Multivariate linear regression analysis revealed that only D36Y and rs55894764 variants significantly affect the dose, although the improvement in the prediction model is small (from 39% to 40%). Conclusion: Our strategy identified novel associations of VKORC1 variants with higher acenocoumarol doses albeit with a low effect size. Further studies are necessary to test their influence on the VKORC1 function and the cost/benefit of their inclusion in pharmacogenetic algorithms.	[Gonzalez-Conejero, Rocio] Univ Murcia, Ctr Reg Hemodonac, Murcia, Spain; Univ Murcia, Morales Meseguer Hosp, Murcia, Spain	University of Murcia; Meseguer General University Hospital Morales; University of Murcia	Gonzalez-Conejero, R (corresponding author), Univ Murcia, Ctr Reg Hemodonac, Murcia, Spain.	rocio.gonzalez@carm.es	Roldan, Vanessa/I-5858-2019; Anton, Ana I. I/M-2962-2018; MANCHADO, JUAN JOSE CEREZO/ABA-4728-2020; Vicente, Vicente/L-6185-2019; Gonzalez-Conejero, Rocio/H-9254-2017	Roldan, Vanessa/0000-0002-4945-6602; Anton, Ana I. I/0000-0003-1527-6096; Vicente, Vicente/0000-0002-4278-3264; Gonzalez-Conejero, Rocio/0000-0002-4772-9822; PADILLA RUIZ, JOSE/0000-0003-1599-7870; Corral, Javier/0000-0003-0288-1107	ISCIII [PI08/1531]; Fundacion Seneca [07703/GERM/07]; Instituto Carlos III (ISCIII); ISCIII (Red RECAVA) [RD06/0014/0039]	ISCIII(Instituto de Salud Carlos III); Fundacion Seneca(Fundacion Seneca); Instituto Carlos III (ISCIII)(Instituto de Salud Carlos III); ISCIII (Red RECAVA)	This work was supported by research grants from ISCIII (PI08/1531), ISCIII (Red RECAVA RD06/0014/0039), Fundacion Seneca (07703/GERM/07), Rio Hortega contract from Instituto Carlos III (ISCIII) (VPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklillu E, 2008, BLOOD, V111, P3903, DOI 10.1182/blood-2008-01-135863; Becquement L, 2011, PHARMACOGENOMICS, V12, P113, DOI 10.2217/PGS.10.147; Bodin L, 2008, J THROMB HAEMOST, V6, P1436, DOI 10.1111/j.1538-7836.2008.03049.x; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Daly AK, 2010, NAT REV GENET, V11, P241, DOI 10.1038/nrg2751; Finkelman BS, 2011, J AM COLL CARDIOL, V57, P612, DOI 10.1016/j.jacc.2010.08.643; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gonzalez-Conejero R, 2007, J THROMB HAEMOST, V5, P1701, DOI 10.1111/j.1538-7836.2007.02630.x; Harrington DJ, 2008, J THROMB HAEMOST, V6, P1663, DOI 10.1111/j.1538-7836.2008.03116.x; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; King CR, 2010, THROMB HAEMOSTASIS, V104, P750, DOI 10.1160/TH09-11-0763; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Kurnik D, 2009, PHARMACOGENOMICS, V10, P1955, DOI 10.2217/PGS.09.149; Limdi NA, 2008, PHARMACOGENOMICS, V9, P1445, DOI 10.2217/14622416.9.10.1445; Loebstein R, 2007, BLOOD, V109, P2477, DOI 10.1182/blood-2006-08-038984; Mitchell C, 2011, PHARMACOGENOMICS, V12, P953, DOI [10.2217/pgs.11.36, 10.2217/PGS.11.36]; Perez-Andreu V, 2009, CURR DRUG METAB, V10, P632, DOI 10.2174/138920009789375432; Perez-Andreu V, 2009, BLOOD, V113, P4977, DOI 10.1182/blood-2008-09-176222; Rost S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-4; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Scott SA, 2008, AM J HUM GENET, V82, P495, DOI 10.1016/j.ajhg.2007.10.002; Shuen AY, 2012, CLIN BIOCHEM, V45, P397, DOI 10.1016/j.clinbiochem.2012.01.002; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309; van Schie RMF, 2011, EUR HEART J, V32, P1909, DOI 10.1093/eurheartj/ehr116; Vandvik O, 2012, CHEST, V141, pE637S, DOI 10.1378/chest.11-2306; Verde Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011210; Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070; Wang DX, 2008, BLOOD, V112, P1013, DOI 10.1182/blood-2008-03-144899; Watzka M, 2011, J THROMB HAEMOST, V9, P109, DOI 10.1111/j.1538-7836.2010.04095.x	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64469	10.1371/journal.pone.0064469	http://dx.doi.org/10.1371/journal.pone.0064469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691226	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900102
J	Chu, C; Celik, E; Rico, F; Moy, VT				Chu, Calvin; Celik, Emrah; Rico, Felix; Moy, Vincent T.			Elongated Membrane Tethers, Individually Anchored by High Affinity alpha(4)beta(1)/VCAM-1 Complexes, Are the Quantal Units of Monocyte Arrests	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPE; CELL-ADHESION; LEUKOCYTE RECRUITMENT; AVIDITY REGULATION; DYNAMIC STRENGTH; PHOSPHOLIPASE-C; UP-REGULATION; ERM PROTEINS; CATCH BONDS; INTEGRIN	The alpha(4)beta(1) integrin facilitates both monocyte rolling and adhesion to the vascular endothelium and is physiologically activated by monocyte chemoattractant protein (MCP-1). The current study investigated the initial events in the adhesion of THP-1 cells to immobilized Vascular Cell Adhesion Molecule 1 (VCAM-1). Using AFM force measurements, cell adhesion was shown to be mediated by two populations of alpha(4)beta(1)/VCAM-1 complexes. A low affinity form of alpha(4)beta(1) was anchored to the elastic elements of the cytoskeleton, while a higher affinity conformer was coupled to the viscous elements of the cell membrane. Within 100 ms of contact, THP-1 cells, stimulated by co-immobilized MCP-1, exhibited a tremendous increase in adhesion to VCAM-1. Enhanced cell adhesion was accompanied by a local decoupling of the cell membrane from the cytoskeleton and the formation of long membrane tethers. The tethers were individually anchored by multiple alpha(4)beta(1)/VCAM-1 complexes that prolonged the extension of the viscous tethers. In vivo, the formation of these membrane tethers may provide the quantal structural units for the arrest of rolling monocytes within the blood vessels.	[Chu, Calvin; Celik, Emrah; Rico, Felix; Moy, Vincent T.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	University of Miami	Moy, VT (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA.	vmoy@miami.edu	Rico, Felix/K-6505-2012	Rico, Felix/0000-0002-7757-8340	National Institutes of Health (NIH) [GM086808, T32NS007044]; National Science Foundation [MRI 0722372]; James & Esther King Biomedical Research Program [24157]; Generalitat de Catalunya; Fulbright Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007044] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); James & Esther King Biomedical Research Program; Generalitat de Catalunya(Generalitat de Catalunya); Fulbright Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grants from the National Institutes of Health (NIH) (GM086808), the National Science Foundation (MRI 0722372), and the James & Esther King Biomedical Research Program (24157) to VTM. FR received funding from the Generalitat de Catalunya and the Fulbright Foundation. CC was supported by NIH training grant T32NS007044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Afrin R, 2003, CELL BIOCHEM BIOPHYS, V39, P101, DOI 10.1385/CBB:39:2:101; Afrin R, 2006, BIOCHEM BIOPH RES CO, V348, P238, DOI 10.1016/j.bbrc.2006.07.050; Alam R, 1996, AM J RESP CRIT CARE, V153, P1398, DOI 10.1164/ajrccm.153.4.8616572; Alon R, 2005, J CELL BIOL, V171, P1073, DOI 10.1083/jcb.200503155; Ashida N, 2001, J BIOL CHEM, V276, P16555, DOI 10.1074/jbc.M009068200; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Brochard-Wyart F, 2006, P NATL ACAD SCI USA, V103, P7660, DOI 10.1073/pnas.0602012103; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chan JR, 2003, J IMMUNOL METHODS, V273, P43, DOI 10.1016/S0022-1759(02)00417-9; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; DiVietro JA, 2007, J IMMUNOL, V178, P3903, DOI 10.4049/jimmunol.178.6.3903; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Ferreira AM, 2006, MICROCIRCULATION, V13, P439, DOI 10.1080/10739680600776062; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Fu GH, 2007, J APPL MECH-T ASME, V74, P373, DOI 10.1115/1.2188017; GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P653, DOI 10.1016/0009-2509(67)80048-4; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Hochmuth FM, 1996, BIOPHYS J, V70, P358, DOI DOI 10.1016/S0006-3495(96)79577-2); Hosu BG, 2007, PHYS BIOL, V4, P67, DOI 10.1088/1478-3975/4/2/001; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Hyduk SJ, 2007, BLOOD, V109, P176, DOI 10.1182/blood-2006-01-029199; Jing Q, 2000, CIRC RES, V87, P52, DOI 10.1161/01.RES.87.1.52; KIM JS, 1995, J NEUROIMMUNOL, V56, P127, DOI 10.1016/0165-5728(94)00138-E; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Krieg M, 2008, ANGEW CHEM INT EDIT, V47, P9775, DOI 10.1002/anie.200803552; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; Rico F, 2010, BIOPHYS J, V99, P1387, DOI 10.1016/j.bpj.2010.06.037; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rullo J, 2012, J CELL BIOL, V197, P115, DOI 10.1083/jcb.201107140; Simon SI, 2005, ANNU REV BIOMED ENG, V7, P151, DOI 10.1146/annurev.bioeng.7.060804.100423; Sun M, 2007, J CELL SCI, V120, P2223, DOI 10.1242/jcs.001370; Sun MZ, 2005, BIOPHYS J, V89, P4320, DOI 10.1529/biophysj.104.058180; Sundd P, 2012, NATURE, V488, P399, DOI 10.1038/nature11248; Sundd P, 2010, NAT METHODS, V7, P821, DOI [10.1038/NMETH.1508, 10.1038/nmeth.1508]; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tees DFJ, 2001, BIOPHYS J, V80, P668, DOI 10.1016/S0006-3495(01)76047-X; TISSOT O, 1992, BIOPHYS J, V61, P204, DOI 10.1016/S0006-3495(92)81827-1; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Williams PM, 2003, ANAL CHIM ACTA, V479, P107, DOI 10.1016/S0003-2670(02)01569-6; Wojcikiewicz EP, 2003, J CELL SCI, V116, P2531, DOI 10.1242/jcs.00465; Zhang XH, 2004, BIOPHYS J, V87, P3470, DOI 10.1529/biophysj.104.045690; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8	52	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64187	10.1371/journal.pone.0064187	http://dx.doi.org/10.1371/journal.pone.0064187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691169	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107900085
J	De Donato, M; Peters, SO; Mitchell, SE; Hussain, T; Imumorin, IG				De Donato, Marcos; Peters, Sunday O.; Mitchell, Sharon E.; Hussain, Tanveer; Imumorin, Ikhide G.			Genotyping-by-Sequencing (GBS): A Novel, Efficient and Cost-Effective Genotyping Method for Cattle Using Next-Generation Sequencing	PLOS ONE			English	Article							GENOME; DISCOVERY; SELECTION; MARKERS	High-throughput genotyping methods have increased the analytical power to study complex traits but high cost has remained a barrier for large scale use in animal improvement. We have adapted genotyping-by-sequencing (GBS) used in plants for genotyping 47 animals representing 7 taurine and indicine breeds of cattle from the US and Africa. Genomic DNA was digested with different enzymes, ligated to adapters containing one of 48 unique bar codes and sequenced by the Illumina HiSeq 2000. PstI was the best enzyme producing 1.4 million unique reads per animal and initially identifying a total of 63,697 SNPs. After removal of SNPs with call rates of less than 70%, 51,414 SNPs were detected throughout all autosomes with an average distance of 48.1 kb, and 1,143 SNPs on the X chromosome at an average distance of 130.3 kb, as well as 191 on unmapped contigs. If we consider only the SNPs with call rates of 90% and over, we identified 39,751 on autosomes, 850 on the X chromosome and 124 on unmapped contigs. Of these SNPs, 28,843 were not tightly linked to other SNPs. Average marker density per autosome was highly correlated with chromosome size (coefficient of correlation = -0.798, r(2) = 0.637) with higher density in smaller chromosomes. Average SNP call rate was 86.5% for all loci, with 53.0% of the loci having call rates >90% and the average minor allele frequency being 0.212. Average observed heterozygosity ranged from 0.046-0.294 among individuals, and from 0.064-0.197 among breeds, with Brangus showing the highest diversity as expected. GBS technique is novel, flexible, sufficiently high-throughput, and capable of providing acceptable marker density for genomic selection or genome-wide association studies at roughly one third of the cost of currently available genotyping technologies.	[De Donato, Marcos; Peters, Sunday O.; Hussain, Tanveer; Imumorin, Ikhide G.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [De Donato, Marcos] Univ Oriente, Lab Genet Mol, Inst Invest Biomed & Ciencias Aplicadas, Cumana, Venezuela; [Peters, Sunday O.] Berry Coll, Dept Anim Sci, Mt Berry, GA USA; [Mitchell, Sharon E.] Cornell Univ, Inst Genom Div, Ithaca, NY 14853 USA; [Hussain, Tanveer] Univ Vet & Anim Sci, Inst Biochem & Biotechnol, Lahore, Pakistan	Cornell University; Cornell University; University of Veterinary & Animal Science - Pakistan	Imumorin, IG (corresponding author), Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA.	igi2@cornell.edu	De Donato, Marcos/I-5307-2012; Peters, Sunday/AAE-9683-2021; Hussain, Tanveer/E-4749-2016; Hussain, Tanveer/GWQ-5172-2022	De Donato, Marcos/0000-0001-8860-6020; Hussain, Tanveer/0000-0002-2522-2406; Peters, Sunday/0000-0002-0216-926X	College of Agriculture and Life Sciences, Cornell University, Ithaca, NY; Zoetis, Inc.; National Research Initiative Competitive Grant Program from the USDA National Institute of Food and Agriculture [2006-35205-16864]; USDA National Institute of Food and Agriculture Research Agreements [2009-65205-05635, 2010-34444-20729]; USDA Federal formula Hatch funds; Higher Education Commission of Pakistan	College of Agriculture and Life Sciences, Cornell University, Ithaca, NY; Zoetis, Inc.; National Research Initiative Competitive Grant Program from the USDA National Institute of Food and Agriculture; USDA National Institute of Food and Agriculture Research Agreements; USDA Federal formula Hatch funds; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work was supported by the College of Agriculture and Life Sciences, Cornell University, Ithaca, NY and Pfizer Animal Health (now Zoetis, Inc.). Additional support by National Research Initiative Competitive Grant Program (Grant No. 2006-35205-16864) from the USDA National Institute of Food and Agriculture; USDA National Institute of Food and Agriculture Research Agreements (Nos. 2009-65205-05635, 2010-34444-20729) and USDA Federal formula Hatch funds appropriated to the Cornell University Agricultural Experiment Station are gratefully acknowledged. We thank the Higher Education Commission of Pakistan for a Visiting fellowship awarded to Tanveer Hussain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barris W, 2012, ANIM PROD SCI, V52, P133, DOI 10.1071/AN11095; Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hawken RJ, 2012, J ANIM SCI, V90, P1398, DOI 10.2527/jas.2011-4410; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P81, DOI 10.1007/s10142-011-0252-1; Ku CS, 2010, J HUM GENET, V55, P403, DOI 10.1038/jhg.2010.55; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perez-Enciso M, 2010, ANIM GENET, V41, P561, DOI 10.1111/j.1365-2052.2010.02057.x; Peters SO, 2012, J ANIMAL SCI; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pryce JE, 2012, ANIM PROD SCI, V52, P107, DOI 10.1071/AN11098; Pryce JE, 2010, J DAIRY SCI, V93, P5455, DOI 10.3168/jds.2010-3256; Pryce J, 2012, ANIM PROD SCI, V52, P180, DOI 10.1071/AN11172; Qanbari S, 2010, ANIM GENET, V41, P346, DOI 10.1111/j.1365-2052.2009.02011.x; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Schefers J. M., 2012, Animal Frontiers, V2, P4, DOI 10.2527/af.2011-0032; Seroussi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-673; Sharma RK, 2011, 53 ANN MAIZ GEN C ST; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Eenennaam AL, 2011, J ANIM SCI, V89, P307, DOI 10.2527/jas.2010-3223; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Zhan BJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-557	38	125	125	0	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e62137	10.1371/journal.pone.0062137	http://dx.doi.org/10.1371/journal.pone.0062137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690931	Green Submitted, gold, Green Published			2022-12-25	WOS:000319107900005
J	Khan, WA; Griffiths, JK; Bennish, ML				Khan, Wasif A.; Griffiths, Jeffrey K.; Bennish, Michael L.			Gastrointestinal and Extra-Intestinal Manifestations of Childhood Shigellosis in a Region Where All Four Species of Shigella Are Endemic	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; RISK-FACTORS; DYSENTERY; CHILDREN; FLEXNERI; TOXINS; INFECTIONS; VIRULENCE; COUNTRIES; DIARRHEA	Objective: To determine the clinical manifestations and outcome of shigellosis among children infected with different species of Shigella. Methods: We identified all patients <15 years infected with Shigella admitted to the icddr, b Dhaka hospital during one year. Study staff reviewed admission records and repeated the physical examinations and history of patients daily. Results: Of 792 children with shigellosis 63% were infected with S. flexneri, 20% with S. dysenteriae type 1, 10% with S. boydii, 4% with S. sonnei, and 3% with S. dysenteriae types 2-10. Children infected with S. dysenteriae type 1, when compared to children infected with other species, were significantly (P < 0.05) more likely to have severe gastrointestinal manifestations: grossly bloody stools (78% vs. 33%), more stools in the 24 h before admission (median 25 vs. 11), and rectal prolapse (52% vs. 15%) - and extra-intestinal manifestations - leukemoid reaction (22% vs. 2%), hemolytic-uremic syndrome (8% vs. 1%), severe hyponatremia (58% vs. 26%) and neurologic abnormalities (24% vs. 16%). The overall fatality rate was 10% and did not differ significantly by species. In a multiple regression analysis young age, malnutrition, hyponatremia, lesser stool frequency, documented seizure, and unconsciousness were predictive of death. Conclusions: Both severe intestinal disease and extra-intestinal manifestations of shigellosis occur with infection by any of the four species of Shigella, but are most common with S. dysenteriae type 1. Among these inpatient children, the risk of death was high with infection of any of the four Shigella species.	[Khan, Wasif A.] Int Ctr Diarrhoeal Dis Res, Ctr Vaccine Sci, Dhaka 1000, Bangladesh; [Griffiths, Jeffrey K.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Bennish, Michael L.] Mpilonhle, Mtubatuba, South Africa	International Centre for Diarrhoeal Disease Research (ICDDR); Massachusetts Department of Public Health; Tufts University	Khan, WA (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Vaccine Sci, GPO Box 128, Dhaka 1000, Bangladesh.	wakhan@icddrb.org			National Institute of Allergy and Infection Diseases [U01 AI45508-01]; Fogarty International Centre of the United States National Institute of Health [K24AI/HDO01671]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI001671] Funding Source: NIH RePORTER	National Institute of Allergy and Infection Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Fogarty International Centre of the United States National Institute of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	icddr, b support the research work. MLB was supported by grants from the National Institute of Allergy and Infection Diseases (U01 AI45508-01 and the Fogarty International Centre (K24AI/HDO01671) of the United States National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 1997, AM J TROP MED HYG, V56, P258, DOI 10.4269/ajtmh.1997.56.258; Ashkenazi Shai, 2004, Semin Pediatr Infect Dis, V15, P246, DOI 10.1053/j.spid.2004.07.005; Baiulescu M, 2002, PEDIATR INFECT DIS J, V21, P170, DOI 10.1097/00006454-200202000-00019; Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; BARRETTCONNOR E, 1970, AM J GASTROENTEROL, V53, P234; BENNISH ML, 1991, GASTROENTEROLOGY, V101, P626, DOI 10.1016/0016-5085(91)90518-P; Bennish ML, 2006, CLIN INFECT DIS, V42, P356, DOI 10.1086/499236; BENNISH ML, 1990, J INFECT DIS, V161, P500, DOI 10.1093/infdis/161.3.500; BENNISH ML, 1991, REV INFECT DIS, V13, pS319; BENNISH ML, 1993, AM J GASTROENTEROL, V88, P53; BENNISH ML, 2012, HUNTERS TROPICAL MED, P454; BENNISH ML, 1988, 28 INT C ANT AG CHEM; BIEDNER B, 1987, AM J OPHTHALMOL, V104, P90, DOI 10.1016/0002-9394(87)90304-7; CDC, 2000, CLIN GROWTH CHARTS; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P444, DOI 10.1097/INF.0b013e3181cb4608; Chopra M, 1997, S AFR MED J, V87, P48; Constantinescu AR, 2004, AM J KIDNEY DIS, V43, P976, DOI 10.1053/j.ajkd.2004.02.010; DESILVA DGH, 1993, GUT, V34, P194, DOI 10.1136/gut.34.2.194; Faruque ASG, 1998, ANN TROP PAEDIATR, V18, P197, DOI 10.1080/02724936.1998.11747947; Fasano A, 1997, GUT, V40, P505, DOI 10.1136/gut.40.4.505; HALE TL, 1991, MICROBIOL REV, V55, P206, DOI 10.1128/MMBR.55.2.206-224.1991; Huang IF, 2005, J CLIN MICROBIOL, V43, P2608, DOI 10.1128/JCM.43.6.2608-2612.2005; HUSKINS WC, 1994, J PEDIATR-US, V125, P14, DOI 10.1016/S0022-3476(94)70115-6; Jennison AV, 2004, FEMS MICROBIOL REV, V28, P43, DOI 10.1016/j.femsre.2003.07.002; Kavaliotis J, 2000, SCAND J INFECT DIS, V32, P207, DOI 10.1080/003655400750045358; KEUSCH GT, 1977, MT SINAI J MED, V44, P33; Khan WA, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.2.e18; KOSTER F, 1978, NEW ENGL J MED, V298, P927, DOI 10.1056/NEJM197804272981702; Kotloff KL, 2004, J INFECT DIS, V190, P1745, DOI 10.1086/424680; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Legros D, 1999, TROP MED INT HEALTH, V4, P428, DOI 10.1046/j.1365-3156.1999.00413.x; Mazumder RN, 1997, J DIARRHOEAL DIS RES, V15, P21; MITRA A K, 1990, Journal of Diarrhoeal Diseases Research, V8, P12; Nathoo K. J., 1998, Central African Journal of Medicine, V44, P272; *NIPORT, 2013, MITR ASS INT 1 2013; Niyogi SK, 2005, J MICROBIOL, V43, P133; O'Loughlin EV, 2001, MICROBES INFECT, V3, P493, DOI 10.1016/S1286-4579(01)01405-8; PAPASIAN CJ, 1995, J CLIN MICROBIOL, V33, P2222, DOI 10.1128/JCM.33.8.2222-2223.1995; RAHAMAN MM, 1975, JOHNS HOPKINS MED J, V136, P65; Ram PK, 2008, EPIDEMIOL INFECT, V136, P577, DOI 10.1017/S0950268807009351; SALAM MA, 1988, J PEDIATR-US, V113, P901, DOI 10.1016/S0022-3476(88)80029-5; Shiga K, 1898, ZENTRALBL BAKTERIOL, V24, P817; Thorpe CM, 2001, INFECT IMMUN, V69, P6140, DOI 10.1128/IAI.69.10.6140-6147.2001; Trofa AF, 1999, CLIN INFECT DIS, V29, P1303, DOI 10.1086/313437; van den Broek JM, 2005, J HEALTH POPUL NUTR, V23, P259; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353	46	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64097	10.1371/journal.pone.0064097	http://dx.doi.org/10.1371/journal.pone.0064097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691156	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900078
J	Chenillat, F; Riviere, P; Capet, X; Franks, PJS; Blanke, B				Chenillat, Fanny; Riviere, Pascal; Capet, Xavier; Franks, Peter J. S.; Blanke, Bruno			California Coastal Upwelling Onset Variability: Cross-Shore and Bottom-Up Propagation in the Planktonic Ecosystem	PLOS ONE			English	Article							CURRENT SYSTEM; SUBMESOSCALE TRANSITION; EQUATORIAL PACIFIC; PART I; PHYTOPLANKTON; DYNAMICS; ZOOPLANKTON; MODEL; SURFACE; PRODUCTIVITY	The variability of the California Current System (CCS) is primarily driven by variability in regional wind forcing. In particular, the timing of the spring transition, i.e., the onset of upwelling-favorable winds, varies considerably in the CCS with changes in the North Pacific Gyre Oscillation. Using a coupled physical-biogeochemical model, this study examines the sensitivity of the ecosystem functioning in the CCS to a lead or lag in the spring transition. An early spring transition results in an increased vertical nutrient flux at the coast, with the largest ecosystem consequences, both in relative amplitude and persistence, hundreds of kilometers offshore and at the highest trophic level of the modeled food web. A budget analysis reveals that the propagation of the perturbation offshore and up the food web is driven by remineralization and grazing/predation involving both large and small plankton species.	[Chenillat, Fanny; Riviere, Pascal] Inst Univ Europe Mer, CNRS UBO IRD IFREMER, Lab Sci Environm Marin LEMAR, Plouzane, France; [Chenillat, Fanny; Blanke, Bruno] Univ Bretagne Occidentale, CNRS IFREMER IRD UBO, Lab Phys Oceans, Brest, France; [Capet, Xavier] Inst Pierre Simon Laplace, CNRS UPMC IRD MNHN, Lab Oceanog & Climat LOCEAN, Paris, France; [Franks, Peter J. S.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of California System; University of California San Diego; Scripps Institution of Oceanography	Chenillat, F (corresponding author), Inst Univ Europe Mer, CNRS UBO IRD IFREMER, Lab Sci Environm Marin LEMAR, Plouzane, France.	fannychenillat@gmail.com	Chenillat, Fanny/E-5278-2018; Blanke, Bruno/H-4280-2015	Chenillat, Fanny/0000-0002-6233-0377; Blanke, Bruno/0000-0002-1309-0952				Bakun A., 1973, SSRF671 NOAA NMFS; Barth JA, 2007, P NATL ACAD SCI USA, V104, P3719, DOI 10.1073/pnas.0700462104; Botsford LW, 2006, DEEP-SEA RES PT II, V53, P3116, DOI 10.1016/j.dsr2.2006.07.011; Capet X, 2008, J PHYS OCEANOGR, V38, P44, DOI 10.1175/2007JPO3672.1; Capet X, 2008, J PHYS OCEANOGR, V38, P29, DOI 10.1175/2007JPO3671.1; Capet X., 2008, GEOPHYS MONOGR SER, V177, P131, DOI [10.1029/177GM10, DOI 10.1029/177GM10]; Capet XJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020123; Castelao RM, 2007, J PHYS OCEANOGR, V37, P2652, DOI 10.1175/2007JPO3679.1; Chai F, 2002, DEEP-SEA RES PT II, V49, P2713, DOI 10.1016/S0967-0645(02)00055-3; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chavez FP, 1989, GLOBAL BIOGEOCHEM CY, V3, P27, DOI 10.1029/GB003i001p00027; Chenillat F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049966; Cloern JE, 1995, LIMNOL OCEANOGR, V40, P1313, DOI 10.4319/lo.1995.40.7.1313; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Di Lorenzo E, 2005, J PHYS OCEANOGR, V35, P336, DOI 10.1175/JPO-2690.1; Di Lorenzo E, 2003, DEEP-SEA RES PT II, V50, P2371, DOI 10.1016/S0967-0645(03)00125-5; Di Lorenzo E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038261; Dorman JG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046245; Garcia H. E., 2006, WORLD OCEAN ATLAS 20; Gentleman W, 2003, DEEP-SEA RES PT II, V50, P2847, DOI 10.1016/J.DSR2.2003.07.001; Gruber N, 2006, DEEP-SEA RES PT I, V53, P1483, DOI 10.1016/j.dsr.2006.06.005; Gruber N, 2011, NAT GEOSCI, V4, P787, DOI [10.1038/NGEO1273, 10.1038/ngeo1273]; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Ji RB, 2010, J PLANKTON RES, V32, P1355, DOI 10.1093/plankt/fbq062; Kishi MJ, 2007, ECOL MODEL, V202, P12, DOI 10.1016/j.ecolmodel.2006.08.021; Kone V, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002427; Kruskal WH, 1972, J AM STAT ASSOC, V47, P583; Landry MR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000744; LANDRY MR, 1977, HELGOLAND WISS MEER, V30, P8, DOI 10.1007/BF02207821; Lathuiliere C, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005827; Legaard KR, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003282; Li QP, 2011, MAR ECOL PROG SER, V438, P59, DOI 10.3354/meps09320; Li QP, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001111; MACISAAC JJ, 1985, DEEP-SEA RES, V32, P503, DOI 10.1016/0198-0149(85)90042-1; Mackas DL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027930; Marchesiello P, 2003, J PHYS OCEANOGR, V33, P753, DOI 10.1175/1520-0485(2003)33<753:ESADOT>2.0.CO;2; Masumoto Y, 2004, J EARTH SIMULATOR, V1, P35; Menge BA, 1997, LIMNOL OCEANOGR, V42, P57, DOI 10.4319/lo.1997.42.1.0057; Moriceau B, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002814; Morozov AY, 2010, J THEOR BIOL, V265, P45, DOI 10.1016/j.jtbi.2010.04.016; Penven P, 2008, ENVIRON MODELL SOFTW, V23, P660, DOI 10.1016/j.envsoft.2007.07.004; PHILANDER SGH, 1982, J PHYS OCEANOGR, V12, P862, DOI 10.1175/1520-0485(1982)012<0862:EBCACU>2.0.CO;2; Powell TM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002506; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Rose KA, 2007, ECOL MODEL, V202, P38, DOI 10.1016/j.ecolmodel.2006.08.016; Sasaki H, 2004, OCEANS '04 MTS/IEEE TECHNO-OCEAN '04, VOLS 1- 2, CONFERENCE PROCEEDINGS, VOLS. 1-4, P1535; Sasaki H, 2006, HIGH RESOLUTION NUME; Schwing F.B., 1996, 231 NOAA NMFS SWFSC; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; SYDEMAN WJ, 2010, NOAA TECH REP, P1; Vignudelli S, 2011, COASTAL ALTIMETRY, P1, DOI 10.1007/978-3-642-12796-0; Wainwright TC, 2007, ECOL MODEL, V202, P120, DOI 10.1016/j.ecolmodel.2006.06.019; Woodson CB, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005623	54	24	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e62281	10.1371/journal.pone.0062281	http://dx.doi.org/10.1371/journal.pone.0062281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690935	Green Published, gold			2022-12-25	WOS:000319052700009
J	Pereira, JA; Quach, S; Dao, HH; Kwong, JC; Deeks, SL; Crowcroft, NS; Quan, SD; Guay, M				Pereira, Jennifer A.; Quach, Susan; Dao, Huy Hao; Kwong, Jeffrey C.; Deeks, Shelley L.; Crowcroft, Natasha S.; Quan, Sherman D.; Guay, Maryse		Public Hlth Agcy Canada Canadian I; Evaluation Grp	Contagious Comments: What Was the Online Buzz About the 2011 Quebec Measles Outbreak?	PLOS ONE			English	Article							VACCINATION	Background: Although interruption of endemic measles was achieved in the Americas in 2002, Quebec experienced an outbreak in 2011 of 776 reported cases; 80% of these individuals had not been fully vaccinated. We analyzed readers' online responses to Canadian news articles regarding the outbreak to better understand public perceptions of measles and vaccination. Methods: We searched Canadian online English and French news sites for articles posted between April 2011 and March 2012 containing the words "measles" and "Quebec". We included articles that i) concerned the outbreak or related vaccination strategies; and ii) generated at least ten comments. Two English and two bilingual researchers coded the unedited comments, categorizing codes to allow themes to emerge. Results: We analyzed 448 comments from 188 individuals, in response to three French articles and six English articles; 112 individuals expressed positive perceptions of measles vaccination (2.2 comments/person), 38 were negative (4.2 comments/person), 11 had mixed feelings (1.5 comments/person), and 27 expressed no opinion (1.1 comments/person). Vaccine-supportive themes involved the success of vaccination in preventing disease spread, societal responsibility to vaccinate for herd immunity, and refutation of the autism link. Those against measles vaccination felt it was a personal rather than societal choice, and conveyed a distrust of vaccine manufacturers, believing that measles infection is not only safe but safer than vaccination. Commenters with mixed feelings expressed uncertainty of the infection's severity, and varied in support of all vaccines based on perceived risk/benefit ratios. Conclusion: The anti-vaccine minority's volume of comments translates to a disproportionately high representation on online boards. Public health messages should address concerns by emphasizing that immunization is always a personal choice in Canada, and that the pharmaceutical industry is strictly controlled. Illustrating the dangers of measles through personal stories, rather than scientific data only, may also serve to strengthen messaging.	[Pereira, Jennifer A.; Quach, Susan; Kwong, Jeffrey C.; Deeks, Shelley L.; Crowcroft, Natasha S.] Publ Hlth Ontario, Toronto, ON, Canada; [Dao, Huy Hao; Guay, Maryse] Univ Sherbrooke, Dept Sci Sante Communautaire, Longueuil, PQ, Canada; [Kwong, Jeffrey C.; Deeks, Shelley L.; Crowcroft, Natasha S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Kwong, Jeffrey C.; Quan, Sherman D.] Univ Hlth Network, Toronto, ON, Canada; [Crowcroft, Natasha S.] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada; [Guay, Maryse] Inst Natl Sante Publ Quebec, Longueuil, PQ, Canada; [Guay, Maryse] Ctr Rech Hop Charles LeMoyne, Longueuil, PQ, Canada	University of Sherbrooke; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Institut national de sante publique du Quebec (INSPQ)	Pereira, JA (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	jennifer.pereira@oahpp.ca			Public Health Agency of Canada; Canadian Institutes of Health Research; Public Health Ontario	Public Health Agency of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Public Health Ontario	The Canadian Association for Immunization Research and Evaluation provided networking assistance. The Public Health Agency of Canada, the Canadian Institutes of Health Research, and the Public Health Ontario provided funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castillo-Solorzano CC, 2011, J INFECT DIS, V204, pS270, DOI 10.1093/infdis/jir166; Ekos RAI, 2011, SURVEY PARENTS KEY I; Henrich N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018479; Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022; Keelan J, 2007, JAMA-J AM MED ASSOC, V298, P2482, DOI 10.1001/jama.298.21.2482; Keelan J, 2010, VACCINE, V28, P1535, DOI 10.1016/j.vaccine.2009.11.060; Manosevitch E., 2009, 10 INT S ON LIN JOUR; Public Health Agency of Canada, 2007, CAN IMM GUID; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Sante et des Services sociaux, 2012, EP PORTR MEASL OUTBR; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Statistics Canada, 2012, POP YEAR PROV TERR; Wilson K, 2005, VACCINE, V23, P3010, DOI 10.1016/j.vaccine.2004.12.002; World Health Organization, 2012, MEASL FACT SHEET	15	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64072	10.1371/journal.pone.0064072	http://dx.doi.org/10.1371/journal.pone.0064072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691152	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700077
J	Quincozes-Santos, A; Bobermin, LD; Latini, A; Wajner, M; Souza, DO; Goncalves, CA; Gottfried, C				Quincozes-Santos, Andre; Bobermin, Larissa Daniele; Latini, Alexandra; Wajner, Moacir; Souza, Diogo Onofre; Goncalves, Carlos-Alberto; Gottfried, Carmem			Resveratrol Protects C6 Astrocyte Cell Line against Hydrogen Peroxide-Induced Oxidative Stress through Heme Oxygenase 1	PLOS ONE			English	Article							RED WINE POLYPHENOL; NITRIC-OXIDE; TRANS-RESVERATROL; NRF2 ACTIVATION; GLUTATHIONE SYNTHESIS; FREE-RADICALS; BRAIN-DAMAGE; GLIAL-CELLS; ANTIOXIDANT; EXPRESSION	Resveratrol, a polyphenol presents in grapes and wine, displays antioxidant and anti-inflammatory properties and cytoprotective effect in brain pathologies associated to oxidative stress and neurodegeneration. In previous work, we demonstrated that resveratrol exerts neuroglial modulation, improving glial functions, mainly related to glutamate metabolism. Astrocytes are a major class of glial cells and regulate neurotransmitter systems, synaptic processing, energy metabolism and defense against oxidative stress. This study sought to determine the protective effect of resveratrol against hydrogen peroxide (H2O2)-induced cytotoxicity in C6 astrocyte cell line, an astrocytic lineage, on neurochemical parameters and their cellular and biochemical mechanisms. H2O2 exposure increased oxidative-nitrosative stress, iNOS expression, cytokine proinflammatory release (TNFa levels) and mitochondrial membrane potential dysfunction and decreased antioxidant defenses, such as SOD, CAT and creatine kinase activity. Resveratrol strongly prevented C6 cells from H2O2-induced toxicity by modulating glial, oxidative and inflammatory responses. Resveratrol per se increased heme oxygenase 1 (HO1) expression and extracellular GSH content. In addition, HO1 signaling pathway is involved in the protective effect of resveratrol against H2O2-induced oxidative damage in astroglial cells. Taken together, these results show that resveratrol represents an important mechanism for protection of glial cells against oxidative stress.	[Quincozes-Santos, Andre; Bobermin, Larissa Daniele; Wajner, Moacir; Souza, Diogo Onofre; Goncalves, Carlos-Alberto; Gottfried, Carmem] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Programa Pos Graduacao Ciencias Biol Bioquim, Porto Alegre, RS, Brazil; [Latini, Alexandra] Univ Fed Santa Catarina, Dept Bioquim, Cent Ciencias Biol, BR-88040900 Florianopolis, SC, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal de Santa Catarina (UFSC)	Quincozes-Santos, A (corresponding author), Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Programa Pos Graduacao Ciencias Biol Bioquim, Porto Alegre, RS, Brazil.	andrequincozes@yahoo.com.br	Wajner, Moacir/K-8763-2015; Quincozes-Santos, André/AAO-2714-2020; Latini, Alexandra/Y-8067-2019; Souza, Diogo O/J-8894-2014; Gottfried, Carmem/AAG-2355-2019; Bobermin, Larissa/AGN-9475-2022; Latini, Alexandra/P-2637-2019; Goncalves, Carlos Alberto/K-1851-2014	Wajner, Moacir/0000-0001-6372-1807; Latini, Alexandra/0000-0003-4255-3589; Souza, Diogo O/0000-0002-4322-0404; Gottfried, Carmem/0000-0001-8838-1300; Quincozes-Santos, Andre/0000-0001-8611-4890	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); FINEP/Rede [IBN 01.06.0842-00]; INCTEN National Institute of Science and Technology for Excitotoxicity and Neuroprotection	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); FINEP/Rede(Financiadora de Inovacao e Pesquisa (Finep)); INCTEN National Institute of Science and Technology for Excitotoxicity and Neuroprotection	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), FINEP/Rede IBN 01.06.0842-00 and INCTEN National Institute of Science and Technology for Excitotoxicity and Neuroprotection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Arredondo F, 2010, FREE RADICAL BIO MED, V49, P738, DOI 10.1016/j.freeradbiomed.2010.05.020; Bai G, 2001, J NEUROSCI RES, V66, P981, DOI 10.1002/jnr.10056; Bastianetto S, 2010, EXP NEUROL, V225, P237, DOI 10.1016/j.expneurol.2010.06.019; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beal MF, 2000, TRENDS NEUROSCI, V23, P298, DOI 10.1016/S0166-2236(00)01584-8; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bobermin LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052164; Browne R W, 1998, Methods Mol Biol, V108, P347; Calabrese V, 2008, NEUROCHEM RES, V33, P2444, DOI 10.1007/s11064-008-9775-9; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Choi IY, 2000, GLIA, V31, P155, DOI 10.1002/1098-1136(200008)31:2<155::AID-GLIA70>3.0.CO;2-1; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Delmas D, 2005, MOL NUTR FOOD RES, V49, P377, DOI 10.1002/mnfr.200400098; Dore S, 2005, NEUROSIGNALS, V14, P61, DOI 10.1159/000085386; dos Santos AQ, 2006, ARCH BIOCHEM BIOPHYS, V453, P161, DOI 10.1016/j.abb.2006.06.025; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dringen R, 2005, J NEUROSCI RES, V79, P157, DOI 10.1002/jnr.20280; Dringen R, 1998, BRAIN RES PROTOC, V2, P223, DOI 10.1016/S1385-299X(97)00047-0; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Erlank H, 2011, FREE RADICAL BIO MED, V51, P2319, DOI 10.1016/j.freeradbiomed.2011.09.033; Escartin C, 2011, J NEUROSCI, V31, P7392, DOI 10.1523/JNEUROSCI.6577-10.2011; Forman HJ, 2007, FREE RADICAL BIO MED, V42, P926, DOI 10.1016/j.freeradbiomed.2007.01.011; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Fukui M, 2010, FREE RADICAL BIO MED, V49, P800, DOI 10.1016/j.freeradbiomed.2010.06.002; Gao HM, 2012, TRENDS PHARMACOL SCI, V33, P295, DOI 10.1016/j.tips.2012.03.008; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Halliwell B, 2007, CARDIOVASC RES, V73, P341, DOI 10.1016/j.cardiores.2006.10.004; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Halliwell B, 2009, FREE RADICAL BIO MED, V46, P531, DOI 10.1016/j.freeradbiomed.2008.11.008; Hamby ME, 2008, NEUROCHEM INT, V52, P962, DOI 10.1016/j.neuint.2007.10.010; Hattori R, 2002, AM J PHYSIOL-HEART C, V282, pH1988, DOI 10.1152/ajpheart.01012.2001; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; HUGHES BP, 1962, CLIN CHIM ACTA, V7, P597, DOI 10.1016/0009-8981(62)90137-7; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Jou MJ, 2008, ADV DRUG DELIVER REV, V60, P1512, DOI 10.1016/j.addr.2008.06.004; Kasdallah-Grissa A, 2007, LIFE SCI, V80, P1033, DOI 10.1016/j.lfs.2006.11.044; Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031; Kim JW, 2010, MOL NUTR FOOD RES, V54, P1497, DOI 10.1002/mnfr.201000016; Klamt F, 2005, J BIOL CHEM, V280, P21346, DOI 10.1074/jbc.M501170200; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kwon KJ, 2011, J PINEAL RES, V50, P110, DOI 10.1111/j.1600-079X.2010.00820.x; Latini A, 2002, BRAIN RES, V956, P367, DOI 10.1016/S0006-8993(02)03573-4; Lee EO, 2010, J NEUROCHEM, V112, P1477, DOI 10.1111/j.1471-4159.2009.06564.x; Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997; Leone S, 2008, MOL CARCINOGEN, V47, P587, DOI 10.1002/mc.20416; Li MH, 2007, J BIOL CHEM, V282, P28577, DOI 10.1074/jbc.M701916200; LISSI E, 1995, FREE RADICAL BIO MED, V18, P153, DOI 10.1016/0891-5849(94)00117-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; Meng QY, 2008, FREE RADICAL BIO MED, V44, P1032, DOI 10.1016/j.freeradbiomed.2007.11.023; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Murias M, 2005, BIOCHEM PHARMACOL, V69, P903, DOI 10.1016/j.bcp.2004.12.001; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Ovesna Z, 2005, NEOPLASMA, V52, P450; Pervaiz S, 2004, DRUG RESIST UPDATE, V7, P333, DOI 10.1016/j.drup.2004.11.001; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Pope SAS, 2008, NEUROCHEM RES, V33, P1410, DOI 10.1007/s11064-008-9602-3; Quincozes-Santos A, 2007, NEUROTOXICOLOGY, V28, P886, DOI 10.1016/j.neuro.2007.03.008; Quincozes-Santos A, 2011, ANN NY ACAD SCI, V1215, P72, DOI 10.1111/j.1749-6632.2010.05857.x; Quincozes-Santos A, 2010, TOXICOL IN VITRO, V24, P916, DOI 10.1016/j.tiv.2009.11.016; Quincozes-Santos A, 2009, NEUROTOX RES, V16, P30, DOI 10.1007/s12640-009-9042-0; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Richard T, 2011, ANN NY ACAD SCI, V1215, P103, DOI 10.1111/j.1749-6632.2010.05865.x; Sakata Y, 2010, EXP NEUROL, V224, P325, DOI 10.1016/j.expneurol.2010.03.032; Scapagnini G, 2004, ANTIOXID REDOX SIGN, V6, P811, DOI 10.1089/ars.2004.6.811; Sebai H, 2010, ECOTOX ENVIRON SAFE, V73, P1078, DOI 10.1016/j.ecoenv.2009.12.031; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Smith-Pearson PS, 2008, FREE RADICAL BIO MED, V45, P1178, DOI 10.1016/j.freeradbiomed.2008.07.015; Soleas GJ, 1997, CLIN BIOCHEM, V30, P91, DOI 10.1016/S0009-9120(96)00155-5; Spanier G, 2009, J PHYSIOL PHARMACOL, V60, P111; Sun AY, 2010, MOL NEUROBIOL, V41, P375, DOI 10.1007/s12035-010-8111-y; Tiwari V, 2011, J NEUROCHEM, V117, P678, DOI 10.1111/j.1471-4159.2011.07236.x; Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, pH1876, DOI 10.1152/ajpheart.00375.2009; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Vargas MR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001094; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; de Almeida LMV, 2008, ARCH BIOCHEM BIOPHYS, V480, P27, DOI 10.1016/j.abb.2008.09.006; de Almeida LMV, 2008, NEUROCHEM RES, V33, P8, DOI 10.1007/s11064-007-9399-5; Vingtdeux V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S6; Virgili M, 2000, NEUROSCI LETT, V281, P123, DOI 10.1016/S0304-3940(00)00820-X; Wakabayashi N, 2010, NRF2 TALKS WHOS LIST; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wendel A, 1981, Methods Enzymol, V77, P325; Yun JM, 2012, J NUTR BIOCHEM, V23, P699, DOI 10.1016/j.jnutbio.2011.03.012	96	97	105	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64372	10.1371/journal.pone.0064372	http://dx.doi.org/10.1371/journal.pone.0064372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691207	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700091
J	Hoffman, JI; Clarke, A; Clark, MS; Peck, LS				Hoffman, Joseph I.; Clarke, Andrew; Clark, Melody S.; Peck, Lloyd S.			Hierarchical Population Genetic Structure in a Direct Developing Antarctic Marine Invertebrate	PLOS ONE			English	Article							PELAGIC LARVAL DURATION; LIFE-HISTORY; CONNECTIVITY; DISPERSAL; PENINSULA; PHYLOGEOGRAPHY; DIVERSITY; PATTERNS; BARRIER; RATES	Understanding the relationship between life-history variation and population structure in marine invertebrates is not straightforward. This is particularly true of polar species due to the difficulty of obtaining samples and a paucity of genomic resources from which to develop nuclear genetic markers. Such knowledge, however, is essential for understanding how different taxa may respond to climate change in the most rapidly warming regions of the planet. We therefore used over two hundred polymorphic Amplified Fragment Length Polymorphisms (AFLPs) to explore population connectivity at three hierachical spatial scales in the direct developing Antarctic topshell Margarella antarctica. To previously published data from five populations spanning a 1500 km transect along the length of the Western Antarctic Peninsula, we added new AFLP data for four populations separated by up to 6 km within Ryder Bay, Adelaide Island. Overall, we found a nonlinear isolation-by-distance pattern, suggestive of weaker population structure within Ryder Bay than is present over larger spatial scales. Nevertheless, significantly positive F-st values were obtained in all but two of ten pairwise population comparisons within the bay following Bonferroni correction for multiple tests. This is in contrast to a previous study of the broadcast spawner Nacella concinna that found no significant genetic differences among several of the same sites. By implication, the topshell's direct-developing lifestyle may constrain its ability to disperse even over relatively small geographic scales.	[Hoffman, Joseph I.] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany; [Clarke, Andrew; Clark, Melody S.; Peck, Lloyd S.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	University of Bielefeld; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Hoffman, JI (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany.	joseph.hoffman@uni-bielefeld.de	Hoffman, Joseph i/K-7725-2012; Clark, Melody S/D-7371-2014	Hoffman, Joseph i/0000-0001-5895-8949; Clark, Melody S/0000-0002-3442-3824	Natural Environment Research Council (NERC) British Antarctic Survey (BAS) Strategic Alliance Fellowship; Natural Environment Research Council [bas0100025, dml011000] Funding Source: researchfish; NERC [dml011000, bas0100025] Funding Source: UKRI	Natural Environment Research Council (NERC) British Antarctic Survey (BAS) Strategic Alliance Fellowship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	JIH was supported by a Natural Environment Research Council (NERC) British Antarctic Survey (BAS) Strategic Alliance Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff DM, 2007, SYST BIOL, V56, P477, DOI 10.1080/10635150701427077; Arndt A, 1998, MOL ECOL, V7, P1053, DOI 10.1046/j.1365-294x.1998.00429.x; Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; Ayre DJ, 2000, EVOLUTION, V54, P1590; Bay LK, 2006, MAR BIOL, V149, P1247, DOI 10.1007/s00227-006-0276-6; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Berkman PA, 2004, DEEP-SEA RES PT II, V51, P1839, DOI 10.1016/j.dsr2.2004.07.017; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; BOSCH I, 1987, BIOL BULL, V173, P126, DOI 10.2307/1541867; Bowden DA, 2006, MAR ECOL PROG SER, V316, P1, DOI 10.3354/meps316001; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; Brown KM, 2004, OECOLOGIA, V141, P121, DOI 10.1007/s00442-004-1648-6; Clarke A, 2000, ANTARCT SCI, V12, P257, DOI 10.1017/S0954102000000316; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke A, 2008, DEEP-SEA RES PT II, V55, P1988, DOI 10.1016/j.dsr2.2008.04.035; Dasmahapatra KK, 2009, HEREDITY, V103, P168, DOI 10.1038/hdy.2009.25; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; DOHERTY PJ, 1995, ECOLOGY, V76, P2373, DOI 10.2307/2265814; Faurby S, 2012, MOL ECOL, V21, P3419, DOI 10.1111/j.1365-294X.2012.05609.x; Fraser CI, 2012, TRENDS ECOL EVOL, V27, P462, DOI 10.1016/j.tree.2012.04.011; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Golledge NR, 2010, GEOGR ANN A, V92A, P111, DOI 10.1111/j.1468-0459.2010.00381.x; Harper L, 2012, PLOS ONE, V7; HEDGECOCK D, 1994, CAL COOP OCEAN FISH, V35, P73; Hellberg ME, 2002, B MAR SCI, V70, P273; HOEGHGULDBERG O, 1995, AM ZOOL, V35, P415; Hoffman JI, 2012, MOL ECOL RESOUR, V12, P861, DOI 10.1111/j.1755-0998.2012.03158.x; Hoffman JI, 2012, POLAR BIOL, V35, P919, DOI 10.1007/s00300-011-1139-2; Hoffman JI, 2011, MAR BIOL, V158, P287, DOI 10.1007/s00227-010-1558-6; Hoffman JI, 2010, MAR BIOL, V157, P765, DOI 10.1007/s00227-009-1360-5; Hoffman JI, 2012, PLOS ONE, pe32415; Hoffman JI, 2011, J HERED, V102, P55, DOI 10.1093/jhered/esq094; Hunter RL, 2008, J HERED, V99, P137, DOI 10.1093/jhered/esm119; Hunter RL, 2010, MAR BIOL, V157, P1693, DOI 10.1007/s00227-010-1443-3; Jenkins DG, 2010, ECOGRAPHY, V33, P315, DOI 10.1111/j.1600-0587.2010.06285.x; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; King JC, 2003, ANTARCT RES SER, V79, P17; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Krabbe K, 2010, POLAR BIOL, V33, P281, DOI 10.1007/s00300-009-0703-5; Ledoux JB, 2012, POLAR BIOL, V35, P611, DOI 10.1007/s00300-011-1106-y; Lee HJE, 2009, MOL ECOL, V18, P2165, DOI 10.1111/j.1365-294X.2009.04169.x; Leese F, 2010, NATURWISSENSCHAFTEN, V97, P583, DOI 10.1007/s00114-010-0674-y; Linse K, 2007, POLAR BIOL, V30, P1059, DOI 10.1007/s00300-007-0265-3; Mahon AR, 2008, MAR BIOL, V155, P315, DOI 10.1007/s00227-008-1029-5; Matschiner M, 2009, MOL ECOL, V18, P2574, DOI 10.1111/j.1365-294X.2009.04220.x; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; O'Hanlon PC, 2000, MOL ECOL, V9, P815, DOI 10.1046/j.1365-294x.2000.00924.x; Peakall R, 2005, MOL ECOLOGY NOTES, V6, P288; Peck LS, 2010, GLOBAL CHANGE BIOL, V16, P2614, DOI 10.1111/j.1365-2486.2009.02071.x; Peck LS, 2007, MAR BIOL, V150, P1191, DOI 10.1007/s00227-006-0428-8; Peck LS, 2006, MAR ECOL PROG SER, V318, P213, DOI 10.3354/meps318213; Peck LS, 2011, MAR GENOM, V4, P237, DOI 10.1016/j.margen.2011.07.001; Peck LS, 2005, ANTARCT SCI, V17, P497, DOI 10.1017/S0954102005002920; Philipp E, 2005, MECH AGEING DEV, V126, P598, DOI 10.1016/j.mad.2004.12.003; PIERTNEY SB, 1995, J EXP MAR BIOL ECOL, V188, P277, DOI 10.1016/0022-0981(94)00189-K; Richards VP, 2007, MOL ECOL, V16, P139, DOI 10.1111/j.1365-294X.2006.03145.x; Riginos C, 2011, ECOGRAPHY, V34, P566, DOI 10.1111/j.1600-0587.2010.06511.x; Rogers AD, 1998, MAR BIOL, V131, P1, DOI 10.1007/s002270050290; Savidge DK, 2009, DEEP-SEA RES PT I, V56, P1633, DOI 10.1016/j.dsr.2009.05.011; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Sherman CDH, 2008, BIOL J LINN SOC, V95, P106, DOI 10.1111/j.1095-8312.2008.01044.x; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Simmons MP, 2007, MOL PHYLOGENET EVOL, V42, P528, DOI 10.1016/j.ympev.2006.08.008; Temby N, 2007, MAR FRESHWATER RES, V58, P733, DOI 10.1071/MF07015; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; Underwood JN, 2009, ECOL APPL, V19, P18, DOI 10.1890/07-1461.1; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Watts PC, 2006, MAR BIOL, V149, P1093, DOI 10.1007/s00227-006-0288-2; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Wilson NG, 2007, MAR BIOL, V152, P895, DOI 10.1007/s00227-007-0742-9	73	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63954	10.1371/journal.pone.0063954	http://dx.doi.org/10.1371/journal.pone.0063954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691125	Green Published, gold, Green Accepted			2022-12-25	WOS:000319107400091
J	Klijn, C; Koudijs, MJ; Kool, J; ten Hoeve, J; Boer, M; de Moes, J; Akhtar, W; van Miltenburg, M; Vendel-Zwaagstra, A; Reinders, MJT; Adams, DJ; van Lohuizen, M; Hilkens, J; Wessels, LFA; Jonkers, J				Klijn, Christiaan; Koudijs, Marco J.; Kool, Jaap; ten Hoeve, Jelle; Boer, Mandy; de Moes, Joost; Akhtar, Waseem; van Miltenburg, Martine; Vendel-Zwaagstra, Annabel; Reinders, Marcel J. T.; Adams, David J.; van Lohuizen, Maarten; Hilkens, John; Wessels, Lodewyk F. A.; Jonkers, Jos			Analysis of Tumor Heterogeneity and Cancer Gene Networks Using Deep Sequencing of MMTV-Induced Mouse Mammary Tumors	PLOS ONE			English	Article							RETROVIRAL INSERTIONAL MUTAGENESIS; VIRUS; ACTIVATION; BREAST; CARCINOGENESIS; TUMORIGENESIS; SITES; WNT-1; MICE; MYB	Cancer develops through a multistep process in which normal cells progress to malignant tumors via the evolution of their genomes as a result of the acquisition of mutations in cancer driver genes. The number, identity and mode of action of cancer driver genes, and how they contribute to tumor evolution is largely unknown. This study deployed the Mouse Mammary Tumor Virus (MMTV) as an insertional mutagen to find both the driver genes and the networks in which they function. Using deep insertion site sequencing we identified around 31000 retroviral integration sites in 604 MMTV-induced mammary tumors from mice with mammary gland-specific deletion of Trp53, Pten heterozygous knockout mice, or wildtype strains. We identified 18 known common integration sites (CISs) and 12 previously unknown CISs marking new candidate cancer genes. Members of the Wnt, Fgf, Fgfr, Rspo and Pdgfr gene families were commonly mutated in a mutually exclusive fashion. The sequence data we generated yielded also information on the clonality of insertions in individual tumors, allowing us to develop a data-driven model of MMTV-induced tumor development. Insertional mutations near Wnt and Fgf genes mark the earliest "initiating" events in MMTV induced tumorigenesis, whereas Fgfr genes are targeted later during tumor progression. Our data shows that insertional mutagenesis can be used to discover the mutational networks, the timing of mutations, and the genes that initiate and drive tumor evolution.	[Klijn, Christiaan; Koudijs, Marco J.; van Miltenburg, Martine; Jonkers, Jos] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Kool, Jaap; Boer, Mandy; de Moes, Joost; Akhtar, Waseem; Vendel-Zwaagstra, Annabel; van Lohuizen, Maarten; Hilkens, John] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Klijn, Christiaan; ten Hoeve, Jelle; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Reinders, Marcel J. T.; Wessels, Lodewyk F. A.] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands; [Adams, David J.] Wellcome Trust Sanger Inst, Cambridge, England	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Delft University of Technology; Wellcome Trust Sanger Institute	Adams, DJ (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	da1@sanger.ac.uk; m.v.lohuizen@nki.nl; j.hilkens@nki.nl; l.wessels@nki.nl; j.jonkers@nki.nl	Jonkers, Jos/AAG-3246-2019	Jonkers, Jos/0000-0002-9264-9792; Klijn, Christiaan/0000-0003-0878-4121; Hilkens, John/0000-0002-0932-7793; Adams, David/0000-0001-9490-0306	Dutch Cancer Society [2001-2489]; Association for International Cancer Research (AICR) [07-585]; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO Program) [050-10-008]; NGI/NWO Horizon Breakthrough grant [40-41009-98-9109]; NGI/NWO Horizon Zenith grant [40-41009-98-11097]; Netherlands Consortium for Systems Biology (NCSB); Cancer Genomics Centre (CGC); Cancer Systems Biology Center (CSBC); Cancer Research-UK; Wellcome Trust [76943]; Cancer Research UK [13031] Funding Source: researchfish	Dutch Cancer Society(KWF Kankerbestrijding); Association for International Cancer Research (AICR); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO Program); NGI/NWO Horizon Breakthrough grant; NGI/NWO Horizon Zenith grant; Netherlands Consortium for Systems Biology (NCSB); Cancer Genomics Centre (CGC); Cancer Systems Biology Center (CSBC); Cancer Research-UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	This work was financially supported by the Dutch Cancer Society (grant 2001-2489 to J.H.), the Association for International Cancer Research (AICR grant 07-585 to J.J.), the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO Program grant 050-10-008 to M.v.L.; NGI/NWO Horizon Breakthrough grant 40-41009-98-9109 and NGI/NWO Horizon Zenith grant 40-41009-98-11097 to J.J.), the Netherlands Consortium for Systems Biology (NCSB), the Cancer Genomics Centre (CGC), and the Cancer Systems Biology Center (CSBC). D.J.A. is funded by Cancer Research-UK and the Wellcome Trust (76943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bittner JJ, 1936, SCIENCE, V84, P162, DOI 10.1126/science.84.2172.162; Chatterjee G, 2002, AM J PATHOL, V161, P2241, DOI 10.1016/S0002-9440(10)64500-2; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Erny KM, 1996, ONCOGENE, V13, P2015; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hilkens J, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1376; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kapoun AM, 1997, ONCOGENE, V14, P2985, DOI 10.1038/sj.onc.1201146; Kool J, 2010, CANCER RES, V70, P520, DOI 10.1158/0008-5472.CAN-09-2736; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; Koudijs MJ, 2011, GENOME RES, V21, P2181, DOI 10.1101/gr.112763.110; KWAN H, 1992, MOL CELL BIOL, V12, P147, DOI 10.1128/MCB.12.1.147; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lowther W, 2005, J VIROL, V79, P10093, DOI 10.1128/JVI.79.15.10093-10096.2005; Marino S, 2002, DEVELOPMENT, V129, P3513; Miyamoto S, 2006, CANCER SCI, V97, P341, DOI 10.1111/j.1349-7006.2006.00188.x; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; SHACKLEFORD GM, 1993, P NATL ACAD SCI USA, V90, P740, DOI 10.1073/pnas.90.2.740; Song IS, 2009, CANCER RES, V69, P3131, DOI 10.1158/0008-5472.CAN-08-2240; Stambolic V, 2000, CANCER RES, V60, P3605; Stenman G, 2010, CELL CYCLE, V9, P2986, DOI 10.4161/cc.9.15.12515; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Theodorou V, 2004, ONCOGENE, V23, P6047, DOI 10.1038/sj.onc.1207816; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; Zhang SL, 1998, P NATL ACAD SCI USA, V95, P2429, DOI 10.1073/pnas.95.5.2429	36	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62113	10.1371/journal.pone.0062113	http://dx.doi.org/10.1371/journal.pone.0062113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690930	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400009
J	Okumura, N; Akutsu, H; Sugawara, T; Miura, T; Takezawa, Y; Hosoda, A; Yoshida, K; Ichida, JK; Yamada, M; Hamatani, T; Kuji, N; Miyado, K; Yoshimura, Y; Umezawa, A				Okumura, Noriko; Akutsu, Hidenori; Sugawara, Tohru; Miura, Takumi; Takezawa, Youki; Hosoda, Akihiro; Yoshida, Keiichi; Ichida, Justin K.; Yamada, Mitsutoshi; Hamatani, Toshio; Kuji, Naoaki; Miyado, Kenji; Yoshimura, Yasunori; Umezawa, Akihiro			beta-Catenin Functions Pleiotropically in Differentiation and Tumorigenesis in Mouse Embryo-Derived Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; PLURIPOTENCY; MARKER; TUMORS; INACTIVATION; REQUIREMENT; CULTURE; SALL4; GENE; MICE	The canonical Wnt/beta-catenin signaling pathway plays a crucial role in the maintenance of the balance between proliferation and differentiation throughout embryogenesis and tissue homeostasis. beta-Catenin, encoded by the Ctnnb1 gene, mediates an intracellular signaling cascade activated by Wnt. It also plays an important role in the maintenance of various types of stem cells including adult stem cells and cancer stem cells. However, it is unclear if beta-catenin is required for the derivation of mouse embryo-derived stem cells. Here, we established beta-catenin-deficient (beta-cat(Delta/Delta)) mouse embryo-derived stem cells and showed that beta-catenin is not essential for acquiring self-renewal potential in the derivation of mouse embryonic stem cells (ESCs). However, teratomas formed from embryo-derived beta-cat(Delta/Delta) ESCs were immature germ cell tumors without multilineage differentiated cell types. Re-expression of functional beta-catenin eliminated their neoplastic, transformed phenotype and restored pluripotency, thereby rescuing the mutant ESCs. Our findings demonstrate that beta-catenin has pleiotropic effects in ESCs; it is required for the differentiation of ESCs and prevents them from acquiring tumorigenic character. These results highlight beta-catenin as the gatekeeper in differentiation and tumorigenesis in ESCs.	[Akutsu, Hidenori; Sugawara, Tohru; Miura, Takumi; Takezawa, Youki; Hosoda, Akihiro; Yoshida, Keiichi; Miyado, Kenji; Umezawa, Akihiro] Natl Ctr Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Okumura, Noriko; Yamada, Mitsutoshi; Hamatani, Toshio; Kuji, Naoaki; Yoshimura, Yasunori] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Ichida, Justin K.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	National Center for Child Health & Development - Japan; Keio University; Harvard University	Akutsu, H (corresponding author), Natl Ctr Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan.	akutsu-h@ncchd.go.jp	MIYADO, KENJI/E-6568-2013; Sugawara, Tohru/W-5304-2019	Miyado, Kenji/0000-0002-8339-6738	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Ministry of Health, Labour and Welfare (MHLW); JST-CREST;  [21390456];  [22770233]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS077435] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; a grant from the Ministry of Health, Labour and Welfare (MHLW) to HA, AU; a Grant-in-aid for Scientific Research (21390456) to HA, and (22770233) to TS; a grant from JST-CREST given to HA. The funders had no control over the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu H, 2009, DIFFERENTIATION, V78, P137, DOI 10.1016/j.diff.2009.08.005; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Bahrami A, 2007, ARCH PATHOL LAB MED, V131, P1267; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Brault V, 2001, DEVELOPMENT, V128, P1253; Cao DF, 2009, AM J SURG PATHOL, V33, P1065, DOI 10.1097/PAS.0b013e3181a13eef; Cao DF, 2009, CANCER-AM CANCER SOC, V115, P2640, DOI 10.1002/cncr.24308; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Epstein JI., 2004, PATHOLOGY GENETICS T, P218; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Ikawa M, 1999, CURR TOP DEV BIOL, V44, P1; Ishii R, 2012, MOL BIOL CELL, V23, P3511, DOI 10.1091/mbc.E11-10-0869; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marikawa Y, 2006, SEMIN CELL DEV BIOL, V17, P175, DOI 10.1016/j.semcdb.2006.04.003; Matsumura H, 2004, BIOCHEM BIOPH RES CO, V321, P275, DOI 10.1016/j.bbrc.2004.06.139; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takezawa Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00068; TALERMAN A, 1980, CANCER, V46, P380, DOI 10.1002/1097-0142(19800715)46:2<380::AID-CNCR2820460228>3.0.CO;2-U; TALERMAN A, 1985, ANN PATHOL, V5, P145; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Xie HR, 2008, DEVELOPMENT, V135, P717, DOI 10.1242/dev.015339; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]	44	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63265	10.1371/journal.pone.0063265	http://dx.doi.org/10.1371/journal.pone.0063265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691006	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400040
J	Hernandez, LG; van Benthem, J; Johnson, GE				Hernandez, Lya G.; van Benthem, Jan; Johnson, George E.			A Mode-of-Action Approach for the Identification of Genotoxic Carcinogens	PLOS ONE			English	Article							DOSE-RESPONSE RELATIONSHIPS; VITRO MICRONUCLEUS TEST; DNA ADDUCT FORMATION; IN-VITRO; BISPHENOL-A; HUMAN-LYMPHOCYTES; CELLS; CHEMICALS; ANEUPLOIDY; ABERRATIONS	Distinguishing between clastogens and aneugens is vital in cancer risk assessment because the default assumption is that clastogens and aneugens have linear and non-linear dose-response curves, respectively. Any observed non-linearity must be supported by mode of action (MOA) analyses where biological mechanisms are linked with dose-response evaluations. For aneugens, the MOA has been well characterised as disruptors of mitotic machinery where chromosome loss via micronuclei (MN) formation is an accepted endpoint used in risk assessment. In this study we performed the cytokinesis-block micronucleus assay and immunofluorescence mitotic machinery visualisation in human lymphoblastoid (AHH-1) and Chinese Hamster fibroblast (V79) cell lines after treatment with the aneugen 17-beta-oestradiol (E-2). Results were compared to previously published data on bisphenol-A (BPA) and Rotenone data. Two concentration-response approaches (the threshold-[Td] and benchmark-dose [BMD] approaches) were applied to derive a point of departure (POD) for in vitro MN induction. BMDs were also derived from the most sensitive carcinogenic endpoint. Ranking comparisons of the PODs from the in vitro MN and the carcinogenicity studies demonstrated a link between these two endpoints for BPA, E-2 and Rotenone. This analysis was extended to include 5 additional aneugens, 5 clastogens and 3 mutagens and further concentration and dose-response correlations were observed between PODs from the in vitro MN and carcinogenicity. This approach is promising and may be further extended to other genotoxic carcinogens, where MOA and quantitative information from the in vitro MN studies could be used in a quantitative manner to further inform cancer risk assessment.	[Hernandez, Lya G.; van Benthem, Jan] Natl Inst Publ Hlth & Environm RIVM, Lab Hlth Protect Res, Bilthoven, Netherlands; [Johnson, George E.] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales	Netherlands National Institute for Public Health & the Environment; Swansea University	Johnson, GE (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.	G.Johnson@swansea.ac.uk	Lin, Zhao/C-8319-2011; Johnson, George/J-2488-2014	Lin, Zhao/0000-0002-6131-9723; Soeteman-Hernandez, Lya G./0000-0003-3529-3694; Johnson, George/0000-0001-5643-9942	Food Standards Agency [T01029]; European Union [QLK4-CT 2000-00058]; Swansea University; United Kingdom Environmental Mutagen Society (UKEMS); National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [NC/K500033/1]	Food Standards Agency; European Union(European Commission); Swansea University; United Kingdom Environmental Mutagen Society (UKEMS); National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs))	Funding for the E2 work was provided by the Food Standards Agency (contract number T01029) and the European Union "Protection of the European population from aneugenic chemicals" (PEP-FAC) project (contract number QLK4-CT 2000-00058). Dr. George E. Johnson was also supported by a Swansea University Bursary as well as United Kingdom Environmental Mutagen Society (UKEMS) bursaries. More recently, he was supported by a Strategic Award from the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs, contract number NC/K500033/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON A, 1995, ENVIRON MOL MUTAGEN, V26, P60, DOI 10.1002/em.2850260109; ATKINSON A, 1995, BIOCHEM BIOPH RES CO, V210, P424, DOI 10.1006/bbrc.1995.1678; Barlow S, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1150; Bolt HM, 2004, TOXICOL SCI, V81, P3, DOI 10.1093/toxsci/kfh178; Clare MG, 2006, MUTAT RES-GEN TOX EN, V607, P37, DOI 10.1016/j.mrgentox.2006.04.001; CRUMP KS, 1984, FUND APPL TOXICOL, V4, P854, DOI 10.1016/0272-0590(84)90107-6; Efthimiou M, 2007, MUTAT RES-FUND MOL M, V617, P125, DOI 10.1016/j.mrfmmm.2007.01.009; El-Zein R, 2011, MUTAGENESIS, V26, P101, DOI 10.1093/mutage/geq071; Elhajouji A, 1995, ENVIRON MOL MUTAGEN, V26, P292, DOI 10.1002/em.2850260405; Elhajouji A, 1997, MUTAGENESIS, V12, P133, DOI 10.1093/mutage/12.3.133; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Foth Heidi, 2005, Arhiv za Higijenu Rada i Toksikologiju, V56, P167; Gocke E, 2009, TOXICOL LETT, V190, P298, DOI 10.1016/j.toxlet.2009.03.008; Gollapudi BB, 2013, ENVIRON MOL MUTAGEN, V54, P8, DOI 10.1002/em.21727; Gollapudi BB, 2012, ENV MOL MUT IN PRESS; Hernandez LG, 2011, ENVIRON MOL MUTAGEN, V52, P518, DOI 10.1002/em.20651; Hilliard CA, 1998, ENVIRON MOL MUTAGEN, V31, P316, DOI 10.1002/(SICI)1098-2280(1998)31:4<316::AID-EM3>3.3.CO;2-2; IVETT JL, 1989, ENVIRON MOL MUTAGEN, V14, P165, DOI 10.1002/em.2850140306; Izzo M, 1998, MUTAGENESIS, V13, P445, DOI 10.1093/mutage/13.5.445; Johnson GE, 2008, MUTAT RES-GEN TOX EN, V651, P56, DOI 10.1016/j.mrgentox.2007.10.019; Johnson GE, 2009, MUTAT RES-GEN TOX EN, V678, P95, DOI 10.1016/j.mrgentox.2009.05.009; Kirkland D, 2010, MUTAT RES-GEN TOX EN, V702, P135, DOI 10.1016/j.mrgentox.2010.02.005; Lutz WK, 2009, MUTAT RES-GEN TOX EN, V678, P118, DOI 10.1016/j.mrgentox.2009.05.010; MacGregor JT, 2009, ILSI HESI PROJECT CO, P65; Ochi T, 1999, MUTAT RES-FUND MOL M, V431, P105, DOI 10.1016/S0027-5107(99)00190-6; OECD, 2010, OECD GUID TEST CHEM; OECD, 1997, OECD GUID TEST CHEM; Parry EM, 2002, MUTAGENESIS, V17, P509, DOI 10.1093/mutage/17.6.509; Parry EM CC, 2002, MUTAGENESIS, V556; Parry JM, 2006, MUTAT RES-GEN TOX EN, V607, P5, DOI 10.1016/j.mrgentox.2006.04.007; Pfeiffer E, 1997, MUTAT RES-GEN TOX EN, V390, P21, DOI 10.1016/S0165-1218(96)00161-9; Slob W, 2002, PROAST SOFTWARE DOSE; Tsutsui T, 1998, INT J CANCER, V75, P290, DOI 10.1002/(SICI)1097-0215(19980119)75:2<290::AID-IJC19>3.3.CO;2-C; Yang AH, 2003, J NEUROSCI, V23, P10454	34	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e64532	10.1371/journal.pone.0064532	http://dx.doi.org/10.1371/journal.pone.0064532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675539	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100063
J	Malaquin, N; Vercamer, C; Bouali, F; Martien, S; Deruy, E; Wernert, N; Chwastyniak, M; Pinet, F; Abbadie, C; Pourtier, A				Malaquin, Nicolas; Vercamer, Chantal; Bouali, Fatima; Martien, Sebastien; Deruy, Emeric; Wernert, Nicolas; Chwastyniak, Maggy; Pinet, Florence; Abbadie, Corinne; Pourtier, Albin			Senescent Fibroblasts Enhance Early Skin Carcinogenic Events via a Paracrine MMP-PAR-1 Axis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCYTE GROWTH-FACTOR; THROMBIN RECEPTOR PAR-1; MET TYROSINE KINASE; ACTIVATED RECEPTOR-1; MATRIX METALLOPROTEINASES; KERATINOCYTE MIGRATION; SECRETORY PHENOTYPE; CELL-PROLIFERATION; CANCER	The incidence of carcinoma increases greatly with aging, but the cellular and molecular mechanisms underlying this correlation are only partly known. It is established that senescent fibroblasts promote the malignant progression of already-transformed cells through secretion of inflammatory mediators. We investigated here whether the senescent fibroblast secretome might have an impact on the very first stages of carcinogenesis. We chose the cultured normal primary human epidermal keratinocyte model, because after these cells reach the senescence plateau, cells with transformed and tumorigenic properties systematically and spontaneously emerge from the plateau. In the presence of medium conditioned by autologous senescent dermal fibroblasts, a higher frequency of post-senescence emergence was observed and the post-senescence emergent cells showed enhanced migratory properties and a more marked epithelial-mesenchymal transition. Using pharmacological inhibitors, siRNAs, and blocking antibodies, we demonstrated that the MMP-1 and MMP-2 matrix metalloproteinases, known to participate in late stages of cancer invasion and metastasis, are responsible for this enhancement of early migratory capacity. We present evidence that MMPs act by activating the protease-activated receptor 1 (PAR-1), whose expression is specifically increased in post-senescence emergent keratinocytes. The physiopathological relevance of these results was tested by analyzing MMP activity and PAR-1 expression in skin sections. Both were higher in skin sections from aged subjects than in ones from young subjects. Altogether, our results suggest that during aging, the dermal and epidermal skin compartments might be activated coordinately for initiation of skin carcinoma, via a paracrine axis in which MMPs secreted by senescent fibroblasts promote very early epithelial-mesenchymal transition of keratinocytes undergoing transformation and oversynthesizing the MMP-activatable receptor PAR-1.	[Malaquin, Nicolas; Vercamer, Chantal; Bouali, Fatima; Martien, Sebastien; Deruy, Emeric; Abbadie, Corinne; Pourtier, Albin] Inst Biol Lille, CNRS, Unite Mixte Rech UMR 8161, Lille, France; [Malaquin, Nicolas; Vercamer, Chantal; Bouali, Fatima; Martien, Sebastien; Deruy, Emeric; Abbadie, Corinne; Pourtier, Albin] Univ Lille1 Sci & Technol, UMR 8161, Villeneuve Dascq, France; [Malaquin, Nicolas; Vercamer, Chantal; Bouali, Fatima; Martien, Sebastien; Deruy, Emeric; Abbadie, Corinne; Pourtier, Albin] Univ Lille 2, UMR 8161, Lille, France; [Malaquin, Nicolas; Vercamer, Chantal; Bouali, Fatima; Martien, Sebastien; Deruy, Emeric; Chwastyniak, Maggy; Pinet, Florence; Abbadie, Corinne; Pourtier, Albin] Inst Pasteur, Lille, France; [Chwastyniak, Maggy; Pinet, Florence] INSERM, Unite Mixte Rech UMR 744, F-59045 Lille, France; [Wernert, Nicolas] Univ Bonn, Inst Pathol, Dept Mol Pathol, Bonn, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bonn	Pourtier, A (corresponding author), Inst Biol Lille, CNRS, Unite Mixte Rech UMR 8161, Lille, France.	albin.pourtier@ibl.fr	ABBADIE, Corinne/F-4949-2018; Pinet, Florence/F-2892-2013	ABBADIE, Corinne/0000-0002-8174-2393; Pinet, Florence/0000-0002-5471-1487	CNRS; Universite de Lille1; Ligue Contre le Cancer (Comite du Pas-de-Calais); Association pour la Recherche sur le Cancer; Pasteur Institute of Lille; Region Nord-Pas-de-Calais/CNRS; Ligue Nationale contre le Cancer; French Research Ministry and Fondation pour la Recherche Medicale; Pasteur Institute of Lille/Region Nord-Pas-de-Calais	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Lille1; Ligue Contre le Cancer (Comite du Pas-de-Calais); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Pasteur Institute of Lille; Region Nord-Pas-de-Calais/CNRS(Region Hauts-de-France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); French Research Ministry and Fondation pour la Recherche Medicale; Pasteur Institute of Lille/Region Nord-Pas-de-Calais(Region Hauts-de-France)	This work was supported by CNRS, Universite de Lille1, Ligue Contre le Cancer (Comite du Pas-de-Calais), Association pour la Recherche sur le Cancer, and Pasteur Institute of Lille. N. M. had a Ph.D. fellowship from Region Nord-Pas-de-Calais/CNRS and Ligue Nationale contre le Cancer. S. M. had a Ph.D. fellowship from French Research Ministry and Fondation pour la Recherche Medicale. E. D. had a fellowship from Pasteur Institute of Lille/Region Nord-Pas-de-Calais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algermissen B, 2000, ARCH DERMATOL RES, V292, P488, DOI 10.1007/s004030000168; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Arciniegas E, 2004, DNA CELL BIOL, V23, P815, DOI 10.1089/1044549042729603; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Bergmann S, 2006, ONCOL REP, V15, P889; Bernard D, 2004, CANCER RES, V64, P472, DOI 10.1158/0008-5472.CAN-03-0005; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carragher LAS, 2010, EMBO MOL MED, V2, P458, DOI 10.1002/emmm.201000099; Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6; CHEN JD, 1995, J INVEST DERMATOL, V104, P729, DOI 10.1111/1523-1747.ep12606970; Choi J, 2000, UROLOGY, V56, P160, DOI 10.1016/S0090-4295(00)00538-0; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Deruy E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012712; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Fujimoto D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-443; Furlan A, 2008, J CELL PHYSIOL, V215, P782, DOI 10.1002/jcp.21360; Gallucci RM, 2004, J INVEST DERMATOL, V122, P764, DOI 10.1111/j.0022-202X.2004.22323.x; Gao L, 2010, EXP CELL RES, V316, P376, DOI 10.1016/j.yexcr.2009.10.022; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Gosselin K, 2009, CANCER RES, V69, P7917, DOI 10.1158/0008-5472.CAN-08-2510; Gosselin K, 2009, AM J PATHOL, V174, P423, DOI 10.2353/ajpath.2009.080332; GYULAI R, 1994, CLIN EXP DERMATOL, V19, P309, DOI 10.1111/j.1365-2230.1994.tb01201.x; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Kang MK, 2003, EXP CELL RES, V287, P272, DOI 10.1016/S0014-4827(03)00061-2; Karagas MR, 2006, CANC EPIDEMIOLOGY PR, P1230, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0064; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Laberge RM, 2012, CANCER MICROENVIRON, V5, P39, DOI 10.1007/s12307-011-0069-4; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; MATSUMOTO K, 1991, EXP CELL RES, V196, P114, DOI 10.1016/0014-4827(91)90462-4; McCawley LJ, 1998, J CELL PHYSIOL, V176, P255, DOI 10.1002/(SICI)1097-4652(199808)176:2<255::AID-JCP4>3.0.CO;2-N; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mine S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004066; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Orlichenko LS, 2008, CLIN EXP METASTAS, V25, P593, DOI 10.1007/s10585-008-9143-9; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Porto IM, 2009, J HISTOCHEM CYTOCHEM, V57, P615, DOI 10.1369/jhc.2009.952127; Radisky DC, 2006, CURR OPIN GENET DEV, V16, P45, DOI 10.1016/j.gde.2005.12.011; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Sabe H, 2011, J BIOCHEM, V149, P633, DOI 10.1093/jb/mvr044; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Stella MC, 1999, INT J BIOCHEM CELL B, V31, P1357, DOI 10.1016/S1357-2725(99)00089-8; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Tulasne D, 1999, MOL BIOL CELL, V10, P551, DOI 10.1091/mbc.10.3.551; Villares GJ, 2011, ONCOTARGET, V2, P8; Wheless L, 2010, CANCER EPIDEM BIOMAR, V19, P1686, DOI 10.1158/1055-9965.EPI-10-0243; Yamaguchi J, 2009, LAB INVEST, V89, P1018, DOI 10.1038/labinvest.2009.65; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Ruiz-Loredo AY, 2011, J CELL PHYSIOL, V226, P414, DOI 10.1002/jcp.22347; Zdanov S, 2007, EXP CELL RES, V313, P3046, DOI 10.1016/j.yexcr.2007.04.033; Zigler M, 2011, CANCER RES, V71, P6561, DOI 10.1158/0008-5472.CAN-11-1432	76	63	68	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63607	10.1371/journal.pone.0063607	http://dx.doi.org/10.1371/journal.pone.0063607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675494	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400047
J	Malm, M; Kronqvist, N; Lindberg, H; Gudmundsdotter, L; Bass, T; Frejd, FY; Hoiden-Guthenberg, I; Varasteh, Z; Orlova, A; Tolmachev, V; Stahl, S; Lofblom, J				Malm, Magdalena; Kronqvist, Nina; Lindberg, Hanna; Gudmundsdotter, Lindvi; Bass, Tarek; Frejd, Fredrik Y.; Hoiden-Guthenberg, Ingmarie; Varasteh, Zohreh; Orlova, Anna; Tolmachev, Vladimir; Stahl, Stefan; Lofblom, John			Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification	PLOS ONE			English	Article							STAPHYLOCOCCAL SURFACE DISPLAY; BREAST-CANCER CELLS; TYROSINE KINASE; HER2 EXPRESSION; IN-VITRO; ERBB3; EGFR; RECEPTOR; PROTEIN; PROLIFERATION	The HER3 receptor is implicated in the progression of various cancers as well as in resistance to several currently used drugs, and is hence a potential target for development of new therapies. We have previously generated Affibody molecules that inhibit heregulin-induced signaling of the HER3 pathways. The aim of this study was to improve the affinity of the binders to hopefully increase receptor inhibition efficacy and enable a high receptor-mediated uptake in tumors. We explored a novel strategy for affinity maturation of Affibody molecules that is based on alanine scanning followed by design of library diversification to mimic the result from an error-prone PCR reaction, but with full control over mutated positions and thus less biases. Using bacterial surface display and flow-cytometric sorting of the maturation library, the affinity for HER3 was improved more than 30-fold down to 21 PM. The affinity is among the higher that has been reported for Affibody molecules and we believe that the maturation strategy should be generally applicable for improvement of affinity proteins. The new binders also demonstrated an improved thermal stability as well as complete refolding after denaturation. Moreover, inhibition of ligand-induced proliferation of HER3-positive breast cancer cells was improved more than two orders of magnitude compared to the previously best-performing clone. Radiolabeled Affibody molecules showed specific targeting of a number of HER3-positive cell lines in vitro as well as targeting of HER3 in in vivo mouse models and represent promising candidates for future development of targeted therapies and diagnostics.	[Malm, Magdalena; Kronqvist, Nina; Lindberg, Hanna; Bass, Tarek; Stahl, Stefan; Lofblom, John] KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, Stockholm, Sweden; [Gudmundsdotter, Lindvi; Frejd, Fredrik Y.; Hoiden-Guthenberg, Ingmarie] Affibody AB, Stockholm, Sweden; [Varasteh, Zohreh; Orlova, Anna] Uppsala Univ, Dept Med Chem, Preclin PET Platform, Uppsala, Sweden; [Frejd, Fredrik Y.; Tolmachev, Vladimir] Uppsala Univ, Unit Biomed Radiat Sci, Uppsala, Sweden	Royal Institute of Technology; Uppsala University; Uppsala University	Stahl, S (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, Stockholm, Sweden.	stefans@biotech.kth.se	Kronqvist, Nina/M-6920-2015; Orlova, Anna/S-9692-2019; Tolmachev, Vladimir/T-3722-2017; Tolmachev, Vladimir/U-3107-2019; Kronqvist, Nina/M-6927-2015	Orlova, Anna/0000-0001-6120-2683; Tolmachev, Vladimir/0000-0002-6122-1734; Tolmachev, Vladimir/0000-0002-6122-1734; Lofblom, John/0000-0001-9423-0541; Malm, Magdalena/0000-0003-1763-9073	Swedish Foundation for Strategic Research (SSF); Swedish Research Council (VR); Swedish Cancer Society (Cancerfonden); Affinomics (EU-collaborative Project); ProNova excellence center for protein technology (VINNOVA - Swedish Governmental Agency for Innovation Systems)	Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Research Council (VR)(Swedish Research Council); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Affinomics (EU-collaborative Project); ProNova excellence center for protein technology (VINNOVA - Swedish Governmental Agency for Innovation Systems)	This work was supported by the Swedish Foundation for Strategic Research (SSF), Swedish Research Council (VR), Swedish Cancer Society (Cancerfonden), Affinomics (EU-collaborative Project) and the ProNova excellence center for protein technology (VINNOVA - Swedish Governmental Agency for Innovation Systems). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Aurisicchio L, 2012, ONCOTARGET, V3, P744, DOI 10.18632/oncotarget.550; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Baum RP, 2010, J NUCL MED, V51, P892, DOI 10.2967/jnumed.109.073239; BREEMAN WAP, 1995, J NUCL MED, V36, P623; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; DEJONG M, 1995, EUR J NUCL MED, V22, P608, DOI 10.1007/BF01254561; Ekerljung L, 2012, BIOCONJUGATE CHEM, V23, P1802, DOI 10.1021/bc3000645; Feldwisch J, 2010, J MOL BIOL, V398, P232, DOI 10.1016/j.jmb.2010.03.002; Friedman M, 2009, BIOTECHNOL APPL BIOC, V54, P121, DOI 10.1042/BA20090096; Frogne T, 2009, BREAST CANCER RES TR, V114, P263, DOI 10.1007/s10549-008-0011-8; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gostring L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040023; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hofland LJ, 2003, J NUCL MED, V44, P1315; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Jonsson A, 2008, PROTEIN ENG DES SEL, V21, P515, DOI 10.1093/protein/gzn028; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kong A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002881; Kronqvist N, 2008, PROTEIN ENG DES SEL, V21, P247, DOI 10.1093/protein/gzm090; Kronqvist N, 2011, PROTEIN ENG DES SEL, V24, P385, DOI 10.1093/protein/gzq118; LaFleur DW, 2013, MABS-AUSTIN, V5, P208, DOI 10.4161/mabs.23043; Liu BL, 2007, INT J CANCER, V120, P1874, DOI 10.1002/ijc.22423; Lofblom J, 2007, J APPL MICROBIOL, V102, P736, DOI 10.1111/j.1365-2672.2006.03127.x; Lofblom J, 2005, FEMS MICROBIOL LETT, V248, P189, DOI 10.1016/j.femsle.2005.05.040; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Orlova A, 2006, J NUCL MED, V47, P512; Robinson MK, 2008, BRIT J CANCER, V99, P1415, DOI 10.1038/sj.bjc.6604700; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Sierke SL, 1997, BIOCHEM J, V322, P757, DOI 10.1042/bj3220757; Tolmachev V, 2006, J NUCL MED, V47, P846; Tolmachev V, 2004, CANCER BIOTHER RADIO, V19, P491, DOI 10.1089/1084978041979616; Tolmachev V, 2012, J NUCL MED, V53, P953, DOI 10.2967/jnumed.111.101527; Tolmachev V, 2012, J NUCL MED, V53, P90, DOI 10.2967/jnumed.111.090829; Tolmachev V, 2010, LANCET ONCOL, V11, P992, DOI 10.1016/S1470-2045(10)70088-7; Tolmachev V, 2010, EUR J NUCL MED MOL I, V37, P613, DOI 10.1007/s00259-009-1283-x; Waibel R, 1999, NAT BIOTECHNOL, V17, P897, DOI 10.1038/12890	39	51	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62791	10.1371/journal.pone.0062791	http://dx.doi.org/10.1371/journal.pone.0062791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675426	Green Submitted, Green Published, gold			2022-12-25	WOS:000318852400011
J	Roe, K; Bratland, A; Vlatkovic, L; Ragnum, HB; Saelen, MG; Olsen, DR; Marignol, L; Ree, AH				Roe, Kathrine; Bratland, Ase; Vlatkovic, Ljiljana; Ragnum, Harald Bull; Saelen, Marie Gron; Olsen, Dag Rune; Marignol, Laure; Ree, Anne Hansen			Hypoxic Tumor Kinase Signaling Mediated by STAT5A in Development of Castration-Resistant Prostate Cancer	PLOS ONE			English	Article							ANDROGEN RECEPTOR; TRANSCRIPTION-5; ANGIOGENESIS; TRANSDUCER; ACTIVATION; EXPRESSION; PREDICTS	In this study, we hypothesized that androgen-deprivation therapy (ADT) in prostate cancer, although initially efficient, induces changes in the tumor kinome, which subsequently promote development of castration-resistant (CR) disease. Recognizing the correlation between tumor hypoxia and poor prognosis in prostate cancer, we further hypothesized that such changes might be influenced by hypoxia. Microarrays with 144 kinase peptide substrates were applied to analyze CWR22 prostate carcinoma xenograft samples from ADT-naive, androgen-deprived (AD), long-term AD (ADL), and CR disease stages. The impact of hypoxia was assessed by matching the xenograft kinase activity profiles with those acquired from hypoxic and normoxic prostate carcinoma cell cultures, whereas the clinical relevance was evaluated by analyzing prostatectomy tumor samples from patients with locally advanced disease, either in ADT-naive or early CR disease stages. By using this novel peptide substrate microarray method we revealed high kinase activity mediated by signal transducer and activator of transcription 5A (STAT5A) in CR prostate cancer. Additionally, we uncovered high STAT5A kinase activity already in regressing ADL xenografts, before renewed CR growth was evidenced. Finally, since increased STAT5A kinase activity also was detected after exposing prostate carcinoma cells to hypoxia, we propose long-term ADT to induce tumor hypoxia and stimulate STAT5A kinase activity, subsequently leading to renewed CR tumor growth. Hence, the study detected STAT5A as a candidate to be further investigated for its potential as marker of advanced prostate cancer and as possible therapeutic target protein.	[Roe, Kathrine; Ree, Anne Hansen] Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway; [Roe, Kathrine] Akershus Univ Hosp, Dept Clin Mol Biol & Lab Sci, Lorenskog, Norway; [Roe, Kathrine; Ragnum, Harald Bull] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Radiat Biol, Oslo, Norway; [Bratland, Ase] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway; [Vlatkovic, Ljiljana] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Saelen, Marie Gron] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumor Biol, Oslo, Norway; [Ragnum, Harald Bull; Saelen, Marie Gron; Ree, Anne Hansen] Univ Oslo, Inst Clin Med, Oslo, Norway; [Olsen, Dag Rune] Univ Bergen, Fac Math & Nat Sci, Bergen, Norway; [Marignol, Laure] St James Hosp, Inst Mol Med, Prostate Mol Oncol Res Grp, Acad Unit Clin & Mol Oncol, Dublin, Ireland; [Marignol, Laure] Univ Dublin Trinity Coll, Dublin 2, Ireland	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Bergen; Trinity College Dublin; Trinity College Dublin	Roe, K (corresponding author), Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway.	Kathrine.Roe@ahus.no	Redalen, Kathrine Roe/AAA-6623-2019; Marignol, Laure/AAE-1407-2020; Redalen, Kathrine/F-3383-2017	Marignol, Laure/0000-0002-2680-6200; Ree, Anne H./0000-0002-8264-3223; Redalen, Kathrine/0000-0002-1172-4632	South-Eastern Norway Regional Health Authority [2009070, 2012002]; Division of Medicine, Akershus University Hospital; European Union [222741- METOXIA]	South-Eastern Norway Regional Health Authority; Division of Medicine, Akershus University Hospital; European Union(European Commission)	This work was supported by the South-Eastern Norway Regional Health Authority grants 2009070 and 2012002 (K.R.), grants from Division of Medicine, Akershus University Hospital, and the European Union 7th Framework Programme grant 222741- METOXIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Dentelli P, 1999, J IMMUNOL, V163, P2151; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dudley AC, 2005, BIOCHEM J, V390, P427, DOI 10.1042/BJ20050351; Folkvord S, 2010, INT J RADIAT ONCOL, V78, P555, DOI 10.1016/j.ijrobp.2010.04.036; Gu L, 2010, ENDOCR-RELAT CANCER, V17, P481, DOI 10.1677/ERC-09-0328; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Joung YH, 2007, BIOCHEM BIOPH RES CO, V358, P733, DOI 10.1016/j.bbrc.2007.04.201; Kanaya K, 2003, BIOCHEM BIOPH RES CO, V306, P750, DOI 10.1016/S0006-291X(03)01041-6; Li HZ, 2005, CLIN CANCER RES, V11, P5863, DOI 10.1158/1078-0432.CCR-05-0562; Li HZ, 2004, CANCER RES, V64, P4774, DOI 10.1158/0008-5472.CAN-03-3499; Liao ZY, 2011, AM J TRANSL RES, V3, P133; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marignol L, 2008, CANCER TREAT REV, V34, P313, DOI 10.1016/j.ctrv.2008.01.006; Mottet N, 2011, EUR UROL, V59, P572, DOI 10.1016/j.eururo.2011.01.025; Movsas B, 2002, UROLOGY, V60, P634, DOI 10.1016/S0090-4295(02)01858-7; Park SY, 2006, CANCER RES, V66, P5121, DOI 10.1158/0008-5472.CAN-05-1341; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Sikkema AH, 2012, CRIT REV ONCOL HEMAT, V82, P171, DOI 10.1016/j.critrevonc.2011.05.002; So AI, 2003, WORLD J UROL, V21, P325, DOI 10.1007/s00345-003-0373-9; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stewart GD, 2010, BJU INT, V105, P8, DOI 10.1111/j.1464-410X.2009.08921.x; Stewart GD, 2008, ONCOL REP, V20, P1561, DOI 10.3892/or_00000180; Tan SH, 2008, CANCER RES, V68, P236, DOI 10.1158/0008-5472.CAN-07-2972; Thomas C, 2011, MOL CANCER THER, V10, P347, DOI 10.1158/1535-7163.MCT-10-0850; WAINSTEIN MA, 1994, CANCER RES, V54, P6049; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	35	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63723	10.1371/journal.pone.0063723	http://dx.doi.org/10.1371/journal.pone.0063723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675504	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400052
J	Ulukaya, E; Frame, FM; Cevatemre, B; Pellacani, D; Walker, H; Mann, VM; Simms, MS; Stower, MJ; Yilmaz, VT; Maitland, NJ				Ulukaya, Engin; Frame, Fiona M.; Cevatemre, Buse; Pellacani, Davide; Walker, Hannah; Mann, Vincent M.; Simms, Matthew S.; Stower, Michael J.; Yilmaz, Veysel T.; Maitland, Norman J.			Differential Cytotoxic Activity of a Novel Palladium-Based Compound on Prostate Cell Lines, Primary Prostate Epithelial Cells and Prostate Stem Cells	PLOS ONE			English	Article							PLATINUM(II) COMPLEXES; IN-VITRO; ANDROGEN DEPRIVATION; ANTICANCER ACTIVITY; CRYSTAL-STRUCTURES; CANCER; AUTOPHAGY; DEATH; PTEN; RESISTANCE	The outcome for patients with advanced metastatic and recurrent prostate cancer is still poor. Therefore, new chemotherapeutics are required, especially for killing cancer stem cells that are thought to be responsible for disease recurrence. In this study, we screened the effect of a novel palladium-based anticancer agent (Pd complex) against six different prostate cancer cell lines, and primary cultures from seven Gleason 6/7 prostate cancer, three Gleason 8/9 prostate cancer and four benign prostate hyperplasia patient samples, as well as cancer stem cells selected from primary cultures. MTT and ATP viability assays were used to assess cell growth and flow cytometry to assess cell cycle status. In addition, immunofluorescence was used to detect gamma H2AX nuclear foci, indicative of DNA damage, and Western blotting to assess the induction of apoptosis and autophagy. The Pd complex showed a powerful growth-inhibitory effect against both cell lines and primary cultures. More importantly, it successfully reduced the viability of cancer stem cells as first reported in this study. The Pd complex induced DNA damage and differentially induced evidence of cell death, as well as autophagy. In conclusion, this novel agent may be promising for use against the bulk of the tumour cell population as well as the prostate cancer stem cells, which are thought to be responsible for the resistance of metastatic prostate cancer to chemotherapy. This study also indicates that the combined use of the Pd complex with an autophagy modulator may be a more promising approach to treat prostate cancer. In addition, the differential effects observed between cell lines and primary cells emphasise the importance of the model used to test novel drugs including its genetic background, and indeed the necessity of using cells cultured from patient samples.	[Ulukaya, Engin] Uludag Univ, Sch Med, Dept Med Biochem, Bursa, Turkey; [Frame, Fiona M.; Pellacani, Davide; Walker, Hannah; Maitland, Norman J.] Univ York, YCR Canc Res Unit, Dept Biol, York YO10 5DD, N Yorkshire, England; [Cevatemre, Buse] Uludag Univ, Fac Arts & Sci, Dept Biol, Bursa, Turkey; [Mann, Vincent M.] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Simms, Matthew S.] Hull & East Yorkshire Hosp NHS Trust, Castle Hill Hosp, Dept Urol, Cottingham, England; [Stower, Michael J.] York Dist Gen Hosp, York, N Yorkshire, England; [Yilmaz, Veysel T.] Uludag Univ, Fac Arts & Sci, Dept Chem, Bursa, Turkey	Uludag University; University of York - UK; Uludag University; University of Hull; University of York - UK; University of Hull; Uludag University	Ulukaya, E (corresponding author), Uludag Univ, Sch Med, Dept Med Biochem, Bursa, Turkey.	eulukaya@uludag.edu.tr	ulukaya, engin/K-5792-2018; Yilmaz, Veysel T./L-7238-2018; Cevatemre, Buse/AHD-2050-2022	Yilmaz, Veysel T./0000-0002-2849-3332; Frame, Fiona/0000-0002-2377-1110; Maitland, Norman/0000-0003-1607-9035	Council of Higher Education; Uludag University; Yorkshire Cancer Research Core Grant; MRC [G0900871] Funding Source: UKRI; Medical Research Council [G0900871] Funding Source: researchfish	Council of Higher Education; Uludag University(Uludag University); Yorkshire Cancer Research Core Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	E. Ulukaya was funded by the Council of Higher Education and the Research Fund of Uludag University. http://www.uludag.edu.tr/. This work was also funded by a Yorkshire Cancer Research Core Grant ( F. M. Frame, D. Pellacani and N. J. Maitland). http:// www.yorkshirecancerresearch.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Masoudi NA, 2010, ARCH PHARM, V343, P222, DOI 10.1002/ardp.200900140; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Brabec V, 2005, DRUG RESIST UPDATE, V8, P131, DOI 10.1016/j.drup.2005.04.006; Budzisz EB, 2004, POL J PHARMACOL, V56, P473; Chen G, 1997, ONCOGENE, V15, P1643, DOI 10.1038/sj.onc.1201347; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cummings SD, 2009, COORDIN CHEM REV, V253, P1495, DOI 10.1016/j.ccr.2008.12.009; Divsalar A, 2010, J PHYS CHEM B, V114, P3639, DOI 10.1021/jp909143b; Dodoff NI, 2009, CHEMIJA, V20, P208; Eryazici I, 2008, CHEM REV, V108, P1834, DOI 10.1021/cr0781059; Frame FM, 2012, ADV EXP MED BIOL, V720, P105, DOI 10.1007/978-1-4614-0254-1_9; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; GRAHAM RD, 1979, J INORG NUCL CHEM, V41, P1245, DOI 10.1016/0022-1902(79)80496-0; Guney E, 2011, POLYHEDRON, V30, P114, DOI 10.1016/j.poly.2010.09.037; Guney E, 2010, INORG CHIM ACTA, V363, P438, DOI 10.1016/j.ica.2009.11.018; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Helgason GV, 2011, BLOOD, V118, P2035, DOI 10.1182/blood-2011-01-330621; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jones JS, 2011, EUR UROL, V60, P411, DOI 10.1016/j.eururo.2011.01.007; Kaini RR, 2012, BIOCHEM BIOPH RES CO, V425, P150, DOI 10.1016/j.bbrc.2012.07.054; Khan H, 2011, EUR J MED CHEM, V46, P4071, DOI 10.1016/j.ejmech.2011.06.007; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Maitland NJ, 2001, RADIAT RES, V155, P133, DOI 10.1667/0033-7587(2001)155[0133:IVMTSC]2.0.CO;2; Maitland NJ, 2010, CURR OPIN MOL THER, V12, P662; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; McCall P, 2008, BRIT J CANCER, V99, P1296, DOI 10.1038/sj.bjc.6604680; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mukherjee S, 2011, INORG CHIM ACTA, V373, P40, DOI 10.1016/j.ica.2011.03.048; Nadeem S, 2010, INORG CHIM ACTA, V363, P3261, DOI 10.1016/j.ica.2010.06.015; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Pelaez MA, 2004, Z ANORG ALLG CHEM, V630, P1489, DOI 10.1002/zaac.200400140; Rau T, 1996, MET IONS BIOL SYST, V32, P339; Ruiz J, 2008, INORG CHEM, V47, P4490, DOI 10.1021/ic701873b; Salim Abu-Surrah, 2008, CANC THER, V6, P1, DOI DOI 10.1007/978-3-662-46875-3708; Schroder F, 2012, BJU INT, V109, P1, DOI 10.1111/j.1464-410X.2012.11215.x; Sharrard RM, 2007, CELL SIGNAL, V19, P129, DOI 10.1016/j.cellsig.2006.05.029; Tamasi G, 2010, J INORG BIOCHEM, V104, P799, DOI 10.1016/j.jinorgbio.2010.03.010; Tusek-Bozic L, 1998, J INORG BIOCHEM, V72, P201, DOI 10.1016/S0162-0134(98)10081-8; Ulukaya E, 2011, EUR J MED CHEM, V46, P4957, DOI 10.1016/j.ejmech.2011.07.055; Ulukaya E, 2011, J CANCER RES CLIN, V137, P1425, DOI 10.1007/s00432-011-1021-1; Valentini A, 2009, J MED CHEM, V52, P484, DOI 10.1021/jm801276a; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wu WKK, 2012, ONCOGENE, V31, P939, DOI 10.1038/onc.2011.295; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yoshimoto M, 2008, MODERN PATHOL, V21, P1451, DOI 10.1038/modpathol.2008.96	50	30	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e64278	10.1371/journal.pone.0064278	http://dx.doi.org/10.1371/journal.pone.0064278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675532	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400066
J	Fiordalisi, JJ; Dewar, BJ; Graves, LM; Madigan, JP; Cox, AD				Fiordalisi, James J.; Dewar, Brian J.; Graves, Lee M.; Madigan, James P.; Cox, Adrienne D.			Src-Mediated Phosphorylation of the Tyrosine Phosphatase PRL-3 Is Required for PRL-3 Promotion of Rho Activation, Motility and Invasion	PLOS ONE			English	Article							MOUSE MELANOMA-CELLS; COLORECTAL-CANCER; FAMILY KINASES; POOR-PROGNOSIS; IN-VITRO; C-SRC; METASTASIS; MECHANISMS; MIGRATION; RECEPTOR	The metastasis-associated tyrosine phosphatase PRL-3/PTP4A is upregulated in numerous cancers, but the mechanisms modulating PRL-3 activity other than its expression levels have not been investigated. Here we report evidence for both Src-dependent tyrosine phosphorylation of PRL-3 and Src-mediated regulation of PRL-3 biological activities. We used structural mutants, pharmacological inhibitors and siRNA to demonstrate Src-dependent phosphorylation of endogenous PRL-3 in SW480 colon cancer cells. We also demonstrated that PRL-3 was not tyrosine phosphorylated in SYF mouse embryo fibroblasts deficient in Src, Yes and Fyn unless Src was re-expressed. Further, we show that platelet-derived growth factor (PDGF) can stimulate PRL-3 phosphorylation in a Src-dependent manner. Finally, we show that PRL-3-induced cell motility, Matrigel invasion and activation of the cytoskeleton-regulating small GTPase RhoC were abrogated in the presence of the phosphodeficient PRL-3 mutant Y53F, or by use of a Src inhibitor. Thus, PRL-3 requires the activity of a Src kinase, likely Src itself, to promote these cancer-associated phenotypes. Our data establish a model for the regulation of PRL-3 by Src that supports the possibility of their coordinate roles in signaling pathways promoting invasion and metastasis, and supports simultaneous use of novel molecularly targeted therapeutics directed at these proteins.	[Fiordalisi, James J.; Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA; [Dewar, Brian J.; Graves, Lee M.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC USA; [Graves, Lee M.; Cox, Adrienne D.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Madigan, James P.; Cox, Adrienne D.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Graves, Lee M.; Cox, Adrienne D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cox, AD (corresponding author), Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA.	adrienne_cox@med.unc.edu	Graves, Lee/AAG-5470-2021	Cox, Adrienne D./0000-0002-4901-2454	National Institutes of Health [CA109550]; NIEHS predoctoral fellowship [T32 EX007126]; NATIONAL CANCER INSTITUTE [R01CA109550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS predoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health grant (CA109550) to J.J.F. and A.D.C. (http://www.nih.gov/). B.J.D. was supported by an NIEHS predoctoral fellowship (T32 EX007126)(http://www.niehs.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Bucciantini M, 1999, FEBS LETT, V456, P73, DOI 10.1016/S0014-5793(99)00828-5; Choi MS, 2011, BIOCHEM BIOPH RES CO, V406, P305, DOI 10.1016/j.bbrc.2011.02.037; Cirri P, 1998, J BIOL CHEM, V273, P32522, DOI 10.1074/jbc.273.49.32522; Dadke S, 2001, MOL CELL BIOCHEM, V221, P147, DOI 10.1023/A:1010909031310; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Dietrich KA, 2009, BIOL CHEM, V390, P1063, DOI 10.1515/BC.2009.110; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Guo K, 2004, CANCER BIOL THER, V3, P945, DOI 10.4161/cbt.3.10.1111; Guzinska-Ustymowicz K, 2011, ANTI-CANCER AGENT ME, V11, P99, DOI 10.2174/187152011794941145; Jeong DG, 2005, J MOL BIOL, V345, P401, DOI 10.1016/j.jmb.2004.10.061; Kakazu A, 2008, INVEST OPHTH VIS SCI, V49, P2927, DOI 10.1167/iovs.07-0709; Kim Nam Won, 2011, J Korean Soc Coloproctol, V27, P231, DOI 10.3393/jksc.2011.27.5.231; Kleer CG, 2002, AM J PATHOL, V160, P579, DOI 10.1016/S0002-9440(10)64877-8; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kozlov G, 2004, J BIOL CHEM, V279, P11882, DOI 10.1074/jbc.M312905200; Krndija D, 2012, J CELL SCI, V125, P3883, DOI 10.1242/jcs.104885; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; Mayinuer A, 2013, ANN SURG ONCOL, V20, P305, DOI 10.1245/s10434-012-2395-2; McParland V, 2011, BIOCHEMISTRY-US, V50, P7579, DOI 10.1021/bi201095z; Ming J, 2012, TUMORI J, V98, P370, DOI 10.1700/1125.12407; Nakamura Y, 2008, ANN SURG ONCOL, V15, P2129, DOI 10.1245/s10434-008-9943-9; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Park S, 2003, J BIOCHEM MOL BIOL, V36, P288; Peng LR, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-110; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Qian F, 2007, MOL MED, V13, P151, DOI 10.2119/2006-00076.Qian; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Schwarzer D, 2006, J AM CHEM SOC, V128, P4192, DOI 10.1021/ja0585174; Sequeira L, 2008, CLIN EXP METASTAS, V25, P569, DOI 10.1007/s10585-008-9173-3; Sun JP, 2005, BIOCHEMISTRY-US, V44, P12009, DOI 10.1021/bi0509191; Tailor P, 1997, J BIOL CHEM, V272, P5371, DOI 10.1074/jbc.272.9.5371; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Tamagawa H, 2012, HEPATO-GASTROENTEROL, P59; Tao JC, 2001, J BIOL CHEM, V276, P29520, DOI 10.1074/jbc.M103721200; TERMUHLEN PM, 1993, J SURG RES, V54, P293, DOI 10.1006/jsre.1993.1046; Ustaalioglu BBO, 2012, CLIN TRANSL ONCOL, V14, P911, DOI 10.1007/s12094-012-0880-5; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Wang Z, 2010, BBA-REV CANCER, V1806, P122, DOI 10.1016/j.bbcan.2010.04.003; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Xu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027165; Zeng Q, 2003, CANCER RES, V63, P2716; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002; Zhang ZS, 2003, J BIOL CHEM, V278, P4668, DOI 10.1074/jbc.M210028200; Zheng P, 2011, CANCER BIOL THER, V12, P742, DOI 10.4161/cbt.12.8.15981; Zimmerman MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058300	58	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64309	10.1371/journal.pone.0064309	http://dx.doi.org/10.1371/journal.pone.0064309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691193	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900092
J	Kemp, MW; Kannan, PS; Saito, M; Newnham, JP; Cox, T; Jobe, AH; Kramer, BW; Kallapur, SG				Kemp, Matthew W.; Kannan, Paranthaman Senthamarai; Saito, Masatoshi; Newnham, John P.; Cox, Tom; Jobe, Alan H.; Kramer, Boris W.; Kallapur, Suhas G.			Selective Exposure of the Fetal Lung and Skin/Amnion (but Not Gastro-Intestinal Tract) to LPS Elicits Acute Systemic Inflammation in Fetal Sheep	PLOS ONE			English	Article							INTRAAMNIOTIC ENDOTOXIN; ANTENATAL ENDOTOXIN; NEONATAL SEPSIS; PRETERM; CHORIOAMNIONITIS; PULMONARY; MATURATION; BIRTH; GLUCOCORTICOIDS; PARTURITION	Inflammation of the uterine environment (commonly as a result of microbial colonisation of the fetal membranes, amniotic fluid and fetus) is strongly associated with preterm labour and birth. Both preterm birth and fetal inflammation are independently associated with elevated risks of subsequent short- and long-term respiratory, gastro-intestinal and neurological complications. Despite numerous clinical and experimental studies to investigate localised and systemic fetal inflammation following exposure to microbial agonists, there is minimal data to describe which fetal organ(s) drive systemic fetal inflammation. We used lipopolysaccharide (LPS) from E. coli in an instrumented ovine model of fetal inflammation and conducted a series of experiments to assess the systemic pro-inflammatory capacity of the three major fetal surfaces exposed to inflammatory mediators in pregnancy (the lung, gastro-intestinal tract and skin/amnion). Exposure of the fetal lung and fetal skin/amnion (but not gastro-intestinal tract) caused a significant acute systemic inflammatory response characterised by altered leucocytosis, neutrophilia, elevated plasma MCP-1 levels and inflammation of the fetal liver and spleen. These novel findings reveal differential fetal organ responses to pro-inflammatory stimulation and shed light on the pathogenesis of fetal systemic inflammation after exposure to chorioamnionitis.	[Kemp, Matthew W.; Saito, Masatoshi; Newnham, John P.; Cox, Tom; Jobe, Alan H.; Kramer, Boris W.; Kallapur, Suhas G.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Kannan, Paranthaman Senthamarai; Jobe, Alan H.; Kallapur, Suhas G.] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH USA; [Saito, Masatoshi] Tohoku Univ Hosp, Div Perinatal Med, Sendai, Miyagi, Japan; [Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Paediat, Sch Oncol & Dev Biol, Maastricht, Netherlands	University of Western Australia; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Tohoku University; Maastricht University	Kallapur, SG (corresponding author), Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia.	suhas.kallapur@cchmc.org	Kramer, Boris/AAO-3183-2021; Senthamaraikannan, Paranthaman/H-3992-2018	Senthamaraikannan, Paranthaman/0000-0002-3333-3720; Newnham, John/0000-0001-9983-7457	NIH [HD 57869]; Ramaciotti Foundations (Australia); Women and Infants Research Foundation (Western Australia); Financial Markets Foundation for Children (Australia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057869] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ramaciotti Foundations (Australia); Women and Infants Research Foundation (Western Australia); Financial Markets Foundation for Children (Australia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH grant HD 57869 to SK and by grants from the Ramaciotti Foundations (Australia), the Women and Infants Research Foundation (Western Australia) and the Financial Markets Foundation for Children (Australia) to MWK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001; Bastek JA, 2011, CLIN PERINATOL, V38, P385, DOI 10.1016/j.clp.2011.06.003; Bessette NW, 2010, REPROD FERT DEVELOP, V22, P459, DOI 10.1071/RD09156; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Collins JJP, 2012, AM J PHYSIOL-LUNG C, V303, pL778, DOI 10.1152/ajplung.00280.2011; Davies JK, 2000, AM J OBSTET GYNECOL, V183, P1088, DOI 10.1067/mob.2000.108888; Elovitz MA, 2011, INT J DEV NEUROSCI, V29, P663, DOI 10.1016/j.ijdevneu.2011.02.011; Fawke J, 2007, SEMIN FETAL NEONAT M, V12, P374, DOI 10.1016/j.siny.2007.06.002; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; GRAVETT MG, 2010, BMC PREGNANCY CHILDB, P10; Jobe AH, 2000, AM J OBSTET GYNECOL, V182, P401, DOI 10.1016/S0002-9378(00)70231-6; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; Jobe AH, 2012, CLIN PERINATOL, V39, P441, DOI 10.1016/j.clp.2012.06.010; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2003, AM J PHYSIOL-LUNG C, V284, pL633, DOI 10.1152/ajplung.00344.2002; Kallapur SG, 2007, J IMMUNOL, V179, P8491, DOI 10.4049/jimmunol.179.12.8491; Kallapur SG, 2011, AM J PHYSIOL-LUNG C, V301, pL285, DOI 10.1152/ajplung.00446.2010; Kallapur SG, 2009, AM J RESP CRIT CARE, V179, P955, DOI 10.1164/rccm.200811-1728OC; Kemp MW, 2011, REPROD SCI, V18, P88, DOI 10.1177/1933719110380470; Kramer BW, 2007, AM J PHYSIOL-LUNG C, V293, pL345, DOI 10.1152/ajplung.00003.2007; Kramer BW, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.058; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; KUYPERS E, 2012, PLOS ONE, P7; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; McAdams R.M., 2011, NEOREVIEWS, V12, P564, DOI DOI 10.1542/NEO.12-10-E564; Moss TJM, 2002, AM J OBSTET GYNECOL, V187, P1059, DOI 10.1067/mob.2002.126296; Musilova I, 2012, ACTA OBSTET GYN SCAN, V91, P1119, DOI 10.1111/j.1600-0412.2012.01450.x; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Newnham JP, 2003, AM J OBSTET GYNECOL, V189, P1458, DOI 10.1067/S0002-9378(03)00758-0; Nitsos I, 2006, J SOC GYNECOL INVEST, V13, P239, DOI 10.1016/j.jsgi.2006.02.011; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Shah TA, 2010, PEDIATR RES, V68, P210, DOI 10.1203/00006450-201011001-00409; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Stoll BJ, 2005, PEDIATR INFECT DIS J, V24, P635, DOI 10.1097/01.inf.0000168749.82105.64; TOMODA S, 1985, AM J PHYSIOL, V249, pR133, DOI 10.1152/ajpregu.1985.249.1.R133; Toti P, 2004, AM J CLIN PATHOL, V122, P765, DOI 10.1309/RV6E9BMC9954A2WU; Vermeulen GM, 2001, EUR J OBSTET GYN R B, V99, P207, DOI 10.1016/S0301-2115(01)00383-9; Willet KE, 2000, PEDIATR RES, V48, P782, DOI 10.1203/00006450-200012000-00014; Wilson TC, 2005, PEDIATR RES, V58, P1204, DOI 10.1203/01.pdr.0000185269.93228.29; WOLFS TGA, 2009, PLOS ONE, P4; Wood NS, 2005, ARCH DIS CHILD-FETAL, V90, P134, DOI 10.1136/adc.2004.052407; World Health Organization (WHO), 2012, BORN TOO SOON GOB AC; Wu X., 2012, P ACM SIGCOMM, P7	44	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63355	10.1371/journal.pone.0063355	http://dx.doi.org/10.1371/journal.pone.0063355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691033	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107900037
J	Frynta, D; Simkova, O; Liskova, S; Landova, E				Frynta, Daniel; Simkova, Olga; Liskova, Silvie; Landova, Eva			Mammalian Collection on Noah's Ark: The Effects of Beauty, Brain and Body Size	PLOS ONE			English	Article							CONSERVATION PRIORITIES; PHYSICAL ATTRACTIVENESS; POPULATION-DYNAMICS; VISITOR INTEREST; PHYLOGENY; ZOOS; INTELLIGENCE; EVOLUTION; ANIMALS; BIODIVERSITY	The importance of today's zoological gardens as the so-called "Noah's Ark'' grows as the natural habitat of many species quickly diminishes. Their potential to shelter a large amount of individuals from many species gives us the opportunity to reintroduce a species that disappeared in nature. However, the selection of animals to be kept in zoos worldwide is highly selective and depends on human decisions driven by both ecological criteria such as population size or vulnerability and audience-driven criteria such as aesthetic preferences. Thus we focused our study on the most commonly kept and bred animal class, the mammals, and we asked which factors affect various aspects of the mammalian collection of zoos. We analyzed the presence/absence, population size, and frequency per species of each of the 123 mammalian families kept in the worldwide zoo collection. Our aim was to explain these data using the human-perceived attractiveness of mammalian families, their body weight, relative brain size and species richness of the family. In agreement with various previous studies, we found that the body size and the attractiveness of mammals significantly affect all studied components of the mammalian collection of zoos. There is a higher probability of the large and attractive families to be kept. Once kept, these animals are presented in larger numbers in more zoos. On the contrary, the relative mean brain size only affects the primary selection whether to keep the family or not. It does not affect the zoo population size or the number of zoos that keep the family.	[Frynta, Daniel; Simkova, Olga; Liskova, Silvie; Landova, Eva] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic	Charles University Prague	Frynta, D (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	frynta@centrum.cz	Landova, Eva/R-8759-2017; Frynta, Daniel/L-7350-2016; Rádlová, Silvie/D-5532-2017; Rádlová, Silvie/L-3388-2019	Landova, Eva/0000-0001-8365-8710; Frynta, Daniel/0000-0002-1375-7972; Rádlová, Silvie/0000-0003-3581-9780; Rádlová, Silvie/0000-0003-3581-9780	Grant Agency of the Czech Academy of Sciences [IAA 601410803];  [SVV-2013-267 201]	Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); 	The project was supported by the Grant Agency of the Czech Academy of Sciences (project number IAA 601410803). Personal costs of OS. and SL were partially supported by the project number SVV-2013-267 201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2008, MOL PHYLOGENET EVOL, V48, P964, DOI 10.1016/j.ympev.2008.05.046; Ahrens T. G., 1921, Journal of Mammalogy, V2, P58, DOI 10.2307/1373684; Andera M, 1997, SVET ZVIRAT; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1999, WALKERS MAMMALS WORL; [Anonymous], 1996, GUTACHTEN MINDESTANF; [Anonymous], 1989, ANIMAL REINTRODUCTIO; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Ashwell KWS, 2008, BRAIN BEHAV EVOLUT, V71, P181, DOI 10.1159/000114406; Balmford A, 2000, CONSERV BIOL, V14, P1193, DOI 10.1046/j.1523-1739.2000.99078.x; Balmford A, 1996, CONSERV BIOL, V10, P719, DOI 10.1046/j.1523-1739.1996.10030719.x; Barros MC, 2008, GENET MOL BIOL, V31, P793, DOI 10.1590/S1415-47572008000400029; BERLIN B, 1992, ETHNOBIOLOGICAL CLAS; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bitgood S., 1987, VISITOR BEHAV, V2, P4, DOI DOI 10.1177/0013916588204006; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; Bowen-Jones E, 2002, ORYX, V36, P189, DOI 10.1017/S0030605302000261; Bowkett AE, 2009, CONSERV BIOL, V23, P773, DOI 10.1111/j.1523-1739.2008.01157.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; CALLICOTT JB, 1990, CONSERV BIOL, V4, P15, DOI 10.1111/j.1523-1739.1990.tb00261.x; Central Intelligence Agency, 2013, COUNTR COMP DISTR FA; Chatterjee HJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-259; Conde DA, 2011, SCIENCE, V331, P1390, DOI 10.1126/science.1200674; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Dalerum F, 2007, J ZOOL, V273, P90, DOI 10.1111/j.1469-7998.2007.00303.x; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Dietz J. M., 1994, P32; Dobson A, 2000, SCIENCE, V288, P985, DOI 10.1126/science.288.5468.985; Earnhardt Joanne M., 2010, P268; EBENHARD T, 1995, TRENDS ECOL EVOL, V10, P438, DOI 10.1016/S0169-5347(00)89176-4; ENTWISTLE AC, 2000, PRIORITIES CONSERVAT, P119; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; FAGEN R, 1974, AM NAT, V108, P850, DOI 10.1086/282960; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; Frankham R., 2002, INTRO CONSERVATION G; Freese CH, 2007, BIOL CONSERV, V136, P175, DOI 10.1016/j.biocon.2006.11.019; Frynta D., 2009, P299; Frynta D, 2011, HUM ECOL, V39, P829, DOI 10.1007/s10745-011-9447-2; Frynta D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012568; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gippoliti S, 2012, BIODIVERS CONSERV, V21, P1359, DOI 10.1007/s10531-012-0256-8; Gunnthorsdottir A, 2001, ANTHROZOOS, V14, P204, DOI 10.2752/089279301786999355; Hale KA, 2007, ANIM CONSERV, V10, P19, DOI 10.1111/j.1469-1795.2006.00093.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Huchon D, 2001, MOL PHYLOGENET EVOL, V20, P238, DOI 10.1006/mpev.2001.0961; Hutchins M, 2004, GRZIMEKS ANIMAL LIFE, V12-16; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Iwaniuk AN, 2001, J COMP PSYCHOL, V115, P29, DOI 10.1037//0735-7036.115.1.29; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Jansa SA, 2009, J MAMMAL, V90, P1083, DOI 10.1644/08-MAMM-A-318.1; JERISON HJ, 1963, HUM BIOL, V35, P263; JERISON HJ, 1955, SCIENCE, V121, P447, DOI 10.1126/science.121.3144.447; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Jiang ZG, 2000, WILDLIFE SOC B, V28, P681; Kaltenborn BP, 2006, BIODIVERS CONSERV, V15, P4633, DOI 10.1007/s10531-005-6196-9; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kleiber M., 1961, FIRE LIFE INTRO ANIM; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Lande R, 1999, GENETICS AND THE EXTINCTION OF SPECIES, P1; Leader-Williams N., 2007, Catalysts for conservation: a direction for zoos in the 21st Century, London, UK, 19-20 February, 2004., P236; Lees C. M., 2009, International Zoo Yearbook, V43, P6, DOI 10.1111/j.1748-1090.2008.00066.x; Macphail EM, 2001, BIOL REV, V76, P341; Maresova J, 2008, ECOL ECON, V64, P554, DOI 10.1016/j.ecolecon.2007.03.012; Maresova J, 2009, ETHOLOGY, V115, P297, DOI 10.1111/j.1439-0310.2009.01620.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Margulis SW, 2003, ZOO BIOL, V22, P587, DOI 10.1002/zoo.10115; Martins EP, 2001, COMPARE VERSION 4 4; Marton-Lefevre J, 2010, SCIENCE, V327, P1179, DOI 10.1126/science.1188424; Mathews F, 2005, BIOL CONSERV, V121, P569, DOI 10.1016/j.biocon.2004.06.007; Mazur N, 2000, YALE FORESTRY ENV SC, V105, P1; McGregor Reid Gordon, 2008, International Zoo Yearbook, V42, P1; Meredith RW, 2009, MOL PHYLOGENET EVOL, V51, P554, DOI 10.1016/j.ympev.2009.02.009; Metrick A, 1996, LAND ECON, V72, P1, DOI 10.2307/3147153; Moss A, 2010, ZOO BIOL, V29, P715, DOI 10.1002/zoo.20316; Myers PR, 2013, ANIMAL DIVERSITY WEB; Overington SE, 2009, ANIM BEHAV, V78, P1001, DOI 10.1016/j.anbehav.2009.06.033; Portmann A, 1979, SCI PHILOS; Price M. R. Stanley, 2003, International Zoo Yearbook, V38, P61, DOI 10.1111/j.1748-1090.2003.tb02065.x; Puan C. L., 2007, International Zoo Yearbook, V41, P226, DOI 10.1111/j.1748-1090.2007.00009.x; Pucek Z, 2002, EUROPEAN BISON CURRE; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Reed DH, 2007, ANIM CONSERV, V10, P275, DOI 10.1111/j.1469-1795.2007.00120.x; Rees PA, 2005, ORYX, V39, P128, DOI 10.1017/S0030605305000335; ROBERTS L, 1988, SCIENCE, V242, P1247, DOI 10.1126/science.242.4883.1247; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; SALTZ D, 1995, ECOL APPL, V5, P327, DOI 10.2307/1942025; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schlegel J, 2010, J NAT CONSERV, V18, P278, DOI 10.1016/j.jnc.2009.12.002; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Shettleworth SJ, 2003, BRAIN BEHAV EVOLUT, V62, P108, DOI 10.1159/000072441; Smith RJ, 2011, TRADE OFFS CONSERVAT, P215; Smith RJ, 2012, CONSERV LETT, V5, P205, DOI 10.1111/j.1755-263X.2012.00229.x; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; SOULE M, 1986, ZOO BIOL, V5, P101, DOI 10.1002/zoo.1430050205; Soule M. E., 1980, CONSERVATION BIOL EV, P151; SPSS Inc, 2007, SPSS VERS 16 0; StatSoft, 2001, STAT VERS 6 0; Stoinski TS, 2004, AM J PRIMATOL, V62, P1, DOI 10.1002/ajp.20002; Tokarska M, 2009, BIOL J LINN SOC, V97, P801, DOI 10.1111/j.1095-8312.2009.01203.x; Verissimo D, 2009, ANIM CONSERV, V12, P549, DOI 10.1111/j.1469-1795.2009.00282.x; Verissimo D, 2011, CONSERV LETT, V4, P1, DOI 10.1111/j.1755-263X.2010.00151.x; Volf J, 2009, EQ 2009 PRAG CZ ZOO, P39; White PCL, 1997, BIOL CONSERV, V82, P345, DOI 10.1016/S0006-3207(97)00036-0; Whitfield P, 1984, LONGMAN ILLUSTRATED; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wilson EO, 2002, FUTURE LIFE; Zimmermann Alexandra, 2010, P281	109	44	44	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63110	10.1371/journal.pone.0063110	http://dx.doi.org/10.1371/journal.pone.0063110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690985	gold, Green Published, Green Submitted			2022-12-25	WOS:000319052700019
J	Goldstein, T; Mena, I; Anthony, SJ; Medina, R; Robinson, PW; Greig, DJ; Costa, DP; Lipkin, WI; Garcia-Sastre, A; Boyce, WM				Goldstein, Tracey; Mena, Ignacio; Anthony, Simon J.; Medina, Rafael; Robinson, Patrick W.; Greig, Denise J.; Costa, Daniel P.; Lipkin, W. Ian; Garcia-Sastre, Adolfo; Boyce, Walter M.			Pandemic H1N1 Influenza Isolated from Free-Ranging Northern Elephant Seals in 2010 off the Central California Coast	PLOS ONE			English	Article							A VIRUS; HARBOR SEALS; PHOCINE HERPESVIRUS-1; SEROLOGIC EVIDENCE; MARINE MAMMALS; EMERGENCE; INFECTION; PARAMYXOVIRUSES; TRANSMISSION; WATERFOWL	Interspecies transmission of influenza A is an important factor in the evolution and ecology of influenza viruses. Marine mammals are in contact with a number of influenza reservoirs, including aquatic birds and humans, and this may facilitate transmission among avian and mammalian hosts. Virus isolation, whole genome sequencing, and hemagluttination inhibition assay confirmed that exposure to pandemic H1N1 influenza virus occurred among free-ranging Northern Elephant Seals (Mirounga angustirostris) in 2010. Nasal swabs were collected from 42 adult female seals in April 2010, just after the animals had returned to the central California coast from their short post-breeding migration in the northeast Pacific. Swabs from two seals tested positive by RT-PCR for the matrix gene, and virus was isolated from each by inoculation into embryonic chicken eggs. Whole genome sequencing revealed greater than 99% homology with A/California/04/2009 (H1N1) that emerged in humans from swine in 2009. Analysis of more than 300 serum samples showed that samples collected early in 2010 (n = 100) were negative and by April animals began to test positive for antibodies against the pH1N1 virus (HI titer of >= 1:40), supporting the molecular findings. In vitro characterizations studies revealed that viral replication was indistinguishable from that of reference strains of pH1N1 in canine kidney cells, but replication was inefficient in human epithelial respiratory cells, indicating these isolates may be elephant seal adapted viruses. Thus findings confirmed that exposure to pandemic H1N1 that was circulating in people in 2009 occurred among free-ranging Northern Elephant Seals in 2010 off the central California coast. This is the first report of pH1N1 (A/Elephant seal/California/1/2010) in any marine mammal and provides evidence for cross species transmission of influenza viruses in free-ranging wildlife and movement of influenza viruses between humans and wildlife.	[Goldstein, Tracey] Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA; [Mena, Ignacio; Medina, Rafael; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Mena, Ignacio; Medina, Rafael; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA; [Anthony, Simon J.; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA; [Medina, Rafael] Pontificia Univ Catolica Chile, Fac Med, Ctr Invest Med, Inst Milenio Inmunol & Inmunoterapia,Lab Mol Viro, Santiago, Chile; [Medina, Rafael] Pontificia Univ Catolica Chile, Fac Med, Div Pediat, Santiago, Chile; [Robinson, Patrick W.; Costa, Daniel P.] Univ Calif Santa Cruz, Ctr Ocean Hlth, Long Marine Lab, Santa Cruz, CA 95064 USA; [Greig, Denise J.] Marine Mammal Ctr, Sausalito, CA USA; [Boyce, Walter M.] Univ Calif Davis, Sch Vet Med, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA	University of California System; University of California Davis; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University of California System; University of California Santa Cruz; University of California System; University of California Davis	Goldstein, T (corresponding author), Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA.	tgoldstein@ucdavis.edu	Lipkin, W. Ian/ABE-6216-2020; Medina, Rafael A./AAW-4418-2020; Mena, Ignacio/I-1222-2019; Costa, Daniel/E-2616-2013	Lipkin, W. Ian/0000-0002-8768-9386; Medina, Rafael A./0000-0002-5013-6884; Mena, Ignacio/0000-0001-5464-7086; Greig, Denise/0000-0003-0783-1002; Costa, Daniel/0000-0002-0233-5782; Garcia-Sastre, Adolfo/0000-0002-6551-1827	CRIP (Center for Research on Influenza Pathogenesis), under the Centers of Excellence for Influenza Research and Surveillance (CEIRS) program; National Institute of Allergy and Infectious Diseases [HHSN266200700009C]; Tagging of Pacific Pelagics program; National Ocean Partnership Program [N00014-02-1-1012]; Office of Naval Research [N00014-00-1-0880, N00014-03-1-0651, N00014-08-1-1195]; International Association of Oil and Gas Producers [JIP2207-23]; Moore Foundation; Packard Foundation; Sloan Foundation; CONICYT Insertion of Human Capital to the Academy grant [79100014]	CRIP (Center for Research on Influenza Pathogenesis), under the Centers of Excellence for Influenza Research and Surveillance (CEIRS) program; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Tagging of Pacific Pelagics program; National Ocean Partnership Program; Office of Naval Research(Office of Naval Research); International Association of Oil and Gas Producers; Moore Foundation(Gordon and Betty Moore Foundation); Packard Foundation(The David & Lucile Packard Foundation); Sloan Foundation(Alfred P. Sloan Foundation); CONICYT Insertion of Human Capital to the Academy grant	Funding for this research was provided by CRIP (Center for Research on Influenza Pathogenesis), under the Centers of Excellence for Influenza Research and Surveillance (CEIRS) program supported by the National Institute of Allergy and Infectious Diseases (contract HHSN266200700009C), the Tagging of Pacific Pelagics program with grants from the National Ocean Partnership Program (N00014-02-1-1012), the Office of Naval Research (N00014-00-1-0880, N00014-03-1-0651 and N00014-08-1-1195), International Association of Oil and Gas Producers contract JIP2207-23, the Moore, Packard, and Sloan Foundations, and benefited from intellectual developments from the PREDICT project of the United States Agency for International Development (USAID) Emerging Pandemic Threats Program, CONICYT Insertion of Human Capital to the Academy grant (79100014) and by the Program Iniciativa Cientifica Milenio from the Chilean Ministry of Economy, Development and Tourism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SJ, 2012, MBIO, V3, DOI 10.1128/mBio.00166-12; Ayers JM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005596; Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; CALLAN RJ, 1995, J GEN VIROL, V76, P199, DOI 10.1099/0022-1317-76-1-199; Danner GR, 2006, MAR MAMMAL SCI, V14, P380; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; GERACI JR, 1982, SCIENCE, V215, P1129; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Goldstein T, 2004, VET MICROBIOL, V103, P131, DOI 10.1016/j.vetmic.2004.06.017; Greig DJ, 2011, THESIS; HINSHAW VS, 1984, J VIROL, V51, P863, DOI 10.1128/JVI.51.3.863-865.1984; HINSHAW VS, 1986, J VIROL, V58, P655, DOI 10.1128/JVI.58.2.655-656.1986; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; Ilyicheva T, 2011, INFECT GENET EVOL, V11, P2107, DOI 10.1016/j.meegid.2011.05.002; King DP, 2001, VET MICROBIOL, V80, P1, DOI 10.1016/S0378-1135(00)00369-2; LANG G, 1981, ARCH VIROL, V68, P189, DOI 10.1007/BF01314571; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Mak GC, 2011, EUROSURVEILLANCE, V16, P6; MANDLER J, 1990, VIROLOGY, V176, P255, DOI 10.1016/0042-6822(90)90250-U; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; Maurer-Stroh S, 2010, PLOS CURR, V2; Medina RA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1026; Metreveli G, 2011, VIRUS GENES, V42, P236, DOI 10.1007/s11262-011-0571-2; Nielsen O, 2001, J WILDLIFE DIS, V37, P820, DOI 10.7589/0090-3558-37.4.820; Ohishi K, 2004, MICROBIOL IMMUNOL, V48, P905, DOI 10.1111/j.1348-0421.2004.tb03610.x; Ohishi K, 2002, MICROBIOL IMMUNOL, V46, P639, DOI 10.1111/j.1348-0421.2002.tb02746.x; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Robinson PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036728; Runstadler JA, 2007, ARCH VIROL, V152, P1901, DOI 10.1007/s00705-007-0994-1; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; STUEN S, 1994, VET REC, V134, P502, DOI 10.1136/vr.134.19.502; Tizard I, 2000, VET IMMUNOLOGY INTRO, P180; USAFSAM, 2009, 311 USAFSAM; Varich NL, 2011, VIRAL IMMUNOL, V24, P101, DOI 10.1089/vim.2010.0088; WEBSTER RG, 1981, NEW ENGL J MED, V304, P911; WEBSTER RG, 1981, VIROLOGY, V113, P712, DOI 10.1016/0042-6822(81)90200-2; Yoo SJ, 2010, J CLIN MICROBIOL, V48, P2314, DOI 10.1128/JCM.00325-10; Zhou HB, 2011, EMERG INFECT DIS, V17, P1757, DOI 10.3201/eid1709.101916	44	48	48	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e62259	10.1371/journal.pone.0062259	http://dx.doi.org/10.1371/journal.pone.0062259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690933	Green Published, gold			2022-12-25	WOS:000319052700008
J	Seay, K; Qi, XH; Zheng, JH; Zhang, C; Chen, K; Dutta, M; Deneroff, K; Ochsenbauer, C; Kappes, JC; Littman, DR; Goldstein, H				Seay, Kieran; Qi, Xiaohua; Zheng, Jian Hua; Zhang, Cong; Chen, Ken; Dutta, Monica; Deneroff, Kathryn; Ochsenbauer, Christina; Kappes, John C.; Littman, Dan R.; Goldstein, Harris			Mice Transgenic for CD4-Specific Human CD4, CCR5 and Cyclin T1 Expression: A New Model for Investigating HIV-1 Transmission and Treatment Efficacy	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; LENTIVIRAL VECTORS; GENE-TRANSFER; INFECTION; REPLICATION; MOUSE; LYMPHOCYTES; INHIBITION; THERAPY; TAT	Mice cannot be used to evaluate HIV-1 therapeutics and vaccines because they are not infectible by HIV-1 due to structural differences between several human and mouse proteins required for HIV-1 entry and replication including CD4, CCR5 and cyclin T1. We overcame this limitation by constructing mice with CD4 enhancer/promoter-regulated human CD4, CCR5 and cyclin T1 genes integrated as tightly linked transgenes (hCD4/R5/cT1 mice) promoting their efficient co-transmission and enabling the murine CD4-expressing cells to support HIV-1 entry and Tat-mediated LTR transcription. All of the hCD4/R5/ cT1 mice developed disseminated infection of tissues that included the spleen, small intestine, lymph nodes and lungs after intravenous injection with an HIV-1 infectious molecular clone (HIV-IMC) expressing Renilla reniformis luciferase (LucR). Furthermore, localized infection of cervical-vaginal mucosal leukocytes developed after intravaginal inoculation of hCD4/R5/ cT1 mice with the LucR-expressing HIV-IMC. hCD4/R5/cT1 mice reproducibly developed in vivo infection after inoculation with LucR-expressing HIV-IMC which could be bioluminescently quantified and visualized with a high sensitivity and specificity which enabled them to be used to evaluate the efficacy of HIV-1 therapeutics. Treatment with highly active anti-retroviral therapy or one dose of VRC01, a broadly neutralizing anti-HIV-1 antibody, almost completed inhibited acute systemic HIV-1 infection of the hCD4/R5/cT1 mice. hCD4/R5/cT1 mice could also be used to evaluate the capacity of therapies delivered by gene therapy to inhibit in vivo HIV infection. VRC01 secreted in vivo by primary B cells transduced with a VRC01-encoding lentivirus transplanted into hCD4/R5/cT1 mice markedly inhibited infection after intravenous challenge with LucR-expressing HIV-IMC. The reproducible infection of CD4/R5/cT1 mice with LucR-expressing HIV-IMC after intravenous or mucosal inoculation combined with the availability of LucR-expressing HIV-IMC expressing transmitted/ founder and clade A/E and C Envs will provide researchers with a highly accessible pre-clinical in vivo HIV-1-infection model to study HIV-1 acquisition, treatment, and prevention.	[Seay, Kieran; Goldstein, Harris] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Qi, Xiaohua; Zheng, Jian Hua; Zhang, Cong; Dutta, Monica; Deneroff, Kathryn; Goldstein, Harris] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Chen, Ken] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Ochsenbauer, Christina; Kappes, John C.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kappes, John C.] Birmingham Vet Affairs Med Ctr, Res Serv, Birmingham, AL USA; [Littman, Dan R.] NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY USA; [Littman, Dan R.] NYU, Sch Med, Skirball Inst Biomol Med, Howard Hughes Med Inst, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; New York University; Howard Hughes Medical Institute; New York University	Goldstein, H (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	harris.goldstein@einstein.yu.edu			National Institutes of Health (National Institute of Drug Abuse) [R01-DA-033788]; National Institutes of Health (National Institute of Allergy and Infectious Diseases) [R01-AI065309]; National Institutes of Health (Einstein-Montefiore Center for AIDS Research) [AI51519]; Charles Michael Chair in Autoimmune Diseases; NIH-funded AIDS training grant [T32-AI007501]; VHA Merit Review Award; NIH Center for HIV-1/AIDS Vaccine Immunology (CHAVI) [UO1-AI067854]; UAB Center for AIDS Research [P30-AI-27767];  [U01-GM-094665];  [U54-GM-094662];  [P30-CA-013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, P30AI051519, P30AI027767, T32AI007501, R01AI065309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094665, U54GM094662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033788] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Drug Abuse)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (Einstein-Montefiore Center for AIDS Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles Michael Chair in Autoimmune Diseases; NIH-funded AIDS training grant; VHA Merit Review Award; NIH Center for HIV-1/AIDS Vaccine Immunology (CHAVI); UAB Center for AIDS Research; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The construct expressing VRC01 was a kind gift of Dr. John Mascola (VRC/NIAID/NIH) which was used to generate VRC01 antibody in the Einstein Macromolecular Therapeutics Facility (supported by U01-GM-094665, U54-GM-094662 and P30-CA-013330) by Man K. Chan. The following reagents were obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: TZM-bl cells, pT4B and pCCR-5.; This work was supported by the National Institutes of Health (National Institute of Drug Abuse R01-DA-033788, National Institute of Allergy and Infectious Diseases R01-AI065309 and the Einstein-Montefiore Center for AIDS Research AI51519). HG was supported by the Charles Michael Chair in Autoimmune Diseases, KS by an NIH-funded AIDS training grant, T32-AI007501 and JCK by a VHA Merit Review Award. Work by JCK and CO was supported by the NIH Center for HIV-1/AIDS Vaccine Immunology (CHAVI), UO1-AI067854; and the UAB Center for AIDS Research (P30-AI-27767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Browning J, 1997, P NATL ACAD SCI USA, V94, P14637, DOI 10.1073/pnas.94.26.14637; Collins KR, 2002, J VIROL, V76, P1697, DOI 10.1128/JVI.76.4.1697-1706.2002; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Fidel PL, 1996, INFECT IMMUN, V64, P3793, DOI 10.1128/IAI.64.9.3793-3799.1996; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Gelderblom HC, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-60; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Imai K, 2009, FEBS J, V276, P7124, DOI 10.1111/j.1742-4658.2009.07424.x; Ince WL, 2010, J VIROL, V84, P2740, DOI 10.1128/JVI.02180-09; Joseph A, 2008, J VIROL, V82, P3078, DOI 10.1128/JVI.01812-07; Joseph A, 2010, J VIROL, V84, P6645, DOI 10.1128/JVI.02339-09; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; Mariani R, 2000, J VIROL, V74, P3859, DOI 10.1128/JVI.74.8.3859-3870.2000; Marozsan AJ, 2003, J VIROL METHODS, V111, P111, DOI 10.1016/S0166-0934(03)00166-6; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Michel N, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-2; Miyawaki A, 2007, NAT METHODS, V4, P616, DOI 10.1038/nmeth0807-616; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mosier D E, 1996, Semin Immunol, V8, P255, DOI 10.1006/smim.1996.0032; Ochiel DO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014306; Ochsenbauer C, 2009, CURR OPIN HIV AIDS, V4, P418, DOI 10.1097/COH.0b013e32832f011e; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Sango K, 2010, AIDS RES HUM RETROV, V26, P735, DOI 10.1089/aid.2009.0136; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sun JL, 2006, J VIROL, V80, P1850, DOI 10.1128/JVI.80.4.1850-1862.2006; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Watanabe S, 2007, J VIROL, V81, P13259, DOI 10.1128/JVI.01353-07; Wege AK, 2008, CURR TOP MICROBIOL, V324, P149; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Wimmer J, 1999, VIROLOGY, V255, P182, DOI 10.1006/viro.1998.9589; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002035; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	48	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63537	10.1371/journal.pone.0063537	http://dx.doi.org/10.1371/journal.pone.0063537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691059	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700042
J	Shuval, K; Gabriel, KP; Leonard, T				Shuval, Kerem; Gabriel, Kelley Pettee; Leonard, Tammy			TV Viewing and BMI by Race/Ethnicity and Socio-Economic Status	PLOS ONE			English	Article							NATIONAL TRENDS SURVEY; PHYSICAL-ACTIVITY; US ADULTS; RISK; WOMEN; TIME; OBESITY; CANCER; ASSOCIATIONS; PREVENTION	Objective: To assess the association between TV viewing and obesity by race/ethnicity and socio-economic status. Design: Cross-sectional analysis of 5,087 respondents to the Health Information National Trends Survey (HINTS), a nationally representative sample of US adults. Multivariate regression models were computed to assess the association between quartiles of TV viewing and BMI, stratified by race/ethnicity, educational attainment, employment and health insurance status. Results: Findings indicate that increased TV viewing was associated with higher odds for being overweight/obese in the entire sample, while adjusting for physical activity and other confounders. After stratification by race/ethnicity, increased odds for overweight/obesity in the 3rd and 4th quartiles of TV viewing (e.g., 3rd quartile-cumulative OR = 1.43, 95%CI 1.07-1.92) was observed in non-Hispanic whites, with statistical significance. In non-Hispanic blacks and Hispanics, the odds were similar to whites, but did not reach statistical significance. Significant relations between greater TV viewing and increased BMI were observed in college graduates and non-graduates, those with health insurance and the employed. Conclusions: This study extends previous research by examining potential inconsistencies in this association between various racial/ethnic groups and some socio-economic variables, which primarily were not found.	[Shuval, Kerem] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Dallas, TX USA; [Gabriel, Kelley Pettee] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Austin, TX USA; [Shuval, Kerem] Univ Texas SW Med Ctr Dallas, Harold C Simmons Canc Ctr, Dallas, TX 75390 USA; [Leonard, Tammy] Univ Texas Dallas, Dept Econ, Dallas, TX 75230 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas	Shuval, K (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Dallas Reg Campus, Dallas, TX USA.	Kerem.Shuval@uth.tmc.edu		Leonard, Tammy/0000-0002-8621-9358				Britton KA, 2012, OBESITY, V20, P1096, DOI 10.1038/oby.2011.359; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Clark BK, 2010, J PHYS ACT HEALTH, V7, P595, DOI 10.1123/jpah.7.5.595; Dunstan DW, 2004, DIABETES CARE, V27, P2603, DOI 10.2337/diacare.27.11.2603; Faridi Z, 2010, HEALTH EDUC RES, V25, P306, DOI 10.1093/her/cyp005; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Henderson VR, 2007, J ADOLESCENT HEALTH, V41, P544, DOI 10.1016/j.jadohealth.2007.04.018; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; King AC, 2010, AM J PREV MED, V38, P17, DOI 10.1016/j.amepre.2009.08.032; Lathan CS, 2010, CANCER-AM CANCER SOC, V116, P1981, DOI 10.1002/cncr.24923; National Cancer Institute, 2005, HINTS HLTH INF NAT T; National Cancer Institute, HINTS HLTH INF NAT T; Nelson DE, 2004, J HEALTH COMMUN, V9, P443, DOI 10.1080/10810730490504233; Patel AV, 2006, AM J EPIDEMIOL, V163, P709, DOI 10.1093/aje/kwj098; Richmond TK, 2010, OBESITY, V18, P1015, DOI 10.1038/oby.2009.391; Shuval K, 2011, PREV CHRONIC DIS, V8; Stamatakis E, 2009, J EPIDEMIOL COMMUN H, V63, P734, DOI 10.1136/jech.2008.085902; Sullivan HW, 2010, PREV CHRONIC DIS, V7; Swinburn B, 2008, INT J OBESITY, V32, pS132, DOI 10.1038/ijo.2008.249; Tucker LA, 2011, OBESITY, V19, P1950, DOI 10.1038/oby.2011.184; United States Department of Health and Human Services, 2008 PHYS ACT GUID A; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Wijndaele K, 2010, MED SCI SPORT EXER, V42, P1511, DOI 10.1249/MSS.0b013e3181d322ac; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104	24	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63579	10.1371/journal.pone.0063579	http://dx.doi.org/10.1371/journal.pone.0063579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145XK	23691070	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700050
J	Vinokur, V; Berenshtein, E; Bulvik, B; Grinberg, L; Eliashar, R; Chevion, M				Vinokur, Vladimir; Berenshtein, Eduard; Bulvik, Baruch; Grinberg, Leonid; Eliashar, Ron; Chevion, Mordechai			The Bitter Fate of the Sweet Heart: Impairment of Iron Homeostasis in Diabetic Heart Leads to Failure in Myocardial Protection by Preconditioning	PLOS ONE			English	Article							POSSIBLE PREDICTIVE CRITERIA; ISOLATED RAT-HEART; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; POSTTRANSCRIPTIONAL REGULATION; ISCHEMIA/REPERFUSION INJURY; REPERFUSION INJURY; POTENTIAL ROLE; TISSUE-INJURY; ISCHEMIA	Cardiovascular dysfunction is a major complication of diabetes. Examining mechanistic aspects underlying the incapacity of the diabetic heart to respond to ischemic preconditioning (IPC), we could show that the alterations in iron homeostasis can explain this phenomenon. Correlating the hemodynamic parameters with levels of ferritin, the main iron storage and detoxifying protein, without and with inhibitors of protein degradation, substantiated this explanation. Diabetic hearts were less sensitive to ischemia-reperfusion stress, as indicated by functional parameters and histology. Mechanistically, since ferritin has been shown to provide cellular protection against insults, including ischemia-reperfusion stress and as the basal ferritin level in diabetic heart was 2-fold higher than in controls, these are in accord with the greater resistance of the diabetic heart to ischemia-reperfusion. Additionally, during ischemia-reperfusion, preceded by IPC, a rapid and extensive loss in ferritin levels, during the prolonged ischemia, in diabetic heart but not in non-diabetic controls, provide additional substantiation to the explanation for loss of respond to IPC. Current research is shedding light on the mechanism behind ferritin degradation as well, suggesting a novel explanation for diabetes-induced loss of cardioprotection.	[Vinokur, Vladimir; Berenshtein, Eduard; Bulvik, Baruch; Grinberg, Leonid; Chevion, Mordechai] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, Jerusalem, Israel; [Vinokur, Vladimir; Eliashar, Ron] Hadassah Univ Hosp, Dept Otolaryngol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Chevion, M (corresponding author), Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, Jerusalem, Israel.	mottiec@ekmd.huji.ac.il	Vinokur, Valerii M/J-7299-2013; Eliashar, Ron/GZH-0089-2022	Eliashar, Ron/0000-0003-0740-4975	Paulina and Dr. Moshe (Monek) Memorial fund; German-Israel Foundation for Scientific Research and Development [GIF 1061-59.2/2008]; Israel Science Foundation [ISF 489/12]	Paulina and Dr. Moshe (Monek) Memorial fund; German-Israel Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation)	This research was supported by funds from the Paulina and Dr. Moshe (Monek) Memorial fund, from the German-Israel Foundation for Scientific Research and Development (GIF 1061-59.2/2008) and from The Israel Science Foundation (ISF 489/12) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berenshtein E, 1997, J MOL CELL CARDIOL, V29, P3025, DOI 10.1006/jmcc.1997.0535; Berenshtein E, 2002, MOL CELL BIOCHEM, V234, P283, DOI 10.1023/A:1015923202082; Blonde L, 2006, J AM ACAD NURSE PRAC, V18, P524, DOI 10.1111/j.1745-7599.2006.00171.x; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; Chen H, 2006, CLIN EXP PHARMACOL P, V33, P910, DOI 10.1111/j.1440-1681.2006.04463.x; CHEVION M, 1993, P NATL ACAD SCI USA, V90, P1102, DOI 10.1073/pnas.90.3.1102; Chevion M, 2008, J MOL CELL IN PRESS; COLLAWN JF, 1984, COMP BIOCHEM PHYS B, V78, P653, DOI 10.1016/0305-0491(84)90113-5; Elia G, 1999, EUR J BIOCHEM, V264, P736, DOI 10.1046/j.1432-1327.1999.00610.x; Evans JMM, 2002, BRIT MED J, V324, P939, DOI 10.1136/bmj.324.7343.939; Fert-Bober J, 2008, PROTEOMICS, V8, P2543, DOI 10.1002/pmic.200800022; FISHBEIN MC, 1981, AM HEART J, V101, P593, DOI 10.1016/0002-8703(81)90226-X; Giordani A, 2000, J PHOTOCH PHOTOBIO B, V54, P43, DOI 10.1016/S1011-1344(99)00154-2; Goldberg IJ, 2004, J CLIN INVEST, V114, P613, DOI 10.1172/JCI200422826; Hadour G, 1998, J MOL CELL CARDIOL, V30, P1869, DOI 10.1006/jmcc.1998.0751; Hassouna A, 2006, CARDIOVASC RES, V69, P450, DOI 10.1016/j.cardiores.2005.11.004; Hayden JM, 2000, CURR OPIN LIPIDOL, V11, P519, DOI 10.1097/00041433-200010000-00010; HEARSE DJ, 1975, J MOL CELL CARDIOL, V7, P397, DOI 10.1016/0022-2828(75)90046-2; Hicks KK, 1997, AM J PHYSIOL-HEART C, V273, pH1888, DOI 10.1152/ajpheart.1997.273.4.H1888; Kersten JR, 2000, AM J PHYSIOL-HEART C, V278, pH1218, DOI 10.1152/ajpheart.2000.278.4.H1218; LENK SE, 1992, AM J PHYSIOL, V263, pE856, DOI 10.1152/ajpendo.1992.263.5.E856; LIU YG, 1993, CIRCULATION, V88, P1273, DOI 10.1161/01.CIR.88.3.1273; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malone MA, 2007, METABOLISM, V56, P1118, DOI 10.1016/j.metabol.2007.04.005; Marfella R, 2006, ACTA CARDIOL, V61, P630, DOI 10.2143/AC.61.6.2017962; Marfella R, 2009, CARDIOVASC PATHOL, V18, P332, DOI 10.1016/j.carpath.2008.09.008; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Mensah K, 2005, J AM COLL CARDIOL, V45, P1287, DOI 10.1016/j.jacc.2005.01.021; Merforth S, 1999, MOL BIOL REP, V26, P83, DOI 10.1023/A:1006966005662; Monteiro P, 2005, HEART, V91, P1621, DOI 10.1136/hrt.2005.063008; Nilsson UA, 2002, FREE RADICAL RES, V36, P677, DOI 10.1080/10715760290029128; Ravingerova T, 2000, MOL CELL BIOCHEM, V210, P143, DOI 10.1023/A:1007129708262; Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16; Rezkalla SH, 2004, NAT CLIN PRACT CARD, V1, P96, DOI 10.1038/ncpcardio0047; Rothfuss A, 2002, MUTAT RES-FUND MOL M, V508, P157, DOI 10.1016/S0027-5107(02)00213-0; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Schwarz ER, 1999, CURR OPIN CARDIOL, V14, P340, DOI 10.1097/00001573-199907000-00010; STEFANINI S, 1982, BIOCHEMISTRY-US, V21, P2293, DOI 10.1021/bi00539a004; TANI M, 1988, CIRC RES, V62, P931, DOI 10.1161/01.RES.62.5.931; Vaisman B, 1999, CLIN CHEM LAB MED, V37, P121, DOI 10.1515/CCLM.1999.022; Vinokur V, 2007, REDOX REP, V12, P246, DOI 10.1179/135100007X239289; YTREHUS K, 1994, AM J PHYSIOL-HEART C, V267, pH2383, DOI 10.1152/ajpheart.1994.267.6.H2383; Zeltcer G, 2002, FREE RADICAL BIO MED, V32, P912, DOI 10.1016/S0891-5849(02)00783-9; Zeltcer G, 1997, FREE RADICAL RES, V27, P627, DOI 10.3109/10715769709097866	44	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e62948	10.1371/journal.pone.0062948	http://dx.doi.org/10.1371/journal.pone.0062948			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690966	Green Submitted, gold, Green Published			2022-12-25	WOS:000319052700014
J	Wang, L; Lu, A; Zhou, HX; Sun, R; Zhao, J; Zhou, CJ; Shen, JP; Wu, SN; Liang, CG				Wang, Lu; Lu, Angeleem; Zhou, Hong-Xia; Sun, Ran; Zhao, Jie; Zhou, Cheng-Jie; Shen, Jiang-Peng; Wu, Sha-Na; Liang, Cheng-Guang			Casein Kinase 1 Alpha Regulates Chromosome Congression and Separation during Mouse Oocyte Meiotic Maturation and Early Embryo Development	PLOS ONE			English	Article							SPINDLE CHECKPOINT; MAMMALIAN OOCYTES; PROTEIN-KINASE; SURVIVIN EXPRESSION; MEIOSIS I; REC8; PHOSPHORYLATION; DEGRADATION; SEGREGATION; ACTIVATION	Casein kinase I alpha (CK1 alpha) is a member of serine/threonine protein kinase, generally present in all eukaryotes. In mammals, CK1a regulates the transition from interphase to metaphase in mitosis. However, little is known about its role in meiosis. Here we examined Ck1 alpha mRNA and protein expression, as well as its subcellular localization in mouse oocytes from germinal vesicle to the late 1-cell stage. Our results showed that the expression level of CK1 alpha was increased in metaphase. Immunostaining results showed that CK1 alpha colocalized with condensed chromosomes during oocyte meiotic maturation and early embryo development. We used the loss-of-function approach by employing CK1 alpha specific morpholino injection to block the function of CK1 alpha. This functional blocking leads to failure of polar body 1 (PB1) extrusion, chromosome misalignment and MII plate incrassation. We further found that D4476, a specific and efficient CK1 inhibitor, decreased the rate of PB1 extrusion. Moreover, D4476 resulted in giant polar body extrusion, oocyte pro-MI arrest, chromosome congression failure and impairment of embryo developmental potential. In addition, we employed pyrvinium pamoate (PP), an allosteric activator of CK1 alpha, to enhance CK1 alpha activity in oocytes. Supplementation of PP induced oocyte meiotic maturation failure, severe congression abnormalities and misalignment of chromosomes. Taken together, our study for the first time demonstrates that CK1 alpha is required for chromosome alignment and segregation during oocyte meiotic maturation and early embryo development.	[Wang, Lu; Lu, Angeleem; Zhou, Hong-Xia; Sun, Ran; Zhao, Jie; Zhou, Cheng-Jie; Shen, Jiang-Peng; Wu, Sha-Na; Liang, Cheng-Guang] Inner Mongolia Univ, Key Lab Natl Educ Minist Mammalian Reprod Biol &, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia University	Liang, CG (corresponding author), Inner Mongolia Univ, Key Lab Natl Educ Minist Mammalian Reprod Biol &, Hohhot, Inner Mongolia, Peoples R China.	liangchengguang@gmail.com	liang, chengguang/E-4837-2011	liang, chengguang/0000-0003-4407-7766; Zhou, Cheng-Jie/0000-0002-0575-5037	National Basic Research Program of China [2011CB111500]; National Natural Science Foundation of China [31160243]; Program of Higher-Level Talents of Inner Mongolia University [Z20100125]; Key Project of Chinese Ministry of Education [211029]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Higher-Level Talents of Inner Mongolia University; Key Project of Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Basic Research Program of China (2011CB111500)(http://www.973.gov.cn/English/Index.aspx), The National Natural Science Foundation of China (31160243)(http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm), Program of Higher-Level Talents of Inner Mongolia University (Z20100125)(http://www.at0086.com/IMUN/index.aspx?view=full) and Key Project of Chinese Ministry of Education (211029)(http://www.dost.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Biswas A, 2011, J BIOL CHEM, V286, P3129, DOI 10.1074/jbc.M110.188565; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; Chaigne A, 2012, EXP CELL RES, V318, P1442, DOI 10.1016/j.yexcr.2012.02.019; Fabritius AS, 2011, CURR OPIN CELL BIOL, V23, P78, DOI 10.1016/j.ceb.2010.07.008; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; Gross SD, 1999, J CELL SCI, V112, P2647; Gross SD, 1997, J CELL SCI, V110, P3083; Han ZM, 2010, J PROTEOME RES, V9, P6025, DOI 10.1021/pr100827j; Hirner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029709; Hlubek F, 2006, BRIT J CANCER, V94, P1672, DOI 10.1038/sj.bjc.6603155; Homer H, 2011, CYTOGENET GENOME RES, V133, P209, DOI 10.1159/000324118; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Hudziak RM, 1996, ANTISENSE NUCLEIC A, V6, P267, DOI 10.1089/oli.1.1996.6.267; Huo LJ, 2006, FRONT BIOSCI-LANDMRK, V11, P2193, DOI 10.2741/1961; Ishiguro T, 2010, NAT CELL BIOL, V12, P500, DOI 10.1038/ncb2052; Kategaya LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031987; Katis VL, 2010, DEV CELL, V18, P397, DOI 10.1016/j.devcel.2010.01.014; Kucherenko Y, 2012, CELL PHYSIOL BIOCHEM, V30, P407, DOI 10.1159/000339034; Lee J, 2003, J CELL SCI, V116, P2781, DOI 10.1242/jcs.00495; Li HB, 2008, NAT CELL BIOL, V10, P1301, DOI 10.1038/ncb1788; Li S., 2010, PLOS ONE, V5; Liang CG, 2005, ENDOCRINOLOGY, V146, P4437, DOI 10.1210/en.2005-0309; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Matsuura S, 2000, AM J HUM GENET, V67, P483, DOI 10.1086/303022; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; ROWLES J, 1991, P NATL ACAD SCI USA, V88, P9548, DOI 10.1073/pnas.88.21.9548; Rumpf C, 2010, CELL CYCLE, V9, P2657, DOI 10.4161/cc.9.13.12146; Santos JA, 1996, J CELL SCI, V109, P1847; Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521; Shuda K, 2009, MOL REPROD DEV, V76, P1094, DOI 10.1002/mrd.21075; Solc P, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101014; Suja JA, 2010, CELL CYCLE, V9, P2929, DOI 10.4161/cc.9.15.12696; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Summerton JE, 2005, ANN NY ACAD SCI, V1058, P62, DOI 10.1196/annals.1359.012; Sun SC, 2009, CELL CYCLE, V8, P3365, DOI 10.4161/cc.8.20.9855; Tapia JC, 2006, P NATL ACAD SCI USA, V103, P15079, DOI 10.1073/pnas.0606845103; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tuazon P. T., 1991, ADV 2 MESSENGER PHOS, V23, P123; Utz AC, 2010, J HISTOCHEM CYTOCHEM, V58, P1, DOI 10.1369/jhc.2009.954628; Vogt E, 2008, MUTAT RES-GEN TOX EN, V651, P14, DOI 10.1016/j.mrgentox.2007.10.015; Wei YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021557; Zelenak C, 2012, CELL PHYSIOL BIOCHEM, V29, P171, DOI 10.1159/000337598; ZHAI LM, 1995, J BIOL CHEM, V270, P12717, DOI 10.1074/jbc.270.21.12717	47	11	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63173	10.1371/journal.pone.0063173	http://dx.doi.org/10.1371/journal.pone.0063173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690993	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700023
J	Akkaya, M; Aknin, ML; Akkaya, B; Barclay, AN				Akkaya, Munir; Aknin, Marie-Laure; Akkaya, Billur; Barclay, A. Neil			Dissection of Agonistic and Blocking Effects of CD200 Receptor Antibodies	PLOS ONE			English	Article							ANTITUMOR IMMUNITY; CELL FUNCTION; SIRP FAMILY; MAST-CELLS; PROTEIN; EXPRESSION; SUPPRESSION; ACTIVATION; ALPHA; MICE	The CD200 receptor (CD200R) is present mainly on myeloid cells and gives inhibitory signals when engaged by its ligand CD200. The interaction is currently of therapeutic interest in cancer and inflammation. However functional effects are complicated by the fact that CD200R is itself polymorphic and also a member of a paired receptor family with four closely related gene products in mice called CD200RLa etc. We show that a second allele of CD200R (termed CD200R(2)) that differs in 7 amino acids also binds CD200 but did not react with the widely used CD200R antibody OX110. Biochemical and functional analysis showed that the CD200/CD200R interaction was blocked by the OX131, mAb that recognises both CD200R(1) and CD200R(2), but not by OX110 mAb. Both mAb can give agonistic inhibitory signals but functional analysis shows OX131 mAb also has the potential to block inhibition by preventing the ligand-receptor interaction and hence gives opposing effects. Although OX131 mAb cross-reacts with the activating receptor CD200RLe, it is specific for CD200R in C57BL/6 whilst OX110 mAb cross-reacts on CD200RLe. The results show the importance of the repertoire of paired receptors in strains or individuals and mAb used with implications for paired receptor analysis and therapeutics.	[Akkaya, Munir; Aknin, Marie-Laure; Barclay, A. Neil] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Akkaya, Billur] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	University of Oxford; University of Oxford	Barclay, AN (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	neil.barclay@path.ox.ac.uk	AKKAYA, BILLUR/AAC-6499-2021; Akkaya, Munir/J-3975-2019	AKKAYA, BILLUR/0000-0002-6808-3776; Akkaya, Munir/0000-0002-9949-9424	Medical Research Council [G9826026]; MRC [G9826026] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was supported by the Medical Research Council (ref G9826026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkaya M, 2013, EUR J IMMUNOL, V43, P303, DOI 10.1002/eji.201242896; Akkaya M, 2010, IMMUNOGENETICS, V62, P15, DOI 10.1007/s00251-009-0415-6; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Boudakov I, 2007, TRANSPLANTATION, V84, P251, DOI 10.1097/01.tp.0000269795.04592.cc; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Cantor AB, 2008, J EXP MED, V205, P611, DOI 10.1084/jem.20070544; Carter PJ, 2011, EXP CELL RES, V317, P1261, DOI 10.1016/j.yexcr.2011.02.013; Caserta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035466; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Cherwinski HM, 2005, J IMMUNOL, V174, P1348, DOI 10.4049/jimmunol.174.3.1348; Clarkson NG, 2009, J BIOL CHEM, V284, P24725, DOI 10.1074/jbc.M109.028209; Coles SJ, 2011, LEUKEMIA, V25, P792, DOI 10.1038/leu.2011.1; Dyer KD, 2007, J IMMUNOL, V179, P1693, DOI 10.4049/jimmunol.179.3.1693; Gorczynski R, 2004, J IMMUNOL, V172, P7744, DOI 10.4049/jimmunol.172.12.7744; Gorczynski RM, 2002, CLIN IMMUNOL, V104, P256, DOI 10.1006/clim.2002.5232; Hatherley D, 2005, J IMMUNOL, V175, P2469, DOI 10.4049/jimmunol.175.4.2469; Jiang L, 2010, IMMUNOLOGY, V129, P55, DOI 10.1111/j.1365-2567.2009.03153.x; Jiang L, 2009, EUR J IMMUNOL, V39, P1167, DOI 10.1002/eji.200839188; Kojima T, 2007, J IMMUNOL, V179, P7093, DOI 10.4049/jimmunol.179.10.7093; Kretz-Rommel A, 2008, EXPERT OPIN BIOL TH, V8, P5, DOI 10.1517/14712598.8.1.5; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; MCGEOCH DJ, 1995, J MOL BIOL, V247, P443, DOI 10.1006/jmbi.1995.0152; Melcher A, 1999, CANCER RES, V59, P2802; Mihrshahi R, 2010, J IMMUNOL, V185, P7216, DOI 10.4049/jimmunol.1002858; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mond JJ, 2003, CURR PROTOCOLS IMMUN; ORTALDO JR, 1986, J EXP MED, V164, P1193, DOI 10.1084/jem.164.4.1193; Pallasch CP, 2009, LEUKEMIA RES, V33, P460, DOI 10.1016/j.leukres.2008.08.021; Reichlin A, 1998, IMMUNOL CELL BIOL, V76, P143, DOI 10.1046/j.1440-1711.1998.00726.x; Rygiel TP, 2012, CURR OPIN IMMUNOL; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Swift S, 2001, CURR PROTOC IMMUNOL; Tomlinson DC, 2005, CANCER RES, V65, P10441, DOI 10.1158/0008-5472.CAN-05-1718; Torrero MN, 2009, CLIN EXP ALLERGY, V39, P361, DOI 10.1111/j.1365-2222.2008.03154.x; Voehringer D, 2004, J BIOL CHEM, V279, P54117, DOI 10.1074/jbc.M406997200; Waldmann Herman, 2001, Current Opinion in Pharmacology, V1, P392, DOI 10.1016/S1471-4892(01)00068-6; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	45	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63325	10.1371/journal.pone.0063325	http://dx.doi.org/10.1371/journal.pone.0063325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691022	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400050
J	Stevens, J; Spang, A				Stevens, Julia; Spang, Anne			N-Glycosylation Is Required for Secretion and Mitosis in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; CELL-DEATH; PROTEINS; OLIGOSACCHARYLTRANSFERASE; INTERFERENCE; DYNAMICS; ISOFORMS; EMBRYOS	N-glycosylation of proteins is an essential process, and N-glucans serve as important beacons in protein folding and ER associated degradation. More importantly, N-glycosylation increases the structural repertoire of proteins because the addition of the N-glucan on proteins will serve as a base for further sugar additions in the Golgi apparatus, and hence complex three-dimensional structures can be build. N-glycosylation is mediated by the ER-resident OST complex, which is essential throughout eukaryotes. Partial knockdown of conserved OST complex members, such as C. elegans RIBO-1, led to an embryonic lethal phenotype. Although the ER morphology was not grossly altered in ribo-1(RNAi) oocytes and embryos, secretion of yolk and of the yolk receptor RME-2 was perturbed in those worms. Perhaps as a consequence of reduced arrival of N-glycosylated proteins at the plasma membrane, cytokinesis occurred less efficiently leading to multinuclear cells. Unexpectedly, we detected a chromosome segregation defect in ribo-1(RNAi) embryos suggesting an essential role of at least one N-glycosylated protein in metaphase-anaphase transition.	[Stevens, Julia; Spang, Anne] Univ Basel, Biozentrum, Basel, Switzerland	University of Basel	Spang, A (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	anne.spang@unibas.ch	Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019	Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203	Max Planck Society; University of Basel; Swiss National Science Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding provided by the Max Planck Society, University of Basel, The Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSON DG, 1982, CHROMOSOMA, V86, P409, DOI 10.1007/BF00292267; Badtke M, 2012, BREAST CANCER RES TR, V131, P75, DOI 10.1007/s10549-011-1399-0; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; BRENNER S, 1974, GENETICS, V77, P71; Edgar LG, 2012, METHOD CELL BIOL, V107, P153, DOI 10.1016/B978-0-12-394620-1.00005-9; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Parry H, 2005, J CELL BIOL, V171, P47, DOI 10.1083/jcb.200503139; Poteryaev D, 2005, MOL BIOL CELL, V16, P2139, DOI 10.1091/mbc.E04-08-0726; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Praitis V, 2001, GENETICS, V157, P1217; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schmutz C, 2005, EUR J CELL BIOL, V84, P75, DOI 10.1016/j.ejcb.2004.10.004; Schmutz C, 2007, DEVELOPMENT, V134, P3495, DOI 10.1242/dev.000802; SHARROCK WJ, 1983, DEV BIOL, V96, P182, DOI 10.1016/0012-1606(83)90321-4; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Trombetta ES, 1998, CURR OPIN STRUC BIOL, V8, P587, DOI 10.1016/S0959-440X(98)80148-6; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729	29	8	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63687	10.1371/journal.pone.0063687	http://dx.doi.org/10.1371/journal.pone.0063687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691084	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000319107400073
J	Choi, EJ; Kim, YH; Choe, SW; Tak, YG; Garrido-Martin, EM; Chang, M; Lee, YJ; Oh, SP				Choi, Eun-Jung; Kim, Yong Hwan; Choe, Se-woon; Tak, Yu Gyoung; Garrido-Martin, Eva M.; Chang, Myron; Lee, Young Jae; Oh, S. Paul			Enhanced Responses to Angiogenic Cues Underlie the Pathogenesis of Hereditary Hemorrhagic Telangiectasia 2	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE-1; ENDOTHELIAL-CELL PROLIFERATION; GROWTH-FACTOR-BETA; TGF-BETA; SIGNAL-TRANSDUCTION; REGULATORY REGION; TUMOR-GROWTH; I RECEPTORS; 1 ALK1; ACTIVIN	Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic vascular disease in which arteriovenous malformations (AVMs) manifest in skin and multiple visceral organs. HHT is caused by heterozygous mutations in endoglin (ENG), activin receptor-like kinase 1 (ALK1), or SMAD4. ALK1 regulates angiogenesis, but the precise function of ALK1 in endothelial cells (ECs) remains elusive. Since most blood vessels of HHT patients do not produce pathological vascular lesions, ALK1 heterozygous ECs may be normal unless additional genetic or environmental stresses are imposed. To investigate the cellular and biochemical phenotypes of Alk1-null versus Alk1-heterozygous ECs, we have generated pulmonary EC lines in which a genotype switch from the Alk1-conditional allele (Alk1(2f)) to the Alk1-null allele (Alk1(1f)) can be induced by tamoxifen treatment. Alk1-null (1 f/1 f) ECs displayed increased migratory properties in vitro in response to bFGF compared with Alk1-het (2 f/1 f) ECs. The 1 f/1 f-ECs formed a denser and more persistent tubular network as compared with their parental 2 f/1 f-ECs. Interestingly, the response to BMP-9 on SMAD1/5 phosphorylation was impaired in both 2 f/1 f- and 1 f/1 f-ECs at a comparable manner, suggesting that other factors in addition to SMADs may play a crucial role for enhanced angiogenic activity in 1 f/1 f-ECs. We also demonstrated in vivo that Alk1-deficient ECs exhibited high migratory and invasive properties. Taken together, these data suggest that enhanced responses to angiogenic cues in ALK1-deficient ECs underlie the pathogenesis of HHT2.	[Choi, Eun-Jung; Kim, Yong Hwan; Choe, Se-woon; Garrido-Martin, Eva M.; Lee, Young Jae; Oh, S. Paul] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA; [Tak, Yu Gyoung; Lee, Young Jae; Oh, S. Paul] Gachon Univ, World Class Univ Program, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Chang, Myron] Univ Florida, Dept Biostat, Gainesville, FL USA	State University System of Florida; University of Florida; Gachon University; State University System of Florida; University of Florida	Oh, SP (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA.	ohp@ufl.edu	Garrido Martín, Eva María/HHM-3287-2022; Kim, Yong Hwan/AAL-8113-2021; Martin, Eva Maria Garrido/A-9497-2017	Garrido Martín, Eva María/0000-0002-8094-2668; Kim, Yong Hwan/0000-0003-1244-4269; Martin, Eva Maria Garrido/0000-0002-8094-2668; Choe, Se-woon/0000-0002-7298-4147; Lee, Young Jae/0000-0002-3841-1994	National Heart, Lung, and Blood Institute [HL64024]; American Heart Association; World Class University (WCU by Korean Ministry of Education, Science and Technology); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064024] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); World Class University (WCU by Korean Ministry of Education, Science and Technology); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute (HL64024) to S.P.O., American Heart Association predoctoral fellowship to Y. H. K., American Heart Association postdoctoral fellowship to E. M. G. M., and in part by World Class University (WCU by Korean Ministry of Education, Science and Technology) to S.P.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; Bayrak-Toydemir P, 2006, AM J MED GENET A, V140A, P2155, DOI 10.1002/ajmg.a.31450; Bourdeau A, 2000, AM J PATHOL, V156, P911, DOI 10.1016/S0002-9440(10)64960-7; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Chang H, 2001, MOL CELL ENDOCRINOL, V180, P39, DOI 10.1016/S0303-7207(01)00513-5; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; Cole SG, 2005, J MED GENET, V42, P577, DOI 10.1136/jmg.2004.028712; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; Dakeishi M, 2002, HUM MUTAT, V19, P140, DOI 10.1002/humu.10026; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, J CELL PHYSIOL, V213, P484, DOI 10.1002/jcp.21126; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hao Q, 2010, STROKE, V41, pE264; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kim JH, 2012, ANGIOGENESIS, V15, P497, DOI 10.1007/s10456-012-9277-x; Kjeldsen AD, 1999, J INTERN MED, V245, P31, DOI 10.1046/j.1365-2796.1999.00398.x; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lednicky JA, 1997, J GEN VIROL, V78, P1697, DOI 10.1099/0022-1317-78-7-1697; Lee NY, 2012, MOL BIOL CELL, V23, P2412, DOI 10.1091/mbc.E11-12-0993; Lux A, 1999, J BIOL CHEM, V274, P9984, DOI 10.1074/jbc.274.15.9984; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; Mallet C, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0494; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Park SO, 2009, J CLIN INVEST, V119, P3487, DOI 10.1172/JCI39482; PASSANITI A, 1992, LAB INVEST, V67, P519; Pece-Barbara N, 1999, HUM MOL GENET, V8, P2171, DOI 10.1093/hmg/8.12.2171; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Ray BN, 2010, CARCINOGENESIS, V31, P435, DOI 10.1093/carcin/bgp327; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Roman BL, 2002, DEVELOPMENT, V129, P3009; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Seki T, 2004, CIRC RES, V94, pE72, DOI 10.1161/01.RES.0000127048.81744.31; Seki T, 2003, CIRC RES, V93, P682, DOI 10.1161/01.RES.0000095246.40391.3B; Shao ES, 2009, BLOOD, V114, P2197, DOI 10.1182/blood-2009-01-199166; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; Stewart AR, 1998, J NEUROVIROL, V4, P182; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; van Meeteren LA, 2012, J BIOL CHEM, V287, P18551, DOI 10.1074/jbc.M111.338103; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Walker EJ, 2011, ANN NEUROL, V69, P954, DOI 10.1002/ana.22348; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	60	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63138	10.1371/journal.pone.0063138	http://dx.doi.org/10.1371/journal.pone.0063138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675457	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400025
J	Penha, FM; Pons, M; Costa, EF; Barros, NMT; Rodrigues, EB; Cardoso, EB; Dib, E; Maia, M; Marin-Castano, ME; Farah, ME				Penha, Fernando M.; Pons, Marianne; Costa, Elaine Fiod; Tenorio Barros, Nilana Meza; Rodrigues, Eduardo B.; Cardoso, Emmerson Badaro; Dib, Eduardo; Maia, Mauricio; Marin-Castano, Maria E.; Farah, Michel Eid			Retinal Pigmented Epithelial Cells Cytotoxicity and Apoptosis through Activation of the Mitochondrial Intrinsic Pathway: Role Of Indocyanine Green, Brilliant Blue and Implications for Chromovitrectomy	PLOS ONE			English	Article							INTERNAL LIMITING MEMBRANE; IDIOPATHIC MACULAR HOLE; TRYPAN BLUE; CYTOCHROME-C; EPIRETINAL MEMBRANE; VITAL DYES; SUBRETINAL INJECTION; INTRAOCULAR SURGERY; CLINICAL-TRIAL; METHYL BLUE	Purpose: To investigate the in vitro effect of four vital dyes on toxicity and apoptosis in a human retinal pigment epithelial (RPE) cell line. Methods: ARPE-19 cells were exposed to brilliant blue (BriB), methyl blue (MetB), acid violet (AcV) and indocyanine green (ICG). Balanced salt solution was used as control. Five different concentrations of each dye (1, 0.5, 0.25, 0.05 and 0.005 mg/mL) and two exposure times (3 and 30 min) were tested. Cell viability was determined by cell count and MTS assay and cell toxicity by LDH assay. Real-time PCR and Western blotting were used to access the apoptosis process. Results: ICG significantly reduced cell viability after 3 minutes of exposure at all concentrations (p < 0.01). BriB was safe at concentrations up to 0.25 mg/mL and MetB at concentrations up to 0.5 mg/mL, while AcV was safe up to 0.05 mg/ml, after 3 minutes of exposure. Toxicity was higher, when the cells were treated for 30 minutes. Expression of Bax, cytochrome c and caspase-9 was upregulated at the mRNA and protein level after ICG exposure, while Bcl-2 was downregulated. AcV and MetB were similar to control. However, BriB resulted in upregulation of Bcl-2, an antiapoptotic protein. Conclusions: The safest dye used on RPE cells was MetB followed by BriB and AcV. ICG was toxic at all concentrations and exposure times tested. Moreover, ICG was the only dye that induced apoptosis in ARPE-19 cells. BriB significantly increased Bcl-2 protein levels, which might protect against the apoptosis process.	[Penha, Fernando M.; Costa, Elaine Fiod; Tenorio Barros, Nilana Meza; Cardoso, Emmerson Badaro; Dib, Eduardo; Maia, Mauricio; Farah, Michel Eid] Univ Fed Sao Paulo, Inst Visao IPEPO, Dept Oftalmol, Sao Paulo, Brazil; [Pons, Marianne; Marin-Castano, Maria E.] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA	Universidade Federal de Sao Paulo (UNIFESP); Bascom Palmer Eye Institute; University of Miami	Penha, FM (corresponding author), Univ Fed Sao Paulo, Inst Visao IPEPO, Dept Oftalmol, Sao Paulo, Brazil.	penhaepm@yahoo.com.br; mcastano@med.miami.edu	Maia, Mauricio/Z-1042-2019; Farah, Michel Eid E/F-3285-2012; Maia, Mauricio/I-5892-2015; Barros, Nilana/E-2589-2012	Maia, Mauricio/0000-0002-7034-8091; Farah, Michel Eid E/0000-0001-5951-0193; Maia, Mauricio/0000-0002-7034-8091; Buchele Rodrigues, Eduardo/0000-0002-4224-0921	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); National Institutes of Health Center [P30EY014801]; Research to Prevent Blindness; Department of Defense (DOD) [W81XWH-09-1-0675]; NATIONAL EYE INSTITUTE [P30EY014801] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Department of Defense (DOD)(United States Department of Defense); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), National Institutes of Health Center Core Grant P30EY014801, Research to Prevent Blindness Unrestricted Grant, and Department of Defense (DOD-grant#W81XWH-09-1-0675). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaiya S, 2011, RETINA-J RET VIT DIS, V31, P1128, DOI 10.1097/IAE.0b013e3181fe543a; Beutel J, 2007, ARCH OPHTHALMOL-CHIC, V125, P326, DOI 10.1001/archopht.125.3.326; Burk SE, 2000, OPHTHALMOLOGY, V107, P2010, DOI 10.1016/S0161-6420(00)00375-4; Christensen UC, 2009, BRIT J OPHTHALMOL, V93, P1005, DOI 10.1136/bjo.2008.151266; Costa EF, 2013, AM J OPHTHALMOL, V155, P705, DOI 10.1016/j.ajo.2012.10.004; Enaida Hiroshi, 2008, Dev Ophthalmol, V42, P115, DOI 10.1159/000138989; Feron EJ, 2002, ARCH OPHTHALMOL-CHIC, V120, P141; Haritoglou C, 2004, RETINA-J RET VIT DIS, V24, P582, DOI 10.1097/00006982-200408000-00012; Haritoglou C, 2009, RETINA-J RET VIT DIS, V29, P1266, DOI 10.1097/IAE.0b013e3181b8626f; Hillenkamp J, 2007, GRAEF ARCH CLIN EXP, V245, P973, DOI 10.1007/s00417-006-0485-1; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Jackson TL, 2004, INVEST OPHTH VIS SCI, V45, P2778, DOI 10.1167/iovs.04-0320; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Li K, 2003, BRIT J OPHTHALMOL, V87, P216, DOI 10.1136/bjo.87.2.216; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luke M, 2008, GRAEF ARCH CLIN EXP, V246, P817, DOI 10.1007/s00417-007-0761-8; Maia M, 2004, RETINA-J RET VIT DIS, V24, P157, DOI 10.1097/00006982-200402000-00024; Maia M, 2004, RETINA-J RET VIT DIS, V24, P69, DOI 10.1097/00006982-200402000-00011; Maia M, 2004, RETINA-J RET VIT DIS, V24, P80, DOI 10.1097/00006982-200402000-00012; Maia M, 2009, BRIT J OPHTHALMOL, V93, P1687, DOI 10.1136/bjo.2008.151597; Maia M, 2007, CURR EYE RES, V32, P309, DOI 10.1080/02713680701199377; Meyer CH, 2004, AM J OPHTHALMOL, V137, P207, DOI 10.1016/j.ajo.2003.09.014; NACHLAS MM, 1960, ANAL BIOCHEM, V1, P317, DOI 10.1016/0003-2697(60)90029-4; Narayanan R, 2005, INVEST OPHTH VIS SCI, V46, P304, DOI 10.1167/iovs.04-0703; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Parone PA, 2002, BIOCHIMIE, V84, P105, DOI 10.1016/S0300-9084(02)01380-9; Penha FM, 2008, J OCUL PHARMACOL TH, V24, P52, DOI 10.1089/jop.2007.0047; Penha FM, 2007, OPHTHALMOLOGY, V114, P899, DOI 10.1016/j.ophtha.2006.09.028; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rodrigues EB, 2010, AM J OPHTHALMOL, V149, P265, DOI 10.1016/j.ajo.2009.08.020; Rodrigues EB, 2009, SURV OPHTHALMOL, V54, P576, DOI 10.1016/j.survophthal.2009.04.011; Rodrigues EB, 2009, RETINA-J RET VIT DIS, V29, P497, DOI 10.1097/IAE.0b013e318196b1ad; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Sayanagi K, 2007, AM J OPHTHALMOL; Sayanagi K, 2007, BRIT J OPHTHALMOL, V91, P939, DOI 10.1136/bjo.2006.108746; Smiddy W E, 1996, Bull Soc Belge Ophtalmol, V262, P31; Stanescu-Segall D, 2009, EYE, V23, P504, DOI 10.1038/eye.2008.249; Thaler S, 2009, RETINA-J RET VIT DIS, V29, P1257, DOI 10.1097/IAE.0b013e3181b8615b; Vaux DL, 1997, CELL, V90, P389, DOI 10.1016/S0092-8674(00)80497-3; Vote BJ, 2004, RETINA-J RET VIT DIS, V24, P736, DOI 10.1097/00006982-200410000-00008; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoon HS, 1996, AM J OPHTHALMOL, V122, P67, DOI 10.1016/S0002-9394(14)71965-8; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	46	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e64094	10.1371/journal.pone.0064094	http://dx.doi.org/10.1371/journal.pone.0064094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675521	gold, Green Published, Green Submitted			2022-12-25	WOS:000318852400060
J	Davis, FM; Azimi, I; Faville, RA; Peters, AA; Jalink, K; Putney, JW; Goodhill, GJ; Thompson, EW; Roberts-Thomson, SJ; Monteith, GR				Davis, F. M.; Azimi, I.; Faville, R. A.; Peters, A. A.; Jalink, K.; Putney, J. W., Jr.; Goodhill, G. J.; Thompson, E. W.; Roberts-Thomson, S. J.; Monteith, G. R.			Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent	ONCOGENE			English	Article						epithelial-mesenchymal transition; calcium; vimentin; STAT3; signal transduction; breast cancer	UP-REGULATION; MIGRATION; ACTIVATION; CHANNELS; TRPM7; CONTRIBUTES; PROGRESSION; METASTASIS; EXPRESSION; ROLES	Signals from the tumor microenvironment trigger cancer cells to adopt an invasive phenotype through epithelial-mesenchymal transition (EMT). Relatively little is known regarding key signal transduction pathways that serve as cytosolic bridges between cell surface receptors and nuclear transcription factors to induce EMT. A better understanding of these early EMT events may identify potential targets for the control of metastasis. One rapid intracellular signaling pathway that has not yet been explored during EMT induction is calcium. Here we show that stimuli used to induce EMT produce a transient increase in cytosolic calcium levels in human breast cancer cells. Attenuation of the calcium signal by intracellular calcium chelation significantly reduced epidermal growth factor (EGF)-and hypoxia-induced EMT. Intracellular calcium chelation also inhibited EGF-induced activation of signal transducer and activator of transcription 3 (STAT3), while preserving other signal transduction pathways such as Akt and extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation. To identify calcium-permeable channels that may regulate EMT induction in breast cancer cells, we performed a targeted siRNA-based screen. We found that transient receptor potential-melastatin- like 7 (TRPM7) channel expression regulated EGF-induced STAT3 phosphorylation and expression of the EMT marker vimentin. Although intracellular calcium chelation almost completely blocked the induction of many EMT markers, including vimentin, Twist and N-cadherin, the effect of TRPM7 silencing was specific for vimentin protein expression and STAT3 phosphorylation. These results indicate that TRPM7 is a partial regulator of EMT in breast cancer cells, and that other calcium-permeable ion channels are also involved in calcium-dependent EMT induction. In summary, this work establishes an important role for the intracellular calcium signal in the induction of EMT in human breast cancer cells. Manipulation of calcium-signaling pathways controlling EMT induction in cancer cells may therefore be an important therapeutic strategy for preventing metastases.	[Davis, F. M.; Azimi, I.; Peters, A. A.; Roberts-Thomson, S. J.; Monteith, G. R.] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia; [Faville, R. A.; Goodhill, G. J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Jalink, K.] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Putney, J. W., Jr.] NIEHS, Lab Signal Transduct, Res Triangle Pk, NC 27709 USA; [Goodhill, G. J.] Univ Queensland, Sch Math & Phys, Brisbane, Qld 4072, Australia; [Thompson, E. W.] St Vincents Inst, Fitzroy, Vic, Australia; [Thompson, E. W.] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia	University of Queensland; University of Queensland; Netherlands Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Queensland; St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne	Monteith, GR (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia.	gregm@uq.edu.au	Thompson, Erik/GPK-2067-2022; Azimi, Iman/E-2043-2011; Putney, James W/F-7247-2019; Roberts-Thomson, Sarah/W-5676-2019; Peters, Amelia/AAP-3886-2021; Peters, Amelia A/E-4254-2010; Roberts-Thomson, Sarah J/B-4282-2011; Monteith, Gregory/B-1626-2008; Thompson, Erik W/A-1425-2009; Davis, Felicity M/P-1387-2016	Thompson, Erik/0000-0002-9723-4924; Azimi, Iman/0000-0001-9477-9999; Putney, James W/0000-0002-3379-4789; Roberts-Thomson, Sarah/0000-0001-8202-5786; Peters, Amelia/0000-0002-0700-7817; Roberts-Thomson, Sarah J/0000-0001-8202-5786; Monteith, Gregory/0000-0002-4345-530X; Thompson, Erik W/0000-0002-9723-4924; Davis, Felicity M/0000-0001-9112-118X; Jalink, Kees/0000-0001-7019-3440; Goodhill, Geoffrey/0000-0001-9789-9355	National Health and Medical Research Council (NHMRC) [569645, 1022263]; Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS); NHMRC Biomedical Postgraduate Scholarship [511262]; UQ Postdoctoral Fellowship; National Breast Cancer Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090087] Funding Source: NIH RePORTER; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS); NHMRC Biomedical Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); UQ Postdoctoral Fellowship; National Breast Cancer Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Breast Cancer Foundation	The research was partially supported by the National Health and Medical Research Council (NHMRC; project grants 569645 and 1022263) and the Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS). FD was funded by an NHMRC Biomedical Postgraduate Scholarship (511262), RF was funded by a UQ Postdoctoral Fellowship and EWT was funded in part by the National Breast Cancer Foundation.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Berg T, 2008, CURR OPIN CHEM BIOL, V12, P464, DOI 10.1016/j.cbpa.2008.07.023; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bonnomet A, 2012, ONCOGENE, V31, P3741, DOI 10.1038/onc.2011.540; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; Chubanov V, 2012, BRIT J PHARMACOL, V166, P1357, DOI 10.1111/j.1476-5381.2012.01855.x; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Cook SJ, 1997, J BIOL CHEM, V272, P13309, DOI 10.1074/jbc.272.20.13309; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Davis FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036923; Davis FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023464; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Gao HX, 2011, CELL CALCIUM, V50, P559, DOI 10.1016/j.ceca.2011.09.003; Gilles C, 1999, J CELL SCI, V112, P4615; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Grice DM, 2010, J BIOL CHEM, V285, P37458, DOI 10.1074/jbc.M110.163329; Hu JJ, 2011, BIOCHEM BIOPH RES CO, V411, P786, DOI 10.1016/j.bbrc.2011.07.025; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ji QS, 2000, ONCOGENE, V19, P1853, DOI 10.1038/sj.onc.1203517; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Langeslag M, 2007, J BIOL CHEM, V282, P232, DOI 10.1074/jbc.M605300200; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lundgren K, 2009, BRIT J CANCER, V101, P1769, DOI 10.1038/sj.bjc.6605369; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; Middelbeek J, 2012, CANCER RES, V72, P4250, DOI 10.1158/0008-5472.CAN-11-3863; Monet M, 2010, CANCER RES, V70, P1225, DOI 10.1158/0008-5472.CAN-09-2205; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Ronnov-Jessen L, 2009, TRENDS MOL MED, V15, P5, DOI 10.1016/j.molmed.2008.11.001; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Shabir S, 2008, CELL CALCIUM, V44, P453, DOI 10.1016/j.ceca.2008.02.008; Su LT, 2011, BIOCHEM J, V434, P513, DOI 10.1042/BJ20101678; Suchanek KM, 2002, MOL CARCINOGEN, V34, P165, DOI 10.1002/mc.10061; Takahashi T, 1999, CIRC RES, V85, P884; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vultur A, 2004, ONCOGENE, V23, P2600, DOI 10.1038/sj.onc.1207378; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	53	230	238	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2014	33	18					2307	2316		10.1038/onc.2013.187	http://dx.doi.org/10.1038/onc.2013.187			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AG5ID	23686305	Green Accepted, Green Submitted			2022-12-25	WOS:000335451800004
J	Shirodkar, P; Fenton, AL; Meng, L; Koch, CA				Shirodkar, Purnata; Fenton, Amanda L.; Meng, Li; Koch, C. Anne			Identification and Functional Characterization of a Ku-binding Motif in Aprataxin Polynucleotide Kinase/Phosphatase-like Factor (APLF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNER-SYNDROME PROTEIN; DNA-DAMAGE RESPONSE; STRAND BREAK REPAIR; END; C2ORF13; TRANSLOCATION; TRANSPORT; DYNAMICS; COMPLEX; KINASE	Aprataxin polynucleotide kinase/phosphatase-like factor (APLF) facilitates nonhomologous end joining (NHEJ) and associates with the core NHEJ components XRCC4-DNA ligase IV and Ku. The APLF forkhead-associated (FHA) domain directs interactions with XRCC4, but the APLF-Ku interaction has not been well characterized. Here we describe an evolutionarily conserved amino acid motif within APLF that is required for mediating the physical interaction between APLF and Ku. This APLF Ku-binding motif possesses a similarity to regions identified in other NHEJ factors, WRN and XLF, which also direct interactions with Ku. Indeed, peptides derived from the Ku-binding region of APLF, WRN, or XLF were sufficient to reconstitute the interaction with Ku in vitro. Although APLF is localized predominantly to the nucleus, it does not possess a nuclear localization signal (NLS). Interestingly, the disruption of the APLF-Ku interaction by substituting key residues in the APLF Ku-binding motif was associated with increased relocalization of APLF to the cytoplasm and reduced association with XRCC4, which was rescued by the introduction of an NLS onto APLF. When human cells stably depleted of APLF were reconstituted with APLF Ku-binding mutants, or with an APLF FHA mutant that is known to disrupt interactions with XRCC4, APLF-dependent NHEJ and the retention of APLF at sites of laser-generated DNA damage were impaired. These data suggest functional requirements for Ku and XRCC4 in APLF-dependent NHEJ and a unique role for Ku as a factor required to facilitate the nuclear retention of APLF.	[Shirodkar, Purnata; Fenton, Amanda L.; Meng, Li; Koch, C. Anne] Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Shirodkar, Purnata; Fenton, Amanda L.; Koch, C. Anne] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Koch, C. Anne] Univ Hlth Network, Radiat Med Program, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Koch, CA (corresponding author), Univ Hlth Network, Radiat Med Program, Princess Margaret Canc Ctr, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	anne.koch@rmp.uhn.on.ca			Canadian Institutes of Health Research (CIHR) [MOP-102691]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grant MOP-102691 (to C. A. K.).	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2007, J BIOL CHEM, V282, P19638, DOI 10.1074/jbc.C700060200; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Caldecott KW, 2003, CELL, V112, P7, DOI 10.1016/S0092-8674(02)01247-3; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Comai L, 2004, MECH AGEING DEV, V125, P521, DOI 10.1016/j.mad.2004.06.004; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; Grundy GJ, 2013, EMBO J, V32, P112, DOI 10.1038/emboj.2012.304; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Karmakar P, 2002, NUCLEIC ACIDS RES, V30, P3583, DOI 10.1093/nar/gkf482; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Knudsen NO, 2009, DNA REPAIR, V8, P682, DOI 10.1016/j.dnarep.2009.03.005; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; Koike M, 2002, J RADIAT RES, V43, P223, DOI 10.1269/jrr.43.223; Li BM, 2002, NUCLEIC ACIDS RES, V30, P3653, DOI 10.1093/nar/gkf488; Li BM, 2001, J BIOL CHEM, V276, P9896, DOI 10.1074/jbc.M008575200; Li GY, 2010, P NATL ACAD SCI USA, V107, P9129, DOI 10.1073/pnas.1000556107; Macrae CJ, 2008, DNA REPAIR, V7, P292, DOI 10.1016/j.dnarep.2007.10.008; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Rulten SL, 2008, MOL CELL BIOL, V28, P4620, DOI 10.1128/MCB.02243-07; Rulten SL, 2011, MOL CELL, V41, P33, DOI 10.1016/j.molcel.2010.12.006; Santagati F, 2001, NUCLEIC ACIDS RES, V29, P1574, DOI 10.1093/nar/29.7.1574; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003; Weterings E, 2009, MOL CELL BIOL, V29, P1134, DOI 10.1128/MCB.00971-08; Wu XT, 1996, MOL CELL BIOL, V16, P5186; Yannone SM, 2001, J BIOL CHEM, V276, P38242; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yano K, 2011, FEBS LETT, V585, P841, DOI 10.1016/j.febslet.2011.02.020	38	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19604	19613		10.1074/jbc.M112.440388	http://dx.doi.org/10.1074/jbc.M112.440388			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689425	Green Published, hybrid			2022-12-25	WOS:000321515800026
J	Artyukhin, AB; Yim, JJ; Srinivasan, J; Izrayelit, Y; Bose, N; von Reuss, SH; Jo, Y; Jordan, JM; Baugh, LR; Cheong, M; Sternberg, PW; Avery, L; Schroeder, FC				Artyukhin, Alexander B.; Yim, Joshua J.; Srinivasan, Jagan; Izrayelit, Yevgeniy; Bose, Neelanjan; von Reuss, Stephan H.; Jo, Yeara; Jordan, James M.; Baugh, L. Ryan; Cheong, Micheong; Sternberg, Paul W.; Avery, Leon; Schroeder, Frank C.			Succinylated Octopamine Ascarosides and a New Pathway of Biogenic Amine Metabolism in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHEROMONE; BIOSYNTHESIS; SEROTONIN; BEHAVIOR; REVEALS	The ascarosides, small-molecule signals derived from combinatorial assembly of primary metabolism-derived building blocks, play a central role in Caenorhabditis elegans biology and regulate many aspects of development and behavior in this model organism as well as in other nematodes. Using HPLC-MS/MS-based targeted metabolomics, we identified novel ascarosides incorporating a side chain derived from succinylation of the neurotransmitter octopamine. These compounds, named osas#2, osas#9, and osas#10, are produced predominantly by L1 larvae, where they serve as part of a dispersal signal, whereas these ascarosides are largely absent from the metabolomes of other life stages. Investigating the biogenesis of these octopamine-derived ascarosides, we found that succinylation represents a previously unrecognized pathway of biogenic amine metabolism. At physiological concentrations, the neurotransmitters serotonin, dopamine, and octopamine are converted to a large extent into the corresponding succinates, in addition to the previously described acetates. Chemically, bimodal deactivation of biogenic amines via acetylation and succinylation parallels posttranslational modification of proteins via acetylation and succinylation of L-lysine. Our results reveal a small-molecule connection between neurotransmitter signaling and interorganismal regulation of behavior and suggest that ascaroside biosynthesis is based in part on co-option of degradative biochemical pathways.	[Artyukhin, Alexander B.; Yim, Joshua J.; Izrayelit, Yevgeniy; Bose, Neelanjan; von Reuss, Stephan H.; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA; [Artyukhin, Alexander B.; Yim, Joshua J.; Izrayelit, Yevgeniy; Bose, Neelanjan; von Reuss, Stephan H.; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Artyukhin, Alexander B.; Avery, Leon] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Srinivasan, Jagan; Jo, Yeara; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Srinivasan, Jagan; Jo, Yeara; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jordan, James M.; Baugh, L. Ryan] Duke Univ, Duke Ctr Syst Biol, Dept Biol, Durham, NC 27708 USA	Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; Virginia Commonwealth University; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Duke University	Schroeder, FC (corresponding author), Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA.	schroeder@cornell.edu	Baugh, L. Ryan/GRS-0507-2022; Srinivasan, Jagan/B-6215-2015; Bose, Neelanjan/B-8054-2017	Baugh, L. Ryan/0000-0003-2148-5492; Bose, Neelanjan/0000-0002-3817-4757; Jordan, James/0000-0002-7620-462X; Schroeder, Frank/0000-0002-4420-0237; Yim, Joshua/0000-0002-9999-1566; Srinivasan, Jagan/0000-0001-5449-7938; von Reuss, Stephan/0000-0003-4325-5495; Cheong, Mi Cheong/0000-0002-7604-6203; Jo, Yeara/0000-0002-1340-1968	National Institutes of Health [GM088290, GM008500, DK83593, GM085285]; National Science Foundation [IOS1120206]; Vassar College Mary Landon Sague Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500, R01GM085285, R01GM088290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Vassar College Mary Landon Sague Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM088290 (to F. C. S.), GM008500 (to Y. I.), DK83593 (to L. A.), and GM085285 (to F. C. S. and P. W. S.), and National Science Foundation Grant IOS1120206 (to L. R. B.), as well as the Vassar College Mary Landon Sague Fellowship (to Y. I.).	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Bose N, 2012, ANGEW CHEM INT EDIT, V51, P12438, DOI 10.1002/anie.201206797; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Chase Daniel L, 2007, WormBook, P1; Cho BT, 2002, TETRAHEDRON-ASYMMETR, V13, P1209; Choe A, 2012, P NATL ACAD SCI USA, V109, P20949, DOI 10.1073/pnas.1218302109; Choe A, 2012, CURR BIOL, V22, P772, DOI 10.1016/j.cub.2012.03.024; Deyrup ST, 2011, P NATL ACAD SCI USA, V108, P9753, DOI 10.1073/pnas.1107020108; ERSPAMER V, 1952, NATURE, V169, P375, DOI 10.1038/169375b0; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Harris G, 2010, J NEUROSCI, V30, P7889, DOI 10.1523/JNEUROSCI.0497-10.2010; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Isaac RE, 1996, PARASITOLOGY, V113, pS157, DOI 10.1017/S0031182000077957; ISAAC RE, 1990, MOL BIOCHEM PARASIT, V43, P193, DOI 10.1016/0166-6851(90)90144-B; Izrayelit Y, 2013, ACS CHEM BIOL, V8, P314, DOI 10.1021/cb3004644; Izrayelit Y, 2012, ACS CHEM BIOL, V7, P1321, DOI 10.1021/cb300169c; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Kaplan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038735; Lee BH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000213; Lee I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044720; Lin HN, 2012, ACS CHEM BIOL, V7, P947, DOI 10.1021/cb3001793; Ludewig AH, 2013, P NATL ACAD SCI USA, V110, P5522, DOI 10.1073/pnas.1214467110; Ludewig Andreas H, 2013, WormBook, P1, DOI 10.1895/wormbook.1.155.1; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Srinivasan J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001237	33	51	51	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18778	18783		10.1074/jbc.C113.477000	http://dx.doi.org/10.1074/jbc.C113.477000			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23689506	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000321335800015
J	Danielewski, JA; Garland, SM; McCloskey, J; Hillman, RJ; Tabrizi, SN				Danielewski, Jennifer A.; Garland, Suzanne M.; McCloskey, Jenny; Hillman, Richard J.; Tabrizi, Sepehr N.			Human Papillomavirus Type 6 and 11 Genetic Variants Found in 71 Oral and Anogenital Epithelial Samples from Australia	PLOS ONE			English	Article							RECURRENT RESPIRATORY PAPILLOMATOSIS; HPV VACCINATION PROGRAM; GENITAL WARTS; INTRAEPITHELIAL NEOPLASIA; GENOTYPE PREVALENCE; GENOMIC DIVERSITY; NATURAL-HISTORY; ANAL CARCINOMA; INNO-LIPA; WOMEN	Genetic variation of 49 human papillomavirus (HPV) 6 and 22 HPV11 isolates from recurrent respiratory papillomatosis (RRP) (n = 17), genital warts (n = 43), anal cancer (n = 6) and cervical neoplasia cells (n = 5), was determined by sequencing the long control region (LCR) and the E6 and E7 genes. Comparative analysis of genetic variability was examined to determine whether different disease states resulting from HPV6 or HPV11 infection cluster into distinct variant groups. Sequence variation analysis of HPV6 revealed that isolates cluster into variants within previously described HPV6 lineages, with the majority (65%) clustering to HPV6 sublineage B1 across the three genomic regions examined. Overall 72 HPV6 and 25 HPV11 single nucleotide variations, insertions and deletions were observed within samples examined. In addition, missense alterations were observed in the E6/E7 genes for 6 HPV6 and 5 HPV11 variants. No nucleotide variations were identified in any isolates at the four E2 binding sites for HPV6 or HPV11, nor were any isolates found to be identical to the HPV6 lineage A or HPV11 sublineage A1 reference genomes. Overall, a high degree of sequence conservation was observed between isolates across each of the regions investigated for both HPV6 and HPV11. Genetic variants identified a slight association with HPV6 and anogenital lesions (p = 0.04). This study provides important information on the genetic diversity of circulating HPV 6 and HPV11 variants within the Australian population and supports the observation that the majority of HPV6 isolates cluster to the HPV6 sublineage B1 with anogenital lesions demonstrating an association with this sublineage (p = 0.02). Comparative analysis of Australian isolates for both HPV6 and HPV11 to those from other geographical regions based on the LCR revealed a high degree of sequence similarity throughout the world, confirming previous observations that there are no geographically specific variants for these HPV types.	[Danielewski, Jennifer A.; Garland, Suzanne M.; Tabrizi, Sepehr N.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia; [Danielewski, Jennifer A.; Garland, Suzanne M.; Tabrizi, Sepehr N.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [McCloskey, Jenny] Royal Perth Hosp, Sexual Hlth Serv, Perth, WA, Australia; [McCloskey, Jenny] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Hillman, Richard J.] Univ Sydney, Western Sydney Sexual Hlth Ctr, Sydney, NSW 2006, Australia	Murdoch Children's Research Institute; University of Melbourne; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Sydney	Tabrizi, SN (corresponding author), Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia.	Sepehr.Tabrizi@thewomens.org.au	McCloskey, Jenny/S-4961-2019; Hillman, Richard/AAM-1177-2020	Hillman, Richard/0000-0002-1859-0761	Royal Women's Hospital Departmental funding	Royal Women's Hospital Departmental funding	This study was supported through Royal Women's Hospital Departmental funding. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Awadhi R, 2011, J MED VIROL, V83, P453, DOI 10.1002/jmv.21981; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Burk Robert D, 2011, Acta Dermatovenerol Alp Pannonica Adriat, V20, P113; Chansaenroj J, 2012, ASIAN PAC J CANCER P, V13, P2619, DOI 10.7314/APJCP.2012.13.6.2619; Combrinck CE, 2012, EPIDEMIOL INFECT, V140, P1095, DOI 10.1017/S0950268811001580; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; Dona MG, 2012, J CLIN VIROL; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Doorbar J, 2007, EXPERT OPIN BIOL TH, V7, P677, DOI 10.1517/14712598.7.5.677; Fairley CK, 2009, SEX TRANSM INFECT, V85, P499, DOI 10.1136/sti.2009.037788; Fairley CK, 2010, SEX HEALTH, V7, P325, DOI 10.1071/SH09145; Frisch M, 1999, J NATL CANCER I, V91, P708, DOI 10.1093/jnci/91.8.708; Gabbott M, 1997, J CLIN MICROBIOL, V35, P3098, DOI 10.1128/JCM.35.12.3098-3103.1997; Gall T, 2011, ANTIVIR RES, V92, P356, DOI 10.1016/j.antiviral.2011.09.007; Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071; Gertig DM, 2011, SEX HEALTH, V8, P171, DOI 10.1071/SH10001; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grassmann K, 1996, VIROLOGY, V223, P185, DOI 10.1006/viro.1996.0467; Hartwig S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-30; HEINZEL PA, 1995, J CLIN MICROBIOL, V33, P1746, DOI 10.1128/JCM.33.7.1746-1754.1995; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Insinga RP, 2008, CANCER EPIDEM BIOMAR, V17, P1611, DOI 10.1158/1055-9965.EPI-07-2922; Jin FY, 2011, VACCINE, V29, P2322, DOI 10.1016/j.vaccine.2011.01.015; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kocjan BJ, 2013, J INFECT DIS, V207, P583, DOI 10.1093/infdis/jis733; Kocjan BJ, 2011, INFECT GENET EVOL, V11, P1805, DOI 10.1016/j.meegid.2011.06.022; Kocjan BJ, 2009, VIROLOGY, V391, P274, DOI 10.1016/j.virol.2009.06.030; Komlos KF, 2011, ACTA DERMATOVEN ALP, V20, P141; Komlos KF, 2012, J MED VIROL, V84, P1233, DOI 10.1002/jmv.23318; Kovelman R, 1999, J GEN VIROL, V80, P2445, DOI 10.1099/0022-1317-80-9-2445; Krige D, 1997, VIRUS RES, V49, P187, DOI 10.1016/S0168-1702(97)01469-X; LEHN H, 1984, J GEN VIROL, V65, P2003, DOI 10.1099/0022-1317-65-11-2003; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Machalek DA, 2012, LANCET ONCOL; Maver PJ, 2011, J MED VIROL, V83, P461, DOI 10.1002/jmv.21994; McCloskey JC, 2007, INT J STD AIDS, V18, P538, DOI 10.1258/095646207781439694; Moore EE, 2011, OBSTET GYNECOL, V117, P101, DOI 10.1097/AOG.0b013e3182020704; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; O'Connor M, 1995, HUMAN PAPILLOMAVIRUS, pIII21; ORIEL JD, 1971, BRIT J VENER DIS, V47, P1; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Panotopoulou E, 2007, J MED VIROL, V79, P1898, DOI 10.1002/jmv.21025; Pirotta M, 2009, SEX TRANSM INFECT, V85, P508, DOI 10.1136/sti.2009.037028; Rabah R, 2001, PEDIATR DEVEL PATHOL, V4, P68, DOI 10.1007/s100240010105; Rady PL, 1998, LARYNGOSCOPE, V108, P735, DOI 10.1097/00005537-199805000-00021; Read TRH, 2011, SEX TRANSM INFECT, V87, P544, DOI 10.1136/sextrans-2011-050234; Reidy PM, 2004, LARYNGOSCOPE, V114, P1906, DOI 10.1097/01.mlg.0000147918.81733.49; Rosty C, 2005, ONCOGENE, V24, P7094, DOI 10.1038/sj.onc.1208854; Rozen S, 2000, Methods Mol Biol, V132, P365; Scarbrough Lefebvre C D, 2011, Public Health, V125, P464, DOI 10.1016/j.puhe.2011.01.016; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; Somers GR, 1997, PEDIATR PATHOL LAB M, V17, P53, DOI 10.1080/107710497175029; Stevens MP, 2006, INT J GYNECOL CANCER, V16, P1017, DOI 10.1111/j.1525-1438.2006.00453.x; Stevens MP, 2006, J CLIN MICROBIOL, V44, P2428, DOI 10.1128/JCM.02608-05; Stevens MP, 2009, J MED VIROL, V81, P1283, DOI 10.1002/jmv.21515; Syrjanen S, 2010, APMIS, V118, P494, DOI 10.1111/j.1600-0463.2010.02620.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan SE, 2011, J CLIN MICROBIOL, V49, P3980, DOI 10.1128/JCM.00516-11; Tan SE, 2010, J CLIN MICROBIOL, V48, P1458, DOI 10.1128/JCM.02311-09; Ure AE, 2012, J VIROL, V86, P13790, DOI 10.1128/JVI.01938-12; Wentzensen N, 2012, LANCET ONCOL; Wiatrak BJ, 2004, LARYNGOSCOPE, V114, P1, DOI 10.1097/01.mlg.000148224.83491.0f; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; Wu XL, 2009, J MED VIROL, V81, P693, DOI 10.1002/jmv.21435	66	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63892	10.1371/journal.pone.0063892	http://dx.doi.org/10.1371/journal.pone.0063892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691108	gold, Green Published			2022-12-25	WOS:000319107900063
J	Levesley, J; Steele, L; Taylor, C; Sinha, P; Lawler, SE				Levesley, Jane; Steele, Lynette; Taylor, Claire; Sinha, Priyank; Lawler, Sean E.			ABT-263 Enhances Sensitivity to Metformin and 2-Deoxyglucose in Pediatric Glioma by Promoting Apoptotic Cell Death	PLOS ONE			English	Article							MITOCHONDRIAL GLUCOSE-OXIDATION; C-MYC; CANCER METABOLISM; GRADE GLIOMA; CYCLE ARREST; GROWTH; 2-DEOXY-D-GLUCOSE; GLIOBLASTOMA; MODELS; RADIOTHERAPY	Pediatric high grade glioma is refractory to conventional multimodal treatment, highlighting a need to develop novel efficacious therapies. We investigated tumor metabolism as a potential therapeutic target in a panel of diverse pediatric glioma cell lines (SF188, KNS42, UW479 and RES186) using metformin and 2-deoxyglucose. As a single agent, metformin had little effect on cell viability overall. SF188 cells were highly sensitive to 2-deoxyglucose however, combination of metformin with 2-deoxyglucose significantly reduced cell proliferation compared to either drug alone in all cell lines tested. In addition, the combination of the two agents was associated with a rapid decrease in cellular ATP and subsequent AMPK activation. However, increased cell death was only observed in select cell lines after prolonged exposure to the drug combination and was caspase independent. Anti-apoptotic BCL-2 family proteins have been indicated as mediators of resistance against metabolic stress. Therefore we sought to determine whether pharmacological inhibition of BCL-2/BCL-xL with ABT-263 could potentiate apoptosis in response to these agents. We found that ABT-263 increased sensitivity to 2-deoxyglucose and promoted rapid and extensive cell death in response to the combination of 2-deoxyglucose and metformin. Furthermore, cell death was inhibited by the pan-caspase inhibitor, z-VAD-FMK suggesting that ABT-263 potentiated caspase-dependent cell death in response to 2-deoxyglucose or its combination with metformin. Overall, these data provide support for the concept that targeting metabolic and anti-apoptotic pathways may be an effective therapeutic strategy in pediatric glioma.	[Levesley, Jane; Steele, Lynette; Sinha, Priyank; Lawler, Sean E.] Univ Leeds, St James Univ Hosp, Leeds Inst Mol Med, Translat Neurooncol Grp, Leeds, W Yorkshire, England; [Taylor, Claire] Univ Leeds, St James Univ Hosp, Leeds Inst Mol Med, Genom Facil, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds	Levesley, J (corresponding author), Univ Leeds, St James Univ Hosp, Leeds Inst Mol Med, Translat Neurooncol Grp, Leeds, W Yorkshire, England.	j.levesley@leeds.ac.uk; s.lawler@leeds.ac.uk			Candlelighters (UK) [1045077]; BTRS (Brain Tumour Research and Support across Yorkshire. UK) [1095931]	Candlelighters (UK); BTRS (Brain Tumour Research and Support across Yorkshire. UK)	This work was supported by a grant from Candlelighters (UK registered charity no. 1045077) and BTRS (Brain Tumour Research and Support across Yorkshire. UK Registered Charity no. 1095931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Blandino G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1859; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Dang CV, 2011, J MOL MED, V89, P205, DOI 10.1007/s00109-011-0730-x; Dwarakanath BS, 2009, J CANCER RES THER, V5, P21, DOI 10.4103/0973-1482.55136; El Mjiyad N, 2011, ONCOGENE, V30, P253, DOI 10.1038/onc.2010.466; Hargrave D, 2009, BRIT J NEUROSURG, V23, P351, DOI 10.1080/02688690903158809; Isakovic A, 2007, CELL MOL LIFE SCI, V64, P1290, DOI 10.1007/s00018-007-7080-4; Jones C, 2012, NAT REV CLIN ONCOL, V9, P400, DOI 10.1038/nrclinonc.2012.87; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; MacDonald TJ, 2011, NEURO-ONCOLOGY, V13, P1049, DOI 10.1093/neuonc/nor092; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Mischel PS, 2012, CELL METAB, V15, P789, DOI 10.1016/j.cmet.2012.05.004; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Munoz-Pinedo C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.123; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Rattan R, 2011, J CELL MOL MED, V15, P166, DOI 10.1111/j.1582-4934.2009.00954.x; Robinson GL, 2012, ONCOGENE; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Sanders RP, 2007, PEDIATR BLOOD CANCER, V49, P888, DOI 10.1002/pbc.21272; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Soritau O, 2011, J BUON, V16, P282; Tagscherer KE, 2008, ONCOGENE, V27, P6646, DOI 10.1038/onc.2008.259; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; TRENT J, 1986, P NATL ACAD SCI USA, V83, P470, DOI 10.1073/pnas.83.2.470; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yamaguchi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024102; Zagorodna O, 2012, ONCOGENE, V31, P2738, DOI 10.1038/onc.2011.454	38	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64051	10.1371/journal.pone.0064051	http://dx.doi.org/10.1371/journal.pone.0064051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691145	gold, Green Submitted, Green Published			2022-12-25	WOS:000319107900075
J	Sung, B; Prasad, S; Yadav, VR; Gupta, SC; Reuter, S; Yamamoto, N; Murakami, A; Aggarwal, BB				Sung, Bokyung; Prasad, Sahdeo; Yadav, Vivek R.; Gupta, Subash C.; Reuter, Simone; Yamamoto, Norio; Murakami, Akira; Aggarwal, Bharat B.			RANKL Signaling and Osteoclastogenesis Is Negatively Regulated by Cardamonin	PLOS ONE			English	Article							NF-KAPPA-B; METASTATIC BONE-DISEASE; RECEPTOR ACTIVATOR; CELL-PROLIFERATION; CLINICAL-FEATURES; KB ACTIVATION; DIFFERENTIATION; KINASE; LIGAND; INHIBITOR	Bone loss/resorption or osteoporosis is a disease that is accelerated with aging and age-associated chronic diseases such as cancer. Bone loss has been linked with human multiple myeloma, breast cancer, and prostate cancer and is usually treated with bisphosphonates, and recently approved denosumab, an antibody against receptor activator of NF-kappa B ligand (RANKL). Because of the numerous side effects of the currently available drugs, the search continues for safe and effective therapies for bone loss. RANKL, a member of the TNF superfamily, has emerged as a major mediator of bone loss via activation of osteoclastogenesis. We have identified cardamonin, a chalcone isolated from Alpinia katsumadai Hayata that can affect osteoclastogenesis through modulation of RANKL. We found that treatment of monocytes with cardamonin suppressed RANKL-induced NF-kappa B activation and this suppression correlated with inhibition of I kappa B alpha kinase and of phosphorylation and degradation of I kappa B alpha, an inhibitor of NF-kappa B. Furthermore, cardamonin also downregulated RANKL-induced phosphorylation of MAPK including ERK and p38 MAPK. Cardamonin suppressed the RANKL-induced differentiation of monocytes to osteoclasts in a dose-dependent and time-dependent manner. We also found that an inhibitor of NF-kappa B essential modulator (NEMO) blocked RANKL-induced osteoclastogenesis, indicating a direct link with NF-kappa B. Finally, osteoclastogenesis induced by human breast cancer cells or human multiple myeloma cells were completely suppressed by cardamonin. Collectively, our results indicate that cardamonin suppresses osteoclastogenesis induced by RANKL and tumor cells by suppressing activation of the NF-kappa B and MAPK pathway.	[Sung, Bokyung; Prasad, Sahdeo; Yadav, Vivek R.; Gupta, Subash C.; Reuter, Simone; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA; [Yamamoto, Norio] House Wellness Foods Corp, Food Sci Res Ctr, Itami, Hyogo, Japan; [Murakami, Akira] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan	University of Texas System; UTMD Anderson Cancer Center; Kyoto University	Aggarwal, BB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Gupta, Subash/AAF-2563-2019; Sung, Bokyung/AAX-5697-2021; Aggarwal, Bharat B/G-3388-2013	Gupta, Subash/0000-0002-0418-1940; Yamamoto, Norio/0000-0002-0622-5441				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Bharti AC, 2004, J IMMUNOL, V172, P5940, DOI 10.4049/jimmunol.172.10.5940; Bheemasankara Rao C, 1976, Planta Med, V29, P391, DOI 10.1055/s-0028-1097682; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Carlin Bruce I., 2000, Cancer, V88, P2989, DOI 10.1002/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.3.CO;2-H; Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200; Chikatsu N, 2000, BIOCHEM BIOPH RES CO, V267, P632, DOI 10.1006/bbrc.1999.2008; Chow YL, 2012, INT IMMUNOPHARMACOL, V12, P657, DOI 10.1016/j.intimp.2012.01.009; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; HANAZAWA S, 1987, CALCIFIED TISSUE INT, V41, P31, DOI 10.1007/BF02555128; Hatziieremia S, 2006, BRIT J PHARMACOL, V149, P188, DOI 10.1038/sj.bjp.0706856; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; ISHIMI Y, 1990, J IMMUNOL, V145, P3297; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Jourdan M, 2007, BRIT J HAEMATOL, V138, P160, DOI 10.1111/j.1365-2141.2007.06629.x; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kim MS, 2006, J CELL BIOCHEM, V97, P512, DOI 10.1002/jcb.20649; Kishida Y, 2007, CLIN CANCER RES, V13, P59, DOI 10.1158/1078-0432.CCR-06-1559; Kobayashi Y, 2005, J BIOL CHEM, V280, P11395, DOI 10.1074/jbc.M411189200; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kyle RA, 2007, J CLIN ONCOL, V25, P2464, DOI 10.1200/JCO.2007.12.1269; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lai FPL, 2004, BRIT J HAEMATOL, V126, P192, DOI 10.1111/j.1365-2141.2004.05018.x; MARIE PJ, 1995, CALCIFIED TISSUE INT, V56, pS13, DOI 10.1007/BF03354642; Martin TJ, 2001, TRENDS ENDOCRIN MET, V12, P2, DOI 10.1016/S1043-2760(00)00351-9; Miyamoto Takeshi, 2003, Keio J Med, V52, P1; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Onishi T, 2010, NAT REV CLIN ONCOL, V7, P641, DOI 10.1038/nrclinonc.2010.134; Reuter S, 2010, MOL CANCER RES, V8, P1425, DOI 10.1158/1541-7786.MCR-10-0141; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67; Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512; Takahashi A, 2011, LIFE SCI, V89, P337, DOI 10.1016/j.lfs.2011.06.027; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200; Xu JK, 2009, CYTOKINE GROWTH F R, V20, P7, DOI 10.1016/j.cytogfr.2008.11.007; Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	44	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64118	10.1371/journal.pone.0064118	http://dx.doi.org/10.1371/journal.pone.0064118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691159	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900080
J	Huang, YP; Wang, YH; Pan, SL				Huang, Ya-Ping; Wang, Yen-Ho; Pan, Shin-Liang			Increased Risk of Ischemic Heart Disease in Young Patients with Newly Diagnosed Ankylosing Spondylitis - A Population-Based Longitudinal Follow-Up Study	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PSORIATIC-ARTHRITIS; NORTHERN NORWAY; INFLAMMATION; ATHEROSCLEROSIS; MANIFESTATIONS; PREVALENCE	Background: Prospective data is sparse on the association between ischemic heart disease (IHD) and ankylosing spondylitis (AS) in the young. The purpose of this population-based, age- and sex-matched follow-up study was to investigate the risk of IHD in young patients with newly diagnosed AS. Methods: A total of 4794 persons aged 18 to 45 years with at least two ambulatory visits in 2001 with the principal diagnosis of AS were enrolled in the AS group. The non-AS group consisted of 23970 age-and sex-matched, randomly sampled subjects without AS. The three-year IHD-free survival rate and cumulative incidence of IHD were calculated using the Kaplan-Meier method. The Cox proportional hazards regression model was used to estimate the hazard ratio of IHD after controlling for demographic and cardiovascular co-morbidities. Results: During follow-up, 70 patients in the AS group and 253 subjects in the non-AS group developed IHD. The cumulative incidence rate of IHD over time was higher in the AS group than the non-AS group. The crude hazard ratio of IHD for the AS group was 1.47 (95% CI, 1.13 to 1.92; p = 0.0043) and the adjusted hazard ratio after controlling for demographic characteristics and comorbid medical disorders was 1.47 (95% CI, 1.13 to 1.92; p = 0.0045). Conclusions: This study showed an increased risk of developing IHD in young patients with newly diagnosed AS.	[Huang, Ya-Ping] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Phys Med & Rehabil, Yunlin, Taiwan; [Wang, Yen-Ho; Pan, Shin-Liang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Wang, Yen-Ho; Pan, Shin-Liang] Natl Taiwan Univ, Coll Med, Dept Phys Med & Rehabil, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Pan, SL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	panslcb@gmail.com		PAN, SHIN-LIANG/0000-0001-6451-4666	Department of Health, Executive Yuan, Republic of China [DOH93-TD-M-113-030, DOH94-TD-M-113-004, DOH95-TD-M-113-002]; National Science Council, Executive Yuan, Republic of China [NSC 101-2314-B-002-088]	Department of Health, Executive Yuan, Republic of China; National Science Council, Executive Yuan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants DOH93-TD-M-113-030, DOH94-TD-M-113-004, and DOH95-TD-M-113-002 from the Department of Health, Executive Yuan, Republic of China, and grant NSC 101-2314-B-002-088 from the National Science Council, Executive Yuan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakland G, 2005, ARTHRIT RHEUM-ARTHR, V53, P850, DOI 10.1002/art.21577; Bodnar N, 2011, J RHEUMATOL, V38, P723, DOI 10.3899/jrheum.100668; BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499, DOI 10.1002/art.1780380407; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Bremander A, 2011, ARTHRIT CARE RES, V63, P550, DOI 10.1002/acr.20408; Brophy S, 2012, SEMIN ARTHRITIS RHEU, V42, P140, DOI 10.1016/j.semarthrit.2012.02.008; Caliskan M, 2008, ATHEROSCLEROSIS, V196, P306, DOI 10.1016/j.atherosclerosis.2006.11.003; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chou CT, 2003, J RHEUMATOL, V30, P321; Divecha H, 2005, CLIN SCI, V109, P171, DOI 10.1042/CS20040326; Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4; Gonzalez-Juanatey C, 2009, MEDICINE, V88, P358, DOI 10.1097/MD.0b013e3181c10773; GRAN JT, 1985, ANN RHEUM DIS, V44, P359, DOI 10.1136/ard.44.6.359; Grundtman C, 2010, ARTHRITIS RHEUM-US, V62, P667, DOI 10.1002/art.27264; Hamdi W, 2012, J RHEUMATOL, V39, P322, DOI 10.3899/jrheum.110792; Han CL, 2006, J RHEUMATOL, V33, P2167; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hermann M, 2007, ANN MED, V39, P18, DOI 10.1080/07853890601073445; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Lange U, 2000, Eur J Med Res, V5, P507; Lautermann D, 2002, CLIN EXP RHEUMATOL, V20, pS11; LEHTINEN K, 1993, ANN RHEUM DIS, V52, P174, DOI 10.1136/ard.52.3.174; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Mathieu S, 2011, ARTHRIT CARE RES, V63, P557, DOI 10.1002/acr.20364; Mathieu S, 2010, JOINT BONE SPINE, V77, P542, DOI 10.1016/j.jbspin.2010.05.001; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peters MJL, 2010, ANN RHEUM DIS, V69, P579, DOI 10.1136/ard.2009.110593; Peters MJL, 2010, J RHEUMATOL, V37, P161, DOI 10.3899/jrheum.090667; Peters MJ, 2004, SEMIN ARTHRITIS RHEU, V34, P585, DOI 10.1016/j.semarthrit.2004.07.010; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Roman MJ, 2007, CIRCULATION, V116, P2346, DOI 10.1161/CIRCULATIONAHA.106.678334; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SUKENIK S, 1987, CLIN RHEUMATOL, V6, P588, DOI 10.1007/BF02330598; Symmons DPM, 2004, ARTHRITIS RHEUM, V50, pS477; Szabo SM, 2011, ARTHRITIS RHEUM-US, V63, P3294, DOI 10.1002/art.30581; van den Berg R, 2012, RHEUMATOLOGY OXFORD; Wu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049343; Zochling J, 2006, ANN RHEUM DIS, V65, P442, DOI 10.1136/ard.2005.041137; Zoller B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033442	41	25	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64155	10.1371/journal.pone.0064155	http://dx.doi.org/10.1371/journal.pone.0064155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691161	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700082
J	Safi, K; Armour-Marshall, K; Baillie, JEM; Isaac, NJB				Safi, Kamran; Armour-Marshall, Katrina; Baillie, Jonathan E. M.; Isaac, Nick J. B.			Global Patterns of Evolutionary Distinct and Globally Endangered Amphibians and Mammals	PLOS ONE			English	Article							HISTORICAL BIOGEOGRAPHY; PHYLOGENETIC DIVERSITY; BIODIVERSITY HOTSPOTS; SPECIES RICHNESS; EXTINCTION RISK; CONSERVATION; ECOLOGY; CLIMATE; IMPACT; THREAT	Background: Conservation of phylogenetic diversity allows maximising evolutionary information preserved within fauna and flora. The "EDGE of Existence'' programme is the first institutional conservation initiative that prioritises species based on phylogenetic information. Species are ranked in two ways: one according to their evolutionary distinctiveness (ED) and second, by including IUCN extinction status, their evolutionary distinctiveness and global endangerment (EDGE). Here, we describe the global patterns in the spatial distribution of priority ED and EDGE species, in order to identify conservation areas for mammalian and amphibian communities. In addition, we investigate whether environmental conditions can predict the observed spatial pattern in ED and EDGE globally. Methods and Principal Findings: Priority zones with high concentrations of ED and EDGE scores were defined using two different methods. The overlap between mammal and amphibian zones was very small, reflecting the different phylo-biogeographic histories. Mammal ED zones were predominantly found on the African continent and the neotropical forests, whereas in amphibians, ED zones were concentrated in North America. Mammal EDGE zones were mainly in South-East Asia, southern Africa and Madagascar; for amphibians they were in central and south America. The spatial pattern of ED and EDGE was poorly described by a suite of environmental variables. Conclusions: Mapping the spatial distribution of ED and EDGE provides an important step towards identifying priority areas for the conservation of mammalian and amphibian phylogenetic diversity in the EDGE of existence programme.	[Safi, Kamran] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Seewiesen, Germany; [Safi, Kamran] Univ Konstanz, Dept Biol, Constance, Germany; [Safi, Kamran; Baillie, Jonathan E. M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Armour-Marshall, Katrina] Univ London Imperial Coll Sci Technol & Med, Berkshire, England; [Isaac, Nick J. B.] Ctr Ecol & Hydrol, Nat Environm Res Council, Oxford, England	Max Planck Society; University of Konstanz; Zoological Society of London; Imperial College London; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Safi, K (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Seewiesen, Germany.	ksafi@orn.mpg.de	Safi, Kamran/B-2079-2008; Isaac, Nick/C-2716-2011	Safi, Kamran/0000-0002-8418-6759; Isaac, Nick/0000-0002-4869-8052	Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allen B, 2009, AM NAT, V174, P236, DOI 10.1086/600101; Atkinson I., 1989, P54; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Boitani L, 2011, PHILOS T R SOC B, V366, P2623, DOI 10.1098/rstb.2011.0117; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bryant D., 1997, LAST FRONTIER FOREST; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Ceballos G, 2002, CONSERV BIOL, V9, P559; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Cox CB, 2000, MEM I OSWALDO CRUZ, V95, P509, DOI 10.1590/S0074-02762000000400012; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Feller AE, 1997, MOL MORPHOLOGY SYSTE, P509; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Hijmans RJ, 2011, RASTER GEOGRAPHIC AN, P18; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Huang S, 2012, BIOL LETTERS, V8, P222, DOI 10.1098/rsbl.2011.0752; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043912; Jetz W, 2008, CONSERV BIOL, V22, P110, DOI 10.1111/j.1523-1739.2007.00847.x; Lobo JM, 2002, GLOBAL ECOL BIOGEOGR, V11, P265, DOI 10.1046/j.1466-822X.2002.00291.x; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pimm Stuart L., 2000, P46; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; Possingham Hugh, 2000, P291, DOI 10.1007/0-387-22648-6_17; Price SA, 2007, P R SOC B, V274, P1845, DOI 10.1098/rspb.2007.0505; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Reid WV, 1998, TRENDS ECOL EVOL, V13, P275, DOI 10.1016/S0169-5347(98)01363-9; Rodrigues ASL, 2011, PHILOS T R SOC B, V366, P2652, DOI 10.1098/rstb.2011.0104; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schweiger O, 2008, OECOLOGIA, V157, P485, DOI 10.1007/s00442-008-1082-2; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Sitas N, 2009, ANIM CONSERV, V12, P231, DOI 10.1111/j.1469-1795.2009.00244.x; Smith RJ, 2012, CONSERV LETT, V5, P205, DOI 10.1111/j.1755-263X.2012.00229.x; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Springer MS, 2011, PHILOS T R SOC B, V366, P2478, DOI 10.1098/rstb.2011.0023; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; van Jaarsveld AS, 1998, S AFR J SCI, V94, P210; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30	56	71	74	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63582	10.1371/journal.pone.0063582	http://dx.doi.org/10.1371/journal.pone.0063582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691071	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000319052700051
J	Chen, FT; Yang, CM; Yang, CH				Chen, Fang-Ting; Yang, Chung-May; Yang, Chang-Hao			The Protective Effects of the Proteasome Inhibitor Bortezomib (Velcade) on Ischemia-Reperfusion Injury in the Rat Retina	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; TUMOR-SUPPRESSOR P53; GENE-EXPRESSION; ISCHEMIA/REPERFUSION INJURY; LYMPHOCYTE RECIRCULATION; OXIDATIVE STRESS; TRAFFIC SIGNALS; GANGLION-CELLS; UP-REGULATION	Purpose: To evaluate the protective effects of bortezomib (Velcade) on ischemia-reperfusion (IR) injury in the rat retina. Methods: The rats were randomized to receive treatment with saline, low-dose bortezomib (0.05 mg/kg), or high-dose bortezomib (0.2 mg/kg) before the induction of IR injury. Electroretinography (ERG) was used to assess functional changes in the retina. The expression of inflammatory mediators (iNOS, ICAM-1, MCP-1, TNF-alpha), anti-oxidant proteins (heme oxygenase, thioredoxin, peroxiredoxin), and pro-apoptotic proteins (p53, bax) were quantified by PCR and western blot analysis. An immunofluorescence study was performed to detect the expression of iNOS, oxidative markers (nitrotyrosine, 8-OHdG, acrolein), NF-kappa B p65, and CD 68. Apoptosis of retinal cells was labeled with in situ TUNEL staining. Neu-N staining was performed in the flat-mounted retina to evaluate the density of retinal ganglion cells. Results: ERG showed a decreased b-wave after IR injury, and pretreatment with bortezomib, especially the high dosage, reduced the functional impairment. Bortezomib successfully reduced the elevation of inflammatory mediators, anti-oxidant proteins, pro-apoptotic proteins and oxidative markers after IR insult in a dose-dependent manner. In a similar fashion, NFkB p65- and CD 68-positive cells were decreased by bortezomib treatment. Retinal cell apoptosis in each layer was attenuated by bortezomib. The retinal ganglion cell density was markedly decreased in the saline and low-dose bortezomib groups but was not significantly changed in the high-dose bortezomib group. Conclusions: Bortezomib had a neuro-protective effect in retinal IR injury, possibly by inhibiting the activation of NF-kappa B related to IR insult and reducing the inflammatory signals and oxidative stress in the retina.	[Chen, Fang-Ting] Far Eastern Mem Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chen, Fang-Ting; Yang, Chung-May; Yang, Chang-Hao] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chen, Fang-Ting; Yang, Chung-May; Yang, Chang-Hao] Natl Taiwan Univ, Coll Med, Dept Ophthalmol, Taipei 10764, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Yang, CH (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	chyangoph@ntu.edu.tw	Yang, Chung-May/AAV-3737-2020; Yang, Chang-Hao/AAR-3759-2021	YANG, CHUNG-MAY/0000-0003-4082-420X; YANG, CHANG-HAO/0000-0002-4328-8716				Abraham E, 2000, CRIT CARE MED, V28, pN100, DOI 10.1097/00003246-200004001-00012; ARCHER DB, 1976, DOC OPHTHALMOL, V40, P339, DOI 10.1007/BF00155046; Asai A, 2002, J CEREBR BLOOD F MET, V22, P705, DOI 10.1097/00004647-200206000-00009; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Biermann J, 2011, MOL VIS, V17, P1275; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; BUCHI ER, 1991, OPHTHALMOLOGICA, V203, P138; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Chen BH, 2011, EXP EYE RES, V93, P599, DOI 10.1016/j.exer.2011.07.007; Chen FT, 2012, INVEST OPHTH VIS SCI, V53, P3682, DOI 10.1167/iovs.12-9505; Chen YG, 2003, J NEUROSCI RES, V72, P125, DOI 10.1002/jnr.10548; CHEUNG JY, 1986, NEW ENGL J MED, V314, P1670; Cho KJ, 2011, BRAIN RES, V1403, P67, DOI 10.1016/j.brainres.2011.06.005; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dvoriantchikova G, 2009, J CEREBR BLOOD F MET, V29, P1755, DOI 10.1038/jcbfm.2009.95; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gomes AV, 2009, MOL CELL PROTEOMICS, V8, P302, DOI 10.1074/mcp.M800058-MCP200; Gustavsson C, 2008, RETINA-J RET VIT DIS, V28, P645, DOI 10.1097/IAE.0b013e31815ec32d; Hangai M, 1996, EXP EYE RES, V63, P501, DOI 10.1006/exer.1996.0140; Hangai M, 1996, OPHTHALMIC RES, V28, P248, DOI 10.1159/000267910; HATCHELL DL, 1994, MICROVASC RES, V47, P344, DOI 10.1006/mvre.1994.1027; HUGHES WF, 1991, EXP EYE RES, V53, P573, DOI 10.1016/0014-4835(91)90215-Z; Ichikawa HT, 2012, ARTHRITIS RHEUM-US, V64, P493, DOI 10.1002/art.33333; Itoh M, 2001, J PHARMACOL EXP THER, V298, P501; Jehle T, 2008, INVEST OPHTH VIS SCI, V49, P1056, DOI 10.1167/iovs.07-1050; Jo N, 2003, INVEST OPHTH VIS SCI, V44, P4054, DOI 10.1167/iovs.02-1308; Kamikubo T, 1996, NEUROCHEM INT, V28, P209, DOI 10.1016/0197-0186(95)00071-2; Katai N, 1999, INVEST OPHTH VIS SCI, V40, P2697; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Laskowski I, 2000, Ann Transplant, V5, P29; Latanich CA, 2009, J INVEST SURG, V22, P301, DOI 10.1080/08941930903040155; Liang ZQ, 2007, BRAIN RES, V1145, P190, DOI 10.1016/j.brainres.2007.01.130; Liu Y, 2012, FREE RADICAL BIO MED, V52, P909, DOI 10.1016/j.freeradbiomed.2011.12.013; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Molineaux SM, 2012, CLIN CANCER RES, V18, P15, DOI 10.1158/1078-0432.CCR-11-0853; Navon A, 2009, J BIOL CHEM, V284, P33713, DOI 10.1074/jbc.R109.018481; Nencioni A, 2007, LEUKEMIA, V21, P30, DOI 10.1038/sj.leu.2404444; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Piper HM, 2003, ANN THORAC SURG, V75, pS644, DOI 10.1016/S0003-4975(02)04686-6; Pye J, 2003, AM J PHYSIOL-HEART C, V284, pH919, DOI 10.1152/ajpheart.00851.2002; Qin ZH, 1999, J NEUROSCI, V19, P4023; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Sun MH, 2010, INVEST OPHTH VIS SCI, V51, P4798, DOI 10.1167/iovs.09-4086; SZABO ME, 1991, INVEST OPHTH VIS SCI, V32, P1471; SZABO ME, 1992, FREE RADICAL BIO MED, V13, P609, DOI 10.1016/0891-5849(92)90035-F; Tezel G, 2000, J NEUROSCI, V20, P8693; Tsujikawa A, 1999, INVEST OPHTH VIS SCI, V40, P1183; Valen G, 2001, J AM COLL CARDIOL, V38, P307, DOI 10.1016/S0735-1097(01)01377-8; Wang JT, 2006, BRAIN RES, V1081, P211, DOI 10.1016/j.brainres.2006.01.077; Williams AJ, 2006, NEUROCHEM INT, V49, P106, DOI 10.1016/j.neuint.2006.03.018; Williams AJ, 2003, J CEREBR BLOOD F MET, V23, P75, DOI 10.1097/01.WCB.0000039285.37737.C2; Willmore WG, 1996, BIOCHEM MOL BIOL INT, V38, P445; Wojcik C, 2002, J CELL MOL MED, V6, P25, DOI 10.1111/j.1582-4934.2002.tb00309.x; Yu XC, 2010, CARDIOVASC RES, V85, P312, DOI 10.1093/cvr/cvp309; Zhao ZQ, 2004, CURR OPIN PHARMACOL, V4, P159, DOI 10.1016/j.coph.2003.10.010; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510	65	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64262	10.1371/journal.pone.0064262	http://dx.doi.org/10.1371/journal.pone.0064262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691186	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400113
J	Kumar, R; Kohli, S; Alam, P; Barkotoky, R; Gupta, M; Tyagi, S; Jain, SK; Pasha, MAQ				Kumar, Rahul; Kohli, Samantha; Alam, Perwez; Barkotoky, Ritankur; Gupta, Mohit; Tyagi, Sanjay; Jain, S. K.; Pasha, M. A. Qadar			Interactions between the FTO and GNB3 Genes Contribute to Varied Clinical Phenotypes in Hypertension	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; C825T POLYMORPHISM; NERVOUS-SYSTEM; HUMAN-DISEASES; 825T ALLELE; FAT-MASS; OBESITY; METAANALYSIS	Background: The genes FTO and GNB3 are implicated in essential hypertension but their interaction remains to be explored. This study investigates the role of interaction between the two genes in the pathophysiology of essential hypertension. Methods/Principal Findings: In a case-control study comprising 750 controls and 550 patients, interaction between the polymorphisms of FTO and GNB3 was examined using multifactor dimensionality reduction (MDR). The influence of interaction on clinical phenotypes like systolic and diastolic blood pressure, mean arterial pressure and body mass index was also investigated. The 3-locus MDR model comprising FTO rs8050136C/A and GNB3 rs1129649T/C and rs5443C/T emerged as the best disease conferring model. Moreover, the interacted-genotypes having either 1, 2, 3, 4 or 5 risk alleles correlated with linearly increasing odds ratios of 1.91 (P=0.027); 3.93 (P=2.08E-06); 4.51 (P=7.63E-07); 7.44 (P=3.66E-08) and 11.57 (P=1.18E-05), respectively, when compared with interacted-genotypes devoid of risk alleles. Furthermore, interactions among haplotypes of FTO (H1-9) and GNB3 (Ha-d) differed by >.1.5-fold for protective-haplotypes, CTGGC+TC [H-2+H-a] and CTGAC+TC [H-4+H-a] (OR=0.39, P=0.003; OR=0.22, P=6.86E-05, respectively) and risk-haplotypes, AAAGC+CT [H-3+H-c] and AAAGC+TT [H-3+H-d] (OR=2.91, P=9.98E-06; OR=2.50, P=0.004, respectively) compared to individual haplotypes. Moreover, the effectiveness of gene-gene interaction was further corroborated with a 1.29-, 1.25- and 1.38-fold higher SBP, MAP and BMI, respectively, in patients having risk interacted-haplotype H-3+H-c and 2.48-fold higher SBP having risk interacted-haplotype H-3+H-d compared to individual haplotypes. Conclusion: Interactions between genetic variants of FTO and GNB3 influence clinical parameters to augment hypertension.	[Kumar, Rahul; Kohli, Samantha; Alam, Perwez; Pasha, M. A. Qadar] CSIR, Funct Genom Unit, Inst Genom & Integrat Biol, Delhi, India; [Barkotoky, Ritankur; Gupta, Mohit; Tyagi, Sanjay] GB Pant Hosp, Dept Cardiol, New Delhi 110002, India; [Jain, S. K.] Hamdard Univ, Dept Biotechnol, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Govind Ballabh Pant Institute of Postgraduate Medical Education & Research; Jamia Hamdard University	Pasha, MAQ (corresponding author), CSIR, Funct Genom Unit, Inst Genom & Integrat Biol, Delhi, India.	qpasha@igib.res.in	Sharma, Dr. Samantha/AAY-7184-2021; Alam, Perwez/ABA-4398-2021	Sharma, Dr. Samantha/0000-0001-9599-4455; Alam, Perwez/0000-0002-7229-8008; Alam, Perwez/0000-0003-0668-2236; Kumar, Rahul/0000-0002-2709-5981				Ahmad T, 2010, AM HEART J, V160, P1163, DOI 10.1016/j.ahj.2010.08.002; Ameur A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp381; Bae Y, 2007, J HUM HYPERTENS, V21, P159, DOI 10.1038/sj.jhh.1002110; Bagos PG, 2007, J HYPERTENS, V25, P487, DOI 10.1097/HJH.0b013e328011db24; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brahmachari SK, 2008, J GENET, V87, P3; Bunnett NW, 2010, CNS NEUROL DISORD-DR, V9, P539; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fall T., 2012, MOL CELL ENDOCRINOL, VS0303-7207, P00413; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hamet P, 2005, AM J HUM GENET, V76, P815, DOI 10.1086/430133; Harrap SB, 2000, AM J EPIDEMIOL, V152, P704, DOI 10.1093/aje/152.8.704; HONG YL, 1994, HYPERTENSION, V24, P663, DOI 10.1161/01.HYP.24.6.663; Jones DW, 1996, AM J HYPERTENS, V9, pS50, DOI 10.1016/0895-7061(96)00183-5; Joyner MJ, 2008, EXP PHYSIOL, V93, P715, DOI 10.1113/expphysiol.2007.039545; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kelly TN, 2009, AM J HYPERTENS, V22, P985, DOI 10.1038/ajh.2009.118; Klenke S, 2011, PHARMACOGENET GENOM, V21, P594, DOI 10.1097/FPC.0b013e3283491153; Mamun AA, 2005, HYPERTENSION, V45, P1083, DOI 10.1161/01.HYP.0000166720.18319.51; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Nejatizadeh A, 2011, GENET MOL BIOL, V34, P553, DOI 10.1590/S1415-47572011005000052; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Newton-Cheh C, 2005, MUTAT RES-FUND MOL M, V573, P54, DOI 10.1016/j.mrfmmm.2005.01.006; Niu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017052; Pausova Z, 2009, CIRC-CARDIOVASC GENE, V2, P260, DOI 10.1161/CIRCGENETICS.109.857359; Pemberton TJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-13; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Potter MA, 2000, EVOL COMPUT, V8, P1, DOI 10.1162/106365600568086; Rana BK, 2007, HYPERTENSION, V49, P96, DOI 10.1161/01.HYP.0000252029.35106.67; Sentinelli F, 2012, EXP DIABETES RES, DOI 10.1155/2012/872176; Siffert W, 2003, CURR HYPERTENS REP, V5, P47, DOI 10.1007/s11906-003-0010-4; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; Souza RP, 2008, PROG NEURO-PSYCHOPH, V32, P1848, DOI 10.1016/j.pnpbp.2008.08.014; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Timpson NJ, 2009, HYPERTENSION, V54, P84, DOI 10.1161/HYPERTENSIONAHA.109.130005; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Wenzel RR, 2002, PHARMACOGENETICS, V12, P489, DOI 10.1097/00008571-200208000-00010; Xia HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022682; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Zhao Q, 2008, PHARMACOGENET GENOM, V18, P459, DOI 10.1097/FPC.0b013e3282f97fb2; Zolk O, 2000, CAN J PHYSIOL PHARM, V78, P187, DOI 10.1139/cjpp-78-3-187	48	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63934	10.1371/journal.pone.0063934	http://dx.doi.org/10.1371/journal.pone.0063934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691120	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400087
J	Schoustra, SE; Kasase, C; Toarta, C; Kassen, R; Poulain, AJ				Schoustra, Sijmen E.; Kasase, Chitundu; Toarta, Cristian; Kassen, Rees; Poulain, Alexandre J.			Microbial Community Structure of Three Traditional Zambian Fermented Products: Mabisi, Chibwantu and Munkoyo	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; FOODS; MICROORGANISMS; DIVERSITY; SYSTEMS; SAFETY	Around the world, raw materials are converted into fermented food products through microbial and enzymatic activity. Products are typically produced using a process known as batch culture, where small volumes of an old culture are used to initiate a fresh culture. Repeated over many years, and provided samples are not shared among producers, batch culture techniques allow for the natural evolution of independent microbial ecosystems. While these products form an important part of the diets of many people because of their nutritional, organoleptic and food safety properties, for many traditional African fermented products the microbial communities responsible for fermentation are largely unknown. Here we describe the microbial composition of three traditional fermented non-alcoholic beverages that are widely consumed across Zambia: the milk based product Mabisi and the cereal based products Munkoyo and Chibwantu. Using culture and non-culture based techniques, we found that six to eight lactic acid bacteria predominate in all products. We then used this data to investigate in more detail the factors affecting community structure. We found that products made from similar raw materials do not harbor microbial communities that are more similar to each other than those made from different raw materials. We also found that samples from the same product taken at the same location were as different from each other in terms of microbial community structure and composition, as those from geographically very distant locations. These results suggest that microbial community structure in these products is neither a simple consequence of the raw materials used, nor the particular suite of microbes available in the environment but that anthropogenic variables (e. g., competition among sellers or organoleptic preferences by different tribes) are important in shaping the microbial community structures.	[Schoustra, Sijmen E.] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands; [Schoustra, Sijmen E.; Toarta, Cristian; Kassen, Rees; Poulain, Alexandre J.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Schoustra, Sijmen E.; Kasase, Chitundu] Univ Zambia, Dept Biol Sci, Lusaka, Zambia; [Schoustra, Sijmen E.; Kasase, Chitundu] Univ Zambia, Dept Food Sci & Technol, Lusaka, Zambia	Wageningen University & Research; University of Ottawa; University of Zambia; University of Zambia	Poulain, AJ (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	apoulain@uottawa.ca	Schoustra, Sijmen E/H-3882-2012	Poulain, Alexandre/0000-0002-0488-3993	Natural Sciences and Engineering Research Council of Canada; University of Ottawa; Province of Ontario	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Ottawa; Province of Ontario	Funds were provided by discovery grants from the Natural Sciences and Engineering Research Council of Canada to AJP and RK, from a Research Development Program grant from the University of Ottawa to AJP as well as from an Early Researcher Awards from the Province of Ontario to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2006, INT J FOOD MICROBIOL, V111, P228, DOI 10.1016/j.ijfoodmicro.2006.06.006; Adam MR, 2004, FOOD MICROBIOLOGY; Ampe F, 1999, APPL ENVIRON MICROB, V65, P5464; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Beukes EM, 2001, INT J FOOD MICROBIOL, V63, P189, DOI 10.1016/S0168-1605(00)00417-7; Blandino A, 2003, FOOD RES INT, V36, P527, DOI 10.1016/S0963-9969(03)00009-7; Caplice E, 1999, INT J FOOD MICROBIOL, V50, P131, DOI 10.1016/S0168-1605(99)00082-3; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; El-Ghaish S, 2011, TRENDS FOOD SCI TECH, V22, P509, DOI 10.1016/j.tifs.2011.05.003; Ercolini D, 2001, SYST APPL MICROBIOL, V24, P610, DOI 10.1078/0723-2020-00076; Haard N.F., 1999, FERMENTED CEREALS GL; Jessup CM, 2005, ADV ECOL RES, V37, P273, DOI 10.1016/S0065-2504(04)37009-1; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kassen R, 2004, ANNU REV MICROBIOL, V58, P207, DOI 10.1146/annurev.micro.58.030603.123654; Lawrence D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001330; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mensah P, 1997, FOOD CONTROL, V8, P271, DOI 10.1016/S0956-7135(97)00020-0; Meyer JR, 2011, P ROY SOC B-BIOL SCI, V278, P392, DOI 10.1098/rspb.2010.0640; Nguz K., 2004, Journal of Science and Technology, P9; Nout MJR, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P817; Obadina AO, 2009, SCI RES ESSAYS, V4, P432; ODUNFA S A, 1988, MIRCEN Journal of Applied Microbiology and Biotechnology, V4, P259, DOI 10.1007/BF01096132; Oyewole OB, 1997, FOOD CONTROL, V8, P289, DOI 10.1016/S0956-7135(97)00075-3; Pogacic T, 2010, FOOD TECHNOL BIOTECH, V48, P3; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sojkowski J, 2006, CULTURE ZAMBIA; Zulu RM, 1997, INT J FOOD MICROBIOL, V34, P249, DOI 10.1016/S0168-1605(96)01195-6	32	51	51	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63948	10.1371/journal.pone.0063948	http://dx.doi.org/10.1371/journal.pone.0063948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691123	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400089
J	Wu, CK; Huang, YT; Lin, HH; Yang, CY; Lien, YC; Lee, JK; Huang, JW; Hung, KY				Wu, Cho-Kai; Huang, Yin-Tsen; Lin, Heng-Hsu; Yang, Chung-Yi; Lien, Yu-Chung; Lee, Jen-Kuang; Huang, Jenq-Wen; Hung, Kuan-Yu			Dissecting the Mechanisms of Left Ventricular Diastolic Dysfunction and Inflammation in Peritoneal Dialysis Patients	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SYSTEM GENE POLYMORPHISMS; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; HEART-FAILURE; EJECTION FRACTION; CYTOKINES; THERAPY; MICE; ECHOCARDIOGRAPHY	Objective: Patients with symptoms of heart failure and preserved left ventricular (LV) systolic function are commonly encountered in clinical practice especially in peritoneal dialysis (PD) patients. We hypothesized that adiposity might influence LV diastolic function through systemic inflammation in this specific group. Methods: We designed a cross-sectional study in 173 prevalent PD patients. LV diastolic dysfunction was diagnosed by echocardiography. PD patient without LV diastolic dysfunction served as the control group. Serum inflammatory biomarkers were examined including tissue necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). The location and amount of adipose tissue were assessed by computerized tomography (CT) at the level of the fourth lumbar vertebra. Results: Subjects with LV diastolic dysfunction had higher levels of the pro-inflammation cytokines and more visceral and peritoneal fat (all P<0.001) than control subjects. A significant correlation was found between visceral adipose tissue and pro-inflammatory cytokines (r = 0.70; P<0.001). Multivariable regression analysis found that the relationship between visceral adipose tissue and LV diastolic dysfunction became insignificant when either TNF-alpha or IL-6 were introduced into the model, although TNF-alpha and IL-6 were both significantly associated with LV diastolic dysfunction even after adjusting for visceral fat (OR = 1.51; 95% CI = 1.09-2.02; P = 0.033 and OR = 1.62; 95% CI = 1.09-1.82; P = 0.031, respectively). Conclusions: Larger amounts of adipose tissue were associated with higher serum pro-inflammatory levels in PD patients, which might be related to the development of LV diastolic dysfunction. Modulating inflammatory reactions in PD patients can be a useful therapeutic approach for managing LV diastolic dysfunction.	[Wu, Cho-Kai] Natl Taiwan Univ, Div Cardiol, Dept Internal Med, Coll Med & Hosp, Taipei 10764, Taiwan; [Wu, Cho-Kai] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Huang, Yin-Tsen] Far Eastern Mem Hosp, Dept Family Med, New Taipei City, Taiwan; [Huang, Yin-Tsen] Far Eastern Mem Hosp, Hlth Management Ctr, New Taipei City, Taiwan; [Lin, Heng-Hsu] Far Eastern Mem Hosp, Dept Internal Med, Div Cardiol, New Taipei City, Taiwan; [Yang, Chung-Yi] Natl Taiwan Univ, Coll Med & Hosp, Dept Med Imaging, Taipei 10764, Taiwan; [Lien, Yu-Chung; Huang, Jenq-Wen; Hung, Kuan-Yu] Natl Taiwan Univ, Div Nephrol, Dept Internal Med, Coll Med & Hosp, Taipei 10764, Taiwan; [Lee, Jen-Kuang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Lee, Jen-Kuang] Far Eastern Mem Hosp, Dept Clin Pathol, New Taipei City, Taiwan; [Lee, Jen-Kuang] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Taiwan University	Lee, JK (corresponding author), Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan.	b85401104@gmail.com; 007378@ntuh.gov.tw	; Stefanadis, Christodoulos/ABH-2232-2020	HUANG, JENQ-WEN/0000-0001-8011-2317; Stefanadis, Christodoulos/0000-0001-5974-6454; HUNG, KUAN-YU/0000-0003-3472-5512; WU, CHO-KAI/0000-0002-3867-150X	Far Eastern Memorial Hospital [FEMH-2012-C-046, FEMH-2012-C-048, FEMH-2012-C-051, FEMH-2012-C-007]	Far Eastern Memorial Hospital	The authors have financial supports from the research grants of Far Eastern Memorial Hospital number: FEMH-2012-C-046, FEMH-2012-C-048, FEMH-2012-C-051, FEMH-2012-C-007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arici M, 2001, KIDNEY INT, V59, P407, DOI 10.1046/j.1523-1755.2001.059002407.x; Bajraktari G, 2009, CROAT MED J, V50, P543, DOI 10.3325/cmj.2009.50.543; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; de Mattos AM, 2013, INFLAMMAINFLAMM 0116; Deswal A, 2001, CIRCULATION, V103, P2055; Ernanuela M, 2007, BIOMED PHARMACOTHER, V61, P360, DOI 10.1016/j.biopha.2007.03.002; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; FINKEL MS, 1992, SCIENCE, V257, P387, DOI 10.1126/science.1631560; Gaasch WH, 2004, ANNU REV MED, V55, P373, DOI 10.1146/annurev.med.55.091902.104417; Gniuli D, 2010, INT J OBESITY, V34, P1726, DOI 10.1038/ijo.2010.99; Hillebrand JJG, 2010, OBESITY, V18, P848, DOI 10.1038/oby.2009.341; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Ikonomidis I, 2010, SHOCK, V33, P141, DOI 10.1097/SHK.0b013e3181ad31f8; Kapadia SR, 2000, J AM COLL CARDIOL, V36, P208, DOI 10.1016/S0735-1097(00)00721-X; Lee JK, 2012, NUTR METAB CARDIOVAS, V22, P974, DOI 10.1016/j.numecd.2011.01.001; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; London GM, 2003, SEMIN DIALYSIS, V16, P85, DOI 10.1046/j.1525-139X.2003.16023.x; Nagueh SF, 2001, CIRCULATION, V103, P1844; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; OGSTON D, 1964, LANCET, V2, P1205; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Paraskevas KI, 2008, INT UROL NEPHROL, V40, P165, DOI 10.1007/s11255-007-9307-6; Prabhu SD, 2004, CIRC RES, V95, P1140, DOI 10.1161/01.RES.0000150734.79804.92; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Saiki A, 2005, INT J OBESITY, V29, P1115, DOI 10.1038/sj.ijo.0803009; SOLERTE SB, 1989, INT J OBESITY, V13, P203; Stenvinkel P, 2006, NEPHROLOGY, V11, P36, DOI 10.1111/j.1440-1797.2006.00541.x; Wu CK, 2008, EUR J CLIN INVEST, V38, P789, DOI 10.1111/j.1365-2362.2008.02017.x; Wu CK, 2012, OBESITY, V20, P730, DOI 10.1038/oby.2011.30; Wu CK, 2011, CRIT CARE MED, V39, P984, DOI 10.1097/CCM.0b013e31820a91b9; Wu CK, 2009, ATHEROSCLEROSIS, V205, P497, DOI 10.1016/j.atherosclerosis.2008.12.033; Wu CK, 2009, J HYPERTENS, V27, P502, DOI 10.1097/HJH.0b013e32831fda3a	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62722	10.1371/journal.pone.0062722	http://dx.doi.org/10.1371/journal.pone.0062722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675418	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100007
J	Zolezzi, JM; Silva-Alvarez, C; Ordenes, D; Godoy, JA; Carvajal, FJ; Santos, MJ; Inestrosa, NC				Zolezzi, Juan M.; Silva-Alvarez, Carmen; Ordenes, Daniela; Godoy, Juan A.; Carvajal, Francisco J.; Santos, Manuel J.; Inestrosa, Nibaldo C.			Peroxisome Proliferator-Activated Receptor (PPAR) gamma and PPAR alpha Agonists Modulate Mitochondrial Fusion-Fission Dynamics: Relevance to Reactive Oxygen Species (ROS)-Related Neurodegenerative Disorders?	PLOS ONE			English	Article							COACTIVATOR 1-ALPHA PGC-1-ALPHA; AMYLOID-BETA; A-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TRANSCRIPTIONAL COACTIVATOR; NUCLEAR RECEPTORS; NEURONS; DYSFUNCTION; EXPRESSION	Recent studies showed that the activation of the retinoid X receptor, which dimerizes with peroxisome proliferator-activated receptors (PPARs), leads to an enhanced clearance of A beta from the brain of transgenic mice model of Alzheimer's disease (AD), because an increased expression of apolipoprotein E and it main transporters. However, the effects observed must involve additional underlying mechanisms that have not been yet explored. Several studies conducted in our laboratory suggest that part of the effects observed for the PPARs agonist might involves mitochondrial function and, particularly, mitochondrial dynamics. In the present study we assessed the effects of oxidative stress challenge on mitochondrial morphology and mitochondrial dynamics-related proteins in hippocampal neurons. Using immunofluorescence, we evaluated the PPAR gamma co-activator 1 alpha (PGC-1 alpha), dynamin related protein 1 (DRP1), mitochondrial fission protein 1 (FIS1), and mitochondrial length, in order to determine if PPARs agonist pre-treatment is able to protect mitochondrial population from hippocampal neurons through modulation of the mitochondrial fusion-fission events. Our results suggest that both a PPAR gamma agonist (ciglitazone) and a PPAR alpha agonist (WY 14.643) are able to protect neurons by modulating mitochondrial fusion and fission, leading to a better response of neurons to oxidative stress, suggesting that a PPAR based therapy could acts simultaneously in different cellular components. Additionally, our results suggest that PGC-1 alpha and mitochondrial dynamics should be further studied in future therapy research oriented to ameliorate neurodegenerative disorders, such as AD.	[Zolezzi, Juan M.] Univ Tarapaca, Fac Ciencias, Dept Biol, Arica, Chile; [Silva-Alvarez, Carmen; Ordenes, Daniela; Godoy, Juan A.; Carvajal, Francisco J.; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac CARE, Santiago, Chile; [Godoy, Juan A.; Santos, Manuel J.; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago, Chile	Universidad de Tarapaca; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac CARE, Santiago, Chile.	ninestrosa@bio.puc.cl	Godoy, Juan A/F-5398-2018	Godoy, Juan A/0000-0001-9920-6698	Basal Centre for Excellence in Science and Technology [PFB 12/2007]; Fondecyt [1120156]	Basal Centre for Excellence in Science and Technology(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by grants from the Basal Centre for Excellence in Science and Technology (PFB 12/2007) and Fondecyt No 1120156 to NCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Austin S, 2011, FREE RADICAL BIO MED, V51, P2243, DOI 10.1016/j.freeradbiomed.2011.08.036; Bachmeier C, 2012, J MOL NEUROSCI; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cavallucci V, 2012, MOL NEUROBIOL, V45, P366, DOI 10.1007/s12035-012-8251-3; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Delerive P, 2002, J BIOL CHEM, V277, P3913, DOI 10.1074/jbc.M109409200; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dinamarca MC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-4; Elgass K., 2013, BIOCHIM BIOPHYS ACTA, V1833, P150, DOI [10.1016/j.bbamcr.2012.05.002, DOI 10.1016/J.BBAMCR.2012.05.002]; Feilchenfeldt J, 2004, CANCER LETT, V203, P25, DOI 10.1016/j.canlet.2003.08.024; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Inestrosa NC, 2013, J ALZHEIMERS DIS, V33, P941, DOI 10.3233/JAD-2012-120397; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Khasabova IA, 2012, J NEUROSCI, V32, P12735, DOI 10.1523/JNEUROSCI.0130-12.2012; LaFerla FM, 2012, NEW ENGL J MED, V367, P570, DOI 10.1056/NEJMcibr1204890; Lalloyer F, 2010, ARTERIOSCL THROM VAS, V30, P894, DOI 10.1161/ATVBAHA.108.179689; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Mysiorek C, 2009, CURR NEUROVASC RES, V6, P181, DOI 10.2174/156720209788970081; Nakamura K, 2007, EUR J NEUROSCI, V26, P3054, DOI 10.1111/j.1460-9568.2007.05868.x; Pancani T, 2009, J NEUROCHEM, V109, P1800, DOI 10.1111/j.1471-4159.2009.06107.x; Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287; Peraza MA, 2006, TOXICOL SCI, V90, P269, DOI 10.1093/toxsci/kfj062; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quintanilla RA, 2005, J BIOL CHEM, V280, P11615, DOI 10.1074/jbc.M411936200; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883; Sabatier N, 1998, J PHYSIOL-LONDON, V513, P699, DOI 10.1111/j.1469-7793.1998.699ba.x; Santos MJ, 2005, J BIOL CHEM, V280, P41057, DOI 10.1074/jbc.M505160200; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	56	72	73	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e64019	10.1371/journal.pone.0064019	http://dx.doi.org/10.1371/journal.pone.0064019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675519	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100055
J	Krieg, E; Albeck, S; Weissman, H; Shimoni, E; Rybtchinski, B				Krieg, Elisha; Albeck, Shira; Weissman, Haim; Shimoni, Eyal; Rybtchinski, Boris			Separation, Immobilization, and Biocatalytic Utilization of Proteins by a Supramolecular Membrane	PLOS ONE			English	Article							TEMPERATURE ELECTRON-MICROSCOPY; PERYLENE BISIMIDE DYES; BLOCK-COPOLYMER; POLYSACCHARIDE ULTRASTRUCTURES; WATER; BINDING; ENZYME; HYDROGELS; ULTRAFILTRATION; NANOFILTRATION	Membrane separation of biomolecules and their application in biocatalysis is becoming increasingly important for biotechnology, demanding the development of new biocompatible materials with novel properties. In the present study, an entirely noncovalent water-based material is used as a membrane for size-selective separation, immobilization, and biocatalytic utilization of proteins. The membrane shows stable performance under physiological conditions, allowing filtration of protein mixtures with a 150 kDa molecular weight cutoff (similar to 8 nm hydrodynamic diameter cutoff). Due to the biocompatibility of the membrane, filtered proteins stay functionally active and retained proteins can be partially recovered. Upon filtration, large enzymes become immobilized within the membrane. They exhibit stable activity when subjected to a constant flux of substrates for prolonged periods of time, which can be used to carry out heterogeneous biocatalysis. The noncovalent membrane material can be easily disassembled, purified, reassembled, and reused, showing reproducible performance after recycling. The robustness, recyclability, versatility, and biocompatibility of the supramolecular membrane may open new avenues for manipulating biological systems.	[Krieg, Elisha; Weissman, Haim; Rybtchinski, Boris] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Albeck, Shira] Weizmann Inst Sci, ISPC, IL-76100 Rehovot, Israel; [Shimoni, Eyal] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Rybtchinski, B (corresponding author), Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel.	boris.rybtchinski@weizmann.ac.il	Krieg, Elisha/J-4591-2014	Krieg, Elisha/0000-0002-2989-9879	Israel Science Foundation; Minerva Foundation; Gerhardt M.J. Schmidt Minerva Center for Supramolecular Architectures; Helen and Martin Kimmel Center for Molecular Design; Yeda Sela Center for Basic Research	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Gerhardt M.J. Schmidt Minerva Center for Supramolecular Architectures; Helen and Martin Kimmel Center for Molecular Design; Yeda Sela Center for Basic Research	This work was supported by grants from the Israel Science Foundation, the Minerva Foundation, the Gerhardt M.J. Schmidt Minerva Center for Supramolecular Architectures, the Helen and Martin Kimmel Center for Molecular Design, and the Yeda Sela Center for Basic Research. E. K. acknowledges the Minerva PhD fellowship. B. R. holds the Abraham and Jennie Fialkow Career Development Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; As Illanes, 2008, ENZYME BIOCATALYSIS; Baker R. W., 2004, MEMBRANE TECHNOLOGY, DOI DOI 10.1002/0470020393; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Beginn U, 2000, ADV MATER, V12, P510, DOI 10.1002/(SICI)1521-4095(200004)12:7<510::AID-ADMA510>3.3.CO;2-V; Beginn U, 1998, ADV MATER, V10, P1391, DOI 10.1002/(SICI)1521-4095(199811)10:16<1391::AID-ADMA1391>3.0.CO;2-0; Benfer S, 2004, ADV ENG MATER, V6, P495, DOI 10.1002/adem.200400577; Bernstein HJ, 2000, TRENDS BIOCHEM SCI, V25, P453, DOI 10.1016/S0968-0004(00)01606-6; Bhattacharjee S, 2006, J MEMBRANE SCI, V275, P141, DOI 10.1016/j.memsci.2005.09.013; BLOKZIJL W, 1993, ANGEW CHEM INT EDIT, V32, P1545, DOI 10.1002/anie.199315451; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady D, 2009, BIOTECHNOL LETT, V31, P1639, DOI 10.1007/s10529-009-0076-4; Cao LQ, 2000, ORG LETT, V2, P1361, DOI 10.1021/ol005593x; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chen ZJ, 2009, CHEM SOC REV, V38, P564, DOI 10.1039/b809359h; Corbin PS, 1998, J AM CHEM SOC, V120, P9710, DOI 10.1021/ja981884d; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g; Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047; Dankers PYW, 2010, MACROMOL BIOSCI, V10, P1345, DOI 10.1002/mabi.201000146; Fenske T, 2012, CHEM-EUR J, V18, P738, DOI 10.1002/chem.201102435; Gibb BC, 2011, ISR J CHEM, V51, P798, DOI 10.1002/ijch.201100058; Gorl D, 2012, ANGEW CHEM INT EDIT, V51, P6328, DOI 10.1002/anie.201108690; Huang Z, 2011, NAT COMMUN, V2, DOI [10.1038/ncomms1465, 10.1038/ncomms1545]; Joerger AC, 2000, BIOCHEMISTRY-US, V39, P6033, DOI 10.1021/bi9927686; Kane RS, 2003, LANGMUIR, V19, P2388, DOI 10.1021/la020737x; Keller K, 2001, TRENDS BIOTECHNOL, V19, P438, DOI 10.1016/S0167-7799(01)01803-0; Khersonsky O, 2011, J MOL BIOL, V407, P391, DOI 10.1016/j.jmb.2011.01.041; Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9; Krieg E, 2011, CHEM-EUR J, V17, P9016, DOI 10.1002/chem.201100809; Krieg E, 2011, NAT NANOTECHNOL, V6, P141, DOI 10.1038/NNANO.2010.274; Krieg E, 2009, J AM CHEM SOC, V131, P14365, DOI 10.1021/ja903938g; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LEHN JM, 1993, SCIENCE, V260, P1762, DOI 10.1126/science.8511582; Lightfoot EN, 2004, BIOTECHNOL BIOENG, V87, P259, DOI 10.1002/bit.20111; Lim YB, 2008, J MATER CHEM, V18, P2909, DOI 10.1039/b802639d; Lo Nostro P, 2006, BIOPHYS CHEM, V124, P208, DOI 10.1016/j.bpc.2006.04.004; Lu JR, 2005, IND ENG CHEM RES, V44, P7610, DOI 10.1021/ie049042c; Lu YY, 2007, CHEM MATER, V19, P3194, DOI 10.1021/cm070200a; Matzelle T, 2008, ACTA MICROSC, V17, P45; Maurus R, 2003, BIOCHEMISTRY-US, V42, P5555, DOI 10.1021/bi020622s; Menger FM, 2002, J AM CHEM SOC, V124, P12408, DOI 10.1021/ja021025w; Nguyen NT, 2001, BIOCHEMISTRY-US, V40, P13177, DOI 10.1021/bi010408o; Nunes SP, 2011, ACS NANO, V5, P3516, DOI 10.1021/nn200484v; Onda M, 1996, J FERMENT BIOENG, V82, P502, DOI 10.1016/S0922-338X(97)86992-9; Oshovsky GV, 2007, ANGEW CHEM INT EDIT, V46, P2366, DOI 10.1002/anie.200602815; Peeva PD, 2012, IND ENG CHEM RES, V51, P7231, DOI 10.1021/ie202893e; Peinemann KV, 2007, NAT MATER, V6, P992, DOI 10.1038/nmat2038; Percec V, 2010, SCIENCE, V328, P1009, DOI 10.1126/science.1185547; Phillip WA, 2010, ACS APPL MATER INTER, V2, P847, DOI 10.1021/am900882t; Prins LJ, 2001, ANGEW CHEM INT EDIT, V40, P2382, DOI 10.1002/1521-3773(20010702)40:13<2382::AID-ANIE2382>3.0.CO;2-G; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Rybtchinski B, 2011, ACS NANO, V5, P6791, DOI 10.1021/nn2025397; Ryu JH, 2008, CHEM COMMUN, P1043, DOI 10.1039/b713737k; Saxena A, 2009, ADV COLLOID INTERFAC, V145, P1, DOI 10.1016/j.cis.2008.07.004; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schmuck C, 2003, J AM CHEM SOC, V125, P452, DOI 10.1021/ja028485+; Serp D, 2002, BIOTECHNOL BIOENG, V79, P253, DOI 10.1002/bit.10287; Serp D, 2002, BIOTECHNOL BIOENG, V79, P243, DOI 10.1002/bit.10286; Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107; Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; Spahn Cynthia, 2008, Recent Patents on Engineering, V2, P195, DOI 10.2174/187221208786306333; SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129; Stoddart JF, 2009, NAT CHEM, V1, P14, DOI 10.1038/nchem.142; Stupp SI, 2010, NANO LETT, V10, P4783, DOI 10.1021/nl103567y; Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384; Tidhar Y, 2011, CHEM-EUR J, V17, P6068, DOI 10.1002/chem.201003419; Tokarev I, 2009, ADV MATER, V21, P241, DOI 10.1002/adma.200801408; Torres-Salas P, 2011, ADV MATER, V23, P5275, DOI 10.1002/adma.201101821; Tran DN, 2011, ACS CATAL, V1, P956, DOI 10.1021/cs200124a; Tyagi P, 2012, ANGEW CHEM INT EDIT, V51, P7166, DOI 10.1002/anie.201201686; Uehara H, 2009, ACS NANO, V3, P924, DOI 10.1021/nn8008728; Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084; van Reis R, 2001, CURR OPIN BIOTECH, V12, P208, DOI 10.1016/S0958-1669(00)00201-9; van Reis R, 2007, J MEMBRANE SCI, V297, P16, DOI 10.1016/j.memsci.2007.02.045; Vandezande P, 2008, CHEM SOC REV, V37, P365, DOI 10.1039/b610848m; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Wurthner F, 2004, CHEM COMMUN, P1564, DOI 10.1039/b401630k; Yang Q, 2011, J MATER CHEM, V21, P2783, DOI 10.1039/c0jm02234a; Yang SY, 2010, ACS NANO, V4, P3817, DOI 10.1021/nn100464u; Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5	84	15	15	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63188	10.1371/journal.pone.0063188	http://dx.doi.org/10.1371/journal.pone.0063188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675461	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400028
J	Teshima, K; Nara, M; Watanabe, A; Ito, M; Ikeda, S; Hatano, Y; Oshima, K; Seto, M; Sawada, K; Tagawa, H				Teshima, K.; Nara, M.; Watanabe, A.; Ito, M.; Ikeda, S.; Hatano, Y.; Oshima, K.; Seto, M.; Sawada, K.; Tagawa, H.			Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma	ONCOGENE			English	Article						BMI1; miR-16; Noxa; apoptosis; side population; mantle cell lymphoma	CANCER STEM-CELLS; HOMOZYGOUS DELETIONS; SELF-RENEWAL; MESENCHYMAL TRANSITION; DOWN-REGULATION; MOUSE MODEL; PHASE-II; GENE; PROLIFERATION; MIR-16	The proto-oncogene BMI1 and its product, Bmi1, is overexpressed in various types of tumors, particularly in aggressive tumors and tumors resistant to conventional chemotherapy. BMI1/Bmi1 is also crucially involved in cancer-initiating cell maintenance, and is recurrently upregulated in mantle cell lymphoma (MCL), especially aggressive variants. Recently, side population (SP) cells were shown to exhibit tumor-initiating characteristics in various types of tumors. In this study, we show that recurrent MCL cases significantly exhibit upregulation of BMI1/Bmi1. We further demonstrate that clonogenic MCL SP shows such tumor-initiating characteristics as high tumorigenicity and self-renewal capability, and that BMI1 was upregulated in the SP from recurrent MCL cases and MCL cell lines. On screening for upstream regulators of BMI1, we found that expression of microRNA-16 (miR-16) was downregulated in MCL SP cells by regulating Bmi1 in the SPs, leading to reductions in tumor size following lymphoma xenografts. Moreover, to investigate downstream targets of BMI1 in MCL, we performed cross-linking/chromatin immunoprecipitation assay against MCL cell lines and demonstrated that Bmi1 directly regulated pro-apoptotic genes such as BCL2L11/Bim and PMAIP1/Noxa, leading to enhance anti-apoptotic potential of MCL. Finally, we found that a proteasome inhibitor bortezomib, which has been recently used for relapsed MCL, effectively induced apoptosis among MCL cells while reducing expression of Bmi1 and increasing miR-16 in MCL SP. These results suggest that upregulation of BMI1 and downregulation of miR-16 in MCL SP has a key role in the disease's progression by reducing MCL cell apoptosis. Our results provide important new insight into the pathogenesis of MCL and strongly suggest that targeting BMI1/Bmi1 might be an effective approach to treating MCL, particularly refractory and recurrent cases.	[Teshima, K.; Nara, M.; Watanabe, A.; Ito, M.; Ikeda, S.; Sawada, K.; Tagawa, H.] Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, Hondo, Akita 0108543, Japan; [Hatano, Y.] Yamamoto Kumiai Gen Hosp, Dept Internal Med, Noshiro, Akita, Japan; [Oshima, K.] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan; [Seto, M.] Aichi Canc Ctr, Res Inst, Dept Mol Med, Nagoya, Aichi 464, Japan	Kurume University; Aichi Cancer Center	Tagawa, H (corresponding author), Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, Hondo, Akita 0108543, Japan.	htagawa0279jp@yahoo.co.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (HT). We wish to express our appreciation to Ms E Kobayashi, Y Abc, K Iwamoto, H Kataho and Mr J Yamashita for their outstanding technical assistance, Drs T Nanjo (Akita University, Akita, Japan), S Nakamura (Nagoya University, Nagoya, Japan) and R Ichinohasama (Tohoku University, Sendai, Japan) for their histological and/or clinical diagnosis of MCL. Drs N Takahashi (Akita University), N Takahashi (Akita University), Y Michishita (Akita University), K Honda (Akita University), M Kume (Hiraka General Hospital), H Oyagi (Hiraka General Hospital), M Katayama (Aichi Cancer Center) and F Arakawa (Kurume University) for collection of primary lymphoma samples and constructive discussion.	Bea S, 2001, CANCER RES, V61, P2409; Bea S, 2009, BLOOD, V113, P3059, DOI 10.1182/blood-2008-07-170183; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dong PX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-99; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Feuring-Buske M, 2001, BLOOD, V97, P3882, DOI 10.1182/blood.V97.12.3882; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Goodell Margaret A, 2005, Methods Mol Biol, V290, P343; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jagani Z, 2010, CANCER RES, V70, P5528, DOI 10.1158/0008-5472.CAN-09-4229; Jares P, 2008, BRIT J HAEMATOL, V142, P149, DOI 10.1111/j.1365-2141.2008.07124.x; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kimura M, 2011, CANCER SCI, V102, P983, DOI 10.1111/j.1349-7006.2011.01891.x; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mitsutake N, 2007, ENDOCRINOLOGY, V148, P1797, DOI 10.1210/en.2006-1553; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; O'Connor OA, 2005, J CLIN ONCOL, V23, P676, DOI 10.1200/JCO.2005.02.050; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Pouliot LM, 2012, CANCER RES, V72, P5945, DOI 10.1158/0008-5472.CAN-12-1400; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rivas MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3187; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Swerdlow SH, 2008, WHO CLASSIFICATION T, P158; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; VANLOHUIZEN M, 1991, NATURE, V353, P353, DOI 10.1038/353353a0; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Wu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014648; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337; Zhang XN, 2010, CANCER RES, V70, P7176, DOI 10.1158/0008-5472.CAN-10-0697; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147; Zhou R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030772; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zhu YH, 2011, CLIN CANCER RES, V17, P7105, DOI 10.1158/1078-0432.CCR-11-0071	58	41	44	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2014	33	17					2191	2203		10.1038/onc.2013.177	http://dx.doi.org/10.1038/onc.2013.177			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF8WJ	23686310				2022-12-25	WOS:000334996000005
J	Distrutti, E; Cipriani, S; Mencarelli, A; Renga, B; Fiorucci, S				Distrutti, Eleonora; Cipriani, Sabrina; Mencarelli, Andrea; Renga, Barbara; Fiorucci, Stefano			Probiotics VSL#3 Protect against Development of Visceral Pain in Murine Model of Irritable Bowel Syndrome	PLOS ONE			English	Article							NEONATAL MATERNAL SEPARATION; CORTICOTROPIN-RELEASING-FACTOR; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; HYDROGEN-SULFIDE; DOUBLE-BLIND; GASTROINTESTINAL-TRACT; MAINTENANCE TREATMENT; ULCERATIVE-COLITIS; GENE-EXPRESSION	Background and Aims: Irritable bowel syndrome (IBS) is linked to post-inflammatory and stress-correlated factors that cause changes in the perception of visceral events. Probiotic bacteria may be effective in treating IBS symptoms. Here, we have investigated whether early life administration of VSL#3, a mixture of 8 probiotic bacteria strains, protects against development of visceral hypersensitivity driven by neonatal maternal separation (NMS), a rat model of IBS. Methods: Male NMS pups were treated orally with placebo or VSL#3 from days 3 to 60, while normal, not separated rats were used as controls. After 60 days from birth, perception of painful sensation induced by colorectal distension (CRD) was measured by assessing the abdominal withdrawal reflex (score 0-4). The colonic gene expression was assessed by using the Agilent Whole Rat Genome Oligo Microarrays platform and confirmed by real time PCR. Results: NMS rats exhibited both hyperalgesia and allodynia when compared to control rats. VSL#3 had a potent analgesic effect on CRD-induced pain without changing the colorectal compliance. The microarray analysis demonstrated that NMS induces a robust change in the expression of subsets of genes (CCL2, NOS3, THP1, NTRK1, CCR2, BDRKRB1, IL-10, TNFRSF1B, TRPV4, CNR1 and OPRL1) involved in pain transmission and inflammation. TPH1, tryptophan hydroxylase 1, a validated target gene in IBS treatment, was markedly upregulated by NMS and this effect was reversed by VSL#3 intervention. Conclusions: Early life administration of VSL#3 reduces visceral pain perception in a model of IBS and resets colonic expression of subsets of genes mediating pain and inflammation.	[Distrutti, Eleonora] Azienda Osped Perugia, SC Gastroenterol & Epatol, Perugia, Italy; [Cipriani, Sabrina; Mencarelli, Andrea; Renga, Barbara; Fiorucci, Stefano] Univ Perugia, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy	University of Perugia; Azienda Ospedaliera di Perugia; University of Perugia	Distrutti, E (corresponding author), Azienda Osped Perugia, SC Gastroenterol & Epatol, Perugia, Italy.	eleonoradistrutti@katamail.com			CDS investments (Italy)	CDS investments (Italy)	This study was supported in part by CDS investments (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Arborelius L, 2007, NEUROSCIENCE, V145, P738, DOI 10.1016/j.neuroscience.2006.12.007; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bian ZX, 2009, J GASTROENTEROL, V44, P666, DOI 10.1007/s00535-009-0058-2; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Brown PM, 2011, GASTROENTEROLOGY, V141, P507, DOI 10.1053/j.gastro.2011.05.005; Caldji C, 2000, NEUROPSYCHOPHARMACOL, V22, P219, DOI 10.1016/S0893-133X(99)00110-4; Chung EKY, 2007, BRAIN RES, V1153, P68, DOI 10.1016/j.brainres.2007.03.047; Coutinho SV, 2002, AM J PHYSIOL-GASTR L, V282, pG307, DOI 10.1152/ajpgi.00240.2001; De Giorgio Roberto, 2008, Curr Gastroenterol Rep, V10, P385, DOI 10.1007/s11894-008-0073-0; Desbonnet L, 2010, NEUROSCIENCE, V170, P1179, DOI 10.1016/j.neuroscience.2010.08.005; Distrutti E, 2006, J PHARMACOL EXP THER, V316, P325, DOI 10.1124/jpet.105.091595; Distrutti E, 2004, AM J GASTROENTEROL, V99, P131, DOI 10.1046/j.1572-0241.2003.04012.x; Distrutti E, 2006, J PHARMACOL EXP THER, V319, P447, DOI 10.1124/jpet.106.106435; Distrutti E, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-36; Distrutti E, 2009, PHARMACOL RES, V59, P319, DOI 10.1016/j.phrs.2009.01.008; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; Faure C, 2010, GASTROENTEROLOGY, V139, P249, DOI 10.1053/j.gastro.2010.03.032; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Gareau MG, 2006, PEDIATR RES, V59, P83, DOI 10.1203/01.pdr.0000190577.62426.45; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; Guandalini S, 2010, J PEDIATR GASTR NUTR, V51, P24, DOI 10.1097/MPG.0b013e3181ca4d95; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Kiank C, 2010, BRAIN BEHAV IMMUN, V24, P41, DOI 10.1016/j.bbi.2009.08.006; Kim HJ, 2005, NEUROGASTROENT MOTIL, V17, P687, DOI 10.1111/j.1365-2982.2005.00695.x; Kim HJ, 2003, ALIMENT PHARM THER, V17, P895, DOI 10.1046/j.1365-2036.2003.01543.x; Largent-Milnes TM, 2010, EXPERT OPIN THER PAT, V20, P291, DOI 10.1517/13543771003602004; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Lopes LV, 2008, J PROTEOMICS, V71, P80, DOI 10.1016/j.jprot.2008.01.007; Ma XL, 2009, AM J PHYSIOL-GASTR L, V296, pG868, DOI 10.1152/ajpgi.90511.2008; MAYER EA, 1994, GASTROENTEROLOGY, V107, P271, DOI 10.1016/0016-5085(94)90086-8; McKernan DP, 2010, NEUROGASTROENTEROL M, V22, P1026; Mencarelli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045425; Mencarelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022978; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; Minderhoud IM, 2007, CLIN GASTROENTEROL H, V5, P714, DOI 10.1016/j.cgh.2007.02.013; Mustazza C, 2011, MED RES REV, V31, P605, DOI 10.1002/med.20197; NESS TJ, 1990, PAIN, V41, P167, DOI 10.1016/0304-3959(90)90021-5; O'Malley D, 2011, PSYCHOPHARMACOLOGY, V214, P221, DOI 10.1007/s00213-010-1885-9; Ohtsuka Y, 2012, PEDIATR RES, V71, P46, DOI 10.1038/pr.2011.11; PIHOKER C, 1993, PSYCHONEUROENDOCRINO, V18, P485, DOI 10.1016/0306-4530(93)90042-J; Ren TH, 2007, AM J PHYSIOL-GASTR L, V292, pG849, DOI 10.1152/ajpgi.00400.2006; Rousseaux C, 2007, NAT MED, V13, P35, DOI 10.1038/nm1521; Talwar R, 2011, CNS NEUROL DISORD-DR, V10, P536, DOI 10.2174/187152711796235005; Thompson WG, 1999, GUT, V45, P43; Venturi A, 1999, ALIMENT PHARM THER, V13, P1103; Vicentic A, 2006, NEUROSCIENCE, V140, P355, DOI 10.1016/j.neuroscience.2006.02.008; Wall GC, 2011, ANN PHARMACOTHER, V45, P1127, DOI 10.1345/aph.1P790	52	72	76	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63893	10.1371/journal.pone.0063893	http://dx.doi.org/10.1371/journal.pone.0063893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691109	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700063
J	Weise, T; Kai, M; Piechulla, B				Weise, Teresa; Kai, Marco; Piechulla, Birgit			Bacterial Ammonia Causes Significant Plant Growth Inhibition	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; VOLATILES; SOIL; ALKALIZATION; RHIZOSPHERE; TRANSPORT; ROOTS; MAIZE; FUNGI; RICE	Many and complex plant-bacteria inter-relationships are found in the rhizosphere, since plants release a variety of photosynthetic exudates from their roots and rhizobacteria produce multifaceted specialized compounds including rich mixtures of volatiles, e.g., the bouquet of Serratia odorifera 4Rx13 is composed of up to 100 volatile organic and inorganic compounds. Here we show that when growing on peptone-rich nutrient medium S. odorifera 4Rx13 and six other rhizobacteria emit high levels of ammonia, which during co-cultivation in compartmented Petri dishes caused alkalization of the neighboring plant medium and subsequently reduced the growth of A. thaliana. It is argued that in nature high-protein resource degradations (carcasses, whey, manure and compost) are also accompanied by bacterial ammonia emission which alters the pH of the rhizosphere and thereby influences organismal diversity and plant-microbe interactions. Consequently, bacterial ammonia emission may be more relevant for plant colonization and growth development than previously thought.	[Weise, Teresa; Kai, Marco; Piechulla, Birgit] Univ Rostock, Inst Biol Sci, D-18055 Rostock, Germany	University of Rostock	Piechulla, B (corresponding author), Univ Rostock, Inst Biol Sci, D-18055 Rostock, Germany.	birgit.piechulla@uni-rostock.de			DFG [Pi 153/26-1]; University of Rostock	DFG(German Research Foundation (DFG)); University of Rostock	The author Birgit Piechulla was supported by DFG (Pi 153/26-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Sarah Hartl for technical assistance, and the University of Rostock and DFG for financial support to BP. We thank Emily Wheeler, Boston, Massachusetts, for improving the English of the manuscript.	Berg G, 2002, APPL ENVIRON MICROB, V68, P3328, DOI 10.1128/AEM.68.7.3328-3338.2002; Blom D, 2011, APPL ENVIRON MICROB, V77, P1000, DOI 10.1128/AEM.01968-10; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Effmert U, 2012, J CHEM ECOL, V38, P665, DOI 10.1007/s10886-012-0135-5; Egamberdieva D, 2008, ENVIRON MICROBIOL, V10, P1, DOI 10.1111/j.1462-2920.2007.01424.x; Fernando WGD, 2005, SOIL BIOL BIOCHEM, V37, P955, DOI 10.1016/j.soilbio.2004.10.021; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; HENDERSON PJ, 1971, ANNU REV MICROBIOL, V25, P393, DOI 10.1146/annurev.mi.25.100171.002141; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Kai M, 2007, ARCH MICROBIOL, V187, P351, DOI 10.1007/s00203-006-0199-0; Kai M, 2010, PLANT SIGNAL BEHAV, V5, P444, DOI 10.4161/psb.5.4.11340; Kai M, 2010, APPL MICROBIOL BIOT, V88, P965, DOI 10.1007/s00253-010-2810-1; Kai M, 2008, PLANT SIGNAL BEHAV, V3, P482, DOI 10.4161/psb.3.7.5681; Kai M, 2009, FEBS LETT, V583, P3473, DOI 10.1016/j.febslet.2009.09.053; KANAPKA JA, 1983, ARCH ORAL BIOL, V28, P1007, DOI 10.1016/0003-9969(83)90055-9; Kleiner D, 1998, B I PASTEUR, V96, P257, DOI 10.1016/S0020-2452(99)80006-2; KNOWLES CJ, 1976, BACTERIOL REV, V40, P652, DOI 10.1128/MMBR.40.3.652-680.1976; Kosegarten H, 1997, PLANT PHYSIOL, V113, P451, DOI 10.1104/pp.113.2.451; Li Q, 2010, PLANT CELL ENVIRON, V33, P1529, DOI 10.1111/j.1365-3040.2010.02162.x; Lima JE, 2010, PLANT CELL, V22, P3621, DOI 10.1105/tpc.110.076216; Loque D, 2004, J EXP BOT, V55, P1293, DOI 10.1093/jxb/erh147; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; LYNCH JM, 1990, PLANT SOIL, V129, P1, DOI 10.1007/BF00011685; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nguyen C, 2003, AGRONOMIE, V23, P375, DOI 10.1051/agro:2003011; Ozogul F, 2007, EUR FOOD RES TECHNOL, V225, P385, DOI 10.1007/s00217-006-0429-3; Plieth C, 2000, PHYSIOL PLANTARUM, V110, P518; RYDEN JC, 1984, J SCI FOOD AGR, V35, P1297, DOI 10.1002/jsfa.2740351206; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Simon J, 2002, FEMS MICROBIOL REV, V26, P285, DOI 10.1111/j.1574-6976.2002.tb00616.x; Uren NC, 2001, BOOKS SOIL PLANT ENV, P19; Vespermann A, 2007, APPL ENVIRON MICROB, V73, P5639, DOI 10.1128/AEM.01078-07; von Reuss SH, 2010, ANGEW CHEM INT EDIT, V49, P2009, DOI 10.1002/anie.200905680; Wenke K., 2012, BIOCOMMUNICATION PLA, P327; Wenke K, 2012, PLANT J, V70, P445, DOI 10.1111/j.1365-313X.2011.04891.x; Wenke K, 2010, PLANTA, V231, P499, DOI 10.1007/s00425-009-1076-2; Wilson GH, 1998, PLANTA, V206, P154, DOI 10.1007/s004250050386; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Yuan LX, 2009, PLANT CELL PHYSIOL, V50, P13, DOI 10.1093/pcp/pcn186; Zou CS, 2007, SOIL BIOL BIOCHEM, V39, P2371, DOI 10.1016/j.soilbio.2007.04.009; Zou CS, 2010, J MICROBIOL, V48, P460, DOI 10.1007/s12275-010-0068-z	43	58	59	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63538	10.1371/journal.pone.0063538	http://dx.doi.org/10.1371/journal.pone.0063538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691060	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700043
J	Gasparini, C; Evans, JP				Gasparini, Clelia; Evans, Jonathan P.			Ovarian Fluid Mediates the Temporal Decline in Sperm Viability in a Fish with Sperm Storage	PLOS ONE			English	Article							COLORFUL MALE GUPPIES; EVOLUTIONARY CONSEQUENCES; POECILIA-RETICULATA; HONEY-BEE; COMPETITION; TRAITS; MALES; VELOCITY; SURVIVAL; FEMALES	A loss of sperm viability and functionality during sperm transfer and storage within the female reproductive tract can have important fitness implications by disrupting fertilization and impairing offspring development and survival. Consequently, mechanisms that mitigate the temporal decline in sperm function are likely to be important targets of selection. In many species, ovarian fluid is known to regulate and maintain sperm quality. In this paper, we use the guppy Poecilia reticulata, a highly polyandrous freshwater fish exhibiting internal fertilization and sperm storage, to determine whether ovarian fluid (OF) influences the decline in sperm viability (the proportion of live sperm in the ejaculate) over time and whether any observed effects depend on male sexual ornamentation. To address these questions we used a paired experimental design in which ejaculates from individual males were tested in vitro both in presence and absence of OF. Our results revealed that the temporal decline in sperm viability was significantly reduced in the presence of OF compared to a saline control. This finding raises the intriguing possibility that OF may play a role in mediating the decline in sperm quality due to the deleterious effects of sperm ageing, although other possible explanations for this observation are discussed. Interestingly, we also show that the age-related decline in sperm viability was contingent on male sexual ornamentation; males with relatively high levels of iridescence (indicating higher sexual attractiveness) exhibited a more pronounced decline in sperm viability over time than their less ornamented counterparts. This latter finding offers possible insights into the functional basis for the previously observed trade-off between these key components of pre- and postcopulatory sexual selection.	[Gasparini, Clelia; Evans, Jonathan P.] Univ Western Australia, Sch Anim Biol M092, Ctr Evolutionary Biol, Crawley, WA, Australia	University of Western Australia	Gasparini, C (corresponding author), Univ Western Australia, Sch Anim Biol M092, Ctr Evolutionary Biol, Crawley, WA, Australia.	clelia.gasparini@uwa.edu.au	Evans, Jonathan/A-1992-2011; Gasparini, Clelia/F-2159-2011; RAHI, DEEPALI/GMW-8189-2022	RAHI, DEEPALI/0000-0002-4818-5572	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [272613]	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme	This research was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (grant no. 272613) to C.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r67; Bernasconi G, 2002, J INSECT PHYSIOL, V48, P197, DOI 10.1016/S0022-1910(01)00164-0; BILLARD R, 1969, ANN BIOL ANIM BIOCH, V9, P251, DOI 10.1051/rnd:19690208; Billard R., 1990, CONTROLS SPERM MOTIL, P155; den Boer SPA, 2009, J INSECT PHYSIOL, V55, P538, DOI 10.1016/j.jinsphys.2009.01.012; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Elofsson H, 2003, J FISH BIOL, V63, P240, DOI 10.1046/j.1095-8649.2003.00153.x; Evans JP, 2011, HEREDITY, V106, P869, DOI 10.1038/hdy.2010.130; Evans JP, 2010, P ROY SOC B-BIOL SCI, V277, P3195, DOI 10.1098/rspb.2010.0826; Evans JP, 2009, NATURWISSENSCHAFTEN, V96, P771, DOI 10.1007/s00114-009-0529-6; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; GARDINER DM, 1978, COMP BIOCHEM PHYS A, V59, P165, DOI 10.1016/0300-9629(78)90200-1; Gasparini C, 2012, NATURWISSENSCHAFTEN, V99, P417, DOI 10.1007/s00114-012-0908-2; Gasparini C, 2011, P ROY SOC B-BIOL SCI, V278, P2495, DOI 10.1098/rspb.2010.2369; Gasparini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012146; Gasparini C, 2009, BIOL LETTERS, V5, P792, DOI 10.1098/rsbl.2009.0413; Giuffrida A, 1996, INSECT BIOCHEM MOLEC, V26, P347, DOI 10.1016/0965-1748(95)00095-X; Greven H, 2011, ECOLOGY EVOLUTION PO; Holman L, 2009, BEHAV ECOL SOCIOBIOL, V63, P1679, DOI 10.1007/s00265-009-0816-4; Houde A.E., 1997, SEX COLOR MATE CHOIC; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Lahnsteiner F, 2002, FISH PHYSIOL BIOCHEM, V27, P49, DOI 10.1023/B:FISH.0000021792.97913.2e; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; LODGE JR, 1971, BIOL REPROD, V5, P252, DOI 10.1093/biolreprod/5.3.252; MAGURRAN AE, 1994, P ROY SOC B-BIOL SCI, V255, P31, DOI 10.1098/rspb.1994.0005; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pilastro A, 2008, BEHAV ECOL, V19, P374, DOI 10.1093/beheco/arm140; Pitcher TE, 2007, J FISH BIOL, V70, P165, DOI 10.1111/j.1095-8649.2006.01292.x; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P247, DOI 10.1016/B978-0-12-372568-4.00007-0; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Reinhardt K, 2007, Q REV BIOL, V82, P375, DOI 10.1086/522811; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Rosengrave P, 2009, CAN J ZOOL, V87, P920, DOI 10.1139/Z09-081; Rosengrave P, 2008, BEHAV ECOL, V19, P1179, DOI 10.1093/beheco/arn089; Simmons LW, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P405, DOI 10.1016/B978-0-12-372568-4.00010-0; Smith CC, 2012, BEHAV ECOL, V23, P820, DOI 10.1093/beheco/ars036; Tarin JJ, 2000, HUM REPROD UPDATE, V6, P532, DOI 10.1093/humupd/6.6.532; Tazzyman SJ, 2009, AM NAT, V174, pE71, DOI 10.1086/603612; Turner E, 2002, J FISH BIOL, V60, P1570, DOI [10.1006/jfbi.2002.2018, 10.1111/j.1095-8649.2002.tb02449.x]; Uhl G, 1996, J ZOOL, V240, P153, DOI 10.1111/j.1469-7998.1996.tb05492.x; Velando A, 2008, BIOESSAYS, V30, P1212, DOI 10.1002/bies.20838; Weirich GF, 2002, APIDOLOGIE, V33, P3, DOI 10.1051/apido:2001001; White J, 2008, P NATL ACAD SCI USA, V105, P13947, DOI 10.1073/pnas.0803067105	45	17	17	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64431	10.1371/journal.pone.0064431	http://dx.doi.org/10.1371/journal.pone.0064431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691216	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400126
J	Gugliesi, F; Bawadekar, M; De Andrea, M; Dell'Oste, V; Caneparo, V; Tincani, A; Gariglio, M; Landolfo, S				Gugliesi, Francesca; Bawadekar, Mandar; De Andrea, Marco; Dell'Oste, Valentina; Caneparo, Valeria; Tincani, Angela; Gariglio, Marisa; Landolfo, Santo			Nuclear DNA Sensor IFI16 as Circulating Protein in Autoimmune Diseases Is a Signal of Damage that Impairs Endothelial Cells through High-Affinity Membrane Binding	PLOS ONE			English	Article							INDUCIBLE GENE IFI16; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; FAMILY; AUTOANTIGEN; INTERFERONS; EXPRESSION; RECEPTORS; SCLEROSIS; PATHWAYS	IFI16, a nuclear pathogenic DNA sensor induced by several pro-inflammatory cytokines, is a multifaceted protein with various functions. It is also a target for autoantibodies as specific antibodies have been demonstrated in the sera of patients affected by systemic autoimmune diseases. Following transfection of virus-derived DNA, or treatment with UVB, IFI16 delocalizes from the nucleus to the cytoplasm and is then eventually released into the extracellular milieu. In this study, using an in-house capture enzyme-linked immunsorbent assay we demonstrate that significant levels of IFI16 protein can also exist as circulating form in the sera of autoimmune patients. We also show that the rIFI16 protein, when added in-vitro to endothelial cells, does not affect cell viability, but severely limits their tubulogenesis and transwell migration activities. These inhibitory effects are fully reversed in the presence of anti-IFI16 N-terminal antibodies, indicating that its extracellular activity resides within the N-terminus. It was further demonstrated that endogenous IFI16 released by apoptotic cells bind neighboring cells in a co-culture. Immunofluorescence assays revealed existence of high-affinity binding sites on the plasma membrane of endothelial cells. Free recombinant IFI16 binds these sites on HUVEC with dissociation constant of 2.7 nM, radioiodinated and unlabeled IFI16 compete for binding sites, with inhibition constant (K-i) of 14.43 nM and half maximal inhibitory concentration (IC50) of 67.88 nM; these data allow us to estimate the presence of 250,000 to 450,000 specific binding sites per cell. Corroborating the results from functional assays, this binding could be completely inhibited using anti-IFI16 N-terminal antibody, but not with an antibody raised against the IFI16 C-terminal. Altogether, these data demonstrate that IFI16 may exist as circulating protein in the sera of autoimmune patients which binds endothelial cells causing damage, suggesting a new pathogenic and alarmin function through which this protein triggers the development of autoimmunity.	[Gugliesi, Francesca; De Andrea, Marco; Dell'Oste, Valentina; Landolfo, Santo] Univ Turin, Sch Med, Dept Publ Hlth & Pediat Sci, Turin, Italy; [Bawadekar, Mandar; De Andrea, Marco; Caneparo, Valeria; Gariglio, Marisa] Univ Piemonte Orientale Amedeo Avogadro, Sch Med, Dept Translat Med, Novara, Italy; [Bawadekar, Mandar; Caneparo, Valeria; Gariglio, Marisa] Univ Piemonte Orientale Amedeo Avogadro, Sch Med, Interdisciplinary Res Ctr Autoimmune Dis, Dept Translat Med, Novara, Italy; [Tincani, Angela] Spedali Civil Brescia, I-25125 Brescia, Italy; [Tincani, Angela] Univ Brescia, Brescia, Italy	University of Turin; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Hospital Spedali Civili Brescia; University of Brescia	Landolfo, S (corresponding author), Univ Turin, Sch Med, Dept Publ Hlth & Pediat Sci, Turin, Italy.	santo.landolfo@unito.it	De Andrea, Marco/J-5253-2012; Tincani, Angela/E-7608-2010	De Andrea, Marco/0000-0002-3188-5783; /0000-0001-6389-5129; Caneparo, Valeria/0000-0002-8210-3235; Gariglio, Marisa/0000-0002-5187-0140; DELL'OSTE, Valentina/0000-0002-9336-7906	MIUR PRIN (Ministero dell'Istruzione, dell'Universita e della Ricerca - Progetti di Ricerca di Interesse Nazionaleto); University of Turin; Lagrange Project-CRT Foundation; Cariplo Foundation-Milan, Italy	MIUR PRIN (Ministero dell'Istruzione, dell'Universita e della Ricerca - Progetti di Ricerca di Interesse Nazionaleto); University of Turin; Lagrange Project-CRT Foundation; Cariplo Foundation-Milan, Italy(Fondazione Cariplo)	This study was supported by MIUR PRIN 2008 (Ministero dell'Istruzione, dell'Universita e della Ricerca - Progetti di Ricerca di Interesse Nazionaleto) to SL, MG and AT, and research funding from the University of Turin 2011 to SL. VC acknowledges a grant for the Lagrange Project-CRT Foundation. MB is a recipient of an international PhD fellowship in Innovative Biomedical Technologies (IBT) funded by Cariplo Foundation-Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach JF, 2005, J AUTOIMMUN, V25, P74, DOI 10.1016/j.jaut.2005.09.024; BACHMANN M, 1992, EXP CELL RES, V201, P387, DOI 10.1016/0014-4827(92)90288-J; Baggetta R, 2010, EUR J IMMUNOL, V40, P2182, DOI 10.1002/eji.200939995; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Caposio P, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M701846200; Choubey D, 2011, J INTERF CYTOK RES, V31, P857, DOI 10.1089/jir.2011.0101; COLEMAN JW, 1981, IMMUNOLOGY, V44, P859; Costa S, 2011, BRIT J DERMATOL, V164, P282, DOI 10.1111/j.1365-2133.2010.10097.x; Costa S, 2011, RHEUMATOLOGY, V50, P674, DOI 10.1093/rheumatology/keq372; Cridland JA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-140; Cristea IM, 2010, J VIROL, V84, P7803, DOI 10.1128/JVI.00139-10; Crow Mary K, 2010, Arthritis Res Ther, V12 Suppl 1, pS5, DOI 10.1186/ar2886; Elkon KB, 2012, CURR OPIN RHEUMATOL, V24, P499, DOI 10.1097/BOR.0b013e3283562c3e; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Gariglio M, 2002, J INTERF CYTOK RES, V22, P815, DOI 10.1089/107999002320271413; Gariglio M, 2011, J INTERF CYTOK RES, V31, P159, DOI 10.1089/jir.2010.0106; Gugliesi F, 2005, J LEUKOCYTE BIOL, V77, P820, DOI 10.1189/jlb.0904507; Gugliesi F, 2011, J INTERF CYTOK RES, V31, P609, DOI 10.1089/jir.2011.0001; Gugliesi F, 2010, J AUTOIMMUN, V35, P114, DOI 10.1016/j.jaut.2010.04.001; Guiducci S, 2008, RHEUMATOLOGY, V47, pV18, DOI 10.1093/rheumatology/ken267; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Higgs BW, 2012, INT J RHEUM DIS, V15, P25, DOI 10.1111/j.1756-185X.2011.01654.x; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; IMAI Y, 1982, CANCER RES, V42, P4394; Kaplan MJ, 2009, AUTOIMMUNITY, V42, P561, DOI 10.1080/08916930903002453; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kong JSW, 2006, AUTOIMMUN REV, V5, P471, DOI 10.1016/j.autrev.2006.02.014; KORISTKA S, 2013, J AUTOIMMUN IN PRESS; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; Mavragani CP, 2010, J AUTOIMMUN, V35, P225, DOI 10.1016/j.jaut.2010.06.012; Mondini M, 2007, ANN NY ACAD SCI, V1110, P47, DOI 10.1196/annals.1423.006; Mondini M, 2006, ARTHRITIS RHEUM, V54, P3939, DOI 10.1002/art.22266; Mondini M, 2010, AUTOIMMUNITY, V43, P226, DOI 10.3109/08916930903510922; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; Pollard KM, 2012, J AUTOIMMUN, V39, P323, DOI 10.1016/j.jaut.2012.04.003; Rashtak Shadi, 2008, V10, P344, DOI 10.1159/000131754; Rekvig OP, 2012, AUTOIMMUN REV, V11, P596, DOI 10.1016/j.autrev.2011.10.021; Ronnblom L, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2884; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Selmi C, 2006, CURR OPIN INVEST DR, V7, P451; Sozzani S, 2010, AUTOIMMUNITY, V43, P196, DOI 10.3109/08916930903510872; Sponza S, 2009, CELL IMMUNOL, V257, P55, DOI 10.1016/j.cellimm.2009.02.007; Unterholzner L, 2011, CELL HOST MICROBE, V9, P351, DOI 10.1016/j.chom.2011.05.001	43	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63045	10.1371/journal.pone.0063045	http://dx.doi.org/10.1371/journal.pone.0063045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690979	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400029
J	Krylova, I; Kumar, RR; Kofoed, EM; Schaufele, F				Krylova, Irina; Kumar, Rachit R.; Kofoed, Eric M.; Schaufele, Fred			A Versatile, Bar-Coded Nuclear Marker/Reporter for Live Cell Fluorescent and Multiplexed High Content Imaging	PLOS ONE			English	Article							HIGH-THROUGHPUT MICROSCOPY; ANDROGEN-RECEPTOR; HYDROGEL MICROPARTICLES; DYNAMICS; LIGAND; LOCALIZATION; PROTEINS; MUTATION; MECHANISMS; PLATFORMS	The screening of large numbers of compounds or siRNAs is a mainstay of both academic and pharmaceutical research. Most screens test those interventions against a single biochemical or cellular output whereas recording multiple complementary outputs may be more biologically relevant. High throughput, multi-channel fluorescence microscopy permits multiple outputs to be quantified in specific cellular subcompartments. However, the number of distinct fluorescent outputs available remains limited. Here, we describe a cellular bar-code technology in which multiple cell-based assays are combined in one well after which each assay is distinguished by fluorescence microscopy. The technology uses the unique fluorescent properties of assay-specific markers comprised of distinct combinations of different 'red' fluorescent proteins sandwiched around a nuclear localization signal. The bar-code markers are excited by a common wavelength of light but distinguished ratiometrically by their differing relative fluorescence in two emission channels. Targeting the bar-code to cell nuclei enables individual cells expressing distinguishable markers to be readily separated by standard image analysis programs. We validated the method by showing that the unique responses of different cell-based assays to specific drugs are retained when three assays are co-plated and separated by the bar-code. Based upon those studies, we discuss a roadmap in which even more assays may be combined in a well. The ability to analyze multiple assays simultaneously will enable screens that better identify, characterize and distinguish hits according to multiple biologically or clinically relevant criteria. These capabilities also enable the re-creation of complex mixtures of cell types that is emerging as a central area of interest in many fields.	[Krylova, Irina; Kumar, Rachit R.; Kofoed, Eric M.; Schaufele, Fred] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Schaufele, F (corresponding author), Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA.	freds@diabetes.ucsf.edu			Congressionally Directed Medical Research Programs [PC040777, PC080258]; National Institutes of Health [P30 DK63720]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Congressionally Directed Medical Research Programs(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Congressionally Directed Medical Research Programs (http://cdmrp.army.mil/, grant numbers PC040777, PC080258). Maintenance of microscopy equipment was partially offset with Center grant support from the National Institutes of Health (http://www.nih.gov/, grant number P30 DK63720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik IU, 2005, CANCER RES, V65, P7959, DOI 10.1158/0008-5472.CAN-04-3541; Appleyard DC, 2011, NAT PROTOC, V6, P1761, DOI 10.1038/nprot.2011.400; BHADRIRAJU K, 2003, DRUG DISCOV TODAY, P612; BRESLIN S, 2012, DRUG DISCOV TODAY, DOI DOI 10.1016/J.DRUDIS.2012.1010.1003.EPUB; Broers JLV, 1999, J CELL SCI, V112, P3463; Carpenter AE, 2007, NAT CHEM BIOL, V3, P461, DOI 10.1038/nchembio.2007.15; Carpenter Anne E., 2009, V486, P193, DOI 10.1007/978-1-60327-545-3_14; Cressman DE, 2001, J IMMUNOL, V167, P3626, DOI 10.4049/jimmunol.167.7.3626; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Dixit R, 2003, PLANT J, V36, P280, DOI 10.1046/j.1365-313X.2003.01868.x; Erdman SE, 2010, INT J CANCER, V127, P768, DOI 10.1002/ijc.25430; Fenton MA, 1997, CLIN CANCER RES, V3, P1383; FISCHERFANTUZZI L, 1988, MOL CELL BIOL, V8, P5495, DOI 10.1128/MCB.8.12.5495; Fujii G, 1999, EXP CELL RES, V251, P299, DOI 10.1006/excr.1999.4575; Fuller CJ, 2010, J MICROSC-OXFORD, V238, P145, DOI [10.1111/j.1365-2818.2009.03337.x, 10.1111/j.1365-2818.2009.05557.x]; Georget V, 1997, MOL CELL ENDOCRINOL, V129, P17, DOI 10.1016/S0303-7207(97)04034-3; Hamilton NA, 2012, METHOD ENZYMOL, V504, P393, DOI 10.1016/B978-0-12-391857-4.00020-3; Hartig SM, 2011, METHODS MOL BIOL, V776, P313, DOI 10.1007/978-1-61779-243-4_18; Haugland RP, 2010, MOL PROBES HDB; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Hoebe RA, 2007, NAT BIOTECHNOL, V25, P249, DOI 10.1038/nbt1278; Jones JO, 2008, ACS CHEM BIOL, V3, P412, DOI 10.1021/cb800054w; Jones JO, 2009, ACS CHEM BIOL, V4, P199, DOI 10.1021/cb900024z; Josson S, 2010, SEMIN CELL DEV BIOL, V21, P26, DOI 10.1016/j.semcdb.2009.11.016; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kofoed EM, 2010, J BIOL CHEM, V285, P2428, DOI 10.1074/jbc.M109.045203; Kofoed EM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940366; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Krucker T, 2011, PHILOS T R SOC A, V369, P4651, DOI 10.1098/rsta.2011.0300; Lee S, 2006, METHOD ENZYMOL, V414, P468, DOI 10.1016/S0076-6879(06)14025-2; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; Lock JG, 2010, EXP CELL RES, V316, P1438, DOI 10.1016/j.yexcr.2010.04.001; LONERGAN PE, 2011, J CARCINOG, V10, pE20; Lorusso G, 2012, SEMIN CANCER BIOL, V22, P226, DOI 10.1016/j.semcancer.2012.03.007; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; Miki Y, 2012, J STEROID BIOCHEM, V131, P68, DOI 10.1016/j.jsbmb.2011.12.004; Moore J, 2008, METHOD CELL BIOL, V85, P555, DOI 10.1016/S0091-679X(08)85024-8; Niles Andrew L, 2009, Curr Chem Genomics, V3, P33, DOI 10.2174/1875397300903010033; Oheim M, 2011, EXPERT OPIN DRUG DIS, V6, P1299, DOI 10.1517/17460441.2011.637105; Park S, 2012, SENSORS-BASEL, V12, P8426, DOI 10.3390/s120608426; Purschke M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1634, DOI 10.1039/c0pp00234h; Riss TL, 2011, METHODS MOL BIOL, V740, P103, DOI 10.1007/978-1-61779-108-6_12; Roy AK, 2001, ANN NY ACAD SCI, V949, P44; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Szafran AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003605; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0; Zock JM, 2009, COMB CHEM HIGH T SCR, V12, P870, DOI 10.2174/138620709789383277	57	6	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63286	10.1371/journal.pone.0063286	http://dx.doi.org/10.1371/journal.pone.0063286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691010	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400042
J	Tang, CH; Lee, TH				Tang, Cheng-Hao; Lee, Tsung-Han			Early Response of Protein Quality Control in Gills Is Associated with Survival of Hypertonic Shock in Mozambique tilapia	PLOS ONE			English	Article							BRANCHIAL CHLORIDE CELLS; OREOCHROMIS-MOSSAMBICUS; HEAT-SHOCK; TETRAODON-NIGROVIRIDIS; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONES; HYPOOSMOTIC STRESS; EURYHALINE TELEOST; RICH CELLS; ION UPTAKE	The protein quality control (PQC) mechanism is essential for cell function and viability. PQC with proper biological function depends on molecular chaperones and proteases. The hypertonicity-induced protein damage and responses of PQC mechanism in aquatic organisms, however, are poorly understood. In this study, we examine the short-term effects of different hypertonic shocks on the levels of heat shock proteins (HSPs, e.g., HSP70 and HSP90), ubiquitin-conjugated proteins and protein aggregation in gills of the Mozambique tilapia (Oreochromis mossambicus). Following transfer from fresh water (FW) to 20% hypertonicity, all examined individuals survived to the end of experiment. Moreover, the levels of branchial HSPs and ubiquitin-conjugated proteins significantly increased at 3 and 24 h post-transfer, respectively. Upregulation of HSPs and ubiquitin-conjugated proteins was sufficient to prevent the accumulation of aggregated proteins. However, the survival rate of tilapia dramatically declined at 5 h and all fish died within 7 h after direct transfer to 30% hypertonicity. We presumed that this result was due to the failed activation of gill PQC system, which resulted in elevating the levels of aggregated proteins at 3 and 4 h. Furthermore, in aggregated protein fractions, the amounts of gill Na+/K+-ATPase (NKA) remained relatively low when fish were transferred to 20% hypertonicity, whereas abundant NKA was found at 4 h post-transfer to 30% hypertonicity. This study demonstrated that the response of PQC in gills is earlier than observable changes in localization of ion-secreting transport proteins upon hypertonic challenge. To our knowledge, this is the first study to investigate the regulation of PQC mechanism in fish and characterize its important role in euryhaline teleost survival in response to hypertonic stress.	[Tang, Cheng-Hao] Natl Dong Hwa Univ, Inst Marine Biotechnol, Pingtung, Taiwan; [Tang, Cheng-Hao] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Lee, Tsung-Han] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lee, Tsung-Han] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan	National Dong Hwa University; National Museum of Marine Biology & Aquarium; National Chung Hsing University; China Medical University Taiwan	Lee, TH (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	thlee@email.nchu.edu.tw		Lee, Tsung-Han/0000-0002-3542-4335	National Science Council of Taiwan [NSC 99-2321-B-005-013-MY3, NSC 101-2313-B-259-002-]; NICHD, USA [N01-HD-6-2915]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); NICHD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported partly by a grant to T-HL (NSC 99-2321-B-005-013-MY3) and partly by a grant to C-HT (NSC 101-2313-B-259-002-) from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The monoclonal antibody T4 was purchased from the Developmental Studies Hybridoma Bank (DSHB) maintained by the Department of Pharmacology and Molecular Sciences, John Hopkins University School of Medicine, Baltimore, MD 2120521205, and the Department of Biological Sciences, University of Iowa, Iowa City, IA 52242, under Contract N01-HD-6-2915, NICHD, USA.	Alfieri RR, 2007, PFLUG ARCH EUR J PHY, V454, P173, DOI 10.1007/s00424-006-0195-x; [Anonymous], 1983, TILAPIINE FISHES GEN; Aufricht C, 1998, AM J PHYSIOL-RENAL, V274, pF268, DOI 10.1152/ajprenal.1998.274.2.F268; Breves JP, 2010, COMP BIOCHEM PHYS A, V155, P294, DOI 10.1016/j.cbpa.2009.10.033; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Choe KP, 2008, AM J PHYSIOL-CELL PH, V295, pC1488, DOI 10.1152/ajpcell.00450.2008; Deane EE, 2009, REV FISH BIOL FISHER, V19, P97, DOI 10.1007/s11160-008-9091-0; Deane EE, 2004, AM J PHYSIOL-REG I, V287, pR1054, DOI 10.1152/ajpregu.00347.2004; Evans DH, 2011, ACTA PHYSIOL, V202, P349, DOI 10.1111/j.1748-1716.2010.02186.x; Evans DH, 2008, AM J PHYSIOL-REG I, V295, pR704, DOI 10.1152/ajpregu.90337.2008; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Evans TG, 2008, J EXP BIOL, V211, P3636, DOI 10.1242/jeb.022160; Fiol DF, 2005, P NATL ACAD SCI USA, V102, P927, DOI 10.1073/pnas.0408956102; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Hamer B, 2008, AQUAT TOXICOL, V89, P137, DOI 10.1016/j.aquatox.2008.06.015; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; Hiroi J, 2008, J EXP BIOL, V211, P2584, DOI 10.1242/jeb.018663; Hirose S, 2003, COMP BIOCHEM PHYS B, V136, P593, DOI 10.1016/S1096-4959(03)00287-2; HOFMANN GE, 1995, J EXP BIOL, V198, P1509; HWANG PP, 1987, MAR BIOL, V94, P643, DOI 10.1007/BF00431411; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Hwang PP, 2009, J EXP BIOL, V212, P1745, DOI 10.1242/jeb.026054; Inokuchi M, 2008, COMP BIOCHEM PHYS A, V151, P151, DOI 10.1016/j.cbpa.2008.06.012; Iwama GK, 1999, AM ZOOL, V39, P901; KABAKOV AE, 1993, EXPERIENTIA, V49, P706, DOI 10.1007/BF01923956; Kalujnaia S, 2010, FASEB J, V24, P3981, DOI 10.1096/fj.10-161000; Kammerer BD, 2010, COMP BIOCHEM PHYS A, V157, P260, DOI 10.1016/j.cbpa.2010.07.009; Kaneko Toyoji, 2008, Aqua-Bioscience Monographs, V1, P1; Katoh F, 2003, J EXP BIOL, V206, P4113, DOI 10.1242/jeb.00659; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Kultz D, 2001, ZOOL-ANAL COMPLEX SY, V104, P198, DOI 10.1078/0944-2006-00025; Kultz D, 1998, J EXP BIOL, V201, P3015; Marshall William S., 2006, P177; Marshall WS, 2002, J EXP ZOOL, V293, P264, DOI 10.1002/jez.10127; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; McCormick SD, 2003, J EXP BIOL, V206, P4575, DOI 10.1242/jeb.00711; Miura E, 2007, PLANT CELL, V19, P1313, DOI 10.1105/tpc.106.049270; Place SP, 2004, AM J PHYSIOL-REG I, V287, pR429, DOI 10.1152/ajpregu.00223.2004; Rinehart JP, 2006, P NATL ACAD SCI USA, V103, P14223, DOI 10.1073/pnas.0606840103; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schlieker C, 2002, J BIOTECHNOL, V96, P13, DOI 10.1016/S0168-1656(02)00033-0; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Somero G. N., 1997, HDB PHYSIOL 14, P441; Soti C, 2007, J BIOSCIENCES, V32, P511, DOI 10.1007/s12038-007-0050-z; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tang CH, 2011, ZOOL STUD, V50, P31; Tang CH, 2010, J EXP BIOL, V213, P683, DOI 10.1242/jeb.040212; Tipsmark CK, 2008, AM J PHYSIOL-REG I, V294, pR1004, DOI 10.1152/ajpregu.00112.2007; Todgham AE, 2007, J COMP PHYSIOL B, V177, P857, DOI 10.1007/s00360-007-0183-2; Vitale A, 2004, PLANT PHYSIOL, V136, P3420, DOI 10.1104/pp.104.050351; Wang PJ, 2009, COMP BIOCHEM PHYS A, V152, P544, DOI 10.1016/j.cbpa.2008.12.012; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888	56	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63112	10.1371/journal.pone.0063112	http://dx.doi.org/10.1371/journal.pone.0063112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690986	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400032
J	Saitoh, M; Shirakihara, T; Fukasawa, A; Horiguchi, K; Sakamoto, K; Sugiya, H; Beppu, H; Fujita, Y; Morita, I; Miyazono, K; Miyazawa, K				Saitoh, Masao; Shirakihara, Takuya; Fukasawa, Akira; Horiguchi, Kana; Sakamoto, Kei; Sugiya, Hiroshi; Beppu, Hideyuki; Fujita, Yasuyuki; Morita, Ikuo; Miyazono, Kohei; Miyazawa, Keiji			Basolateral BMP Signaling in Polarized Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PRIMARY PULMONARY-HYPERTENSION; MESENCHYMAL TRANSITION; MDCK CELLS; RECEPTOR; CANCER; TIGHT; ORGANIZATION; TRAFFICKING; COMPLEXES	Bone morphogenetic proteins (BMPs) regulate various biological processes, mostly mediated by cells of mesenchymal origin. However, the roles of BMPs in epithelial cells are poorly understood. Here, we demonstrate that, in polarized epithelial cells, BMP signals are transmitted from BMP receptor complexes exclusively localized at the basolateral surface of the cell membrane. In addition, basolateral stimulation with BMP increased expression of components of tight junctions and enhanced the transepithelial resistance (TER), counteracting reduction of TER by treatment with TGF-beta or an anti-tumor drug. We conclude that BMPs maintain epithelial polarity via intracellular signaling from basolaterally localized BMP receptors.	[Saitoh, Masao; Fukasawa, Akira; Miyazawa, Keiji] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo, Yamanashi, Japan; [Shirakihara, Takuya] Natl Canc Ctr, Div Metastasis & Invas Signaling, Chuo Ku, Tokyo, Japan; [Saitoh, Masao; Shirakihara, Takuya; Horiguchi, Kana; Miyazono, Kohei] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Sakamoto, Kei] Tokyo Med & Dent Univ, Sect Oral Pathol, Int Res Ctr Mol Sci Tooth & Bone Dis, Grad Sch Med & Dent Sci,Bunkyo Ku, Tokyo, Japan; [Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Vet Biochem Lab, Fujisawa, Kanagawa, Japan; [Beppu, Hideyuki] Toyama Univ, Dept Clin Lab & Mol Pathol, Grad Sch Med & Pharmaceut Sci Res, Toyama 930, Japan; [Fujita, Yasuyuki] Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido, Japan; [Saitoh, Masao; Morita, Ikuo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Int Res Ctr Mol Sci Tooth & Bone Dis, Dept Cellular Physiol Chem, Tokyo, Japan; [Saitoh, Masao; Morita, Ikuo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Tokyo, Japan	University of Yamanashi; National Cancer Center - Japan; University of Tokyo; Tokyo Medical & Dental University (TMDU); Nihon University; University of Toyama; Hokkaido University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Saitoh, M (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo, Yamanashi, Japan.	msaitoh-ind@umin.ac.jp	MIYAZAWA, KEIJI/I-9713-2014	Shirakihara, Takuya/0000-0002-6222-0143	KAKENHI; Global Center of Excellence (GCOE) Program (International Research Center for Molecular Science in Tooth and Bone Diseases); Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22112002, 22390059] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global Center of Excellence (GCOE) Program (International Research Center for Molecular Science in Tooth and Bone Diseases); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by KAKENHI (Grants-in-Aid for Scientific Research), the Global Center of Excellence (GCOE) Program (International Research Center for Molecular Science in Tooth and Bone Diseases), and the Core-to-Core program "Cooperative International Framework in TGF-beta Family Signaling" from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beppu H, 1997, BIOCHEM BIOPH RES CO, V235, P499, DOI 10.1006/bbrc.1997.6816; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2005, TRENDS CELL BIOL, V15, P222, DOI 10.1016/j.tcb.2005.02.006; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Gonzalez A, 2009, FEBS LETT, V583, P3784, DOI 10.1016/j.febslet.2009.10.050; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Gravotta D, 2012, DEV CELL, V22, P811, DOI 10.1016/j.devcel.2012.02.004; Hardwick JC, 2008, NAT REV CANCER, V8, P806, DOI 10.1038/nrc2467; HOBERT M, 1995, J CELL PHYSIOL, V162, P434, DOI 10.1002/jcp.1041620316; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Kallioniemi A, 2012, CANCER GENET-NY, V205, P267, DOI 10.1016/j.cancergen.2012.05.009; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Keita AV, 2012, ANN NY ACAD SCI, V1258, P125, DOI 10.1111/j.1749-6632.2012.06502.x; Ludwig T, 2004, KIDNEY INT, V66, P196, DOI 10.1111/j.1523-1755.2004.00720.x; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Murphy SJ, 2007, MOL BIOL CELL, V18, P3788, DOI 10.1091/mbc.E06-10-0930; Nishihara A, 2002, MOL BIOL CELL, V13, P3055, DOI 10.1091/mbc.E02-02-0063; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Saitoh M, 2012, J BIOCHEM, V151, P563, DOI 10.1093/jb/mvs040; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Simmen T, 2002, NAT CELL BIOL, V4, P154, DOI 10.1038/ncb745; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; STUART RO, 1994, J CELL PHYSIOL, V159, P423, DOI 10.1002/jcp.1041590306; Takahashi D, 2011, GASTROENTEROLOGY, V141, P621, DOI 10.1053/j.gastro.2011.04.056; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511; Yakovich AJ, 2010, J CELL PHYSIOL, V224, P398, DOI 10.1002/jcp.22135; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	36	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62659	10.1371/journal.pone.0062659	http://dx.doi.org/10.1371/journal.pone.0062659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675417	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100006
J	Batista, JDL; de Albuquerque, MDPM; Maruza, M; Ximenes, RAD; Santos, ML; Montarroyos, UR; Miranda-Filho, DD; Lacerda, HR; Rodrigues, LC				Lyra Batista, Joanna d'Arc; Pessoa Militao de Albuquerque, Maria de Fatima; Maruza, Magda; de Alencar Ximenes, Ricardo Arraes; Santos, Marcela Lopes; Montarroyos, Ulisses Ramos; Miranda-Filho, Democrito de Barros; Lacerda, Heloisa Ramos; Rodrigues, Laura Cunha			Incidence and Risk Factors for Tuberculosis in People Living with HIV: Cohort from HIV Referral Health Centers in Recife, Brazil	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ISONIAZID PREVENTIVE THERAPY; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; SOUTH-AFRICA; SMOKING; ANEMIA; INDIVIDUALS; PREVALENCE; PROGNOSIS	Objective: To identify the incidence of and risk factors for tuberculosis in people living with HIV (PLHIV). Design: Observational, prospective cohort study. Methods: A total of 2069 HIV-infected patients was observed between July 2007 and December 2010. The Kaplan-Meier method was used to estimate the probability of survival free of tuberculosis, and Cox regression analysis to identify risk factors associated with the development of tuberculosis. Results: Survival free of tuberculosis (TB) was 91%. The incidence rate of tuberculosis was 2.8 per 100 persons/years. Incidence of tuberculosis was higher when subjects had CD4 cell count,200 cells/mm(3); were not on antiretroviral therapy; in those who had, a body mass index,18.5 kg/m(2), anemia (or were not tested for it), were illiterate or referred previous tuberculosis treatment at entry into the cohort. Those not treated for latent TB infection had a much higher risk (HR = 7.9) of tuberculosis than those with a negative tuberculin skin test (TST). Having a TST >= 5 mm but not being treated for latent TB infection increased the risk of incident tuberculosis even in those with a history of previous tuberculosis. Conclusions: Preventive actions to reduce the risk of TB in people living with HIV should include an appropriate HAART and treatment for latent TB infection in those with TST >= 5 mm. The actions towards enabling rigorous implementation of treatment of latent TB infection and targeting of PLHIV drug users both at the individual and in public health level can reduce substantially the incidence of TB in PLHIV.	[Lyra Batista, Joanna d'Arc; Pessoa Militao de Albuquerque, Maria de Fatima; Santos, Marcela Lopes] Ctr Pesquisas Aggeu Magalhaes Fiocruz, Recife, PE, Brazil; [Maruza, Magda] Hosp Correia Picanco, Recife, PE, Brazil; [de Alencar Ximenes, Ricardo Arraes; Lacerda, Heloisa Ramos] Univ Fed Pernambuco, Recife, PE, Brazil; [de Alencar Ximenes, Ricardo Arraes; Montarroyos, Ulisses Ramos; Miranda-Filho, Democrito de Barros; Lacerda, Heloisa Ramos] Univ Pernambuco, Recife, PE, Brazil; [Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, London WC1, England	Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco; Universidade de Pernambuco (UPE); University of London; London School of Hygiene & Tropical Medicine	Batista, JDL (corresponding author), Ctr Pesquisas Aggeu Magalhaes Fiocruz, Recife, PE, Brazil.	joannalyra@gmail.com	RODRIGUES, LAURA CUNHA/AAO-4130-2021; Montarroyos, Ulisses/AAJ-7527-2020; Batista, Joanna d'Arc/O-9933-2014	Batista, Joanna d'Arc/0000-0002-3703-2845	Ministerio da Saude/Programa DST/AIDS/UNESCO [CSV 182/06]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [150425/2012-0, 301779/2009-0, 300917/2006-6]	Ministerio da Saude/Programa DST/AIDS/UNESCO; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study received support from the Ministerio da Saude/Programa DST/AIDS/UNESCO (CSV 182/06 - Projeto "Estudo Clinico-Epidemiologico da Co-Infeccao HIV/Tuberculose em Recife''). The authors received partial support from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (scholarship 150425/2012-0 to J. D. L. B., 301779/2009-0 to M. F. P. M. and 300917/2006-6 to R.A.A.X.).	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Albuquerque M.D.M., 2009, EPIDEMIOLOGIA SERVIC, V18, P153; [Anonymous], 2011, GUID INT TUB CAS FIN; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3; Belperio PS, 2004, AM J MED, V116, P27, DOI 10.1016/j.amjmed.2003.12.010; BRASIL, 2009, B EL EP MIN SAUD; BRASIL, 2011, SER HIST TAX MORT TU; BRASIL, 2011, VIG EP, P284; Camargo K R Jr, 2000, Cad Saude Publica, V16, P439; Casado JL, 2002, CLIN INFECT DIS, V34, P386, DOI 10.1086/324746; Casanovas FM, 1999, REV ESP SALUD PUBLIC, V73, P549; CDC, 2010, FACT SHEETS ALC PUBL; Crofts JP, 2010, THORAX, V65, P310, DOI 10.1136/thx.2009.124677; Davies PDO, 2006, T ROY SOC TROP MED H, V100, P291, DOI 10.1016/j.trstmh.2005.06.034; de Lannoy LH, 2008, REV SOC BRAS MED TRO, V41, P549, DOI 10.1590/S0037-86822008000600001; de Pinho AMF, 2001, AIDS, V15, P2129, DOI 10.1097/00002030-200111090-00008; Deiss RG, 2009, CLIN INFECT DIS, V48, P72, DOI 10.1086/594126; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Domingos MP, 2008, CAD SAUDE PUBLICA, V24, P887, DOI 10.1590/S0102-311X2008000400020; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Grant AD, 2009, AIDS, V23, P2507, DOI 10.1097/QAD.0b013e3283320dfd; Gupta R, 2007, INDIAN J MED RES, V126, P279; Jerene Degu, 2006, AIDS Res Ther, V3, P10, DOI 10.1186/1742-6405-3-10; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lee SW, 2006, J KOREAN MED SCI, V21, P1028, DOI 10.3346/jkms.2006.21.6.1028; Batista JDL, 2008, INT J EPIDEMIOL, V37, P841, DOI 10.1093/ije/dyn113; Mariz CD, 2011, CAD SAUDE PUBLICA, V27, P1997; Miguez-Burbano MJ, 2003, ADDICT BIOL, V8, P39, DOI 10.1080/1355621031000069864; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Munckhof WJ, 2003, INT J TUBERC LUNG D, V7, P860; Niyongabo T, 1999, NUTRITION, V15, P289, DOI 10.1016/S0899-9007(99)00003-9; Saathoff E, 2011, INT J TUBERC LUNG D, V15, P925, DOI 10.5588/ijtld.10.0477; Seyler C, 2005, AM J RESP CRIT CARE, V172, P123, DOI 10.1164/rccm.200410-1342OC; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; UNAIDS, 2010, GLOB REP UNAIDS REP; Vidrine DJ, 2009, AIDS EDUC PREV, V21, P3, DOI 10.1521/aeap.2009.21.3_supp.3; de Souza CTV, 2009, MEM I OSWALDO CRUZ, V104, P462, DOI 10.1590/S0074-02762009000300011; Wen CP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-156; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2004, Wkly Epidemiol Rec, V79, P6; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Zhou JL, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-46	51	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63916	10.1371/journal.pone.0063916	http://dx.doi.org/10.1371/journal.pone.0063916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675515	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000318852400057
J	Snijder, PM; de Boer, RA; Bos, EM; van den Born, JC; Ruifrok, WPT; Vreeswijk-Baudoin, I; van Dijk, MCRF; Hillebrands, JL; Leuvenink, HGD; van Goor, H				Snijder, Pauline M.; de Boer, Rudolf A.; Bos, Eelke M.; van den Born, Joost C.; Ruifrok, Willem-Peter T.; Vreeswijk-Baudoin, Inge; van Dijk, Marcory C. R. F.; Hillebrands, Jan-Luuk; Leuvenink, Henri G. D.; van Goor, Harry			Gaseous Hydrogen Sulfide Protects against Myocardial Ischemia-Reperfusion Injury in Mice Partially Independent from Hypometabolism	PLOS ONE			English	Article							ANIMATION-LIKE STATE; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; IMPROVES SURVIVAL; HEART-FAILURE; RAT MODEL; H2S; INFARCTION; MECHANISMS; CARDIOPROTECTION	Background: Ischemia-reperfusion injury (IRI) is a major cause of cardiac damage following various pathological processes. Gaseous hydrogen sulfide (H2S) is protective during IRI by inducing a hypometabolic state in mice which is associated with anti-apoptotic, anti-inflammatory and antioxidant properties. We investigated whether gaseous H2S administration is protective in cardiac IRI and whether non-hypometabolic concentrations of H2S have similar protective properties. Methods: Male C57BL/6 mice received a 0, 10, or 100 ppm H2S-N-2 mixture starting 30 minutes prior to ischemia until 5 minutes pre-reperfusion. IRI was inflicted by temporary ligation of the left coronary artery for 30 minutes. High-resolution respirometry equipment was used to assess CO2-production and blood pressure was measured using internal transmitters. The effects of H2S were assessed by histological and molecular analysis. Results: Treatment with 100 ppm H2S decreased CO2-production by 72%, blood pressure by 14% and heart rate by 25%, while treatment with 10 ppm H2S had no effects. At day 1 of reperfusion 10 ppm H2S showed no effect on necrosis, while treatment with 100 ppm H2S reduced necrosis by 62% (p<0.05). Seven days post-reperfusion, both 10 ppm (p<0.01) and 100 ppm (p<0.05) H2S showed a reduction in fibrosis compared to IRI animals. Both 10 ppm and 100 ppm H2S reduced granulocyte-influx by 43% (p<0.05) and 60% (p<0.001), respectively. At 7 days post-reperfusion both 10 and 100 ppm H2S reduced expression of fibronectin by 63% (p<0.05) and 67% (p<0.01) and ANP by 84% and 63% (p<0.05), respectively. Conclusions: Gaseous administration of H2S is protective when administered during a cardiac ischemic insult. Although hypometabolism is restricted to small animals, we now showed that low non-hypometabolic concentrations of H2S also have protective properties in IRI. Since IRI is a frequent cause of myocardial damage during percutaneous coronary intervention and cardiac transplantation, H2S treatment might lead to novel therapeutical modalities.	[Snijder, Pauline M.; Bos, Eelke M.; van den Born, Joost C.; van Dijk, Marcory C. R. F.; Hillebrands, Jan-Luuk; van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Snijder, Pauline M.; Bos, Eelke M.; Leuvenink, Henri G. D.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [de Boer, Rudolf A.; Ruifrok, Willem-Peter T.; Vreeswijk-Baudoin, Inge] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Snijder, PM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	p.m.snijder@umcg.nl	van+Goor, Harry/AAS-7712-2020; de Boer, Rudolf/ABE-9879-2020; van den Born, Joost C./H-3740-2018	van Goor, Harry/0000-0002-6670-1577; Hillebrands, Jan-Luuk/0000-0003-3135-3274; Leuvenink, Henri/0000-0001-5036-2999; Bos, Eelke/0000-0003-3647-6740; van den Born, Joost/0000-0003-2637-4046	J.K. de Cock Foundation; Dutch Organization for Health Research and Development (ZonMW) [40-00506-98-9021]	J.K. de Cock Foundation; Dutch Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This study was financially supported by a grant from the J.K. de Cock Foundation. Microscopic imaging was performed at the UMCG Imaging Center (UMIC), which is supported by the Dutch Organization for Health Research and Development (ZonMW grant 40-00506-98-9021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2006, BRIT J PHARMACOL, V149, P625, DOI 10.1038/sj.bjp.0706906; Aminzadeh MA, 2012, NEPHROL DIAL TRANSPL, V27, P498, DOI 10.1093/ndt/gfr560; Baxter GF, 2002, BASIC RES CARDIOL, V97, P268, DOI 10.1007/s00395-002-0366-7; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Blackstone E, 2007, SHOCK, V27, P370, DOI 10.1097/SHK.0b013e31802e27a0; Bos EM, 2012, TRANSPL INT, V25, P897, DOI 10.1111/j.1432-2277.2012.01514.x; Bos EM, 2009, J AM SOC NEPHROL, V20, P1901, DOI 10.1681/ASN.2008121269; Bracht H, 2012, CRIT CARE MED, V40, P2157, DOI 10.1097/CCM.0b013e31824e6b30; Calvert JW, 2010, CIRCULATION, V122, P11, DOI 10.1161/CIRCULATIONAHA.109.920991; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Damman J, 2011, NEPHROL DIAL TRANSPL, V26, P2345, DOI 10.1093/ndt/gfq717; Dawe GS, 2008, NEUROSCIENCE, V152, P169, DOI 10.1016/j.neuroscience.2007.12.008; De Silva TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028393; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Fu ZF, 2008, LIFE SCI, V82, P1196, DOI 10.1016/j.lfs.2008.04.005; Fukui T, 2001, BIOCHEM BIOPH RES CO, V281, P1200, DOI 10.1006/bbrc.2001.4493; Haouzi P, 2008, RESP PHYSIOL NEUROBI, V160, P109, DOI 10.1016/j.resp.2007.09.001; Hausenloy DJ, 2012, CARDIOVASC RES, V94, P253, DOI 10.1093/cvr/cvs131; HILL BC, 1984, BIOCHEM J, V224, P591, DOI 10.1042/bj2240591; Hishikari K, 2009, CARDIOVASC RES, V81, P123, DOI 10.1093/cvr/cvn254; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Ichihara S, 2002, CIRCULATION, V106, P2244, DOI 10.1161/01.CIR.0000033826.52681.37; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Johansen D, 2006, BASIC RES CARDIOL, V101, P53, DOI 10.1007/s00395-005-0569-9; Kida K, 2011, ANTIOXID REDOX SIGN, V15, P343, DOI 10.1089/ars.2010.3671; Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kohn C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041951; Lavu M, 2011, CLIN SCI, V120, P219, DOI 10.1042/CS20100462; Li J, 2008, PEDIATR CRIT CARE ME, V9, P110, DOI 10.1097/01.PCC.0000298639.08519.0C; Li XH, 2005, CIRC J, V69, P1418, DOI 10.1253/circj.69.1418; Liu H, 2009, J PHARM PHARMACOL, V61, P207, DOI 10.1211/jpp/61.02.0010; Ma LX, 2012, AM J PHYSIOL-HEART C, V302, pH2341, DOI 10.1152/ajpheart.01126.2011; Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491; Mitsuhashi H, 2005, SHOCK, V24, P529, DOI 10.1097/01.shk.0000183393.83272.de; Morrison ML, 2008, J TRAUMA, V65, P183, DOI 10.1097/TA.0b013e3181507579; Ojha N, 2008, AM J PHYSIOL-HEART C, V294, pH2435, DOI 10.1152/ajpheart.01190.2007; Olson KR, 2011, AM J PHYSIOL-REG I, V301, pR297, DOI 10.1152/ajpregu.00045.2011; Qipshidze N, 2012, INT J BIOL SCI, V8, P430, DOI 10.7150/ijbs.3632; Simon F, 2008, SHOCK, V30, P359, DOI 10.1097/SHK.0b013e3181674185; Sivarajah A, 2009, SHOCK, V31, P267, DOI 10.1097/SHK.0b013e318180ff89; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szabo G, 2011, NITRIC OXIDE-BIOL CH, V25, P201, DOI 10.1016/j.niox.2010.11.001; Tokuda K, 2012, ANTIOXID REDOX SIGN, V17, P11, DOI 10.1089/ars.2011.4363; Ufnal M, 2008, ACTA NEUROBIOL EXP, V68, P382; Volpato GP, 2008, ANESTHESIOLOGY, V108, P659, DOI 10.1097/ALN.0b013e318167af0d; Wang XL, 2011, BIOSCIENCE REP, V31, P87, DOI 10.1042/BSR20100003; Wu N, 2010, J BIOL CHEM, V285, P18225, DOI 10.1074/jbc.M110.132142; Yan H, 2004, BIOCHEM BIOPH RES CO, V313, P22, DOI 10.1016/j.bbrc.2003.11.081; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhang HL, 2008, IMMUNOPHARM IMMUNOT, V30, P631, DOI [10.1080/08923970802278045, 10.1080/08923970802278045 ]; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	57	48	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63291	10.1371/journal.pone.0063291	http://dx.doi.org/10.1371/journal.pone.0063291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675473	Green Submitted, gold, Green Published			2022-12-25	WOS:000318852400035
J	DeLucia, M; Mehrens, J; Wu, Y; Ahn, J				DeLucia, Maria; Mehrens, Jennifer; Wu, Ying; Ahn, Jinwoo			HIV-2 and SIVmac Accessory Virulence Factor Vpx Down-regulates SAMHD1 Enzyme Catalysis Prior to Proteasome-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION FACTOR SAMHD1; AICARDI-GOUTIERES SYNDROME; UBIQUITIN LIGASE; PROTEIN; REPLICATION; INFECTION; LYMPHOCYTES; INHIBITION; INTERPLAY; GENE	SAMHD1, a dGTP-regulated deoxyribonucleoside triphosphate (dNTP) triphosphohydrolase, down-regulates dNTP pools in terminally differentiated and quiescent cells, thereby inhibiting HIV-1 infection at the reverse transcription step. HIV-2 and simian immunodeficiency virus (SIV) counteract this restriction via a virion-associated virulence accessory factor, Vpx (Vpr in some SIVs), which loads SAMHD1 onto CRL4-DCAF1 E3 ubiquitin ligase for polyubiquitination, programming it for proteasome-dependent degradation. However, the detailed molecular mechanisms of SAMHD1 recruitment to the E3 ligase have not been defined. Further, whether divergent, orthologous Vpx proteins, encoded by distinct HIV/SIV strains, bind SAMHD1 in a similar manner, at a molecular level, is not known. We applied surface plasmon resonance analysis to assess the requirements for and kinetics of binding between various primate SAMHD1 proteins and Vpx proteins from SIV or HIV-2 strains. Our data indicate that Vpx proteins, bound to DCAF1, interface with the C terminus of primate SAMHD1 proteins with nanomolar affinity, manifested by rapid association and slow dissociation. Further, we provide evidence that Vpx binding to SAMHD1 inhibits its catalytic activity and induces disassembly of a dGTP-dependent oligomer. Our studies reveal a previously unrecognized biochemical mechanism of Vpx-mediated SAMHD1 inhibition: direct down-modulation of its catalytic activity, mediated by the same binding event that leads to SAMHD1 recruitment to the E3 ubiquitin ligase for proteasome-dependent degradation.	[DeLucia, Maria; Mehrens, Jennifer; Wu, Ying; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [DeLucia, Maria; Mehrens, Jennifer; Wu, Ying; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahn, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	jahn@structbio.pitt.edu			National Institutes of Health [P50GM082251]; University of Pittsburgh School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh School of Medicine(University of Pittsburgh); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50GM082251. This work was also supported by funds from the University of Pittsburgh School of Medicine.	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Britan-Rosich E, 2011, J MOL BIOL, V410, P1065, DOI 10.1016/j.jmb.2011.03.058; Chen RX, 2004, J BIOL CHEM, V279, P28419, DOI 10.1074/jbc.M403875200; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goncalves A, 2012, HUM MUTAT, V33, P1116, DOI 10.1002/humu.22087; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; KAWAMURA M, 1994, MICROBIOL IMMUNOL, V38, P871, DOI 10.1111/j.1348-0421.1994.tb02140.x; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Planelles V, 2012, CELL HOST MICROBE, V11, P103, DOI 10.1016/j.chom.2012.02.001; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Puigdomenech I, 2013, J VIROL, V87, P2846, DOI 10.1128/JVI.02514-12; Santa-Marta M, 2005, J BIOL CHEM, V280, P8765, DOI 10.1074/jbc.M409309200; Santa-Marta M, 2007, MOL IMMUNOL, V44, P583, DOI 10.1016/j.molimm.2006.02.005; Schaller T, 2012, SCIENCE, V335, P1313, DOI 10.1126/science.1221057; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Wei W, 2012, CELL MICROBIOL, V14, P1745, DOI 10.1111/j.1462-5822.2012.01835.x; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Wu L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-88; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Yan N, 2012, NAT MED, V18, P1611, DOI 10.1038/nm.2980; Yu HX, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-27; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991; Zhang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037477	44	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19116	19126		10.1074/jbc.M113.469007	http://dx.doi.org/10.1074/jbc.M113.469007			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23677995	hybrid, Green Published			2022-12-25	WOS:000321335800046
J	Gillespie, U; Alassaad, A; Hammarlund-Udenaes, M; Morlin, C; Henrohn, D; Bertilsson, M; Melhus, H				Gillespie, Ulrika; Alassaad, Anna; Hammarlund-Udenaes, Margareta; Morlin, Claes; Henrohn, Dan; Bertilsson, Maria; Melhus, Hakan			Effects of Pharmacists' Interventions on Appropriateness of Prescribing and Evaluation of the Instruments' (MAI, STOPP and STARTs') Ability to Predict Hospitalization-Analyses from a Randomized Controlled Trial	PLOS ONE			English	Article							INAPPROPRIATE MEDICATION USE; ADVERSE DRUG EVENTS; OLDER PERSONS PRESCRIPTIONS; ELDERLY-PATIENTS; SCREENING TOOL; ALERT DOCTORS; EXPLICIT CRITERIA; QUALITY; RISK; INPATIENTS	Background: Appropriateness of prescribing can be assessed by various measures and screening instruments. The aims of this study were to investigate the effects of pharmacists' interventions on appropriateness of prescribing in elderly patients, and to explore the relationship between these results and hospital care utilization during a 12-month follow-up period. Methods: The study population from a previous randomized controlled study, in which the effects of a comprehensive pharmacist intervention on re-hospitalization was investigated, was used. The criteria from the instruments MAI, STOPP and START were applied retrospectively to the 368 study patients (intervention group (I) n = 182, control group (C) n = 186). The assessments were done on admission and at discharge to detect differences over time and between the groups. Hospital care consumption was recorded and the association between scores for appropriateness, and hospitalization was analysed. Results: The number of Potentially Inappropriate Medicines (PIMs) per patient as identified by STOPP was reduced for I but not for C (1.42 to 0.93 vs. 1.46 to 1.66 respectively, p<0.01). The number of Potential Prescription Omissions (PPOs) per patient as identified by START was reduced for I but not for C (0.36 to 0.09 vs. 0.42 to 0.45 respectively, p<0.001). The summated score for MAI was reduced for I but not for C (8.5 to 5.0 and 8.7 to 10.0 respectively, p<0.001). There was a positive association between scores for MAI and STOPP and drug-related readmissions (RR 8-9% and 30-34% respectively). No association was detected between the scores of the tools and total re-visits to hospital. Conclusion: The interventions significantly improved the appropriateness of prescribing for patients in the intervention group as evaluated by the instruments MAI, STOPP and START. High scores in MAI and STOPP were associated with a higher number of drug-related readmissions.	[Gillespie, Ulrika; Hammarlund-Udenaes, Margareta] Uppsala Univ, Dept Pharmaceut Biosci, Div Pharmacokinet & Drug Therapy, Uppsala, Sweden; [Gillespie, Ulrika; Alassaad, Anna; Hammarlund-Udenaes, Margareta; Henrohn, Dan; Melhus, Hakan] Univ Uppsala Hosp, Uppsala, Sweden; [Alassaad, Anna; Henrohn, Dan; Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Morlin, Claes] Univ Uppsala Hosp, Dept Med, Uppsala, Sweden; [Henrohn, Dan] Med Prod Agcy, Uppsala, Sweden; [Bertilsson, Maria] Uppsala Clin Res Ctr, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University; Uppsala University Hospital; Medical Products Agency; Uppsala University	Gillespie, U (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Div Pharmacokinet & Drug Therapy, Uppsala, Sweden.	Ulrika.gillespie@akademiska.se			Swedish Academy for Pharmaceutical Sciences; University Hospital of Uppsala, Uppsala University; Hospital Pharmacy (Apoteket AB)	Swedish Academy for Pharmaceutical Sciences; University Hospital of Uppsala, Uppsala University; Hospital Pharmacy (Apoteket AB)	The study was funded by the non-profit organization Swedish Academy for Pharmaceutical Sciences (one PHD student via annual scholarships). The University Hospital of Uppsala, Uppsala University and The Hospital Pharmacy (Apoteket AB) all co-funded the study by letting all involved physicians and pharmacists in the study participate in meetings and other tasks surrounding the study during work hours. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett K, 2011, BMJ QUAL SAF, V20, P275, DOI 10.1136/bmjqs.2009.039818; Barry PJ, 2007, AGE AGEING, V36, P632, DOI 10.1093/ageing/afm118; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Bonnet-Zamponi D, 2013, J AM GERIATR SOC, V61, P113, DOI 10.1111/jgs.12037; Burnett KM, 2009, AM J HEALTH-SYST PH, V66, P854, DOI 10.2146/ajhp080176; Crotty Maria, 2004, Am J Geriatr Pharmacother, V2, P257, DOI 10.1016/j.amjopharm.2005.01.001; Dalleur O, 2012, DRUG AGING, V29, P829, DOI 10.1007/s40266-012-0016-1; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher PF, 2011, CLIN PHARMACOL THER, V89, P845, DOI 10.1038/clpt.2011.44; Gallagher P, 2008, AGE AGEING, V37, P673, DOI 10.1093/ageing/afn197; Gallagher P, 2009, AGE AGEING, V38, P603, DOI 10.1093/ageing/afp058; Gallagher PF, 2008, AGE AGEING, V37, P96, DOI 10.1093/ageing/afm116; Gillespie U, 2009, ARCH INTERN MED, V169, P894, DOI 10.1001/archinternmed.2009.71; Gurwitz JH, 2002, ARCH INTERN MED, V162, P1670, DOI 10.1001/archinte.162.15.1670; GURWITZ JH, 1990, J AM GERIATR SOC, V38, P542, DOI 10.1111/j.1532-5415.1990.tb02406.x; Hamilton H, 2011, ARCH INTERN MED, V171, P1013, DOI 10.1001/archinternmed.2011.215; Hanlon JT, 2001, J AM GERIATR SOC, V49, P200, DOI 10.1046/j.1532-5415.2001.49042.x; Hanlon JT, 1996, AM J MED, V100, P428, DOI 10.1016/S0002-9343(97)89519-8; HANLON JT, 1992, J CLIN EPIDEMIOL, V45, P1045, DOI 10.1016/0895-4356(92)90144-C; Hellstrom LM, 2011, EUR J CLIN PHARMACOL, V67, P741, DOI 10.1007/s00228-010-0982-3; KOCH GG, 1982, BIOMETRICS, V38, P563, DOI 10.2307/2530041; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; Luo RY, 2012, J EVAL CLIN PRACT, V18, P1196, DOI 10.1111/j.1365-2753.2011.01758.x; Mainz J, 2003, INT J QUAL HEALTH C, V15, pI5, DOI 10.1093/intqhc/mzg084; Patterson SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008165.pub2; Pozzi C, 2010, PHARMACOEPIDEM DR S, V19, P954, DOI 10.1002/pds.1997; Pronovost PJ, 2004, LANCET, V363, P1061, DOI 10.1016/S0140-6736(04)15843-1; Rubin HR, 2001, INT J QUAL HEALTH C, V13, P489, DOI 10.1093/intqhc/13.6.489; Ruggiero C, 2010, DRUG AGING, V27, P747, DOI 10.2165/11538240-000000000-00000; SAMSA GP, 1994, J CLIN EPIDEMIOL, V47, P891, DOI 10.1016/0895-4356(94)90192-9; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Scullin C, 2007, J EVAL CLIN PRACT, V13, P781, DOI 10.1111/j.1365-2753.2006.00753.x; Simonson W, 2005, DRUG AGING, V22, P559, DOI 10.2165/00002512-200522070-00002; Spinewine A, 2007, J AM GERIATR SOC, V55, P658, DOI 10.1111/j.1532-5415.2007.01132.x; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Spinewine A, 2012, DRUG AGING, V29, P495, DOI 10.2165/11631720-000000000-00000; Steinman MA, 2007, MED CARE, V45, P95, DOI 10.1097/01.mlr.0000241111.11991.62; Stokes ME, 2000, CATEGORICAL DATA ANA	42	84	86	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e62401	10.1371/journal.pone.0062401	http://dx.doi.org/10.1371/journal.pone.0062401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RJ	23690938	Green Submitted, gold, Green Published			2022-12-25	WOS:000319107900008
J	Guo, FC; Yang, X; Li, XX; Feng, RN; Guan, CM; Wang, YW; Li, Y; Sun, CH				Guo, Fuchuan; Yang, Xue; Li, Xiaoxia; Feng, Rennan; Guan, Chunmei; Wang, Yanwen; Li, Ying; Sun, Changhao			Nuciferine Prevents Hepatic Steatosis and Injury Induced by a High-Fat Diet in Hamsters	PLOS ONE			English	Article							LIVER-DISEASE; INSULIN-RESISTANCE; NELUMBO-NUCIFERA; GENE-EXPRESSION; ATHEROGENIC DIET; LIPID-METABOLISM; IN-VITRO; MICE; OBESITY; HYPERLIPIDEMIA	Background: Nuciferine is a major active aporphine alkaloid from the leaves of N. nucifera Gaertn that possesses anti-hyperlipidemia, anti-hypotensive, anti-arrhythmic, and insulin secretagogue activities. However, it is currently unknown whether nuciferine can benefit hepatic lipid metabolism. Methodology/Principal Findings: In the current study, male golden hamsters were randomly divided into four groups fed a normal diet, a high-fat diet (HFD), or a HFD supplemented with nuciferine (10 and 15 mg/kg.BW/day). After 8 weeks of intervention, HFD-induced increases in liver and visceral adipose tissue weight, dyslipidemia, liver steatosis, and mild necroinflammation in hamsters were analyzed. Nuciferine supplementation protected against HFD-induced changes, alleviated necroinflammation, and reversed serum markers of metabolic syndrome in hamsters fed a HFD. RT-PCR and western blot analyses revealed that hamsters fed a HFD had up-regulated levels of genes related to lipogenesis, increased free fatty acid infiltration, and down-regulated genes involved in lipolysis and very low density lipoprotein secretion. In addition, gene expression of cytochrome P4502E1 and tumor necrosis factor-alpha were also increased in the HFD group. Nuciferine supplementation clearly suppressed HFD-induced alterations in the expression of genes involved in lipid metabolism. Conclusions/Significance: Nuciferine supplementation ameliorated HFD-induced dyslipidemia as well as liver steatosis and injury. The beneficial effects of nuciferine were associated with altered expression of hepatic genes involved in lipid metabolism.	[Guo, Fuchuan; Yang, Xue; Li, Xiaoxia; Feng, Rennan; Guan, Chunmei; Li, Ying; Sun, Changhao] Harbin Med Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Harbin, Heilongjiang, Peoples R China; [Wang, Yanwen] Natl Res Council Canada, Inst Nutrisci & Hlth, Charlottetown, PE, Canada; [Wang, Yanwen] Univ Prince Edward Isl, Dept Biomed Sci, Charlottetown, PE C1A 4P3, Canada	Harbin Medical University; National Research Council Canada; University of Prince Edward Island	Li, Y (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Harbin, Heilongjiang, Peoples R China.	liying_helen@163.com; sun2002changhao@yahoo.com	SUN, CHANG/GXM-3680-2022		National Natural Science Foundation of China [81130049, 81202185]; National High Technology Research and Development Program of China (863 program) [2010AA023002]; National 12th Five-Year Scientific and Technical Support Program of China [2012BAI02B02]; NSFC-CIHR [30811120432]; Heilongjiang scientific and technological project [GC10C305-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National 12th Five-Year Scientific and Technical Support Program of China; NSFC-CIHR(Canadian Institutes of Health Research (CIHR)); Heilongjiang scientific and technological project	This research has been supported by grants from the National Natural Science Foundation of China (No. 81130049 and No. 81202185), the National High Technology Research and Development Program of China (863 program, No. 2010AA023002), the National 12th Five-Year Scientific and Technical Support Program of China (2012BAI02B02), the NSFC-CIHR (No. 30811120432) and the Heilongjiang scientific and technological project (GC10C305-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Ahn J, 2008, J HEPATOL, V49, P1019, DOI 10.1016/j.jhep.2008.08.012; Basciano H, 2009, AM J PHYSIOL-ENDOC M, V297, pE462, DOI 10.1152/ajpendo.90764.2008; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; BHATTACHARYA SK, 1978, PSYCHOPHARMACOLOGY, V59, P29, DOI 10.1007/BF00428026; Briand F, 2012, J NUTR, V142, P704, DOI 10.3945/jn.111.153197; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Choi MS, 2009, MOL NUTR FOOD RES, V53, P751, DOI 10.1002/mnfr.200800241; Degrace P, 2006, J LIPID RES, V47, P2647, DOI 10.1194/jlr.M600140-JLR200; Du H, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S42; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; FOLCH J, 1957, J BIOL CHEM, V226, P497; Guo FC, 2011, MOL NUTR FOOD RES, V55, P1809, DOI 10.1002/mnfr.201100392; Hu LW, 2010, J PHARM PHARMACOL, V62, P658, DOI [10.1211/jpp.62.05.0015, 10.1211/jpp/62.05.0015]; Huang B, 2010, FOOD CHEM, V120, P873, DOI 10.1016/j.foodchem.2009.11.020; Huang CF, 2011, J AGR FOOD CHEM, V59, P1087, DOI 10.1021/jf103382h; Kashiwada Y, 2005, BIOORGAN MED CHEM, V13, P443, DOI 10.1016/j.bmc.2004.10.020; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lelliott CJ, 2007, ARTERIOSCL THROM VAS, V27, P2707, DOI 10.1161/ATVBAHA.107.155739; LIN MCM, 1995, J LIPID RES, V36, P1073; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo XB, 2005, ANAL CHIM ACTA, V538, P129, DOI 10.1016/j.aca.2005.01.066; Ma WY, 2010, TALANTA, V80, P1292, DOI 10.1016/j.talanta.2009.09.027; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Mukherjee PK, 2009, J PHARM PHARMACOL, V61, P407, DOI 10.1211/jpp/61.04.0001; Nguyen KH, 2012, J ETHNOPHARMACOL, V142, P488, DOI 10.1016/j.jep.2012.05.024; Nozaki Y, 2009, J HEPATOL, V51, P548, DOI 10.1016/j.jhep.2009.05.017; Ono Y, 2006, J ETHNOPHARMACOL, V106, P238, DOI 10.1016/j.jep.2005.12.036; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Singhal NS, 2008, AM J PHYSIOL-ENDOC M, V295, pE331, DOI 10.1152/ajpendo.00577.2007; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016; Vendrell J, 2004, OBES RES, V12, P962, DOI 10.1038/oby.2004.118; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang YL, 2006, J BIOL CHEM, V281, P37603, DOI 10.1074/jbc.M604709200	38	55	61	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63770	10.1371/journal.pone.0063770	http://dx.doi.org/10.1371/journal.pone.0063770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691094	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700060
J	Loe, H; Rognmo, O; Saltin, B; Wisloff, U				Loe, Henrik; Rognmo, Oivind; Saltin, Bengt; Wisloff, Ulrik			Aerobic Capacity Reference Data in 3816 Healthy Men and Women 20-90 Years	PLOS ONE			English	Article							TIME PHYSICAL-ACTIVITY; MAXIMAL OXYGEN-UPTAKE; ALL-CAUSE MORTALITY; CARDIORESPIRATORY FITNESS; EXERCISE CAPACITY; WORK CAPACITY; NORWEGIAN MEN; HEART-RATE; AGE; ADULTS	Purpose: To provide a large reference material on aerobic fitness and exercise physiology data in a healthy population of Norwegian men and women aged 20-90 years. Methods: Maximal and sub maximal levels of VO2, heart rate, oxygen pulse, and rating of perceived exertion (Borg scale: 6-20) were measured in 1929 men and 1881 women during treadmill running. Results: The highest VO2max and maximal heart rate among men and women were observed in the youngest age group (20-29 years) and was 54.4 +/- 8.4 mL.kg(-1).min(-1) and 43.0 +/- 7.7 mL.kg(-1).min(-1) (sex differences, p<0.001) and 196 +/- 10 beats.min(-1) and 194 +/- 9 beats.min(-1) (sex differences, p<0.05), respectively, with a subsequent reduction of approximately 3.5 mL.kg(-1).min(-1) and 6 beats.min(-1) per decade. The highest oxygen pulses were observed in the 3 youngest age groups (20-29 years, 30-39 years, 40-49 years) among men and women; 22.3 mL.beat(-1)+/- 3.6 and 14.7 mL.beat(-1)+/- 2.7 (sex differences, p<0.001), respectively, with no significant difference between these age groups. After the age of 50 we observed an 8% reduction per decade among both sexes. Borg scores appear to give a good estimate of the relative exercise intensity, although observing a slightly different relationship than reported in previous reference material from small populations. Conclusion: This is the largest European reference material of objectively measured parameters of aerobic fitness and exercise-physiology in healthy men and women aged 20-90 years, forming the basis for an easily accessible, valid and understandable tool for improved training prescription in healthy men and women.	[Loe, Henrik; Rognmo, Oivind; Wisloff, Ulrik] NTNU, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Trondheim, Norway; [Loe, Henrik] Valnesfjord Rehabil Ctr, Valnesfjord, Norway; [Saltin, Bengt] Univ Copenhagen Hosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark	Norwegian University of Science & Technology (NTNU); University of Copenhagen	Wisloff, U (corresponding author), NTNU, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Trondheim, Norway.	ulrik.wisloff@ntnu.no	Wisloff, Ulrik/K-2899-2012; Rognmo, Øivind/Q-9369-2019	Wisloff, Ulrik/0000-0002-7211-3587	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; Research Council of Norway; Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Valnesfjord Rehabilitation Center	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; Research Council of Norway(Research Council of Norway); Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Valnesfjord Rehabilitation Center	This study was funded by K.G. Jebsen Foundation, The Norwegian Council on Cardiovascular Disease, The Research Council of Norway (funding for Outstanding Young Investigators (UW) and scholarship (HL)), Foundation for Cardiovascular Research at St. Olav's Hospital, Norwegian State Railways, Roche Norway Incorporated and Valnesfjord Rehabilitation Center. There are no disclosures to report or any conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberton CL, 2011, J STRENGTH COND RES, V25, P155, DOI 10.1519/JSC.0b013e3181bde2b5; ANDERSEN LB, 1987, EUR J APPL PHYSIOL O, V56, P74, DOI 10.1007/BF00696380; [Anonymous], 2006, ACSMS GUIDELINES EXE; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; ASTRAND I, 1967, ERGONOMICS, V10, P293, DOI 10.1080/00140136708930871; Astrand P-O., 1952, EXPT STUDIES PHYS WO; ASTRAND PO, 1976, PROG CARDIOVASC DIS, V19, P51, DOI 10.1016/0033-0620(76)90008-6; Astrand PO, 2003, TXB WORK PHYSL PHYSL, V4th; Batterham A M, 1996, Can J Appl Physiol, V21, P48; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Chamari K, 2005, BRIT J SPORT MED, V39, P97, DOI 10.1136/bjsm.2003.010215; Cordain L, 1998, INT J SPORTS MED, V19, P328, DOI 10.1055/s-2007-971926; Erikssen G, 1998, LANCET, V352, P759, DOI 10.1016/S0140-6736(98)02268-5; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Gellish RL, 2007, MED SCI SPORT EXER, V39, P822, DOI 10.1097/mss.0b013e31803349c6; HELGERUD J, 1994, EUR J APPL PHYSIOL O, V68, P155, DOI 10.1007/BF00244029; Herdy AH, 2011, ARQ BRAS CARDIOL, V96, P54, DOI 10.1590/S0066-782X2010005000155; HERMANSE.L, 1969, J APPL PHYSIOL, V26, P31, DOI 10.1152/jappl.1969.26.1.31; HERMANSEN L, 1965, J APPL PHYSIOL, V20, P425, DOI 10.1152/jappl.1965.20.3.425; Hollenberg M, 1998, J GERONTOL A-BIOL, V53, pB259, DOI 10.1093/gerona/53A.4.B259; Jackson AS, 2009, ARCH INTERN MED, V169, P1781, DOI 10.1001/archinternmed.2009.312; Jackson AS, 1996, MED SCI SPORT EXER, V28, P884, DOI 10.1097/00005768-199607000-00016; KLESGES RC, 1990, MED SCI SPORT EXER, V22, P690, DOI 10.1249/00005768-199010000-00022; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Lange-Andersen L, 1961, PHYS FITNESS TERMS M; Lee DC, 2011, BRIT J SPORT MED, V45, P504, DOI 10.1136/bjsm.2009.066209; MACEK M, 1979, PHYSIOL BOHEMOSLOV, V28, P75; McArdle W, 2010, EXERCISE PHYSL NUTR; MEYER K, 1994, CARDIOLOGY, V85, P341, DOI 10.1159/000176733; Mitchell JH, 2003, OXYGEN TRANSPORT SYS; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nelson MD, 2010, MED SCI SPORT EXER, V42, P255, DOI 10.1249/MSS.0b013e3181b0e534; PADILLA PJ, 2000, REV I NAC ENF RESP, V13, P73; Pollock ML., 1978, HLTH FITNESS PHYS AC; Robergs R, 2002, J EXERCISE PHYSL ONL, V5; Rognmo O, 2004, EUR J CARDIOV PREV R, V11, P216, DOI 10.1097/01.hjr.0000131677.96762.0c; Sanada K, 2007, EUR J APPL PHYSIOL, V99, P475, DOI 10.1007/s00421-006-0375-6; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; Sharma S, 2000, J AM COLL CARDIOL, V36, P864, DOI 10.1016/S0735-1097(00)00816-0; Tager IB, 1998, AM J EPIDEMIOL, V147, P921, DOI 10.1093/oxfordjournals.aje.a009382; Talbot LA, 2000, MED SCI SPORT EXER, V32, P417, DOI 10.1097/00005768-200002000-00024; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; TAYLOR HL, 1969, MEASUREMENT EXERCISE; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Wang CY, 2010, AM J EPIDEMIOL, V171, P426, DOI 10.1093/aje/kwp412; Wasserman K, 2012, PRINCIPLES EXERCISE, V5th; Weiss EP, 2006, J APPL PHYSIOL, V101, P938, DOI 10.1152/japplphysiol.01398.2005	48	127	127	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64319	10.1371/journal.pone.0064319	http://dx.doi.org/10.1371/journal.pone.0064319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691196	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700089
J	Zielke, LG; Bortfeldt, RH; Reissmann, M; Tetens, J; Thaller, G; Brockmann, GA				Zielke, Lea G.; Bortfeldt, Ralf H.; Reissmann, Monika; Tetens, Jens; Thaller, Georg; Brockmann, Gudrun A.			Impact of Variation at the FTO Locus on Milk Fat Yield in Holstein Dairy Cattle	PLOS ONE			English	Article							ASSOCIATION ANALYSES; GENE; OBESITY; MASS; EXPRESSION; CHILDHOOD; GENOTYPE; TRAITS	This study explores the biological role of the Fat Mass and Obesity associated (FTO) gene locus on milk composition in German Holstein cattle. Since FTO controls energy homeostasis and expenditure and the FTO locus has repeatedly shown association with obesity in human studies, we tested FTO as a candidate gene in particular for milk fat yield, which represents a high amount of energy secreted during lactation. The study was performed on 2,402 bulls and 860 cows where dense milk composition data were available. Genetic information was taken from a 2 Mb region around FTO. Five SNPs and two haplotype blocks in a 725 kb region covering FTO and the neighboring genes RPGRIP1L, U6ATAC, and 5 S rRNA were associated with milk fat yield and also affected protein yield in the same direction. Interestingly, higher frequency SNP alleles and haplotypes within the FTO gene increased milk fat and protein yields by up to 2.8 and 2.2 kg per lactation, respectively, while the most frequent haplotype in the upstream block covering exon 1 of FTO to exon 15 of RPGRIP1L had opposite effects with lower fat and milk yield. Both haplotype blocks were also significant in cows. The loci accounted for about 1% of the corresponding trait variance in the population. The association signals not only provided evidence for at least two causative mutations in the FTO locus with a functional effect on milk but also milk protein yield. The pleiotropic effects suggest a biological function on the usage of energy resources and the control of energy balance rather than directly affecting fat and protein synthesis. The identified effect of the obesity gene locus on milk energy content suggests an impact on infant nutrition by breast feeding in humans.	[Zielke, Lea G.; Bortfeldt, Ralf H.; Reissmann, Monika; Brockmann, Gudrun A.] Humboldt Univ, Dept Crop & Anim Sci, D-10099 Berlin, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Humboldt University of Berlin; University of Kiel	Brockmann, GA (corresponding author), Humboldt Univ, Dept Crop & Anim Sci, D-10099 Berlin, Germany.	gudrun.brockmann@agrar.hu-berlin.de		Tetens, Jens/0000-0001-5352-464X	German Federal Ministry of Education and Research [GenoTrack: O315134B]; federal government's special-purpose capital at the Landwirtschaftliche Rentenbank [ZV20000-13]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); federal government's special-purpose capital at the Landwirtschaftliche Rentenbank	The project was supported by the German Federal Ministry of Education and Research GenoTrack: O315134B) and the federal government's special-purpose capital at the Landwirtschaftliche Rentenbank (ZV20000-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bonferroni C. E, 1936, PUBBL R I SUPER SCI, V8; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fan B, 2009, ANIM BIOTECHNOL, V20, P58, DOI 10.1080/10495390902800792; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Fontanesi L, 2009, ANIM GENET, V40, P90, DOI 10.1111/j.1365-2052.2008.01777.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Kreuzer S, 2013, VET MICROBIOL, V163, P392, DOI 10.1016/j.vetmic.2012.12.040; Madsen MB, 2010, ANIM BIOTECHNOL, V21, P51, DOI 10.1080/10495390903381792; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REBOUCHE CJ, 1991, AM J CLIN NUTR, V54, pS1147, DOI 10.1093/ajcn/54.6.1147s; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schmitt AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-80; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Sebert SP, 2010, REPRODUCTION, V139, P265, DOI 10.1530/REP-09-0173; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Strijbis K, 2010, IUBMB LIFE, V62, P357, DOI 10.1002/iub.323; Strucken EM, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-108; Strucken EM, 2010, ARCH TIERZUCHT, V53, P247, DOI 10.5194/aab-53-247-2010; Tews D, 2011, HORM METAB RES, V43, P17, DOI 10.1055/s-0030-1265130; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yang Q, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S134; Zhao FQ, 2007, J DAIRY SCI, V90, pE76, DOI 10.3168/jds.2006-470; Zielke LG, 2011, FRONTIERS GENETICS, V2	35	20	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63406	10.1371/journal.pone.0063406	http://dx.doi.org/10.1371/journal.pone.0063406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691044	gold, Green Published, Green Submitted			2022-12-25	WOS:000319052700034
J	Chen, ZL; Huang, SF; Li, YX; Xu, AL				Chen, Zelin; Huang, Shengfeng; Li, Yuxin; Xu, Anlong			AliquotG:An Improved Heuristic Algorithm for Genome Aliquoting	PLOS ONE			English	Article							DUPLICATIONS; RECONSTRUCTION; REARRANGEMENTS; PERMUTATIONS; TETRAPLOIDY; INVERSION; DISTANCE; REVEALS	An extant genome can be the descendant of an ancient polyploid genome. The genome aliquoting problem is to reconstruct the latter from the former such that the rearrangement distance (i.e., the number of genome rearrangements necessary to transform the former into the latter) is minimal. Though several heuristic algorithms have been published, here, we sought improved algorithms for the problem with respect to the double cut and join (DCJ) distance. The new algorithm makes use of partial and contracted partial graphs, and locally minimizes the distance. Our test results with simulation data indicate that it reliably recovers gene order of the ancestral polyploid genome even when the ancestor is ancient. We also compared the performance of our method with an earlier method using simulation data sets and found that our algorithm has higher accuracy. It is known that vertebrates had undergone two rounds of whole-genome duplication (2R-WGD) during early vertebrate evolution. We used the new algorithm to calculate the DCJ distance between three modern vertebrate genomes and their 2R-WGD ancestor and found that the rearrangement rate might have slowed down significantly since the 2R-WGD. The software AliquotG implementing the algorithm is available as an open-source package from our website (http://mosas.sysu.edu.cn/genome/download_ softwares.php).	[Chen, Zelin; Huang, Shengfeng; Li, Yuxin; Xu, Anlong] Sun Yat Sen Univ, Coll Life Sci, Guangdong Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xu, AL (corresponding author), Sun Yat Sen Univ, Coll Life Sci, Guangdong Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn	Li, Yuxin/K-9197-2016	Li, Yuxin/0000-0001-9739-9860; Huang, Shengfeng/0000-0002-0968-1370	project (NSF) [31171193]; project (863) [2008AA092601]; project (973) [2011CB946101]; Commission of Science and Technology of Guangdong Province; Guangzhou City	project (NSF); project (863)(National High Technology Research and Development Program of China); project (973)(National Basic Research Program of China); Commission of Science and Technology of Guangdong Province; Guangzhou City	This work was supported by project 31171193 (NSF), project 2008AA092601 (863), project 2011CB946101 (973), and projects from the Commission of Science and Technology of Guangdong Province and Guangzhou City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Alekseyev MA, 2007, SIAM J COMPUT, V36, P1748, DOI 10.1137/05064727X; Alekseyev MA, 2007, IEEE ACM T COMPUT BI, V4, P98, DOI 10.1109/TCBB.2007.1002; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bader DA, 2001, J COMPUT BIOL, V8, P483, DOI 10.1089/106652701753216503; Bafna V, 1996, SIAM J COMPUT, V25, P272, DOI 10.1137/S0097539793250627; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; El-Mabrouk N, 1999, P 3 ANN INT C COMP M, P154; Feijao P, 2011, IEEE ACM T COMPUT BI, V8, P1318, DOI 10.1109/TCBB.2011.34; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Hannenhalli S, 1995, TRANSFORMING CABBAGE, P178; Hufton AL, 2008, GENOME RES, V18, P1582, DOI 10.1101/gr.080119.108; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kohn M, 2006, TRENDS GENET, V22, P203, DOI 10.1016/j.tig.2006.02.008; Mixtacki J, 2008, LECT NOTES COMPUT SC, V5092, P276; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Sankoff D, 1992, EDIT DISTANCES GENOM, P121; Semon M, 2007, MOL BIOL EVOL, V24, P860, DOI 10.1093/molbev/msm003; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Stalker J, 2004, GENOME RES, V14, P951, DOI 10.1101/gr.1863004; SUURBALLE JW, 1984, NETWORKS, V14, P325, DOI 10.1002/net.3230140209; Tesler G, 2002, J COMPUT SYST SCI, V65, P587, DOI 10.1016/S0022-0000(02)00011-9; Warren R, 2011, J COMPUT BIOL, V18, P1065, DOI 10.1089/cmb.2011.0087; Warren R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S2; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yancopoulos S, 2005, BIOINFORMATICS, V21, P3340, DOI 10.1093/bioinformatics/bti535	30	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64279	10.1371/journal.pone.0064279	http://dx.doi.org/10.1371/journal.pone.0064279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691189	Green Published, gold			2022-12-25	WOS:000319107400115
J	Zhang, ZH; Wang, JC; Howells, W; Lin, P; Agrawal, A; Edenberg, HJ; Tischfield, JA; Schuckit, MA; Bierut, LJ; Goate, A; Rice, JP				Zhang, Zhehao; Wang, Jen-Chyong; Howells, William; Lin, Peng; Agrawal, Arpana; Edenberg, Howard J.; Tischfield, Jay A.; Schuckit, Marc A.; Bierut, Laura J.; Goate, Alison; Rice, John P.			Dosage Transmission Disequilibrium Test (dTDT) for Linkage and Association Detection	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FAMILY-BASED TESTS; QUANTITATIVE TRAIT LOCI; HAPLOTYPE RELATIVE RISK; POLYMORPHIC DNA MARKER; CASE-PARENT TRIADS; TRANSMISSION/DISEQUILIBRIUM TEST; PEDIGREE ANALYSIS; INFORMATIVE MISSINGNESS; POPULATION ADMIXTURE	Both linkage and association studies have been successfully applied to identify disease susceptibility genes with genetic markers such as microsatellites and Single Nucleotide Polymorphisms (SNPs). As one of the traditional family-based studies, the Transmission/Disequilibrium Test (TDT) measures the over-transmission of an allele in a trio from its heterozygous parents to the affected offspring and can be potentially useful to identify genetic determinants for complex disorders. However, there is reduced information when complete trio information is unavailable. In this study, we developed a novel approach to "infer'' the transmission of SNPs by combining both the linkage and association data, which uses microsatellite markers from families informative for linkage together with SNP markers from the offspring who are genotyped for both linkage and a Genome-Wide Association Study (GWAS). We generalized the traditional TDT to process these inferred dosage probabilities, which we name as the dosage-TDT (dTDT). For evaluation purpose, we developed a simulation procedure to assess its operating characteristics. We applied the dTDT to the simulated data and documented the power of the dTDT under a number of different realistic scenarios. Finally, we applied our methods to a family study of alcohol dependence (COGA) and performed individual genotyping on complete families for the top signals. One SNP (rs4903712 on chromosome 14) remained significant after correcting for multiple testing Methods developed in this study can be adapted to other platforms and will have widespread applicability in genomic research when case-control GWAS data are collected in families with existing linkage data.	[Zhang, Zhehao; Wang, Jen-Chyong; Howells, William; Lin, Peng; Agrawal, Arpana; Bierut, Laura J.; Goate, Alison; Rice, John P.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Edenberg, Howard J.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Tischfield, Jay A.] Rutgers State Univ, Piscataway, NJ USA; [Schuckit, Marc A.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	Washington University (WUSTL); Indiana University System; Indiana University Bloomington; Rutgers State University New Brunswick; University of California System; University of California San Diego	Zhang, ZH (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	zhang.zhehao@wustl.edu; john@zork.wustl.edu	Lin, P/G-7702-2014; Bierut, Laura Jean/W-6806-2019	Bierut, Laura Jean/0000-0002-9952-4810; Tischfield, Jay/0000-0003-3217-8287; Goate, Alison/0000-0002-0576-2472; Edenberg, Howard/0000-0003-0344-9690	National Institutes of Health (NIH) from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U10 AA008401]; National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse and Alcoholism; NIH GEI [U01HG004438]; NIH [HHSN268200782096C]; GWAS; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH GEI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GWAS; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This national collaborative study is supported by National Institutes of Health (NIH) Grant U10 AA008401 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA). Funding support for GWAS genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research, was provided by the National Institute on Alcohol Abuse and Alcoholism, the NIH GEI (U01HG004438), and the NIH contract "High throughput genotyping for studying the genetic contributions to human disease'' (HHSN268200782096C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Allen AS, 2003, AM J HUM GENET, V72, P671, DOI 10.1086/368276; Allison DB, 1997, AM J HUM GENET, V60, P676; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BERG K, 1978, CYTOGENET CELL GENET, V22, P621, DOI 10.1159/000131037; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Caan W, 2002, DRINK DRUGS DEPENDEN; Chen WF, 2007, ACTA GEOL SIN-ENGL, V81, P81; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Edenberg HJ, 2010, ALCOHOL CLIN EXP RES, V34, P840, DOI 10.1111/j.1530-0277.2010.01156.x; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1976, CYTOGENET CELL GENET, V16, P294, DOI 10.1159/000130613; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; George V, 1999, AM J HUM GENET, V65, P236, DOI 10.1086/302444; GEORGE VT, 1987, GENET EPIDEMIOL, V4, P193, DOI 10.1002/gepi.1370040304; Gordon D, 2004, EUR J HUM GENET, V12, P752, DOI 10.1038/sj.ejhg.5201219; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Guo CY, 2008, EUR J HUM GENET, V16, P992, DOI 10.1038/ejhg.2008.38; Guo Chao-Yu, 2007, BMC Proc, V1 Suppl 1, pS26; Guo CY, 2005, HUM HERED, V59, P125, DOI 10.1159/000085571; Gusella JF, NATURE, V306, P234; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Ionita-Laza I, 2008, GENET EPIDEMIOL, V32, P273, DOI 10.1002/gepi.20302; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kanny Dafna, 2011, Morbidity and Mortality Weekly Report, V60, P101; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Laird NM, 2008, ADV GENET, V60, P219, DOI 10.1016/S0065-2660(07)00410-5; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lange C, 2004, STAT APPL GENET MOL, V3; Lange K, 2005, GENET EPIDEMIOL, V29, P36, DOI 10.1002/gepi.20073; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lee W C, 2002, J Cancer Epidemiol Prev, V7, P97, DOI 10.1080/147666502321082755; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Lin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009697; Little R.J.A., 2002, STAT ANAL MISSING DA; MANTEL N, 1959, J NATL CANCER I, V22, P719; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; Martin ER, 2003, AM J HUM GENET, V73, P1016, DOI 10.1086/378779; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; McGinnis RE, 1998, ANN HUM GENET, V62, P159, DOI 10.1046/j.1469-1809.1998.6220159.x; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; MORTON NE, 1955, AM J HUM GENET, V7, P277; Murphy A, 2010, GENET EPIDEMIOL, V34, P582, DOI 10.1002/gepi.20515; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; OTT J, 1974, AM J HUM GENET, V26, P598; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Rice JP, 2003, ENCY HUMAN GENOME, P1; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ronnie S, 2010, EUR J HUM GENET, V18, P1032; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; Schaid DJ, 1999, GENET EPIDEMIOL, V17, pS307; Sobel E, 1996, AM J HUM GENET, V58, P1323; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sun FZ, 1999, AM J EPIDEMIOL, V150, P97; Testino G, 2008, HEPATO-GASTROENTEROL, V55, P371; THOMSON G, 1995, AM J HUM GENET, V57, P487; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Visscher PM, 2006, GENET EPIDEMIOL, V30, P30, DOI 10.1002/gepi.20124; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337; Won S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000741; Xiong MM, 1998, ANN HUM GENET, V62, P431, DOI 10.1046/j.1469-1809.1998.6250431.x; Yang Q, 2000, HUM HERED, V50, P227, DOI 10.1159/000022920; Zhu XF, 2001, GENET EPIDEMIOL, V20, P57, DOI 10.1002/1098-2272(200101)20:1<57::AID-GEPI6>3.0.CO;2-5	85	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63526	10.1371/journal.pone.0063526	http://dx.doi.org/10.1371/journal.pone.0063526			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691058	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400067
J	Patra, P; Klumpp, S				Patra, Pintu; Klumpp, Stefan			Population Dynamics of Bacterial Persistence	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; FLUCTUATING ENVIRONMENTS; GENE-EXPRESSION; AFFECTS FREQUENCY; MUREIN SYNTHESIS; GROWTH; BISTABILITY; INHIBITION; TOLERANCE; CELLS	Persistence is a prime example of phenotypic heterogeneity, where a microbial population splits into two distinct subpopulations with different growth and survival properties as a result of reversible phenotype switching. Specifically, persister cells grow more slowly than normal cells under unstressed growth conditions, but survive longer under stress conditions such as the treatment with bactericidal antibiotics. We analyze the population dynamics of such a population for several typical experimental scenarios, namely a constant environment, shifts between growth and stress conditions, and periodically switching environments. We use an approximation scheme that allows us to map the dynamics to a logistic equation for the subpopulation ratio and derive explicit analytical expressions for observable quantities that can be used to extract underlying dynamic parameters from experimental data. Our results provide a theoretical underpinning for the study of phenotypic switching, in particular for organisms where detailed mechanistic knowledge is scarce.	[Patra, Pintu; Klumpp, Stefan] Max Planck Inst Colloids & Interfaces, Potsdam, Germany	Max Planck Society	Patra, P (corresponding author), Max Planck Inst Colloids & Interfaces, Sci Pk Golm, Potsdam, Germany.	pintu.patra@mpikg.mpg.de	Klumpp, Stefan/AAC-3936-2019; Patra, Pintu/AAF-2635-2019; Klumpp, Stefan/C-2966-2008	Klumpp, Stefan/0000-0003-0584-2146; Klumpp, Stefan/0000-0003-0584-2146; Patra, Pintu/0000-0002-2275-3738				Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; Cataudella I, 2012, NUCL ACIDS RES; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Klumpp S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020403; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; Lechner S, 2012, J MOL MICROB BIOTECH, V22, P381, DOI 10.1159/000346073; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lou CB, 2008, J THEOR BIOL, V255, P205, DOI 10.1016/j.jtbi.2008.07.035; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Pearl S, 2008, PLOS BIOL, V6, P957, DOI 10.1371/journal.pbio.0060120; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Wylie CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001108	30	43	46	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62814	10.1371/journal.pone.0062814	http://dx.doi.org/10.1371/journal.pone.0062814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675428	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100013
J	Sawant, SN; Selvaraj, V; Prabhawathi, V; Doble, M				Sawant, Shilpa N.; Selvaraj, Veerapandian; Prabhawathi, Veluchamy; Doble, Mukesh			Antibiofilm Properties of Silver and Gold Incorporated PU, PCLm, PC and PMMA Nanocomposites under Two Shear Conditions	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL ADHESION; ZINC-OXIDE; ANTIBACTERIAL; SURFACE; NANOPARTICLES; BIOFILM; PARTICLES	Silver and gold nanoparticles (of average size similar to 20-27 nm) were incorporated in PU (Polyurethane), PCLm (Polycaprolactam), PC (polycarbonate) and PMMA (Polymethylmethaacrylate) by swelling and casting methods under ambient conditions. In the latter method the nanoparticle would be present not only on the surface, but also inside the polymer. These nanoparticles were prepared initially by using a cosolvent, THF. PU and PCLm were dissolved and swollen with THF. PC and PMMA were dissolved in CHCl3 and here the cosolvent, THF, acted as an intermediate between water and CHCl3. FTIR indicated that the interaction between the polymer and the nanoparticle was through the functional group in the polymer. The formation of E. coli biofilm on these nanocomposites under low (in a Drip flow biofilm reactor) and high shear (in a Shaker) conditions indicated that the biofilm growth was higher (twice) in the former than in the latter (ratio of shear force = 15). A positive correlation between the contact angle (of the virgin surface) and the number of colonies, carbohydrate and protein attached on it were observed. Ag nanocomposites exhibited better antibiofilm properties than Au. Bacterial attachment was highest on PC and least on PU nanocomposite. Casting method appeared to be better than swelling method in reducing the attachment (by a factor of 2). Composites reduced growth of organisms by six orders of magnitude, and protein and carbohydrate by 2-5 times. This study indicates that these nanocomposites may be suitable for implant applications.	[Sawant, Shilpa N.] Bhabha Atom Res Ctr, Div Chem, Mumbai 400085, Maharashtra, India; [Selvaraj, Veerapandian; Prabhawathi, Veluchamy; Doble, Mukesh] Indian Inst Technol, Dept Biotechnol, Chennai 600036, Tamil Nadu, India	Bhabha Atomic Research Center (BARC); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Doble, M (corresponding author), Indian Inst Technol, Dept Biotechnol, Chennai 600036, Tamil Nadu, India.	genprabha@yahoo.co.in		Veluchamy, Prabhawathi/0000-0002-9703-5714; Doble, Mukeshd/0000-0002-4335-0698; Sawant, Shilpa/0000-0003-2835-4575				Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0; Bollinger RR, 2003, IMMUNOLOGY, V109, P580; Corcione CE, 2009, THERMOCHIM ACTA, V485, P43, DOI 10.1016/j.tca.2008.12.009; Cunningham AB, 2008, BIOFILMS HYPER TXB V; Di Maio E, 2004, POLYMER, V45, P8893, DOI 10.1016/j.polymer.2004.10.037; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Hernandez-Sierra JF, 2008, NANOMED-NANOTECHNOL, V4, P237, DOI 10.1016/j.nano.2008.04.005; Goeres DM, 2009, NAT PROTOC, V4, P783, DOI 10.1038/nprot.2009.59; Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001; Gubin SP, 2002, COLLOID SURFACE A, V202, P155, DOI 10.1016/S0927-7757(01)01074-3; Gupta A, 1998, NAT BIOTECHNOL, V16, P888, DOI 10.1038/nbt1098-888; Hanisch C, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/5/052043; Hetrick EM, 2007, BIOMATERIALS, V28, P1948, DOI 10.1016/j.biomaterials.2007.01.006; Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104; Jung R, 2008, POLYMER, V49, P2071, DOI 10.1016/j.polymer.2008.02.045; Kannan P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/8/085602; Katoch S., 2011, DIFFUS FUNDAM, V15, P28; Katsikogianni MG, 2010, ACTA BIOMATER, V6, P1107, DOI 10.1016/j.actbio.2009.08.006; Khandwekar AP, 2011, J BIOMATER APPL, V26, P227, DOI 10.1177/0885328210367442; Khandwekar AP, 2011, J MATER SCI-MATER M, V22, P1231, DOI 10.1007/s10856-011-4285-8; Khandwekar AP, 2009, J MATER SCI-MATER M, V20, P1115, DOI 10.1007/s10856-008-3655-3; Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.3.CO;2-3; Lansdown A B G, 2002, J Wound Care, V11, P125; Li SH, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5214; Maiti P, 2002, CHEM MATER, V14, P4654, DOI 10.1021/cm020391b; Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240; Meinders JM, 1995, J COLLOID INTERF SCI, V176, P329, DOI 10.1006/jcis.1995.9960; Nair B, 2002, CRYST GROWTH DES, V2, P293, DOI 10.1021/cg0255164; Nandakumar V, 2013, POLYM J, V45, P137, DOI 10.1038/pj.2012.130; Pal A, 2009, MATER CHEM PHYS, V114, P530, DOI 10.1016/j.matchemphys.2008.11.056; Pattanayak A, 2005, POLYMER, V46, P3394, DOI 10.1016/j.polymer.2005.03.021; Pavia DL., 2001, INTRO SPECTROSCOPY; Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003; Prabhakar PK, 2011, COLLOID SURFACE B, V86, P146, DOI 10.1016/j.colsurfb.2011.03.033; Rapoport L, 2004, ADV ENG MATER, V6, P44, DOI 10.1002/adem.200300512; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3; Sanchez-Soto M, 2009, EUR POLYM J, V45, P341, DOI 10.1016/j.eurpolymj.2008.10.026; Sivakumar PM, 2010, COLLOID SURFACE B, V81, P439, DOI 10.1016/j.colsurfb.2010.07.037; Sivakumar PM, 2010, CARBOHYD POLYM, V79, P717, DOI 10.1016/j.carbpol.2009.09.027; Sivakumar PM, 2012, CARBOHYD POLYM, V87, P353, DOI 10.1016/j.carbpol.2011.07.061; Styan K, 2007, KEY ENG MATER, V342-343, P757, DOI 10.4028/www.scientific.net/KEM.342-343.757; Styan KE, 2008, J BIOMED MATER RES A, V86A, P571, DOI 10.1002/jbm.a.31667; Sudhakar M, 2007, INT BIODETER BIODEGR, V60, P144, DOI 10.1016/j.ibiod.2007.02.002; Tang EJ, 2006, POWDER TECHNOL, V161, P209, DOI 10.1016/j.powtec.2005.10.007; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Veeraapandian S, 2012, J BIOMED NANOTECHNOL, V8, P140, DOI 10.1166/jbn.2012.1356; Veluchamy P, 2011, J AGR FOOD CHEM, V59, P10869, DOI 10.1021/jf201124v; Wang XY, 2007, CARBOHYD POLYM, V69, P41, DOI 10.1016/j.carbpol.2006.08.025; Wang ZX, 2009, COORDIN CHEM REV, V253, P1607, DOI 10.1016/j.ccr.2009.01.005; Yeo SY, 2003, POLYM INT, V52, P1053, DOI 10.1002/pi.1215; Yu JG, 2006, J MOL CATAL A-CHEM, V246, P176, DOI 10.1016/j.molcata.2005.10.034; Zhou N.L., 2007, CURR APPL PHYS, V7, P58, DOI [10.1016/j.cap.2006.11.016, DOI 10.1016/J.CAP.2006.11.016]	54	48	49	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63311	10.1371/journal.pone.0063311	http://dx.doi.org/10.1371/journal.pone.0063311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675476	gold, Green Submitted, Green Published			2022-12-25	WOS:000319036100037
J	Pang, LJ; Li, HX; Gao, L; Wang, YM				Pang, Liaojun; Li, Huixian; Gao, Lu; Wang, Yumin			Completely Anonymous Multi-Recipient Signcryption Scheme with Public Verification	PLOS ONE			English	Article						Multi-recipient signcryption; Signcryption; Complete Anonymity; Public verification		Most of the existing multi-recipient signcryption schemes do not take the anonymity of recipients into consideration because the list of the identities of all recipients must be included in the ciphertext as a necessary element for decryption. Although the signer's anonymity has been taken into account in several alternative schemes, these schemes often suffer from the cross-comparison attack and joint conspiracy attack. That is to say, there are few schemes that can achieve complete anonymity for both the signer and the recipient. However, in many practical applications, such as network conference, both the signer's and the recipient's anonymity should be considered carefully. Motivated by these concerns, we propose a novel multi-recipient signcryption scheme with complete anonymity. The new scheme can achieve both the signer's and the recipient's anonymity at the same time. Each recipient can easily judge whether the received ciphertext is from an authorized source, but cannot determine the real identity of the sender, and at the same time, each participant can easily check decryption permission, but cannot determine the identity of any other recipient. The scheme also provides a public verification method which enables anyone to publicly verify the validity of the ciphertext. Analyses show that the proposed scheme is more efficient in terms of computation complexity and ciphertext length and possesses more advantages than existing schemes, which makes it suitable for practical applications. The proposed scheme could be used for network conferences, paid-TV or DVD broadcasting applications to solve the secure communication problem without violating the privacy of each participant.	[Pang, Liaojun; Gao, Lu; Wang, Yumin] Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China; [Pang, Liaojun; Li, Huixian] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Li, Huixian] Northwestern Polytech Univ, Sch Comp Sci & Engn, Xian 710072, Peoples R China	Xidian University; Wayne State University; Northwestern Polytechnical University	Pang, LJ (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China.	liaojun.pang@wayne.edu	Life, FP/M-9555-2013		National Natural Science Foundation of China [61103178, 61103199, 60803151]; Research Fund for the Doctoral Program of Higher Education of China [20096102120045]; Basic Science Research Fund in Xidian University [K5051310006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Basic Science Research Fund in Xidian University	National Natural Science Foundation of China under grant numbers 61103178, 61103199 and 60803151; the Research Fund for the Doctoral Program of Higher Education of China under grant number 20096102120045; Basic Science Research Fund in Xidian University under grant number K5051310006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek J, 2005, LECT NOTES COMPUT SC, V3386, P380; Duan SS, 2006, LECT NOTES COMPUT SC, V4058, P195; Elkamchouchi Hassan, 2009, 2009 International Conference on Networking and Media Convergence (ICNM'09), P70, DOI 10.1109/ICNM.2009.4907192; Fan CI, 2010, IEEE T COMPUT, V59, P1239, DOI 10.1109/TC.2010.23; Gafurov D, 2006, LECT NOTES COMPUT SC, V4277, P479; Huang XY, 2005, AINA 2005: 19TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS, VOL 2, P649; Lal S, 2009, IACRCRYPTOLOGY EPRIN, V2009, P345; Malone-Lee J., 2002, IACR CRYPTOLOGY EPRI; Pang L, 2012, IET COMMUN, V6, P1126, DOI 10.1049/iet-com.2010.0954; Pang Liao-Jun, 2009, Journal of Software, V20, P2907, DOI 10.3724/SP.J.1001.2009.03552; [庞辽军 Pang Liaojun], 2011, [计算机学报, Chinese Journal of Computers], V34, P2104; Qin HW, 2011, SECUR COMMUN NETW, V4, P1331, DOI 10.1002/sec.259; Rivest R.L., 2001, LNCS, V2248, P552, DOI [DOI 10.1007/3-540-45682-1_32, 10.1007/3-540-45682-132]; Selvi SSD, 2009, LECT NOTES COMPUT SC, V5824, P71, DOI 10.1007/978-3-642-04846-3_6; Xiaohui Wang, 2009, Journal of Networks, V4, P641, DOI 10.4304/jnw.4.7.641-648; Xie Qi, 2005, Wuhan University Journal of Natural Sciences, V10, P107, DOI 10.1007/BF02828628; Yu Y, 2007, LECT NOTES COMPUT SC, V4610, P13; Zhang B, 2010, LECT NOTES COMPUT SC, V6059, P15, DOI 10.1007/978-3-642-13577-4_2; Zhang JH, 2009, LECT NOTES COMPUT SC, V5446, P604, DOI 10.1007/978-3-642-00672-2_58; Zheng YL, 1997, LECT NOTES COMPUT SC, V1294, P165	20	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63562	10.1371/journal.pone.0063562	http://dx.doi.org/10.1371/journal.pone.0063562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675490	gold, Green Published, Green Submitted			2022-12-25	WOS:000318852400044
J	Saxena, S; Wahl, J; Huber-Lang, MS; Stadel, D; Braubach, P; Debatin, KM; Beltinger, C				Saxena, Shobhit; Wahl, Joachim; Huber-Lang, Markus S.; Stadel, Dominic; Braubach, Peter; Debatin, Klaus-Michael; Beltinger, Christian			Generation of Murine Sympathoadrenergic Progenitor-Like Cells from Embryonic Stem Cells and Postnatal Adrenal Glands	PLOS ONE			English	Article							NEURAL CREST CELLS; GENE REGULATORY NETWORK; FETAL CHROMAFFIN CELLS; SYMPATHETIC NEURONS; DIRECTED DIFFERENTIATION; GANGLIOSIDE GD2; IN-VITRO; N-MYC; NEUROBLASTOMA; MOUSE	Sympathoadrenergic progenitor cells (SAPs) of the peripheral nervous system (PNS) are important for normal development of the sympathetic PNS and for the genesis of neuroblastoma, the most common and often lethal extracranial solid tumor in childhood. However, it remains difficult to isolate sufficient numbers of SAPs for investigations. We therefore set out to improve generation of SAPs by using two complementary approaches, differentiation from murine embryonic stem cells (ESCs) and isolation from postnatal murine adrenal glands. We provide evidence that selecting for GD2 expression enriches for ESC-derived SAP-like cells and that proliferating SAP-like cells can be isolated from postnatal adrenal glands of mice. These advances may facilitate investigations about the development and malignant transformation of the sympathetic PNS.	[Saxena, Shobhit; Wahl, Joachim; Stadel, Dominic; Debatin, Klaus-Michael; Beltinger, Christian] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany; [Huber-Lang, Markus S.] Univ Ulm, Inst Traumatol Hand & Reconstruct Surg, D-89069 Ulm, Germany; [Braubach, Peter] Univ Ulm, Div Neurophysiol, D-89069 Ulm, Germany	Ulm University; Ulm University; Ulm University	Beltinger, C (corresponding author), Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany.	christian.beltinger@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014; Huber-Lang, Markus/AAJ-2209-2020; Saxena, Shobhit/AAI-1267-2021	Debatin, Klaus-Michael/0000-0002-8397-1886; Saxena, Shobhit/0000-0002-2422-3749	Deutsche Krebshilfe; International Graduate School in Molecular Medicine, Ulm University	Deutsche Krebshilfe(Deutsche Krebshilfe); International Graduate School in Molecular Medicine, Ulm University	This study was supported by funding from the Deutsche Krebshilfe to Christian Beltinger. International Graduate School in Molecular Medicine, Ulm University provided additional support for Shobhit Saxena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilleos A, 2012, CELL RES, V22, P288, DOI 10.1038/cr.2012.11; Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; [Anonymous], 2010, R LANG ENV STAT COMP; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRONNERFRASER M, 1987, DEV BIOL, V123, P321, DOI 10.1016/0012-1606(87)90390-3; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; Chung KF, 2009, STEM CELLS, V27, P2602, DOI 10.1002/stem.180; Ehrhart-Bornstein M, 2010, CELL MOL NEUROBIOL, V30, P1417, DOI 10.1007/s10571-010-9571-3; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Gossrau G, 2007, STEM CELLS, V25, P939, DOI 10.1634/stemcells.2006-0299; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Jozan S, 2007, EXP NEUROL, V205, P525, DOI 10.1016/j.expneurol.2007.03.020; Kawaguchi J, 2010, DEVELOPMENT, V137, P693, DOI 10.1242/dev.046896; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lucas ME, 2006, DEVELOPMENT, V133, P4015, DOI 10.1242/dev.02574; Maurer J, 2007, DIFFERENTIATION, V75, P580, DOI 10.1111/j.1432-0436.2007.00164.x; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Motohashi T, 2007, STEM CELLS, V25, P402, DOI 10.1634/stemcells.2006-0323; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pomp O, 2005, STEM CELLS, V23, P923, DOI 10.1634/stemcells.2005-0038; Pomp O, 2008, BRAIN RES, V1230, P50, DOI 10.1016/j.brainres.2008.07.029; Rao MS, 1997, J NEUROBIOL, V32, P722, DOI 10.1002/(SICI)1097-4695(19970620)32:7<722::AID-NEU7>3.0.CO;2-6; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Reiff T, 2011, DEVELOPMENT, V138, P4699, DOI 10.1242/dev.072157; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Rohrer H, 2011, EUR J NEUROSCI, V34, P1563, DOI 10.1111/j.1460-9568.2011.07860.x; SARIOLA H, 1991, AM J CLIN PATHOL, V96, P248, DOI 10.1093/ajcp/96.2.248; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schulte JH, 2013, ONCOGENE, V32, P1059, DOI 10.1038/onc.2012.106; SCHULZ G, 1984, CANCER RES, V44, P5914; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shi HL, 2008, J COMP NEUROL, V508, P867, DOI 10.1002/cne.21719; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Vukicevic V, 2012, CELL TRANSPLANT; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Weiss WA, 2000, CANCER RES, V60, P2483; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; WOBUS AM, 1991, DIFFERENTIATION, V48, P173, DOI 10.1111/j.1432-0436.1991.tb00255.x; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhou H, 2006, EXP NEUROL, V198, P370, DOI 10.1016/j.expneurol.2005.12.012; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	54	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e64454	10.1371/journal.pone.0064454	http://dx.doi.org/10.1371/journal.pone.0064454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675538	Green Submitted, Green Published, gold			2022-12-25	WOS:000318852400070
J	Putti, S; Calandra, P; Rossi, N; Scarabino, D; Deidda, G; Tocchini-Valentini, GP				Putti, Sabrina; Calandra, Patrizia; Rossi, Nicoletta; Scarabino, Daniela; Deidda, Giancarlo; Tocchini-Valentini, Glauco P.			Highly efficient, in vivo optimized, archaeal endonuclease for controlled RNA splicing in mammalian cells	FASEB JOURNAL			English	Article						bulge-helix-bulge; Methanocaldococcus jannaschii	MESSENGER-RNA; HNRNP A1; EVOLUTION; SELECTION; SEQUENCE; COMPLEX; IDENTIFICATION; ENZYME; M9	ARCHAEA-ExPRESs is an mRNA modification technology that makes use of components derived from the Archaeon Methanocaldococcus jannaschii, namely the tRNA splicing endonuclease (MJ-EndA) and its natural substrate, the bulge-helix-bulge (BHB) structure (1). These components can perform both cis- and trans-splicing in cellular and animal models and may provide a convenient way to modulate gene expression using components independent of cellular regulatory networks. To use MJ-EndA in stable expression mammalian systems, we developed variants characterized by high efficiency and sustainable in vivo activity. The MJ-EndA variants were created by the introduction of proper localization signals followed by mutagenesis and direct selection in mammalian cells. Of note, enzyme selection used an in vivo selection method based on puromycin resistance conferred to cells by BHB-mediated intron splicing from an out-of-frame puromycin N-acetyl transferase (PAC) gene. This approach yielded several endonuclease variants, the best of which showed 40-fold higher activity compared to the parental enzyme and stable processing of 30% of the target mRNA. Notably, these variants showed complete compatibility with long-term expression in mammalian cells, suggesting that they may be usefully applied in functional genomics and genetically modified animal models.Putti, S., Calandra, P., Rossi, N., Scarabino, D., Deidda, G., Tocchini-Valentini, G. P. Highly efficient, in vivo optimized, archaeal endonuclease for controlled RNA splicing in mammalian cells.	[Putti, Sabrina; Calandra, Patrizia; Rossi, Nicoletta; Scarabino, Daniela; Deidda, Giancarlo; Tocchini-Valentini, Glauco P.] European Mouse Mutant Arch, Ist Biol Cellulare & Neurobiol, CNR, Monterotondo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR)	Deidda, G (corresponding author), European Mouse Mutant Arch, Ist Biol Cellulare & Neurobiol, Via E Ramarini 32, I-00015 Monterotondo Scalo Rome, Italy.	giancarlo.deidda@cnr.it	Scarabino, Daniela/AAX-5959-2020; Scarabino, Daniela/AAB-3837-2019; putti, sabrina/H-2574-2019	Scarabino, Daniela/0000-0002-5565-6379; putti, sabrina/0000-0003-3335-043X; DEIDDA, GIANCARLO/0000-0002-0828-5800	Italian Ministry of Research; European Union	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission)	The authors thank G. Di Franco for technical assistance and A. Ferrara and T. Cuccurullo for help with the manuscript. This work was supported by Italian Ministry of Research grants (FIRB Idee Progettuali 2005, CNR Progetto d'Interesse Strategico Invecchiamento 2012-2014) and European Union Framework Programme 7 (EUCOMMTools, PHENOSCALE contracts). The authors declare no conflicts of interest.	BURKE JM, 1993, FASEB J, V7, P106, DOI 10.1096/fasebj.7.1.8422956; Calvin K, 2008, BIOCHEMISTRY-US, V47, P13659, DOI 10.1021/bi801141q; CHAPMAN KB, 1994, CURR OPIN STRUC BIOL, V4, P618, DOI 10.1016/S0959-440X(94)90227-5; Deidda G, 2003, NAT BIOTECHNOL, V21, P1499, DOI 10.1038/nbt908; Deidda G, 2010, FASEB J, V24, P2976, DOI 10.1096/fj.10-154658; Diener JL, 1998, MOL CELL, V1, P883, DOI 10.1016/S1097-2765(00)80087-8; Garcia-Blanco MA, 2003, NAT BIOTECHNOL, V21, P1448, DOI 10.1038/nbt1203-1448; Honey S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e24; Iijima M, 2006, FEBS LETT, V580, P1365, DOI 10.1016/j.febslet.2006.01.058; Izaurralde E, 1997, J CELL BIOL, V137, P27, DOI 10.1083/jcb.137.1.27; JOYCE GF, 1994, CURR OPIN STRUC BIOL, V4, P331, DOI 10.1016/S0959-440X(94)90100-7; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Labrou NE, 2010, CURR PROTEIN PEPT SC, V11, P91, DOI 10.2174/138920310790274617; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; Michael M., 1995, CELL, V83, P415; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847	20	2	2	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3466	3477		10.1096/fj.13-231993	http://dx.doi.org/10.1096/fj.13-231993			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23682120				2022-12-25	WOS:000328840500007
J	Cotter, DG; Ercal, B; d'Avignon, DA; Dietzen, DJ; Crawford, PA				Cotter, David G.; Ercal, Baris; d'Avignon, D. Andre; Dietzen, Dennis J.; Crawford, Peter A.			Impact of Peripheral Ketolytic Deficiency on Hepatic Ketogenesis and Gluconeogenesis during the Transition to Birth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA-TRANSFERASE DEFICIENCY; RAT-LIVER MITOCHONDRIA; KETONE-BODY METABOLISM; FATTY-ACID-METABOLISM; PYRUVATE-DEHYDROGENASE; SUCCINYL-COA; PHOSPHOENOLPYRUVATE CARBOXYKINASE; NEONATAL HYPOGLYCEMIA; MAGNETIC-RESONANCE; MAMMALIAN-TISSUES	Preservation of bioenergetic homeostasis during the transition from the carbohydrate-laden fetal diet to the high fat, low carbohydrate neonatal diet requires inductions of hepatic fatty acid oxidation, gluconeogenesis, and ketogenesis. Mice with loss-of-function mutation in the extrahepatic mitochondrial enzyme CoA transferase (succinyl-CoA: 3-oxoacid CoA transferase, SCOT, encoded by nuclear Oxct1) cannot terminally oxidize ketone bodies and develop lethal hyperketonemic hypoglycemia within 48 h of birth. Here we use this model to demonstrate that loss of ketone body oxidation, an exclusively extrahepatic process, disrupts hepatic intermediary metabolic homeostasis after high fat mother's milk is ingested. Livers of SCOT-knock-out (SCOT-KO) neonates induce the expression of the genes encoding peroxisome proliferator-activated receptor gamma co-activator-1a (PGC-1 alpha), phosphoenolpyruvate carboxykinase (PEPCK), pyruvate carboxylase, and glucose-6-phosphatase, and the neonate's pools of gluconeogenic alanine and lactate are each diminished by 50%. NMR-based quantitative fate mapping of C-13-labeled substrates revealed that livers of SCOT-KO newborn mice synthesize glucose from exogenously administered pyruvate. However, the contribution of exogenous pyruvate to the tricarboxylic acid cycle as acetyl-CoA is increased in SCOT-KO livers and is associated with diminished terminal oxidation of fatty acids. After mother's milk provokes hyperketonemia, livers of SCOT-KO mice diminish de novo hepatic beta-hydroxybutyrate synthesis by 90%. Disruption of beta-hydroxybutyrate production increases hepatic NAD(+)/NADH ratios 3-fold, oxidizing redox potential in liver but not skeletal muscle. Together, these results indicate that peripheral ketone body oxidation prevents hypoglycemia and supports hepatic metabolic homeostasis, which is critical for the maintenance of glycemia during the adaptation to birth.	[Cotter, David G.; Ercal, Baris; Crawford, Peter A.] Washington Univ, Dept Med, Ctr Cardiovasc Res, St Louis, MO 63110 USA; [Cotter, David G.; Dietzen, Dennis J.] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [d'Avignon, D. Andre] Washington Univ, Dept Chem, St Louis, MO 63110 USA; [Crawford, Peter A.] Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Crawford, PA (corresponding author), Washington Univ, Dept Med, Div Cardiol, Sch Med, Campus Box 8086,660 S Euclid Ave, St Louis, MO 63110 USA.	pcrawford@wustl.edu		Crawford, Peter/0000-0001-8597-4426	National Institutes of Health [DK091538, HL007873]; March of Dimes; Children's Discovery Institute through St. Louis Children's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK020579, R01DK091538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Children's Discovery Institute through St. Louis Children's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK091538 (to P. A. C.) and Training Grant HL007873 (to D. G. C.). This work was also supported by the March of Dimes and the Children's Discovery Institute through St. Louis Children's Hospital (to P. A. C.).	Aledo R, 2001, HUM GENET, V109, P19, DOI 10.1007/s004390100554; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; BATENBURG JJ, 1976, J BIOL CHEM, V251, P1364; Berry GT, 2001, J INHERIT METAB DIS, V24, P587, DOI 10.1023/A:1012419911789; BOCK HG, 1975, J BIOL CHEM, V250, P5774; BOUGNERES PF, 1986, J CLIN INVEST, V77, P42, DOI 10.1172/JCI112299; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Cotter DG, 2013, AM J PHYSIOL-ENDOC M, V304, pE363, DOI 10.1152/ajpendo.00547.2012; Cotter DG, 2011, J BIOL CHEM, V286, P6902, DOI 10.1074/jbc.M110.192369; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Cunnane SC, 2003, COMP BIOCHEM PHYS A, V136, P17, DOI 10.1016/S1095-6433(03)00048-5; Dietzen DJ, 2008, RAPID COMMUN MASS SP, V22, P3481, DOI 10.1002/rcm.3754; Fukao T, 1997, PEDIATR RES, V42, P498, DOI 10.1203/00006450-199710000-00013; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Harris DL, 2012, J PEDIATR-US, V161, P787, DOI 10.1016/j.jpeds.2012.05.022; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Huidekoper HH, 2008, EUR J PEDIATR, V167, P859, DOI 10.1007/s00431-007-0598-5; Jones JG, 1997, ANAL BIOCHEM, V249, P201, DOI 10.1006/abio.1997.2172; KassovskaBratinova S, 1996, AM J HUM GENET, V59, P519; LEHNINGER AL, 1960, J BIOL CHEM, V235, P2450; LINCOLN BC, 1987, ARCH BIOCHEM BIOPHYS, V259, P149, DOI 10.1016/0003-9861(87)90480-2; MAGNUSSON I, 1991, J BIOL CHEM, V266, P6975; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Merritt ME, 2011, P NATL ACAD SCI USA, V108, P19084, DOI 10.1073/pnas.1111247108; Minino A. M., 2010, CDC CONTROL PREVENTI, V59, P1; Mitchell GA, 2000, ONLINE METABOLIC MOL, P12; NiezenKoning KE, 1997, EUR J PEDIATR, V156, P870, DOI 10.1007/s004310050733; Orii KE, 2008, TOHOKU J EXP MED, V215, P227, DOI 10.1620/tjem.215.227; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Platt MW, 2005, SEMIN FETAL NEONAT M, V10, P341, DOI 10.1016/j.siny.2005.04.001; PREUVENEERS MJ, 1973, BIOCHEM J, V133, P159, DOI 10.1042/bj1330159; Pryce JW, 2011, J CLIN PATHOL, V64, P1005, DOI 10.1136/jclinpath-2011-200218; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; SCOFIELD RF, 1982, ARCH BIOCHEM BIOPHYS, V214, P268, DOI 10.1016/0003-9861(82)90030-3; STERN JR, 1956, J BIOL CHEM, V221, P15; Sunny NE, 2010, AM J PHYSIOL-ENDOC M, V298, pE1226, DOI 10.1152/ajpendo.00033.2010; TAYLOR SI, 1975, J BIOL CHEM, V250, P2028; TILDON JT, 1972, J CLIN INVEST, V51, P493, DOI 10.1172/JCI106837; Wentz AE, 2010, J BIOL CHEM, V285, P24447, DOI 10.1074/jbc.M110.100651; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; YANG SY, 1987, J BIOL CHEM, V262, P13027; Ziegler A, 2002, NMR BIOMED, V15, P222, DOI 10.1002/nbm.764	49	13	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19739	19749		10.1074/jbc.M113.454868	http://dx.doi.org/10.1074/jbc.M113.454868			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689508	Green Published, hybrid			2022-12-25	WOS:000321515800043
J	Hu, XL; Bardhan, K; Paschall, AV; Yang, DF; Waller, JL; Park, MA; Nayak-Kapoor, A; Samuel, TA; Abrams, SI; Liu, KB				Hu, Xiaolin; Bardhan, Kankana; Paschall, Amy V.; Yang, Dafeng; Waller, Jennifer L.; Park, Mary Anne; Nayak-Kapoor, Asha; Samuel, Thomas A.; Abrams, Scott I.; Liu, Kebin			Deregulation of Apoptotic Factors Bcl-xL and Bax Confers Apoptotic Resistance to Myeloid-derived Suppressor Cells and Contributes to Their Persistence in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; IMMUNE SUPPRESSION; TUMOR MICROENVIRONMENT; IN-VITRO; DEATH; EXPRESSION; FAS; DIFFERENTIATION; INHIBITION; ACCUMULATION	Myeloid-derived suppressor cells (MDSCs) are heterogeneous immature myeloid cells that accumulate in response to tumor progression. Compelling data from mouse models and human cancer patients showed that tumor-induced inflammatory mediators induce MDSC differentiation. However, the mechanisms underlying MDSC persistence is largely unknown. Here, we demonstrated that tumor-induced MDSCs exhibit significantly decreased spontaneous apoptosis as compared with myeloid cells with the same phenotypes from tumor-free mice. Consistent with the decreased apoptosis, cell surface Fas receptor decreased significantly in tumor-induced MDSCs. Screening for changes of key apoptosis mediators downstream the Fas receptor revealed that expression levels of IRF8 and Bax are diminished, whereas expression of Bcl-xL is increased in tumor-induced MDSCs. We further determined that IRF8 binds directly to Bax and Bcl-x promoter in primary myeloid cells in vivo, and IRF8-deficient MDSC-like cells also exhibit increased Bcl-xL and decreased Bax expression. Analysis of CD69 and CD25 levels revealed that cytotoxic T lymphocytes (CTLs) are partially activated in tumor-bearing hosts. Strikingly, FasL but not perforin and granzymes were selectively activated in CTLs in the tumor-bearing host. ABT-737 significantly increased the sensitivity of MDSCs to Fas-mediated apoptosis in vitro. More importantly, ABT-737 therapy increased MDSC spontaneous apoptosis and decreased MDSC accumulation in tumor-bearing mice. Our data thus determined that MDSCs use down-regulation of IRF8 to alter Bax and Bcl-xL expression to deregulate the Fas-mediated apoptosis pathway to evade elimination by host CTLs. Therefore, targeting Bcl-xL is potentially effective in suppression of MDSC persistence in cancer therapy.	[Hu, Xiaolin; Bardhan, Kankana; Paschall, Amy V.; Yang, Dafeng; Liu, Kebin] Georgia Regents Univ, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Waller, Jennifer L.] Georgia Regents Univ, Dept Biostat & Epidemiol, Augusta, GA 30912 USA; [Park, Mary Anne] Georgia Regents Univ, Dept Surg, Augusta, GA 30912 USA; [Nayak-Kapoor, Asha; Samuel, Thomas A.] Georgia Regents Univ, Dept Hematol & Oncol, Med Coll Georgia, Augusta, GA 30912 USA; [Nayak-Kapoor, Asha; Samuel, Thomas A.; Liu, Kebin] Georgia Regents Univ, Ctr Canc, Augusta, GA 30912 USA; [Abrams, Scott I.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Roswell Park Cancer Institute	Liu, KB (corresponding author), Georgia Regents Univ, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.	Kliu@gru.edu		Liu, Kebin/0000-0003-1965-7240	National Institutes of Health [CA133085, CA168512-DRP1, CA140622]; American Cancer Society [RSG-09209]; NATIONAL CANCER INSTITUTE [R01CA140622, U54CA168512, R01CA133085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA133085, CA168512-DRP1 (to K. L.), and CA140622 (to S. I. A.). This work was also supported by American Cancer Society Grant RSG-09209 (to K. L.).	Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Burchert A, 2004, BLOOD, V103, P3480, DOI 10.1182/blood-2003-08-2970; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Fortin C, 2012, J IMMUNOL, V189, P1843, DOI 10.4049/jimmunol.1200584; Fricke I, 2007, CLIN CANCER RES, V13, P4840, DOI 10.1158/1078-0432.CCR-07-0409; Gabriele L, 1999, J EXP MED, V190, P411, DOI 10.1084/jem.190.3.411; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Haile LA, 2010, J IMMUNOL, V185, P203, DOI 10.4049/jimmunol.0903573; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; Jayaraman P, 2012, J IMMUNOL, V188, P5365, DOI 10.4049/jimmunol.1103553; Kilinc MO, 2009, J IMMUNOL, V183, P7656, DOI 10.4049/jimmunol.0902625; Kim PKM, 2001, DRUG RESIST UPDATE, V4, P293, DOI 10.1054/drup.2001.0223; Kober AMM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.93; Koenigsmann J, 2009, LEUKEMIA LYMPHOMA, V50, P2078, DOI 10.3109/10428190903296913; Kusmartsev S, 2003, CANCER RES, V63, P4441; Kusmartsev S, 2008, J IMMUNOL, V181, P346, DOI 10.4049/jimmunol.181.1.346; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lavrik IN, 2008, J BIOL CHEM, V283, P26401, DOI 10.1074/jbc.M800823200; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Lenardo M. J., 2010, ALPS 10 LESSONS INT; Liu K, 2010, WORLD J GASTRO ONCOL, V2, P399, DOI 10.4251/wjgo.v2.i11.399; Mace TA, 2013, CANCER RES, V73, P3007, DOI 10.1158/0008-5472.CAN-12-4601; Melani C, 2007, CANCER RES, V67, P11438, DOI 10.1158/0008-5472.CAN-07-1882; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Meng XW, 2011, J BIOL CHEM, V286, P35823, DOI 10.1074/jbc.M111.240432; Mohr A, 2005, ONCOGENE, V24, P2421, DOI 10.1038/sj.onc.1208432; Mundy-Bosse BL, 2011, CANCER RES, V71, P5101, DOI 10.1158/0008-5472.CAN-10-2670; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Nikolov NP, 2010, BLOOD, V116, P740, DOI 10.1182/blood-2009-08-237560; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Ozao-Choy J, 2009, CANCER RES, V69, P2514, DOI 10.1158/0008-5472.CAN-08-4709; Pilon-Thomas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027729; Qu P, 2011, J IMMUNOL, V187, P3854, DOI 10.4049/jimmunol.1003358; Ramachandran IR, 2013, J IMMUNOL, V190, P3815, DOI 10.4049/jimmunol.1203373; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Rooswinkel RW, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.109; Ryzhov S, 2011, J IMMUNOL, V187, P6120, DOI 10.4049/jimmunol.1101225; Saleem SJ, 2012, J IMMUNOL, V189, P511, DOI 10.4049/jimmunol.1200647; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sinha P, 2011, BLOOD, V117, P5381, DOI 10.1182/blood-2010-11-321752; Solito S, 2011, BLOOD, V118, P2254, DOI 10.1182/blood-2010-12-325753; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Srivastava MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040677; Srivastava MK, 2012, IMMUNOTHERAPY-UK, V4, P291, DOI [10.2217/IMT.11.178, 10.2217/imt.11.178]; Stewart TJ, 2009, J CELL MOL MED, V13, P3939, DOI 10.1111/j.1582-4934.2009.00685.x; Stewart TJ, 2009, J IMMUNOL, V183, P117, DOI 10.4049/jimmunol.0804132; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Toivonen HT, 2011, J BIOL CHEM, V286, P18375, DOI 10.1074/jbc.M110.177097; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812; Yang DF, 2007, J IMMUNOL, V179, P4775, DOI 10.4049/jimmunol.179.7.4775; Yang DF, 2012, J IMMUNOL, V188, P4441, DOI 10.4049/jimmunol.1103035; Yang DF, 2009, CANCER RES, V69, P1080, DOI 10.1158/0008-5472.CAN-08-2520; Yang JN, 2011, J IMMUNOL, V187, P4426, DOI 10.4049/jimmunol.1101034; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004	75	53	55	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19103	19115		10.1074/jbc.M112.434530	http://dx.doi.org/10.1074/jbc.M112.434530			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23677993	Green Published, hybrid			2022-12-25	WOS:000321335800045
J	Gierl, C; Reichenbacher, B; Gaudant, J; Erpenbeck, D; Pharisat, A				Gierl, Christoph; Reichenbacher, Bettina; Gaudant, Jean; Erpenbeck, Dirk; Pharisat, Andre			An Extraordinary Gobioid Fish Fossil from Southern France	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; GOBY TELEOSTEI; PERCIFORMES; ELEOTRIDAE; OLIGOCENE; OSTEOLOGY; OTOLITHS; EOCENE	Background: The classification of gobioid fishes is still under discussion. Several lineages, including the Eleotridae and Butidae, remain difficult to characterize because synapomorphies are rare (Eleotridae) or have not yet been determined (Butidae). Moreover, the fossil record of these groups is scarce. Results: Exceptionally well-preserved fish fossils with otoliths in situ from uppermost Oligocene sediments (approximate to 23-24 Mio. y. ago) in Southern France provide the most in-depth description of a fossil gobioid to date. The species was initially described as Cottus aries Agassiz, then transferred to dagger Lepidocottus Sauvage, and subsequently assigned to Gobius. Based on a comparative analysis of meristic, osteological and otolith data, this species most likely is a member of the family Butidae. This discovery is important because it represents the first record of a fossil butid fish based on articulated skeletons from Europe. Significance: The Butidae and Eleotridae are currently distributed in W-Africa, Madagascar, Asia and Australia, but they do not appear in Europe and also not in the Mediterranean Sea. The new results indicate that several species of the Butidae thrived in Europe during the Oligocene and Early Miocene. Similar to the recent Butidae and Eleotridae, these fishes were adapted to a wide range of salinities and thrived in freshwater, brackish and marginal marine habitats. The fossil Butidae disappeared from Europe and the Mediterranean and Paratethys areas during the Early Miocene, due probably to their lack of competitiveness compared to other Gobioidei that radiated during this period of time. In addition, this study documents the great value of otoliths for gobioid systematics.	[Gierl, Christoph; Reichenbacher, Bettina; Erpenbeck, Dirk] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Gaudant, Jean] Museum Natl Hist Nat, F-75231 Paris, France; [Pharisat, Andre] Museum G CUVIER, Montbeliard, France	University of Munich; Museum National d'Histoire Naturelle (MNHN)	Gierl, C (corresponding author), Univ Munich, Dept Earth & Environm Sci, Munich, Germany.	chris.gierl@t-online.de; b.reichenbacher@lrz.uni-muenchen.de	Reichenbacher, Bettina/AAM-9684-2020	Erpenbeck, Dirk/0000-0003-2716-1085; Reichenbacher, Bettina/0000-0001-6678-5080	Department for Earth and Environmetal Sciences at LMU University	Department for Earth and Environmetal Sciences at LMU University	The work was supported by the Department for Earth and Environmetal Sciences at LMU University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorreta A, 2012, SYST BIODIVERS, V10, P375, DOI 10.1080/14772000.2012.699477; Agusti J, 2001, EARTH-SCI REV, V52, P247, DOI 10.1016/S0012-8252(00)00025-8; Ahnelt Harald, 2004, Proceedings of the California Academy of Sciences, V55, P358; Akihito, 2000, GENE, V259, P5, DOI 10.1016/S0378-1119(00)00488-1; [Anonymous], 1833, RECHERCHES POISSONS; Bajpai S, 2004, CURR SCI INDIA, V87, P433; BIRDSONG RS, 1988, B MAR SCI, V42, P174; BOHME M, 2007, ACTA MUSEI NATL PR B, V63, P175; Chakrabarty P, 2010, ZOOTAXA, P19; Chakrabarty P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044083; de Blainville HMD, 1818, POISSONS FOSSILES NO, P310; Fontes J-C, 1980, B SOC GEOL FR, V7, P491; GAUDANT J, 1981, CR ACAD SCI III-VIE, V292, P1109; Gaudant J, 1996, CR ACAD SCI II A, V322, P71; GAUDANT J, 1978, Geobios (Villeurbanne), V11, P393, DOI 10.1016/S0016-6995(78)80039-4; Gaudant J., 1975, Geologic Mediterraneenne, V2, P111; Gaudant J., 1979, SCI GEOL B, V32, P131, DOI [10.3406/sgeol.1979.1560, DOI 10.3406/SGEOL.1979.1560]; Gaudant Jean, 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V111A, P281; Gill AC, 2012, ZOOTAXA, P41; Gill AC, 2011, ZOOTAXA, P66, DOI 10.11646/zootaxa.2741.1.4; Guieu G, 1988, GEOLOGIE MEDITERRANE, V15, P123; Harrison Ian J., 1992, Faune Tropicale, V28, P822; Harrison IJ, 2003, FAUNE POISSONS EAUX, P671; Hoese D.F., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P588; HOESE DF, 1993, B MAR SCI, V52, P415; Hoese Douglass F., 2006, Memoirs of Museum Victoria, V63, P15; Iwata A, 2012, BIOLOGY OF GOBIES, P61; JOHNSON GD, 1993, B MAR SCI, V52, P441; Kindermann G., 2006, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V108, P13; Larson HK, 2012, BIOLOGY OF GOBIES, P51; Larson HK, 2001, FAO SPECIES IDENTIFI, V6, P3574; Lu Z, 2002, J COMP PHYSIOL A, V188, P595, DOI 10.1007/s00359-002-0334-6; Lu ZM, 1998, HEARING RES, V126, P47, DOI 10.1016/S0378-5955(98)00149-X; MAISEY JG, 1987, COPEIA, P495, DOI 10.2307/1445791; Masuda H., 1984, FISHES JAPANESE ARCH; MILLER PJ, 1989, J NAT HIST, V23, P311, DOI 10.1080/00222938900770201; MILLER PJ, 1973, J ZOOL, V171, P397; Miller PJ, 1998, J NAT HIST, V32, P273, DOI 10.1080/00222939800770141; Mooi RD, 2010, ZOOTAXA, P26; Nelson JS, 1984, FISHES WORLD; Nelson JS, 1994, FISHES WORLD, DOI 10.1002/9781119174844; Nolf D., 1980, Palaeovertebrata (Montpellier), V10, P1; Nolf D, 1995, BEL BAR LIB, P513; Nolf D., 1985, HDB PALEOICHTHYOLOGY, V10; Nolf Dirk, 1992, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V62, P195; Nury D, 1988, BRGM, V163, P411; Nury D, 1988, GEOL MEDITERRAN, V12, P175; Obrhelova N., 1961, Sbornik Geol Ust Csl, VPal. 26, P103; Patzner RA, 2011, BIOL GOBIES; PEZOLD F, 1993, COPEIA, P634; Pezold F, 2011, BIOL GOBIES, P61; Pezold Frank, 2002, Tulane Studies in Zoology and Botany, V31, P19; Pharisat A, 1978, B SOC HIST NAT PAYS, V1978, P44; Popper AN, 2005, MAR FRESHWATER RES, V56, P497, DOI 10.1071/MF04267; Ramcharitar J, 2001, BRAIN BEHAV EVOLUT, V58, P152, DOI 10.1159/000047269; Regan C. T., 1911, Annals & Magazine of Natural History Series 8, V8; REICHENBACHER B, 1992, STUTTGARTER BEITR B, V184, P1; Reichenbacher B, 2007, PALAEONTOL Z, V81, P365; Reichenbacher Bettina, 1999, Palaeovertebrata (Montpellier), V28, P1; Reichenbacher Bettina, 2004, Courier Forschungsinstitut Senckenberg, V246, P113; Reichenbacher Bettina, 2002, Courier Forschungsinstitut Senckenberg, V237, P175; Reichenbacher Bettina, 1997, Palaeontologische Zeitschrift, V71, P173; Reichenbacher Bettina, 2000, Courier Forschungsinstitut Senckenberg, V222, P1; Ruber L, 2012, BIOLOGY OF GOBIES, P23; Sauvage HE, 1875, B SOC GEOL FR, V3, P635; Schliewen UK, 2012, BIOLOGY OF GOBIES, P207; Schwarzhans W., 2010, OTOLITHS MIOCENE N S, P352; Schwarzhans W, 2007, NEUES JAHRB GEOL P-A, V244, P299, DOI 10.1127/0077-7749/2007/0244-0299; Schwarzhans W, 2012, ACTA PALAEONTOL POL, V57, P319, DOI 10.4202/app.2010.0127; Springer VG, 1983, TYSON BELOS NEW GENU; Thacker CE, 2005, MOL PHYLOGENET EVOL, V37, P858, DOI 10.1016/j.ympev.2005.05.004; Thacker CE, 2003, MOL PHYLOGENET EVOL, V26, P354, DOI 10.1016/S1055-7903(02)00361-5; Thacker C, 2012, BIOLOGY OF GOBIES, P129; Thacker C, 2012, Biology of Gobies, P79; Thacker CE, 2009, COPEIA, P93, DOI 10.1643/CI-08-004; Van Tassell JL, 2012, BIOLOGY OF GOBIES, P3; Wang HY, 2001, MOL PHYLOGENET EVOL, V20, P390, DOI 10.1006/mpev.2001.0957; Weiler W., 1963, Abhandlungen senckenb naturf Ges Xo, V504, P1; Wiley E.O., 2010, P123; WINTERBOTTOM R, 1993, B MAR SCI, V52, P395; Yoshino T., 1984, FISHES JAPANESE ARCH, P236	81	44	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64117	10.1371/journal.pone.0064117	http://dx.doi.org/10.1371/journal.pone.0064117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691158	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700081
J	Madsen, J; Sorensen, GL; Nielsen, O; Tornoe, I; Thim, L; Fenger, C; Mollenhauer, J; Holmskov, U				Madsen, Jens; Sorensen, Grith Lykke; Nielsen, Ole; Tornoe, Ida; Thim, Lars; Fenger, Claus; Mollenhauer, Jan; Holmskov, Uffe			A Variant Form of the Human Deleted in Malignant Brain Tumor 1 (DMBT1) Gene Shows Increased Expression in Inflammatory Bowel Diseases and Interacts with Dimeric Trefoil Factor 3 (TFF3)	PLOS ONE			English	Article							SURFACTANT PROTEIN-D; SALIVARY AGGLUTININ; BACTERIA-BINDING; STREPTOCOCCUS-MUTANS; PEPTIDE DOMAIN; MICE LACKING; CRP-DUCTIN; RECEPTOR; GP-340; GLYCOPROTEIN-340	The protein deleted in malignant brain tumors (DMBT1) and the trefoil factor (TFF) proteins have all been proposed to have roles in epithelial cell growth and cell differentiation and shown to be up regulated in inflammatory bowel diseases. A panel of monoclonal antibodies was raised against human DMBT1(gp340). Analysis of lung washings and colon tissue extracts by Western blotting in the unreduced state, two antibodies (Hyb213-1 and Hyb213-6) reacted with a double band of 290 kDa in lung lavage. Hyb213-6, in addition, reacted against a double band of 270 kDa in colon extract while Hyb213-1 showed no reaction. Hyb213-6 showed strong cytoplasmic staining in epithelial cells of both the small and large intestine whereas no staining was seen with Hyb213-1. The number of DMBT1(gp340) positive epithelial cells, stained with Hyb213-6, was significantly up regulated in inflammatory colon tissue sections from patients with ulcerative colitis (p<0.0001) and Crohn's disease (p = 0.006) compared to normal colon tissue. Immunohistochemical analysis of trefoil factor TFF1, 2 and 3 showed that TFF1 and 3 localized to goblet cells in both normal colon tissue and in tissue from patients with ulcerative colitis or Crohn's disease. No staining for TFF2 was seen in goblet cells in normal colon tissue whereas the majority of tissue sections in ulcerative colitis and Crohn's disease showed sparse and scattered TFF2 positive goblet cells. DMBT1 and TFF proteins did therefore not co-localize in the same cells but localized in adjacent cells in the colon. The interaction between DMBT1(gp340) and trefoil TFFs proteins was investigated using an ELISA assay. DMBT1(gp340) bound to solid-phase bound recombinant dimeric TFF3 in a calcium dependent manner (p<0.0001) but did not bind to recombinant forms of monomeric TFF3, TFF2 or glycosylated TFF2. This implies a role for DMBT1 and TFF3 together in inflammatory bowel disease.	[Madsen, Jens] Univ Southampton, Southampton Gen Hosp, Fac Med, Dept Child Hlth Clin & Expt Sci,Sir Henry Wellcom, Southampton, Hants, England; [Madsen, Jens] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Sorensen, Grith Lykke; Tornoe, Ida; Mollenhauer, Jan; Holmskov, Uffe] Univ Southern Denmark, Inst Mol Med, Odense, Denmark; [Nielsen, Ole; Fenger, Claus] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark; [Thim, Lars] Novo Nordisk AS, Dept Prot Engn, Malov, Denmark; [Mollenhauer, Jan] Univ Southern Denmark, Lundbeckfonden Ctr Excellence NanoCAN, Odense, Denmark	University of Southampton; University of Southampton; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Novo Nordisk; Lundbeckfonden; University of Southern Denmark	Madsen, J (corresponding author), Univ Southampton, Southampton Gen Hosp, Fac Med, Dept Child Hlth Clin & Expt Sci,Sir Henry Wellcom, Southampton, Hants, England.	j.madsen@southampton.ac.uk	Holmskov, Uffe/AAA-3056-2022; Madsen, Jens/N-8082-2013; Mollenhauer, Jan/G-4452-2012	Holmskov, Uffe/0000-0002-2391-9445; Madsen, Jens/0000-0003-1664-7645; Sorensen, Grith Lykke/0000-0002-5273-1097	Indian Statistical Institute, Indian Statistical Institute, Kolkata, India	Indian Statistical Institute, Indian Statistical Institute, Kolkata, India	Indian Statistical Institute, Indian Statistical Institute, Kolkata, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biesbrock AR, 1997, GLYCOCONJUGATE J, V14, P415, DOI 10.1023/A:1018587031814; Bikker FJ, 2004, J BIOL CHEM, V279, P47699, DOI 10.1074/jbc.M406095200; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Bikker FJ, 2002, J DENT RES, V81, P134, DOI 10.1177/154405910208100210; Bisgaard HC, 2002, AM J PATHOL, V161, P1187, DOI 10.1016/S0002-9440(10)64395-7; BOACKLE RJ, 1993, MOL IMMUNOL, V30, P309, DOI 10.1016/0161-5890(93)90059-K; Cheng H, 1996, ANAT REC, V244, P327; End C, 2009, EUR J IMMUNOL, V39, P833, DOI 10.1002/eji.200838689; ERICSON T, 1983, EUR J BIOCHEM, V133, P255, DOI 10.1111/j.1432-1033.1983.tb07456.x; Eriksson C, 2007, GLYCOCONJUGATE J, V24, P131, DOI 10.1007/s10719-006-9020-1; Farrell JJ, 2002, J CLIN INVEST, V109, P193, DOI 10.1172/JCI200212529; Frolkis A, 2013, CAN J GASTROENTEROL, V27, pE18, DOI 10.1155/2013/102859; Hartshorn KL, 2006, BIOCHEM J, V393, P545, DOI 10.1042/BJ20050695; Hikita C, 2000, J CELL BIOL, V151, P1235, DOI 10.1083/jcb.151.6.1235; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743; Holmskov U, 1999, P NATL ACAD SCI USA, V96, P10794, DOI 10.1073/pnas.96.19.10794; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; Leito JTD, 2011, MOL IMMUNOL, V49, P185, DOI 10.1016/j.molimm.2011.08.010; LI XJ, 1995, J BIOL CHEM, V270, P17674, DOI 10.1074/jbc.270.30.17674; Lin H, 1998, CLIN CANCER RES, V4, P2447; Madsen J, 2003, EUR J IMMUNOL, V33, P2327, DOI 10.1002/eji.200323972; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Mollenhauer J, 1997, NAT GENET, V17, P32, DOI 10.1038/ng0997-32; Mollenhauer J, 1999, ONCOGENE, V18, P6233, DOI 10.1038/sj.onc.1203071; Mollenhauer J, 2000, CANCER RES, V60, P1704; Mori M, 1999, BRIT J CANCER, V79, P211, DOI 10.1038/sj.bjc.6690035; Muskett FW, 2003, BIOCHEMISTRY-US, V42, P15139, DOI 10.1021/bi030182k; Nagashunmugam T, 1998, J INFECT DIS, V178, P1635, DOI 10.1086/314511; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Oho T, 2004, INFECT IMMUN, V72, P6181, DOI 10.1128/IAI.72.10.6181-6184.2004; Playford RJ, 1996, P NATL ACAD SCI USA, V93, P2137, DOI 10.1073/pnas.93.5.2137; PODOLSKY DK, 1993, J BIOL CHEM, V268, P12230; Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200; Renner M, 2007, GASTROENTEROLOGY, V133, P1499, DOI 10.1053/j.gastro.2007.08.007; Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203; Rossez Y, 2011, BIOCHIMIE, V93, P593, DOI 10.1016/j.biochi.2010.12.002; RUNDEGREN J, 1987, INFECT IMMUN, V55, P288, DOI 10.1128/IAI.55.2.288-292.1987; Silva ED, 2000, J PATHOL, V190, P133; Somerville RPT, 1998, ONCOGENE, V17, P1755, DOI 10.1038/sj.onc.1202066; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takito J, 1999, AM J PHYSIOL-RENAL, V277, pF277, DOI 10.1152/ajprenal.1999.277.2.F277; Takito J, 1996, J CLIN INVEST, V98, P2324, DOI 10.1172/JCI119044; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x; THIM L, 1993, FEBS LETT, V318, P345, DOI 10.1016/0014-5793(93)80543-4; THIM L, 1995, BIOCHEMISTRY-US, V34, P4757, DOI 10.1021/bi00014a033; Thim L, 2000, REGUL PEPTIDES, V90, P61, DOI 10.1016/S0167-0115(00)00110-5; Thornton DJ, 2001, GLYCOBIOLOGY, V11, P969, DOI 10.1093/glycob/11.11.969; Tino MJ, 1999, AM J RESP CELL MOL, V20, P759, DOI 10.1165/ajrcmb.20.4.3439; TOMASETTO C, 1990, EMBO J, V9, P407, DOI 10.1002/j.1460-2075.1990.tb08125.x; Wiede A, 1999, AM J RESP CRIT CARE, V159, P1330, DOI 10.1164/ajrccm.159.4.9804149; Wu WG, 1999, CANCER RES, V59, P1846	55	40	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64441	10.1371/journal.pone.0064441	http://dx.doi.org/10.1371/journal.pone.0064441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691218	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000319052700096
J	Nawal, D; Goli, S				Nawal, Dipty; Goli, Srinivas			Birth Preparedness and Its Effect on Place of Delivery and Post-Natal Check-Ups in Nepal	PLOS ONE			English	Article							NEONATAL-MORTALITY; MATERNAL HEALTH; SAFE MOTHERHOOD; DISTRICT; INDIA; WOMEN	Introduction and Rationale: Number of demographically laggard countries will forego MDGs 4 and 5, and Nepal is not an exception to it. International reports reveal that, lack of adequate birth preparedness is one of the greatest hurdles in achievement of MDG 4 and 5. However, lack of comprehensive evidence at country level in developing countries like Nepal is a hindrance for policy making. In this context, this study estimated birth preparedness among Nepali women and its association with institutional delivery and postnatal care in Nepal. Methodology/Principal Fining: Secondary data such as latest round of Nepal Demographic and Health Survey Data (NDHS, 2011) has been used in the study. Bivariate and multivariate models are applied as the methods of data analyses. Results reveals that only 32 per cent of women in Nepal have birth preparedness. The women who are well prepared belong to higher age group (45%), higher education (36%) and with higher women autonomy (86%). Women, who are well prepared for child birth (OR = 3.137, p < 0.01) have a greater likelihood of going for institutional deliveries that women with no preparation (OR = 1). However, irrespective of level of birth preparedness, women in Nepal preferred to deliver the baby in public health facility that private health Facility. Conclusion and Implications: Findings reveal that birth preparedness is one of the critical factors in determining the likelihood of having institutional delivery and checkups after delivery. At policy perspective, this study fosters that developing countries like Nepal have to ensure adequate and universal birth preparedness in order to achieve goal 4 and 5 of MDGs.	[Nawal, Dipty] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Goli, Srinivas] Giri Inst Dev Studies, Lucknow, Uttar Pradesh, India	International Institute for Population Sciences	Nawal, D (corresponding author), Int Inst Populat Sci, Mumbai, Maharashtra, India.	diptynawal@gmail.com	Goli, Srinivas/J-7238-2012	Goli, Srinivas/0000-0002-8481-484X				Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Antken JM, 2004, SYNTHESIS FINAL EVAL; Arokiasamy P, 2008, J BIOSOC SCI, V40, P183, DOI 10.1017/S0021932007002623; Barco del CR, 2004, MONITORING BIRTH PRE; Berhan Y, 2004, ETHIOP J HLTH DEV, V18, P96, DOI DOI 10.4314/EJHD.V18I2.9944; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Carter A, 2010, 821 DIG; Elizabeth I, 2002, MAKING MOTHERHOOD SA; Fawcus S., 2010, MONOGRAPH MANAGEMENT; Fullerton Judith T, 2005, Health Care Women Int, V26, P561, DOI 10.1080/07399330591004881; Gage AJ, 2007, SOC SCI MED, V65, P1666, DOI 10.1016/j.socscimed.2007.06.001; Gogia S, 2010, B WORLD HEALTH ORGAN, V188, p658B; Hiluf M, 2001, ETHIOP J HEALTH DEV, V8; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horton R, 2010, LANCET, V375, P1581, DOI 10.1016/S0140-6736(10)60547-8; Hundly V, 2011, INVENTORY DISPOSABLE; Jhpiego/MHH Program, 2004, MEAS EFF BEH CHANG I; Kabakyenga JK, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-33; Kaur V, 2009, NURSING MIDWIFERY RE, V5; Kc N P, 2011, J Nepal Health Res Counc, V9, P101; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Kushwah SS, 2009, STUDY ASSESSING BIRT; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; Ministry of Health and Family Welfare, 1997, REPR CHILD HLTH PREP; Ministry of Health and Population (MOHP) [Nepal], 2009, ANN REP DEP HLTH SER; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International, 2011, NEP DEM HLTH SURV KE; Ministry of Health and Population (MOPH) [Nepal] New ERA and ICF International Inc, 2012, NEP DEM HLTH SURV 20; Montgomery MR, 2005, DEMOGRAPHY, V42, P397, DOI 10.1353/dem.2005.0020; Moran AC, 2006, J HEALTH POPUL NUTR, V24, P489; Murray CJL, 2007, LANCET, V370, P1018, DOI 10.1016/S0140-6736(07)61458-5; Mutiso S M, 2008, East Afr Med J, V85, P275; Pembe AB, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-12; Portela A, 2003, BRIT MED BULL, V67, P59, DOI 10.1093/bmb/ldg013; Pradhan EK, 2002, B WORLD HEALTH ORGAN, V80, P887; Pradhan Y V, 2011, J Nepal Health Res Counc, V9, P119; Price N, 2005, DEV PRACT, V15, P151, DOI 10.1080/09614520500041138; Puntney Devkota, 2005, REACHING CONSENSUS M, V63; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sanjay Pandey, 2007, Indian Journal of Community Medicine, V32, P210; Seneviratne HR, 2000, INT J GYNECOL OBSTET, V70, P113, DOI 10.1016/S0020-7292(00)00223-X; Shiffman J, 2004, HEALTH POLICY PLANN, V19, P380, DOI 10.1093/heapol/czh053; Smith K, 2004, KNOWLEDGE ATTITUDES, P8; Smith ND, 2011, INT PROSPECTIVE SEXU, V37, P132; Tuladhar H, 2009, Nepal Med Coll J, V11, P164; United Nations, 2010, UN SUMM HIGH LEV PLE; United States Agency for International Development (USAID) New ERA and Nepal Family Health Program, 2010, FAM PLANN MAT NEWB C; van den Broek NR, 2003, BJOG-INT J OBSTET GY, V110, P902, DOI 10.1111/j.1471-0528.2003.02402.x; Whitworth J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000299; World Health Organization United Nations Children's Fund United Nation Population Division The World Bank, 2012, WORLD TRENDS MAT MOR	52	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e60957	10.1371/journal.pone.0060957	http://dx.doi.org/10.1371/journal.pone.0060957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145XK	23690921	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700004
J	Nyman, AM; Hintermeister, A; Schirmer, K; Ashauer, R				Nyman, Anna-Maija; Hintermeister, Anita; Schirmer, Kristin; Ashauer, Roman			The Insecticide Imidacloprid Causes Mortality of the Freshwater Amphipod Gammarus pulex by Interfering with Feeding Behavior	PLOS ONE			English	Article							MYZUS-PERSICAE; BIOACCUMULATION KINETICS; TOXICITY; ACETYLCHOLINE; EXPOSURE; INHIBITION; PESTICIDES; PHOTOLYSIS; BINDING	If an organism does not feed, it dies of starvation. Even though some insecticides which are used to control pests in agriculture can interfere with feeding behavior of insects and other invertebrates, the link from chemical exposure via affected feeding activity to impaired life history traits, such as survival, has not received much attention in ecotoxicology. One of these insecticides is the neonicotinoid imidacloprid, a neurotoxic substance acting specifically on the insect nervous system. We show that imidacloprid has the potential to indirectly cause lethality in aquatic invertebrate populations at low, sublethal concentrations by impairing movements and thus feeding. We investigated feeding activity, lipid content, immobility, and survival of the aquatic arthropod Gammarus pulex under exposure to imidacloprid. We performed experiments with 14 and 21 days duration, both including two treatments with two high, one day pulses of imidacloprid and one treatment with a low, constant concentration. Feeding of G. pulex as well as lipid content were significantly reduced under exposure to the low, constant imidacloprid concentration (15 mu g/L). Organisms were not able to move and feed - and this caused high mortality after 14 days of constant exposure. In contrast, feeding and lipid content were not affected by repeated imidacloprid pulses. In these treatments, animals were mostly immobilized during the chemical pulses but did recover relatively fast after transfer to clean water. We also performed a starvation experiment without exposure to imidacloprid which showed that starvation alone does not explain the mortality in the constant imidacloprid exposure. Using a multiple stressor toxicokinetic-toxicodynamic modeling approach, we showed that both starvation and other toxic effects of imidacloprid play a role for determining mortality in constant exposure to the insecticide.	[Nyman, Anna-Maija; Hintermeister, Anita; Schirmer, Kristin; Ashauer, Roman] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Environm Toxicol, Dubendorf, Switzerland; [Nyman, Anna-Maija; Schirmer, Kristin] ETH, Dept Environm Syst Sci, Zurich, Switzerland; [Schirmer, Kristin] EPF Lausanne, Sch Architecture Civil & Environm Engn, Lausanne, Switzerland; [Ashauer, Roman] Univ York, Dept Environm, Heslington, Yorks, England	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of York - UK	Nyman, AM (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Environm Toxicol, Dubendorf, Switzerland.	anna-maija.nyman@eawag.ch	SCHIRMER, KRISTIN/AAG-2332-2019; Ashauer, Roman/E-6640-2010	Ashauer, Roman/0000-0002-9579-8793	European Union [PITN-GA-2009-238148]	European Union(European Commission)	This research has been financially supported by the European Union under the 7th Framework Programme (project acronym CREAM, contract number PITN-GA-2009-238148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink J., 1991, Pflanzenschutz-Nachrichten Bayer, V44, P183; Alexander AC, 2007, ENVIRON TOXICOL CHEM, V26, P1726, DOI 10.1897/07-015R.1; ANDERSON NH, 1979, ANNU REV ENTOMOL, V24, P351, DOI 10.1146/annurev.en.24.010179.002031; Ashauer R, 2007, ENVIRON SCI TECHNOL, V41, P5528, DOI 10.1021/es062977v; Ashauer R, 2012, ENVIRON SCI TECHNOL, V46, P3498, DOI 10.1021/es204611h; Ashauer R, 2010, ENVIRON TOXICOL CHEM, V29, P1625, DOI 10.1002/etc.175; Ashauer R, 2010, ENVIRON SCI TECHNOL, V44, P3963, DOI 10.1021/es903478b; Azevedo-Pereira HMVS, 2011, WATER AIR SOIL POLL, V219, P215, DOI 10.1007/s11270-010-0700-x; Beketov MA, 2008, ARCH ENVIRON CON TOX, V55, P247, DOI 10.1007/s00244-007-9104-3; Berghahn R, 2012, AQUAT TOXICOL, V122-123, P56; Blazic M, 2005, 7 SLOV C PLANT PROT, P106; Bliss CI, 1935, ANN APPL BIOL, V22, P134, DOI 10.1111/j.1744-7348.1935.tb07713.x; Bottger R, 2012, ECOTOX ENVIRON SAFE, V81, P49, DOI 10.1016/j.ecoenv.2012.04.015; Dauterman WC, 1994, INTRO BIOCH TOXICOLO; Drobne D, 2008, CHEMOSPHERE, V71, P1326, DOI 10.1016/j.chemosphere.2007.11.042; FLOREY E, 1963, CAN J BIOCHEM PHYS, V41, P2619, DOI 10.1139/y63-292; Jager T, 2011, ENVIRON SCI TECHNOL, V45, P2529, DOI 10.1021/es103092a; Jeschke P., 2008, MODERN CROP PROTECTI, P927, DOI DOI 10.1002/9783527619580.CH29; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Kretschmann A, 2011, ENVIRON SCI TECHNOL, V45, P4995, DOI 10.1021/es104324v; Kreuger J, 1998, SCI TOTAL ENVIRON, V216, P227, DOI 10.1016/S0048-9697(98)00155-7; KREUGER J, 2010, PESTICIDES SURFACE W; Kreutzweiser DP, 2009, ECOTOX ENVIRON SAFE, V72, P1053, DOI 10.1016/j.ecoenv.2008.09.017; KROG J, 1954, BIOL BULL, V107, P397, DOI 10.2307/1538588; Lind RJ, 1998, PESTIC BIOCHEM PHYS, V62, P3, DOI 10.1006/pest.1998.2364; Lind RJ, 2001, INSECT BIOCHEM MOLEC, V31, P533, DOI 10.1016/S0965-1748(00)00153-3; Mohr S, 2012, AQUAT TOXICOL, V110, P25, DOI 10.1016/j.aquatox.2011.11.016; Motulsky H, 2003, PRACTICAL GUIDE CURV; Moza PN, 1998, CHEMOSPHERE, V36, P497, DOI 10.1016/S0045-6535(97)00359-7; NAUEN R, 1995, PESTIC SCI, V44, P145, DOI 10.1002/ps.2780440207; Nauen R, 1998, ENTOMOL EXP APPL, V88, P287, DOI 10.1023/A:1003430331594; NAYLOR C, 1989, HYDROBIOLOGIA, V188, P517, DOI 10.1007/BF00027819; Newman MC, 2000, ENVIRON TOXICOL CHEM, V19, P520, DOI [10.1897/1551-5028(2000)019&lt;0520:TITCIN&gt;2.3.CO;2, 10.1002/etc.5620190235]; Nyman A-M, 2012, ECOTOXICOLO IN PRESS; Pimentel D, 2009, INTEGRATED PEST MANA; Ramakrishnan R, 2000, J ECON ENTOMOL, V93, P422, DOI 10.1603/0022-0493-93.2.422; Sroda S, 2011, CHEMOSPHERE, V83, P538, DOI 10.1016/j.chemosphere.2010.12.023; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Stoughton SJ, 2008, ARCH ENVIRON CON TOX, V54, P662, DOI 10.1007/s00244-007-9073-6; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Wellmann H, 2004, PEST MANAG SCI, V60, P959, DOI 10.1002/ps.920; Wittmer IK, 2010, WATER RES, V44, P2850, DOI 10.1016/j.watres.2010.01.030; Zheng W, 2004, J ENVIRON SCI, V16, P539	43	87	88	4	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e62472	10.1371/journal.pone.0062472	http://dx.doi.org/10.1371/journal.pone.0062472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690941	Green Published, gold			2022-12-25	WOS:000319052700010
J	Guibinga, GH; Murray, F; Barron, N				Guibinga, Ghiabe-Henri; Murray, Fiona; Barron, Nikki			HPRT-Deficiency Dysregulates cAMP-PKA Signaling and Phosphodiesterase 10A Expression: Mechanistic Insight and Potential Target for Lesch-Nyhan Disease?	PLOS ONE			English	Article							ADENYLYL-CYCLASE; PROTEIN-PHOSPHORYLATION; FUNCTIONAL-ANALYSIS; ALPHA-SYNUCLEIN; SMOOTH-MUSCLE; STEM-CELLS; NEURONS; LOCALIZATION; INHIBITORS; PDE10A	Lesch-Nyhan Disease (LND) is the result of mutations in the X-linked gene encoding the purine metabolic enzyme, hypoxanthine guanine phosphoribosyl transferase (HPRT). LND gives rise to severe neurological anomalies including mental retardation, dystonia, chorea, pyramidal signs and a compulsive and aggressive behavior to self injure. The neurological phenotype in LND has been shown to reflect aberrant dopaminergic signaling in the basal ganglia, however there are little data correlating the defect in purine metabolism to the neural-related abnormalities. In the present studies, we find that HPRT-deficient neuronal cell lines have reduced CREB (cAMP response element-binding protein) expression and intracellular cyclic AMP (cAMP), which correlates with attenuated CREB-dependent transcriptional activity and a reduced phosphorylation of protein kinase A (PKA) substrates such as synapsin (p-syn I). Of interest, we found increased expression of phosphodiesterase 10A (PDE10A) in HPRT-deficient cell lines and that the PDE10 inhibitor papaverine and PDE10A siRNA restored cAMP/PKA signaling. Furthermore, reconstitution of HPRT expression in mutant cells partly increased cAMP signaling synapsin phosphorylation. In conclusion, our data show that HPRT-deficiency alters cAMP/PKA signaling pathway, which is in part due to the increased of PDE10A expression and activity. These findings suggest a mechanistic insight into the possible causes of LND and highlight PDE10A as a possible therapeutic target for this intractable neurological disease.	[Guibinga, Ghiabe-Henri; Barron, Nikki] Univ Calif San Diego, Sch Med, Dept Pediat, Div Genet, La Jolla, CA 92093 USA; [Murray, Fiona] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Murray, Fiona] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Guibinga, GH (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, Div Genet, La Jolla, CA 92093 USA.	gguibing@ucsd.edu		Murray, Fiona/0000-0002-5572-4810	National Institute of Health, USA [DK082840]; University of California San Diego Academic Senate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL091061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK082840] Funding Source: NIH RePORTER	National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego Academic Senate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by a grant from DK082840 from the National Institute of Health, USA, and by a research grant from the University of California San Diego Academic Senate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie GS, 2005, FEBS LETT, V579, P3264, DOI 10.1016/j.febslet.2005.03.089; Beninger RJ, 1998, NEUROSCI BIOBEHAV R, V22, P335, DOI 10.1016/S0149-7634(97)00019-5; BITLER CM, 1986, J NEUROCHEM, V47, P107; Borgkvist A, 2007, NEUROSCI BIOBEHAV R, V31, P79, DOI 10.1016/j.neubiorev.2006.03.003; BROWNING MD, 1985, J NEUROCHEM, V45, P11, DOI 10.1111/j.1471-4159.1985.tb05468.x; Ceballos-Picot I, 2009, HUM MOL GENET, V18, P2317, DOI 10.1093/hmg/ddp164; Cristini S, 2010, HUM MOL GENET, V19, P1939, DOI 10.1093/hmg/ddq072; Dworkin S, 2010, EXPERT OPIN THER TAR, V14, P869, DOI 10.1517/14728222.2010.501332; Evans GJO, 2003, BIOCHEM SOC T, V31, P824, DOI 10.1042/bst0310824; GEDYE A, 1992, MED HYPOTHESES, V38, P325, DOI 10.1016/0306-9877(92)90026-9; Guibinga GH, 2005, MOL THER, V11, P645, DOI 10.1016/j.ymthe.2004.12.002; Guibinga GH, 2012, HUM MOL GENET, V21, P609, DOI 10.1093/hmg/ddr495; Guibinga GH, 2010, MOL THER, V18, P54, DOI 10.1038/mt.2009.178; Hebb ALO, 2008, EUR NEUROPSYCHOPHARM, V18, P339, DOI 10.1016/j.euroneuro.2007.08.002; HEMMINGS HC, 1989, FASEB J, V3, P1583, DOI 10.1096/fasebj.3.5.2493406; HOESCHE C, 1995, BBA-GENE STRUCT EXPR, V1261, P249, DOI 10.1016/0167-4781(95)00014-8; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JINNAH HA, 1992, J PHARMACOL EXP THER, V263, P596; JINNAH HA, 2000, METABOLIC MOL BASES, P2537; Kang TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016572; Kelly MP, 2009, PROG BRAIN RES, V179, P67, DOI 10.1016/S0079-6123(09)17908-6; Kim SS, 2011, ARCH PHARM RES, V34, P837, DOI 10.1007/s12272-011-0518-0; Kinast L, 2012, N-S ARCH PHARMACOL, V385, P671, DOI 10.1007/s00210-012-0759-6; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Lewers JC, 2008, NEUROSCIENCE, V152, P761, DOI 10.1016/j.neuroscience.2007.10.065; Mastrangelo L, 2012, P NATL ACAD SCI USA, V109, P3377, DOI 10.1073/pnas.1118067109; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Menniti FS, 2007, CURR OPIN INVESTIG D, V8, P54; Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x; Murray F, 2007, AM J PHYSIOL-LUNG C, V292, pL294, DOI 10.1152/ajplung.00190.2006; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Ostrom RS, 2000, MOL PHARMACOL, V57, P1075; Park B, 2011, J NEURAL TRANSM, V118, P1585, DOI 10.1007/s00702-011-0710-x; Pinto CS, 2006, J NEUROCHEM, V96, P454, DOI 10.1111/j.1471-4159.2005.03570.x; Sahu A, 2011, NEUROENDOCRINOLOGY, V93, P201, DOI 10.1159/000326785; Sahu A, 2010, NEUROSCI LETT, V479, P18, DOI 10.1016/j.neulet.2010.05.018; Sahu M, 2011, NEUROSCI LETT, V505, P93, DOI 10.1016/j.neulet.2011.09.068; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Spiwoks-Becker I, 2011, NEUROENDOCRINOLOGY, V94, P113, DOI 10.1159/000327138; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Truss MC, 1996, UROL RES, V24, P129, DOI 10.1007/BF00304075; Xie Z, 2006, NEUROSCIENCE, V139, P597, DOI 10.1016/j.neuroscience.2005.12.042; Xu Y, 2011, HANDB EXP PHARMACOL, V204, P447, DOI 10.1007/978-3-642-17969-3_19; Yang SW, 2012, BIOORG MED CHEM LETT, V22, P235, DOI 10.1016/j.bmcl.2011.11.023; Zhou ZG, 2011, MOL CELL NEUROSCI, V48, P29, DOI 10.1016/j.mcn.2011.06.002	49	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63333	10.1371/journal.pone.0063333	http://dx.doi.org/10.1371/journal.pone.0063333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691025	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400052
J	Harazono, Y; Muramatsu, T; Endo, H; Uzawa, N; Kawano, T; Harada, K; Inazawa, J; Kozaki, K				Harazono, Yosuke; Muramatsu, Tomoki; Endo, Hironori; Uzawa, Narikazu; Kawano, Tatsuyuki; Harada, Kiyoshi; Inazawa, Johji; Kozaki, Ken-ichi			miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SQUAMOUS-CELL CARCINOMA; CANCER-CELLS; DNA HYPERMETHYLATION; TUMOR-SUPPRESSOR; MIR-200 FAMILY; PANCREATIC-CANCER; BIOLOGICAL PROCESSES; COLORECTAL-CANCER; REPRESSORS ZEB1	Recently, the epithelial-to-mesenchymal transition (EMT) has been demonstrated to contribute to normal and disease processes including cancer progression. To explore EMT-suppressive microRNAs (miRNAs), we established a cell-based reporter system using a stable clone derived from a pancreatic cancer cell line, Panc1, transfected with a reporter construct containing a promoter sequence of CDH1/E-cadherin in the 5' upstream region of the ZsGreen1 reporter gene. Then, we performed function-based screening with 470 synthetic double-stranded RNAs (dsRNAs) mimicking human mature miRNAs using the system and identified miR-655 as a novel EMT-suppressive miRNA. Overexpression of miR-655 not only induced the upregulation of E-cadherin and downregulation of typical EMT-inducers but also suppressed migration and invasion of mesenchymal-like cancer cells accompanied by a morphological shift toward the epithelial phenotype. In addition, we found a significant correlation between miR-655 expression and a better prognosis in esophageal squamous cell carcinoma (ESCC). Moreover, ZEB1 and TGFBR2, which are essential components of the TGF-b signaling pathway, were identified as direct targets of miR-655, suggesting that the activation of the TGF-b-ZEB1-E-cadherin axis by aberrant downregulation of miR-655 may accelerate cancer progression.	[Harazono, Yosuke; Muramatsu, Tomoki; Endo, Hironori; Inazawa, Johji; Kozaki, Ken-ichi] Tokyo Med & Dent Univ, Dept Mol Cytogenet, Tokyo, Japan; [Kozaki, Ken-ichi] Tokyo Med & Dent Univ, Med Res Inst, Dept Therapeut Genom, Tokyo, Japan; [Kozaki, Ken-ichi] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan; [Inazawa, Johji; Kozaki, Ken-ichi] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Dept Genome Med, Tokyo, Japan; [Muramatsu, Tomoki; Inazawa, Johji] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program Int Res Ctr Mo, Tokyo, Japan; [Harazono, Yosuke; Endo, Hironori; Uzawa, Narikazu; Harada, Kiyoshi] Tokyo Med & Dent Univ, Dept Maxillofacial Surg, Tokyo, Japan; [Kawano, Tatsuyuki] Tokyo Med & Dent Univ, Dept Esophagogastr Surg, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Dept Mol Cytogenet, Tokyo, Japan.	johinaz.cgen@mri.tmd.ac.jp; ken-1.cgen@mri.tmd.ac.jp	Kozaki, Ken-ichi/M-6281-2014	Kozaki, Ken-ichi/0000-0003-3286-819X	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare, Japan; New Energy and Industrial Technology Development Organization (NEDO); Osaka Cancer Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Osaka Cancer Research Foundation	This study was supported in part by Grant-in-Aid for Scientific Research (A), (B), and (C), and Scientific Research on Priority Areas and Innovative Areas, and a Global Center of Excellence (GCOE) Program for International Research Center for Molecular Science in Tooth and Bone Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a Health and Labour Sciences Research Grant by the Ministry of Health, Labour and Welfare, Japan; a grant from the New Energy and Industrial Technology Development Organization (NEDO); and Grant for basic and clinical cancer research projects by Osaka Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bader AG, 2012, CANCER RES, V70, P7027; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Haller F, 2010, J PATHOL, V220, P71, DOI 10.1002/path.2610; Haruki S, 2010, CARCINOGENESIS, V31, P1027, DOI 10.1093/carcin/bgq053; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keklikoglou I., 2011, ONCOGENE; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Kozaki K, 2012, CANCER SCI, V103, P837, DOI 10.1111/j.1349-7006.2012.02236.x; Kurasawa Y, 2012, ONCOGENE, V31, P1963, DOI 10.1038/onc.2011.373; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Li L, 2012, J CELL BIOCHEM, V113, P1235, DOI 10.1002/jcb.23457; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu Y, 2012, J CANC RES CLIN ONCO; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Nakamura E, 2008, CANCER SCI, V99, P1390, DOI 10.1111/j.1349-7006.2008.00838.x; Nakano H, 2010, INT J CANCER, V127, P1072, DOI 10.1002/ijc.25143; Ono H, 2012, ONCOGENE; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Suzuki A, 2008, CANCER SCI, V99, P986, DOI 10.1111/j.1349-7006.2008.00779.x; Suzuki E, 2007, ONCOGENE, V26, P7921, DOI 10.1038/sj.onc.1210589; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Zhang J, 2012, CANC METASTASIS REV	51	97	103	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62757	10.1371/journal.pone.0062757	http://dx.doi.org/10.1371/journal.pone.0062757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690952	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400017
J	Zhou, Y; Zhao, ML; Fields, GB; Wu, CF; Branton, WD				Zhou, Yi; Zhao, Mingli; Fields, Gregg B.; Wu, Chun-Fang; Branton, W. Dale			delta/omega-Plectoxin-Pt1a: An Excitatory Spider Toxin with Actions on both Ca2+ and Na+ Channels	PLOS ONE			English	Article							PLECTREURYS-TRISTIS SIMON; PRIMITIVE HUNTING SPIDER; ARRESTED EMBRYONIC NEUROBLASTS; PROTEIN PALMITOYLATION; DROSOPHILA NEURONS; SYNAPTIC-TRANSMISSION; VENOM PEPTIDES; ION CHANNELS; K+ CHANNELS; INSECTICIDAL PEPTIDES	The venom of spider Plectreurys tristis contains a variety of peptide toxins that selectively target neuronal ion channels. O-palmitoylation of a threonine or serine residue, along with a characteristic and highly constrained disulfide bond structure, are hallmarks of a family of toxins found in this venom. Here, we report the isolation and characterization of a new toxin, delta/omega-plectoxin-Pt1a, from this spider venom. It is a 40 amino acid peptide containing an O-palmitoylated Ser-39. Analysis of delta/omega-plectoxin-Pt1a cDNA reveals a small precursor containing a secretion signal sequence, a 14 amino acid N-terminal propeptide, and a C-terminal amidation signal. The biological activity of delta/omega-plectoxin-Pt1a is also unique. It preferentially blocks a subset of Ca2+ channels that is apparently not required for neurotransmitter release; decreases threshold for Na+ channel activation; and slows Na+ channel inactivation. As delta/omega-plectoxin-Pt1a enhances synaptic transmission by prolonging presynaptic release of neurotransmitter, its effects on Na+ and Ca2+ channels may act synergistically to sustain the terminal excitability.	[Zhou, Yi] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Zhao, Mingli; Wu, Chun-Fang] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL USA; [Branton, W. Dale] Univ Minnesota, Sch Med, Dept Neurosci, Minneapolis, MN 55455 USA	State University System of Florida; Florida State University; University of Iowa; Torrey Pines Institute for Molecular Studies, Florida; University of Minnesota System; University of Minnesota Twin Cities	Zhou, Y (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	yzhou@fsu.edu; branton@umn.edu			NIH [NS50355]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050355] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH grants NS50355. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bizzozero OA, 1997, NEUROPEDIATRICS, V28, P23, DOI 10.1055/s-2007-973660; BODI J, 1995, PEPTIDE RES, V8, P228; BRANTON WD, 1993, NATURE, V365, P496, DOI 10.1038/365496a0; BRANTON WD, 1987, J NEUROSCI, V7, P4195; Brennan DF, 2009, TRENDS BIOCHEM SCI, V34, P108, DOI 10.1016/j.tibs.2008.11.005; BYERLY L, 1988, J NEUROSCI, V8, P4379; BYFORD MF, 1991, BIOCHEM J, V280, P261, DOI 10.1042/bj2800261; Chang SC, 2009, MOL MEMBR BIOL, V26, P104, DOI 10.1080/09687680802706432; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; Estrada G, 2007, NAT PROD REP, V24, P145, DOI 10.1039/b603083c; GANETZKY B, 1982, J NEUROPHYSIOL, V47, P501, DOI 10.1152/jn.1982.47.3.501; GANETZKY B, 1986, ANNU REV GENET, V20, P13; GHO M, 1992, J EXP BIOL, V170, P93; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; Hou J, 2008, J NEUROPHYSIOL, V100, P2833, DOI 10.1152/jn.90342.2008; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; KIM JI, 1995, J MOL BIOL, V250, P659, DOI 10.1006/jmbi.1995.0406; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; King GF, 2007, TOXICON, V49, P513, DOI 10.1016/j.toxicon.2006.11.012; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Lee D, 2000, J NEUROPHYSIOL, V83, P1181, DOI 10.1152/jn.2000.83.3.1181; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Leisy DJ, 1996, INSECT BIOCHEM MOLEC, V26, P411, DOI 10.1016/0965-1748(95)00070-4; LEUNG HT, 1989, NEURON, V3, P767, DOI 10.1016/0896-6273(89)90245-6; Loane DJ, 2007, J CELL SCI, V120, P985, DOI 10.1242/jcs.03399; Marley R, 2011, J NEUROPHYSIOL, V106, P18, DOI 10.1152/jn.00808.2010; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; Molloy MP, 2001, ANAL CHEM, V73, P5387, DOI 10.1021/ac0104227; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; MUNDY DI, 1995, BIOCHEM SOC T, V23, P572, DOI 10.1042/bst0230572; Olivera BM, 1997, MOL BIOL CELL, V8, P2101, DOI 10.1091/mbc.8.11.2101; Parker L, 2011, GENETICS, V187, P523, DOI 10.1534/genetics.110.123299; Penaforte CL, 2000, TOXICON, V38, P1443, DOI 10.1016/S0041-0101(99)00237-8; Peng IF, 2007, J NEUROSCI, V27, P1072, DOI 10.1523/JNEUROSCI.4746-06.2007; Platnick N. I., 2013, WORLD SPIDER CATALOG; QUISTAD GB, 1993, TOXICON, V31, P920, DOI 10.1016/0041-0101(93)90229-C; QUISTAD GB, 1994, J BIOL CHEM, V269, P11098; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; SAITO M, 1991, J NEUROSCI, V11, P2135; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Silva JP, 2009, J NEUROCHEM, V111, P275, DOI 10.1111/j.1471-4159.2009.06329.x; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Ueda A, 2006, J NEUROSCI, V26, P6238, DOI 10.1523/JNEUROSCI.0862-06.2006; Vosseller K, 2005, PROTEOMICS, V5, P388, DOI 10.1002/pmic.200401066; Windley MJ, 2012, TOXINS, V4, P191, DOI 10.3390/toxins4030191; WU CF, 1990, J NEUROBIOL, V21, P499, DOI 10.1002/neu.480210310; WU CF, 1989, J EXP BIOL, V147, P21; Yao WD, 1999, J NEUROPHYSIOL, V81, P2472, DOI 10.1152/jn.1999.81.5.2472; Zhao ML, 1997, J NEUROSCI, V17, P2187	54	3	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64324	10.1371/journal.pone.0064324	http://dx.doi.org/10.1371/journal.pone.0064324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691198	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400118
J	Fernandez, LP; Lopez-Marquez, A; Martinez, AM; Gomez-Lopez, G; Santisteban, P				Fernandez, Lara P.; Lopez-Marquez, Aristides; Martinez, Angel M.; Gomez-Lopez, Gonzalo; Santisteban, Pilar			New Insights into FoxE1 Functions: Identification of Direct FoxE1 Targets in Thyroid Cells	PLOS ONE			English	Article							SODIUM/IODIDE SYMPORTER GENE; PAIRED-DOMAIN TRANSCRIPTION; FACTOR PAX8; FACTOR-I; THYROPEROXIDASE PROMOTER; HORMONAL-REGULATION; GENOMIC DATA; FACTOR TTF-2; EXPRESSION; DIFFERENTIATION	Background: FoxE1 is a thyroid-specific forkhead transcription factor essential for thyroid gland development, as well as for the maintenance of the thyroid differentiated state in adults. FoxE1 recognizes and binds to a short DNA sequence present in thyroglobulin (Tg) and thyroperoxidase (Tpo) promoters, but FoxE1 binding to regulatory regions other than Tg and Tpo promoters remains almost unexplored. Improving knowledge of the regulatory functions of FoxE1 is necessary to clarify its role in endocrine syndromes and cancer susceptibility. Methodology/Principal Finding: In order to further investigate downstream FoxE1 targets, we performed a genome-wide expression screening after knocking-down FoxE1 and obtained new insights into FoxE1 transcriptional networks in thyroid follicular cells. After validation, we confirmed Adamts9, Cdh1, Duox2 and S100a4 as upregulated genes and Casp4, Creld2, Dusp5, Etv5, Hsp5a, Nr4a2 and Tm4sf1 as downregulated genes when FoxE1 was silenced. In promoter regions of putative FoxE1-regulated genes and also in the promoters of the classical thyroid genes Nis, Pax8 and Titf1, we performed an in silico search of the FoxE1 binding motif that was in close proximity to the NF1/CTF binding sequence, as previously described for other forkhead factors. Using chromatin immunoprecipitation we detected specific in vivo FoxE1 binding to novel regulatory regions in two relevant thyroid genes, Nis and Duox2. Moreover, we demonstrated simultaneous binding of FoxE1 and NF1/CTF to the Nis upstream enhancer region, as well as a clear functional activation of the Nis promoter by both transcription factors. Conclusions/Significance: In search for potential downstream mediators of FoxE1 function in thyroid cells, we identified two novel direct FoxE1 target genes. To our knowledge, this is the first evidence regarding the implication of Nis and Duox2 in executing the transcriptional program triggered by FoxE1. Furthermore, this study points out the important role of FoxE1 in the regulation of a large number of genes in thyroid cells.	[Fernandez, Lara P.; Lopez-Marquez, Aristides; Martinez, Angel M.; Santisteban, Pilar] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Fernandez, Lara P.; Lopez-Marquez, Aristides; Martinez, Angel M.; Santisteban, Pilar] Univ Autonoma Madrid CSIC UAM, Madrid, Spain; [Martinez, Angel M.; Gomez-Lopez, Gonzalo] Spanish Natl Canc Res Ctr CNIO, Bioinformat Unit, Struct Biol Program, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); Centro Nacional de Investigaciones Oncologicas (CNIO)	Santisteban, P (corresponding author), CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain.	psantisteban@iib.uam.es	Gomez-Lopez, Gonzalo/D-9123-2016; Lopez-Marquez, Aristides/N-8788-2015; Alvarez, Lara Paula Fernandez/ABF-3692-2020; Álvarez, Lara Fernández/Z-4685-2019; López-Márquez, Arístides/AAN-9814-2021; López-Márquez, Arístides/AAA-6500-2021; Santisteban, Pilar/E-7829-2016	Gomez-Lopez, Gonzalo/0000-0002-4146-0551; López-Márquez, Arístides/0000-0002-0124-3261; López-Márquez, Arístides/0000-0002-0124-3261; Santisteban, Pilar/0000-0002-2758-796X; Fernandez Alvarez, Lara Paula/0000-0001-8830-6300; Martinez Montes, Angel Mario/0000-0003-1461-4516	Direccion General de Proyectos de Investigacion [BFU-2010-16025]; FIS, Instituto de Salud Carlos III [RD06/0020/0060, RD12/0036/0030]; Comunidad de Madrid (Spain) [S2011/BMD-2328 TIRONET]; Juan de la Cierva programme of the Spanish Government	Direccion General de Proyectos de Investigacion; FIS, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Comunidad de Madrid (Spain)(Comunidad de Madrid); Juan de la Cierva programme of the Spanish Government	This work was supported by Grants BFU-2010-16025 from the Direccion General de Proyectos de Investigacion; RD06/0020/0060 and RD12/0036/0030 from FIS, Instituto de Salud Carlos III; and S2011/BMD-2328 TIRONET project from the Comunidad de Madrid (Spain). LP Fernandez holds a postdoctoral grant of the Juan de la Cierva programme of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; AZABLANC P, 1993, MOL ENDOCRINOL, V7, P1297, DOI 10.1210/me.7.10.1297; BAMFORTH JS, 1989, J MED GENET, V26, P49, DOI 10.1136/jmg.26.1.49; BJORKMAN U, 1981, J ULTRA MOL STRUCT R, V74, P105, DOI 10.1016/S0022-5320(81)80113-X; BJORKMAN U, 1984, ENDOCRINOLOGY, V115, P392; BRABANT G, 1995, ENDOCRINOLOGY, V136, P3113, DOI 10.1210/en.136.7.3113; Brune K, 2008, CANCER EPIDEM BIOMAR, V17, P3536, DOI 10.1158/1055-9965.EPI-08-0630; Bullock M, 2012, J CLIN ENDOCR METAB, V97, pE1814, DOI 10.1210/jc.2012-1456; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Christophe-Hobertus C, 2007, MOL CELL ENDOCRINOL, V264, P157, DOI 10.1016/j.mce.2006.11.005; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Costamagna E, 2004, J BIOL CHEM, V279, P3439, DOI 10.1074/jbc.M307138200; Cuesta I, 2007, MOL CELL BIOL, V27, P7302, DOI 10.1128/MCB.00758-07; D'Andrea B, 2006, MOL ENDOCRINOL, V20, P1810, DOI 10.1210/me.2005-0463; Damante G, 2001, PROG NUCLEIC ACID RE, V66, P307; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; De Felice M, 1998, NAT GENET, V19, P395, DOI 10.1038/1289; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; Dupuy C, 2000, BIOCHEM BIOPH RES CO, V277, P287, DOI 10.1006/bbrc.2000.3671; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P576, DOI 10.1128/MCB.12.2.576; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Garcia B, 2002, MOL ENDOCRINOL, V16, P342, DOI 10.1210/me.16.2.342; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hishinuma A, 2004, MOL CELL ENDOCRINOL, V221, P33, DOI 10.1016/j.mce.2004.04.003; JACKSON DA, 1993, MOL CELL BIOL, V13, P2401, DOI 10.1128/MCB.13.4.2401; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Lee HS, 2010, STEM CELLS, V28, P501, DOI 10.1002/stem.294; Li W, 2010, ENDOCR-RELAT CANCER, V17, P383, DOI 10.1677/ERC-09-0156; Maijenburg MW, 2012, STEM CELLS DEV, V21, P228, DOI 10.1089/scd.2011.0076; Medina DL, 2000, EUR J ENDOCRINOL, V143, P161, DOI 10.1530/eje.0.1430161; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; NEBL G, 1995, CELL MOL BIOL RES, V41, P85; Ohno M, 1999, MOL CELL BIOL, V19, P2051; Ortiz L, 1999, J BIOL CHEM, V274, P15213, DOI 10.1074/jbc.274.21.15213; Ortiz L, 1997, J BIOL CHEM, V272, P23334, DOI 10.1074/jbc.272.37.23334; Park E, 2012, BIOCHEM BIOPH RES CO, V421, P532, DOI 10.1016/j.bbrc.2012.04.039; Perrone L, 2000, BIOCHEM BIOPH RES CO, V275, P203, DOI 10.1006/bbrc.2000.3232; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Ruiz-Llorente S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-147; SANTISTEBAN P, 1992, MOL ENDOCRINOL, V6, P1310, DOI 10.1210/me.6.8.1310; Venza I, 2010, BRIT J DERMATOL, V162, P1093, DOI 10.1111/j.1365-2133.2009.09560.x; Venza I, 2010, BRIT J DERMATOL, V162, P681, DOI 10.1111/j.1365-2133.2009.09557.x; Venza I, 2011, HUM MOL GENET, V20, P1016, DOI 10.1093/hmg/ddq547; Vigone Maria Cristina, 2005, Hum Mutat, V26, P395; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; YAP AS, 1995, ENDOCRINOLOGY, V136, P4672, DOI 10.1210/en.136.10.4672; Zannini M, 1997, EMBO J, V16, P3185, DOI 10.1093/emboj/16.11.3185; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	51	31	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62849	10.1371/journal.pone.0062849	http://dx.doi.org/10.1371/journal.pone.0062849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675434	gold, Green Published, Green Submitted			2022-12-25	WOS:000319036100015
J	Ramos-Fernandez, G; Aguilar, SES; Schaffner, CM; Vick, LG; Aureli, F				Ramos-Fernandez, Gabriel; Smith Aguilar, Sandra E.; Schaffner, Colleen M.; Vick, Laura G.; Aureli, Filippo			Site Fidelity in Space Use by Spider Monkeys (Ateles geoffroyi) in the Yucatan Peninsula, Mexico	PLOS ONE			English	Article							HOME-RANGE SIZE; NATIONAL-PARK; HABITAT USE; CORE AREAS; FOREST; PATTERNS; BEHAVIOR; QUALITY; DETERMINANTS; MOVEMENTS	Animal home ranges may vary little in their size and location in the short term but nevertheless show more variability in the long term. We evaluated the degree of site fidelity of two groups of spider monkeys (Ateles geoffroyi) over a 10- and 13-year period, respectively, in the northeastern Yucatan peninsula, Mexico. We used the Local Convex Hull method to estimate yearly home ranges and core areas (defined as the 60% probability contour) for the two groups. Home ranges varied from 7.7 to 49.6 ha and core areas varied from 3.1 to 9.2 ha. We evaluated the degree of site fidelity by quantifying the number of years in which different areas were used as either home ranges or core areas. Large tracts were used only as home ranges and only for a few years, whereas small areas were used as either core area or home range for the duration of the study. The sum of the yearly core areas coincided partially with the yearly home ranges, indicating that home ranges contain areas used intermittently. Home ranges, and especially core areas, contained a higher proportion of mature forest than the larger study site as a whole. Across years and only in one group, the size of core areas was positively correlated with the proportion of adult males in the group, while the size of home ranges was positively correlated with both the proportion of males and the number of tree species included in the diet. Our findings suggest that spider monkey home ranges are the result of a combination of long-term site fidelity and year-to-year use variation to enable exploration of new resources.	[Ramos-Fernandez, Gabriel; Smith Aguilar, Sandra E.] Inst Politecn Nacl, Ctr Interdisciplinario Invest El Desarrollo Integ, Unidad Oaxaca, Xoxocotlan, Oaxaca, Mexico; [Schaffner, Colleen M.; Aureli, Filippo] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico; [Schaffner, Colleen M.] Univ Chester, Dept Psychol, Chester, Cheshire, England; [Vick, Laura G.] William Peace Univ, Dept Anthropol, Raleigh, NC USA; [Aureli, Filippo] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England	Instituto Politecnico Nacional - Mexico; Universidad Veracruzana; University of Chester; Liverpool John Moores University	Ramos-Fernandez, G (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Invest El Desarrollo Integ, Unidad Oaxaca, Xoxocotlan, Oaxaca, Mexico.	ramosfer@alumni.upenn.edu	Ramos-Fernandez, Gabriel/F-9798-2015; Ramos-Fernandez, Gabriel/GQR-1310-2022; Smith-Aguilar, Sandra Elizabeth/AAR-2926-2021	Ramos-Fernandez, Gabriel/0000-0001-7175-3905; Ramos-Fernandez, Gabriel/0000-0001-7175-3905; Smith-Aguilar, Sandra Elizabeth/0000-0003-2209-5496; Aureli, Filippo/0000-0002-0671-013X	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [J51278, 157656]; Wenner-Gren Foundation; North of England Zoological Society; British Academy; National Geographic Society; University of Chester; Instituto Politecnico Nacional; William Peace University; Laboratorio Ecotono (INIBIOMA-CONICET); Laboratorio Ecotono (Universidad Nacional del Comahue)	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Wenner-Gren Foundation; North of England Zoological Society; British Academy; National Geographic Society(National Geographic Society); University of Chester; Instituto Politecnico Nacional; William Peace University; Laboratorio Ecotono (INIBIOMA-CONICET); Laboratorio Ecotono (Universidad Nacional del Comahue)	We are grateful to the Consejo Nacional de Ciencia y Tecnologia (CONACYT; grants J51278 and 157656), The Wenner-Gren Foundation, The North of England Zoological Society, The British Academy, The National Geographic Society, The University of Chester, Instituto Politecnico Nacional, William Peace University and Laboratorio Ecotono (INIBIOMA-CONICET and Universidad Nacional del Comahue) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio N, 2012, J ZOOL, V287, P250, DOI 10.1111/j.1469-7998.2012.00911.x; Asensio N, 2012, PRIMATES, V53, P147, DOI 10.1007/s10329-011-0288-9; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; BOLLINGER EK, 1989, AUK, V106, P584; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Cairns MA, 2003, FOREST ECOL MANAG, V186, P125, DOI 10.1016/S0378-1127(03)00229-9; Challeger A, 1998, UTILIZACION CONSERVA; Comision Nacional del Agua, 2005, PATR MENS PREC TEMP; Connor EF, 2000, ECOLOGY, V81, P734, DOI 10.2307/177373; Creel S., 2002, AFRICAN WILD DOG BEH; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; ESRI, 2007, ARCGIS 9 2; Garcia-Frapolli E, 2007, LANDSCAPE URBAN PLAN, V83, P137, DOI 10.1016/j.landurbplan.2007.03.007; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Hanski IK, 2000, J MAMMAL, V81, P798, DOI 10.1644/1545-1542(2000)081<0798:HRSMAN>2.3.CO;2; Janmaat KRL, 2009, INT J PRIMATOL, V30, P443, DOI 10.1007/s10764-009-9352-3; Janson C, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P165; Janson CH, 2007, ANIM COGN, V10, P357, DOI 10.1007/s10071-007-0080-9; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Lurz PWW, 1997, ANIM BEHAV, V54, P427, DOI 10.1006/anbe.1996.0486; McLoughlin PD, 2000, EVOL ECOL, V14, P39, DOI 10.1023/A:1011019031766; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; Ortega YK, 2006, OECOLOGIA, V149, P340, DOI 10.1007/s00442-006-0438-8; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; Powell RA, 2000, METH C CONS, P65; R Core Team, 2012, R LANG ENV STAT COMP; Radespiel U, 2003, AM J PRIMATOL, V59, P139, DOI 10.1002/ajp.10071; Ramos-Fernandez G, 2005, INT J PRIMATOL, V26, P1077, DOI 10.1007/s10764-005-6459-z; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Ramos-Fernandez G, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P191; Ramos-Fernandez G, 2001, PATTERNS ASS FEEDING; Ramos-Fernandez Gabriel, 2003, Neotropical Primates, V11, P155; Schaffner CM, 2012, INT J PRIMATOL, V33, P922, DOI 10.1007/s10764-012-9621-4; Spehar SN, 2010, AM J PRIMATOL, V72, P129, DOI 10.1002/ajp.20763; Suarez SA, 2006, INT J PRIMATOL, V27, P411, DOI 10.1007/s10764-006-9023-6; Switzer PV, 1997, ANIM BEHAV, V53, P865, DOI 10.1006/anbe.1996.0352; SYMINGTON MM, 1990, INT J PRIMATOL, V11, P47, DOI 10.1007/BF02193695; SYMINGTON MM, 1988, AM J PRIMATOL, V15, P45, DOI 10.1002/ajp.1350150106; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Topping DT, 2006, MAR ECOL PROG SER, V326, P257, DOI 10.3354/meps326257; Valero A, 2007, ANIM COGN, V10, P305, DOI 10.1007/s10071-006-0066-z; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; Van Moorter B, 2009, OIKOS, V118, P641, DOI 10.1111/j.1600-0706.2008.17003.x; Wallace RB, 2006, AM J PRIMATOL, V68, P313, DOI 10.1002/ajp.20227; Wallace RB, 2008, AM J PRIMATOL, V70, P271, DOI 10.1002/ajp.20484; Wallace RB, 2008, CAM S BIO EVOL ANTHR, V55, P138; Wartmann FM, 2010, PRIMATES, V51, P119, DOI 10.1007/s10329-009-0186-6; Watts DP, 1998, INT J PRIMATOL, V19, P651, DOI 10.1023/A:1020324909101; Wayne Getz lab, 2005, LOCOH ARCGIS TOOLB; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3	58	34	34	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62813	10.1371/journal.pone.0062813	http://dx.doi.org/10.1371/journal.pone.0062813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675427	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000319036100012
J	Skalova, H; Jarosik, V; Dvorackova, S; Pysek, P				Skalova, Hana; Jarosik, Vojtech; Dvorackova, Sarka; Pysek, Petr			Effect of Intra- and Interspecific Competition on the Performance of Native and Invasive Species of Impatiens under Varying Levels of Shade and Moisture	PLOS ONE			English	Article							ALIEN PLANTS; PHENOTYPIC PLASTICITY; TRAITS; EVOLUTION; DIVERSITY; FRAMEWORK; DYNAMICS; HABITAT; GLANDULIFERA; COMMUNITIES	Many alien plants are thought to be invasive because of unique traits and greater phenotypic plasticity relative to resident species. However, many studies of invasive species are unable to quantify the importance of particular traits and phenotypic plasticity in conferring invasive behavior because traits used in comparative studies are often measured in a single environment and by using plants from a single population. To obtain a deeper insight into the role of environmental factors, local differences and competition in plant invasions, we compared species of Impatiens (Balsaminaceae) of different origin and invasion status that occur in central Europe: native I. noli-tangere and three alien species (highly invasive I. glandulifera, less invasive I. parviflora and potentially invasive I. capensis). In two experiments we harvested late-stage reproductive plants to estimate performance. The first experiment quantified how populations differed in performance under varying light and moisture levels in the absence of competition. The second experiment quantified performance across these environments in the presence of intra-and inter-specific competition. The highly invasive I. glandulifera was the strongest competitor, was the tallest and produced the greatest biomass. Small size and high plasticity were characteristic for I. parviflora. This species appeared to be the second strongest competitor, especially under low soil moisture. The performance of I. capensis was within the range of the other Impatiens species studied, but sometimes limited by alien competitors. Our results suggest that invasion success within the genus Impatiens depends on the ability to grow large under a range of environmental conditions, including competition. The invasive species also exhibited greater phenotypic plasticity across environmental conditions than the native species. Finally, the decreased performance of the native I. noli-tangere in competition with other species studied indicates that this species may be possibly excluded from its sites by invading congeners.	[Skalova, Hana; Jarosik, Vojtech; Dvorackova, Sarka; Pysek, Petr] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Jarosik, Vojtech; Pysek, Petr] Charles Univ Prague, Dept Ecol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague	Skalova, H (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	hana.skalova@ibot.cas.cz	Pysek, Petr/B-1957-2012; Skalova, Hana/H-1627-2014	Skalova, Hana/0000-0002-1252-2952	Academy of Sciences of the Czech Republic;  [GACR 206/07/0668];  [206/09/0563];  [RVO 67985939]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); ; ; 	The work was supported by grants GACR 206/07/0668 and 206/09/0563, long-term research development project no. RVO 67985939. Petr Pysek acknowledges the support of a Praemium Academiae award from the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowski W., 2008, Plant invasions: human perception, ecological impacts and management, P57; Alexander JM, 2010, J BIOGEOGR, V37, P1951, DOI 10.1111/j.1365-2699.2010.02335.x; BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147; BEERLING DJ, 1993, J ECOL, V81, P367, DOI 10.2307/2261507; Bimova K, 2004, J VEG SCI, V15, P495, DOI 10.1111/j.1654-1103.2004.tb02288.x; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blumenthal D, 2009, P NATL ACAD SCI USA, V106, P7899, DOI 10.1073/pnas.0812607106; Burns JH, 2006, BIOL INVASIONS, V8, P797, DOI 10.1007/s10530-005-3838-5; Burns JH, 2004, DIVERS DISTRIB, V10, P387, DOI 10.1111/j.1366-9516.2004.00105.x; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; COOMBE DE, 1956, J ECOL, V44, P701, DOI 10.2307/2256857; Crawley M.J., 1993, GLIM ECOLOGISTS; Crawley M. J, 2002, STAT COMPUTING INTRO; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Foxcroft LC, 2007, CONSERV BIOL, V21, P412, DOI 10.1111/j.1523-1739.2007.00673.x; Foxcroft LC, 2011, CONSERV BIOL, V25, P400, DOI 10.1111/j.1523-1739.2010.01617.x; Franks PJ, 1999, PLANT CELL ENVIRON, V22, P1337, DOI 10.1046/j.1365-3040.1999.00494.x; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Grotkopp E, 2007, AM J BOT, V94, P526, DOI 10.3732/ajb.94.4.526; Hatcher PE, 2003, J ECOL, V91, P147, DOI 10.1046/j.1365-2745.2003.00741.x; Hejda M, 2009, GLOBAL ECOL BIOGEOGR, V18, P372, DOI 10.1111/j.1466-8238.2009.00445.x; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Kartesz JT, 1999, SYNTHESIS N AM FLORA; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kubesova M, 2010, PRESLIA, V82, P81; Lambdon PW, 2008, PRESLIA, V80, P101; Leicht-Young SA, 2007, OECOLOGIA, V154, P273, DOI 10.1007/s00442-007-0839-3; LHOTSKA MARIE, 1966, PRESLIA [PRAHA], V38, P376; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Malikova L., 2010, Ecohydrology and Hydrobiology, V10, P81, DOI 10.2478/v10104-009-0050-8; Mangla S, 2011, PLANT ECOL, V212, P531, DOI 10.1007/s11258-011-9909-z; Molina-Montenegro MA, 2012, BIOL INVASIONS, V14, P21, DOI 10.1007/s10530-011-0055-2; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; Monty A, 2010, OIKOS, V119, P1563, DOI 10.1111/j.1600-0706.2010.17769.x; Moravcova L, 2010, PRESLIA, V82, P365; MORGAN DC, 1979, PLANTA, V145, P253, DOI 10.1007/BF00454449; Palacio-Lopez K, 2011, OIKOS, V120, P1393, DOI 10.1111/j.1600-0706.2010.19114.x; Pathikonda S, 2009, CONSERV BIOL, V23, P164, DOI 10.1111/j.1523-1739.2008.01073.x; Perglova I, 2009, PRESLIA, V81, P357; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Powell KI, 2009, INT J PLANT SCI, V170, P918, DOI 10.1086/600140; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; PYSEK P, 1995, BIOL CONSERV, V74, P41, DOI 10.1016/0006-3207(95)00013-T; PYSEK P, 1993, J BIOGEOGR, V20, P413, DOI 10.2307/2845589; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek Petr, 2007, V193, P97; Pysek P, 2012, PRESLIA, V84, P575; Pysek P, 2012, PRESLIA, V84, P155; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Pysek P, 2010, GLOBAL ECOL BIOGEOGR, V19, P317, DOI 10.1111/j.1466-8238.2009.00514.x; R Development Core Team R, 2009, R LANG ENV STAT COMP; Reinhart KO, 2006, ECOL APPL, V16, P1821, DOI 10.1890/1051-0761(2006)016[1821:ITQEIS]2.0.CO;2; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rejmanek M., 2005, VEGETATION ECOLOGY, DOI DOI 10.1002/9781118452592.CH13; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; RICHARDSON D M, 1989, South African Forestry Journal, P1; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Seastedt TR, 2011, ANNU REV ECOL EVOL S, V42, P133, DOI 10.1146/annurev-ecolsys-102710-145057; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Skalova H, 2012, ANN BOT-LONDON, V110, P1429, DOI 10.1093/aob/mcr316; Skalova H, 2011, PERSPECT PLANT ECOL, V13, P173, DOI 10.1016/j.ppees.2011.03.005; Slavik B., 1997, KVETENA CESKE REPUBL, V5, P234; Sokal RR, 1995, BIOMETRY; Tilman D., 1982, Monographs in Population Biology, pi; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Verbeke G, 2000, LINEAR MIXED MODELS; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Vinton MA, 2006, ECOSYSTEMS, V9, P967, DOI 10.1007/s10021-005-0107-5; Vitousek PM, 1996, AM SCI, V84, P468; Williams JL, 2008, OECOLOGIA, V157, P239, DOI 10.1007/s00442-008-1075-1; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106; Zuur Alain F., 2009, P1	80	52	54	9	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62842	10.1371/journal.pone.0062842	http://dx.doi.org/10.1371/journal.pone.0062842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675432	Green Published, gold			2022-12-25	WOS:000318852400014
J	Asfaw, M; Alvarez-Lacalle, E; Shiferaw, Y				Asfaw, Mesfin; Alvarez-Lacalle, Enric; Shiferaw, Yohannes			The Timing Statistics of Spontaneous Calcium Release in Cardiac Myocytes	PLOS ONE			English	Article							RYANODINE RECEPTOR CHANNELS; UNITARY CA2+ CURRENT; MATHEMATICAL-MODEL; AFTERDEPOLARIZATIONS; WAVES; DYNAMICS; HEART; VARIABILITY; TERMINATION; MECHANISMS	A variety of cardiac arrhythmias are initiated by a focal excitation that disrupts the regular beating of the heart. In some cases it is known that these excitations are due to calcium (Ca) release from the sarcoplasmic reticulum (SR) via propagating subcellular Ca waves. However, it is not understood what are the physiological factors that determine the timing of these excitations at both the subcellular and tissue level. In this paper we apply analytic and numerical approaches to determine the timing statistics of spontaneous Ca release (SCR) in a simplified model of a cardiac myocyte. In particular, we compute the mean first passage time (MFPT) to SCR, in the case where SCR is initiated by spontaneous Ca sparks, and demonstrate that this quantity exhibits either an algebraic or exponential dependence on system parameters. Based on this analysis we identify the necessary requirements so that SCR occurs on a time scale comparable to the cardiac cycle. Finally, we study how SCR is synchronized across many cells in cardiac tissue, and identify a quantitative measure that determines the relative timing of SCR in an ensemble of cells. Using this approach we identify the physiological conditions so that cell-to-cell variations in the timing of SCR is small compared to the typical duration of an SCR event. We argue further that under these conditions inward currents due to SCR can summate and generate arrhythmogenic triggered excitations in cardiac tissue.	[Asfaw, Mesfin; Shiferaw, Yohannes] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA; [Alvarez-Lacalle, Enric] Univ Politecn Cataluna, Dept Fis Aplicada, Barcelona, Spain	California State University System; California State University Northridge; Universitat Politecnica de Catalunya	Shiferaw, Y (corresponding author), Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA.	yshiferaw@csun.edu	Alvarez-Lacalle, Enrique/ADA-6394-2022; Alvarez Lacalle, Enrique/M-1031-2014	Alvarez-Lacalle, Enrique/0000-0001-6824-6857; Alvarez Lacalle, Enrique/0000-0001-6824-6857	National Heart, Lung, and Blood Institute [RO1HL101196]; Secretaria de Estado de Investigacion, Desarrollo e Innovacion (Spain) [FIS2011-28820-C02-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101196] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Secretaria de Estado de Investigacion, Desarrollo e Innovacion (Spain); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute grant RO1HL101196. EA acknowledges funding from the Secretaria de Estado de Investigacion, Desarrollo e Innovacion (Spain), grant FIS2011-28820-C02-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTZELEVITCH C, 1994, J AM COLL CARDIOL, V23, P259, DOI 10.1016/0735-1097(94)90529-0; Baddeley D, 2009, P NATL ACAD SCI USA, V106, P22275, DOI 10.1073/pnas.0908971106; Belevych AE, 2012, CIRC RES, V110, P569, DOI 10.1161/CIRCRESAHA.111.260455; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Chen W, 2012, BIOPHYS J, V102, P461, DOI 10.1016/j.bpj.2011.12.045; Chen W, 2011, AM J PHYSIOL-HEART C, V300, pH1794, DOI 10.1152/ajpheart.01121.2010; Chen W, 2009, AM J PHYSIOL-HEART C, V297, pH171, DOI 10.1152/ajpheart.00098.2009; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Doering CR, 2005, MULTISCALE MODEL SIM, V3, P283, DOI 10.1137/030602800; Falcke M, 2003, BIOPHYS J, V84, P42, DOI 10.1016/S0006-3495(03)74831-0; Gardiner C. W., 1985, HDB STOCHASTIC METHO; Groff JR, 2008, BIOPHYS J, V95, P135, DOI 10.1529/biophysj.107.119982; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hinch R, 2004, BIOPHYS J, V86, P1293, DOI 10.1016/S0006-3495(04)74203-4; JANUARY CT, 1988, PHARMACOL REV, V40, P219; Kettlun C, 2003, J GEN PHYSIOL, V122, P407, DOI 10.1085/jgp.200308843; LAKATTA EG, 1985, FED PROC, V44, P2977; Langer GA, 1997, CIRCULATION, V96, P3761; Laurita KR, 2008, J MOL CELL CARDIOL, V44, P31, DOI 10.1016/j.yjmcc.2007.10.012; LINDENBERG K, 1986, J STAT PHYS, V42, P201, DOI 10.1007/BF01010847; Mejia-Alvarez R, 1999, J GEN PHYSIOL, V113, P177, DOI 10.1085/jgp.113.2.177; Moenke G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051178; Nivala M, 2012, BIOPHYS J, V102, P2433, DOI 10.1016/j.bpj.2012.05.001; Nivala M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00114; Pury PA, 2003, J PHYS A-MATH GEN, V36, P2695, DOI 10.1088/0305-4470/36/11/304; Ramay HR, 2011, CARDIOVASC RES, V91, P598, DOI 10.1093/cvr/cvr143; Restrepo JG, 2008, BIOPHYS J, V95, P3767, DOI 10.1529/biophysj.108.130419; Rovetti R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051920; Schendel T, 2012, EUR BIOPHYS J BIOPHY, V41, P27, DOI 10.1007/s00249-011-0755-7; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Shiferaw Y, 2012, CARDIOVASC RES, V95, P265, DOI 10.1093/cvr/cvs155; Skupin A, 2008, BIOPHYS J, V94, P2404, DOI 10.1529/biophysj.107.119495; Sobie EA, 2002, BIOPHYS J, V83, P59, DOI 10.1016/S0006-3495(02)75149-7; Stuyvers BD, 2000, CIRC RES, V86, P1016, DOI 10.1161/01.RES.86.10.1016; TAKAMATSU T, 1990, FASEB J, V4, P1519, DOI 10.1096/fasebj.4.5.2307330; Ter Keurs HEDJ, 2007, PHYSIOL REV, V87, P457, DOI 10.1152/physrev.00011.2006; Thul R, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.061923; Thurley K, 2012, BBA-GEN SUBJECTS, V1820, P1185, DOI 10.1016/j.bbagen.2011.10.007; Thurley K, 2011, P NATL ACAD SCI USA, V108, P427, DOI 10.1073/pnas.1008435108; Wang SQ, 2004, P NATL ACAD SCI USA, V101, P3979, DOI 10.1073/pnas.0306157101; Wasserstrom JA, 2010, CIRC RES, V107, P1117, DOI 10.1161/CIRCRESAHA.110.229294; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Xie YF, 2010, BIOPHYS J, V99, P1408, DOI 10.1016/j.bpj.2010.06.042	44	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e62967	10.1371/journal.pone.0062967	http://dx.doi.org/10.1371/journal.pone.0062967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690970	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900019
J	Borenstein, DB; Meir, Y; Shaevitz, JW; Wingreen, NS				Borenstein, David Bruce; Meir, Yigal; Shaevitz, Joshua W.; Wingreen, Ned S.			Non-Local Interaction via Diffusible Resource Prevents Coexistence of Cooperators and Cheaters in a Lattice Model	PLOS ONE			English	Article							EVOLUTION; CONFLICT; BIOFILMS; GAMES	Many cellular populations cooperate through the secretion of diffusible extracellular resources, such as digestive enzymes or virulence factors. Diffusion of these resources leads to long-range intercellular interactions, creating the possibility of cooperation but also the risk of exploitation by non-producing neighbors. In the past, considerable attention has been given to game-theoretic lattice models of intercellular cooperation. In these models, coexistence is commonly observed between cooperators (corresponding to resource producers) and cheaters (corresponding to nonproducers). However, these models consider only interactions between direct competitors. We find that when individuals are allowed to interact non-locally through the diffusion of a shared resource coexistence between cooperators and cheaters is lost. Instead, we find population dynamics similar to simple competition, either neutral or biased, with no balancing selection that would favor coexistence. Our results highlight the importance of an accurate treatment of diffusion of shared resources and argue against the generality of the conclusions of game-theoretic lattice models.	[Borenstein, David Bruce; Shaevitz, Joshua W.; Wingreen, Ned S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Meir, Yigal] Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel; [Shaevitz, Joshua W.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Ben Gurion University; Princeton University; Princeton University	Wingreen, NS (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	wingreen@princeton.edu	MEIR, YIGAL/F-1888-2012	Meir, Yigal/0000-0003-1606-8969	National Science Foundation [PHY-0957573]; National Science Foundation Physics of Living Systems program [PHY-0957573]; National Institutes of Health National Human Genome Research Institute training grant [T32 HG003284]; National Institutes of Health [R01 GM082938]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082938] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Physics of Living Systems program; National Institutes of Health National Human Genome Research Institute training grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N.S.W. was supported by National Science Foundation Grant PHY-0957573. D.B.B. was supported in part by the National Science Foundation Physics of Living Systems program (PHY-0957573) and the National Institutes of Health National Human Genome Research Institute training grant T32 HG003284 (Botstein, PI). Y.M. was supported by the National Institutes of Health (www.nih.gov) grant R01 GM082938. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; Czaran T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006655; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HASSAN HM, 1980, J BACTERIOL, V141, P156, DOI 10.1128/JB.141.1.156-163.1980; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hojo K, 2009, J DENT RES, V88, P982, DOI 10.1177/0022034509346811; Juhas M, 2005, ENVIRON MICROBIOL, V7, P459, DOI 10.1111/j.1462-2920.2005.00769.x; Korolev KS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.088103; Korolev KS, 2010, REV MOD PHYS, V82, P1691, DOI 10.1103/RevModPhys.82.1691; Koschwanez JH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001122; LAWRENCE JR, 1994, APPL ENVIRON MICROB, V60, P1166, DOI 10.1128/AEM.60.4.1166-1173.1994; Marsh PD, 2004, CARIES RES, V38, P204, DOI 10.1159/000077756; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Momeni B, 2013, ELIFE, V2, DOI 10.7554/eLife.00230; Moran P., 1962, STAT PROCESSES EVOLU; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; NOWAK MA, 1994, INT J BIFURCAT CHAOS, V4, P33, DOI 10.1142/S0218127494000046; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sugden R, 1986, EC RIGHTS COOPERATIO; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Xavier JB, 2005, ENVIRON MICROBIOL, V7, P1085, DOI 10.1111/j.1462-2920.2005.00787.x; Xavier JB, 2007, P NATL ACAD SCI USA, V104, P876, DOI 10.1073/pnas.0607651104; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	42	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63304	10.1371/journal.pone.0063304	http://dx.doi.org/10.1371/journal.pone.0063304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691017	gold, Green Submitted, Green Published			2022-12-25	WOS:000319107900033
J	Boyd, JD; Brightsmith, DJ				Boyd, Janice D.; Brightsmith, Donald J.			Error Properties of Argos Satellite Telemetry Locations Using Least Squares and Kalman Filtering	PLOS ONE			English	Article							ACCURACY	Study of animal movements is key for understanding their ecology and facilitating their conservation. The Argos satellite system is a valuable tool for tracking species which move long distances, inhabit remote areas, and are otherwise difficult to track with traditional VHF telemetry and are not suitable for GPS systems. Previous research has raised doubts about the magnitude of position errors quoted by the satellite service provider CLS. In addition, no peer-reviewed publications have evaluated the usefulness of the CLS supplied error ellipses nor the accuracy of the new Kalman filtering (KF) processing method. Using transmitters hung from towers and trees in southeastern Peru, we show the Argos error ellipses generally contain < 25% of the true locations and therefore do not adequately describe the true location errors. We also find that KF processing does not significantly increase location accuracy. The errors for both LS and KF processing methods were found to be lognormally distributed, which has important repercussions for error calculation, statistical analysis, and data interpretation. In brief, "good'' positions (location codes 3, 2, 1, A) are accurate to about 2 km, while 0 and B locations are accurate to about 5-10 km. However, due to the lognormal distribution of the errors, larger outliers are to be expected in all location codes and need to be accounted for in the user's data processing. We evaluate five different empirical error estimates and find that 68% lognormal error ellipses provided the most useful error estimates. Longitude errors are larger than latitude errors by a factor of 2 to 3, supporting the use of elliptical error ellipses. Numerous studies over the past 15 years have also found fault with the CLS-claimed error estimates yet CLS has failed to correct their misleading information. We hope this will be reversed in the near future.	[Boyd, Janice D.] Parrot Fund, College Stn, TX USA; [Boyd, Janice D.; Brightsmith, Donald J.] Texas A&M Univ, Schubot Exot Bird Hlth Ctr, Dept Vet Pathobiol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Brightsmith, DJ (corresponding author), Texas A&M Univ, Schubot Exot Bird Hlth Ctr, Dept Vet Pathobiol, College Stn, TX 77843 USA.	dbrightsmith@cvm.tamu.edu		Brightsmith, Donald/0000-0002-3306-6490	Wildlife Preservation Trust; Parrot Fund; Loro Parque Fundacion; Phoenix Landing and Raleigh Durham Cage Bird Society; Phoenix Landing; Raleigh Durham Cage Bird Society	Wildlife Preservation Trust; Parrot Fund; Loro Parque Fundacion; Phoenix Landing and Raleigh Durham Cage Bird Society; Phoenix Landing; Raleigh Durham Cage Bird Society	Schubot Exotic Bird Center, Texas A&M University, supplied equipment and salary for personnel. Rainforest Expeditions provided logistical support, salary for field leader and other personnel, and food and lodging. Wildlife Preservation Trust and The Parrot Fund provided funding towards all aspects of the study. Loro Parque Fundacion funded development of prototypes. Additional funding for various aspects of the project was provided by Phoenix Landing and Raleigh Durham Cage Bird Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brightsmith DJ, 2004, WILSON BULL, V116, P134, DOI 10.1676/03-087B; Britten MW, 1999, J WILDLIFE MANAGE, V63, P1349, DOI 10.2307/3802854; CLS (Collecte Localisation Satellites), 2011, COLLECTE LOCALISATIO; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Craighead FC, 1972, WILDLIFE MONOGR, V32, P3; Dubinin M, 2010, EUR J WILDLIFE RES, V56, P459, DOI 10.1007/s10344-009-0354-4; Fancy S. G., 1988, US FISH WILDLIFE SER, V172; Foster R.B., 1994, TAMBOPATA CANDAMO RE; Guthrie JD, 2011, J WILDLIFE MANAGE, V75, P539, DOI 10.1002/jwmg.137; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kleder M, 2005, VDIST VECTORIZED GEO; Kleder M, 2006, VDISTINV FIND ENDPOI; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Lopez R., 2011, CLSDTMEMO1165; McKeown A, 2012, AUSTRAL ECOL, V37, P295, DOI 10.1111/j.1442-9993.2011.02276.x; Montgomery RA, 2011, J WILDLIFE MANAGE, V75, P702, DOI 10.1002/jwmg.96; Moser BW, 2007, J WILDLIFE MANAGE, V71, P2421, DOI 10.2193/2007-003; Ristic B, 2004, KALMAN FILTER PARTIC; Rodgers A. R, 2001, RADIO TRACKING ANIMA, V82-121; Rose E, 2006, IBIS, V148, P231, DOI 10.1111/j.1474-919x.2006.00499.x; Sharma K, 2010, TELEMETRY WILDLIFE S, V13, P1; Soutullo A, 2007, J WILDLIFE MANAGE, V71, P1010, DOI 10.2193/2006-042; Tosi J. A., 1960, MEMORIA EXPLICATIVA; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Vincenty T., 1975, SURV REV, V23, P88, DOI [10.1179/sre.1975.23.176.88, DOI 10.1179/SRE.1975.23.176.88]; Wegge P, 2007, WILDLIFE BIOL, V13, P87, DOI 10.2981/0909-6396(2007)13[87:GSTPNI]2.0.CO;2; Withey John C., 2001, P43, DOI 10.1016/B978-012497781-5/50004-9	29	36	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63051	10.1371/journal.pone.0063051	http://dx.doi.org/10.1371/journal.pone.0063051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690980	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900023
J	Qian, YN; Pu, YH; Liu, LP; Wang, DZ; Zhao, XQ; Wang, CX; Wang, YL; Liu, GF; Pan, YS; Wang, YJ				Qian, Yining; Pu, Yuehua; Liu, Liping; Wang, David Z.; Zhao, Xingquan; Wang, Chunxue; Wang, Yilong; Liu, Gaifen; Pan, Yuesong; Wang, Yongjun			Low HDL-C Level Is Associated with the Development of Intracranial Artery Stenosis: Analysis from the Chinese IntraCranial AtheroSclerosis (CICAS) Study	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; RISK-FACTORS; STROKE; THERAPY; DISEASE; BURDEN; MEN	Background: Intracranial atherosclerotic stenosis (ICAS) is an important cause of ischemic stroke worldwide. The role of high-density lipoprotein cholesterol (HDL-C) or low-density lipoprotein cholesterol (LDL-C) in the development of ICAS remains to be elucidated. In the current study, we investigated the relationship of HDL-C level and the risk of developing ICAS in Chinese patients with acute ischemic stroke. Methods: From October 2007 to June 2009, a total of 1,984 consecutive ischemic stroke patients were evaluated for the presence of symptomatic ICAS by magnetic resonance angiography (MRA). Patients were classified into two groups: intracranial steno-occlusion (ICAS group, n = 888) and non-intracranial stenosis (NICAS group, n = 1096). Serum lipid profiles were analyzed and compared between the ICAS and NICAS group. Results: Significantly more patients in ICAS group had low HDL-C level (51.6%) than in the NICAS group (42.9%, P < 0.001). The observed association remained significant after adjustment for conventional risk factors [(adjusted OR 1.36; 95% CI (1.13-1.63)]. Such predictive value of low level HDL-C persisted even when LDL-C was at very low level(< 1.8 mmol/L). Patients in the lowest serum HDL-C quartile (< 0.96 mmol/L) had the highest risk of developing ICAS [adjusted OR 1.52; 95% CI (1.17-1.98)] compared to patients in the highest serum HDL-C quartile (>= 1.32 mmol/L) after adjustments for the covariates. Conclusions: Low HDL-C level is strongly associated with the development of ICAS. There was an inverse relationship between the level of HDL-C and the risk of developing ICAS.	[Qian, Yining] Capital Med Univ, Beijing Anzhen Hosp, Dept Neurol, Beijing, Peoples R China; [Pu, Yuehua; Liu, Liping; Zhao, Xingquan; Wang, Chunxue; Wang, Yilong; Liu, Gaifen; Pan, Yuesong; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, David Z.] Univ Illinois, Coll Med, Dept INI Stroke Ctr & Stroke Network, OSF Healthcare Syst, Peoria, IL 61656 USA	Capital Medical University; Capital Medical University; University of Illinois System; University of Illinois Peoria	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com	Pan, Yuesong/AAI-6303-2020; liu, li/HGC-0900-2022	Pan, Yuesong/0000-0003-3082-6789; 	Ministry of Science and Technology; Ministry of Health of the People's Republic of China; National S & T Major Project of China [2008ZX09312-008]; State Key Development Program of Basic Research of China [2009CB521905]; S.H. Ho Cardiovascular Disease and Stroke Center of the Chinese University of Hong Kong	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; National S & T Major Project of China; State Key Development Program of Basic Research of China(State Key Development Program for Basic Research of China); S.H. Ho Cardiovascular Disease and Stroke Center of the Chinese University of Hong Kong	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China, grant no. National S & T Major Project of China (2008ZX09312-008) and State Key Development Program of Basic Research of China (2009CB521905) and in part by the S.H. Ho Cardiovascular Disease and Stroke Center of the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenillas JF, 2004, NEUROLOGY, V63, P27, DOI 10.1212/01.WNL.0000132637.30287.B4; Bang OY, 2005, NEUROLOGY, V65, P296, DOI 10.1212/01.wnl.0000168862.09764.9f; Barter P, 2005, EUR HEART J SUPPL, V7, pF4, DOI 10.1093/eurheartj/sui036; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; CASTELLI WP, 1988, CAN J CARDIOL, V4, pA5; Chapman MJ, 2004, CURR MED RES OPIN, V20, P1253, DOI 10.1185/030079904125004402; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Armiento FP, 2001, STROKE, V32, P2472, DOI 10.1161/hs1101.098520; Farmer JA, 2011, CURR ATHEROSCLER REP, V13, P107, DOI 10.1007/s11883-011-0166-3; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; Gotto AM, 2004, J AM COLL CARDIOL, V43, P717, DOI 10.1016/j.jacc.2003.08.061; Huang YN, 1997, NEUROLOGY, V48, P524, DOI 10.1212/WNL.48.2.524; Huxley RR, 2011, CIRCULATION, V124, P2056, DOI 10.1161/CIRCULATIONAHA.111.028373; Kim Jong S, 2005, J Clin Neurol, V1, P1, DOI 10.3988/jcn.2005.1.1.1; Maron DJ, 2000, AM J CARDIOL, V86, p11L; Navab M, 2009, J LIPID RES, V50, pS145, DOI 10.1194/jlr.R800036-JLR200; Nederkoorn PJ, 2002, AM J NEURORADIOL, V23, P1779; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Park JH, 2011, STROKE, V42, P3040, DOI 10.1161/STROKEAHA.111.620104; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; SACCO RL, 1995, NEUROLOGY, V45, P659, DOI 10.1212/WNL.45.4.659; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Smith JD, 2010, ARTERIOSCL THROM VAS, V30, P151, DOI 10.1161/ATVBAHA.108.179226; Soyama Y, 2003, STROKE, V34, P863, DOI 10.1161/01.STR.0000060869.34009.38; Suri MFK, 2009, J NEUROIMAGING, V19, p11S, DOI 10.1111/j.1552-6569.2009.00415.x; Wannamethee SG, 2000, STROKE, V31, P1882, DOI 10.1161/01.STR.31.8.1882; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Zhao WH, 2007, BIOMED ENVIRON SCI, V20, P329	32	25	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64395	10.1371/journal.pone.0064395	http://dx.doi.org/10.1371/journal.pone.0064395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691210	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900097
J	Thorsing, M; Klitgaard, JK; Atilano, ML; Skov, MN; Kolmos, HJ; Filipe, SR; Kallipolitis, BH				Thorsing, Mette; Klitgaard, Janne K.; Atilano, Magda L.; Skov, Marianne N.; Kolmos, Hans Jorn; Filipe, Sergio R.; Kallipolitis, Birgitte H.			Thioridazine Induces Major Changes in Global Gene Expression and Cell Wall Composition in Methicillin-Resistant Staphylococcus aureus USA300	PLOS ONE			English	Article							LACTAM ANTIBIOTIC-RESISTANCE; PEPTIDOGLYCAN COMPOSITION; CROSS-LINKING; MYCOBACTERIUM-TUBERCULOSIS; PHENOTHIAZINE-DERIVATIVES; MEMBRANE; MUTANT; BIOSYNTHESIS; PHOSPHATIDYLCHOLINE; TRIFLUOPERAZINE	Subinhibitory concentrations of the neuroleptic drug thioridazine (TDZ) are well-known to enhance the killing of methicillin-resistant Staphylococcus aureus (MRSA) by beta-lactam antibiotics, however, the mechanism underlying the synergy between TDZ and beta-lactams is not fully understood. In the present study, we have examined the effect of a subinhibitory concentration of TDZ on antimicrobial resistance, the global transcriptome, and the cell wall composition of MRSA USA300. We show that TDZ is able to sensitize the bacteria to several classes of antimicrobials targeting the late stages of peptidoglycan (PGN) synthesis. Furthermore, our microarray analysis demonstrates that TDZ modulates the expression of genes encoding membrane and surface proteins, transporters, and enzymes involved in amino acid biosynthesis. Interestingly, resemblance between the transcriptional profile of TDZ treatment and the transcriptomic response of S. aureus to known inhibitors of cell wall synthesis suggests that TDZ disturbs PGN biosynthesis at a stage that precedes transpeptidation by penicillin-binding proteins (PBPs). In support of this notion, dramatic changes in the muropeptide profile of USA300 were observed following growth in the presence of TDZ, indicating that TDZ can interfere with the formation of the pentaglycine branches. Strikingly, the addition of glycine to the growth medium relieved the effect of TDZ on the muropeptide profile. Furthermore, exogenous glycine offered a modest protective effect against TDZ-induced beta-lactam sensitivity. We propose that TDZ exposure leads to a shortage of intracellular amino acids, including glycine, which is required for the production of normal PGN precursors with pentaglycine branches, the correct substrate of S. aureus PBPs. Collectively, this work demonstrates that TDZ has a major impact on the cell wall biosynthesis pathway in S. aureus and provides new insights into how MRSA may be sensitized towards beta-lactam antibiotics.	[Thorsing, Mette; Klitgaard, Janne K.; Kallipolitis, Birgitte H.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Klitgaard, Janne K.; Skov, Marianne N.; Kolmos, Hans Jorn] Univ Southern Denmark, Dept Clin Res, Res Unit Clin Microbiol, Odense, Denmark; [Atilano, Magda L.; Filipe, Sergio R.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Surfaces & Pathogenesis, Oeiras, Portugal	University of Southern Denmark; University of Southern Denmark; Universidade Nova de Lisboa	Kallipolitis, BH (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.	bhk@bmb.sdu.dk	Klitgaard, Janne Kudsk/F-8952-2010; Filipe, Sergio Raposo/B-9167-2008	Klitgaard, Janne Kudsk/0000-0001-5255-2980; Filipe, Sergio Raposo/0000-0002-4485-832X; Kallipolitis, Birgitte H./0000-0003-1233-9776; Skov, Marianne Nielsine/0000-0002-2619-0864; Atilano, Magda/0000-0002-3819-2023	Lundbeck Foundation [R32-A2819]; Aase & Ejnar Danielsens Foundation; Brodrene Hartmanns Foundation; Fundacao para a Ciencia e Tecnologia [PEst-OE/EQB/LA0004/2011, PTDC/BIA- MIC/100747/2008]; Lundbeck Foundation [R32-2008-2819] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Aase & Ejnar Danielsens Foundation; Brodrene Hartmanns Foundation; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Lundbeck Foundation(Lundbeckfonden)	Work in BHK's laboratory was funded by The Lundbeck Foundation (grant no. R32-A2819), Aase & Ejnar Danielsens Foundation and Brodrene Hartmanns Foundation. Work in SRF's laboratory was funded by Fundacao para a Ciencia e Tecnologia'' through research grant PEst-OE/EQB/LA0004/2011 and PTDC/BIA- MIC/100747/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral L, 2004, IN VIVO, V18, P725; Antignac A, 2007, J BACTERIOL, V189, P7573, DOI 10.1128/JB.01048-07; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Berger-Bachi B, 2002, ARCH MICROBIOL, V178, P165, DOI 10.1007/s00203-002-0436-0; Bernal P, 2010, J BIOL CHEM, V285, P24055, DOI 10.1074/jbc.M110.114793; Bonde M, 2011, FEMS MICROBIOL LETT, V318, P168, DOI 10.1111/j.1574-6968.2011.02255.x; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; deJonge BLM, 1996, ANTIMICROB AGENTS CH, V40, P1498, DOI 10.1128/AAC.40.6.1498; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Dengler V, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-16; ENYEART JJ, 1992, MOL PHARMACOL, V42, P364; Farha MA, 2013, ACS CHEM BIOL, V8, P226, DOI 10.1021/cb300413m; Felden B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002006; Filipe SR, 2005, EMBO REP, V6, P327, DOI 10.1038/sj.embor.7400371; FORDHAM WD, 1974, J BIOL CHEM, V249, P2478; FRENZEL J, 1978, BIOCHIM BIOPHYS ACTA, V507, P185, DOI 10.1016/0005-2736(78)90415-7; Fujimura T, 2008, ANTIMICROB AGENTS CH, V52, P643, DOI 10.1128/AAC.00395-07; Gardete S, 2004, J BACTERIOL, V186, P1705, DOI 10.1128/JB.186.6.1705-1713.2004; Giannouli S, 2009, BIOCHIMIE, V91, P344, DOI 10.1016/j.biochi.2008.10.009; GUSTAFSON JE, 1992, ANTIMICROB AGENTS CH, V36, P566, DOI 10.1128/AAC.36.3.566; Hendrich AB, 2002, CELL MOL BIOL LETT, V7, P1081; Hendrich AB, 2001, BBA-BIOMEMBRANES, V1510, P414, DOI 10.1016/S0005-2736(00)00373-4; Hendricks O, 2005, BASIC CLIN PHARMACOL, V96, P33, DOI 10.1111/j.1742-7843.2005.pto960105.x; HENKIN TM, 1992, J BACTERIOL, V174, P1299, DOI 10.1128/jb.174.4.1299-1306.1992; HOLMSEN H, 1984, THROMB RES, V36, P419, DOI 10.1016/0049-3848(84)90298-6; HOLMSEN H, 1990, BIOCHEM PHARMACOL, V40, P373, DOI 10.1016/0006-2952(90)90701-L; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jenkins RE, 2012, J ANTIMICROB CHEMOTH, V67, P1405, DOI 10.1093/jac/dks071; Jung H, 2006, J MEMBRANE BIOL, V213, P119, DOI 10.1007/s00232-006-0880-x; Kaatz GW, 2003, ANTIMICROB AGENTS CH, V47, P719, DOI 10.1128/AAC.47.2.719-726.2003; Kim KS, 2005, DRUG CHEM TOXICOL, V28, P303, DOI 10.1081/DCT-200064482; Klitgaard JK, 2008, J ANTIMICROB CHEMOTH, V62, P1215, DOI 10.1093/jac/dkn417; Kohler C, 2005, INT J MED MICROBIOL, V295, P547, DOI 10.1016/j.ijmm.2005.08.002; Koyama N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048981; KRISTIANSEN JEH, 1982, BIOCHIM BIOPHYS ACTA, V685, P379, DOI 10.1016/0005-2736(82)90079-7; Kristiansen MM, 2006, IN VIVO, V20, P361; Kuroda H, 2007, FEMS MICROBIOL LETT, V268, P98, DOI 10.1111/j.1574-6968.2006.00568.x; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Lama A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034037; Lee SH, 2011, CHEM BIOL, V18, P1379, DOI 10.1016/j.chembiol.2011.08.015; Leski TA, 2005, J BACTERIOL, V187, P1815, DOI 10.1128/JB.187.5.1815-1824.2005; Liebeke M, 2011, MOL BIOSYST, V7, P1241, DOI 10.1039/c0mb00315h; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; Moncelli MR, 1996, BIOELECTROCH BIOENER, V39, P227, DOI 10.1016/0302-4598(95)01880-8; Mongkolrattanothai K, 2003, CLIN INFECT DIS, V37, P1050, DOI 10.1086/378277; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Nagappa A, 2005, COLLOID SURFACE B, V43, P21, DOI 10.1016/j.colsurfb.2005.04.001; Nerdal W, 2000, BBA-BIOMEMBRANES, V1464, P165, DOI 10.1016/S0005-2736(00)00125-5; Nimmo GR, 2012, CLIN MICROBIOL INFEC, V18, P725, DOI 10.1111/j.1469-0691.2012.03822.x; O'Neill AJ, 2009, ANTIMICROB AGENTS CH, V53, P1701, DOI 10.1128/AAC.01309-08; Ordway D, 2002, INT J ANTIMICROB AG, V20, P34, DOI 10.1016/S0924-8579(02)00110-3; ORNELASSOARES A, 1994, J BIOL CHEM, V269, P27246; ORNELASSOARES A, 1993, J BIOL CHEM, V268, P26268; Pannee J, 2013, J ALZHEIMERS DIS, V33, P1021, DOI 10.3233/JAD-2012-121471; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Poulsen MO, 2013, RES MICROBIOL, V164, P181, DOI 10.1016/j.resmic.2012.10.007; Rahbar M, 2010, BASIC CLIN PHARMACOL, V107, P676, DOI 10.1111/j.1742-7843.2010.00558.x; RATNAKAR P, 1993, FEMS MICROBIOL LETT, V110, P291, DOI 10.1111/j.1574-6968.1993.tb06337.x; Reed P, 2011, J BACTERIOL, V193, P2549, DOI 10.1128/JB.01474-10; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Rohrer S, 1999, P NATL ACAD SCI USA, V96, P9351, DOI 10.1073/pnas.96.16.9351; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Sieradzki K, 1997, J ANTIMICROB CHEMOTH, V39, P47, DOI 10.1093/jac/39.suppl_1.47; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sobral RG, 2006, J BACTERIOL, V188, P2543, DOI 10.1128/JB.188.7.2543-2553.2006; Sobral RG, 2003, MICROB DRUG RESIST, V9, P231, DOI 10.1089/107662903322286436; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Stapleton PD, 2004, INT J ANTIMICROB AG, V23, P462, DOI 10.1016/j.ijantimicag.2003.09.027; Stranden AM, 1997, J BACTERIOL, V179, P9, DOI 10.1128/jb.179.1.9-16.1997; SUGAI M, 1990, J BACTERIOL, V172, P6494, DOI 10.1128/jb.172.11.6494-6498.1990; Thanacoody HKR, 2007, BRIT J CLIN PHARMACO, V64, P566, DOI 10.1111/j.1365-2125.2007.03021.x; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Weinstein EA, 2005, P NATL ACAD SCI USA, V102, P4548, DOI 10.1073/pnas.0500469102; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Williams JB, 2004, SCHIZOPHR RES, V71, P103, DOI 10.1016/j.schres.2004.01.013; Yam TS, 1998, J ANTIMICROB CHEMOTH, V42, P211, DOI 10.1093/jac/42.2.211; Yao XY, 2012, ANTIMICROB AGENTS CH, V56, P83, DOI 10.1128/AAC.05415-11	90	33	34	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64518	10.1371/journal.pone.0064518	http://dx.doi.org/10.1371/journal.pone.0064518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691239	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900106
J	van Beers, RJ; van der Meer, Y; Veerman, RM				van Beers, Robert J.; van der Meer, Yor; Veerman, Richard M.			What Autocorrelation Tells Us about Motor Variability: Insights from Dart Throwing	PLOS ONE			English	Article							SIGNAL-DEPENDENT NOISE; MOVEMENT VARIABILITY; TASK; EXECUTION; PERFORMANCE; PLAYERS	In sports such as golf and darts it is important that one can produce ballistic movements of an object towards a goal location with as little variability as possible. A factor that influences this variability is the extent to which motor planning is updated from movement to movement based on observed errors. Previous work has shown that for reaching movements, our motor system uses the learning rate (the proportion of an error that is corrected for in the planning of the next movement) that is optimal for minimizing the endpoint variability. Here we examined whether the learning rate is hard-wired and therefore automatically optimal, or whether it is optimized through experience. We compared the performance of experienced dart players and beginners in a dart task. A hallmark of the optimal learning rate is that the lag-1 autocorrelation of movement endpoints is zero. We found that the lag-1 autocorrelation of experienced dart players was near zero, implying a near-optimal learning rate, whereas it was negative for beginners, suggesting a larger than optimal learning rate. We conclude that learning rates for trial-by-trial motor learning are optimized through experience. This study also highlights the usefulness of the lag-1 autocorrelation as an index of performance in studying motor-skill learning.	[van Beers, Robert J.; van der Meer, Yor; Veerman, Richard M.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Beers, RJ (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	r.j.van.beers@vu.nl	van Beers, Robert J/R-7248-2018	van Beers, Robert J/0000-0003-3847-8918	Netherlands Organisation for Scientific Research (NWO) [453-08-004]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Netherlands Organisation for Scientific Research (http://www.nwo.nl/, NWO Grant 453-08-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arutiunian G A, 1968, Biofizika, V13, P536; ARUTYUNYAN GA, 1969, BIOPHYS-USSR, V14, P1162; Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; BEGGS WDA, 1972, Q J EXP PSYCHOL, V24, P448, DOI 10.1080/14640747208400304; BOOTSMA RJ, 1990, J EXP PSYCHOL HUMAN, V16, P21, DOI 10.1037/0096-1523.16.1.21; Bradshaw EJ, 2009, RES Q EXERCISE SPORT, V80, P185, DOI 10.1080/02701367.2009.10599552; Button C, 2003, RES Q EXERCISE SPORT, V74, P257, DOI 10.1080/02701367.2003.10609090; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; DARLING WG, 1987, J MOTOR BEHAV, V19, P291; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fleisig G, 2009, SPORT BIOMECH, V8, P10, DOI 10.1080/14763140802629958; Glazier P, 2011, RES Q EXERCISE SPORT, V82, P157; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Kluger AN, 1996, PSYCHOL BULL, V119, P254, DOI 10.1037/0033-2909.119.2.254; Kudo K, 2000, J MOTOR BEHAV, V32, P337, DOI 10.1080/00222890009601384; Langdown BL, 2012, SPORT BIOMECH, V11, P273, DOI 10.1080/14763141.2011.650187; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; MARSHALL RJ, 1980, BIOMETRIKA, V67, P567; MCDONALD PV, 1989, J MOTOR BEHAV, V21, P245; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; Muller H, 1999, J HUM MOVEMENT STUD, V36, P103; Newell K. M., 2006, MOVEMENT SYSTEM VARI, P3; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schorer J, 2012, EXP BRAIN RES, V217, P287, DOI 10.1007/s00221-011-2992-5; Schorer J, 2007, J MOTOR BEHAV, V39, P409, DOI 10.3200/JMBR.39.5.409-422; Shmuelof L, 2011, NEURON, V72, P469, DOI 10.1016/j.neuron.2011.10.017; Smeets JBJ, 2002, EXP BRAIN RES, V144, P268, DOI 10.1007/s00221-002-1072-2; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2013, J NEUROPHYSIOL, V109, P969, DOI 10.1152/jn.00706.2012; van Beers RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049373; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van Beers RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002070; VEREIJKEN B, 1992, J MOTOR BEHAV, V24, P133, DOI 10.1080/00222895.1992.9941608	39	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64332	10.1371/journal.pone.0064332	http://dx.doi.org/10.1371/journal.pone.0064332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RJ	23691199	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900094
J	Zhang, ZY; Hong, Y; Gao, J; Xiao, SJ; Ma, JW; Zhang, WC; Ren, J; Huang, LS				Zhang, Zhiyan; Hong, Yuan; Gao, Jun; Xiao, Shijun; Ma, Junwu; Zhang, Wanchang; Ren, Jun; Huang, Lusheng			Genome-Wide Association Study Reveals Constant and Specific Loci for Hematological Traits at Three Time Stages in a White Duroc x Erhualian F-2 Resource Population	PLOS ONE			English	Article							BLOOD-CELL; COAT COLOR; PARAMETERS; CHROMOSOME; PLATELET; INFORMATION; LINKAGE; MODEL; SET	Hematological traits are important indicators of immune function and have been commonly examined as biomarkers of disease and disease severity in humans. Pig is an ideal biomedical model for human diseases due to its high degree of similarity with human physiological characteristics. Here, we conducted genome-wide association studies (GWAS) for 18 hematological traits at three growth stages (days 18, 46 and 240) in a White Duroc x Erhualian F-2 intercross. In total, we identified 38 genome-wide significant regions containing 185 genome-wide significant SNPs by single-marker GWAS or LONG-GWAS. The significant regions are distributed on pig chromosomes (SSC) 1, 4, 5, 7, 8, 10, 11, 12, 13, 17 and 18, and most of significant SNPs reside on SSC7 and SSC8. Of the 38 significant regions, 7 show constant effects on hematological traits across the whole life stages, and 6 regions have time-specific effects on the measured traits at early or late stages. The most prominent locus is the genomic region between 32.36 and 84.49 Mb on SSC8 that is associated with multiple erythroid traits. The KIT gene in this region appears to be a promising candidate gene. The findings improve our understanding of the genetic architecture of hematological traits in pigs. Further investigations are warranted to characterize the responsible gene(s) and causal variant(s) especially for the major loci on SSC7 and SSC8.	[Ren, Jun] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Ren, J (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	renjunjxau@hotmail.com; lushenghuang@hotmail.com	Ren, Jun/H-9793-2019		Program for Innovative Research Team of the Ministry of Agriculture of China; Program for Changjiang Scholars and Innovative Research Team in University [IRT1136]	Program for Innovative Research Team of the Ministry of Agriculture of China; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Program for Innovative Research Team of the Ministry of Agriculture of China and Program for Changjiang Scholars and Innovative Research Team in University (IRT1136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Cho IC, 2011, ANIM GENET, V42, P621, DOI 10.1111/j.1365-2052.2011.02204.x; Druet T, 2011, GENETICS, V188, P409, DOI 10.1534/genetics.111.127720; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Dupuis J, 1999, GENETICS, V151, P373; EDFORSLILJA I, 1994, VET IMMUNOL IMMUNOP, V40, P1, DOI 10.1016/0165-2427(94)90011-6; Eding H, 2001, J ANIM BREED GENET, V118, P141, DOI 10.1046/j.1439-0388.2001.00290.x; Escribano L, 1998, LEUKEMIA LYMPHOMA, V30, P459, DOI 10.3109/10428199809057558; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Fesus L, 2005, J ANIM BREED GENET, V122, P127, DOI 10.1111/j.1439-0388.2005.00504.x; Furlotte NA, 2012, GENET EPIDEMIOL, V36, P463, DOI 10.1002/gepi.21640; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Garner C, 2000, BLOOD, V95, P342; Guo Y, 2009, ANIM GENET, V40, P47, DOI 10.1111/j.1365-2052.2008.01802.x; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Hayes BJ, 2008, J ANIM SCI, V86, P2089, DOI 10.2527/jas.2007-0733; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Jackson IJ, 2006, PIGMENT CELL RES, V7, P73; Johansson A, 2005, ANIM GENET, V36, P288, DOI 10.1111/j.1365-2052.2005.01320.x; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Luo WZ, 2012, INT J BIOL SCI, V8, P870, DOI 10.7150/ijbs.4027; Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Sakurai M, 1996, MAMM GENOME, V7, P397, DOI 10.1007/BF03035316; Sartelet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002581; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Soranzo N, 2009, BLOOD, V113, P3831, DOI 10.1182/blood-2008-10-184234; TULLIS JL, 1952, BLOOD, V7, P891, DOI 10.1182/blood.V7.9.891.891; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Wang JY, 2013, ANIM GENET, V44, P34, DOI 10.1111/j.1365-2052.2012.02366.x; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang S, 2009, ANIM GENET, V40, P273, DOI 10.1111/j.1365-2052.2008.01830.x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zou ZZ, 2008, MAMM GENOME, V19, P640, DOI 10.1007/s00335-008-9142-9	40	23	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63665	10.1371/journal.pone.0063665	http://dx.doi.org/10.1371/journal.pone.0063665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691082	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107900052
J	Raw, JL; Miranda, NAF; Perissinotto, R				Raw, Jacqueline L.; Miranda, Nelson A. F.; Perissinotto, Renzo			Chemical Cues Released by an Alien Invasive Aquatic Gastropod Drive Its Invasion Success	PLOS ONE			English	Article							INTERFERENCE COMPETITION; AVOIDANCE-RESPONSE; SOUTH-AFRICA; ECOLOGY; HABITATS; COMMUNICATION; MECHANISMS; THIARIDAE; MOLLUSCA; BEHAVIOR	Background: Chemical cues provide aquatic organisms with sensory information that guides behavioural responses and thus interactions among themselves, each other and the environment. Chemical cues are considered important for predator avoidance, foraging, larval settlement and broadcast spawning in aquatic environments. However, the significance of their role as drivers of direct interactions between heterospecifics has been largely overlooked. Methodology/Principal Findings: A video camera and a demarcated arena were used in situ to record behavioural responses of three native gastropod species, Assiminea cf. capensis, Melanoides tuberculata and Coriandria durbanensis, exposed to treatments representing chemical cues released by a non-native invasive gastropod, Tarebia granifera. The responses were measured quantitatively as displacement and orientation of movement at locations in St Lucia Estuary, within the iSimangaliso Wetland Park, a UNESCO World Heritage Site on the east coast of South Africa. All native gastropods exhibited a negative taxis response to chemical cues released by T. granifera, while T. granifera individuals responded randomly to conspecifics. Displacement was measured relative to the source of the extract, the number of steps taken were determined with path analysis and orientation was determined from the mean (+/- 95% CIs) turning angles, with significant negative turning angles representing negative taxis. Responses to treatments corresponding to the environment and conspecifics were random and undirected, indicating kinesis. Conclusion/Significance: This study presents evidence for interactions driven by chemical cues between a non-native invasive gastropod and several gastropods native to South Africa. The results indicate that chemical cues can facilitate invasion success as the behavioural response of native gastropods is to move away allowing additional food and space resources to become available to T. granifera.	[Raw, Jacqueline L.; Miranda, Nelson A. F.; Perissinotto, Renzo] Univ KwaZulu Natal, Sch Life Sci, Durban, Kwazulu Natal, South Africa	University of Kwazulu Natal	Perissinotto, R (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Durban, Kwazulu Natal, South Africa.	perissinottor@ukzn.ac.za	Miranda, Nelson/H-9349-2013; Raw, Jacqueline/AAS-5664-2020	Miranda, Nelson/0000-0002-9308-6688; Raw, Jacqueline/0000-0002-5270-032X	National Research Foundation (NRF), South Africa; South African Netherlands Research Programme on Alternatives in Development (SANPAD); World Wide Fund for Nature (WWF); iSimangaliso Park Authority; Ezemvelo KZN Wildlife	National Research Foundation (NRF), South Africa(National Research Foundation - South Africa); South African Netherlands Research Programme on Alternatives in Development (SANPAD); World Wide Fund for Nature (WWF); iSimangaliso Park Authority; Ezemvelo KZN Wildlife	This project was funded by the National Research Foundation (NRF), South Africa; the South African Netherlands Research Programme on Alternatives in Development (SANPAD) and the World Wide Fund for Nature (WWF). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank the iSimangaliso Park Authority and Ezemvelo KZN Wildlife for supporting this project. Special thanks go to R. Taylor, S. Kyle, C. Fox and S. Mfeka for their invaluable assistance in the field.	Allstadt A, 2012, J THEOR BIOL, V306, P46, DOI 10.1016/j.jtbi.2012.04.017; Appleton C. C., 2009, Zoologische Mededelingen (Leiden), V83, P525; BENHAMOU S, 1992, ANIM BEHAV, V43, P371, DOI 10.1016/S0003-3472(05)80097-1; BOLTT RE, 1975, T ROY SOC S AFR, V41, P295, DOI 10.1080/00359197509519445; Bourdeau PE, 2010, OECOLOGIA, V162, P987, DOI 10.1007/s00442-009-1488-5; Burks RL, 2002, J CHEM ECOL, V28, P1901, DOI 10.1023/A:1020785525081; Byers JE, 2000, MAR ECOL PROG SER, V203, P123, DOI 10.3354/meps203123; Carazo P, 2010, J EVOLUTION BIOL, V23, P661, DOI 10.1111/j.1420-9101.2010.01944.x; Carr WES, 1988, SENSORY BIOL AQUATIC; CROLL RP, 1983, BIOL REV, V58, P293, DOI 10.1111/j.1469-185X.1983.tb00391.x; Dalesman S, 2010, ANIM BEHAV, V79, P173, DOI 10.1016/j.anbehav.2009.10.024; de Kock KN, 2009, WATER SA, V35, P713; Dicke M, 1988, FUNCT ECOL, V2, P131, DOI 10.2307/2389687; Doi H, 2006, BASIC APPL ECOL, V7, P153, DOI 10.1016/j.baae.2005.04.009; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; Fink P, 2007, MAR FRESHW BEHAV PHY, V40, P155, DOI 10.1080/10236240701602218; Gherardi F, 2004, BEHAVIOUR, V141, P1297, DOI 10.1163/1568539042729702; Grason EW, 2012, OECOLOGIA, V169, P105, DOI 10.1007/s00442-011-2188-5; Hart SP, 2012, OIKOS, V121, P396, DOI 10.1111/j.1600-0706.2011.19557.x; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Hay ME, 1996, J EXP MAR BIOL ECOL, V200, P103, DOI 10.1016/S0022-0981(96)02659-7; Hebert D, 2011, ALIEN INVASIVE ANIMA; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Ingvarsdottir A, 2002, PEST MANAG SCI, V58, P537, DOI 10.1002/ps.510; Jacobsen HP, 2004, OIKOS, V104, P43, DOI 10.1111/j.0030-1299.2004.12369.x; Klose K, 2011, INVERTEBR BIOL, V130, P226, DOI 10.1111/j.1744-7410.2011.00232.x; Lockwood JL, 2007, INVASION ECOLOGY; MacKay F, 2010, ESTUAR COAST SHELF S, V86, P553, DOI 10.1016/j.ecss.2009.11.011; MARLER P, 1967, SCIENCE, V157, P769, DOI 10.1126/science.157.3790.769; Miranda NAF, 2010, S AFR J SCI, V106, P55, DOI 10.4102/sajs.v106i3/4.156; Miranda NAF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031897; Miranda NAF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024337; Pires A, 2000, BIOL BULL-US, V198, P319, DOI 10.2307/1542688; Pizzatto L, 2009, AUSTRAL ECOL, V34, P77, DOI 10.1111/j.1442-9993.2008.01886.x; Rehage JS, 2005, BEHAV ECOL SOCIOBIOL, V57, P256, DOI 10.1007/s00265-004-0850-1; Scott-Phillips TC, 2008, J EVOLUTION BIOL, V21, P387, DOI 10.1111/j.1420-9101.2007.01497.x; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Taylor R, 2006, ENVIRON GEOL, V49, P586, DOI 10.1007/s00254-005-0095-y; Taylor Ricky, 2006, African Journal of Aquatic Science, V31, P31, DOI 10.2989/16085910609503869; TILMAN D, 1987, AM NAT, V129, P769, DOI 10.1086/284672; WILSON EO, 1963, RECENT PROG HORM RES, V19, P673; Wollerman L, 2003, MAR FRESHW BEHAV PHY, V36, P129, DOI 10.1080/10236240310001603756	43	21	21	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64071	10.1371/journal.pone.0064071	http://dx.doi.org/10.1371/journal.pone.0064071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691151	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700076
J	Wang, DZ; Zhang, YJ; Zhang, SF; Lin, L; Hong, HS				Wang, Da-Zhi; Zhang, Ying-Jiao; Zhang, Shu-Fei; Lin, Lin; Hong, Hua-Sheng			Quantitative Proteomic Analysis of Cell Cycle of the Dinoflagellate Prorocentrum donghaiense (Dinophyceae)	PLOS ONE			English	Article							ALEXANDRIUM-CATENELLA DINOPHYCEAE; NUCLEAR ANTIGEN GENE; BOX RNA HELICASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ESCHERICHIA-COLI; OXIDATIVE STRESS; CRYPTHECODINIUM-COHNII; TRANSLATIONAL CONTROL; PROLIFERATING CELLS; KARENIA-BREVIS	Dinoflagellates are the major causative agents of harmful algal blooms in the coastal zone, which has resulted in adverse effects on the marine ecosystem and public health, and has become a global concern. Knowledge of cell cycle regulation in proliferating cells is essential for understanding bloom dynamics, and so this study compared the protein profiles of Prorocentrum donghaiense at different cell cycle phases and identified differentially expressed proteins using 2-D fluorescence difference gel electrophoresis combined with MALDI-TOF-TOF mass spectrometry. The results showed that the synchronized cells of P. donghaiense completed a cell cycle within 24 hours and cell division was phased with the diurnal cycle. Comparison of the protein profiles at four cell cycle phases (G1, S, early and late G2/M) showed that 53 protein spots altered significantly in abundance. Among them, 41 were identified to be involved in a variety of biological processes, e. g. cell cycle and division, RNA metabolism, protein and amino acid metabolism, energy and carbon metabolism, oxidation-reduction processes, and ABC transport. The periodic expression of these proteins was critical to maintain the proper order and function of the cell cycle. This study, to our knowledge, for the first time revealed the major biological processes occurring at different cell cycle phases which provided new insights into the mechanisms regulating the cell cycle and growth of dinoflagellates.	[Wang, Da-Zhi; Zhang, Ying-Jiao; Zhang, Shu-Fei; Lin, Lin; Hong, Hua-Sheng] Xiamen Univ, Coll Environm & Ecol, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Xiamen University	Wang, DZ (corresponding author), Xiamen Univ, Coll Environm & Ecol, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	dzwang@xmu.edu.cn	HUANG, Shuiying/C-3117-2014		Ministry of Science and Technology of the People's Republic of China [2010CB428703, 2011CB111500]; National Natural Science Foundation of China [41230961]; Excellent Group; Program for New Century Excellent Talents in University	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Group; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was partially supported by research grants from the Ministry of Science and Technology of the People's Republic of China (Project No. 2010CB428703 and 2011CB111500), the National Natural Science Foundation of China (41230961), the Excellent Group and the Program for New Century Excellent Talents in University to D.-Z. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyi S, 2008, INFECT GENET EVOL, V8, P205, DOI 10.1016/j.meegid.2007.10.003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Aubourg S, 1999, NUCLEIC ACIDS RES, V27, P628, DOI 10.1093/nar/27.2.628; Barbier M, 2003, J EUKARYOT MICROBIOL, V50, P123, DOI 10.1111/j.1550-7408.2003.tb00246.x; Barbosa MS, 2006, INFECT IMMUN, V74, P382, DOI 10.1128/IAI.74.1.382-389.2006; Barcelo-Batllori S, 2008, MOL CELL PROTEOMICS, V7, P378, DOI 10.1074/mcp.M700198-MCP200; Bertomeu T, 2004, BIOCHEM BIOPH RES CO, V323, P1172, DOI 10.1016/j.bbrc.2004.09.008; Bhaud Y, 2000, J CELL SCI, V113, P1231; BRAVO R, 1980, J CELL BIOL, V84, P795, DOI 10.1083/jcb.84.3.795; Brown PJB, 2009, ADV MICROB PHYSIOL, V54, P1, DOI 10.1016/S0065-2911(08)00001-5; Brunelle SA, 2011, J EUKARYOT MICROBIOL, V58, P373, DOI 10.1111/j.1550-7408.2011.00560.x; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Chan KL, 2002, APPL ENVIRON MICROB, V68, P2278, DOI 10.1128/AEM.68.5.2278-2284.2002; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Czarna M, 2010, PROTEOMICS, V10, P6, DOI 10.1002/pmic.200900352; Daga RR, 1999, J CELL SCI, V112, P3137; Dean M, 2001, J LIPID RES, V42, P1007; Dolah FV, 2000, SEAFOOD FRESHWATER T, P19; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; Fisher RP, 1997, CURR OPIN GENET DEV, V7, P32, DOI 10.1016/S0959-437X(97)80106-2; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; GERACI JR, 1989, CAN J FISH AQUAT SCI, V46, P1895, DOI 10.1139/f89-238; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098; Hallegraeff G, 2005, MANUAL HARMFUL MARIN, P25; Harlow LD, 2007, PHYCOLOGIA, V46, P666, DOI 10.2216/07-25.1; Harlow LD, 2007, PHYCOLOGIA, V46, P46, DOI 10.2216/06-28.1; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; Hohfeld I, 1998, PROTIST, V149, P75, DOI 10.1016/S1434-4610(98)70011-2; Huang JA, 2010, ACTA OCEANOL SIN, V29, P90, DOI 10.1007/s13131-010-0040-0; Imamura O, 1998, NUCLEIC ACIDS RES, V26, P2063, DOI 10.1093/nar/26.9.2063; Jenal U, 2009, RES MICROBIOL, V160, P687, DOI 10.1016/j.resmic.2009.09.006; KELLER MD, 1987, J PHYCOL, V23, P633; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Lai MC, 2010, MOL CELL BIOL, V30, P5444, DOI 10.1128/MCB.00560-10; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; Lam CMC, 2001, J PHYCOL, V37, P79, DOI 10.1046/j.1529-8817.2001.037001079.x; Landsberg J.H., 1998, HARMFUL ALGAE, P97; Larkum T, 1997, ADV BOT RES, V27, P257; Lin SJ, 2011, RES MICROBIOL, V162, P551, DOI 10.1016/j.resmic.2011.04.006; LIN SJ, 1995, J PHYCOL, V31, P388, DOI 10.1111/j.0022-3646.1995.00388.x; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Liu HY, 2002, J BIOL CHEM, V277, P2637, DOI 10.1074/jbc.M109016200; Liu JW, 2005, J APPL PHYCOL, V17, P323, DOI 10.1007/s10811-005-5943-3; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MIYACHI K, 1978, J IMMUNOL, V121, P2228; Naryzhny SN, 2005, J BIOL CHEM, V280, P13888, DOI 10.1074/jbc.M500304200; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Reichheld JP, 1999, PLANT J, V17, P647, DOI 10.1046/j.1365-313X.1999.00413.x; ROBINSON EA, 1974, J BIOL CHEM, V249, P5088; Rothfield L, 1999, ANNU REV GENET, V33, P423, DOI 10.1146/annurev.genet.33.1.423; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Soyer-Gobillard M, 2009, ENCY MICROBIOLOGY, P617; Spector D.L., 1984, P107; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Stucki M, 2001, PROG NUCLEIC ACID RE, V65, P261; Tannu NS, 2006, NAT PROTOC, V1, P1732, DOI 10.1038/nprot.2006.256; Taroncher-Oldenburg G, 2000, APPL ENVIRON MICROB, V66, P2105, DOI 10.1128/AEM.66.5.2105-2112.2000; THOMAS D, 1988, MOL CELL BIOL, V8, P5132, DOI 10.1128/MCB.8.12.5132; Toulza E, 2010, APPL ENVIRON MICROB, V76, P4521, DOI 10.1128/AEM.02345-09; VANDOLAH FM, 1995, J PHYCOL, V31, P395; Wagner MA, 2009, J BACTERIOL, V191, P1695, DOI 10.1128/JB.01536-08; Wang DZ, 2012, J PROTEOMICS, V75, P5564, DOI 10.1016/j.jprot.2012.08.001; Wang DZ, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/471020; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Wong JTY, 2005, BIOESSAYS, V27, P730, DOI 10.1002/bies.20250; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhao LY, 2009, HYDROBIOLOGIA, V627, P19, DOI 10.1007/s10750-009-9712-1; Zhou M-J, 2003, CHINESE J APPL ECOLO, V14, P1031; Zhou Mingjiang, 2010, P133; Zhuang Y, 2013, HARMFUL ALG IN PRESS	79	93	96	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63659	10.1371/journal.pone.0063659	http://dx.doi.org/10.1371/journal.pone.0063659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691081	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700057
J	Argiles, A; Siwy, J; Duranton, F; Gayrard, N; Dakna, M; Lundin, U; Osaba, L; Delles, C; Mourad, G; Weinberger, KM; Mischak, H				Argiles, Angel; Siwy, Justyna; Duranton, Flore; Gayrard, Nathalie; Dakna, Mohammed; Lundin, Ulrika; Osaba, Lourdes; Delles, Christian; Mourad, Georges; Weinberger, Klaus M.; Mischak, Harald			CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MASS-SPECTROMETRY; URINARY; PROTEIN; BIOMARKERS; DIAGNOSIS	National Kidney Foundation CKD staging has allowed uniformity in studies on CKD. However, early diagnosis and predicting progression to end stage renal disease are yet to be improved. Seventy six patients with different levels of CKD, including outpatients and dialysed patients were studied for transcriptome, metabolome and proteome description. High resolution urinary proteome analysis was blindly performed in the 53 non-anuric out of the 76 CKD patients. In addition to routine clinical parameters, CKD273, a urinary proteomics-based classifier and its peptides were quantified. The baseline values were analyzed with regard to the clinical parameters and the occurrence of death or renal death during follow-up (3.6 years) as the main outcome measurements. None of the patients with CKD273<0.55 required dialysis or died while all fifteen patients that reached an endpoint had a CKD273 score >0.55. Unsupervised clustering analysis of the CKD273 peptides separated the patients into two main groups differing in CKD associated parameters. Among the 273 biomarkers, peptides derived from serum proteins were relatively increased in patients with lower glomerular filtration rate, while collagen-derived peptides were relatively decreased (p<0.05; Spearman). CKD273 was different in the groups with different renal function (p<0.003). The CKD273 classifier separated CKD patients according to their renal function and informed on the likelihood of experiencing adverse outcome. Recently defined in a large population, CKD273 is the first proteomic-based classifier successfully tested for prognosis of CKD progression in an independent cohort.	[Argiles, Angel; Duranton, Flore; Gayrard, Nathalie] RD Nephrol, Montpellier, France; [Argiles, Angel] Nephrol Dialyse St Guilhem, Sete, France; [Argiles, Angel; Mourad, Georges] Serv Nephrol Dialyse Peritoneale & Transplantat, Montpellier, France; [Siwy, Justyna; Dakna, Mohammed; Mischak, Harald] Mosaiques Diagnost & Therapeut AG, Hannover, Germany; [Siwy, Justyna] Charite, D-13353 Berlin, Germany; [Lundin, Ulrika; Weinberger, Klaus M.] Biocrates Life Sci AG, Innsbruck, Austria; [Osaba, Lourdes] Progenika Biopharma SA, Derio, Vizcaya, Spain; [Delles, Christian; Mischak, Harald] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Grifols; University of Glasgow	Mischak, H (corresponding author), Mosaiques Diagnost & Therapeut AG, Hannover, Germany.	mischak@mosaiques-diagnostics.com	gayrard, nathalie/AAO-2888-2020; Duranton, Flore/ABB-6225-2021; Duranton, Flore/A-8373-2015	gayrard, nathalie/0000-0001-8283-8429; Duranton, Flore/0000-0003-3202-0551; Duranton, Flore/0000-0003-3202-0551; Siwy, Justyna/0000-0003-1407-2534; Mischak, Harald/0000-0003-0323-0306; Weinberger, Klaus/0000-0002-8947-5306; Argiles, Angel/0000-0001-7029-4532	Eurotransbio Program of the FP6, of the European Commission; EU through EU-MASCARA [HEALTH-2011-278249]; EU through SysKID [HEALTH-F2-2009-241544]	Eurotransbio Program of the FP6, of the European Commission; EU through EU-MASCARA; EU through SysKID	The project carried out by the UROSYSTEOMICS consortium was partly funded by the Eurotransbio Program of the FP6, of the European Commission. AA and HM are members of the European Uraemic Toxin working group of the European Society of Artificial Organs (ESAO). HM was supported in part by EU Funding through EU-MASCARA (HEALTH-2011-278249) and SysKID (HEALTH-F2-2009-241544). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2000, DIABETES CARE, V23, P281; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fliser D, 2007, J AM SOC NEPHROL, V18, P1057, DOI 10.1681/ASN.2006090956; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; HAMMES MS, 1995, KIDNEY INT, V48, P501, DOI 10.1038/ki.1995.320; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Kolch W, 2005, MASS SPECTROM REV, V24, P959, DOI 10.1002/mas.20051; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Lieske JC, 1997, KIDNEY INT, V51, P679, DOI 10.1038/ki.1997.98; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mendelssohn DC, 2009, AM J KIDNEY DIS, V54, P954, DOI 10.1053/j.ajkd.2009.05.023; Mischak H, 2009, MASS SPECTROM REV, V28, P703, DOI 10.1002/mas.20205; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Neilson EG, 2006, NAT CLIN PRACT NEPHR, V2, P101, DOI 10.1038/ncpneph0093; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Prajczer S, 2010, NEPHROL DIAL TRANSPL, V25, P1896, DOI 10.1093/ndt/gfp748; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; Rossing K, 2008, J AM SOC NEPHROL, V19, P1283, DOI 10.1681/ASN.2007091025; Singh DK, 2009, DIABETES RES CLIN PR, V85, P258, DOI 10.1016/j.diabres.2009.06.022; Snell-Bergeon JK, 2009, DIABETES TECHNOL THE, V11, P1, DOI 10.1089/dia.2008.0040; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; US Renal Data System, 2012, ANN DAT REP; Verstrepen WA, 2001, NEPHROL DIAL TRANSPL, V16, P712, DOI 10.1093/ndt/16.4.712; WELLWOOD JM, 1975, BRIT MED J, V3, P408, DOI 10.1136/bmj.3.5980.408; Wittke S, 2005, AM J TRANSPLANT, V5, P2479, DOI 10.1111/j.1600-6143.2005.01053.x; YU H, 1983, J CLIN PATHOL, V36, P253, DOI 10.1136/jcp.36.3.253	30	101	103	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62837	10.1371/journal.pone.0062837	http://dx.doi.org/10.1371/journal.pone.0062837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690958	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000319107400020
J	Corena-McLeod, M; Walss-Bass, C; Oliveros, A; Villegas, AG; Ceballos, C; Charlesworth, CM; Madden, B; Linser, PJ; Van Ekeris, L; Smith, K; Richelson, E				Corena-McLeod, Maria; Walss-Bass, Consuelo; Oliveros, Alfredo; Villegas, Andres Gordillo; Ceballos, Carolina; Charlesworth, Cristine M.; Madden, Benjamin; Linser, Paul J.; Van Ekeris, Leslie; Smith, Kristin; Richelson, Elliott			New Model of Action for Mood Stabilizers: Phosphoproteome from Rat Pre-Frontal Cortex Synaptoneurosomal Preparations	PLOS ONE			English	Article							MITOCHONDRIAL TRANSPORT; SYNAPTIC VESICLES; BIPOLAR DISORDER; OXIDATIVE-PHOSPHORYLATION; STATISTICAL-MODEL; AXONAL-TRANSPORT; DENDRITIC SPINES; F-ACTIN; PROTEINS; BRAIN	Background: Mitochondrial short and long-range movements are necessary to generate the energy needed for synaptic signaling and plasticity. Therefore, an effective mechanism to transport and anchor mitochondria to pre- and post-synaptic terminals is as important as functional mitochondria in neuronal firing. Mitochondrial movement range is regulated by phosphorylation of cytoskeletal and motor proteins in addition to changes in mitochondrial membrane potential. Movement direction is regulated by serotonin and dopamine levels. However, data on mitochondrial movement defects and their involvement in defective signaling and neuroplasticity in relationship with mood disorders is scarce. We have previously reported the effects of lithium, valproate and a new antipsychotic, paliperidone on protein expression levels at the synaptic level. Hypothesis: Mitochondrial function defects have recently been implicated in schizophrenia and bipolar disorder. We postulate that mood stabilizer treatment has a profound effect on mitochondrial function, synaptic plasticity, mitochondrial migration and direction of movement. Methods: Synaptoneurosomal preparations from rat pre- frontal cortex were obtained after 28 daily intraperitoneal injections of lithium, valproate and paliperidone. Phosphorylated proteins were identified using 2D-DIGE and nano LC-ESI tandem mass spectrometry. Results: Lithium, valproate and paliperidone had a substantial and common effect on the phosphorylation state of specific actin, tubulin and myosin isoforms as well as other proteins associated with neurofilaments. Furthermore, different subunits from complex III and V of the electron transfer chain were heavily phosphorylated by treatment with these drugs indicating selective phosphorylation. Conclusions: Mood stabilizers have an effect on mitochondrial function, mitochondrial movement and the direction of this movement. The implications of these findings will contribute to novel insights regarding clinical treatment and the mode of action of these drugs.	[Corena-McLeod, Maria; Oliveros, Alfredo; Richelson, Elliott] Mayo Clin, Neuropsycopharmacol Lab, Jacksonville, FL 32224 USA; [Walss-Bass, Consuelo] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Villegas, Andres Gordillo] Univ Florida, Coll Med, Hlth Sci Ctr, Dept Med,Div Hematol Oncol, Gainesville, FL USA; [Ceballos, Carolina] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA; [Charlesworth, Cristine M.; Madden, Benjamin] Mayo Clin, Mayo Prote Res Ctr, Rochester, MN USA; [Linser, Paul J.; Van Ekeris, Leslie] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA; [Smith, Kristin] Mayo Clin, Jacksonville, FL 32224 USA	Mayo Clinic; University of Texas System; University of Texas Health San Antonio; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Mayo Clinic; State University System of Florida; University of Florida; Mayo Clinic	Corena-McLeod, M (corresponding author), Mayo Clin, Neuropsycopharmacol Lab, Jacksonville, FL 32224 USA.	pilarcorena@gmail.com	Walss-Bass, Consuelo/K-5702-2015	Walss-Bass, Consuelo/0000-0003-2474-5448	Mayo Foundation; Janssen Ortho McNeil Scientific Affairs	Mayo Foundation; Janssen Ortho McNeil Scientific Affairs	Funding was provided by Mayo Foundation and Janssen Ortho McNeil Scientific Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SM, 2010, BIOORG MED CHEM LETT, V20, P2665, DOI 10.1016/j.bmcl.2010.02.024; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; ARNOLD SE, 1991, P NATL ACAD SCI USA, V88, P10850, DOI 10.1073/pnas.88.23.10850; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Ben-Shachar D, 1999, INT J NEUROPSYCHOPH, V2, P245, DOI 10.1017/S1461145799001649; Ben-Shachar D, 2002, J NEUROCHEM, V83, P1241, DOI 10.1046/j.1471-4159.2002.01263.x; Benitez-King G, 2004, CNS NEUROL DISORD-DR, V3, P515, DOI 10.2174/1568007043336761; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Borcherding DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025537; Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; Brodin L, 1999, PHILOS T R SOC B, V354, P365, DOI 10.1098/rstb.1999.0388; Buckman JF, 2001, J NEUROSCI METH, V104, P165, DOI 10.1016/S0165-0270(00)00340-X; Cai Q, 2011, NEUROSCI RES, V70, P9, DOI 10.1016/j.neures.2011.02.005; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Chen S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002804; COHEN RS, 1985, CELL MOL NEUROBIOL, V5, P271, DOI 10.1007/BF00711012; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Corena-McLeod MD, 2008, BRAIN RES, V1233, P8, DOI 10.1016/j.brainres.2008.07.021; Dahl JR, 2005, PSYCHIAT GENET, V15, P277, DOI 10.1097/00041444-200512000-00010; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Edelman DB, 2011, JOVE-J VIS EXP, DOI 10.3791/2599; El Far O, 2011, J NEUROCHEM, V117, P603, DOI 10.1111/j.1471-4159.2011.07234.x; English JA, 2009, PROTEOMICS, V9, P3368, DOI 10.1002/pmic.200900015; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Frey BN, 2006, J PSYCHIATR NEUROSCI, V31, P326; Fujiyama K, 2003, SYNAPSE, V49, P143, DOI 10.1002/syn.10220; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; GEORGE HJ, 1981, BIOCHEMISTRY-US, V20, P2402, DOI 10.1021/bi00512a006; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; GOZES I, 1981, NATURE, V294, P477, DOI 10.1038/294477a0; GREENGARD P, 1994, ADV SEC MESS PHOSPH, V29, P31; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Johnston-Wilson NL, 2000, MOL PSYCHIATR, V5, P142, DOI 10.1038/sj.mp.4000696; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; LETERRIER JF, 1994, MICROSC RES TECHNIQ, V27, P233, DOI 10.1002/jemt.1070270305; LI X, 1995, CYTOGENET CELL GENET, V71, P301, DOI 10.1159/000134132; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; LINDEN M, 1989, J BIOENERG BIOMEMBR, V21, P507, DOI 10.1007/BF00762522; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Maurer I, 2001, SCHIZOPHR RES, V48, P125, DOI 10.1016/S0920-9964(00)00075-X; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Minamikawa T, 1999, J CELL SCI, V112, P2419; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Morciano M, 2009, J NEUROCHEM, V108, P662, DOI 10.1111/j.1471-4159.2008.05824.x; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; MORRIS RL, 1993, J CELL SCI, V104, P917; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Mukaetova-Ladinska EB, 2002, NEUROSCI LETT, V317, P161, DOI 10.1016/S0304-3940(01)02458-2; Nasrallah HA, 2010, BRAIN RES, V1354, P23, DOI 10.1016/j.brainres.2010.07.075; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicol Scott, 1998, Biochemical Society Transactions, V26, pS110; Pennington K, 2008, MOL PSYCHIATR, V13, P1102, DOI 10.1038/sj.mp.4002098; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Priel A, 2010, J BIOL PHYS, V36, P3, DOI 10.1007/s10867-009-9153-0; Prince JA, 1999, NEUROPSYCHOPHARMACOL, V21, P372, DOI 10.1016/S0893-133X(99)00016-0; Rintoul GL, 2006, J NEUROCHEM, V97, P800, DOI 10.1111/j.1471-4159.2006.03788.x; Rintoul GL, 2003, J NEUROSCI, V23, P7881; RUMBACH L, 1983, J NEUROL SCI, V61, P417, DOI 10.1016/0022-510X(83)90174-0; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Silverman-Gavrila LB, 2009, J NEUROCHEM, V109, P716, DOI 10.1111/j.1471-4159.2009.05973.x; SMITH DF, 1976, BRIT J PHARMACOL, V56, P399, DOI 10.1111/j.1476-5381.1976.tb07449.x; SMYTHE GA, 1979, AUST J BIOL SCI, V32, P329, DOI 10.1071/BI9790329; STAPPENBECK TS, 1994, J BIOL CHEM, V269, P29351; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tilleman K, 2002, PROTEOMICS, V2, P656, DOI 10.1002/1615-9861(200206)2:6<656::AID-PROT656>3.0.CO;2-Z; Turecki G, 2001, MOL PSYCHIATR, V6, P570, DOI 10.1038/sj.mp.4000888; URANOVA NA, 1989, ZH NEVROPATOL PSIKH, V89, P56; Verge B, 2011, EUR PSYCHIAT, V26, P45, DOI 10.1016/j.eurpsy.2010.08.008; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Wagner OI, 2003, J NEUROSCI, V23, P9046; Whatley SA, 1996, NEUROCHEM RES, V21, P995, DOI 10.1007/BF02532409; Whatley SA, 1998, MOL PSYCHIATR, V3, P227, DOI 10.1038/sj.mp.4000375; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zhang WD, 2002, J NEUROSCI RES, V69, P427, DOI 10.1002/jnr.10313; Zhang ZS, 2010, NEURON, V68, P1097, DOI 10.1016/j.neuron.2010.11.035; Zhao S, 2012, J COMP NEUROL	95	23	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e52147	10.1371/journal.pone.0052147	http://dx.doi.org/10.1371/journal.pone.0052147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690912	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400001
J	Morano, JP; Gibson, BA; Altice, FL				Morano, Jamie P.; Gibson, Britton A.; Altice, Frederick L.			The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting	PLOS ONE			English	Article							ADMINISTERED ANTIRETROVIRAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; INFECTED DRUG-USERS; C VIRUS-INFECTION; BUPRENORPHINE/NALOXONE TREATMENT; SUBSTANCE-ABUSE; CARE SETTINGS; UNITED-STATES; HEPATITIS; SERVICES	Introduction: Despite recommendations for generation-based HCV and once lifetime HIV screening, thousands of individuals in the U.S. still remain untested and undiagnosed. This cross-sectional study examines the correlates of HCV and HIV monoinfection and HIV/HCV coinfection in an urban Northeast setting. Methods: Utilizing an electronic database from a mobile medical clinic in New Haven, CT from January 2003 to July 2011, 8,311 individuals underwent structured health assessment and screening for HIV and HCV. Results: HIV [N = 601 (8.0%)] and HCV [N = 753 (10.1%)] infection were identified, and 197 (26.1%) of the 753 with HCV were coinfected with HIV. Both monoinfection and coinfection status were independently correlated with crack cocaine use and increasing age. HIV/HCV coinfection was correlated with men having sex with men (MSM) (AOR = 38.53, p < 0.0080), shooting gallery use (AOR = 3.06, p < 0.0070), and not completing high school (AOR = 2.51, p < 0.0370). HCV monoinfection correlated with health insurance (AOR = 2.16, p < 0.0020), domestic violence (AOR = 1.99, p < 0.0070), and being Hispanic (AOR = 2.63, p < 0.0001), while HIV monoinfection correlated with having had syphilis (AOR = 2.66, p < 0.0001) and being Black (AOR = 1.73, p = 0.0010). Conclusions: Though HIV and HCV share common transmission risk behaviors, independent correlates with viral infection status in an urban Northeast setting are distinct and have important implications for surveillance, healthcare delivery, disease prevention, and clinical care.	[Morano, Jamie P.; Gibson, Britton A.; Altice, Frederick L.] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect,AIDS Program, New Haven, CT 06510 USA; [Altice, Frederick L.] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT USA	Yale University; Yale University	Morano, JP (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect,AIDS Program, New Haven, CT 06510 USA.	jpmorano@alumni.princeton.edu		Gibson, Britton/0000-0003-0058-4272; Altice, Frederick/0000-0002-7860-693X	National Institutes on Drug Abuse for Career Development and Research [K24 DA017072, R01 DA030762, R01 DA029910]; National Institutes of Allergy and Infectious Diseases [T32 A1007517]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072, R01DA029910, R01DA030762] Funding Source: NIH RePORTER	National Institutes on Drug Abuse for Career Development and Research; National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for the study was provided by the National Institutes on Drug Abuse for Career Development (FLA: K24 DA017072) and Research (FLA: R01 DA030762, R01 DA029910) and The National Institutes of Allergy and Infectious Diseases (JPM: T32 A1007517). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 2005, J URBAN HEALTH, V82, P151, DOI 10.1093/jurban/jti016; Altice FL, 2004, CLIN INFECT DIS, V38, pS376, DOI 10.1086/421400; Altice FL, 2007, CLIN INFECT DIS, V45, P770, DOI 10.1086/521166; Altice FL, 2011, JAIDS-J ACQ IMM DEF, V56, pS22, DOI 10.1097/QAI.0b013e318209751e; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; American Public Health Association, 2012, WHY DO WE NEED AFF C; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Baum CF, 2006, STATA J, V6, P590, DOI 10.1177/1536867X0600600412; Bradshaw D, 2013, CURR OPIN INFECT DIS, V26, P66, DOI 10.1097/QCO.0b013e32835c2120; Centers for Disease Control and Prevention, 2011, HIV VIR HEP FACT SHE; Connecticut Department of Public Health, 2012, NEW HAV PEOPL LIV HI; CT Department of Public Health, 2010, EP PROF HIV AIDS HEP; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Heimer R., 1994, AIDS and Public Policy Journal, V9, P59; Hermanstyne KA, 2012, J PUBLIC HEALTH-UK, V34, P330, DOI 10.1093/pubmed/fds018; Lacombe K, 2012, GUT, V61, P47, DOI 10.1136/gutjnl-2012-302062; Leichliter J, J ACQUIR IMMUNE DEFI; Liebman J, 2002, PUBLIC HEALTH NURS, V19, P345, DOI 10.1046/j.1525-1446.2002.19504.x; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Macneil J, 2011, DRUG ALCOHOL REV, V30, P26, DOI 10.1111/j.1465-3362.2010.00188.x; Maru DSR, 2008, AIDS BEHAV, V12, P284, DOI 10.1007/s10461-007-9336-2; Maru DSR, 2009, JAIDS-J ACQ IMM DEF, V50, P176, DOI 10.1097/QAI.0b013e3181938e7e; Matser A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057740; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Mermin J, 2012, JAMA-J AM MED ASSOC, V308, P347, DOI 10.1001/jama.2012.8693; Meyer JP, 2011, J WOMENS HEALTH, V20, P991, DOI 10.1089/jwh.2010.2328; National Alliance of State & Territorial AIDS Directors, 2012, ADAP WATCH; Nuttbrock L, 2000, J ACQ IMMUN DEF SYND, V25, P86, DOI 10.1097/00126334-200009010-00012; Pollock HA, 2002, J GEN INTERN MED, V17, P341, DOI 10.1046/j.1525-1497.2002.10663.x; Rosen DL, 2009, AM J PUBLIC HEALTH, V99, pS452, DOI 10.2105/AJPH.2007.133124; Russell M, 2009, AM J PUBLIC HEALTH, V99, pS173, DOI 10.2105/AJPH.2007.126383; Saber-Tehrani AS, 2012, CONTEMP CLIN TRIALS, V33, P436, DOI 10.1016/j.cct.2011.11.002; Schwarz RK, 2009, AM J DRUG ALCOHOL AB, V35, P439, DOI 10.3109/00952990903447741; Siskin A, 2011, TREATMENT NONCITIZEN; Smith-Rohrberg D, 2006, JAIDS-J ACQ IMM DEF, V43, pS48, DOI 10.1097/01.qai.0000248338.74943.85; Spradling PR, 2010, JAIDS-J ACQ IMM DEF, V53, P388, DOI 10.1097/QAI.0b013e3181b67527; Springer SA, 2010, J URBAN HEALTH, V87, P592, DOI 10.1007/s11524-010-9438-4; Sulkowski MS, 2007, J VIRAL HEPATITIS, V14, P371, DOI 10.1111/j.1365-2893.2006.00816.x; Sullivan LE, 2006, CLIN INFECT DIS, V43, pS191, DOI 10.1086/508183; U.S. Census Bureau, 2012, SEL SOC CHAR US 2007; U.S. Department of Health and Human Services, 2012, AFF CAR ACT HELPS PE; United States Census, 2010, STAT COUNT QUICK FAC; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Weiss L, 2011, JAIDS-J ACQ IMM DEF, V56, pS68, DOI 10.1097/QAI.0b013e31820a8226	44	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64321	10.1371/journal.pone.0064321	http://dx.doi.org/10.1371/journal.pone.0064321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RE	23691197	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400117
J	Ando, S; Hatamoto, Y; Sudo, M; Kiyonaga, A; Tanaka, H; Higaki, Y				Ando, Soichi; Hatamoto, Yoichi; Sudo, Mizuki; Kiyonaga, Akira; Tanaka, Hiroaki; Higaki, Yasuki			The Effects of Exercise Under Hypoxia on Cognitive Function	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; ENDURING MEMORY IMPAIRMENT; HUMAN BRAIN-FUNCTION; CEREBRAL-BLOOD-FLOW; HIGH-ALTITUDE; INCREMENTAL EXERCISE; VERTEBRAL ARTERIES; HYPOBARIC HYPOXIA; ISOCAPNIC HYPOXIA; DYNAMIC EXERCISE	Increasing evidence suggests that cognitive function improves during a single bout of moderate exercise. In contrast, exercise under hypoxia may compromise the availability of oxygen. Given that brain function and tissue integrity are dependent on a continuous and sufficient oxygen supply, exercise under hypoxia may impair cognitive function. However, it remains unclear how exercise under hypoxia affects cognitive function. The purpose of this study was to examine the effects of exercise under different levels of hypoxia on cognitive function. Twelve participants performed a cognitive task at rest and during exercise at various fractions of inspired oxygen (FIO2: 0.209, 0.18, and 0.15). Exercise intensity corresponded to 60% of peak oxygen uptake under normoxia. The participants performed a Go/No-Go task requiring executive control. Cognitive function was evaluated using the speed of response (reaction time) and response accuracy. We monitored pulse oximetric saturation (SpO(2)) and cerebral oxygenation to assess oxygen availability. SpO(2) and cerebral oxygenation progressively decreased during exercise as the FIO2 level decreased. Nevertheless, the reaction time in the Go-trial significantly decreased during moderate exercise. Hypoxia did not affect reaction time. Neither exercise nor difference in FIO2 level affected response accuracy. An additional experiment indicated that cognitive function was not altered without exercise. These results suggest that the improvement in cognitive function is attributable to exercise, and that hypoxia has no effects on cognitive function at least under the present experimental condition. Exercise-cognition interaction should be further investigated under various environmental and exercise conditions.	[Ando, Soichi; Kiyonaga, Akira; Tanaka, Hiroaki; Higaki, Yasuki] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka 81401, Japan; [Hatamoto, Yoichi] Fukuoka Univ, Grad Sch Sports & Hlth Sci, Fukuoka 81401, Japan; [Sudo, Mizuki; Kiyonaga, Akira; Tanaka, Hiroaki; Higaki, Yasuki] Fukuoka Univ, Inst Phys Act, Fukuoka 81401, Japan	Fukuoka University; Fukuoka University; Fukuoka University	Ando, S (corresponding author), Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka 81401, Japan.	sando@fukuoka-u.ac.jp	Ando, Soichi/AAC-5105-2019	Ando, Soichi/0000-0003-0896-7008				Addante RJ, 2012, NEUROPSYCHOLOGIA, V50, P3004, DOI 10.1016/j.neuropsychologia.2012.07.038; Ainslie PN, 2007, AM J PHYSIOL-HEART C, V292, pH976, DOI 10.1152/ajpheart.00639.2006; Amann M, 2007, J PHYSIOL-LONDON, V581, P389, DOI 10.1113/jphysiol.2007.129700; Amann M, 2009, HIGH ALT MED BIOL, V10, P149, DOI 10.1089/ham.2008.1105; Ando S, 2011, EUR J APPL PHYSIOL, V111, P1973, DOI 10.1007/s00421-011-1827-1; Ando S, 2010, J APPL PHYSIOL, V108, P1210, DOI 10.1152/japplphysiol.01115.2009; Binks AP, 2008, J APPL PHYSIOL, V104, P212, DOI 10.1152/japplphysiol.00069.2007; Borg G, 1975, PHYS WORK EFFORT, P39; Boushel R, 2001, SCAND J MED SCI SPOR, V11, P213, DOI 10.1034/j.1600-0838.2001.110404.x; Brisswalter J, 2002, SPORTS MED, V32, P555, DOI 10.2165/00007256-200232090-00002; CHMURA J, 1994, INT J SPORTS MED, V15, P172, DOI 10.1055/s-2007-1021042; CUMMINGS JL, 1984, NEUROLOGY, V34, P679, DOI 10.1212/WNL.34.5.679; Di Paola M, 2008, HIPPOCAMPUS, V18, P719, DOI 10.1002/hipo.20432; Dietrich A, 2011, NEUROSCI BIOBEHAV R, V35, P1305, DOI 10.1016/j.neubiorev.2011.02.001; Duncan A, 1996, PEDIATR RES, V39, P889, DOI 10.1203/00006450-199605000-00025; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; Erickson KI, 2007, CEREB CORTEX, V17, P192, DOI 10.1093/cercor/bhj137; Etnier JL, 2009, J SPORT EXERCISE PSY, V31, P469, DOI 10.1123/jsep.31.4.469; Gervain J, 2011, DEV COGN NEUROS-NETH, V1, P22, DOI 10.1016/j.dcn.2010.07.004; GIBSON GE, 1981, AM J MED, V70, P1247, DOI 10.1016/0002-9343(81)90834-2; Goodall S, 2010, J APPL PHYSIOL, V109, P1842, DOI 10.1152/japplphysiol.00458.2010; Grego F, 2005, INT J SPORTS MED, V26, P27, DOI 10.1055/s-2004-817915; Hampson DB, 2001, SPORTS MED, V31, P935, DOI 10.2165/00007256-200131130-00004; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hornbein TF, 2001, J EXP BIOL, V204, P3129; Horner AJ, 2012, CURR BIOL, V22, P2369, DOI 10.1016/j.cub.2012.10.055; Hoshi Y, 2003, PSYCHOPHYSIOLOGY, V40, P511, DOI 10.1111/1469-8986.00053; Imray CHE, 2005, J APPL PHYSIOL, V99, P699, DOI 10.1152/japplphysiol.00973.2004; Iwasaki K, 2007, J CEREBR BLOOD F MET, V27, P776, DOI 10.1038/sj.jcbfm.9600384; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Joyce J, 2009, BRAIN COGNITION, V71, P14, DOI 10.1016/j.bandc.2009.03.004; Kallenberg K, 2008, J CEREBR BLOOD F MET, V28, P1635, DOI 10.1038/jcbfm.2008.55; Kantowitz B.H., 1974, HUMAN INFORMATION PR, P41; Koike A, 2004, CHEST, V125, P182, DOI 10.1378/chest.125.1.182; Kolb JC, 2004, RESP PHYSIOL NEUROBI, V141, P191, DOI 10.1016/j.resp.2004.04.014; Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006; Lambourne K, 2010, MED SCI SPORT EXER, V42, P1396, DOI 10.1249/MSS.0b013e3181cbee11; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Mecklinger A, 1998, BRAIN, V121, P1919, DOI 10.1093/brain/121.10.1919; MEEUSEN R, 1995, SPORTS MED, V20, P160, DOI 10.2165/00007256-199520030-00004; Millet GY, 2012, J APPL PHYSIOL, V112, P1335, DOI 10.1152/japplphysiol.00804.2011; Neubauer JA, 2004, J APPL PHYSIOL, V96, P367, DOI 10.1152/japplphysiol.00831.2003; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pneurobio.2004.03.005; Ogoh S, 2010, J APPL PHYSIOL, V108, P538, DOI 10.1152/japplphysiol.01235.2009; Okagawa S, 2004, NEUROSCI RES, V49, P325, DOI 10.1016/j.neures.2004.03.011; Pagani M, 2011, ACTA PHYSIOL, V202, P203, DOI 10.1111/j.1748-1716.2011.02264.x; Paola MD, 2008, EUR J NEUROL, V15, P1050, DOI [10.1111/j.1468-1331.2008.02243.x, 10.1111/j.1468-1331.2008.02137.x]; Peltonen JE, 2007, RESP PHYSIOL NEUROBI, V155, P71, DOI 10.1016/j.resp.2006.03.008; Perrey S, 2008, METHODS, V45, P289, DOI 10.1016/j.ymeth.2008.04.005; Pontifex MB, 2009, MED SCI SPORT EXER, V41, P927, DOI 10.1249/MSS.0b013e3181907d69; Raichle ME, 2001, LUNG BIOL HEALTH DIS, V161, P377; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Sato K, 2011, J PHYSIOL-LONDON, V589, P2847, DOI 10.1113/jphysiol.2010.204461; Sato K, 2010, J APPL PHYSIOL, V109, P864, DOI 10.1152/japplphysiol.01359.2009; Subudhi AW, 2008, AM J PHYSIOL-HEART C, V294, pH164, DOI 10.1152/ajpheart.01104.2007; Subudhi AW, 2007, J APPL PHYSIOL, V103, P177, DOI 10.1152/japplphysiol.01460.2006; Subudhi AW, 2009, J APPL PHYSIOL, V106, P1153, DOI 10.1152/japplphysiol.91475.2008; Usui C, 2004, HIGH ALT MED BIOL, V5, P77, DOI 10.1089/152702904322963717; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Verges S, 2012, AM J PHYSIOL-REG I, V302, pR903, DOI 10.1152/ajpregu.00555.2011; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Virues-Ortega J, 2006, DEVELOPMENTAL SCI, V9, P400, DOI 10.1111/j.1467-7687.2006.00505.x; Virues-Ortega Javier, 2004, Neuropsychology Review, V14, P197; Vogiatzis I, 2011, J PHYSIOL-LONDON, V589, P4027, DOI 10.1113/jphysiol.2011.210880; Wilmore JH, 2008, PHYSL SPORT EXERCISE, P292; Yonelinas AP, 2004, COGN AFFECT BEHAV NE, V4, P393, DOI 10.3758/CABN.4.3.393; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	70	58	60	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63630	10.1371/journal.pone.0063630	http://dx.doi.org/10.1371/journal.pone.0063630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675496	Green Published, gold			2022-12-25	WOS:000318852400048
J	Nilmeier, JP; Kirshner, DA; Wong, SE; Lightstone, FC				Nilmeier, Jerome P.; Kirshner, Daniel A.; Wong, Sergio E.; Lightstone, Felice C.			Rapid Catalytic Template Searching as an Enzyme Function Prediction Procedure	PLOS ONE			English	Article							PROTEIN FUNCTION PREDICTION; COMBINATORIAL EXTENSION CE; 3D COORDINATE TEMPLATES; LIGAND-BINDING-SITES; STRUCTURAL CLASSIFICATION; DIVERGENT EVOLUTION; FUNCTION INFERENCE; GENE ONTOLOGY; CLUSTAL-W; SEQUENCE	We present an enzyme protein function identification algorithm, Catalytic Site Identification (CatSId), based on identification of catalytic residues. The method is optimized for highly accurate template identification across a diverse template library and is also very efficient in regards to time and scalability of comparisons. The algorithm matches three-dimensional residue arrangements in a query protein to a library of manually annotated, catalytic residues - The Catalytic Site Atlas (CSA). Two main processes are involved. The first process is a rapid protein-to-template matching algorithm that scales quadratically with target protein size and linearly with template size. The second process incorporates a number of physical descriptors, including binding site predictions, in a logistic scoring procedure to re-score matches found in Process 1. This approach shows very good performance overall, with a Receiver-Operator-Characteristic Area Under Curve (AUC) of 0.971 for the training set evaluated. The procedure is able to process cofactors, ions, nonstandard residues, and point substitutions for residues and ions in a robust and integrated fashion. Sites with only two critical (catalytic) residues are challenging cases, resulting in AUCs of 0.9411 and 0.5413 for the training and test sets, respectively. The remaining sites show excellent performance with AUCs greater than 0.90 for both the training and test data on templates of size greater than two critical (catalytic) residues. The procedure has considerable promise for larger scale searches.	[Nilmeier, Jerome P.; Kirshner, Daniel A.; Wong, Sergio E.; Lightstone, Felice C.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Lightstone, FC (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA USA.	lightstone1@llnl.gov			Defense Threat Reduction Agency (DTRA) [B094679I]; LDRD [12-SI-004]; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); LDRD; U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	The authors gratefully acknowledge the Defense Threat Reduction Agency (DTRA) for supporting this work (grant B094679I). A portion of this work was also funded by LDRD 12-SI-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. Release Number LLNL-POST-564184.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arakaki AK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-107; ARTYMIUK PJ, 1994, J MOL BIOL, V243, P327, DOI 10.1006/jmbi.1994.1657; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ausiello G, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S5; BAIROCH A, 1994, NUCLEIC ACIDS RES, V22, P3626, DOI 10.1093/nar/22.17.3626; Barker JA, 2003, BIOINFORMATICS, V19, P1644, DOI 10.1093/bioinformatics/btg226; Brakoulias A, 2004, PROTEINS, V56, P250, DOI 10.1002/prot.20123; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Chen BY, 2007, J COMPUT BIOL, V14, P791, DOI 10.1089/cmb.2007.R017; Coutsias EA, 2004, J COMPUT CHEM, V25, P1849, DOI 10.1002/jcc.20110; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Gerlt JA, 2011, BIOCHEMISTRY; Gerlt JA, 2012, J BIOL CHEM, V287, P29, DOI 10.1074/jbc.R111.240945; Glanville JG, 2007, NUCLEIC ACIDS RES, V35, pW27, DOI 10.1093/nar/gkm325; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Gold ND, 2006, NUCLEIC ACIDS RES, V34, pD231, DOI 10.1093/nar/gkj062; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Holliday GL, 2007, NUCLEIC ACIDS RES, V35, pD515, DOI 10.1093/nar/gkl774; Jambon M, 2003, PROTEINS, V52, P137, DOI 10.1002/prot.10339; Kalyanaraman C, 2008, STRUCTURE, V16, P1668, DOI 10.1016/j.str.2008.08.015; Kinjo Akira R, 2007, Biophysics (Nagoya-shi), V3, P75, DOI 10.2142/biophysics.3.75; Kinoshita K, 2003, PROTEIN SCI, V12, P1589, DOI 10.1110/ps.0368703; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; KLEYWEGT GJ, 1989, J MAGN RESON, V85, P186, DOI 10.1016/0022-2364(89)90335-1; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Krishnamurthy N, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r83; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Liang MP, 2003, NUCLEIC ACIDS RES, V31, P3324, DOI 10.1093/nar/gkg553; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Liu P, 2010, J COMPUT CHEM, V31, P1561, DOI 10.1002/jcc.21439; Marti-Renom MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S4; Meng EC, 2004, PROTEINS, V55, P962, DOI 10.1002/prot.20099; MITCHELL EM, 1990, J MOL BIOL, V212, P151, DOI 10.1016/0022-2836(90)90312-A; Moll M, 2008, LABELHASH FLEXIBLE E; Moll M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-555; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nosrati GR, 2012, PROTEIN SCI, V21, P697, DOI 10.1002/pro.2055; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orengo C A, 2003, Methods Biochem Anal, V44, P249; Pegg S, 2005, REPRESENTING STRUCTU, P358; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Polacco BJ, 2006, BIOINFORMATICS, V22, P723, DOI 10.1093/bioinformatics/btk038; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Ren JY, 2010, NUCLEIC ACIDS RES, V38, pW441, DOI 10.1093/nar/gkq400; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Russell RB, 1998, J MOL BIOL, V279, P1211, DOI 10.1006/jmbi.1998.1844; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; Schmitt S, 2002, J MOL BIOL, V323, P387, DOI 10.1016/S0022-2836(02)00811-2; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Shindyalov IN, 2001, NUCLEIC ACIDS RES, V29, P228, DOI 10.1093/nar/29.1.228; Shulman-Peleg A, 2004, J MOL BIOL, V339, P607, DOI 10.1016/j.jmb.2004.04.012; Sjolander K, 1996, COMPUT APPL BIOSCI, V12, P327; Skolnick J, 2009, BRIEF BIOINFORM, V10, P378, DOI 10.1093/bib/bbp017; Song L, 2007, NAT CHEM BIOL, V3, P486, DOI 10.1038/nchembio.2007.11; Spriggs RV, 2003, J CHEM INF COMP SCI, V43, P412, DOI 10.1021/ci0255984; Stark A, 2003, NUCLEIC ACIDS RES, V31, P3341, DOI 10.1093/nar/gkg506; Styczynski MP, 2008, NAT BIOTECHNOL, V26, P274, DOI 10.1038/nbt0308-274; Team R, 2010, R LANG ENV STAT COMP; Theobald DL, 2005, ACTA CRYSTALLOGR A, V61, P478, DOI 10.1107/S0108767305015266; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian WD, 2004, NUCLEIC ACIDS RES, V32, P6226, DOI 10.1093/nar/gkh956; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Torrance JW, 2005, J MOL BIOL, V347, P565, DOI 10.1016/j.jmb.2005.01.044; Tseng YY, 2009, J MOL BIOL, V387, P451, DOI 10.1016/j.jmb.2008.12.072; Tseng YY, 2006, MOL BIOL EVOL, V23, P421, DOI 10.1093/molbev/msj048; ULLMANN JR, 1976, J ACM, V23, P31, DOI 10.1145/321921.321925; Wallace AC, 1996, PROTEIN SCI, V5, P1001; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Webb E. C., 1992, ENZYME NOMENCLATURE; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Wolfson HJ, 1997, IEEE COMPUT SCI ENG, V4, P10, DOI 10.1109/99.641604; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Xie L, 2009, BIOINFORMATICS, V25, pI305, DOI 10.1093/bioinformatics/btp220; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571	85	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62535	10.1371/journal.pone.0062535	http://dx.doi.org/10.1371/journal.pone.0062535			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675414	Green Submitted, Green Published, gold			2022-12-25	WOS:000318852400006
J	Arbour, VM; Currie, PJ				Arbour, Victoria M.; Currie, Philip J.			Euoplocephalus tutus and the Diversity of Ankylosaurid Dinosaurs in the Late Cretaceous of Alberta, Canada, and Montana, USA	PLOS ONE			English	Article							STRATIGRAPHIC DISTRIBUTION; ORNITHISCHIA ANKYLOSAURIA; ARMORED DINOSAURS; MISSING ENTRIES; PARK FORMATION; DERMAL ARMOR; REDESCRIPTION; REPTILIA; SKULL; CERATOPSIDAE	Few ankylosaurs are known from more than a single specimen, but the ankylosaurid Euoplocephalus tutus (from the Late Cretaceous of Alberta, Canada and Montana, USA) is represented by dozens of skulls and partial skeletons, and is therefore an important taxon for understanding intraspecific variation in ankylosaurs. Euoplocephalus is unusual compared to other dinosaurs from the Late Cretaceous of Alberta because it is recognized from the Dinosaur Park, Horseshoe Canyon, and Two Medicine formations. A comprehensive review of material attributed to Euoplocephalus finds support for the resurrection of its purported synonyms Anodontosaurus lambei and Scolosaurus cutleri, and the previously resurrected Dyoplosaurus acutosquameus. Anodontosaurus is found primarily in the Horseshoe Canyon Formation of Alberta and is characterized by ornamentation posterior to the orbits and on the first cervical half ring, and wide, triangular knob osteoderms. Euoplocephalus is primarily found in Megaherbivore Assemblage Zone 1 in the Dinosaur Park Formation of Alberta and is characterized by the absence of ornamentation posterior to the orbits and on the first cervical half ring, and keeled medial osteoderms on the first cervical half ring. Scolosaurus is found primarily in the Two Medicine Formation of Montana (although the holotype is from Dinosaur Provincial Park), and is characterized by long, back-swept squamosal horns, ornamentation posterior to the orbit, and low medial osteoderms on the first cervical half ring; Oohkotokia horneri is morphologically indistinguishable from Scolosaurus cutleri. Dyoplosaurus was previously differentiated from Euoplocephalus sensu lato by the morphology of the pelvis and pes, and these features also differentiate Dyoplosaurus from Anodontosaurus and Scolosaurus; a narrow tail club knob is probably also characteristic for Dyoplosaurus.	[Arbour, Victoria M.; Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Arbour, VM (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	arbour@ualberta.ca	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161	Alberta Ingenuity Studentship; Dinosaur Research Institute; Izaak Walton Killam Doctoral Scholarship; Korea-Mongolia International Dinosaur Project; National Science and Engineering Research Council (Canada Graduate Scholarship - Doctoral; Postgraduate Scholarship - Masters; Michael Smith Foreign Study Supplement); University of Alberta China Institute; University of Alberta Graduate Students Association; University of Alberta Women in Scholarship, Engineering, Science and Technology	Alberta Ingenuity Studentship; Dinosaur Research Institute; Izaak Walton Killam Doctoral Scholarship; Korea-Mongolia International Dinosaur Project; National Science and Engineering Research Council (Canada Graduate Scholarship - Doctoral; Postgraduate Scholarship - Masters; Michael Smith Foreign Study Supplement); University of Alberta China Institute(University of Alberta); University of Alberta Graduate Students Association(University of Alberta); University of Alberta Women in Scholarship, Engineering, Science and Technology	This work was supported by Alberta Ingenuity Studentship (http://www.albertainnovates.ca/), Dinosaur Research Institute (http://www.dinosaurresearch.com/index.htm), Izaak Walton Killam Doctoral Scholarship (http://www.killamtrusts.ca/uofAlberta.asp), Korea-Mongolia International Dinosaur Project (http://www.digitaldreammachine.com/gobifieldwork/kid/home.html), National Science and Engineering Research Council (Canada Graduate Scholarship - Doctoral; Postgraduate Scholarship - Masters; Michael Smith Foreign Study Supplement) (http://www.nserc-crsng.gc.ca/index_eng.asp), University of Alberta China Institute (http://www.china.ualberta.ca/), University of Alberta Graduate Students Association (http://www.gsa.ualberta.ca/), University of Alberta Women in Scholarship, Engineering, Science and Technology (http://www.wisest.ualberta.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Geological Survey, 2012, ALB TOWN SYST ATS UN; American Museum of Natural History, 2012, DIV PAL COLL DAT; [Anonymous], 1999, WALKERS MAMMALS WORL; Arbour VM, 2013, ACTA PALAEONTOL POL, V58, P55, DOI 10.4202/app.2011.0081; Arbour VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039323; Arbour VM, 2009, J VERTEBR PALEONTOL, V29, P1117, DOI 10.1671/039.029.0405; Arbour VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006738; Baszio Sven, 1997, Courier Forschungsinstitut Senckenberg, V196, P33; Blows WT, 2001, LIFE O PAST, P363; Brinkman DB, 1998, PALAIOS, V13, P160, DOI 10.2307/3515487; Brown B, 1908, B AM MUS NAT HIST, V24, P187; CARPENTER K, 1982, CAN J EARTH SCI, V19, P689, DOI 10.1139/e82-058; Carpenter K, 2004, CAN J EARTH SCI, V41, P961, DOI 10.1139/E04-043; Carpenter K, 2011, PALAEONTOGR ABT A, V294, P1; Coombs W, 1971, THESIS COLUMBIA U NE; COOMBS W P JR, 1978, Palaeontology (Oxford), V21, P143; Coombs W.P. Jr, 1978, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V161, P176; Coombs W.P. Jr, 1986, Journal of Vertebrate Paleontology, V6, P162; COOMBS WP, 1978, J PALEONTOL, V52, P642; COOMBS WP, 1979, J PALEONTOL, V53, P666; COOMBS WP, 1995, CAN J EARTH SCI, V32, P902, DOI 10.1139/e95-075; COOMBS WP, 1972, J PALEONTOL, V46, P637; Currie PJ, 2005, LIFE O PAST, P537; Dixon J. R., 2000, AMPHIBIANS REPTILES; Eberth DA, 2012, CAN J EARTH SCI, V49, P1053, DOI 10.1139/E2012-035; Eberth DA, 2005, LIFE O PAST, P54; Evans DC, 2007, THESIS U TORONTO ONT; Fanti F, 2009, PALAEOGEOGR PALAEOCL, V275, P37, DOI 10.1016/j.palaeo.2009.02.007; GANGLOFF RA, 1995, J VERTEBR PALEONTOL, V15, P195, DOI 10.1080/02724634.1995.10011218; Gilmore C. W., 1930, Proceedings of the United States National Museum, V77, P1; Gilmore C. W., 1933, American Museum Novitates, V679, P1; Gilmore C.W., 1917, US GEOLOGICAL SURVEY, V103, P1; Gilmore CW, 1923, CAN FIELD NAT, V37, P1; Godefroit Pascal, 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V69, P17; Goloboff P.A., 2008, TNT TREE ANAL USING; Haas G., 1969, American Museum Novitates, VNo. 2399, P1; Hill RV, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)395<0001:ANSOPG>2.0.CO;2; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Lambe L. M., 1902, Contributions to Canadian Palaeontology, Viii, pUnpaginated; Lambe L.M., 1910, OTTAWA NATURALIST, V14, P149; Larson D. W, 2010, THESIS U ALBERTA EDM; Maddison WP, 2011, MESQUITE MODULAR SYS; Maidment SCR, 2010, LETHAIA, V43, P95, DOI 10.1111/j.1502-3931.2009.00172.x; MALEEV E. A., 1952, DOKLADY AKAD NAUK SSSR, V87, P273; Maleev E.A., 1956, T PALEONTOL I AKAD N, V62, P51; Mallon JC, 2012, PALAEOGEOGR PALAEOCL, V350, P124, DOI 10.1016/j.palaeo.2012.06.024; Mallon JC, 2011, J VERTEBR PALEONTOL, V31, P1047, DOI 10.1080/02724634.2011.601484; Maryaska T., 1977, PALAEONTOLOGIA POLON, V37, P85; Miles CA, 2009, CURR SCI INDIA, V96, P65; Miyashita T, 2011, J ANAT, V219, P661, DOI 10.1111/j.1469-7580.2011.01427.x; Nopcsa F., 1928, GEOLOGICA HUNGARIA S, V1, P3; Nopesa F., 1915, Jahrb Kgl Ungar Geol Reich Budapest, V23, P1; OLIVER JA, 1951, COPEIA, P127, DOI 10.2307/1437541; Osborn H. F., 1923, American Museum Novitates, V95, P1; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Pang QQ, 1998, PROG NAT SCI, V8, P326; Parks W. A., 1924, University of Toronto Studies Geological Series, V18, P1; Parsons WL, 2009, CAN J EARTH SCI, V46, P721, DOI 10.1139/E09-045; Penkalski P, 2001, LIFE O PAST, P261; Penkalski P, 2013, ACTA PALAEO IN PRESS, DOI DOI 10.4202/APP.2012.0125.IN; Penkalski P, 2013, CAN J EARTH SCI, V50, P171, DOI 10.1139/cjes-2012-0098; ROGERS RR, 1993, CAN J EARTH SCI, V30, P1066, DOI 10.1139/e93-090; Ross F.D., 1983, P305; Ryan Michael J., 2001, P279; Ryan MJ, 2005, LIFE O PAST, P312; Ryan MJ, 2003, THESIS U CALGARY ALB; Ryan MJ, 2011, NEW PERSPECTIVES HOR, P141; Rybczynski N, 2001, LIFE O PAST, P299; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sternberg C. M., 1929, Bulletin Canada Dept Mines Ottawa, V54, P28; Sternberg CM, 1929, B NATL MUSEUM CANADA, V54, P70; Sullivan RM, 1999, J VERTEBR PALEONTOL, V19, P126, DOI 10.1080/02724634.1999.10011128; Tanke Darren H., 2010, P541; Tanks DH, 2005, LIFE O PAST, P34; Thompson RS, 2012, J SYST PALAEONTOL, V10, P301, DOI 10.1080/14772019.2011.569091; Trexler David, 2001, P298; TUMANOVA TA, 1993, PALEONTOL ZH, P92; Tumanova TA, 1983, T SOVM SOV MONG PAL, V24, P110; Vickaryous MK, 2003, ZOOL J LINN SOC-LOND, V137, P157, DOI 10.1046/j.1096-3642.2003.00045.x; Vickaryous MK, 2001, LIFE O PAST, P318; Wilkinson M, 2003, J VERTEBR PALEONTOL, V23, P311, DOI 10.1671/0272-4634(2003)023[0311:MEAMTI]2.0.CO;2; Wilkinson M, 1995, SYST BIOL, V44, P501, DOI 10.1093/sysbio/44.4.501; Wilkinson M, 2001, TAXEQ3 SOFTWARE DOCU; Witmer LM, 2008, ANAT REC, V291, P1362, DOI 10.1002/ar.20794	85	55	56	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62421	10.1371/journal.pone.0062421	http://dx.doi.org/10.1371/journal.pone.0062421			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23690940	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600026
J	Antonov, AV; Krestyaninova, M; Knight, RA; Rodchenkov, I; Melino, G; Barlev, NA				Antonov, A. V.; Krestyaninova, M.; Knight, R. A.; Rodchenkov, I.; Melino, G.; Barlev, N. A.			PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome	ONCOGENE			English	Article						bioinformatics; computational oncology; survival	P73 TRANSCRIPTIONAL ACTIVITY; BREAST-CANCER; PROGNOSTIC MARKER; MICROARRAY DATA; ONLINE TOOL; P53; BIOMARKERS; RESOURCE; DATABASE; THERAPY	Multiple clinical studies have correlated gene expression with survival outcome in cancer on a genome-wide scale. However, in many cases, no obvious correlation between expression of well-known tumour-related genes (that is, p53, p73 and p21) and survival rates of patients has been observed. This can be mainly explained by the complex molecular mechanisms involved in cancer, which mask the clinical relevance of a gene with multiple functions if only gene expression status is considered. As we demonstrate here, in many such cases, the expression of the gene interaction partners (gene 'interactome') correlates significantly with cancer survival and is indicative of the role of that gene in cancer. On the basis of this principle, we have implemented a free online datamining tool (http://www.bioprofiling.de/PPISURV). PPISURV automatically correlates expression of an input gene interactome with survival rates on >40 publicly available clinical expression data sets covering various tumours involving about 8000 patients in total. To derive the query gene interactome, PPISURV employs several public databases including protein-protein interactions, regulatory and signalling pathways and protein post-translational modifications.	[Antonov, A. V.; Knight, R. A.; Melino, G.] Univ Leicester, Med Res Council, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Antonov, A. V.; Melino, G.; Barlev, N. A.] Technol Univ, Mol Pharmacol Lab, St Petersburg, Russia; [Krestyaninova, M.] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Rodchenkov, I.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Melino, G.] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Barlev, N. A.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Barlev, N. A.] Russian Acad Sci, Inst Cytol, Gene Express Programme, St Petersburg 194064, Russia	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester; University of Helsinki; University of Toronto; University of Rome Tor Vergata; University of Leicester; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Antonov, AV (corresponding author), Univ Leicester, Med Res Council, Toxicol Unit, Hodgkin Bldg,POB 138, Leicester LE1 9HN, Leics, England.	aa668@le.ac.uk; nb155@le.ac.uk	Barlev, Nikolai A/K-5268-2017	Barlev, Nikolai A/0000-0001-7111-2446; Krestyaninova, Maria/0000-0002-8705-8111	UK Medical Research Council (MRC); Russian Federal [14.B37.21.1967, 16.740.11.036, 11.G34.31.0069]; Medical Research Council [MC_U132670600] Funding Source: researchfish; MRC [MC_U132670600] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Russian Federal; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (MRC) and funding from Russian Federal grants 14.B37.21.1967 (to AA) 16.740.11.036 (to NB) and 11.G34.31.0069 (to GM).	Antonov AV, 2013, CELL DEATH DIFFER, V20, P367, DOI 10.1038/cdd.2012.137; Antonov AV, 2011, NUCLEIC ACIDS RES, V39, pW323, DOI 10.1093/nar/gkr372; Antonov AV, 2010, NUCLEIC ACIDS RES, V38, pW78, DOI 10.1093/nar/gkq482; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Callagy GM, 2006, CLIN CANCER RES, V12, P2468, DOI 10.1158/1078-0432.CCR-05-2719; Castiglione F, 1999, ANTICANCER RES, V19, P4555; Ciardiello F, 2002, ANN ONCOL, V13, P501, DOI 10.1093/annonc/mdf191; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; Dietmann S, 2010, NUCLEIC ACIDS RES, V38, pW118, DOI 10.1093/nar/gkq515; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Malatesta M, 2013, ONCOGENE, V32, P4721, DOI 10.1038/onc.2012.463; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Na II, 2007, J KOREAN MED SCI, V22, P393, DOI 10.3346/jkms.2007.22.3.393; Rufini Alessandro, 2011, Genes Cancer, V2, P491, DOI 10.1177/1947601911408890; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Tandon S, 2010, CANCER EPIDEM BIOMAR, V19, P574, DOI 10.1158/1055-9965.EPI-09-0981; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Wu H, 2011, MOL CANCER RES, V9, P1780, DOI 10.1158/1541-7786.MCR-11-0157; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527	29	49	49	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 27	2014	33	13					1621	1628		10.1038/onc.2013.119	http://dx.doi.org/10.1038/onc.2013.119			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9QY	23686313				2022-12-25	WOS:000334344700002
J	Oku, S; Takahashi, N; Fukata, Y; Fukata, M				Oku, Shinichiro; Takahashi, Naoki; Fukata, Yuko; Fukata, Masaki			In Silico Screening for Palmitoyl Substrates Reveals a Role for DHHC1/3/10 (zDHHC1/3/11)-mediated Neurochondrin Palmitoylation in Its Targeting to Rab5-positive Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN PALMITOYLATION; DIFFERENTIAL REGULATION; NEURONAL DEVELOPMENT; SYNAPTIC PLASTICITY; AUXILIARY SUBUNITS; MEMBRANE-PROTEINS; AMPA RECEPTORS; IDENTIFICATION; TRAFFICKING	Protein palmitoylation, a common post-translational lipid modification, plays an important role in protein trafficking and functions. Recently developed palmitoyl-proteomic methods identified many novel substrates. However, the whole picture of palmitoyl substrates has not been clarified. Here, we performed global in silico screening using the CSS-Palm 2.0 program, free software for prediction of palmitoylation sites, and selected 17 candidates as novel palmitoyl substrates. Of the 17 candidates, 10 proteins, including 6 synaptic proteins (Syd-1, transmembrane AMPA receptor regulatory protein (TARP) gamma-2, TARP gamma-8, cornichon-2, Ca2+/calmodulin-dependent protein kinase II alpha, and neurochondrin (Ncdn)/norbin), one focal adhesion protein (zyxin), two ion channels (TRPM8 and TRPC1), and one G-protein-coupled receptor (orexin 2 receptor), were palmitoylated. Using the DHHC palmitoylating enzyme library, we found that all tested substrates were palmitoylated by the Golgi-localized DHHC3/7 subfamily. Ncdn, a regulator for neurite outgrowth and synaptic plasticity, was robustly palmitoylated by the DHHC1/10 (zDHHC1/11; z1/11) subfamily, whose substrate has not yet been reported. As predicted by CSS-Palm 2.0, Cys-3 and Cys-4 are the palmitoylation sites for Ncdn. Ncdn was specifically localized in somato-dendritic regions, not in the axon of rat cultured neurons. Stimulated emission depletion microscopy revealed that Ncdn was localized to Rab5-positive early endosomes in a palmitoylation-dependent manner, where DHHC1/10 (z1/11) were also distributed. Knockdown of DHHC1, -3, or -10 (z11) resulted in the loss of Ncdn from Rab5-positive endosomes. Thus, through in silico screening, we demonstrate that Ncdn and the DHHC1/10 (z1/11) and DHHC3/7 subfamilies are novel palmitoyl substrate-enzyme pairs and that Ncdn palmitoylation plays an essential role in its specific endosomal targeting.	[Oku, Shinichiro; Takahashi, Naoki; Fukata, Yuko; Fukata, Masaki] Natl Inst Nat Sci, Div Membrane Physiol, Dept Cell Physiol, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan; [Oku, Shinichiro; Fukata, Yuko; Fukata, Masaki] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Sch Life Sci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Fukata, M (corresponding author), Natl Inst Physiol Sci, Div Membrane Physiol, Dept Cell Physiol, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	mfukata@nips.ac.jp	Fukata, Masaki/AAZ-2476-2021	Fukata, Masaki/0000-0001-5200-9806; Fukata, Yuko/0000-0001-7724-8643	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21680029, 23110520, 20670005]; Funding Program for Next Generation World-Leading Researchers [LS123]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in whole or in part, by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants 21680029 and 23110520 (to Y. F.) and 20670005 (to M. F.) and by the Funding Program for Next Generation World-Leading Researchers (LS123; to M. F.).	Apweiler R, 2004, CURR OPIN CHEM BIOL, V8, P76, DOI 10.1016/j.cbpa.2003.12.004; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Dateki M, 2005, J BIOL CHEM, V280, P20503, DOI 10.1074/jbc.M414033200; DeSouza S, 2002, J NEUROSCI, V22, P3493; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; El-Husseini AE, 2000, J BIOL CHEM, V275, P23904, DOI 10.1074/jbc.M909919199; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mirza SP, 2007, PHYSIOL GENOMICS, V30, P89, DOI 10.1152/physiolgenomics.00279.2006; Mochizuki R, 2003, BIOCHEM BIOPH RES CO, V310, P1219, DOI 10.1016/j.bbrc.2003.09.153; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ogasawara O, 2006, NUCLEIC ACIDS RES, V34, pD628, DOI 10.1093/nar/gkj137; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Schwaibold EMC, 2008, BIOCHEM BIOPH RES CO, V373, P366, DOI 10.1016/j.bbrc.2008.06.042; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shinozaki K, 1997, BIOCHEM BIOPH RES CO, V240, P766, DOI 10.1006/bbrc.1997.7660; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Van Itallie CM, 2005, J CELL SCI, V118, P1427, DOI 10.1242/jcs.01735; Wang Hong, 2010, Commun Integr Biol, V3, P487, DOI 10.4161/cib.3.6.12844; Wang H, 2009, SCIENCE, V326, P1554, DOI 10.1126/science.1178496; WYLLIE DJA, 1994, NEURON, V13, P635, DOI 10.1016/0896-6273(94)90031-0; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200	51	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19816	19829		10.1074/jbc.M112.431676	http://dx.doi.org/10.1074/jbc.M112.431676			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23687301	Green Published, hybrid			2022-12-25	WOS:000321515800050
J	Mediouni, S; Darque, A; Ravaux, I; Baillat, G; Devaux, C; Loret, EP				Mediouni, Sonia; Darque, Albert; Ravaux, Isabelle; Baillat, Gilbert; Devaux, Christian; Loret, Erwann P.			Identification of a Highly Conserved Surface on Tat Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 TAT; CIRCULAR-DICHROISM; STRUCTURAL CHARACTERIZATION; HOMONUCLEAR H-1-NMR; PROTEIN; VIRUS; ANTIBODY; TRANSACTIVATION; CONFORMATION; ASSIGNMENT	Extracellular Tat is suspected to protect HIV-1-infected cells from cellular immunity. Seropositive patients are unable to produce neutralizing antibodies against Tat, and Tat is still secreted under antiviral treatment. In mice, the Tat OYI vaccine candidate generates neutralizing antibodies such as the mAb 7G12. A peptide called MIMOOX was designed from fragments of Tat OYI identified as the possible binding site for mAb 7G12. MIMOOX was chemically synthesized, and its structure was stabilized with a disulfide bridge. Circular dichroism spectra showed that MIMOOX had mainly beta turns but no alpha helix as Tat OYI. MIMOOX was recognized by mAb 7G12 in ELISA only in reduced conditions. Moreover, a competitive recognition assay with mAb 7G12 between MIMOOX and Tat variants showed that MIMOOX mimics a highly conserved surface in Tat variants. Rat immunizations with MIMOOX induce antibodies recognizing Tat variants from the main HIV-1 subtypes and confirm the Tat OYI vaccine approach.	[Mediouni, Sonia; Darque, Albert; Ravaux, Isabelle; Baillat, Gilbert; Loret, Erwann P.] Aix Marseille Univ, Equipe Technol Rech Appl VIH ETRAV 1, Fac Pharm, UMR 5236,CNRS, F-13385 Marseille 5, France; [Devaux, Christian] UM2, UM1, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, UMR 5236,CNRS, F-34293 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Loret, EP (corresponding author), Aix Marseille Univ, Equipe Technol Rech Appl VIH ETRAV 1, Fac Pharm, UMR 5236,CNRS, 27 BD Jean Moulin, F-13385 Marseille 5, France.	erwann.loret@univ-amu.fr			BIOSANTECH (Sofia Antipolis, France); MIMETICS (Lausanne, Switzerland)	BIOSANTECH (Sofia Antipolis, France); MIMETICS (Lausanne, Switzerland)	This work was supported by BIOSANTECH (Sofia Antipolis, France) and MIMETICS (Lausanne, Switzerland).	Bachler BC, 2013, J VIROL, V87, P4403, DOI 10.1128/JVI.02888-12; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Campbell GR, 2007, VACCINE, V25, P8441, DOI 10.1016/j.vaccine.2007.09.070; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Caselli E, 1999, J IMMUNOL, V162, P5631; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Ensoli B, 2008, AIDS, V22, P2207, DOI 10.1097/QAD.0b013e32831392d4; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Ensoli B, 2009, VACCINE, V28, P371, DOI 10.1016/j.vaccine.2009.10.038; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; FURLINI MCRG, 1995, J ACQ IMMUN DEF SYND, V10, P408, DOI 10.1097/00042560-199512000-00003; Goldstein G, 2012, HUM VACC IMMUNOTHER, V8, P1425, DOI 10.4161/hv.21616; Gregoire C, 2001, BIOPOLYMERS, V62, P324, DOI 10.1002/bip.10000; Guillon C, 2007, VACCINE, V25, P7491, DOI 10.1016/j.vaccine.2007.08.060; Hardy F, 1997, J IMMUNOL METHODS, V200, P155, DOI 10.1016/S0022-1759(96)00201-3; HUET T, 1989, AIDS, V3, P707, DOI 10.1097/00002030-198911000-00004; KOKEN SEC, 1994, J BIOL CHEM, V269, P8366; Lakhashe SK, 2011, VACCINE, V29, P5611, DOI 10.1016/j.vaccine.2011.06.017; Lecoq A, 2008, VACCINE, V26, P2615, DOI 10.1016/j.vaccine.2008.02.057; Liao WT, 2012, VACCINE, V30, P2453, DOI 10.1016/j.vaccine.2012.01.055; Longo O, 2009, VACCINE, V27, P3306, DOI 10.1016/j.vaccine.2009.01.090; LORET EP, 1992, P NATL ACAD SCI USA, V89, P9734, DOI 10.1073/pnas.89.20.9734; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mayol K, 2007, VACCINE, V25, P6047, DOI 10.1016/j.vaccine.2007.05.048; Mediouni S, 2012, J BIOL CHEM, V287, P11942, DOI 10.1074/jbc.M111.319863; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Mediouni Sonia, 2011, Infectious Disorders - Drug Targets, V11, P57; Moreau E, 2004, J VIROL, V78, P3792, DOI 10.1128/JVI.78.7.3792-3796.2004; Opi S, 2002, J BIOL CHEM, V277, P35915, DOI 10.1074/jbc.M204393200; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; Pfeiffer B, 2003, ANGEW CHEM INT EDIT, V42, P2368, DOI 10.1002/anie.200250348; Reynell L, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13535; Rodman TC, 2001, EXP HEMATOL, V29, P1004, DOI 10.1016/S0301-472X(01)00678-6; Senkaali D, 2008, AIDS RES HUM RETROV, V24, P587, DOI 10.1089/aid.2007.0171; Serriere J, 2011, J MOL BIOL, V405, P33, DOI 10.1016/j.jmb.2010.10.033; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; STEINAA L, 1994, ARCH VIROL, V139, P263, DOI 10.1007/BF01310790; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Valvatne H, 1996, AIDS RES HUM RETROV, V12, P611, DOI 10.1089/aid.1996.12.611; Watkins JD, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-8; Watkins JD, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-83; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WONGSTAAL F, 1985, NATURE, V317, P395, DOI 10.1038/317395a0	44	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19072	19080		10.1074/jbc.M113.466011	http://dx.doi.org/10.1074/jbc.M113.466011			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23678001	Green Published, hybrid			2022-12-25	WOS:000321335800042
J	Allegrini, S; Filoni, DN; Galli, A; Collavoli, A; Pesi, R; Camici, M; Tozzi, MG				Allegrini, Simone; Filoni, Daniela Nicole; Galli, Alvaro; Collavoli, Anita; Pesi, Rossana; Camici, Marcella; Tozzi, Maria Grazia			Expression of Bovine Cytosolic 5 '-Nucleotidase (cN-II) in Yeast: Nucleotide Pools Disturbance and Its Consequences on Growth and Homologous	PLOS ONE			English	Article							5-NUCLEOTIDASE; IDENTIFICATION; ENZYME; CELLS	Cytosolic 5'-nucleotidase II is a widespread IMP hydrolyzing enzyme, essential for cell vitality, whose role in nucleotide metabolism and cell function is still to be exactly determined. Cytosolic 5'-nucleotidase overexpression and silencing have both been demonstrated to be toxic for mammalian cultured cells. In order to ascertain the effect of enzyme expression on a well-known eukaryote simple model, we expressed cytosolic 5'-nucleotidase II in Saccharomyces cerevisiae, which normally hydrolyzes IMP through the action of a nucleotidase with distinct functional and structural features. Heterologous expression was successful. The yeast cells harbouring cytosolic 5'-nucleotidase II displayed a shorter duplication time and a significant modification of purine and pyrimidine derivatives concentration as compared with the control strain. Furthermore the capacity of homologous recombination in the presence of mutagenic compounds of yeast expressing cytosolic 5'-nucleotidase II was markedly impaired.	[Allegrini, Simone; Filoni, Daniela Nicole] Univ Sassari, Dipartimento Chim Farm, I-07100 Sassari, Italy; [Filoni, Daniela Nicole; Pesi, Rossana; Camici, Marcella; Tozzi, Maria Grazia] Univ Pisa, Dipartimento Biol, Unita Biochim, Pisa, Italy; [Galli, Alvaro; Collavoli, Anita] Ist Fisiologia Clin, Consiglio Nazl Ric, Pisa, Italy	University of Sassari; University of Pisa; Consiglio Nazionale delle Ricerche (CNR)	Allegrini, S (corresponding author), Univ Sassari, Dipartimento Chim Farm, I-07100 Sassari, Italy.	enomis@uniss.it	Pesi, Rossana/AAQ-3102-2020; Tozzi, Maria Grazia/A-6018-2016; Allegrini, Simone/F-9192-2010; Galli, Alvaro/AAL-7247-2020; Galli, Alvaro/K-3146-2018	Tozzi, Maria Grazia/0000-0002-1075-7096; Allegrini, Simone/0000-0002-7005-654X; Galli, Alvaro/0000-0002-9091-5639; Pesi, Rossana/0000-0003-4785-7282	REGIONE AUTONOMA DELLA SARDEGNA [L.R.07/08/2007, CRP 3360]	REGIONE AUTONOMA DELLA SARDEGNA(Regione Sardegna)	This work was financially supported by a grant from the REGIONE AUTONOMA DELLA SARDEGNA, L.R.07/08/2007, CRP 3360 (TITLE: Modulation of expression by inducible silencing; heterologous expression in S. cerevisiae; two-hybrid system. Three models to make clear the physiological role of cytosolic 5'nucleotidase II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrin S, 2001, J BIOL CHEM, V276, P33526, DOI 10.1074/jbc.M104088200; Allegrini S, 2004, EUR J BIOCHEM, V271, P4881, DOI 10.1111/j.1432-1033.2004.04457.x; Allegrini S, 1997, BIOCHEM J, V328, P483, DOI 10.1042/bj3280483; Aylon Y, 2004, DNA REPAIR, V3, P797, DOI 10.1016/j.dnarep.2004.04.013; Barsotti C, 2003, CELL MOL LIFE SCI, V60, P786, DOI 10.1007/s00018-003-2371-x; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; Careddu MG, 2008, BBA-MOL CELL RES, V1783, P1529, DOI 10.1016/j.bbamcr.2008.03.018; Filoni DN, 2011, NUCLEOS NUCLEOT NUCL, V30, P1155, DOI 10.1080/15257770.2011.628355; Friedecky D, 2007, ELECTROPHORESIS, V28, P373, DOI 10.1002/elps.200600262; Galli A, 1999, MUTAT RES-FUND MOL M, V429, P13, DOI 10.1016/S0027-5107(99)00097-4; GALLI A, 1995, MOL GEN GENET, V248, P301, DOI 10.1007/BF02191597; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gazziola C, 1999, EXP CELL RES, V253, P474, DOI 10.1006/excr.1999.4681; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Ipata Piero Luigi, 2006, Purinergic Signal, V2, P669, DOI 10.1007/s11302-006-9009-z; ITOH R, 1994, BIOCHEM J, V298, P593, DOI 10.1042/bj2980593; ITOH R, 1992, COMP BIOCHEM PHYS B, V103, P153, DOI 10.1016/0305-0491(92)90427-S; ITOH R, 1993, COMP BIOCHEM PHYS B, V105, P13, DOI 10.1016/0305-0491(93)90163-Y; Itoh Roichi, 2003, BMC Biochem, V4, P4, DOI 10.1186/1471-2091-4-4; Kaiser C., 1994, METHODS YEAST GENETI; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Nakanishi T, 2002, J BIOL CHEM, V277, P22103, DOI 10.1074/jbc.M200573200; Pesi R, 1998, ADV EXP MED BIOL, V431, P495; PESI R, 1994, ARCH BIOCHEM BIOPHYS, V312, P75, DOI 10.1006/abbi.1994.1282; Pesi R, 2008, NEUROCHEM RES, V33, P59, DOI 10.1007/s11064-007-9407-9; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Rampazzo C, 1999, EUR J BIOCHEM, V261, P689, DOI 10.1046/j.1432-1327.1999.00320.x; Spychala J, 1999, EUR J BIOCHEM, V259, P851, DOI 10.1046/j.1432-1327.1999.00099.x; Srinivasan Bharath, 2007, In Silico Biology, V7, P187; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Wallden K, 2007, J BIOL CHEM, V282, P17828, DOI 10.1074/jbc.M700917200; Walther T, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.100	37	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63914	10.1371/journal.pone.0063914	http://dx.doi.org/10.1371/journal.pone.0063914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691116	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900066
J	Kim, H; Zamel, R; Bai, XH; Liu, MY				Kim, Hyunhee; Zamel, Ricardo; Bai, Xiao-Hui; Liu, Mingyao			PKC Activation Induces Inflammatory Response and Cell Death in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; ACUTE LUNG INJURY; KINASE-C-DELTA; GENE-EXPRESSION; INNATE IMMUNITY; TNF-ALPHA; DIFFERENTIAL REGULATION; PROTEIN; APOPTOSIS; INTERLEUKIN-8	A variety of airborne pathogens can induce inflammatory responses in airway epithelial cells, which is a crucial component of host defence. However, excessive inflammatory responses and chronic inflammation also contribute to different diseases of the respiratory system. We hypothesized that the activation of protein kinase C (PKC) is one of the essential mechanisms of inflammatory response in airway epithelial cells. In the present study, we stimulated human bronchial lung epithelial (BEAS-2B) cells with the phorbol ester Phorbol 12, 13-dibutyrate (PDBu), and examined gene expression profile using microarrays. Microarray analysis suggests that PKC activation induced dramatic changes in gene expression related to multiple cellular functions. The top two interaction networks generated from these changes were centered on NF kappa B and TNF-alpha, which are two commonly known pathways for cell death and inflammation. Subsequent tests confirmed the decrease in cell viability and an increase in the production of various cytokines. Interestingly, each of the increased cytokines was differentially regulated at mRNA and/or protein levels by different sub-classes of PKC isozymes. We conclude that pathological cell death and cytokine production in airway epithelial cells in various situations may be mediated through PKC related signaling pathways. These findings suggest that PKCs can be new targets for treatment of lung diseases.	[Kim, Hyunhee; Zamel, Ricardo; Bai, Xiao-Hui; Liu, Mingyao] Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada; [Kim, Hyunhee; Liu, Mingyao] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Liu, Mingyao] Univ Toronto, Fac Med, Inst Med Sci, Dept Surg, Toronto, ON M5S 1A8, Canada; [Liu, Mingyao] Univ Toronto, Fac Med, Inst Med Sci, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto	Liu, MY (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada.	mingyao.liu@utoronto.ca		Liu, Mingyao/0000-0002-9188-8417	Canadian Institutes of Health Research (CIHR) [MOP-13270, MOP-42546, MOP-119514]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The Canadian Institutes of Health Research (CIHR) operating grants MOP-13270, MOP-42546 and MOP-119514 supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnemri ES, 1997, J CELL BIOCHEM, V64, P33, DOI 10.1002/(SICI)1097-4644(199701)64:1<33::AID-JCB6>3.0.CO;2-0; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bin W, 2001, AM J PHYSIOL-LUNG C, V280, pL675, DOI 10.1152/ajplung.2001.280.4.L675; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; CHEN CC, 1995, J IMMUNOL, V155, P3538; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Dempsey EC, 2007, PHARMACOL RES, V55, P545, DOI 10.1016/j.phrs.2007.04.010; dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004; dos Santos CC, 2008, CRIT CARE MED, V36, P855, DOI 10.1097/CCM.0B013E3181659333; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200; Hermesh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037334; Hong JY, 2010, SCAND J IMMUNOL, V72, P15, DOI 10.1111/j.1365-3083.2010.02404.x; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Krunkosky TM, 2000, AM J RESP CELL MOL, V22, P685, DOI 10.1165/ajrcmb.22.6.3925; Le Page C, 2000, Rev Immunogenet, V2, P374; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lounsbury KM, 2002, AM J PATHOL, V160, P1991, DOI 10.1016/S0002-9440(10)61149-2; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Nelson S, 1998, INFECT DIS CLIN N AM, V12, P555, DOI 10.1016/S0891-5520(05)70198-7; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; POLUNOVSKY VA, 1994, EXP CELL RES, V214, P584, DOI 10.1006/excr.1994.1296; Shimizu S, 2000, AM J PHYSIOL-LUNG C, V279, pL503, DOI 10.1152/ajplung.2000.279.3.L503; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038049; Shtrichman R, 2001, CURR OPIN MICROBIOL, V4, P251, DOI 10.1016/S1369-5274(00)00199-5; Shukla A, 2003, AM J RESP CELL MOL, V29, P198, DOI 10.1165/rcmb.2002-0248OC; Simet SM, 2010, AM J RESP CELL MOL, V43, P635, DOI 10.1165/rcmb.2009-0297OC; Slevogt H, 2008, EUR RESPIR J, V31, P725, DOI 10.1183/09031936.00103507; Tanaka C, 1997, BIOCHEM BIOPH RES CO, V232, P568, DOI 10.1006/bbrc.1997.6264; Tang PS, 2008, AM J PHYSIOL-LUNG C, V294, pL632, DOI 10.1152/ajplung.00262.2007; Wajant H, 2003, ESSAYS BIOCHEM, V39, P53, DOI 10.1042/bse0390053; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wyatt TA, 1999, AM J RESP CELL MOL, V21, P283, DOI 10.1165/ajrcmb.21.2.3636; Xiao H, 2012, CELL MOL LIFE SCI; Xiao HL, 2013, J CELL PHYSIOL, V228, P416, DOI 10.1002/jcp.24146; Xiao HL, 2010, MOL CELL BIOL, V30, P5545, DOI 10.1128/MCB.00382-10; Xiao H, 2009, J CELL PHYSIOL, V218, P366, DOI 10.1002/jcp.21609; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200	39	47	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64182	10.1371/journal.pone.0064182	http://dx.doi.org/10.1371/journal.pone.0064182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691166	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107900083
J	Bacchus, C; Cheret, A; Avettand-Fenoel, V; Nembot, G; Melard, A; Blanc, C; Lascoux-Combe, C; Slama, L; Allegre, T; Allavena, C; Yazdanpanah, Y; Duvivier, C; Katlama, C; Goujard, C; Seksik, BCP; Leplatois, A; Molina, JM; Meyer, L; Autran, B; Rouzioux, C				Bacchus, Charline; Cheret, Antoine; Avettand-Fenoel, Veronique; Nembot, Georges; Melard, Adeline; Blanc, Catherine; Lascoux-Combe, Caroline; Slama, Laurence; Allegre, Thierry; Allavena, Clotilde; Yazdanpanah, Yazdan; Duvivier, Claudine; Katlama, Christine; Goujard, Cecile; Seksik, Bao Chau Phung; Leplatois, Anne; Molina, Jean-Michel; Meyer, Laurence; Autran, Brigitte; Rouzioux, Christine		OPTIPRIM ANRS 147 Study Grp	A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+Cell Subsets within One Month Post-Infection	PLOS ONE			English	Article							CD4(+) T-CELLS; INFECTION; DNA; REPLICATION; RESERVOIRS; DIAGNOSIS; INFANTS; TISSUES; LEVEL	Optimizing therapeutic strategies for an HIV cure requires better understanding the characteristics of early HIV-1 spread among resting CD4+ cells within the first month of primary HIV-1 infection (PHI). We studied the immune distribution, diversity, and inducibility of total HIV-DNA among the following cell subsets: monocytes, peripheral blood activated and resting CD4 T cells, long-lived (naive [TN] and central-memory [TCM]) and short-lived (transitional-memory [TTM] and effector-memory cells [TEM]) resting CD4+ T cells from 12 acutely-infected individuals recruited at a median 36 days from infection. Cells were sorted for total HIV-DNA quantification, phylogenetic analysis and inducibility, all studied in relation to activation status and cell signaling. One month post-infection, a single CCR5-restricted viral cluster was massively distributed in all resting CD4+ subsets from 88% subjects, while one subject showed a slight diversity. High levels of total HIV-DNA were measured among TN (median 3.4 log copies/millioncells), although10-foldless(p = 0.0005) than in equally infected TCM(4.5), TTM(4.7) and TEM(4.6) cells. CD3-CD4+ monocytesharbored a low viral burden(median 2.3 log copies/million cells), unlike equally infected resting and activated CD4+ T cells (4.5 log copies/million cells). The skewed repartition of resting CD4 subsets influenced their contribution to the pool of resting infected CD4+ T cells, two thirds of which consisted of short-lived TTM and TEM subsets, whereas long-lived TN and TCM subsets contributed the balance. Each resting CD4 subset produced HIV in vitro after stimulation with anti-CD3/anti-CD28+ IL-2 with kinetics and magnitude varying according to subset differentiation, while IL-7 preferentially induced virus production from long-lived resting TN cells. In conclusion, with in a month of infection, a clonal HIV-1 cluster is massively distributed among resting CD4T-cell subsets with a flexible inducibility, suggesting that subset activation and skewed immune homeostasis determine the conditions of viral dissemination and early establishment of the HIV reservoir.	[Bacchus, Charline; Autran, Brigitte] Univ Paris 06, UMR S 945, F-75013 Paris, France; [Bacchus, Charline; Autran, Brigitte] INSERM, UMR S 945, F-75013 Paris, France; [Cheret, Antoine; Avettand-Fenoel, Veronique; Melard, Adeline; Rouzioux, Christine] Paris Descartes Univ, Necker Enfants Malad Hosp, Virol Lab, Sorbonne Paris Cite,EA 3620, Paris, France; [Cheret, Antoine; Yazdanpanah, Yazdan] Gustave Dron Hosp, Dept Infect Dis, Tourcoing, France; [Nembot, Georges; Meyer, Laurence] Le Kremlin Bicetre Hosp, INSERM, Dept Epidemiol & Publ Hlth, U1018, Paris, France; [Blanc, Catherine] Univ Paris 06, Pitie Salpetriere Hosp, CyPS Flow Cytometry Platform, F-75013 Paris, France; [Lascoux-Combe, Caroline] Hop St Louis, AP HP, Dept Infect Dis, Paris, France; [Slama, Laurence] Tenon Hosp, AP HP, Dept Infect Dis, Paris, France; [Allegre, Thierry] Aix en Provence Hosp, Dept Hematol, Aix En Provence, France; [Allavena, Clotilde] Hop Hotel Dieu, Dept Infect Dis, Nantes, France; [Duvivier, Claudine] Necker Pasteur Infect Dis Ctr, Med Ctr, Inst Pasteur, Paris, France; [Katlama, Christine] Hop La Pitie Salpetriere, AP HP, Dept Infect Dis, Paris, France; [Goujard, Cecile] Le Kremlin Bicetre Hosp, AP HP, Internal Med & Infect Dis Dept, Paris, France; [Seksik, Bao Chau Phung] Hop Xavier Bichat, AP HP, Dept Infect Dis, Paris, France; [Leplatois, Anne] LArchet Hosp, Dept Infect Dis, Nice, France; [Molina, Jean-Michel] Sorbonne Paris Cite Univ, INSERM, St Louis Hosp, Infect Dis Unit,U941, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Autran, B (corresponding author), Univ Paris 06, UMR S 945, F-75013 Paris, France.	brigitte.autran@psl.aphp.fr	Allavena, Clotilde/AAH-4310-2019; Avettand-Fenoel, Véronique/O-6285-2017; Slama, Laurence/GYJ-7508-2022	Avettand-Fenoel, Véronique/0000-0002-7022-2990; 	National French Agency on AIDS Research (Agence Nationale de Recherche sur le Sida); Merck Sharp Dohme; Jansen; ViiV Healthcare; Gilead; Pierre and Marie Curie University; ANRS; scientific committee of the OPTIPRIM ANRS [147]	National French Agency on AIDS Research (Agence Nationale de Recherche sur le Sida); Merck Sharp Dohme(Merck & Company); Jansen; ViiV Healthcare; Gilead(Gilead Sciences); Pierre and Marie Curie University; ANRS(ANRSFrench National Research Agency (ANR)); scientific committee of the OPTIPRIM ANRS	This research was funded by the National French Agency on AIDS Research (Agence Nationale de Recherche sur le Sida, http://www.anrs.fr/), and supported by Merck Sharp & Dohme, Jansen, ViiV Healthcare and Gilead. C. Bacchus received a predoctoral fellowship from Pierre and Marie Curie University. The funders and supporters had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the ANRS for supporting the study, and also acknowledge the scientific committee of the OPTIPRIM ANRS 147 study for its members' intellectual and conceptual contributions. We particularly want to thank Catherine Blanc and Benedicte Hoareau for their exceptional cell sorting capacities at the CyPS Flow Cytometry platform at Pitie- Salpetriere hospital.	Ananworanich J, PLOS ONE, V7; Avettand-Fenoel V, 2011, J MED VIROL, V83, P1499, DOI 10.1002/jmv.22132; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Benaroch P, RETROVIROLOGY, V7, P29; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Centlivre M, J LEUKOC BIOL; Chomont N, 2009, NAT MED; Chomont N, 2007, AIDS, V21, P153, DOI 10.1097/QAD.0b013e328011f94b; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Chun TW, AIDS; Cohen MS, N ENGL J MED, V364, P1943; Cohen MS, 2002, J INFECT DIS, V202, pS270; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Ganesan A, 2010, J INFECT DIS, V201, P272, DOI 10.1086/649430; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LOES SKD, 1993, CLIN INFECT DIS, V17, P59, DOI 10.1093/clinids/17.1.59; Managlia EZ, 2006, VIROLOGY, V350, P443, DOI 10.1016/j.virol.2006.02.019; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Pedroza-Martins L, 2002, J VIROL, V76, P6929, DOI 10.1128/JVI.76.14.6929-6943.2002; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Schacker T, 2001, J INFECT DIS, V183, P555, DOI 10.1086/318524; Siliciano RF, 2012, INT AIDS SOC PRECONF; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x	33	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64219	10.1371/journal.pone.0064219	http://dx.doi.org/10.1371/journal.pone.0064219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691172	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400106
J	Barmeyer, C; Ye, JH; Soroka, C; Geibel, P; Hingsammer, LM; Weitgasser, L; Atway, D; Geibel, JP; Binder, HJ; Rajendran, VM				Barmeyer, Christian; Ye, Jeff Huaqing; Soroka, Carol; Geibel, Peter; Hingsammer, Lukas M.; Weitgasser, Laurence; Atway, Danny; Geibel, John P.; Binder, Henry J.; Rajendran, Vazhaikkurichi M.			Identification of Functionally Distinct Na-HCO3 Co-Transporters in Colon	PLOS ONE			English	Article							RAT DISTAL COLON; NA-H EXCHANGE; INTRACELLULAR PH REGULATION; SODIUM-BICARBONATE COTRANSPORTER; RENAL PROXIMAL TUBULE; BASOLATERAL MEMBRANE; NA+-HCO3-COTRANSPORTER; NA+/HCO3-COTRANSPORTER; NA+HCO3-COTRANSPORTER; TISSUE DISTRIBUTION	Na-HCO3 cotransport (NBC) regulates intracellular pH (pHi) and HCO3 secretion in rat colon. NBC has been characterized as a 5,5'-diisothiocyanato-2-2'-stilbene (DIDS)-sensitive transporter in several tissues, while the colonic NBC is sensitive to both amiloride and DIDS. In addition, the colonic NBC has been identified as critical for pHi regulation as it is activated by intravesicular acid pH. Molecular studies have identified several characteristically distinct NBC isoforms [i.e. electrogenic (NBCe) and electroneutral (NBCn)] that exhibit tissue specific expression. This study was initiated to establish the molecular identity and specific function of NBC isoforms in rat colon. Northern blot and reverse transcriptase PCR (RT-PCR) analyses revealed that electrogenic NBCe1B or NBCe1C (NBCe1B/C) isoform is predominantly expressed in proximal colon, while electroneutral NBCn1C or NBCn1D (NBCn1C/D) is expressed in both proximal and distal colon. Functional analyses revealed that amiloride-insensitive, electrogenic, pH gradient-dependent NBC activity is present only in basolateral membranes of proximal colon. In contrast, amiloride-sensitive, electroneutral, [H+]-dependent NBC activity is present in both proximal and distal colon. Both electrogenic and electroneutral NBC activities are saturable processes with an apparent Km for Na of 7.3 and 4.3 mM, respectively; and are DIDS-sensitive with apparent Ki of 8.9 and 263.8 mu M, respectively. In addition to Na-H exchanger isoform-1 (NHE1), pHi acidification is regulated by a HCO3-dependent mechanism that is HOE694-insensitive in colonic crypt glands. We conclude from these data that electroneutral, amiloride-sensitive NBC is encoded by NBCn1C/D and is present in both proximal and distal colon, while NBCe1B/C encodes electrogenic, amiloride-insensitive Na-HCO3 cotransport in proximal colon. We also conclude that NBCn1C/D regulates HCO3-dependent HOE694-insensitive Na-HCO3 cotransport and plays a critical role in pHi regulation in colonic epithelial cells.	[Barmeyer, Christian; Ye, Jeff Huaqing; Soroka, Carol; Binder, Henry J.; Rajendran, Vazhaikkurichi M.] Yale Univ, Dept Internal Med, New Haven, CT 06520 USA; [Geibel, Peter; Hingsammer, Lukas M.; Weitgasser, Laurence; Atway, Danny; Geibel, John P.] Yale Univ, Dept Surg, New Haven, CT USA; [Geibel, John P.; Binder, Henry J.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA; [Rajendran, Vazhaikkurichi M.] W Virginia Univ, Sch Med, Dept Biochem & Microbiol, Morgantown, WV 26506 USA	Yale University; Yale University; Yale University; West Virginia University	Rajendran, VM (corresponding author), Yale Univ, Dept Internal Med, New Haven, CT 06520 USA.	vrajendran@hsc.wvu.edu			Wellcome Trust; National Institute of Diabetes and Digestive and Kidney Diseases Research [DK-018777]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018777] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Diabetes and Digestive and Kidney Diseases Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Wellcome Trust and National Institute of Diabetes and Digestive and Kidney Diseases Research grants DK-018777. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Bevensee MO, 1997, J GEN PHYSIOL, V110, P467, DOI 10.1085/jgp.110.4.467; BEVENSEE MO, 2000, AM J PHYSIOL-CELL PH, V278, P1211; BORON WF, 1983, J GEN PHYSIOL, V81, P29, DOI 10.1085/jgp.81.1.29; BORON WF, 1983, J GEN PHYSIOL, V81, P53, DOI 10.1085/jgp.81.1.53; BORON WF, 2001, J PHYSL, V451, P365; Burnham CE, 1997, J BIOL CHEM, V272, P19111, DOI 10.1074/jbc.272.31.19111; Chen MM, 2012, J PHYSIOL-LONDON, V590, P3317, DOI 10.1113/jphysiol.2011.226506; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; CHOI I, 1999, AM J PHYSIOL, V276, P584; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; DART C, 1992, J PHYSIOL-LONDON, V451, P365, DOI 10.1113/jphysiol.1992.sp019169; DELCASTILLO JR, 1991, AM J PHYSIOL, V261, pG1005, DOI 10.1152/ajpgi.1991.261.6.G1005; FORBUSH B, 1983, ANAL BIOCHEM, V128, P159, DOI 10.1016/0003-2697(83)90356-1; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Grichtchenko II, 2000, J GEN PHYSIOL, V115, P533, DOI 10.1085/jgp.115.5.533; Ikuma M, 1999, AM J PHYSIOL-GASTR L, V276, pG539, DOI 10.1152/ajpgi.1999.276.2.G539; Ikuma M, 2003, AM J PHYSIOL-CELL PH, V285, pC912, DOI 10.1152/ajpcell.00396.2002; Ishiguro H, 1996, J PHYSIOL-LONDON, V495, P169, DOI 10.1113/jphysiol.1996.sp021582; Kim YB, 2003, BIOCHEM BIOPH RES CO, V304, P593, DOI 10.1016/S0006-291X(03)00632-6; Kurtz I, 2004, J MEMBRANE BIOL, V197, P77, DOI 10.1007/s00232-003-0643-x; LOMAX RB, 1994, AM J PHYSIOL, V266, pG71, DOI 10.1152/ajpgi.1994.266.1.G71; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marino CR, 1999, AM J PHYSIOL-GASTR L, V277, pG487, DOI 10.1152/ajpgi.1999.277.2.G487; Praetorius J, 2001, AM J PHYSIOL-GASTR L, V280, pG332, DOI 10.1152/ajpgi.2001.280.3.G332; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; RAJENDRAN VM, 1991, J CLIN INVEST, V88, P1379, DOI 10.1172/JCI115444; RAJENDRAN VM, 1995, J BIOL CHEM, V270, P11051, DOI 10.1074/jbc.270.19.11051; RAJENDRAN VM, 1994, J BIOL CHEM, V269, P156; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; Schmitt BM, 1999, AM J PHYSIOL-RENAL, V276, pF27, DOI 10.1152/ajprenal.1999.276.1.F27; Soleimani M, 2001, J MEMBRANE BIOL, V183, P71, DOI 10.1007/s00232-001-0055-8; UMESAKI Y, 1979, PFLUG ARCH EUR J PHY, V379, P43, DOI 10.1007/BF00622903; Vidyasagar S, 2004, AM J PHYSIOL-CELL PH, V287, pC612, DOI 10.1152/ajpcell.00474.2003; Vorum H, 2000, AM J PHYSIOL-RENAL, V279, pF901, DOI 10.1152/ajprenal.2000.279.5.F901; YUN CHC, 1995, AM J PHYSIOL-GASTR L, V269, pG1, DOI 10.1152/ajpgi.1995.269.1.G1; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; ZHAO H, 1994, J GEN PHYSIOL, V104, P57, DOI 10.1085/jgp.104.1.57	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62864	10.1371/journal.pone.0062864	http://dx.doi.org/10.1371/journal.pone.0062864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690961	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400022
J	Chang, WP; Wu, JJS; Shyu, BC				Chang, Wei-Pang; Wu, Jose Jiun-Shian; Shyu, Bai-Chuang			Thalamic Modulation of Cingulate Seizure Activity Via the Regulation of Gap Junctions in Mice Thalamocingulate Slice	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; RAT HIPPOCAMPAL SLICES; SPONTANEOUS EPILEPTIFORM ACTIVITY; CONNEXIN 36-DEFICIENT MICE; TEMPORAL-LOBE EPILEPSY; IN-VITRO; SYNAPTIC-TRANSMISSION; NETWORK ACTIVITY; LONG-TERM; EXTRACELLULAR POTASSIUM	The thalamus is an important target for deep brain stimulation in the treatment of seizures. However, whether the modulatory effect of thalamic inputs on cortical seizures occurs through the modulation of gap junctions has not been previously studied. Therefore, we tested the effects of different gap junction blockers and couplers in a drug-resistant seizure model and studied the role of gap junctions in the thalamic modulation on cortical seizures. Multielectrode array and calcium imaging were used to record the cortical seizures induced by 4-aminopyridine (250 mu M) and bicuculline (5-50 mu M) in a novel thalamocingulate slice preparation. Seizure-like activity was significantly attenuated by the pan-gap junction blockers carbenoxolone and octanol and specific neuronal gap junction blocker mefloquine. The gap junction coupler trimethylamine significantly enhanced seizure-like activity. Gap junction blockers did not influence the initial phase of seizure-like activity, but they significantly decreased the amplitude and duration of the maintenance phase. The development of seizures is regulated by extracellular potassium concentration. Carbenoxolone partially restored the amplitude and duration after removing the thalamic inputs. A two-dimensional current source density analysis showed that the sink and source signals shifted to deeper layers after removing the thalamic inputs during the clonic phase. These results indicate that the regulatory mechanism of deep brain stimulation in the thalamus occurs partially though gap junctions.	[Chang, Wei-Pang; Shyu, Bai-Chuang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Wu, Jose Jiun-Shian] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Shyu, Bai-Chuang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Shyu, BC (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	bmbai@gate.sinica.edu.tw	Shyu, Bai Chuang/Q-2622-2018	Shyu, Bai Chuang/0000-0001-5619-2281	National Science Council [99-2320-B-001-016-MY3]; Academia Sinica, Taiwan, Republic of China	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan, Republic of China(Academia Sinica - Taiwan)	This study was supported by grants from the National Science Council (http://web1.nsc.gov.tw/) (99-2320-B-001-016-MY3) and Academia Sinica (http://www.sinica.edu.tw/index.shtml), Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2011, J NEUROSCI, V31, P6542, DOI 10.1523/JNEUROSCI.6512-10.2011; Ammann D, 1986, ION SELECTIVE MICROE, Vxv; Amzica F, 2002, J NEUROSCI, V22, P1042, DOI 10.1523/JNEUROSCI.22-03-01042.2002; Anderson T, 2004, J PHYSIOL-LONDON, V559, P301, DOI 10.1113/jphysiol.2004.064998; Anderson TR, 2006, J NEUROSCI, V26, P841, DOI 10.1523/JNEUROSCI.3523-05.2006; Bancaud J, 1992, Adv Neurol, V57, P3; Bertram EH, 2001, EPILEPSIA, V42, P967, DOI 10.1046/j.1528-1157.2001.042008967.x; Bikson M, 2002, NEUROSCIENCE, V115, P251, DOI 10.1016/S0306-4522(02)00320-2; Bocian R, 2011, EUR J NEUROSCI, V33, P471, DOI 10.1111/j.1460-9568.2010.07545.x; Borck C, 1999, J NEUROPHYSIOL, V82, P2130, DOI 10.1152/jn.1999.82.5.2130; Bordey A, 1998, EPILEPSY RES, V32, P286, DOI 10.1016/S0920-1211(98)00059-X; Bostanci MO, 2007, NEUROPHARMACOLOGY, V52, P362, DOI 10.1016/j.neuropharm.2006.08.008; Bruckner C, 1999, NEUROSCI LETT, V268, P163, DOI 10.1016/S0304-3940(99)00341-9; Chang WC, 2012, NEUROSCIENCE, V222, P302, DOI 10.1016/j.neuroscience.2012.07.014; Chang WP, 2011, EPILEPSIA, V52, P2344, DOI 10.1111/j.1528-1167.2011.03312.x; Chang WP, 2011, EPILEPSIA; Cruikshank SJ, 2005, PROG BRAIN RES, V149, P41, DOI 10.1016/S0079-6123(05)49004-4; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Degen J, 2004, J COMP NEUROL, V473, P511, DOI 10.1002/cne.20085; Dudek F Edward, 2002, Epilepsy Curr, V2, P137, DOI 10.1046/j.1535-7597.2002.t01-1-00052.x; Duffy S, 1999, Adv Neurol, V79, P573; Engel J, 1996, CAN J NEUROL SCI, V23, P167, DOI 10.1017/S0317167100038464; Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Ghai RS, 2000, J NEUROPHYSIOL, V84, P274, DOI 10.1152/jn.2000.84.1.274; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gigout S, 2006, NEUROBIOL DIS, V22, P496, DOI 10.1016/j.nbd.2005.12.011; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; GROENEWEGEN HJ, 1988, NEUROSCIENCE, V24, P379, DOI 10.1016/0306-4522(88)90339-9; Hatanaka N, 2003, J COMP NEUROL, V462, P121, DOI 10.1002/cne.10720; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Iglesias R, 2009, CELL COMMUN ADHES, V16, P131, DOI 10.3109/15419061003642618; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Jahromi SS, 2002, J NEUROPHYSIOL, V88, P1893, DOI 10.1152/jn.2002.88.4.1893; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; Juhasz C, 1999, NEUROLOGY, V53, P2037, DOI 10.1212/WNL.53.9.2037; Kahane P, 2010, CURR OPIN NEUROL, V23, P177, DOI 10.1097/WCO.0b013e3283374a39; Klaassen A, 2006, P NATL ACAD SCI USA, V103, P19152, DOI 10.1073/pnas.0608215103; Kohling R, 2001, NEUROSCIENCE, V105, P579, DOI 10.1016/S0306-4522(01)00222-6; Konopacki J, 2004, BRAIN RES, V1019, P270, DOI 10.1016/j.brainres.2004.05.083; KRETTEK JE, 1977, J COMP NEUROL, V171, P157, DOI 10.1002/cne.901710204; Kuroda M, 1998, PROG NEUROBIOL, V54, P417, DOI 10.1016/S0301-0082(97)00070-1; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Langlois M, 2010, J NEUROSCI, V30, P16523, DOI 10.1523/JNEUROSCI.1109-10.2010; Lee CM, 2007, EUR J NEUROSCI, V25, P2847, DOI 10.1111/j.1460-9568.2007.05485.x; Lim SN, 2007, EPILEPSIA, V48, P342, DOI 10.1111/j.1528-1167.2006.00898.x; Logan JV, 2011, BRIDGING GAP UNDERST; Maier N, 2002, J PHYSIOL-LONDON, V541, P521, DOI 10.1113/jphysiol.2002.017624; Mann EO, 2008, CURR OPIN NEUROL, V21, P155, DOI 10.1097/WCO.0b013e3282f52f5f; Margineanu DG, 2001, NEUROPHARMACOLOGY, V41, P377, DOI 10.1016/S0028-3908(01)00080-6; Margineanu DG, 2006, BRAIN RES BULL, V71, P23, DOI 10.1016/j.brainresbull.2006.07.011; Marty A, 2005, TRENDS NEUROSCI, V28, P284, DOI 10.1016/j.tins.2005.04.003; McCagh J, 2009, EPILEPSY RES, V86, P1, DOI 10.1016/j.eplepsyres.2009.04.007; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Nadkarni S., 2009, CINGULATE NEUROBIOLO, P633; Nemani VM, 2005, HISTOL HISTOPATHOL, V20, P253, DOI 10.14670/HH-20.253; Panuccio G, 2008, BIOPHYS BIOENG LETT, V1, P7; Panuccio G, 2009, EPILEPSIA, V50, P521, DOI 10.1111/j.1528-1167.2008.01779.x; Park EH, 2006, J THEOR BIOL, V238, P666, DOI 10.1016/j.jtbi.2005.06.015; PERREAULT P, 1992, J NEUROSCI, V12, P104; Pinto DJ, 2005, J NEUROSCI, V25, P8131, DOI 10.1523/JNEUROSCI.2278-05.2005; PRINCE DA, 1967, ELECTROEN CLIN NEURO, V23, P83; Quiroga R Quian, 2002, Electromyogr Clin Neurophysiol, V42, P323; Rogawski MA, 2005, NAT MED, V11, P919, DOI 10.1038/nm0905-919; Ross FM, 2000, NEUROSCIENCE, V100, P789, DOI 10.1016/S0306-4522(00)00346-8; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Shimono K, 2001, NEUROCOMPUTING, P38; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Sun JJ, 2007, EUR J NEUROSCI, V26, P1995, DOI 10.1111/j.1460-9568.2007.05819.x; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Szente M, 2002, NEUROSCIENCE, V115, P1067, DOI 10.1016/S0306-4522(02)00533-X; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tovar KR, 2009, J NEUROPHYSIOL, V102, P974, DOI 10.1152/jn.00060.2009; TRAUB RD, 1993, J PHYSIOL-LONDON, V472, P267, DOI 10.1113/jphysiol.1993.sp019946; Uusisaaria M, 2002, NEUROPHARMACOLOGY, V43, P563, DOI 10.1016/S0028-3908(02)00156-9; VELASCO F, 1995, EPILEPSIA, V36, P63, DOI 10.1111/j.1528-1157.1995.tb01667.x; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; Wang CC, 2004, BRAIN RES, V995, P226, DOI 10.1016/j.brainres.2003.10.006; Wu LJ, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-32; Xiong ZQ, 1999, EUR J NEUROSCI, V11, P1677, DOI 10.1046/j.1460-9568.1999.00587.x; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009	86	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62952	10.1371/journal.pone.0062952	http://dx.doi.org/10.1371/journal.pone.0062952			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690968	Green Published, gold			2022-12-25	WOS:000319107400024
J	Huang, GH; Yu, DS; Mao, NY; Zhu, Z; Zhang, H; Jiang, ZY; Li, HY; Zhang, Y; Shi, J; Zhang, S; Wang, XH; Xu, WB				Huang, Guohong; Yu, Deshan; Mao, Naiying; Zhu, Zhen; Zhang, Hui; Jiang, Zhongyi; Li, Hongyu; Zhang, Yan; Shi, Jing; Zhang, Shuang; Wang, Xinhua; Xu, Wenbo			Viral Etiology of Acute Respiratory Infection in Gansu Province, China, 2011	PLOS ONE			English	Article							PCR ASSAY; CHILDREN; DIAGNOSIS; VIRUSES; RHINOVIRUS; INFANTS; DISEASE	Background: Acute respiratory infections (ARIs) are the leading cause of children and their leading killer. ARIs are responsible for at least six percent of the world's disability and death. Viruses are one of the most common agents causing ARIs. Few studies on the viral etiology and clinical characteristics of ARIs have been performed in the northwest region of China, including Gansu Province. Methods: Clinical and demographic information and throat swabs were collected from 279 patients from January 1st to December 30st, 2011. Multiplex RT-PCR was performed to detect 16 respiratory viral pathogens. Results: 279 patients were admitted for ARIs. The patients aged from 1 month to 12 years, with the median age of 2 years. Of which, 105 (37.6%) were positive for at least one pathogen. A total of 136 respiratory viral pathogens were identified from the 105 patients. Respiratory syncytial virus (RSV) was the most frequently detected pathogen (26.5%, 36/136), followed by parainfluenza virus (PIV) 1-3 (22.1%, 30/136), human rhinovirus (HRV) (21.3%, 29/136), human coronavirus (CoV) (10.3%, 14/136) and human adenovirus (HAdV) (9.6%, 13/136). Influenza A (Flu A), human metapneumovirus (hMPV) and human bocavirus (BoCA) were found 4.4%, 3.7% and 2.2%, respectively. Influenza B (Flu B) and seasonal influenza A H1N1(sH1N1) were not detected. Single-infections were detected in 30.5% (85/279) of cases. RSV was the most common pathogens in patients under 1 year and showed seasonal variation with peaks during winter and spring. Conclusions: This paper presents data on the epidemiology of viral pathogens associated with ARIs among children in Gansu Province, China. RSV is most frequently detected in our study. The findings could serve as a reference for local CDC in drawing up further plans to prevent and control ARIs.	[Huang, Guohong; Mao, Naiying; Zhu, Zhen; Zhang, Yan; Shi, Jing; Zhang, Shuang; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China; [Yu, Deshan; Zhang, Hui; Jiang, Zhongyi; Li, Hongyu; Wang, Xinhua] Gansu Ctr Dis Control & Prevent, Lanzhou, Peoples R China; [Huang, Guohong] Xinjiang Med Univ, Urumqi, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Xinjiang Medical University	Wang, XH (corresponding author), Gansu Ctr Dis Control & Prevent, Lanzhou, Peoples R China.	wangxinhua1964@163.com; wenbo_xu1@yahoo.com.cn	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	National Infectious Diseases Surveillance Program [2012ZX10004201, 2012ZX10004202, 20121004-208]	National Infectious Diseases Surveillance Program	This work was supported by the National Infectious Diseases Surveillance Program (2012ZX10004201, 2012ZX10004202, and 20121004-208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck ET, 2010, FUTURE MICROBIOL, V5, P901, DOI [10.2217/fmb.10.48, 10.2217/FMB.10.48]; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Bharaj P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-89; Brittain-Long R, 2012, SCAND J INFECT DIS, V44, P9, DOI 10.3109/00365548.2011.598876; Brittain-Long R, 2010, J CLIN VIROL, V47, P263, DOI 10.1016/j.jcv.2009.12.010; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Esposito S, 2006, J MED VIROL, V78, P1609, DOI 10.1002/jmv.20745; Greenberg SB, 2011, SEMIN RESP CRIT CARE, V32, P433, DOI 10.1055/s-0031-1283283; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; He J., 2011, J MICROBES INFECT, V6, P90; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Kim C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021610; Kim YK, 2008, SCAND J INFECT DIS, V40, P946, DOI 10.1080/00365540802398937; Lam WY, 2007, J CLIN MICROBIOL, V45, P3631, DOI 10.1128/JCM.00280-07; Li Jin, 2011, Chinese Journal of Virology, V27, P526; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mahony JB, 2010, EXPERT REV ANTI-INFE, V8, P1273, DOI [10.1586/eri.10.121, 10.1586/ERI.10.121]; Mathisen Maria, 2010, Pediatr Infect Dis J, V29, pe1, DOI 10.1097/INF.0b013e3181c2a1b9; Matthew J, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-16; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Pierangeli A, 2007, J MED VIROL, V79, P463, DOI 10.1002/jmv.20832; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Ren LL, 2011, J MED VIROL, V83, P291, DOI 10.1002/jmv.21956; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Weber MW, 2002, B WORLD HEALTH ORGAN, V80, P562; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health Organization, 2002, WORLD HLTH REP, P192; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174; Zhao Baihui, 2011, Wei Sheng Yan Jiu, V40, P635; Zou Li-rong, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P825, DOI 10.3760/cma.j..issn.0253-9624.2011.09.013	32	39	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64254	10.1371/journal.pone.0064254	http://dx.doi.org/10.1371/journal.pone.0064254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691184	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400111
J	Li, W; Yan, FG; Zhou, HB; Lin, XP; Wu, YF; Chen, C; Zhou, NY; Chen, ZH; Li, JD; Shen, HH				Li, Wen; Yan, Fugui; Zhou, Hongbin; Lin, Xiaoping; Wu, Yinfang; Chen, Ce; Zhou, Niya; Chen, Zhihua; Li, Jian-dong; Shen, Huahao			P-aeruginosa Lipopolysaccharide-Induced MUC5AC and CLCA3 Expression Is Partly through Duox1 In Vitro and In Vivo	PLOS ONE			English	Article							ALPHA-CONVERTING ENZYME; NADPH OXIDASE; MUCIN EXPRESSION; EPITHELIAL-CELLS; DIFFERENTIAL REGULATION; MUCUS OVERPRODUCTION; OXIDATIVE STRESS; AIRWAY; ACTIVATION; RESPONSES	Background: We have previously found that reactive oxygen species (ROS) are involved in Pseudomonas aeruginosa lipopolysaccharide (PA-LPS) induced MUC5AC in airway epithelial cells. Dual oxidase1 (Duox1), a member of NADPH oxidase(Nox), is known to be responsible for ROS production in respiratory tract epithelial cells. Our aim was to clarify whether Duox1 was also involved in the PA-LPS-induced MUC5AC and calcium dependent chloride channel 3(Clca3), another recognized marker of goblet cell hyperplasia and mucus hyper-production. Methods: PA-LPS-induced Duox1 mRNA levels were examined in A549 cells, primary mouse tracheal epithelial cells (mTECS) and lung tissues of mice. Nox inhibitors diphenyleneiodonium chloride (DPI) and Duox1 siRNA were used to investigate whether Duox1 is involved in PA-LPS-induced MUC5AC and Clca3 expression both in vitro and in vivo. Results: Duox1 is induced by PA-LPS in A549 cells, primary mTECs and lung tissues of mice. DPI significantly inhibited PA-LPS-induced up-regulation of Duox1, Muc5ac and Clca3 in primary mouse trachea epithelial cells and lung tissues of mice. Knockdown of Duox1 markedly inhibited PA-LPS-induced MUC5AC expression via a ROS-TGF-alpha cascade in A549 cells. Furthermore, DPI significantly inhibited PA-LPS-induced increases in inflammatory cells accumulated in mouse lungs. Conclusions: We demonstrate for the first time that PA-LPS-induced MUC5AC and Clca3 expression is partly through Duox1, and provide supportive evidence for Duox1 as a potential target in treatments of mucin over-production diseases.	[Li, Wen; Yan, Fugui; Zhou, Hongbin; Wu, Yinfang; Chen, Ce; Zhou, Niya; Chen, Zhihua; Shen, Huahao] Zhejiang Univ, Sch Med, Hosp 2, Dept Resp & Crit Care Med, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Xiaoping] Fujian Med Univ, Hosp 2, Dept Resp & Crit Care Med, Quanzhou, Fujian, Peoples R China; [Li, Jian-dong] Georgia State Univ, Dept Biol, Ctr Inflammat Immun & Infect, Atlanta, GA USA; [Shen, Huahao] State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Zhejiang University; Fujian Medical University; University System of Georgia; Georgia State University; State Key Laboratory of Respiratory Disease	Shen, HH (corresponding author), Zhejiang Univ, Sch Med, Hosp 2, Dept Resp & Crit Care Med, Hangzhou 310003, Zhejiang, Peoples R China.	hh_shen@yahoo.com.cn		Li, Jian-Dong/0000-0002-5593-050X	National Natural Science Foundation for Distinguished Young Scholars of China [30825019]; National Natural Science Foundation of China [30770948, 30871129, 81070013, 81170037, 81000008]; Natural Science Foundation of Zhejiang Province [Y2090614]; National Institute of Health [RO1DC004562, RO1DC005843]; Medical Science Project of Zhejiang Province [2009A100]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005843, R01DC004562] Funding Source: NIH RePORTER	National Natural Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Science Project of Zhejiang Province; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by grants from National Natural Science Foundation for Distinguished Young Scholars of China (No. 30825019), National Natural Science Foundation of China (No. 30770948, No. 30871129, No. 81070013, No. 81170037, No. 81000008), the Natural Science Foundation of Zhejiang Province (No. Y2090614), National Institute of Health RO1DC004562 and RO1DC005843 and the Medical Science Project of Zhejiang Province(No. 2009A100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belcher CE, 2000, P NATL ACAD SCI USA, V97, P13847, DOI 10.1073/pnas.230262797; Boots AW, 2009, J BIOL CHEM, V284, P17858, DOI 10.1074/jbc.M809761200; BOUCHER RC, 2000, TXB RESP MED, P1291; Caillou B, 2001, J CLIN ENDOCR METAB, V86, P3351, DOI 10.1210/jc.86.7.3351; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; Cressman VL, 1998, AM J RESP CELL MOL, V19, P853, DOI 10.1165/ajrcmb.19.6.3194; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Fischer H, 2009, ANTIOXID REDOX SIGN, V11, P2453, DOI [10.1089/ars.2009.2558, 10.1089/ARS.2009.2558]; Fujimoto K, 2002, AM J RESP CRIT CARE, V165, pA599; Gao XP, 2002, J IMMUNOL, V168, P3974, DOI 10.4049/jimmunol.168.8.3974; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hoshino M, 2002, AM J RESP CRIT CARE, V165, P1132, DOI 10.1164/ajrccm.165.8.2107068; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; Hovenberg HW, 1996, GLYCOCONJUGATE J, V13, P839, DOI 10.1007/BF00702348; Kim HJ, 2008, AM J RESP CELL MOL, V39, P598, DOI 10.1165/rcmb.2007-0262OC; KNOWLES MR, 1991, NEW ENGL J MED, V325, P533, DOI 10.1056/NEJM199108223250802; Kohri K, 2002, EUR RESPIR J, V20, P1263, DOI 10.1183/09031936.02.00001402; Kong XN, 2010, J IMMUNOL, V185, P569, DOI 10.4049/jimmunol.0902315; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Lora JM, 2005, J BIOL CHEM, V280, P36510, DOI 10.1074/jbc.M507977200; LUNDGREN JD, 1990, J ALLERGY CLIN IMMUN, V85, P399, DOI 10.1016/0091-6749(90)90147-V; Nakanaga T, 2007, AM J PHYSIOL-LUNG C, V292, pL1289, DOI 10.1152/ajplung.00356.2006; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Rada B, 2008, J IMMUNOL, V181, P4883, DOI 10.4049/jimmunol.181.7.4883; Rigutto S, 2009, J BIOL CHEM, V284, P6725, DOI 10.1074/jbc.M806893200; Schwarzer C, 2004, J BIOL CHEM, V279, P36454, DOI 10.1074/jbc.M404983200; Shao MXG, 2005, J IMMUNOL, V175, P4009, DOI 10.4049/jimmunol.175.6.4009; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Shao MXG, 2004, AM J PHYSIOL-LUNG C, V287, pL420, DOI 10.1152/ajplung.00019.2004; Shao MXG, 2003, P NATL ACAD SCI USA, V100, P11618, DOI 10.1073/pnas.1534804100; Shen H, 2008, BIOCHEM BIOPH RES CO, V365, P795, DOI 10.1016/j.bbrc.2007.11.060; Song KS, 2003, J BIOL CHEM, V278, P23243, DOI 10.1074/jbc.M300096200; Thai P, 2005, AM J RESP CELL MOL, V33, P523, DOI 10.1165/rcmb.2004-0220RC; Wang BN, 2002, J BIOL CHEM, V277, P949, DOI 10.1074/jbc.M107484200; Yan FG, 2008, BIOCHEM BIOPH RES CO, V366, P513, DOI 10.1016/j.bbrc.2007.11.172; Zhang WJ, 2009, FREE RADICAL BIO MED, V46, P791, DOI 10.1016/j.freeradbiomed.2008.12.003	40	14	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63945	10.1371/journal.pone.0063945	http://dx.doi.org/10.1371/journal.pone.0063945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691121	gold, Green Submitted, Green Published			2022-12-25	WOS:000319107400088
J	Kazak, L; Reyes, A; He, JY; Wood, SR; Brea-Calvo, G; Holen, TT; Holt, IJ				Kazak, Lawrence; Reyes, Aurelio; He, Jiuya; Wood, Stuart R.; Brea-Calvo, Gloria; Holen, Torgeir T.; Holt, Ian J.			A Cryptic Targeting Signal Creates a Mitochondrial FEN1 Isoform with Tailed R-Loop Binding Properties	PLOS ONE			English	Article							FLAP ENDONUCLEASE-1; CELL MITOCHONDRIA; GENOME STABILITY; SORTING SIGNALS; DNA-REPLICATION; LAGGING-STRAND; RNA-POLYMERASE; DAMAGE REPAIR; PROTEINS; TRANSCRIPTION	A growing number of DNA transacting proteins is found in the nucleus and in mitochondria, including the DNA repair and replication protein Flap endonuclease 1, FEN1. Here we show a truncated FEN1 isoform is generated by alternative translation initiation, exposing a mitochondrial targeting signal. The shortened form of FEN1, which we term FENMIT, localizes to mitochondria, based on import into isolated organelles, immunocytochemistry and subcellular fractionation. In vitro FENMIT binds to flap structures containing a 59 RNA flap, and prefers such substrates to single-stranded RNA. FENMIT can also bind to R-loops, and to a lesser extent to D-loops. Exposing human cells to ethidium bromide results in the generation of RNA/DNA hybrids near the origin of mitochondrial DNA replication. FENMIT is recruited to the DNA under these conditions, and is released by RNase treatment. Moreover, high levels of recombinant FENMIT expression inhibit mtDNA replication, following ethidium bromide treatment. These findings suggest FENMIT interacts with RNA/DNA hybrids in mitochondrial DNA, such as those found at the origin of replication.	[Kazak, Lawrence; Reyes, Aurelio; He, Jiuya; Wood, Stuart R.; Brea-Calvo, Gloria] Wellcome Trust Res Labs, Mitochondrial Biol Unit, MRC, Cambridge, England; [Holen, Torgeir T.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Holt, Ian J.] Natl Inst Med Res, MRC, London NW7 1AA, England	Wellcome Trust Sanger Institute; University of Oslo; MRC National Institute for Medical Research	Holt, IJ (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	iholt@nimr.mrc.ac.uk	Brea-Calvo, Gloria/N-4728-2014	Brea-Calvo, Gloria/0000-0001-5536-6868; holt, ian/0000-0001-5468-0193	UK Medical Research Council; Cambridge University Commonwealth Trust Fellowship; Medical Research Council [MC_UP_1202/14, MC_U105663140] Funding Source: researchfish; MRC [MC_UP_1202/14, MC_U105663140] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge University Commonwealth Trust Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Elizabeth Ing-Simmons for help with experiments using recombinant FEN1, and our colleagues and collaborators for their support and advice, in particular Drs Jaakko Pohjoismaki and Johannes Spelbrink. The TWINKLE and TFAM antibodies were kind gifts of Dr. Anu Suomalainen and Dr. Rudolph Wiesner, respectively. LK was the recipient of a Cambridge University Commonwealth Trust Fellowship.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bazykin GA, 2011, NUCLEIC ACIDS RES, V39, P567, DOI 10.1093/nar/gkq806; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; BREEN GAM, 1980, J CELL BIOL, V86, P723, DOI 10.1083/jcb.86.3.723; CARRE D, 1978, BIOCHEMISTRY-US, V17, P3263, DOI 10.1021/bi00609a014; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CURRAN J, 1988, EMBO J, V7, P245, DOI 10.1002/j.1460-2075.1988.tb02806.x; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Guo ZG, 2008, MOL CELL BIOL, V28, P4310, DOI 10.1128/MCB.00200-08; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Kaiser MW, 1999, J BIOL CHEM, V274, P21387, DOI 10.1074/jbc.274.30.21387; Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008; Kazak L, 2013, NUCLEIC ACIDS RES, V41, P2354, DOI 10.1093/nar/gks1347; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu R, 2006, NUCLEIC ACIDS RES, V34, P1772, DOI 10.1093/nar/gkl106; Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921; Moe SE, 2008, J NEUROSCI METH, V171, P233, DOI 10.1016/j.jneumeth.2008.03.012; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; PRATS AC, 1989, J MOL BIOL, V205, P363, DOI 10.1016/0022-2836(89)90347-1; Reyes A, 2011, NUCLEIC ACIDS RES, V39, P5098, DOI 10.1093/nar/gkr052; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; Sharma NK, 2012, NUCLEIC ACIDS RES, V40, P712, DOI 10.1093/nar/gkr758; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Wanrooij PH, 2010, P NATL ACAD SCI USA, V107, P16072, DOI 10.1073/pnas.1006026107; WARING MJ, 1964, BIOCHIM BIOPHYS ACTA, V87, P358, DOI 10.1016/0926-6550(64)90238-5; Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771	49	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62340	10.1371/journal.pone.0062340	http://dx.doi.org/10.1371/journal.pone.0062340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675412	Green Submitted, gold, Green Published			2022-12-25	WOS:000319036100003
J	Shen, BZ; Yu, Y; Chen, H; Cao, X; Lao, XZ; Fang, YL; Shi, Y; Chen, J; Zheng, H				Shen, Bingzheng; Yu, Yan; Chen, Hui; Cao, Xin; Lao, Xingzhen; Fang, Yongliang; Shi, Yun; Chen, Jiao; Zheng, Heng			Inhibitor Discovery of Full-Length New Delhi Metallo-beta-Lactamase-1 (NDM-1)	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; STANDARD NUMBERING SCHEME; ESCHERICHIA-COLI; EMERGENCE; DENSITY; IMP-1; RESISTANCE; MEROPENEM; MECHANISM; ENERGY	New Delhi metallo-beta-lactmase-1 (NDM-1) has recently attracted extensive attention for its biological activities to catalyze the hydrolysis of almost all of beta-lactam antibiotics. To study the catalytic property of NDM-1, the steady-kinetic parameters of NDM-1 toward several kinds of b-lactam antibiotics have been detected. It could effectively hydrolyze most beta-lactams (k(cat)/K-m ratios between 0.03 to 1.28 mu mol(-1).s(-1)), except aztreonam. We also found that thiophene-carboxylic acid derivatives could inhibit NDM-1 and have shown synergistic antibacterial activity in combination with meropenem. Flexible docking and quantum mechanics (QM) study revealed electrostatic interactions between the sulfur atom of thiophene-carboxylic acid derivatives and the zinc ion of NDM-1, along with hydrogen bond between inhibitor and His189 of NDM-1. The interaction models proposed here can be used in rational design of NDM-1 inhibitors.	[Shen, Bingzheng; Fang, Yongliang; Zheng, Heng] Chinese Acad Sci, State Key Lab Soil & Sustainable Agr, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China; [Shen, Bingzheng; Chen, Hui; Lao, Xingzhen; Fang, Yongliang; Shi, Yun; Chen, Jiao; Zheng, Heng] China Pharmaceut Univ, Dept Pharmaceut Bioinformat, Nanjing, Jiangsu, Peoples R China; [Yu, Yan] Huazhong Univ Sci & Technol, Dept Gastroenterol & Hepatol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Cao, Xin] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Shen, Bingzheng] Wuhan Univ, Dept Pharm, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; China Pharmaceutical University; Huazhong University of Science & Technology; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Wuhan University	Zheng, H (corresponding author), Chinese Acad Sci, State Key Lab Soil & Sustainable Agr, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China.	zhengh18@hotmail.com	CHEN, JIAO/GZA-5784-2022; Cao, Xin/L-7110-2019; Shi, Yun/AAG-3890-2020; chen, JJ/HGB-6029-2022	Cao, Xin/0000-0003-1722-023X; Shi, Yun/0000-0003-3365-4679; 	State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences [Y052010040]; Fundamental Research Funds for the Central Universities of China [JKZ2009007]	State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences(Chinese Academy of Sciences); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the Open Project Program of State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences (No. Y052010040) and the Fundamental Research Funds for the Central Universities of China (No. JKZ2009007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; [Anonymous], 2009, DISC STUD VERS 2 5 U; BECKE AD, 1988, J CHEM PHYS, V88, P2547, DOI 10.1063/1.454033; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Guo Y, 2011, PROTEIN CELL, V2, P384, DOI 10.1007/s13238-011-1055-9; Hammond GG, 1999, FEMS MICROBIOL LETT, V179, P289, DOI 10.1111/j.1574-6968.1999.tb08740.x; Hao QR, 2013, J PEPT SCI, V19, P173, DOI 10.1002/psc.2488; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Jamal W, 2012, INT J ANTIMICROB AG, V39, P183, DOI 10.1016/j.ijantimicag.2011.10.002; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Laraki N, 1999, ANTIMICROB AGENTS CH, V43, P902, DOI 10.1128/AAC.43.4.902; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LEVY M, 1979, P NATL ACAD SCI USA, V76, P6062, DOI 10.1073/pnas.76.12.6062; Menikarachchi LC, 2010, CURR TOP MED CHEM, V10, P46, DOI 10.2174/156802610790232297; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Moloughney JG, 2005, FEMS MICROBIOL LETT, V243, P65, DOI 10.1016/j.femsle.2004.11.042; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P4914, DOI 10.1128/AAC.00878-10; Riley KE, 2007, J CHEM THEORY COMPUT, V3, P407, DOI 10.1021/ct600185a; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Shen B, 2012, Faming Zhuanli Shenqing, Patent No. [CN102304108A, 102304108]; Sherwood P, 2003, J MOL STRUC-THEOCHEM, V632, P1, DOI 10.1016/S0166-1280(03)00285-9; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Thomas PA, 2011, CURR CLIN PATHOL, P1, DOI 10.1007/978-1-60327-154-7_1; Ververs TFT, 2000, CRIT CARE MED, V28, P3412, DOI 10.1097/00003246-200010000-00006; Wachino J, 2011, ANTIMICROB AGENTS CH, V55, P5143, DOI 10.1128/AAC.05045-11; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Yang H, 2012, BIOCHEMISTRY-US, V51, P3839, DOI 10.1021/bi300056y; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036	35	32	38	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62955	10.1371/journal.pone.0062955	http://dx.doi.org/10.1371/journal.pone.0062955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675445	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100026
J	Agampodi, SB; Wickramasinghe, ND; Horton, J; Agampodi, TC				Agampodi, Suneth Buddhika; Wickramasinghe, Nuwan Dharshana; Horton, Jennifer; Agampodi, Thilini Chanchala			Minor Ailments in Pregnancy Are Not a Minor Concern for Pregnant Women: A Morbidity Assessment Survey in Rural Sri Lanka	PLOS ONE			English	Article							NAUSEA; QUALITY; ILLNESS; COST	Background: Although maternal mortality has become a major focus on global public health agenda, maternal morbidity is a neglected area of research. The purpose of this paper is to present the burden of acute maternal illness during pregnancy. Methods: A cross sectional study was carried out in Anuradhapura district, Sri Lanka. Pregnant women residing in the Anuradhapura district with a gestational age more than 24 weeks through 36 weeks were recruited to the study using a two-stage cluster sampling technique. All pregnant women who consented participated in a detailed interview using a structured questionnaire. Self reported episodes of acute illness during pregnancy were the main outcome measures. Secondary outcomes were utilization of medical services and frequency of hospitalizations. Results: Nausea and vomiting during pregnancy (NVP) was experienced by 325 (69.7%) of the 466 pregnant women studied. Other common symptoms were backache (152, 32.6%), dizziness (112, 24.0%) and heartburn/regurgitation (107, 23.0%). Of the 421 pregnant women who reported ill health conditions 260 (61.8%) women sought medical treatment for these illnesses. Total number of episodes that needed treatment seeking were 373. Hospitalizations were reported by 83 (17.8%) pregnant women and the total number of hospitalizations was 109. The leading cause of hospitalization was NVP which accounted for 43.1% of total admissions and 49.1% of total days spent in hospitals. Conclusions: Minor maternal ill health conditions affecting day-to-day life have a major burden on pregnancy period. Evidence based management guidelines and health promotion strategies are needed to control and prevent these conditions, in order to provide comprehensive, good quality maternal health care.	[Agampodi, Suneth Buddhika; Wickramasinghe, Nuwan Dharshana; Horton, Jennifer; Agampodi, Thilini Chanchala] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Maternal & Child Hlth Res Unit, Saliya Pura, Sri Lanka	Rajarata University of Sri Lanka	Agampodi, SB (corresponding author), Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Maternal & Child Hlth Res Unit, Saliya Pura, Sri Lanka.	sunethagampodi@yahoo.com	Wickramasinghe, Nuwan Darshana/I-3578-2019; Agampodi, Thilini/AAN-5396-2021; Agampodi, Suneth/G-3320-2012	Wickramasinghe, Nuwan Darshana/0000-0001-6025-6022; Agampodi, Thilini/0000-0002-7977-6578; Agampodi, Suneth/0000-0001-7810-1774; Horton, Jennifer/0000-0002-9220-4654	Maternal Health Task Force of EngenderHealth	Maternal Health Task Force of EngenderHealth	This study was funded by the Maternal Health Task Force of EngenderHealth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agampodi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042333; Attard CL, 2002, AM J OBSTET GYNECOL, V186, pS220, DOI 10.1067/mob.2002.122605; Bamigboye AA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001066.pub2; Chou FH, 2008, INT J NURS STUD, V45, P1185, DOI 10.1016/j.ijnurstu.2007.08.004; Chowdhury Mahbub-E-Elahi Khan, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P598; Dahanayaka N J, 2011, Ceylon Med J, V56, P128, DOI 10.4038/cmj.v56i3.3608; Department of Community Medicine RUoSL, 2010, DIS BURD EC IMP MAT; Dowswell T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007065.pub2; Gill K, 2007, WOM DEL C LOND, P1; Koken G, 2008, J PSYCHOSOM OBST GYN, V29, P91, DOI 10.1080/01674820701733697; Lacasse A, 2008, BJOG-INT J OBSTET GY, V115, P1484, DOI 10.1111/j.1471-0528.2008.01891.x; Matthews A, COCHRANE DATABASE SY; OBRIEN B, 1992, BIRTH-ISS PERINAT C, V19, P138, DOI 10.1111/j.1523-536X.1992.tb00671.x; Padma GR, 2004, MATERNAL MORBIDITY R, P1; Pennick VE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001139.pub2; Piwko C, 2005, VALUE HEALTH, V8, P303, DOI 10.1016/S1098-3015(10)62780-5; Piwko C, 2007, CURR MED RES OPIN, V23, P833, DOI 10.1185/030079907X178739; Smith J B, 1996, JNMA J Nepal Med Assoc, V34, P132; Swallow B L, 2004, J Obstet Gynaecol, V24, P28; Thalagala E, 2010, DAT QUAL MAT MORB SU; Wilson Ronee E, 2007, Int J Fertil Womens Med, V52, P121; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Young G, 2000, COCHRANE DB SYST REV	23	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e64214	10.1371/journal.pone.0064214	http://dx.doi.org/10.1371/journal.pone.0064214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675528	Green Submitted, gold, Green Published			2022-12-25	WOS:000318852400063
J	Riddle, RC; Diegel, CR; Leslie, JM; Van Koevering, KK; Faugere, MC; Clemens, TL; Williams, BO				Riddle, Ryan C.; Diegel, Cassandra R.; Leslie, Julie M.; Van Koevering, Kyle K.; Faugere, Marie-Claude; Clemens, Thomas L.; Williams, Bart O.			Lrp5 and Lrp6 Exert Overlapping Functions in Osteoblasts during Postnatal Bone Acquisition	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; BETA-CATENIN; DENSITY; MUTATION; GENE; MICE; MASS; MOUSE; CLONING; MEMBER	The canonical Wnt signaling pathway is critical for skeletal development and maintenance, but the precise roles of the individual Wnt co-receptors, Lrp5 and Lrp6, that enable Wnt signals to be transmitted in osteoblasts remain controversial. In these studies, we used Cre-loxP recombination, in which Cre-expression is driven by the human osteocalcin promoter, to determine the individual contributions of Lrp5 and Lrp6 in postnatal bone acquisition and osteoblast function. Mice selectively lacking either Lrp5 or Lrp6 in mature osteoblasts were born at the expected Mendelian frequency but demonstrated significant reductions in whole-body bone mineral density. Bone architecture measured by microCT revealed that Lrp6 mutant mice failed to accumulate normal amounts of trabecular bone. By contrast, Lrp5 mutants had normal trabecular bone volume at 8 weeks of age, but with age, these mice also exhibited trabecular bone loss. Both mutants also exhibited significant alterations in cortical bone structure. In vitro differentiation was impaired in both Lrp5 and Lrp6 null osteoblasts as indexed by alkaline phosphatase and Alizarin red staining, but the defect was more pronounced in Lrp6 mutant cells. Mice lacking both Wnt co-receptors developed severe osteopenia similar to that observed previously in mice lacking beta-catenin in osteoblasts. Likewise, calvarial cells doubly deficient for Lrp5 and Lrp6 failed to form osteoblasts when cultured in osteogenic media, but instead attained a chondrocyte-like phenotype. These results indicate that expression of both Lrp5 and Lrp6 are required within mature osteoblasts for normal postnatal bone development.	[Riddle, Ryan C.; Leslie, Julie M.; Clemens, Thomas L.] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA; [Riddle, Ryan C.; Clemens, Thomas L.] Vet Adm Med Ctr, Baltimore, MD 21218 USA; [Diegel, Cassandra R.; Van Koevering, Kyle K.; Williams, Bart O.] Van Andel Res Inst, Ctr Skeletal Dis & Tumor Metastasis, Grand Rapids, MI USA; [Diegel, Cassandra R.; Van Koevering, Kyle K.; Williams, Bart O.] Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI USA; [Faugere, Marie-Claude] Univ Kentucky, Dept Med, Lexington, KY 40506 USA	Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Van Andel Institute; Van Andel Institute; University of Kentucky	Riddle, RC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA.	rriddle1@jhmi.org; bart.williams@vai.org	Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301; Diegel, Cassandra/0000-0002-6526-9372	National Institutes of Health [AR053293, AR04910]; Van Andel Research Institute; Veterans Administration; Genentech; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Van Andel Research Institute; Veterans Administration(US Department of Veterans Affairs); Genentech(Roche HoldingGenentech); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the National Institutes of Health (B.O.W. AR053293, T.L.C AR04910) and Van Andel Research Institute. R. C. R is the recipient of a Career Development Award from the Veterans Administration. T. L. C. is the recipient of a Research Career Scientist Award from the Veterans Administration.; While there are no direct competing interests associated with this study, BOW did receive support for other indirectly related studies from Genentech. Bart O. Williams is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brault V, 2001, DEVELOPMENT, V128, P1253; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Chen D, 1999, GENOMICS, V55, P314, DOI 10.1006/geno.1998.5688; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Figueroa DJ, 2000, J HISTOCHEM CYTOCHEM, V48, P1357, DOI 10.1177/002215540004801006; Frost M, 2010, J BONE MINER RES, V25, P673, DOI 10.1002/jbmr.44; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kim DH, 1998, J BIOCHEM-TOKYO, V124, P1072, DOI 10.1093/oxfordjournals.jbchem.a022223; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Yadav VK, 2010, CALCIFIED TISSUE INT, V86, P382, DOI 10.1007/s00223-010-9350-7; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhong ZD, 2012, J CELL BIOCHEM, V113, P31, DOI 10.1002/jcb.23324	37	80	89	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63323	10.1371/journal.pone.0063323	http://dx.doi.org/10.1371/journal.pone.0063323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675479	Green Submitted, Green Published, gold			2022-12-25	WOS:000318852400037
J	Sweeting, B; Brown, E; Khan, MQ; Chakrabartty, A; Pai, EF				Sweeting, Braden; Brown, Eric; Khan, M. Qasim; Chakrabartty, Avijit; Pai, Emil F.			N-Terminal Helix-Cap in alpha-Helix 2 Modulates beta-State Misfolding in Rabbit and Hamster Prion Proteins	PLOS ONE			English	Article							NMR STRUCTURE; SCRAPIE; PRP; STABILITY; RESIDUES; SUSCEPTIBILITY; CONFORMATION; RESISTANCE; CONVERSION; INFECTION	Susceptibility of a particular species to prion disease is affected by small differences in the sequence of PrP and correlates with the propensity of its PrP to assume the beta-state. A helix-cap motif in the beta 2-alpha 2-loop of native a-helical rabbit PrP, a resistant species, contains sequence differences that influence intra-and interspecies transmission. To determine the effect the helix-cap motif on beta-state refolding propensity, we mutated S170N, S174N, and S170N/ S174N of the rabbit PrP helix-cap to resemble that of hamster PrP and conversely, N170S, N174S, and N170S/ N174S of hamster PrP to resemble the helix-cap of rabbit PrP. High-resolution crystal structures (1.45-1.6 angstrom) revealed that these mutations ablate hydrogen-bonding interactions within the helix-cap motif in rabbit PrPC. They also alter the beta-state-misfolding propensity of PrP; the serine mutations in hamster PrP decrease the propensity up to 35%, whereas the asparagine mutations in rabbit PrP increase it up to 42%. Rapid dilution of rabbit and hamster into beta-state buffer conditions causes quick conversion to beta-state monomers. Kinetic monitoring using size-exclusion chromatography showed that the monomer population decreases exponentially mirrored by an increase in an octameric species. The monomer-octamer transition rates are faster for hamster than for rabbit PrP. The N170S/N174S mutant of hamster PrP has a smaller octamer component at the endpoint compared to the wild-type, whereas the kinetics of octamer formation in mutant and wild-type rabbit PrP are comparable. These findings demonstrate that the sequence of the beta 2-alpha 2 helix-cap affects refolding to the beta-state and subsequently, may influence susceptibility to prion disease.	[Sweeting, Braden; Brown, Eric; Chakrabartty, Avijit; Pai, Emil F.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Sweeting, Braden; Khan, M. Qasim; Chakrabartty, Avijit; Pai, Emil F.] Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M4X 1K9, Canada; [Khan, M. Qasim; Chakrabartty, Avijit; Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Pai, EF (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	pai@hera.med.utoronto.ca	Pai, Emil/R-8908-2019	Pai, Emil/0000-0002-1162-7242; Chakrabartty, Avi/0000-0001-7002-8381	PrioNet Canada; CIHR; Canada Research Chairs program; Ontario Ministry of Health and Long Term Care; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	PrioNet Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This research was supported by grants from PrioNet Canada (A. C. and E. F. P.), the CIHR Strategic Training Program in Protein Folding and Interaction Dynamics (M. Q. K. and B. S.), and the Canada Research Chairs program (E. F. P.). This study was supported in part by the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the OMOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the help we received from the staff of the Canadian Macromolecular Crystallography Facility. Parts of the research described in this paper was performed at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Chianini F, 2012, P NATL ACAD SCI USA, V109, P5080, DOI 10.1073/pnas.1120076109; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Julien O, 2009, PROTEIN SCI, V18, P2172, DOI 10.1002/pro.231; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Khan MQ, 2010, P NATL ACAD SCI USA, V107, P19808, DOI 10.1073/pnas.1005267107; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Loftus B, 1997, GENE, V184, P215, DOI 10.1016/S0378-1119(96)00598-7; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore Jo, 2011, BMC Res Notes, V4, P501, DOI 10.1186/1756-0500-4-501; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nisbet RM, 2010, J VIROL, V84, P6678, DOI 10.1128/JVI.02709-09; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Piening N, 2006, J BIOL CHEM, V281, P9373, DOI 10.1074/jbc.M512239200; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Raymond GJ, 2012, J VIROLOGY; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhang JP, 2011, J THEOR BIOL, V269, P88, DOI 10.1016/j.jtbi.2010.10.020; Zhang JP, 2010, J THEOR BIOL, V264, P119, DOI 10.1016/j.jtbi.2010.01.024	46	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63047	10.1371/journal.pone.0063047	http://dx.doi.org/10.1371/journal.pone.0063047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675452	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400021
J	Okochi-Takada, E; Hattori, N; Tsukamoto, T; Miyamoto, K; Ando, T; Ito, S; Yamamura, Y; Wakabayashi, M; Nobeyama, Y; Ushijima, T				Okochi-Takada, E.; Hattori, N.; Tsukamoto, T.; Miyamoto, K.; Ando, T.; Ito, S.; Yamamura, Y.; Wakabayashi, M.; Nobeyama, Y.; Ushijima, T.			ANGPTL4 is a secreted tumor suppressor that inhibits angiogenesis	ONCOGENE			English	Article						epigenetics; angiogenesis; tumor suppressor; gastric cancer; DNA methylation	ANGIOPOIETIN-LIKE 4; ISLAND METHYLATOR PHENOTYPE; VASCULAR-PERMEABILITY; EPIGENETIC FIELD; DNA METHYLATION; FREQUENT LOSS; PROTEINS; CANCER; 19P13.3; GENES	Tumor suppressors with extracellular function are likely to have advantages as targets for cancer therapy, but few are known. Here, we focused on angiopoietin-like 4 (ANGPTL4), which is a secreted glycoprotein involved in lipoprotein metabolism and angiogenesis, is methylation-silenced in human cancers, but has unclear roles in cancer development and progression. We found a deletion mutation in its coiled-coil domain at its N-terminal in human gastric cancers, in addition to hypermethylation of the ANGPTL4 promoter CpG islands. Forced expression of wild-type ANGPTL4, but not ANGPTL4 with the deletion, at physiological levels markedly suppressed in vivo tumorigenicity and tumor angiogenesis, indicating that the latter caused the former. Tumor-derived ANGPTL4 suppressed in vitro vascular tube formation and proliferation of human umbilical vascular endothelial cells, partly due to suppression of ERK signaling. These showed that ANGPTL4 is a genetically and epigenetically inactivated secreted tumor suppressor that inhibits tumor angiogenesis.	[Okochi-Takada, E.; Hattori, N.; Ando, T.; Wakabayashi, M.; Nobeyama, Y.; Ushijima, T.] Natl Canc Ctr, Div Epigen, Tokyo 1040045, Japan; [Tsukamoto, T.] Aichi Canc Ctr, Res Inst, Oncol Pathol Div, Nagoya, Aichi 464, Japan; [Miyamoto, K.] Natl Hosp Org, Kure Med Ctr, Div Mol Oncol, Kureshi, Japan; [Miyamoto, K.] Chugoku Canc Ctr, Kureshi, Japan; [Ando, T.] Toyama Univ, Dept Internal Med 3, Toyama 930, Japan; [Ito, S.; Yamamura, Y.] Aichi Canc Ctr, Cent Hosp, Dept Surg Gastroenterol, Nagoya, Aichi 464, Japan; [Nobeyama, Y.] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan	National Cancer Center - Japan; Aichi Cancer Center; University of Toyama; Aichi Cancer Center; Jikei University	Ushijima, T (corresponding author), Natl Canc Ctr, Div Epigen, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tushijim@ncc.go.jp	Tsukamoto, Tetsuya/ABD-4397-2020; Ushijima, Toshikazu/AAP-5742-2021	Tsukamoto, Tetsuya/0000-0002-7502-8724; Ushijima, Toshikazu/0000-0003-3405-7817; Hattori, Naoko/0000-0002-0901-4869	Third-term Comprehensive Cancer Control Strategy from the Ministry of Health, Labour and Welfare, Japan; National Cancer Center Research and Development Fund; Research Resident Fellowships from the Foundation for Promotion of Cancer Research	Third-term Comprehensive Cancer Control Strategy from the Ministry of Health, Labour and Welfare, Japan; National Cancer Center Research and Development Fund(National Cancer Center - Japan); Research Resident Fellowships from the Foundation for Promotion of Cancer Research	We are grateful to Dr Masabumi Shibuya, Tokyo Medical and Dental University, for his expert advice. This study was supported by the Third-term Comprehensive Cancer Control Strategy from the Ministry of Health, Labour and Welfare, Japan and by National Cancer Center Research and Development Fund. YN is a recipient of a Research Resident Fellowships from the Foundation for Promotion of Cancer Research.	Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Asada K, 2013, ONCOGENE, V32, P2140, DOI 10.1038/onc.2012.228; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Enomoto S, 2007, CANCER SCI, V98, P1853, DOI 10.1111/j.1349-7006.2007.00625.x; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hattori N, 2011, CANCER SCI, V102, P1337, DOI 10.1111/j.1349-7006.2011.01955.x; Hermann LM, 2005, CLIN IMMUNOL, V115, P93, DOI 10.1016/j.clim.2004.12.002; Hoglund M, 1998, GENE CHROMOSOME CANC, V21, P8; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Ito Y, 2003, CANCER RES, V63, P6651; Kaneda A, 2002, CANCER RES, V62, P6645; Kishore R, 2007, J MOL CELL CARDIOL, V42, P461, DOI 10.1016/j.yjmcc.2006.11.012; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li KQ, 2004, CHINESE MED J-PEKING, V117, P1364; Ma T, 2010, P NATL ACAD SCI USA, V107, P14363, DOI 10.1073/pnas.1001065107; Mei R, 2000, GENOME RES, V10, P1126, DOI 10.1101/gr.10.8.1126; Miida T, 2010, CURR OPIN LIPIDOL, V21, P70, DOI 10.1097/MOL.0b013e328333269e; Nakayama T, 2010, ONCOL REP, V24, P599, DOI 10.3892/or_00000897; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Ota N, 2006, ANTICANCER RES, V26, P3729; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Shi Y, 2007, ACTA PHARMACOL SIN, V28, P1499, DOI 10.1111/j.1745-7254.2007.00692.x; Sobottka SB, 2000, J NEURO-ONCOL, V49, P187, DOI 10.1023/A:1006442024874; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Tanner JE, 2004, MOL CANCER RES, V2, P281; Trojan J, 2000, GUT, V47, P272, DOI 10.1136/gut.47.2.272; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; Zhu HB, 2004, ONCOGENE, V23, P4984, DOI 10.1038/sj.onc.1207645; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	36	43	44	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2014	33	17					2273	2278		10.1038/onc.2013.174	http://dx.doi.org/10.1038/onc.2013.174			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF8WJ	23686315				2022-12-25	WOS:000334996000013
J	Zhang, SF; Schones, DE; Malicet, C; Rochman, M; Zhou, M; Foisner, R; Bustin, M				Zhang, Shaofei; Schones, Dustin E.; Malicet, Cedric; Rochman, Mark; Zhou, Ming; Foisner, Roland; Bustin, Michael			High Mobility Group Protein N5 (HMGN5) and Lamina-associated Polypeptide 2 alpha (LAP2 alpha) Interact and Reciprocally Affect Their Genome-wide Chromatin Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL-PROTEINS; LINKER HISTONE; RNA-SEQ; DIFFERENTIATION; H1; NUCLEOSOMES; COMPLEXES	The interactions of nuclear lamins with the chromatin fiber play an important role in regulating nuclear architecture and chromatin function; however, the full spectrum of these interactions is not known. We report that the N-terminal domain of the nucleosome-binding protein HMGN5 interacts with the C-terminal domain of the lamin-binding protein LAP2 alpha and that these proteins reciprocally alter their interaction with chromatin. Chromatin immunoprecipitation analysis of cells lacking either HMGN5 or LAP2 alpha reveals that loss of either protein affects the genome-wide distribution of the remaining partner. Our study identifies a new functional link between chromatin-binding and lamin-binding proteins.	[Zhang, Shaofei; Malicet, Cedric; Rochman, Mark; Bustin, Michael] NCI, NIH, Prot Sect, Lab Metab,Ctr Canc Res, Bethesda, MD 20892 USA; [Schones, Dustin E.] Beckman Res Inst City Hope, Dept Canc Biol, Duarte, CA 91010 USA; [Zhou, Ming] NCI Frederick, SAIC Frederick Inc, Adv Technol Program, Lab Prote & Analyt Technol, Frederick, MD 21702 USA; [Foisner, Roland] Med Univ Vienna, Max Perutz Labs, A-1030 Vienna, Austria	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); City of Hope; Beckman Research Institute of City of Hope; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Bustin, M (corresponding author), NCI, NIH, Prot Sect, Lab Metab,Ctr Canc Res, Bethesda, MD 20892 USA.	Bustin@helix.nih.gov	Foisner, Roland/AAD-1833-2019; Bustin, Michael/G-6155-2015; Zhang, Shaofei/J-5273-2017	Bustin, Michael/0000-0002-5147-7242; Foisner, Roland/0000-0003-4734-4647; Rochman, Mark/0000-0002-0818-927X	Center for Cancer Research, Intramural Program of the NCI, National Institutes of Health; United States-Israel Binational Science Foundation (BSF) [2009236]; NCI [K22 HL101950]; Austrian Research Fund (FWF) [P22043-B12]; Austrian Science Fund (FWF) [P 22043] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC004496, ZIABC011154] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL101950] Funding Source: NIH RePORTER	Center for Cancer Research, Intramural Program of the NCI, National Institutes of Health; United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Austrian Research Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Center for Cancer Research, Intramural Program of the NCI, National Institutes of Health (to M. B.). This work was also supported by United States-Israel Binational Science Foundation (BSF) Grants 2009236 (to M. B.) and NCI Grant K22 HL101950 (to D. E. S.) and by Grant P22043-B12 of the Austrian Research Fund (FWF) (to R. F.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; Cuddapah S, 2011, MOL CELL BIOL, V31, P700, DOI 10.1128/MCB.00740-10; Dechat T, 2000, J CELL SCI, V113, P3473; Dechat T, 2010, COLD SH Q B, V75, P533, DOI 10.1101/sqb.2010.75.018; Dechat T, 2009, ADV ENZYME REGUL, V49, P157, DOI 10.1016/j.advenzreg.2008.12.003; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lim JH, 2002, J BIOL CHEM, V277, P20774, DOI 10.1074/jbc.M200404200; Malicet C, 2011, MOL CELL BIOL, V31, P2742, DOI 10.1128/MCB.05216-11; Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Rochman M, 2009, MOL CELL, V35, P642, DOI 10.1016/j.molcel.2009.07.002; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ueda T, 2008, MOL CELL BIOL, V28, P2872, DOI 10.1128/MCB.02181-07; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	27	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18104	18109		10.1074/jbc.C113.469544	http://dx.doi.org/10.1074/jbc.C113.469544			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23673662	hybrid, Green Published			2022-12-25	WOS:000320721900016
J	Bodle, JC; Rubenstein, CD; Phillips, ME; Bernacki, SH; Qi, J; Banes, AJ; Loboa, EG				Bodle, Josephine C.; Rubenstein, Candace D.; Phillips, Michelle E.; Bernacki, Susan H.; Qi, Jie; Banes, Albert J.; Loboa, Elizabeth G.			Primary Cilia: The Chemical Antenna Regulating Human Adipose-Derived Stem Cell Osteogenesis	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; PKD1 GENE-PRODUCT; SENSORY ORGANELLE; TISSUE; BONE; COMPLEX; DIFFERENTIATION	Adipose-derived stem cells (ASC) are multipotent stem cells that show great potential as a cell source for osteogenic tissue replacements and it is critical to understand the underlying mechanisms of lineage specification. Here we explore the role of primary cilia in human ASC (hASC) differentiation. This study focuses on the chemosensitivity of the primary cilium and the action of its associated proteins: polycystin-1 (PC1), polycystin-2 (PC2) and intraflagellar transport protein-88 (IFT88), in hASC osteogenesis. To elucidate cilia-mediated mechanisms of hASC differentiation, siRNA knockdown of PC1, PC2 and IFT88 was performed to disrupt cilia-associated protein function. Immunostaining of the primary cilium structure indicated phenotypic-dependent changes in cilia morphology. hASC cultured in osteogenic differentiation media yielded cilia of a more elongated conformation than those cultured in expansion media, indicating cilia-sensitivity to the chemical environment and a relationship between the cilium structure and phenotypic determination. Abrogation of PC1, PC2 and IFT88 effected changes in both hASC proliferation and differentiation activity, as measured through proliferative activity, expression of osteogenic gene markers, calcium accretion and endogenous alkaline phosphatase activity. Results indicated that IFT88 may be an early mediator of the hASC differentiation process with its knockdown increasing hASC proliferation and decreasing Runx2, alkaline phosphatase and BMP-2 mRNA expression. PC1 and PC2 knockdown affected later osteogenic gene and end-product expression. PC1 knockdown resulted in downregulation of alkaline phosphatase and osteocalcin gene expression, diminished calcium accretion and reduced alkaline phosphatase enzymatic activity. Taken together our results indicate that the structure of the primary cilium is intimately associated with the process of hASC osteogenic differentiation and that its associated proteins are critical players in this process. Elucidating the dynamic role of the primary cilium and its associated proteins will help advance the application of hASC in generating autologous tissue engineered therapies in critical defect bone injuries.	[Bodle, Josephine C.; Rubenstein, Candace D.; Phillips, Michelle E.; Bernacki, Susan H.; Banes, Albert J.; Loboa, Elizabeth G.] Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, Raleigh, NC USA; [Bodle, Josephine C.; Rubenstein, Candace D.; Phillips, Michelle E.; Bernacki, Susan H.; Banes, Albert J.; Loboa, Elizabeth G.] N Carolina State Univ, Raleigh, NC 27695 USA; [Qi, Jie; Banes, Albert J.] Flexcell Int Corp, Hillsborough, NC USA; [Loboa, Elizabeth G.] N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Loboa, EG (corresponding author), Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, Raleigh, NC USA.	egloboa@ncsu.edu			National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering grant [R03EB008790]; North Carolina Translational and Clinical Sciences Institute [10KR51023]; National Science Foundation/Chemical, Bioengineering, Environmental, and Transport Systems grant [1133427]; National Science Foundation Graduate Research Fellowship Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB008790] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering grant; North Carolina Translational and Clinical Sciences Institute; National Science Foundation/Chemical, Bioengineering, Environmental, and Transport Systems grant; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering grant R03EB008790 (EGL), North Carolina Translational and Clinical Sciences Institute # 10KR51023 (EGL), National Science Foundation/Chemical, Bioengineering, Environmental, and Transport Systems grant 1133427 (EGL), and the National Science Foundation Graduate Research Fellowship Program (JCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Alaiwi WA, 2009, SENSORS-BASEL, V9, P7003, DOI 10.3390/s90907003; Bernacki SH, 2008, METHOD CELL BIOL, V86, P257, DOI 10.1016/S0091-679X(08)00011-3; Bodle JC, 2011, TISSUE ENG PART B-RE, V17, P195, DOI 10.1089/ten.teb.2010.0738; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Forman JR, 2005, J MOL BIOL, V349, P861, DOI 10.1016/j.jmb.2005.04.008; Geng L, 1996, J CLIN INVEST, V98, P2674, DOI 10.1172/JCI119090; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Goetz SC, 2009, METHOD CELL BIOL, V94, P199, DOI 10.1016/S0091-679X(08)94010-3; Hanson AD, 2009, ANN BIOMED ENG, V37, P955, DOI 10.1007/s10439-009-9648-7; Huan YH, 1999, J CLIN INVEST, V104, P1459, DOI 10.1172/JCI5111; Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; McCullen S, 2010, TISSUE ENG C; Meyer R A, 2001, BMC Musculoskelet Disord, V2, P2, DOI 10.1186/1471-2474-2-2; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Raymond MH, 1999, GENOMICS, V60, P210, DOI 10.1006/geno.1999.5893; Robert A, 2007, J CELL SCI, V120, P918, DOI 10.1242/jcs.03422; Santos N, 2008, DEV DYNAM, V237, P1972, DOI 10.1002/dvdy.21540; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Slough J, 2008, DEV DYNAM, V237, P2304, DOI 10.1002/dvdy.21669; Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x; Xiao ZS, 2010, ANN NY ACAD SCI, V1192, P410, DOI 10.1111/j.1749-6632.2009.05239.x; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	30	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e62554	10.1371/journal.pone.0062554	http://dx.doi.org/10.1371/journal.pone.0062554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690943	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900010
J	Chambers, ST; Murdoch, D; Morris, A; Holland, D; Pappas, P; Almela, M; Fernandez-Hidalgo, N; Almirante, B; Bouza, E; Forno, D; del Rio, A; Hannan, MM; Harkness, J; Kanafani, ZA; Lalani, T; Lang, S; Raymond, N; Read, K; Vinogradova, T; Woods, CW; Wray, D; Corey, GR; Chu, VH; Clara, L; Sanchez, M; Nacinovich, F; Fernandez Oses, P; Ronderos, R; Sucari, A; Thierer, J; Casabe, J; Cortes, C; Altclas, J; Kogan, S; Spelman, D; Athan, E; Harris, O; Kennedy, K; Tan, R; Gordon, D; Papanicolas, L; Eisen, D; Grigg, L; Street, A; Korman, T; Kotsanas, D; Dever, R; Jones, P; Konecny, P; Lawrence, R; Rees, D; Ryan, S; Feneley, MP; Harkness, J; Jones, P; Ryan, S; Jones, P; Ryan, S; Jones, P; Post, J; Reinbott, P; Ryan, S; Gattringer, R; Wiesbauer, F; Andrade, AR; Passos de Brito, AC; Guimaraes, AC; Grinberg, M; Mansur, AJ; Siciliano, RF; Varejao Strabelli, TM; Campos Vieira, ML; de Medeiros Tranchesi, RA; Paiva, MG; Fortes, CQ; Ramos, AD; Ferraiuoli, G; Golebiovski, W; Lamas, C; Santos, M; Weksler, C; Karlowsky, JA; Keynan, Y; Morris, AM; Rubinstein, E; Jones, SB; Garcia, P; Cereceda, M; Fica, A; Mella, RM; Barsic, B; Bukovski, S; Krajinovic, V; Pangercic, A; Rudez, I; Vincelj, J; Freiberger, T; Pol, J; Zaloudikova, B; Ashour, Z; El Kholy, A; Mishaal, M; Rizk, H; Aissa, N; Alauzet, C; Alla, F; Campagnac, C; Doco-Lecompte, T; Selton-Suty, C; Casalta, JP; Fournier, PE; Habib, G; Raoult, D; Thuny, F; Delahaye, F; Delahaye, A; Vandenesch, F; Donal, E; Donnio, PY; Michelet, C; Revest, M; Tattevin, P; Violette, J; Chevalier, F; Jeu, A; Dan; Rusinaru; Sorel, C; Tribouilloy, C; Bernard, Y; Chirouze, C; Hoen, B; Leroy, J; Plesiat, P; Naber, C; Neuerburg, C; Mazaheri, B; Naber, C; Neuerburg, C; Athanasia, S; Giannitsioti, E; Mylona, E; Paniara, O; Papanicolaou, K; Pyros, J; Skoutelis, A; Sharma, G; Francis, J; Nair, L; Thomas, V; Venugopal, K; Hannan, M; Hurley, J; Gilon, D; Israel, S; Korem, M; Strahilevitz, J; Rubinstein, E; Strahilevitz, J; Tripodi, MF; Casillo, R; Cuccurullo, S; Dialetto, G; Durante-Mangoni, E; Irene, M; Ragone, E; Utili, R; Cecchi, E; De Rosa, F; Forno, D; Imazio, M; Trinchero, R; Tebini, A; Grossi, P; Lattanzio, M; Toniolo, A; Goglio, A; Raglio, A; Ravasio, V; Rizzi, M; Suter, F; Carosi, G; Magri, S; Signorini, L; Baban, T; Kanafani, Z; Kanj, SS; Sfeir, J; Yasmine, M; Abidin, I; Tamin, SS; Martinez, ER; Nieto, GIS; van der Meer, JTM; Chambers, S; Holland, D; Morris, A; Raymond, N; Read, K; Murdoch, DR; Dragulescu, S; Ionac, A; Mornos, C; Butkevich, OM; Chipigina, N; Kirill, O; Vadim, K; Vinogradova, T; Edathodu, J; Halim, M; Lum, LN; Tan, RS; Lejko-Zupanc, T; Logar, M; Mueller-Premru, M; Commerford, P; Commerford, A; Deetlefs, E; Hansa, C; Ntsekhe, M; Almela, M; Armero, Y; Azqueta, M; Castaneda, X; Cervera, C; del Rio, A; Falces, C; Garcia-de-la-Maria, C; Fita, G; Gatell, JM; Marco, F; Mestres, CA; Miro, JM; Moreno, A; Ninot, S; Pare, C; Pericas, J; Ramirez, J; Rovira, I; Sitges, M; Anguera, I; Font, B; Guma, JR; Bermejo, J; Bouza, E; Garcia Fernandez, MA; Gonzalez-Ramallo, V; Marin, M; Munoz, P; Pedromingo, M; Roda, J; Rodriguez-Creixems, M; Solis, J; Almirante, B; Fernandez-Hidalgo, N; Tornos, P; de Alarcon, A; Parra, R; Alestig, E; Johansson, M; Olaison, L; Snygg-Martin, U; Pachirat, O; Pachirat, P; Pussadhamma, B; Senthong, V; Casey, A; Elliott, T; Lambert, P; Watkin, R; Eyton, C; Klein, JL; Bradley, S; Kauffman, C; Bedimo, R; Chu, VH; Corey, GR; Crowley, AL; Douglas, P; Drew, L; Fowler, VG; Holland, T; Lalani, T; Mudrick, D; Samad, Z; Sexton, D; Stryjewski, M; Wang, A; Woods, CW; Lerakis, S; Cantey, R; Steed, L; Wray, D; Dickerman, SA; Bonilla, H; DiPersio, J; Salstrom, SJ; Baddley, J; Patel, M; Peterson, G; Stancoven, A; Afonso, L; Kulman, T; Levine, D; Rybak, M; Cabell, CH; Baloch, K; Chu, VH; Corey, GR; Dixon, CC; Fowler, VG; Harding, T; Jones-Richmond, M; Pappas, P; Park, LP; Redick, T; Stafford, J; Anstrom, K; Athan, E; Bayer, AS; Cabell, CH; Chu, VH; Corey, GR; Fowler, VG; Hoen, B; Karchmer, AW; Miro, JM; Murdoch, DR; Sexton, DJ; Wang, A; Bayer, AS; Cabell, CH; Chu, V; Corey, GR; Durack, DT; Phil, D; Eykyn, S; Fowler, VG; Hoen, B; Miro, JM; Moreillon, P; Olaison, L; Raoult, D; Rubinstein, E; Sexton, DJ				Chambers, Stephen T.; Murdoch, David; Morris, Arthur; Holland, David; Pappas, Paul; Almela, Manel; Fernandez-Hidalgo, Nuria; Almirante, Benito; Bouza, Emilio; Forno, Davide; del Rio, Ana; Hannan, Margaret M.; Harkness, John; Kanafani, Zeina A.; Lalani, Tahaniyat; Lang, Selwyn; Raymond, Nigel; Read, Kerry; Vinogradova, Tatiana; Woods, Christopher W.; Wray, Dannah; Corey, G. Ralph; Chu, Vivian H.; Clara, Liliana; Sanchez, Marisa; Nacinovich, Francisco; Fernandez Oses, Pablo; Ronderos, Ricardo; Sucari, Adriana; Thierer, Jorge; Casabe, Jose; Cortes, Claudia; Altclas, Javier; Kogan, Silvia; Spelman, Denis; Athan, Eugene; Harris, Owen; Kennedy, Karina; Tan, Ren; Gordon, David; Papanicolas, Lito; Eisen, Damon; Grigg, Leeanne; Street, Alan; Korman, Tony; Kotsanas, Despina; Dever, Robyn; Jones, Phillip; Konecny, Pam; Lawrence, Richard; Rees, David; Ryan, Suzanne; Feneley, Michael P.; Harkness, John; Jones, Phillip; Ryan, Suzanne; Jones, Phillip; Ryan, Suzanne; Jones, Phillip; Post, Jeffrey; Reinbott, Porl; Ryan, Suzanne; Gattringer, Rainer; Wiesbauer, Franz; Andrade, Adriana Ribas; Passos de Brito, Ana Claudia; Guimaraes, Armenio Costa; Grinberg, Max; Mansur, Alfredo Jose; Siciliano, Rinaldo Focaccia; Varejao Strabelli, Tania Mara; Campos Vieira, Marcelo Luiz; de Medeiros Tranchesi, Regina Aparecida; Paiva, Marcelo Goulart; Fortes, Claudio Querido; Ramos, Auristela de Oliveira; Ferraiuoli, Giovanna; Golebiovski, Wilma; Lamas, Cristiane; Santos, Marisa; Weksler, Clara; Karlowsky, James A.; Keynan, Yoav; Morris, Andrew M.; Rubinstein, Ethan; Jones, Sandra Braun; Garcia, Patricia; Cereceda, M.; Fica, Alberto; Mella, Rodrigo Montagna; Barsic, Bruno; Bukovski, Suzana; Krajinovic, Vladimir; Pangercic, Ana; Rudez, Igor; Vincelj, Josip; Freiberger, Tomas; Pol, Jiri; Zaloudikova, Barbora; Ashour, Zainab; El Kholy, Amani; Mishaal, Marwa; Rizk, Hussien; Aissa, Neijla; Alauzet, Corentine; Alla, Francois; Campagnac, Catherine; Doco-Lecompte, Thanh; Selton-Suty, Christine; Casalta, Jean-Paul; Fournier, Pierre-Edouard; Habib, Gilbert; Raoult, Didier; Thuny, Franck; Delahaye, Francois; Delahaye, Armelle; Vandenesch, Francois; Donal, Erwan; Donnio, Pierre Yves; Michelet, Christian; Revest, Matthieu; Tattevin, Pierre; Violette, Jeremie; Chevalier, Florent; Jeu, Antoine; Dan; Rusinaru; Sorel, Claire; Tribouilloy, Christophe; Bernard, Yvette; Chirouze, Catherine; Hoen, Bruno; Leroy, Joel; Plesiat, Patrick; Naber, Christoph; Neuerburg, Carl; Mazaheri, Bahram; Naber, Christoph; Neuerburg, Carl; Athanasia, Sofia; Giannitsioti, Efthymia; Mylona, Elena; Paniara, Olga; Papanicolaou, Konstantinos; Pyros, John; Skoutelis, Athanasios; Sharma, Gautam; Francis, Johnson; Nair, Lathi; Thomas, Vinod; Venugopal, Krishnan; Hannan, Margaret; Hurley, John; Gilon, Dan; Israel, Sarah; Korem, Maya; Strahilevitz, Jacob; Rubinstein, Ethan; Strahilevitz, Jacob; Tripodi, Marie Francoise; Casillo, Roberta; Cuccurullo, Susanna; Dialetto, Giovanni; Durante-Mangoni, Emanuele; Irene, Mattucci; Ragone, Enrico; Utili, Riccardo; Cecchi, Enrico; De Rosa, Francesco; Forno, Davide; Imazio, Massimo; Trinchero, Rita; Tebini, Alessandro; Grossi, Paolo; Lattanzio, Mariangela; Toniolo, Antonio; Goglio, Antonio; Raglio, Annibale; Ravasio, Veronica; Rizzi, Marco; Suter, Fredy; Carosi, Giampiero; Magri, Silvia; Signorini, Liana; Baban, Tania; Kanafani, Zeina; Kanj, Souha S.; Sfeir, Jad; Yasmine, Mohamad; Abidin, Imran; Tamin, Syahidah Syed; Martinez, Eduardo Rivera; Nieto, Gabriel Israel Soto; van der Meer, Jan T. M.; Chambers, Stephen; Holland, David; Morris, Arthur; Raymond, Nigel; Read, Kerry; Murdoch, David R.; Dragulescu, Stefan; Ionac, Adina; Mornos, Cristian; Butkevich, O. M.; Chipigina, Natalia; Kirill, Ozerecky; Vadim, Kulichenko; Vinogradova, Tatiana; Edathodu, Jameela; Halim, Magid; Lum, Luh-Nah; Tan, Ru-San; Lejko-Zupanc, Tatjana; Logar, Mateja; Mueller-Premru, Manica; Commerford, Patrick; Commerford, Anita; Deetlefs, Eduan; Hansa, Cass; Ntsekhe, Mpiko; Almela, Manuel; Armero, Yolanda; Azqueta, Manuel; Castaneda, Ximena; Cervera, Carlos; del Rio, Ana; Falces, Carlos; Garcia-de-la-Maria, Cristina; Fita, Guillermina; Gatell, Jose M.; Marco, Francesc; Mestres, Carlos A.; Miro, Jose M.; Moreno, Asuncion; Ninot, Salvador; Pare, Carlos; Pericas, Joan; Ramirez, Jose; Rovira, Irene; Sitges, Marta; Anguera, Ignasi; Font, Bernat; Guma, Joan Raimon; Bermejo, Javier; Bouza, Emilio; Garcia Fernandez, Miguel Angel; Gonzalez-Ramallo, Victor; Marin, Mercedes; Munoz, Patricia; Pedromingo, Miguel; Roda, Jorge; Rodriguez-Creixems, Marta; Solis, Jorge; Almirante, Benito; Fernandez-Hidalgo, Nuria; Tornos, Pilar; de Alarcon, Aristides; Parra, Ricardo; Alestig, Eric; Johansson, Magnus; Olaison, Lars; Snygg-Martin, Ulrika; Pachirat, Orathai; Pachirat, Pimchitra; Pussadhamma, Burabha; Senthong, Vichai; Casey, Anna; Elliott, Tom; Lambert, Peter; Watkin, Richard; Eyton, Christina; Klein, John L.; Bradley, Suzanne; Kauffman, Carol; Bedimo, Roger; Chu, Vivian H.; Corey, G. Ralph; Crowley, Anna Lisa; Douglas, Pamela; Drew, Laura; Fowler, Vance G.; Holland, Thomas; Lalani, Tahaniyat; Mudrick, Daniel; Samad, Zaniab; Sexton, Daniel; Stryjewski, Martin; Wang, Andrew; Woods, Christopher W.; Lerakis, Stamatios; Cantey, Robert; Steed, Lisa; Wray, Dannah; Dickerman, Stuart A.; Bonilla, Hector; DiPersio, Joseph; Salstrom, Sara-Jane; Baddley, John; Patel, Mukesh; Peterson, Gail; Stancoven, Amy; Afonso, Luis; Kulman, Theresa; Levine, Donald; Rybak, Michael; Cabell, Christopher H.; Baloch, Khaula; Chu, Vivian H.; Corey, G. Ralph; Dixon, Christy C.; Fowler, Vance G.; Harding, Tina; Jones-Richmond, Marian; Pappas, Paul; Park, Lawrence P.; Redick, Thomas; Stafford, Judy; Anstrom, Kevin; Athan, Eugene; Bayer, Arnold S.; Cabell, Christopher H.; Chu, Vivian H.; Corey, G. Ralph; Fowler, Vance G.; Hoen, Bruno; Karchmer, A. W.; Miro, Jose M.; Murdoch, David R.; Sexton, Daniel J.; Wang, Andrew; Bayer, Arnold S.; Cabell, Christopher H.; Chu, Vivian; Corey, G. Ralph; Durack, David T.; Phil, D.; Eykyn, Susannah; Fowler, Vance G.; Hoen, Bruno; Miro, Jose M.; Moreillon, Phillipe; Olaison, Lars; Raoult, Didier; Rubinstein, Ethan; Sexton, Daniel J.		Int Collaboration Endocarditis Pro	HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort	PLOS ONE			English	Article							HEALTH-CARE PROFESSIONALS; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL THERAPY; HEART-FAILURE; REFERRAL BIAS; DIAGNOSIS; MANAGEMENT; PROFILE; STROKE; GUIDELINES	The HACEK organisms (Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species) are rare causes of infective endocarditis (IE). The objective of this study is to describe the clinical characteristics and outcomes of patients with HACEK endocarditis (HE) in a large multi-national cohort. Patients hospitalized with definite or possible infective endocarditis by the International Collaboration on Endocarditis Prospective Cohort Study in 64 hospitals from 28 countries were included and characteristics of HE patients compared with IE due to other pathogens. Of 5591 patients enrolled, 77 (1.4%) had HE. HE was associated with a younger age (47 vs. 61 years; p < 0.001), a higher prevalence of immunologic/vascular manifestations (32% vs. 20%; p < 0.008) and stroke (25% vs. 17% p = 0.05) but a lower prevalence of congestive heart failure (15% vs. 30%; p = 0.004), death in-hospital (4% vs. 18%; p = 0.001) or after 1 year follow-up (6% vs. 20%; p = 0.01) than IE due to other pathogens (n = 5514). On multivariable analysis, stroke was associated with mitral valve vegetations (OR 3.60; CI 1.34-9.65; p < 0.01) and younger age (OR 0.62; CI 0.49-0.90; p < 0.01). The overall outcome of HE was excellent with the in-hospital mortality (4%) significantly better than for non-HE (18%; p < 0.001). Prosthetic valve endocarditis was more common in HE (35%) than non-HE (24%). The outcome of prosthetic valve and native valve HE was excellent whether treated medically or with surgery. Current treatment is very successful for the management of both native valve prosthetic valve HE but further studies are needed to determine why HE has a predilection for younger people and to cause stroke. The small number of patients and observational design limit inferences on treatment strategies. Self selection of study sites limits epidemiological inferences.	[Chambers, Stephen T.; Murdoch, David] Univ Otago, Christchurch & Christchurch Hosp, Dept Pathol, Christchurch, New Zealand; [Morris, Arthur] Auckland City Hosp, Microbiol Lab, Auckland, New Zealand; [Holland, David] Middlemore Hosp, Microbiol Lab, Auckland 6, New Zealand; [Pappas, Paul] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Almela, Manel] Univ Barcelona, Hosp Clin IDIBAPS, Dept Microbiol, Barcelona, Spain; [Fernandez-Hidalgo, Nuria; Almirante, Benito] Hosp Univ Vall dHebron, Dept Infect Dis, Barcelona, Spain; [Bouza, Emilio] Univ Gregorio Maranon, Gen Hosp, Clin Microbiol & Infect Dis Serv, Madrid, Spain; [Forno, Davide] Maria Vittoria Hosp, Dept Cardiol, Turin, Italy; [del Rio, Ana] Univ Barcelona, Hosp Clin IDIBAPS, Dept Clin Med Infect & Trop Dis, Barcelona, Spain; [Hannan, Margaret M.] Mater Hosp, Dept Med Microbiol, Dublin, Ireland; [Harkness, John] Dept Microbiol, Sydney, NSW, Australia; [Kanafani, Zeina A.] Amer Univ Beirut, Div Infect Dis, Beirut, Lebanon; [Lalani, Tahaniyat] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD USA; [Lang, Selwyn] Middlemore Hosp, Dept Microbiol, Auckland 6, New Zealand; [Raymond, Nigel] Wellington Hosp, Dept Infect Dis, Wellington, New Zealand; [Read, Kerry] North Shore Hosp, Dept Infect Dis, Auckland, New Zealand; [Vinogradova, Tatiana] Russian State Med Univ, Inst Expt Cardiol, Moscow 117437, Russia; [Woods, Christopher W.] VA Med Ctr, Dept Med, Durham, NC USA; [Wray, Dannah] Med Univ S Carolina, Div Infect Dis, Charleston, SC 29425 USA; [Corey, G. Ralph; Chu, Vivian H.] Duke Univ, Med Ctr, Durham, NC USA; [Clara, Liliana; Sanchez, Marisa] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Nacinovich, Francisco; Fernandez Oses, Pablo; Ronderos, Ricardo; Sucari, Adriana; Thierer, Jorge] Inst Cardiovasc Buenos Aires, Buenos Aires, DF, Argentina; [Casabe, Jose; Cortes, Claudia] Hosp Univ Fdn Favaloro, Buenos Aires, DF, Argentina; [Altclas, Javier; Kogan, Silvia] Sanatorio Trinidad Mitre, Buenos Aires, DF, Argentina; [Spelman, Denis] Alfred Hosp, Melbourne, Vic, Australia; [Athan, Eugene; Harris, Owen] Barwon Hlth, Geelong, Vic, Australia; [Kennedy, Karina] Canberra Hosp, Canberra, ACT, Australia; [Tan, Ren; Gordon, David; Papanicolas, Lito] Flinders Med Ctr, Adelaide, SA, Australia; [Eisen, Damon; Grigg, Leeanne; Street, Alan] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Korman, Tony; Kotsanas, Despina] Southern Hlth, Melbourne, Vic, Australia; [Dever, Robyn; Jones, Phillip; Konecny, Pam; Lawrence, Richard; Rees, David; Ryan, Suzanne] St George Hosp, Sydney, NSW, Australia; [Feneley, Michael P.; Harkness, John; Jones, Phillip; Ryan, Suzanne] St Vincents Hosp, Sydney, NSW, Australia; [Jones, Phillip; Ryan, Suzanne; Jones, Phillip; Post, Jeffrey; Reinbott, Porl; Ryan, Suzanne] Univ New S Wales, Sydney, NSW, Australia; [Gattringer, Rainer; Wiesbauer, Franz] Vienna Gen Hosp, Vienna, Austria; [Andrade, Adriana Ribas; Passos de Brito, Ana Claudia; Guimaraes, Armenio Costa] Ana Neri Hosp, Salvador, BA, Brazil; [Grinberg, Max; Mansur, Alfredo Jose; Siciliano, Rinaldo Focaccia; Varejao Strabelli, Tania Mara; Campos Vieira, Marcelo Luiz] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [de Medeiros Tranchesi, Regina Aparecida; Paiva, Marcelo Goulart] Hosp 9 Julho, Sao Paulo, Brazil; [Fortes, Claudio Querido] Hosp Univ Clementino Fraga Filho UFRJ, Rio De Janeiro, Brazil; [Ramos, Auristela de Oliveira] Inst Dante Pazzanese Cardiologia, Sao Paulo, Brazil; [Ferraiuoli, Giovanna; Golebiovski, Wilma; Lamas, Cristiane; Santos, Marisa; Weksler, Clara] Inst Nacl Cardiol, Rio De Janeiro, Brazil; [Karlowsky, James A.; Keynan, Yoav; Morris, Andrew M.; Rubinstein, Ethan] Univ Manitoba, Winnipeg, MB, Canada; [Jones, Sandra Braun; Garcia, Patricia] Univ Catolica Chile, Hosp Clin Pont, Santiago, Chile; [Cereceda, M.; Fica, Alberto; Mella, Rodrigo Montagna] Univ Chile, Hosp Clin, Santiago, Chile; [Barsic, Bruno; Bukovski, Suzana; Krajinovic, Vladimir; Pangercic, Ana; Rudez, Igor; Vincelj, Josip] Univ Hosp Infect Dis Zagreb, Zagreb, Croatia; [Freiberger, Tomas; Pol, Jiri; Zaloudikova, Barbora] Ctr Cardiovasc Surg & Transplantat, Brno, Czech Republic; [Ashour, Zainab; El Kholy, Amani; Mishaal, Marwa; Rizk, Hussien] Cairo Univ, Med Sch, Cairo, Egypt; [Aissa, Neijla; Alauzet, Corentine; Alla, Francois; Campagnac, Catherine; Doco-Lecompte, Thanh; Selton-Suty, Christine] CHU Nancy Brabois, Nancy, France; [Casalta, Jean-Paul; Fournier, Pierre-Edouard; Habib, Gilbert; Raoult, Didier; Thuny, Franck] Fac Med Marseille, Marseille, France; [Delahaye, Francois; Delahaye, Armelle; Vandenesch, Francois] Hosp Louis Pradel, Lyon, France; [Donal, Erwan; Donnio, Pierre Yves; Michelet, Christian; Revest, Matthieu; Tattevin, Pierre; Violette, Jeremie] Pontchaillou Univ, Rennes, France; [Chevalier, Florent; Jeu, Antoine; Dan; Rusinaru; Sorel, Claire; Tribouilloy, Christophe] South Hosp Amiens, Amiens, France; [Bernard, Yvette; Chirouze, Catherine; Hoen, Bruno; Leroy, Joel; Plesiat, Patrick] Univ Med Ctr Besancon, Besancon, France; [Naber, Christoph; Neuerburg, Carl] Univ Bergmannsheil Bochum, Bochum, Germany; [Mazaheri, Bahram; Naber, Christoph; Neuerburg, Carl] Univ Essen Gesamthsch, Essen, Germany; [Athanasia, Sofia; Giannitsioti, Efthymia] Attikon Univ, Gen Hosp, Athens, Greece; [Mylona, Elena; Paniara, Olga; Papanicolaou, Konstantinos; Pyros, John; Skoutelis, Athanasios] Evangelismos Gen Hosp Athens, Athens, Greece; [Sharma, Gautam] All India Inst Med Sci, New Delhi, India; [Francis, Johnson; Nair, Lathi; Thomas, Vinod; Venugopal, Krishnan] Med Coll Calicut, Calicut, Kerala, India; [Hannan, Margaret; Hurley, John] Mater Hosp, Dublin, Ireland; [Gilon, Dan; Israel, Sarah; Korem, Maya; Strahilevitz, Jacob] Hadassah Hebrew Univ, Jerusalem, Israel; [Rubinstein, Ethan; Strahilevitz, Jacob] Tel Aviv Univ, Sch Med, Tel Aviv, Israel; [Tripodi, Marie Francoise] Univ Studi Salerno, Fisciano, Italy; [Casillo, Roberta; Cuccurullo, Susanna; Dialetto, Giovanni; Durante-Mangoni, Emanuele; Irene, Mattucci; Ragone, Enrico; Utili, Riccardo] Seconda Univ Napoli, Naples, Italy; [Cecchi, Enrico; De Rosa, Francesco; Forno, Davide; Imazio, Massimo; Trinchero, Rita] Maria Vittoria Hosp, Turin, Italy; [Tebini, Alessandro; Grossi, Paolo; Lattanzio, Mariangela; Toniolo, Antonio] Ospedale Circolo Varese, Varese, Italy; [Goglio, Antonio; Raglio, Annibale; Ravasio, Veronica; Rizzi, Marco; Suter, Fredy] Ospedali Riuniti Bergamo, Bergamo, Italy; [Carosi, Giampiero; Magri, Silvia; Signorini, Liana] Univ Brescia, Spedali Civili, Brescia, Italy; [Baban, Tania; Kanafani, Zeina; Kanj, Souha S.; Sfeir, Jad; Yasmine, Mohamad] Amer Univ Beirut, Med Ctr, Beirut, Lebanon; [Abidin, Imran] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Tamin, Syahidah Syed] Natl Heart Inst, Kuala Lumpur, Malaysia; [Martinez, Eduardo Rivera; Nieto, Gabriel Israel Soto] Inst Nacl Cardiologia Ignacio Chavez, Mexico City, DF, Mexico; [van der Meer, Jan T. M.] Univ Amsterdam, Amsterdam, Netherlands; [Chambers, Stephen] Univ Otago, Christchurch, New Zealand; [Holland, David] Middlemore Hosp, Auckland, New Zealand; [Morris, Arthur] Diagnost Medlab, Auckland, New Zealand; [Raymond, Nigel] Wellington Hosp, Wellington, New Zealand; [Read, Kerry] North Shore Hosp, Auckland, New Zealand; [Murdoch, David R.] Univ Otago, Dunedin, New Zealand; [Dragulescu, Stefan; Ionac, Adina; Mornos, Cristian] Victor Babes Univ Med & Pharm, Timisoara, Romania; [Butkevich, O. M.] Russian Presidential Affairs Govt Med Ctr Russian, Learning Sci Ctr, Med Ctr, Moscow, Russia; [Chipigina, Natalia; Kirill, Ozerecky; Vadim, Kulichenko; Vinogradova, Tatiana] Russian Med State Univ, Moscow, Russia; [Edathodu, Jameela; Halim, Magid] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia; [Lum, Luh-Nah; Tan, Ru-San] Natl Heart Ctr, Singapore, Singapore; [Lejko-Zupanc, Tatjana; Logar, Mateja; Mueller-Premru, Manica] Med Ctr Ljublijana, Ljubljana, Slovenia; [Commerford, Patrick; Commerford, Anita; Deetlefs, Eduan; Hansa, Cass; Ntsekhe, Mpiko] Univ Cape Town, Groote Schuur Hosp, Rondebosch, South Africa; [Almela, Manuel; Armero, Yolanda; Azqueta, Manuel; Castaneda, Ximena; Cervera, Carlos; del Rio, Ana; Falces, Carlos; Garcia-de-la-Maria, Cristina; Fita, Guillermina; Gatell, Jose M.; Marco, Francesc; Mestres, Carlos A.; Miro, Jose M.; Moreno, Asuncion; Ninot, Salvador; Pare, Carlos; Pericas, Joan; Ramirez, Jose; Rovira, Irene; Sitges, Marta] Univ Barcelona, IDIBAPS, Hosp Clin, Barcelona, Spain; [Anguera, Ignasi; Font, Bernat; Guma, Joan Raimon] Hosp Sabadell, Sabadell, Spain; [Bermejo, Javier; Bouza, Emilio; Garcia Fernandez, Miguel Angel; Gonzalez-Ramallo, Victor; Marin, Mercedes; Munoz, Patricia; Pedromingo, Miguel; Roda, Jorge; Rodriguez-Creixems, Marta; Solis, Jorge] Hosp Gen Univ Gregorio Maranon, Madrid, Spain; [Almirante, Benito; Fernandez-Hidalgo, Nuria; Tornos, Pilar] Hosp Univ Vall Hebron, Barcelona, Spain; [de Alarcon, Aristides; Parra, Ricardo] Hosp Univ Virgen Rocio, Seville, Spain; [Alestig, Eric; Johansson, Magnus; Olaison, Lars; Snygg-Martin, Ulrika] Sahlgrenska Univ Ostra, Gothenburg, Sweden; [Pachirat, Orathai; Pachirat, Pimchitra; Pussadhamma, Burabha; Senthong, Vichai] Khon Kaen Univ, Khon Kaen, Thailand; [Casey, Anna; Elliott, Tom; Lambert, Peter; Watkin, Richard] Queen Elizabeth Hosp, Kowloon, Hong Kong, Peoples R China; [Eyton, Christina; Klein, John L.] St Thomas Hosp, London, England; [Bradley, Suzanne; Kauffman, Carol] Ann Arbor VA Med Ctr, Ann Arbor, MI USA; [Bedimo, Roger] Dallas VA Med Ctr, Dallas, TX USA; [Chu, Vivian H.; Corey, G. Ralph; Crowley, Anna Lisa; Douglas, Pamela; Drew, Laura; Fowler, Vance G.; Holland, Thomas; Lalani, Tahaniyat; Mudrick, Daniel; Samad, Zaniab; Sexton, Daniel; Stryjewski, Martin; Wang, Andrew; Woods, Christopher W.] Duke Univ Med Ctr, Durham, NC 27710 USA; [Lerakis, Stamatios] Emory Univ, Atlanta, GA 30322 USA; [Cantey, Robert; Steed, Lisa; Wray, Dannah] Med Univ South Carolina, Charleston, SC USA; [Dickerman, Stuart A.] New York Univ Med Ctr, New York, NY USA; [Bonilla, Hector; DiPersio, Joseph; Salstrom, Sara-Jane] Summa Hlth Syst, Akron, OH USA; [Baddley, John; Patel, Mukesh] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Peterson, Gail; Stancoven, Amy] UT Southwestern Med Ctr, Dallas, TX USA; [Afonso, Luis; Kulman, Theresa; Levine, Donald; Rybak, Michael] Wayne State Univ, Detroit, MI 48202 USA; [Cabell, Christopher H.] Quintiles, San Francisco, CA 94105 USA; [Baloch, Khaula; Chu, Vivian H.; Corey, G. Ralph; Dixon, Christy C.; Fowler, Vance G.; Harding, Tina; Jones-Richmond, Marian; Pappas, Paul; Park, Lawrence P.; Redick, Thomas; Stafford, Judy] ICE Coordinating Ctr, Durham, NC USA; [Anstrom, Kevin; Athan, Eugene; Bayer, Arnold S.; Cabell, Christopher H.; Chu, Vivian H.; Corey, G. Ralph; Fowler, Vance G.; Hoen, Bruno; Karchmer, A. W.; Miro, Jose M.; Murdoch, David R.; Sexton, Daniel J.; Wang, Andrew] ICE Publ Comm, Durham, NC USA; [Bayer, Arnold S.; Cabell, Christopher H.; Chu, Vivian; Corey, G. Ralph; Durack, David T.; Phil, D.; Eykyn, Susannah; Fowler, Vance G.; Hoen, Bruno; Miro, Jose M.; Moreillon, Phillipe; Olaison, Lars; Raoult, Didier; Rubinstein, Ethan; Sexton, Daniel J.] ICE Steering Comm, Durham, NC USA	Christchurch Hospital New Zealand; University of Otago; Auckland City Hospital; Duke University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Universitari Vall d'Hebron; General University Gregorio Maranon Hospital; Maria Vittoria Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Mater Misericordiae University Hospital; University College Dublin; American University of Beirut; Uniformed Services University of the Health Sciences - USA; National Medical Research Center of Cardiology; Pirogov Russian National Research Medical University; Medical University of South Carolina; Duke University; Hospital Italiano de Buenos Aires; University of Buenos Aires; Instituto Cardiovascular de Buenos Aires (ICBA); University of Buenos Aires; Florey Institute of Neuroscience & Mental Health; Australian National University; Canberra Hospital; Flinders Medical Centre; Royal Melbourne Hospital; St George Hospital; St Vincents Hospital Sydney; University of New South Wales Sydney; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Instituto Dante Pazzanese de Cardiologia; University of Manitoba; Pontificia Universidad Catolica de Chile; Universidad Catolica del Norte; Universidad de Chile; Egyptian Knowledge Bank (EKB); Cairo University; CHU de Nancy; UDICE-French Research Universities; Aix-Marseille Universite; CHU Lyon; CHU Rennes; Universite de Franche-Comte; CHU Besancon; Ruhr University Bochum; University of Duisburg Essen; University Hospital Attikon; All India Institute of Medical Sciences (AIIMS) New Delhi; Mater Misericordiae University Hospital; University College Dublin; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; University of Salerno; Universita della Campania Vanvitelli; Maria Vittoria Hospital; Ospedali Riuniti di Bergamo; University of Brescia; American University of Beirut; Universiti Malaya; Institute Jantung Negara; University of Amsterdam; University of Otago; University of Otago; Victor Babes University of Medicine & Pharmacy, Timisoara; Pirogov Russian National Research Medical University; King Faisal Specialist Hospital & Research Center; National Heart Centre Singapore; University of Cape Town; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; General University Gregorio Maranon Hospital; Hospital Universitari Vall d'Hebron; Virgen del Rocio University Hospital; Sahlgrenska University Hospital; Khon Kaen University; Guy's & St Thomas' NHS Foundation Trust; Duke University; Emory University; Medical University of South Carolina; New York University; Summa Health System; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wayne State University; IQVIA	Chambers, ST (corresponding author), Univ Otago, Christchurch & Christchurch Hosp, Dept Pathol, Christchurch, New Zealand.	steve.chambers@cdhb.govt.nz	Muñoz, Patricia/E-9431-2017; Giannitsioti, Efthymia/AAQ-5897-2020; Konecny, Pam/W-1788-2019; Thuny, Franck/ABB-2408-2021; Neuerburg, Carl/AAE-7269-2020; Lamas, Cristiane/AAV-4157-2020; Rudez, Igor/O-3950-2019; alla, francois/D-2295-2014; ntsekhe, mpiko/AAI-8001-2021; Lalani, Tahaniyat/HCI-8313-2022; DE ROSA, Francesco Giuseppe/AAC-7275-2022; Lerakis, Stamatios/AAR-7597-2021; andrade, adriana r/O-3507-2014; Post, Jeffrey/AAL-7115-2020; Chipigina, Natalia/Y-2754-2019; RAOULT, Didier/A-8434-2008; de la Maria, Cristina Garcia/H-7302-2017; Pericàs, Juan M/N-5674-2019; Post, Jeffrey/AAF-4960-2020; De Rosa, Francesco Giuseppe/J-3049-2013; Revest, Matthieu/L-9533-2015; Marco, Francesc D/K-2900-2017; eisen, damon/AAC-7433-2019; Murdoch, David/A-2012-2009; Cervera, Carlos/U-4538-2018; Holland, Thomas/AAA-6096-2022; Gonzalez Ramallo, Victor José/Y-6248-2018; donal, erwan/ABC-9736-2020; Grossi, Paolo Antonio/A-6158-2013; Fournier, Pierre-Edouard/AAC-6155-2021; /AAT-7830-2020; Bouza, Emilio/D-8661-2014; Thuny, Franck/ABC-7157-2020; Thuny, Franck/GSD-2668-2022; da Silva Santos, Marisa/ABA-3418-2020; yasmin, Mohamad/M-5472-2018; Vincelj, Josip/ABE-3053-2021; Gatell, Jose M/ABC-3607-2020; Sfeir, Jad G./X-4788-2018; Toniolo, Antonio/AAA-2845-2021; Altclas, Javier/AFN-4965-2022; Toniolo, Antonio Q./B-4103-2015; Fowler, Vance/AAW-2017-2021; Kholy, Amani El/ABA-4759-2020; Francis, Johnson/N-3588-2015; Korman, Tony/I-3099-2013; solis, jorge/E-2709-2018	Muñoz, Patricia/0000-0001-5706-5583; Konecny, Pam/0000-0003-0166-2287; Thuny, Franck/0000-0002-8727-7154; Neuerburg, Carl/0000-0002-1373-093X; Lamas, Cristiane/0000-0002-5561-999X; Rudez, Igor/0000-0002-7735-6721; ntsekhe, mpiko/0000-0002-0851-7675; Lalani, Tahaniyat/0000-0002-9361-2991; DE ROSA, Francesco Giuseppe/0000-0001-8338-0130; Post, Jeffrey/0000-0003-1475-9272; Chipigina, Natalia/0000-0002-2083-0437; RAOULT, Didier/0000-0002-0633-5974; de la Maria, Cristina Garcia/0000-0002-0585-9469; Pericàs, Juan M/0000-0002-3645-3293; Marco, Francesc D/0000-0002-1863-6379; Cervera, Carlos/0000-0002-0161-1749; Gonzalez Ramallo, Victor José/0000-0002-9867-1472; Grossi, Paolo Antonio/0000-0003-2883-5061; Fournier, Pierre-Edouard/0000-0001-8463-8885; /0000-0001-6539-1709; Bouza, Emilio/0000-0001-6967-9267; Thuny, Franck/0000-0002-8727-7154; da Silva Santos, Marisa/0000-0002-2174-6800; yasmin, Mohamad/0000-0002-5859-1769; Vincelj, Josip/0000-0003-0064-9128; Sfeir, Jad G./0000-0003-1576-1534; Toniolo, Antonio Q./0000-0003-3008-2126; Francis, Johnson/0000-0003-1084-8075; Moreno Camacho, Asuncion/0000-0002-5850-5007; Querido Fortes, Claudio/0000-0002-9700-9743; Douglas, Pamela/0000-0001-9876-4049; Falces, Carlos/0000-0002-3483-3786; Wang, Andrew/0000-0001-8729-0933; Kanj, Souha/0000-0001-6413-3396; Almirante, Benito/0000-0002-1189-2361; Papanicolas, Lito/0000-0002-5838-7274; Korman, Tony/0000-0002-6155-8353; Israel, Sarah/0000-0001-5646-0071; Selton-Suty, Christine/0000-0003-4129-5784; Chambers, Stephen/0000-0002-0698-3285; Sexton, Daniel J/0000-0001-9604-5948; alla, francois/0000-0002-5793-7190; Eisen, Damon/0000-0002-8987-4358; Stryjewski, Martin/0000-0002-4986-6564; solis, jorge/0000-0002-4227-7062; Tan, Ru San/0000-0003-2086-6517; GIANNITSIOTI, EFTHYMIA/0000-0003-2715-7457; Pussadhamma, Burabha/0000-0002-9688-823X; Kanafani, Zeina/0000-0001-8814-1286; Bermejo, Javier/0000-0002-5241-2758; Ionac, Adina/0000-0003-0635-8663; Athan, Eugene/0000-0001-9838-6471; Durante-Mangoni, Emanuele/0000-0002-5381-3537; Keynan, Yoav/0000-0003-4948-4707; Lambert, Peter/0000-0002-8243-2741; Gordon, David/0000-0003-3276-9685; Rizk, Hussien/0000-0001-5791-2359; Fernandez-Hidalgo, Nuria/0000-0002-2115-344X; ALAUZET, Corentine/0000-0001-7953-4870; Holland, Thomas/0000-0001-7745-9010; Imazio, Massimo/0000-0002-5722-0245	American Heart Association [0675027N]; International Society of Cardiovascular Infectious Diseases; International Society of Chemotherapy; "Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III'', Madrid, Spain; Spanish Network for Research in Infectious Diseases [REIPI RD06/0008]; Fundacion Privada Maximo Soriano Jimenez (Barcelona, Spain)	American Heart Association(American Heart Association); International Society of Cardiovascular Infectious Diseases; International Society of Chemotherapy; "Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III'', Madrid, Spain; Spanish Network for Research in Infectious Diseases; Fundacion Privada Maximo Soriano Jimenez (Barcelona, Spain)	This work was supported by the American Heart Association 0675027N (VHC), educational grants from International Society of Cardiovascular Infectious Diseases, International Society of Chemotherapy, the "Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III'', Madrid, Spain, and the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008) (MA, CGDM) and the Fundacion Privada Maximo Soriano Jimenez (Barcelona, Spain) (CGDM). The funders had no role in study design, data collection adn analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1994, CIRCULATION, V90, P1588, DOI 10.1161/01.CIR.90.3.1588; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Benito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004; Brouqui P, 2001, CLIN MICROBIOL REV, V14, P177, DOI 10.1128/CMR.14.1.177-207.2001; Chu VH, 2009, HEART, V95, P570, DOI 10.1136/hrt.2008.152975; Chu VH, 2005, CLIN INFECT DIS, V41, P406, DOI 10.1086/431590; DarrasJoly C, 1997, CLIN INFECT DIS, V24, P1087, DOI 10.1086/513624; Das M, 1997, ANNU REV MED, V48, P25, DOI 10.1146/annurev.med.48.1.25; Dickerman SA, 2007, AM HEART J, V154, P1086, DOI 10.1016/j.ahj.2007.07.023; Fernandez-Hidalgo N, 2011, CLIN MICROBIOL INFEC, V17, P769, DOI 10.1111/j.1469-0691.2010.03314.x; Ferreiros E, 2006, AM HEART J, V151, P545, DOI 10.1016/j.ahj.2005.04.008; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Horstkotte D, 2004, EUR HEART J, V25, P267, DOI 10.1016/j.ehj.2003.11.008; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kanafani ZA, 2010, EUR J CLIN MICROBIOL, V29, P1203, DOI 10.1007/s10096-010-0983-2; Lawrence HP, 2008, COMMUNITY DENT ORAL, V36, P305, DOI 10.1111/j.1600-0528.2007.00395.x; LERNER PI, 1966, NEW ENGL J MED, V274, P199, DOI 10.1056/NEJM196601272740407; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lu PL, 2000, J CLIN MICROBIOL, V38, P2015, DOI 10.1128/JCM.38.5.2015-2017.2000; Malani AN, 2006, EUR J CLIN MICROBIOL, V25, P587, DOI 10.1007/s10096-006-0189-9; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Okazaki S, 2011, CEREBROVASC DIS, V32, P483, DOI 10.1159/000331475; PASCHALIS C, 1990, EUR NEUROL, V30, P87, DOI 10.1159/000117317; Paturel L, 2004, CLIN MICROBIOL INFEC, V10, P98, DOI 10.1111/j.1469-0691.2004.00794.x; PELLETIER LL, 1977, MEDICINE, V56, P287, DOI 10.1097/00005792-197707000-00002; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Tleyjeh IM, 2005, JAMA-J AM MED ASSOC, V293, P3022, DOI 10.1001/jama.293.24.3022; Tleyjeh IM, 2007, CHEST, V132, P1025, DOI 10.1378/chest.06-2048; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354	31	100	104	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63181	10.1371/journal.pone.0063181	http://dx.doi.org/10.1371/journal.pone.0063181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690995	Green Published, Green Accepted, gold			2022-12-25	WOS:000319107900026
J	de Vega, M				de Vega, Miguel			The Minimal Bacillus subtilis Nonhomologous End Joining Repair Machinery	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-LIGASE-D; KU PROTEIN; POLYMERASE COMPONENT; BACTERIAL HOMOLOGS; ABASIC SITES; NHEJ; COMPLEX; FAMILY; EXPRESSION	It is widely accepted that repair of double-strand breaks in bacteria that either sporulate or that undergo extended periods of stationary phase relies not only on homologous recombination but also on a minimal nonhomologous end joining (NHEJ) system consisting of a dedicated multifunctional ATP-dependent DNA Ligase D (LigD) and the DNA-end-binding protein Ku. Bacillus subtilis is one of the bacterial members with a NHEJ system that contributes to genome stability during the stationary phase and germination of spores, having been characterized exclusively in vivo. Here, the in vitro analysis of the functional properties of the purified B. subtilis LigD (BsuLigD) and Ku (BsuKu) proteins is presented. The results show that the essential biochemical signatures exhibited by BsuLigD agree with its proposed function in NHEJ: i) inherent polymerization activity showing preferential insertion of NMPs, ii) specific recognition of the phosphate group at the downstream 5' end, iii) intrinsic ligase activity, iv) ability to promote realignments of the template and primer strands during elongation of mispaired 3' ends, and v) it is recruited to DNA by BsuKu that stimulates the inherent polymerization and ligase activities of the enzyme allowing it to deal with and to hold different and unstable DNA realignments.	Ctr Biol Mol Severo Ochoa CSIC UAM, Inst Biol Mol Eladio Vinuela CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	de Vega, M (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, Inst Biol Mol Eladio Vinuela CSIC, Madrid, Spain.	mdevega@cbm.uam.es	de Vega, Miguel/K-2878-2014	de Vega, Miguel/0000-0003-1285-7549	Spanish Ministry of Economy and Competitiveness [BFU2011-23720]; Fundacion Ramon Areces	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion Ramon Areces	This work was supported by the Spanish Ministry of Economy and Competitiveness [grant BFU2011-23720] to MV and by an institutional grant from Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ayora S, 2011, FEMS MICROBIOL REV, V35, P1055, DOI 10.1111/j.1574-6976.2011.00272.x; Banos B, 2008, NUCLEIC ACIDS RES, V36, P5736, DOI 10.1093/nar/gkn526; Banos B, 2010, P NATL ACAD SCI USA, V107, P19219, DOI 10.1073/pnas.1013603107; Bliss TM, 1997, J BIOL CHEM, V272, P5765, DOI 10.1074/jbc.272.9.5765; Brissett NC, 2007, SCIENCE, V318, P456, DOI 10.1126/science.1145112; Brissett NC, 2011, MOL CELL, V41, P221, DOI 10.1016/j.molcel.2010.12.026; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Cardenas PP, 2009, NUCLEIC ACIDS RES, V37, P4157, DOI 10.1093/nar/gkp314; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Daley JM, 2005, J BIOL CHEM, V280, P29030, DOI 10.1074/jbc.M505277200; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; DEMEDICIS E, 1986, APPL ENVIRON MICROB, V52, P567; Doherty AJ, 2001, FEBS LETT, V500, P186, DOI 10.1016/S0014-5793(01)02589-3; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Ferreira MG, 2004, GENE DEV, V18, P2249, DOI 10.1101/gad.315804; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Gong CL, 2004, J BIOL CHEM, V279, P20594, DOI 10.1074/jbc.M401841200; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Koonin EV, 2000, J MOL MICROB BIOTECH, V2, P509; Krejci L, 2003, PROG NUCLEIC ACID RE, V74, P159, DOI 10.1016/S0079-6603(03)01013-4; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lecointe F, 2004, MOL MICROBIOL, V53, P1721, DOI 10.1111/j.1365-2958.2004.04233.x; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; Lees-Miller SP, 2003, BIOCHIMIE, V85, P1161, DOI 10.1016/j.biochi.2003.10.011; Li ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020045; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Mascarenhas J, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-20; Moeller R, 2007, J BACTERIOL, V189, P3306, DOI 10.1128/JB.00018-07; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Pitcher RS, 2007, ANNU REV MICROBIOL, V61, P259, DOI 10.1146/annurev.micro.61.080706.093354; Pitcher RS, 2007, J MOL BIOL, V366, P391, DOI 10.1016/j.jmb.2006.10.046; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Sinha KM, 2007, J BIOL CHEM, V282, P15114, DOI 10.1074/jbc.M701167200; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Weller GR, 2001, FEBS LETT, V505, P340, DOI 10.1016/S0014-5793(01)02831-9; Yakovleva L, 2006, J BIOL CHEM, V281, P25026, DOI 10.1074/jbc.M603302200; Zhu H, 2006, P NATL ACAD SCI USA, V103, P1711, DOI 10.1073/pnas.0509083103; Zhu H, 2005, J BIOL CHEM, V280, P33707, DOI 10.1074/jbc.M506838200; Zhu H, 2005, J BIOL CHEM, V280, P25973, DOI 10.1074/jbc.M504002200; Zhu H, 2005, J BIOL CHEM, V280, P418, DOI 10.1074/jbc.M410110200; Zhu H, 2007, NUCLEIC ACIDS RES, V35, P3631, DOI 10.1093/nar/gkm145; Zhu H, 2006, J BIOL CHEM, V281, P13873, DOI 10.1074/jbc.M600055200; Zhu H, 2010, J BIOL CHEM, V285, P4815, DOI 10.1074/jbc.M109.073874	57	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64232	10.1371/journal.pone.0064232	http://dx.doi.org/10.1371/journal.pone.0064232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691176	Green Published, gold			2022-12-25	WOS:000319107900087
J	Khademullah, CS; Ferguson, AV				Khademullah, C. Sahara; Ferguson, Alastair V.			Depolarizing Actions of Hydrogen Sulfide on Hypothalamic Paraventricular Nucleus Neurons	PLOS ONE			English	Article							H2S; CHANNEL; NEUROENDOCRINE; VASORELAXANT; MODULATION	Hydrogen sulfide (H2S) is a novel neurotransmitter that has been shown to influence cardiovascular functions as well and corticotrophin hormone (CRH) secretion. Since the paraventricular nucleus of the hypothalamus (PVN) is a central relay center for autonomic and endocrine functions, we sought to investigate the effects of H2S on the neuronal population of the PVN. Whole cell current clamp recordings were acquired from the PVN neurons and sodium hydrosulfide hydrate (NaHS) was bath applied at various concentrations (0.1, 1, 10, and 50 mM). NaHS (1, 10, and 50 mM) elicited a concentration-response relationship from the majority of recorded neurons, with almost exclusively depolarizing effects following administration. Cells responded and recovered from NaHS administration quickly and the effects were repeatable. Input differences from baseline and during the NaHS-induced depolarization uncovered a biphasic response, implicating both a potassium and non-selective cation conductance. The results from the neuronal population of the PVN shed light on the possible physiological role that H2S has in autonomic and endocrine function.	[Khademullah, C. Sahara; Ferguson, Alastair V.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Ferguson, AV (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	avf@queensu.ca		Khademullah, C. Sahara/0000-0003-3887-8946	Canadian Institute of Health Research [MT-12192]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Funding provided by the Canadian Institute of Health Research (MT-12192; www.cihr-irsc.gc.c). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Ahmad FUD, 2012, RENAL FAILURE, V34, P203, DOI 10.3109/0886022X.2011.643365; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Bianca RDD, 2011, J PHARMACOL EXP THER, V337, P59, DOI 10.1124/jpet.110.176016; Caliendo G, 2010, J MED CHEM, V53, P6275, DOI 10.1021/jm901638j; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Dello Russo C, 2000, J NEUROENDOCRINOL, V12, P225; Dombkowski RA, 2004, AM J PHYSIOL-REG I, V286, pR678, DOI 10.1152/ajpregu.00419.2003; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Gan XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050102; Herman JP, 1996, CRIT REV NEUROBIOL, V10, P371, DOI 10.1615/CritRevNeurobiol.v10.i3-4.50; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Hu H, 2008, NEUROSCIENCE, V156, P1074, DOI 10.1016/j.neuroscience.2008.08.025; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; KOMBIAN SB, 1993, J NEUROPHYSIOL, V70, P81, DOI 10.1152/jn.1993.70.1.81; Lang RJ, 1998, BRIT J PHARMACOL, V123, P505, DOI 10.1038/sj.bjp.0701605; Lu M, 2012, ANTIOXID REDOX SIGN, V17, P849, DOI 10.1089/ars.2011.4507; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Nelson MT, 2006, CURR PHARM DESIGN, V12, P2189, DOI 10.2174/138161206777585184; Olson KR, 2008, AM J PHYSIOL-REG I, V295, pR669, DOI 10.1152/ajpregu.00807.2007; Olson KR, 2012, ANTIOXID REDOX SIGN, V17, P32, DOI 10.1089/ars.2011.4401; Pan Zan, 2011, Human Genomics, V5, P108; Peers C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00477; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; Powers-Martin K, 2008, AM J PHYSIOL-REG I, V295, pR1341, DOI 10.1152/ajpregu.00063.2008; Ramchandra R, 2013, J PHYSIOL-LONDON, V591, P93, DOI 10.1113/jphysiol.2012.236059; Sen U, 2012, AM J PHYSIOL-CELL PH, V303, pC41, DOI 10.1152/ajpcell.00398.2011; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Stern JE, 2001, J PHYSIOL-LONDON, V537, P161, DOI 10.1111/j.1469-7793.2001.0161k.x; Strege PR, 2011, AM J PHYSIOL-GASTR L, V300, pG1105, DOI 10.1152/ajpgi.00556.2010; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TASKER JG, 1991, J PHYSIOL-LONDON, V434, P271, DOI 10.1113/jphysiol.1991.sp018469; Tay AS, 2010, NEUROSCIENCE, V167, P277, DOI 10.1016/j.neuroscience.2010.02.006; Telezhkin V, 2009, ADV EXP MED BIOL, V648, P65, DOI 10.1007/978-90-481-2259-2_7; Umemura K, 2007, ANTIOXID REDOX SIGN, V9, P2035, DOI 10.1089/ars.2007.1802; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Xie L, 2012, AM J PHYSIOL-CELL PH, V303, pC81, DOI 10.1152/ajpcell.00281.2011; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	46	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64495	10.1371/journal.pone.0064495	http://dx.doi.org/10.1371/journal.pone.0064495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691233	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900104
J	Lekva, T; Bollerslev, J; Sahraoui, A; Scholz, H; Boyum, H; Evang, JA; Godang, K; Aukrust, P; Ueland, T				Lekva, Tove; Bollerslev, Jens; Sahraoui, Afaf; Scholz, Hanne; Boyum, Hege; Evang, Johan Arild; Godang, Kristin; Aukrust, Pal; Ueland, Thor			Thioredoxin Interacting Protein Is a Potential Regulator of Glucose and Energy Homeostasis in Endogenous Cushing's Syndrome	PLOS ONE			English	Article							METABOLIC SYNDROME; DIABETES-MELLITUS; BONE; INSULIN; EXPRESSION; TXNIP; OSTEOCALCIN; CORTISOL; HUMANS	Recent studies have described bone as an endocrine organ regulating glucose metabolism, with insulin signaling regulating osteocalcin secretion and osteocalcin regulating beta cell function. We have previously demonstrated increased bone expression of TXNIP in patients with endogenous Cushing's syndrome (CS), and we hypothesized that TXNIP could contribute to the dysregulated glucose metabolism in CS. We studied 33 CS patients and 29 matched controls, with bone biopsies from nine patients, before and after surgical treatment. In vitro, the effect of silencing TXNIP (siTXNIP) in osteoblasts, including its effect on human islet cells, was examined. Our major findings were: (i) The high mRNA levels of TXNIP in bone from CS patients were significantly associated with high levels of glucose and insulin, increased insulin resistance, and decreased insulin sensitivity in these patients. (ii) Silencing TXNIP in osteoblasts enhanced their OC response to insulin and glucose and down-regulated interleukin (IL)-8 levels in these cells. (iii) Conditional media from siTXNIP-treated osteoblasts promoted insulin content and anti-inflammatory responses in human islet cells. We recently demonstrated that the thioredoxin/TXNIP axis may mediate some detrimental effects of glucocorticoid excess on bone tissue in CS. Here we show that alterations in this axis also may affect glucose metabolism in these patients.	[Lekva, Tove; Bollerslev, Jens; Boyum, Hege; Evang, Johan Arild; Godang, Kristin] Oslo Univ Hosp, Dept Endocrinol, Sect Specialized Endocrinol, Oslo, Norway; [Lekva, Tove; Evang, Johan Arild; Aukrust, Pal; Ueland, Thor] Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Sahraoui, Afaf; Scholz, Hanne] Oslo Univ Hosp, Sect Transplantat, Oslo, Norway; [Sahraoui, Afaf; Scholz, Hanne] Oslo Univ Hosp, Inst Surg Res, Oslo, Norway; [Boyum, Hege] Oslo Univ Hosp, Div Obstet & Gynecol, Natl Resource Ctr Womens Hlth, Oslo, Norway; [Lekva, Tove; Bollerslev, Jens; Aukrust, Pal; Ueland, Thor] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Lekva, T (corresponding author), Oslo Univ Hosp, Dept Endocrinol, Sect Specialized Endocrinol, Oslo, Norway.	tove.lekva@medisin.uio.no	Scholz, Hanne/J-8150-2016	Lekva, Tove/0000-0002-7962-4726; Scholz, Hanne/0000-0003-2755-4399	JDRF award (ECIT Islet for Basic Research program) [31-2008-413]	JDRF award (ECIT Islet for Basic Research program)	Human islets were provided through the JDRF award 31-2008-413 (ECIT Islet for Basic Research program). The authors are grateful to the Nordic Network for Islet Transplantation and to dr. Ole Kristoffer Olstad and the Affymetrix Microarray Core Facility at Oslo University Hospital/Ulleval for performing and analyzing the microarray experiment.	Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Barahona MJ, 2009, J BONE MINER RES, V24, P1841, DOI [10.1359/JBMR.090505, 10.1359/jbmr.090505]; Brennan-Speranza TC, 2012, J CLIN INVEST, V122, P4172, DOI 10.1172/JCI63377; Chanson P, 2010, NEUROENDOCRINOLOGY, V92, P96, DOI 10.1159/000314272; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; Dostert A, 2004, CURR PHARM DESIGN, V10, P2807; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2012, BONE, V50, P452, DOI 10.1016/j.bone.2011.06.018; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Godang K, 1999, EUR J ENDOCRINOL, V141, P126, DOI 10.1530/eje.0.1410126; Goto M, 2005, TRANSPLANT P, V37, P1315, DOI 10.1016/j.transproceed.2004.11.042; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Kaimul AM, 2007, FREE RADICAL BIO MED, V43, P861, DOI 10.1016/j.freeradbiomed.2007.05.032; Kakisaka Y, 2002, HORM METAB RES, V34, P160, DOI 10.1055/s-2002-23201; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI [10.1359/jbmr.081234, 10.1359/JBMR.081234]; Koenen TB, 2011, DIABETES, V60, P517, DOI 10.2337/db10-0266; Kristo C, 2002, EUR J ENDOCRINOL, V146, P389, DOI 10.1530/eje.0.1460389; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lekva T, 2012, EUR J ENDOCRINOL, V166, P1039, DOI 10.1530/EJE-11-1082; Lekva T, 2010, J CLIN ENDOCR METAB, V95, P246, DOI 10.1210/jc.2009-0595; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Mancini Tatiana, 2004, Pituitary, V7, P249, DOI 10.1007/s11102-005-1051-2; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Miyamoto S, 2005, INTERNAL MED, V44, P1127, DOI 10.2169/internalmedicine.44.1127; Motyl KJ, 2010, ARCH BIOCHEM BIOPHYS, V503, P2, DOI 10.1016/j.abb.2010.07.030; Munir A, 2010, NEUROENDOCRINOLOGY, V92, P82, DOI 10.1159/000314316; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Okuda M, 2001, ARTERIOSCL THROM VAS, V21, P1483, DOI 10.1161/hq0901.095550; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Rani S, 2010, CELL PHYSIOL BIOCHEM, V25, P667, DOI 10.1159/000315086; Resmini E, 2009, ACTA DIABETOL, V46, P85, DOI 10.1007/s00592-009-0112-9; Reuwer AQ, 2009, HORMONES CARDIOVASCU, V35, P478; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Sereg M, 2011, STEROIDS, V76, P38, DOI 10.1016/j.steroids.2010.08.007; Yamamoto M, 2008, ANTIOXID REDOX SIGN, V10, P43, DOI 10.1089/ars.2007.1586	40	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64247	10.1371/journal.pone.0064247	http://dx.doi.org/10.1371/journal.pone.0064247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691179	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107900088
J	Vuguin, PM; Hartil, K; Kruse, M; Kaur, H; Lin, CLV; Fiallo, A; Glenn, AS; Patel, A; Williams, L; Seki, Y; Katz, EB; Charron, MJ				Vuguin, Patricia M.; Hartil, Kirsten; Kruse, Michael; Kaur, Harpreet; Lin, Chia-Lei Vivian; Fiallo, Ariana; Glenn, Alan Scott; Patel, Avanee; Williams, Lyda; Seki, Yoshinori; Katz, Ellen B.; Charron, Maureen J.			Shared Effects of Genetic and Intrauterine and Perinatal Environment on the Development of Metabolic Syndrome	PLOS ONE			English	Article							HIGH-FAT DIET; FOR-GESTATIONAL-AGE; HEPATIC INSULIN-RESISTANCE; ADIPOSE-TISSUE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; SKELETAL-MUSCLE; KNOCKOUT MICE; FETAL-GROWTH; PREDICTS OBESITY; LIPID-METABOLISM	Genetic and environmental factors, including the in utero environment, contribute to Metabolic Syndrome. Exposure to high fat diet exposure in utero and lactation increases incidence of Metabolic Syndrome in offspring. Using GLUT4 heterozygous (G4+/-) mice, genetically predisposed to Type 2 Diabetes Mellitus, and wild-type littermates we demonstrate genotype specific differences to high fat in utero and lactation. High fat in utero and lactation increased adiposity and impaired insulin and glucose tolerance in both genotypes. High fat wild type offspring had increased serum glucose and PAI-1 levels and decreased adiponectin at 6 wks of age compared to control wild type. High fat G4+/- offspring had increased systolic blood pressure at 13 wks of age compared to all other groups. Potential fetal origins of adult Metabolic Syndrome were investigated. Regardless of genotype, high fat in utero decreased fetal weight and crown rump length at embryonic day 18.5 compared to control. Hepatic expression of genes involved in glycolysis, gluconeogenesis, oxidative stress and inflammation were increased with high fat in utero. Fetal serum glucose levels were decreased in high fat G4+/- compared to high fat wild type fetuses. High fat G4+/-, but not high fat wild type fetuses, had increased levels of serum cytokines (IFN-gamma, MCP-1, RANTES and M-CSF) compared to control. This data demonstrates that high fat during pregnancy and lactation increases Metabolic Syndrome male offspring and that heterozygous deletion of GLUT4 augments susceptibility to increased systolic blood pressure. Fetal adaptations to high fat in utero that may predispose to Metabolic Syndrome in adulthood include changes in fetal hepatic gene expression and alterations in circulating cytokines. These results suggest that the interaction between in utero-perinatal environment and genotype plays a critical role in the developmental origin of health and disease.	[Vuguin, Patricia M.; Kaur, Harpreet] Childrens Hosp Montefiore, Div Pediat Endocrinol, Bronx, NY USA; [Kaur, Harpreet] Childrens Hosp Montefiore, Div Neonatol, Bronx, NY USA; [Hartil, Kirsten; Kruse, Michael; Lin, Chia-Lei Vivian; Fiallo, Ariana; Glenn, Alan Scott; Patel, Avanee; Williams, Lyda; Seki, Yoshinori; Katz, Ellen B.; Charron, Maureen J.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Charron, Maureen J.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Charron, Maureen J.] Yeshiva Univ Albert Einstein Coll Med, Dept Obstet & Gynecol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Vuguin, PM (corresponding author), Childrens Hosp Montefiore, Div Pediat Endocrinol, Bronx, NY USA.	pvuguin@nshs.edu; charron@einstein.yu.edu		Lin, Chia-Lei/0000-0002-8729-320X; vuguin, patricia/0000-0002-4982-0400	National Institutes of Health [DK47435, HL58119, K08-HD042172, F31-DK093332]; ADA Mentor based postdoctoral fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD042172] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK093332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA Mentor based postdoctoral fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health DK47435 and HL58119 (MJC) and K08-HD042172 (PV) and F31-DK093332 (LW), and an ADA Mentor based postdoctoral fellowship (MJC). Additional support was generously provided by the Diabetes Research and Training, Liver, and Cancer Centers of Albert Einstein College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge H., 2010, INT J OBES LOND, V35, P325; Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; Amarilyo G, 2011, J PERINATOL, V31, P30, DOI 10.1038/jp.2010.53; BAGCHI A, 1994, PEDIATR RES, V36, P244, DOI 10.1203/00006450-199408000-00017; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Burke-Gaffney A, 2005, TRENDS PHARMACOL SCI, V26, P398, DOI 10.1016/j.tips.2005.06.005; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Cai GW, 2008, CYTOKINE, V44, P242, DOI 10.1016/j.cyto.2008.08.006; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Dabelea D, 2000, J Matern Fetal Med, V9, P83, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<83::AID-MFM17>3.0.CO;2-O; Drake AJ, 2007, CLIN SCI, V113, P219, DOI 10.1042/CS20070107; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Eriksson JG, 2003, DIABETES CARE, V26, P3006, DOI 10.2337/diacare.26.11.3006; Etienne-Manneville S, 1999, J IMMUNOL, V163, P668; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Fitzpatrick E, 2012, PEDIATR OBES, V7, P471, DOI 10.1111/j.2047-6310.2012.00082.x; Goodell LS, 2009, J COMMUN HEALTH, V34, P370, DOI 10.1007/s10900-009-9164-6; Haggarty P, 2002, PLACENTA, V23, pS28, DOI 10.1053/plac.2002.0791; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hartil K, 2009, PEDIATR RES, V66, P368, DOI 10.1203/PDR.0b013e3181b33375; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Herrera E, 2000, DIABETES-METAB RES, V16, P202, DOI 10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.3.CO;2-R; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Jackson CM, 2012, AM J PHYSIOL-RENAL, V302, pF774, DOI 10.1152/ajprenal.00491.2011; Jankun J, 2012, INT J MOL MED, V29, P3, DOI 10.3892/ijmm.2011.810; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Knudsen VK, 2008, EUR J CLIN NUTR, V62, P463, DOI 10.1038/sj.ejcn.1602745; Lambert JF, 2000, J NEUROSCI METH, V95, P127, DOI 10.1016/S0165-0270(99)00157-0; Lee SA, 2008, BBA-MOL BASIS DIS, V1782, P421, DOI 10.1016/j.bbadis.2008.03.004; Li J, 2000, FASEB J, V14, P1117, DOI 10.1096/fasebj.14.9.1117; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Martin-Gronert MS, 2012, REV ENDOCR METAB DIS, V13, P85, DOI 10.1007/s11154-012-9210-z; Masuyama H, 2012, ENDOCRINOLOGY, V153, P2823, DOI 10.1210/en.2011-2161; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Naukkarinen J, 2011, INT J OBES LOND, V36, P1017; Neitzke U, 2011, MICROCIRCULATION, V18, P304, DOI 10.1111/j.1549-8719.2011.00089.x; Nemet D, 2003, PEDIATR RES, V53, P148, DOI 10.1203/00006450-200301000-00025; Neta GI, 2010, AM J EPIDEMIOL, V171, P859, DOI 10.1093/aje/kwq028; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Ouhilal S, 2012, AM J PHYSIOL-ENDOC M, V302, pE522, DOI 10.1152/ajpendo.00420.2011; Pihlajamaki J, 2004, J LIPID RES, V45, P507, DOI 10.1194/jlr.M300368-JLR200; Poston L, 2011, PROG BIOPHYS MOL BIO, V106, P315, DOI 10.1016/j.pbiomolbio.2010.11.011; Poulsen P, 2006, DIABETES, V55, P1819, DOI 10.2337/db05-1462; Raghupathy R, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/734865; Ramnanan CJ, 2010, DIABETES, V59, P1302, DOI 10.2337/db09-1625; Ranalletta M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1178, DOI 10.1152/ajpendo.00628.2006; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; Rebholz SL, 2011, AM J PHYSIOL-ENDOC M, V301, pE416, DOI 10.1152/ajpendo.00619.2010; SANTALUCIA T, 1992, ENDOCRINOLOGY, V130, P837, DOI 10.1210/en.130.2.837; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; Strakovsky RS, 2011, J PHYSIOL-LONDON, V589, P2707, DOI 10.1113/jphysiol.2010.203950; STUDELSKA DR, 1992, AM J PHYSIOL, V263, pE102, DOI 10.1152/ajpendo.1992.263.1.E102; Sun Y, 2002, J BIOL CHEM, V277, P23301, DOI 10.1074/jbc.M200964200; Symonds ME, 2003, J ENDOCRINOL, V179, P293, DOI 10.1677/joe.0.1790293; Thorn SR, 2009, ENDOCRINOLOGY, V150, P3021, DOI 10.1210/en.2008-1789; Vuguin P, 2004, DIABETES, V53, P2617, DOI 10.2337/diabetes.53.10.2617; Vuguin P, 2002, J Matern Fetal Neonatal Med, V11, P254, DOI 10.1080/713605519; Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545; Vuguin PM, 2006, ENDOCRINOLOGY, V147, P3995, DOI 10.1210/en.2005-1410; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Wolff Cindy Brattan, 1995, Nutrition and Health (Bicester), V10, P121; Wright RJ, 2010, AM J RESP CRIT CARE, V182, P25, DOI 10.1164/rccm.200904-0637OC; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Yoon BH, 1996, AM J OBSTET GYNECOL, V174, P1433, DOI 10.1016/S0002-9378(96)70585-9; Zhao L, 2011, J GASTROEN HEPATOL, V26, P875, DOI 10.1111/j.1440-1746.2010.06560.x	76	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63021	10.1371/journal.pone.0063021	http://dx.doi.org/10.1371/journal.pone.0063021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690974	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900021
J	Filbey, FM; Dunlop, J; Myers, US				Filbey, Francesca M.; Dunlop, Joseph; Myers, Ursula S.			Neural Effects of Positive and Negative Incentives during Marijuana Withdrawal	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; DECISION-MAKING; BRAIN ACTIVITY; ORBITOFRONTAL CORTEX; CANNABIS WITHDRAWAL; TOBACCO SMOKING; HUMAN AVOIDANCE; DRUG-ADDICTION; RISK-TAKING; REWARD	In spite of evidence suggesting two possible mechanisms related to drug-seeking behavior, namely reward-seeking and harm avoidance, much of the addiction literature has focused largely on positive incentivization mechanisms associated with addiction. In this study, we examined the contributing neural mechanisms of avoidance of an aversive state to drug-seeking behavior during marijuana withdrawal. To that end, marijuana users were scanned while performing the monetary incentive delay task in order to assess positive and negative incentive processes. The results showed a group x incentive interaction, such that marijuana users had greater response in areas that underlie reward processes during positive incentives while controls showed greater response in the same areas, but to negative incentives. Furthermore, a negative correlation between withdrawal symptoms and response in the amygdala during negative incentives was found in the marijuana users. These findings suggest that although marijuana users have greater reward sensitivity and less harm avoidance than controls, that attenuated amygdala response, an area that underlies fear and avoidance, was present in marijuana users with greater marijuana withdrawal symptoms. This is concordant with models of drug addiction that involve multiple sources of reinforcement in substance use disorders, and suggests the importance of strategies that focus on respective mechanisms.	[Filbey, Francesca M.; Dunlop, Joseph] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr Brain Hlth, Richardson, TX 75083 USA; [Myers, Ursula S.] Univ Calif San Diego, Dept Psychiat, San Diego State Univ, Dept Psychol,Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA	University of Texas System; University of Texas Dallas; California State University System; San Diego State University; University of California System; University of California San Diego	Filbey, FM (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Ctr Brain Hlth, Richardson, TX 75083 USA.	Francesca.Filbey@utdallas.edu	Filbey, Francesca/V-1366-2019; Filbey, Francesca M./J-5163-2014; Myers, Ursula/V-2448-2019	Filbey, Francesca/0000-0002-7466-4796; Myers, Ursula/0000-0002-6054-7353	National Institute on Drug Abuse/National Institutes of Health [KO1 DA021632]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030344, K01DA021632] Funding Source: NIH RePORTER	National Institute on Drug Abuse/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by a National Institute on Drug Abuse/National Institutes of Health grant: #KO1 DA021632 to Francesca Filbey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TB, 2004, PSYCHOL REV, V111, P33, DOI 10.1037/0033-295X.111.1.33; Barad M, 2006, BIOL PSYCHIAT, V60, P322, DOI 10.1016/j.biopsych.2006.05.029; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Bjork JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011440; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Budney AJ, 2003, J ABNORM PSYCHOL, V112, P393, DOI 10.1037/0021-843X.112.3.393; Budney AJ, 2002, J CLIN PHARMACOL, V42, p28S, DOI 10.1002/j.1552-4604.2002.tb06000.x; CHEREK DR, 1989, PHARMACOL BIOCHEM BE, V32, P677, DOI 10.1016/0091-3057(89)90017-8; Clithero JA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00087; Cooper JC, 2009, SOC COGN AFFECT NEUR, V4, P409, DOI 10.1093/scan/nsp031; Cooper ZD, 2008, ADDICT BIOL, V13, P188, DOI 10.1111/j.1369-1600.2007.00095.x; Copersino ML, 2006, AM J ADDICTION, V15, P8, DOI 10.1080/10550490500418997; Cousijn J., 2012, ADDICTION BIOL; Cousijn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042394; Debiec J, 2010, NAT NEUROSCI, V13, P536, DOI 10.1038/nn.2520; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Eissenberg T, 2004, ADDICTION, V99, P5, DOI 10.1111/j.1360-0443.2004.00735.x; Filbey FM, 2008, NEUROPSYCHOPHARMACOL, V33, P1391, DOI 10.1038/sj.npp.1301513; Filbey FM, 2009, P NATL ACAD SCI USA, V106, P13016, DOI 10.1073/pnas.0903863106; First MB, 2002, STRUCTURED CLIN INTE; Freire L, 2002, IEEE T MED IMAGING, V21, P470, DOI 10.1109/TMI.2002.1009383; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Gloria R, 2009, PSYCHOPHYSIOLOGY, V46, P681, DOI 10.1111/j.1469-8986.2009.00823.x; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hommer DW, 2011, ANN NY ACAD SCI, V1216, P50, DOI 10.1111/j.1749-6632.2010.05898.x; Hutcheson DM, 2001, NAT NEUROSCI, V4, P943, DOI 10.1038/nn0901-943; JARVIS MJ, 1994, ADDICTION, V89, P1371, DOI 10.1111/j.1360-0443.1994.tb03732.x; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Koob GF, 2008, ANNU REV PSYCHOL, V59, P29, DOI 10.1146/annurev.psych.59.103006.093548; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Leventhal AM, 2007, ADDICT BEHAV, V32, P2976, DOI 10.1016/j.addbeh.2007.06.014; LEVIN K, 2010, ART NEWS, V109, P111; McClernon FJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2148, DOI 10.1038/sj.npp.1301618; Nestor L, 2010, NEUROIMAGE, V49, P1133, DOI 10.1016/j.neuroimage.2009.07.022; Pomerleau OF, 2003, NICOTINE TOB RES, V5, P711, DOI 10.1080/1462220031000158627; Roberts AJ, 2000, NEUROPSYCHOPHARMACOL, V22, P581, DOI 10.1016/S0893-133X(99)00167-0; ROESE NJ, 1993, PSYCHOL BULL, V114, P363, DOI 10.1037/0033-2909.114.2.363; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Schlund MW, 2010, NEUROIMAGE, V53, P769, DOI 10.1016/j.neuroimage.2010.06.058; Schneider S, 2012, AM J PSYCHIAT, V169, P39, DOI 10.1176/appi.ajp.2011.11030489; Scott D, 2010, BIOL PSYCHIAT, V68, P726, DOI 10.1016/j.biopsych.2010.05.017; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaidya JG, 2012, NEUROPSYCHOPHARMACOL, V37, P618, DOI 10.1038/npp.2011.227; van Hell HH, 2010, EUR NEUROPSYCHOPHARM, V20, P153, DOI 10.1016/j.euroneuro.2009.11.010; Verdejo-Garcia A, 2009, NEUROPHARMACOLOGY, V56, P48, DOI 10.1016/j.neuropharm.2008.07.035; Weiss F, 2001, NEUROTOX RES, V3, P145, DOI 10.1007/BF03033235; Wilson SJ, 2008, J ABNORM PSYCHOL, V117, P428, DOI 10.1037/0021-843X.117.2.428; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Wrase J, 2007, NEUROIMAGE, V35, P787, DOI 10.1016/j.neuroimage.2006.11.043	64	41	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e61470	10.1371/journal.pone.0061470	http://dx.doi.org/10.1371/journal.pone.0061470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23690923	Green Published, gold			2022-12-25	WOS:000319052700005
J	Lin, AY; Almeida, JPM; Bear, A; Liu, N; Luo, L; Foster, AE; Drezek, RA				Lin, Adam Yuh; Almeida, Joao Paulo Mattos; Bear, Adham; Liu, Nathan; Luo, Laureen; Foster, Aaron Edward; Drezek, Rebekah Anna			Gold Nanoparticle Delivery of Modified CpG Stimulates Macrophages and Inhibits Tumor Growth for Enhanced Immunotherapy	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; CELLULAR UPTAKE; TLR9 AGONISTS; LYMPH-NODE; DNA; OLIGONUCLEOTIDES; CELLS; BIODISTRIBUTION; INJECTION; ADJUVANT	Gold nanoparticle accumulation in immune cells has commonly been viewed as a side effect for cancer therapeutic delivery; however, this phenomenon can be utilized for developing gold nanoparticle mediated immunotherapy. Here, we conjugated a modified CpG oligodeoxynucleotide immune stimulant to gold nanoparticles using a simple and scalable self-assembled monolayer scheme that enhanced the functionality of CpG in vitro and in vivo. Nanoparticles can attenuate systemic side effects by enhancing CpG delivery passively to innate effector cells. The use of a triethylene glycol (TEG) spacer on top of the traditional poly-thymidine spacer increased CpG macrophage stimulatory effects without sacrificing DNA content on the nanoparticle, which directly correlates to particle uptake. In addition, the immune effects of modified CpG-AuNPs were altered by the core particle size, with smaller 15 nm AuNPs generating maximum immune response. These TEG modified CpG-AuNP complexes induced macrophage and dendritic cell tumor infiltration, significantly inhibited tumor growth, and promoted survival in mice when compared to treatments with free CpG.	[Lin, Adam Yuh; Almeida, Joao Paulo Mattos; Liu, Nathan; Luo, Laureen; Drezek, Rebekah Anna] Rice Univ, Dept Bioengn, Houston, TX 77251 USA; [Bear, Adham; Foster, Aaron Edward] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Rice University; Baylor College of Medicine	Drezek, RA (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	drezek@rice.edu	Liu, Nathan/A-6484-2016	Liu, Nathan/0000-0002-4129-7846; Lin, Adam/0000-0001-9359-882X	Cancer Prevention and Research Institute of Texas [5RP100189]; National Institutes of Health [R01CA172836]; Keck Center of the Gulf Coast Consortia Nanobiology Interdisciplinary Graduate Training Program, National Institute of Biomedical Imaging and Bioengineering (NIBIB) [T32EB009379]; National Science Foundation; Howard Hughes Medical Institute Med into Grad fellowship; Medical Scientist Training Program at Baylor College of Medicine; Edward Josephine Hudson Scholarship,; Ruth L. Kirschstein National Research Service Awards [F30]; NATIONAL CANCER INSTITUTE [F30CA165686, R01CA172836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009379] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Center of the Gulf Coast Consortia Nanobiology Interdisciplinary Graduate Training Program, National Institute of Biomedical Imaging and Bioengineering (NIBIB); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute Med into Grad fellowship; Medical Scientist Training Program at Baylor College of Medicine; Edward Josephine Hudson Scholarship,; Ruth L. Kirschstein National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This project was funded by the Cancer Prevention and Research Institute of Texas 5RP100189 and National Institutes of Health R01CA172836. In addition, this research was funded by a training fellowship from the Keck Center of the Gulf Coast Consortia Nanobiology Interdisciplinary Graduate Training Program, National Institute of Biomedical Imaging and Bioengineering (NIBIB) T32EB009379. J. Almeida would also like to acknowledge support from the National Science Foundation Graduate Research Fellowship and the Howard Hughes Medical Institute Med into Grad fellowship. A. Lin would like to acknowledge support from the Medical Scientist Training Program at Baylor College of Medicine, the Edward Josephine Hudson Scholarship, and the Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral MD/PhD Fellows (F30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JPM, 2011, NANOMEDICINE-UK, V6, P815, DOI [10.2217/nnm.11.79, 10.2217/NNM.11.79]; Arnida Janat-Amsbury MM, EUROPEAN J IN PRESS; Askew D, 2000, J IMMUNOL, V165, P6889, DOI 10.4049/jimmunol.165.12.6889; Behboudi S, 2000, IMMUNOLOGY, V99, P361, DOI 10.1046/j.1365-2567.2000.00979.x; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Bourquin C, 2008, J IMMUNOL, V181, P2990, DOI 10.4049/jimmunol.181.5.2990; Buhtoiarov IN, 2007, IMMUNOLOGY, V120, P412, DOI 10.1111/j.1365-2567.2006.02517.x; Chen HC, 2011, BIOMATERIALS, V32, P1731, DOI 10.1016/j.biomaterials.2010.10.059; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Cubillos-Ruiz JR, 2009, J CLIN INVEST, V119, P2231, DOI 10.1172/JCI37716; de Jong S, 2007, CANCER IMMUNOL IMMUN, V56, P1251, DOI 10.1007/s00262-006-0276-x; Demers LM, 2000, ANAL CHEM, V72, P5535, DOI 10.1021/ac0006627; Franca A, 2011, NANOMEDICINE LOND; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Giljohann DA, 2007, NANO LETT, V7, P3818, DOI 10.1021/nl072471q; Heckelsmiller K, 2002, J IMMUNOL, V169, P3892, DOI 10.4049/jimmunol.169.7.3892; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Huang XH, 2007, NANOMEDICINE-UK, V2, P681, DOI 10.2217/17435889.2.5.681; Hurst SJ, 2006, ANAL CHEM, V78, P8313, DOI 10.1021/ac0613582; Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108; Khlebtsov N, 2011, CHEM SOC REV; Krieg AM, 2008, ONCOGENE, V27, P161, DOI 10.1038/sj.onc.1210911; Kwong B, 2011, BIOMATERIALS, V32, P5134, DOI 10.1016/j.biomaterials.2011.03.067; Lee IH, 2012, ANGEW CHEM INT EDIT, V51, P8800, DOI 10.1002/anie.201203193; Lou YY, 2011, J IMMUNOTHER, V34, P279, DOI 10.1097/CJI.0b013e31820d2a05; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Mao X, 2009, CHEM COMMUN, P3065, DOI 10.1039/b822582f; Massich MD, 2010, ACS NANO, V4, P5641, DOI 10.1021/nn102228s; Murad YM, 2009, BIODRUGS, V23, P361, DOI 10.2165/11316930-000000000-00000; Nardini E, 2005, J CELL PHYSIOL, V204, P889, DOI 10.1002/jcp.20360; Nierkens S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008368; Qiao GM, 2011, CHEM COMMUN, V47, P7458, DOI 10.1039/c1cc11490e; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; Schuller VJ, 2011, ACS NANO, V5, P9696, DOI 10.1021/nn203161y; Shirota Y, 2012, J IMMUNOL, V188, P1592, DOI 10.4049/jimmunol.1101304; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Taton T Andrew, 2002, Curr Protoc Nucleic Acid Chem, VChapter 12, DOI 10.1002/0471142700.nc1202s09; Wei M, 2012, ANGEW CHEM INT EDIT, V51, P1202, DOI 10.1002/anie.201105187; Weiner GJ, 2000, J LEUKOCYTE BIOL, V68, P455; Wilson KD, 2007, INT IMMUNOPHARMACOL, V7, P1064, DOI 10.1016/j.intimp.2007.04.002; Yao L, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2786984; Zoglmeier C, 2011, CLIN CANCER RES, V17, P1765, DOI 10.1158/1078-0432.CCR-10-2672	42	170	178	0	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63550	10.1371/journal.pone.0063550	http://dx.doi.org/10.1371/journal.pone.0063550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691064	gold, Green Published			2022-12-25	WOS:000319052700046
J	Zhang, JQ; Li, ZN; Guo, C; Liu, GF; Bao, MZ				Zhang, Jiaqi; Li, Zhineng; Guo, Cong; Liu, Guofeng; Bao, Manzhu			Isolation and Functional Analyses of a Putative Floral Homeotic C-Function Gene in a Basal Eudicot London Plane Tree (Platanus acerifolia)	PLOS ONE			English	Article							MADS-BOX GENES; AGAMOUS HOMOLOG; ECTOPIC EXPRESSION; OVULE DEVELOPMENT; ARABIDOPSIS; EVOLUTION; PROTEINS; ORTHOLOGUES; PISTILLATA; COMPLEXES	The identification of mutants in model plant species has led to the isolation of the floral homeotic function genes that play crucial roles in flower organ specification. However, floral homeotic C-function genes are rarely studied in basal eudicots. Here, we report the isolation and characterization of the AGAMOUS (AG) orthologous gene (PaAG) from a basal eudicot London plane tree (Platanus acerifolia Willd). Phylogenetic analysis showed that PaAG belongs to the C-clade AG group of genes. PaAG was found to be expressed predominantly in the later developmental stages of male and female inflorescences. Ectopic expression of PaAG-1 in tobacco (Nicotiana tabacum) resulted in morphological alterations of the outer two flower whorls, as well as some defects in vegetative growth. Scanning electron micrographs (SEMs) confirmed homeotic sepal-to-carpel transformation in the transgenic plants. Protein interaction assays in yeast cells indicated that PaAG could interact directly with PaAP3 (a B-class MADS-box protein in P. acerifolia), and also PaSEP1 and PaSEP3 (E-class MADS-box proteins in P. acerifolia). This study performed the functional analysis of AG orthologous genes outside core eudicots and monocots. Our findings demonstrate a conserved functional role of AG homolog in London plane tree, which also represent a contribution towards understanding the molecular mechanisms of flower development in this monoecious tree species.	[Zhang, Jiaqi; Li, Zhineng; Guo, Cong; Liu, Guofeng; Bao, Manzhu] Huazhong Agr Univ, Coll Hort & Forestry Sci, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Bao, MZ (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry Sci, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Hubei, Peoples R China.	mzbao@mail.hzau.edu.cn			National Natural Science Foundation of China [31171995, 31200526, 31272206]; International Foundation for Science [D/4831-1]; China Postdoctoral Science Foundation [20110491159]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Foundation for Science(International Foundation for Science); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by the National Natural Science Foundation of China (grant nos. 31171995, 31200526 and 31272206), the International Foundation for Science (D/4831-1) and the China Postdoctoral Science Foundation (grant no. 20110491159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGENENT GC, 1995, PLANT CELL, V7, P1569, DOI 10.1105/tpc.7.10.1569; Benedito VA, 2004, J EXP BOT, V55, P1391, DOI 10.1093/jxb/erh156; Boss PK, 2001, PLANT MOL BIOL, V45, P541, DOI 10.1023/A:1010634132156; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Brunner AM, 2000, PLANT MOL BIOL, V44, P619, DOI 10.1023/A:1026550205851; Chaidamsari T, 2006, PLANT SCI, V170, P968, DOI 10.1016/j.plantsci.2006.01.006; Chen YY, 2012, PLANT CELL PHYSIOL, V53, P1053, DOI 10.1093/pcp/pcs048; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; COLOMBO L, 1995, PLANT CELL, V7, P1859, DOI 10.1105/tpc.7.11.1859; Davies B, 1996, EMBO J, V15, P4330, DOI 10.1002/j.1460-2075.1996.tb00807.x; Du NX, 2010, PLANT MOL BIOL REP, V28, P344, DOI 10.1007/s11105-009-0163-7; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; Ferrario S, 2004, CURR OPIN PLANT BIOL, V7, P84, DOI 10.1016/j.pbi.2003.11.003; Gao XM, 2006, PLANT SCI, V170, P674, DOI 10.1016/j.plantsci.2005.11.001; Guo Yulong, 2007, Journal of Genetics and Genomics, V34, P527, DOI 10.1016/S1673-8527(07)60058-7; Hama E, 2004, PLANTA, V218, P712, DOI 10.1007/s00425-003-1157-6; Heijmans K, 2012, PLANT CELL, V24, P2305, DOI 10.1105/tpc.112.097030; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Johansen B, 2002, MOL PHYLOGENET EVOL, V23, P458, DOI 10.1016/S1055-7903(02)00032-5; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Kitahara K, 2004, PLANT SCI, V166, P1245, DOI 10.1016/j.plantsci.2003.12.040; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Lemmetyinen J, 2004, PHYSIOL PLANTARUM, V121, P149, DOI 10.1111/j.0031-9317.2004.00303.x; Li Z, 2012, BIOL PLANTARUM, V56, P585, DOI 10.1007/s10535-012-0112-4; Li ZN, 2008, FUNCT PLANT BIOL, V35, P159, DOI 10.1071/FP07212; Li ZN, 2012, J PLANT RES, V125, P381, DOI 10.1007/s10265-011-0456-4; MANDEL MA, 1992, CELL, V71, P133, DOI 10.1016/0092-8674(92)90272-E; Meguro A, 2003, SEX PLANT REPROD, V15, P221, DOI 10.1007/s00497-002-0158-0; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Rutledge R, 1998, PLANT J, V15, P625, DOI 10.1046/j.1365-313x.1998.00250.x; SUBIZA J, 1994, CLIN EXP ALLERGY, V24, P1123, DOI 10.1111/j.1365-2222.1994.tb03317.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tani E, 2009, PLANT PHYSIOL BIOCH, V47, P690, DOI 10.1016/j.plaphy.2009.03.013; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Varela S, 1997, J ALLERGY CLIN IMMUN, V100, P748, DOI 10.1016/S0091-6749(97)70268-9; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Western TL, 1999, PLANT J, V18, P329, DOI 10.1046/j.1365-313X.1999.00448.x; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Yao JL, 2001, P NATL ACAD SCI USA, V98, P1306, DOI 10.1073/pnas.031502498; Zhang JQ, 2011, GENE, V473, P82, DOI 10.1016/j.gene.2010.11.005	43	6	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63389	10.1371/journal.pone.0063389	http://dx.doi.org/10.1371/journal.pone.0063389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691041	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700033
J	Zhang, LN; Liu, PP; Wang, LY; Yuan, F; Xu, LT; Xin, YF; Fei, LJ; Zhong, QL; Huang, Y; Xu, LM; Hao, LM; Qiu, XJ; Le, YP; Ye, M; Duan, SW				Zhang, Li-Na; Liu, Pan-Pan; Wang, Lingyan; Yuan, Fang; Xu, Leiting; Xin, Yanfei; Fei, Li-Juan; Zhong, Qi-Long; Huang, Yi; Xu, Limin; Hao, Ling-Mei; Qiu, Xu-Jun; Le, Yanping; Ye, Meng; Duan, Shiwei			Lower ADD1 Gene Promoter DNA Methylation Increases the Risk of Essential Hypertension	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; BLOOD-PRESSURE; ALPHA-ADDUCIN; COLORECTAL-CANCER; POINT MUTATIONS; ANGIOTENSIN-II; GENOME-WIDE; IN-VIVO; ASSOCIATION; POLYMORPHISM	The goal of our study is to investigate the contribution of promoter DNA methylation of alpha-adducin (ADD1) gene to the risk of essential hypertension (EH). Using the bisulphite pyrosequencing technology, DNA methylation levels of five CpG dinucleotides on ADD1 promoter were measured among 33 EH cases and 28 healthy controls. Significantly higher ADD1 DNA methylation levels were observed in the females than in the males (CpG1: P = 0.016; CpG2-5: P = 0.021). A breakdown analysis by gender showed that lower CpG1 methylation was associated with an increased risk of EH in females (adjusted P = 0.042). A much more significant association between lower CpG2-5 methylation levels and the increased risk of EH was found in males (adjusted P = 0.008). CpG1 methylation was inversely correlated with age in females (r = -0.407, P = 0.019) but not in males. ADD1 CpG1 and CpG2-5 methylation levels were significantly lower in post-menopausal (> 50 years) women than pre-menopausal (<= 50 years) women (CpG1: P = 0.006; CpG2-5: P = 0.034). A significant interaction between CpG1 methylation and age was found in females (CpG1*age: P = 0.029). CpG2-5 methylation was shown as a significant predictor of EH in males [area under curve (AUC) = 0.855, P = 0.001], in contrast that CpG1 methylation was a trend toward indicator in females (AUC = 0.699, P = 0.054). In addition, significant differences were observed between males and females for alanine aminotransferase (ALT, P = 0.001), aspartate aminotransferase (AST, P = 0.005) and uric acid (P < 0.001). The concentration of AST was inversely correlated with ADD1 CpG2-5 methylation levels in female controls (r = -0.644, P = 0.024). These observations may bring new hints to elaborate the pathogenesis of EH.	[Zhang, Li-Na; Liu, Pan-Pan; Yuan, Fang; Xu, Leiting; Fei, Li-Juan; Zhong, Qi-Long; Huang, Yi; Xu, Limin; Le, Yanping; Duan, Shiwei] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo, Zhejiang, Peoples R China; [Wang, Lingyan] Ningbo 2 Hosp, Bank Blood Prod, Ningbo, Zhejiang, Peoples R China; [Xin, Yanfei] Zhejiang Acad Med Sci, State Key Lab Safety Evaluat New Drugs, Hangzhou, Zhejiang, Peoples R China; [Hao, Ling-Mei; Qiu, Xu-Jun] Seventh Hosp Ningbo, Clin Lab, Ningbo, Zhejiang, Peoples R China; [Ye, Meng] Ningbo Univ, Affiliated Hosp, Ningbo, Zhejiang, Peoples R China	Ningbo University; Zhejiang Academy of Medical Sciences; Ningbo University	Zhang, LN (corresponding author), Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo, Zhejiang, Peoples R China.	zhanglina@nbu.edu.cn; dryemeng@yahoo.com.cn; duanshiwei@nbu.edu.cn	Duan, Shiwei/AAA-4782-2022	Xin, Yanfei/0000-0001-6624-9333; Duan, Shiwei/0000-0001-7682-2877; Huang, Yi/0000-0003-3598-9747	National Natural Science Foundation of China [31100919]; Zhejiang Provincial Natural Science Foundation of China [R13H020004]; K.C. Wong Magna Fund in Ningbo University; Natural Science Foundation of Ningbo City [2011A610037]; Ningbo social development research projects [2012C50032]; Key Program of Education Commission of Zhejiang Province [Z201017918]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); K.C. Wong Magna Fund in Ningbo University; Natural Science Foundation of Ningbo City; Ningbo social development research projects; Key Program of Education Commission of Zhejiang Province	The research was supported by the grants from National Natural Science Foundation of China (31100919), Zhejiang Provincial Natural Science Foundation of China under Grant No. R13H020004, K.C. Wong Magna Fund in Ningbo University, Natural Science Foundation of Ningbo City (2011A610037), Ningbo social development research projects (2012C50032), and Key Program of Education Commission of Zhejiang Province (Z201017918). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN J, 1991, J STEROID BIOCHEM, V40, P511, DOI 10.1016/0960-0760(91)90270-F; Benza RL, 2008, CHEST, V134, P775, DOI 10.1378/chest.07-0767; BIANCHI G, 1994, P NATL ACAD SCI USA, V91, P3999, DOI 10.1073/pnas.91.9.3999; Binder A, 2007, CURR OPIN CARDIOL, V22, P176, DOI 10.1097/HCO.0b013e3280d357f9; Busch CP, 1999, J HUM GENET, V44, P225, DOI 10.1007/s100380050148; CASARI G, 1995, HYPERTENSION, V25, P320, DOI 10.1161/01.HYP.25.3.320; Chen An, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P1120; Chen Dong-li, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1890; Cheung BMY, 2011, CLIN CHIM ACTA, V412, P1326, DOI 10.1016/j.cca.2011.03.030; Coatmellec-Taglioni G, 2002, AM J HYPERTENS, V15, P143, DOI 10.1016/S0895-7061(01)02269-5; Danser AHJ, 1998, J HYPERTENS, V16, P853; Deng AY, 2008, CLIN EXP HYPERTENS, V30, P511, DOI 10.1080/10641960802251933; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; Ferrandi M, 1996, HYPERTENSION, V28, P1018, DOI 10.1161/01.HYP.28.6.1018; Ferrandi M, 1999, AM J PHYSIOL-HEART C, V277, pH1338, DOI 10.1152/ajpheart.1999.277.4.H1338; Fisher NDL, 1997, HYPERTENSION, V29, P980, DOI 10.1161/01.HYP.29.4.980; Friso S, 2008, ATHEROSCLEROSIS, V199, P323, DOI 10.1016/j.atherosclerosis.2007.11.029; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Guay SP, 2012, EPIGENETICS-US, V7, P464, DOI 10.4161/epi.19633; He J, 2007, J HUM HYPERTENS, V21, P639, DOI 10.1038/sj.jhh.1002207; IKAI E, 1995, J HUM HYPERTENS, V9, P101; Iwai N, 1997, LANCET, V350, P369, DOI 10.1016/S0140-6736(05)63430-7; Jalal DI, 2012, AM J KIDNEY DIS; Jiang QX, 2011, INDIAN J BIOCHEM BIO, V48, P301; Kamitani A, 1998, HYPERTENSION, V32, P138, DOI 10.1161/01.HYP.32.1.138; Kinoshita M, 2012, NEUROMOL MED; Koturbash I, 2008, MUTAT RES-FUND MOL M, V642, P28, DOI 10.1016/j.mrfmmm.2008.04.002; Kulkarni A, 2011, DNA CELL BIOL, V30, P79, DOI 10.1089/dna.2010.1084; KURTZ TW, 1993, AM J MED, V94, P77, DOI 10.1016/0002-9343(93)90124-8; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030214; Liu K, 2011, HYPERTENS RES, V34, P389, DOI 10.1038/hr.2010.252; Liu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013057; Ma L, 2012, J MED CHEM; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; Manunta P, 1998, KIDNEY INT, V53, P1471, DOI 10.1046/j.1523-1755.1998.00931.x; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Melas PA, 2012, FASEB J, V26, P2712, DOI 10.1096/fj.11-202069; Mo Yu-jing, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P84; Morita S, 2012, INT J MOL SCI, V13, P8259, DOI 10.3390/ijms13078259; Muller HM, 2003, CANCER RES, V63, P7641; Muller HM, 2004, ANN NY ACAD SCI, V1022, P44, DOI 10.1196/annals.1318.008; Niu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017052; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Raiche J, 2004, BIOCHEM BIOPH RES CO, V325, P39, DOI 10.1016/j.bbrc.2004.10.002; Ramu P, 2010, Indian J Hum Genet, V16, P8, DOI 10.4103/0971-6866.64938; Rands VF, 2012, GENDER MED, V9, P207, DOI 10.1016/j.genm.2012.06.001; Razavizade M, 2012, HEPATOB PANCREAT DIS, V11, P513, DOI 10.1016/S1499-3872(12)60216-1; RAZIN A, 1984, P NATL ACAD SCI-BIOL, V81, P2275, DOI 10.1073/pnas.81.8.2275; Reynolds E, 2006, LANCET NEUROL, V5, P949, DOI 10.1016/S1474-4422(06)70598-1; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Sebag IA, 2011, AM J PHYSIOL-HEART C, V301, pH1706, DOI 10.1152/ajpheart.00088.2011; Seda O, 2008, HYPERTENSION, V51, P1156, DOI 10.1161/HYPERTENSIONAHA.107.105247; Shimodaira Masanori, 2008, Int J Med Sci, V5, P29; Silva-Antonialli MM, 2004, CARDIOVASC RES, V62, P587, DOI 10.1016/j.cardiores.2004.01.020; Smolarek I, 2010, MED SCI MONITOR, V16, pCR149; Svetkey LP, 2011, AM J HYPERTENS, V24, P209, DOI 10.1038/ajh.2010.223; Tohidi M, 2012, J HUM HYPERTENS, V26, P525, DOI 10.1038/jhh.2011.70; Tripodi G, 1996, J CLIN INVEST, V97, P2815, DOI 10.1172/JCI118737; Wang JG, 2002, KIDNEY INT, V62, P2152, DOI 10.1046/j.1523-1755.2002.00691.x; Wang Z, 2010, J HUM HYPERTENS, V24, P327, DOI 10.1038/jhh.2009.67; Wang Zuo-Guang, 2011, Zhonghua Yi Xue Za Zhi, V91, P1238; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; Xu H, 2012, PSYCHIAT RES; Yagil C, 1998, HYPERTENSION, V31, P119, DOI 10.1161/01.HYP.31.1.119; Zhang X, 2012, BRIT J CANCER, V106, P1335, DOI 10.1038/bjc.2012.76; Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053	70	19	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63455	10.1371/journal.pone.0063455	http://dx.doi.org/10.1371/journal.pone.0063455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691048	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700036
J	Tang, S; Huang, G; Tong, XM; Xu, L; Cai, R; Li, J; Zhou, X; Song, SL; Huang, C; Cheng, JK				Tang, Shuang; Huang, Gang; Tong, Xuemei; Xu, Lian; Cai, Rong; Li, Jie; Zhou, Xiang; Song, Shaoli; Huang, Chen; Cheng, Jinke			Role of SUMO-Specific Protease 2 in Reprogramming Cellular Glucose Metabolism	PLOS ONE			English	Article							CANCER-CELLS; STABILIZATION; EXPRESSION; MECHANISM; PROTEINS; HYPOXIA; PTEN	Most cancer cells exhibit a shift in glucose metabolic strategy, displaying increased glycolysis even with adequate oxygen supply. SUMO-specific proteases (SENPs) de-SUMOylate substrates including HIF1 alpha and p53, two key regulators in cancer glucose metabolism, to regulate their activity, stability and subcellular localization. However, the role of SENPs in tumor glucose metabolism remains unclear. Here we report that SUMO-specific protease 2 (SENP2) negatively regulates aerobic glycolysis in MCF7 and MEF cells. Over-expression of SENP2 reduces the glucose uptake and lactate production, increasing the cellular ATP levels in MCF7 cells, while SENP2 knockout MEF cells show increased glucose uptake and lactate production along with the decreased ATP levels. Consistently, the MCF7 cells over-expressing SENP2 exhibit decreased expression levels of key glycolytic enzymes and an increased rate of glucose oxidation compared with control MCF7 cells, indicating inhibited glycolysis but enhanced oxidative mitochondrial respiration. Moreover, SENP2 over-expressing MCF7 cells demonstrated a reduced amount of phosphorylated AKT, whereas SENP2 knockout MEFs exhibit increased levels of phosphorylated AKT. Furthermore, inhibiting AKT phosphorylation by LY294002 rescued the phenotype induced by SENP2 deficiency in MEFs. In conclusion, SENP2 represses glycolysis and shifts glucose metabolic strategy, in part through inhibition of AKT phosphorylation. Our study reveals a novel function of SENP2 in regulating glucose metabolism.	[Tang, Shuang; Huang, Gang; Xu, Lian; Zhou, Xiang; Song, Shaoli; Huang, Chen] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China; [Tang, Shuang; Huang, Gang; Xu, Lian; Zhou, Xiang; Song, Shaoli; Huang, Chen] SJTUSM, Inst Hlth Sci, Shanghai, Peoples R China; [Tang, Shuang; Huang, Gang; Xu, Lian; Zhou, Xiang; Song, Shaoli; Huang, Chen] Chinese Acad Sci, SIBS, Shanghai, Peoples R China; [Tong, Xuemei; Cai, Rong; Li, Jie; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvirom & Inflammat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Huang, G (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China.	huang2802@163.com	Tang, Shuang/I-2709-2019; song, sl/GRS-1884-2022	Tang, Shuang/0000-0002-3501-7836; 	National Natural Science Foundation of China [81071180]; National Basic Research Program of China (973 Program) [2012CB932604, 2012CB910102]; New Drug Discovery Project [2012ZX0 9506-001-005]; Shanghai Leading Academic Discipline Project [S30203]; Ministry of Science and Technology of China Grant [2012BAI02B05]; Research Fund for the Doctoral Program of Shanghai Jiao Tong University School of Medicine [BXJ201220]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); New Drug Discovery Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Ministry of Science and Technology of China Grant; Research Fund for the Doctoral Program of Shanghai Jiao Tong University School of Medicine(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was financially supported by National Natural Science Foundation of China (No. 81071180), National Basic Research Program of China (973 Program) (Nos. 2012CB932604, 2012CB910102), New Drug Discovery Project (No. 2012ZX0 9506-001-005), Shanghai Leading Academic Discipline Project (No. S30203), Ministry of Science and Technology of China Grant (No. 2012BAI02B05) and Research Fund for the Doctoral Program of Shanghai Jiao Tong University School of Medicine (No. BXJ201220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbor TA, 2011, J BIOL CHEM, V286, P4718, DOI 10.1074/jbc.M110.115931; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Dai XQ, 2011, DIABETES, V60, P838, DOI 10.2337/db10-0440; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gonzalez-Santamaria J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.135; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hernandez-Aya LF, 2011, ONCOLOGIST, V16, P404, DOI 10.1634/theoncologist.2010-0402; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Jiang M, 2011, CELL DEATH DIFFER, V18, P1005, DOI 10.1038/cdd.2010.168; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Pandey D, 2011, ARTERIOSCL THROM VAS, V31, P1634, DOI 10.1161/ATVBAHA.111.226621; Nguyen QD, 2011, TRANSL ONCOL, V4, P241, DOI 10.1593/tlo.11118; Thanan R, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/165879; Tuttle SW, 2007, J BIOL CHEM, V282, P36790, DOI 10.1074/jbc.M700327200; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Xu Y, 2011, CANCER LETT, V309, P78, DOI 10.1016/j.canlet.2011.05.019; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1852; Zhao F, 2010, ONCOGENE, V29, P2962, DOI 10.1038/onc.2010.67	24	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63965	10.1371/journal.pone.0063965	http://dx.doi.org/10.1371/journal.pone.0063965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691130	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400093
J	Zundorf, IC; Lewald, J; Karnath, HO				Zuendorf, Ida C.; Lewald, Joerg; Karnath, Hans-Otto			Neural Correlates of Sound Localization in Complex Acoustic Environments	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; POSITRON-EMISSION-TOMOGRAPHY; EVENT-RELATED FMRI; STREAM SEGREGATION; SELECTIVE ATTENTION; SPATIAL ATTENTION; PARIETAL CORTEX; FUNCTIONAL NEUROANATOMY; PREFRONTAL CORTEX; PLANUM TEMPORALE	Listening to and understanding people in a "cocktail-party situation'' is a remarkable feature of the human auditory system. Here we investigated the neural correlates of the ability to localize a particular sound among others in an acoustically cluttered environment with healthy subjects. In a sound localization task, five different natural sounds were presented from five virtual spatial locations during functional magnetic resonance imaging (fMRI). Activity related to auditory stream segregation was revealed in posterior superior temporal gyrus bilaterally, anterior insula, supplementary motor area, and frontoparietal network. Moreover, the results indicated critical roles of left planum temporale in extracting the sound of interest among acoustical distracters and the precuneus in orienting spatial attention to the target sound. We hypothesized that the left-sided lateralization of the planum temporale activation is related to the higher specialization of the left hemisphere for analysis of spectrotemporal sound features. Furthermore, the precuneus - a brain area known to be involved in the computation of spatial coordinates across diverse frames of reference for reaching to objects - seems to be also a crucial area for accurately determining locations of auditory targets in an acoustically complex scene of multiple sound sources. The precuneus thus may not only be involved in visuo-motor processes, but may also subserve related functions in the auditory modality.	[Zuendorf, Ida C.; Karnath, Hans-Otto] Univ Tubingen, Ctr Neurol, Hertie Inst Clin Brain Res, Div Neuropsychol, Tubingen, Germany; [Lewald, Joerg] Ruhr Univ Bochum, Dept Cognit Psychol, Bochum, Germany; [Lewald, Joerg] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Karnath, Hans-Otto] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Karnath, HO (corresponding author), Univ Tubingen, Ctr Neurol, Hertie Inst Clin Brain Res, Div Neuropsychol, Tubingen, Germany.	Karnath@uni-tuebingen.de	Lewald, Jörg/D-3034-2009	Lewald, Jörg/0000-0001-9351-0170	Deutsche Forschungsgemeinschaft [KA 1258/12-1, LE 673/2-1]; Tuebingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	Supported by the Deutsche Forschungsgemeinschaft (KA 1258/12-1; LE 673/2-1). www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Peter Dillmann for preparing the auditory stimuli, software, and part of the electronic equipment, Michael Erb for his support in determining the functional imaging parameters, and Johannes Rennig for his assistance during fMRI data acquisiton. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University.	Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Alain C, 2005, NEUROIMAGE, V26, P592, DOI 10.1016/j.neuroimage.2005.02.006; Alain C, 2005, J COGNITIVE NEUROSCI, V17, P811, DOI 10.1162/0898929053747621; Alain C, 2007, HEARING RES, V229, P225, DOI 10.1016/j.heares.2007.01.011; Altmann CF, 2007, NEUROIMAGE, V35, P1192, DOI 10.1016/j.neuroimage.2007.01.007; ANDERSON TJ, 1994, BRAIN, V117, P1073, DOI 10.1093/brain/117.5.1073; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Arnott SR, 2011, NEUROSCI BIOBEHAV R, V35, P2162, DOI 10.1016/j.neubiorev.2011.04.005; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Barrett DJK, 2006, NEUROIMAGE, V32, P968, DOI 10.1016/j.neuroimage.2006.03.050; Bellmann A, 2001, BRAIN, V124, P676, DOI 10.1093/brain/124.4.676; Bidet-Caulet A, 2007, J NEUROSCI, V27, P9252, DOI 10.1523/JNEUROSCI.1402-07.2007; BISIACH E, 1984, BRAIN, V107, P37, DOI 10.1093/brain/107.1.37; Boersma P, 2001, GLOT INT, V5, P341; BREGMAN AS, 1971, J EXP PSYCHOL, V89, P244, DOI 10.1037/h0031163; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Cohen YE, 2009, HEARING RES, V258, P100, DOI 10.1016/j.heares.2009.01.011; Cohen YE, 2004, J NEUROSCI, V24, P11307, DOI 10.1523/JNEUROSCI.3935-04.2004; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Cohen YE, 2004, CROSSMODAL SPACE CRO, P99; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; Cusack R, 2005, J COGNITIVE NEUROSCI, V17, P641, DOI 10.1162/0898929053467541; Deike S, 2004, NEUROREPORT, V15, P1511, DOI 10.1097/01.wnr.0000132919.12990.34; Deike S, 2010, HEARING RES, V265, P30, DOI 10.1016/j.heares.2010.03.005; Deouell LY, 2007, NEURON, V55, P985, DOI 10.1016/j.neuron.2007.08.019; Dykstra AR, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00074; Fishman YI, 2001, J NEUROPHYSIOL, V86, P2761, DOI 10.1152/jn.2001.86.6.2761; Fishman YI, 2010, J NEUROSCI, V30, P12480, DOI 10.1523/JNEUROSCI.1780-10.2010; FOX PT, 1985, J NEUROPHYSIOL, V54, P348, DOI 10.1152/jn.1985.54.2.348; Gardner B, 1994, J ACOUST SOC AM, V97, P3907; Getzmann S, 2010, HEARING RES, V259, P44, DOI 10.1016/j.heares.2009.09.021; Gottlieb J, 2002, CURR OPIN NEUROBIOL, V12, P134, DOI 10.1016/S0959-4388(02)00312-4; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; Gutschalk A, 2007, J NEUROSCI, V27, P13074, DOI 10.1523/JNEUROSCI.2299-07.2007; Hashimoto R, 2000, NEUROIMAGE, V12, P147, DOI 10.1006/nimg.2000.0603; Hill KT, 2010, CEREB CORTEX, V20, P583, DOI 10.1093/cercor/bhp124; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Hugdahl K, 2000, HUM BRAIN MAPP, V10, P87, DOI 10.1002/(SICI)1097-0193(200006)10:2<87::AID-HBM50>3.0.CO;2-V; Karnath HO, 2005, CEREB CORTEX, V15, P1561, DOI 10.1093/cercor/bhi034; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kiebel S, 2003, HUMAN BRAIN FUNCTION, P275; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Kondo HM, 2009, J NEUROSCI, V29, P12695, DOI 10.1523/JNEUROSCI.1549-09.2009; Lewald J, 2004, NEUROPSYCHOLOGIA, V42, P1598, DOI 10.1016/j.neuropsychologia.2004.04.012; Lewald J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0005.2002; Lewald J, 2000, BEHAV BRAIN RES, V108, P105, DOI 10.1016/S0166-4328(99)00141-2; Lewald J, 2008, EUR J NEUROSCI, V27, P1261, DOI 10.1111/j.1460-9568.2008.06094.x; Lewald J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025146; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Marcell ME, 2000, J CLIN EXP NEUROPSYC, V22, P830, DOI 10.1076/jcen.22.6.830.949; Mayer AR, 2007, J COGNITIVE NEUROSCI, V19, P455, DOI 10.1162/jocn.2007.19.3.455; Mayer AR, 2006, NEUROIMAGE, V30, P938, DOI 10.1016/j.neuroimage.2005.10.050; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; Micheyl C, 2010, HEARING RES, V266, P36, DOI 10.1016/j.heares.2009.09.012; Muller NG, 2003, J NEUROSCI, V23, P9812; Muller RA, 2001, BRAIN LANG, V76, P70, DOI 10.1006/brln.2000.2398; Nakai Toshiharu, 2005, Magn Reson Med Sci, V4, P75, DOI 10.2463/mrms.4.75; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; PINEK B, 1989, CORTEX, V25, P175, DOI 10.1016/S0010-9452(89)80035-8; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Recanzone GH, 2010, BEHAV BRAIN RES, V206, P1, DOI 10.1016/j.bbr.2009.08.015; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Schadwinkel S, 2011, J NEUROPHYSIOL, V105, P1977, DOI 10.1152/jn.00461.2010; Schadwinkel S, 2010, CEREB CORTEX, V20, P2863, DOI 10.1093/cercor/bhq037; Shomstein S, 2006, J NEUROSCI, V26, P435, DOI 10.1523/JNEUROSCI.4408-05.2006; Shomstein S, 2004, J NEUROSCI, V24, P10702, DOI 10.1523/JNEUROSCI.2939-04.2004; Smith DV, 2010, J COGNITIVE NEUROSCI, V22, P347, DOI 10.1162/jocn.2009.21241; Smith KR, 2010, J COGNITIVE NEUROSCI, V22, P632, DOI 10.1162/jocn.2009.21196; Snyder JS, 2007, PSYCHOL BULL, V133, P780, DOI 10.1037/0033-2909.133.5.780; Snyder JS, 2006, J COGNITIVE NEUROSCI, V18, P1, DOI 10.1162/089892906775250021; Stevens AA, 1998, ARCH GEN PSYCHIAT, V55, P1097, DOI 10.1001/archpsyc.55.12.1097; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Sweeney JA, 1996, J NEUROPHYSIOL, V75, P454, DOI 10.1152/jn.1996.75.1.454; Teki S, 2011, J NEUROSCI, V31, P164, DOI 10.1523/JNEUROSCI.3788-10.2011; Tranel D, 2003, NEUROPSYCHOLOGIA, V41, P847, DOI 10.1016/S0028-3932(02)00223-3; Warren JD, 2003, J NEUROSCI, V23, P5799; Weeks RA, 1999, NEUROSCI LETT, V262, P155, DOI 10.1016/S0304-3940(99)00062-2; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zatorre RJ, 1999, NEUROIMAGE, V10, P544, DOI 10.1006/nimg.1999.0491; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zimmer U, 2006, NEUROPSYCHOLOGIA, V44, P454, DOI 10.1016/j.neuropsychologia.2005.05.021; Zimmer U, 2003, J COGNITIVE NEUROSCI, V15, P694, DOI 10.1162/089892903322307410; Zundorf IC, 2011, CORTEX, V47, P741, DOI 10.1016/j.cortex.2010.08.002	97	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64259	10.1371/journal.pone.0064259	http://dx.doi.org/10.1371/journal.pone.0064259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691185	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400112
J	Cole, S; Richardson, R; McNally, GP				Cole, Sindy; Richardson, Rick; McNally, Gavan P.			Ventral Hippocampal Kappa Opioid Receptors Mediate the Renewal of Fear following Extinction in the Rat	PLOS ONE			English	Article							INACTIVATION DISRUPTS; NOR-BINALTORPHIMINE; PREFRONTAL CORTEX; AMYGDALA; DORSAL; ACQUISITION; PROJECTIONS; ANTAGONISTS; EXPRESSION; STRESS	The hippocampus is part of a neural network which regulates the renewal of fear following extinction. Both the ventral (VH) and dorsal (DH) hippocampus have been shown to be necessary for renewal, however the critical receptors and neurotransmitters mediating these contributions are poorly understood. One candidate mechanism is the kappa opioid receptor (KOR) system, which has been implicated in fear learning and anxiety. Here we examined the effect of the KOR antagonist norbinaltorphamine hydrochloride (norBNI), infused into either the VH or DH, on the renewal of extinguished fear. We found that an infusion of norBNI into the VH significantly reduced the relapse of fear on test compared to that seen in saline controls (Experiment 1), while similar infusions of norBNI into the DH had no effect on renewal (Experiment 2). These findings show that hippocampal KORs are involved in fear renewal and also identify a dissociation in the contribution of VH and DH KORs to the expression of renewed fear.	[Cole, Sindy; Richardson, Rick; McNally, Gavan P.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	McNally, GP (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	g.mcnally@unsw.edu.au		McNally, Gavan/0000-0001-9061-6463; Richardson, Rick/0000-0003-1833-9777	Australian Research Council [DP0880854]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council award to Rick Richardson and Gavan P. McNally (DP0880854) (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilkei-Gorzo A, 2012, J NEUROSCI, V32, P9335, DOI 10.1523/JNEUROSCI.1034-12.2012; Bird K. D., 2004, ANAL VARIANCE VIA CO; BOUTON ME, 1979, LEARN MOTIV, V10, P445, DOI 10.1016/0023-9690(79)90057-2; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Cole S, 2011, LEARN MEMORY, V18, P88, DOI 10.1101/lm.2049511; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Drake CT, 2007, PROG BRAIN RES, V163, P245, DOI 10.1016/S0079-6123(07)63015-5; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; FANSELOW MS, 1991, PEPTIDES, V12, P1033, DOI 10.1016/0196-9781(91)90056-U; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Grillon C, 2007, NEUROPSYCHOPHARMACOL, V32, P225, DOI 10.1038/sj.npp.1301204; Halasy K, 2000, J CHEM NEUROANAT, V19, P233, DOI 10.1016/S0891-0618(00)00068-5; HENKE PG, 1990, BRAIN RES BULL, V25, P691, DOI 10.1016/0361-9230(90)90044-Z; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; HORAN P, 1992, J PHARMACOL EXP THER, V260, P1237; Ishikawa A, 2006, J NEUROPHYSIOL, V96, P2134, DOI 10.1152/jn.00069.2006; Ji JZ, 2005, LEARN MEMORY, V12, P270, DOI 10.1101/lm.91705; Kanoski SE, 2013, BIOL PSYCHIAT, V73, P915, DOI 10.1016/j.biopsych.2012.07.002; Kishi T, 2000, J COMP NEUROL, V419, P205, DOI 10.1002/(SICI)1096-9861(20000403)419:2<205::AID-CNE5>3.0.CO;2-0; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Lemos JC, 2011, RECEPT SER, P265, DOI 10.1007/978-1-60761-993-2_11; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; NEUMAIER JF, 1988, J PHARMACOL EXP THER, V244, P564; Orsini CA, 2011, J NEUROSCI, V31, P17269, DOI 10.1523/JNEUROSCI.4095-11.2011; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rescorla RA, 2001, HANDBOOK OF CONTEMPORARY LEARNING THEORIES, P119; Shirayama Y, 2004, J NEUROCHEM, V90, P1258, DOI 10.1111/j.1471-4159.2004.02589.x; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; TEMPEL A, 1987, P NATL ACAD SCI USA, V84, P4308, DOI 10.1073/pnas.84.12.4308; Zhang H, 2007, EUR J PHARMACOL, V570, P89, DOI 10.1016/j.ejphar.2007.05.045; ZUKIN RS, 1988, P NATL ACAD SCI USA, V85, P4061, DOI 10.1073/pnas.85.11.4061	42	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e58701	10.1371/journal.pone.0058701	http://dx.doi.org/10.1371/journal.pone.0058701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675405	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400001
J	Koyama-Nasu, R; Haruta, R; Nasu-Nishimura, Y; Taniue, K; Katou, Y; Shirahige, K; Todo, T; Ino, Y; Mukasa, A; Saito, N; Matsui, M; Takahashi, R; Hoshino-Okubo, A; Sugano, H; Manabe, E; Funato, K; Akiyama, T				Koyama-Nasu, R.; Haruta, R.; Nasu-Nishimura, Y.; Taniue, K.; Katou, Y.; Shirahige, K.; Todo, T.; Ino, Y.; Mukasa, A.; Saito, N.; Matsui, M.; Takahashi, R.; Hoshino-Okubo, A.; Sugano, H.; Manabe, E.; Funato, K.; Akiyama, T.			The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells	ONCOGENE			English	Article						ALK; cancer stem cell; glioblastoma; kinase; pleiotrophin; SOX2	ANAPLASTIC LYMPHOMA KINASE; EMBRYONIC STEM; MOUSE MODELS; LUNG-CANCER; HB-GAM; SOX2; EXPRESSION; GENE; IDENTIFICATION; MOLECULE	Increasing evidence suggests that brain tumors arise from the transformation of neural stem/precursor/progenitor cells. Much current research on human brain tumors is focused on the stem-like properties of glioblastoma. Here we show that anaplastic lymphoma kinase (ALK) and its ligand pleiotrophin are required for the self-renewal and tumorigenicity of glioblastoma stem cells (GSCs). Furthermore, we demonstrate that pleiotrophin is transactivated directly by SOX2, a transcription factor essential for the maintenance of both neural stem cells and GSCs. We speculate that the pleiotrophin-ALK axis may be a promising target for the therapy of glioblastoma.	[Koyama-Nasu, R.; Haruta, R.; Nasu-Nishimura, Y.; Taniue, K.; Takahashi, R.; Hoshino-Okubo, A.; Sugano, H.; Manabe, E.; Funato, K.; Akiyama, T.] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo 1130032, Japan; [Katou, Y.; Shirahige, K.] Univ Tokyo, Inst Mol & Cellular Biosci, Ctr Epigenet Dis, Lab Genome Struct & Funct,Bunkyo Ku, Tokyo 1130032, Japan; [Todo, T.; Ino, Y.; Mukasa, A.; Saito, N.] Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1130032, Japan.	akiyama@iam.u-tokyo.ac.jp	Mukasa, Akitake/H-7615-2019	Mukasa, Akitake/0000-0001-7776-9086; Funato, Kosuke/0000-0003-2437-1116; Todo, Tomoki/0000-0003-0523-8010	Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan; Grants-in-Aid for Scientific Research [25670138] Funding Source: KAKEN	Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks), Grants-in-Aid for Scientific Research on Innovative Areas (Integrative Research on Cancer Microenvironment Network), Takeda Science Foundation and, in part, by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan.	Amet LEA, 2001, MOL CELL NEUROSCI, V17, P1014, DOI 10.1006/mcne.2001.0998; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernhardt M, 2012, BIOTECHNOL J, V7, P810, DOI 10.1002/biot.201100347; Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Carpenter EL, 2012, NAT REV CLIN ONCOL, V9, P391, DOI 10.1038/nrclinonc.2012.72; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dirks WG, 2002, INT J CANCER, V100, P49, DOI 10.1002/ijc.10435; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gandhi L, 2012, CLIN CANCER RES, V18, P3737, DOI 10.1158/1078-0432.CCR-11-2393; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Hienola A, 2004, MOL CELL NEUROSCI, V26, P75, DOI 10.1016/j.mcn.2004.01.018; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Koyama-Nasu R, 2013, ONCOGENE, V32, P3840, DOI 10.1038/onc.2012.399; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Melosky B, 2012, CURR ONCOL, V19, pS59, DOI 10.3747/co.19.1054; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Parikh JR, 2010, NUCLEIC ACIDS RES, V38, pW109, DOI 10.1093/nar/gkq424; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perez-Pinera P, 2007, CELL CYCLE, V6, P2877, DOI 10.4161/cc.6.23.5090; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; Raetz EA, 2002, AM J PATHOL, V161, P875, DOI 10.1016/S0002-9440(10)64248-4; RAULO E, 1994, J BIOL CHEM, V269, P12999; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schmitz M, 2007, BRIT J CANCER, V96, P1293, DOI 10.1038/sj.bjc.6603696; Sell S, 2006, TUMOR BIOL, V27, P59, DOI 10.1159/000092323; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stylianou DC, 2009, ONCOGENE, V28, P3296, DOI 10.1038/onc.2009.184; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Turner SD, 2005, LEUKEMIA, V19, P1128, DOI 10.1038/sj.leu.2403797; Wurdak H, 2010, CELL STEM CELL, V6, P37, DOI 10.1016/j.stem.2009.11.002; Ying M, 2011, ONCOGENE, V30, P3454, DOI 10.1038/onc.2011.58; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	50	25	26	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2014	33	17					2236	2244		10.1038/onc.2013.168	http://dx.doi.org/10.1038/onc.2013.168			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF8WJ	23686309				2022-12-25	WOS:000334996000009
J	Ueda, Y; Makino, A; Murase-Tamada, K; Sakai, S; Inaba, T; Hullin-Matsuda, F; Kobayashi, T				Ueda, Yoshibumi; Makino, Asami; Murase-Tamada, Kotono; Sakai, Shota; Inaba, Takehiko; Hullin-Matsuda, Francoise; Kobayashi, Toshihide			Sphingomyelin regulates the transbilayer movement of diacylglycerol in the plasma membrane of Madin-Darby canine kidney cells	FASEB JOURNAL			English	Article						lipid probe; C1AB domain; ceramides; flip-flop	PROTEIN-KINASE-C; PHOSPHOLIPASE-C; QUANTITATIVE-ANALYSIS; PHOSPHATASE ENZYMES; LIPID-METABOLISM; GOLGI-APPARATUS; MODEL MEMBRANES; PHASE-DIAGRAM; MDCK CELLS; CHOLESTEROL	Diacylglycerol (DAG) is a key component in lipid metabolism and signaling. Previous model membrane studies using DAG analogs suggest their rapid membrane transbilayer movement. However, little is known about the DAG distribution and dynamics in cell membranes. Using live-cell fluorescence microscopy, we monitored the transbilayer movement of DAG with the yellow fluorescent protein-tagged C1AB domain from protein kinase C- (EYFP-C1AB), which selectively binds DAG. When HeLa cells were treated with Bacillus cereus phospholipase C (Bc-PLC) to produce DAG on the outer leaflet of the plasma membrane, intracellularly expressed EYFP-C1AB probe accumulated at the plasma membrane, indicating the transbilayer movement of the outer leaflet DAG to the inner leaflet. This Bc-PLC-induced translocation of EYFP-C1AB probe to the plasma membrane was not observed in the sphingolipid-enriched plasma membrane of Madin-Darby canine kidney cells, but was recovered after cell treatment with sphingomyelinase or preincubation with an inhibitor of sphingolipid biosynthesis. The inhibitory effect of sphingomyelin (SM) on the transbilayer movement of DAG was reproduced in model membranes using a fluorescent short-chain DAG analog. These results demonstrate that the SM content on the outer leaflet regulates the transbilayer movement of DAG in the plasma membrane, thus providing new insights into the dynamics of DAG in cell pathophysiology.Ueda, Y., Makino, A., Murase-Tamada, K., Sakai, S., Inaba, T., Hullin-Matsuda, F., Kobayashi, T. Sphingomyelin regulates the transbilayer movement of diacylglycerol in the plasma membrane of Madin-Darby canine kidney cells.	[Ueda, Yoshibumi; Makino, Asami; Murase-Tamada, Kotono; Sakai, Shota; Inaba, Takehiko; Hullin-Matsuda, Francoise; Kobayashi, Toshihide] Rikagaku Kenkyujo RIKEN, Lipid Biol Lab, Wako, Saitama, Japan; [Hullin-Matsuda, Francoise; Kobayashi, Toshihide] Univ Lyon 1, INSERM, U1060, F-69622 Villeurbanne, France	RIKEN; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Kobayashi, T (corresponding author), RIKEN, Lipid Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kobayasi@riken.jp	Hullin-Matsuda, Françoise/N-3880-2017; KOBAYASHI, TOSHIHIDE/S-8313-2019; Ueda, Yoshibumi/AHA-4956-2022; Kobayashi, Toshihide/B-6298-2015	Hullin-Matsuda, Françoise/0000-0002-6042-2841; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Ueda, Yoshibumi/0000-0003-1500-3469; Kobayashi, Toshihide/0000-0002-4811-7270; Inaba, Takehiko/0000-0002-8770-4662	Lipid Dynamics Program of RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22390018, 24657143, 23790115]; Naito Foundation; Japan Society for the Promotion of Science for Young Scientists [05J04184]; Grants-in-Aid for Scientific Research [24657143] Funding Source: KAKEN	Lipid Dynamics Program of RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful to Drs. T. Hayakawa and P. Greimel for their comments on the model membrane study and Drs. T. Okazaki and S. Mitsutake for the discussion on SMS2. The authors thank Dr. M. Sato (University of Tokyo, Tokyo, Japan) for the cDNA clone of C1AB, and Dr. K. Kim for his help during the purification of the DAG probe from insect cells. In addition, the authors express special grateful thoughts to Dr R. E. Pagano, who passed away September 22, 2010, not only for providing the cDNA tool during this work, but for all the fruitful contributions to the field of membrane lipid trafficking that he inspired. The authors also thank the members of the T. K. laboratory for critically reading the manuscript. This work was supported by the Lipid Dynamics Program of RIKEN, Grants-in-Aid for Scientific Research 22390018, 24657143 (to T. K.) and 23790115 (to A. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Naito Foundation (to T. K.). Y. U. was the recipient of a research fellowship of the Japan Society for the Promotion of Science for Young Scientists (05J04184).	Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; ALLAN D, 1978, NATURE, V276, P289, DOI 10.1038/276289a0; Amtmann E, 1996, DRUG EXP CLIN RES, V22, P287; Arora A, 2004, BIOCHEM BIOPH RES CO, V318, P920, DOI 10.1016/j.bbrc.2004.04.118; Bai JN, 1997, BIOCHEMISTRY-US, V36, P8840, DOI 10.1021/bi970145r; Baumann NA, 2000, J BIOL CHEM, V275, P7378, DOI 10.1074/jbc.275.10.7378; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bourbon NA, 2002, J BIOL CHEM, V277, P3286, DOI 10.1074/jbc.M110541200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Cerbon J, 2003, BIOCHEM J, V373, P917, DOI 10.1042/BJ20021732; Contreras F. -Xabier, 2009, V462, P155, DOI 10.1007/978-1-60327-115-8_10; Contreras FX, 2003, J BIOL CHEM, V278, P37169, DOI 10.1074/jbc.M303206200; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; DEKRUYFF B, 1973, BIOCHIM BIOPHYS ACTA, V307, P1, DOI 10.1016/0005-2736(73)90020-5; Ding T, 2008, J LIPID RES, V49, P376, DOI 10.1194/jlr.M700401-JLR200; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Fukami K, 2002, J BIOCHEM, V131, P293, DOI 10.1093/oxfordjournals.jbchem.a003102; GANONG BR, 1984, BIOCHEMISTRY-US, V23, P4977, DOI 10.1021/bi00316a023; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Ishitsuka R, 2011, J LIPID RES, V52, P2084, DOI 10.1194/jlr.D018184; Kates M, 1986, TECHNIQUES LIPIDOLOG, V3; KAWATO S, 1978, BIOCHEMISTRY-US, V17, P5026, DOI 10.1021/bi00616a026; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; KOBAYASHI T, 1988, CELL, V55, P797, DOI 10.1016/0092-8674(88)90135-3; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; Kol MA, 2003, BIOCHEMISTRY-US, V42, P231, DOI 10.1021/bi0268403; KOYNOVA RD, 1985, FEBS LETT, V187, P65, DOI 10.1016/0014-5793(85)81215-1; KREMER JMH, 1977, BIOCHEMISTRY-US, V16, P3932, DOI 10.1021/bi00636a033; KUTCHAI H, 1983, BIOCHIM BIOPHYS ACTA, V736, P137, DOI 10.1016/0005-2736(83)90277-8; LEWIS RNAH, 1987, BIOCHEMISTRY-US, V26, P6118, DOI 10.1021/bi00393a026; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; MARGGRAF WD, 1984, BIOCHIM BIOPHYS ACTA, V793, P346, DOI 10.1016/0005-2760(84)90248-0; Marsh D., 2013, HDB LIPID BILAYERS, DOI 10.1201/9781420088335-8; MATEO CR, 1995, BIOPHYS J, V68, P978, DOI 10.1016/S0006-3495(95)80273-0; MAUCO G, 1984, BIOCHEM J, V224, P933, DOI 10.1042/bj2240933; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Murate M, 2010, BIOCHEMISTRY-US, V49, P4732, DOI 10.1021/bi100007u; Naylor CE, 1998, NAT STRUCT BIOL, V5, P738, DOI 10.1038/1447; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Ogushi F, 2012, CHEM PHYS LETT, V522, P96, DOI 10.1016/j.cplett.2011.11.057; OTNAESS AB, 1977, EUR J BIOCHEM, V79, P459, DOI 10.1111/j.1432-1033.1977.tb11828.x; PAGANO RE, 1985, J BIOL CHEM, V260, P1909; PAGANO RE, 1988, TRENDS BIOCHEM SCI, V13, P202, DOI 10.1016/0968-0004(88)90082-5; Paris L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2575; Ramoni C, 2001, J IMMUNOL, V167, P2642, DOI 10.4049/jimmunol.167.5.2642; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rothblat GH, 1999, J LIPID RES, V40, P781; Sakurai J, 2004, J BIOCHEM, V136, P569, DOI 10.1093/jb/mvh161; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shogomori H, 2008, BBA-GEN SUBJECTS, V1780, P612, DOI 10.1016/j.bbagen.2007.09.001; SRIPADA PK, 1987, J LIPID RES, V28, P710; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; ULLMAN MD, 1974, J BIOL CHEM, V249, P1506; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; VAN HELVOORT A, 1994, J BIOL CHEM, V269, P1763; VAN MEER G, 1982, EMBO J, V1, P847, DOI 10.1002/j.1460-2075.1982.tb01258.x; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vieu C, 1996, J LIPID RES, V37, P1153; Villani M, 2008, BIOCHEM J, V414, P31, DOI 10.1042/BJ20071240; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; VOS JP, 1995, FEBS LETT, V368, P393, DOI 10.1016/0014-5793(95)00695-6; Wuttke A, 2013, FASEB J, V27, P1610, DOI 10.1096/fj.12-221499; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zambon AC, 2000, AM J PHYSIOL-RENAL, V279, pF1045, DOI 10.1152/ajprenal.2000.279.6.F1045	81	19	19	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3284	3297		10.1096/fj.12-226548	http://dx.doi.org/10.1096/fj.12-226548			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23682124	Bronze			2022-12-25	WOS:000329877600033
J	Dillenburg-Pilla, P; Maria, AG; Reis, RI; Floriano, EM; Pereira, CD; De Lucca, FL; Ramos, SG; Pesquero, JB; Jasiulionis, MG; Costa-Neto, CM				Dillenburg-Pilla, Patricia; Maria, Andrea G.; Reis, Rosana I.; Floriano, Elaine Medeiros; Pereira, Cacilda Dias; De Lucca, Fernando Luiz; Ramos, Simone Gusmao; Pesquero, Joao B.; Jasiulionis, Miriam G.; Costa-Neto, Claudio M.			Activation of the Kinin B1 Receptor Attenuates Melanoma Tumor Growth and Metastasis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; B-1 RECEPTOR; GENE-EXPRESSION; CELL-MIGRATION; BREAST-CANCER; BRADYKININ; ANGIOGENESIS; IDENTIFICATION; MECHANISMS; SYSTEM	Melanoma is a very aggressive tumor that does not respond well to standard therapeutic approaches, such as radio-and chemotherapies. Furthermore, acquiring the ability to metastasize in melanoma and many other tumor types is directly related to incurable disease. The B1 kinin receptor participates in a variety of cancer-related pathophysiological events, such as inflammation and angiogenesis. Therefore, we investigated whether this G protein-coupled receptor plays a role in tumor progression. We used a murine melanoma cell line that expresses the kinin B1 receptor and does not express the kinin B2 receptor to investigate the precise contribution of activation of the B1 receptor in tumor progression and correlated events using various in vitro and in vivo approaches. Activation of the kinin B1 receptor in the absence of B2 receptor inhibits cell migration in vitro and decreases tumor formation in vivo. Moreover, tumors formed from cells stimulated with B1-specific agonist showed several features of decreased aggressiveness, such as smaller size and infiltration of inflammatory cells within the tumor area, higher levels of pro-inflammatory cytokines implicated in the host anti-tumor immune response, lower number of cells undergoing mitosis, a poorer vascular network, no signs of invasion of surrounding tissues or metastasis and increased animal survival. Our findings reveal that activation of the kinin B1 receptor has a host protective role during murine melanoma tumor progression, suggesting that the B1 receptor could be a new anti-tumor GPCR and provide new opportunities for therapeutic targeting.	[Dillenburg-Pilla, Patricia; Maria, Andrea G.; Reis, Rosana I.; Pereira, Cacilda Dias; De Lucca, Fernando Luiz; Costa-Neto, Claudio M.] Univ Sao Paulo, Fac Med, Dept Biochem & Immunol, BR-14049 Ribeirao Preto, Brazil; [Floriano, Elaine Medeiros; Ramos, Simone Gusmao] Univ Sao Paulo, Fac Med, Dept Pathol, BR-14049 Ribeirao Preto, Brazil; [Pesquero, Joao B.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Jasiulionis, Miriam G.] Univ Fed Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Costa-Neto, CM (corresponding author), Univ Sao Paulo, Fac Med, Dept Biochem & Immunol, BR-14049 Ribeirao Preto, Brazil.	claudio@fmrp.usp.br	Maria, Andrea Gutierrez/AAR-6104-2021; Jasiulionis, Miriam/G-2207-2012; Maria, Andrea Gutierrez/AAR-9211-2020; Costa-Neto, Claudio/K-7291-2015; dos Reis, Rosana Maria/E-3346-2012	Jasiulionis, Miriam/0000-0002-4135-0440; Maria, Andrea Gutierrez/0000-0002-1615-8254; Costa-Neto, Claudio/0000-0002-7256-6412; Ramos, Simone/0000-0002-1981-5248; dos Reis, Rosana Maria/0000-0001-9631-4167; Reis, Rosana/0000-0002-0465-8331	Sao Paulo State Research Foundation (FAPESP) [2006/61810-6, 2010/13346-4]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Sao Paulo State Research Foundation (FAPESP grants 2006/61810-6 and 2010/13346-4). (www.fapesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barki-Harrington L, 2003, BIOCHEM J, V371, P581, DOI 10.1042/BJ20021708; Blankenstein T, 2012, NAT REV CANCER, V12, P307, DOI 10.1038/nrc3246; BROCKER EB, 1988, INT J CANCER, V41, P562, DOI 10.1002/ijc.2910410415; Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012; Chan W, 2003, FMOS SOLID PHASE PEP; Costa-Neto CM, 2008, INT IMMUNOPHARMACOL, V8, P135, DOI 10.1016/j.intimp.2007.08.003; Crespo J, 2013, CURR OPIN IMMUNOL; Deshayes F, 2005, TRENDS ENDOCRIN MET, V16, P293, DOI 10.1016/j.tem.2005.07.009; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Duterme C, 2009, J BIOL CHEM, V284, P33495, DOI 10.1074/jbc.M109.044362; Ehrenfeld P, 2011, CANCER LETT, V301, P106, DOI 10.1016/j.canlet.2010.09.020; Esseghir S, 2006, J PATHOL, V210, P420, DOI 10.1002/path.2071; Fernandes PD, 2011, PEPTIDES, V32, P1849, DOI 10.1016/j.peptides.2011.07.023; Fidler IJ, 2002, LANCET ONCOL, V3, P53, DOI 10.1016/S1470-2045(01)00622-2; Fujita M, 2002, BIOCHEM BIOPH RES CO, V294, P441, DOI 10.1016/S0006-291X(02)00496-5; Gera L, 2008, INT IMMUNOPHARMACOL, V8, P289, DOI 10.1016/j.intimp.2007.06.006; Gilgunn S, 2013, NAT REV UROL; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanif K, 2010, HYPERTENS RES, V33, P11, DOI 10.1038/hr.2009.184; Hermann A, 1999, IMMUNOPHARMACOLOGY, V45, P135, DOI 10.1016/S0162-3109(99)00066-1; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hii SI, 1998, BRIT J CANCER, V77, P880, DOI 10.1038/bjc.1998.145; Ikeda Y, 2004, CANCER RES, V64, P5178, DOI 10.1158/0008-5472.CAN-03-3589; Ishihara K, 2001, JPN J PHARMACOL, V87, P318, DOI 10.1254/jjp.87.318; Kang HS, 2011, MOL CANCER THER, V10, P580, DOI 10.1158/1535-7163.MCT-10-0763; Kitago M, 2009, CLIN CANCER RES, V15, P2988, DOI 10.1158/1078-0432.CCR-08-3172; Kwak SJ, 2011, APOPTOSIS, V16, P478, DOI 10.1007/s10495-011-0585-1; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; LIU TY, 1989, ANAL BIOCHEM, V182, P383, DOI 10.1016/0003-2697(89)90612-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DY, 2010, J CELL BIOCHEM, V110, P141, DOI 10.1002/jcb.22520; Luo LY, 2001, CLIN CANCER RES, V7, P2372; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Meigs TE, 2002, J BIOL CHEM, V277, P24594, DOI 10.1074/jbc.M201984200; Miyajima A, 2002, CANCER RES, V62, P4176; Molina L, 2009, BREAST CANCER RES TR, V118, P499, DOI 10.1007/s10549-009-0314-4; Morissette G, 2006, CAN J PHYSIOL PHARM, V84, P1107, DOI 10.1139/Y06-031; Navenot JM, 2005, CANCER RES, V65, P10450, DOI 10.1158/0008-5472.CAN-05-1757; Oba-Shinjo SM, 2006, NEOPLASIA, V8, P231, DOI 10.1593/neo.05781; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Perlis C, 2004, ONCOLOGIST, V9, P182, DOI 10.1634/theoncologist.9-2-182; PESQUERO JB, 1994, J BIOL CHEM, V269, P26920; Planque C, 2008, CLIN CANCER RES, V14, P1355, DOI 10.1158/1078-0432.CCR-07-4117; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; REGOLI D, 1977, CAN J PHYSIOL PHARM, V55, P855, DOI 10.1139/y77-115; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; Rodrigues-Ferreira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035667; Stewart JM, 2005, PEPTIDES, V26, P1288, DOI 10.1016/j.peptides.2005.03.052; Taub JS, 2003, CANCER RES, V63, P2037; Wu J, 2002, INT J CANCER, V98, P29, DOI 10.1002/ijc.10142; YANG HYT, 1970, BIOCHIM BIOPHYS ACTA, V214, P374, DOI 10.1016/0005-2795(70)90017-6; YANG HYT, 1971, J PHARMACOL EXP THER, V177, P291; Zuzack JS, 1996, J PHARMACOL EXP THER, V277, P1337	56	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64453	10.1371/journal.pone.0064453	http://dx.doi.org/10.1371/journal.pone.0064453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691222	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900101
J	Matsuoka, J; Yashiro, M; Doi, Y; Fuyuhiro, Y; Kato, Y; Shinto, O; Noda, S; Kashiwagi, S; Aomatsu, N; Hirakawa, T; Hasegawa, T; Shimizu, K; Shimizu, T; Miwa, A; Yamada, N; Sawada, T; Hirakawa, K				Matsuoka, Junko; Yashiro, Masakazu; Doi, Yosuke; Fuyuhiro, Yuhiko; Kato, Yukihiro; Shinto, Osamu; Noda, Satoru; Kashiwagi, Shinichiro; Aomatsu, Naoki; Hirakawa, Toshiki; Hasegawa, Tsuyoshi; Shimizu, Kiyoshi; Shimizu, Toshiyuki; Miwa, Atsushi; Yamada, Nobuya; Sawada, Tetsuji; Hirakawa, Kosei			Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGF beta Signaling	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; INDUCIBLE FACTOR; PROGNOSTIC INDICATORS; CARCINOMA; ESTABLISHMENT; METASTASIS; DISEASE; LINES; PROGRESSION	Epithelial mesenchymal transition (EMT) is considered to be correlated with malignancy of cancer cells and responsible for cancer invasion and metastasis. We previously reported that distant metastasis was associated with hypoxia in gastric cancer. We therefore investigated the effect of hypoxic condition on EMT of gastric cancer cells. Gastric cancer cells were cultured in normoxia (21% O-2) or hypoxia (1% O-2) for 24 h. EMT was evaluated as the percentage of spindle-shaped cells in total cells. Effect of transforming growth factor beta 1 (TGF beta 1) or tyrosine kinase inhibitors on the EMT was evaluated. The expression level of TGF beta 1 and TGF beta R was evaluated by real time RT-PCR. The TGF beta 1 production from cancer cells was measured by ELISA. Hypoxia stimulated EMT of OCUM-2MD3 and OCUM-12 cells, but not that of OCUM-2M cells. The expression level of TGF beta 1 mRNA under hypoxia was significantly higher than that under normoxia in all of three cell lines. The expression level of TGF beta R mRNA was significantly increased by hypoxia in OCUM-2MD3 cells, but not in OCUM-2M cells. TGF beta R inhibitor, SB431542 or Ki26894, significantly suppressed EMT of OCUM-2MD3 and OCUM-12. TGF beta 1 production from OCUM-2MD3 and OCUM-12 cells was significantly increased under hypoxia in comparison with that under normoxia. These findings might suggest that hypoxia stimulates the EMT of gastric cancer cells via autocrine TGF beta/TGF beta R signaling.	[Matsuoka, Junko; Yashiro, Masakazu; Doi, Yosuke; Fuyuhiro, Yuhiko; Kato, Yukihiro; Shinto, Osamu; Noda, Satoru; Hirakawa, Toshiki; Hasegawa, Tsuyoshi; Yamada, Nobuya; Sawada, Tetsuji; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 558, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Oncol Inst Geriatr & Med Sci, Abeno Ku, Osaka 558, Japan; [Shimizu, Kiyoshi] Kyowa Hakko Kirin Co Ltd, Pharmacol Res Labs, Tokyo, Japan; [Shimizu, Toshiyuki] Kyowa Hakko Kirin Co Ltd, Res Planning Dept, Chiyoda Ku, Tokyo, Japan; [Miwa, Atsushi] Kyowa Hakko Kirin Co Ltd, Biol Res Labs, Chiyoda Ku, Tokyo, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Kyowa Kirin Ltd; Kyowa Kirin Ltd; Kyowa Kirin Ltd	Yashiro, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 558, Japan.	m9312510@med.osaka-cu.ac.jp	Kashiwagi, Shinichiro/AAC-7070-2019; Kashiwagi, Shinichiro/AAE-5243-2020	Kashiwagi, Shinichiro/0000-0002-0460-9599; Kashiwagi, Shinichiro/0000-0002-0460-9599	National Cancer Center Research and Development Fund [23-A-9]; Ministry of Education, Science, Sports, Culture and Technology of Japan [20591573, 22390262, 23390329]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the National Cancer Center Research and Development Fund (23-A-9), and by Grants-in Aid for Scientific Research (KAKENHI, Nos. 20591573, 22390262, and 23390329) from the Ministry of Education, Science, Sports, Culture and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandre Alcazar MA, 2011, PLOS ONE, V6, pe26371, DOI DOI 10.1371/JOURNAL.PONE.0026371; Bartkowiak K, 2011, CANC MICROENVIRON; Chen CY, 2002, HEPATO-GASTROENTEROL, V49, P874; Copple BL, 2010, LIVER INT, V30, P669, DOI 10.1111/j.1478-3231.2010.02205.x; Devarajan E., 2011, INT J CANC; Griffiths EA, 2007, BRIT J CANCER, V96, P95, DOI 10.1038/sj.bjc.6603524; Griffiths EA, 2005, EUR J CANCER, V41, P2792, DOI 10.1016/j.ejca.2005.09.008; Guan F, 2010, FASEB J, V24, P4889, DOI 10.1096/fj.10-162107; Gupta R, 2011, INT J ONCOL, V38, P733, DOI 10.3892/ijo.2010.883; Haase VH, 2009, KIDNEY INT, V76, P492, DOI 10.1038/ki.2009.222; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Hung CM, 2011, J AGR FOOD CHEM, V59, P9683, DOI 10.1021/jf2021489; Ivaska Johanna, 2011, Small GTPases, V2, P51; Iwatsuki M, 2010, ANN SURG ONCOL, V17, P2526, DOI 10.1245/s10434-010-1041-0; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kato Y, 2010, BRIT J CANCER, V102, P898, DOI 10.1038/sj.bjc.6605543; Kizaka-Kondoh S, 2009, CLIN CANCER RES, V15, P3433, DOI 10.1158/1078-0432.CCR-08-2267; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lunt SJ, 2009, CLIN EXP METASTAS, V26, P19, DOI 10.1007/s10585-008-9182-2; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Miyazono K, 2012, UPSALA J MED SCI, V117, P143, DOI 10.3109/03009734.2011.638729; Beltrao HDM, 2009, TROP DOCT, V39, P231, DOI 10.1258/td.2009.090035; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Noda S, 2010, EUR J CANCER, V46, P995, DOI 10.1016/j.ejca.2010.01.007; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qiu H, 2009, CANCER SCI, V100, P181, DOI 10.1111/j.1349-7006.2008.01004.x; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; SEKIGUCHI M, 1978, JPN J EXP MED, V48, P61; Shinto O, 2010, BRIT J CANCER, V102, P844, DOI 10.1038/sj.bjc.6605561; Smith A., 2012, ORAL ONCOL; Vergara D, 2011, CANCER LETT, V310, P1, DOI 10.1016/j.canlet.2011.04.009; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; YASHIRO M, 1995, BRIT J CANCER, V72, P1200, DOI 10.1038/bjc.1995.486; Yashiro M, 1996, CLIN EXP METASTAS, V14, P43, DOI 10.1007/BF00157685; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang W, 2009, ANAT REC, V292, P1114, DOI 10.1002/ar.20934; Zhong H, 1999, CANCER RES, V59, P5830; Zhou GF, 2009, AM J PHYSIOL-LUNG C, V297, pL1120, DOI 10.1152/ajplung.00007.2009	42	78	87	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e62310	10.1371/journal.pone.0062310	http://dx.doi.org/10.1371/journal.pone.0062310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23690936	Green Submitted, gold, Green Published			2022-12-25	WOS:000319107900007
J	Wu, ZY; Liu, SQ; Huang, DJ				Wu, Ziyun; Liu, Shao Quan; Huang, Dejian			Dietary Restriction Depends on Nutrient Composition to Extend Chronological Lifespan in Budding Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							CALORIC RESTRICTION; STATIONARY-PHASE; NONQUIESCENT CELLS; SCH9; LONGEVITY; DROSOPHILA; GROWTH; QUIESCENT; PATHWAYS; SIRTUINS	The traditional view on dietary restriction has been challenged with regard to extending lifespan of the fruit fly Drosophila melanogaster. This is because studies have shown that changing the balance of dietary components without reduction of dietary intake can increase lifespan, suggesting that nutrient composition other than dietary restriction play a pivotal role in regulation of longevity. However, this opinion has not been reflected in yeast aging studies. Inspired by this new finding, response surface methodology was applied to evaluate the relationships between nutrients (glucose, amino acids and yeast nitrogen base) and lifespan as well as biomass production in four Saccharomyces cerevisiae strains (wild-type BY4742, sch9 Delta, tor1 Delta, and sir2 Delta mutants) using a high throughput screening assay. Our results indicate that lifespan extension by a typical dietary restriction regime was dependent on the nutrients in media and that nutrient composition was a key determinant for yeast longevity. Four different yeast strains were cultured in various media, which showed similar response surface trends in biomass production and viability at day two but greatly different trends in lifespan. The pH of aging media was dependent on glucose concentration and had no apparent correlation with lifespan under conditions where amino acids and YNB were varied widely, and simply buffering the pH of media could extend lifespan significantly. Furthermore, the results showed that strain sch9 Delta was more responsive in nutrient-sensing than the other three strains, suggesting that Sch9 (serine-threonine kinase pathway) was a major nutrient-sensing factor that regulates cell growth, cell size, metabolism, stress resistance and longevity. Overall, our findings support the notion that nutrient composition might be a more effective way than simple dietary restriction to optimize lifespan and biomass production from yeast to other organisms.	[Wu, Ziyun; Liu, Shao Quan; Huang, Dejian] Natl Univ Singapore, Dept Chem, Food Sci & Technol Programme, Singapore 117548, Singapore	National University of Singapore	Huang, DJ (corresponding author), Natl Univ Singapore, Dept Chem, Food Sci & Technol Programme, Singapore 117548, Singapore.	chmhdj@nus.edu.sg	Liu, shao quan/D-3172-2016; Huang, Dejian/A-7439-2010; Wu, Ziyun/C-1592-2009	Liu, shao quan/0000-0003-0868-2731; Wu, Ziyun/0000-0001-8239-1890; Huang, Dejian/0000-0002-2305-3960	National University of Singapore Virtual Institute for the Study of Aging (VISA) [R143-000-437-290]	National University of Singapore Virtual Institute for the Study of Aging (VISA)	The authors are grateful for the financial support of National University of Singapore Virtual Institute for the Study of Aging (VISA) (grant number: R143-000-437-290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Aragon AD, 2008, MOL BIOL CELL, V19, P1271, DOI 10.1091/mbc.E07-07-0666; Bas D, 2007, J FOOD ENG, V78, P836, DOI 10.1016/j.jfoodeng.2005.11.024; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Elshorbagy AK, 2010, NUTRITION, V26, P1201, DOI 10.1016/j.nut.2009.09.017; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; Fanson BG, 2009, AGING CELL, V8, P514, DOI 10.1111/j.1474-9726.2009.00497.x; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Goldberg AA, 2009, EXP GERONTOL, V44, P555, DOI 10.1016/j.exger.2009.06.001; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Ja WW, 2009, P NATL ACAD SCI USA, V106, P18633, DOI 10.1073/pnas.0908016106; Jiang JC, 2000, FASEB J, V14, P2135; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kaeberlein M, 2006, SCIENCE, V312, DOI 10.1126/science.1124608; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Lamming DW, 2006, SCIENCE, P312; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Lombard DB, 2011, NATURE, V477, P410, DOI 10.1038/477410a; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Meydani M, 2001, ANN NY ACAD SCI, V928, P226; Mieulet V, 2009, AMINO ACIDS, V37, P67; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Minois N, 2009, AGING CELL, V8, P36, DOI 10.1111/j.1474-9726.2008.00446.x; Murakami C, 2012, CELL CYCLE, V11, P3087, DOI 10.4161/cc.21465; Murakami CJ, 2008, J GERONTOL A-BIOL, V63, P113, DOI 10.1093/gerona/63.2.113; Murakami CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024530; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; Thomas KC, 2002, APPL ENVIRON MICROB, V68, P1616, DOI 10.1128/AEM.68.4.1616-1623.2002; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wu ZY, 2011, EXP GERONTOL, V46, P915, DOI 10.1016/j.exger.2011.08.002; Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3	51	38	39	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64448	10.1371/journal.pone.0064448	http://dx.doi.org/10.1371/journal.pone.0064448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691220	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900099
J	Chao, J; Yang, L; Buch, S; Gao, L				Chao, Jie; Yang, Lu; Buch, Shilpa; Gao, Lie			Angiotensin II Increased Neuronal Stem Cell Proliferation: Role of AT2R	PLOS ONE			English	Article							NF-KAPPA-B; TYPE-2 RECEPTOR; POTASSIUM CHANNELS; DELAYED RECTIFIER; AT(2) RECEPTOR; PROTEIN-KINASE; CA2+ CURRENTS; ION CHANNELS; BRAIN; EXPRESSION	Angiotensin II (Ang II), known a potent vasoactive substance in the renin-angiotensin system in the brain, plays a critical role in systemic blood pressure control. However, increasing evidence indicated that the physiological role of Ang II go beyond its vasoactive effect. In the present study, we demonstrated that Ang II type-1 receptor (AT1R) and type-2 receptor (AT2R) were expressed in primary rat hippocampal neuronal stem cells (NSCs). Treatment of rat hippocampal NSCs with Ang II increased cell proliferation. Pretreatment of NSCs with specific AT2R, but not AT1R, antagonist significantly suppressed Ang II-induced cell proliferation. Furthermore, Ang II stimulated ERK and Akt phosphorylation in NSCs. Pretreatment of MEK inhibitor, but not PI3K inhibitor, inhibited Ang II-induced ERK phosphorylation as well as cell proliferation. In addition, stimulation of NSCs with Ang II decreased expression of K-V 1.2/K-V 3.1 channels and blocked K+ currents which lie downstream of ERK activation. Taken together, these findings underpin the role of AT2R as a novel target that regulates cell proliferation mediated by Ang II with implications for therapeutic intervention for regulation of neurogenesis.	[Chao, Jie; Gao, Lie] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA; [Yang, Lu; Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Gao, L (corresponding author), Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA.	lgao@unmc.edu	Jie, Chao/J-1004-2019	Jie, Chao/0000-0002-7800-3557; Buch, Shilpa/0000-0002-3103-6685	NIH [RO1HL093028]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by NIH grant RO1HL093028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager EI, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-19; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Attali B, 1997, J NEUROSCI, V17, P8234; BUMPUS FM, 1991, HYPERTENSION, V17, P720, DOI 10.1161/01.HYP.17.5.720; Caballero R, 2004, CARDIOVASC RES, V62, P86, DOI 10.1016/j.cardiores.2003.12.029; Cao ZM, 2000, KIDNEY INT, V58, P2437, DOI 10.1046/j.1523-1755.2000.00427.x; Chu KY, 2010, AM J PHYSIOL-CELL PH, V298, pC313, DOI 10.1152/ajpcell.00575.2008; CLAPHAM DE, 1994, ANNU REV NEUROSCI, V17, P441; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; de Gasparo M, 2000, PHARMACOL REV, V52, P415; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Gao L, 2010, AM J PHYSIOL-HEART C, V298, pH945, DOI 10.1152/ajpheart.00145.2009; Gelband CH, 1997, ENDOCRINOLOGY, V138, P2195, DOI 10.1210/en.138.5.2195; Gendron L, 1999, MOL ENDOCRINOL, V13, P1615, DOI 10.1210/me.13.9.1615; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; Guimond MO, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/351758; Guimond Marie-Odile, 2012, Front Endocrinol (Lausanne), V3, P164, DOI 10.3389/fendo.2012.00164; Han HJ, 2007, J CELL PHYSIOL, V211, P618, DOI 10.1002/jcp.20967; Horiuchi M, 2010, J RENIN-ANGIO-ALDO S, V11, P1, DOI 10.1177/1470320309347793; Huang XC, 1996, J BIOL CHEM, V271, P15635, DOI 10.1074/jbc.271.26.15635; KANG J, 1993, AM J PHYSIOL, V265, pC607, DOI 10.1152/ajpcell.1993.265.3.C607; Kaus A, 2010, STEM CELLS DEV, V19, P999, DOI 10.1089/scd.2009.0416; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Laflamme L, 1996, J BIOL CHEM, V271, P22729, DOI 10.1074/jbc.271.37.22729; Lang F, 2006, CONTRIB NEPHROL, V152, P142, DOI 10.1159/000096321; Learish RD, 2000, DEV BRAIN RES, V122, P97; Leung KK, 2012, STEM CELLS, V30, P525, DOI 10.1002/stem.1008; Li Gui-Rong, 2011, World J Stem Cells, V3, P19, DOI 10.4252/wjsc.v3.i3.19; Li HW, 2005, REGUL PEPTIDES, V126, P213, DOI 10.1016/j.regpep.2004.10.005; Li JM, 2007, MOL ENDOCRINOL, V21, P499, DOI 10.1210/me.2006-0005; Liebau S, 2006, J NEUROCHEM, V99, P426, DOI 10.1111/j.1471-4159.2006.03967.x; Lober RM, 2006, J NEUROSCI, V26, P12602, DOI 10.1523/JNEUROSCI.4020-06.2006; Luo CX, 2010, STEM CELLS, V28, P2041, DOI 10.1002/stem.522; Macfarlane SN, 2000, GLIA, V30, P39, DOI 10.1002/(SICI)1098-1136(200003)30:1<39::AID-GLIA5>3.0.CO;2-S; Marshall RP, 2000, AM J RESP CRIT CARE, V161, P1999, DOI 10.1164/ajrccm.161.6.9907004; Meffert S, 1996, MOL CELL ENDOCRINOL, V122, P59, DOI 10.1016/0303-7207(96)03873-7; Mogi M, 2013, GERIATR GERONTOL INT, V13, P13, DOI 10.1111/j.1447-0594.2012.00900.x; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Pan SJ, 2001, AM J PHYSIOL-CELL PH, V281, pC17, DOI 10.1152/ajpcell.2001.281.1.C17; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Peng H, 2008, GLIA, V56, P903, DOI 10.1002/glia.20665; Phillips MI, 2008, J MOL MED, V86, P715, DOI 10.1007/s00109-008-0331-5; Piotrowska MJ, 2006, CELL PROLIFERAT, V39, P441, DOI 10.1111/j.1365-2184.2006.00403.x; Porrello ER, 2009, FRONT BIOSCI-LANDMRK, V14, P958, DOI 10.2741/3289; Rodgers KE, 2000, STEM CELLS, V18, P287, DOI 10.1634/stemcells.18-4-287; Rouzaire-Dubois B, 1998, J PHYSIOL-LONDON, V510, P93, DOI 10.1111/j.1469-7793.1998.093bz.x; Smith DO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001604; Steckelings UM, 2010, J RENIN-ANGIO-ALDO S, V11, P67, DOI 10.1177/1470320309347791; Stroth U, 2000, MOL BRAIN RES, V78, P175, DOI 10.1016/S0169-328X(00)00093-0; Stroth U, 1998, MOL BRAIN RES, V53, P187, DOI 10.1016/S0169-328X(97)00298-2; Sumners C, 1996, AM J PHYSIOL-CELL PH, V271, pC154, DOI 10.1152/ajpcell.1996.271.1.C154; Tian CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005546; Veerasingham SJ, 2003, BRIT J PHARMACOL, V139, P191, DOI 10.1038/sj.bjp.0705262; Venkatesan A, 2007, CELL MOL LIFE SCI, V64, P2120, DOI 10.1007/s00018-007-7063-5; Wang SP, 2008, CLIN EXP PHARMACOL P, V35, P1077, DOI 10.1111/j.1440-1681.2008.04964.x; Wang ZB, 2005, NEUROSCI LETT, V373, P38, DOI 10.1010/j.neulet.2004.09.068; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Wright JW, 2013, PFLUG ARCH EUR J PHY, V465, P133, DOI 10.1007/s00424-012-1102-2; Wright JW, 2011, PROG NEUROBIOL, V95, P49, DOI 10.1016/j.pneurobio.2011.07.001; Yasuda T, 2008, MOL CELL NEUROSCI, V37, P284, DOI 10.1016/j.mcn.2007.10.003; Yasuda T, 2010, J NEUROCHEM, V114, P946, DOI 10.1111/j.1471-4159.2010.06822.x; Yu L, 2010, J RENIN-ANGIO-ALDO S, V11, P214, DOI 10.1177/1470320310379065; Zhu MY, 1997, AM J PHYSIOL-CELL PH, V273, pC1040, DOI 10.1152/ajpcell.1997.273.3.C1040	66	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63488	10.1371/journal.pone.0063488	http://dx.doi.org/10.1371/journal.pone.0063488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691054	gold, Green Published, Green Submitted			2022-12-25	WOS:000319052700039
J	Lendrum, PE; Anderson, CR; Monteith, KL; Jenks, JA; Bowyer, RT				Lendrum, Patrick E.; Anderson, Charles R., Jr.; Monteith, Kevin L.; Jenks, Jonathan A.; Bowyer, R. Terry			Migrating Mule Deer: Effects of Anthropogenically Altered Landscapes	PLOS ONE			English	Article							WINTER HABITAT SELECTION; PLANT PHENOLOGY; DISTANCE MIGRATION; POPULATIONS; MOVEMENTS; RESPONSES; SURVIVAL; BEHAVIOR; INDEXES; ELK	Background: Migration is an adaptive strategy that enables animals to enhance resource availability and reduce risk of predation at a broad geographic scale. Ungulate migrations generally occur along traditional routes, many of which have been disrupted by anthropogenic disturbances. Spring migration in ungulates is of particular importance for conservation planning, because it is closely coupled with timing of parturition. The degree to which oil and gas development affects migratory patterns, and whether ungulate migration is sufficiently plastic to compensate for such changes, warrants additional study to better understand this critical conservation issue. Methodology/Principal Findings: We studied timing and synchrony of departure from winter range and arrival to summer range of female mule deer (Odocoileus hemionus) in northwestern Colorado, USA, which has one of the largest natural-gas reserves currently under development in North America. We hypothesized that in addition to local weather, plant phenology, and individual life-history characteristics, patterns of spring migration would be modified by disturbances associated with natural-gas extraction. We captured 205 adult female mule deer, equipped them with GPS collars, and observed patterns of spring migration during 2008-2010. Conclusions/Significance: Timing of spring migration was related to winter weather (particularly snow depth) and access to emerging vegetation, which varied among years, but was highly synchronous across study areas within years. Additionally, timing of migration was influenced by the collective effects of anthropogenic disturbance, rate of travel, distance traveled, and body condition of adult females. Rates of travel were more rapid over shorter migration distances in areas of high natural-gas development resulting in the delayed departure, but early arrival for females migrating in areas with high development compared with less-developed areas. Such shifts in behavior could have consequences for timing of arrival on birthing areas, especially where mule deer migrate over longer distances or for greater durations.	[Lendrum, Patrick E.; Monteith, Kevin L.; Bowyer, R. Terry] Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA; [Anderson, Charles R., Jr.] Colorado Div Parks & Wildlife, Grand Junction, CO USA; [Monteith, Kevin L.] Univ Wyoming, Wyoming Cooperat Fish & Wildlife Res Unit, Laramie, WY 82071 USA; [Jenks, Jonathan A.] S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA	Idaho; Idaho State University; Colorado Parks & Wildlife; University of Wyoming; South Dakota State University	Lendrum, PE (corresponding author), Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA.	lendpatr@isu.edu	Jenks, Jonathan A/B-7321-2009	Anderson Jr, Charles R./0000-0002-3063-1757	Colorado Parks and Wildlife (CPW); came from Federal Aid in Wildlife Restoration; Colorado Mule Deer Association; Colorado Mule Deer Foundation; Colorado Oil and Gas Conservation Commission; Williams Production LMT CO.; EnCana Corp.; Exxon Mobil Production Co.; Shell Petroleum; Marathon Oil Corp.; Idaho State University; Shell Petroleum and Marathon Oil Corp	Colorado Parks and Wildlife (CPW); came from Federal Aid in Wildlife Restoration; Colorado Mule Deer Association; Colorado Mule Deer Foundation; Colorado Oil and Gas Conservation Commission; Williams Production LMT CO.; EnCana Corp.; Exxon Mobil Production Co.(Exxon Mobil Corporation); Shell Petroleum; Marathon Oil Corp.; Idaho State University; Shell Petroleum and Marathon Oil Corp	This project was funded and supported by the Colorado Parks and Wildlife (CPW). The authors thank C. Bishop, D. Freddy, and M. Michaels from CPW for helping administer the project. Additionally, the authors thank personnel at Little Hills State Wildlife Area for field support and coordination. The authors thank Quicksilver Air Inc. for assistance in capturing deer from helicopters, L. Gepfert and L. Coulter for fixed-wing aircraft support, and L. Wolfe, C. Bishop, and D. Finley of CPW for crucial assistance during capture efforts. Additional funding and support came from Federal Aid in Wildlife Restoration, Colorado Mule Deer Association, Colorado Mule Deer Foundation, Colorado Oil and Gas Conservation Commission, Williams Production LMT CO., EnCana Corp., Exxon Mobil Production Co., Shell Petroleum, Marathon Oil Corp., and Idaho State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge funding from multiple commercial sources (Williams Production LMT CO., EnCana Corp., Exxon Mobil Production Co., Shell Petroleum and Marathon Oil Corp) and declare that this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; Alves JA, 2012, OIKOS, V121, P464, DOI 10.1111/j.1600-0706.2011.19678.x; ANDERSEN R, 1991, J APPL ECOL, V28, P102, DOI 10.2307/2404117; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Bolger DT, 2008, ECOL LETT, V11, P63; BOYCE MS, 1991, APPL ANIM BEHAV SCI, V29, P239, DOI 10.1016/0168-1591(91)90251-R; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cameron RD, 2005, ARCTIC, V58, P1; Cook RC, 2010, J WILDLIFE MANAGE, V74, P880, DOI 10.2193/2009-031; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; Fieberg J, 2008, J WILDLIFE MANAGE, V72, P1211, DOI 10.2193/2007-403; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; GARROTT RA, 1987, J WILDLIFE MANAGE, V51, P634, DOI 10.2307/3801282; Grovenburg TW, 2009, CAN J ZOOL, V87, P876, DOI 10.1139/Z09-076; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; KRAUSMAN PR, 1985, WILDLIFE SOC B, V13, P71; Lendrum PE, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00165.1; Monteith KL, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00096.1; Mysterud A, 1999, J ZOOL, V247, P479, DOI 10.1111/j.1469-7998.1999.tb01011.x; Mysterud A, 2001, J ANIM ECOL, V70, P915, DOI 10.1046/j.0021-8790.2001.00559.x; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Nicholson MC, 1997, J MAMMAL, V78, P483, DOI 10.2307/1382900; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; PARKER KL, 1984, J WILDLIFE MANAGE, V48, P474, DOI 10.2307/3801180; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Post E, 2008, P ROY SOC B-BIOL SCI, V275, P2005, DOI 10.1098/rspb.2008.0463; Pulido F, 2007, CLIM RES, V35, P5, DOI 10.3354/cr00711; ROBINETTE W. LESLIE, 1957, JOUR WILDLIFE MANAGEMENT, V21, P134, DOI 10.2307/3797579; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Sawyer H, 2013, J APPL ECOL, V50, P68, DOI 10.1111/1365-2664.12013; Sawyer H, 2011, J ANIM ECOL, V80, P1078, DOI 10.1111/j.1365-2656.2011.01845.x; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Singh NJ, 2011, J APPL ECOL, V48, P35, DOI 10.1111/j.1365-2664.2010.01905.x; St-Louis A, 2013, J WILDLIFE MANAGE, V77, P599, DOI 10.1002/jwmg.488; Stephenson TR, 2002, WILDLIFE SOC B, V30, P557; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC, 2002, J WILDLIFE MANAGE, V66, P300, DOI 10.2307/3803162; Whittington J, 2004, ECOL SOC, V9	42	60	62	3	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64548	10.1371/journal.pone.0064548	http://dx.doi.org/10.1371/journal.pone.0064548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691246	Green Published, gold			2022-12-25	WOS:000319107400132
J	Wang, YY; Yu, XH; Wang, FQ; Wang, Y; Wang, YP; Li, HM; Lv, XX; Lu, DX; Wang, HD				Wang, Yiyang; Yu, Xiaohui; Wang, Faqiang; Wang, Yuan; Wang, Yanping; Li, Hongmei; Lv, Xiuxiu; Lu, Daxiang; Wang, Huadong			Yohimbine Promotes Cardiac NE Release and Prevents LPS-Induced Cardiac Dysfunction via Blockade of Presynaptic alpha(2A)-Adrenergic Receptor	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; MYOCARDIAL DYSFUNCTION; NITRIC-OXIDE; SEPSIS; HEART; STIMULATION; EXPRESSION; BERBERINE; RATS	Myocardial depression is an important contributor to mortality in sepsis. We have recently demonstrated that alpha 2-adrenoceptor (AR) antagonist, yohimbine (YHB), attenuates lipopolysaccharide (LPS)-induced myocardial depression. However, the mechanisms for this action of YHB are unclear. Here, we demonstrated that YHB decreased nitric oxide (NO) and tumor necrosis factor-alpha (TNF-alpha) levels in the myocardium and plasma, attenuated cardiac and hepatic dysfunction, but not kidney and lung injuries in endotoxemic mice. Immunohistochemical analysis revealed that cardiac alpha(2A)-AR was mostly located in sympathetic nerve presynaptic membrane; YHB decreased cardiac alpha(2A)-AR level and promoted cardiac norepinephrine (NE) release in endotoxemic mice. Reserpine that exhausted cardiac NE without markedly decreasing plasma NE level abrogated the inhibitory effects of YHB on cardiac TNF-alpha and iNOS expression as well as cardiac dysfunction, but not the suppressive effects of YHB on plasma TNF-alpha and NO elevation in LPS-challenged mice. Furthermore, both reserpine and YHB significantly inhibited LPS-induced myocardial apoptosis. alpha(1)-AR, beta(2)-AR, but not beta(1)-AR antagonists reversed the inhibitory effect of YHB on LPS-stimulated myocardial apoptosis. However, beta(1)-AR antagonist attenuated LPS-caused cardiomyocyte apoptosis, partly abolished the protective effect of YHB on the left ventricular ejection fraction in endotoxemic mice. Altogether, these findings indicate that YHB attenuates LPS-induced cardiac dysfunction, at least in part, through blocking presynaptic alpha(2A)-AR and thus increasing cardiac NE release. YHB-elevated cardiac NE improves cardiac function via suppressing cardiac iNOS and TNF-alpha expression, activating beta(1)-AR and inhibiting cardiomyocyte apoptosis through alpha(1)- and beta(2)-AR in endotoxemic mice. However, cardiac beta(1)-AR activation promotes LPS-induced cardiomyocyte apoptosis.	[Wang, Yiyang; Yu, Xiaohui; Wang, Faqiang; Wang, Yuan; Wang, Yanping; Li, Hongmei; Lv, Xiuxiu; Lu, Daxiang; Wang, Huadong] Jinan Univ, Sch Med, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Wang, Yanping; Li, Hongmei; Lv, Xiuxiu; Lu, Daxiang; Wang, Huadong] Jinan Univ, Sch Med, Key Lab State Adm Tradit Chinese Med Peoples Repu, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Wang, HD (corresponding author), Jinan Univ, Sch Med, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	owanghd@jnu.edu.cn		wang, yiyang/0000-0002-0318-6715	National Natural Science Foundation of China [81170222, 30971191]; Guangdong Natural Science Foundation [S2011020005408]; fundamental Research Funds for the Central Universities [21611403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by grants from the National Natural Science Foundation of China (81170222 and 30971191), the Guangdong Natural Science Foundation (S2011020005408), and fundamental Research Funds for the Central Universities (21611403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarten G, 2001, J INFECT DIS, V183, P1617, DOI 10.1086/320712; Carlson DL, 2005, CRIT CARE MED, V33, P1021, DOI 10.1097/01.CCM.0000163398.79679.66; Cheng ZQ, 2002, CARDIOVASC RES, V56, P225, DOI 10.1016/S0008-6363(02)00543-6; Chopra M, 2009, PHARMACOL RES, V60, P303, DOI 10.1016/j.phrs.2009.04.009; Fernandes CJ, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/896430; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Grigoleit JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028330; Gyires K, 2009, NEUROCHEM INT, V55, P447, DOI 10.1016/j.neuint.2009.05.014; Heusch G, 2011, J MOL CELL CARDIOL, V51, P16, DOI 10.1016/j.yjmcc.2011.03.007; Iwai-Kanai E, 1999, CIRCULATION, V100, P305, DOI 10.1161/01.CIR.100.3.305; Kang BY, 2003, EUR J PHARMACOL, V467, P223, DOI 10.1016/S0014-2999(03)01628-5; KOGANEI H, 1995, BIOL PHARM BULL, V18, P1207; Lancel S, 2005, CIRCULATION, V111, P2596, DOI 10.1161/CIRCULATIONAHA.104.490979; Martinez-Olivares R, 2006, AUTON NEUROSCI-BASIC, V128, P64, DOI 10.1016/j.autneu.2006.04.004; McDonald TE, 2000, AM J PHYSIOL-HEART C, V279, pH2053; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; Miksa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005504; Peng TQ, 2003, CARDIOVASC RES, V59, P893, DOI 10.1016/S0008-6363(03)00509-1; SCHLAG G, 1991, RESUSCITATION, V21, P137, DOI 10.1016/0300-9572(91)90044-Y; SEITELBERGER R, 1988, CIRC RES, V62, P436, DOI 10.1161/01.RES.62.3.436; Simms MG, 1999, AM J PHYSIOL-HEART C, V277, pH253, DOI 10.1152/ajpheart.1999.277.1.H253; Smart KR, 2000, AM SURGEON, V66, P947; SPENGLER RN, 1990, J IMMUNOL, V145, P1430; Tatsumi T, 2004, J MOL CELL CARDIOL, V37, P775, DOI 10.1016/j.yjmcc.2004.06.014; Wang YY, 2011, SHOCK, V35, P322, DOI 10.1097/SHK.0b013e3181facf73; Wiersinga W Joost, 2010, Ned Tijdschr Geneeskd, V154, pA1130; Yang J, 2006, ACTA PHARMACOL SIN, V27, P173, DOI 10.1111/j.1745-7254.2006.00257.x; Yang SL, 2000, AM J PHYSIOL-GASTR L, V279, pG1274, DOI 10.1152/ajpgi.2000.279.6.G1274; Zhang FM, 2010, J MOL MED, V88, P289, DOI 10.1007/s00109-009-0555-z; Zhang HQ, 2008, SHOCK, V29, P617, DOI 10.1097/SHK.0b013e318157ea14; Zhang T, 2010, CAN J PHYSIOL PHARM, V88, P92, DOI 10.1139/Y09-097	31	27	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63622	10.1371/journal.pone.0063622	http://dx.doi.org/10.1371/journal.pone.0063622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691077	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107400070
J	Zhao, YB; Hu, J; Miao, GY; Qu, LJ; Wang, ZD; Li, G; Lv, P; Ma, DL; Chen, YY				Zhao, Yuanbo; Hu, Jia; Miao, Guangyan; Qu, Liujing; Wang, Zhenda; Li, Ge; Lv, Ping; Ma, Dalong; Chen, Yingyu			Transmembrane Protein 208:A Novel ER-Localized Protein That Regulates Autophagy and ER Stress	PLOS ONE			English	Article							LC3; IDENTIFICATION; ATF4	Autophagy and endoplasmic reticulum (ER) stress are both tightly regulated cellular processes that play central roles in various physiological and pathological conditions. Recent reports have indicated that ER stress is a potent inducer of autophagy. However, little is known about the underlying molecular link between the two processes. Here we report a novel human protein, transmembrane protein 208 (TMEM208) that can regulate both autophagy and ER stress. When overexpressed, TMEM208 impaired autophagy as characterized by the decrease of the accumulation of LC3-II, decreased degradation of autophagic substrates, and reduced expression of critical effectors and vital molecules of the ER stress and autophagy processes. In contrast, knockdown of the TMEM208 gene promoted autophagy, as demonstrated by the increase of LC3-II, increased degradation of autophagic substrates, and enhanced expression levels for genes key in the ER stress and autophagic processes. Taken together, our results reveal that this novel ER-located protein regulates both ER stress and autophagy, and represents a possible link between the two different cellular processes.	[Zhao, Yuanbo; Hu, Jia; Miao, Guangyan; Qu, Liujing; Wang, Zhenda; Li, Ge; Lv, Ping; Ma, Dalong; Chen, Yingyu] Peking Univ, Hlth Sci Ctr, Minist Hlth, Key Lab Med Immunol, Beijing 100871, Peoples R China; [Zhao, Yuanbo; Hu, Jia; Miao, Guangyan; Qu, Liujing; Wang, Zhenda; Li, Ge; Lv, Ping; Ma, Dalong; Chen, Yingyu] Peking Univ, Hlth Sci Ctr, Ctr Human Dis Genom, Beijing 100871, Peoples R China	Peking University; Peking University	Chen, YY (corresponding author), Peking Univ, Hlth Sci Ctr, Minist Hlth, Key Lab Med Immunol, Beijing 100871, Peoples R China.	yingyu_chen@bjmu.edu.cn		Miao, Guangyan/0000-0001-6683-7995	National Key Basic Research Program of China (973 Program) [2011CB910103]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by a grant from the National Key Basic Research Program of China (973 Program, 2011CB910103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Deegan S, 2013, CELL MOL LIFE SCI, V70, P2425, DOI 10.1007/s00018-012-1173-4; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Ju JS, 2009, AUTOPHAGY, V5, P511, DOI 10.4161/auto.5.4.7761; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; KLIONSKY DJ, 2012, AUTOPHAGY, V8, P4; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Larsen KB, 2010, AUTOPHAGY, V6, P784, DOI 10.4161/auto.6.6.12510; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li YJ, 2013, AUTOPHAGY, V9, P150, DOI 10.4161/auto.22742; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; McKnight NC, 2012, EMBO J, V31, P1931, DOI 10.1038/emboj.2012.36; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pike LRG, 2013, BIOCHEM J, V449, P389, DOI 10.1042/BJ20120972; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Sagne C, 1996, BIOCHEM J, V316, P825, DOI 10.1042/bj3160825; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Takeda J, 2013, NUCLEIC ACIDS RES, V41, pD915, DOI 10.1093/nar/gks1245; Yang J, 2011, AUTOPHAGY, V7, P748, DOI 10.4161/auto.7.7.15822; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200	32	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64228	10.1371/journal.pone.0064228	http://dx.doi.org/10.1371/journal.pone.0064228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691174	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400107
J	Pearson, SH; Avery, HW; Kilham, SS; Velinsky, DJ; Spotila, JR				Pearson, Steven H.; Avery, Harold W.; Kilham, Susan S.; Velinsky, David J.; Spotila, James R.			Stable Isotopes of C and N Reveal Habitat Dependent Dietary Overlap between Native and Introduced Turtles Pseudemys rubriventris and Trachemys scripta	PLOS ONE			English	Article							FRESH-WATER TURTLES; COMPETITION; FOOD; CONSERVATION; NITROGEN; DISCRIMINATION; FRAGMENTATION; TEMPERATURE; COEXISTENCE; DISTURBANCE	Habitat degradation and species introductions are two of the leading causes of species declines on a global scale. Invasive species negatively impact native species through predation and competition for limited resources. The impacts of invasive species may be increased in habitats where habitat degradation is higher due to reductions of prey abundance and distribution. Using stable isotope analyses and extensive measurements of resource availability we determined how resource availability impacts the long term carbon and nitrogen assimilation of the invasive red-eared slider turtle (Trachemys scripta elegans) and a native, threatened species, the red-bellied turtle (Pseudemys rubriventris) at two different freshwater wetland complexes in Pennsylvania, USA. At a larger wetland complex with greater vegetative species richness and diversity, our stable isotope analyses showed dietary niche partitioning between species, whereas analyses from a smaller wetland complex with lower vegetative species richness and diversity showed significant dietary niche overlap. Determining the potential for competition between these two turtle species is important to understanding the ecological impacts of red-eared slider turtles in wetland habitats. In smaller wetlands with increased potential for competition between native turtles and invasive red-eared slider turtles we expect that when shared resources become limited, red-eared slider turtles will negatively impact native turtle species leading to long term population declines. Protection of intact wetland complexes and the reduction of introduced species populations are paramount to preserving populations of native species.	[Pearson, Steven H.; Kilham, Susan S.; Velinsky, David J.; Spotila, James R.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Avery, Harold W.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Pearson, SH (corresponding author), Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA.	shp36@drexel.edu	Pearson, Steven/X-8726-2019	Pearson, Steven/0000-0001-5098-9476	PA Fish and Boat Commission SWG Project [T-38]; DuPont Clear into the Future Student Fellowship; Betz Chair of Environmental Science at Drexel University	PA Fish and Boat Commission SWG Project; DuPont Clear into the Future Student Fellowship; Betz Chair of Environmental Science at Drexel University	Funding for this research has come from three sources: PA Fish and Boat Commission SWG Project T-38, DuPont Clear into the Future Student Fellowship to Steven Pearson, The Betz Chair of Environmental Science at Drexel University. The funders at the PA Fish and Boat Commission and at DuPont Clear into the Future had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Betz Chair of Environmental Science at Drexel University was involved in study design, data analysis, and preparation of the manuscript.	Alves-Stanley CD, 2010, MAR ECOL PROG SER, V402, P255, DOI 10.3354/meps08450; Amarasekare P, 2002, P ROY SOC B-BIOL SCI, V269, P2541, DOI 10.1098/rspb.2002.2181; Amarasekare P, 2004, AM NAT, V164, P310, DOI 10.1086/422858; AVERY HW, 1993, PHYSIOL ZOOL, V66, P902, DOI 10.1086/physzool.66.6.30163746; AVERY HW, 1984, COPEIA, P209, DOI 10.2307/1445055; Avery HW, 2006, FINAL REPORT RED BEL; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bellgraph BJ, 2008, T AM FISH SOC, V137, P790, DOI 10.1577/T07-102.1; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Bulte G, 2008, FRESHWATER BIOL, V53, P497, DOI 10.1111/j.1365-2427.2007.01915.x; Cadi A, 2004, BIODIVERS CONSERV, V13, P2511, DOI 10.1023/B:BIOC.0000048451.07820.9c; Cadotte MW, 2007, ECOLOGY, V88, P823, DOI 10.1890/06-1117; CHAIKOFF IL, 1946, J BIOL CHEM, V166, P683; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; CONGDON JD, 1985, HERPETOLOGICA, V41, P194; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; CREE A, 1995, CONSERV BIOL, V9, P373, DOI 10.1046/j.1523-1739.1995.9020373.x; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Ernst C.H., 1994, TURTLES US CANADA; Ervin GN, 2007, WETLANDS, V27, P620, DOI 10.1672/0277-5212(2007)27[620:AESOTF]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fry B., 2006, STABLE ISOTOPE ECOLO; Gibbons J.W., 1990, P124; GRAHAM TE, 1971, COPEIA, P353; HANSEN RM, 1976, J RANGE MANAGE, V29, P347, DOI 10.2307/3897105; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Kamler JF, 2007, SOUTHWEST NAT, V52, P504, DOI 10.1894/0038-4909(2007)52[504:DOSFVV]2.0.CO;2; Kemp SJ, 2008, MAR ECOL PROG SER, V371, P233, DOI 10.3354/meps07641; Kilham SS, 2009, INT VER THEOR ANGEW, V30, P749; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Litzgus JD, 2008, COPEIA, P86, DOI 10.1643/CH-07-093; Luiselli L, 2004, HERPETOL J, V14, P57; Luiselli L, 2006, J TROP ECOL, V22, P695, DOI 10.1017/S0266467406003634; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McCutchan J. H., 2001, SIL P, V27, P1922, DOI [10.1080/03680770.1998.11902437, DOI 10.1080/03680770.1998.11902437]; Miranda NAF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031897; Paoletti G, 2007, EMU, V107, P52, DOI 10.1071/MU05042; Parmenter R.R., 1990, P257; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; POLIS GA, 1987, ECOLOGY, V68, P332, DOI 10.2307/1939264; Polo-Cavia N, 2010, BIOL INVASIONS, V12, P2141, DOI 10.1007/s10530-009-9615-0; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; R Development Core Team, 2011, R LANG ENV STAT COMP; Reich KJ, 2007, BIOL LETTERS, V3, P712, DOI 10.1098/rsbl.2007.0394; Rodda GH, 1997, BIOSCIENCE, V47, P565, DOI 10.2307/1313163; ROWE JW, 1992, J HERPETOL, V26, P111, DOI 10.2307/1565040; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; SEASTEDT TR, 1991, OECOLOGIA, V87, P72, DOI 10.1007/BF00323782; Seminoff JA, 2007, COPEIA, P534, DOI 10.1643/0045-8511(2007)2007[534:SCANID]2.0.CO;2; Shenko AN, 2012, INTEGR ZOOL, V7, P16, DOI [10.1111/j.1749-4877.2012.00272.x, 10.1111/j.1749-4877.2011.00274.x]; SIBLY RM, 1994, FUNCT ECOL, V8, P486, DOI 10.2307/2390073; Steiniger S, 2009, ECOL INFORM, V4, P183, DOI 10.1016/j.ecoinf.2009.07.004; Swihart RK, 2003, DIVERS DISTRIB, V9, P1, DOI 10.1046/j.1472-4642.2003.00158.x; TILMAN D, 1981, ECOLOGY, V62, P802, DOI 10.2307/1937747; Titus John E., 1993, Lake and Reservoir Management, V7, P155; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Wallace BP, 2009, J EXP MAR BIOL ECOL, V373, P50, DOI 10.1016/j.jembe.2009.03.006; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	60	11	11	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62891	10.1371/journal.pone.0062891	http://dx.doi.org/10.1371/journal.pone.0062891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675437	gold, Green Published, Green Submitted			2022-12-25	WOS:000319036100018
J	Demir, YK; Akan, Z; Kerimoglu, O				Demir, Yusuf K.; Akan, Zafer; Kerimoglu, Oya			Sodium Alginate Microneedle Arrays Mediate the Transdermal Delivery of Bovine Serum Albumin	PLOS ONE			English	Article							SKIN-BARRIER FUNCTION; DRUG; PENETRATION; PATCHES	Background: The "poke and release" strategy for the delivery of macromolecules using polymeric microneedle (MN) is of great importance because it eliminates microneedle reuse, the risks of biohazardous sharps and cross contamination, and it requires no special disposal mechanism. The main objective of this study was the determination of the stability and delivery of bovine serum albumin (BSA) that was transported across human skin via sodium alginate (SA) microneedle arrays (MNs) and SA needle free patches using two different analytical methods. Methodology and Findings: The capability of two analytical methods, the bicinchoninic acid (BCA) assay and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), to precisely detect and quantify BSA within different types of polymeric MNs was assessed. The ex vivo protein release of BSA across dermatomed human abdominal skin from 10 w/w SA MNs was compared to that from needle-free patches using Franz diffusion cells. The developed applicator was mechanically characterized using a Texture Analyzer. The patch mold and its components were fabricated using a rapid prototyping machine. Conclusions/Significance: The BCA method was able to precisely detect BSA that had been loaded into SA MNs. However, the use of SDS-PAGE as the analytical method resulted in significantly different amounts of BSA recovered from differently conditioned polymeric MNs. The permeation of BSA across dermatomed human abdominal skin by SA MNs, which were composed of 100 pyramidal needles, increased by approximately 15.4 fold compared to the permeation obtained with SA needle-free patches. The ease of use of the applicator during the release studies was also demonstrated, as was its mechanical characterization.	[Demir, Yusuf K.; Kerimoglu, Oya] Marmara Univ, Fac Pharm, Dept Pharmaceut Technol, Istanbul, Turkey; [Akan, Zafer] Celal Bayar Univ, Sch Med, Dept Biophys, Manisa, Turkey	Marmara University; Celal Bayar University	Demir, YK (corresponding author), Marmara Univ, Fac Pharm, Dept Pharmaceut Technol, Istanbul, Turkey.	ykdemir@marmara.edu.tr	Demir, Yusuf Kemal/H-4375-2019; Sipahigil, Oya/AAA-2809-2019	Demir, Yusuf Kemal/0000-0001-7754-7192; akan, zafer/0000-0002-4150-1720	Marmara University Scientific Research Projects Commission (BAPKO), Istanbul [SAG-C-DRP-130711-0247]	Marmara University Scientific Research Projects Commission (BAPKO), Istanbul(Marmara University)	This work was partially sponsored by the Marmara University Scientific Research Projects Commission (BAPKO), Istanbul (Project Number SAG-C-DRP-130711-0247). The authors gratefully acknowledge assistance provided by Bilkent University Mechanical Engineering Department. The authors also acknowledge Plastic Surgery Departments at Haydarpasa Numune Hospital and Marmara University for supplying electric dermatome machine, and volunteer subjects, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akan Z, 2010, BIOELECTROMAGNETICS, V31, P603, DOI 10.1002/bem.20607; Al-Zahrani S, 2012, EXPERT OPIN DRUG DEL, V9, P541, DOI 10.1517/17425247.2012.676038; [Anonymous], 1996, ICH HARMONISED TRIPA; Arora A, 2008, INT J PHARMACEUT, V364, P227, DOI 10.1016/j.ijpharm.2008.08.032; Bos JD, 2000, EXP DERMATOL, V9, P165, DOI 10.1034/j.1600-0625.2000.009003165.x; Chen XF, 2011, ADV FUNCT MATER, V21, P464, DOI 10.1002/adfm.201000966; Demir YK, 2012, THESIS MARMARA U I H; Donnelly RF, 2010, J CONTROL RELEASE, V147, P333, DOI 10.1016/j.jconrel.2010.08.008; Donnelly RF, 2011, PHARM RES-DORDR, V28, P41, DOI 10.1007/s11095-010-0169-8; Donnelly RF, 2009, DRUG DEV IND PHARM, V35, P1242, DOI 10.1080/03639040902882280; Falo LD, 2011, USA, Patent No. [US 2011/0098651 Al, 20110098651]; Fu K, 2000, NAT BIOTECHNOL, V18, P24, DOI 10.1038/71875; Gomez C, 2011, J PHARM SCI-US, V100, P223, DOI 10.1002/jps.22270; Hirschberg HJHB, 2010, J CONTROL RELEASE, V147, P211, DOI 10.1016/j.jconrel.2010.06.028; Huang CM, 2007, SEMIN IMMUNOPATHOL, V29, P71, DOI 10.1007/s00281-007-0059-2; Kim YC, 2011, DRUG DELIV TRANSL RE, V1, P7, DOI 10.1007/s13346-010-0005-z; Korkmaz E, 2011, THESIS BILKENT U; Lee JW, 2008, BIOMATERIALS, V29, P2113, DOI 10.1016/j.biomaterials.2007.12.048; LONG GL, 1983, ANAL CHEM, V55, pA712, DOI 10.1021/ac00258a001; Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F; Migalska K, 2011, PHARM RES-DORDR, V28, P1919, DOI 10.1007/s11095-011-0419-4; Mikszta JA, 2002, NAT MED, V8, P415, DOI 10.1038/nm0402-415; Naik, 2000, Pharm Sci Technol Today, V3, P318, DOI 10.1016/S1461-5347(00)00295-9; Nakanishi T, 1997, DEV BIOLOGICALS, V90, P59; O'Neil JM, 2006, MERCK INDEX ENCY CHE; Park JH, 2006, PHARM RES-DORDR, V23, P1008, DOI 10.1007/s11095-006-0028-9; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023; Proksch E, 2006, J DERMATOL SCI, V43, P159, DOI 10.1016/j.jdermsci.2006.06.003; Raphael AP, 2010, SMALL, V6, P1785, DOI 10.1002/smll.201000326; Ryan E, 2012, EUR J PHARM SCI, V47, P297, DOI 10.1016/j.ejps.2012.06.012; Scher GH, 1963, USA, Patent No. 3075883; Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182; Thermo Fisher Scientific Inc, 2011, CHEM PROT ASS; Tuo J, 2011, Patent, Patent No. [US 2011/0195124 Al, 20110195124]; Umrethia M, 2010, J PHARMACEUT BIOMED, V51, P1175, DOI 10.1016/j.jpba.2009.12.004; van der Maaden K, 2012, J CONTROL RELEASE, V161, P645, DOI 10.1016/j.jconrel.2012.01.042; Vanbever R, 1997, PHARMACEUT RES, V14, P638, DOI 10.1023/A:1012161313701	39	38	39	7	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63819	10.1371/journal.pone.0063819	http://dx.doi.org/10.1371/journal.pone.0063819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675508	Green Published, gold, Green Submitted			2022-12-25	WOS:000318852400054
J	Jia, WY; Cao, L; Yang, SW; Dong, HL; Zhang, Y; Wei, HD; Jing, W; Hou, LC; Wang, C				Jia, Wenyuan; Cao, Li; Yang, Shuangwen; Dong, Hailong; Zhang, Yun; Wei, Haidong; Jing, Wei; Hou, Lichao; Wang, Chen			Regulatory T Cells Are Protective in Systemic Inflammation Response Syndrome Induced by Zymosan in Mice	PLOS ONE			English	Article							ORGAN DYSFUNCTION SYNDROME; SELF-TOLERANCE; CECAL LIGATION; MORTALITY; DEPLETION; MECHANISMS; SEPSIS	Systemic inflammation response syndrome (SIRS) is a key and mainly detrimental process in the pathophysiology of multiple organ dysfunction syndrome. The balance of pro-inflammation and anti-inflammation controls the initiation and development of SIRS. However, the endogenous counterregulatory immune mechanisms that are involved in the development of SIRS are not well understood. CD4(+)CD25(+)Foxp3 (forkhead box P3)(+) regulatory T lymphocytes (Treg cells) play a key role in the immunological balance of the body. Thus, our aim was to investigate the contribution of these key immunomodulators (Treg cells) to the immune dysfunction that is observed in zymosan-induced SIRS in mice. We first evaluated the level of Treg cells in the lung of mice 6 h, 1 d, 2 d, 3 d, 5 d, and 7 d after the injection of zymosan or normal saline by western blot, real-time PCR and flow cytometry. We found that the number of Treg cells and the levels of the Treg cell-related transcription factor (Foxp3) and cytokines (IL-10) in the zymosan-treated group significantly decreased on day 1 and day 2 and significantly increased on day 5 compared with the NS-treated group. In the next experiment, the mice were injected with 200 mu g of anti-CD25 mAb (clone PC61) to deplete the Treg cells and then injected with zymosan 2 days later. The number of Treg cells decreased by more than 50% after the injection of the PC61 mAb. In addition, the expression of the anti-inflammatory cytokine IL-10 also decreased. Moreover, the depletion of the Treg cells profoundly increased the mice'mortality and the degree of lung tissue injury. In conclusion, Treg cells tend to play a protective role in pathogenesis of the zymosan-induced generalized inflammation, and IL-10 signaling is associated with their immunomodulatory effect.	[Jia, Wenyuan; Cao, Li; Yang, Shuangwen; Dong, Hailong; Wei, Haidong; Hou, Lichao; Wang, Chen] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi Provinc, Peoples R China; [Zhang, Yun] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Shaanxi Provinc, Peoples R China; [Jing, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Ultrasonog, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wang, C (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi Provinc, Peoples R China.	wangchen@fmmu.edu.cn		Dong, Hailong/0000-0001-8984-9067; Hou, Lichao/0000-0001-7861-6938	National Natural Science Foundation of China [30972854]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by research grants from the National Natural Science Foundation of China (30972854 to Chen Wang, 300,000 yuan). (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER CC, 1983, SURGERY, V94, P331; Bosmann M, 2011, SHOCK, V36, P396, DOI 10.1097/SHK.0b013e3182295f5f; Couper KN, 2007, J IMMUNOL, V178, P4136, DOI 10.4049/jimmunol.178.7.4136; Couper KN, 2009, J IMMUNOL, V182, P3985, DOI 10.4049/jimmunol.0803053; Ferrer TJ, 1998, J SURG RES, V77, P157, DOI 10.1006/jsre.1998.5372; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Jan A, 1986, ARCH SURG; Jansen MJJM, 1997, SHOCK, V8, P261, DOI 10.1097/00024382-199710000-00005; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; McNeill A, 2007, SCAND J IMMUNOL, V65, P63, DOI 10.1111/j.1365-3083.2006.01870.x; Nascimento DC, 2010, CRIT CARE MED, V38, P1718, DOI 10.1097/CCM.0b013e3181e78ad0; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Tenorio EP, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/786078; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Seely AJE, 2000, CRIT CARE MED, V28, P2193, DOI 10.1097/00003246-200007000-00003; Sharma R, 2011, J IMMUNOL, V186, P1268, DOI 10.4049/jimmunol.1002677; Taylor J, 2006, ANTIOCH REV, V64, P176; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; Volman TJH, 2005, SHOCK, V23, P291, DOI 10.1097/01.shk.0000155350.95435.28; Volman TJH, 2004, ANN SURG, V240, P142, DOI 10.1097/01.sla.0000130725.52373.e7; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4	27	11	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e64397	10.1371/journal.pone.0064397	http://dx.doi.org/10.1371/journal.pone.0064397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675534	Green Submitted, gold, Green Published			2022-12-25	WOS:000318852400067
J	Todoroff, J; Lemaire, MM; Fillee, C; Jurion, F; Renauld, JC; Huygen, K; Vanbever, R				Todoroff, Julie; Lemaire, Muriel M.; Fillee, Catherine; Jurion, Fabienne; Renauld, Jean-Christophe; Huygen, Kris; Vanbever, Rita			Mucosal and Systemic Immune Responses to Mycobacterium tuberculosis Antigen 85A following Its Co-Delivery with CpG, MPLA or LTB to the Lungs in Mice	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; PROTECTIVE EFFICACY; INFLUENZA VACCINE; ADJUVANT; IMMUNIZATION; IMMUNOGENICITY; ENTEROTOXIN; MECHANISMS; INFECTION; DEFENSE	Pulmonary vaccination is a promising route for immunization against tuberculosis because the lung is the natural site of infection with Mycobacterium tuberculosis. Yet, adjuvants with a suitable safety profile need to be found to enhance mucosal immunity to recombinant antigens. The aim of this study was to evaluate the immunogenicity, the safety and the protective efficacy of a subunit vaccine composed of the immunodominant mycolyl-transferase antigen 85A (Ag85A) and one of three powerful mucosal adjuvants: the oligodeoxynucleotide containing unmethylated cytosine-phosphate-guanine motifs (CpG), the monophosphoryl lipid A of Salmonella minnesota (MPLA) or the B subunit of heat-labile enterotoxin of Escherichia coli (LTB). BALB/c mice were vaccinated in the deep lungs. Our results showed that lung administration of these adjuvants could specifically induce different types of T cell immunity. Both CpG and MPLA induced a Th-1 type immune response with significant antigen-specific IFN-gamma production by spleen mononuclear cells in vitro and a tendency of increased IFN-gamma in the lungs. Moreover, MPLA triggered a Th-17 response reflected by high IL-17A levels in the spleen and lungs. By contrast, LTB promoted a Th-2 biased immune response, with a production of IL-5 but not IFN-gamma by spleen mononuclear cells in vitro. CpG did not induce inflammation in the lungs while LTB and MPLA showed a transient inflammation including a neutrophil influx one day after pulmonary administration. Pulmonary vaccination with Ag85A without or with MPLA or LTB tended to decrease bacterial counts in the spleen and lungs following a virulent challenge with M. tuberculosis H37Rv. In conclusion, CpG and MPLA were found to be potential adjuvants for pulmonary vaccination against tuberculosis, providing Th-1 and Th-17 immune responses and a good safety profile.	[Todoroff, Julie; Vanbever, Rita] Catholic Univ Louvain, Louvain Drug Res Inst, Pharmaceut & Drug Delivery Grp, B-1200 Brussels, Belgium; [Lemaire, Muriel M.; Renauld, Jean-Christophe] Catholic Univ Louvain, de Duve Inst, Expt Med Unit, B-1200 Brussels, Belgium; [Lemaire, Muriel M.; Jurion, Fabienne; Renauld, Jean-Christophe] Ludwig Inst Canc Res, Brussels Branch, Brussels, Belgium; [Fillee, Catherine] Clin Univ St Luc, Dept Biol Clin, B-1200 Brussels, Belgium; [Huygen, Kris] Sci Inst Publ Hlth, Serv Immunol, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Vanbever, R (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Pharmaceut & Drug Delivery Grp, B-1200 Brussels, Belgium.	rita.vanbever@uclouvain.be	; Renauld, Jean-Christophe/B-7268-2012	Huygen, Kris/0000-0001-7808-0512; Renauld, Jean-Christophe/0000-0003-1736-2131	Fonds de la Recherche Scientifique Medicale, Belgium [3.4530.09 FNRS]; Fonds National de la Recherche Scientifique (FNRS, Belgium); FWO-Vlaanderen [G.0063.09N]	Fonds de la Recherche Scientifique Medicale, Belgium(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); FWO-Vlaanderen(FWO)	The work was supported by the Fonds de la Recherche Scientifique Medicale (grant number 3.4530.09 FNRS, Belgium; www1.frs-fnrs.be) and by the Fonds National de la Recherche Scientifique (FNRS, Belgium). The work was also partially supported by grant G.0063.09N of FWO-Vlaanderen. Rita Vanbever is Senior research associate of the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge JR, 2000, VACCINE, V18, P2416, DOI 10.1016/S0264-410X(99)00572-1; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Barry M, 2007, EXPERT OPIN BIOL TH, V7, P1731, DOI 10.1517/14712598.7.11.1731; Boom WH, 1996, INFECT AGENT DIS, V5, P73; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cooper AM, 2012, CURR OPIN IMMUNOL, V24, P431, DOI 10.1016/j.coi.2012.04.008; D'Souza S, 2003, INFECT IMMUN, V71, P483; da Hora VP, 2011, VACCINE, V29, P1538, DOI 10.1016/j.vaccine.2010.11.091; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Drent M, 1996, EUR RESPIR J, V9, P1736, DOI 10.1183/09031936.96.09081736; Elamin AA, 2009, J MICROBIOL METH, V79, P358, DOI 10.1016/j.mimet.2009.10.010; Fingerut E, 2006, VET IMMUNOL IMMUNOP, V112, P253, DOI 10.1016/j.vetimm.2006.03.005; Fischer G, 2010, WORLD J MICROB BIOT, V26, P489, DOI 10.1007/s11274-009-0195-z; Garcia-Contreras L, 2008, P NATL ACAD SCI USA, V105, P4656, DOI 10.1073/pnas.0800043105; Gartner T, 2007, IMMUNOL LETT, V111, P26, DOI 10.1016/j.imlet.2007.04.010; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; GRUBHOFER N, 1995, IMMUNOL LETT, V44, P19, DOI 10.1016/0165-2478(94)00188-W; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Jeyanathan M, 2008, J IMMUNOL, V181, P5618, DOI 10.4049/jimmunol.181.8.5618; Krieg AM, 2000, VACCINE, V19, P618, DOI 10.1016/S0264-410X(00)00249-8; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Lemaire MM, 2011, J IMMUNOL, V187, P3530, DOI 10.4049/jimmunol.1101720; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Lu DM, 2007, EXPERT REV VACCINES, V6, P213, DOI 10.1586/14760584.6.2.213; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Minne A, 2007, IMMUNOLOGY, V122, P316, DOI 10.1111/j.1365-2567.2007.02641.x; Nicod LP, 1999, RESPIRATION, V66, P2, DOI 10.1159/000029329; Ottenhoff THM, 2012, TRENDS MICROBIOL, V20, P419, DOI 10.1016/j.tim.2012.06.002; ROCHE PW, 1995, TRENDS MICROBIOL, V3, P397, DOI 10.1016/S0966-842X(00)88986-6; Romano M, 2006, IMMUNOLOGY, V118, P321, DOI 10.1111/j.1365-2567.2006.02373.x; Romano M, 2012, EXPERT OPIN BIOL TH, V12, P1601, DOI 10.1517/14712598.2012.721768; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Santosuosso M, 2007, J IMMUNOL, V178, P2387, DOI 10.4049/jimmunol.178.4.2387; Scriba TJ, 2011, J INFECT DIS, V203, P1832, DOI 10.1093/infdis/jir195; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Stephenson I, 2006, J VIROL, V80, P4962, DOI 10.1128/JVI.80.10.4962-4970.2006; Stop TB Partnership, 2009, TUB VACC CAND; Sundaramurthy V, 2007, MICROBES INFECT, V9, P1671, DOI 10.1016/j.micinf.2007.09.007; Todoroff J, 2013, EUR J PHARM BIOPHARM, V84, P40, DOI 10.1016/j.ejpb.2012.11.020; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; WHO, 2006, STOP TB STRAT	41	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63344	10.1371/journal.pone.0063344	http://dx.doi.org/10.1371/journal.pone.0063344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675482	Green Submitted, Green Published, gold			2022-12-25	WOS:000318852400038
J	Ding, Z; Joy, M; Bhargava, R; Gunsaulus, M; Lakshman, N; Miron-Mendoza, M; Petroll, M; Condeelis, J; Wells, A; Roy, P				Ding, Z.; Joy, M.; Bhargava, R.; Gunsaulus, M.; Lakshman, N.; Miron-Mendoza, M.; Petroll, M.; Condeelis, J.; Wells, A.; Roy, P.			Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis	ONCOGENE			English	Article						profilin-1; breast cancer; metastasis	TUMOR-CELLS; CARCINOMA-CELLS; MIGRATION; PROLIFERATION; CYTOKINESIS; MOTILITY; PROTEIN; OVEREXPRESSION; LAMELLIPODIN; INHIBITION	Profilin1 (Pfn1), a ubiquitously expressed actin-binding protein, has an indispensable role in migration and proliferation of normal cells. Seemingly contrary to its essential cellular functions, Pfn1's expression is downregulated in breast cancer, the significance of which is unclear. In this study, expression profiling of Pfn1 in human breast cancer specimens correlates lower Pfn1 expression levels with propensity to metastasize. Xenograft experiments further establish a causal relationship between loss of Pfn1 expression and increased dissemination of breast cancer cells (BCCs) from the primary mammary tumor. BCCs exhibit a hyperinvasive phenotype (marked by matrix metalloproteinase-9 upregulation, faster invasion through collagen matrix) and acquire increased proficiency to transmigrate through endothelial barrier (an obligatory step for vascular dissemination) when Pfn1 expression is suppressed. In Pfn1-deficient cells, hyperinvasiveness involves a phosphatidylinositol 3-kinase-PI(3,4)P-2 signaling axis while augmented transendothelial migration occurs in a vascular endothelial growth factor-dependent manner. Contrasting these dissemination promoting activities, loss of Pfn1, however, dramatically inhibits metastatic outgrowth of disseminated BCCs, suggesting that Pfn1 has a key role in the metastatic colonization process. In summary, this study shows that Pfn1 has a dichotomous role in early vs late steps of breast cancer metastasis.	[Ding, Z.; Joy, M.; Gunsaulus, M.; Wells, A.; Roy, P.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA; [Bhargava, R.; Wells, A.; Roy, P.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15219 USA; [Bhargava, R.] Magee Womens Hosp, Pittsburgh, PA USA; [Lakshman, N.; Miron-Mendoza, M.; Petroll, M.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA; [Condeelis, J.] Albert Einstein Coll Med, Dept Cell Biol & Anat, New York, NY USA; [Wells, A.; Roy, P.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA; [Roy, P.] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yeshiva University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Roy, P (corresponding author), Univ Pittsburgh, Dept Bioengn, 306 Ctr Bioengn,300 Technol Dr, Pittsburgh, PA 15219 USA.	par19@pitt.edu		Wells, Alan/0000-0002-1637-8150; Roy, Partha/0000-0002-4946-8531; Petroll, W. Matthew/0000-0003-0795-4539	National Cancer Institute of the National Institute of Health [2R01CA108607-07]; Magee Women's Research Institute; NATIONAL CANCER INSTITUTE [R01CA108607] Funding Source: NIH RePORTER	National Cancer Institute of the National Institute of Health; Magee Women's Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute of the National Institute of Health (2R01CA108607-07) and the Magee Women's Research Institute to PR.	Artym Vira V., 2009, V522, P211, DOI 10.1007/978-1-59745-413-1_15; Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Bottcher RT, 2009, EMBO J, V28, P1157, DOI 10.1038/emboj.2009.58; Chao Y, 2012, CANCER MICROENVIRON, V5, P19, DOI 10.1007/s12307-011-0085-4; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Gau D, 2011, CELL MOL BIOENG, V4, P1, DOI 10.1007/s12195-010-0133-z; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; GOLDSCHMIDTCLERMONT PJ, 1991, SCIENCE, V251, P1231, DOI 10.1126/science.1848725; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; Ho MY, 2012, MOL CANCER RES, V10, P1109, DOI 10.1158/1541-7786.MCR-12-0160; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Karlsson R, 2007, MOL BIOL INTELL UNIT, P29, DOI 10.1007/978-0-387-46407-7_3; Khadka DK, 2009, DEV BIOL, V332, P396, DOI 10.1016/j.ydbio.2009.06.008; Kim A, 2010, INVEST OPHTH VIS SCI, V51, P864, DOI 10.1167/iovs.09-4200; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Kullmann JA, 2012, EMBO REP, V13, P75, DOI 10.1038/embor.2011.211; Lederer M, 2005, J CELL SCI, V118, P331, DOI 10.1242/jcs.01618; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Roy P, 2004, CELL MOTIL CYTOSKEL, V57, P84, DOI 10.1002/cm.10160; Sato A, 2006, DEVELOPMENT, V133, P4219, DOI 10.1242/dev.02590; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Smith K, 2010, CELL HOST MICROBE, V7, P13, DOI 10.1016/j.chom.2009.12.004; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Wu N, 2006, PROTEOMICS, V6, P6095, DOI 10.1002/pmic.200500321; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038; Zou L, 2009, CELL MOTIL CYTOSKEL, V66, P1048, DOI 10.1002/cm.20407	38	41	41	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 17	2014	33	16					2065	2074		10.1038/onc.2013.166	http://dx.doi.org/10.1038/onc.2013.166			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF3GH	23686314	Green Accepted			2022-12-25	WOS:000334599100006
J	Uranga, RM; Katz, S; Salvador, GA				Maria Uranga, Romina; Katz, Sebastian; Alejandra Salvador, Gabriela			Enhanced Phosphatidylinositol 3-kinase (PI3K)/Akt Signaling Has Pleiotropic Targets in Hippocampal Neurons Exposed to Iron-induced Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; NUCLEAR TRANSLOCATION; SUPEROXIDE-DISMUTASE; AKT PHOSPHORYLATION; SYNAPTIC ENDINGS; CELL-DEATH; NEURODEGENERATION; PATHWAY; BRAIN; ACTIVATION	The PI3K/Akt pathway is a key component in synaptic plasticity and neuronal survival. The aim of this work was to investigate the participation of the PI3K/Akt pathway and its outcome on different molecular targets such as glycogen synthase kinase 3 beta (GSK3 beta) and Forkhead box-O (FoxO) transcription factors during mild oxidative stress triggered by iron overload. The exposure of mouse hippocampal neurons (HT22) to different concentrations of Fe2+ (25-200 mu M) for 24 h led us to define a mild oxidative injury status (50 mu M Fe2+) in which cell morphology showed changes typical of neuronal damage with increased lipid peroxidation and cellular oxidant levels but no alteration of cellular viability. There was a simultaneous increase in both Akt and GSK3 beta phosphorylation. Levels of phospho-FoxO3a (inactive form) increased in the cytosolic fraction of cells treated with iron in a PI3K-dependent manner. Moreover, PI3K and Akt translocated to the nucleus in response to oxidative stress. Iron-overloaded cells harboring a constitutively active form of Akt showed decreased oxidants levels. Indeed, GSH synthesis under oxidative stress conditions was regulated by activated Akt. Our results show that activation of the PI3K/Akt pathway during iron-induced neurotoxicity regulates multiple targets such as GSK3 beta, FoxO transcriptional activity, and glutathione metabolism, thus modulating the neuronal response to oxidative stress.	[Maria Uranga, Romina; Alejandra Salvador, Gabriela] Inst Invest Bioquim Bahia Blanca, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Maria Uranga, Romina; Katz, Sebastian; Alejandra Salvador, Gabriela] Univ Nacl Sur, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Maria Uranga, Romina; Katz, Sebastian; Alejandra Salvador, Gabriela] Consejo Nacl Invest Cient & Tecn, RA-8000 Bahia Blanca, Buenos Aires, Argentina	National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Salvador, GA (corresponding author), Inst Invest Bioquim Bahia Blanca, La Carrindanga Km 7, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	salvador@criba.edu.ar	Uranga, Romina M/A-7660-2011; Salvador, Gabriela/GOJ-7718-2022	Uranga, Romina Maria/0000-0002-8113-4646	Universidad Nacional del Sur [PGI 24/B179]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT-2010-0936]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 11220090100687]; Fundacion Florencio Fiorini	Universidad Nacional del Sur; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Florencio Fiorini	This work was supported by Universidad Nacional del Sur Grant PGI 24/B179), by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) Grant PICT-2010-0936), by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grant PIP 11220090100687), and by the Fundacion Florencio Fiorini.	Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Ayton S, 2013, FREE RADICAL BIO MED, V62, P76, DOI 10.1016/j.freeradbiomed.2012.10.558; Badve S, 2010, AM J PATHOL, V176, P2139, DOI 10.2353/ajpath.2010.090477; Bartzokis G, 2004, ANN NY ACAD SCI, V1012, P224, DOI 10.1196/annals.1306.019; Berg Daniela, 2006, Top Magn Reson Imaging, V17, P5, DOI 10.1097/01.rmr.0000245461.90406.ad; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Boehme KA, 2008, P NATL ACAD SCI USA, V105, P7785, DOI 10.1073/pnas.0703423105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castellani RJ, 2007, NEUROCHEM RES, V32, P1640, DOI 10.1007/s11064-007-9360-7; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Choi H, 2012, NEUROTOXICOLOGY, V33, P85, DOI 10.1016/j.neuro.2011.12.005; CONNOR JR, 1992, ANN NEUROL, V32, pS51, DOI 10.1002/ana.410320710; Dai YX, 2007, J PSYCHIATR NEUROSCI, V32, P323; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Fan CD, 2013, J BIOL CHEM, V288, P1674, DOI 10.1074/jbc.M112.416339; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; Fukunaga K, 2005, J PHARMACOL SCI, V98, P205, DOI 10.1254/jphs.FMJ05001X3; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Joseph JA, 2005, NEUROCHEM RES, V30, P927, DOI 10.1007/s11064-005-6967-4; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Lee YJ, 2009, J NEUROCHEM, V111, P90, DOI 10.1111/j.1471-4159.2009.06297.x; Lijnen PJ, 2010, AM J HYPERTENS, V23, P1128, DOI 10.1038/ajh.2010.128; Los M, 2009, BIOESSAYS, V31, P492, DOI 10.1002/bies.200900005; Lu Q, 2013, EXP PHYSIOL, V98, P934, DOI 10.1113/expphysiol.2012.068361; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; Uranga RM, 2009, TOXICOL SCI, V111, P331, DOI 10.1093/toxsci/kfp152; Mateos MV, 2012, BBA-MOL CELL RES, V1823, P2136, DOI 10.1016/j.bbamcr.2012.09.005; Mateos MV, 2008, NEUROCHEM INT, V53, P199, DOI 10.1016/j.neuint.2008.07.005; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Min YK, 2007, EXP CELL RES, V313, P312, DOI 10.1016/j.yexcr.2006.10.013; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nguyen TLX, 2006, BIOCHEM BIOPH RES CO, V349, P789, DOI 10.1016/j.bbrc.2006.08.120; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Diez GR, 2012, NEUROCHEM INT, V61, P749, DOI 10.1016/j.neuint.2012.06.012; Ryder J, 2004, CELL SIGNAL, V16, P187, DOI 10.1016/j.cellsig.2003.07.004; Salvador Gabriela A, 2010, Int J Alzheimers Dis, V2011, P720658, DOI 10.4061/2011/720658; Salvador GA, 2010, BIOFACTORS, V36, P103, DOI 10.1002/biof.80; Schneider SA, 2009, J NEUROL NEUROSUR PS, V80, P589, DOI 10.1136/jnnp.2008.169953; Schneider SA, 2013, J NEURAL TRANSM, V120, P695, DOI 10.1007/s00702-012-0922-8; Shi QL, 2007, ALZ DIS ASSOC DIS, V21, P276, DOI 10.1097/WAD.0b013e31815721c3; Su B, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-32; Toker A, 2000, MOL PHARMACOL, V57, P652, DOI 10.1124/mol.57.4.652; Toker Alex, 2012, Adv Biol Regul, V52, P78; Uranga RM, 2010, NEUROSCIENCE, V170, P381, DOI 10.1016/j.neuroscience.2010.07.044; Uranga RM, 2007, J NEUROSCI RES, V85, P2924, DOI 10.1002/jnr.21406; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wang SH, 2012, CURR NEUROVASC RES, V9, P20, DOI 10.2174/156720212799297137; Webster KA, 2004, CIRC RES, V94, P856, DOI 10.1161/01.RES.0000126699.49835.5D; WINTERBOURN CC, 1994, ARCH BIOCHEM BIOPHYS, V314, P284, DOI 10.1006/abbi.1994.1444	60	77	79	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19773	19784		10.1074/jbc.M113.457622	http://dx.doi.org/10.1074/jbc.M113.457622			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23687303	hybrid, Green Published			2022-12-25	WOS:000321515800046
J	Mandal, P; Verma, N; Chauhan, S; Tomar, RS				Mandal, Papita; Verma, Naveen; Chauhan, Sakshi; Tomar, Raghuvir S.			Unexpected Histone H3 Tail-clipping Activity of Glutamate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLTRANSFERASE COMPLEXES; REGULATED EVENT; CHROMATIN; CLEAVAGE; TRANSCRIPTION; PROTEOLYSIS; PROTEINS; BINDING; WATER	Clipping of histone tails has been reported in several organisms. However, the significance and regulation of histone tail clipping largely remains unclear. According to recent discoveries H3 clipping has been found to be involved in regulation of gene expression and chromatin dynamics. Earlier we had provided evidence of tissue-specific proteolytic processing of histone H3 in White Leghorn chicken liver nuclei. In this study we identify a novel activity of glutamate dehydrogenase (GDH) as a histone H3-specific protease in chicken liver tissue. This protease activity is regulated by divalent ions and thiol-disulfide conversion in vitro. GDH specifically clips H3 in its free as well as chromatin-bound form. Furthermore, we have found an inhibitor that inhibits the H3-clipping activity of GDH. Like previously reported proteases, GDH too may have the potential to regulate/modulate post-translational modifications of histone H3 by removing the N-terminal residues of the histone. In short, our findings identify an unexpected proteolytic activity of GDH specific to histone H3 that is regulated by redox state, ionic concentrations, and a cellular inhibitor in vitro.	[Mandal, Papita; Verma, Naveen; Chauhan, Sakshi; Tomar, Raghuvir S.] Indian Inst Sci Educ & Res Bhopal, Lab Chromatin Biol, Dept Biol Sci, Bhopal 462023, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Tomar, RS (corresponding author), Indian Inst Sci Educ & Res Bhopal, Lab Chromatin Biol, Transit Campus,ITI Gas Rahat Bldg, Bhopal 462023, Madhya Pradesh, India.	rst@iiserb.ac.in	Verma, Naveen/AGI-5147-2022	Verma, Naveen/0000-0003-4211-579X	Department of Biotechnology, Council of Scientific and Industrial Research, Government of India; Indian Institute of Science Education and Research Bhopal; University Grants Commission	Department of Biotechnology, Council of Scientific and Industrial Research, Government of India; Indian Institute of Science Education and Research Bhopal; University Grants Commission(University Grants Commission, India)	This work was supported by grants from the Department of Biotechnology, Council of Scientific and Industrial Research, Government of India and Indian Institute of Science Education and Research Bhopal (to R. S. T.).; Recipient of a fellowship from the University Grants Commission.	ALLIS CD, 1984, J CELL BIOL, V99, P1669, DOI 10.1083/jcb.99.5.1669; ALLIS CD, 1984, EXP CELL RES, V153, P287, DOI 10.1016/0014-4827(84)90601-3; ALLIS CD, 1980, CELL, V20, P55; An WJ, 2003, J BIOL CHEM, V278, P1504, DOI 10.1074/jbc.M209355200; BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; Belsham GJ, 2000, J VIROL, V74, P272, DOI 10.1128/JVI.74.1.272-280.2000; Bertin A, 2004, BIOCHEMISTRY-US, V43, P4773, DOI 10.1021/bi036210g; Chandy M, 2006, EUKARYOT CELL, V5, P1738, DOI 10.1128/EC.00165-06; Chodaparambil JV, 2006, E SCHERING RES FDN W, V57, P29; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Depken M, 2009, BIOPHYS J, V96, P777, DOI 10.1016/j.bpj.2008.09.055; EICKBUSH TH, 1976, CELL, V9, P785, DOI 10.1016/0092-8674(76)90141-0; ELIA MC, 1988, J BIOL CHEM, V263, P9958; FALK MM, 1990, J VIROL, V64, P748, DOI 10.1128/JVI.64.2.748-756.1990; Grillo C, 2002, BIOCHEM BIOPH RES CO, V295, P67, DOI 10.1016/S0006-291X(02)00634-4; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Kaul R, 1997, J BACTERIOL, V179, P5928, DOI 10.1128/jb.179.18.5928-5934.1997; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee MK, 2002, EXTREMOPHILES, V6, P151, DOI 10.1007/s007920100238; Lee WK, 2000, J CELL BIOCHEM, V76, P244; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mandal P, 2012, BIOCHEM BIOPH RES CO, V421, P261, DOI 10.1016/j.bbrc.2012.03.149; Pattenden Samantha G, 2005, Genome Biol, V6, P355, DOI 10.1186/gb-2005-6-11-355; Peterson CL, 2002, EMBO REP, V3, P319, DOI 10.1093/embo-reports/kvf075; Santos-Rosa H, 2009, NAT STRUCT MOL BIOL, V16, P17, DOI 10.1038/nsmb.1534; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; SUROWY CS, 1983, P NATL ACAD SCI-BIOL, V80, P5510, DOI 10.1073/pnas.80.18.5510; TESAR M, 1990, VIROLOGY, V174, P364, DOI 10.1016/0042-6822(90)90090-E; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028	31	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18743	18757		10.1074/jbc.M113.462531	http://dx.doi.org/10.1074/jbc.M113.462531			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23673664	Green Published, hybrid			2022-12-25	WOS:000321335800010
J	DeFisher, LE; Bonter, DN				DeFisher, Luke E.; Bonter, David N.			Effects of Invasive European Fire Ants (Myrmica rubra) on Herring Gull (Larus argentatus) Reproduction	PLOS ONE			English	Article							SOLENOPSIS-INVICTA; NORTHERN BOBWHITE; BIRD ISLAND; SUCCESS; TEXAS; CONSEQUENCES; BIODIVERSITY; HYMENOPTERA; SEYCHELLES; FORMICIDAE	Various invasive ant species have negatively affected reproductive success in birds by disrupting nest site selection, incubation patterns, food supply, and by direct predation on nestlings. Impacts can be particularly severe when non-native ants colonize seabird nesting islands where thousands of birds may nest in high densities on the ground or in burrows or crevices. Here we report on the first documented effects of Myrmica rubra, the European fire ant, on the reproduction of birds in its non-native range. We documented herring gulls (Larus argentatus) on Appledore Island, Maine, engaging in more erratic incubation behaviors at nests infested by the ants. Newly-hatched chicks in some nests were swarmed by ants, leading to rapid chick death. Due to high overall rates of chick mortality, survival probabilities did not vary between nests with and without ant activity, however chick growth rates were slower at nests with ants than at ant-free nests. Ant infestation likely leads to longer-term fitness consequences because slower growth rates early in life may ultimately lead to lower post-fledging survival probabilities.	[DeFisher, Luke E.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Bonter, David N.] Cornell Lab Ornithol, Ithaca, NY USA	Cornell University; Cornell University	Bonter, DN (corresponding author), Cornell Lab Ornithol, Ithaca, NY USA.	dnb23@cornell.edu	Bonter, David/H-1313-2013	Bonter, David/0000-0003-1768-1941	Cornell Lab for Ornithology's Redhead Fund for Student Research	Cornell Lab for Ornithology's Redhead Fund for Student Research	Funding was provided by the Cornell Lab for Ornithology's Redhead Fund for Student Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho T, 1999, ECOLOGY, V80, P998, DOI 10.1890/0012-9658(1999)080[0998:RSOETC]2.0.CO;2; ALLEN CR, 1995, ECOL APPL, V5, P632, DOI 10.2307/1941972; Allen CR, 2001, J AGR URBAN ENTOMOL, V18, P249; Bestelmeyer B, 2000, ANTS STANDARD METHOD, P280; BRIAN MV, 1952, J ANIM ECOL, V21, P12, DOI 10.2307/1907; Campomizzi AJ, 2009, CONDOR, V111, P534, DOI 10.1525/cond.2009.090066; Clavero M, 2009, BIOL CONSERV, V142, P2043, DOI 10.1016/j.biocon.2009.03.034; Davis NE, 2008, CONSERV BIOL, V22, P1165, DOI 10.1111/j.1523-1739.2008.00984.x; DELNICKI D E, 1977, Southwestern Naturalist, V22, P275, DOI 10.2307/3669820; Dickinson VM, 1995, WILSON BULL, V107, P761; Ellis JC, 2006, CONDOR, V108, P211, DOI 10.1650/0010-5422(2006)108[0211:NAAABS]2.0.CO;2; Feare C, 1999, BIRD CONSERV INT, V9, P95, DOI 10.1017/S0959270900003385; Garnas J, 2004, THESIS U MAINE; Gerlach J, 2004, J INSECT CONSERV, V8, P15, DOI 10.1023/B:JICO.0000027454.78591.97; Gill, 1994, BIRDS N AM; Giuliano WM, 1996, J WILDLIFE MANAGE, V60, P309, DOI 10.2307/3802229; Groden E, 2005, J ECON ENTOMOL, V98, P1774, DOI 10.1603/0022-0493-98.6.1774; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Hooper LM, 1998, SOCIOBIOLOGY, V31, P283; Kim M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1087, DOI 10.1007/s00265-010-0923-2; Kopachena JG, 2000, SOUTHWEST NAT, V45, P477, DOI 10.2307/3672596; Lowe S, 2000, ALIENS, V12, ps1; Pedersen EK, 1996, J WILDLIFE MANAGE, V60, P164, DOI 10.2307/3802051; PIEROTTI R, 1982, ECOLOGY, V63, P854, DOI 10.2307/1936804; Plentovich S, 2009, BIOL INVASIONS, V11, P289, DOI 10.1007/s10530-008-9233-2; Rome MS, 2004, WATERBIRDS, V27, P200, DOI 10.1675/1524-4695(2004)027[0200:FEAIBH]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SAS Institute, 2003, SAS VERS 9 2; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; SIKES PJ, 1986, SOUTHWEST NAT, V31, P105, DOI 10.2307/3670967; Smith JE, 2007, EVOL ECOL RES, V9, P433	31	14	18	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64185	10.1371/journal.pone.0064185	http://dx.doi.org/10.1371/journal.pone.0064185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691168	gold, Green Published, Green Submitted			2022-12-25	WOS:000319107900084
J	Deng, YX; Yang, ZW; Gao, Y; Xu, H; Zheng, BJ; Jiang, M; Xu, J; He, ZY; Wang, XR				Deng, Yuxiao; Yang, Zhongwei; Gao, Yuan; Xu, Huan; Zheng, Beijie; Jiang, Min; Xu, Jin; He, Zhengyu; Wang, Xiangrui			Toll-Like Receptor 4 Mediates Acute Lung Injury Induced by High Mobility Group Box-1	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; INNATE IMMUNITY; PROTEIN; HMGB1; CYTOKINE; CELLS; LIPOPOLYSACCHARIDE; RECOGNITION	Background: Acute lung injury (ALI) is considered to be the major cause of respiratory failure in critically ill patients. Clinical studies have found that in patients with sepsis and after hemorrhage, the elevated level of high mobility group box1(HMGB-1) in their circulation is highly associated with ALI, but the underlying mechanism remains unclear. Extracellular HMGB-1 has cytokine-like properties and can bind to Toll-like Receptor-4 (TLR4), which was reported to play an important role in the pathogenesis of ALI. The aim of this study was to determine whether HMGB-1 directly contributes to ALI and whether TLR4 signaling pathway is involved in this process. Methods: Recombinant human HMGB-1 (rhHMGB-1) was used to induce ALI in male Sprague-Dawley rats. Lung specimens were collected 2 h after HMGB-1 treatment. The levels of TNF-alpha, IL-1 beta, TLR4 protein, and TLR4 mRNA in lungs as well as pathological changes of lung tissue were assessed. In cell studies, the alveolar macrophage cell line, NR8383, was collected 24 h after rhHMGB-1 treatment and the levels of TNF-alpha and IL-1 beta in cultured medium as well as TLR4 protein and mRNA levels in the cell were examined. TLR4-shRNA-lentivirus was used to inhibit TLR4 expression, and a neutralizing anti-HMGB1 antibody was used to neutralize rhHMGB-1 both in vitro and in vivo. Results: Features of lung injury and significant elevation of IL-1 alpha and TNF-alpha levels were found in lungs of rhHMGB-1-treated animals. Cultured NR8383 cells were activated by rhHMGB-1 treatment and resulted in the release of IL-1 beta and TNF-alpha. TLR4 expression was greatly up-regulated by rhHMGB-1. Inhibition of TLR4 or neutralization of HMGB1 with a specific antibody also attenuated the inflammatory response induced by HMGB-1 both in vivo and in vitro. Conclusion: HMGB-1 can activate alveolar macrophages to produce proinflammatory cytokines and induce ALI through a mechanism that relies on TLR-4.	[Deng, Yuxiao; Yang, Zhongwei; Gao, Yuan; Xu, Huan; Zheng, Beijie; Xu, Jin; He, Zhengyu; Wang, Xiangrui] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Jiang, Min] Inst Brain Sci, Shanghai, Peoples R China; [Jiang, Min] Key Lab Med Neurobiol, Shanghai, Peoples R China	Shanghai Jiao Tong University	He, ZY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Anesthesiol, Shanghai 200030, Peoples R China.	hzyyy@163.com; xiangruiwang@gmail.com	gao, yuan/GWM-8846-2022; GAO, YUAN/AFF-0781-2022	He, Zhengyu/0000-0001-7354-850X	National Natural Science Foundation of China (NSFC) [81000025, 81170062]; Science and Technology Commission of Shanghai Municipality Foundation [10411951600]; Specialized Research Fund for the Doctoral Program of Higher Education [20110073110073]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Foundation(Science & Technology Commission of Shanghai Municipality (STCSM)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by the grants from the National Natural Science Foundation of China (NSFC) (No. 81000025, 81170062), a grant from the Science and Technology Commission of Shanghai Municipality Foundation (No. 10411951600), and a grant from the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20110073110073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Baudouin S, 2010, CRIT CARE MED, V38, P328, DOI 10.1097/CCM.0b013e3181b3a81e; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Dumitriu IE, 2005, TRENDS IMMUNOL, V26, P381, DOI 10.1016/j.it.2005.04.009; Fink MP, 2007, CRIT CARE, V11, DOI 10.1186/cc6088; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Hall RI, 1997, ANESTH ANALG, V85, P766, DOI 10.1097/00000539-199710000-00011; Hatada T, 2005, THROMB HAEMOSTASIS, V94, P975, DOI 10.1160/TH05-05-0316; He ZY, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-126; He ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035926; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hu GC, 2010, CRIT CARE MED, V38, P194, DOI 10.1097/CCM.0b013e3181bc7c17; Huttunen HJ, 2004, J INTERN MED, V255, P351, DOI 10.1111/j.1365-2796.2003.01301.x; Kaczorowski DJ, 2008, J LEUKOCYTE BIOL, V83, P546, DOI 10.1189/jlb.0607374; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Kokkola R, 2002, ARTHRITIS RHEUM, V46, P2598, DOI 10.1002/art.10540; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Luo Y, 2011, PULM PHARMACOL THER, V24, P240, DOI 10.1016/j.pupt.2010.12.005; Lv TF, 2009, J TRAUMA, V66, P124, DOI 10.1097/TA.0b013e318181e555; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Miller BE, 1997, J CARDIOTHOR VASC AN, V11, P355, DOI 10.1016/S1053-0770(97)90106-3; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Perros F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-125; Tian J, 2011, ANESTH ANALG, V113, P112, DOI 10.1213/ANE.0b013e3182159c15; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; ULICH TR, 1994, CLIN IMMUNOL IMMUNOP, V72, P137, DOI 10.1006/clin.1994.1117; Voll RE, 2008, ISR MED ASSOC J, V10, P26; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648	38	43	52	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64375	10.1371/journal.pone.0064375	http://dx.doi.org/10.1371/journal.pone.0064375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691208	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900096
J	Hao, PP; Chen, YG; Liu, YP; Zhang, MX; Yang, JM; Gao, F; Zhang, Y; Zhang, C				Hao, Pan-Pan; Chen, Yu-Guo; Liu, Yan-Ping; Zhang, Ming-Xiang; Yang, Jian-Min; Gao, Fei; Zhang, Yun; Zhang, Cheng			Association of Plasma Angiotensin-(1-7) Level and Left Ventricular Function in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							DYSFUNCTION; MODEL; ECHOCARDIOGRAPHY; OVEREXPRESSION; ACE2	Background: We recently found that overexpression of angiotensin (Ang)-converting enzyme 2, which metabolizes Ang-II to Ang-(1-7) and Ang-I to Ang-(1-9), may prevent diabetes-induced left ventricular remodeling and dysfunction in rats. Our objective was to evaluate the association of plasma Ang-(1-7) level and left ventricular function in patients with type 2 diabetes mellitus. Methodology/Principal Findings: We measured the left ventricular ejection fraction (EF), ratio of early to late left ventricular filling velocity (E/A) and ratio of early diastolic mitral inflow to annular velocity (E/Ea) by ultrasonography in 110 patients with type 2 diabetes mellitus for more than 5 years. Anthropometric and fasting blood values were obtained from medical records. The plasma Ang-(1-7) level in patients with a poor EF (<50%) was significantly lower than that in patients with EF >= 50%; the level in patients with E/A <1 was significantly lower than that in patients with E/A >= 1; and the level in patients with E/Ea >15 was significantly lower than that in patients with E/Ea <= 15. Ang-(1-7) level was negatively correlated with E/Ea and Log-N-terminal pro-B-type natriuretic peptide and positively with EF and E/A. Stepwise multiple regression analysis revealed that Ang-(1-7), hemoglobin A1c and Ang-II levels as well as duration of diabetes predicted EF; Ang-(1-7) level, fasting blood glucose, low-density lipoprotein cholesterol level and duration of diabetes predicted E/A; and Ang-(1-7) and hemoglobin A1c levels predicted E/Ea. Conclusions/Significance: Plasma Ang-(1-7) level is independently associated with left ventricular function in patients with type 2 diabetes mellitus and may be a biomarker for assessing cardiac function in such patients.	[Zhang, Yun] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Zhang, Y (corresponding author), Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China.	zhangyun@sdu.edu.cn; zhangcheng8003@yahoo.cn	liu, yan/HCI-5542-2022; Yang, Jianmin/AAB-4237-2020	Gao, Fei/0000-0002-1235-8005	National 973 Basic Research Program of China [2011CB503906, 2012CB518603]; National High-tech Research and Development Program of China [2012AA02A510]; Program of Introducing Talents of Discipline to Universities [B07035]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]; National Natural Science Foundation of China [81100102, 81100147, 81100207, 81170136, 81170275, 81270350]; Graduate Independent Innovation Foundation of Shandong University	National 973 Basic Research Program of China(National Basic Research Program of China); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Independent Innovation Foundation of Shandong University	This work was supported by the National 973 Basic Research Program of China (grant nos. 2011CB503906, 2012CB518603), the National High-tech Research and Development Program of China (grant no. 2012AA02A510), the Program of Introducing Talents of Discipline to Universities (grant no. B07035), the State Program of National Natural Science Foundation of China for Innovative Research Group (grant no. 81021001), grants of the National Natural Science Foundation of China (grant nos. 81100102, 81100147, 81100207, 81170136, 81170275, 81270350), and the Graduate Independent Innovation Foundation of Shandong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini JP, 2008, DIABETES METAB, V34, P355, DOI 10.1016/j.diabet.2008.02.004; Ceylan-Isik AF, 2006, CLIN EXP PHARMACOL P, V33, P102, DOI 10.1111/j.1440-1681.2006.04331.x; Dong B, 2008, ARTERIOSCL THROM VAS, V28, P1270, DOI 10.1161/ATVBAHA.108.164715; Dong B, 2012, J AM COLL CARDIOL, V59, P739, DOI 10.1016/j.jacc.2011.09.071; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Epelman S, 2009, J CARD FAIL, V15, P565, DOI 10.1016/j.cardfail.2009.01.014; Feng YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048910; Flores-Munoz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045564; From AM, 2009, AM J CARDIOL, V103, P1463, DOI 10.1016/j.amjcard.2009.01.358; Hao PP, 2013, INT J CARDIOL, V168, P614, DOI 10.1016/j.ijcard.2013.01.206; Johnson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020828; Karvounis HI, 2004, ANGIOLOGY, V55, P549, DOI 10.1177/000331970405500511; Kuenzli A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009946; McCollum LT, 2012, PEPTIDES, V34, P380, DOI 10.1016/j.peptides.2012.01.020; Ocaranza MP, 2006, HYPERTENSION, V48, P572, DOI 10.1161/01.HYP.0000237862.94083.45; Ommen SR, 2000, CIRCULATION, V102, P1788; Pei ZH, 2010, TOXICOL LETT, V199, P173, DOI 10.1016/j.toxlet.2010.08.021; Ren J, 2004, ENDOCRINE, V25, P73, DOI 10.1385/ENDO:25:2:073; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Serneri GGN, 2001, CIRC RES, V88, P961, DOI 10.1161/hh0901.089882; Shah AM, 2011, AM HEART J, V162, P685, DOI 10.1016/j.ahj.2011.07.015; Shrestha NR, 2009, J NEPAL MED ASSOC, V48, P20; Singh Kulwinder, 2011, Ther Adv Cardiovasc Dis, V5, P159, DOI 10.1177/1753944711409281; Sowers JR, 1998, ARCH INTERN MED, V158, P617, DOI 10.1001/archinte.158.6.617; Tesanovic S, 2010, ARTERIOSCL THROM VAS, V30, P1606, DOI 10.1161/ATVBAHA.110.204453; Verma A, 2012, MOL THER, V20, P28, DOI 10.1038/mt.2011.155; Yousif MHM, 2012, PHARMACOL RES, V66, P269, DOI 10.1016/j.phrs.2012.05.001; Yu XY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016239, 10.1371/journal.pone.0028397]; Zhang C, 2010, P NATL ACAD SCI USA, V107, P15886, DOI 10.1073/pnas.1001253107; Zhang Weihua, 2003, Exp Clin Cardiol, V8, P173	31	25	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e62788	10.1371/journal.pone.0062788	http://dx.doi.org/10.1371/journal.pone.0062788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690953	gold, Green Submitted, Green Published			2022-12-25	WOS:000319107400018
J	Li, Y; O'Neill, C				Li, Yan; O'Neill, Chris			5 '-methylcytosine and 5 '-hydroxymethylcytosine Each Provide Epigenetic Information to the Mouse Zygote	PLOS ONE			English	Article							DNA METHYLATION; PREIMPLANTATION EMBRYOS; PATERNAL GENOME; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; REPLICATION; OOCYTES; 5-METHYLCYTOSINE; MECHANISMS; MAMMALS	Covalent modification of cytosine nucleotides within the genome encode essential epigenetic information, with methylation (5meC) and hydroxymethylation (5hmC) having received most attention. It has been proposed that the formation of 5hmC is an intermediate in the active demethylation of 5meC. Some reports show that global loss of 5meC in the newly fertilised embryo is accompanied by increased 5hmC, but others have failed to confirm this finding. These analyses have relied on immuno-localization of these modifications. In this study we have established the conditions required for equilibrium binding of antibodies to 5meC and 5hmC in zygotes. Simultaneous detection of these antigens required denaturation of chromatin by acid treatment followed by antigen retrieval by tryptic digestion. Equilibrium binding then required incubation at 4 degrees C for greater than 6 h. These are more demanding conditions than generally reported and resulted in the consistent detection of 5meC and 5hmC in both male and female pronuclei throughout zygotic maturation. No dynamic reciprocal change in the level of 5meC relative to 5hmC was observed. Both 5meC and 5hmC accumulated within the peri-nucleolar regions and this was more pronounced in the male pronucleus. Staining of 5meC was relatively more intense within the cortical and 5hmC in the central regions of pronuclei. The results are not consistent with a role for 5hmC in global demethylation in the zygote. The persistence of both modifications throughout zygotic maturation, and their differing patterns of localization and solvent exposure infer each modification provides its own epigenetic information to the early embryo.	[Li, Yan; O'Neill, Chris] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Ctr Dev & Regenerat Med, Sydney, NSW 2006, Australia	University of Sydney; Kolling Institute of Medical Research	O'Neill, C (corresponding author), Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Ctr Dev & Regenerat Med, Sydney, NSW 2006, Australia.	chris.oneill@sydney.edu.au			Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by grants from the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot PG, 1997, DEVELOPMENT, V124, P4615; Auclair G, 2012, BIOCHIMIE, V94, P2202, DOI 10.1016/j.biochi.2012.05.016; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Beaujean N, 2004, BIOL REPROD, V71, P185, DOI 10.1095/biolreprod.103.026559; Beaujean N, 2004, P NATL ACAD SCI USA, V101, P7636, DOI 10.1073/pnas.0400730101; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo Junjie U, 2011, CELL, V145, P423; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Huang Y., 2010, PLOS ONE, V5; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030687; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; ONeill C, 1997, BIOL REPROD, V56, P229, DOI 10.1095/biolreprod56.1.229; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Polanski Z, 2008, INT J DEV BIOL, V52, P295, DOI 10.1387/ijdb.072347zp; Salvaing J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038156; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Shi W, 2004, BIOL REPROD, V71, P340, DOI 10.1095/biolreprod.103.024554; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	34	61	61	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63689	10.1371/journal.pone.0063689	http://dx.doi.org/10.1371/journal.pone.0063689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691085	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400074
J	Nguyen, GD; Gokhan, S; Molero, AE; Mehler, MF				Nguyen, Giang D.; Gokhan, Solen; Molero, Aldrin E.; Mehler, Mark F.			Selective Roles of Normal and Mutant Huntingtin in Neural Induction and Early Neurogenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NERVOUS-SYSTEM; CAG REPEATS; MOUSE MODEL; HES GENES; DISEASE; DIFFERENTIATION; PROMOTES; NEURODEGENERATION; INACTIVATION	Huntington's disease (HD) is a neurodegenerative disorder caused by abnormal polyglutamine expansion in the amino-terminal end of the huntingtin protein (Htt) and characterized by progressive striatal and cortical pathology. Previous reports have shown that Htt is essential for embryogenesis, and a recent study by our group revealed that the pathogenic form of Htt (mHtt) causes impairments in multiple stages of striatal development. In this study, we have examined whether HD-associated striatal developmental deficits are reflective of earlier maturational alterations occurring at the time of neurulation by assessing differential roles of Htt and mHtt during neural induction and early neurogenesis using an in vitro mouse embryonic stem cell (ESC) clonal assay system. We demonstrated that the loss of Htt in ESCs (KO ESCs) severely disrupts the specification of primitive and definitive neural stem cells (pNSCs, dNSCs, respectively) during the process of neural induction. In addition, clonally derived KO pNSCs and dNSCs displayed impaired proliferative potential, enhanced cell death and altered multi-lineage potential. Conversely, as observed in HD knock-in ESCs (Q111 ESCs), mHtt enhanced the number and size of pNSC clones, which exhibited enhanced proliferative potential and precocious neuronal differentiation. The transition from Q111 pNSCs to fibroblast growth factor 2 (FGF2)-responsive dNSCs was marked by potentiation in the number of dNSCs and altered proliferative potential. The multi-lineage potential of Q111 dNSCs was also enhanced with precocious neurogenesis and oligodendrocyte progenitor elaboration. The generation of Q111 epidermal growth factor (EGF)-responsive dNSCs was also compromised, whereas their multi-lineage potential was unaltered. These abnormalities in neural induction were associated with differential alterations in the expression profiles of Notch, Hes1 and Hes5. These cumulative observations indicate that Htt is required for multiple stages of neural induction, whereas mHtt enhances this process and promotes precocious neurogenesis and oligodendrocyte progenitor cell elaboration.	[Nguyen, Giang D.; Gokhan, Solen; Molero, Aldrin E.; Mehler, Mark F.] Albert Einstein Coll Med, Roslyn & Leslie Goldstein Lab Stem Cell Biol & Re, Bronx, NY 10467 USA; [Nguyen, Giang D.; Gokhan, Solen; Molero, Aldrin E.; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Bronx, NY 10467 USA; [Gokhan, Solen; Molero, Aldrin E.; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Nguyen, Giang D.; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Nguyen, Giang D.; Gokhan, Solen; Molero, Aldrin E.; Mehler, Mark F.] Albert Einstein Coll Med, Rose F Kennedy Ctr Res Intellectual & Dev Disabil, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Einstein Canc Ctr, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Ctr Epigen, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Mehler, MF (corresponding author), Albert Einstein Coll Med, Roslyn & Leslie Goldstein Lab Stem Cell Biol & Re, Bronx, NY 10467 USA.	mark.mehler@einstein.yu.edu	Molero, Aldrin/AAN-5240-2020	Molero, Aldrin/0000-0001-8250-1236	National Institutes of Health [NS071571, HD071593, MH66290]; F.M. Kirby Foundation; Alpern Family Foundation; Mildred and Bernard H. Kayden Foundation; Roslyn and Leslie Goldstein Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071571, R01NS073758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F.M. Kirby Foundation; Alpern Family Foundation; Mildred and Bernard H. Kayden Foundation; Roslyn and Leslie Goldstein Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M.F.M. is supported by grants from the National Institutes of Health (NS071571, HD071593, MH66290), as well as by the F.M. Kirby, Alpern Family, Mildred and Bernard H. Kayden and Roslyn and Leslie Goldstein Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAJANO JJ, 2009, PLOS ONE, V0004; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Batista CMC, 2006, J NEUROSCI, V26, P10452, DOI 10.1523/JNEUROSCI.2850-06.2006; Berrios GE, 2001, PSYCHIAT RES, V102, P217, DOI 10.1016/S0165-1781(01)00257-8; Braak H, 2009, ADV ANAT EMBRYOL CEL, V201, P1; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brandt J, 2002, J INT NEUROPSYCH SOC, V8, P918, DOI 10.1017/S1355617702870060; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Conforti P, 2013, NEUROBIOL DIS, V50, P160, DOI 10.1016/j.nbd.2012.10.015; Curtis MA, 2005, NEUROSCIENCE, V132, P777, DOI 10.1016/j.neuroscience.2004.12.051; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Curto M, 1998, BIOCHEM BIOPH RES CO, V243, P555, DOI 10.1006/bbrc.1997.7982; DOGAN I, 2012, NEURODEGENERATIVE DI; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Faux CH, 2001, J NEUROSCI, V21, P5587, DOI 10.1523/JNEUROSCI.21-15-05587.2001; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hatakeyama J, 2006, CEREB CORTEX, V16, pI132, DOI 10.1093/cercor/bhj166; Hitoshi S, 2004, GENE DEV, V18, P1806, DOI 10.1101/gad.1208404; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; Joshi PR, 2009, J NEUROSCI, V29, P2414, DOI 10.1523/JNEUROSCI.5687-08.2009; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kassubek J, 2004, NEUROLOGY, V62, P523, DOI 10.1212/WNL.62.3.523-a; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kennedy L, 2000, HUM MOL GENET, V9, P2539, DOI 10.1093/hmg/9.17.2539; Kobayashi T, 2010, GENES CELLS, V15, P689, DOI 10.1111/j.1365-2443.2010.01413.x; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorincz MT, 2009, MOL CELL NEUROSCI, V40, P1, DOI 10.1016/j.mcn.2008.06.004; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Marder K, 2012, NEUROLOGY, V79, P621, DOI 10.1212/WNL.0b013e3182648bfe; Mason HA, 2005, DEVELOPMENT, V132, P4247, DOI 10.1242/dev.02008; Milnerwood AJ, 2010, TRENDS NEUROSCI, V33, P513, DOI 10.1016/j.tins.2010.08.002; Molero AE, 2009, P NATL ACAD SCI USA, V106, P21900, DOI 10.1073/pnas.0912171106; Moores JN, 2008, EUR J NEUROSCI, V28, P599, DOI 10.1111/j.1460-9568.2008.06359.x; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; MYERS RH, 1991, J NEUROPATH EXP NEUR, V50, P729, DOI 10.1097/00005072-199111000-00005; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Ogata T, 2011, NEUROSCIENCE, V176, P132, DOI 10.1016/j.neuroscience.2010.12.015; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Paulsen JS, 2006, BIOL PSYCHIAT, V59, P57, DOI 10.1016/j.biopsych.2005.06.003; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Schippling S, 2009, BIOL PSYCHIAT, V65, P959, DOI 10.1016/j.biopsych.2008.12.026; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Woda JM, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-17; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	66	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64368	10.1371/journal.pone.0064368	http://dx.doi.org/10.1371/journal.pone.0064368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691206	gold, Green Submitted, Green Published			2022-12-25	WOS:000319107400123
J	Pezoa, D; Yang, HJ; Blondel, CJ; Santiviago, CA; Andrews-Polymenis, HL; Contreras, I				Pezoa, David; Yang, Hee-Jeong; Blondel, Carlos J.; Santiviago, Carlos A.; Andrews-Polymenis, Helene L.; Contreras, Ines			The Type VI Secretion System Encoded in SPI-6 Plays a Role in Gastrointestinal Colonization and Systemic Spread of Salmonella enterica serovar Typhimurium in the Chicken	PLOS ONE			English	Article							III SECRETION; PATHOGENICITY ISLAND-1; SEROTYPE TYPHIMURIUM; PATHOGENESIS; IDENTIFICATION; VIRULENCE; CONTRIBUTE; EFFECTOR; GENES; INVASION	The role of the Salmonella Pathogenicity Islands (SPIs) in pathogenesis of Salmonella enterica Typhimurium infection in the chicken is poorly studied, while many studies have been completed in murine models. The Type VI Secretion System (T6SS) is a recently described protein secretion system in Gram-negative bacteria. The genus Salmonella contains five phylogenetically distinct T6SS encoded in differentially distributed genomic islands. S. Typhimurium harbors a T6SS encoded in SPI-6 (T6SS(SPI-6)), which contributes to the ability of Salmonella to colonize mice. On the other hand, serotype Gallinarum harbors a T6SS encoded in SPI-19 (T6SS(SPI-19)) that is required for colonization of chicks. In this work, we investigated the role of T6SS(SPI-6) in infection of chicks by S. Typhimurium. Oral infection of White Leghorn chicks showed that a Delta T6SS(SPI-6) mutant had reduced colonization of the gut and internal organs, compared with the wild-type strain. Transfer of the intact T6SS(SPI-6) gene cluster into the T6SS mutant restored bacterial colonization. In addition, our results showed that transfer of T6SS(SPI-19) from S. Gallinarum to the Delta T6SS(SPI-6) mutant of S. Typhimurium not only complemented the colonization defect but also resulted in a transient increase in the colonization of the cecum and ileum of chicks at days 1 and 3 post-infection. Our data indicates that T6SS(SPI-6) contributes to chicken colonization and suggests that both T6SS(SPI-6) and T6SS(SPI-19) perform similar functions in vivo despite belonging to different phylogenetic families.	[Pezoa, David; Blondel, Carlos J.; Santiviago, Carlos A.; Contreras, Ines] Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Yang, Hee-Jeong; Andrews-Polymenis, Helene L.] Texas A&M Univ Syst Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, Coll Med, College Stn, TX USA	Universidad de Chile; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Andrews-Polymenis, HL (corresponding author), Texas A&M Univ Syst Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, Coll Med, College Stn, TX USA.	HAndrews@medicine.tamhsc.edu; icontrer@uchile.cl	Santiviago, Carlos/N-9991-2018; Blondel, Carlos/X-7380-2019; Blondel, Carlos J/B-1287-2010	Santiviago, Carlos/0000-0002-7043-7908; Blondel, Carlos/0000-0002-7099-6347; Blondel, Carlos J/0000-0002-7099-6347; Yang, Hee-Jeong/0000-0002-7351-8404	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile [1100092]; FONDECYT [3120175, 1110172]; FULBRIGHT; CONICYT [21090041, AT-21121297]; "Beca de Pasantias Doctorales en el Extranjero'' CHILE GRANT [75110062 BCH-3]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FULBRIGHT; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); "Beca de Pasantias Doctorales en el Extranjero'' CHILE GRANT	This work was supported by grant 1100092 from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile. CJB was supported by Postdoctoral Fellowship 3120175 from FONDECYT. David Pezoa was supported by fellowships from FULBRIGHT, "Beca Doctorado Nacional 2009'' CONICYT (No21090041), "Beca de Apoyo a la Realizacion de Tesis Doctoral 2012'' CONICYT (No AT-21121297) and from "Beca de Pasantias Doctorales en el Extranjero 2011'' CHILE GRANT (No75110062 BCH-3). CAS was supported by grant 1110172 from FONDECYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Blondel CJ, 2013, INFECT IMMUN, V81, P1207, DOI 10.1128/IAI.01165-12; Blondel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011724; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Brawn LC, 2007, CELL HOST MICROBE, V1, P63, DOI 10.1016/j.chom.2007.02.001; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Chan K, 2005, INFECT IMMUN, V73, P5438, DOI 10.1128/IAI.73.9.5438-5449.2005; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Pace F, 2010, INFECT IMMUN, V78, P4990, DOI 10.1128/IAI.00531-10; Dieye Y, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-3; Dorsey CW, 2005, MOL MICROBIOL, V57, P196, DOI 10.1111/j.1365-2958.2005.04666.x; Fookes M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002191; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Haneda T, 2009, FEMS MICROBIOL LETT, V297, P241, DOI 10.1111/j.1574-6968.2009.01686.x; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; House D, 2001, CURR OPIN INFECT DIS, V14, P573, DOI 10.1097/00001432-200110000-00011; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; Jones MA, 2007, AVIAN PATHOL, V36, P199, DOI 10.1080/03079450701264118; Klumpp J, 2007, MICROBIOL-SGM, V153, P1207, DOI 10.1099/mic.0.2006/004747-0; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Liu J, 2012, J BASIC MICROB, V52, P1; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Mulder DT, 2012, INFECT IMMUN, V80, P1996, DOI 10.1128/IAI.06205-11; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Porter SB, 1997, AVIAN DIS, V41, P45, DOI 10.2307/1592442; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Sivula CP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-182; Smith RL, 1998, MICROBIOL-SGM, V144, P1835, DOI 10.1099/00221287-144-7-1835; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Turner AK, 1998, INFECT IMMUN, V66, P2099, DOI 10.1128/IAI.66.5.2099-2106.1998; Wang M, 2011, CURR MICROBIOL, V63, P22, DOI 10.1007/s00284-011-9935-z; Wilson JW, 2004, J MICROBIOL METH, V57, P297, DOI 10.1016/j.mimet.2004.01.007; World Health Organization, WHO GLOB FOODB INF N	50	35	38	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63917	10.1371/journal.pone.0063917	http://dx.doi.org/10.1371/journal.pone.0063917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691117	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400086
J	Saeedi, H; Costello, MJ; von Cosel, R				Saeedi, Hanieh; Costello, Mark J.; von Cosel, Rudo			First Report of Anterior Pallial Tentacles in Solen dactylus (Bivalvia: Solenidae) from the Northern Persian Gulf, Iran	PLOS ONE			English	Article							COAST	Solenidae are deep burrowing bivalves inhabiting intertidal and shallow sub-tidal soft bottom sediments mostly in tropical and sub-tropical areas. Solen dactylus has a restricted distribution within the Indian Ocean. Solen dactylus is frequently found on the sandy-muddy coast of the northern Persian Gulf, Iran. Specimens of S. dactylus were collected since 2006 from Bandar Abbas to study their biology and ecology. During these studies, an unexpected pair of anterior pallial tentacles at the dorsal end of the anterior pallial crest of the mantle was found. In the tentacles, two kinds of epithelial cells (pyramidal and vacuolated) and fibres (radial and longitudinal), and a branch of the pallial nerve located in the centre of a haemocoel, were determined. A possible coherence of a furrow parallel to the anterior shell margin with the presence of anterior pallial tentacles is discussed. All species with long anterior pallial tentacles have anterior shell furrows. Anterior pallial tentacles were found in 10 species of Solenidae from Asia to the Middle East and Europe. The function of the tentacles is unknown. However, more species need to be examined for anterior pallial tentacles and anterior shell furrows to determine if they reflect a common evolutionary history or ecology.	[Saeedi, Hanieh; Costello, Mark J.] Univ Auckland, Inst Marine Sci, Auckland 1, New Zealand; [von Cosel, Rudo] Museum Natl Hist Nat, F-75231 Paris, France	University of Auckland; Museum National d'Histoire Naturelle (MNHN)	Saeedi, H (corresponding author), Univ Auckland, Inst Marine Sci, Auckland 1, New Zealand.	hsae002@aucklanduni.ac.nz	Costello, Mark/C-9267-2013; Saeedi, Hanieh/AAD-9374-2020	Costello, Mark/0000-0003-2362-0328; 	New Zealand International Doctoral Research Scholarship (NZIDRS); University of Auckland	New Zealand International Doctoral Research Scholarship (NZIDRS); University of Auckland	HS was supported by a New Zealand International Doctoral Research Scholarship (NZIDRS) and the University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSCH D, 1982, SEA SHELLS OMAN; Bouchet P, 2012, SOLENIDAE; Cosel R von, 2002, COLLECTANEA MALACOLO; Guerra A., 2011, RAZOR CLAMS BIOL AQU; MORTON B, 1988, J MOLLUS STUD, V54, P135, DOI 10.1093/mollus/54.1.135; Oliver, 1995, SEA SHELLS E ARABIA, P196; Saeedi H, 2012, IRAN J FISH SCI, V11, P165; Saeedi H., 2011, J PERSIAN GULF, V2, P13; Saeedi H, 2009, J MAR BIOL ASSOC UK, V89, P1635, DOI 10.1017/S0025315409000964; Simone LRL, 2009, ARCH MOLLUSKENKD, V138, P113, DOI 10.1127/arch.moll/1869-0963/138/113-122; Veeravaitaya N, 2010, THESIS MAHIDOL U BAN; von Cosel R., 1993, Archiv fuer Molluskenkunde, V122, P207; von Cosel R, 1990, BIVALVIA; VONCOSEL R, 1989, J CONCHOL, V33, P189	14	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63487	10.1371/journal.pone.0063487	http://dx.doi.org/10.1371/journal.pone.0063487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691053	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400066
J	von Ossowski, I; Pietila, TE; Rintahaka, J; Nummenmaa, E; Makinen, VM; Reunanen, J; Satokari, R; de Vos, WM; Palva, I; Palva, A				von Ossowski, Ingemar; Pietila, Taija E.; Rintahaka, Johanna; Nummenmaa, Elina; Makinen, Veli-Matti; Reunanen, Justus; Satokari, Reetta; de Vos, Willem M.; Palva, Ilkka; Palva, Airi			Using Recombinant Lactococci as an Approach to Dissect the Immunomodulating Capacity of Surface Piliation in Probiotic Lactobacillus rhamnosus GG	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; FUNCTIONAL-ANALYSIS; DENDRITIC CELLS; PROTEIN; ADHESION; PILI; STREPTOCOCCUS; COLONIZATION; PERSISTENCE; MECHANISMS	Primarily arising from their well understood beneficial health effects, many lactobacilli strains are considered good candidates for use as probiotics in humans and animals. Lactobacillar probiosis can itself be best typified by the Lactobacillus rhamnosus GG strain, which, with its well-documented clinical benefits, has emerged as one of the most widely used probiotics in the food and health-supplement industries. Even so, many facets of its molecular mechanisms and limitations as a beneficial commensal bacterium still remain to be thoroughly explored and dissected. Because L. rhamnosus GG is one of only a few such strains exhibiting surface piliation (called SpaCBA), we sought to examine whether this particular type of cell-surface appendage has a discernible immunomodulating capacity and is able to trigger targeted responses in human immune-related cells. Thus, presented herein for this study, we recombinantly engineered Lactococcus lactis to produce native (and pilin-deleted) SpaCBA pili that were assembled in a structurally authentic form and anchored to the cell surface, and which had retained mucus-binding functionality. By using these recombinant lactococcal constructs, we were able to demonstrate that the SpaCBA pilus can be a contributory factor in the activation of Toll-like receptor 2-dependent signaling in HEK cells as well as in the modulation of pro- and anti-inflammatory cytokine (TNF-alpha, IL-6, IL-10, and IL-12) production in human monocyte-derived dendritic cells. From these data, we suggest that the recombinant-expressed and surface-anchored SpaCBA pilus, given its projected functioning in the gut environment, might be viewed as a new microbe-associated molecular pattern (MAMP)-like modulator of innate immunity. Accordingly, our study has brought some new insight to the molecular immunogenicity of the SpaCBA pilus, thus opening the way to a better understanding of its possible role in the multifaceted nature of L. rhamnosus GG probiosis within the human gut.	[von Ossowski, Ingemar; Pietila, Taija E.; Rintahaka, Johanna; Nummenmaa, Elina; Makinen, Veli-Matti; Reunanen, Justus; Satokari, Reetta; de Vos, Willem M.; Palva, Ilkka; Palva, Airi] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Satokari, Reetta] Univ Turku, Turku, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [de Vos, Willem M.] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland	University of Helsinki; University of Turku; Wageningen University & Research; University of Helsinki	von Ossowski, I (corresponding author), Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland.	ingemar.von.ossowski@helsinki.fi; airi.palva@helsinki.fi	Satokari, Reetta/C-4782-2011	von Ossowski, Ingemar Eric/0000-0002-9899-671X; Nummenmaa, Elina/0000-0001-7041-2375; Satokari, Reetta/0000-0002-4258-3414	Academy of Finland [141140, 137389]; Faculty of Veterinary Medicine (University of Helsinki); European Research Council [250172]	Academy of Finland(Academy of Finland); Faculty of Veterinary Medicine (University of Helsinki); European Research Council(European Research Council (ERC)European Commission)	This study, including some salary costs of the AP team, was financed by the Academy of Finland-funded Center of Excellence in Microbial Food Safety (CoE-MiFoSa) research program (141140) (http://www.aka.fi), as well as partly by budget funding from the Faculty of Veterinary Medicine (University of Helsinki; http://www.helsinki.fi/university/index.html) and by a European Research Council grant (250172). Salary funding to WMdV was through an Academy of Finland Professorship (137389). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alander M, 1999, APPL ENVIRON MICROB, V65, P351; Bahey-El-Din M, 2010, CURR GENE THER, V10, P34, DOI 10.2174/156652310790945557; Basset A, 2013, J BIOL CHEM, V288, P2665, DOI 10.1074/jbc.M112.398875; Bermudez-Brito M, 2012, ANN NUTR METAB, V61, P160, DOI 10.1159/000342079; Bonetti Antonella, 2002, Microbial Ecology in Health and Disease, V14, P228, DOI 10.1080/08910600310002118; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Claes IJJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-161; Claes IJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031588; Danne C, 2012, RES MICROBIOL, V163, P645, DOI 10.1016/j.resmic.2012.10.012; De Champs C, 2003, J CLIN MICROBIOL, V41, P1270, DOI 10.1128/JCM.41.3.1270-1273.2003; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Dicks LMT, 2010, BENEF MICROBES, V1, P11, DOI 10.3920/BM2009.0012; Doron S, 2005, GASTROENTEROL CLIN N, V34, P483, DOI 10.1016/j.gtc.2005.05.011; Doron Shira, 2006, Expert Rev Anti Infect Ther, V4, P261, DOI 10.1586/14787210.4.2.261; Douillard FP, 2013, APPL ENVIRON MICROB, V79, P1923, DOI 10.1128/AEM.03467-12; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Garcia-Fruitos E, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-157; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kelly D, 2012, NUTR REV, V70, pS18, DOI 10.1111/j.1753-4887.2012.00498.x; Kosaka A, 2012, INT IMMUNOPHARMACOL, V14, P729, DOI 10.1016/j.intimp.2012.10.007; Latvala S, 2008, WORLD J GASTROENTERO, V14, P5570, DOI 10.3748/wjg.14.5570; Lavelle EC, 2010, MUCOSAL IMMUNOL, V3, P17, DOI 10.1038/mi.2009.124; Lebeer S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-15; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2011, MICROB BIOTECHNOL, V4, P368, DOI 10.1111/j.1751-7915.2010.00199.x; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; Ouwehand AC, 2002, CLIN DIAGN LAB IMMUN, V9, P184, DOI 10.1128/CDLI.9.1.184-186.2002; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Quigley BR, 2010, INFECT IMMUN, V78, P1294, DOI 10.1128/IAI.01037-09; Rajput IR, 2012, PAK VET J, V32, P303; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Salminen S, 2010, CURR OPIN BIOTECH, V21, P157, DOI 10.1016/j.copbio.2010.03.016; Schmidt SV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00274; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P3189, DOI 10.1128/AEM.70.6.3189-3194.2004; Tsai YT, 2012, APPL MICROBIOL BIOT, V96, P853, DOI 10.1007/s00253-012-4407-3; Veckman V, 2004, J LEUKOCYTE BIOL, V75, P764, DOI 10.1189/jlb.1003461; Velez MP, 2010, FEMS IMMUNOL MED MIC, V59, P386, DOI 10.1111/j.1574-695X.2010.00680.x; Vesterlund S, 2005, J MICROBIOL METH, V60, P225, DOI 10.1016/j.mimet.2004.09.013; von Ossowski I, 2011, APPL ENVIRON MICROB, V77, P4465, DOI 10.1128/AEM.02497-10; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; Wall R, 2007, FEMS MICROBIOL ECOL, V59, P127, DOI 10.1111/j.1574-6941.2006.00202.x; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Yebra MJ, 2012, FOOD INDUSTRIAL PROCESSES - METHODS AND EQUIPMENT, P143	53	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64416	10.1371/journal.pone.0064416	http://dx.doi.org/10.1371/journal.pone.0064416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691212	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400124
J	Wickert, LE; Blanchette, JB; Waldschmidt, NV; Bertics, PJ; Denu, JM; Denlinger, LC; Lenertz, LY				Wickert, Lisa E.; Blanchette, Joshua B.; Waldschmidt, Noelle V.; Bertics, Paul J.; Denu, John M.; Denlinger, Loren C.; Lenertz, Lisa Y.			The C-Terminus of Human Nucleotide Receptor P2X7 Is Critical for Receptor Oligomerization and N-Linked Glycosylation	PLOS ONE			English	Article							DELTA-FOSB STABILITY; P2X(7) RECEPTOR; ENDOPLASMIC-RETICULUM; TRAFFICKING; CELLS; LIPOPOLYSACCHARIDE; IDENTIFICATION; TRANSCRIPTION; MECHANISMS; COMPLEXES	Background: The P2X(7) receptor binds extracellular ATP to mediate numerous inflammatory responses and is considered a potential biomarker and therapeutic target for diverse inflammatory and neurological diseases. P2X(7) contains many single nucleotide polymorphisms, including several mutations located within its intracellular C-terminal trafficking domain. Mutations within the trafficking domain result in attenuated receptor activity and cell surface presentation, but the mechanisms by which amino acid changes within this region promote altered P2X(7) function have not been elucidated. Methods and Results: We analyzed the amino acid sequence of P2X(7) for any potential trafficking signals and found that P2X(7) contains putative Arg-X-Arg ER retention sequences. Alanine substitutions near or within these sequences were constructed, and we determined that single mutation of R574 and R578 but not R576 or K579 attenuates P2X(7)-stimulated activation of ERK1/2 and induction of the transcription factors Delta FosB and DFosB. We found that mutation of R578 within the trafficking domain to the naturally occurring Gln substitution disrupts P2X(7) localization at the plasma membrane and results in R578Q displaying a higher apparent molecular weight in comparison to wild-type receptor. We used the glycosidase endoglycosidase H to determine that this difference in mass is due in part to the R578Q mutant possessing a larger mass of oligosaccharides, indicative of improper N-linked glycosylation addition and/or trimming. Chemical cross-linking experiments were also performed and suggest that the R578Q variant also does not form trimers as well as wild-type receptor, a function required for its full activity. Conclusions: These data demonstrate the distal C-terminus of P2X(7) is important for oligomerization and post-translational modification of the receptor, providing a mechanism by which mutations in the trafficking domain disrupt P2X(7) activity and localization at the plasma membrane.	[Wickert, Lisa E.; Blanchette, Joshua B.; Bertics, Paul J.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA; [Denlinger, Loren C.] Univ Wisconsin, Dept Med, Madison, WI USA; [Waldschmidt, Noelle V.; Lenertz, Lisa Y.] St Olaf Coll, Dept Biol, Northfield, MN 55057 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Saint Olaf College	Lenertz, LY (corresponding author), St Olaf Coll, Dept Biol, Northfield, MN 55057 USA.	lenertz@stolaf.edu			NIH [5 P01 HL088594]; Hartwell Foundation; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant 5 P01 HL088594 and postdoctoral fellowships from The Hartwell Foundation and the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boumechache M, 2009, J BIOL CHEM, V284, P13446, DOI 10.1074/jbc.M901255200; Bradley HJ, 2010, FEBS LETT, V584, P4740, DOI 10.1016/j.febslet.2010.11.007; Carle TL, 2007, EUR J NEUROSCI, V25, P3009, DOI 10.1111/j.1460-9568.2007.05575.x; Denlinger LC, 2005, J IMMUNOL, V174, P4424, DOI 10.4049/jimmunol.174.7.4424; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Denlinger LC, 2001, J IMMUNOL, V167, P1871, DOI 10.4049/jimmunol.167.4.1871; Denlinger LC, 2006, CLIN CHEM, V52, P995, DOI 10.1373/clinchem.2005.065425; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Garcia-Huerta P, 2012, J BIOL CHEM, V287, P44628, DOI 10.1074/jbc.M112.390971; Gavala ML, 2010, J BIOL CHEM, V285, P34288, DOI 10.1074/jbc.M110.142091; GRUNBERG J, 1995, ARCH BIOCHEM BIOPHYS, V323, P367, DOI 10.1006/abbi.1995.9952; Gunosewoyo H, 2010, EXPERT OPIN THER PAT, V20, P625, DOI 10.1517/13543771003702424; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Lenertz LY, 2011, IMMUNOL RES, V50, P22, DOI 10.1007/s12026-011-8203-4; Lenertz LY, 2010, BIOCHEMISTRY-US, V49, P4611, DOI 10.1021/bi902083n; Lenertz LY, 2009, PURINERG SIGNAL, V5, P175, DOI 10.1007/s11302-009-9133-7; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Nicke A, 2008, BIOCHEM BIOPH RES CO, V377, P803, DOI 10.1016/j.bbrc.2008.10.042; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Romagnoli R, 2008, EXPERT OPIN THER TAR, V12, P647, DOI 10.1517/14728222.12.5.647 ; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Ulery PG, 2006, J NEUROSCI, V26, P5131, DOI 10.1523/JNEUROSCI.4970-05.2006; Van Craenenbroeck Kathleen, 2012, Subcell Biochem, V63, P43, DOI 10.1007/978-94-007-4765-4_3; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200	27	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63789	10.1371/journal.pone.0063789	http://dx.doi.org/10.1371/journal.pone.0063789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691096	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400078
J	Zhang, B; Choi, JJ; Eum, SY; Daunert, S; Toborek, M				Zhang, Bei; Choi, Jeong June; Eum, Sung Yong; Daunert, Sylvia; Toborek, Michal			TLR4 Signaling Is Involved in Brain Vascular Toxicity of PCB153 Bound to Nanoparticles	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS PCBS; ENDOTHELIAL-CELL LINE; GENE-EXPRESSION; OCCLUDIN PHOSPHORYLATION; EXPERIMENTAL STROKE; ADHESION MOLECULES; UP-REGULATION; INFLAMMATION; RECEPTOR; PERMEABILITY	PCBs bind to environmental particles; however, potential toxicity exhibited by such complexes is not well understood. The aim of the present study is to study the hypothesis that assembling onto nanoparticles can influence the PCB153-induced brain endothelial toxicity via interaction with the toll-like receptor 4 (TLR4). To address this hypothesis, TLR4-deficient and wild type control mice (males, 10 week old) were exposed to PCB153 (5 ng/g body weight) bound to chemically inert silica nanoparticles (PCB153-NPs), PCB153 alone, silica nanoparticles (NPs; diameter, 20 nm), or vehicle. Selected animals were also subjected to 40 min ischemia, followed by a 24 h reperfusion. As compared to exposure to PCB153 alone, treatment with PCB153-NP potentiated the brain infarct volume in control mice. Importantly, this effect was attenuated in TLR4-deficient mice. Similarly, PCB153-NP-induced proinflammatory responses and disruption of tight junction integrity were less pronounced in TLR4-deficient mice as compared to control animals. Additional in vitro experiments revealed that TLR4 mediates toxicity of PCB153-NP via recruitment of tumor necrosis factor-associated factor 6 (TRAF6). The results of current study indicate that binding to seemingly inert nanoparticles increase cerebrovascular toxicity of PCBs and suggest that targeting the TLR4/TRAF6 signaling may protect against these effects.	[Zhang, Bei] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY USA; [Zhang, Bei; Choi, Jeong June; Eum, Sung Yong; Daunert, Sylvia; Toborek, Michal] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33152 USA	University of Kentucky; University of Miami	Toborek, M (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33152 USA.	mtoborek@med.miami.edu			National Institutes of Health (NIH) [ES07380, CA133257, MH63022, MH072567, DA027569]; NATIONAL CANCER INSTITUTE [R01CA133257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072567, R01MH063022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027569] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the grants from the National Institutes of Health (NIH) ES07380, CA133257, MH63022, MH072567, and DA027569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salman F, 2012, TOXICOL APPL PHARM, V263, P7, DOI 10.1016/j.taap.2012.05.016; Arslan F, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/704202; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chen GY, 2012, BIOMATERIALS, V33, P6559, DOI 10.1016/j.biomaterials.2012.05.064; Chen L, 2012, NANOMEDICINE; Chen L, 2009, J NEUROSCI RES, V87, P1718, DOI 10.1002/jnr.21973; Choi JJ, 2012, TOXICOLOGY; Chrysikou LP, 2009, ATMOS ENVIRON, V43, P290, DOI 10.1016/j.atmosenv.2008.09.048; DETMERS PA, 1990, J EXP MED, V171, P1155, DOI 10.1084/jem.171.4.1155; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eum SY, 2006, TOXICOL SCI, V92, P311, DOI 10.1093/toxsci/kfj194; Eum SY, 2006, MOL CANCER RES, V4, P361, DOI 10.1158/1541-7786.MCR-05-0119; Eum SY, 2009, TOXICOL APPL PHARM, V240, P299, DOI 10.1016/j.taap.2009.07.022; Eum SY, 2004, EXP CELL RES, V296, P231, DOI 10.1016/j.yexcr.2004.01.030; Fu S, 2009, CHEMOSPHERE, V74, P1477, DOI 10.1016/j.chemosphere.2008.11.051; Goncharov A, 2010, J HYPERTENS, V28, P2053, DOI 10.1097/HJH.0b013e32833c5f3e; HALSALL CJ, 1995, ENVIRON SCI TECHNOL, V29, P2368, DOI 10.1021/es00009a032; Hansen LG, 1998, ENVIRON HEALTH PERSP, V106, P171, DOI 10.2307/3433919; Hatcher Martin JM, 2012, NEUROTOXICOLOGY; Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200; Huang W, 2011, FASEB J, V25, P3979, DOI 10.1096/fj.11-188607; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Johnson JYM, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-87; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kimbrough RD, 1989, BACKGROUND LEVELS HU, P345; Konat J, 2001, SCI TOTAL ENVIRON, V280, P1, DOI 10.1016/S0048-9697(01)00785-9; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee YW, 2004, MOL MED, V10, P19, DOI 10.2119/2004-00024.Lee; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lind L, 2012, J INTERN MED, V271, P537, DOI 10.1111/j.1365-2796.2012.02536.x; Mandel I, 2012, J CELL BIOCHEM, V113, P2415, DOI 10.1002/jcb.24118; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; Mukaida N, 1998, CYTOKINE GROWTH F R, V9, P9, DOI 10.1016/S1359-6101(97)00022-1; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Nagyoszi P, 2010, NEUROCHEM INT, V57, P556, DOI 10.1016/j.neuint.2010.07.002; Norstrom K, 2010, ENVIRON INT, V36, P855, DOI 10.1016/j.envint.2009.03.005; Orion D, 2008, EUR J NEUROL, V15, P323, DOI 10.1111/j.1468-1331.2008.02066.x; PACCAUD JP, 1990, BIOCHEM BIOPH RES CO, V166, P187, DOI 10.1016/0006-291X(90)91929-M; Pessah IN, 2010, PHARMACOL THERAPEUT, V125, P260, DOI 10.1016/j.pharmthera.2009.10.009; Rhee JW, 2007, J BIOCHEM MOL BIOL, V40, P88; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Roberts JW, 1995, REV ENVIRON CONTA<D>, V143, P59; ROGAN WJ, 1988, SCIENCE, V241, P334, DOI 10.1126/science.3133768; Sawa Y, 2008, J HISTOCHEM CYTOCHEM, V56, P97, DOI 10.1369/jhc.7A7299.2007; Seelbach M, 2010, ENVIRON HEALTH PERSP, V118, P479, DOI 10.1289/ehp.0901334; Shcherbatykh Ivan, 2005, Environ Health, V4, P18, DOI 10.1186/1476-069X-4-18; Silverstone AE, 2012, ENVIRON HEALTH PERSP, V120, P727, DOI 10.1289/ehp.1104247; Singh AK, 2004, TOXICOLOGY, V201, P197, DOI 10.1016/j.tox.2004.04.015; Sipka S, 2008, ENVIRON TOXICOL PHAR, V25, P251, DOI 10.1016/j.etap.2007.10.020; Sipos E, 2012, TOXICOL SCI, V126, P362, DOI 10.1093/toxsci/kfr349; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; Takeda K, 2007, CURR PROTOC IMMUNOL; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; THELEN M, 1988, FASEB J, V2, P2702, DOI 10.1096/fasebj.2.11.2840318; Wassermann M, 1979, Ann N Y Acad Sci, V320, P69; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wong PW, 1996, MOL PHARMACOL, V49, P740; YOSHIMURA T, 1987, J IMMUNOL, V139, P788; Younglai EV, 2002, ARCH ENVIRON CON TOX, V43, P121, DOI 10.1007/s00244-001-0048-8; Zhang B, 2012, J NEUROIMMUNE PHARM; Zhang B, 2012, J NEUROIMMUNE PHARM, V7, P991, DOI 10.1007/s11481-012-9403-y; Zhang B, 2010, J NEUROSCI RES, V88, P2859, DOI 10.1002/jnr.22450; Zhou H, 2009, J IMMUNOL, V183, P5244, DOI 10.4049/jimmunol.0901309; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	67	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63159	10.1371/journal.pone.0063159	http://dx.doi.org/10.1371/journal.pone.0063159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690990	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107400033
J	Zhang, M; Yu, H; Yang, YY; Song, C; Hu, XJ; Zhang, GR				Zhang, Min; Yu, Hao; Yang, Yanyan; Song, Chao; Hu, Xinjun; Zhang, Guren			Analysis of the Transcriptome of Blowfly Chrysomya megacephala (Fabricius) Larvae in Responses to Different Edible Oils	PLOS ONE			English	Article							DIPTERA CALLIPHORIDAE; GENE-EXPRESSION; FATTY-ACIDS; BODY; TEMPERATURE; GENOME; TOOL	Background: Chrysomya megacephala (Fabricius), a prevalent necrophagous blowfly that is easily mass reared, is noted for being a mechanical vector of pathogenic microorganisms, a pollinator of numerous crops, and a resource insect in forensic investigation in the postmortem interval. In the present study, in order to comprehensively understand the physiological and biochemical functions of C. megacephala, we performed RNA-sequencing and digital gene expression (DGE) profiling using Solexa/Illumina sequencing technology. Methodology/Principal Findings: A total of 39,098,662 clean reads were assembled into 27,588 unigenes with a mean length of 768 nt. All unigenes were searched against the Nt database, Nr database, Swiss-Prot, Cluster of Orthologous Groups (COG) and Kyoto Encyclopedia of Genes and Genome (KEGG) with the BLASTn or BLASTx algorithm (E-value<0.00001) for annotations. In total, 7,081 unigenes and 14,099 unigenes were functionally classified into 25 COG categories and 240 KEGG pathways, respectively. Furthermore, 20,216 unigenes were grouped into 48 sub-categories belonging to 3 main Gene Ontology (GO) categories (ontologies). Using the transcriptome data as references, we analyzed the differential gene expressions between a soybean oil-fed group (SOF) and a lard oil-fed group (LOF), compared to the negative control group (NC), using the DGE approach. We finally obtained 1,566 differentially expressed genes in SOF/NC, and 1,099 genes in LOF/NC. For further analysis, GO and KEGG functional enrichment were performed on all differentially expressed genes, and a group of differentially expressed candidate genes related to lipometabolism were identified. Conclusions/Significance: This study provides a global survey of C. megacephala and provides the basis for further research on the functional genomics of this insect.	[Zhang, Min; Yu, Hao; Yang, Yanyan; Song, Chao; Hu, Xinjun; Zhang, Guren] Sun Yat Sen Univ, Inst Entomol, State Key Lab Biol Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, GR (corresponding author), Sun Yat Sen Univ, Inst Entomol, State Key Lab Biol Control, Guangzhou 510275, Guangdong, Peoples R China.	zhanggr@mail.sysu.edu.cn		Zhang, Min/0000-0002-1362-0984	973 Program [2013CB127602]; Fundamental Research Funds for the Central Universities [3165004]	973 Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding for this study was provided jointly by the 973 Program (2013CB127602) and the Fundamental Research Funds for the Central Universities (3165004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baer B, 2001, P NATL ACAD SCI USA, V98, P3926, DOI 10.1073/pnas.061027998; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Batcabe JP, 2000, ARCH INSECT BIOCHEM, V44, P112, DOI 10.1002/1520-6327(200007)44:3&lt;112::AID-ARCH2&gt;3.0.CO;2-L; Bauerfeind SS, 2007, J INSECT PHYSIOL, V53, P964, DOI 10.1016/j.jinsphys.2007.01.013; Benjamini Y, 2001, ANN STAT, V29, P1165; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; CATTS EP, 1992, ANNU REV ENTOMOL, V37, P253, DOI 10.1146/annurev.en.37.010192.001345; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Fougeron AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026899; Gonzalez MS, 1999, LIPIDS, V34, P1199, DOI 10.1007/s11745-999-0472-7; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hood-Nowotny R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045222; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Li XJ, 2012, ANIM GENET, V43, P144, DOI 10.1111/j.1365-2052.2011.02240.x; Li ZX, 2012, APPL ENERG, V94, P349, DOI 10.1016/j.apenergy.2012.01.068; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahat NA, 2012, TROP BIOMED, V29, P9; Martinez-Sanchez A, 2001, PAN-PAC ENTOMOL, V77, P240; Merkey AB, 2011, J INSECT PHYSIOL, V57, P1437, DOI 10.1016/j.jinsphys.2011.07.013; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Olea MS, 2011, FLA ENTOMOL, V94, P345, DOI 10.1653/024.094.0231; Overgaard J, 2008, J INSECT PHYSIOL, V54, P619, DOI 10.1016/j.jinsphys.2007.12.011; Reigada C, 2005, NEOTROP ENTOMOL, V34, P163, DOI 10.1590/S1519-566X2005000200003; Sing KW, 2012, ANIM NUTR FEED TECHN, V12, P35; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Sung I-Hsin, 2006, Formosan Entomologist, V26, P161; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tomberlin JK, 2001, FLA ENTOMOL, V84, P300, DOI 10.2307/3496184; Ueyama M, 2005, INSECT BIOCHEM MOLEC, V35, P911, DOI 10.1016/j.ibmb.2005.03.007; Ujvari B, 2009, COMP BIOCHEM PHYS A, V154, P383, DOI 10.1016/j.cbpa.2009.07.012; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yang ST, 2012, J MED ENTOMOL, V49, P424, DOI 10.1603/ME11133; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	46	13	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e63168	10.1371/journal.pone.0063168	http://dx.doi.org/10.1371/journal.pone.0063168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23690992	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107400034
J	Canuel, M; Sun, XW; Asselin, MC; Paramithiotis, E; Prat, A; Seidah, NG				Canuel, Maryssa; Sun, Xiaowei; Asselin, Marie-Claude; Paramithiotis, Eustache; Prat, Annik; Seidah, Nabil G.			Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Can Mediate Degradation of the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1)	PLOS ONE			English	Article							LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; SECRETED PCSK9; CHOLESTEROL; MUTATIONS; BINDING; EXPRESSION; DECREASES; APOPTOSIS; CLEAVAGE	Elevated LDL-cholesterol (LDLc) levels are a major risk factor for cardiovascular disease and atherosclerosis. LDLc is cleared from circulation by the LDL receptor (LDLR). Proprotein convertase subtilisin/kexin 9 (PCSK9) enhances the degradation of the LDLR in endosomes/lysosomes, resulting in increased circulating LDLc. PCSK9 can also mediate the degradation of LDLR lacking its cytosolic tail, suggesting the presence of as yet undefined lysosomal-targeting factor(s). Herein, we confirm this, and also eliminate a role for the transmembrane-domain of the LDLR in mediating its PCSK9-induced internalization and degradation. Recent findings from our laboratory also suggest a role for PCSK9 in enhancing tumor metastasis. We show herein that while the LDLR is insensitive to PCSK9 in murine B16F1 melanoma cells, PCSK9 is able to induce degradation of the low density lipoprotein receptor-related protein 1 (LRP-1), suggesting distinct targeting mechanisms for these receptors. Furthermore, PCSK9 is still capable of acting upon the LDLR in CHO 13-5-1 cells lacking LRP-1. Conversely, PCSK9 also acts on LRP-1 in the absence of the LDLR in CHO-A7 cells, where re-introduction of the LDLR leads to reduced PCSK9-mediated degradation of LRP-1. Thus, while PCSK9 is capable of inducing degradation of LRP-1, the latter is not an essential factor for LDLR regulation, but the LDLR effectively competes with LRP-1 for PCSK9 activity. Identification of PCSK9 targets should allow a better understanding of the consequences of PCSK9 inhibition for lowering LDLc and tumor metastasis.	[Canuel, Maryssa; Sun, Xiaowei; Asselin, Marie-Claude; Prat, Annik; Seidah, Nabil G.] Univ Montreal, Biochem Neuroendocrinol Lab, Clin Res Inst Montreal, Montreal, PQ, Canada; [Paramithiotis, Eustache] Caprion Proteom Inc, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Seidah, NG (corresponding author), Univ Montreal, Biochem Neuroendocrinol Lab, Clin Res Inst Montreal, Montreal, PQ, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013; Prat, Annik/S-6757-2018	Seidah, Nabil/0000-0001-6503-9342; Prat, Annik/0000-0002-8007-5277	CIHR [MOP-102741, CTP-82946]; Strauss Foundation; Canada Chair [216684]; Canadian Heart and Stroke Research Fellowship Award	CIHR(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair; Canadian Heart and Stroke Research Fellowship Award	This research was supported by CIHR grants MOP-102741 and CTP-82946, a Strauss Foundation grant, and a Canada Chair #216684. MC was supported by a Canadian Heart and Stroke Research Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Boucher P, 2011, BIOCHEM PHARMACOL, V81, P1, DOI 10.1016/j.bcp.2010.09.018; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; FITZGERALD DJ, 1995, J CELL BIOL, V129, P1533, DOI 10.1083/jcb.129.6.1533; Franchini M, 2011, CLIN CHEM LAB MED, V49, P967, DOI 10.1515/CCLM.2011.154; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; JANG A, 1991, CLIN EXP METASTAS, V9, P393, DOI 10.1007/BF01769358; Jehle AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/jcb.200601030; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Kysenius K, 2012, CELL MOL LIFE SCI, V69, P1903, DOI 10.1007/s00018-012-0977-6; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Langlois B, 2009, PATHOL BIOL, V57, P548, DOI 10.1016/j.patbio.2008.07.015; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Luna Saavedra YG, 2012, J BIOL CHEM; Marduel M, 2013, HUM MUTAT, V34, P83, DOI 10.1002/humu.22215; Martin SS, 2012, MED CLIN N AM, V96, P13, DOI 10.1016/j.mcna.2012.01.009; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Sun XW, 2012, NEOPLASIA, V14, P1122, DOI 10.1593/neo.121252; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Willnow TE, 1999, J MOL MED-JMM, V77, P306, DOI 10.1007/s001090050356; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	50	149	155	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e64145	10.1371/journal.pone.0064145	http://dx.doi.org/10.1371/journal.pone.0064145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675525	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100058
J	Du, X; Zhu, YJ; Song, Y; Li, TM; Luo, T; Sun, G; Yang, CG; Cao, CM; Lu, Y; Li, M				Du, Xin; Zhu, Yuanjun; Song, Yan; Li, Tianming; Luo, Tao; Sun, Gang; Yang, Chongguang; Cao, Cuiming; Lu, Yuan; Li, Min			Molecular Analysis of Staphylococcus epidermidis Strains Isolated from Community and Hospital Environments in China	PLOS ONE			English	Article							CATABOLIC MOBILE ELEMENT; COAGULASE-NEGATIVE STAPHYLOCOCCI; ACME-ARCA GENE; METHICILLIN-RESISTANT; ANTIMICROBIAL RESISTANCE; BIOFILM FORMATION; AUREUS; SEQUENCE; MEC; INFECTIONS	Background: Staphylococcus epidermidis is a common cause of nosocomial infections worldwide. This study analyzed the differences in genetic endowment and clonal lineages with pathogenesis and resistance traits of S. epidermidis isolates collected from community and hospital environments (patients and healthcare staff) of the same ecological niche, time period, and geographical location in China. Methodology/Principal Findings: Molecular epidemiology and population analysis showed that nasal colonization rates of S. epidermidis in the community of Shanghai area of China and in healthcare personnel were 44.8% (methicillin-resistant S. epidermidis, MRSE: 17.2%) and 61.3% (MRSE: 30.0%), respectively. 86.7% of clinical isolates were MRSE. Among the strains studied, 44 sequence types (STs) were identified with 91.7% belonging to clonal complex 2 (CC2). Only 40.8% isolates from patients were also found in healthy individuals. MRSE-ST2-SCCmecIII was the predominant clone in clinical isolates, almost resistant to all antibiotics tested. Biofilm-related genes IS256 and icaA were detected in majority of the predominant clinical MRSE-ST2 clone with a 40.5% biofilm-positive rate. No ST2 isolate was found in community setting. We found a high prevalence of arginine catabolic mobile element (ACME) (74.1%). The prevalence of ACME-arc and ACME-opp3 clusters was 71.6% and 32.4%, respectively. Methicillin-sensitive S. epidermidis (MSSE) isolates harbored more ACME (83.3%) than MRSE isolates (67.7%), and there was no association between ACME and SCCmec types. An association was found between low-level ACME presence and invasive infections. Conclusions/Significance: We observed a high level of diversity within S. epidermidis in this study, with CC2 as the dominant clonal complex in both community and hospital settings. Only 40.8% of the isolates from patients were also found in healthy individuals. Contrary to that biofilm formation and multiple antibiotic resistance were associated closely with pathogenicity of S. epidermidis, ACME was more likely to be an indicator for colonization rather than a virulence factor.	[Du, Xin; Zhu, Yuanjun; Song, Yan; Li, Tianming; Lu, Yuan; Li, Min] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China; [Luo, Tao; Sun, Gang; Yang, Chongguang] Fudan Univ, Key Lab Med Mol Virol, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Luo, Tao; Sun, Gang; Yang, Chongguang] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Cao, Cuiming] Shandong Univ, Jinan Cent Hosp, Dept Lab Med, Jinan 250100, Shandong, Peoples R China	Fudan University; Fudan University; Fudan University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Lu, Y (corresponding author), Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China.	yuanlu@hsh.stn.sh.cn; ruth_limin124@yahoo.com	Du, Xin/ABD-4327-2022; Yang, Chongguang/N-3298-2016; Du, Xin/AAG-4635-2022; Yang, Chongguang/S-9117-2019; , 罗涛/AHA-1191-2022	Du, Xin/0000-0002-6907-3609; Yang, Chongguang/0000-0001-8109-4974; Du, Xin/0000-0002-6907-3609; Yang, Chongguang/0000-0001-8109-4974; 	National Natural Science Foundation of China [30900026, 81171623, 812111033]; Outstanding Young Talent Plan of Shanghai [2011039]; Ming Dao Plan of Fudan University [MDJH2012016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Talent Plan of Shanghai; Ming Dao Plan of Fudan University	This study was supported by a grant from the National Natural Science Foundation of China (grants 30900026, 81171623 and 812111033), Outstanding Young Talent Plan of Shanghai (2011039) and Ming Dao Plan of Fudan University (MDJH2012016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier F, 2011, J ANTIMICROB CHEMOTH, V66, P29, DOI 10.1093/jac/dkq410; Bogado I, 2002, INFECT CONT HOSP EP, V23, P447, DOI 10.1086/502083; Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004; Cuevas O, 2004, ANTIMICROB AGENTS CH, V48, P4240, DOI 10.1128/AAC.48.11.4240-4245.2004; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Ellington MJ, 2008, J ANTIMICROB CHEMOTH, V61, P73, DOI 10.1093/jac/dkm422; Galdbart JO, 1999, J CLIN MICROBIOL, V37, P1306, DOI 10.1128/JCM.37.5.1306-1312.1999; Goering RV, 2007, J CLIN MICROBIOL, V45, P1981, DOI 10.1128/JCM.00273-07; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Granslo HN, 2010, PEDIATR RES, V68, P237, DOI [10.1203/PDR.0b013e3181eb01e0, 10.1203/00006450-201011001-00463]; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jamaluddin TZMT, 2008, J CLIN MICROBIOL, V46, P3778, DOI 10.1128/JCM.02262-07; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kozitskaya S, 2005, J CLIN MICROBIOL, V43, P4751, DOI 10.1128/JCM.43.9.4751-4757.2005; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Li M, 2009, J MED MICROBIOL, V58, P456, DOI 10.1099/jmm.0.007567-0; Maki H, 1997, J BACTERIOL, V179, P6944, DOI 10.1128/jb.179.22.6944-6948.1997; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Miragaia M, 2005, MICROB DRUG RESIST, V11, P83, DOI 10.1089/mdr.2005.11.83; Miragaia M, 2002, J CLIN MICROBIOL, V40, P430, DOI 10.1128/JCM.40.2.430-438.2002; Miragaia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007722; Nikbakht M, 2008, J HOSP INFECT, V69, P46, DOI 10.1016/j.jhin.2008.01.034; Nunes APF, 2005, J HOSP INFECT, V59, P19, DOI 10.1016/j.jhin.2004.07.021; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Iorio NLP, 2012, DIAGN MICR INFEC DIS, V72, P32, DOI 10.1016/j.diagmicrobio.2011.09.017; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Rolo J, 2012, J ANTIMICROB CHEMOTH, V67, P1333, DOI 10.1093/jac/dks068; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Silva FR, 2001, EPIDEMIOL INFECT, V127, P57, DOI 10.1017/S095026880100574X; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Wang L, 2008, J INFECT DIS, V197, P1254, DOI 10.1086/586714; Widerstrom M, 2012, J CLIN MICROBIOL, V50, P2147, DOI 10.1128/JCM.06456-11; Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012	38	65	67	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62742	10.1371/journal.pone.0062742	http://dx.doi.org/10.1371/journal.pone.0062742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675424	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100011
J	Labrique, AB; Zaman, K; Hossain, Z; Saha, P; Yunus, M; Hossain, A; Ticehurst, J; Kmush, B; Nelson, KE				Labrique, Alain B.; Zaman, K.; Hossain, Zahid; Saha, Parimalendu; Yunus, Mohammad; Hossain, Anowar; Ticehurst, John; Kmush, Brittany; Nelson, Kenrad E.			An Exploratory Case Control Study of Risk Factors for Hepatitis E in Rural Bangladesh	PLOS ONE			English	Article							E VIRUS-INFECTION; ACUTE SPORADIC HEPATITIS; WEST KALIMANTAN BORNEO; PHYLOGENETIC ANALYSIS; VIRAL-HEPATITIS; HIGH PREVALENCE; BLOOD-DONORS; SOUTH-INDIA; TRANSMISSION; ANTIBODIES	Hepatitis E virus (HEV) is the major cause of epidemic and sporadic hepatitis globally. Outbreaks are associated with fecal contamination of drinking water, yet the environmental reservoir of HEV between epidemics remains unclear. In contrast to neighboring countries, where epidemics and sporadic disease co-occur, HEV-endemic communities in rural Bangladesh seldom report outbreaks; sporadic hepatitis E is reported from urban and rural areas of the country. Besides typical enteric risk factors, other routes for HEV infection and disease are unclear. We conducted monthly household surveillance of a southern Bangladeshi community of 23,500 people to find incident cases of acute hepatitis E over a 22 month period. An algorithm was used to capture 279 candidate cases, of which 46 were confirmed acute HEV infections. An exploratory case-control study was conducted to identify putative risk factors for disease. Nearly 70% of cases were over 15 years old. Female gender seemed protective (OR: 0.34) against hepatitis E in this conservative setting, as was the use of sanitary latrines (OR: 0.28). Socioeconomic status or animal exposures were not significant predictors of disease, although outdoor employment and recent urban travel were. Unexpectedly, recent contact with a "jaundiced" patient and a history of injection exposure in the 3 months prior to disease (OR: 15.50) were significant. Susceptible individuals from "endemic" communities share similar enteric exposure risks to those commonly associated with tourists from non-endemic countries. This study also raises the novel possibility of parenteral and person-to-person transmission of HEV in non-epidemic, sporadic disease settings.	[Labrique, Alain B.; Kmush, Brittany] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Zaman, K.; Hossain, Zahid; Saha, Parimalendu; Yunus, Mohammad; Hossain, Anowar] Icddr B, Dhaka, Bangladesh; [Ticehurst, John] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Labrique, Alain B.; Nelson, Kenrad E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Labrique, AB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	alabriqu@jhsph.edu	Kmush, Brittany L/O-5329-2019	Kmush, Brittany L/0000-0003-2143-7554; Labrique, Alain/0000-0003-2502-7819; Hossain, Mohammad Zahid/0000-0003-0511-4085; Ticehurst, John/0000-0002-7137-8495; Yunus, Mohammed/0000-0003-1116-4978	National Institutes of Health (NIH) [AI51/31/2004]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was conducted under an R01 grant AI51/31/2004 from the National Institutes of Health (NIH). Additional support was provided in kind (HAV, HBV, HCV, and HEV antibody testing of study specimens) by the Armed Forces Research Institute of Medical Sciences (AFRIMS), a special foreign activity of the Walter Reed Army Institute of Research (WRAIR) in Bangkok, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL R, 1994, J HEPATOL, V21, P718, DOI 10.1016/S0168-8278(94)80229-7; Ahmed M, 2009, INDIAN J MED MICROBI, V27, P48; Arankalle VA, 2001, J VIRAL HEPATITIS, V8, P293, DOI 10.1046/j.1365-2893.2001.00279.x; ARANKALLE VA, 1995, J INFECT DIS, V171, P447, DOI 10.1093/infdis/171.2.447; Arankalle VA, 2001, J VIRAL HEPATITIS, V8, P223, DOI 10.1046/j.1365-2893.2001.00290.x; Arankalle VA, 2003, J MED VIROL, V69, P391, DOI 10.1002/jmv.10301; Arankalle VA, 1999, J VIRAL HEPATITIS, V6, P161, DOI 10.1046/j.1365-2893.1999.00141.x; Arora NK, 1996, J MED VIROL, V48, P215, DOI 10.1002/(SICI)1096-9071(199603)48:3&lt;215::AID-JMV1&gt;3.0.CO;2-B; Baylis SA, 2010, VOX SANG, V98, P479, DOI 10.1111/j.1423-0410.2009.01258.x; Boccia D, 2006, CLIN INFECT DIS, V42, P1679, DOI 10.1086/504322; Chauhan Naresh T, 2010, Indian J Community Med, V35, P294, DOI 10.4103/0970-0218.66864; Clayson ET, 1997, J INFECT DIS, V176, P763, DOI 10.1086/517296; CLAYSON ET, 1995, J INFECT DIS, V172, P927, DOI 10.1093/infdis/172.4.927; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; CORWIN A, 1995, T ROY SOC TROP MED H, V89, P262, DOI 10.1016/0035-9203(95)90529-4; Corwin A, 1997, AM J TROP MED HYG, V57, P62, DOI 10.4269/ajtmh.1997.57.62; Corwin AL, 1996, AM J TROP MED HYG, V54, P559, DOI 10.4269/ajtmh.1996.54.559; Corwin AL, 1999, T ROY SOC TROP MED H, V93, P255, DOI 10.1016/S0035-9203(99)90014-7; Dilawari J B, 1994, Indian J Gastroenterol, V13, P44; Echevarria JM, 2010, J CLIN VIROL; Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384; Faveau V, 1994, MATLAB WOMEN CHILDRE; Guo QS, 2010, J CLIN MICROBIOL, V48, P317, DOI 10.1128/JCM.01466-09; Gupta R S, 1995, J Commun Dis, V27, P175; Hau CH, 1999, AM J TROP MED HYG, V60, P277, DOI 10.4269/ajtmh.1999.60.277; Health and DemographicSurveillance System-Matlab, 2006, REG HLTH DEM EV 2004; Hossain Z, 2006, 8 CAPGAN COMM C DIAR; Innis BL, 2002, CLIN DIAGN LAB IMMUN, V9, P639, DOI 10.1128/CDLI.9.3.639-648.2002; Jameel S, 1999, Expert Rev Mol Med, V1999, P1, DOI 10.1017/S1462399499001271; Khan WI, 2000, ASIAN PAC J ALLERGY, V18, P99; Labrique A, 2007, THESIS J HOPKINS U B; Labrique AB, 1999, EPIDEMIOL REV, V21, P162, DOI 10.1093/oxfordjournals.epirev.a017994; Labrique AB, 2010, EMERG INFECT, V9, P53; Labrique AB, 2010, AM J EPIDEMIOL, V172, P952, DOI 10.1093/aje/kwq225; Labrique AB, 2009, AM J TROP MED HYG, V81, P875, DOI 10.4269/ajtmh.2009.09-0352; LONGER CF, 1994, EPIDEMIOLOGY HEPATIT, P409; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Maine D, 1996, STUD FAMILY PLANN, V27, P179, DOI 10.2307/2137952; Malathi S, 1998, J TROP PEDIATRICS, V44, P275, DOI 10.1093/tropej/44.5.275; Mast EE, 1998, HEPATOLOGY, V27, P857, DOI 10.1002/hep.510270331; Mathur P, 2001, Indian Pediatr, V38, P461; Matlab HDSS, 2009, SR106 MATL HDSS; Matsuda H, 2003, J INFECT DIS, V188, P944, DOI 10.1086/378074; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Myint KSA, 2006, T ROY SOC TROP MED H, V100, P938, DOI 10.1016/j.trstmh.2005.12.005; NAIDU S S, 1957, Indian J Med Res, V45, P71; NANDA SK, 1995, GASTROENTEROLOGY, V108, P225, DOI 10.1016/0016-5085(95)90028-4; Purcell Robert H, 2010, J Infect Dis, V202, P819, DOI 10.1086/655900; Rab MA, 1997, AM J TROP MED HYG, V57, P151, DOI 10.4269/ajtmh.1997.57.151; Seriwatana J, 2002, CLIN DIAGN LAB IMMUN, V9, P1072, DOI 10.1128/CDLI.9.5.1072-1078.2002; Sheikh A, 2002, AM J TROP MED HYG, V66, P721, DOI 10.4269/ajtmh.2002.66.721; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Shukla P, 2007, J VIRAL HEPATITIS, V14, P310, DOI 10.1111/j.1365-2893.2006.00815.x; Siddiqui AR, 2005, CLIN INFECT DIS, V40, P908, DOI 10.1086/428357; Singh Jagvir, 1995, Journal of Communicable Diseases, V27, P92; Somani SK, 2003, J VIRAL HEPATITIS, V10, P446, DOI 10.1046/j.1365-2893.2003.00458.x; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P95, DOI 10.1016/j.trstmh.2004.12.005; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P89, DOI 10.1016/j.trstmh.2005.05.019; Streatfield PK, 2005, HLTH DEMOGRAPHIC SUR; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Teshale EH, 2010, CLIN INFECT DIS, V50, P1006, DOI 10.1086/651077; TICEHURST JR, 1999, MANUAL CLIN MICROBIO, P1057; Toyoda K, 2008, J GASTROEN HEPATOL, V23, P1885, DOI 10.1111/j.1440-1746.2008.05568.x; TSAREV SA, 1994, J MED VIROL, V43, P135, DOI 10.1002/jmv.1890430207; VANGINNIKEN J, 1998, HLTH DEMOGRAPHIC SUR; Wibawa IDN, 2004, J MED VIROL, V73, P38, DOI 10.1002/jmv.20059; Wu JC, 1998, HEPATOLOGY, V27, P1415, DOI 10.1002/hep.510270532; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6; Zijlstra JG, 1997, LANCET, V350, P289, DOI 10.1016/S0140-6736(05)62253-2	69	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e61351	10.1371/journal.pone.0061351	http://dx.doi.org/10.1371/journal.pone.0061351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675410	gold, Green Published, Green Submitted			2022-12-25	WOS:000319036100001
J	Lin, YY; Jean, YH; Lee, HP; Chen, WF; Sun, YM; Su, JH; Lu, Y; Huang, SY; Hung, HC; Sung, PJ; Sheu, JH; Wen, ZH				Lin, Yen-You; Jean, Yen-Hsuan; Lee, Hsin-Pai; Chen, Wu-Fu; Sun, Yu-Min; Su, Jui-Hsin; Lu, Yi; Huang, Shi-Ying; Hung, Han-Chun; Sung, Ping-Jyun; Sheu, Jyh-Horng; Wen, Zhi-Hong			A Soft Coral-Derived Compound, 11-epi-Sinulariolide Acetate Suppresses Inflammatory Response and Bone Destruction in Adjuvant-Induced Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; FIBROBLAST-LIKE SYNOVIOCYTES; RHEUMATOID-ARTHRITIS; CATHEPSIN-K; ANTIINFLAMMATORY CEMBRANOIDS; OSTEOCLAST DIFFERENTIATION; SINULARIA-QUERCIFORMIS; TRANSGENIC MICE; DOWN-REGULATION; JOINT DISEASE	In recent years, a significant number of metabolites with potent anti-inflammatory properties have been discovered from marine organisms, and several of these compounds are now under clinical trials. In the present study, we isolated 11-epi-sinulariolide acetate (Ya-s11), a cembrane-type compound with anti-inflammatory effects, from the Formosa soft coral Sinularia querciformis. Preliminary screening revealed that Ya-s11 significantly inhibited the expression of the proinflammatory proteins induced nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated murine macrophages. We also examined the therapeutic effects of Ya-s11 on adjuvant-induced arthritis (AIA) in female Lewis rats, which demonstrate features similar to human rheumatoid arthritis (RA). Animal experiments revealed that Ya-s11 (subcutaneously 9 mg/kg once every 2 days from day 7 to day 28 postimmunization) significantly inhibited AIA characteristics. Moreover, Ya-s11 also attenuated protein expression of cathepsin K, matrix metalloproteinases-9 (MMP-9), tartrate-resistant acid phosphatase (TRAP), and tumor necrosis factor-alpha (TNF-alpha) in ankle tissues of AIA-rats. Based on its attenuation of the expression of proinflammatory proteins and disease progression in AIA rats, the marine-derived compound Ya-s11 may serve as a useful therapeutic agent for the treatment of RA.	[Lin, Yen-You; Lee, Hsin-Pai; Lu, Yi; Huang, Shi-Ying; Sheu, Jyh-Horng; Wen, Zhi-Hong] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan; [Jean, Yen-Hsuan; Lee, Hsin-Pai] Pingtung Christian Hosp, Sect Orthoped Surg, Pingtung, Taiwan; [Chen, Wu-Fu] Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Dept Neurosurg,Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Sun, Yu-Min; Hung, Han-Chun] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Su, Jui-Hsin; Sung, Ping-Jyun] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan; [Su, Jui-Hsin; Sung, Ping-Jyun] Natl Museum Marine Biol & Aquarium, Taiwan Coral Res Ctr, Pingtung, Taiwan	National Sun Yat Sen University; Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; National Dong Hwa University; National Museum of Marine Biology & Aquarium	Sheu, JH (corresponding author), Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan.	sheu@mail.nsysu.edu.tw; wzh@mail.nsysu.edu.tw	Sung, Ping-Jyun/Z-4162-2019; Hung, Han-Chun/A-9347-2010; Wen, Zhi-Hong/AAG-8034-2019; Sheu, Jyh-Horng/T-9521-2017	Hung, Han-Chun/0000-0002-0013-3247; Sheu, Jyh-Horng/0000-0002-1216-5991; Huang, Shi-Ying/0000-0002-0370-1553	National Science Council, Taiwan [NSC100-2325-B-110-001, NSC99-2313-B110-003-MY03]; Pingtung Christian Hospital, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Pingtung Christian Hospital, Taiwan	This work was supported, in part, by grants from the National Science Council, Taiwan (NSC100-2325-B-110-001 and NSC99-2313-B110-003-MY03), and Pingtung Christian Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2011, J MANAGE CARE PHARM, V17, pS3, DOI 10.18553/jmcp.2011.17.s9-b.S03; Baharav E, 2004, J NUTR, V134, P1964, DOI 10.1093/jn/134.8.1964; Cascao R, 2012, AUTOIMMUN REV, V11, P856, DOI 10.1016/j.autrev.2012.02.022; Chao CH, 2011, MAR DRUGS, V9, P1955, DOI 10.3390/md9101955; Chen WF, 2012, N-S ARCH PHARMACOL, V385, P265, DOI 10.1007/s00210-011-0710-2; Cheng SY, 2010, J NAT PROD, V73, P1184, DOI 10.1021/np100185a; Choi YH, 2012, ARCH PHARM RES, V35, P801, DOI 10.1007/s12272-012-0506-z; Conway JG, 2001, J PHARMACOL EXP THER, V298, P900; Cuzzocrea S, 2005, ARTHRITIS RHEUM-US, V52, P1929, DOI 10.1002/art.21044; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fujita K, 2012, IMMUNOL LETT, V144, P1, DOI 10.1016/j.imlet.2012.02.012; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Hah YS, 2010, ARTHRITIS RHEUM-US, V62, P2313, DOI 10.1002/art.27545; Hamade E, 2012, MED CHEM, V8, P401, DOI 10.2174/1573406411208030401; Hofkens W, 2011, J CONTROL RELEASE, V152, P363, DOI 10.1016/j.jconrel.2011.03.001; Hou WS, 2001, AM J PATHOL, V159, P2167, DOI 10.1016/S0002-9440(10)63068-4; Huang JL, 2011, EUR J PHARMACOL, V670, P304, DOI 10.1016/j.ejphar.2011.07.045; Ishida S, 2009, IMMUNOLOGY, V128, pe315, DOI 10.1111/j.1365-2567.2008.02965.x; Jean YH, 2008, EUR J PHARMACOL, V578, P323, DOI 10.1016/j.ejphar.2007.08.048; Kamel HN, 2005, PHARM BIOL, V43, P253, DOI 10.1080/13880200590928852; Kaneko M, 2001, RHEUMATOLOGY, V40, P247, DOI 10.1093/rheumatology/40.3.247; KASHMAN Y, 1977, ISRAEL J CHEM, V16, P1; Kim KC, 2005, ARCH PHARM RES, V28, P1257, DOI 10.1007/BF02978209; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; Klein LE, 2005, CELL CYCLE, V4, P501, DOI 10.4161/cc.4.3.1550; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu Y, 2008, J NAT PROD, V71, P1754, DOI 10.1021/np8003563; Lu Y, 2011, ARCH PHARM RES, V34, P1263, DOI 10.1007/s12272-011-0804-x; Lu Y, 2010, CHEM PHARM BULL, V58, P464, DOI 10.1248/cpb.58.464; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Morko J, 2005, ARTHRITIS RHEUM-US, V52, P3713, DOI 10.1002/art.21423; Niki Y, 2001, J CLIN INVEST, V107, P1127, DOI 10.1172/JCI11530; Noguchi M, 2005, EUR J PHARMACOL, V513, P229, DOI 10.1016/j.ejphar.2005.01.058; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Ochi Y, 2011, BONE, V49, P1351, DOI 10.1016/j.bone.2011.09.041; Ross MH, 2005, CONNECT TISSUE, P146; SANO H, 1992, J CLIN INVEST, V89, P97, DOI 10.1172/JCI115591; SATO A, 1985, TETRAHEDRON, V41, P4303, DOI 10.1016/S0040-4020(01)97201-1; Scott DL, 2003, CLIN EXP RHEUMATOL, V21, pS20; Shin HS, 2012, BIOSCI BIOTECH BIOCH, V76, P847, DOI 10.1271/bbb.110908; Shiota N, 2010, BRIT J PHARMACOL, V159, P626, DOI 10.1111/j.1476-5381.2009.00561.x; Shiozawa S, 2011, ARCH IMMUNOL THER EX, V59, P89, DOI 10.1007/s00005-011-0116-3; Su JH, 2012, ARCH PHARM RES, V35, P779, DOI 10.1007/s12272-012-0503-2; Su JH, 2011, MAR DRUGS, V9, P944, DOI 10.3390/md9060944; Svelander L, 2009, EUR J PHARMACOL, V613, P155, DOI 10.1016/j.ejphar.2009.03.074; Takahashi D, 2009, ARTHRITIS RHEUM-US, V60, P2372, DOI 10.1002/art.24718; Tow K, 2004, LAB INVEST, V84, P1092, DOI 10.1038/labinvest.3700132; Tsuboi H, 2003, ANN RHEUM DIS, V62, P196, DOI 10.1136/ard.62.3.196; Turull A, 2000, INFLAMMATION, V24, P533, DOI 10.1023/A:1007025423232; Yamashita A, 2002, J IMMUNOL, V168, P450, DOI 10.4049/jimmunol.168.1.450; Yang CR, 2010, SHOCK, V33, P662, DOI 10.1097/SHK.0b013e3181cc0738; YOCUM DE, 1986, ARTHRITIS RHEUM, V29, P262, DOI 10.1002/art.1780290215	54	20	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62926	10.1371/journal.pone.0062926	http://dx.doi.org/10.1371/journal.pone.0062926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675440	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100021
J	Xiao, CL; Chen, XZ; Du, YL; Li, ZF; Wei, L; Zhang, G; He, QY				Xiao, Chuan-Le; Chen, Xiao-Zhou; Du, Yang-Li; Li, Zhe-Fu; Wei, Li; Zhang, Gong; He, Qing-Yu			Dispec: A Novel Peptide Scoring Algorithm Based on Peptide Matching Discriminability	PLOS ONE			English	Article							PROTEIN IDENTIFICATION; TANDEM; PROTEOMICS; DATABASE	Identifying peptides from the fragmentation spectra is a fundamental step in mass spectrometry (MS) data processing. The significance (discriminability) of every peak varies, providing additional information for potentially enhancing the identification sensitivity and the correct match rate. However this important information was not considered in previous algorithms. Here we presented a novel method based on Peptide Matching Discriminability (PMD), in which the PMD information of every peak reflects the discriminability of candidate peptides. In addition, we developed a novel peptide scoring algorithm Dispec based on PMD, by taking three aspects of discriminability into consideration: PMD, intensity discriminability and m/z error discriminability. Compared with Mascot and Sequest, Dispec identified remarkably more peptides from three experimental datasets with the same confidence at 1% PSM-level FDR. Dispec is also robust and versatile for various datasets obtained on different instruments. The concept of discriminability enhances the peptide identification and thus may contribute largely to the proteome studies. As an open-source program, Dispec is freely available at http://bioinformatics.jnu.edu.cn/software/dispec/.	[Xiao, Chuan-Le; Zhang, Gong; He, Qing-Yu] Jinan Univ, Coll Life Sci & Technol, Guangdong Higher Educ Inst, Key Lab Funct Prot Res,Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China; [Chen, Xiao-Zhou; Du, Yang-Li; Wei, Li] Yunnan Univ Nationalities, Sch Math & Comp Sci, Kunming, Peoples R China; [Li, Zhe-Fu] Jinan Univ, Network & Educ Technol Ctr, Guangzhou, Guangdong, Peoples R China	Jinan University; Yunnan Minzu University; Jinan University	Zhang, G (corresponding author), Jinan Univ, Coll Life Sci & Technol, Guangdong Higher Educ Inst, Key Lab Funct Prot Res,Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China.	zhanggong@jnu.edu.cn; tqyhe@jnu.edu.cn	He, Qing-Yu/H-7078-2014; Zhang, Gong/Q-7419-2017	He, Qing-Yu/0000-0003-0503-9492; Zhang, Gong/0000-0003-0418-3433	National "973" Projects of China [2011CB910700]; National Natural Science Foundation of China [31200612, 20871057]; Foundation for Distinguished Young Talents in Higher Education of Guangdong, China [2012LYM_0026]; Fundamental Research Funds for the Central Universities [11610101, 21611201]; Pearl River Rising Star of Science and Technology of Guangzhou City [2011048b]; "211" Projects	National "973" Projects of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Distinguished Young Talents in Higher Education of Guangdong, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Pearl River Rising Star of Science and Technology of Guangzhou City; "211" Projects	This work was collectively supported by National "973" Projects of China (2011CB910700), National Natural Science Foundation of China (31200612 and 20871057), Foundation for Distinguished Young Talents in Higher Education of Guangdong, China (2012LYM_0026), the Fundamental Research Funds for the Central Universities (11610101 and 21611201)?"211" Projects and the Pearl River Rising Star of Science and Technology of Guangzhou City (2011048b). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chi H, 2010, J PROTEOME RES, V9, P2713, DOI 10.1021/pr100182k; Colinge J, 2007, PLOS COMPUT BIOL, V3, P1151, DOI 10.1371/journal.pcbi.0030114; Cox J., 2011, J PROTEOME RES; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dagda Ruben K, 2010, J Proteomics Bioinform, V3, P39; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fu Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000455; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kapp EA, 2005, PROTEOMICS, V5, P3475, DOI 10.1002/pmic.200500126; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Klimek J, 2008, J PROTEOME RES, V7, P96, DOI 10.1021/pr070244j; Li WZ, 2011, J PROTEOME RES, V10, P1593, DOI 10.1021/pr100959y; Matthiesen R, 2007, PROTEOMICS, V7, P2815, DOI 10.1002/pmic.200700116; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ramakrishnan SR, 2009, BIOINFORMATICS, V25, P1397, DOI 10.1093/bioinformatics/btp168; Sun XS, 2011, OMICS, V15, P477, DOI 10.1089/omi.2010.0113; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Xiao CL, 2013, J PROTEOME RES, V12, P328, DOI 10.1021/pr300781t; Yadav AK, 2011, J PROTEOME RES, V10, P2154, DOI 10.1021/pr200031z; Zhang N, 2002, PROTEOMICS, V2, P1406, DOI 10.1002/1615-9861(200210)2:10<1406::AID-PROT1406>3.0.CO;2-9	23	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62724	10.1371/journal.pone.0062724	http://dx.doi.org/10.1371/journal.pone.0062724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675420	Green Published, Green Submitted, gold			2022-12-25	WOS:000319036100009
J	Ederveen, THA; Overmars, L; van Hijum, SAFT				Ederveen, Thomas H. A.; Overmars, Lex; van Hijum, Sacha A. F. T.			Reduce Manual Curation by Combining Gene Predictions from Multiple Annotation Engines, a Case Study of Start Codon Prediction	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; TECHNOLOGIES; RESOURCE; PROGRAMS; SERVER; SET	Nowadays, prokaryotic genomes are sequenced faster than the capacity to manually curate gene annotations. Automated genome annotation engines provide users a straight-forward and complete solution for predicting ORF coordinates and function. For many labs, the use of AGEs is therefore essential to decrease the time necessary for annotating a given prokaryotic genome. However, it is not uncommon for AGEs to provide different and sometimes conflicting predictions. Combining multiple AGEs might allow for more accurate predictions. Here we analyzed the ab initio open reading frame (ORF) calling performance of different AGEs based on curated genome annotations of eight strains from different bacterial species with GC% ranging from 35-52%. We present a case study which demonstrates a novel way of comparative genome annotation, using combinations of AGEs in a pre-defined order (or path) to predict ORF start codons. The order of AGE combinations is from high to low specificity, where the specificity is based on the eight genome annotations. For each AGE combination we are able to derive a so-called projected confidence value, which is the average specificity of ORF start codon prediction based on the eight genomes. The projected confidence enables estimating likeliness of a correct prediction for a particular ORF start codon by a particular AGE combination, pinpointing ORFs notoriously difficult to predict start codons. We correctly predict start codons for 90.5+/-4.8% of the genes in a genome (based on the eight genomes) with an accuracy of 81.1+/-7.6%. Our consensus-path methodology allows a marked improvement over majority voting (9.7+/-4.4%) and with an optimal path ORF start prediction sensitivity is gained while maintaining a high specificity.	[Ederveen, Thomas H. A.; Overmars, Lex; van Hijum, Sacha A. F. T.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Overmars, Lex; van Hijum, Sacha A. F. T.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [van Hijum, Sacha A. F. T.] NIZO Food Res, Kluyver Ctr Genom Ind Fermentat, Ede, Netherlands; [van Hijum, Sacha A. F. T.] Top Inst Food & Nutr, Wageningen, Netherlands	Radboud University Nijmegen; NIZO Food Research; Top Institute Food & Nutrition	van Hijum, SAFT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands.	svhijum@cmbi.ru.nl	van Hijum, Sacha/F-6445-2014; Ederveen, Thomas HA/G-6294-2016	Ederveen, Thomas HA/0000-0003-0068-1275; van Hijum, Sacha/0000-0003-0741-2991	NIZO; TIFN	NIZO; TIFN	Funding for this study for SH's contribution came from both NIZO and TIFN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bocs S, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-5; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chaudhuri RR, 2006, NUCLEIC ACIDS RES, V34, pD335, DOI 10.1093/nar/gkj140; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hemmerich C, 2010, BIOINFORMATICS, V26, P1122, DOI 10.1093/bioinformatics/btq090; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Meyer F, 2009, NUCLEIC ACIDS RES, V37, P6643, DOI 10.1093/nar/gkp698; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Pavlovic V, 2002, BIOINFORMATICS, V18, P19, DOI 10.1093/bioinformatics/18.1.19; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; Richardson EJ, 2013, BRIEF BIOINFORM, V14, P1, DOI 10.1093/bib/bbs007; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Shah SP, 2003, BIOINFORMATICS, V19, P1296, DOI 10.1093/bioinformatics/btg139; Siezen RJ, 2008, APPL ENVIRON MICROB, V74, P424, DOI 10.1128/AEM.01850-07; Siezen RJ, 2012, J BACTERIOL, V194, P195, DOI 10.1128/JB.06275-11; Siezen RJ, 2010, MICROB BIOTECHNOL, V3, P362, DOI 10.1111/j.1751-7915.2010.00191.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Wall ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002284; Yada T, 2003, Pac Symp Biocomput, P375; Yok N, 2010, IEEE ENG MED BIO, P6190, DOI 10.1109/IEMBS.2010.5627744; Yok NG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-20; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093	45	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63523	10.1371/journal.pone.0063523	http://dx.doi.org/10.1371/journal.pone.0063523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675487	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400042
J	Sun, T; Tian, H; Wang, CQ; Yin, P; Zhu, YQ; Chen, XH; Tang, ZD				Sun, Ting; Tian, Hua; Wang, Changqian; Yin, Ping; Zhu, Yaqin; Chen, Xianghua; Tang, Zhengde			A Survey of Congenital Heart Disease and Other Organic Malformations Associated with Different Types of Orofacial Clefts in Eastern China	PLOS ONE			English	Article							BIRTH-DEFECTS; ORAL CLEFTS; PALATE; LIP; ANOMALIES	Background: A high incidence of orofacial clefts is reported in China, but no data has shown the relation between cleft types and the incidence of other defects so far. The aim of this study is to assess the incidence of congenital heart diseases and other organic defects associated with different types of orofacial clefts. Methodology and Principal Findings: All children with orofacial clefts, which were sought out from the Health Information System of Shanghai Ninth People's Hospital between 1st Jan 2009 and 30th Dec 2011, were enrolled in this study. All subjects underwent a thorough examination and grouped by the cleft phenotype. The numbers and types of other organic defects were recorded and analyzed statistically using SPSS 17.0. Of 2180 cases reported as having orofacial clefts, 657 (30.1%) had other congenital abnormalities, which were significantly more common in cleft palate (47.9% (329/687)) than that in cleft lip (10.6% (80/755)) or cleft lip and palate (33.6% (248/738)) (P<0.01). In subgroups, unilateral cleft lip and palate had a statistically higher incidence of associated abnormalities than bilateral cleft lip and palate (P<0.01). The most common malformation was congenital heart disease, which counted 45.1% (296/657) of all malformations. Disorders of the central nervous system (14.3%(94/657)) and Skeletal anomalies (13.1%(86/657)) were also frequently associated. Additionally, the most common defect in heart was atrial septal defect, which was 39.7% (118/296) of all congenital heart diseases. Conclusions and Significance: As the high incidence of heart defects and other organic abnormalities in the children with cleft palate in Eastern China, special attention should be paid to them and echocardiography should be a proposed examination in the evaluation of children with cleft palate before any surgical correction being executed.	[Sun, Ting; Wang, Changqian; Yin, Ping; Zhu, Yaqin; Chen, Xianghua; Tang, Zhengde] Shanghai Jiao Tong Univ, Dept Cardiol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Tian, Hua] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, T (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China.	beibeisun2008@163.com; changqianwang@hotmail.com			Specialized Research Fund for the Doctoral Program of Higher Education of China [20110073120105]; Research Project of Shanghai Municipal Health Bureau [2011169]	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research Project of Shanghai Municipal Health Bureau	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education of China (20110073120105) Research Project of Shanghai Municipal Health Bureau (2011169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altunhan H, 2012, BRIT J ORAL MAX SURG, V50, P541, DOI 10.1016/j.bjoms.2011.08.001; Aqrabawi H E, 2008, East Mediterr Health J, V14, P356; Barbosa MM, 2003, PEDIATR CARDIOL, V24, P369, DOI 10.1007/s00246-002-0335-9; Beriaghi S, 2009, J CLIN PEDIATR DENT, V33, P207, DOI 10.17796/jcpd.33.3.c244761467507721; Dai L, 2010, BIRTH DEFECTS RES A, V88, P41, DOI 10.1002/bdra.20607; Genisca AE, 2009, AM J MED GENET A, V149A, P1149, DOI 10.1002/ajmg.a.32854; Han J, 2006, TOXICOL LETT, V166, P248, DOI 10.1016/j.toxlet.2006.07.308; Liang Chi-Di, 1999, Acta Paediatrica Taiwanica, V40, P414; Luijsterburg AJM, 2011, CLEFT PALATE-CRAN J, V48, P173, DOI 10.1597/08-150; Rittler M, 2008, CLEFT PALATE-CRAN J, V45, P525, DOI 10.1597/06-250.1; Sarkozi Andrea, 2005, BMC Oral Health, V5, P4, DOI 10.1186/1472-6831-5-4; Shafi T, 2003, BRIT J PLAST SURG, V56, P106, DOI 10.1016/S0007-1226(03)00044-4; SHPRINTZEN RJ, 1985, AM J MED GENET, V20, P585, DOI 10.1002/ajmg.1320200404; Slator Rona, 2009, J Fam Health Care, V19, P101; Vallino-Napoli LD, 2006, CLEFT PALATE-CRAN J, V43, P571, DOI 10.1597/05-123; Yang XY, 2009, CHINESE MED J-PEKING, V122, P1128, DOI 10.3760/cma.j.issn.0366-6999.2009.10.002; Yi N. N., 1999, Annals Academy of Medicine Singapore, V28, P655	17	42	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54726	10.1371/journal.pone.0054726	http://dx.doi.org/10.1371/journal.pone.0054726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349958	Green Submitted, gold, Green Published			2022-12-25	WOS:000313943000048
J	Kato, T; Thompson, JR; Park, EY				Kato, Tatsuya; Thompson, James R.; Park, Enoch Y.			Construction of New Ligation-Independent Cloning Vectors for the Expression and Purification of Recombinant Proteins in Silkworms Using BmNPV Bacmid System	PLOS ONE			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; TRIGLYCERIDE TRANSFER PROTEIN; MICROSOMAL TRIGLYCERIDE; ESCHERICHIA-COLI; DISULFIDE-ISOMERASE; MEMBRANE-PROTEINS; COEXPRESSION; COMPLEX; SCALE; SET	A ligation independent cloning (LIC) system has been developed to facilitate the rapid and high-efficiency cloning of genes in a Bombyx mori expression system. This system was confirmed by the expression of human microsomal triglyceride transfer protein (hMTP) fused with EGFP in silkworm larvae and pupae. Moreover, hMTP and human protein disulfide isomerase (hPDI) genes were inserted into two LIC vectors harboring gcLINK sequences and were combined by using the LIC through gcLINK sequences. The constructed vector was incorporated into the Bombyx mori nucleopolyhedrovirus (BmNPV) bacmid, and injected into silkworm larvae. The expressed hMTP-hPDI complex was purified from the fat bodies of silkworm larvae. This LIC vector system was applied to express the E1, E2, and E3 subunits of human alpha-ketoglutarate dehydrogenase (KGDH) in silkworm larvae. The expressed proteins were purified easily from fat bodies using three different affinity chromatography steps. The LIC vectors constructed as described in this report allow for the rapid expression and purification of recombinant proteins or their complexes by using the BmNPV bacmid system.	[Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Biotechnol Lab,Suruga Ku, Shizuoka 4228529, Japan; [Thompson, James R.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; [Park, Enoch Y.] Shizuoka Univ, Grad Sch Sci & Technol, Lab Biotechnol Integrated Biosci Sect, Suruga Ku, Shizuoka, Japan; [Park, Enoch Y.] Shizuoka Univ, Res Inst Green Sci & Technol, Biotechnol Lab, Suruga Ku, Shizuoka, Japan	Shizuoka University; Mayo Clinic; Shizuoka University; Shizuoka University	Park, EY (corresponding author), Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Biotechnol Lab,Suruga Ku, Shizuoka 4228529, Japan.	acypark@ipc.shizuoka.ac.jp	Park, Enoch/AAU-2614-2020; Kato, Tatsuya/E-3095-2010	Kato, Tatsuya/0000-0001-7990-2557; Park, Enoch Y./0000-0002-7840-1424	Japan Society for the Promotion of Science (JSPS), Japan; Promotion of Nanobio-technology Research to support aging and welfare society from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Promotion of Nanobio-technology Research to support aging and welfare society from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported partly by Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from Japan Society for the Promotion of Science (JSPS), Japan, and funded partly by Promotion of Nanobio-technology Research to support aging and welfare society from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 2004, MOL CELL PROTEOMICS, V3, P934, DOI 10.1074/mcp.T400008-MCP200; Alzari PM, 2006, ACTA CRYSTALLOGR D, V62, P1103, DOI 10.1107/S0907444906029775; Aoki T, 1996, FEBS LETT, V384, P193, DOI 10.1016/0014-5793(96)00289-X; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1114, DOI 10.1107/S0907444906029805; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bardoczy V, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-32; Cabrita LD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-12; Chanda PK, 2006, PROTEIN EXPRES PURIF, V47, P217, DOI 10.1016/j.pep.2005.10.019; Du DN, 2009, MOL BIOTECHNOL, V43, P154, DOI 10.1007/s12033-009-9183-7; HAUN RS, 1992, GENE, V112, P37, DOI 10.1016/0378-1119(92)90300-E; Hsu TA, 1997, BIOTECHNOL PROGR, V13, P96, DOI 10.1021/bp960088d; Huo J, 2010, PROTEIN EXPRES PURIF, V72, P95, DOI 10.1016/j.pep.2010.01.014; Lamberg A, 1996, BIOCHEM J, V315, P533, DOI 10.1042/bj3150533; Lee J, 2009, PROTEIN EXPRES PURIF, V63, P58, DOI 10.1016/j.pep.2008.09.005; Li M, 2009, J MOL BIOL, V385, P820, DOI 10.1016/j.jmb.2008.11.021; McLain AL, 2011, FREE RADICAL RES, V45, P29, DOI 10.3109/10715762.2010.534163; Motohashi T, 2005, BIOCHEM BIOPH RES CO, V326, P564, DOI 10.1016/j.bbrc.2004.11.060; Qin HJ, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-51; Ritchie PJ, 1999, BIOCHEM J, V338, P305, DOI 10.1042/0264-6021:3380305; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Shi QL, 2011, J BIOL CHEM, V286, P17640, DOI 10.1074/jbc.M110.203018; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; WETTERAU JR, 1985, CHEM PHYS LIPIDS, V38, P205, DOI 10.1016/0009-3084(85)90068-4; Zhou YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022224	26	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e64007	10.1371/journal.pone.0064007	http://dx.doi.org/10.1371/journal.pone.0064007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675518	Green Published, Green Submitted, gold			2022-12-25	WOS:000318852400059
J	Lee, YA; Kim, YH; Kim, BJ; Kim, BG; Kim, KJ; Auh, JH; Schmidt, JA; Ryu, BY				Lee, Yong-An; Kim, Yong-Hee; Kim, Bang-Jin; Kim, Byung-Gak; Kim, Ki-Jung; Auh, Joong-Hyuck; Schmidt, Jonathan A.; Ryu, Buom-Yong			Cryopreservation in Trehalose Preserves Functional Capacity of Murine Spermatogonial Stem Cells	PLOS ONE			English	Article							FLOW-CYTOMETRIC DETECTION; MOUSE TESTES; GERM-CELLS; PHOSPHATIDYLSERINE EXPRESSION; HEMATOPOIETIC-CELLS; TESTICULAR TISSUE; CANCER-TREATMENT; A SPERMATOGONIA; SELF-RENEWAL; ANNEXIN-V	Development of techniques to isolate, culture, and transplant human spermatogonial stem cells (SSCs) has the future potential to treat male infertility. To maximize the efficiency of these techniques, methods for SSC cryopreservation need to be developed to bank SSCs for extended periods of time. Although, it has been demonstrated that SSCs can reinitiate spermatogenesis after freezing, optimal cryopreservation protocols that maximize SSC proliferative capacity post-thaw have not been identified. The objective of this study was to develop an efficient cryopreservation technique for preservation of SSCs. To identify efficient cryopreservation methods for long-term preservation of SSCs, isolated testis cells enriched for SSCs were placed in medium containing dimethyl sulfoxide (DMSO) or DMSO and trehalose (50 mM, 100 mM, or 200 mM), and frozen in liquid nitrogen for 1 week, 1 month, or 3 months. Freezing in 50 mM trehalose resulted in significantly higher cell viability compared to DMSO at all thawing times and a higher proliferation rate compared to DMSO for the 1 week freezing period. Freezing in 200 mM trehalose did not result in increased cell viability; however, proliferation activity was significantly higher and percentage of apoptotic cells was significantly lower compared to DMSO after freezing for 1 and 3 months. To confirm the functionality of SSCs frozen in 200 mM trehalose, SSC transplantation was performed. Donor SSCs formed spermatogenic colonies and sperm capable of generating normal progeny. Collectively, these results indicate that freezing in DMSO with 200 mM trehalose serves as an efficient method for the cryopreservation of SSCs.	[Lee, Yong-An; Kim, Yong-Hee; Kim, Bang-Jin; Kim, Byung-Gak; Kim, Ki-Jung; Ryu, Buom-Yong] Chung Ang Univ, Dept Anim Sci & Technol, Ansung, Gyeonggi Do, South Korea; [Auh, Joong-Hyuck] Chung Ang Univ, Dept Food Sci & Technol, Ansung, Gyeonggi Do, South Korea; [Schmidt, Jonathan A.] Spokane Community Coll, Dept Sci, Spokane, WA USA	Chung Ang University; Chung Ang University	Ryu, BY (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Ansung, Gyeonggi Do, South Korea.	byryu@cau.ac.kr	Auh, Joong Hyuck/ABG-9137-2021	Auh, Joong Hyuck/0000-0001-9425-2599; Park, Chankyu/0000-0003-4855-2210; Lee, Yong-An/0000-0001-7253-2397	Next-Generation BioGreen 21 Program [PJ0080482012]; Rural Development Administration, a National Research Foundation of Korea; Ministry of Education, Science and Technology [2012-0006786]	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, a National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work has been supported by the Next-Generation BioGreen 21 Program (No.PJ0080482012) and Rural Development Administration, a National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (2012-0006786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagla EME, 2003, BIOL REPROD, V69, P1245, DOI 10.1095/biolreprod.103.017889; Araki Y, 2010, BIOL REPROD, V83, P951, DOI 10.1095/biolreprod.109.082800; Avarbock MR, 1996, NAT MED, V2, P693, DOI 10.1038/nm0696-693; Brook PF, 2001, FERTIL STERIL, V75, P269, DOI 10.1016/S0015-0282(00)01721-0; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; De Rooij DG, 2000, J ANDROL, V21, P776; De Rooij DG, 1992, ANN NY ACAD SCI, V364, P140; Dirami G, 1999, BIOL REPROD, V61, P225, DOI 10.1095/biolreprod61.1.225; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; Erdag G, 2002, CRYOBIOLOGY, V44, P218, DOI 10.1016/S0011-2240(02)00023-8; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Eroglu A, 2001, CRYOBIOLOGY, V43, P320; Ewing L L, 1980, Int Rev Physiol, V22, P41; FOSSA SD, 1989, BRIT J UROL, V64, P524, DOI 10.1111/j.1464-410X.1989.tb05292.x; Frederickx V, 2004, HUM REPROD, V19, P948, DOI 10.1093/humrep/deh154; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Izadyar F, 2002, J ANDROL, V23, P537; Ji L, 2004, BIOTECHNOL BIOENG, V88, P299, DOI 10.1002/bit.20243; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2003, HUM REPROD, V18, P2660, DOI 10.1093/humrep/deg483; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Keros V, 2007, HUM REPROD, V22, P1384, DOI 10.1093/humrep/del508; Kim BG, 2010, BIOL REPROD, V82, P1162, DOI 10.1095/biolreprod.109.079558; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lass A, 2001, HUM REPROD UPDATE, V7, P370, DOI 10.1093/humupd/7.4.370; Limaye LS, 2001, J HEMATOTH STEM CELL, V10, P709, DOI 10.1089/152581601753193931; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MAZUR P, 1988, ANN NY ACAD SCI, V541, P514, DOI 10.1111/j.1749-6632.1988.tb22288.x; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagano M, 2002, FERTIL STERIL, V78, P1225, DOI 10.1016/S0015-0282(02)04345-5; Nagano M, 2001, BIOL REPROD, V64, P1409, DOI 10.1095/biolreprod64.5.1409; Ogawa T, 2004, ARCH HISTOL CYTOL, V67, P297, DOI 10.1679/aohc.67.297; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Royere D, 1996, HUM REPROD UPDATE, V2, P553, DOI 10.1093/humupd/2.6.553; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Sasnoor LM, 2005, TRANSPLANTATION, V80, P1251, DOI 10.1097/01.tp.0000169028.01327.90; Schlatt S, 2002, HUM REPROD, V17, P55, DOI 10.1093/humrep/17.1.55; Schmidt JA, 2011, BIOL REPROD, V84, P698, DOI 10.1095/biolreprod.110.088229; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; vanPelt AMM, 1996, BIOL REPROD, V55, P439, DOI 10.1095/biolreprod55.2.439; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wu X, 2012, HUM REPROD, V27, P1249, DOI 10.1093/humrep/des077	54	73	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54889	10.1371/journal.pone.0054889	http://dx.doi.org/10.1371/journal.pone.0054889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23675467	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100108
J	Chen, XH; Yang, GX; Song, JH; Xu, H; Li, D; Goldsmith, J; Zeng, HY; Parsons-Wingerter, PA; Reinecker, HC; Kelly, CP				Chen, Xinhua; Yang, Guoxun; Song, Joo-Hye; Xu, Hua; Li, Dan; Goldsmith, Jeffrey; Zeng, Huiyan; Parsons-Wingerter, Patricia A.; Reinecker, Hans-Christian; Kelly, Ciaran P.			Probiotic Yeast Inhibits VEGFR Signaling and Angiogenesis in Intestinal Inflammation	PLOS ONE			English	Article							DIFFICILE TOXIN-A; ANTIBIOTIC-ASSOCIATED DIARRHEA; ENDOTHELIAL GROWTH-FACTOR; SACCHAROMYCES-BOULARDII; BOWEL-DISEASE; ULCERATIVE-COLITIS; CHOLERA-TOXIN; PATHOGENESIS; PREVENTION; CELLS	Background and Aims: Saccharomyces boulardii (Sb) can protect against intestinal injury and tumor formation, but how this probiotic yeast controls protective mucosal host responses is unclear. Angiogenesis is an integral process of inflammatory responses in inflammatory bowel diseases (IBD) and required for mucosal remodeling during restitution. The aim of this study was to determine whether Sb alters VEGFR (vascular endothelial growth factor receptor) signaling, a central regulator of angiogenesis. Methods: HUVEC were used to examine the effects of Sb on signaling and on capillary tube formation (using the ECMatrix (TM) system). The effects of Sb on VEGF-mediated angiogenesis were examined in vivo using an adenovirus expressing VEGF-A(164) in the ears of adult nude mice (NuNu). The effects of Sb on blood vessel volume branching and density in DSS-induced colitis was quantified using VESsel GENeration (VESGEN) software. Results: 1) Sb treatment attenuated weight-loss (p<0.01) and histological damage (p<0.01) in DSS colitis. VESGEN analysis of angiogenesis showed significantly increased blood vessel density and volume in DSS-treated mice compared to control. Sb treatment significantly reduced the neo-vascularization associated with acute DSS colitis and accelerated mucosal recovery restoration of the lamina propria capillary network to a normal morphology. 2) Sb inhibited VEGF-induced angiogenesis in vivo in the mouse ear model. 3) Sb also significantly inhibited angiogenesis in vitro in the capillary tube assay in a dose-dependent manner (p<0.01). 4) In HUVEC, Sb reduced basal VEGFR-2 phosphorylation, VEGFR-2 phosphorylation in response to VEGF as well as activation of the downstream kinases PLC gamma and Erk1/2. Conclusions: Our findings indicate that the probiotic yeast S boulardii can modulate angiogenesis to limit intestinal inflammation and promote mucosal tissue repair by regulating VEGFR signaling.	[Chen, Xinhua; Yang, Guoxun; Xu, Hua; Li, Dan; Kelly, Ciaran P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA; [Song, Joo-Hye; Reinecker, Hans-Christian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA USA; [Goldsmith, Jeffrey] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol & Lab Med, Boston, MA 02215 USA; [Zeng, Huiyan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Mol & Vasc Med, Boston, MA 02215 USA; [Parsons-Wingerter, Patricia A.] John Glenn NASA Res Ctr, Cleveland, OH USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Aeronautics & Space Administration (NASA)	Chen, XH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA.	xchen1@bidmc.harvard.edu			NIH [PO1 DK 33506, DK-068181, DK-043351, AI-093588]; Crohn's & Colitis Foundation of America; Global Probiotic Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, R01DK068181, P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America; Global Probiotic Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants PO1 DK 33506 (CPK, HCR), DK-068181, DK-043351 and AI-093588 (HCR), Crohn's & Colitis Foundation of America (Research Fellowship and Career Development Award, XC) and Global Probiotic Council (Young Investigator Award, XC). NASA and PPW have filed a United States patent application for the VESGEN software. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandao RL, 1998, APPL ENVIRON MICROB, V64, P564; BUTS JP, 1990, DIGEST DIS SCI, V35, P251, DOI 10.1007/BF01536771; Castagliuolo I, 1999, INFECT IMMUN, V67, P302, DOI 10.1128/IAI.67.1.302-307.1999; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Chen XH, 2008, THERAPEUTIC MICROBIOLOGY: PROBIOTICS AND RELATED STRATEGIES, P51; Chen XH, 2009, GASTROENTEROLOGY, V137, P914, DOI 10.1053/j.gastro.2009.05.050; Chidlow JH, 2007, AM J PHYSIOL-GASTR L, V293, pG5, DOI 10.1152/ajpgi.00107.2007; Chidlow JH, 2006, AM J PATHOL, V169, P2014, DOI 10.2353/ajpath.2006.051021; Czerucka D, 2002, MICROBES INFECT, V4, P733, DOI 10.1016/S1286-4579(02)01592-7; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; Danese S, 2008, PATHOBIOLOGY, V75, P22, DOI 10.1159/000113791; Danese S, 2007, GUT, V56, P855, DOI 10.1136/gut.2006.114314; DIAS RS, 1995, BRAZ J MED BIOL RES, V28, P323; DOUGHERVERMAZEN M, 1994, BIOCHEM BIOPH RES CO, V205, P728, DOI 10.1006/bbrc.1994.2726; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Guslandi M, 2000, DIGEST DIS SCI, V45, P1462, DOI 10.1023/A:1005588911207; Guslandi M, 2003, EUR J GASTROEN HEPAT, V15, P697, DOI 10.1097/00042737-200306000-00017; Guslandi M, 2011, J CLIN GASTROENTEROL, V45, P475, DOI 10.1097/MCG.0b013e318207f584; Guslandi M, 2010, J CLIN GASTROENTEROL, V44, P385, DOI 10.1097/MCG.0b013e3181cb4233; Hatoum OA, 2005, INFLAMM BOWEL DIS, V11, P304, DOI 10.1097/01.MIB.0000160772.78951.61; Im E, 2009, AM J PHYSIOL-GASTR L, V297, pG999, DOI 10.1152/ajpgi.00204.2009; Kanazawa S, 2001, AM J GASTROENTEROL, V96, P822; Kapsoritakis A, 2003, INT J COLORECTAL DIS, V18, P418, DOI 10.1007/s00384-003-0495-y; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; McFarland LV, 2006, AM J GASTROENTEROL, V101, P812, DOI 10.1111/j.1572-0241.2006.00465.x; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913; McFarland Lynne V, 2007, Travel Med Infect Dis, V5, P97, DOI 10.1016/j.tmaid.2005.10.003; Mumy KL, 2008, AM J PHYSIOL-GASTR L, V294, pG599, DOI 10.1152/ajpgi.00391.2007; Nagy JA, 2008, METHOD ENZYMOL, V444, P43, DOI 10.1016/S0076-6879(08)02803-6; Papa A, 2008, DIGEST DIS, V26, P149, DOI 10.1159/000116773; Parsons-Wingerter P, INVEST OPHTHALMOL VI, V51, P498; POTHOULAKIS C, 1993, GASTROENTEROLOGY, V104, P1108, DOI 10.1016/0016-5085(93)90280-P; Qamar A, 2001, INFECT IMMUN, V69, P2762, DOI 10.1128/IAI.69.4.2762-2765.2001; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rodrigues ACP, 2000, J APPL MICROBIOL, V89, P404, DOI 10.1046/j.1365-2672.2000.01128.x; Rodrigues ACP, 1996, J APPL BACTERIOL, V81, P251, DOI 10.1111/j.1365-2672.1996.tb04325.x; Sandor Z, 2006, BIOCHEM BIOPH RES CO, V350, P147, DOI 10.1016/j.bbrc.2006.09.021; Scaldaferri F, 2009, GASTROENTEROLOGY, V136, P585, DOI 10.1053/j.gastro.2008.09.064; Sitohy B, CANC RES, V72, P1909; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Sullivan A, 2002, INT J ANTIMICROB AG, V20, P313, DOI 10.1016/S0924-8579(02)00199-1; SURAWICZ CM, 1989, GASTROENTEROLOGY, V96, P981, DOI 10.1016/0016-5085(89)91613-2; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; Tsiolakidou G, 2008, DIGEST LIVER DIS, V40, P673, DOI 10.1016/j.dld.2008.02.010; Vickerman MB, 2009, ANAT REC, V292, P320, DOI 10.1002/ar.20862	48	56	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e64227	10.1371/journal.pone.0064227	http://dx.doi.org/10.1371/journal.pone.0064227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23826208	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100060
J	Liu, JY				Liu, J. Y.			Status of Marine Biodiversity of the China Seas	PLOS ONE			English	Review								China's seas cover nearly 5 million square kilometers extending from the tropical to the temperate climate zones and bordering on 32,000 km of coastline, including islands. Comprehensive systematic study of the marine biodiversity within this region began in the early 1950s with the establishment of the Qingdao Marine Biological Laboratory of the Chinese Academy of Sciences. Since that time scientists have carried out intensive multidisciplinary research on marine life in the China seas and have recorded 22,629 species belonging to 46 phyla. The marine flora and fauna of the China seas are characterized by high biodiversity, including tropical and subtropical elements of the Indo-West Pacific warm-water fauna in the South and East China seas, and temperate elements of North Pacific temperate fauna mainly in the Yellow Sea. The southern South China Sea fauna is characterized by typical tropical elements paralleled with the Philippine-New Guinea-Indonesia Coral triangle typical tropical faunal center. This paper summarizes advances in studies of marine biodiversity in China's seas and discusses current research mainly on characteristics and changes in marine biodiversity, including the monitoring, assessment, and conservation of endangered species and particularly the strengthening of effective management. Studies of (1) a tidal flat in a semi-enclosed embayment, (2) the impact of global climate change on a cold-water ecosystem, (3) coral reefs of Hainan Island and Xisha-Nansha atolls, (4) mangrove forests of the South China Sea, (5) a threatened seagrass field, and (6) an example of stock enhancement practices of the Chinese shrimp fishery are briefly introduced. Besides the overexploitation of living resources (more than 12.4 million tons yielded in 2007), the major threat to the biodiversity of the China seas is environmental deterioration (pollution, coastal construction), particularly in the brackish waters of estuarine environments, which are characterized by high productivity and represent spawning and nursery areas for several economically important species. In the long term, climate change is also a major threat. Finally, challenges in marine biodiversity studies are briefly discussed along with suggestions to strengthen the field. Since 2004, China has participated in the Census of Marine Life, through which advances in the study of zooplankton and zoobenthos biodiversity were finally summarized.	Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Liu, JY (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	pmilos@usb.ve		Pedrosa Domellof, Fatima/0000-0002-0648-4996	External Cooperation Program of the Chinese Academy of Sciences [GJHZ200808]; Main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences [KZCX2-YW-417, KSCX2-EW-Z-5]; Special funds for science infrastructure of the Ministry of Science and Technology of the People's Republic of China [2006FY110500-4]; Alfred P. Sloan Foundation	External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Special funds for science infrastructure of the Ministry of Science and Technology of the People's Republic of China; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Dr. Liu received funding for this study from the following organizations: The External Cooperation Program of the Chinese Academy of Sciences (GJHZ200808); Main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences (KZCX2-YW-417), (KSCX2-EW-Z-5); Special funds for science infrastructure of the Ministry of Science and Technology of the People's Republic of China (2006FY110500-4); and The Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, DIVERSITY SPECIES XI; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Bureau of Fisheries Ministry of Agriculture of China, 2007, CHIN FISH STAT YB; Bureau of Fisheries Ministry of Agriculture of China, 2009, CHIN FISH STAT YB; Chen Q, 2003, LATIN CHINESE NAMES; Cheng J, 2003, LIVING RESOURCES OCE; Department of Marine Geology Institute of Oceanology Chinese Academy of Sciences, 1982, GEOL YELL E CHIN SEA; Fang J, 1996, MAR FISH RES, V17, P95; FUJIAN Marine Environment and Fishery Resources Monitor Center, 2010, MAR BIOD SURV REP QU; Guan BX, 2006, J OCEANOGR, V62, P1, DOI 10.1007/s10872-006-0028-8; Gurjanova E. F., 1958, Bull Inst mar Biol Peking, V1, P1; Huang X, 2007, STUDY SEAGRASS S CHI; HUANG Z, 1994, MARINE SPECIES THEIR; Huang Z. G, 2004, BIODIVERSITY MARINE; Jia X, 2004, FISHERY ECOLOGICAL E; Jin X, 2005, LIVING RESOURCES HAB; Lee YC, 1998, YELLOW SEA ATLAS; Li G, 2004, MARINE ECOLOGY; Li J. J., 2011, J ZHEJIANG OCEAN U N, V30, P381; Liao K., 1999, NATL PHYS ATLAS CHIN; Lin AK, 2008, SATELLITE REMOTE SEN; LIN P, 1999, MANGROVE ECOSYSTEM C; Liu R, 1983, P INT S SED CONT SHE; Liu R, 1991, P 2 INT S MAR SCI YE, P240; Liu R, 2006, J MARINE SCI BIOTECH, V1, P40; Liu R, 1998, P EUR AS WORKSH INV, P351; Liu R. Y., 1963, OCEANOLOGIA LIMNOLOG, V5, P306; Liu R.Y., 1992, ECOLOGY LIVING RESOU, P2; Liu RuiYu, 2011, Biodiversity Science, V19, P614, DOI 10.3724/SP.J.1003.2011.13185; Liu Ruiyu, 2007, P103; Liu RY, 2008, CHECKLIST MARINE BIO; Ng PKL, 2000, RAFFLES B ZOOL, P3; Ning X, 2002, RES EVALUATION AQUAC; Qi Y, 2003, RED TIDES CHINESE CO; SHAW PT, 1994, DEEP-SEA RES PT I, V41, P1663, DOI 10.1016/0967-0637(94)90067-1; Song Haitang, 2003, ACTA OCEANOLOGICA S, V1, P8; Song Haitang, 2006, EC SHRIMP CRAB SPECI, P1; Sun S, 2007, P WORKSH BIOD MARG S, P97; Tang Q, 2006, MARINE BIOL RESOURCE; Ushakov PV, 1955, VESTN AN SSSR+, V56, P14; WANG S., 2005, CHINA SPECIES RED LI, VIII; Wang S, 2009, CHINA SPECIES RED A, V2; Wang S, 1999, CHINA RED DATA BOOK; Wang S, 2009, CHINA SPECIES RED B, V2; Wang S, 2004, CHINA SPECIES RED LI, VI; Wang WQ, 2007, MANGROVES CHINA; WANG Y, 1987, CONT SHELF RES, V7, P329, DOI 10.1016/0278-4343(87)90104-X; Wang Y. S. J., 2012, OCEANOGRAPHY CHINA; Xu G.Z., 1989, ENV RESOURCES DAYA B; Yu Cun-gen, 2009, Marine Fisheries, V31, P27; Yue P. Q., 1998, CHINA RED DATA BOOK; Zhang S., 2007, ECOLOGICAL ENV BIORE; Zheng Q.N., 2006, J GEOPHYS RES OCEANS, V111; Zheng T, 1982, GEOLOGY HUANGHAI DON, P198; Zheng Y., 2003, BIOL RESOURCES ENV E; Zhong Zhenru, 1986, MARINE FIEHERIES, V3, P99; ZHOU D, 1994, OCEANOLOGY CHINA SEA; Zhou M, 2012, OCEANOGRAPHY CHINA; Zhou MJ, 2008, CONT SHELF RES, V28, P1483, DOI 10.1016/j.csr.2007.02.009; Zhuang Q, 1984, STUDIA MARINA SINICA, V22, P79; Zhuang Q., 1981, OCEANOLOGIA LIMNOLOG, V12, P341; Zou R, 1966, OCEANOLOGIA LIMNOLOG, V2, P153; Zuo T., 2003, COMMUNITY STRUCTURE	63	232	256	29	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e50719	10.1371/journal.pone.0050719	http://dx.doi.org/10.1371/journal.pone.0050719			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23675523	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800005
J	Jiang, FS; Li, WP; Huang, YF; Chen, YT; Jin, B; Chen, NP; Ding, ZS; Ding, XH				Jiang, Fusheng; Li, Weiping; Huang, Yanfen; Chen, Yitao; Jin, Bo; Chen, Nipi; Ding, Zhishan; Ding, Xinghong			Antioxidant, Antityrosinase and Antitumor Activity Comparison: The Potential Utilization of Fibrous Root Part of Bletilla striata (Thunb.) Reichb.f.	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; TYROSINASES; PREVENTION; EXTRACTS; SEQUENCE; ORCHIDS; AGENTS; PLANT	This study was carried out to evaluate the utilization probability of the fibrous root part (FRP) of Bletilla striata, which was usually discarded and harvesting pseudobulb part (PSP). The chemical composition, total phenolic content, DPPH radical scavenging activity, Ferric-reducing antioxidant power and tyrosinase inhibition activity were compared between FRP and PSP. Antioxidant and pro-oxidant effect as well as antitumor effect of the extract of FRP and PSP were analyzed by in vitro cell system as well. Thin layer chromatography and high performance liquid chromatography analysis indicated that the chemical compositions in the two parts were similar, but the content in FRP was much higher than PSP. Meanwhile, the FRP extracts showed higher phenolic content, stronger DPPH scavenging activity, Ferric-reducing antioxidant capacity and tyrosinase inhibition activity. Sub-fraction analysis revealed that the distribution characteristic of phenolic components and other active constituents in FRP and PSP were consistent, and mainly deposited in chloroform and acetoacetate fractions. Especially, the chloroform sub-fraction (sch) of FRP showed extraordinary DPPH scavenging activity and tyrosinase inhibition activity, with IC50 0.848 mg/L and 4.3 mg/L, respectively. Besides, tyrosinase inhibition activity was even stronger than the positive compound arbutin (31.8 mg/L). Moreover, In vitro cell system analysis confirmed that FRP extract exerts comparable activity with PSP, especially, the sub-fraction sch of FRP showed better antioxidant activity at low dosage and stronger per-oxidant activity at high dosage, and both sch of FRP and PSP can dose-dependent induce HepG2 cells apoptosis, which implied tumor therapeutic effect. Considering that an additional 0.3 kg FRP would be obtained when producing 1.0 kg PSP, our work demonstrated that FRP is very potential to be used together with PSP.	[Jiang, Fusheng; Huang, Yanfen; Chen, Yitao; Jin, Bo; Chen, Nipi; Ding, Zhishan] Zhejiang Chinese Med Univ, Inst Biotechnol, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Li, Weiping] Zhejiang Chinese Med Univ, Dept Med Chem, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Ding, Xinghong] Zhejiang Chinese Med Univ, Anal & Testing Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Ding, XH (corresponding author), Zhejiang Chinese Med Univ, Anal & Testing Ctr, Hangzhou, Zhejiang, Peoples R China.	xinghongding@163.com	黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022; Sinnaeve, Davy/F-2293-2013; Rokni-Zadeh, Hassan/B-8098-2008	Madder, Annemieke/0000-0003-0179-7608; Sinnaeve, Davy/0000-0003-2556-5895; Rokni-Zadeh, Hassan/0000-0001-5503-0344; Dai, Haibin/0000-0002-5768-2714; Martins, Jose/0000-0001-7350-2253; De Vleeschouwer, Matthias/0000-0001-6889-1928; Rozenski, Jef/0000-0001-9624-5536	Public Welfare Technology Research Projects of Zhejiang Province [2011C22047]; New-Shoot Talented Man Plan Project of Zhejiang Province [2010R4100581/4CE2011R4100191/4CE2012R410038]	Public Welfare Technology Research Projects of Zhejiang Province; New-Shoot Talented Man Plan Project of Zhejiang Province	This research was supported by the Public Welfare Technology Research Projects of Zhejiang Province (No. 2011C22047, http://www.zjkjt.gov.cn/) and New-Shoot Talented Man Plan Project of Zhejiang Province (No. 2010R4100581/4CE2011R4100191/4CE2012R410038, http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Canadanovic-Brunet JM, 2009, INT J FOOD SCI TECH, V44, P269, DOI 10.1111/j.1365-2621.2007.01680.x; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; Ding ZS, 2008, MOLECULES, V13, P220, DOI 10.3390/molecules13020220; Duan XW, 2007, MOLECULES, V12, P759, DOI 10.3390/12040759; Gan RY, 2010, J MED PLANTS RES, V4, P2438; Kaji H, 2009, J CLIN PHARM THER, V34, P197, DOI 10.1111/j.1365-2710.2008.00993.x; Kong JM, 2003, ACTA PHARMACOL SIN, V24, P7; Lei TC, 1999, CHINESE TRADITIONAL, V30, P336; Liang QY, 2006, J GUANGXI MED U, V23, P36; Lin SQ, 1994, THESIS NATL CHENG KU; Luo Y, 2010, J BIOMED MATER RES A, V94A, P193, DOI 10.1002/jbm.a.32711; Maisuthisakul P, 2009, FOOD CHEM, V117, P332, DOI 10.1016/j.foodchem.2009.04.010; Mao XL, 2011, CENTRAL S PHARM, V9, P604; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; Marxen K, 2007, SENSORS-BASEL, V7, P2080, DOI 10.3390/s7102080; Morita H, 2005, BIOORG MED CHEM LETT, V15, P1051, DOI 10.1016/j.bmcl.2004.12.026; Pasciu V, 2010, TOXICOL SCI, V114, P101, DOI 10.1093/toxsci/kfp301; Gutierrez RMP, 2010, J MED PLANTS RES, V4, P592; PONNAZHAGAN S, 1994, J INVEST DERMATOL, V102, P744, DOI 10.1111/1523-1747.ep12376924; [黄海云 Rui Haiyun], 2003, [南京师大学报. 自然科学版, Journal of Nanjing Normal University. Natural Science], V26, P94; Shi J, 2009, THESIS HAINAN U HAIN; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Smit N, 2009, INT J MOL SCI, V10, P5326, DOI 10.3390/ijms10125326; Sun DF, 2006, CHINESE WILD PLANT R, V25, P34; Sun F, 2007, J DALIAN I LIGHT IND, V26, P97; TAKAGI S, 1983, PHYTOCHEMISTRY, V22, P1011, DOI 10.1016/0031-9422(83)85044-4; VanGelder CWG, 1997, PHYTOCHEMISTRY, V45, P1309, DOI 10.1016/S0031-9422(97)00186-6; VIDENSEK N, 1990, J NAT PROD, V53, P1609, DOI 10.1021/np50072a039; Wang CM, 2006, BIOTECHNOL LETT, V28, P539, DOI 10.1007/s10529-006-0011-x; Wazir D, 2011, J PLANT BIOCHEM BIOT, V20, P234, DOI 10.1007/s13562-011-0051-8; Wojdylo A, 2007, FOOD CHEM, V105, P940, DOI 10.1016/j.foodchem.2007.04.038; Yang Y, 2009, ASIA PACIFIC TRADITI, V5, P23; Zhang HH, 2010, FREE RADICAL BIO MED, V49, P2010, DOI 10.1016/j.freeradbiomed.2010.09.031; Zhu JY, 2011, THESIS FUJIAN U TRAD	35	73	82	6	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58004	10.1371/journal.pone.0058004	http://dx.doi.org/10.1371/journal.pone.0058004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	24098758	Green Published, Green Submitted, gold			2022-12-25	WOS:000315524900220
J	Zhu, X; Silva, LCR; Doane, TA; Horwath, WR				Zhu, Xia; Silva, Lucas C. R.; Doane, Timothy A.; Horwath, William R.			Iron: The Forgotten Driver of Nitrous Oxide Production in Agricultural Soil	PLOS ONE			English	Article							SPECTROPHOTOMETRIC DETERMINATION; WETLAND SOILS; NO EMISSIONS; FERROUS IRON; OXIDATION; REDUCTION; N2O; NITRATE; MICROORGANISMS; HYDROXYLAMINE	In response to rising interest over the years, many experiments and several models have been devised to understand emission of nitrous oxide (N2O) from agricultural soils. Notably absent from almost all of this discussion is iron, even though its role in both chemical and biochemical reactions that generate N2O was recognized well before research on N2O emission began to accelerate. We revisited iron by exploring its importance alongside other soil properties commonly believed to control N2O production in agricultural systems. A set of soils from California's main agricultural regions was used to observe N2O emission under conditions representative of typical field scenarios. Results of multivariate analysis showed that in five of the twelve different conditions studied, iron ranked higher than any other intrinsic soil property in explaining observed emissions across soils. Upcoming studies stand to gain valuable information by considering iron among the drivers of N2O emission, expanding the current framework to include coupling between biotic and abiotic reactions.	[Zhu, Xia] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Zhu, Xia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhu, Xia; Silva, Lucas C. R.; Doane, Timothy A.; Horwath, William R.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis	Doane, TA (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	tadoane@ucdavis.edu	Zhu-Barker, Xia/F-1520-2015; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022; Silva, Lucas/AAA-2476-2022; Feng, Yingang/B-6304-2008	Zhu-Barker, Xia/0000-0001-9050-3696; Silva, Lucas C R/0000-0002-4838-327X; Silva, Lucas/0000-0002-4838-327X; zhu, xinshu/0000-0002-2238-539X; He, Zhili/0000-0001-8225-7333; Feng, Yingang/0000-0002-0879-1316	California Department of Resources Recycling and Recovery [IWM09027]; J. G. Boswell Endowed Chair in Soil Science; University of California Agricultural Experiment Station	California Department of Resources Recycling and Recovery; J. G. Boswell Endowed Chair in Soil Science; University of California Agricultural Experiment Station(University of California System)	Support was provided by the California Department of Resources Recycling and Recovery (www.calrecycle.ca.gov), Agreement IWM09027; the J. G. Boswell Endowed Chair in Soil Science; and the University of California Agricultural Experiment Station (http://caes.ucdavis.edu/research/agexpstn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson G, 2002, J CHEM SOC DALTON, P2548, DOI 10.1039/b201602h; BOUWMAN AF, 1993, GLOBAL BIOGEOCHEM CY, V7, P557, DOI 10.1029/93GB01186; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI [10.1029/2001GB001811, 10.1029/2001GB001812]; BREMNER JM, 1946, NATURE, V158, P790, DOI 10.1038/158790b0; Bremner JM, 1997, NUTR CYCL AGROECOSYS, V49, P7, DOI 10.1023/A:1009798022569; BREMNER JM, 1980, SOIL BIOL BIOCHEM, V12, P263, DOI 10.1016/0038-0717(80)90072-3; BURESH RJ, 1976, J ENVIRON QUAL, V5, P320, DOI 10.2134/jeq1976.00472425000500030021x; Burger M, 2011, ACS SYM SER, V1072, P179; Burt R, 1992, 42 USDA; CASSEL DK, 1986, AGRONOMY, V9, P901; Chalamet A, 1976, SOIL BIOL BIOCHEM, V9, P281; CHAO TT, 1966, SOIL SCI SOC AM PRO, V30, P193, DOI 10.2136/sssaj1966.03615995003000020016x; Clement JC, 2005, SOIL BIOL BIOCHEM, V37, P2323, DOI 10.1016/j.soilbio.2005.03.027; Davidson EA, 2000, BIOSCIENCE, V50, P667, DOI 10.1641/0006-3568(2000)050[0667:TACMOS]2.0.CO;2; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Dobbie KE, 1999, J GEOPHYS RES-ATMOS, V104, P26891, DOI 10.1029/1999JD900378; Dominik P, 2000, TALANTA, V51, P701, DOI 10.1016/S0039-9140(99)00324-0; EICHNER MJ, 1990, J ENVIRON QUAL, V19, P272, DOI 10.2134/jeq1990.00472425001900020013x; Finzi AC, 2011, FRONT ECOL ENVIRON, V9, P74, DOI 10.1890/100137; Freibauer A, 2003, BIOGEOCHEMISTRY, V63, P93, DOI 10.1023/A:1023398108860; Freney JR, 1997, NUTR CYCL AGROECOSYS, V49, P1, DOI 10.1023/A:1009702832489; Glass JB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00061; Goetz O., 2010, HDB PARTIAL LEAST SQ, P411, DOI [10.1007/978-3-540-32827-8_33, DOI 10.1007/978-3-540-32827-8]; HANSEN HCB, 1994, GEOCHIM COSMOCHIM AC, V58, P2599, DOI 10.1016/0016-7037(94)90131-7; HENDRICKSON AH, 1945, PLANT PHYSIOL, V20, P517, DOI 10.1104/pp.20.4.517; Li CS, 2000, J GEOPHYS RES-ATMOS, V105, P4369, DOI 10.1029/1999JD900949; LOVELAND PJ, 1984, J SOIL SCI, V35, P243, DOI 10.1111/j.1365-2389.1984.tb00280.x; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; Marcoulides GA, 2009, MIS QUART, V33, P171; MEIKLEJOHN J, 1953, J GEN MICROBIOL, V8, P58, DOI 10.1099/00221287-8-1-58; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; ROBERTSON K, 1994, J ENVIRON QUAL, V23, P805, DOI 10.2134/jeq1994.00472425002300040027x; Sahrawat K. L., 1986, Advances in Soil Science, USA, V4, P103; SCHUPPLI PA, 1983, SOIL SCI SOC AM J, V47, P1026, DOI 10.2136/sssaj1983.03615995004700050037x; Shrestha J, 2009, SOIL SCI, V174, P156, DOI 10.1097/SS.0b013e3181988fbf; Silver WL, 2011, IRON REDOX ENGINE DR; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Skiba U., 2000, CHEMOSPHERE GLOBAL C, V2, P379, DOI DOI 10.1016/S1465-9972(00)00016-7; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Straub KL, 1996, APPL ENVIRON MICROB, V62, P1458, DOI 10.1128/AEM.62.4.1458-1460.1996; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Thomson AJ, 2012, PHILOS T R SOC B, V367, P1157, DOI 10.1098/rstb.2011.0415; Veihmeyer FJ, 1931, SOIL SCI, V32, P181, DOI 10.1097/00010694-193109000-00003; VERDOUW H, 1978, WATER RES, V12, P399, DOI 10.1016/0043-1354(78)90107-0; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Williams EJ, 1992, GLOBAL BIOGEOCHEM CY, V6, P351, DOI 10.1029/92GB02124	46	194	208	28	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60146	10.1371/journal.pone.0060146	http://dx.doi.org/10.1371/journal.pone.0060146			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555906	Green Published, gold, Green Submitted			2022-12-25	WOS:000317263900060
J	Zhu, XY; Li, P; Yang, YB; Liu, ML				Zhu, Xin-Yuan; Li, Pei; Yang, Ya-Bing; Liu, Mei-Lin			Xuezhikang, Extract of Red Yeast Rice, Improved Abnormal Hemorheology, Suppressed Caveolin-1 and Increased eNOS Expression in Atherosclerotic Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BLOOD-CELLS; HEART-DISEASE; ERYTHROCYTES; VISCOSITY; AORTA; DEFORMABILITY; PATHOGENESIS; ACTIVATION; PATHWAY	Background: Xuezhikang is the extract of red yeast rice, which has been widely used for the management of atherosclerotic disease, but the molecular basis of its antiatherosclerotic effects has not yet been fully identified. Here we investigated the changes of eNOS in vascular endothelia and RBCs, eNOS regulatory factor Caveolin-1 in endothelia, and hemorheological parameters in atherosclerotic rats to explore the protective effects of Xuezhikang. Methodology/Principal Findings: Wistar rats were divided into 4 groups (n = 12/group) group C, controls; group M, high-cholesterol diet (HCD) induced atherosclerotic models; group X, HCD+Xuezhikang; and group L, HCD+Lovastatin. In group X, Xuezhikang inhibited oxidative stress, down-regulated caveolin-1 in aorta wall (P<0.05), up-regulated eNOS expression in vascular endothelia and erythrocytes (P<0.05), increased NOx (nitrite and nitrate) in plasma and cGMP in erythrocyte plasma and aorta wall (P<0.05), increased erythrocyte deformation index (EDI), and decreased whole blood viscosity and plasma viscosity (P<0.05), with the improvement of arterial pathology. Conclusions/Significance: Xuezhikang up-regulated eNOS expression in vascular endothelia and RBCs, increased plasma NOx and improved abnormal hemorheology in high cholesterol diet induced atherosclerotic rats. The elevated eNOS/NO and improved hemorheology may be beneficial to atherosclerotic disease.	[Zhu, Xin-Yuan; Li, Pei; Yang, Ya-Bing; Liu, Mei-Lin] Peking Univ, Dept Geriatr, Hosp 1, Beijing 100871, Peoples R China	Peking University	Liu, ML (corresponding author), Peking Univ, Dept Geriatr, Hosp 1, Beijing 100871, Peoples R China.	meilinliu@yahoo.com	Zhu-Barker, Xia/F-1520-2015; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022; Silva, Lucas/AAA-2476-2022; Feng, Yingang/B-6304-2008	Zhu-Barker, Xia/0000-0001-9050-3696; Silva, Lucas C R/0000-0002-4838-327X; Silva, Lucas/0000-0002-4838-327X; zhu, xinshu/0000-0002-2238-539X; He, Zhili/0000-0001-8225-7333; Feng, Yingang/0000-0002-0879-1316	China Health & Medical Development Foundation	China Health & Medical Development Foundation	This work was supported by China Health & Medical Development Foundation (http://www.chmdf.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almofti MR, 2006, CLIN EXP PHARMACOL P, V33, P305, DOI 10.1111/j.1440-1681.2006.04366.x; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; Chen LY, 1998, J CARDIOVASC PHARM, V32, P57, DOI 10.1097/00005344-199807000-00009; Cokic VP, 2008, BLOOD, V111, P1117, DOI 10.1182/blood-2007-05-088732; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engel D, 2011, FASEB J, V25, P3838, DOI 10.1096/fj.11-183350; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Gori T, 2011, CLIN HEMORHEOL MICRO, V49, P37, DOI 10.3233/CH-2011-1455; HAHN R, 1989, ANGIOLOGY, V40, P914, DOI 10.1177/000331978904001010; Herold S, 2004, INORG CHEM, V43, P3783, DOI 10.1021/ic035340a; Heyman SN, 1999, MICROCIRCULATION, V6, P199; Horn P, 2011, FREE RADICAL RES, V45, P653, DOI 10.3109/10715762.2011.574288; Huang ZY, 2004, LIFE SCI, V75, P3103, DOI 10.1016/j.lfs.2004.04.054; JORIS I, 1983, AM J PATHOL, V113, P341; Jubelin BC, 1996, AM J HYPERTENS, V9, P1214, DOI 10.1016/S0895-7061(96)00257-9; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Koenig W, 1998, ARTERIOSCL THROM VAS, V18, P768, DOI 10.1161/01.ATV.18.5.768; Korbut RA, 2002, J PHYSIOL PHARMACOL, V53, P655; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Kuwai T, 2006, J ATHEROSCLER THROMB, V13, P286, DOI 10.5551/jat.13.286; Lam TY, 2006, EUR J PHARMACOL, V546, P134, DOI 10.1016/j.ejphar.2006.07.003; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee AJ, 1998, CIRCULATION, V97, P1467; Lee BK, 2008, CLIN HEMORHEOL MICRO, V39, P43, DOI 10.3233/CH-2008-1066; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Li JJ, 2005, CLIN CHIM ACTA, V352, P217, DOI 10.1016/j.cccn.2004.09.026; Lu ZL, 2008, AM J CARDIOL, V101, P1689, DOI 10.1016/j.amjcard.2008.02.056; Ma JY, 2000, J AGR FOOD CHEM, V48, P5220, DOI 10.1021/jf000338c; MONCADA S, 1991, PHARMACOL REV, V43, P109; Ozuyaman B, 2008, TRENDS MOL MED, V14, P314, DOI 10.1016/j.molmed.2008.05.002; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Rassaf T, 2003, NAT MED, V9, P481, DOI 10.1038/nm0503-481; Recchia FA, 2000, AM J PHYSIOL-HEART C, V279, pH852, DOI 10.1152/ajpheart.2000.279.2.H852; Toda N, 2011, INT J ANGIOL, V20, P121, DOI 10.1055/s-0031-1283220; Tsuda K, 2000, BIOCHEM BIOPH RES CO, V275, P946, DOI 10.1006/bbrc.2000.3408; Xue ZH, 2007, CLIN EXP PHARMACOL P, V34, P27, DOI 10.1111/j.1440-1681.2007.04547.x; Zorio E, 2008, CLIN HEMORHEOL MICRO, V39, P33, DOI 10.3233/CH-2008-1065	40	194	208	28	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62731	10.1371/journal.pone.0062731	http://dx.doi.org/10.1371/journal.pone.0062731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23555906	Green Submitted, gold, Green Published			2022-12-25	WOS:000318852400008
